Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",-0.8521987790554194,-2.048875302182094,0.0,0.0,0.0,61/102,9.87%,RPS13;RPS4X;RPL28;RPS27A;RPS8;RPL38;RPS21;RPL31;RPL37A;RPS14;RPL12;RPLP1;RPL3;RPL23A;RPL39;RPL32;RPS11;RPL5;RPS15;RPS12;RPS25;RPS23;RPS27;RPS20;RPL29;RPLP2;RPL19;RPS24;RPL13A;RPL41;RPL7A;RPL35;RPL37;RPS18;RPL10;RPL10A;RPL11;RPS3;RPL23;RPS3A;RPL4;RPS26;RPL30;RPL36;RPL24;RPL14;RPL18A;RPS6;RPS2;RPS7;RPL34;RPL15;PNRC2;RPL21;RPS5;EIF4A3;RPL27A;RPL6;RPL27;RPL18;NCBP2
prerank,Reactome_2022__Selenocysteine Synthesis R-HSA-2408557,-0.8575905874707553,-2.0387366114212453,0.0,0.0,0.0,56/79,9.60%,RPS13;RPS4X;RPL28;RPS27A;RPS8;RPL38;RPS21;RPL31;RPL37A;RPS14;RPL12;RPLP1;RPL3;RPL23A;RPL39;RPL32;RPS11;RPL5;RPS15;RPS12;RPS25;RPS23;RPS27;FAU;RPS20;RPL29;RPLP2;RPL19;RPS24;RPL13A;RPL41;RPL7A;RPL35;RPL37;RPL10A;RPL11;RPS3;RPL23;RPS3A;RPL4;RPL30;RPL36AL;RPL36;RPL14;RPL18A;RPS6;RPS2;RPS7;RPL34;RPL15;RPL21;RPS5;RPL27A;RPL6;RPL27;RPL18
prerank,GO_Biological_Process_2021__cytoplasmic translation (GO:0002181),-0.8514037296000116,-2.0290727984754535,0.0,0.0,0.0,58/84,9.60%,RPS13;RPS4X;RPL28;RPS27A;RPS8;RPL38;RPS21;RPL31;RPL37A;RPS14;RPL12;RPLP1;RPL3;RPL23A;RPL39;RPL32;RPS11;RPL5;RPS15;RPS12;RPS25;RPS23;RPS27;RPS20;RPL29;RPL19;RPS24;RPL13A;RPL41;RPL7A;RPL35;RPL37;RPS18;RPL10;RPL10A;RPL11;RPS3;RPL23;TMA7;RPS3A;RPL4;RPS26;RPL30;RPL36;RPL24;RPL14;RPL18A;RPS6;RPS2;RPS7;RPL34;RPL15;RPL21;RPS5;RPL27A;RPL6;RPL27;RPL18
prerank,Reactome_2022__Nonsense Mediated Decay (NMD) Enhanced By Exon Junction Complex (EJC) R-HSA-975957,-0.8490326716284318,-2.0173401219321714,0.0,0.0,0.0,59/99,9.87%,RPS13;RPS4X;RPL28;RPS27A;RPS8;RPL38;RPS21;RPL31;RPL37A;RPS14;RPL12;RPLP1;RPL3;RPL23A;RPL39;RPL32;RPS11;RPL5;RPS15;RPS12;RPS25;RPS23;RPS27;FAU;RPS20;RPL29;RPLP2;RPL19;RPS24;RPL13A;RPL41;RPL7A;RPL35;RPL37;RPL10A;RPL11;RPS3;RPL23;RPS3A;RPL4;RPL30;RPL36AL;RPL36;RPL14;RPL18A;RPS6;RPS2;RPS7;RPL34;RPL15;PNRC2;RPL21;RPS5;EIF4A3;RPL27A;RPL6;RPL27;RPL18;NCBP2
prerank,GO_Biological_Process_2021__SRP-dependent cotranslational protein targeting to membrane (GO:0006614),-0.8607490484488086,-2.0135820388982535,0.0,0.0,0.0,59/84,9.60%,RPS13;RPS4X;RPL28;RPS27A;RPS8;RPL38;RPS21;RPL31;RPL37A;RPS14;RPL12;RPLP1;RPL3;RPL23A;RPL39;RPL32;RPS11;RPL5;RPS15;RPS12;RPS25;RPS23;RPS27;SRP14;RPS20;RPL29;RPLP2;RPL19;RPS24;RPL13A;RPL41;RPL7A;RPL35;RPL37;RPS18;RPL10;RPL10A;RPL11;RPS3;RPL23;RPS3A;RPL4;RPS26;RPL30;RPL36;RPL24;RPL14;RPL18A;RPS6;RPS2;RPS7;RPL34;RPL15;RPL21;RPS5;RPL27A;RPL6;RPL27;RPL18
prerank,Reactome_2022__Eukaryotic Translation Termination R-HSA-72764,-0.8579833145832717,-1.9896110866447698,0.0,0.0,0.0,56/77,9.60%,RPS13;RPS4X;RPL28;RPS27A;RPS8;RPL38;RPS21;RPL31;RPL37A;RPS14;RPL12;RPLP1;RPL3;RPL23A;RPL39;RPL32;RPS11;RPL5;RPS15;RPS12;RPS25;RPS23;RPS27;FAU;RPS20;RPL29;RPLP2;RPL19;RPS24;RPL13A;RPL41;RPL7A;RPL35;RPL37;RPL10A;RPL11;RPS3;RPL23;RPS3A;RPL4;RPL30;RPL36AL;RPL36;RPL14;RPL18A;RPS6;RPS2;RPS7;RPL34;RPL15;RPL21;RPS5;RPL27A;RPL6;RPL27;RPL18
prerank,Reactome_2022__Peptide Chain Elongation R-HSA-156902,-0.8562500199206953,-1.9865602985749162,0.0,0.0,0.0,56/76,9.60%,RPS13;RPS4X;RPL28;RPS27A;RPS8;RPL38;RPS21;RPL31;RPL37A;RPS14;RPL12;RPLP1;RPL3;RPL23A;RPL39;RPL32;RPS11;RPL5;RPS15;RPS12;RPS25;RPS23;RPS27;FAU;RPS20;RPL29;RPLP2;RPL19;RPS24;RPL13A;RPL41;RPL7A;RPL35;RPL37;RPL10A;RPL11;RPS3;RPL23;RPS3A;RPL4;RPL30;RPL36AL;RPL36;RPL14;RPL18A;RPS6;RPS2;RPS7;RPL34;RPL15;RPL21;RPS5;RPL27A;RPL6;RPL27;RPL18
prerank,KEGG_2021_Human__Ribosome,-0.8238700928566329,-1.9859039437553432,0.0,0.0,0.0,70/106,12.11%,RPS13;RPS4X;RPL36A-HNRNPH2;RPL28;RPS27A;RPS8;RPL38;RPS21;RPL31;RPL37A;RPS14;RPL12;RPLP1;RPL3;RPL23A;RPL39;RPL32;RPS11;RPL5;RPS15;RPS12;RPS25;RPS23;RPS27;FAU;RPS20;RPL29;RPLP2;RPL19;RPS24;RPL13A;RPL41;RPL7A;RPL35;RPL37;RPS18;RPL10;RPL10A;RPL11;RPS3;RPL23;RPS3A;RPL4;RPS26;RPL30;RPL36AL;MRPS7;RPL36;RPL24;RPL14;RPL18A;RPS6;RPS2;RPS7;RPL34;RPL15;MRPL19;RPL21;RPS5;RPL27A;RPL6;RPL27;RPL18;RPLP0;RPS9;MRPS11;MRPS10;MRPS15;MRPL16;MRPL32
prerank,GO_Biological_Process_2021__cotranslational protein targeting to membrane (GO:0006613),-0.8536435050347304,-1.9837027023813634,0.0,0.0,0.0,59/87,9.60%,RPS13;RPS4X;RPL28;RPS27A;RPS8;RPL38;RPS21;RPL31;RPL37A;RPS14;RPL12;RPLP1;RPL3;RPL23A;RPL39;RPL32;RPS11;RPL5;RPS15;RPS12;RPS25;RPS23;RPS27;SRP14;RPS20;RPL29;RPLP2;RPL19;RPS24;RPL13A;RPL41;RPL7A;RPL35;RPL37;RPS18;RPL10;RPL10A;RPL11;RPS3;RPL23;RPS3A;RPL4;RPS26;RPL30;RPL36;RPL24;RPL14;RPL18A;RPS6;RPS2;RPS7;RPL34;RPL15;RPL21;RPS5;RPL27A;RPL6;RPL27;RPL18
prerank,Reactome_2022__Response Of EIF2AK4 (GCN2) To Amino Acid Deficiency R-HSA-9633012,-0.8373278694761269,-1.9782688654124967,0.0,0.0,0.0,56/86,9.60%,RPS13;RPS4X;RPL28;RPS27A;RPS8;RPL38;RPS21;RPL31;RPL37A;RPS14;RPL12;RPLP1;RPL3;RPL23A;RPL39;RPL32;RPS11;RPL5;RPS15;RPS12;RPS25;RPS23;RPS27;FAU;RPS20;RPL29;RPLP2;RPL19;RPS24;RPL13A;RPL41;RPL7A;RPL35;RPL37;RPL10A;RPL11;RPS3;RPL23;RPS3A;RPL4;RPL30;RPL36AL;RPL36;RPL14;RPL18A;RPS6;RPS2;RPS7;RPL34;RPL15;RPL21;RPS5;RPL27A;RPL6;RPL27;RPL18
prerank,Reactome_2022__Viral mRNA Translation R-HSA-192823,-0.855820525642591,-1.97745599605324,0.0,0.0,0.0,56/78,9.60%,RPS13;RPS4X;RPL28;RPS27A;RPS8;RPL38;RPS21;RPL31;RPL37A;RPS14;RPL12;RPLP1;RPL3;RPL23A;RPL39;RPL32;RPS11;RPL5;RPS15;RPS12;RPS25;RPS23;RPS27;FAU;RPS20;RPL29;RPLP2;RPL19;RPS24;RPL13A;RPL41;RPL7A;RPL35;RPL37;RPL10A;RPL11;RPS3;RPL23;RPS3A;RPL4;RPL30;RPL36AL;RPL36;RPL14;RPL18A;RPS6;RPS2;RPS7;RPL34;RPL15;RPL21;RPS5;RPL27A;RPL6;RPL27;RPL18
prerank,GO_Biological_Process_2021__protein targeting to ER (GO:0045047),-0.8428719524279192,-1.9740704914414282,0.0,0.0,0.0,59/95,9.60%,RPS13;RPS4X;RPL28;RPS27A;RPS8;RPL38;RPS21;RPL31;RPL37A;RPS14;RPL12;RPLP1;RPL3;RPL23A;RPL39;RPL32;RPS11;RPL5;RPS15;RPS12;RPS25;RPS23;RPS27;SRP14;RPS20;RPL29;RPLP2;RPL19;RPS24;RPL13A;RPL41;RPL7A;RPL35;RPL37;RPS18;RPL10;RPL10A;RPL11;RPS3;RPL23;RPS3A;RPL4;RPS26;RPL30;RPL36;RPL24;RPL14;RPL18A;RPS6;RPS2;RPS7;RPL34;RPL15;RPL21;RPS5;RPL27A;RPL6;RPL27;RPL18
prerank,Reactome_2022__SRP-dependent Cotranslational Protein Targeting To Membrane R-HSA-1799339,-0.8354711698380591,-1.9723189865448263,0.0,0.0,0.0,57/98,9.60%,RPS13;RPS4X;RPL28;RPS27A;RPS8;RPL38;RPS21;RPL31;RPL37A;RPS14;RPL12;RPLP1;RPL3;RPL23A;RPL39;RPL32;RPS11;RPL5;RPS15;RPS12;RPS25;RPS23;RPS27;FAU;SRP14;RPS20;RPL29;RPLP2;RPL19;RPS24;RPL13A;RPL41;RPL7A;RPL35;RPL37;RPL10A;RPL11;RPS3;RPL23;RPS3A;RPL4;RPL30;RPL36AL;RPL36;RPL14;RPL18A;RPS6;RPS2;RPS7;RPL34;RPL15;RPL21;RPS5;RPL27A;RPL6;RPL27;RPL18
prerank,Reactome_2022__Nonsense Mediated Decay (NMD) Independent Of Exon Junction Complex (EJC) R-HSA-975956,-0.8559774635761804,-1.9721525201595729,0.0,0.0,0.0,57/81,9.87%,RPS13;RPS4X;RPL28;RPS27A;RPS8;RPL38;RPS21;RPL31;RPL37A;RPS14;RPL12;RPLP1;RPL3;RPL23A;RPL39;RPL32;RPS11;RPL5;RPS15;RPS12;RPS25;RPS23;RPS27;FAU;RPS20;RPL29;RPLP2;RPL19;RPS24;RPL13A;RPL41;RPL7A;RPL35;RPL37;RPL10A;RPL11;RPS3;RPL23;RPS3A;RPL4;RPL30;RPL36AL;RPL36;RPL14;RPL18A;RPS6;RPS2;RPS7;RPL34;RPL15;RPL21;RPS5;RPL27A;RPL6;RPL27;RPL18;NCBP2
prerank,Reactome_2022__Eukaryotic Translation Elongation R-HSA-156842,-0.8470545848261611,-1.965721723474499,0.0,0.0,0.0,56/79,9.60%,RPS13;RPS4X;RPL28;RPS27A;RPS8;RPL38;RPS21;RPL31;RPL37A;RPS14;RPL12;RPLP1;RPL3;RPL23A;RPL39;RPL32;RPS11;RPL5;RPS15;RPS12;RPS25;RPS23;RPS27;FAU;RPS20;RPL29;RPLP2;RPL19;RPS24;RPL13A;RPL41;RPL7A;RPL35;RPL37;RPL10A;RPL11;RPS3;RPL23;RPS3A;RPL4;RPL30;RPL36AL;RPL36;RPL14;RPL18A;RPS6;RPS2;RPS7;RPL34;RPL15;RPL21;RPS5;RPL27A;RPL6;RPL27;RPL18
prerank,Reactome_2022__Cap-dependent Translation Initiation R-HSA-72737,-0.822774609504955,-1.9645107981539904,0.0,0.0,0.0,60/104,11.15%,RPS13;RPS4X;RPL28;RPS27A;RPS8;RPL38;RPS21;RPL31;RPL37A;RPS14;RPL12;RPLP1;RPL3;RPL23A;RPL39;RPL32;RPS11;RPL5;RPS15;RPS12;RPS25;RPS23;RPS27;FAU;RPS20;RPL29;RPLP2;EIF2B1;RPL19;RPS24;RPL13A;RPL41;RPL7A;RPL35;RPL37;RPL10A;RPL11;RPS3;RPL23;RPS3A;RPL4;RPL30;RPL36AL;RPL36;RPL14;RPL18A;RPS6;RPS2;RPS7;RPL34;RPL15;RPL21;RPS5;RPL27A;RPL6;RPL27;RPL18;EIF3K;RPLP0;RPS9
prerank,Reactome_2022__GTP Hydrolysis And Joining Of 60S Ribosomal Subunit R-HSA-72706,-0.8255242702862887,-1.9602108713364979,0.0,0.0,0.0,59/97,11.15%,RPS13;RPS4X;RPL28;RPS27A;RPS8;RPL38;RPS21;RPL31;RPL37A;RPS14;RPL12;RPLP1;RPL3;RPL23A;RPL39;RPL32;RPS11;RPL5;RPS15;RPS12;RPS25;RPS23;RPS27;FAU;RPS20;RPL29;RPLP2;RPL19;RPS24;RPL13A;RPL41;RPL7A;RPL35;RPL37;RPL10A;RPL11;RPS3;RPL23;RPS3A;RPL4;RPL30;RPL36AL;RPL36;RPL14;RPL18A;RPS6;RPS2;RPS7;RPL34;RPL15;RPL21;RPS5;RPL27A;RPL6;RPL27;RPL18;EIF3K;RPLP0;RPS9
prerank,Reactome_2022__Formation Of A Pool Of Free 40S Subunits R-HSA-72689,-0.8409335909093261,-1.9590218969724726,0.0,0.0,0.0,59/87,11.15%,RPS13;RPS4X;RPL28;RPS27A;RPS8;RPL38;RPS21;RPL31;RPL37A;RPS14;RPL12;RPLP1;RPL3;RPL23A;RPL39;RPL32;RPS11;RPL5;RPS15;RPS12;RPS25;RPS23;RPS27;FAU;RPS20;RPL29;RPLP2;RPL19;RPS24;RPL13A;RPL41;RPL7A;RPL35;RPL37;RPL10A;RPL11;RPS3;RPL23;RPS3A;RPL4;RPL30;RPL36AL;RPL36;RPL14;RPL18A;RPS6;RPS2;RPS7;RPL34;RPL15;RPL21;RPS5;RPL27A;RPL6;RPL27;RPL18;EIF3K;RPLP0;RPS9
prerank,Reactome_2022__L13a-mediated Translational Silencing Of Ceruloplasmin Expression R-HSA-156827,-0.8281461833715067,-1.947468358439387,0.0,0.0,0.0,59/96,11.15%,RPS13;RPS4X;RPL28;RPS27A;RPS8;RPL38;RPS21;RPL31;RPL37A;RPS14;RPL12;RPLP1;RPL3;RPL23A;RPL39;RPL32;RPS11;RPL5;RPS15;RPS12;RPS25;RPS23;RPS27;FAU;RPS20;RPL29;RPLP2;RPL19;RPS24;RPL13A;RPL41;RPL7A;RPL35;RPL37;RPL10A;RPL11;RPS3;RPL23;RPS3A;RPL4;RPL30;RPL36AL;RPL36;RPL14;RPL18A;RPS6;RPS2;RPS7;RPL34;RPL15;RPL21;RPS5;RPL27A;RPL6;RPL27;RPL18;EIF3K;RPLP0;RPS9
prerank,Reactome_2022__Selenoamino Acid Metabolism R-HSA-2408522,-0.8039837618580125,-1.9442381521886272,0.0,0.0,0.0,60/95,11.32%,RPS13;RPS4X;RPL28;RPS27A;RPS8;RPL38;RPS21;RPL31;RPL37A;RPS14;RPL12;RPLP1;RPL3;RPL23A;RPL39;RPL32;RPS11;RPL5;RPS15;RPS12;RPS25;RPS23;RPS27;FAU;RPS20;RPL29;RPLP2;RPL19;RPS24;RPL13A;RPL41;RPL7A;RPL35;RPL37;RPL10A;RPL11;RPS3;RPL23;RPS3A;RPL4;RPL30;RPL36AL;RPL36;RPL14;RPL18A;RPS6;RPS2;RPS7;RPL34;RPL15;RPL21;RPS5;RPL27A;RPL6;RPL27;RPL18;LARS1;RPLP0;RPS9;KARS1
prerank,PanglaoDB_Augmented_2021__T Cells,-0.8592439501978547,-1.9357828204761383,0.0,0.0,0.0,30/85,5.75%,CCL4;ITK;GNLY;JAML;NKG7;SKAP1;THEMIS;CCL3;MYO1G;CD96;CD2;CXCR4;CCL5;JUNB;PYHIN1;IL7R;CD69;GRAP2;IFIT3;PSTPIP1;SELL;RORA;GZMB;PRF1;CD247;SLAMF6;SNX20;LSP1;IL10RA;TXK
prerank,CellMarker_Augmented_2021__CD8+ Regulatory T cell:Undefined,-0.8939597608680695,-1.9343827650954029,0.0,0.0,0.0,21/52,4.22%,CCL4;ITK;GNLY;JAML;NKG7;THEMIS;MYO1G;CD96;CD2;CCL5;SCML4;PYHIN1;GPR183;IKZF3;PSTPIP1;SELL;GZMB;PRF1;CD247;SLAMF6;SNX20
prerank,GO_Biological_Process_2021__peptide biosynthetic process (GO:0043043),-0.7839573143359321,-1.9308703394354565,0.0,0.0,0.0,64/128,9.60%,RPS13;RPS4X;HARS2;RPL28;RPS27A;RPS8;RPL38;RPS21;RPL31;WARS1;RPL37A;RPS14;RPL12;RPLP1;RPL3;RPL23A;RPL39;RPL32;RPS11;RPL5;RPS15;RPS12;RPS25;RPS23;RPS27;RPS20;RPL29;RPLP2;RPL19;RPS24;RPL13A;RPL41;RPL7A;RPL35;RPL37;RPS18;RPL10;RPL10A;RPL11;RPS3;RPL23;ABCF1;RPS3A;RPL4;RPS26;RPL30;MRPS7;RPL36;MRPL51;RPL24;RPL14;RPL18A;RPS6;RPS2;RPS7;RPL34;RPL15;RPL21;RPS5;RPL27A;MRPL52;RPL6;RPL27;RPL18
prerank,CellMarker_Augmented_2021__Naive T cell:Umbilical Cord Blood,-0.9080814294813437,-1.9248730839332422,0.0,0.0,0.0,23/46,4.22%,ITK;GNLY;TRGC2;JAML;NKG7;THEMIS;MYO1G;ACAP1;CD96;CD2;SCML4;PYHIN1;CD69;GRAP2;NLRC3;ZNF831;PSTPIP1;SELL;GZMB;PRF1;CD247;SLAMF6;SNX20
prerank,CellMarker_Augmented_2021__T cell:Brain,-0.9080814294813437,-1.9248730839332422,0.0,0.0,0.0,23/46,4.22%,ITK;GNLY;TRGC2;JAML;NKG7;THEMIS;MYO1G;ACAP1;CD96;CD2;SCML4;PYHIN1;CD69;GRAP2;NLRC3;ZNF831;PSTPIP1;SELL;GZMB;PRF1;CD247;SLAMF6;SNX20
prerank,CellMarker_Augmented_2021__Memory T cell:Peripheral Blood,-0.9080814294813437,-1.9248730839332422,0.0,0.0,0.0,23/46,4.22%,ITK;GNLY;TRGC2;JAML;NKG7;THEMIS;MYO1G;ACAP1;CD96;CD2;SCML4;PYHIN1;CD69;GRAP2;NLRC3;ZNF831;PSTPIP1;SELL;GZMB;PRF1;CD247;SLAMF6;SNX20
prerank,CellMarker_Augmented_2021__T cell:Tonsil,-0.9080814294813437,-1.9248730839332422,0.0,0.0,0.0,23/46,4.22%,ITK;GNLY;TRGC2;JAML;NKG7;THEMIS;MYO1G;ACAP1;CD96;CD2;SCML4;PYHIN1;CD69;GRAP2;NLRC3;ZNF831;PSTPIP1;SELL;GZMB;PRF1;CD247;SLAMF6;SNX20
prerank,CellMarker_Augmented_2021__Memory T cell:Liver,-0.9080814294813437,-1.9248730839332422,0.0,0.0,0.0,23/46,4.22%,ITK;GNLY;TRGC2;JAML;NKG7;THEMIS;MYO1G;ACAP1;CD96;CD2;SCML4;PYHIN1;CD69;GRAP2;NLRC3;ZNF831;PSTPIP1;SELL;GZMB;PRF1;CD247;SLAMF6;SNX20
prerank,Reactome_2022__Regulation Of Expression Of SLITs And ROBOs R-HSA-9010553,-0.801487144376846,-1.9199874675805129,0.0,0.0,0.0,67/142,11.16%,RPS13;UBC;RPS4X;RPL28;RPS27A;RPS8;RPL38;RPS21;RPL31;RPL37A;RPS14;RPL12;RPLP1;RPL3;RPL23A;RPL39;RPL32;RPS11;RPL5;RPS15;RPS12;PSMB3;RPS25;RPS23;RPS27;FAU;RPS20;RPL29;RPLP2;RPL19;RPS24;RPL13A;RPL41;RPL7A;RPL35;RPL37;ELOB;RPL10A;RPL11;RPS3;RPL23;RPS3A;RPL4;RPL30;RPL36AL;RPL36;RPL14;RPL18A;PSMB6;PSMA7;RPS6;RPS2;RPS7;RPL34;RPL15;RPL21;RPS5;EIF4A3;RPL27A;PSMB9;RPL6;RPL27;RPL18;NCBP2;RPLP0;RPS9;RBX1
prerank,CellMarker_Augmented_2021__Follicular T cell:Undefined,-0.8844622765895145,-1.912217138394932,0.0,0.0,0.0,16/39,5.34%,CCL4;JAML;NKG7;MYO1G;CD37;ACAP1;CD2;CD69;PSTPIP1;GZMB;PRF1;CD247;SLAMF6;SNX20;LSP1;IL10RA
prerank,CellMarker_Augmented_2021__Epithelial cell:Corneal Epithelium,-0.7958361178459292,-1.9116147224661753,0.0,0.0,0.0,34/93,9.00%,CCL4;BCL2A1;BTN3A1;SAT1;HLA-B;PPP1R15A;FOS;ZFP36;JUNB;DUSP1;GPR183;CARD16;IL7R;CD69;GADD45B;CSRNP1;B2M;OAS2;LSP1;SAMD9L;HLA-C;SP110;PHF11;GBP3;TRIM22;NLRC5;HLA-F;CYTIP;TNFRSF1B;TNFAIP3;APOBEC3G;CD44;GBP2;PSMB9
prerank,CellMarker_Augmented_2021__Plasmablast:Blood,-0.8575513576941537,-1.9047011179730098,0.0,0.0,0.0,22/62,5.34%,ITK;GNLY;JAML;NKG7;THEMIS;MYO1G;ACAP1;CD96;CD2;CCL5;SCML4;PYHIN1;NLRC3;ZNF831;PSTPIP1;SELL;GZMB;PRF1;CD247;SLAMF6;SNX20;IL10RA
prerank,KEGG_2021_Human__Coronavirus disease,-0.7817001184941834,-1.9045243129536822,0.0,0.0,0.0,71/156,9.60%,MX2;RPS13;RPS4X;OAS3;RPL36A-HNRNPH2;MX1;FOS;RPL28;RPS27A;RPS8;RPL38;RPS21;RPL31;RPL37A;RPS14;RPL12;RPLP1;RPL3;RPL23A;RPL39;RPL32;RPS11;RPL5;RPS15;RPS12;RPS25;RPS23;RPS27;FAU;RPS20;RPL29;OAS2;RPLP2;RPL19;RPS24;RPL13A;RPL41;RPL7A;RPL35;RPL37;RPS18;RPL10;RPL10A;RPL11;F13A1;RPS3;RPL23;RPS3A;RPL4;RPS26;RPL30;RPL36AL;C5AR1;EIF2AK2;RPL36;RPL24;RPL14;RPL18A;RPS6;RPS2;RPS7;RPL34;RPL15;RPL21;OAS1;RPS5;RPL27A;RPL6;RPL27;STAT1;RPL18
prerank,Reactome_2022__Cellular Response To Starvation R-HSA-9711097,-0.7812727705694553,-1.9024097058745286,0.0,0.0,0.0,59/125,9.93%,RPS13;RPS4X;RPL28;RPS27A;RPS8;RPL38;RPS21;RPL31;RPL37A;RPS14;RPL12;RPLP1;RPL3;RPL23A;RPL39;RPL32;RPS11;RPL5;RPS15;RPS12;RPS25;RPS23;RPS27;FAU;RPS20;RPL29;RPLP2;RPL19;RPS24;RPL13A;RPL41;RPL7A;RPL35;RPL37;ATP6V1F;RPL10A;RPL11;RPS3;RPL23;LAMTOR5;RPS3A;RPL4;RPL30;RPL36AL;RPL36;RPL14;RPL18A;RPS6;RPS2;RPS7;RPL34;RPL15;RPL21;RPS5;RPL27A;RPL6;RPL27;RPL18;ITFG2
prerank,Reactome_2022__Influenza Viral RNA Transcription And Replication R-HSA-168273,-0.7732064880636317,-1.9013801635345837,0.0,0.0,0.0,57/120,9.60%,RPS13;RPS4X;RPL28;RPS27A;RPS8;RPL38;RPS21;RPL31;RPL37A;RPS14;RPL12;RPLP1;RPL3;RPL23A;RPL39;RPL32;RPS11;RPL5;RPS15;RPS12;RPS25;RPS23;RPS27;FAU;RPS20;RPL29;RPLP2;RPL19;RPS24;RPL13A;RPL41;RPL7A;RPL35;RPL37;RPL10A;RPL11;RPS3;RPL23;RPS3A;RPL4;RPL30;RPL36AL;RPL36;RPL14;RPL18A;POLR2G;RPS6;RPS2;RPS7;RPL34;RPL15;RPL21;RPS5;RPL27A;RPL6;RPL27;RPL18
prerank,CellMarker_Augmented_2021__Cytotoxic T cell:Peripheral Blood,-0.8584491084012112,-1.8938781215851412,0.0,0.0,0.0,21/69,5.48%,CCL4;GNLY;TRGC2;JAML;NKG7;CD2;MNDA;VNN2;CLEC12A;AIF1;PSTPIP1;SELL;FCER1G;GZMB;PRF1;CD247;SNX20;NCF4;PLEK;IL10RA;CD300LF
prerank,CellMarker_Augmented_2021__Cytotoxic T cell:Blood,-0.8584491084012112,-1.8938781215851412,0.0,0.0,0.0,21/69,5.48%,CCL4;GNLY;TRGC2;JAML;NKG7;CD2;MNDA;VNN2;CLEC12A;AIF1;PSTPIP1;SELL;FCER1G;GZMB;PRF1;CD247;SNX20;NCF4;PLEK;IL10RA;CD300LF
prerank,CellMarker_Augmented_2021__FOXP3+ Natural Regulatory T (Treg) cell:Blood,-0.850835225482338,-1.8902969975347914,0.0,0.0,0.0,22/67,5.34%,CCL4;ITK;GNLY;JAML;NKG7;MYO1G;CD37;ACAP1;CD2;PYHIN1;GPR183;PSTPIP1;SELL;GZMB;PRF1;CD247;SLAMF6;SNX20;NCF4;LSP1;PLEK;IL10RA
prerank,PanglaoDB_Augmented_2021__NK Cells,-0.8547246653866328,-1.8885762236408106,0.0,0.0,0.0,28/83,5.75%,CCL4;ITK;GNLY;TRGC2;JAML;SPON2;SAMD3;NKG7;THEMIS;CCL3;MYO1G;CD96;CD2;CXCR4;CCL5;PYHIN1;CD69;VNN2;GRAP2;PSTPIP1;SELL;GZMB;PRF1;CD247;SLAMF6;SNX20;IL10RA;TXK
prerank,CellMarker_Augmented_2021__Natural Regulatory T (Treg) cell:Blood,-0.9165617223972822,-1.886599365895123,0.0,0.0,0.0,18/34,4.22%,ITK;GNLY;JAML;THEMIS;MYO1G;ACAP1;CD96;CD2;SCML4;PYHIN1;IKZF3;NLRC3;ZNF831;PSTPIP1;PRF1;CD247;SLAMF6;SNX20
prerank,Reactome_2022__rRNA Processing In Nucleus And Cytosol R-HSA-8868773,-0.7583604370243359,-1.885888505014845,0.0,0.0,0.0,63/156,9.90%,RPS13;RPS4X;RPL28;RPS27A;RPS8;RPL38;RPS21;RPL31;RPL37A;RPS14;RPL12;RPLP1;RPL3;RPL23A;RPL39;RPL32;RPS11;RPL5;RPS15;RPS12;RPS25;RPS23;RPS27;FAU;RPS20;RPL29;RPLP2;RPL19;RPS24;RPL13A;RPL41;RPL7A;RPL35;RPL37;UTP3;RPL10A;RPL11;RPS3;RPL23;RPS3A;RPL4;RPL30;RPL36AL;RPL36;RPL14;EXOSC10;RPL18A;RPS6;RPS2;BUD23;RPS7;RPL34;RPL15;RPL21;RPS5;RPL27A;RPL6;RBM28;UTP25;RPL27;RPL18;WDR46;EXOSC1
prerank,CellMarker_Augmented_2021__Oligodendrocyte Precursor cell:Brain,0.6792453584350263,1.8845328240321606,0.0,0.5360693120923783,0.27,53/91,22.69%,NPAS3;CNTN2;GRID2;NCAN;PCDH15;GFAP;FAM135B;ZNF536;PLPPR4;LRRC4C;PCDH17;SLC1A2;LHFPL3;TNR;GRIA3;GRIA4;CA10;CTNNA2;CADM2;GRIA1;LRRTM2;GRM5;PTPN5;PTPRD;GRIN2B;MEGF11;RUNX1T1;NTRK2;JAM2;CSMD2;GRIA2;NFASC;CSRNP3;ROBO2;PPFIA2;GRIN2A;ADGRB3;CLASP2;NXPH1;DLGAP1;DCLK1;PHYHIPL;GABRB2;TMEM132B;SCD5;AMER2;NOVA1;SYNPR;NRXN1;LSAMP;DLG2;RAB3C;OPCML
prerank,Reactome_2022__Major Pathway Of rRNA Processing In Nucleolus And Cytosol R-HSA-6791226,-0.7648226414540776,-1.8817048257554807,0.0,0.0,0.0,63/149,9.90%,RPS13;RPS4X;RPL28;RPS27A;RPS8;RPL38;RPS21;RPL31;RPL37A;RPS14;RPL12;RPLP1;RPL3;RPL23A;RPL39;RPL32;RPS11;RPL5;RPS15;RPS12;RPS25;RPS23;RPS27;FAU;RPS20;RPL29;RPLP2;RPL19;RPS24;RPL13A;RPL41;RPL7A;RPL35;RPL37;UTP3;RPL10A;RPL11;RPS3;RPL23;RPS3A;RPL4;RPL30;RPL36AL;RPL36;RPL14;EXOSC10;RPL18A;RPS6;RPS2;BUD23;RPS7;RPL34;RPL15;RPL21;RPS5;RPL27A;RPL6;RBM28;UTP25;RPL27;RPL18;WDR46;EXOSC1
prerank,GO_Biological_Process_2021__protein localization to cilium (GO:0061512),0.867458913949777,1.8781091872757842,0.0,0.29134201744150995,0.29,4/24,5.34%,TULP2;BBS9;TULP3;INVS
prerank,GO_Biological_Process_2021__translation (GO:0006412),-0.7468622355757343,-1.8759718242335917,0.0,0.0,0.0,76/175,12.11%,RPS13;RPS4X;HARS2;RPL28;RPS27A;RPS8;RPL38;RPS21;RPL31;WARS1;RPL37A;RPS14;RPL12;RPLP1;RPL3;RPL23A;RPL39;RPL32;RPS11;RPL5;RPS15;RPS12;RPS25;RPS23;RPS27;RPS20;RPL29;RPLP2;RPL19;RPS24;NARS1;RPL13A;RPL41;RPL7A;RPL35;RPL37;RPS18;RPL10;RPL10A;RPL11;RPS3;RPL23;TMA7;ABCF1;MRPL57;RPS3A;RPL4;RPS26;RPL30;MRPS7;RPL36;MRPL51;RPL24;RPL14;RPL18A;RPS6;RPS2;RPS7;RPL34;RPL15;RPL21;RPS5;RPL27A;MRPL52;RPL6;RPL27;RPL18;LARS1;RPLP0;RPS9;KARS1;MRPS11;GTPBP2;MRPS15;MRPL16;MRPL32
prerank,Reactome_2022__Influenza Infection R-HSA-168255,-0.7471097345285851,-1.8751319190906772,0.0,0.0,0.0,58/137,9.60%,RPS13;RPS4X;RPL28;RPS27A;RPS8;RPL38;RPS21;RPL31;RPL37A;RPS14;RPL12;RPLP1;RPL3;RPL23A;RPL39;RPL32;RPS11;RPL5;RPS15;RPS12;RPS25;RPS23;RPS27;FAU;RPS20;RPL29;RPLP2;RPL19;RPS24;RPL13A;RPL41;RPL7A;RPL35;RPL37;RPL10A;RPL11;RPS3;RPL23;RPS3A;RPL4;RPL30;RPL36AL;EIF2AK2;RPL36;RPL14;RPL18A;POLR2G;RPS6;RPS2;RPS7;RPL34;RPL15;RPL21;RPS5;RPL27A;RPL6;RPL27;RPL18
prerank,CellMarker_Augmented_2021__Plasmacytoid Dendritic cell:Peripheral Blood,-0.8364737086205648,-1.874003115560321,0.0,0.0,0.0,21/73,5.34%,CCL4;GNLY;TRGC2;JAML;NKG7;MYO1G;CD37;CD2;MNDA;PSTPIP1;SELL;FCER1G;GZMB;PRF1;CD247;SNX20;NCF4;LSP1;IL3RA;PLEK;IL10RA
prerank,CellMarker_Augmented_2021__Natural Memory B cell:Undefined,-0.9023594801244491,-1.8718784075691917,0.0,0.0,0.0,17/34,4.22%,GNLY;JAML;NKG7;CD37;ACAP1;CD2;PYHIN1;GRAP2;NLRC3;ZNF831;PSTPIP1;SELL;GZMB;PRF1;CD247;SLAMF6;SNX20
prerank,Reactome_2022__Signaling By ROBO Receptors R-HSA-376176,-0.7451991437591852,-1.868149169060765,0.0,0.0001919027423121117,0.01,65/176,9.87%,RPS13;UBC;RPS4X;RPL28;RPS27A;RPS8;RPL38;CXCR4;RPS21;RPL31;RPL37A;RPS14;RPL12;RPLP1;RPL3;RPL23A;RPL39;RPL32;RPS11;RPL5;RPS15;RPS12;PSMB3;RPS25;RPS23;RPS27;FAU;RPS20;RPL29;RPLP2;RPL19;RPS24;RPL13A;RPL41;RPL7A;RPL35;RPL37;ELOB;RPL10A;RPL11;RPS3;RPL23;RPS3A;RPL4;RPL30;RPL36AL;RPL36;RPL14;RPL18A;PSMB6;PSMA7;RPS6;RPS2;RPS7;RPL34;RPL15;RPL21;RPS5;EIF4A3;RPL27A;PSMB9;RPL6;RPL27;RPL18;NCBP2
prerank,GO_Biological_Process_2021__regulation of lipid biosynthetic process (GO:0046890),0.8585591910337167,1.8673951705600815,0.0,0.22918905372065448,0.32,4/22,2.30%,PRKAB2;AVIL;ADIPOR2;PDK4
prerank,GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process (GO:0000956),-0.7697505427186387,-1.8640710530863014,0.0,0.0001879047685139427,0.01,64/153,9.87%,RPS13;RPS4X;RPL28;RPS27A;RPS8;RPL38;ZFP36;RPS21;RPL31;RPL37A;RPS14;RPL12;RPLP1;RPL3;RPL23A;RPL39;RPL32;RPS11;RPL5;RPS15;RPS12;RPS25;RPS23;RPS27;RPS20;RPL29;RPLP2;RPL19;RPS24;RPL13A;RPL41;RPL7A;RPL35;RPL37;RPS18;RPL10;RPL10A;RPL11;RPS3;RPL23;RPS3A;RPL4;RPS26;RPL30;RPL36;RPL24;RPL14;EXOSC10;RPL18A;POLR2G;RPS6;RPS2;RPS7;RPL34;RPL15;PNRC2;RPL21;RPS5;EIF4A3;RPL27A;RPL6;RPL27;RPL18;NCBP2
prerank,Reactome_2022__rRNA Processing R-HSA-72312,-0.7474179553231696,-1.8640057683370594,0.0,0.0001840699773197806,0.01,63/161,9.90%,RPS13;RPS4X;RPL28;RPS27A;RPS8;RPL38;RPS21;RPL31;RPL37A;RPS14;RPL12;RPLP1;RPL3;RPL23A;RPL39;RPL32;RPS11;RPL5;RPS15;RPS12;RPS25;RPS23;RPS27;FAU;RPS20;RPL29;RPLP2;RPL19;RPS24;RPL13A;RPL41;RPL7A;RPL35;RPL37;UTP3;RPL10A;RPL11;RPS3;RPL23;RPS3A;RPL4;RPL30;RPL36AL;RPL36;RPL14;EXOSC10;RPL18A;RPS6;RPS2;BUD23;RPS7;RPL34;RPL15;RPL21;RPS5;RPL27A;RPL6;RBM28;UTP25;RPL27;RPL18;WDR46;EXOSC1
prerank,CellMarker_Augmented_2021__T cell:Eye,-0.8388453674182947,-1.862311091235606,0.0,0.00036077715554677,0.02,26/68,9.21%,CCL4;ITK;JAML;NKG7;MYO1G;CD37;ACAP1;CD96;CD2;PYHIN1;GPR183;CD69;SELL;GZMB;PRF1;CD247;SLAMF6;SNX20;NCF4;PLEK;IL10RA;SP140;GIMAP2;CYTIP;APOBEC3G;SAMSN1
prerank,PanglaoDB_Augmented_2021__Thymocytes,-0.8320679497192157,-1.8579172303417226,0.0,0.000530554640509956,0.03,21/75,5.34%,CCL4;GNLY;JAML;NKG7;MYO1G;CD37;CD2;CXCR4;CD69;VNN2;PSTPIP1;SELL;GZMB;PRF1;CD247;SLAMF6;SNX20;NCF4;LSP1;PLEK;IL10RA
prerank,CellMarker_Augmented_2021__pro-Natural Killer Cell (pro-NK cell):Peripheral Blood,-0.845568104503679,-1.8550271751105236,0.0,0.0005203516666539952,0.03,21/67,5.34%,CCL4;GNLY;TRGC2;JAML;NKG7;STAT4;CCL3;CD2;GPR183;RGS2;AIF1;BTG2;CD14;FCER1G;GZMB;RGS1;PRF1;CD247;TSPAN32;PLEK;IL10RA
prerank,CellMarker_Augmented_2021__Thymocyte:Undefined,-0.840339337164079,-1.8535656425914038,0.0,0.0005105337106793915,0.03,20/61,6.48%,CCL4;JAML;NKG7;MYO1G;CD37;ACAP1;CD2;PYHIN1;GPR183;CD69;PSTPIP1;SELL;PRF1;SLAMF6;SNX20;NCF4;LSP1;PLEK;IL10RA;SP140
prerank,CellMarker_Augmented_2021__T cell:Spleen,-0.8961311924867887,-1.8505666193572003,0.0,0.0005010793827038472,0.03,17/39,4.22%,ITK;GNLY;TRGC2;JAML;NKG7;THEMIS;CD96;CD2;PYHIN1;GRAP2;PSTPIP1;SELL;GZMB;PRF1;CD247;SLAMF6;SNX20
prerank,PanglaoDB_Augmented_2021__T Memory Cells,-0.848316437409118,-1.8470883455941796,0.0,0.0004919688484728682,0.03,24/75,5.34%,ITK;GNLY;JAML;NKG7;SKAP1;THEMIS;MYO1G;ACAP1;CD96;CD2;PYHIN1;IL7R;CD69;GRAP2;PSTPIP1;SELL;GZMB;PRF1;CD247;SLAMF6;SNX20;LSP1;ARHGEF1;IL10RA
prerank,PanglaoDB_Augmented_2021__T Helper Cells,-0.8584364122162916,-1.8467560350815153,0.0,0.0004831836904644241,0.03,20/58,4.22%,CCL4;ITK;GNLY;JAML;NKG7;THEMIS;MYO1G;CD96;CD2;CXCR4;CCL5;PYHIN1;CD69;SELL;RORA;GZMB;PRF1;CD247;SLAMF6;SNX20
prerank,GO_Biological_Process_2021__cellular macromolecule biosynthetic process (GO:0034645),-0.7148733089923823,-1.8459806975386728,0.0,0.0004747067836141711,0.03,84/233,13.60%,RPS13;RPS4X;HARS2;RPL28;RPS27A;RPS8;RPL38;RPS21;RPL31;WARS1;RPL37A;RPS14;GCNT1;RPL12;RPLP1;RPL3;RPL23A;RPL39;RPL32;RPS11;RPL5;RPS15;RPS12;RPS25;RPS23;RPS27;POLE3;RPS20;RPL29;RPLP2;RPL19;RPS24;RPL13A;RPL41;RPL7A;RPL35;RPL37;RPS18;PTMA;HUS1;ING5;RPL10;RPL10A;RPL11;RPS3;RPL23;ABCF1;TIPIN;RPS3A;RPL4;RPS26;RPL30;MRPS7;RPL36;MRPL51;RPL24;RPL14;RPL18A;POLR2G;RPS6;RPS2;RPS7;RPL34;RPL15;RPL21;RPS5;RPL27A;MRPL52;RPL6;RPL27;RPL18;RPLP0;RPS9;MRPS11;ING4;GTPBP2;MRPS15;MRPL32;KAT5;RPS28;MCM7;EEF1B2;RAD9A;RPL9
prerank,CellMarker_Augmented_2021__Responder T cell:Peripheral Blood,-0.8038622187637214,-1.844585764715814,0.0,0.0004665221838966854,0.03,20/78,5.48%,CCL4;JAML;NKG7;MYO1G;CD37;CD2;MNDA;GPR183;AIF1;PSTPIP1;SELL;FCER1G;GZMB;SLAMF6;SNX20;NCF4;LSP1;PLEK;IL10RA;CD300LF
prerank,PanglaoDB_Augmented_2021__Monocytes,-0.7675193513771499,-1.8434379963039966,0.0,0.00045861502823741956,0.03,43/127,11.39%,CCL4;JAML;CD36;CCL3;ADGRE1;MX1;CXCR4;MNDA;VNN2;CLEC12A;RGS2;IFIT3;AIF1;IFIT1;CD14;SELL;FCER1G;RGS1;IFITM3;SNX20;NCF4;LSP1;TNFSF10;PLEK;IL10RA;CD300LF;PECAM1;C5AR1;SIRPB2;PLSCR1;TNFRSF1B;TYMP;OAS1;LY6E;CD44;NCF2;MS4A6A;ITGB2;CSF2RB;HLA-DRA;TYROBP;ITGAL;CSF3R
prerank,CellMarker_Augmented_2021__Natural Killer cell:Lung,-0.8984890365412924,-1.838764709912974,0.0,0.000436423978483996,0.03,21/46,4.22%,ITK;GNLY;TRGC2;JAML;NKG7;CD37;ACAP1;CD96;CCL5;SCML4;PYHIN1;VNN2;GRAP2;NLRC3;PSTPIP1;FCAR;GZMB;PRF1;CD247;SLAMF6;SNX20
prerank,CellMarker_Augmented_2021__Natural Killer cell:Gut,-0.8984890365412924,-1.838764709912974,0.0,0.000436423978483996,0.03,21/46,4.22%,ITK;GNLY;TRGC2;JAML;NKG7;CD37;ACAP1;CD96;CCL5;SCML4;PYHIN1;VNN2;GRAP2;NLRC3;PSTPIP1;FCAR;GZMB;PRF1;CD247;SLAMF6;SNX20
prerank,CellMarker_Augmented_2021__Natural Killer cell:Splenic Red Pulp,-0.8984890365412924,-1.838764709912974,0.0,0.000436423978483996,0.03,21/46,4.22%,ITK;GNLY;TRGC2;JAML;NKG7;CD37;ACAP1;CD96;CCL5;SCML4;PYHIN1;VNN2;GRAP2;NLRC3;PSTPIP1;FCAR;GZMB;PRF1;CD247;SLAMF6;SNX20
prerank,CellMarker_Augmented_2021__Natural Regulatory T (Treg) cell:Peripheral Blood,-0.8242759238763374,-1.8359148166077186,0.0,0.0008589932274923096,0.05,24/72,7.88%,CCL4;ITK;JAML;THEMIS;MYO1G;CD96;CD2;PYHIN1;GPR183;IL7R;CD69;NLRC3;PSTPIP1;SELL;PRF1;CD247;SLAMF6;SNX20;LSP1;PLEK;IL10RA;SP140;GIMAP2;CYTIP
prerank,CellMarker_Augmented_2021__Cytotoxic T cell:Liver,-0.9553103592216137,-1.8349756362859913,0.0,0.0008199480807881136,0.05,16/20,4.14%,ITK;GNLY;TRGC2;JAML;NKG7;THEMIS;CD96;CD2;SCML4;PYHIN1;GRAP2;ZNF831;GZMB;PRF1;CD247;SLAMF6
prerank,CellMarker_Augmented_2021__CD8+ T cell:Liver,-0.9553103592216137,-1.8349756362859913,0.0,0.0008199480807881136,0.05,16/20,4.14%,ITK;GNLY;TRGC2;JAML;NKG7;THEMIS;CD96;CD2;SCML4;PYHIN1;GRAP2;ZNF831;GZMB;PRF1;CD247;SLAMF6
prerank,CellMarker_Augmented_2021__CD8+ Cytotoxic T cell:Peripheral Blood,-0.9553103592216137,-1.8349756362859913,0.0,0.0008199480807881136,0.05,16/20,4.14%,ITK;GNLY;TRGC2;JAML;NKG7;THEMIS;CD96;CD2;SCML4;PYHIN1;GRAP2;ZNF831;GZMB;PRF1;CD247;SLAMF6
prerank,CellMarker_Augmented_2021__T Helper1 (Th1) cell:Brain,-0.9055593794109713,-1.831252178708561,0.0,0.0010611092810199117,0.06,17/36,4.22%,GNLY;JAML;NKG7;MYO1G;ACAP1;CD96;CD2;SCML4;PYHIN1;NLRC3;PSTPIP1;SELL;GZMB;PRF1;CD247;SLAMF6;SNX20
prerank,CellMarker_Augmented_2021__T Helper17 (Th17) cell:Brain,-0.9055593794109713,-1.831252178708561,0.0,0.0010611092810199117,0.06,17/36,4.22%,GNLY;JAML;NKG7;MYO1G;ACAP1;CD96;CD2;SCML4;PYHIN1;NLRC3;PSTPIP1;SELL;GZMB;PRF1;CD247;SLAMF6;SNX20
prerank,CellMarker_Augmented_2021__Induced Regulatory T (Treg) cell:Peripheral Blood,-0.8592622411614272,-1.831174550504095,0.0,0.0010457308856428116,0.06,18/48,5.34%,ITK;GNLY;JAML;NKG7;MYO1G;CD37;CD96;CD2;PYHIN1;GPR183;IL7R;PSTPIP1;GZMB;PRF1;CD247;SLAMF6;SNX20;IL10RA
prerank,CellMarker_Augmented_2021__T Helper17 (Th17) cell:Umbilical Cord Blood,-0.9254622554619181,-1.8272211902510764,0.0,0.001159640857114618,0.06,18/29,4.14%,ITK;GNLY;TRGC2;JAML;NKG7;THEMIS;CD96;CD2;KLRC4-KLRK1;SCML4;PYHIN1;GRAP2;ZNF831;SELL;GZMB;PRF1;CD247;SLAMF6
prerank,CellMarker_Augmented_2021__T2 (Transitional) B cell:Bone Marrow,-0.8438771236367255,-1.825710432806082,0.0,0.001111984383534565,0.06,20/58,5.33%,GNLY;JAML;NKG7;MYO1G;CD37;ACAP1;CD2;MNDA;PYHIN1;VNN2;GRAP2;ZNF831;PSTPIP1;SELL;PRF1;CD247;SLAMF6;SNX20;NCF4;PLEK
prerank,CellMarker_Augmented_2021__Transitional B cell:Bone Marrow,-0.8438771236367255,-1.825710432806082,0.0,0.001111984383534565,0.06,20/58,5.33%,GNLY;JAML;NKG7;MYO1G;CD37;ACAP1;CD2;MNDA;PYHIN1;VNN2;GRAP2;ZNF831;PSTPIP1;SELL;PRF1;CD247;SLAMF6;SNX20;NCF4;PLEK
prerank,CellMarker_Augmented_2021__T1 (Transitional) B cell:Bone Marrow,-0.8438771236367255,-1.825710432806082,0.0,0.001111984383534565,0.06,20/58,5.33%,GNLY;JAML;NKG7;MYO1G;CD37;ACAP1;CD2;MNDA;PYHIN1;VNN2;GRAP2;ZNF831;PSTPIP1;SELL;PRF1;CD247;SLAMF6;SNX20;NCF4;PLEK
prerank,CellMarker_Augmented_2021__Endometrial Progenitor cell:Endometrium,0.664264452372797,1.8249940996103418,0.0,0.3496104209298119,0.57,29/82,16.62%,PCBP4;SCRIB;PKD1;PTPN23;IPO13;TMEM184B;ACAP3;MAST2;TPRN;ABHD8;GIT1;GPS1;LRRC20;SCAF1;SMYD5;UBA1;PEX5;ANKRD52;CLUH;PLXNA1;MEGF8;SBF1;BAG6;SCYL1;LZTR1;ATP13A2;ABCB8;NACC1;PLEKHM2
prerank,CellMarker_Augmented_2021__Suppressor T cell:Peripheral Blood,-0.8064703051794598,-1.8244563732790202,0.0,0.001096957567540855,0.06,21/76,5.48%,GNLY;TRGC2;JAML;NKG7;MYO1G;CD2;MNDA;VNN2;AIF1;PSTPIP1;SELL;FCER1G;GZMB;PRF1;CD247;SNX20;NCF4;LSP1;PLEK;IL10RA;CD300LF
prerank,CellMarker_Augmented_2021__Definitive Endoderm cell:Germ,-0.8148151385155297,-1.8240130877295786,0.0,0.0010542189610132891,0.06,20/72,5.34%,CCL4;TRGC2;JAML;NKG7;MYO1G;CD37;ARHGAP4;CD2;CXCR4;GPR183;CD69;AIF1;PSTPIP1;SELL;CD247;SLAMF6;SNX20;NCF4;PLEK;IL10RA
prerank,CellMarker_Augmented_2021__Pancreatic Stem cell:Pancreatic Acinar Tissue,-0.8148151385155297,-1.8240130877295786,0.0,0.0010542189610132891,0.06,20/72,5.34%,CCL4;TRGC2;JAML;NKG7;MYO1G;CD37;ARHGAP4;CD2;CXCR4;GPR183;CD69;AIF1;PSTPIP1;SELL;CD247;SLAMF6;SNX20;NCF4;PLEK;IL10RA
prerank,CellMarker_Augmented_2021__Endocrine Progenitor cell:Pancreatic Acinar Tissue,-0.8148151385155297,-1.8240130877295786,0.0,0.0010542189610132891,0.06,20/72,5.34%,CCL4;TRGC2;JAML;NKG7;MYO1G;CD37;ARHGAP4;CD2;CXCR4;GPR183;CD69;AIF1;PSTPIP1;SELL;CD247;SLAMF6;SNX20;NCF4;PLEK;IL10RA
prerank,PanglaoDB_Augmented_2021__T Cells Naive,-0.8371770819399701,-1.8224847169101974,0.0,0.0011563370370088783,0.06,19/58,5.34%,GNLY;JAML;NKG7;MYO1G;CD37;CD96;CD2;PYHIN1;VNN2;GRAP2;PSTPIP1;SELL;GZMB;PRF1;CD247;SLAMF6;SNX20;LSP1;IL10RA
prerank,PanglaoDB_Augmented_2021__T Follicular Helper Cells,-0.8270820715727423,-1.82049225958764,0.0,0.0011416998593252216,0.06,21/72,5.34%,CCL4;GNLY;JAML;NKG7;MYO1G;CD37;CD2;PYHIN1;GPR183;VNN2;PSTPIP1;SELL;GZMB;PRF1;CD247;SLAMF6;SNX20;NCF4;LSP1;PLEK;IL10RA
prerank,CellMarker_Augmented_2021__T Helper cell:Bone Marrow,-0.9037845755990506,-1.8171314770606168,0.0,0.0012401714721920218,0.07,20/37,4.22%,ITK;GNLY;JAML;THEMIS;MYO1G;ACAP1;CD96;CD2;CCL5;SCML4;PYHIN1;GRAP2;IKZF3;NLRC3;ZNF831;SELL;PRF1;CD247;SLAMF6;SNX20
prerank,PanglaoDB_Augmented_2021__T Regulatory Cells,-0.834381822984159,-1.8152859847899327,0.0,0.0013362116872102593,0.08,24/64,8.06%,CCL4;ITK;GNLY;JAML;CD96;CD2;CCL5;PYHIN1;GPR183;CD69;PSTPIP1;SELL;GZMB;PRF1;CD247;SLAMF6;SNX20;LSP1;PLEK;IL10RA;SP140;HLA-F;CYTIP;TNFRSF1B
prerank,CellMarker_Augmented_2021__Lymphoid cell:Blood,-0.8061556971397322,-1.8106909697568274,0.0,0.0014299094579597591,0.08,17/69,7.96%,ITK;GNLY;SAMD3;NKG7;THEMIS;CD2;KLRC4-KLRK1;SCML4;RORA;GZMB;PRF1;CD247;RNPC3;TSPAN32;FYN;CRBN;SPOCK2
prerank,PanglaoDB_Augmented_2021__Bergmann Glia,0.6372569589313989,1.8100634039105135,0.0,0.37524851846466484,0.66,30/100,12.47%,NPAS3;SLC39A12;GRIN3A;CNTN2;NCAN;GFAP;HEPACAM;SLC1A3;CDH20;KCND3;PLPPR4;LRRC4C;SLC1A2;TNR;GRIA3;GRIA4;CA10;CTNNA2;SLC4A4;CADM2;GRIA1;LRRTM2;PSD2;GRM5;PTPN5;PTCH1;METRN;GRIN2B;RBFOX1;NTRK2
prerank,CellMarker_Augmented_2021__Natural Killer T (NKT) cell:Liver,-0.9432563235087896,-1.8093609081807212,0.0,0.0013958639946750032,0.08,16/25,4.14%,ITK;GNLY;TRGC2;JAML;NKG7;THEMIS;CD96;CD2;SCML4;PYHIN1;GRAP2;ZNF831;GZMB;PRF1;CD247;SLAMF6
prerank,CellMarker_Augmented_2021__Cytokine Induced Killer cell:Blood,-0.9432563235087896,-1.8093609081807212,0.0,0.0013958639946750032,0.08,16/25,4.14%,ITK;GNLY;TRGC2;JAML;NKG7;THEMIS;CD96;CD2;SCML4;PYHIN1;GRAP2;ZNF831;GZMB;PRF1;CD247;SLAMF6
prerank,CellMarker_Augmented_2021__M1 macrophage:Lung,-0.7905483316271044,-1.8034434811576963,0.0,0.002334440418243806,0.13,33/71,11.24%,CCL4;BCL2A1;CCL3;MX1;RSAD2;MNDA;CARD16;MS4A4A;MARCO;IFIT3;DHX58;B2M;SIGLEC1;CD14;FCER1G;OAS2;TNFSF10;SAMD9L;PLEK;GBP3;PARP9;TYMP;OAS1;IFI44;GBP2;PSMB9;NCF2;IRF1;CSF2RB;EPSTI1;TNFSF13B;TYROBP;TAP1
prerank,CellMarker_Augmented_2021__T cell:Placenta,-0.9380284809278613,-1.8020244739281288,0.0,0.0024121728423185202,0.14,17/24,4.14%,ITK;GNLY;TRGC2;JAML;NKG7;THEMIS;CD96;CD2;SCML4;PYHIN1;GRAP2;NLRC3;ZNF831;GZMB;PRF1;CD247;SLAMF6
prerank,CellMarker_Augmented_2021__Dendritic cell:Placenta,-0.7943474884221411,-1.800666349118017,0.0,0.00238444671769417,0.14,28/83,11.27%,CCL4;JAML;BCL2A1;CCL3;MYO1G;MNDA;GPR183;VNN2;AIF1;CD14;FCER1G;BTK;SNX20;NCF4;LSP1;PLEK;IL10RA;CD300LF;CYTIP;TNFRSF1B;SAMSN1;NCF2;ITGB2;CSF2RB;NCKAP1L;HLA-DRA;TYROBP;ITGAL
prerank,CellMarker_Augmented_2021__Naive T cell:Bone Marrow,-0.8088448255922529,-1.799164994709154,0.0,0.0025623377524628555,0.14,22/75,8.06%,CCL4;GNLY;JAML;NKG7;MYO1G;CD37;CD2;GPR183;VNN2;PSTPIP1;SELL;PRF1;SLAMF6;SNX20;NCF4;LSP1;PLEK;IL10RA;SP140;GIMAP2;CYTIP;TNFRSF1B
prerank,CellMarker_Augmented_2021__T Helper2 (Th2) cell:Brain,-0.8499766269678789,-1.7986388010534489,0.0,0.00253354744063743,0.14,18/51,6.48%,GNLY;JAML;NKG7;MYO1G;CD37;ACAP1;CD2;GRAP2;PSTPIP1;SELL;GZMB;PRF1;CD247;SLAMF6;SNX20;LSP1;IL10RA;SP140
prerank,CellMarker_Augmented_2021__Liver Progenitor cell:Fetal Liver,0.7328881685329907,1.7927119606574424,0.0,0.4234170653483278,0.72,11/45,6.95%,SHROOM3;COL16A1;PLXNB1;LRP4;FKBP9;COL5A2;DLG5;PHLDB1;DAG1;MAGI1;TBC1D16
prerank,CellMarker_Augmented_2021__Follicular Helper (Tfh) T cell:Salivary Gland,-0.9213295091465413,-1.7917148032271155,0.0,0.002806044543141545,0.15,17/32,4.14%,ITK;GNLY;TRGC2;JAML;NKG7;THEMIS;CD96;CD2;SCML4;PYHIN1;GRAP2;ZNF831;SELL;GZMB;PRF1;CD247;SLAMF6
prerank,PanglaoDB_Augmented_2021__Gamma Delta T Cells,-0.9124933539357152,-1.791151423190539,0.0,0.0027752088888213077,0.15,10/25,3.81%,GNLY;TRGC2;SPON2;NKG7;CD96;CD2;CCL5;GZMB;PRF1;CD247
prerank,CellMarker_Augmented_2021__CD4+ T cell:Colon,-0.8997610224980955,-1.7909582439277858,0.0,0.002843080845341394,0.15,21/38,6.48%,ITK;GNLY;JAML;NKG7;THEMIS;CD96;CD2;SCML4;PYHIN1;VNN2;IKZF3;NLRC3;ZNF831;SELL;GZMB;PRF1;CD247;SLAMF6;SNX20;IL10RA;SP140
prerank,CellMarker_Augmented_2021__IL-17Ralpha T cell:Peripheral Blood,-0.9360996503618808,-1.790331937951481,0.0,0.003006476296223083,0.15,17/24,4.14%,ITK;GNLY;TRGC2;JAML;NKG7;THEMIS;CD96;CD2;SCML4;PYHIN1;IL7R;GRAP2;ZNF831;GZMB;PRF1;CD247;SLAMF6
prerank,CellMarker_Augmented_2021__Leukocyte:Peripheral Blood,-0.7893421349662321,-1.7893108174028318,0.0,0.002974492505837731,0.15,23/77,9.46%,ITK;JAML;NKG7;MYO1G;CD37;ACAP1;CD96;CD2;PYHIN1;GPR183;IKZF3;NLRC3;PSTPIP1;SELL;SLAMF6;SNX20;NCF4;PLEK;IL10RA;GIMAP2;CYTIP;SAMSN1;P2RY8
prerank,CellMarker_Augmented_2021__Oligodendrocyte Progenitor cell:Brain,0.6895634981749976,1.788759930605685,0.0,0.37957702843808155,0.74,16/59,14.53%,COL5A3;COL16A1;SLC1A3;ARNT2;PHLDB1;TIMP3;PLPPR4;CNRIP1;NTM;CDH11;COL11A1;RUNX1T1;COL6A1;FBXL7;PDE1C;NFASC
prerank,GO_Biological_Process_2021__neutrophil chemotaxis (GO:0030593),-0.9137401385667896,-1.7881855927632075,0.0,0.0029431820584078605,0.15,5/21,3.26%,CCL4;JAML;CCL3;CCL5;FCER1G
prerank,CellMarker_Augmented_2021__Neuronal Progenitor cell:Undefined,0.6767906531123137,1.7879558369160826,0.038461538461538464,0.33795674023215155,0.76,40/76,21.09%,NPAS3;KCNQ2;CNTN2;DPYSL5;NCAN;GALNT13;NOL4;SNAP91;FZD3;CSPG5;PURG;GRIA4;CADM2;GRM5;SNCB;SLC35F1;CAMKV;MARK1;ERBB4;GRIA2;CSRNP3;ADGRB3;MAPK4;ATRNL1;TMEM178B;NXPH1;PNMA2;MAP6;PCLO;PPM1E;MAP2;DCLK1;CNTN1;PHYHIPL;SYT4;GRIK3;LRP1B;MEGF10;AMER2;CACNA1B
prerank,CellMarker_Augmented_2021__Memory B cell:Liver,-0.9136908901505911,-1.7876731358982574,0.0,0.00288621724437416,0.15,9/17,6.48%,NKG7;CD2;PYHIN1;SELL;PRF1;CD247;SLAMF6;LSP1;SP140
prerank,CellMarker_Augmented_2021__Switched Memory B cell:Blood,-0.9136908901505911,-1.7876731358982574,0.0,0.00288621724437416,0.15,9/17,6.48%,NKG7;CD2;PYHIN1;SELL;PRF1;CD247;SLAMF6;LSP1;SP140
prerank,CellMarker_Augmented_2021__Memory B cell:Peripheral Blood,-0.9136908901505911,-1.7876731358982574,0.0,0.00288621724437416,0.15,9/17,6.48%,NKG7;CD2;PYHIN1;SELL;PRF1;CD247;SLAMF6;LSP1;SP140
prerank,CellMarker_Augmented_2021__Plasma cell:Sinonasal Mucosa,-0.9136908901505911,-1.7876731358982574,0.0,0.00288621724437416,0.15,9/17,6.48%,NKG7;CD2;PYHIN1;SELL;PRF1;CD247;SLAMF6;LSP1;SP140
prerank,CellMarker_Augmented_2021__Non-switched B cell:Blood,-0.9136908901505911,-1.7876731358982574,0.0,0.00288621724437416,0.15,9/17,6.48%,NKG7;CD2;PYHIN1;SELL;PRF1;CD247;SLAMF6;LSP1;SP140
prerank,KEGG_2021_Human__GnRH signaling pathway,0.6822671921040453,1.7860378163260808,0.0,0.3094699651934261,0.77,7/68,6.41%,EGR1;PLA2G4C;MAPK11;MAP2K1;GNAQ;PLCB4;ADCY9
prerank,CellMarker_Augmented_2021__T cell:Fetal Liver,-0.8283770149793974,-1.7852123679324043,0.0,0.0032148459405157725,0.17,20/63,5.34%,ITK;GNLY;JAML;NKG7;MYO1G;CD37;ACAP1;CD96;CD2;PYHIN1;GRAP2;PSTPIP1;SELL;GZMB;PRF1;CD247;SLAMF6;SNX20;LSP1;IL10RA
prerank,PanglaoDB_Augmented_2021__Nuocytes,-0.9145597480539381,-1.7838973088734438,0.0,0.0033601793898963873,0.19,17/29,4.14%,ITK;GNLY;JAML;THEMIS;BCL11B;CD96;CD2;PYHIN1;IL7R;CD69;ZNF831;SELL;RORA;GZMB;PRF1;CD247;SLAMF6
prerank,Reactome_2022__Metabolism Of Amino Acids And Derivatives R-HSA-71291,-0.697897050721558,-1.7832150915436784,0.0,0.003327556289023607,0.19,78/240,11.32%,IL4I1;RPS13;RPS4X;APIP;RPL28;RPS27A;RPS8;SLC7A5;RPL38;RPS21;RPL31;RPL37A;RPS14;RPL12;RPLP1;RPL3;RPL23A;RPL39;RPL32;RPS11;RPL5;RPS15;RPS12;PSMB3;RPS25;RPS23;RPS27;FAU;RPS20;RPL29;RPLP2;RPL19;RPS24;RPL13A;DUOX1;RPL41;PDHX;RPL7A;RPL35;RPL37;SLC38A1;GATM;RPL10A;RPL11;GLUL;KMO;RPS3;RPL23;RPS3A;RPL4;RPL30;TXN2;RPL36AL;CRYM;RPL36;RPL14;RPL18A;PSMB6;PSMA7;RPS6;RPS2;RPS7;RPL34;RPL15;RPL21;RPS5;RPL27A;PSMB9;RPL6;RPL27;RPL18;DIO2;LARS1;SLC36A4;RPLP0;RPS9;ASRGL1;KARS1
prerank,CellMarker_Augmented_2021__T cell:Kidney,-0.9306326420084614,-1.7825314466084006,0.0,0.0035557363888023006,0.2,16/23,4.14%,ITK;GNLY;TRGC2;JAML;NKG7;THEMIS;CD96;CD2;SCML4;PYHIN1;GRAP2;ZNF831;GZMB;PRF1;CD247;SLAMF6
prerank,CellMarker_Augmented_2021__CD4+ Memory T cell:Lymphoid Tissue,-0.8640446698226064,-1.782388003873571,0.0,0.0035218722327184696,0.2,19/50,5.34%,GNLY;JAML;NKG7;MYO1G;CD37;ACAP1;CD2;PYHIN1;VNN2;PSTPIP1;SELL;GZMB;PRF1;CD247;SLAMF6;SNX20;NCF4;LSP1;IL10RA
prerank,PanglaoDB_Augmented_2021__Megakaryocytes,-0.7685410223048812,-1.7807421831529215,0.0,0.0036588249265356396,0.21,29/91,11.96%,GNLY;JAML;SPON2;NKG7;CXCR4;MNDA;VNN2;CLEC12A;AIF1;PSTPIP1;FCER1G;SNX20;NCF4;TSPAN32;PLEK;F13A1;CD300LF;PECAM1;C5AR1;TNFRSF1B;FERMT3;LILRB3;SLC11A1;ITGB2;CSF2RB;VEGFA;TYROBP;CSF3R;TSPAN9
prerank,CellMarker_Augmented_2021__Naive Regulatory T (Treg) cell:Peripheral Blood,-0.7999752610330263,-1.779587428909224,0.0,0.003624630301053998,0.21,21/78,8.06%,CCL4;ITK;JAML;NKG7;MYO1G;CD37;CD2;PYHIN1;GPR183;IL7R;PSTPIP1;PRF1;SLAMF6;SNX20;NCF4;LSP1;PLEK;IL10RA;GIMAP2;CYTIP;TNFRSF1B
prerank,CellMarker_Augmented_2021__Proximal Tubular cell:Kidney,-0.8665909135436501,-1.7784537596268297,0.0,0.003591068909377572,0.21,22/43,7.88%,ITK;GNLY;JAML;THEMIS;CD96;CD2;SCML4;PYHIN1;CD69;GRAP2;IKZF3;NLRC3;ZNF831;SELL;PRF1;CD247;SLAMF6;SNX20;CD93;PECAM1;GIMAP2;CYTIP
prerank,CellMarker_Augmented_2021__Switched Memory B cell:Peripheral Blood,-0.8298356768658287,-1.778304476549932,0.0,0.003372482106198068,0.21,16/42,9.46%,NKG7;MYO1G;CD37;ACAP1;VNN2;PSTPIP1;SELL;PRF1;CD247;SLAMF6;SNX20;NCF4;LSP1;SP140;CYTIP;P2RY8
prerank,CellMarker_Augmented_2021__Non-switched Memory B cell:Peripheral Blood,-0.8298356768658287,-1.778304476549932,0.0,0.003372482106198068,0.21,16/42,9.46%,NKG7;MYO1G;CD37;ACAP1;VNN2;PSTPIP1;SELL;PRF1;CD247;SLAMF6;SNX20;NCF4;LSP1;SP140;CYTIP;P2RY8
prerank,CellMarker_Augmented_2021__Double-negative Memory B cell:Peripheral Blood,-0.8298356768658287,-1.778304476549932,0.0,0.003372482106198068,0.21,16/42,9.46%,NKG7;MYO1G;CD37;ACAP1;VNN2;PSTPIP1;SELL;PRF1;CD247;SLAMF6;SNX20;NCF4;LSP1;SP140;CYTIP;P2RY8
prerank,CellMarker_Augmented_2021__IgG Memory B cell:Undefined,-0.8298356768658287,-1.778304476549932,0.0,0.003372482106198068,0.21,16/42,9.46%,NKG7;MYO1G;CD37;ACAP1;VNN2;PSTPIP1;SELL;PRF1;CD247;SLAMF6;SNX20;NCF4;LSP1;SP140;CYTIP;P2RY8
prerank,CellMarker_Augmented_2021__Memory B cell:Blood,-0.8298356768658287,-1.778304476549932,0.0,0.003372482106198068,0.21,16/42,9.46%,NKG7;MYO1G;CD37;ACAP1;VNN2;PSTPIP1;SELL;PRF1;CD247;SLAMF6;SNX20;NCF4;LSP1;SP140;CYTIP;P2RY8
prerank,CellMarker_Augmented_2021__Class-switched Memory B cell:Peripheral Blood,-0.8298356768658287,-1.778304476549932,0.0,0.003372482106198068,0.21,16/42,9.46%,NKG7;MYO1G;CD37;ACAP1;VNN2;PSTPIP1;SELL;PRF1;CD247;SLAMF6;SNX20;NCF4;LSP1;SP140;CYTIP;P2RY8
prerank,CellMarker_Augmented_2021__Double-negative B cell:Peripheral Blood,-0.8298356768658287,-1.778304476549932,0.0,0.003372482106198068,0.21,16/42,9.46%,NKG7;MYO1G;CD37;ACAP1;VNN2;PSTPIP1;SELL;PRF1;CD247;SLAMF6;SNX20;NCF4;LSP1;SP140;CYTIP;P2RY8
prerank,CellMarker_Augmented_2021__T Helper cell:Blood,-0.769462080531692,-1.7781304750514402,0.0,0.003343408984592912,0.21,27/84,11.27%,JAML;NKG7;MYO1G;CD37;ACAP1;CD2;MNDA;VNN2;CLEC12A;AIF1;PSTPIP1;SELL;FCER1G;SNX20;NCF4;LSP1;TSPAN32;PLEK;IL10RA;CD300LF;CYTIP;FERMT3;ITGB2;CSF2RB;NCKAP1L;TYROBP;ITGAL
prerank,CellMarker_Augmented_2021__Activated B cell:Peripheral Blood,-0.8259014547929289,-1.7772326976172512,0.0,0.0033919219752260427,0.22,17/35,11.24%,NKG7;SKAP1;CD2;GRAP2;B2M;SELL;GZMB;GMIP;PRF1;CD247;LSP1;HLA-C;NLRC5;FERMT3;PSMB9;IRF1;TAP1
prerank,Reactome_2022__SARS-CoV-2 Modulates Host Translation Machinery R-HSA-9754678,-0.83608406109165,-1.7770427225913106,0.0,0.0033631768737410763,0.22,22/38,8.46%,RPS13;RPS4X;RPS27A;RPS8;RPS21;RPS14;RPS11;RPS15;RPS12;RPS25;RPS23;RPS27;FAU;RPS20;RPS24;SNRPD2;RPS3;RPS3A;RPS6;RPS2;RPS7;RPS5
prerank,GO_Biological_Process_2021__regulation of axonogenesis (GO:0050770),0.752196962642853,1.7763219672118375,0.0,0.32280695532519305,0.82,23/44,18.25%,PLXNB1;LRP4;PLXNA2;CHODL;LRRC4C;PLXNA3;PLXNB2;ROBO1;PLXNC1;BRSK1;METRN;LINGO1;PTEN;RTN4;NTRK2;PLXNA1;ROBO2;GSK3B;TIAM2;KIF13B;BRSK2;MARK2;MAP6
prerank,CellMarker_Augmented_2021__B1 cell:Salivary Gland,-0.9241247505940059,-1.7745999348002048,0.0,0.0033822858332509687,0.23,14/23,4.14%,ITK;GNLY;JAML;NKG7;THEMIS;CD96;CD2;PYHIN1;ZNF831;SELL;GZMB;PRF1;CD247;SLAMF6
prerank,CellMarker_Augmented_2021__T cell:Salivary Gland,-0.9241247505940059,-1.7745999348002048,0.0,0.0033822858332509687,0.23,14/23,4.14%,ITK;GNLY;JAML;NKG7;THEMIS;CD96;CD2;PYHIN1;ZNF831;SELL;GZMB;PRF1;CD247;SLAMF6
prerank,Reactome_2022__Translation R-HSA-72766,-0.7106040931795767,-1.7728433182718233,0.0,0.003428873792386657,0.24,96/235,15.90%,RPS13;RPS4X;RPL28;RPS27A;RPS8;RPL38;RPS21;RPL31;WARS1;RPL37A;RPS14;RPL12;RPLP1;RPL3;RPL23A;RPL39;RPL32;RPS11;RPL5;RPS15;RPS12;RPS25;RPS23;RPS27;FAU;SRP14;RPS20;RPL29;RPLP2;EIF2B1;RPL19;RPS24;NARS1;RPL13A;RPL41;RPL7A;RPL35;RPL37;RPL10A;RPL11;RPS3;RPL23;MRPL57;RPS3A;RPL4;RPL30;RPL36AL;AURKAIP1;MRPS7;RPL36;MRPL51;RPL14;RPL18A;RPS6;RPS2;RPS7;RPL34;RPL15;MRPL19;RPL21;GADD45GIP1;RPS5;RPL27A;MRPL52;RPL6;MRPL50;RPL27;RPL18;LARS1;EIF3K;RPLP0;MTIF3;RPS9;KARS1;MRPS11;TARS2;MRPS10;MRPS15;MRPL16;MRPL32;DARS2;CHCHD1;RPS28;EEF1B2;RPL9;OXA1L;SSR4;UBA52;RPL8;RPS27L;RPN1;MRPL43;EIF2S2;EIF3G;GARS1;MRPS18C
prerank,GO_Biological_Process_2021__regulation of cell migration involved in sprouting angiogenesis (GO:0090049),0.8490494695855052,1.7652082186482427,0.0,0.36232352714544147,0.86,5/19,6.06%,KLF4;ANXA1;FGF2;HDAC9;CIB1
prerank,PanglaoDB_Augmented_2021__Pulmonary Alveolar Type I Cells,0.7554851794983074,1.7641602323469774,0.0,0.33698560017401313,0.86,5/39,1.36%,SHROOM3;COL16A1;PLXNB1;PDPN;FKBP9
prerank,GO_Biological_Process_2021__positive regulation of ion transport (GO:0043270),-0.8898066480779268,-1.763230785505965,0.0,0.004583644189323717,0.31,4/32,1.49%,CCL4;CCL3;MYLK;CCL5
prerank,CellMarker_Augmented_2021__T cell:Synovium,-0.9440992405576868,-1.762937738185705,0.0,0.004438131675376933,0.31,16/21,4.14%,ITK;GNLY;TRGC2;JAML;NKG7;THEMIS;CD96;CD2;SCML4;PYHIN1;GRAP2;ZNF831;GZMB;PRF1;CD247;SLAMF6
prerank,CellMarker_Augmented_2021__T cell:Bone Marrow,-0.9440992405576868,-1.762937738185705,0.0,0.004438131675376933,0.31,16/21,4.14%,ITK;GNLY;TRGC2;JAML;NKG7;THEMIS;CD96;CD2;SCML4;PYHIN1;GRAP2;ZNF831;GZMB;PRF1;CD247;SLAMF6
prerank,CellMarker_Augmented_2021__T cell:Colorectum,-0.9440992405576868,-1.762937738185705,0.0,0.004438131675376933,0.31,16/21,4.14%,ITK;GNLY;TRGC2;JAML;NKG7;THEMIS;CD96;CD2;SCML4;PYHIN1;GRAP2;ZNF831;GZMB;PRF1;CD247;SLAMF6
prerank,CellMarker_Augmented_2021__T cell:Optic Nerve,-0.9440992405576868,-1.762937738185705,0.0,0.004438131675376933,0.31,16/21,4.14%,ITK;GNLY;TRGC2;JAML;NKG7;THEMIS;CD96;CD2;SCML4;PYHIN1;GRAP2;ZNF831;GZMB;PRF1;CD247;SLAMF6
prerank,CellMarker_Augmented_2021__CD4+ Cytotoxic T cell:Liver,-0.838816791923652,-1.762624343455066,0.0,0.004403185756673177,0.31,21/69,6.85%,CCL4;PZP;GNLY;SPON2;SAMD3;NKG7;OSBPL5;MYBL1;TGFBR3;RUNX3;CCL5;SYNE2;GZMB;PRF1;SYNE1;ARL4C;LPCAT1;PLEK;GLUL;EFHD2;GSTP1
prerank,CellMarker_Augmented_2021__T cell:Ascites,-0.8183321663720899,-1.7590332337147274,0.0,0.004862035885298268,0.33,16/59,5.34%,GNLY;TRGC2;JAML;NKG7;THEMIS;CD2;MNDA;AIF1;PSTPIP1;SELL;FCER1G;GZMB;PRF1;CD247;SNX20;IL10RA
prerank,CellMarker_Augmented_2021__CD4+ Memory T cell:Peripheral Blood,-0.8640911393815287,-1.7571259737357796,0.0,0.0050340998448386515,0.35,16/30,7.88%,GNLY;NKG7;CD96;CD2;PYHIN1;IL7R;SELL;GZMB;PRF1;CD247;SLAMF6;SNX20;LSP1;SP140;GIMAP2;CYTIP
prerank,CellMarker_Augmented_2021__Stem cell:Gastrointestinal Tract,0.6368411602500131,1.75343656617976,0.0,0.37112490837164647,0.89,14/78,12.82%,SHROOM3;PANK3;EPS8;GOLM1;UBTD2;SCARB2;PLCB4;KITLG;ALCAM;ITGAV;MAGI3;FNBP1L;LRRC1;SH3RF1
prerank,PanglaoDB_Augmented_2021__Neutrophils,-0.7531881819554709,-1.7519993203010689,0.0,0.005689178222083681,0.38,26/83,11.39%,JAML;CCL3;MYLK;OAS3;MNDA;VNN2;CLEC12A;AIF1;PSTPIP1;CD14;SELL;FCER1G;SNX20;NCF4;PLEK;CD300LF;PECAM1;C5AR1;SIRPB2;LILRB3;NCF2;SLC11A1;ITGB2;CSF2RB;TYROBP;CSF3R
prerank,CellMarker_Augmented_2021__Naive B cell:Undefined,-0.7901477413207632,-1.7469533602535088,0.0,0.006286268619375538,0.41,22/60,11.91%,JAML;NKG7;MYO1G;CD37;ACAP1;VNN2;NLRC3;PSTPIP1;SELL;PRF1;SLAMF6;SNX20;NCF4;LSP1;PLEK;IL10RA;SP140;CYTIP;P2RY8;NCKAP1L;ITGAL;PATL2
prerank,CellMarker_Augmented_2021__Naive B cell:Peripheral Blood,-0.7901477413207632,-1.7469533602535088,0.0,0.006286268619375538,0.41,22/60,11.91%,JAML;NKG7;MYO1G;CD37;ACAP1;VNN2;NLRC3;PSTPIP1;SELL;PRF1;SLAMF6;SNX20;NCF4;LSP1;PLEK;IL10RA;SP140;CYTIP;P2RY8;NCKAP1L;ITGAL;PATL2
prerank,GO_Biological_Process_2021__cellular response to nitrogen compound (GO:1901699),-0.8889883709690973,-1.7444092560417113,0.0,0.0063746339513902975,0.42,1/15,0.51%,DDX11
prerank,PanglaoDB_Augmented_2021__Eosinophils,-0.7413002957500358,-1.7429676851008944,0.0,0.00679822625190742,0.44,25/86,11.39%,JAML;NKG7;MYO1G;CCL5;MNDA;CD69;VNN2;CLEC12A;AIF1;PSTPIP1;FCER1G;SNX20;NCF4;PLEK;IL10RA;CD300LF;C5AR1;CYTIP;TNFRSF1B;ITGB2;CSF2RB;NCKAP1L;TYROBP;ITGAL;CSF3R
prerank,GO_Biological_Process_2021__icosanoid metabolic process (GO:0006690),0.7960190284954214,1.7427197173944229,0.0,0.4128732590028255,0.92,3/27,0.68%,CPA1;FAAH;PLA2G4C
prerank,CellMarker_Augmented_2021__CD4+ Regulatory T cell:Undefined,-0.8300405553986459,-1.7426531541248094,0.0,0.006764571666501937,0.44,15/49,5.34%,GNLY;JAML;NKG7;MYO1G;CD37;ACAP1;CD2;PSTPIP1;GZMB;PRF1;CD247;SLAMF6;SNX20;NCF4;IL10RA
prerank,CellMarker_Augmented_2021__Regulatory T (Treg) cell:Ascites,-0.8300405553986459,-1.7426531541248094,0.0,0.006764571666501937,0.44,15/49,5.34%,GNLY;JAML;NKG7;MYO1G;CD37;ACAP1;CD2;PSTPIP1;GZMB;PRF1;CD247;SLAMF6;SNX20;NCF4;IL10RA
prerank,CellMarker_Augmented_2021__Circulating Stem Like cell:Peripheral Blood,-0.7624954982499288,-1.7406738045317298,0.0,0.00717604196251787,0.45,23/49,14.24%,MX2;SLFN12L;IL7R;PARP14;FCAR;PARP15;SP110;PHF11;TRIM22;TNFAIP8;NLRP12;KLRD1;APOBEC3G;CD44;VENTX;CFLAR;IRF1;C5AR2;NABP1;MLKL;PRDM1;REL;APOL6
prerank,PanglaoDB_Augmented_2021__Gamma (PP) Cells,0.6520206873911637,1.7403152460559637,0.0,0.39855587985998553,0.92,37/81,21.03%,ESRRG;PPARGC1A;PDZRN4;PLPPR1;NOL4;SNAP91;PBX1;PLPPR4;PCDH17;MAGI1;SHC2;NFIB;ASXL3;GUCY1A2;PTPRD;THSD7A;NTRK2;ABCC8;ERBB4;GRIA2;CNTN4;NFASC;CSRNP3;PPFIA2;KALRN;MAPK4;SORBS2;CNTN3;MAP6;PCLO;MAP2;CNTN1;PHYHIPL;SYT4;FAM149A;GAREM1;NOVA1
prerank,CellMarker_Augmented_2021__Embryonic Stem cell:Tooth,0.8008848109062139,1.7401537514477894,0.02631578947368421,0.3736461373687365,0.92,5/24,7.03%,FLVCR1;GRID2;L2HGDH;POU2F1;FAM124A
prerank,Reactome_2022__RUNX1 Regulates Genes Involved In Megakaryocyte Differentiation And Platelet Function R-HSA-8936459,-0.8012688340852914,-1.73976185344915,0.0,0.0074508325602050335,0.47,11/42,9.35%,NR4A3;H2BC4;H2BC26;H2AC20;PRKCQ;H2AC6;H3-3B;H2AJ;H2BC21;H2BC5;H2BC9
prerank,GO_Biological_Process_2021__modulation by host of symbiont process (GO:0051851),-0.8466980429658798,-1.738704266222666,0.0,0.007916333269191715,0.5,4/27,4.48%,CCL4;CCL3;CCL5;CTDP1
prerank,CellMarker_Augmented_2021__Effector Regulatory T (Treg) cell:Peripheral Blood,-0.7754429740119453,-1.7382842449094844,0.0,0.007988637015678477,0.5,24/80,11.27%,CCL4;JAML;NKG7;MYO1G;CD37;CD2;GPR183;AIF1;PSTPIP1;SLAMF6;SNX20;NCF4;LSP1;PLEK;IL10RA;CYTIP;TNFRSF1B;ITGA4;SAMSN1;P2RY8;ITGB2;NCKAP1L;TYROBP;ITGAL
prerank,GO_Biological_Process_2021__cellular response to chemokine (GO:1990869),-0.9046906203147265,-1.7378982371306726,0.0,0.007995947596337987,0.5,5/17,1.54%,CCL4;CCL3;RIPOR2;CCL5;DUSP1
prerank,Reactome_2022__FOXO-mediated Transcription R-HSA-9614085,0.686833542901334,1.7369684624462538,0.0,0.36606267603239134,0.93,10/47,5.98%,KLF4;PPARGC1A;PCBP4;CCNG2;SIRT1;NFYC;FBXO32;SMAD2;DDIT3;SMAD3
prerank,CellMarker_Augmented_2021__Regulatory T (Treg) cell:Brain,-0.7706327558207042,-1.7368274725355557,0.0,0.008066672315922499,0.51,18/80,5.34%,CCL4;JAML;NKG7;MYO1G;CD37;CD2;GPR183;AIF1;PSTPIP1;FCER1G;GZMB;PRF1;SLAMF6;SNX20;NCF4;LSP1;PLEK;IL10RA
prerank,PanglaoDB_Augmented_2021__Pyramidal Cells,0.6301095433982363,1.7353017863805944,0.0,0.35155270104608866,0.93,43/89,21.61%,KCNQ2;CNTN2;NCAN;GFAP;CDH20;KCND3;SNAP91;NGB;GRIA3;GRIA4;CA10;OLFM3;CTNNA2;KCNC2;CADM2;GRIA1;SATB2;SORCS3;PSD2;GRM5;SNCB;PTPN5;GRIN2B;RTN4;RBFOX1;GRIA2;DAB1;GRIN2A;ADGRB3;NXPH1;KCNB1;MAP2;KCND2;SYT4;GRM3;AGER;AMER2;CACNG3;CACNA1B;GRM1;KCNB2;SYNPR;NRXN1
prerank,PanglaoDB_Augmented_2021__T Cytotoxic Cells,-0.9073357903089944,-1.735175762067223,0.0,0.00845177252504671,0.52,16/30,4.14%,ITK;GNLY;JAML;NKG7;THEMIS;CD96;CD2;PYHIN1;CD69;GRAP2;ZNF831;SELL;GZMB;PRF1;CD247;SLAMF6
prerank,CellMarker_Augmented_2021__Colonic Stem cell:Colon,0.7223409847704313,1.7349552287607972,0.0,0.33427663053815354,0.93,11/39,7.24%,SHROOM3;LRP4;FKBP9;DLG5;FRAS1;ASAP2;DAG1;GPR161;MAGI1;TBC1D16;TANC1
prerank,GO_Biological_Process_2021__neutrophil migration (GO:1990266),-0.8859097891338132,-1.7345312924160847,0.0,0.008518349505965403,0.53,6/23,5.65%,CCL4;JAML;CCL3;CCL5;FCER1G;PECAM1
prerank,CellMarker_Augmented_2021__Acinar cell:Pancreatic Islet,0.7543994209903214,1.734113555211176,0.0,0.31989353515077795,0.93,3/27,1.27%,CPA1;TIFA;PDIA2
prerank,GO_Biological_Process_2021__regulation of fatty acid biosynthetic process (GO:0042304),0.7594749561204251,1.7328177149914676,0.06896551724137931,0.31076481860427724,0.93,3/20,2.30%,PRKAB2;ADIPOR2;PDK4
prerank,CellMarker_Augmented_2021__Effector CD8+ Memory T (Tem) cell:Peripheral Blood,-0.7944608216869098,-1.7315619785502603,0.0,0.00895722593081636,0.54,21/67,10.35%,GNLY;SPON2;FLNA;SAMD3;OSBPL5;MYO1G;TGFBR3;GZMB;SYNE1;ARL4C;LPCAT1;PLEK;GLUL;EFHD2;EMP3;KLRD1;ZNF600;SH3BP5;LLGL2;LITAF;TTC38
prerank,GO_Biological_Process_2021__cellular nitrogen compound biosynthetic process (GO:0044271),0.8200840778420606,1.7279550427751802,0.02040816326530612,0.316768229872769,0.95,4/15,10.57%,ACER2;ABCA2;SPTLC2;GCH1
prerank,GO_Biological_Process_2021__antigen receptor-mediated signaling pathway (GO:0050851),-0.7328101248114944,-1.726447287467838,0.0,0.010131413272203816,0.59,33/138,12.85%,ITK;BTN3A1;SKAP1;THEMIS;THEMIS2;MNDA;PRKCQ;NFKBID;GRAP2;VAV3;PSMB3;BTK;EIF2B1;CD247;BTN3A3;HLA-DRB5;TXK;BTN3A2;BTN2A1;PSMB6;PSMA7;FYN;BTN2A2;PRKD2;PSMB9;SPG21;NCKAP1L;HLA-DRA;PSMD12;PLEKHA1;PTPRC;PSMD8;PSMA5
prerank,PanglaoDB_Augmented_2021__Decidual Cells,-0.9333027859319812,-1.7261009524338156,0.0,0.010123848752587934,0.59,17/24,4.14%,CCL4;GNLY;TRGC2;JAML;NKG7;SKAP1;CD96;CD2;KLRC4-KLRK1;CCL5;PYHIN1;GRAP2;SELL;GZMB;PRF1;CD247;SLAMF6
prerank,GO_Biological_Process_2021__response to hydroxyurea (GO:0072710),-0.9291860062288055,-1.7220818504790403,0.0,0.011091459849579755,0.63,1/9,0.51%,DDX11
prerank,GO_Biological_Process_2021__regulation of fatty acid metabolic process (GO:0019217),0.9129894656034138,1.7208714294223961,0.0,0.34353023969624996,0.97,4/11,5.17%,PRKAB2;ADIPOR2;PDK4;PPARG
prerank,PanglaoDB_Augmented_2021__Peri-islet Schwann Cells,0.6411268780183962,1.720632773085214,0.03225806451612903,0.3301876197670446,0.97,22/65,15.62%,COL16A1;LRP4;ARNT2;GULP1;PHLDB1;PBX1;SEMA3B;MAGI1;NUAK1;NTM;CDH11;PTPRG;ENAH;RUNX1T1;GPC6;TJP1;FBXL7;ADCY6;FERMT2;NFASC;CSRNP3;ANTXR1
prerank,GO_Biological_Process_2021__cellular protein metabolic process (GO:0044267),-0.6692655978594209,-1.7187245688920012,0.0,0.011864483638786396,0.66,78/275,11.44%,RPS13;USP6;RPS4X;HARS2;RPL28;RPS27A;RPS8;RPL38;RPS21;RPL31;WARS1;RPL37A;RPS14;RPL12;RPLP1;RPL3;RPL23A;RPL39;RPL32;RPS11;RPL5;RPS15;RPS12;RPS25;YES1;RPS23;RPS27;RPS20;RPL29;RPLP2;RPL19;RPS24;RPL13A;RPL41;RPL7A;RPL35;RPL37;RPS18;RPL10;RPL10A;RPL11;ERO1A;RPS3;RPL23;IGF1;ABCF1;RPS3A;RPL4;RPS26;RPL30;MRPS7;RPL36;MRPL51;RPL24;RPL14;RPL18A;RPS6;RPS2;RPS7;RPL34;RPL15;CSF2RA;RPL21;RPS5;RPL27A;MRPL52;GPC3;RPL6;RPL27;RPL18;GGCX;CSF2RB;ADPRH;CCDC59;RPLP0;RPS9;SPARCL1;MRPS11
prerank,KEGG_2021_Human__Pancreatic secretion,0.713819662524004,1.718654106989192,0.0,0.3253707650786783,0.97,9/52,9.38%,CPA1;TRPC1;RAP1A;GNAQ;PLCB4;ADCY9;SLC4A4;SLC9A1;CA2
prerank,GO_Biological_Process_2021__leukotriene metabolic process (GO:0006691),0.9344795146321028,1.7177176479156595,0.0,0.3168904712786885,0.97,1/14,0.01%,CPA1
prerank,"Reactome_2022__mRNA Activation Upon Binding Of Cap-Binding Complex And eIFs, Subsequent Binding To 43S R-HSA-72662",-0.7948230549139687,-1.7155988256876857,0.0,0.012687329970061412,0.67,21/53,8.46%,RPS13;RPS4X;RPS27A;RPS8;RPS21;RPS14;RPS11;RPS15;RPS12;RPS25;RPS23;RPS27;FAU;RPS20;RPS24;RPS3;RPS3A;RPS6;RPS2;RPS7;RPS5
prerank,GO_Biological_Process_2021__branching morphogenesis of an epithelial tube (GO:0048754),0.8580171656503306,1.715217511680918,0.0,0.316375850051299,0.98,6/13,7.23%,NRP1;PKD2;TGFBR2;FGF2;PKD1;SALL1
prerank,Reactome_2022__Translation Initiation Complex Formation R-HSA-72649,-0.7954461058121437,-1.714881257933742,0.0,0.012782501868710066,0.67,21/52,8.46%,RPS13;RPS4X;RPS27A;RPS8;RPS21;RPS14;RPS11;RPS15;RPS12;RPS25;RPS23;RPS27;FAU;RPS20;RPS24;RPS3;RPS3A;RPS6;RPS2;RPS7;RPS5
prerank,CellMarker_Augmented_2021__Lymphocyte:Undefined,-0.8046121055354257,-1.7123362537255546,0.0,0.013529143333003875,0.7,23/63,8.06%,GNLY;JAML;BCL2A1;NKG7;SRGN;CD96;CD2;PYHIN1;CD69;VNN2;GRAP2;SELL;GZMB;PRF1;CD247;SLAMF6;SNX20;NCF4;LSP1;PLEK;GIMAP2;CYTIP;TNFRSF1B
prerank,CellMarker_Augmented_2021__Lymphocyte:Peripheral Blood,-0.7529081138440612,-1.7107903236767623,0.0,0.013912321684483288,0.7,22/68,11.39%,JAML;NKG7;MYO1G;MNDA;CLEC12A;MS4A4A;AIF1;FCER1G;BTK;SNX20;NCF4;PLEK;CD300LF;FERMT3;SAMSN1;MS4A6A;ITGB2;CSF2RB;NCKAP1L;TYROBP;ITGAL;CSF3R
prerank,CellMarker_Augmented_2021__CD8+ T cell:Lymphoid Tissue,-0.9383939192107348,-1.7095205318144389,0.0,0.014583362294017164,0.72,15/20,4.14%,ITK;GNLY;SKAP1;THEMIS;CD96;CD2;SCML4;PYHIN1;IKZF3;ZNF831;SELL;GZMB;PRF1;CD247;SLAMF6
prerank,PanglaoDB_Augmented_2021__Embryonic Stem Cells,0.6231765692304033,1.7087460528812377,0.0,0.3292164797089062,0.98,26/83,16.64%,SHROOM3;KLF4;LRP4;SMAD1;FRAS1;GULP1;SMAD2;SMAD3;MAGI1;KITLG;PTPRG;ENAH;ANO6;FNBP1L;ARHGAP42;DCBLD2;TJP1;PTK2;FERMT2;CD276;ANTXR1;PARD3;NACC1;COL4A5;WWC2;RAI14
prerank,GO_Biological_Process_2021__rRNA metabolic process (GO:0016072),-0.6884621394835703,-1.7085144058287869,0.0,0.014838415268455864,0.72,54/137,12.02%,RPL28;RPL38;RPL31;RPL37A;RPS14;RPL12;RPLP1;RPL3;RPL23A;RPL39;RPL32;RPL5;RPS15;RPS25;RPS27;RPL29;RPLP2;RPL19;RPS24;RPL13A;RPL41;RPL7A;RPL35;RPL37;UTP3;RPL10;RPL10A;RPL11;RPL23;RPL4;RPL30;RPL36;RPL24;RPL14;EXOSC10;RPL18A;RPS6;RPS2;RPS7;RPL34;RPL15;RPL21;RPL27A;RPL6;RPL27;RPL18;WDR46;EXOSC1;DDX27;RPLP0;RPS9;NOB1;NOP53;WDR55
prerank,CellMarker_Augmented_2021__White Blood cell:Blood,-0.7474348985675846,-1.7080422944160787,0.0,0.01470683946177916,0.72,25/83,11.27%,ITK;JAML;MYO1G;CD37;ACAP1;CD2;GPR183;CD69;AIF1;PSTPIP1;SELL;SLAMF6;SNX20;NCF4;PLEK;IL10RA;GIMAP2;CYTIP;TNFRSF1B;SAMSN1;P2RY8;ITGB2;NCKAP1L;TYROBP;ITGAL
prerank,CellMarker_Augmented_2021__Hematopoietic cell:Undefined,-0.7474348985675846,-1.7080422944160787,0.0,0.01470683946177916,0.72,25/83,11.27%,ITK;JAML;MYO1G;CD37;ACAP1;CD2;GPR183;CD69;AIF1;PSTPIP1;SELL;SLAMF6;SNX20;NCF4;PLEK;IL10RA;GIMAP2;CYTIP;TNFRSF1B;SAMSN1;P2RY8;ITGB2;NCKAP1L;TYROBP;ITGAL
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transport (GO:0051928),-0.9349713089814815,-1.7052538788018912,0.0,0.015812543051654318,0.72,4/22,1.49%,CCL4;CCL3;MYLK;CCL5
prerank,CellMarker_Augmented_2021__Beta cell:Undefined,-0.8796983994267097,-1.7047596840412893,0.0,0.015713093095354604,0.72,7/25,4.89%,GNLY;JAML;NKG7;ACAP1;GRAP2;PRF1;TSPAN32
prerank,CellMarker_Augmented_2021__Responder T cell:Blood,-0.7409410461449356,-1.7026726049422924,0.0,0.016009486277387918,0.72,26/84,11.27%,CCL4;JAML;CD37;CD2;MNDA;GPR183;AIF1;PSTPIP1;FCER1G;SNX20;CD93;NCF4;LSP1;PLEK;IL10RA;PECAM1;CYTIP;TNFRSF1B;SAMSN1;MS4A6A;ITGB2;CSF2RB;NCKAP1L;HLA-DRA;TYROBP;ITGAL
prerank,GO_Biological_Process_2021__T cell receptor signaling pathway (GO:0050852),-0.7249737549861031,-1.7018896743052954,0.0,0.016190154961648533,0.74,22/123,9.00%,ITK;BTN3A1;SKAP1;THEMIS;THEMIS2;PRKCQ;NFKBID;GRAP2;PSMB3;EIF2B1;CD247;BTN3A3;HLA-DRB5;TXK;BTN3A2;BTN2A1;PSMB6;PSMA7;FYN;BTN2A2;PRKD2;PSMB9
prerank,"Reactome_2022__Formation Of Ternary Complex, And Subsequently, 43S Complex R-HSA-72695",-0.8022677011086364,-1.7012619817833528,0.0,0.01631291768135858,0.74,21/46,8.46%,RPS13;RPS4X;RPS27A;RPS8;RPS21;RPS14;RPS11;RPS15;RPS12;RPS25;RPS23;RPS27;FAU;RPS20;RPS24;RPS3;RPS3A;RPS6;RPS2;RPS7;RPS5
prerank,GO_Biological_Process_2021__regulation of BMP signaling pathway (GO:0030510),0.7249617994596633,1.700255536085515,0.0,0.35724559104207215,1.0,16/40,14.65%,UBE2D1;ACVR2A;SMAD1;SMAD7;UBE2O;PPARG;SMAD2;SPART;LEMD3;BMPR1B;SORL1;BMPR1A;TWSG1;PCSK6;SMURF1;XIAP
prerank,Reactome_2022__Ribosomal Scanning And Start Codon Recognition R-HSA-72702,-0.7937442213556469,-1.7000858648559762,0.0,0.016544841949154024,0.75,21/52,8.46%,RPS13;RPS4X;RPS27A;RPS8;RPS21;RPS14;RPS11;RPS15;RPS12;RPS25;RPS23;RPS27;FAU;RPS20;RPS24;RPS3;RPS3A;RPS6;RPS2;RPS7;RPS5
prerank,CellMarker_Augmented_2021__Microglial cell:Optic Nerve,-0.7459429854994462,-1.6999002559963603,0.0,0.01644395876653723,0.75,24/81,11.39%,JAML;NKG7;MYO1G;MNDA;CLEC12A;MS4A4A;AIF1;PSTPIP1;FCER1G;BTK;SNX20;NCF4;PLEK;IL10RA;CD300LF;CYTIP;SAMSN1;MS4A6A;ITGB2;CSF2RB;NCKAP1L;TYROBP;ITGAL;CSF3R
prerank,PanglaoDB_Augmented_2021__Basophils,-0.7222472947536306,-1.6993809227435126,0.0,0.01650828802653402,0.76,32/109,11.39%,CCL4;JAML;OSBPL5;H1-3;PLEKHG5;CCL3;MNDA;GPR183;CD69;H2AC6;CLEC12A;MS4A4A;AIF1;SIGLEC1;CD14;FCER1G;CD93;NCF4;IL3RA;PLEK;F13A1;CD300LF;SIRPB2;ENPP3;CD44;LILRB3;NCF2;MS4A6A;CSF2RB;TYROBP;ITGAL;CSF3R
prerank,CellMarker_Augmented_2021__Basophil:Umbilical Cord Blood,-0.7541074149526463,-1.6979519491932595,0.0,0.01754985259662752,0.79,27/75,11.27%,JAML;NKG7;MYO1G;CD96;CD2;GPR183;CD69;VNN2;GRAP2;NLRC3;AIF1;PRF1;SLAMF6;SNX20;NCF4;PLEK;IL10RA;GIMAP2;CYTIP;ENPP3;SAMSN1;MS4A6A;ITGB2;CSF2RB;NCKAP1L;TYROBP;ITGAL
prerank,KEGG_2021_Human__Systemic lupus erythematosus,-0.7834661677552954,-1.697240252833859,0.0,0.017714806440021044,0.81,16/50,10.77%,H2AC8;H2BC7;H4C3;H2BC4;H2AC20;H2AC6;SSB;HLA-DRB5;H2BC18;H3-3B;H2AJ;H2BC21;H2BC5;H2BC9;H2BC8;HLA-DRA
prerank,PanglaoDB_Augmented_2021__Alveolar Macrophages,-0.7159523494852792,-1.6963178686378368,0.0,0.018038857777338504,0.81,30/90,11.39%,CCL4;CD36;CCL3;MNDA;CLEC12A;MS4A4A;MARCO;AIF1;SIGLEC1;CD14;FCER1G;PLET1;NCF4;PLEK;LILRB4;CD300LF;C5AR1;SIRPB2;TNFRSF1B;OLR1;TYMP;TNFAIP2;LILRB3;NCF2;SLC11A1;MS4A6A;ITGB2;CSF2RB;TYROBP;CSF3R
prerank,GO_Biological_Process_2021__negative regulation of viral genome replication (GO:0045071),-0.7926575330360516,-1.6958163457814388,0.0,0.018198965982462807,0.81,15/37,8.67%,OAS3;MX1;RSAD2;CCL5;IFIT1;OAS2;IFITM3;SHFL;ILF3;EIF2AK2;PLSCR1;SRPK1;OAS1;RNASEL;APOBEC3G
prerank,CellMarker_Augmented_2021__Transitional B cell:Peripheral Blood,-0.8416720699867749,-1.6917214109065997,0.0,0.018930312958195344,0.82,10/35,4.41%,JAML;NKG7;MYO1G;CD37;ACAP1;VNN2;SELL;SLAMF6;SNX20;NCF4
prerank,CellMarker_Augmented_2021__Regulatory B cell:Undefined,-0.8416720699867749,-1.6917214109065997,0.0,0.018930312958195344,0.82,10/35,4.41%,JAML;NKG7;MYO1G;CD37;ACAP1;VNN2;SELL;SLAMF6;SNX20;NCF4
prerank,CellMarker_Augmented_2021__Naive B cell:Blood,-0.8416720699867749,-1.6917214109065997,0.0,0.018930312958195344,0.82,10/35,4.41%,JAML;NKG7;MYO1G;CD37;ACAP1;VNN2;SELL;SLAMF6;SNX20;NCF4
prerank,CellMarker_Augmented_2021__Endocrine Progenitor cell:Pancreas,0.662087879872523,1.6916250318140884,0.0,0.38651374313906983,1.0,11/64,7.01%,SHROOM3;PLXNB1;LRP4;NMNAT2;DLG5;B4GALNT4;ARNT2;ADGRB2;MAGI1;TBC1D16;NUAK1
prerank,GO_Biological_Process_2021__negative regulation of cellular response to growth factor stimulus (GO:0090288),0.6655440524933125,1.6912451216480333,0.0,0.3763011089792922,1.0,12/48,12.30%,UBE2D1;ACVR2A;SPRY2;SMAD1;FGF2;SMAD7;PPARG;SPART;LEMD3;BMPR1B;SORL1;BMPR1A
prerank,CellMarker_Augmented_2021__Enteroendocrine cell:Small Intestine,0.8595668650269526,1.6906691760785977,0.0,0.36636258693269874,1.0,1/15,0.01%,CPA1
prerank,GO_Biological_Process_2021__rRNA processing (GO:0006364),-0.6759760529180733,-1.690662832734253,0.0,0.019394378881993996,0.83,55/148,12.02%,RPL28;RPL38;RPL31;RPL37A;RPS14;RPL12;RPLP1;RPL3;RPL23A;RPL39;RPL32;RPL5;RPS15;RPS25;RPS27;RPL29;RPLP2;RPL19;RPS24;RPL13A;RPL41;RPL7A;RPL35;RPL37;UTP3;RPL10;RPL10A;RPL11;RPL23;RPL4;RPL30;RPL36;RPL24;RPL14;EXOSC10;RPL18A;RPS6;RPS2;RPS7;RPL34;RPL15;RPL21;RPL27A;RPL6;RPL27;RPL18;WDR46;NSA2;EXOSC1;DDX27;RPLP0;RPS9;NOB1;NOP53;WDR55
prerank,CellMarker_Augmented_2021__Effector CD4+ Memory T (Tem) cell:Blood,-0.7685621422196494,-1.6899297379731877,0.0,0.0198531107147145,0.83,26/74,11.27%,JAML;NKG7;MYO1G;CD37;ACAP1;CD2;PYHIN1;GPR183;CD69;VNN2;PSTPIP1;SELL;PRF1;SLAMF6;SNX20;NCF4;LSP1;PLEK;IL10RA;SP140;CYTIP;SAMSN1;P2RY8;ITGB2;NCKAP1L;ITGAL
prerank,PanglaoDB_Augmented_2021__Cardiac Stem And Precursor Cells,0.6526524959273862,1.689808632962352,0.0,0.35949839243085707,1.0,18/51,18.51%,LRP4;FKBP9;WNT5A;MAGI1;NUAK1;KITLG;TANC1;PTPRG;GNA11;ENAH;TJP1;ADCY6;FERMT2;CD276;ANTXR1;RAI14;RBFOX2;SNX7
prerank,PanglaoDB_Augmented_2021__Plasmacytoid Dendritic Cells,-0.7287842053795669,-1.6890939738131105,0.0,0.020151981116969583,0.84,24/111,5.48%,CCL4;JAML;NKG7;MYO1G;CD37;MCTP2;CXCR4;MNDA;GPR183;VNN2;AIF1;PSTPIP1;SELL;FCER1G;GZMB;BTK;SLAMF6;SNX20;NCF4;LSP1;IL3RA;PLEK;IL10RA;CD300LF
prerank,GO_Biological_Process_2021__ncRNA processing (GO:0034470),-0.6506961146562678,-1.6878464994755014,0.0,0.020549948774752098,0.86,57/170,12.02%,RPL28;RPL38;RPL31;RPL37A;RPS14;RPL12;RPLP1;RPL3;RPL23A;RPL39;RPL32;RPL5;RPS15;RPS25;RPS27;RPL29;SSB;RPLP2;RPL19;RPS24;RPL13A;RPL41;RPL7A;RPL35;RPL37;UTP3;RPL10;RPL10A;RPL11;RPL23;RPL4;RPL30;RPL36;RPL24;RPL14;EXOSC10;RPL18A;RPS6;RPS2;RPS7;RPL34;RPL15;RPL21;RPL27A;RPL6;RPL27;RPL18;WDR46;EXOSC1;ZCCHC8;DDX27;RPLP0;RPS9;KARS1;NOB1;NOP53;WDR55
prerank,CellMarker_Augmented_2021__PP cell:Pancreas,0.9230168082400756,1.6867579940639228,0.0,0.3609213463128353,1.0,1/9,0.01%,CPA1
prerank,PanglaoDB_Augmented_2021__Delta Cells,0.6388792187701202,1.6863015283920577,0.0,0.35160819476369654,1.0,29/77,20.32%,LEPR;PPARGC1A;PLPPR1;NOL4;SNAP91;PLPPR4;PCDH17;BAIAP3;GRIA3;SHC2;UNC5B;ASXL3;LCORL;PTPRD;ABCC8;GRIA2;CNTN4;NFASC;CSRNP3;KALRN;MAPK4;SORBS2;UCP2;MAP6;CNTN1;PHYHIPL;SYT4;UNC5D;FAM149A
prerank,CellMarker_Augmented_2021__Endothelial cell:Plasma,-0.7447322334749814,-1.6838130658372104,0.0,0.02257405083435298,0.89,23/83,11.39%,JAML;MYO1G;CD37;MNDA;CLEC12A;AIF1;FCER1G;BTK;SNX20;CD93;NCF4;TSPAN32;PLEK;CD300LF;PECAM1;SIRPB2;TNFRSF1B;FERMT3;CSF2RB;NCKAP1L;TYROBP;ITGAL;CSF3R
prerank,PanglaoDB_Augmented_2021__Glutaminergic Neurons,0.5960623250101684,1.6837209846054226,0.0,0.3505815609879503,1.0,41/81,22.69%,CNTN2;NCAN;NOL4;SNAP91;SCN3B;SLC1A2;KCTD16;TNR;GRIA4;CA10;OLFM3;CTNNA2;KCNC2;FUT9;GRIA1;PSD2;GRM5;PTPN5;GRIN2B;RBFOX1;GRIA2;CSRNP3;PPFIA2;GRIN2A;NXPH1;PHYHIPL;GRM3;TMEM132B;CELF5;AMER2;CACNG3;CACNA1B;GRM1;SYNPR;NRXN1;GABRA2;GRIN1;LSAMP;DLG2;GLS;OPCML
prerank,PanglaoDB_Augmented_2021__Enterocytes,-0.7608921343458697,-1.6834340993818886,0.0,0.022548572221673124,0.89,7/43,4.37%,SPON2;CD36;COL18A1;DEGS2;CD55;SLC51A;AQP11
prerank,KEGG_2021_Human__NF-kappa B signaling pathway,-0.7727867134176944,-1.6805426954523794,0.0,0.023631911445731166,0.9,7/70,3.54%,CCL4;BCL2A1;CARD14;PRKCQ;GADD45B;CD14;BTK
prerank,CellMarker_Augmented_2021__Natural Killer cell:Liver,-0.7449400828256101,-1.6792761381483763,0.013888888888888888,0.024252242122866207,0.9,19/68,11.39%,GNLY;JAML;MNDA;CLEC12A;MS4A4A;AIF1;SIGLEC1;CD14;FCER1G;CD93;IL10RA;F13A1;CD300LF;C5AR1;LILRB3;SLC11A1;MS4A6A;TYROBP;CSF3R
prerank,GO_Biological_Process_2021__lymphocyte chemotaxis (GO:0048247),-0.9686199658844805,-1.6787657320991083,0.0,0.024417238427889135,0.9,5/12,1.61%,CCL4;CCL3;CH25H;CCL5;GPR183
prerank,GO_Biological_Process_2021__negative regulation of blood vessel endothelial cell migration (GO:0043537),0.7408898427697169,1.6782231367844391,0.0,0.36252395900019235,1.0,4/22,7.30%,KLF4;FGF2;PPARG;TNF
prerank,CellMarker_Augmented_2021__Merkel cell:Skin,0.8056428808895457,1.6776849959400684,0.0,0.3545172338551426,1.0,1/19,0.04%,SHROOM3
prerank,CellMarker_Augmented_2021__Non-classical monocyte:Bone Marrow,-0.7370413439130885,-1.6770222950751004,0.0,0.0256706822215971,0.92,29/77,17.50%,GNLY;JAML;MNDA;VNN2;CLEC12A;AIF1;SELL;FCER1G;CD93;PLEK;IL10RA;F13A1;CD300LF;PECAM1;SLC11A1;MS4A6A;CSF2RB;TYROBP;CSF3R;PTPRC;MYO1F;LY86;FPR1;IGSF6;CREBRF;FCGR3A;LST1;GIMAP4;EVI2B
prerank,CellMarker_Augmented_2021__Dendritic cell:Blood,-0.7596771263852622,-1.6769581549775034,0.0,0.025530405269566514,0.92,22/82,11.20%,CCL4;JAML;BCL2A1;CCL3;MNDA;GPR183;CLEC12A;AIF1;FCER1G;BTK;SNX20;NCF4;PLEK;IL10RA;CD300LF;CCL3L3;CYTIP;SAMSN1;ITGB2;CSF2RB;NCKAP1L;TYROBP
prerank,CellMarker_Augmented_2021__T cell:Skin,-0.8487991589181402,-1.6760623151033303,0.0,0.026126932595982123,0.93,20/34,9.00%,CCL4;ITK;BCL2A1;CD96;CD2;CCL5;PYHIN1;GPR183;IL7R;CD69;B2M;GZMB;SLAMF6;SP140;NLRC5;CYTIP;APOBEC3G;CD44;GBP2;PSMB9
prerank,CellMarker_Augmented_2021__B cell:Thyroid,-0.8249416927686148,-1.675246398763582,0.0,0.026326981620980513,0.93,12/32,11.27%,NKG7;MYO1G;CD37;ACAP1;SELL;SLAMF6;NCF4;SP140;CYTIP;CD72;P2RY8;ITGAL
prerank,PanglaoDB_Augmented_2021__Natural Killer T Cells,-0.7698544932690244,-1.6751308029365273,0.0,0.02623393026220465,0.93,25/70,5.81%,CCL4;ITK;GNLY;JAML;NKG7;THEMIS;MYO1G;CD96;CD2;CXCR4;PYHIN1;CD69;GRAP2;ZNF831;PSTPIP1;SELL;RORA;GZMB;PRF1;CD247;SLAMF6;SNX20;LSP1;IL10RA;IL12RB2
prerank,GO_Biological_Process_2021__cellular response to tumor necrosis factor (GO:0071356),-0.7080691255547252,-1.6726632364749907,0.0,0.028119395947027667,0.93,21/114,10.01%,CCL4;CCL3;TNFRSF11B;ZFP36;CCL5;CARD14;PID1;TNFRSF25;PSMB3;AIM2;RPS3;GBP3;PSMB6;PSMA7;TNFRSF1B;TMSB4X;GBP2;PSMB9;CHI3L1;STAT1;EIF5A
prerank,GO_Biological_Process_2021__cellular response to interferon-gamma (GO:0071346),-0.7492665526862646,-1.672595582937464,0.014705882352941176,0.02801780037756831,0.93,23/75,10.77%,CCL4;MT2A;CCL3;OAS3;HLA-B;GAPDH;CCL5;TRIM5;AIF1;B2M;OAS2;RPL13A;HLA-C;HLA-DRB5;GBP3;TRIM22;HLA-F;OAS1;CD44;GBP2;STAT1;IRF1;HLA-DRA
prerank,PanglaoDB_Augmented_2021__Oligodendrocyte Progenitor Cells,0.5803771508260911,1.6720618077377392,0.0,0.3687344097669982,1.0,30/83,17.15%,CNTN2;NCAN;PCDH15;GFAP;ZNF536;ARNT2;SNAP91;PLPPR4;CSPG5;LRRC4C;HAPLN2;CHST1;LHFPL3;TNR;NTM;CA10;PSD2;SNCB;OLIG1;PTPN5;NRXN2;SLC35F1;LINGO1;GRIA2;NFASC;LRRC4B;ADGRB3;MAPK4;ETV5;NXPH1
prerank,GO_Biological_Process_2021__response to laminar fluid shear stress (GO:0034616),0.9260712968698066,1.6719472579388246,0.0,0.36009873355770633,1.0,2/8,2.59%,KLF4;SMAD7
prerank,GO_Biological_Process_2021__cellular response to hydroxyurea (GO:0072711),-0.9293662592042198,-1.6716122965115496,0.0,0.028346776507246214,0.93,1/8,0.51%,DDX11
prerank,CellMarker_Augmented_2021__Monocyte:Liver,-0.7240295082104484,-1.6709268026270525,0.0136986301369863,0.028482407016850265,0.93,30/69,17.23%,JAML;MNDA;VNN2;CLEC12A;MS4A4A;AIF1;SIGLEC1;CD14;FCER1G;NCF4;CD300LF;C5AR1;SIRPB2;TYMP;LILRB3;NCF2;SLC11A1;MS4A6A;ITGB2;CSF2RB;TYROBP;CSF3R;FCGR1CP;CASP5;MYO1F;LY86;FPR1;IGSF6;FCGR3A;GIMAP4
prerank,CellMarker_Augmented_2021__Immature neuron:Undefined,0.6357111047905437,1.6701510932205792,0.0,0.3618325738566265,1.0,30/69,21.09%,KCNQ2;DPYSL5;NCAN;CHD5;NOL4;SNAP91;CSPG5;VGF;ELAVL2;KCTD16;PURG;OLFM3;CTNNA2;BRSK1;SNCB;CAMKV;SYT14;SLC12A5;TMEM145;GRIA2;FRMD5;FAM171B;NXPH1;PNMA2;RIMS2;FSTL5;SYT4;GRM3;CELF5;CACNA1B
prerank,GO_Biological_Process_2021__DNA packaging (GO:0006323),-0.8943019368980464,-1.6663481483344247,0.03225806451612903,0.030836057928277594,0.97,4/15,3.75%,H1-4;H1-3;H1-2;H1-0
prerank,PanglaoDB_Augmented_2021__Platelets,-0.6853502038557368,-1.6660377418585843,0.0,0.03086335822841509,0.97,35/143,11.39%,JAML;CD36;SLC2A3;SRGN;THEMIS2;CXCR4;CCL5;MNDA;CARD16;CD69;VNN2;CLEC12A;GRAP2;AIF1;SELL;FCER1G;OST4;CD93;NCF4;LSP1;PLEK;ERO1A;F13A1;CD300LF;PECAM1;SIRPB2;TNFRSF1B;FERMT3;CD226;NCF2;ITGB2;CSF2RB;VEGFA;TYROBP;CSF3R
prerank,GO_Biological_Process_2021__cellular response to laminar fluid shear stress (GO:0071499),0.9460424188773426,1.6640877716009408,0.0,0.38540386878691174,1.0,1/5,0.08%,KLF4
prerank,PanglaoDB_Augmented_2021__Radial Glia Cells,0.6123801107986538,1.663385028354886,0.0,0.3799641939097646,1.0,36/80,19.89%,NPAS3;LRP4;CNTN2;NCAN;GFAP;SLC1A3;ZNF536;NLGN1;ARNT2;SNAP91;PLPPR4;LRRC4C;PCDH17;PURG;NTM;ASXL3;GUCY1A2;PTPN5;PTPRD;SLC35F1;RUNX1T1;NTRK2;FBXL7;MARK1;GRIA2;NFASC;CSRNP3;PPFIA2;ADGRB3;MAPK4;CDH4;MAP6;CRMP1;MAP2;DCLK1;PHYHIPL
prerank,GO_Biological_Process_2021__ribosome biogenesis (GO:0042254),-0.6762034027711166,-1.6614084010243648,0.0,0.03378780873838274,0.98,59/162,12.02%,RBIS;RPL28;RPL38;RPL31;RPL37A;RPS14;RPL12;RPLP1;RPL3;RPL23A;RPL39;RPL32;RPL5;RPS15;RPS25;RPS27;RPL29;RPLP2;RPL19;RPS24;RPL13A;RPL41;RPL7A;RPL35;RPL37;UTP3;METTL17;RPL10;RPL10A;RPL11;GLUL;RPL23;RPL4;RPL30;RPL36;RPL24;RPL14;EXOSC10;RPL18A;RPS6;RPS2;RPS7;RPL34;RPL15;RPL21;RPL27A;RPL6;RPL27;RPL18;WDR46;EXOSC1;NPM1;DDX27;RPLP0;RPS9;EIF2A;NOB1;NOP53;WDR55
prerank,CellMarker_Augmented_2021__Cytotrophoblast:Endometrium,-0.7775966003997605,-1.660902350118545,0.0,0.033718787999178886,0.98,12/37,10.38%,JAML;SAT1;MCTP2;VNN2;TNFSF10;ANKRD22;DTX3L;PARP9;HLA-F;OAS1;CFLAR;IRF1
prerank,CellMarker_Augmented_2021__Trophoblast cell:Endometrium,-0.7775966003997605,-1.660902350118545,0.0,0.033718787999178886,0.98,12/37,10.38%,JAML;SAT1;MCTP2;VNN2;TNFSF10;ANKRD22;DTX3L;PARP9;HLA-F;OAS1;CFLAR;IRF1
prerank,Reactome_2022__Deposition Of New CENPA-containing Nucleosomes At Centromere R-HSA-606279,-0.8368142257919007,-1.6592962750694318,0.015384615384615385,0.03446710325312892,0.98,12/27,12.68%,H2BC4;H2BC26;H2AC20;H2AC6;H2AJ;H2BC21;CENPU;H2BC5;H2BC9;ITGB3BP;NPM1;H2BC11
prerank,GO_Biological_Process_2021__chemokine-mediated signaling pathway (GO:0070098),-0.9040673327195818,-1.6584235070821998,0.0,0.03465841456204377,0.98,3/13,1.49%,CCL4;CCL3;CCL5
prerank,Reactome_2022__ERK/MAPK Targets R-HSA-198753,0.7802219169751896,1.6559645443105353,0.022222222222222223,0.40628968614116023,1.0,5/19,11.38%,DUSP6;MAPK11;PPP2R1B;DUSP7;MAPK1
prerank,Reactome_2022__PRC2 Methylates Histones And DNA R-HSA-212300,-0.8245795273312064,-1.655297753311471,0.0,0.037353190347014065,0.98,11/23,13.12%,H2BC4;H2BC26;H2AC20;H2AC6;H3-3B;H2AJ;H2BC21;H2BC5;H2BC9;H2BC11;DNMT1
prerank,GO_Biological_Process_2021__regulation of hemoglobin biosynthetic process (GO:0046984),0.9832708746927131,1.655004340698675,0.0,0.40166352804602834,1.0,1/6,0.08%,KLF4
prerank,Reactome_2022__Diseases Associated With TLR Signaling Cascade R-HSA-5602358,-0.8398491195005335,-1.6548961865041132,0.0,0.0373014571626874,0.98,3/23,4.18%,CD36;BTK;NDUFA2
prerank,Reactome_2022__B-WICH Complex Positively Regulates rRNA Expression R-HSA-5250924,-0.7724980047726996,-1.652709443451074,0.0,0.03873844707683443,0.98,12/37,13.01%,H2BC4;H2BC26;H2AC20;H2AC6;TAF1D;H3-3B;H2AJ;H2BC21;H2BC5;H2BC9;H2BC11;TAF1C
prerank,Reactome_2022__Apoptosis Induced DNA Fragmentation R-HSA-140342,-0.9269496608877382,-1.6504435874353396,0.0,0.03984702912009101,0.98,4/11,3.75%,H1-4;H1-3;H1-2;H1-0
prerank,GO_Biological_Process_2021__sympathetic ganglion development (GO:0061549),0.8992516352272256,1.6484463948959287,0.038461538461538464,0.42814609519665375,1.0,2/5,5.40%,NRP1;FZD3
prerank,GO_Biological_Process_2021__cellular response to fluid shear stress (GO:0071498),0.9189288084645045,1.6481944583722015,0.0,0.41978045576891604,1.0,2/9,1.00%,KLF4;PKD2
prerank,KEGG_2021_Human__Glucagon signaling pathway,0.6320493223693887,1.6474039230373851,0.0,0.41467680482508246,1.0,14/69,10.95%,PRKAB2;PFKP;PPARGC1A;CPT1C;PFKM;SIRT1;GNAQ;CPT1A;PLCB4;ACACB;GYS1;PPP3CA;PCK2;PDE3B
prerank,GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),-0.7364861298859124,-1.646826846536011,0.0,0.04197159977895591,0.99,18/65,12.85%,CD36;HLA-B;B2M;PSMB3;FCER1G;NCF4;HLA-C;PSMB6;PSMA7;MFSD6;HLA-F;PSMB9;NCF2;TAP1;PSMD12;CYBA;PSMD8;PSMA5
prerank,CellMarker_Augmented_2021__Dendritic cell:Thymus,-0.7291992565933823,-1.645905519659278,0.0,0.04243130339250805,0.99,25/82,11.27%,CCL4;BCL2A1;CCL3;MYO1G;CD37;MNDA;GPR183;AIF1;FCER1G;RGS1;BTK;SNX20;NCF4;PLEK;IL10RA;LILRB4;CCL3L3;CYTIP;TNFRSF1B;SAMSN1;ITGB2;CSF2RB;NCKAP1L;TYROBP;ITGAL
prerank,Reactome_2022__Regulation Of PTEN Gene Transcription R-HSA-8943724,0.6779778549640738,1.6456524221626776,0.0,0.4147759007493823,1.0,6/49,5.17%,EGR1;RRAGD;RNF2;CBX6;MTA2;PPARG
prerank,CellMarker_Augmented_2021__Decidual cell:Blood,-0.7033256754367199,-1.6434433415927792,0.0,0.044345525369290484,0.99,25/78,9.17%,CEBPD;SAT1;OAS3;FOSL2;ZFP36;JUNB;DUSP1;CD55;GADD45B;CSRNP1;CTSB;IER3;TNFSF10;SAMD9L;BHLHE40;GBP3;PARP9;HLA-F;SGK1;TNFAIP3;TYMP;PFKFB3;CD44;GBP2;S100A6
prerank,GO_Biological_Process_2021__negative regulation of viral process (GO:0048525),-0.7632141758024235,-1.643412727577268,0.014084507042253521,0.04412920573334272,0.99,19/48,9.65%,OAS3;MX1;RSAD2;ZFP36;CCL5;TRIM5;IFIT1;OAS2;IFITM3;SHFL;ILF3;EIF2AK2;PLSCR1;SRPK1;OAS1;RNASEL;APOBEC3G;STAT1;TRIM13
prerank,GO_Biological_Process_2021__negative regulation by host of viral transcription (GO:0043922),-0.9347289885771677,-1.6426341497803487,0.0,0.04439660627723602,0.99,3/11,1.49%,CCL4;CCL3;CCL5
prerank,GO_Biological_Process_2021__insulin secretion (GO:0030073),0.7960816249809357,1.6415285664284818,0.0,0.4314192594273879,1.0,1/11,0.34%,ANXA1
prerank,CellMarker_Augmented_2021__Flk1+ Mesodermal cell:Pluripotent Stem Cell,0.6674186194588554,1.641450900433025,0.0,0.422960058262145,1.0,15/59,13.54%,SHROOM3;ZNRF3;FRAS1;KIAA1671;FZD3;ARHGEF26;MAGI1;NEDD4L;TACC2;MAGI3;ENAH;COBL;FNBP1L;TJP1;MARK1
prerank,CellMarker_Augmented_2021__Pigment Epithelial cell:Eye,0.6620704811759891,1.6405820593577871,0.0,0.4179637404064738,1.0,32/60,22.76%,NPAS3;LRP4;SLC39A12;NCAN;SLC1A3;FZD3;CSPG5;LHFPL3;GRM5;NKAIN3;ST6GALNAC5;GRIN2B;DCBLD2;MARK1;GRIA2;FRMD5;GAD1;TNC;NXPH1;IL1RAPL1;PCLO;KIAA1549L;MAP2;DCLK1;ZNF462;CNTN1;MEGF10;SCD5;EPHA5;NR2F1;OPCML;TENM2
prerank,Reactome_2022__Assembly Of ORC Complex At Origin Of Replication R-HSA-68616,-0.8557276585779706,-1.6403992845262496,0.0,0.046186447449224184,0.99,9/19,9.35%,H2BC4;H2BC26;H2AC20;H2AC6;H3-3B;H2AJ;H2BC21;H2BC5;H2BC9
prerank,CellMarker_Augmented_2021__Glial cell:Brain,0.6554712046711877,1.6402969350330643,0.0,0.3897739990485344,1.0,32/70,21.57%,SLC39A12;CNTN2;NCAN;GFAP;CDH20;SLC1A2;HAPLN2;TNR;GRIA4;CA10;CTNNA2;KCNC2;CADM2;MOBP;GPM6A;GRIA1;PSD2;GRM5;SNCB;GRIN2B;GRIA2;SLC24A2;SNTG1;ST8SIA5;NXPH1;TTYH1;DPP6;GRM3;AMER2;CACNG3;GRM1;SYNPR
prerank,CellMarker_Augmented_2021__Glial cell:Sympathetic Ganglion,0.6554712046711877,1.6402969350330643,0.0,0.3897739990485344,1.0,32/70,21.57%,SLC39A12;CNTN2;NCAN;GFAP;CDH20;SLC1A2;HAPLN2;TNR;GRIA4;CA10;CTNNA2;KCNC2;CADM2;MOBP;GPM6A;GRIA1;PSD2;GRM5;SNCB;GRIN2B;GRIA2;SLC24A2;SNTG1;ST8SIA5;NXPH1;TTYH1;DPP6;GRM3;AMER2;CACNG3;GRM1;SYNPR
prerank,CellMarker_Augmented_2021__Astrocyte:Spinal Cord,0.6554712046711877,1.6402969350330643,0.0,0.3897739990485344,1.0,32/70,21.57%,SLC39A12;CNTN2;NCAN;GFAP;CDH20;SLC1A2;HAPLN2;TNR;GRIA4;CA10;CTNNA2;KCNC2;CADM2;MOBP;GPM6A;GRIA1;PSD2;GRM5;SNCB;GRIN2B;GRIA2;SLC24A2;SNTG1;ST8SIA5;NXPH1;TTYH1;DPP6;GRM3;AMER2;CACNG3;GRM1;SYNPR
prerank,CellMarker_Augmented_2021__Schwann cell:Intervertebral Disc,0.6554712046711877,1.6402969350330643,0.0,0.3897739990485344,1.0,32/70,21.57%,SLC39A12;CNTN2;NCAN;GFAP;CDH20;SLC1A2;HAPLN2;TNR;GRIA4;CA10;CTNNA2;KCNC2;CADM2;MOBP;GPM6A;GRIA1;PSD2;GRM5;SNCB;GRIN2B;GRIA2;SLC24A2;SNTG1;ST8SIA5;NXPH1;TTYH1;DPP6;GRM3;AMER2;CACNG3;GRM1;SYNPR
prerank,CellMarker_Augmented_2021__Gastric Stem cell:Gastric Corpus,0.7861049574441629,1.6381879424430177,0.03225806451612903,0.3907049791794565,1.0,11/30,12.87%,SHROOM3;PLXNB1;GOLM1;DLG5;JAG1;RUNX1;TANC1;PTPRK;ENAH;ITGA2;TJP1
prerank,KEGG_2021_Human__Cytosolic DNA-sensing pathway,-0.8387350835127039,-1.6378986328978562,0.0,0.048392704998821555,0.99,3/35,4.19%,CCL4;CCL5;AIM2
prerank,GO_Biological_Process_2021__granulocyte chemotaxis (GO:0071621),-0.8310922141674433,-1.6377650641503432,0.015625,0.04820431611791174,0.99,5/24,3.26%,CCL4;JAML;CCL3;CCL5;FCER1G
prerank,CellMarker_Augmented_2021__Macrophage:Alveolus,-0.7167320673421517,-1.6369238516733948,0.0,0.048919664305687026,0.99,22/82,11.27%,JAML;NKG7;MYO1G;MNDA;CLEC12A;AIF1;PSTPIP1;FCER1G;SNX20;NCF4;LSP1;PLEK;IL10RA;CD300LF;CYTIP;FERMT3;NCF2;ITGB2;CSF2RB;NCKAP1L;TYROBP;ITGAL
prerank,CellMarker_Augmented_2021__Transitional B cell:Blood,-0.8528158573882945,-1.636919704905114,0.0,0.048687817555423105,0.99,7/30,5.38%,TC2N;CCDC88C;DTHD1;VAV3;SIDT1;TNFSF10;SLC37A1
prerank,GO_Biological_Process_2021__response to interferon-beta (GO:0035456),-0.8613214185888862,-1.6367295286095072,0.0,0.048543246990432144,0.99,10/17,10.38%,MNDA;PYHIN1;XAF1;IFITM3;AIM2;SHFL;PLSCR1;OAS1;STAT1;IRF1
prerank,Reactome_2022__Activated PKN1 Stimulates Transcription Of Androgen Receptor Regulated KLK2 And KLK3 R-HSA-5625886,-0.8651656104294075,-1.636557185528385,0.0,0.04852706810523456,0.99,9/17,9.35%,H2BC4;H2BC26;H2AC20;H2AC6;H3-3B;H2AJ;H2BC21;H2BC5;H2BC9
prerank,GO_Biological_Process_2021__polarized epithelial cell differentiation (GO:0030859),0.8308389663766116,1.6352433690499666,0.02040816326530612,0.3990381011302336,1.0,3/10,5.14%,SCRIB;MSN;RAB10
prerank,KEGG_2021_Human__AGE-RAGE signaling pathway in diabetic complications,0.6641324722675511,1.6351962062230145,0.0,0.392669783507608,1.0,9/69,7.30%,EGR1;SERPINE1;TGFBR2;MAPK11;PIM1;SMAD2;SMAD3;PLCB4;TNF
prerank,GO_Biological_Process_2021__positive regulation of hemoglobin biosynthetic process (GO:0046985),0.987023273238011,1.6344776774124736,0.0,0.38981561933674025,1.0,1/5,0.08%,KLF4
prerank,Reactome_2022__ER-Phagosome Pathway R-HSA-1236974,-0.7249544208857197,-1.6342221786197235,0.0,0.05066053048682447,0.99,18/71,14.82%,CD36;UBC;HLA-B;RPS27A;B2M;PSMB3;BTK;NDUFA2;HLA-C;PSMB6;PSMA7;HLA-F;PSMB9;PSMD12;PSMD8;PSMA5;HLA-E;UBA52
prerank,Reactome_2022__Antiviral Mechanism By IFN-stimulated Genes R-HSA-1169410,-0.6930467815127691,-1.6340773471610917,0.014705882352941176,0.050592703440628446,0.99,13/73,9.56%,FLNA;MX2;UBC;OAS3;MX1;RPS27A;IFIT1;OAS2;EIF2AK2;OAS1;RNASEL;EIF4A3;STAT1
prerank,Reactome_2022__RHO GTPases Activate PKNs R-HSA-5625740,-0.7686141714057078,-1.6340665195303423,0.0,0.05035847796173665,0.99,10/39,9.35%,H2BC4;H2BC26;H2AC20;H2AC6;H3-3B;H2AJ;H2BC21;PPP1CB;H2BC5;H2BC9
prerank,GO_Biological_Process_2021__regulation of immune response (GO:0050776),-0.7148816942149534,-1.6328227703081037,0.012048192771084338,0.05091613082313287,0.99,26/92,11.83%,JAML;IL4I1;HLA-B;RSAD2;CD96;DHX58;B2M;CD200R1;SELL;CD247;SLAMF6;HLA-C;CD300LF;PLSCR1;HLA-F;ITGA4;KLRD1;OSCAR;CD226;IRF1;ITGB2;HLA-DRA;ERAP1;TYROBP;ITGAL;APPL1
prerank,CellMarker_Augmented_2021__Neutrophil:Vagina,-0.7297472085536106,-1.631845624355926,0.0136986301369863,0.051634161711280845,0.99,20/59,13.94%,JAML;MNDA;VNN2;CLEC12A;AIF1;CD14;FCER1G;NCF4;CD300LF;C5AR1;SIRPB2;LILRB3;NCF2;MS4A6A;CSF2RB;TYROBP;CSF3R;FCGR1CP;CASP5;MYO1F
prerank,CellMarker_Augmented_2021__Thymic Emigrant cell:Blood,-0.7421920942540573,-1.6299918992732465,0.0,0.05279866591449306,1.0,28/85,11.27%,JAML;NKG7;MYO1G;CD37;CD2;MNDA;GPR183;VNN2;AIF1;PSTPIP1;SELL;FCER1G;SLAMF6;SNX20;NCF4;LSP1;PLEK;IL10RA;PECAM1;GIMAP2;CYTIP;TNFRSF1B;SAMSN1;ITGB2;CSF2RB;NCKAP1L;TYROBP;ITGAL
prerank,CellMarker_Augmented_2021__Naive CD4+ T cell:Blood,-0.7380795233383102,-1.6297133287418655,0.0,0.052927648614872744,1.0,26/82,11.27%,JAML;NKG7;MYO1G;CD37;CD2;MNDA;GPR183;VNN2;AIF1;PSTPIP1;SELL;FCER1G;SLAMF6;SNX20;NCF4;LSP1;PLEK;IL10RA;GIMAP2;CYTIP;TNFRSF1B;SAMSN1;ITGB2;NCKAP1L;TYROBP;ITGAL
prerank,CellMarker_Augmented_2021__Villous Stromal cell:Placenta,0.7721902355489474,1.6296139764374422,0.0,0.4094071759850202,1.0,13/28,14.07%,COL16A1;FKBP9;SVEP1;COL5A2;TIMP3;CTSK;CDH11;EPAS1;FAM114A1;COL6A1;COL15A1;GPNMB;MMP14
prerank,GO_Biological_Process_2021__activation of adenylate cyclase activity (GO:0007190),-0.8494401336102313,-1.6292432824105163,0.031746031746031744,0.053137087841843275,1.0,1/17,0.10%,CALCR
prerank,GO_Biological_Process_2021__response to tumor necrosis factor (GO:0034612),-0.771355875483509,-1.6283065347600145,0.0,0.054035317215901366,1.0,7/56,5.67%,CCL4;CCL3;ZFP36;CCL5;PID1;RPS3;GBP3
prerank,Reactome_2022__Signaling By BMP R-HSA-201451,0.8495369888143507,1.6281736936751152,0.0,0.40787882441811396,1.0,4/16,2.59%,UBE2D1;ACVR2A;SMAD1;SMAD7
prerank,GO_Biological_Process_2021__regulation of calcium ion transport (GO:0051924),-0.8336793963300692,-1.6265594085133088,0.014084507042253521,0.055006382460045654,1.0,5/39,1.49%,CCL4;CCL3;MYLK;PLN;CCL5
prerank,Reactome_2022__DNA Damage/Telomere Stress Induced Senescence R-HSA-2559586,-0.8348166479766552,-1.625155056266218,0.0,0.05649222647679892,1.0,16/33,12.89%,H1-4;H1-3;H1-2;H2BC4;H2BC26;H2AC20;H2AC6;H1-0;H2AJ;H2BC21;H2BC5;H2BC9;HIRA;TERF2IP;H2BC11;KAT5
prerank,GO_Biological_Process_2021__regulation of protein sumoylation (GO:0033233),0.8577891537696407,1.6250888746089196,0.04081632653061224,0.4149080286484487,1.0,3/11,7.49%,EGR1;SAE1;GNL3L
prerank,GO_Biological_Process_2021__semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),0.8740752990001864,1.6249855124885817,0.027777777777777776,0.4091534457444205,1.0,6/11,7.75%,PLXNB1;NRP1;PLXNA2;PLXNA3;PLXNB2;PLXNC1
prerank,KEGG_2021_Human__Glycosaminoglycan biosynthesis,0.6821567597121558,1.6237348029453678,0.0,0.4084166866041598,1.0,12/35,11.46%,B3GNT2;HS3ST5;CHST7;CSGALNACT1;HS2ST1;EXTL2;B4GALT4;B4GALT7;CHST1;CHST15;EXT1;UST
prerank,Reactome_2022__Keratan Sulfate/Keratin Metabolism R-HSA-1638074,0.8568222279430638,1.623280239364256,0.0,0.40417083510522195,1.0,4/16,6.57%,B3GNT2;GLB1;B4GALT4;CHST1
prerank,CellMarker_Augmented_2021__Myeloid-derived Suppressor cell:Liver,-0.6968172400987044,-1.6226917527346276,0.0,0.058746014708500605,1.0,34/81,20.71%,JAML;MNDA;CLEC12A;AIF1;FCER1G;BTK;SNX20;NCF4;PLEK;IL10RA;CD300LF;NCF2;SLC11A1;ITGB2;CSF2RB;NCKAP1L;TYROBP;ITGAL;CSF3R;PTPRC;HAVCR2;MYO1F;LY86;IGSF6;FCGR3A;LST1;PARVG;RNASE6;ARHGAP30;MPEG1;NCF1;RASGRP4;CLEC7A;PIK3R6
prerank,CellMarker_Augmented_2021__Myeloid-derived Suppressor cell:Blood,-0.6968172400987044,-1.6226917527346276,0.0,0.058746014708500605,1.0,34/81,20.71%,JAML;MNDA;CLEC12A;AIF1;FCER1G;BTK;SNX20;NCF4;PLEK;IL10RA;CD300LF;NCF2;SLC11A1;ITGB2;CSF2RB;NCKAP1L;TYROBP;ITGAL;CSF3R;PTPRC;HAVCR2;MYO1F;LY86;IGSF6;FCGR3A;LST1;PARVG;RNASE6;ARHGAP30;MPEG1;NCF1;RASGRP4;CLEC7A;PIK3R6
prerank,CellMarker_Augmented_2021__Intermediate monocyte:Blood,-0.7220206437845496,-1.6223632837603654,0.013888888888888888,0.05823413869423407,1.0,26/66,17.23%,JAML;MNDA;VNN2;CLEC12A;MS4A4A;AIF1;SIGLEC1;CD14;FCER1G;NCF4;CD300LF;C5AR1;SIRPB2;LILRB3;NCF2;SLC11A1;MS4A6A;TYROBP;CSF3R;FCGR1CP;MYO1F;LY86;FPR1;IGSF6;FCGR3A;GIMAP4
prerank,CellMarker_Augmented_2021__Classical monocyte:Blood,-0.7220206437845496,-1.6223632837603654,0.013888888888888888,0.05823413869423407,1.0,26/66,17.23%,JAML;MNDA;VNN2;CLEC12A;MS4A4A;AIF1;SIGLEC1;CD14;FCER1G;NCF4;CD300LF;C5AR1;SIRPB2;LILRB3;NCF2;SLC11A1;MS4A6A;TYROBP;CSF3R;FCGR1CP;MYO1F;LY86;FPR1;IGSF6;FCGR3A;GIMAP4
prerank,CellMarker_Augmented_2021__CD14++CD16- monocyte:Blood,-0.7220206437845496,-1.6223632837603654,0.013888888888888888,0.05823413869423407,1.0,26/66,17.23%,JAML;MNDA;VNN2;CLEC12A;MS4A4A;AIF1;SIGLEC1;CD14;FCER1G;NCF4;CD300LF;C5AR1;SIRPB2;LILRB3;NCF2;SLC11A1;MS4A6A;TYROBP;CSF3R;FCGR1CP;MYO1F;LY86;FPR1;IGSF6;FCGR3A;GIMAP4
prerank,CellMarker_Augmented_2021__Non-classical monocyte:Blood,-0.7220206437845496,-1.6223632837603654,0.013888888888888888,0.05823413869423407,1.0,26/66,17.23%,JAML;MNDA;VNN2;CLEC12A;MS4A4A;AIF1;SIGLEC1;CD14;FCER1G;NCF4;CD300LF;C5AR1;SIRPB2;LILRB3;NCF2;SLC11A1;MS4A6A;TYROBP;CSF3R;FCGR1CP;MYO1F;LY86;FPR1;IGSF6;FCGR3A;GIMAP4
prerank,CellMarker_Augmented_2021__Epithelial cell:Embryoid Body,0.6509325154620319,1.622066933619199,0.0,0.40613946909010495,1.0,20/63,16.66%,COL16A1;PDPN;LRP4;RASSF8;SVEP1;WNT5A;RASAL2;TIMP3;MAGI1;ROBO1;PTPRG;TACC2;ENAH;BMPR1A;TJP1;MARK1;FERMT2;ANTXR1;COL4A5;TNC
prerank,CellMarker_Augmented_2021__Neutrophil:Lung,-0.7433382886363716,-1.621399784187721,0.0,0.058919126376631596,1.0,19/70,11.39%,JAML;MNDA;VNN2;CLEC12A;PSTPIP1;FCAR;FCER1G;SNX20;NCF4;PLEK;CD300LF;C5AR1;NLRP12;SLC11A1;ITGB2;NCKAP1L;TYROBP;ITGAL;CSF3R
prerank,CellMarker_Augmented_2021__Neuron:Spinal Cord,0.6207723052430093,1.6200506248722386,0.0,0.4087357127047066,1.0,41/85,22.93%,NPAS3;NCAN;NMNAT2;NBEA;NLGN1;ARNT2;SNAP91;PLPPR4;TMEFF2;MAGI1;NUAK1;KCTD16;CADM2;MMP16;GUCY1A2;ENAH;TTLL7;TJP1;MARK1;GRIA2;NFASC;CSRNP3;PPFIA2;FAM171B;MAPK4;ATRNL1;MAP6;PCLO;RBFOX2;CRMP1;MAP2;DCLK1;ZNF462;CNTN1;PHYHIPL;LRP1B;PRICKLE2;DLG2;LIMCH1;OPCML;GLRB
prerank,CellMarker_Augmented_2021__Fat Cell (adipocyte):Adipose Tissue,0.8887259472599499,1.6196826822651582,0.05128205128205128,0.4039942641855604,1.0,3/10,5.17%,PPARGC1A;ADIPOR2;PPARG
prerank,CellMarker_Augmented_2021__Intestinal Stem cell:Colon,0.6185657754300264,1.6196741201039622,0.0,0.37669735444329283,1.0,36/78,22.00%,NPAS3;CNTN2;NMNAT2;NLGN1;ARNT2;PBX1;PLPPR4;NUAK1;NTM;CDH11;MMP16;PTPRG;GUCY1A2;PTPRD;ENAH;RUNX1T1;FBXL7;MARK1;NFASC;CSRNP3;PPFIA2;FAM171B;ADGRB3;ATRNL1;MAP6;CRMP1;MAP2;DCLK1;ZNF462;CNTN1;TMEM132B;MEGF10;NOVA1;PRICKLE2;LRFN5;LSAMP
prerank,CellMarker_Augmented_2021__Intestinal Stem cell:Esophagus,0.6185657754300264,1.6196741201039622,0.0,0.37669735444329283,1.0,36/78,22.00%,NPAS3;CNTN2;NMNAT2;NLGN1;ARNT2;PBX1;PLPPR4;NUAK1;NTM;CDH11;MMP16;PTPRG;GUCY1A2;PTPRD;ENAH;RUNX1T1;FBXL7;MARK1;NFASC;CSRNP3;PPFIA2;FAM171B;ADGRB3;ATRNL1;MAP6;CRMP1;MAP2;DCLK1;ZNF462;CNTN1;TMEM132B;MEGF10;NOVA1;PRICKLE2;LRFN5;LSAMP
prerank,CellMarker_Augmented_2021__Intestinal Stem cell:Intestine,0.6185657754300264,1.6196741201039622,0.0,0.37669735444329283,1.0,36/78,22.00%,NPAS3;CNTN2;NMNAT2;NLGN1;ARNT2;PBX1;PLPPR4;NUAK1;NTM;CDH11;MMP16;PTPRG;GUCY1A2;PTPRD;ENAH;RUNX1T1;FBXL7;MARK1;NFASC;CSRNP3;PPFIA2;FAM171B;ADGRB3;ATRNL1;MAP6;CRMP1;MAP2;DCLK1;ZNF462;CNTN1;TMEM132B;MEGF10;NOVA1;PRICKLE2;LRFN5;LSAMP
prerank,CellMarker_Augmented_2021__Esophageal Mucosal cell:Esophagus,0.6185657754300264,1.6196741201039622,0.0,0.37669735444329283,1.0,36/78,22.00%,NPAS3;CNTN2;NMNAT2;NLGN1;ARNT2;PBX1;PLPPR4;NUAK1;NTM;CDH11;MMP16;PTPRG;GUCY1A2;PTPRD;ENAH;RUNX1T1;FBXL7;MARK1;NFASC;CSRNP3;PPFIA2;FAM171B;ADGRB3;ATRNL1;MAP6;CRMP1;MAP2;DCLK1;ZNF462;CNTN1;TMEM132B;MEGF10;NOVA1;PRICKLE2;LRFN5;LSAMP
prerank,CellMarker_Augmented_2021__Small Intestinal Stem cell:Small Intestinal Crypt,0.6185657754300264,1.6196741201039622,0.0,0.37669735444329283,1.0,36/78,22.00%,NPAS3;CNTN2;NMNAT2;NLGN1;ARNT2;PBX1;PLPPR4;NUAK1;NTM;CDH11;MMP16;PTPRG;GUCY1A2;PTPRD;ENAH;RUNX1T1;FBXL7;MARK1;NFASC;CSRNP3;PPFIA2;FAM171B;ADGRB3;ATRNL1;MAP6;CRMP1;MAP2;DCLK1;ZNF462;CNTN1;TMEM132B;MEGF10;NOVA1;PRICKLE2;LRFN5;LSAMP
prerank,CellMarker_Augmented_2021__Adipose-derived Stromal cell:Visceral Adipose Tissue,0.5979474841719432,1.619346737165911,0.03333333333333333,0.368010969399802,1.0,25/60,23.74%,COL16A1;PDPN;SEMA5A;PHLDB1;PLPPR4;NTM;CDH11;PTPRD;NTRK2;FBXL7;SGIP1;NFASC;TNC;TMEM132C;CX3CL1;CNTN3;MAP6;BAALC;DCLK1;NAV1;PRICKLE2;OPCML;PLPP3;SEMA6D;FGF14
prerank,CellMarker_Augmented_2021__Adipose-derived Stem cell:Visceral Adipose Tissue,0.5979474841719432,1.619346737165911,0.03333333333333333,0.368010969399802,1.0,25/60,23.74%,COL16A1;PDPN;SEMA5A;PHLDB1;PLPPR4;NTM;CDH11;PTPRD;NTRK2;FBXL7;SGIP1;NFASC;TNC;TMEM132C;CX3CL1;CNTN3;MAP6;BAALC;DCLK1;NAV1;PRICKLE2;OPCML;PLPP3;SEMA6D;FGF14
prerank,PanglaoDB_Augmented_2021__Retinal Progenitor Cells,0.635389678089175,1.618678264747308,0.0,0.36565315020191586,1.0,28/60,21.09%,KCNQ2;LRP4;DPYSL5;NCAN;ZNF536;GALNT13;NOL4;SNAP91;CSPG5;LRRC4C;PURG;CADM2;SNCB;SLC35F1;LINGO1;CAMKV;GRIA2;CSRNP3;MAPK4;BRSK2;MAP6;PCLO;PHYHIPL;GRIK3;UNC5D;CELF5;MEGF10;CACNA1B
prerank,GO_Biological_Process_2021__response to estradiol (GO:0032355),0.7918092831444313,1.618568705745742,0.025,0.36156291395305334,1.0,4/20,4.06%,ANXA1;RUVBL2;NCOA3;NRIP1
prerank,PanglaoDB_Augmented_2021__Immature Neurons,0.6189212664139878,1.6174594716549775,0.0,0.3627392510828724,1.0,49/96,22.69%,NPAS3;KCNQ2;CNTN2;DPYSL5;NCAN;ZNF536;NOL4;SNAP91;SCN3B;LRRC4C;ROBO1;PURG;GRIA4;OLFM3;CTNNA2;FUT9;CADM2;SOX5;PTPN5;SLC35F1;CAMKV;NF1;RBFOX1;SLC12A5;GRIA2;CSRNP3;ROBO2;PPFIA2;ADGRB3;MAPK4;ATRNL1;CLASP2;NXPH1;PCLO;HIVEP2;DCLK1;PHYHIPL;SYT4;GRM3;GRIK3;CELF5;AMER2;NOVA1;CACNA1B;SYNPR;NRXN1;LSAMP;RAB3C;OPCML
prerank,CellMarker_Augmented_2021__Activated B cell:Undefined,-0.7272670585196337,-1.6164393057337314,0.0,0.06403016973982006,1.0,14/77,5.34%,CCL4;JAML;MYO1G;CD37;MNDA;VNN2;AIF1;BTK;SLAMF6;SNX20;NCF4;LSP1;PLEK;IL10RA
prerank,CellMarker_Augmented_2021__Dendritic cell:Bone Marrow,-0.7232342673502483,-1.616335035453373,0.0,0.06387149213006121,1.0,25/79,11.27%,CCL4;JAML;BCL2A1;CCL3;MYO1G;MNDA;GPR183;AIF1;FCER1G;BTK;SNX20;NCF4;LSP1;PLEK;IL10RA;LILRB4;CYTIP;SAMSN1;NCF2;ITGB2;CSF2RB;NCKAP1L;HLA-DRA;TYROBP;ITGAL
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-lysine acetylation (GO:2000758),0.7657927247878078,1.616134710097528,0.05405405405405406,0.36330349574956294,1.0,5/18,8.29%,PPARGC1A;RUVBL2;RPS6KA4;DIP2B;SOX4
prerank,PanglaoDB_Augmented_2021__Schwann Cells,0.6168203479704659,1.6152961483372488,0.0,0.3621273372347064,1.0,19/82,10.47%,COL16A1;BAG3;LGI4;LRP4;RGS11;CNTN2;GFAP;ASPA;ARNT2;PHLDB1;PLPPR4;SEMA3B;HAPLN2;CHST1;NTM;SHC2;CD82;PSD2;OLIG1
prerank,GO_Biological_Process_2021__negative regulation of BMP signaling pathway (GO:0030514),0.7604922949013028,1.614280255652332,0.0,0.36126410162747236,1.0,10/31,12.30%,UBE2D1;ACVR2A;SMAD1;SMAD7;PPARG;SPART;LEMD3;BMPR1B;SORL1;BMPR1A
prerank,CellMarker_Augmented_2021__Macrophage:Intervertebral Disc,-0.677852265353929,-1.6140520067746669,0.025974025974025976,0.06587266654160576,1.0,26/90,11.20%,CCL4;JAML;MNDA;CLEC12A;MS4A4A;AIF1;SIGLEC1;CD14;FCER1G;CD93;NCF4;LSP1;PLEK;IL10RA;LILRB4;CD300LF;PECAM1;C5AR1;TNFRSF1B;NCF2;MS4A6A;ITGB2;CSF2RB;NCKAP1L;HLA-DRA;TYROBP
prerank,CellMarker_Augmented_2021__Monocyte:Bone Marrow,-0.7288291759187987,-1.6138165734488326,0.0,0.06589940170997916,1.0,23/71,11.39%,JAML;MNDA;VNN2;CLEC12A;MS4A4A;AIF1;CD14;FCER1G;CD93;NCF4;PLEK;IL10RA;CD300LF;PECAM1;C5AR1;SIRPB2;LILRB3;SLC11A1;MS4A6A;ITGB2;CSF2RB;TYROBP;CSF3R
prerank,KEGG_2021_Human__AMPK signaling pathway,0.6011818567983959,1.6131309891616117,0.0,0.3612641016274723,1.0,19/93,8.78%,PRKAB2;LEPR;PFKP;PPARGC1A;CPT1C;PFKM;IGF1R;ADIPOR2;SIRT1;TBC1D1;TSC2;RAB10;PPARG;CPT1A;ADRA1A;CAB39;ACACB;PPP2R1B;GYS1
prerank,Reactome_2022__HDACs Deacetylate Histones R-HSA-3214815,-0.7765929339992326,-1.613037614067582,0.0,0.06615521782324776,1.0,10/40,9.35%,H2AC25;H2BC4;H2BC26;H2AC20;H2AC6;CHD3;H2BC18;H2BC21;H2BC5;H2BC9
prerank,Reactome_2022__AMPK Inhibits chREBP Transcriptional Activity R-HSA-163680,0.9484581830876534,1.612938036348677,0.0,0.3577957442769782,1.0,2/7,1.53%,PRKAB2;ADIPOR2
prerank,GO_Biological_Process_2021__regulation of glucose transmembrane transport (GO:0010827),-0.8631284880801451,-1.6125249958054384,0.0,0.06648498847470541,1.0,1/14,0.08%,NR4A3
prerank,KEGG_2021_Human__Apelin signaling pathway,0.5520881542154544,1.6120492391376726,0.0,0.35783654848110164,1.0,12/92,6.62%,EGR1;PRKAB2;PPARGC1A;SERPINE1;ACTA2;MAP2K1;GNAQ;SMAD2;SMAD3;PLCB4;ADCY9;JAG1
prerank,Reactome_2022__L1CAM Interactions R-HSA-373760,0.5985010068987038,1.6119023851479044,0.0,0.3542176900428404,1.0,17/74,12.55%,NRP1;KCNQ2;CNTN2;MSN;NCAN;SCN3A;MAP2K1;RPS6KA4;SCN3B;DNM3;SPTAN1;ALCAM;SCN8A;ITGAV;RPS6KA6;MAPK1;ITGA2
prerank,PanglaoDB_Augmented_2021__Melanocytes,0.6368872180384967,1.611730512472636,0.0,0.35041412304689196,1.0,25/71,16.66%,COL16A1;EPS8;RASSF8;FKBP9;COL5A2;MITF;BNC2;PHLDB1;RASAL2;PPARG;TIMP3;TANC1;SASH1;LOXL2;EPAS1;ITGAV;FAM114A1;COL6A1;GPNMB;MMP14;ENPP1;ANTXR1;STARD13;RAI14;TNC
prerank,CellMarker_Augmented_2021__Primordial Germ cell:Germ,0.6837889066805708,1.6111388493193508,0.05405405405405406,0.3494779927400658,1.0,26/51,21.61%,ZNF804B;NCAN;PCDH15;SLC9C2;NOL4;RALYL;KCTD16;TNR;CA10;CTNNA2;KCNC2;MOBP;GRM5;GRIN2B;CACNA1E;NELL1;GRIA2;GRIN2A;NXPH1;PEX5L;DLGAP1;GABRB2;GRM3;AMER2;GRM1;NRXN1
prerank,Reactome_2022__NGF-stimulated Transcription R-HSA-9031628,0.671052690239838,1.6100243982952793,0.04878048780487805,0.3509198232553918,1.0,2/21,1.30%,EGR1;CDK5R1
prerank,Reactome_2022__FOXO-mediated Transcription Of Cell Cycle Genes R-HSA-9617828,0.872879994264319,1.6086447598040265,0.023809523809523808,0.35245909843368445,1.0,5/12,5.98%,KLF4;PCBP4;CCNG2;SMAD2;SMAD3
prerank,"GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",-0.7231487034076759,-1.6085085866150444,0.0,0.0710943218283341,1.0,17/62,14.31%,CD36;HLA-B;B2M;PSMB3;NCF4;HLA-C;PSMB6;PSMA7;HLA-F;PSMB9;NCF2;TAP1;PSMD12;CYBA;PSMD8;PSMA5;HLA-E
prerank,GO_Biological_Process_2021__negative regulation of wound healing (GO:0061045),0.7933762752990288,1.6084201092245345,0.0,0.3489701088035669,1.0,9/15,16.96%,SERPINE1;FGF2;SERPINE2;TNF;CRK;PTEN;CLASP1;SLC12A2;CLASP2
prerank,Reactome_2022__Chemokine Receptors Bind Chemokines R-HSA-380108,-0.9449449950319866,-1.6079397603158139,0.0,0.0715893581665505,1.0,4/12,1.49%,CCL4;CCL3;CXCR4;CCL5
prerank,Reactome_2022__Respiratory Electron Transport R-HSA-611105,-0.7158333952691366,-1.6071437946787337,0.0,0.07253124064638189,1.0,31/71,18.82%,CYCS;COX7C;UQCRB;NDUFC1;NDUFA2;UQCRH;NDUFA1;TMEM126B;NDUFB9;NDUFA12;NDUFB4;UQCR10;COX4I1;COX5B;ETFB;NDUFB1;NDUFS8;NDUFS5;COX18;COX6C;NDUFS6;NDUFB7;ETFDH;NUBPL;UQCRC1;NDUFB3;UQCRQ;NDUFS7;NDUFA3;SURF1;COX20
prerank,GO_Biological_Process_2021__negative regulation of interleukin-8 production (GO:0032717),0.8601702738804811,1.6070675915280532,0.0,0.35214382977712944,1.0,2/11,0.34%,KLF4;ANXA1
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Umbilical Cord Blood,-0.7002971235923902,-1.6062094265432205,0.0136986301369863,0.07387698185158963,1.0,29/86,11.20%,SRGN;HLA-B;ZFP36;CARD16;IL7R;DHX58;B2M;FCER1G;OAS2;CMAHP;CD93;BTN3A3;NCF4;LSP1;SAMD9L;PHF11;PLEK;PECAM1;GBP3;TRIM22;NLRC5;TNFRSF1B;FERMT3;IFI44;GBP2;ITGB2;CSF2RB;HLA-DRA;TYROBP
prerank,Reactome_2022__Transcriptional Regulation Of Granulopoiesis R-HSA-9616222,-0.8080730917786039,-1.605515878069264,0.0,0.07420530131132429,1.0,11/31,12.68%,H2BC4;H2BC26;H2AC20;H2AC6;H3-3B;H2AJ;H2BC21;H2BC5;H2BC9;CSF3R;H2BC11
prerank,KEGG_2021_Human__Alcoholism,-0.6886219133782986,-1.6042814196776933,0.0,0.07538460935344547,1.0,15/81,9.35%,H2AC8;H2BC7;H4C3;H2BC4;H2AC20;H2AC6;GNB5;H2BC18;H3-3B;H2AJ;H2BC21;PPP1CB;H2BC5;CALM1;H2BC9
prerank,Reactome_2022__Carnitine Metabolism R-HSA-200425,0.8967607203356873,1.6027181829246786,0.02,0.3666523625952078,1.0,2/8,5.35%,PRKAB2;CPT1A
prerank,GO_Biological_Process_2021__negative regulation of response to wounding (GO:1903035),0.8523369661735423,1.6026356435577318,0.0,0.3629997561994643,1.0,4/13,8.31%,SERPINE1;FGF2;CRK;GIT1
prerank,GO_Biological_Process_2021__sphingosine metabolic process (GO:0006670),0.8508356693659509,1.6021413232958204,0.02127659574468085,0.36126410162747236,1.0,4/13,6.65%,ACER2;ABCA2;PLPP1;SPTLC2
prerank,KEGG_2021_Human__Chemokine signaling pathway,-0.703890129512834,-1.6020772803340992,0.0,0.07810677558097592,1.0,6/114,2.19%,CCL4;ITK;CCL3;CXCR4;CCL5;VAV3
prerank,Reactome_2022__Recruitment And ATM-mediated Phosphorylation Of Repair And Signal Proteins At DNA Double Strand Breaks R-HSA-5693565,-0.7650337797094029,-1.602032156100045,0.0,0.07797204239265906,1.0,14/42,14.82%,UBC;H2BC4;H2BC26;RPS27A;UBXN1;EYA2;H2BC21;H2BC5;ABRAXAS1;H2BC9;H2BC11;KAT5;BRCA1;UBA52
prerank,PanglaoDB_Augmented_2021__Neuroendocrine Cells,0.55814815197613,1.6014583413953634,0.0,0.36017156906206665,1.0,38/87,22.69%,CNTN2;NCAN;GFAP;ZNF536;SNAP91;SCN3B;PLPPR4;LRRC4C;PDE10A;GRIA4;CA10;OLFM3;KCNC2;CADM2;PSD2;GRM5;SNCB;PTPN5;RBFOX1;NEGR1;CXCL14;GRIA2;NFASC;FXYD7;CSRNP3;PPFIA2;ADGRB3;CLASP2;NXPH1;PHYHIPL;SYT4;GRM3;AMER2;SYNPR;NRXN1;LSAMP;RAB3C;OPCML
prerank,GO_Biological_Process_2021__cellular response to organonitrogen compound (GO:0071417),0.6139109256672769,1.601388357731068,0.0,0.3566987421789043,1.0,7/72,6.73%,EGR1;RRAGD;PKD2;AANAT;RAP1A;GLRA1;CPEB4
prerank,Reactome_2022__HCMV Late Events R-HSA-9610379,-0.7061533889452762,-1.6012887126531916,0.014705882352941176,0.07864502018778675,1.0,16/66,12.68%,H2AC25;CEBPD;H2BC4;H2BC26;H2AC20;H2AC6;H2BC18;TXN2;H2BC21;SNF8;H2BC5;H2BC9;VPS28;NUP50;VPS37B;H2BC11
prerank,CellMarker_Augmented_2021__Neural cell:Embryoid Body,0.6412171926230782,1.601077478433513,0.0,0.3553183461694823,1.0,24/53,20.67%,KCNQ2;DPYSL5;GRID2;NCAN;NLGN1;SNAP91;FZD3;PURG;PTPN5;PTPRD;SLC35F1;LINGO1;CAMKV;MARK1;CSRNP3;MAPK4;ADGRV1;MAP6;CRMP1;DCLK1;SYT4;UNC5D;TMEM132B;MEGF10
prerank,GO_Biological_Process_2021__cardiac muscle cell membrane repolarization (GO:0099622),0.828191215283721,1.6010018768332515,0.022222222222222223,0.3517292719657502,1.0,4/10,5.43%,KCNJ2;KCNIP2;KCND3;KCNJ5
prerank,Reactome_2022__DNA Double Strand Break Response R-HSA-5693606,-0.7630635918377632,-1.5992139238622058,0.0,0.0807731850272728,1.0,14/43,14.82%,UBC;H2BC4;H2BC26;RPS27A;UBXN1;EYA2;H2BC21;H2BC5;ABRAXAS1;H2BC9;H2BC11;KAT5;BRCA1;UBA52
prerank,KEGG_2021_Human__Longevity regulating pathway,0.6074687406618801,1.5990457667676923,0.0,0.3570687765763146,1.0,11/79,8.06%,PRKAB2;PPARGC1A;IGF1R;ADIPOR2;SIRT1;EIF4EBP2;TSC2;PPARG;CAT;ADCY9;EIF4E2
prerank,GO_Biological_Process_2021__regulation of lamellipodium assembly (GO:0010591),0.7494991206646962,1.5990058736365569,0.0,0.3535334421547669,1.0,5/25,8.34%,AVIL;FER;AKIRIN1;WASF2;AUTS2
prerank,GO_Biological_Process_2021__negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),-0.8401983603520264,-1.598082697810943,0.0,0.08157491531163358,1.0,4/14,5.33%,RPGRIP1L;CCL5;RGS2;PLEK
prerank,CellMarker_Augmented_2021__Neural Progenitor cell:Eye,0.6357720186061091,1.5977257394052757,0.0,0.3513075588954906,1.0,21/60,16.64%,LRP4;RASSF8;FKBP9;COL5A2;PHLDB1;GPR161;MAGI1;UNC13B;TBC1D16;NUAK1;MMP16;PTPRG;ENAH;COL6A1;TJP1;FBXL7;ADCY6;FERMT2;CD276;ANTXR1;RAI14
prerank,CellMarker_Augmented_2021__Neural Stem cell:Spinal Cord,0.6357720186061091,1.5977257394052757,0.0,0.3513075588954906,1.0,21/60,16.64%,LRP4;RASSF8;FKBP9;COL5A2;PHLDB1;GPR161;MAGI1;UNC13B;TBC1D16;NUAK1;MMP16;PTPRG;ENAH;COL6A1;TJP1;FBXL7;ADCY6;FERMT2;CD276;ANTXR1;RAI14
prerank,KEGG_2021_Human__Signaling pathways regulating pluripotency of stem cells,0.5890490637923772,1.5974441041683607,0.0,0.3488260385751617,1.0,13/76,7.68%,KLF4;ACVR2A;IGF1R;SMAD1;FGF2;MAPK11;MAP2K1;WNT5A;FZD3;SMAD2;SMAD3;WNT2B;DVL3
prerank,Reactome_2022__Base Excision Repair R-HSA-73884,-0.7599551185715848,-1.5964012289485867,0.0,0.08323954853880297,1.0,17/42,13.98%,H2BC4;H2BC26;H2AC20;SMUG1;H2AC6;POLE3;OGG1;H2AJ;H2BC21;H2BC5;H2BC9;PARP2;PARG;TERF2IP;H2BC11;APEX1;RPA3
prerank,PanglaoDB_Augmented_2021__Acinar Cells,0.9607259327829603,1.596343155327156,0.0,0.350165358105891,1.0,1/8,0.01%,CPA1
prerank,GO_Biological_Process_2021__positive regulation of glucose metabolic process (GO:0010907),0.8959872057896676,1.5963354094696485,0.024390243902439025,0.3468619113313071,1.0,2/8,2.51%,PPARGC1A;SIRT1
prerank,Reactome_2022__Metalloprotease DUBs R-HSA-5689901,-0.848535075221324,-1.5962977005627776,0.02857142857142857,0.08297874577575709,1.0,5/22,1.91%,H2AC25;UBC;H2AC20;RPS27A;H2AC6
prerank,Reactome_2022__NoRC Negatively Regulates rRNA Expression R-HSA-427413,-0.7265928531349015,-1.5944329715069405,0.0,0.08512759775799782,1.0,14/51,13.12%,H2BC4;H2BC26;H2AC20;H2AC6;TAF1D;GTF2H5;H3-3B;H2AJ;H2BC21;H2BC5;H2BC9;H2BC11;TAF1C;DNMT1
prerank,CellMarker_Augmented_2021__Epithelial Stem cell:Laryngeal Squamous Epithelium,0.6601568585659494,1.593716115016312,0.0,0.34494894865074777,1.0,13/38,13.83%,PLXNB1;PCBP4;LRP4;CHST1;TBC1D16;SHC2;UNC5B;CELSR2;LINGO1;RTKN;COL6A1;MARK1;SORCS2
prerank,CellMarker_Augmented_2021__Mesenchymal Stromal cell:Liver,0.6601568585659494,1.593716115016312,0.0,0.34494894865074777,1.0,13/38,13.83%,PLXNB1;PCBP4;LRP4;CHST1;TBC1D16;SHC2;UNC5B;CELSR2;LINGO1;RTKN;COL6A1;MARK1;SORCS2
prerank,CellMarker_Augmented_2021__Epithelial Stem cell:Corneal Epithelium,0.6601568585659494,1.593716115016312,0.0,0.34494894865074777,1.0,13/38,13.83%,PLXNB1;PCBP4;LRP4;CHST1;TBC1D16;SHC2;UNC5B;CELSR2;LINGO1;RTKN;COL6A1;MARK1;SORCS2
prerank,CellMarker_Augmented_2021__Epithelial Progenitor cell:Corneal Epithelium,0.6601568585659494,1.593716115016312,0.0,0.34494894865074777,1.0,13/38,13.83%,PLXNB1;PCBP4;LRP4;CHST1;TBC1D16;SHC2;UNC5B;CELSR2;LINGO1;RTKN;COL6A1;MARK1;SORCS2
prerank,GO_Biological_Process_2021__positive regulation of cell projection organization (GO:0031346),0.6084427502115479,1.5935412991079658,0.0,0.3429961697230317,1.0,31/88,18.87%,AVIL;PLXNB1;PLXNA2;RAP1A;CHODL;WNT5A;RELN;PLXNA3;SCARB2;PLXNB2;ROBO1;DVL3;PLXNC1;FUT9;NPTN;ZNF804A;PTPRD;METRN;NTRK2;PRKCI;PLXNA1;MAP3K13;CAPRIN2;ROBO2;TIAM2;IL1RAPL1;CX3CL1;RAPGEF2;MARK2;MAP6;SCN1B
prerank,CellMarker_Augmented_2021__Preadipocyte:Adipose Tissue,-0.675110411525896,-1.5931922433344154,0.0,0.08625723659401943,1.0,24/85,11.39%,JAML;CD36;MNDA;CLEC12A;MS4A4A;AIF1;SIGLEC1;FCER1G;SNX20;CD93;NCF4;PLEK;IL10RA;F13A1;LILRB4;CD300LF;PECAM1;SIRPB2;TNFRSF1B;MS4A6A;CSF2RB;NCKAP1L;TYROBP;CSF3R
prerank,GO_Biological_Process_2021__establishment of apical/basal cell polarity (GO:0035089),0.8694226359282315,1.5930324633047308,0.025,0.3414944647296556,1.0,2/10,1.49%,SCRIB;MSN
prerank,CellMarker_Augmented_2021__Glutamatergic neuron:Brain,0.5996841468796558,1.5926370185958287,0.0,0.33970994883268457,1.0,34/69,23.08%,KCNQ2;CNTN2;NCAN;SNAP91;RALYL;SCN3B;NGB;TNR;GRIA4;CA10;OLFM3;CTNNA2;KCNC2;CADM2;PSD2;GRM5;SNCB;PTPN5;RBFOX1;SLC12A5;GRIA2;NXPH1;SYT4;GRM3;CELF5;AMER2;CACNG3;CACNA1B;GRM1;SYNPR;NRXN1;RAB3C;OPCML;SYP
prerank,Reactome_2022__Antigen processing-Cross Presentation R-HSA-1236975,-0.6981163196693203,-1.592492189005187,0.0,0.08655799739798,1.0,19/83,12.85%,CD36;UBC;HLA-B;RPS27A;B2M;PSMB3;BTK;NDUFA2;NCF4;HLA-C;PSMB6;PSMA7;HLA-F;PSMB9;NCF2;PSMD12;CYBA;PSMD8;PSMA5
prerank,GO_Biological_Process_2021__negative regulation of DNA metabolic process (GO:0051053),-0.8016882721048166,-1.5923800965266457,0.0,0.08625272744321894,1.0,6/24,8.56%,H1-4;H1-3;H1-2;H1-0;RPS3;H1-10
prerank,GO_Biological_Process_2021__sympathetic nervous system development (GO:0048485),0.8399835949691457,1.591530391029126,0.0975609756097561,0.3413301741183164,1.0,4/7,12.21%,NRP1;FZD3;SOX4;NF1
prerank,CellMarker_Augmented_2021__Monocyte:Subcutaneous Adipose Tissue,-0.7066770731121487,-1.5914085805481486,0.0,0.08670630662115245,1.0,37/84,19.56%,JAML;MNDA;VNN2;CLEC12A;AIF1;CD14;FCER1G;SNX20;NCF4;LSP1;PLEK;IL10RA;LILRB4;CD300LF;CYTIP;TNFRSF1B;MS4A6A;ITGB2;CSF2RB;NCKAP1L;TYROBP;ITGAL;CSF3R;PTPRC;HAVCR2;MYO1F;LY86;FPR1;IGSF6;FCGR3A;LST1;GIMAP4;EVI2B;PARVG;RNASE6;ARHGAP30;MPEG1
prerank,CellMarker_Augmented_2021__Macrophage:Subcutaneous Adipose Tissue,-0.7066770731121487,-1.5914085805481486,0.0,0.08670630662115245,1.0,37/84,19.56%,JAML;MNDA;VNN2;CLEC12A;AIF1;CD14;FCER1G;SNX20;NCF4;LSP1;PLEK;IL10RA;LILRB4;CD300LF;CYTIP;TNFRSF1B;MS4A6A;ITGB2;CSF2RB;NCKAP1L;TYROBP;ITGAL;CSF3R;PTPRC;HAVCR2;MYO1F;LY86;FPR1;IGSF6;FCGR3A;LST1;GIMAP4;EVI2B;PARVG;RNASE6;ARHGAP30;MPEG1
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Brown Adipose Tissue,0.6039104604189865,1.5913042499815633,0.0,0.3395781218944347,1.0,34/84,20.93%,ESRRG;PPARGC1A;LRP4;FRAS1;PBX1;MAGI1;PLEKHA5;DTNA;PTPRG;ASXL3;GUCY1A2;TACC2;PTPRD;ENAH;COBL;RUNX1T1;GPC6;TJP1;MARK1;ERBB4;HFM1;FERMT2;CSRNP3;KALRN;MAPK4;SORBS2;FARP1;ZNF385B;PCLO;DCLK1;PHYHIPL;LRP1B;GAREM1;PRKG1
prerank,PanglaoDB_Augmented_2021__Macrophages,-0.6833840107866629,-1.5911444968647515,0.0,0.08664968842849953,1.0,45/152,11.39%,CCL4;NR4A3;JAML;CD36;CCL3;ADGRE1;MYO1G;RUNX3;CCL5;MNDA;CLEC12A;MS4A4A;CHIT1;AIF1;PARP14;SIGLEC1;CD14;CD200R1;FCER1G;RGS1;PLTP;SNX20;NCF4;LSP1;PLEK;IL10RA;F13A1;LILRB4;CD300LF;SELENOP;C5AR1;CYTIP;TNFRSF1B;RBPJ;EGLN3;SAMSN1;NCF2;SLC11A1;MS4A6A;ITGB2;CSF2RB;HLA-DRA;TYROBP;ITGAL;CSF3R
prerank,GO_Biological_Process_2021__negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),0.9228498758609321,1.591041290430212,0.0,0.3378562774675165,1.0,1/9,0.08%,KLF4
prerank,PanglaoDB_Augmented_2021__Purkinje Neurons,0.571082647774859,1.590745668901446,0.0,0.3360642621701383,1.0,47/104,23.08%,KCNQ2;CNTN2;GRID2;NCAN;PKP4;SLC22A15;SNAP91;GRIA3;GRIA4;CA10;OLFM3;MRPS35;CTNNA2;CADM2;SHANK2;PSD2;GRM5;SNCB;CLSTN3;PTPN5;NRXN2;RBFOX1;SLC12A5;GRIA2;SLC24A2;CACNG2;GAD1;ADGRB3;NXPH1;DLGAP1;HIVEP2;PPM1E;SYT4;GRM3;GRIK3;CELF5;CNTNAP2;AMER2;PRKG1;CACNA1B;CERK;SYNPR;NRXN1;GRIN1;RAB3C;OPCML;SYP
prerank,GO_Biological_Process_2021__central nervous system neuron differentiation (GO:0021953),0.7289966920462991,1.5895680260790088,0.027777777777777776,0.33845054026171345,1.0,8/22,12.47%,GRID2;CHD5;MDGA2;RYK;ZC4H2;SOX4;KNDC1;NTRK2
prerank,GO_Biological_Process_2021__fatty-acyl-CoA biosynthetic process (GO:0046949),0.6784643846529046,1.589172147989221,0.0,0.3367815791533959,1.0,7/20,20.80%,PPT1;HACD2;ELOVL6;GCDH;FASN;ACACA;SCD5
prerank,CellMarker_Augmented_2021__Macrophage:Retinal Pigment Epithelium,-0.6734832515469338,-1.5879478512431735,0.014705882352941176,0.08923404550691022,1.0,27/79,11.93%,BCL2A1;SRGN;MNDA;CARD16;CLEC12A;MS4A4A;MARCO;SIGLEC1;CD14;FCER1G;CTSB;SAMD9L;LILRB4;CD300LF;C5AR1;SIRPB2;TNFRSF1B;TYMP;OSCAR;TNFAIP2;GBP2;LILRB3;NCF2;ITGB2;CSF2RB;TYROBP;MLKL
prerank,CellMarker_Augmented_2021__Macrophage:Artery,-0.6734832515469338,-1.5879478512431735,0.014705882352941176,0.08923404550691022,1.0,27/79,11.93%,BCL2A1;SRGN;MNDA;CARD16;CLEC12A;MS4A4A;MARCO;SIGLEC1;CD14;FCER1G;CTSB;SAMD9L;LILRB4;CD300LF;C5AR1;SIRPB2;TNFRSF1B;TYMP;OSCAR;TNFAIP2;GBP2;LILRB3;NCF2;ITGB2;CSF2RB;TYROBP;MLKL
prerank,CellMarker_Augmented_2021__Macrophage:Lymph Node,-0.6734832515469338,-1.5879478512431735,0.014705882352941176,0.08923404550691022,1.0,27/79,11.93%,BCL2A1;SRGN;MNDA;CARD16;CLEC12A;MS4A4A;MARCO;SIGLEC1;CD14;FCER1G;CTSB;SAMD9L;LILRB4;CD300LF;C5AR1;SIRPB2;TNFRSF1B;TYMP;OSCAR;TNFAIP2;GBP2;LILRB3;NCF2;ITGB2;CSF2RB;TYROBP;MLKL
prerank,CellMarker_Augmented_2021__Macrophage:Eye,-0.6734832515469338,-1.5879478512431735,0.014705882352941176,0.08923404550691022,1.0,27/79,11.93%,BCL2A1;SRGN;MNDA;CARD16;CLEC12A;MS4A4A;MARCO;SIGLEC1;CD14;FCER1G;CTSB;SAMD9L;LILRB4;CD300LF;C5AR1;SIRPB2;TNFRSF1B;TYMP;OSCAR;TNFAIP2;GBP2;LILRB3;NCF2;ITGB2;CSF2RB;TYROBP;MLKL
prerank,CellMarker_Augmented_2021__Macrophage:Visceral Adipose Tissue,-0.6734832515469338,-1.5879478512431735,0.014705882352941176,0.08923404550691022,1.0,27/79,11.93%,BCL2A1;SRGN;MNDA;CARD16;CLEC12A;MS4A4A;MARCO;SIGLEC1;CD14;FCER1G;CTSB;SAMD9L;LILRB4;CD300LF;C5AR1;SIRPB2;TNFRSF1B;TYMP;OSCAR;TNFAIP2;GBP2;LILRB3;NCF2;ITGB2;CSF2RB;TYROBP;MLKL
prerank,CellMarker_Augmented_2021__Monocyte:Kidney,-0.6734832515469338,-1.5879478512431735,0.014705882352941176,0.08923404550691022,1.0,27/79,11.93%,BCL2A1;SRGN;MNDA;CARD16;CLEC12A;MS4A4A;MARCO;SIGLEC1;CD14;FCER1G;CTSB;SAMD9L;LILRB4;CD300LF;C5AR1;SIRPB2;TNFRSF1B;TYMP;OSCAR;TNFAIP2;GBP2;LILRB3;NCF2;ITGB2;CSF2RB;TYROBP;MLKL
prerank,CellMarker_Augmented_2021__Glutamatergic neuron:Dorsolateral Prefrontal Cortex,0.6072668385181267,1.587885783611556,0.0,0.3393163363135452,1.0,36/78,21.57%,CNTN2;NCAN;GFAP;SNAP91;GRIK2;SCN3B;KCTD16;NTM;GRIA3;GRIA4;KCNC2;GRIA1;PSD2;GRM5;PTPN5;TTLL7;GRIN2B;RBFOX1;GRIA2;PDE1C;SYT16;FAM171B;GRIN2A;PEX5L;IL1RAPL1;PNMA2;KIAA1549L;DCLK1;GRM3;TMEM132B;CELF5;AMER2;CACNG3;GRM1;EPHA5;SYNPR
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Chorionic Villus,-0.7187274065739785,-1.587866378546031,0.0,0.08906686027560884,1.0,47/92,18.87%,JAML;SRGN;GPR183;XAF1;CARD16;CD69;FCER1G;CMAHP;SNX20;CD93;NCF4;LSP1;SAMD9L;PHF11;PLEK;IL10RA;PECAM1;TRIM22;NLRC5;GIMAP2;CYTIP;TNFRSF1B;CD44;GBP2;SAMSN1;CFLAR;MS4A6A;ITGB2;CSF2RB;NCKAP1L;HLA-DRA;TYROBP;PTPRC;HAVCR2;HLA-E;APOL3;HLA-DPA1;CIITA;CD74;HLA-DPB1;FCGR3A;GIMAP4;EVI2B;CASP4;PARVG;RNASE6;TNFRSF14
prerank,PanglaoDB_Augmented_2021__Myeloid-derived Suppressor Cells,-0.7378700500072303,-1.5876864693613446,0.014084507042253521,0.08917322146533373,1.0,36/73,19.56%,JAML;ADGRE1;MNDA;VNN2;CLEC12A;AIF1;PSTPIP1;FCER1G;SNX20;NCF4;PLEK;CD300LF;C5AR1;SIRPB2;CYTIP;TNFRSF1B;LILRB3;NCF2;ITGB2;CSF2RB;TYROBP;ITGAL;CSF3R;PTPRC;MYO1F;LY86;FPR1;IGSF6;S100A4;FCGR3A;LST1;EVI2B;PARVG;RNASE6;ARHGAP30;MPEG1
prerank,GO_Biological_Process_2021__branching involved in ureteric bud morphogenesis (GO:0001658),0.9230046826032259,1.5874710894151987,0.0,0.33814936305360044,1.0,3/5,7.23%,PKD2;FGF2;SALL1
prerank,Reactome_2022__Activation Of PPARGC1A (PGC-1alpha) By Phosphorylation R-HSA-2151209,0.9274009407419179,1.5866001465611046,0.0,0.33891195996146795,1.0,3/7,2.65%,PRKAB2;PPARGC1A;MAPK11
prerank,GO_Biological_Process_2021__response to interferon-alpha (GO:0035455),-0.8766323813907229,-1.5860934338501602,0.0,0.0912793329635249,1.0,4/13,6.90%,MX2;PYHIN1;IFITM3;EIF2AK2
prerank,GO_Biological_Process_2021__lipid oxidation (GO:0034440),0.9244506519306628,1.5855578439282767,0.0,0.34089384674944806,1.0,3/8,1.59%,PPARGC1A;ADIPOR2;PLA2G7
prerank,GO_Biological_Process_2021__positive regulation of sprouting angiogenesis (GO:1903672),0.8691679469659126,1.5851350246821616,0.02040816326530612,0.34040025392682227,1.0,3/11,2.26%,KLF4;SMAD1;FGF2
prerank,CellMarker_Augmented_2021__M2 macrophage:Lung,-0.6771401619717651,-1.584979548556666,0.027777777777777776,0.09239003000191161,1.0,24/79,11.20%,CCL4;CCL3;MNDA;CLEC12A;MS4A4A;MARCO;AIF1;SIGLEC1;CD14;FCER1G;CD93;PLEK;IL10RA;LILRB4;CD300LF;PECAM1;C5AR1;TYMP;NCF2;MS4A6A;ITGB2;CSF2RB;HLA-DRA;TYROBP
prerank,GO_Biological_Process_2021__keratan sulfate metabolic process (GO:0042339),0.8310344525248728,1.5849169661072688,0.0,0.3387025757968018,1.0,4/17,6.57%,B3GNT2;GLB1;B4GALT4;CHST1
prerank,"Reactome_2022__Respiratory Electron Transport, ATP Synthesis By Chemiosmotic Coupling, Heat Production By Uncoupling Proteins R-HSA-163200",-0.6910286879229579,-1.584101616888443,0.0,0.09329051074399689,1.0,36/87,18.82%,CYCS;COX7C;UQCRB;NDUFC1;NDUFA2;UQCRH;NDUFA1;TMEM126B;NDUFB9;ATP5PD;NDUFA12;ATP5F1E;NDUFB4;UQCR10;COX4I1;COX5B;ETFB;NDUFB1;NDUFS8;ATP5ME;NDUFS5;COX18;COX6C;NDUFS6;NDUFB7;ETFDH;NUBPL;UQCRC1;NDUFB3;UQCRQ;ATP5F1C;NDUFS7;NDUFA3;SURF1;ATP5F1D;COX20
prerank,Reactome_2022__Translesion Synthesis By Y Family DNA Polymerases Bypasses Lesions On DNA Template R-HSA-110313,-0.7973434440755768,-1.5831585955594067,0.01818181818181818,0.0943854733145128,1.0,3/30,3.35%,UBC;RPS27A;POLE3
prerank,CellMarker_Augmented_2021__Lymphoblast:Fetal Liver,-0.9553830813301715,-1.5818299827114815,0.0,0.09560594621989406,1.0,7/9,3.81%,ITK;THEMIS;CD96;CD2;GRAP2;PRF1;CD247
prerank,PanglaoDB_Augmented_2021__Langerhans Cells,-0.6825396278965722,-1.5813272165896057,0.01282051282051282,0.09611848941135348,1.0,35/91,15.96%,CCL4;JAML;MNDA;MS4A4A;AIF1;SIGLEC1;FCER1G;SNX20;NCF4;LSP1;PLEK;IL10RA;LILRB4;CD300LF;HLA-DRB5;HLA-F;CYTIP;NCF2;MS4A6A;ITGB2;CSF2RB;NCKAP1L;HLA-DRA;TYROBP;ITGAL;PTPRC;HAVCR2;MYO1F;HLA-DRB6;LY86;HLA-DPA1;CIITA;HLA-DMB;CD74;IGSF6
prerank,CellMarker_Augmented_2021__Granulosa cell:Fetal Gonad,-0.7100810441101408,-1.580953154616835,0.0,0.09632882691758887,1.0,49/110,16.40%,H2AC8;MT2A;H1-3;CEBPD;SRGN;RPS27A;GAPDH;TFRC;RPL31;RPS14;SYNE2;RPL12;RPS11;RPS23;CD14;RPS27;POLE3;IFITM3;SCN9A;PTMA;GATM;HLA-DRB5;OSMR;EMP3;PLAG1;RPL34;GPC3;CHI3L1;LDHA;MEIS1;HINT1;WDR46;EIF5A;HLA-DRA;SLC35F2;QPRT;PGK1;RPS28;LRRN3;ZNF217;COPE;TET1;UBA52;SPRY1;RPL8;PNMA1;ATP1A1;CDKN1C;MT3
prerank,GO_Biological_Process_2021__protein export from nucleus (GO:0006611),0.6745857916937925,1.5809028680712471,0.05555555555555555,0.3512752324580491,1.0,5/24,7.82%,NUTF2;PKD1;NUP42;XPO1;RANBP3L
prerank,GO_Biological_Process_2021__regulation of amyloid precursor protein catabolic process (GO:1902991),0.8636344414231207,1.5796996018644403,0.046511627906976744,0.35373967786992777,1.0,3/10,6.50%,ABCA2;PICALM;TMED10
prerank,GO_Biological_Process_2021__organelle fission (GO:0048285),-0.7500003506867181,-1.5783060668709747,0.08771929824561403,0.09980840539439488,1.0,3/19,5.76%,MX2;MX1;FIS1
prerank,GO_Biological_Process_2021__regulation of DNA recombination (GO:0000018),-0.7956034000334686,-1.5778891170533895,0.030303030303030304,0.10006957599107488,1.0,5/28,3.75%,H1-4;H1-3;H1-2;IL7R;H1-0
prerank,PanglaoDB_Augmented_2021__Taste Receptor Cells,0.595918091125476,1.5772992335617073,0.0,0.35853277021395813,1.0,25/82,14.91%,CACNA1A;KCNT1;CNTN2;AP3B2;SGSM1;FAM135B;ASPA;OTUD7A;SCN3B;SLC1A2;RUNDC3A;TNR;GRIA4;CTNNA2;KCNC2;CYP46A1;MOBP;SV2B;ZNF493;UNC80;CACNA1E;GRIA2;SLC24A2;CACNG2;CACNB4
prerank,Reactome_2022__Keratan Sulfate Biosynthesis R-HSA-2022854,0.8656126637001187,1.5769420199843514,0.02564102564102564,0.35472011169724765,1.0,3/13,6.57%,B3GNT2;B4GALT4;CHST1
prerank,GO_Biological_Process_2021__keratan sulfate biosynthetic process (GO:0018146),0.8656126637001187,1.5769420199843514,0.02564102564102564,0.35472011169724765,1.0,3/13,6.57%,B3GNT2;B4GALT4;CHST1
prerank,GO_Biological_Process_2021__membrane repolarization during cardiac muscle cell action potential (GO:0086013),0.7818623933479405,1.5761951640354321,0.04878048780487805,0.35485902521349105,1.0,5/11,10.99%,KCNJ2;KCNIP2;KCND3;KCNJ5;KCNN2
prerank,GO_Biological_Process_2021__regulation of long-term neuronal synaptic plasticity (GO:0048169),0.8714282234950235,1.5733683254948245,0.0,0.3644423781813797,1.0,4/10,8.88%,SYNGR1;NETO1;SHANK3;NPTN
prerank,CellMarker_Augmented_2021__Neutrophil:Kidney,-0.7927470642437336,-1.5732614840558492,0.015151515151515152,0.10652765465599173,1.0,11/28,11.39%,BCL2A1;SAT1;FOS;MNDA;VNN2;RGS2;SELL;BASP1;NAMPT;TYROBP;CSF3R
prerank,Reactome_2022__Defective Pyroptosis R-HSA-9710421,-0.8091195176889643,-1.572512617045684,0.0,0.10725277395874087,1.0,11/23,13.12%,H2BC4;H2BC26;H2AC20;H2AC6;H3-3B;H2AJ;H2BC21;H2BC5;H2BC9;H2BC11;DNMT1
prerank,GO_Biological_Process_2021__potassium ion export across plasma membrane (GO:0097623),0.9220087033475663,1.5723194024246523,0.03333333333333333,0.36582042791527936,1.0,2/6,4.38%,KCNIP2;KCND3
prerank,GO_Biological_Process_2021__regulation of plasminogen activation (GO:0010755),0.8855309361026575,1.5712523358433954,0.029411764705882353,0.367177909742703,1.0,4/9,6.90%,SERPINE1;SERPINE2;HPN;RUNX1
prerank,CellMarker_Augmented_2021__Granulocyte-monocyte progenitor:Germ,-0.6789541354933779,-1.571128930931186,0.012658227848101266,0.10852514256330446,1.0,36/89,17.50%,JAML;MYO1G;MNDA;GPR183;AIF1;FCER1G;SNX20;CD93;NCF4;IL3RA;PLEK;IL10RA;LILRB4;PECAM1;GIMAP2;CYTIP;TNFRSF1B;SAMSN1;MS4A6A;ITGB2;CSF2RB;NCKAP1L;HLA-DRA;TYROBP;ITGAL;PTPRC;HAVCR2;MYO1F;LY86;HLA-DPA1;CIITA;CD74;HLA-DPB1;LST1;GIMAP4;EVI2B
prerank,CellMarker_Augmented_2021__Megakaryocyte-erythroid progenitor:Germ,-0.6789541354933779,-1.571128930931186,0.012658227848101266,0.10852514256330446,1.0,36/89,17.50%,JAML;MYO1G;MNDA;GPR183;AIF1;FCER1G;SNX20;CD93;NCF4;IL3RA;PLEK;IL10RA;LILRB4;PECAM1;GIMAP2;CYTIP;TNFRSF1B;SAMSN1;MS4A6A;ITGB2;CSF2RB;NCKAP1L;HLA-DRA;TYROBP;ITGAL;PTPRC;HAVCR2;MYO1F;LY86;HLA-DPA1;CIITA;CD74;HLA-DPB1;LST1;GIMAP4;EVI2B
prerank,GO_Biological_Process_2021__error-prone translesion synthesis (GO:0042276),-0.8259551763566216,-1.5706597484075313,0.03125,0.10897668381255929,1.0,2/18,1.30%,UBC;RPS27A
prerank,GO_Biological_Process_2021__neuron projection extension (GO:1990138),0.7222512281195926,1.5700886219182646,0.029411764705882353,0.36894689853185586,1.0,5/27,9.71%,NRP1;SEMA5A;AUTS2;FLRT1;ALCAM
prerank,GO_Biological_Process_2021__regulation of megakaryocyte differentiation (GO:0045652),-0.7182592257764792,-1.5700836745441806,0.0,0.10984375896557909,1.0,2/41,1.65%,NR4A3;PRKCQ
prerank,GO_Biological_Process_2021__regulation of smooth muscle cell proliferation (GO:0048660),-0.776344019742663,-1.568951310510328,0.0,0.11153920066948628,1.0,7/29,9.56%,NR4A3;CCL5;AIF1;APOD;IGF1;TNFAIP3;STAT1
prerank,GO_Biological_Process_2021__negative regulation of protein processing (GO:0010955),0.8643862879460276,1.5686385606260798,0.05714285714285714,0.37266071583915494,1.0,4/9,8.81%,SERPINE1;SERPINE2;LRRK2;SNX12
prerank,GO_Biological_Process_2021__aerobic electron transport chain (GO:0019646),-0.7073682223943581,-1.5685629303036603,0.028169014084507043,0.11175136360641973,1.0,24/50,18.32%,CYCS;COX7C;UQCRB;NDUFC1;NDUFA2;UQCRH;NDUFA1;NDUFB9;NDUFA12;NDUFB4;UQCR10;COX4I1;COX5B;NDUFB1;NDUFS8;NDUFS5;COX6C;NDUFS6;NDUFB7;UQCRC1;NDUFB3;UQCRQ;NDUFS7;NDUFA3
prerank,Reactome_2022__Regulation Of TP53 Activity Thru Methylation R-HSA-6804760,-0.8543608159829258,-1.5682332210843515,0.0,0.11177080251789069,1.0,2/17,1.30%,UBC;RPS27A
prerank,CellMarker_Augmented_2021__Plasma cell:Salivary Gland,0.7191655916900539,1.5676688201764215,0.1,0.37325803577615935,1.0,5/29,6.63%,SHROOM3;FKBP9;DLG5;DAG1;DHCR24
prerank,Reactome_2022__Acyl Chain Remodelling Of PE R-HSA-1482839,0.8517540451911962,1.5674940814100975,0.0,0.3683066137037563,1.0,1/11,0.68%,PLA2G4C
prerank,GO_Biological_Process_2021__phosphatidylethanolamine acyl-chain remodeling (GO:0036152),0.8517540451911962,1.5674940814100975,0.0,0.3683066137037563,1.0,1/11,0.68%,PLA2G4C
prerank,CellMarker_Augmented_2021__T Helper cell:Salivary Gland,-0.6910049378896808,-1.5665561887645874,0.0,0.11373974535395538,1.0,33/83,17.23%,JAML;CD2;MNDA;GPR183;CLEC12A;MS4A4A;AIF1;PSTPIP1;SIGLEC1;FCER1G;SNX20;NCF4;LSP1;PLEK;IL10RA;CD300LF;CYTIP;TNFRSF1B;MS4A6A;ITGB2;NCKAP1L;TYROBP;ITGAL;CSF3R;PTPRC;HAVCR2;MYO1F;LY86;CD74;HLA-DPB1;FCGR3A;LST1;GIMAP4
prerank,CellMarker_Augmented_2021__T Helper cell:Eye,-0.6910049378896808,-1.5665561887645874,0.0,0.11373974535395538,1.0,33/83,17.23%,JAML;CD2;MNDA;GPR183;CLEC12A;MS4A4A;AIF1;PSTPIP1;SIGLEC1;FCER1G;SNX20;NCF4;LSP1;PLEK;IL10RA;CD300LF;CYTIP;TNFRSF1B;MS4A6A;ITGB2;NCKAP1L;TYROBP;ITGAL;CSF3R;PTPRC;HAVCR2;MYO1F;LY86;CD74;HLA-DPB1;FCGR3A;LST1;GIMAP4
prerank,GO_Biological_Process_2021__chromatin assembly (GO:0031497),-0.7611007226507864,-1.5662343489861266,0.0,0.11381510090631931,1.0,11/40,10.59%,H1-4;H1-3;H1-2;POLE3;H1-0;H2BC18;H2BC21;H2BC5;H1-10;H2BC9;NPM1
prerank,CellMarker_Augmented_2021__Platelet:Blood,-0.7822659132427197,-1.565586323883706,0.034482758620689655,0.11470702245171695,1.0,11/27,12.25%,CD36;CCL5;CD69;CD14;CD63;PECAM1;ITGA6;CD226;VEGFA;CSF3R;CD47
prerank,Reactome_2022__SARS-CoV-2-host Interactions R-HSA-9705683,-0.6412535852450196,-1.5654088012799225,0.0,0.11440268656357212,1.0,31/153,11.42%,RPS13;RPS4X;HLA-B;RPS27A;RPS8;RPS21;RPS14;RPS11;B2M;RPS15;RPS12;RPS25;RPS23;RPS27;FAU;RPS20;RPS24;SNRPD2;HLA-C;RPS3;RPS3A;RPS6;RPS2;RPS7;NLRP12;HLA-F;RPS5;STAT1;NUP50;RPS9;STING1
prerank,GO_Biological_Process_2021__mitochondrial ATP synthesis coupled electron transport (GO:0042775),-0.7096614909758029,-1.5653531815202812,0.028169014084507043,0.1141004568061411,1.0,25/51,18.32%,CYCS;COX7C;UQCRB;NDUFC1;NDUFA2;UQCRH;NDUFA1;NDUFB9;NDUFA12;NDUFB4;UQCR10;COX4I1;COX5B;NDUFB1;NDUFS8;NDUFS5;COA6;COX6C;NDUFS6;NDUFB7;UQCRC1;NDUFB3;UQCRQ;NDUFS7;NDUFA3
prerank,PanglaoDB_Augmented_2021__Parietal Cells,0.6159517626611024,1.565339775187605,0.037037037037037035,0.37499879673542924,1.0,20/70,11.74%,HID1;PLXNB1;FAAH;SRCIN1;HIP1R;RAP1GAP;KIAA1671;NEO1;NDRG2;MTUS1;PLPPR1;TPPP;BAIAP3;PIK3C2B;SLC12A6;SHC2;SHANK2;PTCH1;COBL;ZDHHC11B
prerank,GO_Biological_Process_2021__positive regulation of neurogenesis (GO:0050769),0.6105921107204682,1.5653166933235674,0.05555555555555555,0.37242188101884927,1.0,22/52,18.25%,PLXNB1;PLXNA2;CHODL;FZD3;PLXNA3;PLXNB2;LIG4;ROBO1;PLXNC1;SHANK3;NPTN;NUMBL;PTPRD;METRN;NTRK2;PLXNA1;CAPRIN2;ROBO2;TIAM2;IL1RAPL1;CX3CL1;MAP6
prerank,GO_Biological_Process_2021__regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),-0.7036623804730214,-1.5645442580800888,0.0,0.11467115280180527,1.0,16/62,12.85%,UBC;RPS27A;PSMB3;ELOB;PSMB6;PSMA7;RBPJ;EGLN3;PSMB9;CITED2;RBX1;VEGFA;HIF1A;PSMD12;PSMD8;PSMA5
prerank,GO_Biological_Process_2021__gene expression (GO:0010467),-0.6036261398730153,-1.5643764120753434,0.0,0.11452505066540508,1.0,73/291,9.87%,RPS13;RPS4X;HARS2;RPL28;RPS27A;RPS8;RPL38;RPS21;RPL31;WARS1;RPL37A;RPS14;RPL12;RPLP1;RPL3;DHX38;RPL23A;RPL39;RPL32;RPS11;RPL5;RPS15;RPS12;RPS25;RPS23;RPS27;RPS20;RPL29;RPLP2;RPL19;RPS24;RPL13A;RPL41;RPL7A;RPL35;RPL37;RPS18;PTMA;TSPAN32;RPL10;RPL10A;RPL11;RPS3;RPL23;ABCF1;RPS3A;RPL4;RPS26;RPL30;MRPS7;RPL36;MRPL51;RPL24;RPL14;RPL18A;POLR2G;RPS6;RPS2;RPS7;RPL34;RPL15;RPL21;RNASEL;RPS5;EIF4A3;RPL27A;MRPL52;RPL6;RPL27;CHTOP;RPL18;U2AF2;NCBP2
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Serum,-0.8295123668946224,-1.5643604735421406,0.017543859649122806,0.11416373004288202,1.0,9/24,11.62%,TC2N;CXCR4;CLDN7;SLC37A1;CD44;OVOL2;LLGL2;FBP1;FAAH2
prerank,GO_Biological_Process_2021__potassium ion transport (GO:0006813),0.5903433117963102,1.5639604360504793,0.0,0.3754618957168755,1.0,20/56,14.30%,KCNQ2;PKD2;SLC9C2;KCNJ2;SLC1A3;KCNIP2;KCND3;KCNJ5;HPN;KCNC2;SLC9A1;KCNMB4;KCNK6;KCNK13;KCNN2;SLC9A9;ABCC8;KCNH5;KCNMB3;SLC24A2
prerank,CellMarker_Augmented_2021__Neutrophil:Pluripotent Stem Cell,-0.6904403187425683,-1.5634957429257719,0.02702702702702703,0.1153132444264676,1.0,28/72,17.50%,JAML;MNDA;VNN2;CLEC12A;AIF1;FCER1G;NCF4;LSP1;PLEK;CD300LF;C5AR1;SIRPB2;TNFRSF1B;LILRB3;NCF2;MS4A6A;ITGB2;CSF2RB;TYROBP;CSF3R;PTPRC;MYO1F;FPR1;IGSF6;FCGR3A;LST1;GIMAP4;EVI2B
prerank,GO_Biological_Process_2021__ribosomal small subunit assembly (GO:0000028),-0.8043062129564301,-1.5629010377472754,0.03773584905660377,0.1159640857114618,1.0,11/14,18.57%,RPS14;RPS15;RPS27;MRPS7;RPS5;MRPS11;LOC102724159;RPS28;RPS27L;RRP7A;RPS19
prerank,GO_Biological_Process_2021__phosphatidylinositol acyl-chain remodeling (GO:0036149),0.868178027912268,1.5628306579958375,0.022727272727272728,0.37780743856191334,1.0,1/8,0.68%,PLA2G4C
prerank,GO_Biological_Process_2021__positive regulation of lamellipodium assembly (GO:0010592),0.7483875630036605,1.5625606386721276,0.02564102564102564,0.37607398751408244,1.0,4/18,8.34%,AVIL;AKIRIN1;WASF2;AUTS2
prerank,GO_Biological_Process_2021__positive regulation of gluconeogenesis (GO:0045722),0.9464114126209546,1.5622302260506828,0.02564102564102564,0.3743644461358767,1.0,2/5,2.51%,PPARGC1A;SIRT1
prerank,PanglaoDB_Augmented_2021__Meningeal Cells,0.6295800746419928,1.5620241928105512,0.03571428571428571,0.37307742178674447,1.0,15/50,15.62%,COL16A1;LRP4;SVEP1;COL5A2;PHLDB1;TIMP3;MAGI1;CDH11;GUCY1A2;RUNX1T1;COL6A1;TJP1;FBXL7;FERMT2;ANTXR1
prerank,GO_Biological_Process_2021__regulation of dendritic spine morphogenesis (GO:0061001),0.6780813490585212,1.5616908685581792,0.0,0.3718079079729746,1.0,11/27,15.82%,CDK5R1;SRCIN1;NLGN1;LRRK2;RELN;SHANK3;PDLIM5;TANC2;PTEN;CAPRIN2;PPFIA2
prerank,GO_Biological_Process_2021__cellular response to heat (GO:0034605),0.6538167677290375,1.56162842040466,0.0,0.36945317455015264,1.0,2/31,0.68%,BAG3;POLR2D
prerank,CellMarker_Augmented_2021__Endometrial Stem cell:Uterus,-0.7207817263720662,-1.5615628677599058,0.01282051282051282,0.11801693393309595,1.0,14/70,9.97%,ZFP36;JUNB;GADD45B;ZMYND15;CTSB;IER3;IFITM3;BHLHE40;ABCC3;SLC16A3;TNFAIP3;TYMP;TNFAIP2;SSH3
prerank,GO_Biological_Process_2021__protein depalmitoylation (GO:0002084),0.9193009175797138,1.560928865216307,0.0,0.36763478040886,1.0,3/6,6.49%,LYPLAL1;PPT1;ABHD17B
prerank,GO_Biological_Process_2021__macromolecule depalmitoylation (GO:0098734),0.9193009175797138,1.560928865216307,0.0,0.36763478040886,1.0,3/6,6.49%,LYPLAL1;PPT1;ABHD17B
prerank,GO_Biological_Process_2021__positive regulation of focal adhesion assembly (GO:0051894),0.7997294015626946,1.5605910721455694,0.02702702702702703,0.3662034100026397,1.0,2/13,0.61%,COL16A1;NRP1
prerank,GO_Biological_Process_2021__positive regulation of nitrogen compound metabolic process (GO:0051173),0.8363224287013215,1.5602242907269497,0.02857142857142857,0.36433085970580403,1.0,3/13,7.30%,KLF4;HPN;TNF
prerank,CellMarker_Augmented_2021__Platelet:Bone Marrow,-0.6745858272490598,-1.5599949440982177,0.0,0.11894183313720018,1.0,33/86,17.50%,JAML;MNDA;CLEC12A;MS4A4A;AIF1;FCER1G;SNX20;CD93;NCF4;PLEK;IL10RA;LILRB4;CD300LF;PECAM1;GIMAP2;TNFRSF1B;SAMSN1;MS4A6A;ITGB2;CSF2RB;NCKAP1L;TYROBP;ITGAL;CSF3R;PTPRC;HAVCR2;MYO1F;LY86;IGSF6;FCGR3A;LST1;GIMAP4;EVI2B
prerank,CellMarker_Augmented_2021__Endothelial Progenitor cell:Umbilical Cord Blood,-0.6745858272490598,-1.5599949440982177,0.0,0.11894183313720018,1.0,33/86,17.50%,JAML;MNDA;CLEC12A;MS4A4A;AIF1;FCER1G;SNX20;CD93;NCF4;PLEK;IL10RA;LILRB4;CD300LF;PECAM1;GIMAP2;TNFRSF1B;SAMSN1;MS4A6A;ITGB2;CSF2RB;NCKAP1L;TYROBP;ITGAL;CSF3R;PTPRC;HAVCR2;MYO1F;LY86;IGSF6;FCGR3A;LST1;GIMAP4;EVI2B
prerank,CellMarker_Augmented_2021__Endothelial cell:Eye,-0.6745858272490598,-1.5599949440982177,0.0,0.11894183313720018,1.0,33/86,17.50%,JAML;MNDA;CLEC12A;MS4A4A;AIF1;FCER1G;SNX20;CD93;NCF4;PLEK;IL10RA;LILRB4;CD300LF;PECAM1;GIMAP2;TNFRSF1B;SAMSN1;MS4A6A;ITGB2;CSF2RB;NCKAP1L;TYROBP;ITGAL;CSF3R;PTPRC;HAVCR2;MYO1F;LY86;IGSF6;FCGR3A;LST1;GIMAP4;EVI2B
prerank,CellMarker_Augmented_2021__Endothelial cell:Embryonic Stem Cell,-0.6745858272490598,-1.5599949440982177,0.0,0.11894183313720018,1.0,33/86,17.50%,JAML;MNDA;CLEC12A;MS4A4A;AIF1;FCER1G;SNX20;CD93;NCF4;PLEK;IL10RA;LILRB4;CD300LF;PECAM1;GIMAP2;TNFRSF1B;SAMSN1;MS4A6A;ITGB2;CSF2RB;NCKAP1L;TYROBP;ITGAL;CSF3R;PTPRC;HAVCR2;MYO1F;LY86;IGSF6;FCGR3A;LST1;GIMAP4;EVI2B
prerank,Reactome_2022__TICAM1-dependent Activation Of IRF3/IRF7 R-HSA-9013973,-0.8670132438291419,-1.559581434948065,0.0,0.11893620227858517,1.0,2/12,1.30%,UBC;RPS27A
prerank,Reactome_2022__GPCR Ligand Binding R-HSA-500792,-0.6660974060299603,-1.5594968775148619,0.013888888888888888,0.11866092491405393,1.0,15/105,7.63%,CCL4;CALCR;CCL3;ADGRE1;CHRM2;CXCR4;CCL5;GPR183;CD55;CD200R1;GNB5;ACKR4;TACR1;C5AR1;GNRHR
prerank,GO_Biological_Process_2021__regulation of cellular catabolic process (GO:0031329),0.6277838854026316,1.5592486852710148,0.0,0.3653009975554201,1.0,8/52,7.92%,ACER2;RRAGD;DAPK2;DEPP1;LRRK2;DDIT3;SCARB2;BOK
prerank,GO_Biological_Process_2021__negative regulation of blood vessel morphogenesis (GO:2000181),0.7134101980387749,1.558992245217305,0.0,0.3637613189198281,1.0,7/36,5.26%,KLF4;YJEFN3;SPRY2;AMOT;SPRED1;PPARG;PTPRM
prerank,GO_Biological_Process_2021__regulation of gluconeogenesis (GO:0006111),0.736059672184733,1.558203767794474,0.046511627906976744,0.36404594798755896,1.0,2/17,2.51%,PPARGC1A;SIRT1
prerank,CellMarker_Augmented_2021__Induced Pluripotent Stem cell:Undefined,0.7814544386026558,1.5575039983487597,0.0,0.36395341255770164,1.0,3/13,5.98%,KLF4;SMAD2;SMAD3
prerank,GO_Biological_Process_2021__epithelial cell morphogenesis (GO:0003382),-0.9198981223334328,-1.5574009933262312,0.0,0.12185188697275014,1.0,2/6,0.86%,COL18A1;CCDC88C
prerank,PanglaoDB_Augmented_2021__Trophoblast Progenitor Cells,-0.730526264264649,-1.5572216271315433,0.0,0.12183670772713942,1.0,23/66,17.04%,TC2N;SIGIRR;ZFP36;JUNB;CD55;CTDSP1;HLA-C;NBEAL2;HLA-F;TYMP;PRKD2;KIAA0040;LITAF;IRF1;TAP1;PIM3;OSTF1;NOD2;HLA-E;IFI35;DEDD2;PARP12;IRF7
prerank,GO_Biological_Process_2021__ribosomal small subunit biogenesis (GO:0042274),-0.7189493977958911,-1.5571656765231283,0.05,0.121465598257276,1.0,20/36,17.31%,RPS14;RPS15;RPS25;RPS27;RPS24;METTL17;MRPS7;RPS6;RPS7;RPS5;NPM1;MRPS11;LOC102724159;NOB1;RPS28;SURF6;RPS27L;RRP7A;RPS16;EMG1
prerank,CellMarker_Augmented_2021__Prostate Stem cell:Prostate,-0.645174142682994,-1.556848106329459,0.0,0.11928267208712742,1.0,31/84,11.93%,SRGN;OAS3;FOSL2;HLA-B;CARD16;IL7R;MDFIC;IFIT3;PARP14;B2M;ANXA2;ETS1;SAMD9L;SP110;PHF11;GBP3;DTX3L;NLRC5;PARP9;EMP3;TNFAIP3;IFI44;CD44;GBP2;PSMB9;SAMD9;S100A6;SLFN5;IRF1;TAP1;MLKL
prerank,CellMarker_Augmented_2021__Muller Glia Precursor cell:Retina,-0.645174142682994,-1.556848106329459,0.0,0.11928267208712742,1.0,31/84,11.93%,SRGN;OAS3;FOSL2;HLA-B;CARD16;IL7R;MDFIC;IFIT3;PARP14;B2M;ANXA2;ETS1;SAMD9L;SP110;PHF11;GBP3;DTX3L;NLRC5;PARP9;EMP3;TNFAIP3;IFI44;CD44;GBP2;PSMB9;SAMD9;S100A6;SLFN5;IRF1;TAP1;MLKL
prerank,CellMarker_Augmented_2021__Cancer Stem-Like cell:Oral Cavity,-0.645174142682994,-1.556848106329459,0.0,0.11928267208712742,1.0,31/84,11.93%,SRGN;OAS3;FOSL2;HLA-B;CARD16;IL7R;MDFIC;IFIT3;PARP14;B2M;ANXA2;ETS1;SAMD9L;SP110;PHF11;GBP3;DTX3L;NLRC5;PARP9;EMP3;TNFAIP3;IFI44;CD44;GBP2;PSMB9;SAMD9;S100A6;SLFN5;IRF1;TAP1;MLKL
prerank,CellMarker_Augmented_2021__Myometrial Stem cell:Myometrium,-0.645174142682994,-1.556848106329459,0.0,0.11928267208712742,1.0,31/84,11.93%,SRGN;OAS3;FOSL2;HLA-B;CARD16;IL7R;MDFIC;IFIT3;PARP14;B2M;ANXA2;ETS1;SAMD9L;SP110;PHF11;GBP3;DTX3L;NLRC5;PARP9;EMP3;TNFAIP3;IFI44;CD44;GBP2;PSMB9;SAMD9;S100A6;SLFN5;IRF1;TAP1;MLKL
prerank,CellMarker_Augmented_2021__Serous Acinar cell:Salivary Gland,-0.645174142682994,-1.556848106329459,0.0,0.11928267208712742,1.0,31/84,11.93%,SRGN;OAS3;FOSL2;HLA-B;CARD16;IL7R;MDFIC;IFIT3;PARP14;B2M;ANXA2;ETS1;SAMD9L;SP110;PHF11;GBP3;DTX3L;NLRC5;PARP9;EMP3;TNFAIP3;IFI44;CD44;GBP2;PSMB9;SAMD9;S100A6;SLFN5;IRF1;TAP1;MLKL
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Myometrium,-0.645174142682994,-1.556848106329459,0.0,0.11928267208712742,1.0,31/84,11.93%,SRGN;OAS3;FOSL2;HLA-B;CARD16;IL7R;MDFIC;IFIT3;PARP14;B2M;ANXA2;ETS1;SAMD9L;SP110;PHF11;GBP3;DTX3L;NLRC5;PARP9;EMP3;TNFAIP3;IFI44;CD44;GBP2;PSMB9;SAMD9;S100A6;SLFN5;IRF1;TAP1;MLKL
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Amniotic Fluid,-0.645174142682994,-1.556848106329459,0.0,0.11928267208712742,1.0,31/84,11.93%,SRGN;OAS3;FOSL2;HLA-B;CARD16;IL7R;MDFIC;IFIT3;PARP14;B2M;ANXA2;ETS1;SAMD9L;SP110;PHF11;GBP3;DTX3L;NLRC5;PARP9;EMP3;TNFAIP3;IFI44;CD44;GBP2;PSMB9;SAMD9;S100A6;SLFN5;IRF1;TAP1;MLKL
prerank,GO_Biological_Process_2021__Fc-epsilon receptor signaling pathway (GO:0038095),-0.6700646098976707,-1.556226552026052,0.013333333333333334,0.119825425460045,1.0,13/97,9.00%,NR4A3;ITK;FOS;PRKCQ;GRAP2;VAV3;PSMB3;FCER1G;BTK;PSMB6;PSMA7;CALM1;PSMB9
prerank,Reactome_2022__Interleukin-23 Signaling R-HSA-9020933,-0.9433990241583114,-1.555453662229419,0.015873015873015872,0.12032607520584551,1.0,1/6,0.41%,STAT4
prerank,GO_Biological_Process_2021__interleukin-23-mediated signaling pathway (GO:0038155),-0.9433990241583114,-1.555453662229419,0.015873015873015872,0.12032607520584551,1.0,1/6,0.41%,STAT4
prerank,GO_Biological_Process_2021__diol biosynthetic process (GO:0034312),0.8269845510155825,1.5548898290560489,0.061224489795918366,0.37373428224662486,1.0,4/12,10.57%,ACER2;ABCA2;SPTLC2;GCH1
prerank,GO_Biological_Process_2021__positive regulation of isotype switching (GO:0045830),-0.8936090844612484,-1.5547081357812835,0.0,0.12143300925982949,1.0,1/11,1.44%,TFRC
prerank,Reactome_2022__Endosomal/Vacuolar Pathway R-HSA-1236977,-0.857247360378742,-1.5546618591543178,0.06666666666666667,0.12113435507440602,1.0,4/9,7.77%,HLA-B;B2M;HLA-C;HLA-F
prerank,CellMarker_Augmented_2021__Primordial Germ cell:Pluripotent Stem Cell,-0.6839136741896374,-1.5545262276685634,0.013157894736842105,0.1205710446721163,1.0,24/63,17.23%,JAML;MNDA;VNN2;CLEC12A;AIF1;FCER1G;PLEK;CD300LF;C5AR1;MS4A6A;CSF2RB;HLA-DRA;TYROBP;CSF3R;PTPRC;MYO1F;LY86;HLA-DPA1;FPR1;CD74;HLA-DPB1;FCGR3A;LST1;GIMAP4
prerank,CellMarker_Augmented_2021__Primordial Germ cell:Embryonic Stem Cell,-0.6839136741896374,-1.5545262276685634,0.013157894736842105,0.1205710446721163,1.0,24/63,17.23%,JAML;MNDA;VNN2;CLEC12A;AIF1;FCER1G;PLEK;CD300LF;C5AR1;MS4A6A;CSF2RB;HLA-DRA;TYROBP;CSF3R;PTPRC;MYO1F;LY86;HLA-DPA1;FPR1;CD74;HLA-DPB1;FCGR3A;LST1;GIMAP4
prerank,CellMarker_Augmented_2021__Red Blood Cell (erythrocyte):Blood,-0.7348797730626145,-1.5533285428522305,0.0,0.12180470110466185,1.0,16/58,11.39%,JAML;MNDA;CD69;VNN2;CLEC12A;GRAP2;AIF1;BTK;SLAMF6;NCF4;CYTIP;SAMSN1;MS4A6A;NCKAP1L;TYROBP;CSF3R
prerank,PanglaoDB_Augmented_2021__Kupffer Cells,-0.6510892386943881,-1.5529779584190984,0.013333333333333334,0.12212870429563707,1.0,40/100,17.07%,JAML;ADGRE1;MNDA;CLEC12A;MS4A4A;MARCO;CHIT1;AIF1;SIGLEC1;CD14;FCER1G;PLTP;NCF4;PLEK;IL10RA;LILRB4;CD300LF;C5AR1;SIRPB2;TNFRSF1B;TYMP;LILRB3;NCF2;SLC11A1;MS4A6A;ITGB2;CSF2RB;HLA-DRA;TYROBP;CSF3R;FTL;HAVCR2;MYO1F;LY86;FPR1;SLC15A3;IGSF6;FCGR3A;IRF7;LST1
prerank,GO_Biological_Process_2021__error-free translesion synthesis (GO:0070987),-0.8053671513012545,-1.552335859709902,0.07936507936507936,0.12298454905204147,1.0,2/19,1.30%,UBC;RPS27A
prerank,GO_Biological_Process_2021__B cell receptor signaling pathway (GO:0050853),-0.8491233208987206,-1.5512383985105362,0.016666666666666666,0.12475942941035045,1.0,4/21,3.54%,ITK;MNDA;VAV3;BTK
prerank,GO_Biological_Process_2021__negative regulation of mononuclear cell migration (GO:0071676),-0.8746554408225489,-1.5509181420043532,0.05,0.12504335158966226,1.0,1/8,1.54%,DUSP1
prerank,KEGG_2021_Human__Glutamatergic synapse,0.5702205643882848,1.5505790558912447,0.0,0.3894394562256133,1.0,19/77,11.85%,CACNA1A;TRPC1;PLA2G4C;GRIN3A;SLC1A3;GNAQ;GRIK2;SLC1A2;PLCB4;ADCY9;GRIA3;GRIA4;SHANK3;SHANK2;PPP3CA;GRIA1;GRM5;MAPK1;GRIN2B
prerank,GO_Biological_Process_2021__cellular polysaccharide biosynthetic process (GO:0033692),0.8588025366724791,1.549818161471924,0.022222222222222223,0.38977530786262893,1.0,5/11,10.88%,B3GNT2;CSGALNACT1;HS2ST1;FUT9;EXT1
prerank,GO_Biological_Process_2021__fatty-acyl-CoA metabolic process (GO:0035337),0.7268699906723439,1.5495747200287717,0.0,0.38835890924953276,1.0,5/15,20.80%,PPT1;GCDH;FASN;ACACA;SCD5
prerank,PanglaoDB_Augmented_2021__Dopaminergic Neurons,0.605254940937585,1.5494894271392239,0.04,0.38638104077087704,1.0,28/71,21.61%,KCNQ2;CNTN2;SRCIN1;DPYSL5;NCAN;CHD5;NOL4;SNAP91;SMAD3;OLFM3;SNCB;PTPN5;LINGO1;CAMKV;ABCC8;GRIA2;CSRNP3;MAPK4;ATRNL1;NXPH1;BRSK2;PHYHIPL;SYT4;GRIK3;CELF5;CACNA1B;KCNB2;NRXN1
prerank,GO_Biological_Process_2021__phosphatidylethanolamine metabolic process (GO:0046337),0.818471631482198,1.5491550369843545,0.04878048780487805,0.38529082602882153,1.0,4/15,10.72%,ETNPPL;NAPEPLD;CHKA;SELENOI
prerank,GO_Biological_Process_2021__urogenital system development (GO:0001655),0.9228907261073039,1.5489567152630552,0.020833333333333332,0.3835705333923192,1.0,1/5,0.34%,ANXA1
prerank,KEGG_2021_Human__Long-term depression,0.6897335260136633,1.5487570058759141,0.024390243902439025,0.3825107511921093,1.0,14/45,11.38%,CACNA1A;PLA2G4C;IGF1R;GRID2;MAP2K1;GNAQ;PLCB4;GUCY1A1;GRIA3;PPP2R1B;GRIA1;GUCY1A2;GNA11;MAPK1
prerank,Reactome_2022__RNA Polymerase I Promoter Escape R-HSA-73772,-0.7344108898967722,-1.548754833260181,0.015384615384615385,0.12783091807644814,1.0,11/37,9.35%,H2BC4;H2BC26;H2AC20;H2AC6;TAF1D;GTF2H5;H3-3B;H2AJ;H2BC21;H2BC5;H2BC9
prerank,GO_Biological_Process_2021__regulation of calcium-mediated signaling (GO:0050848),-0.8570830559179755,-1.548719538776619,0.0,0.12754860053022732,1.0,2/16,0.62%,CCL4;CCL3
prerank,GO_Biological_Process_2021__acidic amino acid transport (GO:0015800),0.8317585976885499,1.5481000530798574,0.022727272727272728,0.3835826658726886,1.0,3/11,6.03%,SLC1A3;SLC25A18;SLC1A2
prerank,GO_Biological_Process_2021__regulation of lymphocyte differentiation (GO:0045619),-0.8781475684776777,-1.5480410726044684,0.0,0.12831935946517786,1.0,4/13,2.84%,IL4I1;CD2;IKZF3;PRELID1
prerank,GO_Biological_Process_2021__embryonic limb morphogenesis (GO:0030326),0.7066848124896522,1.5477258554670272,0.0,0.3826057819412601,1.0,6/19,13.48%,SALL1;WDPCP;HDAC1;PTCH1;MEGF8;NIPBL
prerank,Reactome_2022__Infectious Disease R-HSA-5663205,-0.5695834632430157,-1.547634155769038,0.0,0.12869925135942117,1.0,136/704,13.26%,CALCR;H2AC25;RPS13;UBC;RPS4X;CEBPD;H2BC4;H2BC26;H2AC20;HLA-B;RPL28;RPS27A;RPS8;RPL38;CXCR4;RPS21;RPL31;RPL37A;RPS14;H2AC6;RPL12;VAV3;RPLP1;RPL3;ZCRB1;RPL23A;RPL39;RPL32;CHD3;PARP14;RPS11;PSTPIP1;B2M;RPL5;RPS15;RPS12;PSMB3;RPS25;YES1;RPS23;RPS27;FAU;RPS20;RPL29;RPLP2;BTK;RPL19;RPS24;CD247;RPL13A;RPL41;RNF213;SNRPD2;RPL7A;RPL35;GTF2H5;RPL37;CTDP1;ELOB;GNB5;RPL10A;HLA-C;RPL11;RPS3;RPL23;SLC25A5;RANBP1;RPS3A;H2BC18;RPL4;RPL30;TXN2;RPL36AL;PARP9;PRKAR1B;EIF2AK2;RPL36;H2BC21;RPL14;RPL18A;POLR2G;PSMB6;RNMT;PSMA7;RPS6;FYN;RPS2;RPS7;SV2C;NLRP12;CRBN;RPL34;SNF8;RPL15;SRPK1;ACTG1;HLA-F;ITGA4;RPL21;H2BC5;CALM1;RPS5;RPL27A;APOBEC3G;GPC3;PSMB9;RPL6;H2BC9;RPL27;STAT1;RPL18;COMT;NCBP2;VPS28;NPM1;NCKAP1L;RPLP0;NUP50;RPS9;RBX1;VEGFA;STING1;SDC3;IFNGR2;ENTPD5;PSMD12;CYFIP2;VPS37B;CYBA;H2BC11;PSMD8;PSMA5;ATP1B3;DDX5;PGK1;RPS28
prerank,CellMarker_Augmented_2021__Urothelium cell:Undefined,-0.7813583509765795,-1.5473960089438206,0.0136986301369863,0.12888433902802676,1.0,10/39,11.39%,JAML;MNDA;RNASET2;CLEC12A;CD300LF;SIRPB2;OSCAR;TYROBP;FBP1;CSF3R
prerank,CellMarker_Augmented_2021__Mucosal-associated Invariant T cell:Liver,-0.728938355657552,-1.5473602578447343,0.0,0.12854742267164168,1.0,7/49,3.27%,TC2N;JAML;IL4I1;CEBPD;ME1;DUSP1;RORA
prerank,Reactome_2022__Interferon Gamma Signaling R-HSA-877300,-0.7068349476719461,-1.547109050620029,0.029850746268656716,0.12867718547834797,1.0,18/62,11.78%,MT2A;BCL11B;OAS3;HLA-B;TRIM5;B2M;OAS2;HLA-C;HLA-DRB5;TRIM22;HLA-F;OAS1;CD44;GBP2;STAT1;IRF1;HLA-DRA;IFNGR2
prerank,GO_Biological_Process_2021__response to interferon-gamma (GO:0034341),-0.7462176002105348,-1.5464325010005602,0.015384615384615385,0.129432891906885,1.0,9/42,6.14%,CCL4;CCL3;GAPDH;CCL5;AIF1;RPL13A;IFITM3;GBP3;SHFL
prerank,Reactome_2022__Nuclear Events Stimulated By ALK Signaling In Cancer R-HSA-9725371,-0.7864260037633847,-1.546226817148194,0.019230769230769232,0.12947770507047482,1.0,4/18,11.16%,BCL2A1;RPS6;NPM1;RBX1
prerank,Reactome_2022__RHO GTPases Activate PAKs R-HSA-5627123,-0.8428641479608512,-1.5456473584968267,0.0,0.12990144429446765,1.0,4/20,8.36%,FLNA;MYLK;PPP1CB;CALM1
prerank,PanglaoDB_Augmented_2021__B Cells Memory,-0.6911543624183256,-1.545304609442476,0.012987012987012988,0.13007960765484963,1.0,24/89,9.60%,JAML;NKG7;MYO1G;CD37;ACAP1;MNDA;PYHIN1;CD69;VNN2;IKZF3;SELL;BTK;SLAMF6;AIM2;SNX20;NCF4;LSP1;PLEK;IL10RA;SP140;CYTIP;CD72;P2RY8;BANK1
prerank,Reactome_2022__Interleukin-10 Signaling R-HSA-6783783,-0.8723358775574931,-1.544922263677918,0.0,0.1305259440366225,1.0,3/18,1.49%,CCL4;CCL3;CCL5
prerank,Reactome_2022__Termination Of Translesion DNA Synthesis R-HSA-5656169,-0.8236076284245962,-1.5448989899502323,0.0,0.13019116104180317,1.0,3/24,3.35%,UBC;RPS27A;POLE3
prerank,CellMarker_Augmented_2021__Neuron:Adipose Tissue,0.5943860979134328,1.5440068415333927,0.02857142857142857,0.3938525380694328,1.0,27/72,21.09%,KCNQ2;CPT1C;CNTN2;DPYSL5;NCAN;NMNAT2;ARNT2;CHD5;SNAP91;ELAVL2;KCTD16;BRSK1;SNCB;CAMKV;GRIA2;TYRO3;FAM171B;NXPH1;PNMA2;BRSK2;KIAA1549L;CRMP1;MAP2;DCLK1;SYT4;CELF5;CACNA1B
prerank,GO_Biological_Process_2021__fatty acid oxidation (GO:0019395),0.6490618019676966,1.543690559055122,0.047619047619047616,0.3926874192229495,1.0,3/39,1.69%,PPARGC1A;ADIPOR2;ACADS
prerank,Reactome_2022__Receptor-type Tyrosine-Protein Phosphatases R-HSA-388844,0.7534134504725142,1.542979947176642,0.047619047619047616,0.393122092647112,1.0,8/15,18.43%,IL1RAPL2;SLITRK5;PTPRD;PPFIA3;LRRC4B;PPFIA2;IL1RAPL1;PPFIBP1
prerank,CellMarker_Augmented_2021__Microglial cell:Brain,-0.8418841241938124,-1.5423855944858995,0.03076923076923077,0.13475615565118598,1.0,4/20,3.07%,CCL4;BCL2A1;GPR183;CD14
prerank,GO_Biological_Process_2021__positive regulation of axonogenesis (GO:0050772),0.7103782728068032,1.542261877277518,0.07407407407407407,0.39355165226628436,1.0,18/31,20.63%,PLXNB1;PLXNA2;CHODL;PLXNA3;PLXNB2;ROBO1;PLXNC1;METRN;NTRK2;PLXNA1;MAP3K13;ROBO2;TIAM2;SHTN1;MAP6;SEMA4D;TIAM1;ZFYVE27
prerank,Reactome_2022__Processing Of DNA Double-Strand Break Ends R-HSA-5693607,-0.6942670546555473,-1.5420486813485867,0.0,0.134891162817228,1.0,16/54,14.82%,UBC;H2BC4;H2BC26;RPS27A;HUS1;TIPIN;H2BC21;H2BC5;ABRAXAS1;H2BC9;H2BC11;KAT5;RAD9A;RPA3;BRCA1;UBA52
prerank,GO_Biological_Process_2021__negative regulation of lymphocyte apoptotic process (GO:0070229),-0.9639277210846349,-1.5419886948093946,0.01818181818181818,0.13454646575221357,1.0,2/6,1.65%,CCL5;PRKCQ
prerank,GO_Biological_Process_2021__ventricular cardiac muscle cell membrane repolarization (GO:0099625),0.9060294408323627,1.5417087184690987,0.025,0.39336283618067724,1.0,2/5,5.43%,KCND3;KCNJ5
prerank,Reactome_2022__Cellular Responses To Stimuli R-HSA-8953897,-0.5705313505146066,-1.5416521046206093,0.0,0.13465476776142682,1.0,124/557,12.89%,H1-4;MT2A;H1-3;DDX11;RPS13;UBC;H1-2;RPS4X;H2BC4;H2BC26;H2AC20;CYCS;PPP1R15A;FOS;RPL28;RPS27A;RPS8;RPL38;RPS21;RPL31;RPL37A;RPS14;H2AC6;RPL12;RPLP1;RPL3;COX7C;RPL23A;RPL39;RPL32;ATF5;RPS11;RPL5;RPS15;RPS12;PSMB3;RPS25;DNAJB9;RPS23;RPS27;FAU;RORA;RPS20;RPL29;RPLP2;RPL19;RPS24;H1-0;RPL13A;RPL41;RPL7A;RPL35;ETS1;NCF4;RPL37;ELOB;ATP6V1F;RPL10A;RPL11;ERO1A;RPS3;RPL23;LAMTOR5;RPS3A;RPL4;H3-3B;H2AJ;HDGF;RPL30;TXN2;RPL36AL;GSTP1;RPL36;H2BC21;RPL14;RPL18A;PSMB6;PSMA7;RPS6;RPS2;RPS7;RPL34;RPL15;RPL21;H2BC5;RPS5;RPL27A;COX4I1;GCLM;EGLN3;COX5B;PSMB9;RPL6;VENTX;H2BC9;RPL27;RPL18;FKBP14;NCF2;EXOSC1;ITFG2;DCTN6;CITED2;KDM6B;RPLP0;NUP50;COX18;RPS9;RBX1;VEGFA;DCTN4;HIF1A;ATF3;PSMD12;ANAPC11;HIRA;DNAJC2;HSPA1B;TERF2IP;CYBA;H2BC11;PSMD8;PSMA5;KAT5
prerank,GO_Biological_Process_2021__activin receptor signaling pathway (GO:0032924),0.836181352567026,1.5414299394400923,0.09523809523809523,0.3922954141828704,1.0,3/7,5.98%,ACVR2A;SMAD2;SMAD3
prerank,GO_Biological_Process_2021__positive regulation of histone acetylation (GO:0035066),0.7605141407679294,1.540653236952686,0.04878048780487805,0.39305911486039546,1.0,3/19,5.00%,PPARGC1A;RUVBL2;RPS6KA4
prerank,Reactome_2022__Regulation Of TLR By Endogenous Ligand R-HSA-5686938,-0.9026757484460639,-1.5392655301560092,0.0,0.138677025405551,1.0,2/8,4.18%,CD36;NDUFA2
prerank,Reactome_2022__Cleavage Of Damaged Pyrimidine R-HSA-110329,-0.8236259359273345,-1.5391988822802682,0.0,0.13850889041897926,1.0,12/21,12.68%,H2BC4;H2BC26;H2AC20;SMUG1;H2AC6;OGG1;H2AJ;H2BC21;H2BC5;H2BC9;TERF2IP;H2BC11
prerank,GO_Biological_Process_2021__ribosome assembly (GO:0042255),-0.7206549390855426,-1.5385755072451008,0.017543859649122806,0.13926208569793688,1.0,20/37,13.26%,RPS14;RPL3;RPL23A;RPL5;RPS15;RPS27;RPL10;RPL11;MRPS7;RPL24;RPS5;RPL6;NPM1;RPLP0;EIF2A;MRPS11;LOC102724159;NOP53;TRAF7;RPS28
prerank,Reactome_2022__Translesion Synthesis By POLI R-HSA-5656121,-0.8503953810651066,-1.5384523960193301,0.0,0.13911944675371815,1.0,2/14,1.30%,UBC;RPS27A
prerank,GO_Biological_Process_2021__lipid import into cell (GO:0140354),-0.9662525732425922,-1.5383846398463052,0.0,0.13889920488550644,1.0,1/6,0.52%,CD36
prerank,GO_Biological_Process_2021__regulation of cellular biosynthetic process (GO:0031326),0.703280167979087,1.537593070346547,0.07317073170731707,0.40245383512782373,1.0,7/22,4.05%,PRKAB2;AVIL;ADIPOR2;PDK4;SIRT1;MITF;SIRPA
prerank,GO_Biological_Process_2021__negative regulation of B cell receptor signaling pathway (GO:0050859),0.9562860130538936,1.5370434156134616,0.0,0.401752317994201,1.0,1/5,1.61%,CD22
prerank,GO_Biological_Process_2021__protein deacylation (GO:0035601),0.7663767728413933,1.5367984350389747,0.045454545454545456,0.4003304176025839,1.0,6/20,9.84%,SIRT1;LYPLAL1;PPT1;ABHD17B;SIRT6;HDAC1
prerank,GO_Biological_Process_2021__antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),-0.8615398270578436,-1.5365577056218658,0.0,0.14227758056172476,1.0,5/11,7.02%,GNLY;GAPDH;RPL39;RPL30;H2BC21
prerank,KEGG_2021_Human__Toll-like receptor signaling pathway,-0.7092252380696732,-1.5364853835894743,0.0,0.14197152907755461,1.0,5/68,3.07%,CCL4;CCL3;FOS;CCL5;CD14
prerank,Reactome_2022__ERCC6 (CSB) And EHMT2 (G9a) Positively Regulate rRNA Expression R-HSA-427389,-0.7766522210309134,-1.535536702690521,0.029411764705882353,0.14340373575002002,1.0,10/27,9.35%,H2BC4;H2BC26;H2AC20;H2AC6;CHD3;H3-3B;H2AJ;H2BC21;H2BC5;H2BC9
prerank,GO_Biological_Process_2021__receptor internalization (GO:0031623),-0.7559886634946,-1.5349842109858913,0.03125,0.14397489495351404,1.0,6/37,5.46%,MX2;CD36;MX1;TFRC;FCER1G;LILRB4
prerank,GO_Biological_Process_2021__defense response to virus (GO:0051607),-0.6708443161578291,-1.5349685588969384,0.013157894736842105,0.1436150777044392,1.0,26/82,11.93%,FLNA;MX2;OAS3;MX1;RSAD2;IFI44L;DDIT4;TRIM5;IFIT3;IFIT1;OAS2;PRF1;IFITM3;SHFL;PHB2;NLRC5;EIF2AK2;PLSCR1;IFIT2;OAS1;RNASEL;APOBEC3G;STAT1;IRF1;STING1;MLKL
prerank,CellMarker_Augmented_2021__Paneth cell:Large Intestine,-0.6001189197343725,-1.5340420230948277,0.0,0.14490187892651252,1.0,57/258,11.39%,CCL4;NR4A3;BCL2A1;IL4I1;CCL3;SRGN;CD37;RSAD2;RUNX3;SLC7A5;CXCR4;TPP1;MS4A4A;AIF1;ATF5;SIGLEC1;NAIP;CD14;FCER1G;BTK;ARL4C;SNX20;NCF4;LSP1;EYA2;LPCAT1;GATM;ZNF331;PLEK;GLA;F13A1;LILRB4;RNF144B;C5AR1;SGK1;NAMPT;TNFRSF1B;TNFAIP3;FERMT3;EIF4A3;PFKFB3;VPS9D1;GPR137B;METRNL;TNFAIP2;CNEP1R1;SAMSN1;CHI3L1;NCF2;MS4A6A;ITGB2;CSF2RB;NCKAP1L;HLA-DRA;TNFSF13B;TYROBP;CSF3R
prerank,PanglaoDB_Augmented_2021__Chromaffin Cells,0.5685103090828916,1.5338969757730472,0.0,0.40972234452847833,1.0,39/91,22.69%,LRP4;CNTN2;SERPINE1;ARNT2;SNAP91;PLPPR4;PCDH17;KCTD16;GRIA4;STX1A;ASXL3;GUCY1A2;PTPRD;TTLL7;RBFOX1;GRIA2;NFASC;CSRNP3;SLC12A2;KALRN;FAM171B;ADGRB3;MAPK4;RAPGEF2;MAP6;PCLO;CRMP1;MAP2;DCLK1;CNTN1;PHYHIPL;SYT4;UNC5D;CACNA1B;SYNPR;NRXN1;LSAMP;RAB3C;OPCML
prerank,CellMarker_Augmented_2021__Eosinophil:Lung,-0.7555185529275572,-1.5335391478927114,0.0,0.14541266745226702,1.0,15/37,15.16%,MNDA;CLEC12A;AIF1;FCER1G;NCF4;CD300LF;SIRPB2;NLRP12;OSCAR;TYROBP;CSF3R;FCGR1CP;MYO1F;C19ORF38;FPR1
prerank,KEGG_2021_Human__Protein digestion and absorption,0.6658784958673997,1.5331813558097576,0.0967741935483871,0.4107595095343895,1.0,7/42,4.30%,CPA1;COL5A3;COL16A1;COL5A2;SLC7A8;SLC3A2;COL24A1
prerank,GO_Biological_Process_2021__antiviral innate immune response (GO:0140374),-0.8411229617144065,-1.5331723133817796,0.06666666666666667,0.1457417064616697,1.0,4/9,8.28%,MX1;IFIT1;PHB2;OAS1
prerank,PanglaoDB_Augmented_2021__Glomus Cells,0.5813669939487985,1.5330728696389009,0.03571428571428571,0.40905070292402385,1.0,34/70,24.52%,COL16A1;LRP4;ARNT2;PHLDB1;PLPPR4;MAGI1;CHST1;NUAK1;NTM;SHC2;GUCY1A2;EPAS1;GPC6;COL6A1;FBXL7;ABCC8;FERMT2;NFASC;ANTXR1;TNFRSF1A;MAP6;RBFOX2;CRMP1;DCLK1;PRICKLE2;HTRA1;NR2F1;LIMCH1;PLPP3;DAB2IP;SEMA6D;GPC1;ARHGEF17;LIFR
prerank,GO_Biological_Process_2021__regulation of cellular amine metabolic process (GO:0033238),-0.7305234294114014,-1.5325611246169002,0.0,0.14670585181061452,1.0,16/40,22.96%,PSMB3;ODC1;PSMB6;PSMA7;PSMB9;AZIN1;PSMD12;PSMD8;PSMA5;PSMA3;PSMC4;PSME2;PSME1;PSMB5;PSMC3;PSME3
prerank,Reactome_2022__Positive Epigenetic Regulation Of rRNA Expression R-HSA-5250913,-0.7016707176152581,-1.531968215039382,0.04054054054054054,0.1478932269322358,1.0,11/51,9.35%,H2BC4;H2BC26;H2AC20;H2AC6;CHD3;TAF1D;H3-3B;H2AJ;H2BC21;H2BC5;H2BC9
prerank,GO_Biological_Process_2021__axon extension (GO:0048675),0.7265998795970054,1.5317747799984722,0.0,0.4116338993095822,1.0,4/21,9.71%,NRP1;SEMA5A;AUTS2;ALCAM
prerank,Reactome_2022__RUNX1 Regulates Transcription Of Genes Involved In Differentiation Of HSCs R-HSA-8939236,-0.7063425812536709,-1.5316433155529328,0.0,0.14811118337966414,1.0,19/68,12.85%,UBC;H2BC4;H2BC26;H2AC20;RPS27A;H2AC6;PSMB3;H3-3B;H2AJ;H2BC21;PSMB6;PSMA7;H2BC5;PSMB9;H2BC9;PSMD12;H2BC11;PSMD8;PSMA5
prerank,"Reactome_2022__Base-Excision Repair, AP Site Formation R-HSA-73929",-0.8162892059515089,-1.531205952135757,0.0,0.14875741539631523,1.0,12/22,12.68%,H2BC4;H2BC26;H2AC20;SMUG1;H2AC6;OGG1;H2AJ;H2BC21;H2BC5;H2BC9;TERF2IP;H2BC11
prerank,KEGG_2021_Human__Cushing syndrome,0.5665983151824141,1.530901179702668,0.04,0.4125789276829162,1.0,18/82,11.88%,TCF7L1;LDLR;E2F3;RAP1A;MAP2K1;GNAQ;WNT5A;PBX1;NCEH1;FZD3;PLCB4;ADCY9;WNT2B;DVL3;TCF7L2;GNA11;MAPK1;CDK6
prerank,Reactome_2022__G2/M Checkpoints R-HSA-69481,-0.6518935595228921,-1.5305306841067574,0.0,0.1499543037579871,1.0,23/102,14.82%,UBC;H2BC4;H2BC26;RPS27A;PSMB3;HUS1;H2BC21;PSMB6;PSMA7;H2BC5;ABRAXAS1;PSMB9;H2BC9;PSMD12;H2BC11;PSMD8;PSMA5;KAT5;MCM7;RAD9A;RPA3;BRCA1;UBA52
prerank,GO_Biological_Process_2021__interferon-gamma-mediated signaling pathway (GO:0060333),-0.7316398741910978,-1.5302242294829775,0.01694915254237288,0.15056667779887137,1.0,17/51,11.78%,MT2A;OAS3;HLA-B;TRIM5;B2M;OAS2;HLA-C;HLA-DRB5;TRIM22;HLA-F;OAS1;CD44;GBP2;STAT1;IRF1;HLA-DRA;IFNGR2
prerank,GO_Biological_Process_2021__lipoprotein catabolic process (GO:0042159),0.9122114161178295,1.530075756140799,0.0,0.4144100081058137,1.0,3/7,6.49%,LYPLAL1;PPT1;ABHD17B
prerank,GO_Biological_Process_2021__dynamin family protein polymerization involved in membrane fission (GO:0003373),-0.9260617413735617,-1.529927978893858,0.0,0.15065694237860272,1.0,2/7,1.19%,MX2;MX1
prerank,GO_Biological_Process_2021__dynamin family protein polymerization involved in mitochondrial fission (GO:0003374),-0.9260617413735617,-1.529927978893858,0.0,0.15065694237860272,1.0,2/7,1.19%,MX2;MX1
prerank,Reactome_2022__Vif-mediated Degradation Of APOBEC3G R-HSA-180585,-0.7215501842632758,-1.5296291261584707,0.013888888888888888,0.15073907396809108,1.0,17/46,19.69%,UBC;RPS27A;PSMB3;ELOB;PSMB6;PSMA7;APOBEC3G;PSMB9;RBX1;PSMD12;PSMD8;PSMA5;UBA52;PSMA3;PSMC4;PSME2;PSME1
prerank,Reactome_2022__Meiotic Synapsis R-HSA-1221632,-0.7797065819457808,-1.5293466481610003,0.0,0.1508704468650129,1.0,12/34,9.35%,SYCE2;H2BC4;H2BC26;H2AC20;SYNE2;H2AC6;STAG3;SYNE1;H2AJ;H2BC21;H2BC5;H2BC9
prerank,GO_Biological_Process_2021__regulation of neuronal synaptic plasticity (GO:0048168),0.722250328937875,1.5293318301230088,0.07317073170731707,0.4153295383067821,1.0,4/22,7.28%,SYNGR1;NETO1;GRIK2;SHISA9
prerank,Reactome_2022__CRMPs In Sema3A Signaling R-HSA-399956,0.7762174920921142,1.5292047843651893,0.030303030303030304,0.4135156591033954,1.0,5/13,5.95%,NRP1;CDK5R1;DPYSL5;PLXNA2;PLXNA3
prerank,Reactome_2022__FCERI Mediated Ca+2 Mobilization R-HSA-2871809,-0.7909714666800335,-1.52903554759554,0.01639344262295082,0.15097631928203775,1.0,6/24,8.36%,ITK;GRAP2;VAV3;BTK;TXK;CALM1
prerank,PanglaoDB_Augmented_2021__Astrocytes,0.5821884326920463,1.5288517745611239,0.0,0.41272927530308606,1.0,26/100,12.47%,PLXNB1;LGI4;SLC39A12;CNTN2;NCAN;AANAT;PLA2G7;LUZP2;GFAP;SLC1A3;CDH20;PLPPR4;GSTA4;SLC1A2;NTM;GRIA3;CA10;SLC4A4;CADM2;PSD2;GRM5;PTPN5;LCAT;SLC25A46;RBFOX1;NTRK2
prerank,KEGG_2021_Human__Autoimmune thyroid disease,-0.7595098479219218,-1.5288478745637588,0.046875,0.15088392546360122,1.0,11/21,16.72%,HLA-B;GZMB;PRF1;HLA-C;HLA-DRB5;HLA-F;HLA-DRA;HLA-E;HLA-DPA1;HLA-DMB;HLA-DPB1
prerank,PanglaoDB_Augmented_2021__Dendritic Cells,-0.6362212435018134,-1.5280630319437811,0.0,0.15212277193922208,1.0,22/140,5.49%,CCL4;NR4A3;JAML;ADGRE1;HLA-B;CXCR4;MNDA;VNN2;CLEC12A;AIF1;CD14;FCER1G;SNX20;NCF4;LSP1;HLA-C;PLEK;IL10RA;KMO;LILRB4;CD300LF;HLA-DRB5
prerank,Reactome_2022__Cellular Responses To Stress R-HSA-2262752,-0.5647757956492314,-1.5275712483380435,0.0,0.15320741060480683,1.0,123/553,12.89%,H1-4;H1-3;DDX11;RPS13;UBC;H1-2;RPS4X;H2BC4;H2BC26;H2AC20;CYCS;PPP1R15A;FOS;RPL28;RPS27A;RPS8;RPL38;RPS21;RPL31;RPL37A;RPS14;H2AC6;RPL12;RPLP1;RPL3;COX7C;RPL23A;RPL39;RPL32;ATF5;RPS11;RPL5;RPS15;RPS12;PSMB3;RPS25;DNAJB9;RPS23;RPS27;FAU;RORA;RPS20;RPL29;RPLP2;RPL19;RPS24;H1-0;RPL13A;RPL41;RPL7A;RPL35;ETS1;NCF4;RPL37;ELOB;ATP6V1F;RPL10A;RPL11;ERO1A;RPS3;RPL23;LAMTOR5;RPS3A;RPL4;H3-3B;H2AJ;HDGF;RPL30;TXN2;RPL36AL;GSTP1;RPL36;H2BC21;RPL14;RPL18A;PSMB6;PSMA7;RPS6;RPS2;RPS7;RPL34;RPL15;RPL21;H2BC5;RPS5;RPL27A;COX4I1;GCLM;EGLN3;COX5B;PSMB9;RPL6;VENTX;H2BC9;RPL27;RPL18;FKBP14;NCF2;EXOSC1;ITFG2;DCTN6;CITED2;KDM6B;RPLP0;NUP50;COX18;RPS9;RBX1;VEGFA;DCTN4;HIF1A;ATF3;PSMD12;ANAPC11;HIRA;DNAJC2;HSPA1B;TERF2IP;CYBA;H2BC11;PSMD8;PSMA5;KAT5
prerank,Reactome_2022__MyD88 Deficiency (TLR2/4) R-HSA-5602498,-0.9088596192671579,-1.527197176414395,0.0,0.15382047746002234,1.0,3/9,4.18%,CD36;BTK;NDUFA2
prerank,Reactome_2022__Metabolism Of RNA R-HSA-8953854,-0.5719012987576358,-1.5270389582877693,0.0,0.1536724916614189,1.0,126/536,15.38%,RPS13;UBC;RPS4X;PPIE;RPL28;RPS27A;RPS8;RPL38;ZFP36;RPS21;RPL31;RPL37A;RPS14;RPL12;RPLP1;RPL3;DHX16;ZCRB1;DHX38;RPL23A;RPL39;RPL32;CSTF2T;RPS11;RPL5;RPS15;RPS12;PSMB3;RPS25;RPS23;RPS27;FAU;RPS20;RPL29;RPLP2;SNRNP27;RPL19;RPS24;RPL13A;RPL41;SNRPD2;RNPC3;RPL7A;RPL35;GTF2H5;RPL37;UTP3;RPL10A;RPL11;RPS3;RPL23;RPS3A;RPL4;RPL30;RBM22;RPL36AL;RPL36;RPL14;EXOSC10;RPL18A;POLR2G;PSMB6;RNMT;PSMA7;RPS6;RPS2;BUD23;RPS7;GTPBP3;RPL34;RPL15;ENPP2;PNRC2;RPL21;RPS5;EIF4A3;RPL27A;CD44;LSM7;PSMB9;RPL6;PDCD7;RBM28;UTP25;RPL27;CHTOP;CRNKL1;RPL18;ZRSR2;U2AF2;WDR46;NCBP2;EXOSC1;RTCB;SMNDC1;XPOT;RPLP0;NUP50;RPS9;PRPF3;NOB1;BUD31;GCFC2;PSMD12;CSNK1D;PSMD8;PSMA5;DDX23;SRSF2;DDX5;SRSF7;RPS28;RPL9;CWC25;SNRPA1;COLEC12;HSPA1A;CCAR1;PPWD1;UBA52;NHP2;NOP10;RPL8;RPS27L;EFTUD2;OSGEP
prerank,Reactome_2022__RNA Polymerase I Promoter Opening R-HSA-73728,-0.8635393496008722,-1.5263858048001653,0.01639344262295082,0.15464664018842628,1.0,9/15,9.35%,H2BC4;H2BC26;H2AC20;H2AC6;H3-3B;H2AJ;H2BC21;H2BC5;H2BC9
prerank,CellMarker_Augmented_2021__Dendritic cell:Spleen,-0.658036302382638,-1.526181961651698,0.013333333333333334,0.15415464751118038,1.0,41/84,20.71%,JAML;MNDA;CLEC12A;AIF1;PSTPIP1;FCER1G;SNX20;NCF4;PLEK;IL10RA;LILRB4;CD300LF;C5AR1;CSF2RA;TNFRSF1B;LILRB3;NCF2;SLC11A1;MS4A6A;ITGB2;CSF2RB;NCKAP1L;TYROBP;ITGAL;CSF3R;PTPRC;HAVCR2;MYO1F;LY86;FPR1;IGSF6;FCGR3A;LST1;EVI2B;PARVG;RNASE6;MPEG1;NCF1;RASGRP4;CLEC7A;PIK3R6
prerank,CellMarker_Augmented_2021__Myeloid Dendritic cell:Thymus,-0.658036302382638,-1.526181961651698,0.013333333333333334,0.15415464751118038,1.0,41/84,20.71%,JAML;MNDA;CLEC12A;AIF1;PSTPIP1;FCER1G;SNX20;NCF4;PLEK;IL10RA;LILRB4;CD300LF;C5AR1;CSF2RA;TNFRSF1B;LILRB3;NCF2;SLC11A1;MS4A6A;ITGB2;CSF2RB;NCKAP1L;TYROBP;ITGAL;CSF3R;PTPRC;HAVCR2;MYO1F;LY86;FPR1;IGSF6;FCGR3A;LST1;EVI2B;PARVG;RNASE6;MPEG1;NCF1;RASGRP4;CLEC7A;PIK3R6
prerank,GO_Biological_Process_2021__intracellular lipid transport (GO:0032365),0.8019529311493967,1.52551948572375,0.020833333333333332,0.424732803491612,1.0,3/15,7.76%,PRKAB2;CPT1A;ACACB
prerank,GO_Biological_Process_2021__response to cadmium ion (GO:0046686),-0.8325639315393079,-1.5254192631455332,0.0,0.15509548764591038,1.0,2/16,1.22%,MT2A;FOS
prerank,GO_Biological_Process_2021__positive regulation of biosynthetic process (GO:0009891),-0.7272958492144388,-1.5251243739845668,0.0,0.15528369682925483,1.0,2/24,1.49%,CD36;CCL5
prerank,GO_Biological_Process_2021__cellular response to epidermal growth factor stimulus (GO:0071364),-0.8071800348770183,-1.5247252982555748,0.029850746268656716,0.15616840473101185,1.0,2/22,1.48%,SYAP1;ZFP36
prerank,Reactome_2022__Transcriptional Regulation Of Pluripotent Stem Cells R-HSA-452723,0.7760951546395924,1.524598607002273,0.0,0.4267615262972107,1.0,6/13,10.81%,KLF4;PBX1;SMAD2;SALL1;HIF3A;EPAS1
prerank,GO_Biological_Process_2021__pre-replicative complex assembly (GO:0036388),-0.7223339821280668,-1.5245323874644432,0.0,0.15604091734253583,1.0,20/51,22.96%,UBC;RPS27A;PSMB3;PSMB6;PSMA7;PSMB9;PSMD12;PSMD8;PSMA5;MCM7;UBA52;PSMA3;PSMC4;PSME2;PSME1;MCM6;PSMB5;PSMC3;MCM5;PSME3
prerank,CellMarker_Augmented_2021__Sertoli cell:Seminal Plasma,0.686797922598712,1.5244199424494738,0.05555555555555555,0.4253593454646045,1.0,7/27,7.82%,ETNPPL;SLC25A18;NDRG2;PLPPR1;RELN;SLC1A2;RANBP3L
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA gap filling (GO:0006297)",-0.7747117899430565,-1.5244187778912106,0.046153846153846156,0.1558901820651693,1.0,2/19,1.30%,UBC;RPS27A
prerank,Reactome_2022__Beta Oxidation Of hexanoyl-CoA To butanoyl-CoA R-HSA-77350,0.9549626761720412,1.5240135412447966,0.0,0.424896897817872,1.0,1/5,1.69%,ACADS
prerank,Reactome_2022__Gap-filling DNA Repair Synthesis And Ligation In GG-NER R-HSA-5696397,-0.8337943497854409,-1.5238546191481521,0.017857142857142856,0.15645607201852982,1.0,3/18,3.35%,UBC;RPS27A;POLE3
prerank,Reactome_2022__Autodegradation Of E3 Ubiquitin Ligase COP1 R-HSA-349425,-0.7215124787844241,-1.523840040560005,0.013513513513513514,0.15604325916359968,1.0,15/44,19.69%,UBC;RPS27A;CARD16;PSMB3;PSMB6;PSMA7;PSMB9;PSMD12;PSMD8;PSMA5;UBA52;PSMA3;PSMC4;PSME2;PSME1
prerank,CellMarker_Augmented_2021__Neutrophil:Blood,-0.8221151467832117,-1.5228280832548216,0.0,0.1578400055517119,1.0,5/15,6.88%,JAML;CD14;SELL;PECAM1;C5AR1
prerank,Reactome_2022__Apoptotic Execution Phase R-HSA-75153,-0.7355455130140014,-1.522626065778188,0.03225806451612903,0.15778082294745552,1.0,5/39,3.75%,H1-4;H1-3;H1-2;PRKCQ;H1-0
prerank,GO_Biological_Process_2021__sphingoid biosynthetic process (GO:0046520),0.8640158001925071,1.522355443801285,0.041666666666666664,0.42734230160425873,1.0,3/9,6.65%,ACER2;ABCA2;SPTLC2
prerank,GO_Biological_Process_2021__sphingosine biosynthetic process (GO:0046512),0.8640158001925071,1.522355443801285,0.041666666666666664,0.42734230160425873,1.0,3/9,6.65%,ACER2;ABCA2;SPTLC2
prerank,GO_Biological_Process_2021__chondroitin sulfate metabolic process (GO:0030204),0.7607178265440793,1.5220785058155133,0.03333333333333333,0.42572352298640637,1.0,6/18,9.98%,NCAN;CHST7;CSGALNACT1;UGDH;CSPG5;CHST15
prerank,Reactome_2022__Protein-protein Interactions At Synapses R-HSA-6794362,0.587309183729518,1.5218399434998038,0.0,0.4246045733986939,1.0,28/65,18.64%,IL1RAPL2;SLITRK5;EPB41;NLGN1;LIN7A;GRIA3;GRIA4;SHANK3;PDLIM5;SHANK2;SHARPIN;GRIA1;LRRTM2;GRM5;STX1A;LRRTM4;PTPRD;PPFIA3;NRXN2;GRIN2B;LRRC4B;NLGN4Y;PPFIA2;GRIN2A;DLGAP4;IL1RAPL1;PPFIBP1;DLGAP1
prerank,GO_Biological_Process_2021__regulation of transcription by RNA polymerase I (GO:0006356),-0.8804234797510081,-1.521600013766757,0.0,0.15932750298623063,1.0,1/12,0.28%,FLNA
prerank,GO_Biological_Process_2021__chromosome condensation (GO:0030261),-0.7477316540553504,-1.5204140416309218,0.05970149253731343,0.1614312925112995,1.0,6/29,8.56%,H1-4;H1-3;H1-2;H1-0;TTN;H1-10
prerank,"GO_Biological_Process_2021__chemical synaptic transmission, postsynaptic (GO:0099565)",0.7835718194559942,1.5187914671739875,0.023809523809523808,0.43623210941448354,1.0,7/14,16.68%,GRID2;INSYN2A;LRRK2;GLRA1;GRIN2B;GSK3B;GRIN2A
prerank,GO_Biological_Process_2021__positive regulation of T-helper 17 type immune response (GO:2000318),-0.9171195747688475,-1.5186428512055596,0.01639344262295082,0.1644401605457641,1.0,2/7,1.70%,PRKCQ;NFKBID
prerank,GO_Biological_Process_2021__positive regulation of glucose transmembrane transport (GO:0010828),-0.7764537165114519,-1.5184661964031063,0.03389830508474576,0.16441130374202803,1.0,2/21,5.56%,NR4A3;IGF1
prerank,Reactome_2022__Negative Epigenetic Regulation Of rRNA Expression R-HSA-5250941,-0.6833925891799376,-1.5184649174971598,0.0,0.16398536772197098,1.0,14/53,13.12%,H2BC4;H2BC26;H2AC20;H2AC6;TAF1D;GTF2H5;H3-3B;H2AJ;H2BC21;H2BC5;H2BC9;H2BC11;TAF1C;DNMT1
prerank,GO_Biological_Process_2021__glycolipid metabolic process (GO:0006664),0.6530297720262691,1.51824490404829,0.0,0.4363257578134285,1.0,5/35,5.16%,ARSA;PGAP1;ABCA2;GLB1;ST6GALNAC3
prerank,GO_Biological_Process_2021__negative regulation of reproductive process (GO:2000242),-0.9069978729572409,-1.5181531246429714,0.017241379310344827,0.1641442833666603,1.0,2/6,5.56%,DUSP1;IGF1
prerank,CellMarker_Augmented_2021__Proerythroblast:Germ,-0.676826902866992,-1.5180706143696099,0.0,0.16395369059738202,1.0,21/82,11.20%,IL4I1;CCL3;SRGN;MYO1G;TFRC;MS4A4A;SIGLEC1;FCER1G;BTK;NCF4;LSP1;PLEK;LILRB4;CD300LF;TNFRSF1B;FERMT3;NCF2;ITGB2;CSF2RB;NCKAP1L;TYROBP
prerank,CellMarker_Augmented_2021__Natural Killer cell:Lymph Node,-0.6736658492556287,-1.517418244746618,0.04054054054054054,0.16494657355782275,1.0,13/65,11.39%,GNLY;NKG7;SCML4;PRF1;CD247;TSPAN32;FYN;NLRP12;SPOCK2;KLRD1;SLC11A1;TYROBP;CSF3R
prerank,GO_Biological_Process_2021__mammary gland epithelium development (GO:0061180),0.7880281527613142,1.5173306304405492,0.05405405405405406,0.4383805499176026,1.0,4/9,15.47%,SCRIB;ZNF703;ERBB4;AKT2
prerank,GO_Biological_Process_2021__histone H2A-K119 monoubiquitination (GO:0036353),0.9107077778966084,1.5172749963522052,0.05,0.4362144236779074,1.0,1/6,1.33%,RNF2
prerank,GO_Biological_Process_2021__glucose homeostasis (GO:0042593),0.6244128314658833,1.5171839906907632,0.034482758620689655,0.43477646117988566,1.0,9/52,5.72%,LEPR;PPARGC1A;IGF1R;ADIPOR2;PDK4;SIRT1;MCU;PPARG;BACE2
prerank,KEGG_2021_Human__Viral protein interaction with cytokine and cytokine receptor,-0.7953158957606967,-1.5168428872577329,0.0,0.16611937873669544,1.0,9/28,8.06%,CCL4;CCL3;CXCR4;CCL5;TNFSF10;IL10RA;ACKR4;CCL3L3;TNFRSF1B
prerank,GO_Biological_Process_2021__regulation of cardiac muscle hypertrophy (GO:0010611),-0.7836968214903223,-1.5166039950860892,0.015873015873015872,0.16645575156173226,1.0,3/20,5.56%,NR4A3;RGS2;IGF1
prerank,PanglaoDB_Augmented_2021__Glycinergic Neurons,0.6229646885332097,1.5164107656600914,0.029411764705882353,0.4354611541095614,1.0,19/61,14.85%,KCNQ2;CNTN2;NCAN;B4GALNT4;ADGRB2;SNAP91;CSPG5;NGB;BRSK1;PSD2;GRM5;SNCB;CELSR2;PPFIA3;LINGO1;CAMKV;GRIA2;GAD1;LRRC4B
prerank,Reactome_2022__Acyl Chain Remodelling Of PI R-HSA-1482922,0.9008665424783568,1.516238052995655,0.022727272727272728,0.43409960598784986,1.0,1/6,0.68%,PLA2G4C
prerank,GO_Biological_Process_2021__autonomic nervous system development (GO:0048483),0.8768494106358478,1.5162139720691181,0.05,0.43205586347743924,1.0,4/6,12.21%,NRP1;SOX4;PHACTR4;NF1
prerank,GO_Biological_Process_2021__B cell proliferation (GO:0042100),0.8188439813250642,1.515915859368055,0.0,0.4315900262336506,1.0,1/9,0.44%,CD180
prerank,GO_Biological_Process_2021__defense response to symbiont (GO:0140546),-0.6737180816204186,-1.5158729315717303,0.0,0.1676417318439902,1.0,25/77,11.93%,FLNA;MX2;OAS3;MX1;RSAD2;IFI44L;DDIT4;TRIM5;IFIT3;IFIT1;OAS2;PRF1;IFITM3;SHFL;NLRC5;EIF2AK2;PLSCR1;IFIT2;OAS1;RNASEL;APOBEC3G;STAT1;IRF1;STING1;MLKL
prerank,Reactome_2022__Activation Of AMPK Downstream Of NMDARs R-HSA-9619483,0.793931077524372,1.5158601892567425,0.11428571428571428,0.42952137428519754,1.0,1/8,0.12%,PRKAB2
prerank,GO_Biological_Process_2021__NADH dehydrogenase complex assembly (GO:0010257),-0.7090099427031425,-1.51461370318445,0.046153846153846156,0.16974382032863577,1.0,21/48,18.32%,DMAC1;NDUFC1;NDUFA2;NDUFA1;TMEM126B;NDUFB9;NDUFA12;NDUFB4;TIMM21;NDUFB1;NDUFS8;NDUFS5;BCS1L;OXA1L;NDUFS6;NDUFB7;NUBPL;TMEM126A;NDUFB3;NDUFS7;NDUFA3
prerank,GO_Biological_Process_2021__mitochondrial respiratory chain complex I assembly (GO:0032981),-0.7090099427031425,-1.51461370318445,0.046153846153846156,0.16974382032863577,1.0,21/48,18.32%,DMAC1;NDUFC1;NDUFA2;NDUFA1;TMEM126B;NDUFB9;NDUFA12;NDUFB4;TIMM21;NDUFB1;NDUFS8;NDUFS5;BCS1L;OXA1L;NDUFS6;NDUFB7;NUBPL;TMEM126A;NDUFB3;NDUFS7;NDUFA3
prerank,GO_Biological_Process_2021__transport along microtubule (GO:0010970),0.82988117940216,1.5144060756310287,0.02702702702702703,0.43278571061507437,1.0,2/12,7.65%,BAG3;COPG1
prerank,CellMarker_Augmented_2021__Red Blood Cell (erythrocyte):Placenta,-0.802885469887884,-1.5141847687241512,0.03076923076923077,0.17029595101695003,1.0,13/31,15.33%,GNLY;MNDA;CLEC12A;GRAP2;BTK;PRF1;TSPAN32;SLC11A1;TYROBP;CSF3R;MYO1F;FPR1;KLRF1
prerank,GO_Biological_Process_2021__cellular response to interferon-beta (GO:0035458),-0.859972103044158,-1.5136103939538719,0.0,0.1711186091933638,1.0,6/11,10.38%,MNDA;PYHIN1;AIM2;OAS1;STAT1;IRF1
prerank,Reactome_2022__Nuclear Signaling By ERBB4 R-HSA-1251985,0.6398712309559931,1.5135985342774838,0.02564102564102564,0.4348244080800214,1.0,7/24,14.14%,GFAP;MXD4;NRG1;TAB2;NRG3;NRG2;ERBB4
prerank,Reactome_2022__OAS Antiviral Response R-HSA-8983711,-0.9134318486055989,-1.5134419097392473,0.0,0.17102836441788946,1.0,5/7,8.32%,FLNA;OAS3;OAS2;OAS1;RNASEL
prerank,GO_Biological_Process_2021__regulation of telomere capping (GO:1904353),-0.8293235173345721,-1.5134322648131244,0.017543859649122806,0.17064396867256143,1.0,2/17,1.65%,PKIB;PRKCQ
prerank,GO_Biological_Process_2021__regulation of T-helper 2 cell differentiation (GO:0045628),0.9108969724527892,1.5129203190857887,0.0425531914893617,0.43548560199315406,1.0,1/5,0.34%,ANXA1
prerank,CellMarker_Augmented_2021__CD8+ T cell:Lung,-0.6827756793905219,-1.5128624122536543,0.014084507042253521,0.17141435905458377,1.0,24/62,16.52%,PPIE;GTF3C6;NDUFA2;GLA;TMA7;LAMTOR5;TRAPPC4;POLR2G;MRPL52;COMMD8;EXOSC1;BLOC1S2;RBX1;COA6;MED11;UXT;RPA3;CDC26;NOP10;SLC25A19;TMEM258;TMEM126A;MRPS18C;SCNM1
prerank,GO_Biological_Process_2021__regulation of cellular amino acid metabolic process (GO:0006521),-0.7209135863847815,-1.5127873533660898,0.0,0.171076017445834,1.0,16/41,22.96%,PSMB3;ODC1;PSMB6;PSMA7;PSMB9;AZIN1;PSMD12;PSMD8;PSMA5;PSMA3;PSMC4;PSME2;PSME1;PSMB5;PSMC3;PSME3
prerank,GO_Biological_Process_2021__positive regulation of calcium-mediated signaling (GO:0050850),-0.9801223425990324,-1.5124126023654028,0.0,0.171211702495138,1.0,2/7,0.62%,CCL4;CCL3
prerank,CellMarker_Augmented_2021__Monocyte:Spleen,-0.6843872013252952,-1.5119071829830022,0.028985507246376812,0.1719524950317441,1.0,31/76,17.23%,JAML;MNDA;VNN2;CLEC12A;MS4A4A;AIF1;SIGLEC1;CD14;FCER1G;NCF4;PLEK;IL10RA;CD300LF;C5AR1;SIRPB2;LILRB3;NCF2;SLC11A1;MS4A6A;ITGB2;CSF2RB;TYROBP;CSF3R;HAVCR2;MYO1F;LY86;FPR1;IGSF6;FCGR3A;LST1;GIMAP4
prerank,Reactome_2022__Orc1 Removal From Chromatin R-HSA-68949,-0.7015083341001709,-1.511311991145381,0.0,0.17289103763019842,1.0,21/53,22.96%,UBC;RPS27A;PSMB3;PSMB6;PSMA7;PSMB9;RBX1;PSMD12;PSMD8;PSMA5;MCM7;UBA52;PSMA3;PSMC4;PSME2;PSME1;MCM6;PSMB5;PSMC3;MCM5;PSME3
prerank,GO_Biological_Process_2021__regulation of cell-cell adhesion involved in gastrulation (GO:0070587),0.8838921954283704,1.5112732149548698,0.045454545454545456,0.43841370893842596,1.0,3/5,10.86%,KLF4;MYADM;WNK1
prerank,GO_Biological_Process_2021__negative regulation of heterotypic cell-cell adhesion (GO:0034115),0.8838921954283704,1.5112732149548698,0.045454545454545456,0.43841370893842596,1.0,3/5,10.86%,KLF4;MYADM;WNK1
prerank,GO_Biological_Process_2021__regulation of hydrolase activity (GO:0051336),0.5526289464784775,1.5111672813429442,0.0,0.43687362806779534,1.0,19/55,13.77%,PLXNB1;PLXNA2;RAP1GAP;FGD4;PLXNA3;SCARB2;TBC1D10B;PLXNB2;CRK;PLXNC1;TDG;ARHGAP15;FBXW11;NF1;NTRK2;RABGAP1;PLXNA1;VAV1;PTK2
prerank,CellMarker_Augmented_2021__Myeloid-derived Suppressor cell:Peripheral Blood,-0.7867768640150208,-1.5111164242935307,0.015625,0.17302122249303636,1.0,7/24,9.70%,TFRC;CD69;CD14;SELL;ITGA4;ITGA6;CD226
prerank,Reactome_2022__DNA Damage Bypass R-HSA-73893,-0.7318799310467188,-1.5106591930092008,0.058823529411764705,0.17379660011648107,1.0,7/39,14.82%,UBC;RPS27A;POLE3;RBX1;WDR48;RPA3;UBA52
prerank,Reactome_2022__Nuclear Events (Kinase And Transcription Factor Activation) R-HSA-198725,0.6671367928121117,1.5104408975565085,0.06896551724137931,0.43851135653767837,1.0,8/40,9.65%,EGR1;DUSP6;CDK5R1;MAPK11;VGF;SH3GL3;PPP2R1B;DUSP7
prerank,KEGG_2021_Human__Neutrophil extracellular trap formation,-0.6264307223064727,-1.5101226002341068,0.0,0.17450151211945067,1.0,23/103,12.68%,H2AC8;H2BC7;H4C3;H2BC4;H2AC20;H2AC6;NCF4;SLC25A5;H2BC18;H3-3B;H2AJ;C5AR1;H2BC21;ACTG1;H2BC5;H2BC9;NCF2;H2BC8;ITGB2;ACTB;ITGAL;CYBA;H2BC11
prerank,GO_Biological_Process_2021__negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),-0.8392539901894828,-1.5092706533474143,0.07272727272727272,0.17591210446746072,1.0,4/13,4.24%,PPP1R15A;DNAJB9;DDRGK1;RACK1
prerank,KEGG_2021_Human__Hedgehog signaling pathway,0.6244374819803821,1.5088670954560361,0.058823529411764705,0.4432264815105435,1.0,13/38,15.67%,CSNK1G1;SPOPL;PTCH2;GPR161;HHAT;DISP1;BTRC;FBXW11;PTCH1;CSNK1E;MEGF8;SMURF1;GSK3B
prerank,GO_Biological_Process_2021__establishment of melanosome localization (GO:0032401),-0.8502324449958056,-1.5085122030013745,0.03508771929824561,0.17610928669481932,1.0,2/11,5.18%,BBS2;RAB11A
prerank,GO_Biological_Process_2021__melanosome localization (GO:0032400),-0.8502324449958056,-1.5085122030013745,0.03508771929824561,0.17610928669481932,1.0,2/11,5.18%,BBS2;RAB11A
prerank,GO_Biological_Process_2021__melanosome transport (GO:0032402),-0.8502324449958056,-1.5085122030013745,0.03508771929824561,0.17610928669481932,1.0,2/11,5.18%,BBS2;RAB11A
prerank,GO_Biological_Process_2021__pigment granule transport (GO:0051904),-0.8502324449958056,-1.5085122030013745,0.03508771929824561,0.17610928669481932,1.0,2/11,5.18%,BBS2;RAB11A
prerank,CellMarker_Augmented_2021__Trophoblast Stem cell:Undefined,-0.8781200111069888,-1.5084787214412203,0.06896551724137931,0.17585697151135946,1.0,5/10,9.33%,ZNF185;CLDN7;JUP;OVOL2;LLGL2
prerank,GO_Biological_Process_2021__platelet activating factor metabolic process (GO:0046469),0.8789372597542189,1.508398188265744,0.04,0.4428398665110951,1.0,2/7,1.59%,PLA2G4C;PLA2G7
prerank,Reactome_2022__Glycosaminoglycan Metabolism R-HSA-1630316,0.5768741381967152,1.508217882544407,0.034482758620689655,0.4415267757282601,1.0,18/69,12.44%,B3GNT2;HS3ST5;HS3ST4;NCAN;CHST7;CSGALNACT1;GLB1;HS2ST1;B4GALT4;CSPG5;HPSE;B4GALT7;CHST1;SLC9A1;CHST15;EXT1;UST;GPC6
prerank,GO_Biological_Process_2021__regulation of reactive oxygen species biosynthetic process (GO:1903426),-0.7887066524064912,-1.5081047069851636,0.07407407407407407,0.17613000965403758,1.0,1/15,0.52%,CD36
prerank,GO_Biological_Process_2021__peptide hormone secretion (GO:0030072),0.7881868561888667,1.5080848547089762,0.027777777777777776,0.4401170439181838,1.0,1/12,0.34%,ANXA1
prerank,Reactome_2022__SCF(Skp2)-mediated Degradation Of P27/P21 R-HSA-187577,-0.7056549595765702,-1.5077116074671268,0.02857142857142857,0.1764017287718718,1.0,19/46,22.96%,UBC;RPS27A;PSMB3;PSMB6;PSMA7;PSMB9;PSMD12;PSMD8;PSMA5;CCND1;UBA52;PSMA3;PSMC4;PSME2;PSME1;PSMB5;PSMC3;CDKN1B;PSME3
prerank,GO_Biological_Process_2021__regulation of protein modification by small protein conjugation or removal (GO:1903320),0.747754570475778,1.5072201728047137,0.06521739130434782,0.44218942851866755,1.0,1/19,0.03%,EGR1
prerank,CellMarker_Augmented_2021__Stem cell:Esophagus,0.5983886480499743,1.5071083104695528,0.03571428571428571,0.4406817774930099,1.0,28/64,20.67%,LRP4;FRAS1;NEO1;ARNT2;PLPPR4;MAGI1;NUAK1;CACHD1;SHC2;PTPRG;GUCY1A2;PTPRD;ENAH;LINGO1;GPC6;FBXL7;MARK1;NFASC;CSRNP3;ANTXR1;MAP6;RBFOX2;CRMP1;MAP2;DCLK1;CNTN1;PHYHIPL;MEGF10
prerank,GO_Biological_Process_2021__regulation of cytoskeleton organization (GO:0051493),0.5933833313869801,1.5066586931523227,0.03225806451612903,0.4406917226036923,1.0,19/77,18.65%,PLXNB1;PDGFA;HIP1R;CDK10;PHLDB1;TPPP;CRK;MAPK1;TJP1;PTK2;CLASP1;RHOBTB1;GSK3B;IQCJ-SCHIP1;PRKAA1;P2RX7;MARK2;MAP6;TAOK2
prerank,PanglaoDB_Augmented_2021__B Cells Naive,-0.665819773341546,-1.5060425430209,0.0,0.1804320449005593,1.0,26/99,11.27%,JAML;NKG7;MYO1G;CD37;ACAP1;CD2;MNDA;PYHIN1;CD69;VNN2;IKZF3;STAG3;PSTPIP1;SELL;SLAMF6;SNX20;NCF4;PLEK;IL10RA;SP140;CYTIP;CD72;BANK1;ABCB4;NCKAP1L;ITGAL
prerank,CellMarker_Augmented_2021__Monocyte:Lung,-0.6485198180790224,-1.5059162057977566,0.014285714285714285,0.18030185249560934,1.0,26/75,11.39%,CD36;MNDA;CLEC12A;MS4A4A;MARCO;AIF1;SIGLEC1;CD14;FCER1G;CD93;NCF4;PLEK;F13A1;LILRB4;CD300LF;PECAM1;C5AR1;SIRPB2;TYMP;LILRB3;NCF2;MS4A6A;ITGB2;CSF2RB;TYROBP;CSF3R
prerank,Reactome_2022__Cytosolic Sensors Of Pathogen-Associated DNA R-HSA-1834949,-0.6910000731493745,-1.5057186947217853,0.02666666666666667,0.18032368979576868,1.0,4/50,4.19%,UBC;RPS27A;NLRC3;AIM2
prerank,GO_Biological_Process_2021__MyD88-dependent toll-like receptor signaling pathway (GO:0002755),-0.7724478740323583,-1.5053946150402575,0.015873015873015872,0.18082012939485245,1.0,5/26,3.54%,CD36;UBC;RPS27A;CD14;BTK
prerank,GO_Biological_Process_2021__positive regulation of chromatin binding (GO:0035563),-0.9006534731447617,-1.5047798149944767,0.01694915254237288,0.18165861668610933,1.0,4/7,6.59%,DDX11;DTX3L;MED25;PARP9
prerank,PanglaoDB_Augmented_2021__Trigeminal Neurons,0.534311782998157,1.50456703172682,0.0,0.4484528778562985,1.0,48/104,22.69%,AVIL;VAMP1;CNTN2;NCAN;ZNF536;GDAP1;SNAP91;SCN3B;PLPPR4;PARM1;DHCR24;KCTD16;GRIA4;CA10;OLFM3;CADM2;GRM5;ASXL3;PTPN5;PTPRD;CCDC92;RBFOX1;GRIA2;NFASC;CSRNP3;PPFIA2;NKAIN2;ADGRB3;MAPK4;GCNT2;PRKX;MAP6;CRMP1;MAP2;DCLK1;PHYHIPL;SYT4;AMER2;NOVA1;CACNA1B;LRFN5;SYNPR;NRXN1;CPNE3;LSAMP;DLG2;RAB3C;OPCML
prerank,Reactome_2022__G Alpha (S) Signaling Events R-HSA-418555,-0.6650625265519667,-1.5045095919932927,0.04838709677419355,0.1817200172759981,1.0,4/57,6.63%,CALCR;PDE4A;GNB5;PRKAR1B
prerank,Reactome_2022__TP53 Regulates Transcription Of Genes Involved In G1 Cell Cycle Arrest R-HSA-6804116,0.856306206220973,1.5043980046596699,0.045454545454545456,0.4469904925130016,1.0,2/7,7.81%,PCBP4;ZNF385A
prerank,PanglaoDB_Augmented_2021__Red Pulp Macrophages,-0.6460072517543282,-1.5042901461576395,0.0273972602739726,0.1822096026083895,1.0,33/81,17.23%,JAML;ADGRE1;MNDA;CLEC12A;MS4A4A;MARCO;AIF1;SIGLEC1;CD14;FCER1G;NCF4;PLEK;LILRB4;CD300LF;C5AR1;SIRPB2;LILRB3;NCF2;SLC11A1;MS4A6A;CSF2RB;TYROBP;CSF3R;FCGR1CP;HAVCR2;CASP5;MYO1F;LY86;FPR1;IGSF6;FCGR3A;LST1;GIMAP4
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced neuron death (GO:1903204),-0.8702535020650093,-1.503935952617142,0.0,0.18263274846843303,1.0,2/10,4.24%,NR4A3;RACK1
prerank,GO_Biological_Process_2021__axon extension involved in axon guidance (GO:0048846),0.7852310059059914,1.5029380901287213,0.075,0.4495895096301021,1.0,2/7,9.71%,NRP1;ALCAM
prerank,GO_Biological_Process_2021__neuron projection extension involved in neuron projection guidance (GO:1902284),0.7852310059059914,1.5029380901287213,0.075,0.4495895096301021,1.0,2/7,9.71%,NRP1;ALCAM
prerank,Reactome_2022__ECM Proteoglycans R-HSA-3000178,0.6618523826149137,1.5027176552322798,0.030303030303030304,0.448719200917122,1.0,8/26,12.55%,LRP4;NCAN;SERPINE1;DAG1;TNR;DMTF1;ITGAV;ITGA2
prerank,GO_Biological_Process_2021__midbrain dopaminergic neuron differentiation (GO:1904948),0.897544191108796,1.5013298710956662,0.022222222222222223,0.45323933942066646,1.0,2/5,7.29%,WNT5A;RYK
prerank,Reactome_2022__HCMV Infection R-HSA-9609646,-0.6515398249956114,-1.5012596674060084,0.014705882352941176,0.1887683308543472,1.0,16/95,12.68%,H2AC25;CEBPD;H2BC4;H2BC26;H2AC20;H2AC6;H2BC18;TXN2;H2BC21;SNF8;H2BC5;H2BC9;VPS28;NUP50;VPS37B;H2BC11
prerank,PanglaoDB_Augmented_2021__B Cells,-0.6741110102470038,-1.5011531809739864,0.012658227848101266,0.18866347833398014,1.0,29/106,11.27%,JAML;NKG7;MYO1G;CD37;ACAP1;CD2;CXCR4;CD55;CD69;VNN2;IFIT3;PSTPIP1;CD14;SELL;SLAMF6;SNX20;NCF4;LSP1;PLEK;IL10RA;SP140;CYTIP;CD72;P2RY8;BANK1;CSF2RB;NCKAP1L;HLA-DRA;ITGAL
prerank,GO_Biological_Process_2021__positive regulation of telomere capping (GO:1904355),-0.8672797877292732,-1.5008181671384082,0.01818181818181818,0.18915334043460946,1.0,2/12,1.65%,PKIB;PRKCQ
prerank,GO_Biological_Process_2021__positive regulation of osteoblast differentiation (GO:0045669),0.6841865300289919,1.5005455295059125,0.0,0.45506582617158703,1.0,10/25,14.29%,ATRAID;ACVR2A;CTNNBIP1;TMEM119;FBN2;BMPR1B;HGF;BMPR1A;NELL1;FERMT2
prerank,CellMarker_Augmented_2021__Epithelial cell:Placenta,-0.840577585476255,-1.4999919085752573,0.0,0.1905936592859169,1.0,3/15,6.67%,ARSJ;ANXA2;OSMR
prerank,Reactome_2022__AUF1 (hnRNP D0) Binds And Destabilizes mRNA R-HSA-450408,-0.6942839608116842,-1.4999541638086495,0.0273972602739726,0.19025291803335817,1.0,15/47,19.69%,UBC;RPS27A;PSMB3;PSMB6;PSMA7;PSMB9;PSMD12;PSMD8;PSMA5;HSPA1A;UBA52;PSMA3;PSMC4;PSME2;PSME1
prerank,GO_Biological_Process_2021__pyroptosis (GO:0070269),-0.8706744144616566,-1.4993008739048836,0.0,0.19138890926844424,1.0,4/14,4.19%,APIP;NAIP;GZMB;AIM2
prerank,Reactome_2022__ERKs Are Inactivated R-HSA-202670,0.8209664483169749,1.4985787511411237,0.0784313725490196,0.4611231966723134,1.0,4/10,11.38%,DUSP6;PPP2R1B;DUSP7;MAPK1
prerank,PanglaoDB_Augmented_2021__Choroid Plexus Cells,0.622272552366832,1.49760836085529,0.038461538461538464,0.4634142850879381,1.0,14/62,14.09%,SHROOM3;PLXNB1;NEO1;SLC31A1;SCARB2;MAGI1;UNC13B;SHC2;SHANK2;COBL;GPC6;TJP1;ADCY6;CHMP1A
prerank,GO_Biological_Process_2021__quinone biosynthetic process (GO:1901663),0.8084935717909176,1.497150136726357,0.023809523809523808,0.46062706336541887,1.0,2/10,4.98%,UBIAD1;COQ9
prerank,GO_Biological_Process_2021__ubiquinone biosynthetic process (GO:0006744),0.8084935717909176,1.497150136726357,0.023809523809523808,0.46062706336541887,1.0,2/10,4.98%,UBIAD1;COQ9
prerank,GO_Biological_Process_2021__defense response to bacterium (GO:0042742),-0.6822969451972906,-1.4960885338923238,0.0,0.1994996753486772,1.0,16/54,14.41%,GNLY;OAS3;HAMP;RPL39;NAIP;FCER1G;OAS2;RPL30;H2BC21;OAS1;GBP2;SLC11A1;H2BC11;NOD2;HLA-E;COLEC12
prerank,GO_Biological_Process_2021__epithelial tube morphogenesis (GO:0060562),0.6989030739630757,1.4959389740069815,0.05555555555555555,0.46390809275053363,1.0,3/16,3.46%,SCRIB;PKD2;PKD1
prerank,Reactome_2022__Immunoregulatory Interactions Between A Lymphoid And A non-Lymphoid Cell R-HSA-198933,-0.7089919767832688,-1.4958302693279022,0.014084507042253521,0.19964400967989285,1.0,20/57,11.27%,JAML;HLA-B;CD96;B2M;SIGLEC1;CD200R1;SELL;CD247;SLAMF6;HLA-C;LILRB4;CD300LF;HLA-F;ITGA4;KLRD1;OSCAR;CD226;ITGB2;TYROBP;ITGAL
prerank,GO_Biological_Process_2021__dicarboxylic acid transport (GO:0006835),0.8399095136152984,1.4957952729998505,0.05263157894736842,0.46249911916627867,1.0,4/14,6.03%,PDPN;SLC1A3;SLC25A18;SLC1A2
prerank,GO_Biological_Process_2021__cellular response to cadmium ion (GO:0071276),-0.8341220583996787,-1.4956051329734534,0.0,0.19991323474120035,1.0,2/15,1.22%,MT2A;FOS
prerank,GO_Biological_Process_2021__development of primary male sexual characteristics (GO:0046546),0.8504756615530543,1.4953700434019908,0.02564102564102564,0.4629185025183195,1.0,5/10,11.17%,LHFPL2;WNT5A;WNT2B;KITLG;NCOA4
prerank,Reactome_2022__Signaling By GPCR R-HSA-372790,-0.576106786398549,-1.494933813373878,0.0,0.2014339118469466,1.0,28/276,6.92%,CCL4;CALCR;PLEKHG5;CCL3;PDE4A;ADGRE1;CHRM2;CXCR4;CCL5;GPR183;CD55;PRKCQ;MGLL;RASGRF2;VAV3;CD200R1;RGS1;BTK;RGS16;GNB5;ARHGEF1;ACKR4;TACR1;RGS4;PRKAR1B;ARHGEF3;C5AR1;OBSCN
prerank,GO_Biological_Process_2021__mast cell degranulation (GO:0043303),-0.9895586570984931,-1.4949331476323147,0.0,0.20050564497207587,1.0,1/5,0.08%,NR4A3
prerank,GO_Biological_Process_2021__mast cell activation involved in immune response (GO:0002279),-0.9895586570984931,-1.4949331476323147,0.0,0.20050564497207587,1.0,1/5,0.08%,NR4A3
prerank,CellMarker_Augmented_2021__Osteoclast:Bone,-0.935107203094365,-1.4947921116737835,0.0,0.20045939884058464,1.0,1/5,0.10%,CALCR
prerank,GO_Biological_Process_2021__negative regulation of biomineral tissue development (GO:0070168),-0.8518907596355328,-1.4945305638877873,0.0,0.20057885895536023,1.0,2/13,0.93%,CCL3;SRGN
prerank,Reactome_2022__Packaging Of Telomere Ends R-HSA-171306,-0.8626821946799207,-1.4943534762213069,0.0,0.20028498383443114,1.0,10/15,12.68%,H2BC4;H2BC26;H2AC20;H2AC6;H2AJ;H2BC21;H2BC5;H2BC9;TERF2IP;H2BC11
prerank,GO_Biological_Process_2021__regulation of response to biotic stimulus (GO:0002831),-0.7742611816096565,-1.4939894814728591,0.029850746268656716,0.20065140431779266,1.0,7/26,11.83%,CD36;CD55;TRIM5;DHX58;IRF1;ERAP1;APPL1
prerank,GO_Biological_Process_2021__regulation of dendritic spine development (GO:0060998),0.7406654042296053,1.4935897532717166,0.03333333333333333,0.4695127305216885,1.0,7/19,15.82%,GRIN3A;DLG5;NLGN1;SHANK3;TANC2;ARF6;PPFIA2
prerank,CellMarker_Augmented_2021__B cell:Spleen,-0.6891356956221335,-1.4935324687882656,0.028169014084507043,0.2013654271932741,1.0,19/75,11.27%,JAML;NKG7;MYO1G;CD37;ACAP1;VNN2;AIF1;PSTPIP1;BTK;SLAMF6;SNX20;NCF4;PLEK;IL10RA;CYTIP;SAMSN1;P2RY8;NCKAP1L;ITGAL
prerank,PanglaoDB_Augmented_2021__Trophoblast Stem Cells,0.763763472946952,1.4934724198471574,0.045454545454545456,0.4681478597858426,1.0,1/14,0.04%,SHROOM3
prerank,Reactome_2022__Anti-inflammatory Response Favoring Leishmania Infection R-HSA-9662851,-0.6725970209180657,-1.4933575365610614,0.0,0.20131775253550163,1.0,7/63,8.36%,CALCR;YES1;CD247;GNB5;PRKAR1B;FYN;CALM1
prerank,GO_Biological_Process_2021__regulation of relaxation of cardiac muscle (GO:1901897),-0.9628233671963041,-1.4925449779484175,0.0,0.20276330612758944,1.0,1/5,0.73%,PLN
prerank,GO_Biological_Process_2021__inclusion body assembly (GO:0070841),0.9686063647234302,1.4925361205941443,0.0,0.4701313922474964,1.0,1/5,0.35%,BAG3
prerank,GO_Biological_Process_2021__positive regulation of mitophagy in response to mitochondrial depolarization (GO:0098779),-0.8667470373849347,-1.4923713948476334,0.10638297872340426,0.20261065483166737,1.0,1/7,0.92%,TOMM7
prerank,GO_Biological_Process_2021__ribosomal large subunit assembly (GO:0000027),-0.8232085207516747,-1.492268341216485,0.018867924528301886,0.20241797293713246,1.0,10/17,12.56%,RPL3;RPL23A;RPL5;RPL10;RPL11;RPL24;RPL6;RPLP0;NOP53;TRAF7
prerank,Reactome_2022__Ub-specific Processing Proteases R-HSA-5689880,-0.6080133603217737,-1.4910563857683614,0.0,0.20507012304305425,1.0,24/139,12.85%,H2AC25;UBC;H2BC4;H2BC26;H2AC20;RPS27A;H2AC6;PSMB3;ADRM1;H2BC18;H2BC21;PSMB6;PSMA7;H2BC5;MAT2B;PSMB9;H2BC9;CFTR;HIF1A;WDR48;PSMD12;H2BC11;PSMD8;PSMA5
prerank,PanglaoDB_Augmented_2021__Osteoclast Precursor Cells,-0.6426630346350285,-1.4909594837771516,0.0,0.20491331699875534,1.0,25/93,11.20%,CCL4;BCL2A1;CCL3;SRGN;MNDA;GPR183;MS4A4A;FCER1G;NCF4;SAMD9L;PLEK;LILRB4;C5AR1;CSF2RA;TNFRSF1B;TNFAIP3;TYMP;GBP2;NCF2;CFLAR;MS4A6A;IRF1;ITGB2;CSF2RB;TYROBP
prerank,PanglaoDB_Augmented_2021__Erythroid-like And Erythroid Precursor Cells,-0.6975567490118257,-1.490827024281289,0.02702702702702703,0.2047369911858464,1.0,22/66,15.33%,NKG7;CD36;RSAD2;MNDA;CD55;VNN2;CLEC12A;GRAP2;BTK;NCF4;TSPAN32;CD300LF;ITGA4;CD44;CSF2RB;CSF3R;CD47;UROS;MYO1F;C19ORF38;FPR1;KLRF1
prerank,GO_Biological_Process_2021__monocarboxylic acid transport (GO:0015718),-0.7558714458608282,-1.4904254496008313,0.0410958904109589,0.2052071404871729,1.0,8/25,14.37%,CD36;SLC51A;ABCC3;SLC16A3;SLC16A7;ABCB4;SLC16A6;ATP8B1
prerank,Reactome_2022__Translesion Synthesis By REV1 R-HSA-110312,-0.8621119596737054,-1.4903943092922234,0.0,0.2047692214880691,1.0,2/13,1.30%,UBC;RPS27A
prerank,GO_Biological_Process_2021__pyruvate metabolic process (GO:0006090),-0.7034506902908879,-1.4900305814409782,0.014925373134328358,0.2052773804305369,1.0,7/34,9.55%,NR4A3;ME1;GAPDH;PDHX;SLC16A3;HK2;LDHA
prerank,GO_Biological_Process_2021__xenobiotic transport (GO:0042908),-0.838470700499027,-1.4899582421949666,0.03389830508474576,0.20492142435056537,1.0,4/11,11.64%,SLC7A5;ABCC3;ABCB1;ABCA8
prerank,GO_Biological_Process_2021__actin filament capping (GO:0051693),0.7636490527575821,1.4898825492759398,0.1,0.4767145485390402,1.0,3/16,1.66%,AVIL;EPS8;GSN
prerank,GO_Biological_Process_2021__barbed-end actin filament capping (GO:0051016),0.7636490527575821,1.4898825492759398,0.1,0.4767145485390402,1.0,3/16,1.66%,AVIL;EPS8;GSN
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell membrane repolarization (GO:0099623),-0.8740614550465895,-1.4886997513403293,0.0,0.20766685050984812,1.0,1/12,0.28%,FLNA
prerank,Reactome_2022__FCERI Mediated MAPK Activation R-HSA-2871796,-0.741335093904709,-1.488388965486099,0.08955223880597014,0.2080255446114534,1.0,3/25,2.19%,FOS;GRAP2;VAV3
prerank,CellMarker_Augmented_2021__CD1C+ A Dendritic cell:Blood,-0.7827127463468596,-1.4882407328196554,0.03278688524590164,0.20786498365939732,1.0,4/21,4.85%,SLC2A3;CD2;PID1;LPCAT1
prerank,KEGG_2021_Human__Hematopoietic cell lineage,-0.7009134288176124,-1.4879092519226214,0.046153846153846156,0.2082812609445119,1.0,15/41,11.39%,CD36;CD37;CD2;TFRC;CD55;IL7R;CD14;IL3RA;HLA-DRB5;CSF2RA;ITGA4;ITGA6;CD44;HLA-DRA;CSF3R
prerank,GO_Biological_Process_2021__cellular response to catecholamine stimulus (GO:0071870),-0.7788775426713935,-1.4873642921518997,0.043478260869565216,0.20915163561395442,1.0,1/20,0.08%,NR4A3
prerank,Reactome_2022__RMTs Methylate Histone Arginines R-HSA-3214858,-0.7078981176782267,-1.4872120441623193,0.015151515151515152,0.2090094409354561,1.0,6/29,10.13%,H2AC25;H2AC20;H2AC6;H2AJ;RPS2;SMARCD1
prerank,GO_Biological_Process_2021__interleukin-27-mediated signaling pathway (GO:0070106),-0.8428190486643321,-1.4870012541187037,0.05454545454545454,0.2090652302356091,1.0,4/12,9.56%,MX1;OAS2;OAS1;STAT1
prerank,CellMarker_Augmented_2021__Mesoderm cell:Undefined,0.6038437244155476,1.4866590645307471,0.034482758620689655,0.49137228359375673,1.0,28/58,24.58%,PCBP4;SCRIB;TMEM184B;PRKCSH;STK25;GPS1;SCAF1;ATAD3A;SH3GL1;CSNK1E;FASN;PLXNA1;MEGF8;GALNT2;NACC1;ERCC2;PTOV1;FAM234A;TRIM28;USP5;MBD3;SGTA;TTYH3;ABL1;CDH2;GPC1;THOP1;SLC4A2
prerank,Reactome_2022__Recognition Of DNA Damage By PCNA-containing Replication Complex R-HSA-110314,-0.7904790175930011,-1.4866123699946812,0.0,0.20949494436171065,1.0,7/24,14.82%,UBC;RPS27A;POLE3;RBX1;WDR48;RPA3;UBA52
prerank,GO_Biological_Process_2021__regulation of B cell differentiation (GO:0045577),-0.8445537356163336,-1.4862222522372357,0.04081632653061224,0.2103354397043914,1.0,3/12,3.54%,IL4I1;IKZF3;BTK
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Peripheral Blood,0.6998550347863874,1.4861476492641388,0.027777777777777776,0.49165801632440365,1.0,6/27,3.17%,TPM2;NRP1;SERPINE1;GSN;TGFBR2;ACTA2
prerank,KEGG_2021_Human__Viral myocarditis,-0.6801823803588005,-1.485633043748081,0.05555555555555555,0.21134874780644752,1.0,19/43,16.72%,CYCS;HLA-B;CD55;PRF1;HLA-C;HLA-DRB5;FYN;ACTG1;HLA-F;ITGB2;ACTB;HLA-DRA;ITGAL;CCND1;HLA-E;HLA-DPA1;HLA-DMB;RAC1;HLA-DPB1
prerank,GO_Biological_Process_2021__phosphatidylserine metabolic process (GO:0006658),-0.7952208454364966,-1.484978894074735,0.03125,0.21243591946457854,1.0,2/19,7.40%,OSBPL5;PLSCR1
prerank,CellMarker_Augmented_2021__Oocyte:Ovary,0.7414954929314432,1.4848578729679993,0.046511627906976744,0.4953545699059915,1.0,2/12,3.88%,TULP2;TEX14
prerank,CellMarker_Augmented_2021__Lymphocyte:Blood,-0.660875357418912,-1.4841737786675675,0.012987012987012988,0.2145140359928522,1.0,22/69,15.39%,HLA-B;MNDA;CARD16;CLEC12A;B2M;CD14;FCER1G;GLIPR2;HLA-C;CD300LF;OSCAR;GBP2;NCF2;LITAF;TYROBP;FCGR1CP;OSTF1;HLA-E;LY86;FPR1;KLRF1;SLC31A2
prerank,KEGG_2021_Human__Cocaine addiction,0.7313309713031778,1.4840981654138885,0.04878048780487805,0.49615545570289143,1.0,9/23,21.96%,GRIN3A;CDK5R1;GRIN2B;JUN;GRIA2;GRIN2A;CREB3L2;GRM3;GRIN1
prerank,Reactome_2022__RNA Polymerase I Transcription R-HSA-73864,-0.6719978384185803,-1.4836286730652308,0.014084507042253521,0.21541661841429446,1.0,12/55,9.35%,H2BC4;H2BC26;H2AC20;H2AC6;CHD3;TAF1D;GTF2H5;H3-3B;H2AJ;H2BC21;H2BC5;H2BC9
prerank,Reactome_2022__RNA Polymerase I Promoter Clearance R-HSA-73854,-0.6719978384185803,-1.4836286730652308,0.014084507042253521,0.21541661841429446,1.0,12/55,9.35%,H2BC4;H2BC26;H2AC20;H2AC6;CHD3;TAF1D;GTF2H5;H3-3B;H2AJ;H2BC21;H2BC5;H2BC9
prerank,GO_Biological_Process_2021__mast cell mediated immunity (GO:0002448),-0.989555245081956,-1.4835339527140963,0.0,0.2153024960521047,1.0,1/6,0.08%,NR4A3
prerank,GO_Biological_Process_2021__spinal cord development (GO:0021510),0.8508481570655148,1.4834408321401282,0.05128205128205128,0.4971914727524656,1.0,5/7,12.21%,PKD2;PKD1;RELN;SOX4;NF1
prerank,GO_Biological_Process_2021__regulation of tumor necrosis factor production (GO:0032680),-0.6563629797711157,-1.4833779322435632,0.04285714285714286,0.2151695084878456,1.0,21/76,14.31%,CCL3;OAS3;CD2;ZFP36;NLRC3;CD14;OAS2;CLU;IGF1;GSTP1;TNFAIP3;OAS1;SELENOS;TYROBP;C5AR2;CD47;CYBA;PTPRC;HAVCR2;NOD2;HLA-E
prerank,GO_Biological_Process_2021__chondroitin sulfate biosynthetic process (GO:0030206),0.790898685001578,1.4833442918346587,0.0,0.4954740524720158,1.0,6/14,9.98%,NCAN;CHST7;CSGALNACT1;UGDH;CSPG5;CHST15
prerank,GO_Biological_Process_2021__glucosamine-containing compound metabolic process (GO:1901071),0.8444302584193261,1.4829832724387106,0.025,0.4946340029451413,1.0,5/8,12.99%,CHST7;LARGE1;EXTL2;CHST1;RENBP
prerank,GO_Biological_Process_2021__positive regulation of organelle organization (GO:0010638),0.648584743555934,1.4827099841326965,0.08108108108108109,0.4939918830159897,1.0,2/27,0.34%,PPARGC1A;ANXA1
prerank,GO_Biological_Process_2021__negative regulation of cell-cell adhesion (GO:0022408),0.7050737564622114,1.4826874900392943,0.034482758620689655,0.49226098587790806,1.0,8/23,13.77%,KLF4;MYADM;JAG1;WNK1;FXYD5;GTPBP4;ZNF703;PTK2
prerank,CellMarker_Augmented_2021__Exhausted CD8+ T cell:Liver,-0.5840418155757421,-1.4826161061191152,0.0125,0.21679462371587224,1.0,45/191,12.88%,CCL3;SRGN;OAS3;MX1;GAPDH;TFRC;WARS1;GCNT1;RGS2;GABARAPL1;IKZF3;PARP14;PSTPIP1;RGS1;MTHFD1;CBLB;CTSB;NCF4;LSP1;SAMD9L;CD63;SP140;NAPA;SRI;PLSCR1;SRGAP3;TNFRSF1B;TNFAIP3;TYMP;EID1;LY6E;RBPJ;APOBEC3G;GBP2;SAMSN1;LDHA;SLC2A8;MS4A6A;BLOC1S2;HLA-DRA;EPSTI1;CREM;PON2;PSMA5;PRDM1
prerank,Reactome_2022__GPCR Downstream Signaling R-HSA-388396,-0.5739291768223234,-1.4825254900749407,0.0,0.2166782884515136,1.0,25/256,6.92%,CCL4;CALCR;PLEKHG5;PDE4A;CHRM2;CXCR4;CCL5;GPR183;PRKCQ;MGLL;RASGRF2;VAV3;CD200R1;RGS1;BTK;RGS16;GNB5;ARHGEF1;ACKR4;TACR1;RGS4;PRKAR1B;ARHGEF3;C5AR1;OBSCN
prerank,GO_Biological_Process_2021__RIG-I signaling pathway (GO:0039529),-0.9092812798521189,-1.4823716785565149,0.03571428571428571,0.21658168047802365,1.0,2/5,6.40%,OAS3;PHB2
prerank,GO_Biological_Process_2021__secondary alcohol metabolic process (GO:1902652),-0.7499998517257479,-1.4822569353813824,0.09090909090909091,0.2162935808599811,1.0,2/25,0.88%,OSBPL5;CH25H
prerank,Reactome_2022__Complex I Biogenesis R-HSA-6799198,-0.6983496351386826,-1.482097642957838,0.04477611940298507,0.2162556484920209,1.0,20/41,22.44%,NDUFC1;NDUFA2;NDUFA1;TMEM126B;NDUFB9;NDUFA12;NDUFB4;NDUFB1;NDUFS8;NDUFS5;NDUFS6;NDUFB7;NUBPL;NDUFB3;NDUFS7;NDUFA3;NDUFAF6;NDUFS2;NDUFA10;NDUFAB1
prerank,GO_Biological_Process_2021__artery development (GO:0060840),0.7663640208078434,1.4816303430402191,0.02702702702702703,0.49442872130683563,1.0,7/13,15.51%,NRP1;PKD2;SMAD7;ROBO1;NF1;TGFBR1;ROBO2
prerank,GO_Biological_Process_2021__positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),0.8361968284238409,1.48154833721745,0.044444444444444446,0.4926628900606067,1.0,4/10,6.06%,ANXA1;FGF2;HDAC9;CIB1
prerank,GO_Biological_Process_2021__regulation of osteoblast differentiation (GO:0045667),0.5811208603904383,1.4815446966168089,0.0,0.490676346149072,1.0,16/50,14.29%,ATRAID;ACVR2A;CTNNBIP1;PPARG;RANBP3L;TMEM119;FBN2;BMPR1B;TWIST2;HGF;PTCH1;CDK6;BMPR1A;PTK2;NELL1;FERMT2
prerank,GO_Biological_Process_2021__regulation of amyloid precursor protein biosynthetic process (GO:0042984),0.8445270996497117,1.4796073047405978,0.044444444444444446,0.4982065503076102,1.0,2/8,5.72%,ABCA2;BACE2
prerank,CellMarker_Augmented_2021__Stem cell:Lacrimal Gland,0.5958053034209251,1.4790704630387657,0.04,0.4946340029451413,1.0,13/51,12.87%,GCLC;RAP1GAP;MTUS1;NCEH1;PPARG;TIMP3;KITLG;PTPRK;EPAS1;MAP7;COBL;ARHGAP42;TJP1
prerank,CellMarker_Augmented_2021__Stem cell:Limbal Epithelium,0.5958053034209251,1.4790704630387657,0.04,0.4946340029451413,1.0,13/51,12.87%,GCLC;RAP1GAP;MTUS1;NCEH1;PPARG;TIMP3;KITLG;PTPRK;EPAS1;MAP7;COBL;ARHGAP42;TJP1
prerank,CellMarker_Augmented_2021__Corneal Epithelial Progenitor cell:Embryonic Stem Cell,0.5958053034209251,1.4790704630387657,0.04,0.4946340029451413,1.0,13/51,12.87%,GCLC;RAP1GAP;MTUS1;NCEH1;PPARG;TIMP3;KITLG;PTPRK;EPAS1;MAP7;COBL;ARHGAP42;TJP1
prerank,GO_Biological_Process_2021__cellular response to nutrient levels (GO:0031669),0.6277183623045932,1.4787526301243894,0.0,0.4941989731430767,1.0,5/44,3.81%,RRAGD;PDK4;MAP1LC3A;SIRT1;LRRK2
prerank,Reactome_2022__Suppression Of Phagosomal Maturation R-HSA-9637687,-0.8442620490376981,-1.4787292474555764,0.05454545454545454,0.22560037597379062,1.0,2/11,1.30%,UBC;RPS27A
prerank,Reactome_2022__Loss Of Function Of TGFBR1 In Cancer R-HSA-3656534,0.8322057579244104,1.478416539119821,0.058823529411764705,0.49205952969297845,1.0,3/6,5.98%,TGFBR2;SMAD2;SMAD3
prerank,Reactome_2022__SMAD2/3 Phosphorylation Motif Mutants In Cancer R-HSA-3304356,0.8322057579244104,1.478416539119821,0.058823529411764705,0.49205952969297845,1.0,3/6,5.98%,TGFBR2;SMAD2;SMAD3
prerank,CellMarker_Augmented_2021__Natural Killer cell:Peripheral Blood,-0.8915541327246468,-1.478106157599014,0.0,0.22645821877766603,1.0,5/10,3.81%,GNLY;NKG7;CCL3;GZMB;CD247
prerank,GO_Biological_Process_2021__cellular response to oxidised low-density lipoprotein particle stimulus (GO:0140052),-0.9519144727756967,-1.4774544034645045,0.0,0.2280164902382355,1.0,1/6,0.52%,CD36
prerank,GO_Biological_Process_2021__negative regulation of plasminogen activation (GO:0010757),0.9060297463083147,1.4772072069167033,0.08571428571428572,0.49669261754754923,1.0,2/5,2.96%,SERPINE1;SERPINE2
prerank,Reactome_2022__Translocation Of SLC2A4 (GLUT4) To Plasma Membrane R-HSA-1445148,0.5505633564366472,1.4763508109260512,0.03333333333333333,0.49793411572376983,1.0,14/46,21.61%,PRKAB2;EXOC8;TBC1D1;RAB10;YWHAG;SNAP23;PRKAB1;AKT2;RAB14;MYO1E;RALA;REXO2;YWHAE;RHOQ
prerank,CellMarker_Augmented_2021__Epithelial cell:Mammary Epithelium,-0.8693003931442866,-1.4761178456204709,0.0,0.2314670276902698,1.0,5/13,9.97%,CLDN7;JUP;OVOL2;LLGL2;SSH3
prerank,GO_Biological_Process_2021__negative regulation of protein maturation (GO:1903318),0.9040642831271484,1.475844236180259,0.041666666666666664,0.4979915879523484,1.0,3/5,8.81%,SERPINE2;LRRK2;SNX12
prerank,GO_Biological_Process_2021__Golgi localization (GO:0051645),0.7756321186146213,1.4753839452719906,0.023809523809523808,0.49813860619227124,1.0,4/11,11.51%,STK25;TBCCD1;COPG1;RIPOR1
prerank,Reactome_2022__Activation Of RAC1 R-HSA-428540,0.7248975704011279,1.4752541234569199,0.04878048780487805,0.497029481755216,1.0,2/11,7.38%,NCK2;ROBO1
prerank,GO_Biological_Process_2021__regulation of podosome assembly (GO:0071801),0.8615033528802555,1.4751010992953695,0.024390243902439025,0.49575025588553023,1.0,3/7,7.30%,GSN;LCP1;TNF
prerank,Reactome_2022__Regulation Of Activated PAK-2p34 By Proteasome Mediated Degradation R-HSA-211733,-0.7095447020857171,-1.4747889076418044,0.013888888888888888,0.23473253166561905,1.0,15/42,20.89%,UBC;RPS27A;PSMB3;PSMB6;PSMA7;PSMB9;PSMD12;PSMD8;PSMA5;UBA52;PSMA3;PSMC4;PSME2;PSME1;PSMB5
prerank,GO_Biological_Process_2021__positive regulation of signaling receptor activity (GO:2000273),0.6799464217426161,1.4747885186695973,0.05405405405405406,0.4948811123746931,1.0,7/21,10.80%,NRP1;TGFA;NCOA3;RELN;SHANK3;HDAC1;FBXW7
prerank,GO_Biological_Process_2021__negative regulation of cell cycle G1/S phase transition (GO:1902807),0.7274741328070662,1.4747457775371402,0.043478260869565216,0.49326529857929863,1.0,2/21,1.00%,KLF4;PKD2
prerank,GO_Biological_Process_2021__synaptic vesicle membrane organization (GO:0048499),0.7208322739655949,1.474692804917619,0.0851063829787234,0.49166172579750567,1.0,5/15,10.74%,SYNGR1;STX11;STX1A;STX2;SNAP23
prerank,GO_Biological_Process_2021__G-quadruplex DNA unwinding (GO:0044806),-0.8820651867467011,-1.4746250716999978,0.03508771929824561,0.23458078572920485,1.0,1/7,0.51%,DDX11
prerank,GO_Biological_Process_2021__regulation of Notch signaling pathway (GO:0008593),0.6115566652738503,1.474588058528743,0.0,0.4902461600661061,1.0,11/50,14.07%,MFNG;MAML2;YJEFN3;RFNG;TSPAN15;JAG1;MAML3;POGLUT1;FBXW7;PRKCI;MMP14
prerank,GO_Biological_Process_2021__modification-dependent macromolecule catabolic process (GO:0043632),-0.8934022653750957,-1.474493342129487,0.03389830508474576,0.23444854381112018,1.0,2/8,1.30%,UBC;RPS27A
prerank,GO_Biological_Process_2021__respiratory electron transport chain (GO:0022904),0.6975981724364684,1.4744692945136744,0.024390243902439025,0.48884123768607035,1.0,2/12,3.49%,PPARGC1A;SLC25A18
prerank,"GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (GO:0002480)",-0.8583850772689339,-1.474359362607871,0.05454545454545454,0.23435451346216596,1.0,4/7,7.77%,HLA-B;B2M;HLA-C;HLA-F
prerank,GO_Biological_Process_2021__inflammatory response (GO:0006954),-0.647758639624571,-1.4743169659965654,0.0,0.23403538918411562,1.0,21/100,11.47%,CCL4;CCL3;FOS;CD96;CXCR4;CCL5;MGLL;AIF1;SIGLEC1;NAIP;CD14;ABCF1;TACR1;C5AR1;OLR1;CD44;CHI3L1;SLC11A1;ITGB2;ITGAL;C5AR2
prerank,CellMarker_Augmented_2021__Multipotent Progenitor cell:Heart,0.646900441864766,1.4742301170561132,0.03225806451612903,0.4879269532552269,1.0,7/44,7.17%,SHROOM3;GOLM1;DLG5;FRAS1;GULP1;PLCB4;KITLG
prerank,Reactome_2022__HCMV Early Events R-HSA-9609690,-0.6621747785716056,-1.474090424969448,0.029411764705882353,0.23411137146577046,1.0,10/73,9.35%,H2AC25;H2BC4;H2BC26;H2AC20;H2AC6;H2BC18;TXN2;H2BC21;H2BC5;H2BC9
prerank,Reactome_2022__Antimicrobial Peptides R-HSA-6803157,-0.85274450512112,-1.4739131930013685,0.0,0.23390635084723158,1.0,3/12,4.89%,GNLY;CLU;TSPAN32
prerank,GO_Biological_Process_2021__monocyte chemotaxis (GO:0002548),-0.82905439729967,-1.4739010920209823,0.016666666666666666,0.2334594202197577,1.0,3/12,1.49%,CCL4;CCL3;CCL5
prerank,GO_Biological_Process_2021__positive regulation of tumor necrosis factor production (GO:0032760),-0.6931215893277441,-1.4737878923523688,0.03125,0.23325659380056404,1.0,13/50,14.31%,CCL3;OAS3;CD2;CD14;OAS2;CLU;OAS1;TYROBP;CYBA;PTPRC;HAVCR2;NOD2;HLA-E
prerank,"Reactome_2022__Synthesis, Secretion, And Deacylation Of Ghrelin R-HSA-422085",0.8104315586968858,1.473670849144042,0.14705882352941177,0.4889762665865342,1.0,2/10,1.59%,KLF4;PLA2G7
prerank,GO_Biological_Process_2021__water-soluble vitamin metabolic process (GO:0006767),-0.6683458301231725,-1.4730781031084998,0.06451612903225806,0.23461673166897168,1.0,12/45,20.15%,SLC2A3;VNN2;MTHFD1;CYB5A;FLAD1;SLC25A19;SHMT1;MCCC2;SLC2A1;FOLR2;MMAA;MMAB
prerank,GO_Biological_Process_2021__ganglion development (GO:0061548),0.8390841831595464,1.472602153339713,0.044444444444444446,0.49136076755711605,1.0,2/6,5.40%,NRP1;FZD3
prerank,GO_Biological_Process_2021__membrane repolarization during action potential (GO:0086011),0.815366973803718,1.4725867443807796,0.075,0.48962723642318356,1.0,3/9,4.38%,KCNJ2;KCNIP2;KCND3
prerank,GO_Biological_Process_2021__histone H2A monoubiquitination (GO:0035518),0.791263776026339,1.4718900050332056,0.05263157894736842,0.49117468977371603,1.0,2/15,5.39%,RNF2;RYBP
prerank,Reactome_2022__ADORA2B Mediated Anti-Inflammatory Cytokine Production R-HSA-9660821,-0.704663396742977,-1.4717788982508269,0.03508771929824561,0.238532344662687,1.0,3/39,6.63%,CALCR;GNB5;PRKAR1B
prerank,PanglaoDB_Augmented_2021__Crypt Cells,0.6393019660472252,1.4716360169885965,0.08571428571428572,0.49048285524564794,1.0,11/46,11.62%,HID1;SPON1;AMOT;NEO1;NDRG2;AHCYL2;PBX1;PARM1;SHC2;ASXL3;COBL
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Lung,0.7742151215064381,1.4712018418299635,0.058823529411764705,0.49064983860406086,1.0,2/12,0.66%,KLF4;PDPN
prerank,GO_Biological_Process_2021__positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001269),0.8340519237358601,1.4711390038035654,0.043478260869565216,0.4891993992134668,1.0,2/7,10.07%,GSN;LGALS9
prerank,Reactome_2022__Stabilization Of P53 R-HSA-69541,-0.6881606687662485,-1.4710626805496188,0.04,0.24048723638474376,1.0,15/49,19.69%,UBC;RPS27A;CARD16;PSMB3;PSMB6;PSMA7;PSMB9;PSMD12;PSMD8;PSMA5;UBA52;PSMA3;PSMC4;PSME2;PSME1
prerank,Reactome_2022__Ubiquitin Mediated Degradation Of Phosphorylated Cdc25A R-HSA-69601,-0.7069304311971931,-1.4710528678191659,0.0273972602739726,0.2399944346708406,1.0,14/42,19.69%,UBC;RPS27A;PSMB3;PSMB6;PSMA7;PSMB9;PSMD12;PSMD8;PSMA5;UBA52;PSMA3;PSMC4;PSME2;PSME1
prerank,CellMarker_Augmented_2021__Secretory Progenitor cell:Large Intestine,-0.8475091879646466,-1.4709210577017537,0.05454545454545454,0.2399094305826604,1.0,3/12,8.20%,ARHGAP4;SYNE1;TYMP
prerank,PanglaoDB_Augmented_2021__Alpha Cells,0.5471457734749648,1.4705992090428082,0.05714285714285714,0.48958172036389297,1.0,29/69,23.74%,DEPP1;PLPPR1;NOL4;PLPPR4;PCDH17;MAGI1;GRIA3;SHC2;ASXL3;PTPRD;FXYD5;RUNX1T1;GPC6;ABCC8;CNTN4;NFASC;CSRNP3;SORBS2;PEMT;CNTN3;UCP2;MAP6;PHYHIPL;SYT4;KCNB2;GLS;RAB3C;SEMA6D;FGF14
prerank,KEGG_2021_Human__Nicotine addiction,0.6905085745905919,1.470201736487844,0.07317073170731707,0.4892856953785822,1.0,16/22,21.96%,CACNA1A;GRIN3A;GABRR2;GRIA3;GRIA4;GRIA1;GRIN2B;GRIA2;GRIN2A;GABRD;GABRB2;GABRG3;CACNA1B;GABRA4;GABRA2;GRIN1
prerank,Reactome_2022__Cleavage Of Damaged Purine R-HSA-110331,-0.8545352881824825,-1.4701386521767705,0.0,0.24223609015283132,1.0,11/17,12.68%,H2BC4;H2BC26;H2AC20;H2AC6;OGG1;H2AJ;H2BC21;H2BC5;H2BC9;TERF2IP;H2BC11
prerank,GO_Biological_Process_2021__intracellular cholesterol transport (GO:0032367),0.7587555361007818,1.469869348905255,0.075,0.488655239362186,1.0,2/13,4.97%,LDLR;STARD4
prerank,GO_Biological_Process_2021__semaphorin-plexin signaling pathway involved in axon guidance (GO:1902287),0.8731540798447229,1.4692190755186396,0.05,0.4895384287312162,1.0,5/8,7.75%,PLXNB1;PLXNA2;PLXNA3;PLXNB2;PLXNC1
prerank,Reactome_2022__Regulation Of RUNX3 Expression And Activity R-HSA-8941858,-0.6757395015873485,-1.4688337931698776,0.013333333333333334,0.24536153088789242,1.0,10/49,12.85%,UBC;RPS27A;RUNX3;PSMB3;PSMB6;PSMA7;PSMB9;PSMD12;PSMD8;PSMA5
prerank,GO_Biological_Process_2021__L-glutamate transmembrane transport (GO:0015813),0.8950609061669645,1.4686896060856938,0.041666666666666664,0.4907076732477217,1.0,3/6,6.03%,SLC1A3;SLC25A18;SLC1A2
prerank,GO_Biological_Process_2021__TRAIL-activated apoptotic signaling pathway (GO:0036462),0.9290445573446169,1.4686223105731553,0.04081632653061224,0.48912162699608924,1.0,2/5,4.66%,ZDHHC3;TNFRSF10A
prerank,Reactome_2022__Acyl Chain Remodelling Of PS R-HSA-1482801,-0.8913501229768652,-1.468280016742438,0.03076923076923077,0.24629273804729956,1.0,1/9,0.49%,OSBPL5
prerank,GO_Biological_Process_2021__extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),0.7066486142547532,1.4673776269446177,0.07894736842105263,0.49252353012603156,1.0,5/23,7.87%,BAG3;ZDHHC3;TNFRSF10A;TNF;SORT1
prerank,PanglaoDB_Augmented_2021__Podocytes,0.5704449247230581,1.4673417361597203,0.047619047619047616,0.49090096811173,1.0,43/105,24.52%,COL16A1;RASSF8;FKBP9;MYO1D;PHLDB1;RASAL2;DACH1;MAGI1;UNC13B;NUAK1;KITLG;TANC1;KANK1;NFIB;LOXL2;PTPRG;MERTK;ENAH;THSD7A;GOLIM4;TJP1;ADCY6;FERMT2;ANTXR1;COL4A5;STARD13;RAI14;MYO1E;RBFOX2;SNX7;PTPRO;NTN4;PRICKLE2;HTRA1;CTTN;CD2AP;LIMCH1;PLPP3;DAB2IP;MAGI2;CADPS2;ARHGEF17;LIFR
prerank,CellMarker_Augmented_2021__Regulatory B cell:Peripheral Blood,-0.6904440386777899,-1.4673249275503355,0.013513513513513514,0.24866547151073518,1.0,11/59,5.48%,JAML;NKG7;CD37;MNDA;VNN2;CLEC12A;AIF1;BTK;NCF4;PLEK;CD300LF
prerank,CellMarker_Augmented_2021__Immune cell:Undefined,-0.831970926698427,-1.4671815083629076,0.03225806451612903,0.2485272591752345,1.0,8/16,12.82%,CD96;CD2;CD69;SLAMF6;LILRB3;ITGB2;ITGAL;PTPRC
prerank,PanglaoDB_Augmented_2021__Endothelial Cells (Blood Brain Barrier),0.5545946671545933,1.4670942630269805,0.027777777777777776,0.49052524547890686,1.0,11/74,7.23%,PLXNB1;LRP4;ZNRF3;MTCL1;GFAP;ARNT2;ADGRB2;SEMA3B;TBC1D16;NUAK1;SALL1
prerank,GO_Biological_Process_2021__striated muscle cell development (GO:0055002),0.8886950033672356,1.4669988142627692,0.11363636363636363,0.4894135552147731,1.0,3/5,8.30%,PGM5;TMOD2;TMOD3
prerank,GO_Biological_Process_2021__atrial cardiac muscle cell action potential (GO:0086014),0.8290067810211239,1.4669820423133149,0.05263157894736842,0.48777809488558205,1.0,3/9,10.99%,SCN3B;KCNJ5;KCNN2
prerank,GO_Biological_Process_2021__regulation of myeloid cell differentiation (GO:0045637),-0.6702570233235463,-1.4669355957439074,0.016129032258064516,0.24889979519034738,1.0,2/48,1.65%,NR4A3;PRKCQ
prerank,GO_Biological_Process_2021__positive regulation of ossification (GO:0045778),0.7248477287214775,1.4668000257999294,0.05555555555555555,0.48680602550681396,1.0,13/25,17.67%,ATRAID;ACVR2A;ZBTB16;WNT5A;TMEM119;FBN2;BMPR1B;ANO6;BMPR1A;SLC8A1;NELL1;ADGRV1;P2RX7
prerank,CellMarker_Augmented_2021__Natural Killer T (NKT) cell:Kidney,-0.9198651546180113,-1.4667739176909595,0.0,0.24892532672780923,1.0,4/6,3.78%,GNLY;TRGC2;IL7R;PRF1
prerank,CellMarker_Augmented_2021__Hematopoietic Stem cell:Tooth,-0.6397239575059763,-1.466574264064243,0.02857142857142857,0.24905964198812233,1.0,31/84,18.97%,JAML;CD2;GPR183;CD69;AIF1;BTK;SNX20;CD93;NCF4;PLEK;IL10RA;PECAM1;CYTIP;SAMSN1;MS4A6A;CSF2RB;NCKAP1L;TYROBP;ITGAL;PTPRC;MYO1F;HLA-DPA1;HLA-DPB1;FCGR3A;LST1;GIMAP4;EVI2B;PARVG;RNASE6;PPP1R16B;TESPA1
prerank,GO_Biological_Process_2021__positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),-0.6861258160855761,-1.4665723894205982,0.03076923076923077,0.24855952222509398,1.0,13/52,14.31%,CCL3;OAS3;CD2;CD14;OAS2;CLU;OAS1;TYROBP;CYBA;PTPRC;HAVCR2;NOD2;HLA-E
prerank,CellMarker_Augmented_2021__Follicular Dendritic cell:Spleen,-0.6667838240562175,-1.4665486537618755,0.0,0.24809755696567964,1.0,21/78,11.39%,JAML;MYO1G;CD37;MNDA;VNN2;CLEC12A;AIF1;PSTPIP1;BTK;SLAMF6;SNX20;NCF4;PLEK;IL10RA;CD300LF;CYTIP;CSF2RB;NCKAP1L;TYROBP;ITGAL;CSF3R
prerank,KEGG_2021_Human__Neurotrophin signaling pathway,0.4991360869742439,1.4664706245207955,0.0,0.4862873868821635,1.0,35/93,27.64%,GAB1;MAPK11;RAP1A;MAP2K1;CRK;SORT1;IRAK1;SHC2;IRAK3;RPS6KA6;MAPK1;NTRK2;MAPKAPK2;JUN;IRAK2;TRAF6;MAP3K5;AKT2;GSK3B;PIK3CA;MAP2K2;MAP3K1;AKT3;YWHAE;FRS2;ABL1;KRAS;PIK3R1;MAP2K7;CAMK2D;CAMK2B;MAPK14;NFKBIE;NTRK3;KIDINS220
prerank,Reactome_2022__Cellular Senescence R-HSA-2559583,-0.5936287481515209,-1.4662891834422023,0.012987012987012988,0.2483229161628418,1.0,25/115,12.89%,H1-4;H1-3;UBC;H1-2;H2BC4;H2BC26;H2AC20;FOS;RPS27A;H2AC6;H1-0;ETS1;H3-3B;H2AJ;TXN2;H2BC21;H2BC5;VENTX;H2BC9;KDM6B;ANAPC11;HIRA;TERF2IP;H2BC11;KAT5
prerank,Reactome_2022__Energy Dependent Regulation Of mTOR By LKB1-AMPK R-HSA-380972,0.7007616732201947,1.464561438037491,0.10714285714285714,0.492853579505221,1.0,4/24,7.11%,PRKAB2;RRAGD;TSC2;CAB39
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte chemotaxis (GO:0140131),-0.9085070640062743,-1.4641841627940517,0.03773584905660377,0.2539122256403016,1.0,3/10,1.49%,CCL4;CCL3;CCL5
prerank,Reactome_2022__Response Of Mtb To Phagocytosis R-HSA-9637690,-0.7614791954919169,-1.463972299288456,0.03571428571428571,0.25394543408854814,1.0,3/18,3.95%,UBC;RPS27A;RNF213
prerank,Reactome_2022__Oxidative Stress Induced Senescence R-HSA-2559580,-0.6219727237311704,-1.463687387683591,0.04054054054054054,0.2544088609790046,1.0,13/66,9.35%,UBC;H2BC4;H2BC26;H2AC20;FOS;RPS27A;H2AC6;H3-3B;H2AJ;TXN2;H2BC21;H2BC5;H2BC9
prerank,GO_Biological_Process_2021__positive regulation of telomere maintenance (GO:0032206),-0.7177914440764892,-1.463629703033164,0.03389830508474576,0.25406514272309,1.0,2/25,1.65%,PKIB;PRKCQ
prerank,Reactome_2022__Formation Of Senescence-Associated Heterochromatin Foci (SAHF) R-HSA-2559584,-0.8876134735553436,-1.4635544028338607,0.0,0.2538299472589453,1.0,4/14,3.75%,H1-4;H1-3;H1-2;H1-0
prerank,Reactome_2022__DNA Double-Strand Break Repair R-HSA-5693532,-0.6108993420971848,-1.4635270766913606,0.0136986301369863,0.2533817819218051,1.0,24/104,14.82%,UBC;H2BC4;H2BC26;RPS27A;UBXN1;POLE3;EYA2;HUS1;MUS81;TIPIN;H2BC21;BRCA2;POLM;H2BC5;ABRAXAS1;H2BC9;PARP2;XRCC3;H2BC11;KAT5;RAD9A;RPA3;BRCA1;UBA52
prerank,GO_Biological_Process_2021__regulation of response to cytokine stimulus (GO:0060759),0.7399864937565824,1.4633240154954927,0.027777777777777776,0.49598710235717264,1.0,4/15,8.84%,KLF4;WNT5A;RUNX1;IRAK1
prerank,GO_Biological_Process_2021__gamma-delta T cell activation (GO:0046629),-0.9905347553538908,-1.4632984550889925,0.0,0.25375371532145596,1.0,2/5,0.19%,ITK;JAML
prerank,GO_Biological_Process_2021__long-chain fatty acid import into cell (GO:0044539),-0.9038796960815969,-1.4630724213636335,0.04285714285714286,0.2538401079159533,1.0,1/8,0.52%,CD36
prerank,Reactome_2022__DNA Methylation R-HSA-5334118,-0.8463161348636087,-1.4628469839889588,0.03225806451612903,0.2541387998453721,1.0,11/15,13.12%,H2BC4;H2BC26;H2AC20;H2AC6;H3-3B;H2AJ;H2BC21;H2BC5;H2BC9;H2BC11;DNMT1
prerank,PanglaoDB_Augmented_2021__Transient Cells,0.5543432710779409,1.462291264617078,0.0,0.499058829600843,1.0,21/65,13.87%,HID1;PLXNB1;FKBP9;GCLC;RAP1GAP;TSPAN15;MYO1D;MTUS1;DAG1;PARM1;SCARB2;UNC13B;PLXNB2;UNC5B;EPAS1;ITGAV;GNA11;COBL;RTKN;ADCY6;GPR107
prerank,GO_Biological_Process_2021__glycosaminoglycan biosynthetic process (GO:0006024),0.5757874906831134,1.462116041663872,0.07692307692307693,0.49798460300827163,1.0,11/53,6.57%,B3GNT2;HS3ST5;NCAN;CHST7;CSGALNACT1;HS2ST1;B4GALT4;UGDH;CSPG5;B4GALT7;CHST1
prerank,Reactome_2022__HDR Thru Homologous Recombination (HRR) Or Single Strand Annealing (SSA) R-HSA-5693567,-0.6264435084736857,-1.4619852333581518,0.014492753623188406,0.2565762241506147,1.0,20/76,14.82%,UBC;H2BC4;H2BC26;RPS27A;POLE3;HUS1;MUS81;TIPIN;H2BC21;BRCA2;H2BC5;ABRAXAS1;H2BC9;XRCC3;H2BC11;KAT5;RAD9A;RPA3;BRCA1;UBA52
prerank,GO_Biological_Process_2021__positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),-0.7490083268473565,-1.4618385105518266,0.017857142857142856,0.256391827860684,1.0,2/15,5.56%,NR4A3;IGF1
prerank,GO_Biological_Process_2021__mitochondrial fission (GO:0000266),-0.7570880096260371,-1.4618027065329733,0.08771929824561403,0.25601437507623087,1.0,3/15,5.76%,MX2;MX1;FIS1
prerank,GO_Biological_Process_2021__cellular response to hormone stimulus (GO:0032870),-0.671241982034202,-1.4612160379916777,0.014492753623188406,0.2571504228570691,1.0,2/43,3.91%,NR4A3;CTSB
prerank,GO_Biological_Process_2021__positive regulation of cellular protein localization (GO:1903829),-0.6797914354656049,-1.4611054976821274,0.0,0.2570186282730321,1.0,12/48,11.20%,RIC3;TFRC;PYHIN1;DDRGK1;DTX3L;LAMTOR5;PARP9;FYN;ENTR1;GPR137B;VPS28;TYROBP
prerank,GO_Biological_Process_2021__regulation of chromatin binding (GO:0035561),-0.8717782903439719,-1.4610182387136894,0.04918032786885246,0.25676475133355314,1.0,5/9,8.76%,DDX11;DTX3L;MED25;PARP9;BTAF1
prerank,Reactome_2022__Class A/1 (Rhodopsin-like Receptors) R-HSA-373076,-0.659432714163307,-1.4608815486353348,0.043478260869565216,0.2567216125734211,1.0,11/73,7.63%,CCL4;CCL3;CHRM2;CXCR4;CCL5;GPR183;CD200R1;ACKR4;TACR1;C5AR1;GNRHR
prerank,GO_Biological_Process_2021__SMAD protein complex assembly (GO:0007183),0.9078072962272409,1.4601705771657465,0.041666666666666664,0.5052988058667065,1.0,3/5,5.98%,SMAD1;SMAD2;SMAD3
prerank,Reactome_2022__Ubiquitin-dependent Degradation Of Cyclin D R-HSA-75815,-0.6982442907570962,-1.4601402803768029,0.0273972602739726,0.25838831967133513,1.0,15/43,19.69%,UBC;RPS27A;PSMB3;PSMB6;PSMA7;PSMB9;PSMD12;PSMD8;PSMA5;CCND1;UBA52;PSMA3;PSMC4;PSME2;PSME1
prerank,GO_Biological_Process_2021__positive regulation of ERK1 and ERK2 cascade (GO:0070374),-0.6344524604941897,-1.4596502879873612,0.0,0.25926505048703696,1.0,15/94,9.28%,CCL4;CALCR;CD36;CCL3;CCL5;GPR183;PDGFD;MARCO;GLIPR2;PHB2;C5AR1;MAP3K12;PRKD2;CD44;CHI3L1
prerank,GO_Biological_Process_2021__carnitine shuttle (GO:0006853),0.8663662737679794,1.4594718474980501,0.02127659574468085,0.5068754498668399,1.0,3/8,7.76%,PRKAB2;CPT1A;ACACB
prerank,GO_Biological_Process_2021__apical protein localization (GO:0045176),0.8892168636733261,1.4594224076510671,0.058823529411764705,0.5054288522988699,1.0,1/6,0.04%,SHROOM3
prerank,Reactome_2022__RHOV GTPase Cycle R-HSA-9013424,0.6371441293265605,1.4591821868768389,0.0,0.5049401582287972,1.0,7/30,15.15%,DLG5;MAP3K11;NCK2;GIT1;SPTAN1;SH3RF1;GIT2
prerank,GO_Biological_Process_2021__regulation of nucleocytoplasmic transport (GO:0046822),-0.8549369352471738,-1.4590364617045861,0.01694915254237288,0.2601384027639499,1.0,1/11,0.35%,MX2
prerank,Reactome_2022__Activated NOTCH1 Transmits Signal To Nucleus R-HSA-2122948,-0.7507054034316454,-1.4582197717311038,0.04411764705882353,0.2622225498825033,1.0,2/23,1.30%,UBC;RPS27A
prerank,Reactome_2022__Diseases Of Programmed Cell Death R-HSA-9645723,-0.6779089912732283,-1.4582124863299006,0.046153846153846156,0.26175386717212873,1.0,9/44,9.35%,H2BC4;H2BC26;H2AC20;H2AC6;H3-3B;H2AJ;H2BC21;H2BC5;H2BC9
prerank,GO_Biological_Process_2021__negative regulation of ubiquitin protein ligase activity (GO:1904667),-0.926190806504404,-1.458133388148546,0.019230769230769232,0.2616325521690226,1.0,4/5,7.39%,RPL5;RPL11;RPL23;RPS7
prerank,GO_Biological_Process_2021__artery morphogenesis (GO:0048844),0.7709624379296565,1.45695962100745,0.027777777777777776,0.5133918793834176,1.0,7/14,15.21%,NRP1;PKD2;SMAD7;JAG1;NF1;BMPR1A;TGFBR1
prerank,GO_Biological_Process_2021__maintenance of synapse structure (GO:0099558),-0.9058564687985962,-1.4569562431819554,0.01639344262295082,0.26477111229013195,1.0,2/6,6.19%,CHCHD10;RAB3A
prerank,GO_Biological_Process_2021__negative regulation of platelet activation (GO:0010544),0.7705069880521234,1.455973463869927,0.02564102564102564,0.5161364171616999,1.0,2/11,2.96%,PDGFA;SERPINE2
prerank,GO_Biological_Process_2021__zinc ion transmembrane transport (GO:0071577),0.7699288051001276,1.4556800309779636,0.05263157894736842,0.5159686682044675,1.0,3/14,5.71%,SLC39A12;SLC39A14;SLC39A8
prerank,Reactome_2022__Role Of GTSE1 In G2/M Progression After G2 Checkpoint R-HSA-8852276,-0.6953128984090317,-1.455521396630865,0.041666666666666664,0.26848292329286827,1.0,14/46,19.69%,UBC;RPS27A;PSMB3;PSMB6;PSMA7;PSMB9;PSMD12;PSMD8;PSMA5;UBA52;PSMA3;PSMC4;PSME2;PSME1
prerank,Reactome_2022__Translesion Synthesis By POLH R-HSA-110320,-0.8368256218768196,-1.4554618153951675,0.07547169811320754,0.2680402467067003,1.0,2/17,1.30%,UBC;RPS27A
prerank,Reactome_2022__DAP12 Signaling R-HSA-2424491,-0.7777917680203379,-1.4551935571942398,0.047619047619047616,0.26840517185235696,1.0,9/21,14.31%,GRAP2;VAV3;B2M;BTK;FYN;KLRD1;TYROBP;PIK3CB;HLA-E
prerank,Reactome_2022__FBXL7 Down-Regulates AURKA During Mitotic Entry And In Early Mitosis R-HSA-8854050,-0.6925776489691147,-1.4551789852677564,0.04054054054054054,0.2678958641258819,1.0,15/46,19.69%,UBC;RPS27A;PSMB3;PSMB6;PSMA7;PSMB9;RBX1;PSMD12;PSMD8;PSMA5;UBA52;PSMA3;PSMC4;PSME2;PSME1
prerank,CellMarker_Augmented_2021__Epithelial cell:Bone Marrow,-0.6665480039030595,-1.454902232163284,0.02857142857142857,0.2681913514244455,1.0,33/79,18.84%,JAML;MNDA;VNN2;CLEC12A;MS4A4A;AIF1;SIGLEC1;CD14;FCER1G;NCF4;TNFSF10;PLEK;IL10RA;CD300LF;NCF2;MS4A6A;ITGB2;CSF2RB;HLA-DRA;TYROBP;FBP1;CSF3R;PTPRC;MYO1F;LY86;FPR1;CD74;IGSF6;FCGR3A;GIMAP4;FOLR2;HLA-DRB1;RNASE6
prerank,GO_Biological_Process_2021__regulation of integrin activation (GO:0033623),-0.8749821808241935,-1.454901101540268,0.014925373134328358,0.26768437344443713,1.0,2/9,5.33%,SKAP1;PLEK
prerank,Reactome_2022__Recycling Of Bile Acids And Salts R-HSA-159418,-0.8448302517921303,-1.4547849882230823,0.08064516129032258,0.2674345754442213,1.0,2/9,4.96%,SLC51A;ABCC3
prerank,CellMarker_Augmented_2021__Naive CD4+ T cell:Peripheral Blood,-0.6764880461467414,-1.4543518015722572,0.0410958904109589,0.2683917059696099,1.0,7/26,13.55%,GPR183;CD55;IL7R;TXK;RPS5;EEF1B2;LRRN3
prerank,Reactome_2022__Infection With Mycobacterium Tuberculosis R-HSA-9635486,-0.7275124648065893,-1.454197666658939,0.03389830508474576,0.26819237892830616,1.0,4/21,3.95%,UBC;RPS27A;B2M;RNF213
prerank,CellMarker_Augmented_2021__Monocyte:Fetal Kidney,-0.547856080088257,-1.454112066547574,0.0,0.2679261118091937,1.0,160/630,16.04%,JAML;BCL2A1;MX2;SYAP1;CEBPD;SAT1;SLC2A3;ADGRE1;TOMM7;SRGN;MYO1G;CD37;EPN1;HLA-B;THEMIS2;PPP1R15A;ZFP36;DUSP1;MNDA;CD55;NFKBID;RNASET2;CARD16;WARS1;CTDSP1;VNN2;CLEC12A;RGS2;SIDT2;AIF1;BTG2;CSRNP1;PSTPIP1;PRELID1;NAIP;CD14;FCAR;SELL;FCER1G;UQCRB;GMIP;ANXA2;GLIPR2;CTSB;IER3;NDUFA2;CD93;NCF4;LSP1;NDUFA1;PADI2;CHCHD10;HLA-C;SLC16A3;PLEK;IL10RA;NR1H2;GLUL;CD300LF;HLA-DRB5;BASP1;CD63;PECAM1;LAMTOR5;RNF144B;SULF2;MSL3;EFHD2;IQSEC1;C5AR1;IER2;EMP3;PLSCR1;NLRP12;RAB3D;SAT2;HK2;CCL3L3;CYTIP;CSF2RA;NAMPT;TNFRSF1B;TNFAIP3;OLR1;TYMP;ACAA1;OSCAR;CD44;TM9SF2;TNFAIP2;COX5B;OTUD1;GBP2;LILRB3;S100A6;VENTX;SAMSN1;GABARAPL2;NCF2;NDUFB1;CFLAR;BEST1;SLC11A1;LITAF;MS4A6A;SPG21;ITGB2;CITED2;SLC36A4;TRPM4;NCKAP1L;HLA-DRA;KDM6B;TNFSF13B;GK;TYROBP;FBP1;HIF1A;CSF3R;NABP1;BTG1;TBC1D8;IFNGR2;PIM3;CYBA;ATF1;PTPRC;CLTB;PGK1;SEC62;RGL4;CWC25;NUDT16;MYO1F;GPX1;NOD2;SLC16A6;ANKRD13D;HLA-E;C19ORF38;TMEM167A;IGF2R;NDUFS6;LY86;RASA2;UBA52;NOP10;FPR1;SMARCD3;TMEM258;SLC31A2;TALDO1;SLC15A3;LGALS1;CD74;DENND3;SLU7;GNB2;IGSF6;SLC4A1AP
prerank,Reactome_2022__Degradation Of AXIN R-HSA-4641257,-0.6914855151124947,-1.453988453870354,0.013513513513513514,0.2678466354241891,1.0,14/46,19.69%,UBC;RPS27A;PSMB3;PSMB6;PSMA7;PSMB9;PSMD12;PSMD8;PSMA5;UBA52;PSMA3;PSMC4;PSME2;PSME1
prerank,Reactome_2022__ABC-family Proteins Mediated Transport R-HSA-382556,-0.638309347012727,-1.4537659288640248,0.025,0.26805405482213285,1.0,18/77,12.85%,ABCA9;UBC;RPS27A;ABCA6;PSMB3;ABCC3;ABCB1;ABCF1;PSMB6;PSMA7;PSMB9;ABCB4;CFTR;ABCB9;ABCA8;PSMD12;PSMD8;PSMA5
prerank,PanglaoDB_Augmented_2021__His Bundle Cells,0.5931389963870053,1.4537427134287655,0.03571428571428571,0.5225837819205037,1.0,26/64,20.68%,RASSF8;FGF2;PHLDB1;GPR161;PDE10A;MAGI1;NTM;CDH11;PTPRG;GUCY1A2;TACC2;ENAH;RUNX1T1;BMPR1A;FLRT2;TJP1;FBXL7;FERMT2;TYRO3;NFASC;ANTXR1;FARP1;PPFIBP1;SLIT3;ZNF462;NAV1
prerank,GO_Biological_Process_2021__protein heterooligomerization (GO:0051291),0.7089251457686153,1.4536130348307268,0.045454545454545456,0.5213468288110006,1.0,6/15,12.14%,PKD2;PKD1;TMEM120B;KCNC2;GRIN2B;CPSF7
prerank,GO_Biological_Process_2021__regulation of T-helper 2 cell cytokine production (GO:2000551),-0.9620083658228654,-1.4535713797276786,0.03225806451612903,0.2676939620625894,1.0,1/5,1.20%,RSAD2
prerank,GO_Biological_Process_2021__positive regulation of T-helper 2 cell cytokine production (GO:2000553),-0.9620083658228654,-1.4535713797276786,0.03225806451612903,0.2676939620625894,1.0,1/5,1.20%,RSAD2
prerank,GO_Biological_Process_2021__regulation of T cell migration (GO:2000404),-0.8234034106776194,-1.4532115994015236,0.037037037037037035,0.26818550916736433,1.0,5/13,4.08%,RIPOR2;CCL5;AIF1;CD200R1;APOD
prerank,GO_Biological_Process_2021__N-terminal protein amino acid acetylation (GO:0006474),0.7182352740721578,1.453201312952582,0.06060606060606061,0.5212408745269167,1.0,3/12,13.59%,AANAT;NAA20;NAA35
prerank,Reactome_2022__ATF6 (ATF6-alpha) Activates Chaperone Genes R-HSA-381183,0.7856571961399667,1.452659080962247,0.04,0.5216372704336862,1.0,2/9,5.85%,NFYC;DDIT3
prerank,GO_Biological_Process_2021__positive regulation of immunoglobulin mediated immune response (GO:0002891),-0.8425888364804934,-1.4526295449374387,0.08771929824561403,0.26936131135604624,1.0,2/11,9.70%,TFRC;CD226
prerank,Reactome_2022__Interferon Signaling R-HSA-913531,-0.5949136130392232,-1.452616746905087,0.025974025974025976,0.26886249411279434,1.0,32/145,10.95%,MT2A;FLNA;MX2;BCL11B;UBC;OAS3;HLA-B;MX1;RSAD2;RPS27A;XAF1;TRIM5;IFIT3;B2M;IFIT1;OAS2;IFITM3;HLA-C;HLA-DRB5;TRIM22;EIF2AK2;HLA-F;IFIT2;OAS1;RNASEL;EIF4A3;CD44;GBP2;STAT1;IRF1;HLA-DRA;NUP50
prerank,Reactome_2022__Regulation Of Apoptosis R-HSA-169911,-0.7060360805948812,-1.4521509182069134,0.04285714285714286,0.269599232086267,1.0,15/44,19.69%,UBC;RPS27A;PSMB3;PSMB6;PSMA7;PSMB9;PSMD12;PSMD8;PSMA5;UBA52;MED12;PSMA3;PSMC4;PSME2;PSME1
prerank,Reactome_2022__SARS-CoV-2 Infection R-HSA-9694516,-0.5689153185161437,-1.452129187320419,0.0,0.2691517395670414,1.0,38/222,11.54%,RPS13;UBC;RPS4X;HLA-B;RPS27A;RPS8;RPS21;RPS14;ZCRB1;PARP14;RPS11;B2M;RPS15;RPS12;RPS25;RPS23;RPS27;FAU;RPS20;RPS24;SNRPD2;HLA-C;RPS3;RPS3A;PARP9;RPS6;RPS2;RPS7;NLRP12;SRPK1;HLA-F;RPS5;GPC3;STAT1;NUP50;RPS9;STING1;SDC3
prerank,Reactome_2022__Negative Regulation Of NOTCH4 Signaling R-HSA-9604323,-0.6868465314039973,-1.4521214294514528,0.028985507246376812,0.26867267453816784,1.0,15/47,19.69%,UBC;RPS27A;PSMB3;PSMB6;PSMA7;PSMB9;RBX1;PSMD12;PSMD8;PSMA5;UBA52;PSMA3;PSMC4;PSME2;PSME1
prerank,Reactome_2022__Translesion Synthesis By POLK R-HSA-5655862,-0.8618289553638784,-1.4520732946154573,0.0,0.2683445892704261,1.0,2/14,1.30%,UBC;RPS27A
prerank,Reactome_2022__Bile Acid And Bile Salt Metabolism R-HSA-194068,-0.7226515791695486,-1.4520536848679144,0.06557377049180328,0.2679349609312939,1.0,3/23,4.96%,CH25H;SLC51A;ABCC3
prerank,CellMarker_Augmented_2021__Mesoderm cell:Germ,-0.8724463125042956,-1.4517548632130015,0.02857142857142857,0.26845190269187547,1.0,7/11,8.71%,TFRC;CD14;PECAM1;ITGA4;ITGA6;CD72;CD44
prerank,GO_Biological_Process_2021__ganglioside metabolic process (GO:0001573),0.7982117420455617,1.4513509878802862,0.04878048780487805,0.5268002129236121,1.0,4/11,15.06%,ABCA2;ST6GALNAC3;ST6GALNAC5;ST8SIA4
prerank,CellMarker_Augmented_2021__CD4+ T cell:Undefined,-0.9114118613708821,-1.4512611918511735,0.0,0.2694286435847451,1.0,4/6,3.24%,CD2;IL7R;CD69;SELL
prerank,Reactome_2022__Degradation Of GLI1 By Proteasome R-HSA-5610780,-0.676292458997803,-1.4511981337863993,0.02857142857142857,0.2690521971588982,1.0,15/50,19.69%,UBC;RPS27A;PSMB3;PSMB6;PSMA7;PSMB9;RBX1;PSMD12;PSMD8;PSMA5;UBA52;PSMA3;PSMC4;PSME2;PSME1
prerank,KEGG_2021_Human__Mineral absorption,-0.713537384389185,-1.4510901855103469,0.031746031746031744,0.2690056987669769,1.0,2/26,0.90%,MT2A;FTH1
prerank,GO_Biological_Process_2021__negative regulation of cell cycle G2/M phase transition (GO:1902750),-0.6860645818235734,-1.4508629846047374,0.027777777777777776,0.26910696011465896,1.0,16/47,22.96%,ATF5;PSMB3;PSMB6;PSMA7;PSMB9;RBX1;PSMD12;PSMD8;PSMA5;PSMA3;PSMC4;PSME2;PSME1;PSMB5;PSMC3;PSME3
prerank,Reactome_2022__Formation Of beta-catenin:TCF Transactivating Complex R-HSA-201722,-0.6880313620396393,-1.4508307606836808,0.017241379310344827,0.26870040872505574,1.0,10/36,9.35%,H2BC4;H2BC26;H2AC20;RUNX3;H2AC6;H3-3B;H2AJ;H2BC21;H2BC5;H2BC9
prerank,Reactome_2022__Cholesterol Biosynthesis R-HSA-191273,0.7456419640446074,1.450574266628229,0.024390243902439025,0.527865734232841,1.0,10/18,20.27%,IDI1;DHCR24;FDFT1;TM7SF2;MSMO1;HMGCS1;MVD;SC5D;ARV1;SQLE
prerank,GO_Biological_Process_2021__negative regulation of erythrocyte differentiation (GO:0045647),-0.966468262676778,-1.4502829812957074,0.0,0.27001098258199163,1.0,1/5,1.48%,ZFP36
prerank,GO_Biological_Process_2021__nucleosome organization (GO:0034728),-0.690414024150877,-1.4497587473693256,0.015873015873015872,0.27107216659978833,1.0,12/55,10.59%,H1-4;H1-3;H1-2;POLE3;H1-0;H2BC18;H2BC21;H2BC5;H1-10;H2BC9;SMARCD1;NPM1
prerank,CellMarker_Augmented_2021__Basophil:Lung,-0.6318036864662758,-1.4497014959260197,0.04054054054054054,0.27076195279324605,1.0,12/73,5.43%,CCL4;JAML;CD36;CD2;MS4A4A;MARCO;SIGLEC1;CD14;FCER1G;CD93;TNFSF10;F13A1
prerank,GO_Biological_Process_2021__antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),-0.7178523912257112,-1.4496939371497861,0.0,0.2702740934188438,1.0,12/28,15.88%,HLA-B;B2M;FCER1G;HLA-C;MFSD6;HLA-F;ERAP1;ABCB9;TAP1;HLA-E;ERAP2;SEC13
prerank,GO_Biological_Process_2021__T cell chemotaxis (GO:0010818),-0.938590125250686,-1.4494384899280224,0.017857142857142856,0.2706477546376938,1.0,2/6,1.61%,CCL3;GPR183
prerank,GO_Biological_Process_2021__regulation of trans-synaptic signaling (GO:0099177),0.6667156503463159,1.4492097260071914,0.0,0.5321720155967673,1.0,8/28,5.73%,CACNA1A;GRID2;EIF4EBP2;NLGN1;GRID1;GRIK2;RELN;LRRC4C
prerank,GO_Biological_Process_2021__keratinocyte differentiation (GO:0030216),0.7512356244742027,1.448916202812459,0.030303030303030304,0.531727744773642,1.0,3/16,6.62%,ANXA1;WNT5A;JAG1
prerank,Reactome_2022__Peptide Ligand-Binding Receptors R-HSA-375276,-0.709647822744135,-1.4488986866269125,0.05714285714285714,0.2719106820440468,1.0,8/38,6.88%,CCL4;CCL3;CXCR4;CCL5;CD200R1;ACKR4;TACR1;C5AR1
prerank,GO_Biological_Process_2021__magnesium ion transport (GO:0015693),0.8124758865426592,1.4488026597740427,0.0425531914893617,0.5303753312954758,1.0,4/10,8.80%,NIPA2;NIPAL2;NIPA1;SLC41A1
prerank,GO_Biological_Process_2021__insulin receptor signaling pathway (GO:0008286),0.5679834673075246,1.4485716439853686,0.0,0.5299019421127723,1.0,6/48,2.61%,GRB10;FER;IGF1R;PDK4;SLC39A14;GAB1
prerank,GO_Biological_Process_2021__regulation of release of cytochrome c from mitochondria (GO:0090199),-0.6880495779700564,-1.4484152208269654,0.07462686567164178,0.2729266250630471,1.0,9/28,18.04%,PRELID1;TNFSF10;CLU;IGF1;PDCD5;BMF;GPX1;PINK1;FAM162A
prerank,GO_Biological_Process_2021__regulation of histamine secretion by mast cell (GO:1903593),-0.9480977140145039,-1.4483502062554838,0.0,0.27261586852049313,1.0,1/5,2.43%,SNX6
prerank,Reactome_2022__GP1b-IX-V Activation Signaling R-HSA-430116,-0.9698877768311138,-1.4482574994509236,0.017543859649122806,0.27237064631479585,1.0,1/5,0.28%,FLNA
prerank,GO_Biological_Process_2021__N-acetylglucosamine metabolic process (GO:0006044),0.819010635380856,1.4482527375853775,0.05263157894736842,0.5295824736457841,1.0,5/10,12.99%,CHST7;LARGE1;EXTL2;CHST1;RENBP
prerank,GO_Biological_Process_2021__negative regulation of leukocyte chemotaxis (GO:0002689),-0.8604854244086773,-1.4482444255304636,0.03278688524590164,0.27190121455467803,1.0,2/7,4.71%,DUSP1;PADI2
prerank,GO_Biological_Process_2021__aromatic amino acid family metabolic process (GO:0009072),-0.909411503313021,-1.4478481000184455,0.13559322033898305,0.27238033291547065,1.0,1/5,0.34%,IL4I1
prerank,GO_Biological_Process_2021__regulation of protein deacetylation (GO:0090311),0.8757200945840129,1.447791609278163,0.08888888888888889,0.5298665465597526,1.0,3/5,10.28%,SPRED1;SPRED2;DYRK1A
prerank,GO_Biological_Process_2021__cellular defense response (GO:0006968),-0.7700991840629384,-1.4477303062512106,0.03076923076923077,0.27210479515816555,1.0,6/23,6.88%,ITK;GNLY;MNDA;PRF1;LSP1;C5AR1
prerank,CellMarker_Augmented_2021__CD1C-CD141- Dendritic cell:Blood,-0.5797591571995869,-1.4476483723934348,0.0,0.2717022993235649,1.0,60/261,14.31%,MT2A;BCL2A1;FLNA;ERICH1;INSIG1;SAT1;FTH1;MYO1G;DUSP1;WARS1;CLEC12A;MS4A4A;SIDT2;IFIT3;RAB37;AIF1;FCAR;IFITM3;TNFSF10;TSPAN32;ABCC3;CDH23;GLUL;CD300LF;NBEAL2;PECAM1;RNF144B;ARHGEF3;C5AR1;SIRPB2;CABP4;GIMAP2;RAB3D;ACOT9;IFIT2;CYTIP;NAMPT;TNFRSF1B;TYMP;OAS1;LY6E;AMPD2;GBP2;SAMSN1;NCF2;SLC11A1;IRF1;TYROBP;ITGAL;TBC1D8;IFNGR2;GPR155;PTPRC;ATP1B3;NR4A1;FTL;NUDT16;CAMK1;APOL6;HLA-E
prerank,Reactome_2022__AKT Phosphorylates Targets In Cytosol R-HSA-198323,0.6885108122342263,1.4473191935665262,0.06666666666666667,0.5303736224909494,1.0,5/11,15.67%,CASP9;TSC2;MDM2;AKT2;GSK3B
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Breast,-0.8757116556149088,-1.44716323271862,0.0,0.27283373298450647,1.0,4/8,11.19%,PROCR;ITGA6;CD44;VEGFA
prerank,Reactome_2022__Detoxification Of Reactive Oxygen Species R-HSA-3299685,-0.7804574483878024,-1.4470334019381825,0.046875,0.2727022730950475,1.0,9/20,14.09%,CYCS;NCF4;ERO1A;TXN2;GSTP1;NCF2;CYBA;SOD1;GPX1
prerank,GO_Biological_Process_2021__regulation of Golgi organization (GO:1903358),0.6997761521125545,1.4470248473178984,0.025,0.5297942532551766,1.0,5/15,11.38%,RAB33B;MAP2K1;PDE4DIP;RBSN;MAPK1
prerank,"Reactome_2022__Cell Death Signaling Via NRAGE, NRIF And NADE R-HSA-204998",-0.6613135246592514,-1.4469929711585956,0.04411764705882353,0.2723485749610339,1.0,8/59,6.92%,PLEKHG5;UBC;RPS27A;RASGRF2;VAV3;ARHGEF1;ARHGEF3;OBSCN
prerank,CellMarker_Augmented_2021__Myotube:Muscle,0.667672679891543,1.4465739255698995,0.04,0.5303355522603026,1.0,4/18,9.24%,AVIL;MYOM1;MSS51;LDB3
prerank,Reactome_2022__NOTCH3 Activation And Transmission Of Signal To Nucleus R-HSA-9013507,-0.7752623849565426,-1.4462091174022078,0.03076923076923077,0.2745368064369765,1.0,2/18,1.30%,UBC;RPS27A
prerank,GO_Biological_Process_2021__aggrephagy (GO:0035973),-0.6871577615939355,-1.4457983726183927,0.03333333333333333,0.2752431691087045,1.0,6/26,14.82%,UBC;RPS27A;ACBD5;CFTR;DYNC1LI2;UBA52
prerank,CellMarker_Augmented_2021__Eosinophil:Sinonasal Mucosa,-0.7033033189263641,-1.4455542702018496,0.05970149253731343,0.27550399365021105,1.0,13/47,11.20%,SRGN;MYO1G;CD69;AIF1;BTK;NCF4;TSPAN32;PLEK;FERMT3;SAMSN1;CSF2RB;NCKAP1L;TYROBP
prerank,GO_Biological_Process_2021__N-terminal peptidyl-methionine acetylation (GO:0017196),0.8183874142961319,1.445472014919026,0.05263157894736842,0.5342136304526235,1.0,1/5,5.00%,NAA20
prerank,CellMarker_Augmented_2021__Megakaryocyte:Umbilical Cord Blood,-0.7090689589360564,-1.4454619977964858,0.04,0.2751478665704548,1.0,11/41,11.39%,CD36;MNDA;CLEC12A;FCER1G;CD93;F13A1;PECAM1;MS4A6A;CSF2RB;TYROBP;CSF3R
prerank,Reactome_2022__Formyl Peptide Receptors Bind Formyl Peptides And Many Other Ligands R-HSA-444473,0.9034539660862793,1.4454074969001078,0.06521739130434782,0.5328136806593812,1.0,2/5,2.10%,ANXA1;FPR3
prerank,GO_Biological_Process_2021__phosphatidylserine acyl-chain remodeling (GO:0036150),-0.8887638419036165,-1.445138117394226,0.046875,0.27566023746803464,1.0,1/10,0.49%,OSBPL5
prerank,"Reactome_2022__TICAM1,TRAF6-dependent Induction Of TAK1 Complex R-HSA-9014325",-0.8197334699864955,-1.444944789048185,0.05454545454545454,0.27591896856803366,1.0,2/11,1.30%,UBC;RPS27A
prerank,Reactome_2022__ATF6 (ATF6-alpha) Activates Chaperones R-HSA-381033,0.7659456471053256,1.4447859507088823,0.022727272727272728,0.5337828304365082,1.0,2/11,5.85%,NFYC;DDIT3
prerank,CellMarker_Augmented_2021__Lymphoid cell:Undefined,-0.7660503444577091,-1.4447820132317737,0.0,0.2761925114566889,1.0,8/21,12.82%,IL7R;CD69;SELL;GZMB;ITGA4;KLRD1;IL18R1;PTPRC
prerank,GO_Biological_Process_2021__establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),0.6624817783843513,1.444647175553796,0.02702702702702703,0.5327974585211108,1.0,4/24,5.96%,SCRIB;MSN;MTCL1;LIN7A
prerank,GO_Biological_Process_2021__receptor metabolic process (GO:0043112),-0.7254680338298843,-1.4446107629462246,0.046153846153846156,0.276261185369118,1.0,6/44,5.46%,MX2;CD36;MX1;TFRC;FCER1G;LILRB4
prerank,CellMarker_Augmented_2021__Germinal Center B cell:Lymphoid Tissue,-0.6731198587216775,-1.4445382520778105,0.02631578947368421,0.2759538112934344,1.0,19/71,10.77%,JAML;CD37;THEMIS2;MNDA;VNN2;CLEC12A;AIF1;SELL;BTK;SNX20;NCF4;PLEK;CD300LF;CYTIP;FERMT3;NCF2;CSF2RB;NCKAP1L;HLA-DRA
prerank,CellMarker_Augmented_2021__Neutrophil:Undefined,-0.7817563437952475,-1.4439312247992813,0.06153846153846154,0.2774607673724076,1.0,7/17,11.39%,CD55;FCAR;CD93;CSF2RA;CD44;ITGB2;CSF3R
prerank,Reactome_2022__IRAK4 Deficiency (TLR2/4) R-HSA-5603041,-0.8821460902959644,-1.4439075851388903,0.017857142857142856,0.27708996328044966,1.0,3/10,4.18%,CD36;BTK;NDUFA2
prerank,GO_Biological_Process_2021__pantothenate metabolic process (GO:0015939),-0.9025255355130548,-1.443896395640209,0.07547169811320754,0.27667370723947243,1.0,1/5,1.92%,VNN2
prerank,GO_Biological_Process_2021__cGMP-mediated signaling (GO:0019934),-0.8307547809235868,-1.4436701684266495,0.08771929824561403,0.27686536540321954,1.0,1/8,0.52%,CD36
prerank,GO_Biological_Process_2021__postsynaptic neurotransmitter receptor internalization (GO:0098884),-0.9296033624991988,-1.44342838860139,0.023255813953488372,0.2764563435480597,1.0,2/5,1.19%,MX2;MX1
prerank,GO_Biological_Process_2021__postsynaptic endocytosis (GO:0140239),-0.9296033624991988,-1.44342838860139,0.023255813953488372,0.2764563435480597,1.0,2/5,1.19%,MX2;MX1
prerank,GO_Biological_Process_2021__positive regulation of actin cytoskeleton reorganization (GO:2000251),0.7197917948143567,1.4433403367571493,0.16666666666666666,0.5367289543960195,1.0,1/12,0.61%,NRP1
prerank,KEGG_2021_Human__GnRH secretion,0.6517575579624023,1.4432751508821002,0.0,0.5354117376329491,1.0,14/40,18.09%,TRPC1;GABBR1;MAP2K1;GNAQ;KCNJ5;PLCB4;KCNN2;GNA11;MAPK1;AKT2;TRPC4;PIK3CA;PLCB3;MAP2K2
prerank,CellMarker_Augmented_2021__Stem cell:Placenta,0.6309035645498475,1.4431321678420588,0.0,0.5326930120771682,1.0,10/36,10.81%,COL5A3;COL16A1;TPM2;SERPINE1;COL5A2;TIMP3;CDH11;LOXL2;HEG1;EPAS1
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Breast,0.6309035645498475,1.4431321678420588,0.0,0.5326930120771682,1.0,10/36,10.81%,COL5A3;COL16A1;TPM2;SERPINE1;COL5A2;TIMP3;CDH11;LOXL2;HEG1;EPAS1
prerank,CellMarker_Augmented_2021__Monocyte:Plasma,-0.639427758922672,-1.4428760453399525,0.029850746268656716,0.2773783267816776,1.0,20/69,11.39%,JAML;MNDA;CLEC12A;MS4A4A;MARCO;SIGLEC1;CD14;FCER1G;CD93;CD300LF;C5AR1;SIRPB2;TYMP;LILRB3;NCF2;SLC11A1;MS4A6A;ITGB2;TYROBP;CSF3R
prerank,CellMarker_Augmented_2021__Monocyte:Synovium,-0.639427758922672,-1.4428760453399525,0.029850746268656716,0.2773783267816776,1.0,20/69,11.39%,JAML;MNDA;CLEC12A;MS4A4A;MARCO;SIGLEC1;CD14;FCER1G;CD93;CD300LF;C5AR1;SIRPB2;TYMP;LILRB3;NCF2;SLC11A1;MS4A6A;ITGB2;TYROBP;CSF3R
prerank,GO_Biological_Process_2021__nucleosome positioning (GO:0016584),-0.9144550660019918,-1.4427959624789608,0.05660377358490566,0.27713544320312783,1.0,4/9,3.75%,H1-4;H1-3;H1-2;H1-0
prerank,Reactome_2022__Lipophagy R-HSA-9613354,0.9012374698142137,1.4426371574600962,0.02564102564102564,0.5330292214755973,1.0,1/7,0.12%,PRKAB2
prerank,GO_Biological_Process_2021__regulation of activin receptor signaling pathway (GO:0032925),0.8396787199435106,1.4426122194672886,0.045454545454545456,0.5314872147282828,1.0,3/8,9.38%,ACVR2A;SMAD7;LEMD3
prerank,GO_Biological_Process_2021__NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356),-0.8782506532356871,-1.4424962781255704,0.01818181818181818,0.27772453049001355,1.0,3/8,8.03%,NUDT12;PARP9;NAMPT
prerank,PanglaoDB_Augmented_2021__Endothelial Cells,-0.6175643138038505,-1.4423918219340963,0.02631578947368421,0.2774818846686167,1.0,19/77,12.34%,CD36;MYLK;PROCR;SRGN;SLC7A5;CD55;F8;MGLL;CD93;ETS1;PECAM1;SGK1;PCDH12;PTPRB;USHBP1;SPARCL1;ABCA8;A2M;FLT1
prerank,KEGG_2021_Human__Necroptosis,-0.6382864644033892,-1.442228404567979,0.0,0.2775775257982292,1.0,15/96,11.93%,H2AC8;STAT4;FTH1;H2AC20;H2AC6;TNFSF10;GLUL;SLC25A5;H2AJ;EIF2AK2;TNFAIP3;STAT1;CFLAR;IFNGR2;MLKL
prerank,GO_Biological_Process_2021__amino sugar metabolic process (GO:0006040),0.9097565675854434,1.4419843142225577,0.022727272727272728,0.5325804015131405,1.0,3/6,6.70%,CSGALNACT1;EXTL2;GFPT1
prerank,GO_Biological_Process_2021__lipid transport (GO:0006869),-0.6530352481883458,-1.441939086940618,0.038461538461538464,0.2779944177332794,1.0,8/65,4.96%,ABCA9;OSBPL5;CD36;SLC51A;ABCA6;PRELID1;PLTP;ABCC3
prerank,GO_Biological_Process_2021__cellular response to sterol depletion (GO:0071501),-0.8963441756237416,-1.4414917122769808,0.07142857142857142,0.2781524719541214,1.0,1/8,0.72%,INSIG1
prerank,GO_Biological_Process_2021__SREBP signaling pathway (GO:0032933),-0.8963441756237416,-1.4414917122769808,0.07142857142857142,0.2781524719541214,1.0,1/8,0.72%,INSIG1
prerank,GO_Biological_Process_2021__protein-DNA complex assembly (GO:0065004),-0.6248058528623225,-1.4414561009531324,0.014492753623188406,0.2778045039797215,1.0,22/98,14.82%,UBC;RPS27A;XPA;PSMB3;GTF2H5;H2BC18;CENPV;H2BC21;PSMB6;PSMA7;H2BC5;PSMB9;H2BC9;NPM1;RBX1;PSMD12;H2BC11;PSMD8;PSMA5;MCM7;RPA3;UBA52
prerank,CellMarker_Augmented_2021__Myoepithelial cell:Undefined,-0.6879718108993274,-1.4411334951129224,0.0625,0.2782029912354962,1.0,12/27,8.99%,OAS3;FOSL2;ZFP36;JUNB;DUOX1;TNFSF10;BHLHE40;GBP3;TNFAIP3;OAS1;CD44;GBP2
prerank,GO_Biological_Process_2021__regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),0.7116494391550712,1.4409245569434863,0.03225806451612903,0.5353163050319141,1.0,6/22,15.21%,ACVR2A;SMAD7;GDF11;BMPR1A;TWSG1;TGFBR1
prerank,GO_Biological_Process_2021__negative regulation of osteoclast differentiation (GO:0045671),-0.7834851851864788,-1.4408801648058647,0.03571428571428571,0.2784786629935927,1.0,4/13,9.06%,CCL3;LILRB4;GPR137B;LILRB3
prerank,CellMarker_Augmented_2021__Lake Et al.Science.Ex7:Brain,0.5615731001175054,1.4405846796074813,0.0,0.5354258573299308,1.0,35/69,22.69%,GRID2;ZNF536;LARGE1;NLGN1;PBX1;PLPPR4;NTM;GRIA3;CDH11;MMP16;PREX2;ASXL3;GUCY1A2;PTPN5;PTPRD;SLC35F1;RUNX1T1;FBXL7;JAM2;CSMD2;NFASC;CSRNP3;ROBO2;DCLK1;TUB;GRIK3;TMEM132B;MEGF10;PRKG1;NOVA1;LRFN5;NRXN1;LSAMP;CXCL12;OPCML
prerank,PanglaoDB_Augmented_2021__Intercalated Cells,0.6187779692163138,1.4405478930721003,0.030303030303030304,0.5340022983906526,1.0,9/29,17.71%,ESRRG;NPHP1;JAG1;TACC2;CCDC40;ERBB4;MAP3K13;CX3CL1;RSPH3
prerank,GO_Biological_Process_2021__long-chain fatty-acyl-CoA metabolic process (GO:0035336),0.6959130132927762,1.4404464745726888,0.05263157894736842,0.5328005967747418,1.0,2/15,8.59%,HACD2;ELOVL6
prerank,CellMarker_Augmented_2021__Macrophage:Undefined,-0.7349223582352399,-1.4404139825530236,0.04285714285714286,0.27942039110057193,1.0,4/21,5.63%,ADGRE1;SIGLEC1;CD14;CD63
prerank,CellMarker_Augmented_2021__Cancer Stem-Like cell:Endometrium,-0.6412714584724583,-1.4402608139365405,0.025,0.279329896689693,1.0,19/74,11.27%,JAML;CCDC88C;CD2;CXCR4;DTHD1;CD69;VAV3;AIF1;BTG2;RGS1;CD247;PLEK;IL10RA;CYTIP;SPOCK2;SAMSN1;HLA-DRA;TYROBP;ITGAL
prerank,PanglaoDB_Augmented_2021__Microfold Cells,-0.6254853179393668,-1.4402117278823423,0.04054054054054054,0.2789526549420252,1.0,21/80,9.97%,CEBPD;SAT1;OAS3;FOSL2;ZFP36;JUNB;ZMYND15;CD14;CTSB;IER3;TNFSF10;ANKRD22;BHLHE40;ABCC3;HLA-C;GBP3;DTX3L;TYMP;OAS1;TNFAIP2;SSH3
prerank,GO_Biological_Process_2021__positive regulation of B cell proliferation (GO:0030890),-0.7688696905081683,-1.4399482678452273,0.08955223880597014,0.2792403117806396,1.0,7/18,15.77%,TFRC;GPR183;VAV3;NCKAP1L;TNFSF13B;PTPRC;CD74
prerank,PanglaoDB_Augmented_2021__Neuroblasts,0.5732607577745515,1.439861349326962,0.037037037037037035,0.5335543840390838,1.0,31/71,20.28%,KCNQ2;DPYSL5;GRID2;NCAN;SIRT1;B4GALNT4;ADGRB2;NOL4;SNAP91;CNR1;PBX1;CSPG5;ELAVL2;PURG;POU6F2;BRSK1;GRM5;SLC35F1;LINGO1;CAMKV;ERBB4;LRRC4B;CSRNP3;DAB1;MAPK4;BRSK2;MARK2;CRMP1;PPM1E;SYT4;UNC5D
prerank,GO_Biological_Process_2021__establishment or maintenance of apical/basal cell polarity (GO:0035088),0.7306552145277262,1.439570400309785,0.08695652173913043,0.5333148057456586,1.0,6/14,18.36%,SCRIB;MTCL1;PRKCI;PARD3;MARK2;ERBIN
prerank,GO_Biological_Process_2021__regulation of B cell receptor signaling pathway (GO:0050855),0.6863729448346534,1.4395221815297823,0.05405405405405406,0.5317387902621298,1.0,2/17,6.90%,CD22;RUNX1
prerank,Reactome_2022__Aggrephagy R-HSA-9646399,-0.7118336815676417,-1.4388455897734007,0.06060606060606061,0.28237287136763684,1.0,2/22,1.30%,UBC;RPS27A
prerank,GO_Biological_Process_2021__regulation of nucleobase-containing compound metabolic process (GO:0019219),0.857621139597536,1.438684311544663,0.022222222222222223,0.5343493411460368,1.0,1/8,0.47%,PCBP4
prerank,GO_Biological_Process_2021__second-messenger-mediated signaling (GO:0019932),-0.6703765797237379,-1.4384132173859585,0.05970149253731343,0.2834806499708746,1.0,6/44,6.11%,CD36;CCL3;MCTP2;CXCR4;BTK;ACKR4
prerank,GO_Biological_Process_2021__sulfur compound biosynthetic process (GO:0044272),0.5329398588439763,1.4383710435104522,0.0,0.533794569613856,1.0,11/60,7.66%,B3GNT2;GCLC;NCAN;CHST7;CSGALNACT1;B4GALT4;UGDH;CSPG5;GSTA4;CHST1;HPGDS
prerank,KEGG_2021_Human__Human cytomegalovirus infection,-0.5937597916728287,-1.4382228525785345,0.012048192771084338,0.2834741968021189,1.0,14/153,8.36%,CCL4;CCL3;CYCS;HLA-B;CXCR4;CCL5;B2M;GNB5;HLA-C;ARHGEF1;IL10RA;HLA-F;CCL3L3;CALM1
prerank,GO_Biological_Process_2021__fusion of virus membrane with host plasma membrane (GO:0019064),-0.909170631948327,-1.4377864706599819,0.018518518518518517,0.2838951248871349,1.0,1/6,1.43%,CXCR4
prerank,GO_Biological_Process_2021__membrane fusion involved in viral entry into host cell (GO:0039663),-0.909170631948327,-1.4377864706599819,0.018518518518518517,0.2838951248871349,1.0,1/6,1.43%,CXCR4
prerank,GO_Biological_Process_2021__negative regulation of receptor binding (GO:1900121),-0.9101419789037193,-1.4375487706090349,0.1016949152542373,0.2835231381896063,1.0,1/5,2.81%,B2M
prerank,GO_Biological_Process_2021__regulation of receptor binding (GO:1900120),-0.9101419789037193,-1.4375487706090349,0.1016949152542373,0.2835231381896063,1.0,1/5,2.81%,B2M
prerank,GO_Biological_Process_2021__carboxylic acid catabolic process (GO:0046395),-0.8904692826408689,-1.4371961632165546,0.04918032786885246,0.2839929416249141,1.0,1/8,0.34%,IL4I1
prerank,CellMarker_Augmented_2021__Cartilage Progenitor cell:Cartilage,0.6129037446521426,1.4369058321317967,0.0,0.5381627876668083,1.0,20/48,18.96%,LRP4;COL5A2;FRAS1;PHLDB1;GPR161;MAGI1;ROBO1;PTPRG;ENAH;LINGO1;GPC6;FBXL7;MARK1;ADCY6;FERMT2;ANTXR1;COL4A5;RAI14;RBFOX2;CRMP1
prerank,GO_Biological_Process_2021__positive regulation of vascular associated smooth muscle cell migration (GO:1904754),-0.9745144249563783,-1.436422527502908,0.0,0.2860213948566629,1.0,1/5,0.08%,NR4A3
prerank,GO_Biological_Process_2021__negative regulation of lipid biosynthetic process (GO:0051055),0.6965850189633658,1.436140812486995,0.15625,0.540069829346799,1.0,4/13,11.26%,ABCA2;ASXL3;FBXW7;ACADVL
prerank,GO_Biological_Process_2021__GPI anchor metabolic process (GO:0006505),0.7087075319504855,1.436084816927676,0.07317073170731707,0.5387399472522587,1.0,3/18,1.13%,PIGQ;PIGU;PGAP1
prerank,Reactome_2022__Signaling By NODAL R-HSA-1181150,0.7796396542874569,1.4356554471302787,0.11363636363636363,0.5385245385895115,1.0,5/11,13.56%,ACVR2A;SMAD2;SMAD3;MAPK1;PCSK6
prerank,GO_Biological_Process_2021__positive regulation of transcription regulatory region DNA binding (GO:2000679),-0.8269403865584891,-1.4354077908709362,0.09433962264150944,0.2887255665463316,1.0,4/10,5.78%,H1-0;DDRGK1;IGF1;LAMTOR5
prerank,CellMarker_Augmented_2021__Epidermal Stem cell:Foreskin,0.5069938712488833,1.4352693759676933,0.0,0.5386896663320889,1.0,26/88,23.11%,CTBS;AFTPH;SPOPL;PICALM;SEL1L;TMED5;CCPG1;CD164;SNAP23;NCOA4;STT3B;COG3;COPB1;SCAF11;PRKAA1;PTBP3;DDX3X;TMEM260;ARFIP1;TRAPPC8;CD46;CD2AP;ADAM10;EDEM3;EFCAB14;UHMK1
prerank,GO_Biological_Process_2021__negative regulation of response to biotic stimulus (GO:0002832),-0.7948005974009555,-1.435156116016977,0.05,0.2890660312792224,1.0,5/21,8.14%,SIGIRR;CARD16;NLRC3;DHX58;TNFAIP3
prerank,"GO_Biological_Process_2021__mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",-0.7099123153441608,-1.4350626590198983,0.08196721311475409,0.2888582996213811,1.0,17/30,22.44%,NDUFC1;NDUFA2;NDUFA1;NDUFB9;NDUFA12;NDUFB4;NDUFB1;NDUFS8;NDUFS5;NDUFS6;NDUFB7;NDUFB3;NDUFS7;NDUFA3;NDUFS2;NDUFA10;NDUFAB1
prerank,GO_Biological_Process_2021__regulation of Cdc42 protein signal transduction (GO:0032489),0.9372096601061302,1.4345479054870343,0.0,0.5408132883055852,1.0,1/6,0.61%,NRP1
prerank,Reactome_2022__Protein Folding R-HSA-391251,0.5493884990119483,1.434530862904622,0.0,0.5393254875814305,1.0,9/64,11.13%,TUBA1C;RGS11;FKBP9;GNAQ;PFDN4;TCP1;SKIC2;FBXW7;GNA11
prerank,CellMarker_Augmented_2021__Acinar cell:Salivary Gland,0.5974491070113227,1.434524629662176,0.0,0.5377780629278124,1.0,11/49,16.55%,LHFPL2;PDK4;RCN3;KCTD12;MMRN1;VCL;IL13RA1;CHST15;PDLIM7;RHOBTB1;INPP5A
prerank,GO_Biological_Process_2021__positive regulation of integrin-mediated signaling pathway (GO:2001046),-0.8895873249111061,-1.434423426438066,0.05555555555555555,0.29040789611585954,1.0,2/6,5.63%,FLNA;CD63
prerank,GO_Biological_Process_2021__canonical Wnt signaling pathway (GO:0060070),0.6708759143794094,1.4341726122798144,0.08571428571428572,0.5379093669393773,1.0,13/30,15.80%,TCF7L1;LRRK2;WNT5A;FZD3;WNT2B;RYK;DVL3;BCL9L;TCF7L2;PTEN;CSNK1E;GSK3B;BCL9
prerank,GO_Biological_Process_2021__monocarboxylic acid biosynthetic process (GO:0072330),-0.6567911993250727,-1.4339168512694933,0.06451612903225806,0.2913187105266749,1.0,4/36,4.89%,CH25H;LIPG;PER2;GATM
prerank,Reactome_2022__Kinesins R-HSA-983189,0.6492530907808682,1.4336791521974424,0.05,0.5384136385301,1.0,5/26,17.33%,KIFC2;CENPE;KIF15;KIF6;KIF13B
prerank,GO_Biological_Process_2021__regulation of chromatin silencing (GO:0031935),-0.8849666193037085,-1.4334725635192558,0.017857142857142856,0.2923589755593116,1.0,4/11,3.75%,H1-4;H1-3;H1-2;H1-0
prerank,Reactome_2022__Signaling By NTRKs R-HSA-166520,0.5166688874287665,1.4332893262095765,0.0,0.5385762085215262,1.0,18/95,12.49%,EGR1;DUSP6;PIGU;CDK5R1;MAPK11;RAP1A;MAP2K1;VGF;CRK;SH3GL3;PPP2R1B;DNM3;SHC2;DUSP7;MAPK1;GRIN2B;NTRK2;MAPKAPK2
prerank,GO_Biological_Process_2021__regulation of synapse organization (GO:0050807),0.6972682413765617,1.43322960553448,0.0,0.537184011985198,1.0,8/18,18.25%,WNT5A;ABHD17B;TNF;CTNNA2;PDLIM5;SETD5;IL1RAPL1;NEDD4
prerank,Reactome_2022__GSK3B And BTRC:CUL1-mediated-degradation Of NFE2L2 R-HSA-9762114,-0.6745819326905365,-1.4331533748772431,0.028169014084507043,0.2926173020558493,1.0,18/46,22.04%,UBC;RPS27A;PSMB3;PSMB6;PSMA7;PSMB9;RBX1;PSMD12;PSMD8;PSMA5;UBA52;PSMA3;PSMC4;PSME2;PSME1;PSMB5;NFE2L2;PSMC3
prerank,PanglaoDB_Augmented_2021__Microglia,-0.5844091919451385,-1.4330576972701434,0.011627906976744186,0.292654802395764,1.0,30/134,11.42%,CCL4;JAML;CCL3;FOS;MNDA;GPR183;CLEC12A;MS4A4A;AIF1;SIGLEC1;CD14;FCER1G;CD93;NCF4;LSP1;PLEK;IL10RA;LILRB4;CD300LF;PECAM1;C5AR1;TNFRSF1B;NCF2;MS4A6A;ITGB2;CSF2RB;HLA-DRA;TYROBP;CSF3R;STING1
prerank,Reactome_2022__Post-chaperonin Tubulin Folding Pathway R-HSA-389977,0.7500748876053336,1.432978128690516,0.045454545454545456,0.5368439787283499,1.0,1/12,0.54%,TUBA1C
prerank,CellMarker_Augmented_2021__Germ cell:Gonad,0.6229529851618808,1.4329662055764023,0.08108108108108109,0.535397630207787,1.0,11/40,16.43%,FLVCR1;SYCP3;MGAT4C;WDPCP;KIR3DX1;ZNF90;ZNF493;ZNF665;LRRC69;FAM221A;ASB3
prerank,GO_Biological_Process_2021__cellular response to copper ion (GO:0071280),-0.9252960170951927,-1.4328633134804323,0.0,0.292794674491427,1.0,1/6,0.25%,MT2A
prerank,GO_Biological_Process_2021__regulation of mesenchymal cell proliferation (GO:0010464),0.8383998585866301,1.4327280092857608,0.02702702702702703,0.5345623706228532,1.0,4/6,4.48%,PDGFA;TGFBR2;CTNNBIP1;WNT5A
prerank,GO_Biological_Process_2021__glycerophospholipid metabolic process (GO:0006650),0.5714428031283646,1.4326995540718699,0.06060606060606061,0.5330974565562987,1.0,3/47,1.59%,PIGQ;PLA2G4C;PLA2G7
prerank,GO_Biological_Process_2021__negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),-0.8219238773367431,-1.4325596491351809,0.13846153846153847,0.2931972207780213,1.0,3/10,12.68%,CARD16;GSTP1;H2BC11
prerank,GO_Biological_Process_2021__negative regulation of cell adhesion mediated by integrin (GO:0033629),0.8768449795833395,1.4322274987844814,0.02040816326530612,0.5335387985694577,1.0,4/6,10.95%,ACER2;SERPINE1;WNK1;PDE3B
prerank,GO_Biological_Process_2021__electron transport chain (GO:0022900),0.6978731312089588,1.4320688103984665,0.08108108108108109,0.5326495710329509,1.0,1/13,0.24%,PPARGC1A
prerank,CellMarker_Augmented_2021__Lake Et al.Science.In2:Brain,0.5234629463941168,1.4316880716859877,0.0,0.5323613227794863,1.0,40/91,22.06%,FER;PGAP1;GRID2;PCDH15;SCN3B;MGAT4C;FZD3;GPR137C;PLEKHA5;KCTD16;DNAJC18;CTNNA2;LRRTM4;PTPN5;RPS6KA6;TTLL7;GRIN2B;SYT14;RBFOX1;SLC24A2;FRMD5;CSRNP3;SLC7A11;CDH8;SYT16;ATRNL1;CLASP2;ADGRV1;PEX5L;IL1RAPL1;RIMS2;HOMER1;GRM3;KLHL7;TMEM132B;AMER2;CACNA1B;GRM1;SYNPR;DLG2
prerank,GO_Biological_Process_2021__regulation of interleukin-1 production (GO:0032652),0.801036226360826,1.4314181789701934,0.06976744186046512,0.5321407341801359,1.0,3/8,6.50%,ANXA1;SIRPA;TMED10
prerank,GO_Biological_Process_2021__lymphocyte migration (GO:0072676),-0.9297031116358431,-1.4312929390143465,0.03571428571428571,0.29695520970510236,1.0,4/6,1.49%,CCL4;CCL3;MYO1G;CCL5
prerank,Reactome_2022__Cellular Response To Chemical Stress R-HSA-9711123,-0.5850225606659143,-1.431148772247563,0.0,0.2968543210805471,1.0,42/138,22.04%,UBC;CYCS;RPS27A;COX7C;PSMB3;NCF4;ERO1A;TXN2;GSTP1;PSMB6;PSMA7;COX4I1;GCLM;COX5B;PSMB9;NCF2;COX18;RBX1;PSMD12;CYBA;PSMD8;PSMA5;COX6C;SOD1;GPX1;UBA52;SMARCD3;TALDO1;PSMA3;PSMC4;CSNK2A2;SURF1;COX20;PSME2;PSME1;NCF1;PSMB5;TXNRD2;NFE2L2;COX7B;SIN3B;PSMC3
prerank,Reactome_2022__Caspase-mediated Cleavage Of Cytoskeletal Proteins R-HSA-264870,0.7479501635169199,1.4307833326422992,0.07142857142857142,0.533106511915007,1.0,3/12,9.11%,GSN;GAS2;SPTAN1
prerank,GO_Biological_Process_2021__positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),0.7006839834581782,1.430221410283527,0.05,0.5339027123007006,1.0,6/23,7.30%,EGR1;KLF4;FGF2;PPARG;SMAD3;TNF
prerank,GO_Biological_Process_2021__positive regulation of smooth muscle cell proliferation (GO:0048661),-0.716697639920848,-1.4302061721121768,0.03636363636363636,0.29935775430812234,1.0,4/29,5.56%,NR4A3;CCL5;AIF1;IGF1
prerank,GO_Biological_Process_2021__potassium ion transmembrane transport (GO:0071805),0.5747556767431337,1.4300841397031263,0.0,0.5332213620342422,1.0,22/63,15.56%,KCNQ2;PKD2;SLC9C2;KCNJ2;SLC1A3;KCNIP2;KCND3;KCNJ5;HPN;SLC12A6;KCNC2;SLC9A1;KCNK6;KCNK13;KCNN2;SLC9A9;SLC12A5;ABCC8;KCNH5;SLC24A2;SLC12A2;ABCB8
prerank,Reactome_2022__Glycolysis R-HSA-70171,0.5574183756381543,1.4293111014234208,0.030303030303030304,0.5354490881897017,1.0,7/56,8.13%,PFKP;PFKM;NUP153;NUP188;NUP42;MAP4K5;PPP2R1B
prerank,GO_Biological_Process_2021__regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),-0.7610808870757895,-1.4289430477820835,0.03076923076923077,0.30269551927335886,1.0,3/15,7.16%,ZFP36;BTG2;POLR2G
prerank,Reactome_2022__Activation Of Gene Expression By SREBF (SREBP) R-HSA-2426168,0.6503428659209188,1.4287981004061843,0.02857142857142857,0.5360367599116586,1.0,14/35,20.27%,NFYC;IDI1;FDFT1;ACACB;TM7SF2;ELOVL6;HMGCS1;TBL1XR1;MVD;FASN;SC5D;ACACA;NCOA2;SQLE
prerank,GO_Biological_Process_2021__regulation of T cell apoptotic process (GO:0070232),-0.9441074505711622,-1.428639158267074,0.03773584905660377,0.3031949174166967,1.0,3/5,2.84%,CCL5;PRKCQ;PRELID1
prerank,CellMarker_Augmented_2021__Interstitial cell:Dorsolateral Prefrontal Cortex,-0.6024182611624342,-1.4284468418421346,0.04054054054054054,0.3031715254536481,1.0,23/81,15.37%,CD36;CARD16;B2M;TNFSF10;SAMD9L;SP110;PHF11;GBP3;DTX3L;PARP9;GSTK1;ACAA1;OAS1;GBP2;PSMB9;MYL12A;MTIF3;FMO4;OSTF1;APOL3;NMRK1;ETFDH;IFI35
prerank,Reactome_2022__Citric Acid (TCA) Cycle And Respiratory Electron Transport R-HSA-1428517,-0.5984178956145703,-1.4284078884181175,0.0125,0.3028735784185504,1.0,51/123,21.62%,CYCS;MDH2;COX7C;UQCRB;NDUFC1;PDHX;NDUFA2;UQCRH;NDUFA1;TMEM126B;SLC16A3;NDUFB9;ATP5PD;NDUFA12;ATP5F1E;NDUFB4;UQCR10;COX4I1;COX5B;ETFB;LDHA;NDUFB1;IDH3B;NDUFS8;ATP5ME;NDUFS5;COX18;PDPR;COX6C;NDUFS6;NDUFB7;ETFDH;NUBPL;UQCRC1;NDUFB3;UQCRQ;ATP5F1C;DLST;NDUFS7;NDUFA3;PDK3;SURF1;ATP5F1D;COX20;PDHB;ACO2;PDHA1;ATP5MC2;NDUFAF6;COX7B;NDUFS2
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle hypertrophy (GO:0010613),-0.7912846514228141,-1.4282712814021463,0.04918032786885246,0.3027497578486275,1.0,2/14,5.56%,NR4A3;IGF1
prerank,GO_Biological_Process_2021__regulation of histone acetylation (GO:0035065),0.6609198197041348,1.4282519499514292,0.11428571428571428,0.5368483882392971,1.0,3/26,5.00%,PPARGC1A;RUVBL2;RPS6KA4
prerank,GO_Biological_Process_2021__positive regulation of protein modification by small protein conjugation or removal (GO:1903322),0.5639249090715913,1.4282101453332758,0.037037037037037035,0.535454256722224,1.0,12/54,14.94%,UBE2D1;SMAD7;SAE1;LRRK2;DCUN1D4;LAPTM5;UBE2L3;FBXW7;DCUN1D1;UBA2;XIAP;TRAF6
prerank,GO_Biological_Process_2021__branching involved in blood vessel morphogenesis (GO:0001569),0.8639899312030035,1.4281784249042175,0.13513513513513514,0.5341646939174144,1.0,2/5,1.95%,NRP1;TGFBR2
prerank,GO_Biological_Process_2021__glutamate receptor signaling pathway (GO:0007215),0.6578248893869673,1.427924827733851,0.0,0.5337514529480922,1.0,18/28,21.96%,GRIN3A;CDK5R1;GRID2;GNAQ;GRIK2;CPEB4;GRIA3;GRIA4;GRM5;GRIN2B;GRIA2;GRIN2A;KCNB1;HOMER1;GRM3;GRIK3;GRM1;GRIN1
prerank,Reactome_2022__G2/M DNA Damage Checkpoint R-HSA-69473,-0.645862983514272,-1.427918502784695,0.045454545454545456,0.3033467345400038,1.0,12/50,14.26%,H2BC4;H2BC26;HUS1;H2BC21;H2BC5;ABRAXAS1;H2BC9;H2BC11;KAT5;RAD9A;RPA3;BRCA1
prerank,Reactome_2022__Degradation Of GLI2 By Proteasome R-HSA-5610783,-0.6691624419017825,-1.4275843469490652,0.029850746268656716,0.30335728819501895,1.0,15/50,19.69%,UBC;RPS27A;PSMB3;PSMB6;PSMA7;PSMB9;RBX1;PSMD12;PSMD8;PSMA5;UBA52;PSMA3;PSMC4;PSME2;PSME1
prerank,Reactome_2022__GLI3 Is Processed To GLI3R By Proteasome R-HSA-5610785,-0.6691624419017825,-1.4275843469490652,0.029850746268656716,0.30335728819501895,1.0,15/50,19.69%,UBC;RPS27A;PSMB3;PSMB6;PSMA7;PSMB9;RBX1;PSMD12;PSMD8;PSMA5;UBA52;PSMA3;PSMC4;PSME2;PSME1
prerank,GO_Biological_Process_2021__regulation of neuron differentiation (GO:0045664),0.5617165295108498,1.4275626610549526,0.05714285714285714,0.5333725925920932,1.0,13/42,20.12%,CDK5R1;NLGN1;LRRK2;ZC4H2;BRINP3;YWHAG;CNTN4;MMD;MOSMO;BIN1;TIAM1;FGFR1;ZFHX2
prerank,GO_Biological_Process_2021__positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),-0.7841416533881325,-1.4273158389056009,0.03225806451612903,0.3035776295739534,1.0,3/13,7.16%,ZFP36;BTG2;POLR2G
prerank,GO_Biological_Process_2021__limb development (GO:0060173),0.6792862778535688,1.4272315179936361,0.09090909090909091,0.5335720948000225,1.0,7/17,13.38%,LRP4;ZNRF3;SALL1;BMPR1B;PTCH1;KAT2A;MEGF8
prerank,CellMarker_Augmented_2021__Granulocyte:Blood,-0.7700839512757562,-1.4270895996729012,0.04838709677419355,0.3038688542254045,1.0,19/34,18.12%,SCML4;PYHIN1;SLFN12L;CLEC12A;FCAR;PARP15;C5AR1;NLRP12;C3ORF62;KLRD1;CD226;SLC11A1;CSF3R;C5AR2;MYO1F;FPR1;IGSF6;LST1;RHD
prerank,GO_Biological_Process_2021__positive regulation of cold-induced thermogenesis (GO:0120162),0.5759520032806524,1.4266015992350312,0.034482758620689655,0.5349199079687734,1.0,7/62,1.53%,PRKAB2;LEPR;ESRRG;PPARGC1A;GRB10;IGF1R;ADIPOR2
prerank,GO_Biological_Process_2021__microtubule bundle formation (GO:0001578),0.6668621336843245,1.4264567137303783,0.05405405405405406,0.533999669345526,1.0,10/23,20.68%,MAP1S;MTCL1;TPPP;TOGARAM1;ZNF207;CCDC40;CLASP1;NCKAP5L;CHP1;NAV1
prerank,GO_Biological_Process_2021__regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),0.6372809789793461,1.4259981489524427,0.07142857142857142,0.5345133710727996,1.0,6/31,7.30%,EGR1;KLF4;FGF2;PPARG;SMAD3;TNF
prerank,Reactome_2022__Sema4D Induced Cell Migration And Growth-Cone Collapse R-HSA-416572,0.7547505859787554,1.4259704130234006,0.09090909090909091,0.5331242243073717,1.0,1/16,0.43%,PLXNB1
prerank,GO_Biological_Process_2021__regulation of protein localization to nucleus (GO:1900180),-0.7325596518114075,-1.4259386236422713,0.03333333333333333,0.30684640246127226,1.0,7/29,6.59%,TFRC;PYHIN1;GLUL;LILRB4;DTX3L;LAMTOR5;PARP9
prerank,Reactome_2022__Amyloid Fiber Formation R-HSA-977225,-0.690779602353695,-1.4254138481065588,0.03333333333333333,0.3080306220459448,1.0,11/41,9.35%,UBC;H2BC4;H2BC26;H2AC20;RPS27A;H2AC6;B2M;H3-3B;H2BC21;H2BC5;H2BC9
prerank,CellMarker_Augmented_2021__Neural Stem cell:Undefined,-0.7216473066247898,-1.4249197602563004,0.09523809523809523,0.3089831207753439,1.0,2/28,1.43%,CALCR;CXCR4
prerank,GO_Biological_Process_2021__positive chemotaxis (GO:0050918),0.8425409202587648,1.424875127679378,0.06382978723404255,0.5365746207405153,1.0,4/10,4.14%,NRP1;SCRIB;SEMA5A;TSC2
prerank,GO_Biological_Process_2021__axonal fasciculation (GO:0007413),0.7538958886265507,1.4248510146252518,0.038461538461538464,0.5351874119314742,1.0,5/11,14.50%,CDK5R1;SEMA5A;RTN4;MEGF8;CNTN4
prerank,GO_Biological_Process_2021__regulation of ketone biosynthetic process (GO:0010566),0.9513987049056633,1.4247801937743005,0.044444444444444446,0.5341217967197235,1.0,1/5,0.03%,EGR1
prerank,Reactome_2022__Activation Of HOX Genes During Differentiation R-HSA-5619507,-0.6341655786761076,-1.4247332761024936,0.028169014084507043,0.30906481483649756,1.0,12/52,9.63%,H2BC4;H2BC26;H2AC20;H2AC6;ZNF335;H3-3B;H2AJ;H2BC21;POLR2G;H2BC5;H2BC9;MEIS1
prerank,CellMarker_Augmented_2021__Pancreatic Ductal Stem cell:Pancreas,0.8924912459908577,1.4246616929434919,0.08,0.5329052751287662,1.0,1/5,0.01%,CPA1
prerank,Reactome_2022__Aberrant Regulation Of Mitotic Cell Cycle Due To RB1 Defects R-HSA-9687139,0.6329842227440549,1.4246188252625425,0.07317073170731707,0.531632790218202,1.0,8/24,15.55%,UBE2D1;E2F3;FZR1;CDC23;ANAPC16;CDK6;ANAPC1;CCND3
prerank,GO_Biological_Process_2021__embryonic digit morphogenesis (GO:0042733),0.8192702519458558,1.4246099332172635,0.14583333333333334,0.5302424717435481,1.0,3/8,9.84%,SALL1;WDPCP;HDAC1
prerank,GO_Biological_Process_2021__cellular response to light stimulus (GO:0071482),0.6084795617952743,1.4243220197152153,0.038461538461538464,0.5299161686840136,1.0,7/37,10.90%,ZBTB1;RUVBL2;CASP9;PARP1;EIF2S1;PTPRK;ERCC4
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA incision (GO:0033683)",-0.7219709663406999,-1.4242923349596799,0.03333333333333333,0.3098280351945549,1.0,5/30,4.34%,UBC;RPS27A;XPA;OGG1;GTF2H5
prerank,GO_Biological_Process_2021__regulation of G protein-coupled receptor signaling pathway (GO:0008277),-0.6684488570023664,-1.424096703666173,0.030303030303030304,0.30990814387435395,1.0,10/51,8.36%,CALCR;DYNLT1;RPGRIP1L;CCL5;MGLL;RGS2;RGS16;PLEK;RGS4;CALM1
prerank,CellMarker_Augmented_2021__Purkinje cell:Undefined,0.6815654766166033,1.4239280309472842,0.13043478260869565,0.5300875025853345,1.0,2/19,2.32%,CA8;GFAP
prerank,GO_Biological_Process_2021__regulation of protein exit from endoplasmic reticulum (GO:0070861),-0.8593355402075511,-1.4238617332492476,0.06666666666666667,0.3100729564096828,1.0,1/10,0.72%,INSIG1
prerank,GO_Biological_Process_2021__regulation of sister chromatid cohesion (GO:0007063),-0.9249599693916394,-1.423193082337932,0.0784313725490196,0.3116085447712345,1.0,1/6,0.51%,DDX11
prerank,GO_Biological_Process_2021__male gonad development (GO:0008584),0.8178497188352523,1.4231614277865579,0.025,0.5318962434075397,1.0,4/9,11.17%,WNT5A;WNT2B;KITLG;NCOA4
prerank,GO_Biological_Process_2021__regulation of neuron projection development (GO:0010975),0.5222700874097118,1.4231447506173522,0.05555555555555555,0.5305816000178186,1.0,43/128,18.96%,AVIL;PTPN9;CDK5R1;SRCIN1;LRRK2;RAP1A;WNT5A;RELN;LRRC4C;CIB1;SCARB2;PLXNB2;KANK1;CTNNA2;BRSK1;SHANK3;FUT9;PDLIM5;NPTN;ZNF804A;TANC2;KNDC1;CSMD3;PTEN;NTRK2;PRKCI;MARK1;DCC;ADCY6;BAG5;FKBP4;GSK3B;PPFIA2;IL1RAPL1;KIF13B;CX3CL1;RAPGEF2;CAMSAP2;BRSK2;MYLIP;MARK2;SCN1B;CRMP1
prerank,GO_Biological_Process_2021__ribonucleoprotein complex assembly (GO:0022618),-0.5928618007236399,-1.4229457272096553,0.05405405405405406,0.3118548699002479,1.0,33/103,17.48%,RPL38;RPS14;RPL3;RPL23A;RPL5;RPS15;RPS27;SNRPD2;RPL10;RPL11;EIF2D;MRPS7;RPL24;SRPK1;RPS5;RPL6;CRNKL1;ZRSR2;RPLP0;MRPS11;LOC102724159;NOP53;GCFC2;TRAF7;DDX23;RPS28;RPS27L;EIF2S2;RRP7A;LSM4;SNRNP200;LUC7L3;PRPF18
prerank,PanglaoDB_Augmented_2021__Mammary Epithelial Cells,-0.7615357271710714,-1.4229333873921048,0.0847457627118644,0.3113957823813059,1.0,6/21,8.80%,BTN3A1;CLDN7;PADI2;PRLR;BTN2A2;OVOL2
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell contraction (GO:0086004),-0.7611979289850921,-1.422852882492709,0.07692307692307693,0.3110506942479289,1.0,8/18,18.55%,PLN;JUP;SRI;FGF13;TRPM4;DSC2;PKP2;AKAP9
prerank,GO_Biological_Process_2021__eosinophil chemotaxis (GO:0048245),-0.9779715183764376,-1.4228169711092586,0.018518518518518517,0.310167358610038,1.0,3/5,1.49%,CCL4;CCL3;CCL5
prerank,GO_Biological_Process_2021__eosinophil migration (GO:0072677),-0.9779715183764376,-1.4228169711092586,0.018518518518518517,0.310167358610038,1.0,3/5,1.49%,CCL4;CCL3;CCL5
prerank,GO_Biological_Process_2021__negative regulation of cytokine-mediated signaling pathway (GO:0001960),-0.7209201024609491,-1.4224695468180777,0.10526315789473684,0.3108481741987796,1.0,9/33,8.28%,SIGIRR;OAS3;CARD16;PARP14;PADI2;NR1H2;NLRC5;GSTP1;OAS1
prerank,CellMarker_Augmented_2021__Common Lymphoid progenitor:Undefined,-0.6236422725194606,-1.422316325158025,0.02564102564102564,0.3109675343042276,1.0,35/88,17.50%,JAML;MNDA;XAF1;AIF1;FCER1G;SNX20;CD93;NCF4;LSP1;PLEK;IL10RA;PECAM1;GIMAP2;CYTIP;TNFRSF1B;SAMSN1;CFLAR;MS4A6A;CSF2RB;NCKAP1L;HLA-DRA;TYROBP;ITGAL;PTPRC;HAVCR2;MYO1F;APOL3;HLA-DPA1;CIITA;IGSF6;HLA-DPB1;FCGR3A;LST1;GIMAP4;EVI2B
prerank,Reactome_2022__Signaling By MAPK Mutants R-HSA-9652817,0.8728985794047255,1.4221321319526183,0.06976744186046512,0.5330559592998434,1.0,3/5,11.38%,DUSP6;DUSP7;MAPK1
prerank,Reactome_2022__Homology Directed Repair R-HSA-5693538,-0.6143183349121787,-1.4221190134649466,0.04477611940298507,0.31107256290952157,1.0,21/79,14.82%,UBC;H2BC4;H2BC26;RPS27A;POLE3;HUS1;MUS81;TIPIN;H2BC21;BRCA2;H2BC5;ABRAXAS1;H2BC9;PARP2;XRCC3;H2BC11;KAT5;RAD9A;RPA3;BRCA1;UBA52
prerank,Reactome_2022__Transcriptional Regulation By RUNX1 R-HSA-8878171,-0.5675633947425148,-1.4219376066073945,0.0,0.3112469687748352,1.0,18/143,10.13%,NR4A3;UBC;H2BC4;H2BC26;H2AC20;RPS27A;PRKCQ;H2AC6;PSMB3;H3-3B;H2AJ;H2BC21;PSMB6;PSMA7;H2BC5;PSMB9;H2BC9;SMARCD1
prerank,GO_Biological_Process_2021__proteolysis (GO:0006508),0.49181185442927344,1.421910027270661,0.038461538461538464,0.5324812051407303,1.0,12/144,7.06%,CPA1;MMP17;CTSF;DESI2;CTSC;CPM;ATG4C;BACE2;CTSK;HPN;BMP1;FOLH1
prerank,GO_Biological_Process_2021__positive regulation of posttranscriptional gene silencing (GO:0060148),-0.8549479064245447,-1.421719750760368,0.06666666666666667,0.3113512419917322,1.0,1/9,1.48%,ZFP36
prerank,Reactome_2022__UCH Proteinases R-HSA-5689603,-0.6462159180320542,-1.4211452722123696,0.043478260869565216,0.3126503724320372,1.0,10/73,9.00%,H2AC25;UBC;H2AC20;RPS27A;H2AC6;PSMB3;ADRM1;PSMB6;PSMA7;PSMB9
prerank,GO_Biological_Process_2021__positive regulation of protein-containing complex assembly (GO:0031334),-0.6172280744801516,-1.4203318455767757,0.0125,0.3146254317256717,1.0,12/86,6.39%,SKAP1;CD36;TFRC;XPA;WARS1;MPP7;RACK1;GTF2H5;CLU;PLEK;RPS3;MED25
prerank,GO_Biological_Process_2021__positive regulation of muscle hypertrophy (GO:0014742),-0.7922550572625491,-1.420018008722057,0.06451612903225806,0.3150981124654451,1.0,2/13,5.56%,NR4A3;IGF1
prerank,CellMarker_Augmented_2021__Type I pneumocyte:Undefined,0.683572503074321,1.4199009281098138,0.09090909090909091,0.5395256530866975,1.0,6/26,12.87%,SHROOM3;KIAA1671;MAGI1;TACC2;COBL;TJP1
prerank,KEGG_2021_Human__Hippo signaling pathway,0.5359707093319478,1.419892215358529,0.038461538461538464,0.5381437892846319,1.0,29/90,15.71%,SCRIB;SERPINE1;AMOT;SMAD1;TGFBR2;DLG5;SMAD7;TCF7L1;WNT5A;FZD3;SMAD2;SMAD3;WNT2B;DVL3;PPP2R1B;CTNNA2;MOB1B;YWHAG;BTRC;BMPR1B;FBXW11;TCF7L2;BMPR1A;CSNK1E;PRKCI;TGFBR1;CCND3;GSK3B;PARD3
prerank,Reactome_2022__Degradation Of DVL R-HSA-4641258,-0.6688909889202627,-1.4197194089386636,0.04,0.31536184106594006,1.0,16/47,19.69%,UBC;RPS27A;PSMB3;PSMB6;PSMA7;PSMB9;RBX1;PSMD12;PSMD8;PSMA5;UBA52;HECW1;PSMA3;PSMC4;PSME2;PSME1
prerank,CellMarker_Augmented_2021__Adventitial cell:Skeletal Muscle,-0.6043329899359443,-1.4195967447451228,0.0273972602739726,0.3153208914233236,1.0,29/91,17.50%,JAML;MNDA;MS4A4A;AIF1;FCER1G;SNX20;CD93;PLEK;IL10RA;F13A1;LILRB4;PECAM1;TNFRSF1B;SAMSN1;MS4A6A;CSF2RB;NCKAP1L;HLA-DRA;TYROBP;CSF3R;PTPRC;HAVCR2;MYO1F;HLA-DPA1;HLA-DPB1;FCGR3A;LST1;GIMAP4;EVI2B
prerank,GO_Biological_Process_2021__negative regulation of inflammatory response to antigenic stimulus (GO:0002862),-0.6623026539007827,-1.4195812082443824,0.04477611940298507,0.31489391409019113,1.0,6/52,9.83%,CALCR;YES1;CD247;PRKAR1B;FYN;SELENOS
prerank,GO_Biological_Process_2021__peptidyl-lysine methylation (GO:0018022),0.6804552762879665,1.4194506038905363,0.08571428571428572,0.5381992276245877,1.0,5/17,15.35%,SETD7;VCPKMT;SETD3;SETD2;SETD4
prerank,GO_Biological_Process_2021__regulation of mitochondrial fusion (GO:0010635),-0.9314542043597311,-1.41914241291446,0.015151515151515152,0.3154872294172537,1.0,2/7,1.81%,TFRC;PID1
prerank,Reactome_2022__Late Endosomal Microautophagy R-HSA-9615710,-0.6949360818866024,-1.4190800578798695,0.07936507936507936,0.31511629679788195,1.0,7/28,16.16%,UBC;RPS27A;VPS28;CFTR;VPS37B;UBA52;MVB12A
prerank,GO_Biological_Process_2021__regulation of bicellular tight junction assembly (GO:2000810),0.7196219272479646,1.418993421485039,0.10810810810810811,0.5384061178572738,1.0,4/13,12.87%,NPHP1;RUNX1;TNF;TJP1
prerank,KEGG_2021_Human__T cell receptor signaling pathway,-0.6346121170755183,-1.418843413702003,0.039473684210526314,0.3155290008784993,1.0,7/74,3.88%,ITK;FOS;PRKCQ;GRAP2;VAV3;CD247;CBLB
prerank,GO_Biological_Process_2021__cellular response to bacterial lipopeptide (GO:0071221),-0.9298794533477873,-1.4186731362692682,0.017241379310344827,0.31557035239353115,1.0,2/5,3.07%,CD36;CD14
prerank,GO_Biological_Process_2021__cellular response to cholesterol (GO:0071397),0.8583999944432714,1.4184502957775964,0.05,0.5400043211591208,1.0,3/6,10.96%,GRAMD1A;GRAMD1C;PTCH1
prerank,GO_Biological_Process_2021__T cell differentiation (GO:0030217),0.702977404045602,1.4184083466012087,0.10810810810810811,0.538877064177566,1.0,4/23,8.29%,LEPR;ANXA1;LIG4;SOX4
prerank,GO_Biological_Process_2021__skin development (GO:0043588),0.6366118935295945,1.4183470180575912,0.0,0.537574955593368,1.0,9/30,6.63%,COL5A3;ANXA1;PDGFA;COL5A2;PKD1;WNT5A;FA2H;JAG1;DHCR24
prerank,Reactome_2022__NF-kB Is Activated And Signals Survival R-HSA-209560,-0.8341091813877857,-1.4183109615642742,0.07936507936507936,0.31606323418215326,1.0,2/11,1.30%,UBC;RPS27A
prerank,GO_Biological_Process_2021__regulation of viral genome replication (GO:0045069),-0.6594014024943156,-1.4182010865358121,0.06153846153846154,0.31581666911688844,1.0,16/50,8.67%,PPIE;OAS3;MX1;RSAD2;CCL5;IFIT1;OAS2;IFITM3;SHFL;ILF3;EIF2AK2;PLSCR1;SRPK1;OAS1;RNASEL;APOBEC3G
prerank,GO_Biological_Process_2021__regulation of nuclear division (GO:0051783),0.7716455235749757,1.418029335682454,0.0975609756097561,0.5373608282521706,1.0,3/9,10.82%,BORA;RCC1;CDK13
prerank,GO_Biological_Process_2021__myoblast migration (GO:0051451),0.8842262126370087,1.417516357214641,0.0,0.5383461237453917,1.0,2/6,4.73%,ANXA1;AKIRIN1
prerank,PanglaoDB_Augmented_2021__Hepatic Stellate Cells,0.576684823500899,1.4166412779979316,0.07142857142857142,0.5404618532784196,1.0,13/46,9.97%,COL16A1;TPM2;SVEP1;COL5A2;GFAP;ACTA2;PHLDB1;PPARG;TIMP3;RELN;VCL;CDH11;HGF
prerank,GO_Biological_Process_2021__coenzyme A biosynthetic process (GO:0015937),0.8170068408192421,1.4166148398650629,0.044444444444444446,0.5365141090655715,1.0,2/10,4.53%,PANK3;PANK1
prerank,GO_Biological_Process_2021__ribonucleoside bisphosphate biosynthetic process (GO:0034030),0.8170068408192421,1.4166148398650629,0.044444444444444446,0.5365141090655715,1.0,2/10,4.53%,PANK3;PANK1
prerank,GO_Biological_Process_2021__purine nucleoside bisphosphate biosynthetic process (GO:0034033),0.8170068408192421,1.4166148398650629,0.044444444444444446,0.5365141090655715,1.0,2/10,4.53%,PANK3;PANK1
prerank,GO_Biological_Process_2021__positive regulation of myeloid cell apoptotic process (GO:0033034),0.8922303150354491,1.4165287099311876,0.06976744186046512,0.535507332566349,1.0,2/6,2.51%,ANXA1;SIRT1
prerank,GO_Biological_Process_2021__positive regulation of cartilage development (GO:0061036),0.8495261076351635,1.4165162303519594,0.06976744186046512,0.5341811207894662,1.0,5/9,9.95%,ZBTB16;BMP1;SOX5;BMPR1B;LOXL2
prerank,CellMarker_Augmented_2021__Stem cell:Ovarian Cortex,0.6935701959707302,1.4165155223878363,0.09090909090909091,0.5328321785652503,1.0,5/26,7.28%,FLVCR1;GRID2;POU2F1;FZD3;SHISA9
prerank,GO_Biological_Process_2021__purine ribonucleoside triphosphate metabolic process (GO:0009205),0.7804942204740896,1.4164796921367457,0.05555555555555555,0.5316074494575059,1.0,4/10,13.57%,EFL1;LRRK2;MFN1;AK3
prerank,Reactome_2022__Regulation Of Innate Immune Responses To Cytosolic DNA R-HSA-3134975,-0.8615260652605881,-1.4160409594291345,0.045454545454545456,0.32206593049812454,1.0,2/8,1.30%,UBC;RPS27A
prerank,GO_Biological_Process_2021__negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),0.7276281824080694,1.415969987979547,0.047619047619047616,0.5319700274248595,1.0,7/23,13.76%,KLF4;PKD2;NACC2;SLFN11;PTEN;CDK6;GPNMB
prerank,Reactome_2022__Assembly Of HIV Virion R-HSA-175474,-0.7645938534806727,-1.4159089698745821,0.1016949152542373,0.32196091248964204,1.0,6/15,16.16%,UBC;RPS27A;VPS28;VPS37B;UBA52;MVB12A
prerank,GO_Biological_Process_2021__epidermal cell differentiation (GO:0009913),0.6334758868051468,1.4158905359892349,0.07692307692307693,0.531045670287873,1.0,4/21,9.84%,ANXA1;WNT5A;JAG1;HDAC1
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Oral Mucosa,0.6638369864179829,1.4157131783460724,0.06060606060606061,0.5302716059452922,1.0,4/26,8.39%,COL5A3;ACTA2;CNRIP1;CDH11
prerank,KEGG_2021_Human__Melanogenesis,0.5744587101552161,1.4156801417139082,0.0,0.5290654790546323,1.0,18/54,19.12%,MITF;TCF7L1;MAP2K1;GNAQ;WNT5A;FZD3;PLCB4;ADCY9;WNT2B;KITLG;DVL3;TCF7L2;MAPK1;ADCY6;GSK3B;PLCB3;MAP2K2;CREB3L2
prerank,Reactome_2022__Chondroitin Sulfate Biosynthesis R-HSA-2022870,0.7759930015194836,1.4156535639137644,0.0,0.5277783850288686,1.0,5/13,9.98%,NCAN;CHST7;CSGALNACT1;CSPG5;CHST15
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell migration (GO:1904752),-0.945533971872607,-1.4156274433595966,0.0,0.32255001349977064,1.0,1/8,0.08%,NR4A3
prerank,Reactome_2022__Semaphorin Interactions R-HSA-373755,0.5636390735677224,1.4146975557078578,0.0,0.5297364186115157,1.0,6/52,2.08%,PLXNB1;NRP1;CDK5R1;DPYSL5;SEMA5A;PLXNA2
prerank,Reactome_2022__Dual Incision In TC-NER R-HSA-6782135,-0.6402651282425982,-1.414478789949702,0.056338028169014086,0.3257182007852409,1.0,8/52,7.16%,UBC;PPIE;RPS27A;XPA;POLE3;UVSSA;GTF2H5;POLR2G
prerank,Reactome_2022__Vpu Mediated Degradation Of CD4 R-HSA-180534,-0.6772401280431969,-1.4142620416647553,0.028169014084507043,0.3257437949160442,1.0,14/44,19.69%,UBC;RPS27A;PSMB3;PSMB6;PSMA7;PSMB9;PSMD12;PSMD8;PSMA5;UBA52;PSMA3;PSMC4;PSME2;PSME1
prerank,CellMarker_Augmented_2021__Platelet:Liver,-0.6449732673413467,-1.4141721592264083,0.08450704225352113,0.32509158907420904,1.0,14/51,14.59%,CD37;GMIP;TSPAN32;ARHGEF1;NBEAL2;FERMT3;LILRB3;DGKD;MAX;RGL4;MYO1F;C19ORF38;TLN1;ALOX12
prerank,CellMarker_Augmented_2021__T Helper cell:Lung,-0.6449732673413467,-1.4141721592264083,0.08450704225352113,0.32509158907420904,1.0,14/51,14.59%,CD37;GMIP;TSPAN32;ARHGEF1;NBEAL2;FERMT3;LILRB3;DGKD;MAX;RGL4;MYO1F;C19ORF38;TLN1;ALOX12
prerank,Reactome_2022__G Alpha (I) Signaling Events R-HSA-418594,-0.591675740365912,-1.4141086704557764,0.02631578947368421,0.3247939549654773,1.0,13/124,6.88%,CCL4;PDE4A;CHRM2;CXCR4;CCL5;GPR183;RGS1;RGS16;GNB5;ACKR4;RGS4;PRKAR1B;C5AR1
prerank,KEGG_2021_Human__ABC transporters,-0.6832316600592181,-1.4140872180630508,0.05084745762711865,0.324389354992931,1.0,9/27,11.64%,ABCA9;ABCA6;ABCC3;ABCB1;ABCB4;CFTR;ABCB9;TAP1;ABCA8
prerank,GO_Biological_Process_2021__chondroitin sulfate catabolic process (GO:0030207),0.8103231956187783,1.4140257585483667,0.045454545454545456,0.5304582806453566,1.0,2/7,5.57%,NCAN;CSPG5
prerank,Reactome_2022__CS/DS Degradation R-HSA-2024101,0.8103231956187783,1.4140257585483667,0.045454545454545456,0.5304582806453566,1.0,2/7,5.57%,NCAN;CSPG5
prerank,Reactome_2022__Loss Of Function Of SMAD2/3 In Cancer R-HSA-3304349,0.8313148406652904,1.4139986076751725,0.08888888888888889,0.5279375054139126,1.0,3/7,5.98%,TGFBR2;SMAD2;SMAD3
prerank,Reactome_2022__Signaling By TGF-beta Receptor Complex In Cancer R-HSA-3304351,0.8313148406652904,1.4139986076751725,0.08888888888888889,0.5279375054139126,1.0,3/7,5.98%,TGFBR2;SMAD2;SMAD3
prerank,KEGG_2021_Human__Antigen processing and presentation,-0.6550126240564713,-1.4138620148429029,0.0273972602739726,0.32456482165047107,1.0,23/46,19.69%,HLA-B;B2M;CTSB;HLA-C;HLA-DRB5;HLA-F;KLRD1;HLA-DRA;TAP1;HSPA1B;HLA-E;HSPA1A;HLA-DPA1;CIITA;HLA-DMB;CD74;HLA-DPB1;RFX5;HSPA2;HLA-DRB1;PSME2;NFYB;PSME1
prerank,GO_Biological_Process_2021__response to dsRNA (GO:0043331),0.8060660332577916,1.4138390050303915,0.10869565217391304,0.5273861774549058,1.0,2/7,10.79%,SLC3A2;IRAK3
prerank,GO_Biological_Process_2021__ubiquinone metabolic process (GO:0006743),0.7639642375827598,1.4137926432511256,0.07692307692307693,0.5263531626598545,1.0,2/11,4.98%,UBIAD1;COQ9
prerank,Reactome_2022__Zinc Influx Into Cells By SLC39 Gene Family R-HSA-442380,0.9097491064344001,1.4135747343916019,0.02040816326530612,0.5260357772478073,1.0,2/5,5.71%,SLC39A14;SLC39A8
prerank,KEGG_2021_Human__Allograft rejection,-0.7265738134661446,-1.4129948414631606,0.06779661016949153,0.3267560310799714,1.0,11/20,16.72%,HLA-B;GZMB;PRF1;HLA-C;HLA-DRB5;HLA-F;HLA-DRA;HLA-E;HLA-DPA1;HLA-DMB;HLA-DPB1
prerank,Reactome_2022__SARS-CoV Infections R-HSA-9679506,-0.545909883691474,-1.412583987448439,0.011363636363636364,0.32766565098077743,1.0,46/290,11.78%,RPS13;UBC;RPS4X;HLA-B;RPS27A;RPS8;RPS21;RPS14;ZCRB1;CHD3;PARP14;RPS11;B2M;RPS15;RPS12;RPS25;RPS23;RPS27;FAU;RPS20;BTK;RPS24;SNRPD2;HLA-C;RPS3;RPS3A;PARP9;RPS6;RPS2;RPS7;NLRP12;CRBN;SRPK1;HLA-F;ITGA4;RPS5;GPC3;STAT1;COMT;NUP50;RPS9;RBX1;VEGFA;STING1;SDC3;IFNGR2
prerank,GO_Biological_Process_2021__cellular response to interferon-alpha (GO:0035457),-0.9012614642666087,-1.4125187121329597,0.03278688524590164,0.32731279605938945,1.0,1/7,1.60%,PYHIN1
prerank,GO_Biological_Process_2021__positive regulation of calcium ion import (GO:0090280),-0.9703881437956519,-1.4124844796744036,0.0,0.32688069653341806,1.0,2/5,0.62%,CALCR;CCL3
prerank,GO_Biological_Process_2021__dendritic cell chemotaxis (GO:0002407),-0.8887919951891409,-1.4124547765805515,0.01639344262295082,0.32646323941921057,1.0,3/8,1.61%,CXCR4;CCL5;GPR183
prerank,KEGG_2021_Human__Ovarian steroidogenesis,0.6773464306557166,1.4120473188307678,0.027777777777777776,0.530880446964223,1.0,4/20,6.41%,PLA2G4C;IGF1R;LDLR;ADCY9
prerank,Reactome_2022__DAP12 Interactions R-HSA-2172127,-0.7129203509414322,-1.4119958377305246,0.07936507936507936,0.32732788302621707,1.0,11/24,14.31%,HLA-B;GRAP2;VAV3;B2M;BTK;HLA-C;FYN;KLRD1;TYROBP;PIK3CB;HLA-E
prerank,GO_Biological_Process_2021__regulation of T cell mediated immune response to tumor cell (GO:0002840),-0.9207193731233441,-1.4118435081145193,0.05454545454545454,0.3273506458249515,1.0,1/5,0.34%,IL4I1
prerank,Reactome_2022__GAB1 Signalosome R-HSA-180292,0.8127560749535013,1.411662695470026,0.06521739130434782,0.5314304683195231,1.0,2/10,2.15%,PIGU;TGFA
prerank,GO_Biological_Process_2021__stress-activated protein kinase signaling cascade (GO:0031098),-0.7171091793241632,-1.4116004054121674,0.07246376811594203,0.32771921928077724,1.0,3/27,1.30%,UBC;CCDC88C;RPS27A
prerank,KEGG_2021_Human__Graft-versus-host disease,-0.7250446708930635,-1.41151904532185,0.06666666666666667,0.32747567068094696,1.0,12/22,16.72%,HLA-B;GZMB;PRF1;HLA-C;HLA-DRB5;HLA-F;KLRD1;HLA-DRA;HLA-E;HLA-DPA1;HLA-DMB;HLA-DPB1
prerank,GO_Biological_Process_2021__cellular response to vascular endothelial growth factor stimulus (GO:0035924),0.644596434070724,1.4114025629749516,0.09090909090909091,0.531244180374945,1.0,4/23,2.61%,ANXA1;NRP1;SPRY2;GAB1
prerank,Reactome_2022__NLRP3 Inflammasome R-HSA-844456,-0.7568201292726855,-1.4113382035656834,0.06349206349206349,0.3275644350508468,1.0,2/15,6.33%,PSTPIP1;TXN2
prerank,Reactome_2022__Activation Of IRF3/IRF7 Mediated By TBK1/IKK Epsilon R-HSA-936964,-0.7499406857083072,-1.411335947899291,0.08196721311475409,0.32708343000671924,1.0,3/16,4.18%,UBC;RPS27A;NDUFA2
prerank,GO_Biological_Process_2021__tryptophan catabolic process (GO:0006569),-0.8961046993653886,-1.4111834546825472,0.018867924528301886,0.3271460592654124,1.0,2/5,5.45%,IL4I1;KMO
prerank,Reactome_2022__Aberrant Regulation Of Mitotic Exit In Cancer Due To RB1 Defects R-HSA-9687136,0.6991943983518415,1.4110292587110345,0.10869565217391304,0.531452878192822,1.0,4/15,10.68%,UBE2D1;FZR1;CDC23;ANAPC16
prerank,Reactome_2022__Class B/2 (Secretin Family Receptors) R-HSA-373080,-0.737608439162342,-1.4109946620192781,0.08620689655172414,0.32723491634147,1.0,4/26,4.88%,CALCR;ADGRE1;CD55;GNB5
prerank,Reactome_2022__Membrane Binding And Targetting Of GAG Proteins R-HSA-174490,-0.769830120379407,-1.4109683756310392,0.09836065573770492,0.32687517941699135,1.0,6/14,16.16%,UBC;RPS27A;VPS28;VPS37B;UBA52;MVB12A
prerank,CellMarker_Augmented_2021__M2 macrophage:Brain,-0.5870101944429038,-1.4107435711345795,0.02631578947368421,0.32597292558481633,1.0,30/86,17.23%,JAML;MNDA;CLEC12A;MS4A4A;MARCO;AIF1;SIGLEC1;CD14;FCER1G;CD93;IL10RA;F13A1;LILRB4;CD300LF;PECAM1;C5AR1;SLC11A1;MS4A6A;HLA-DRA;TYROBP;CSF3R;PTPRC;HAVCR2;MYO1F;LY86;FPR1;IGSF6;FCGR3A;LST1;GIMAP4
prerank,CellMarker_Augmented_2021__M2 macrophage:Serum,-0.5870101944429038,-1.4107435711345795,0.02631578947368421,0.32597292558481633,1.0,30/86,17.23%,JAML;MNDA;CLEC12A;MS4A4A;MARCO;AIF1;SIGLEC1;CD14;FCER1G;CD93;IL10RA;F13A1;LILRB4;CD300LF;PECAM1;C5AR1;SLC11A1;MS4A6A;HLA-DRA;TYROBP;CSF3R;PTPRC;HAVCR2;MYO1F;LY86;FPR1;IGSF6;FCGR3A;LST1;GIMAP4
prerank,CellMarker_Augmented_2021__Kupffer cell:Fetal Liver,-0.5870101944429038,-1.4107435711345795,0.02631578947368421,0.32597292558481633,1.0,30/86,17.23%,JAML;MNDA;CLEC12A;MS4A4A;MARCO;AIF1;SIGLEC1;CD14;FCER1G;CD93;IL10RA;F13A1;LILRB4;CD300LF;PECAM1;C5AR1;SLC11A1;MS4A6A;HLA-DRA;TYROBP;CSF3R;PTPRC;HAVCR2;MYO1F;LY86;FPR1;IGSF6;FCGR3A;LST1;GIMAP4
prerank,CellMarker_Augmented_2021__Periodontal Ligament Stem cell:Periodontal Ligament,-0.6121163027564538,-1.4106760457055996,0.03896103896103896,0.32566955298302547,1.0,33/89,17.50%,JAML;MNDA;MS4A4A;AIF1;FCER1G;SNX20;CD93;NCF4;PLEK;IL10RA;F13A1;PECAM1;GIMAP2;CYTIP;TNFRSF1B;SAMSN1;MS4A6A;ITGB2;CSF2RB;NCKAP1L;HLA-DRA;TYROBP;ITGAL;PTPRC;HAVCR2;MYO1F;HLA-DPA1;CD74;HLA-DPB1;FCGR3A;LST1;GIMAP4;EVI2B
prerank,GO_Biological_Process_2021__negative regulation of T-helper cell differentiation (GO:0045623),0.9441285324151715,1.410455023134516,0.024390243902439025,0.5326153296205416,1.0,2/5,2.59%,ANXA1;SMAD7
prerank,Reactome_2022__Signaling By NTRK1 (TRKA) R-HSA-187037,0.5287738936095213,1.4102497829880587,0.06896551724137931,0.5323154822522665,1.0,13/82,9.65%,EGR1;DUSP6;CDK5R1;MAPK11;RAP1A;MAP2K1;VGF;CRK;SH3GL3;PPP2R1B;DNM3;SHC2;DUSP7
prerank,GO_Biological_Process_2021__response to organonitrogen compound (GO:0010243),0.670626224759117,1.4101934959773983,0.08823529411764706,0.5312625181355496,1.0,9/26,18.00%,RNF139;RCN3;GLRA1;SEL1L;UBXN6;IRAK3;RNF185;IRF5;BRSK2
prerank,GO_Biological_Process_2021__mitochondrial respiratory chain complex assembly (GO:0033108),-0.6376890405894873,-1.4100980326278942,0.057971014492753624,0.32692484334633654,1.0,30/68,22.44%,DMAC1;NDUFC1;NDUFA2;NDUFA1;TMEM126B;NDUFB9;NDUFA12;NDUFB4;TIMM21;NDUFB1;NDUFS8;NDUFS5;BCS1L;COX18;TTC19;OXA1L;NDUFS6;NDUFB7;NUBPL;TMEM126A;NDUFB3;NDUFS7;NDUFA3;SURF1;COX20;UQCC2;NDUFAF6;NDUFS2;NDUFA10;NDUFAB1
prerank,GO_Biological_Process_2021__positive regulation of protein-containing complex disassembly (GO:0043243),0.7828868970645644,1.4099751471717117,0.08695652173913043,0.5308279437403205,1.0,2/10,7.30%,IGF1R;TNF
prerank,"GO_Biological_Process_2021__maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",-0.6762728420569106,-1.4098174667132866,0.0967741935483871,0.32724840902584734,1.0,7/24,11.56%,RPS8;RPS21;RPS14;UTP3;WDR46;MRPS11;LOC102724159
prerank,Reactome_2022__HDL Assembly R-HSA-8963896,0.902910298762867,1.409756019379255,0.07272727272727272,0.5303954436858801,1.0,1/5,6.72%,BMP1
prerank,GO_Biological_Process_2021__regulation of integrin-mediated signaling pathway (GO:2001044),-0.8379871238823522,-1.4096073125361923,0.11538461538461539,0.32749272187657236,1.0,2/9,5.63%,FLNA;CD63
prerank,Reactome_2022__DNA Repair R-HSA-73894,-0.5642929032291877,-1.4095417595749242,0.0,0.3272410420633221,1.0,43/227,14.82%,UBC;PPIE;H2BC4;H2BC26;H2AC20;RPS27A;SMUG1;XPA;H2AC6;UBXN1;COPS6;POLE3;UVSSA;OGG1;GTF2H5;EYA2;HUS1;MUS81;TIPIN;H2AJ;H2BC21;POLR2G;BRCA2;POLM;H2BC5;ABRAXAS1;H2BC9;PARP2;XRCC3;RBX1;PARG;WDR48;COPS8;TERF2IP;H2BC11;KAT5;APEX1;RAD9A;RPA3;BRCA1;ERCC8;FANCB;UBA52
prerank,GO_Biological_Process_2021__positive regulation of metabolic process (GO:0009893),0.548591692438537,1.4093867544082777,0.038461538461538464,0.5306309277668034,1.0,7/72,1.53%,PRKAB2;LEPR;ESRRG;PPARGC1A;GRB10;IGF1R;ADIPOR2
prerank,Reactome_2022__Cell Surface Interactions At Vascular Wall R-HSA-202733,-0.6345932202326496,-1.4092702439953573,0.07692307692307693,0.3277579764839217,1.0,23/81,14.27%,JAML;PROCR;CD2;SLC7A5;YES1;CD99L2;SELL;FCER1G;SLC16A3;PECAM1;SELENOP;FYN;OLR1;ITGA4;ITGA6;CD44;ITGB2;ITGAL;SDC3;CD47;ATP1B3;PIK3CB;PICK1
prerank,CellMarker_Augmented_2021__Eosinophil:Blood,-0.8422363676118898,-1.4088994076746015,0.046875,0.32844237301793844,1.0,5/10,11.39%,CD69;IL3RA;CSF2RA;CD44;CSF3R
prerank,Reactome_2022__Sema3A PAK Dependent Axon Repulsion R-HSA-399954,0.6892331243228188,1.408342883466053,0.075,0.5343254121304957,1.0,3/16,5.95%,NRP1;PLXNA2;PLXNA3
prerank,GO_Biological_Process_2021__regulation of protein processing (GO:0070613),0.8267309915908001,1.4079997176059553,0.10256410256410256,0.5341362370951359,1.0,5/10,8.81%,RNF139;SERPINE2;LRRK2;RUNX1;SNX12
prerank,GO_Biological_Process_2021__regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),-0.8082469820485965,-1.4079604401310408,0.10526315789473684,0.3312141929447721,1.0,2/8,9.58%,DUSP1;XRCC3
prerank,CellMarker_Augmented_2021__M2 macrophage:Undefined,0.8940257451413626,1.4079520465864026,0.07317073170731707,0.5330663541821065,1.0,3/6,5.06%,MSR1;MRC1;VSIG4
prerank,Reactome_2022__Signaling By Activin R-HSA-1502540,0.8077872502787111,1.4077686220968406,0.13043478260869565,0.5329360111500828,1.0,4/9,11.38%,ACVR2A;SMAD2;SMAD3;MAPK1
prerank,PanglaoDB_Augmented_2021__Leydig Cells,0.5619778211882055,1.4075431620986092,0.03125,0.5326691793711785,1.0,13/47,13.72%,ESRRG;COL16A1;FKBP9;SVEP1;TIMP3;CDH11;SASH1;TACC2;EPAS1;PTCH1;FAM114A1;TJP1;CXCL14
prerank,Reactome_2022__Other Interleukin Signaling R-HSA-449836,0.7035890070790003,1.4074199774933858,0.11363636363636363,0.531965903396019,1.0,1/15,0.25%,IFNLR1
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",-0.7620216753846041,-1.4072982741344646,0.03278688524590164,0.33248776867325713,1.0,4/19,4.34%,UBC;RPS27A;XPA;GTF2H5
prerank,CellMarker_Augmented_2021__Natural Killer cell:Undefined,-0.6760192942302201,-1.4071737593932836,0.014705882352941176,0.3324636542434582,1.0,14/38,17.61%,IL7R;CD69;SELL;GZMB;SLAMF6;IL12RB2;ITGA4;KLRD1;CD226;IL18R1;PTPRC;KLRF1;FCGR3A;IL18
prerank,CellMarker_Augmented_2021__Common Lymphoid progenitor:Germ,-0.6365400466568928,-1.4071413702944022,0.05194805194805195,0.33206487619057656,1.0,35/75,19.61%,CD36;MNDA;XAF1;MS4A4A;AIF1;FCER1G;CMAHP;CD93;TNFSF10;SAMD9L;PLEK;F13A1;PECAM1;TRIM22;GIMAP2;TNFRSF1B;CFLAR;MS4A6A;CSF2RB;NCKAP1L;HLA-DRA;TYROBP;CSF3R;PTPRC;APOL3;HLA-DPA1;CIITA;HLA-DPB1;FCGR3A;GIMAP4;EVI2B;FOLR2;RNASE6;MPEG1;LILRB5
prerank,Reactome_2022__VEGFR2 Mediated Vascular Permeability R-HSA-5218920,-0.7255624200288948,-1.407078257991136,0.046153846153846156,0.3318220791144756,1.0,4/22,8.36%,VAV3;JUP;THEM4;CALM1
prerank,GO_Biological_Process_2021__negative regulation of transcription by competitive promoter binding (GO:0010944),0.8577122699073725,1.407027474360508,0.05660377358490566,0.5324940611055083,1.0,2/6,6.26%,SMAD7;DACH1
prerank,GO_Biological_Process_2021__lysosome localization (GO:0032418),-0.7623204031202612,-1.4067921369362273,0.06451612903225806,0.3322757602585752,1.0,4/25,10.75%,NR4A3;RAB3A;KXD1;BLOC1S2
prerank,CellMarker_Augmented_2021__Megakaryocyte:Blood,-0.6050421263093101,-1.406515188202604,0.039473684210526314,0.33257374880787843,1.0,34/69,20.40%,MNDA;CLEC12A;MS4A4A;AIF1;CD14;FCER1G;NCF4;PLEK;CD300LF;C5AR1;SIRPB2;TNFRSF1B;OSCAR;LILRB3;NCF2;SLC11A1;MS4A6A;ITGB2;CSF2RB;TYROBP;CSF3R;FCGR1CP;MYO1F;LY86;FPR1;IGSF6;FCGR3A;LST1;PARVG;RNASE6;MPEG1;NCF1;TLR2;RASGRP4
prerank,CellMarker_Augmented_2021__Stem cell:Gastric Gland,0.5770891884811973,1.4064658685163782,0.034482758620689655,0.5276722026751265,1.0,16/67,12.87%,PPARGC1A;LRP4;ZNRF3;FRAS1;NEO1;GSTA4;KHDRBS3;MAGI1;SALL1;ROBO1;PTPRG;GUCY1A2;PTPRD;ENAH;GPC6;TJP1
prerank,CellMarker_Augmented_2021__Gastric Stem cell:Gastric Gland,0.5770891884811973,1.4064658685163782,0.034482758620689655,0.5276722026751265,1.0,16/67,12.87%,PPARGC1A;LRP4;ZNRF3;FRAS1;NEO1;GSTA4;KHDRBS3;MAGI1;SALL1;ROBO1;PTPRG;GUCY1A2;PTPRD;ENAH;GPC6;TJP1
prerank,CellMarker_Augmented_2021__Somatic Stem cell:Endometrium,0.5770891884811973,1.4064658685163782,0.034482758620689655,0.5276722026751265,1.0,16/67,12.87%,PPARGC1A;LRP4;ZNRF3;FRAS1;NEO1;GSTA4;KHDRBS3;MAGI1;SALL1;ROBO1;PTPRG;GUCY1A2;PTPRD;ENAH;GPC6;TJP1
prerank,CellMarker_Augmented_2021__Corneal Limbal Stem cell:Limbal Epithelium,0.5770891884811973,1.4064658685163782,0.034482758620689655,0.5276722026751265,1.0,16/67,12.87%,PPARGC1A;LRP4;ZNRF3;FRAS1;NEO1;GSTA4;KHDRBS3;MAGI1;SALL1;ROBO1;PTPRG;GUCY1A2;PTPRD;ENAH;GPC6;TJP1
prerank,CellMarker_Augmented_2021__Intestinal Stem cell:Gastrointestinal Tract,0.5770891884811973,1.4064658685163782,0.034482758620689655,0.5276722026751265,1.0,16/67,12.87%,PPARGC1A;LRP4;ZNRF3;FRAS1;NEO1;GSTA4;KHDRBS3;MAGI1;SALL1;ROBO1;PTPRG;GUCY1A2;PTPRD;ENAH;GPC6;TJP1
prerank,CellMarker_Augmented_2021__Ovarian Somatic cell:Ovary,0.5770891884811973,1.4064658685163782,0.034482758620689655,0.5276722026751265,1.0,16/67,12.87%,PPARGC1A;LRP4;ZNRF3;FRAS1;NEO1;GSTA4;KHDRBS3;MAGI1;SALL1;ROBO1;PTPRG;GUCY1A2;PTPRD;ENAH;GPC6;TJP1
prerank,GO_Biological_Process_2021__regulation of epithelial to mesenchymal transition (GO:0010717),0.6211379853958512,1.4064384395050025,0.03225806451612903,0.5266174788998058,1.0,19/45,15.21%,PDPN;SPRY2;TGFBR2;SMAD7;SPRED1;SPRED2;PHLDB1;USF3;DAG1;SMAD2;SMAD3;HPN;LOXL2;BCL9L;PTEN;ZNF703;FERMT2;CLASP1;TGFBR1
prerank,Reactome_2022__Prevention Of Phagosomal-Lysosomal Fusion R-HSA-9636383,-0.871588844130185,-1.4063297324915112,0.017857142857142856,0.3326653173581542,1.0,2/8,1.30%,UBC;RPS27A
prerank,PanglaoDB_Augmented_2021__Adrenergic Neurons,0.6529898125446126,1.4062460786533064,0.05555555555555555,0.5261569859817247,1.0,5/31,4.25%,HID1;FAAH;RAP1GAP;RNF208;PLPPR1
prerank,Reactome_2022__Interleukin-35 Signaling R-HSA-8984722,-0.8548544097296015,-1.4062130586248676,0.07272727272727272,0.33261549635668614,1.0,3/10,9.56%,STAT4;IL12RB2;STAT1
prerank,KEGG_2021_Human__Tyrosine metabolism,-0.8015156656260445,-1.4061490784717452,0.09523809523809523,0.3322839597393831,1.0,1/8,0.34%,IL4I1
prerank,GO_Biological_Process_2021__positive regulation of transporter activity (GO:0032411),-0.8814442728006735,-1.4060610410990155,0.038461538461538464,0.33205571178072396,1.0,2/7,7.98%,STK39;SGK1
prerank,GO_Biological_Process_2021__positive regulation of dendritic spine development (GO:0060999),0.682749837499435,1.4058022255778715,0.10256410256410256,0.5268479363109727,1.0,4/18,8.67%,DLG5;NLGN1;RELN;SHANK3
prerank,CellMarker_Augmented_2021__Endocrine cell:Pancreas,0.552099486673958,1.4053731108074714,0.038461538461538464,0.5270290426266875,1.0,18/73,14.52%,LRP4;ZNRF3;SRCIN1;NMNAT2;MTCL1;ARNT2;SPIRE2;SNAP91;RASAL2;CSPG5;MAGI1;VGF;MAGI3;ENAH;TTLL7;TJP1;PTK2;TYRO3
prerank,KEGG_2021_Human__Histidine metabolism,0.7997089526292798,1.4051036703172473,0.06818181818181818,0.5271561088190536,1.0,2/11,3.00%,CARNS1;ASPA
prerank,GO_Biological_Process_2021__positive regulation of biomineral tissue development (GO:0070169),0.7084598933176397,1.4049053164464864,0.0975609756097561,0.5266454928493955,1.0,11/22,17.67%,ATRAID;ACVR2A;TMEM119;FBN2;BMPR1B;ANO6;BMPR1A;SLC8A1;NELL1;ADGRV1;P2RX7
prerank,GO_Biological_Process_2021__positive regulation of hormone metabolic process (GO:0032352),0.9036379888389278,1.4048561474703496,0.0425531914893617,0.5256074851024332,1.0,1/5,0.03%,EGR1
prerank,GO_Biological_Process_2021__regulation of homotypic cell-cell adhesion (GO:0034110),-0.8497706453664791,-1.40482788433537,0.05,0.3355713011595966,1.0,2/10,1.65%,CCL5;PRKCQ
prerank,GO_Biological_Process_2021__regulation of innate immune response (GO:0045088),-0.6553738419350094,-1.4047445470131008,0.028985507246376812,0.3354411077774671,1.0,15/48,16.01%,CCL5;NLRC3;DHX58;CDC37;PARP9;PLSCR1;TNFAIP3;RNASEL;IRF1;TASL;ERAP1;APPL1;HLA-E;IFI35;POLR3C
prerank,GO_Biological_Process_2021__outflow tract septum morphogenesis (GO:0003148),0.7151330266033147,1.4045660302683476,0.10810810810810811,0.5252876755285565,1.0,5/16,15.51%,NRP1;TGFBR2;ROBO1;BMPR1A;ROBO2
prerank,GO_Biological_Process_2021__response to prostaglandin E (GO:0034695),-0.8904832473451054,-1.4045497406785048,0.047619047619047616,0.3358081151205105,1.0,1/5,1.03%,TGFBR3
prerank,Reactome_2022__Generation Of Second Messenger Molecules R-HSA-202433,-0.7554165755834539,-1.404354496036735,0.09433962264150944,0.335906939076603,1.0,4/21,5.49%,ITK;GRAP2;CD247;HLA-DRB5
prerank,"GO_Biological_Process_2021__mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)",-0.8400078721337932,-1.4040602626922678,0.06779661016949153,0.3362341462328137,1.0,4/9,7.47%,CYCS;UQCRB;UQCRH;UQCR10
prerank,Reactome_2022__Nonhomologous End-Joining (NHEJ) R-HSA-5693571,-0.6840314310719807,-1.4038246440461644,0.031746031746031744,0.33652237631310533,1.0,10/36,14.26%,H2BC4;H2BC26;H2BC21;POLM;H2BC5;ABRAXAS1;H2BC9;H2BC11;KAT5;BRCA1
prerank,GO_Biological_Process_2021__sterol metabolic process (GO:0016125),-0.7219724109520929,-1.4035758007711503,0.05084745762711865,0.3368477999699495,1.0,3/36,0.88%,OSBPL5;INSIG1;CH25H
prerank,GO_Biological_Process_2021__folic acid transport (GO:0015884),0.8785979296985921,1.4035095206104582,0.09523809523809523,0.5281595740622921,1.0,1/5,0.66%,PDPN
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte migration (GO:2000403),-0.7869787034135549,-1.4034628995958505,0.08333333333333333,0.3367042618930006,1.0,2/9,2.67%,CCL5;AIF1
prerank,Reactome_2022__Inflammasomes R-HSA-622312,-0.7390828663108238,-1.403078137363074,0.08333333333333333,0.3376096029111686,1.0,3/20,6.33%,PSTPIP1;AIM2;TXN2
prerank,Reactome_2022__Conversion From APC/C:Cdc20 To APC/C:Cdh1 In Late Anaphase R-HSA-176407,0.6998822354191921,1.402328430726978,0.11904761904761904,0.5318076952232564,1.0,6/14,15.48%,UBE2D1;FZR1;CDC23;ANAPC16;ANAPC1;CDC14A
prerank,GO_Biological_Process_2021__response to zinc ion (GO:0010043),-0.763968203952769,-1.4022418746905365,0.08333333333333333,0.3400387763957599,1.0,1/11,0.25%,MT2A
prerank,Reactome_2022__Chaperonin-mediated Protein Folding R-HSA-390466,0.5577104451037049,1.4022249203087702,0.05555555555555555,0.5310561296300965,1.0,9/61,11.13%,TUBA1C;RGS11;FKBP9;GNAQ;PFDN4;TCP1;SKIC2;FBXW7;GNA11
prerank,GO_Biological_Process_2021__inositol phosphate-mediated signaling (GO:0048016),0.7783237539532006,1.4020907400364317,0.13636363636363635,0.5303865059993619,1.0,7/11,18.52%,ADGRB2;NFAT5;PPP3CA;NFATC3;INPP5A;PPP3CB;NFATC2
prerank,Reactome_2022__Regulation Of BACH1 Activity R-HSA-9708530,-0.8302666463597983,-1.4018726300171642,0.05555555555555555,0.3407101859662531,1.0,2/11,1.30%,UBC;RPS27A
prerank,GO_Biological_Process_2021__regulation of establishment or maintenance of cell polarity (GO:0032878),-0.7604097564323116,-1.4016627198792675,0.04918032786885246,0.3408513879600865,1.0,3/14,9.33%,RIPOR2;RACK1;LLGL2
prerank,GO_Biological_Process_2021__negative regulation of interleukin-1 production (GO:0032692),-0.758025669135493,-1.4014792796106337,0.015384615384615385,0.34097963475492776,1.0,6/17,8.14%,CARD16;LILRB4;IGF1;GSTP1;NLRP12;TNFAIP3
prerank,CellMarker_Augmented_2021__T cell:Peripheral Blood,-0.848024089219241,-1.4013610228307836,0.08064516129032258,0.34086918107344855,1.0,3/6,3.24%,CD2;IL7R;SELL
prerank,GO_Biological_Process_2021__cytokine-mediated signaling pathway (GO:0019221),-0.5494522180791488,-1.4013111511185325,0.0,0.340583656423805,1.0,72/368,11.39%,CCL4;MT2A;MX2;STAT4;CD36;CCL3;UBC;CEBPD;OAS3;TNFRSF11B;HLA-B;MX1;RSAD2;FOS;RPS27A;CCL5;JUNB;CARD14;XAF1;IL7R;GRAP2;TRIM5;IFIT3;B2M;IFIT1;TNFRSF25;PSMB3;FCER1G;RORA;OAS2;ANXA2;DUOX1;IFITM3;AIM2;HLA-C;IL3RA;IL10RA;F13A1;LILRB4;CD300LF;HLA-DRB5;IL12RB2;TRIM22;RHOU;OSMR;PRLR;PSMB6;PSMA7;FYN;HLA-F;IFIT2;CSF2RA;TNFRSF1B;OAS1;RNASEL;CFL1;TMSB4X;CD44;GBP2;PSMB9;STAT1;EIF5A;IRF1;ITGB2;CSF2RB;HLA-DRA;RPLP0;TNFSF13B;RBX1;VEGFA;HIF1A;CSF3R
prerank,GO_Biological_Process_2021__long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),0.7152846775391235,1.400901991123221,0.17142857142857143,0.5337438018186299,1.0,2/11,8.59%,HACD2;ELOVL6
prerank,GO_Biological_Process_2021__positive regulation of mast cell activation (GO:0033005),-0.937140949010405,-1.4008970412089754,0.03571428571428571,0.3412996926068837,1.0,1/5,0.08%,NR4A3
prerank,GO_Biological_Process_2021__positive regulation of leukocyte cell-cell adhesion (GO:1903039),-0.746447692089646,-1.400873027449954,0.09523809523809523,0.3408894397700921,1.0,4/21,4.35%,NR4A3;SKAP1;PRKCQ;ETS1
prerank,Reactome_2022__RAF-independent MAPK1/3 Activation R-HSA-112409,0.7187532643492642,1.4003102525285223,0.05714285714285714,0.5351307606267949,1.0,4/16,11.38%,DUSP6;MAP2K1;DUSP7;MAPK1
prerank,GO_Biological_Process_2021__negative regulation of signaling receptor activity (GO:2000272),-0.7824924863930469,-1.4003080373728751,0.06451612903225806,0.3422143475435337,1.0,4/17,5.46%,CALCR;SNX6;CBLB;LILRB4
prerank,Reactome_2022__Paracetamol ADME R-HSA-9753281,-0.8525591662603319,-1.4002398331197043,0.07142857142857142,0.3420032890616532,1.0,3/9,6.85%,SLC38A1;ABCC3;GSTP1
prerank,CellMarker_Augmented_2021__Abnormal Plasma cell:Peripheral Blood,0.51851698814261,1.4002241844274501,0.0,0.5341443737628541,1.0,21/77,14.53%,PPARGC1A;PDZRN4;ZNF536;LARGE1;SCN3A;NDRG2;KCND3;CADM1;LRRC4C;PCDH17;PARM1;AUTS2;SLC4A4;ASXL3;PTPRD;THSD7A;NTRK2;SLC8A1;CXCL14;CNTN4;NFASC
prerank,GO_Biological_Process_2021__cardiac muscle cell action potential (GO:0086001),0.6647274770391993,1.4001374274635852,0.08823529411764706,0.5333181090768951,1.0,4/20,5.10%,KCNJ2;KCNIP2;KCND3;SCN3B
prerank,Reactome_2022__Phototransduction Cascade R-HSA-2514856,-0.8348836909462185,-1.3998592283544387,0.03278688524590164,0.3426760948115786,1.0,3/15,8.36%,PRKCQ;GNB5;CALM1
prerank,Reactome_2022__FLT3 Signaling In Disease R-HSA-9682385,-0.7625758995517556,-1.3995853332734256,0.07142857142857142,0.3431855421771341,1.0,2/23,1.30%,UBC;RPS27A
prerank,CellMarker_Augmented_2021__Epithelial cell:Bladder,-0.8413711186460558,-1.398867087731667,0.1111111111111111,0.34453474995192745,1.0,3/8,9.97%,CLDN7;OVOL2;SSH3
prerank,CellMarker_Augmented_2021__Type II pneumocyte:Undefined,-0.8413711186460558,-1.398867087731667,0.1111111111111111,0.34453474995192745,1.0,3/8,9.97%,CLDN7;OVOL2;SSH3
prerank,KEGG_2021_Human__Proteasome,-0.6679243504069968,-1.3987747825659986,0.05555555555555555,0.3443095837349473,1.0,15/39,22.96%,PSMB3;ADRM1;PSMB6;PSMA7;PSMB9;PSMD12;PSMD8;PSMA5;PSMA3;PSMC4;PSME2;PSME1;PSMB5;PSMC3;PSME3
prerank,Reactome_2022__NIK To Noncanonical NF-kB Signaling R-HSA-5676590,-0.6578532348490036,-1.3987321802010333,0.04225352112676056,0.3439244144452017,1.0,14/51,19.69%,UBC;RPS27A;PSMB3;PSMB6;PSMA7;PSMB9;PSMD12;PSMD8;PSMA5;UBA52;PSMA3;PSMC4;PSME2;PSME1
prerank,GO_Biological_Process_2021__regulation of tissue remodeling (GO:0034103),0.7915727934664191,1.3985520356472918,0.0,0.538037489276872,1.0,2/11,6.90%,LEPR;RUNX1
prerank,CellMarker_Augmented_2021__Endothelial cell:Blood,-0.6177108938905177,-1.3984830516203428,0.04,0.34447802345110373,1.0,25/90,10.77%,SRGN;GPR183;XAF1;IL7R;CD69;RGS1;CMAHP;SYNE1;CD93;ETS1;LSP1;SAMD9L;PLEK;IL10RA;PECAM1;TRIM22;SP140;NLRC5;CYTIP;TNFRSF1B;ITGA4;SAMSN1;CSF2RB;NCKAP1L;HLA-DRA
prerank,GO_Biological_Process_2021__protein-DNA covalent cross-linking repair (GO:0106300),0.8797956363967333,1.3984478867878831,0.02040816326530612,0.5370512186700083,1.0,1/5,4.47%,TEX264
prerank,KEGG_2021_Human__Cortisol synthesis and secretion,0.5922703218514634,1.3984081170368334,0.09090909090909091,0.5361466595306371,1.0,8/35,13.60%,LDLR;GNAQ;PBX1;NCEH1;PLCB4;ADCY9;GNA11;ADCY6
prerank,CellMarker_Augmented_2021__Hair Follicle cell:Hair Follicle,-0.6224016380463312,-1.398336576809237,0.043478260869565216,0.3443770737833564,1.0,23/79,10.62%,SRGN;FOSL2;ZFP36;XAF1;IL7R;MS4A4A;OAS2;CMAHP;CD93;TNFSF10;SAMD9L;PHF11;PECAM1;GBP3;DTX3L;NLRC5;CD44;GBP2;SAMD9;CFLAR;MS4A6A;IRF1;CSF2RB
prerank,GO_Biological_Process_2021__cytoplasmic pattern recognition receptor signaling pathway in response to virus (GO:0039528),-0.8212135097847454,-1.398319005191101,0.07246376811594203,0.34395647438604576,1.0,2/8,6.40%,OAS3;PHB2
prerank,GO_Biological_Process_2021__regulation of nuclease activity (GO:0032069),-0.8921741614813026,-1.3977772745697583,0.03773584905660377,0.3451959078208401,1.0,3/5,8.28%,OAS3;OAS2;OAS1
prerank,CellMarker_Augmented_2021__Platelet:Undefined,-0.7499439754997569,-1.3974510787353065,0.05660377358490566,0.3457938593929399,1.0,4/13,9.70%,CD36;PECAM1;ITGA6;CD226
prerank,GO_Biological_Process_2021__intracellular distribution of mitochondria (GO:0048312),0.8167800976484823,1.3974354882280426,0.11904761904761904,0.5392850076491278,1.0,2/5,13.10%,LRRK2;CLUH
prerank,GO_Biological_Process_2021__aorta development (GO:0035904),0.8303858898185276,1.3973717557638763,0.045454545454545456,0.5383795131117383,1.0,3/7,7.38%,PKD2;JAG1;ROBO1
prerank,"GO_Biological_Process_2021__wound healing, spreading of epidermal cells (GO:0035313)",-0.9279980275930128,-1.39726414248716,0.0196078431372549,0.34587549042636,1.0,2/5,3.99%,COL5A1;PLET1
prerank,GO_Biological_Process_2021__positive regulation of smoothened signaling pathway (GO:0045880),0.734706570226348,1.3971544376979572,0.044444444444444446,0.5384768856870598,1.0,2/9,4.51%,DLG5;STK36
prerank,GO_Biological_Process_2021__positive regulation of telomere maintenance via telomere lengthening (GO:1904358),-0.7128877008009835,-1.3971225649892873,0.029850746268656716,0.34582228159567935,1.0,2/30,1.65%,PKIB;PRKCQ
prerank,GO_Biological_Process_2021__regulation of inflammatory response to antigenic stimulus (GO:0002861),-0.6624000323795547,-1.3970922216135562,0.029850746268656716,0.3454270164083302,1.0,5/52,7.36%,CALCR;YES1;CD247;PRKAR1B;FYN
prerank,GO_Biological_Process_2021__negative regulation of transcription by RNA polymerase I (GO:0016479),-0.9092063411509524,-1.39657304583311,0.06382978723404255,0.3466072544104439,1.0,1/5,0.28%,FLNA
prerank,GO_Biological_Process_2021__negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),-0.8197553957433042,-1.3963605991755355,0.05172413793103448,0.34662640292549296,1.0,1/12,2.68%,PARP14
prerank,GO_Biological_Process_2021__negative regulation of hydrogen peroxide-induced cell death (GO:1903206),-0.8247226548204222,-1.3962684652630466,0.10526315789473684,0.3464020603814281,1.0,2/9,4.24%,NR4A3;RACK1
prerank,Reactome_2022__Dectin-1 Mediated Noncanonical NF-kB Signaling R-HSA-5607761,-0.6562169145890032,-1.3960384371057135,0.041666666666666664,0.3466888562449268,1.0,14/52,19.69%,UBC;RPS27A;PSMB3;PSMB6;PSMA7;PSMB9;PSMD12;PSMD8;PSMA5;UBA52;PSMA3;PSMC4;PSME2;PSME1
prerank,GO_Biological_Process_2021__negative regulation of lymphocyte migration (GO:2000402),-0.8281568261764043,-1.396014370172878,0.06557377049180328,0.3463800590972926,1.0,4/9,4.71%,RIPOR2;CD200R1;APOD;PADI2
prerank,GO_Biological_Process_2021__negative regulation of chromatin organization (GO:1905268),-0.8870483066965674,-1.3960137230122265,0.017857142857142856,0.3449871097979737,1.0,4/9,3.75%,H1-4;H1-3;H1-2;H1-0
prerank,GO_Biological_Process_2021__negative regulation of gene silencing (GO:0060969),-0.8870483066965674,-1.3960137230122265,0.017857142857142856,0.3449871097979737,1.0,4/9,3.75%,H1-4;H1-3;H1-2;H1-0
prerank,GO_Biological_Process_2021__negative regulation of chromatin silencing (GO:0031936),-0.8870483066965674,-1.3960137230122265,0.017857142857142856,0.3449871097979737,1.0,4/9,3.75%,H1-4;H1-3;H1-2;H1-0
prerank,CellMarker_Augmented_2021__Neutrophil:Spleen,-0.6674230326526495,-1.3958669210974866,0.041666666666666664,0.3448002260314134,1.0,17/49,14.64%,MNDA;CLEC12A;AIF1;FCER1G;BTK;NCF4;TSPAN32;PLEK;CD300LF;SIRPB2;OSCAR;CSF2RB;TYROBP;CSF3R;MYO1F;C19ORF38;LY86
prerank,CellMarker_Augmented_2021__Neutrophil:Brain,-0.6674230326526495,-1.3958669210974866,0.041666666666666664,0.3448002260314134,1.0,17/49,14.64%,MNDA;CLEC12A;AIF1;FCER1G;BTK;NCF4;TSPAN32;PLEK;CD300LF;SIRPB2;OSCAR;CSF2RB;TYROBP;CSF3R;MYO1F;C19ORF38;LY86
prerank,Reactome_2022__SHC1 Events In ERBB4 Signaling R-HSA-1250347,0.7960811556042819,1.3958578273180933,0.044444444444444446,0.542330609835639,1.0,4/8,14.14%,NRG1;NRG3;NRG2;ERBB4
prerank,"Reactome_2022__Inactivation, Recovery And Regulation Of Phototransduction Cascade R-HSA-2514859",-0.8349103486726102,-1.3956976730984325,0.03278688524590164,0.34488176685111793,1.0,3/14,8.36%,PRKCQ;GNB5;CALM1
prerank,Reactome_2022__Fatty acyl-CoA Biosynthesis R-HSA-75105,0.5939775590689692,1.395509080583958,0.07142857142857142,0.5424954117331012,1.0,6/23,20.80%,PPT1;HACD2;ELOVL6;FASN;ACACA;SCD5
prerank,GO_Biological_Process_2021__positive regulation of release of cytochrome c from mitochondria (GO:0090200),-0.7107421055941878,-1.3951471464594514,0.10606060606060606,0.3462498620834201,1.0,5/18,18.04%,TNFSF10;PDCD5;BMF;PINK1;FAM162A
prerank,GO_Biological_Process_2021__regulation of B cell proliferation (GO:0030888),-0.6960073364201373,-1.3949901958247632,0.06944444444444445,0.34631724558410987,1.0,9/28,12.82%,TFRC;MNDA;GPR183;VAV3;IKZF3;NCKAP1L;TNFSF13B;TYROBP;PTPRC
prerank,GO_Biological_Process_2021__axon regeneration (GO:0031103),-0.8985566564703911,-1.394787144664293,0.03636363636363636,0.34644441948033416,1.0,1/7,4.08%,APOD
prerank,GO_Biological_Process_2021__response to interleukin-1 (GO:0070555),-0.6842234743668126,-1.394740783787836,0.04477611940298507,0.3461999378077123,1.0,3/40,1.49%,CCL4;CCL3;CCL5
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, preincision complex assembly (GO:0006294)",-0.7018353607609173,-1.3947072829426526,0.046153846153846156,0.3459441425203113,1.0,4/25,4.34%,UBC;RPS27A;XPA;GTF2H5
prerank,GO_Biological_Process_2021__macromolecule biosynthetic process (GO:0009059),-0.8883623045688486,-1.3944419343109369,0.09259259259259259,0.34644163943232886,1.0,3/5,10.20%,COL5A1;RPS23;SLC11A1
prerank,Reactome_2022__p75NTR Signals Via NF-kB R-HSA-193639,-0.7943598230428547,-1.3941622290301534,0.10606060606060606,0.3468543069844988,1.0,2/14,1.30%,UBC;RPS27A
prerank,GO_Biological_Process_2021__positive regulation of T cell cytokine production (GO:0002726),-0.795128350904293,-1.393842255989515,0.07407407407407407,0.3475518370970701,1.0,3/15,2.81%,RSAD2;CD55;B2M
prerank,GO_Biological_Process_2021__response to X-ray (GO:0010165),0.7515019138389553,1.3937676962674113,0.09523809523809523,0.5474431008955534,1.0,5/13,18.27%,ANXA1;LIG4;NIPBL;BLM;IKBIP
prerank,GO_Biological_Process_2021__positive regulation of extracellular matrix organization (GO:1903055),0.7389412298023168,1.3937467034902036,0.06666666666666667,0.5464027500966219,1.0,3/11,6.90%,PDPN;SMAD3;RUNX1
prerank,Reactome_2022__Triglyceride Metabolism R-HSA-8979227,-0.7675808157133868,-1.3935209170032505,0.08620689655172414,0.3483189206570118,1.0,3/15,11.17%,MGLL;PPP1CB;GK
prerank,Reactome_2022__Inhibition Of DNA Recombination At Telomere R-HSA-9670095,-0.7189104391781285,-1.393167234318048,0.078125,0.348810666889471,1.0,12/27,12.68%,H2BC4;H2BC26;H2AC20;H2AC6;H3-3B;H2AJ;H2BC21;POLR2G;H2BC5;H2BC9;TERF2IP;H2BC11
prerank,Reactome_2022__Reproduction R-HSA-1474165,-0.647861934299387,-1.3930781791185922,0.1095890410958904,0.3487314709125604,1.0,14/55,9.35%,SYCE2;H2BC4;H2BC26;H2AC20;SYNE2;H2AC6;STAG3;SYNE1;H3-3B;H2AJ;H2BC21;BRCA2;H2BC5;H2BC9
prerank,GO_Biological_Process_2021__positive regulation of bone mineralization (GO:0030501),0.7112817914850669,1.3926903771272836,0.09523809523809523,0.549217704009956,1.0,11/21,17.67%,ATRAID;ACVR2A;TMEM119;FBN2;BMPR1B;ANO6;BMPR1A;SLC8A1;NELL1;ADGRV1;P2RX7
prerank,Reactome_2022__Downregulation Of ERBB4 Signaling R-HSA-1253288,-0.8718859676814774,-1.3925182478648555,0.017543859649122806,0.3501695486409106,1.0,2/9,1.30%,UBC;RPS27A
prerank,GO_Biological_Process_2021__negative regulation of proteolysis (GO:0045861),0.684316577505164,1.3924920542591166,0.075,0.5488352746787525,1.0,5/18,13.44%,SERPINE2;LRRK2;TIMP3;SNX12;BAG6
prerank,GO_Biological_Process_2021__regulation of ERK1 and ERK2 cascade (GO:0070372),-0.5796431580979199,-1.3924858561149198,0.05063291139240506,0.3498638833218973,1.0,20/136,9.28%,CCL4;CALCR;CD36;CCL3;APIP;TGFBR3;CCL5;GPR183;PDGFD;MARCO;EPHB1;GLIPR2;SEMA6A;PHB2;GSTP1;C5AR1;MAP3K12;PRKD2;CD44;CHI3L1
prerank,Reactome_2022__Effects Of PIP2 Hydrolysis R-HSA-114508,-0.7437655602120119,-1.392378225579799,0.04918032786885246,0.34975997635379524,1.0,2/21,2.02%,PRKCQ;MGLL
prerank,GO_Biological_Process_2021__glutamine metabolic process (GO:0006541),-0.8555021637830689,-1.3922345367578262,0.03225806451612903,0.34980981335099287,1.0,2/7,5.41%,NIT2;GLUL
prerank,GO_Biological_Process_2021__negative regulation of MyD88-independent toll-like receptor signaling pathway (GO:0034128),-0.9108214404093116,-1.3921788679989724,0.02040816326530612,0.34945865654922426,1.0,1/5,3.07%,CD14
prerank,Reactome_2022__Signaling To RAS R-HSA-167044,0.6886012294779692,1.3918237641981817,0.05714285714285714,0.5505985763388122,1.0,4/14,19.04%,MAPK11;SHC2;MAPKAPK2;RALA
prerank,GO_Biological_Process_2021__response to growth factor (GO:0070848),0.6369853657988239,1.391612206437713,0.07894736842105263,0.5503406662080876,1.0,4/26,6.06%,KLF4;ACVR2A;TGFBR2;CIB1
prerank,Reactome_2022__Apoptosis R-HSA-109581,-0.5745791308842487,-1.3907110089367154,0.036585365853658534,0.3539831471019108,1.0,13/144,4.62%,H1-4;H1-3;UBC;H1-2;APIP;CYCS;RPS27A;PRKCQ;PSMB3;GZMB;H1-0;NDUFA2;TNFSF10
prerank,GO_Biological_Process_2021__DNA methylation (GO:0006306),-0.7576383593566326,-1.3906508774440614,0.09836065573770492,0.3536274648501457,1.0,3/16,14.27%,FOS;DNMT1;PICK1
prerank,GO_Biological_Process_2021__negative regulation of mitochondrion organization (GO:0010823),-0.7279464158337865,-1.3905886724464886,0.04918032786885246,0.3533784052865335,1.0,5/20,5.57%,TFRC;PRELID1;CLU;IGF1;SLC25A5
prerank,GO_Biological_Process_2021__regulation of G1/S transition of mitotic cell cycle (GO:2000045),0.5987207202336788,1.3904424035467777,0.03225806451612903,0.5540019155797263,1.0,5/48,5.15%,KLF4;ANXA1;PKD2;PKD1;UBE2E2
prerank,Reactome_2022__SIRT1 Negatively Regulates rRNA Expression R-HSA-427359,-0.7836146511338304,-1.3901385624998586,0.015625,0.3544201588528055,1.0,12/19,13.01%,H2BC4;H2BC26;H2AC20;H2AC6;TAF1D;H3-3B;H2AJ;H2BC21;H2BC5;H2BC9;H2BC11;TAF1C
prerank,KEGG_2021_Human__Adipocytokine signaling pathway,0.5588714868489612,1.390044524794931,0.07142857142857142,0.5545397694561971,1.0,5/50,1.53%,PRKAB2;LEPR;PPARGC1A;CPT1C;ADIPOR2
prerank,Reactome_2022__SLC Transporter Disorders R-HSA-5619102,0.5272378274908859,1.3899634905311495,0.0,0.5537749042253044,1.0,20/55,22.62%,SLC1A3;SLC3A2;NUP153;NUP188;NUP42;MAP4K5;SLC12A6;SLC4A4;SLC9A9;SLC40A1;SLC26A3;NDC1;NUP133;SLC9A7;NUP205;MAP4K2;SLC7A7;SLC17A5;NUP98;SLC11A2
prerank,GO_Biological_Process_2021__cell differentiation in hindbrain (GO:0021533),0.8152102903426954,1.3898071414826447,0.023255813953488372,0.5532129494356174,1.0,2/7,9.53%,GRID2;KNDC1
prerank,GO_Biological_Process_2021__membrane fusion (GO:0061025),-0.7571392234263133,-1.3896380506147756,0.034482758620689655,0.35562319618181615,1.0,4/28,6.51%,MX2;MX1;RIMS1;NAPA
prerank,GO_Biological_Process_2021__DNA-dependent DNA replication (GO:0006261),-0.5788623849426862,-1.3895289102109452,0.0375,0.3555128974405428,1.0,29/99,22.17%,UBC;RPS27A;PSMB3;POLE3;PSMB6;PSMA7;PSMB9;PSMD12;PSMD8;PSMA5;DDX23;MCM7;RPA3;UBA52;RECQL5;RFC1;PSMA3;MGME1;PSMC4;WRN;PSME2;PSME1;PRIM1;MCM6;PSMB5;POLG;PSMC3;CDC7;MCM5
prerank,KEGG_2021_Human__Other types of O-glycan biosynthesis,0.6109835613445038,1.389482908827621,0.18181818181818182,0.5534751300574736,1.0,13/32,15.84%,MFNG;RFNG;ST6GAL2;GALNT13;GALNTL6;POGLUT1;C1GALT1;GALNT7;GXYLT1;GALNT1;EOGT;GALNT2;GALNT17
prerank,GO_Biological_Process_2021__chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),0.6466179523046878,1.3894725791858302,0.03125,0.5523695563091485,1.0,6/19,9.98%,NCAN;CHST7;CSGALNACT1;UGDH;CSPG5;CHST15
prerank,Reactome_2022__Diseases Of Mitotic Cell Cycle R-HSA-9675126,0.6304134952357285,1.389305138487916,0.07142857142857142,0.551838973632191,1.0,8/26,15.55%,UBE2D1;E2F3;FZR1;CDC23;ANAPC16;CDK6;ANAPC1;CCND3
prerank,GO_Biological_Process_2021__positive regulation of cellular extravasation (GO:0002693),-0.8694610671414429,-1.3890853088427053,0.125,0.35664130343978956,1.0,1/7,0.96%,RIPOR2
prerank,GO_Biological_Process_2021__regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),-0.8383400550408058,-1.388798959937696,0.078125,0.3569500240131562,1.0,2/8,4.08%,CBLB;APOD
prerank,CellMarker_Augmented_2021__Hematopoietic Stem cell:Bone Marrow,-0.7101730442882281,-1.3887370589086567,0.08333333333333333,0.35668694942283863,1.0,8/25,8.71%,PROCR;CXCR4;IL7R;CD93;ABCB1;PECAM1;ITGA6;CD44
prerank,GO_Biological_Process_2021__regulation of protein kinase A signaling (GO:0010738),-0.7805889197771205,-1.3885283031482307,0.10204081632653061,0.3568318827812747,1.0,2/12,6.63%,CALCR;PRKAR1B
prerank,GO_Biological_Process_2021__DNA alkylation (GO:0006305),-0.7739737243212567,-1.3884694371463673,0.0967741935483871,0.35614555692826416,1.0,1/14,1.22%,FOS
prerank,GO_Biological_Process_2021__DNA methylation or demethylation (GO:0044728),-0.7739737243212567,-1.3884694371463673,0.0967741935483871,0.35614555692826416,1.0,1/14,1.22%,FOS
prerank,Reactome_2022__ISG15 Antiviral Mechanism R-HSA-1169408,-0.6030469755236654,-1.388002145694081,0.07142857142857142,0.3572644473806173,1.0,9/66,10.95%,MX2;UBC;MX1;RPS27A;IFIT1;EIF2AK2;EIF4A3;STAT1;NUP50
prerank,GO_Biological_Process_2021__regulation of transcription regulatory region DNA binding (GO:2000677),-0.7855253689602372,-1.3878337078308973,0.10344827586206896,0.35744262984723635,1.0,3/12,5.56%,PER2;H1-0;IGF1
prerank,GO_Biological_Process_2021__positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),0.7262557648621488,1.3877826769722572,0.08823529411764706,0.557817900910305,1.0,5/15,15.21%,ACVR2A;GDF11;BMPR1A;TWSG1;TGFBR1
prerank,GO_Biological_Process_2021__organophosphate catabolic process (GO:0046434),-0.8972639746237188,-1.3872199464747035,0.017857142857142856,0.3590310866208866,1.0,2/5,8.11%,LIPG;ENPP2
prerank,GO_Biological_Process_2021__mesonephric tubule development (GO:0072164),0.8087705823486071,1.3871017997056452,0.08333333333333333,0.5594013634891771,1.0,3/6,7.23%,PKD2;PKD1;SALL1
prerank,Reactome_2022__Cooperation Of Prefoldin And TriC/CCT In Actin And Tubulin Folding R-HSA-389958,0.642593991653952,1.3869277346562852,0.06451612903225806,0.5587853662218559,1.0,3/23,6.90%,TUBA1C;PFDN4;TCP1
prerank,Reactome_2022__Transcription-Coupled Nucleotide Excision Repair (TC-NER) R-HSA-6781827,-0.6171089228665171,-1.3868145084145131,0.04225352112676056,0.3597724304336916,1.0,9/63,7.16%,UBC;PPIE;RPS27A;XPA;COPS6;POLE3;UVSSA;GTF2H5;POLR2G
prerank,Reactome_2022__SUMOylation Of Transcription Cofactors R-HSA-3899300,0.6116888623665088,1.3867276953706298,0.07692307692307693,0.5585899271114857,1.0,4/37,4.06%,PPARGC1A;RNF2;UHRF2;NRIP1
prerank,GO_Biological_Process_2021__positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034),-0.7485831210900629,-1.3865982887076544,0.13725490196078433,0.3599813235860051,1.0,2/11,6.59%,DTX3L;PARP9
prerank,GO_Biological_Process_2021__regulation of calcium ion-dependent exocytosis (GO:0017158),0.7176310964796989,1.3865491971478832,0.06666666666666667,0.558174504320993,1.0,5/15,19.97%,DOC2A;STX1A;SYT17;KCNB1;SYT4
prerank,PanglaoDB_Augmented_2021__GABAergic Neurons,0.531343733251855,1.3863852141526658,0.047619047619047616,0.557418071689773,1.0,27/80,17.15%,CNTN2;NCAN;GFAP;ZNF536;SNAP91;PLPPR4;PARM1;CHST1;KCTD16;CA10;OLFM3;KCNC2;CADM2;PSD2;GRM5;SNCB;PTPN5;RBFOX1;NTRK2;ABCC8;GRIA2;GAD1;PPFIA2;NKAIN2;ADGRB3;MAPK4;NXPH1
prerank,CellMarker_Augmented_2021__Pancreatic Stem cell:Pancreas,0.5400743550012639,1.3862386403098814,0.07692307692307693,0.5567869666659968,1.0,31/58,24.55%,ESRRG;GRID2;ST6GAL2;PBX1;PLEKHA5;GRIA4;PREX2;ASXL3;HIF3A;PTPN5;PTPRD;SLC35F1;RUNX1T1;CSRNP3;ROBO2;KALRN;DAB1;FGFR2;DCLK1;UNC5D;TMEM132B;MEGF10;CNTNAP2;NRXN1;LSAMP;RAB3C;SEMA6D;SNCAIP;MAGI2;COL14A1;CADPS
prerank,GO_Biological_Process_2021__response to unfolded protein (GO:0006986),0.5605779236226921,1.385999564057069,0.0975609756097561,0.5568899048032611,1.0,9/38,17.42%,BAG3;DNAJB2;DDIT3;STT3B;HSPA14;ERP44;HSPD1;TM7SF3;HSPH1
prerank,GO_Biological_Process_2021__negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),-0.7960039963748571,-1.3859763036691253,0.1111111111111111,0.36165260458321813,1.0,2/8,3.88%,SNX6;CBLB
prerank,GO_Biological_Process_2021__granulocyte differentiation (GO:0030851),0.759958405303036,1.3856645914373968,0.08333333333333333,0.5569924131361945,1.0,1/11,3.96%,CBFA2T3
prerank,CellMarker_Augmented_2021__EBV+ B Lymphoma cell:Lymph,0.5691891022609301,1.3856641139223913,0.047619047619047616,0.5535256553780854,1.0,38/84,24.12%,GOLM1;ZSWIM4;ZNF787;PICALM;UBTD2;ARAP3;LASP1;PLXNB2;IL13RA1;CANT1;YWHAG;CTBP2;SNX12;KPNA4;RNF19B;MPZL1;BAG6;YKT6;GPR107;SMURF1;CCNYL1;NACC1;ZFAND3;PLCB3;PTPN12;B4GALT5;YTHDF1;STK35;MBOAT7;GNS;LAMP1;SBNO2;TTYH3;RCOR1;KPNB1;PHC2;OXSR1;PGD
prerank,CellMarker_Augmented_2021__EBV+ B Lymphoma cell:Liver,0.5691891022609301,1.3856641139223913,0.047619047619047616,0.5535256553780854,1.0,38/84,24.12%,GOLM1;ZSWIM4;ZNF787;PICALM;UBTD2;ARAP3;LASP1;PLXNB2;IL13RA1;CANT1;YWHAG;CTBP2;SNX12;KPNA4;RNF19B;MPZL1;BAG6;YKT6;GPR107;SMURF1;CCNYL1;NACC1;ZFAND3;PLCB3;PTPN12;B4GALT5;YTHDF1;STK35;MBOAT7;GNS;LAMP1;SBNO2;TTYH3;RCOR1;KPNB1;PHC2;OXSR1;PGD
prerank,CellMarker_Augmented_2021__EBV+ B Lymphoma cell:Kidney,0.5691891022609301,1.3856641139223913,0.047619047619047616,0.5535256553780854,1.0,38/84,24.12%,GOLM1;ZSWIM4;ZNF787;PICALM;UBTD2;ARAP3;LASP1;PLXNB2;IL13RA1;CANT1;YWHAG;CTBP2;SNX12;KPNA4;RNF19B;MPZL1;BAG6;YKT6;GPR107;SMURF1;CCNYL1;NACC1;ZFAND3;PLCB3;PTPN12;B4GALT5;YTHDF1;STK35;MBOAT7;GNS;LAMP1;SBNO2;TTYH3;RCOR1;KPNB1;PHC2;OXSR1;PGD
prerank,GO_Biological_Process_2021__sensory perception of chemical stimulus (GO:0007606),-0.8231268850067781,-1.385606571357363,0.11864406779661017,0.36241077659548304,1.0,2/10,6.88%,CD36;C5AR1
prerank,GO_Biological_Process_2021__aromatic amino acid family catabolic process (GO:0009074),-0.8680639635191718,-1.3853595131166507,0.12727272727272726,0.36259253104283334,1.0,2/6,5.45%,IL4I1;KMO
prerank,Reactome_2022__RHOD GTPase Cycle R-HSA-9013405,0.577733651522685,1.3852385221843704,0.058823529411764705,0.5540927064632941,1.0,5/39,9.38%,VAPB;PLXNB1;TMPO;RAB7A;LEMD3
prerank,GO_Biological_Process_2021__positive regulation of B cell activation (GO:0050871),-0.708905385795707,-1.3847488452895123,0.08064516129032258,0.3639787085492366,1.0,9/34,15.77%,TFRC;GPR183;VAV3;BTK;NCKAP1L;TNFSF13B;PTPRC;NOD2;CD74
prerank,Reactome_2022__NRIF Signals Cell Death From Nucleus R-HSA-205043,-0.8021537979909377,-1.3844460427333731,0.11475409836065574,0.36471957427320234,1.0,2/12,1.30%,UBC;RPS27A
prerank,Reactome_2022__Release Of Apoptotic Factors From Mitochondria R-HSA-111457,-0.917625098905023,-1.3843862754680913,0.05,0.36437119193134127,1.0,1/5,1.08%,CYCS
prerank,PanglaoDB_Augmented_2021__Purkinje Fiber Cells,0.5117664371179674,1.384254418763331,0.030303030303030304,0.5567762653981384,1.0,38/79,22.69%,KCNQ2;CPT1C;CNTN2;GRID2;NCAN;SNAP91;SCN3B;PCDH17;PURG;NTM;GRIA4;CTNNA2;GRIA1;ASXL3;GUCY1A2;PTPN5;PTPRD;SLC35F1;RUNX1T1;RBFOX1;GRIA2;NFASC;CSRNP3;ROBO2;ADGRB3;MAPK4;PNMA2;CRMP1;DCLK1;CNTN1;UNC5D;TMEM132B;NOVA1;CACNA1B;NRXN1;LSAMP;RAB3C;OPCML
prerank,GO_Biological_Process_2021__GTP metabolic process (GO:0046039),0.7192097955110845,1.3842216523347541,0.07894736842105263,0.5557724423440928,1.0,4/12,13.57%,EFL1;LRRK2;MFN1;AK3
prerank,GO_Biological_Process_2021__phosphatidylethanolamine biosynthetic process (GO:0006646),0.8505538071372474,1.3841727476979542,0.06976744186046512,0.5548446865497201,1.0,3/9,10.72%,ETNPPL;CHKA;SELENOI
prerank,KEGG_2021_Human__Tight junction,0.47693558193212854,1.3841412077798065,0.045454545454545456,0.5537293046075187,1.0,17/109,13.64%,PRKAB2;TUBA1C;SCRIB;MSN;AMOT;RAP1A;VASP;MAGI1;RUNX1;PPP2R1B;NEDD4L;AFDN;TJP1;PRKCI;JAM2;PRKAB1;JUN
prerank,CellMarker_Augmented_2021__Lake Et al.Science.Ex4:Brain,0.8804222990849899,1.3840702042785058,0.0625,0.5528095378486486,1.0,1/5,0.34%,ANXA1
prerank,GO_Biological_Process_2021__neuron projection fasciculation (GO:0106030),0.7474851157715636,1.383837269635142,0.13333333333333333,0.5525131560215923,1.0,4/9,14.50%,CDK5R1;SEMA5A;RTN4;CNTN4
prerank,GO_Biological_Process_2021__regulation of osteoclast differentiation (GO:0045670),-0.7256410870469714,-1.383708361472342,0.03333333333333333,0.3659670423851171,1.0,4/19,9.06%,CCL3;LILRB4;GPR137B;LILRB3
prerank,GO_Biological_Process_2021__homologous chromosome pairing at meiosis (GO:0007129),-0.7980548092343088,-1.3835166333462419,0.09836065573770492,0.3661773958813783,1.0,4/11,9.53%,SYCE2;STAG3;MEI4;IHO1
prerank,Reactome_2022__Pexophagy R-HSA-9664873,-0.7771708432212553,-1.3834411147483072,0.1509433962264151,0.3659197123467572,1.0,2/11,1.30%,UBC;RPS27A
prerank,Reactome_2022__Peptide Hormone Metabolism R-HSA-2980736,0.5916058916666128,1.3833290659466482,0.10344827586206896,0.5532406538550535,1.0,3/40,2.76%,KLF4;PLA2G7;EXOC8
prerank,GO_Biological_Process_2021__adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),-0.6771680240010653,-1.3832924439647176,0.11428571428571428,0.3660043245617942,1.0,3/42,1.54%,CALCR;ADGRE1;ADGRD1
prerank,CellMarker_Augmented_2021__B cell:Salivary Gland,-0.6992191662107076,-1.3830821251948775,0.08695652173913043,0.36515640026504215,1.0,14/43,7.88%,JAML;CD37;MNDA;PYHIN1;VNN2;IKZF3;SELL;PRF1;SLAMF6;SNX20;LSP1;PLEK;SP140;CYTIP
prerank,CellMarker_Augmented_2021__B cell:Brain,-0.6992191662107076,-1.3830821251948775,0.08695652173913043,0.36515640026504215,1.0,14/43,7.88%,JAML;CD37;MNDA;PYHIN1;VNN2;IKZF3;SELL;PRF1;SLAMF6;SNX20;LSP1;PLEK;SP140;CYTIP
prerank,CellMarker_Augmented_2021__B cell:Synovium,-0.6992191662107076,-1.3830821251948775,0.08695652173913043,0.36515640026504215,1.0,14/43,7.88%,JAML;CD37;MNDA;PYHIN1;VNN2;IKZF3;SELL;PRF1;SLAMF6;SNX20;LSP1;PLEK;SP140;CYTIP
prerank,GO_Biological_Process_2021__embryonic hemopoiesis (GO:0035162),0.7995245733609658,1.382963355168822,0.1,0.5536566387664441,1.0,2/8,7.17%,TGFBR2;KITLG
prerank,KEGG_2021_Human__Oxidative phosphorylation,-0.6085506508414072,-1.3827808213735011,0.05,0.3655361506890327,1.0,30/83,18.76%,COX7C;UQCRB;NDUFC1;NDUFA2;UQCRH;NDUFA1;ATP6V1F;NDUFB9;ATP5PD;NDUFA12;ATP5F1E;NDUFB4;UQCR10;COX4I1;COX5B;NDUFB1;NDUFS8;ATP5ME;NDUFS5;COX7A2;COX6C;NDUFS6;NDUFB7;UQCRC1;NDUFB3;UQCRQ;ATP5F1C;NDUFS7;NDUFA3;ATP5F1D
prerank,Reactome_2022__Glycogen Metabolism R-HSA-8982491,-0.7747685387402726,-1.3827469586518948,0.06451612903225806,0.3651340942194647,1.0,4/18,8.36%,UBC;RPS27A;PHKG1;CALM1
prerank,GO_Biological_Process_2021__negative regulation of calcium ion transmembrane transport (GO:1903170),-0.9109825736497689,-1.382695426578491,0.0784313725490196,0.36484607083489146,1.0,1/6,0.73%,PLN
prerank,GO_Biological_Process_2021__negative regulation of bone mineralization (GO:0030502),-0.8864648559444156,-1.3825150473604058,0.061224489795918366,0.36485226672175075,1.0,2/7,0.93%,CCL3;SRGN
prerank,Reactome_2022__2-LTR Circle Formation R-HSA-164843,0.7779531055923424,1.3824252773233088,0.08333333333333333,0.5549710137117543,1.0,3/8,14.26%,LIG4;HMGA1;SGIP1
prerank,Reactome_2022__Triglyceride Catabolism R-HSA-163560,-0.7996157478965504,-1.3821002657667174,0.07017543859649122,0.3655687271438756,1.0,2/10,7.67%,MGLL;PPP1CB
prerank,GO_Biological_Process_2021__regulation of cell cycle checkpoint (GO:1901976),0.787865084658266,1.3817582679384088,0.14285714285714285,0.5568710139462144,1.0,2/6,18.66%,FEM1B;RFWD3
prerank,GO_Biological_Process_2021__Fc receptor signaling pathway (GO:0038093),-0.6025248330850042,-1.381573473654648,0.027777777777777776,0.3669590113019254,1.0,12/96,9.00%,ITK;FOS;PRKCQ;GRAP2;VAV3;PSMB3;FCER1G;BTK;PSMB6;PSMA7;CALM1;PSMB9
prerank,Reactome_2022__Hh Mutants Are Degraded By ERAD R-HSA-5362768,-0.6551478823194518,-1.3815316941525073,0.0641025641025641,0.3666139181318316,1.0,14/47,19.69%,UBC;RPS27A;PSMB3;PSMB6;PSMA7;PSMB9;PSMD12;PSMD8;PSMA5;UBA52;PSMA3;PSMC4;PSME2;PSME1
prerank,GO_Biological_Process_2021__histone H3-K36 methylation (GO:0010452),0.8200563652129532,1.3815246663083516,0.1111111111111111,0.5567581338977389,1.0,3/5,14.78%,SETD3;SETD2;SETD5
prerank,GO_Biological_Process_2021__positive regulation of ubiquitin protein ligase activity (GO:1904668),0.7829124209308309,1.3815170664949168,0.13333333333333333,0.5556333699908748,1.0,4/8,11.81%,FZR1;CDC14B;BTRC;PTEN
prerank,Reactome_2022__Endosomal Sorting Complex Required For Transport (ESCRT) R-HSA-917729,-0.7112945441567194,-1.3812636684024997,0.09836065573770492,0.36689868573895523,1.0,7/27,16.16%,UBC;RPS27A;SNF8;VPS28;VPS37B;UBA52;MVB12A
prerank,GO_Biological_Process_2021__phospholipid dephosphorylation (GO:0046839),0.5997535594560817,1.3811186028760574,0.06451612903225806,0.5560168421575269,1.0,7/28,17.59%,PLPPR1;PLPP1;PLPP5;PLPPR4;PTEN;MTMR9;PIP4P2
prerank,GO_Biological_Process_2021__acute-phase response (GO:0006953),-0.9087783510677667,-1.3809783096926693,0.03571428571428571,0.3674519816521906,1.0,2/5,7.40%,SIGIRR;PLSCR1
prerank,GO_Biological_Process_2021__positive regulation of growth (GO:0045927),0.5447658424400782,1.3807027959805747,0.13043478260869565,0.5563987711766268,1.0,12/48,22.55%,CDKN2AIP;CIB1;HPN;TAF9B;MMP14;TGFBR1;MTPN;DDX3X;PPM1F;CSNK2A1;MFSD2A;ADAM10
prerank,CellMarker_Augmented_2021__M2 macrophage:Peripheral Blood,-0.8666722272896449,-1.3804117328540138,0.08333333333333333,0.36919155442303164,1.0,4/8,4.62%,CD36;CXCR4;CD14;TNFSF10
prerank,GO_Biological_Process_2021__positive regulation of telomere maintenance via telomerase (GO:0032212),-0.720137230855054,-1.3802396344262333,0.03125,0.36929301830641925,1.0,2/28,1.65%,PKIB;PRKCQ
prerank,GO_Biological_Process_2021__peptidyl-lysine monomethylation (GO:0018026),0.7478125533807212,1.3800015144653168,0.075,0.5583470310164198,1.0,4/9,15.35%,SETD7;SETD3;SETD2;SETD4
prerank,GO_Biological_Process_2021__vascular endothelial growth factor signaling pathway (GO:0038084),0.7625608474791765,1.3799703102559338,0.061224489795918366,0.5573215153686728,1.0,2/8,2.61%,NRP1;GAB1
prerank,Reactome_2022__PTK6 Regulates RTKs And Their Effectors AKT1 And DOK1 R-HSA-8849469,-0.8941419303784618,-1.3795732198936308,0.045454545454545456,0.3708695276489613,1.0,2/8,1.30%,UBC;RPS27A
prerank,GO_Biological_Process_2021__interstrand cross-link repair (GO:0036297),-0.6827485617651845,-1.3794519042891822,0.1095890410958904,0.3708235491108818,1.0,9/35,14.82%,UBC;RPS27A;XPA;MUS81;XRCC3;WDR48;RPA3;FANCB;UBA52
prerank,GO_Biological_Process_2021__regulation of lens fiber cell differentiation (GO:1902746),0.8954066112815677,1.3793747809211727,0.07017543859649122,0.5588639115370021,1.0,4/5,3.94%,SPRY2;FGF2;SPRED1;SPRED2
prerank,GO_Biological_Process_2021__3'-UTR-mediated mRNA destabilization (GO:0061158),-0.8481292143110679,-1.3791103723751,0.08196721311475409,0.3712793830042811,1.0,1/11,1.48%,ZFP36
prerank,CellMarker_Augmented_2021__Langerhans cell:Skin,-0.623198071337959,-1.3789253990298973,0.0625,0.3712998225835508,1.0,26/56,19.56%,JAML;MNDA;MS4A4A;AIF1;SIGLEC1;FCER1G;LSP1;IL10RA;F13A1;CD300LF;MS4A6A;CSF2RB;HLA-DRA;TYROBP;NOD2;LY86;HLA-DPA1;ADAP2;HLA-DMB;IGSF6;HLA-DPB1;FOLR2;HLA-DRB1;RNASE6;ARHGAP30;MPEG1
prerank,GO_Biological_Process_2021__positive regulation of reactive oxygen species biosynthetic process (GO:1903428),-0.890564205372392,-1.3788763366237333,0.03571428571428571,0.3709754493703331,1.0,1/5,0.52%,CD36
prerank,Reactome_2022__Binding And Uptake Of Ligands By Scavenger Receptors R-HSA-2173782,-0.7064706095114419,-1.3787690537654973,0.12698412698412698,0.3708295978426391,1.0,3/19,2.39%,CD36;FTH1;MARCO
prerank,GO_Biological_Process_2021__positive regulation of interleukin-17 production (GO:0032740),-0.8138101185387543,-1.3786947335429163,0.09836065573770492,0.37069519912176424,1.0,3/12,4.14%,SLC7A5;PRKCQ;SLAMF6
prerank,GO_Biological_Process_2021__response to iron ion (GO:0010039),-0.8060765152174668,-1.3783198093722342,0.0967741935483871,0.371480802114896,1.0,3/9,11.34%,HAMP;B2M;HIF1A
prerank,GO_Biological_Process_2021__regulation of fertilization (GO:0080154),0.8801590244473875,1.3781760879628682,0.06521739130434782,0.5630518861628095,1.0,1/5,0.84%,LHFPL2
prerank,GO_Biological_Process_2021__coenzyme A metabolic process (GO:0015936),0.7973486796731362,1.3780574836155661,0.06666666666666667,0.5622088429002778,1.0,2/12,4.53%,PANK3;PANK1
prerank,Reactome_2022__Negative Regulation Of FLT3 R-HSA-9706369,-0.8708447054662046,-1.3780133616369403,0.03389830508474576,0.37220914332835936,1.0,2/11,1.30%,UBC;RPS27A
prerank,Reactome_2022__Metabolic Disorders Of Biological Oxidation Enzymes R-HSA-5579029,0.7002496256998735,1.3776067547628676,0.13953488372093023,0.5629214312347012,1.0,2/13,1.41%,AHCY;GCLC
prerank,GO_Biological_Process_2021__global genome nucleotide-excision repair (GO:0070911),-0.7233533448843719,-1.3770565173800953,0.078125,0.3750137050671205,1.0,4/23,4.34%,UBC;RPS27A;XPA;GTF2H5
prerank,Reactome_2022__Hydrolysis Of LPC R-HSA-1483115,0.9286111233012441,1.3770128961008863,0.020833333333333332,0.5641861290137177,1.0,1/5,0.68%,PLA2G4C
prerank,Reactome_2022__MTOR Signaling R-HSA-165159,0.6171408069213774,1.3769105136387203,0.11538461538461539,0.5635073840716223,1.0,4/34,7.11%,PRKAB2;RRAGD;TSC2;CAB39
prerank,Reactome_2022__P75 NTR Receptor-Mediated Signaling R-HSA-193704,-0.5878676972831047,-1.3768240292893943,0.07792207792207792,0.3751397956742592,1.0,8/79,6.92%,PLEKHG5;UBC;RPS27A;RASGRF2;VAV3;ARHGEF1;ARHGEF3;OBSCN
prerank,GO_Biological_Process_2021__negative regulation of fibroblast proliferation (GO:0048147),-0.8075011628324278,-1.3766453825650582,0.03773584905660377,0.3752655779914049,1.0,5/15,6.85%,FTH1;NLRC3;EMD;MED25;GSTP1
prerank,Reactome_2022__Cyclin E Associated Events During G1/S Transition R-HSA-69202,-0.6073457504198357,-1.3763495935983487,0.08333333333333333,0.37576548609314225,1.0,20/63,22.96%,UBC;RPS27A;PSMB3;PSMB6;PSMA7;PSMB9;PSMD12;MAX;PSMD8;PSMA5;CCND1;UBA52;PSMA3;PSMC4;PSME2;PSME1;PSMB5;PSMC3;CDKN1B;PSME3
prerank,CellMarker_Augmented_2021__Dopaminergic neuron:Midbrain,0.7636039400717977,1.3762608908719147,0.05,0.5639967717524521,1.0,4/15,6.05%,SHROOM3;FKBP9;DAG1;SEMA3B
prerank,CellMarker_Augmented_2021__Epithelial cell:Uterus,0.7636039400717977,1.3762608908719147,0.05,0.5639967717524521,1.0,4/15,6.05%,SHROOM3;FKBP9;DAG1;SEMA3B
prerank,GO_Biological_Process_2021__T cell migration (GO:0072678),-0.8127237987810458,-1.3762368428158518,0.12903225806451613,0.37574720764125646,1.0,3/9,1.61%,CCL3;MYO1G;GPR183
prerank,GO_Biological_Process_2021__muscle tissue development (GO:0060537),0.8166373532848521,1.3761885502070248,0.07692307692307693,0.5631618256828053,1.0,4/6,12.21%,PGM5;POGLUT1;PTCH1;NF1
prerank,CellMarker_Augmented_2021__Amacrine cell:Eye,0.6220434544513961,1.3759088895448488,0.15625,0.5630857034936343,1.0,4/23,1.52%,KCNQ2;DPYSL5;GRID2;NCAN
prerank,GO_Biological_Process_2021__regulation of neurotransmitter transport (GO:0051588),-0.8075927557145852,-1.3757153892756646,0.12162162162162163,0.37724502875519295,1.0,2/12,1.34%,MCTP2;RIMS1
prerank,Reactome_2022__NCAM1 Interactions R-HSA-419037,0.7142435305212237,1.3756473180243127,0.14893617021276595,0.5629413287599246,1.0,6/15,16.03%,CNTN2;NCAN;COL6A1;CACNB4;ST8SIA4;COL4A5
prerank,GO_Biological_Process_2021__positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),-0.7132143041482284,-1.3755799723000735,0.09230769230769231,0.3771481870575906,1.0,5/17,18.97%,RPS3;PRKD2;CD226;PTPRC;TESPA1
prerank,GO_Biological_Process_2021__regulation of cholesterol esterification (GO:0010872),0.8266889871185555,1.3754500364043871,0.027777777777777776,0.5623642119835768,1.0,2/7,4.97%,ABCA2;STARD4
prerank,Reactome_2022__Formation Of TC-NER Pre-Incision Complex R-HSA-6781823,-0.637815858845135,-1.3753613468005743,0.07042253521126761,0.3773146017108063,1.0,8/46,7.16%,UBC;PPIE;RPS27A;XPA;COPS6;UVSSA;GTF2H5;POLR2G
prerank,GO_Biological_Process_2021__negative regulation of ERK1 and ERK2 cascade (GO:0070373),0.60360227451897,1.3750546214720802,0.05263157894736842,0.5627908377545918,1.0,6/31,5.20%,DUSP6;SPRY2;SPRED1;SPRED2;SIRPA;TIMP3
prerank,Reactome_2022__Meiosis R-HSA-1500620,-0.6575574224144278,-1.3746234836720608,0.07042253521126761,0.37918817422485457,1.0,14/49,9.35%,SYCE2;H2BC4;H2BC26;H2AC20;SYNE2;H2AC6;STAG3;SYNE1;H3-3B;H2AJ;H2BC21;BRCA2;H2BC5;H2BC9
prerank,CellMarker_Augmented_2021__Erythroid precursor:Bone Marrow,-0.616123066200481,-1.374329434578882,0.07142857142857142,0.37976715309782266,1.0,6/62,3.60%,MYO1G;CD37;ARHGAP4;NFKBID;BTK;GMIP
prerank,GO_Biological_Process_2021__nucleotide-sugar biosynthetic process (GO:0009226),0.6971769913741003,1.3740911730890684,0.09523809523809523,0.5660326743540042,1.0,6/16,13.68%,GNPNAT1;UGDH;GFPT1;SLC35D1;RENBP;NANS
prerank,Reactome_2022__RUNX1 Regulates Transcription Of Genes Involved In Differentiation Of Keratinocytes R-HSA-8939242,0.8057361481212745,1.3737289656012892,0.09523809523809523,0.5661557601192175,1.0,4/6,19.41%,CTSK;RUNX1;CBFB;SOCS4
prerank,GO_Biological_Process_2021__regulation of adaptive immune response (GO:0002819),-0.7900793846028988,-1.3736627347766204,0.0625,0.38142575122288813,1.0,2/13,0.40%,IL4I1;SKAP1
prerank,Reactome_2022__IRAK2 Mediated Activation Of TAK1 Complex R-HSA-937042,-0.79830405825824,-1.3736425673210528,0.08771929824561403,0.3810517846931257,1.0,2/10,1.30%,UBC;RPS27A
prerank,KEGG_2021_Human__Parkinson disease,-0.5654657842114255,-1.3736407709958953,0.023809523809523808,0.3805915772236895,1.0,38/180,14.82%,TUBB8;UBC;CYCS;RPS27A;DUSP1;COX7C;PSMB3;UQCRB;NDUFC1;NDUFA2;UQCRH;NDUFA1;ADRM1;SLC25A5;NDUFB9;TXN2;ATP5PD;NDUFA12;ATP5F1E;PSMB6;NDUFB4;PSMA7;UQCR10;CALM1;COX4I1;COX5B;NDUFB1;NDUFS8;NDUFS5;PSMD12;COX7A2;PSMD8;PSMA5;COX6C;TUBB4B;NDUFS6;NDUFB7;UBA52
prerank,Reactome_2022__Glycogen Synthesis R-HSA-3322077,-0.86016492909612,-1.3732223259077403,0.12121212121212122,0.38137278749640924,1.0,2/9,1.30%,UBC;RPS27A
prerank,CellMarker_Augmented_2021__Basophil:Peripheral Blood,-0.91153075089371,-1.3731683260826244,0.019230769230769232,0.3811523714097277,1.0,4/5,8.26%,CD69;IL3RA;CD63;ENPP3
prerank,GO_Biological_Process_2021__platelet aggregation (GO:0070527),-0.684641835098914,-1.3726627719100464,0.07692307692307693,0.38234346746227643,1.0,8/27,14.58%,FLNA;PLEK;ACTG1;FERMT3;MYL12A;ACTB;PIK3CB;TLN1
prerank,GO_Biological_Process_2021__adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),-0.611898955043755,-1.3724665128834377,0.06756756756756757,0.3826427662059597,1.0,6/67,3.46%,CALCR;ADGRE1;CHRM2;ADGRD1;MARCO;RGS1
prerank,GO_Biological_Process_2021__regulation of double-strand break repair via nonhomologous end joining (GO:2001032),-0.6961196263748688,-1.3723057173877915,0.08771929824561403,0.3826923104935486,1.0,3/21,8.09%,DTX3L;PARP9;CYREN
prerank,GO_Biological_Process_2021__negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),-0.6405155461879583,-1.372233185678367,0.041666666666666664,0.3824064814188785,1.0,17/50,22.96%,PSMB3;PSMB6;PSMA7;PSMB9;RBX1;NABP1;PSMD12;PSMD8;PSMA5;CHFR;PSMA3;PSMC4;PSME2;PSME1;PSMB5;PSMC3;PSME3
prerank,Reactome_2022__NR1H3 And NR1H2 Regulate Gene Expression Linked To Cholesterol Transport And Efflux R-HSA-9029569,-0.6745505073430488,-1.3719507196085001,0.046875,0.38281264648435714,1.0,4/31,5.38%,ARL4C;APOD;PLTP;NR1H2
prerank,Reactome_2022__Prefoldin Mediated Transfer Of Substrate To CCT/TriC R-HSA-389957,0.6451740510241515,1.371940336159379,0.0625,0.5717997233964671,1.0,3/22,6.90%,TUBA1C;PFDN4;TCP1
prerank,Reactome_2022__HATs Acetylate Histones R-HSA-3214847,-0.6123467443260812,-1.3718724464821,0.043478260869565216,0.3825489348498018,1.0,13/80,9.35%,H2AC25;H2BC4;H2BC26;H2AC20;H2AC6;TAF6L;ING3;ING5;H2BC18;MSL3;H2BC21;H2BC5;H2BC9
prerank,Reactome_2022__Proton-coupled Monocarboxylate Transport R-HSA-433692,-0.9059710100451424,-1.371594145113615,0.06666666666666667,0.3829755109955856,1.0,3/5,6.91%,EMB;SLC16A3;SLC16A7
prerank,GO_Biological_Process_2021__regulation of NLRP3 inflammasome complex assembly (GO:1900225),-0.8270679476158781,-1.371416079306866,0.13846153846153847,0.38309970389414477,1.0,3/9,6.90%,CD36;NLRC3;EIF2AK2
prerank,KEGG_2021_Human__Hepatitis C,-0.5682740739207939,-1.3712483887418208,0.013157894736842105,0.3832666015957522,1.0,13/104,9.94%,MX2;OAS3;CYCS;MX1;RSAD2;IFIT1;OAS2;CLDN7;EIF2AK2;OAS1;RNASEL;STAT1;CFLAR
prerank,GO_Biological_Process_2021__pharyngeal system development (GO:0060037),0.8384280531397542,1.3709399725257962,0.11627906976744186,0.5748697451128832,1.0,3/5,15.21%,PTCH1;BMPR1A;TGFBR1
prerank,GO_Biological_Process_2021__negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),0.6245730030907917,1.3708528487964724,0.16279069767441862,0.5739832210545927,1.0,3/18,7.80%,RAP1GAP;CDK10;KANK1
prerank,Reactome_2022__InlA-mediated Entry Of Listeria Monocytogenes Into Host Cells R-HSA-8876493,-0.8688379140110181,-1.3707613913622414,0.08064516129032258,0.3843887318874649,1.0,2/8,1.30%,UBC;RPS27A
prerank,GO_Biological_Process_2021__cellular response to inorganic substance (GO:0071241),-0.7508601180681602,-1.3707216780667142,0.07142857142857142,0.3840496415020759,1.0,1/14,0.51%,DDX11
prerank,CellMarker_Augmented_2021__Leukocyte:Undefined,-0.9693235301932981,-1.37068554596545,0.017241379310344827,0.3837756280217972,1.0,2/5,3.07%,CD69;CD14
prerank,Reactome_2022__Vitamin C (Ascorbate) Metabolism R-HSA-196836,-0.8958638027612422,-1.3703875107097507,0.037037037037037035,0.384208412090288,1.0,2/5,4.51%,SLC2A3;CYB5A
prerank,GO_Biological_Process_2021__regulation by virus of viral protein levels in host cell (GO:0046719),-0.8505645347119697,-1.370100226656236,0.10714285714285714,0.384714976293949,1.0,4/7,12.16%,DYNLT1;IFIT1;STAT1;TBC1D20
prerank,CellMarker_Augmented_2021__Mast cell:Kidney,0.5344969442730679,1.3699473973047036,0.08108108108108109,0.5765872250971782,1.0,11/56,10.35%,EGR1;NDRG2;SIGLEC8;CPM;TIMP3;BACE2;PRDX6;CNRIP1;HPGDS;CD82;ALOX5AP
prerank,Reactome_2022__Senescence-Associated Secretory Phenotype (SASP) R-HSA-2559582,-0.6306712068604295,-1.3693230869027917,0.09090909090909091,0.38661861985383306,1.0,13/49,9.35%,UBC;H2BC4;H2BC26;H2AC20;FOS;RPS27A;H2AC6;H3-3B;H2AJ;H2BC21;H2BC5;VENTX;H2BC9
prerank,KEGG_2021_Human__Axon guidance,0.47927700064678513,1.368935503938088,0.08,0.5797200929714762,1.0,34/130,15.77%,PLXNB1;TRPC1;NRP1;DPYSL5;SEMA5A;PLXNA2;NEO1;NCK2;WNT5A;FZD3;LRRC4C;PLXNA3;SEMA3B;PLXNB2;RYK;ROBO1;PLXNC1;PPP3CA;UNC5B;BMPR1B;EPHA6;PTCH1;ENAH;MAPK1;PLXNA1;DCC;PTK2;SSH2;SRGAP2;NFATC3;ROBO2;GSK3B;PARD3;TRPC4
prerank,GO_Biological_Process_2021__aspartate family amino acid biosynthetic process (GO:0009067),-0.8905318685888883,-1.3686129867370174,0.01694915254237288,0.3885710693916409,1.0,1/6,3.80%,MTHFD1
prerank,Reactome_2022__Fc Epsilon Receptor (FCERI) Signaling R-HSA-2454202,-0.5731171067446935,-1.3682692943594201,0.03896103896103896,0.38919847278863334,1.0,16/112,9.00%,ITK;UBC;FOS;RPS27A;PRKCQ;GRAP2;VAV3;PSMB3;FCER1G;BTK;TXK;PSMB6;PSMA7;FYN;CALM1;PSMB9
prerank,CellMarker_Augmented_2021__Megakaryocyte Progenitor cell:Peripheral Blood,-0.7663812588662937,-1.3682541680431775,0.06451612903225806,0.38878205680132916,1.0,8/19,16.96%,MNDA;CLEC12A;GRAP2;F13A1;MAX;FPR1;KLRF1;FCGR3A
prerank,GO_Biological_Process_2021__positive regulation of vasculogenesis (GO:2001214),0.7917493174750095,1.368170676805757,0.15217391304347827,0.5813169684934867,1.0,2/5,6.25%,RAP1A;RIN2
prerank,GO_Biological_Process_2021__negative regulation of intracellular protein transport (GO:0090317),-0.7052763068057099,-1.3680027688832572,0.08823529411764706,0.3890890259688001,1.0,3/19,4.08%,INSIG1;MDFIC;APOD
prerank,GO_Biological_Process_2021__negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665),-0.9610073872176066,-1.3676614761236334,0.03636363636363636,0.389501383783979,1.0,2/5,1.78%,SIGIRR;CARD16
prerank,CellMarker_Augmented_2021__Monocyte:Undefined,-0.5903245880840511,-1.36742334836562,0.0684931506849315,0.3896372082657434,1.0,27/69,15.96%,MNDA;CLEC12A;MS4A4A;MARCO;AIF1;SIGLEC1;CD14;FCER1G;CD93;NCF4;LILRB4;CD300LF;C5AR1;SIRPB2;OSCAR;LILRB3;NCF2;SLC11A1;MS4A6A;CSF2RB;TYROBP;CSF3R;FCGR1CP;MYO1F;LY86;FPR1;IGSF6
prerank,GO_Biological_Process_2021__cell morphogenesis involved in neuron differentiation (GO:0048667),0.5314415574602592,1.367417149514711,0.09375,0.5831984967948167,1.0,22/57,19.59%,LRP4;SLITRK5;MAP1S;RAB10;PLPPR4;TMEM106B;RYK;CTNNA2;BRSK1;BTBD3;KLF7;CELSR2;DCC;CNTN4;PARD3;SHTN1;FARP1;BRSK2;MAP6;TAOK2;MAP2;FGFR2
prerank,GO_Biological_Process_2021__activation of phospholipase C activity (GO:0007202),-0.7436261981662735,-1.367387553120907,0.09836065573770492,0.38926457707189793,1.0,4/19,6.88%,ITK;TXK;PHB2;C5AR1
prerank,CellMarker_Augmented_2021__Astroglial Progenitor cell:Embryo,-0.6067635191796508,-1.3670286291610292,0.06756756756756757,0.38998191825545053,1.0,12/72,8.99%,BTN3A1;HLA-B;CTDSP1;B2M;BTN3A3;LSP1;TSPAN32;HLA-C;GSTK1;SPOCK2;RNPEPL1;GBP2
prerank,"Reactome_2022__Antigen Presentation: Folding, Assembly, Peptide Loading Of Class I MHC R-HSA-983170",-0.6960130409490054,-1.3666667347088015,0.07936507936507936,0.39056028138523285,1.0,8/25,15.88%,HLA-B;B2M;HLA-C;HLA-F;ERAP1;HLA-E;ERAP2;SEC13
prerank,GO_Biological_Process_2021__interleukin-35-mediated signaling pathway (GO:0070757),-0.8561516245132452,-1.3666324296462575,0.13725490196078433,0.3902300742101204,1.0,3/9,9.56%,STAT4;IL12RB2;STAT1
prerank,CellMarker_Augmented_2021__Bone Marrow Stromal cell:Bone Marrow,-0.8168395616636367,-1.3666071891431373,0.11475409836065574,0.38984795496714203,1.0,3/11,8.80%,ARSJ;SPATS2L;OVOL2
prerank,Reactome_2022__p38MAPK Events R-HSA-171007,0.7144888813699465,1.3664875203691238,0.09302325581395349,0.5856532677044544,1.0,3/10,19.04%,MAPK11;MAPKAPK2;RALA
prerank,GO_Biological_Process_2021__membrane invagination (GO:0010324),0.8080894550850605,1.36610070945673,0.11363636363636363,0.5856475903950444,1.0,2/6,14.49%,FNBP1L;SMURF1
prerank,GO_Biological_Process_2021__snRNA transcription by RNA polymerase III (GO:0042796),-0.8191493973720695,-1.366076015569867,0.06557377049180328,0.39121378138811364,1.0,1/8,2.61%,SNAPC1
prerank,PanglaoDB_Augmented_2021__Ionocytes,0.6126450691627434,1.3660408083304578,0.10869565217391304,0.584752340808368,1.0,1/21,0.04%,SHROOM3
prerank,Reactome_2022__Activation Of NF-kappaB In B Cells R-HSA-1169091,-0.6281886061913065,-1.366007642184261,0.03896103896103896,0.39094704005781983,1.0,15/58,19.69%,UBC;RPS27A;PSMB3;PSMB6;PSMA7;PSMB9;PSMD12;PSMD8;PSMA5;REL;UBA52;PSMA3;PSMC4;PSME2;PSME1
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",-0.7053515750730218,-1.3659149954569132,0.06451612903225806,0.39071241953000174,1.0,4/28,4.34%,UBC;RPS27A;XPA;GTF2H5
prerank,GO_Biological_Process_2021__replicative senescence (GO:0090399),0.9030628631890222,1.3657916800232635,0.09090909090909091,0.5845708212816887,1.0,1/6,1.65%,SERPINE1
prerank,Reactome_2022__VLDLR Internalisation And Degradation R-HSA-8866427,-0.7806704053004414,-1.3657583635581463,0.09375,0.3907090742075398,1.0,6/15,15.66%,UBC;RPS27A;NR1H2;VLDLR;UBA52;AP2S1
prerank,Reactome_2022__Pre-NOTCH Processing In Golgi R-HSA-1912420,0.7629582964445945,1.3656721904655813,0.08823529411764706,0.58381395449439,1.0,4/11,12.19%,MFNG;RFNG;SEL1L;RAB6A
prerank,Reactome_2022__Negative Regulation Of MET Activity R-HSA-6807004,-0.7262047521252561,-1.3656505190834876,0.14516129032258066,0.3906743100743682,1.0,3/21,7.21%,UBC;RPS27A;RNMT
prerank,CellMarker_Augmented_2021__Mesenchymal Stromal cell:Lymph,-0.8640050144252368,-1.3656459811086683,0.14754098360655737,0.3898107284931468,1.0,4/6,12.82%,CD14;PECAM1;CD44;PTPRC
prerank,CellMarker_Augmented_2021__Mesenchymal Stromal cell:Tonsil,-0.8640050144252368,-1.3656459811086683,0.14754098360655737,0.3898107284931468,1.0,4/6,12.82%,CD14;PECAM1;CD44;PTPRC
prerank,Reactome_2022__ERBB2 Regulates Cell Motility R-HSA-6785631,0.7683146571642471,1.365607271929099,0.09523809523809523,0.5828609408518648,1.0,5/9,14.14%,NRG1;NRG3;MEMO1;NRG2;ERBB4
prerank,GO_Biological_Process_2021__response to chemokine (GO:1990868),-0.7132164760213063,-1.3655289122309493,0.16,0.3897875639745615,1.0,3/11,7.09%,RIPOR2;DUSP1;STK39
prerank,KEGG_2021_Human__Phagosome,-0.584256787520138,-1.3653951620523317,0.05333333333333334,0.3897435988447158,1.0,30/108,16.96%,TUBB8;CD36;HLA-B;TFRC;MARCO;CD14;FCAR;NCF4;ATP6V1F;HLA-C;HLA-DRB5;ACTG1;HLA-F;OLR1;NCF2;ITGB2;ACTB;HLA-DRA;TAP1;CYBA;TUBB4B;DYNC1LI2;HLA-E;COLEC12;HLA-DPA1;C3;HLA-DMB;RAC1;HLA-DPB1;FCGR3A
prerank,GO_Biological_Process_2021__negative regulation of androgen receptor signaling pathway (GO:0060766),0.8113406535660788,1.3651819697713632,0.0625,0.5830371767223429,1.0,2/9,9.84%,SIRT1;HDAC1
prerank,KEGG_2021_Human__Fatty acid degradation,0.6125521070847351,1.36506188840635,0.05405405405405406,0.5823976495350622,1.0,7/29,13.81%,CPT1C;ACADS;CPT1A;ACOX3;ACADVL;GCDH;ECI1
prerank,CellMarker_Augmented_2021__Stem cell:Periodontal Ligament,0.6434094754331233,1.3645089068102378,0.13157894736842105,0.5831457844955688,1.0,1/11,0.08%,KLF4
prerank,GO_Biological_Process_2021__regulation of tau-protein kinase activity (GO:1902947),0.7960532364487379,1.364500636060445,0.11538461538461539,0.5820475815115846,1.0,1/8,0.03%,EGR1
prerank,Reactome_2022__Deregulated CDK5 Triggers Neurodegenerative Pathways In Alzheimers Disease Models R-HSA-8862803,0.684782313994117,1.3640816700847591,0.15217391304347827,0.5824430753197224,1.0,1/14,1.30%,CDK5R1
prerank,PanglaoDB_Augmented_2021__Cajal-Retzius Cells,0.4714271298092364,1.3638750222610478,0.045454545454545456,0.5822248842363953,1.0,36/119,11.99%,KCNQ2;SLITRK5;CNTN2;DPYSL5;GRID2;NCAN;SMAD1;INSYN2A;ZNF536;NBEA;NLGN1;GALNT13;NOL4;SNAP91;CNR1;RELN;TMEM170B;CNRIP1;NRG1;DACH1;ELAVL2;GNL3L;PURG;DNM3;OLFM3;FUT9;CADM2;ZDBF2;CLSTN2;SNCB;RGMB;PTPN5;SLC35F1;LINGO1;CAMKV;SLC25A46
prerank,GO_Biological_Process_2021__endoplasmic reticulum membrane organization (GO:0090158),0.7641559656291468,1.3636208696030363,0.07142857142857142,0.582116627208602,1.0,1/9,0.24%,VAPB
prerank,GO_Biological_Process_2021__regulation of response to endoplasmic reticulum stress (GO:1905897),-0.7659860715484041,-1.3631657316894548,0.09259259259259259,0.3961674781376454,1.0,3/12,5.38%,AQP11;CLU;NR1H2
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),0.7241717812430499,1.3631496631303155,0.06521739130434782,0.5829672084326827,1.0,3/9,15.49%,STK25;MAP3K5;ZNF622
prerank,Reactome_2022__Programmed Cell Death R-HSA-5357801,-0.5533195115964985,-1.3631348003701338,0.03529411764705882,0.3958457769812614,1.0,25/170,12.96%,H1-4;H1-3;UBC;H1-2;APIP;CYCS;RPS27A;PRKCQ;PSMB3;CDC37;GZMB;H1-0;NDUFA2;TNFSF10;PSMB6;PSMA7;PSMB9;CFLAR;IRF1;APPL1;MLKL;PSMD12;PSMD8;PSMA5;BMF
prerank,GO_Biological_Process_2021__regulation of lipid storage (GO:0010883),0.6567984729464472,1.3630694627595457,0.075,0.5822057121678174,1.0,4/12,10.85%,SIRT1;TNF;FBXW7;ITGAV
prerank,GO_Biological_Process_2021__sarcoplasmic reticulum calcium ion transport (GO:0070296),-0.9217814852590607,-1.3629541284418145,0.09615384615384616,0.3960755425684399,1.0,1/5,0.62%,CCL3
prerank,GO_Biological_Process_2021__synaptic vesicle budding (GO:0070142),-0.7734825517097799,-1.3629042501325708,0.12244897959183673,0.39577544577990315,1.0,2/8,1.19%,MX2;MX1
prerank,CellMarker_Augmented_2021__Mitotic Fetal Germ cell:Fetal Gonad,-0.5198128608056005,-1.3624367548520553,0.0,0.3967200980260991,1.0,88/435,10.90%,FLNA;RPS13;RPS4X;SAT1;TOMM7;CYCS;PPP1R15A;NCBP2AS2;RPL28;RPL38;RPL31;TPP1;RPS14;SMIM10L1;GCNT1;RPL12;RPL3;GABARAPL1;DDIT4;RPL23A;RPL39;RPL32;RPS25;GSTM4;BTF3;RPS24;CLDN7;MTHFD1;RPL13A;PCSK1N;GLIPR2;RPL41;IFITM3;PLTP;RPL7A;RPL35;UQCRH;RPL37;RPS18;HUS1;LPCAT1;RPL10A;BPHL;RPL11;JUP;RPS3;RPL23;CD63;MRPL57;PPP1R3B;RPS3A;RPL4;TRAPPC4;TMSB10;PHB2;CORO1B;MRPS7;GSTP1;RPL24;RPL14;RPL18A;PSMB6;RPS6;RPS2;RPS7;ATG2A;RPL34;RPL15;RNF44;LY6E;RPL27A;TMSB4X;UNC45A;VENTX;ETFB;ZNF589;RPL27;LDHA;RPL18;WDR46;CFLAR;LITAF;PTN;NPM1;ACTB;EIF3K;NDUFS5;RPLP0
prerank,GO_Biological_Process_2021__regulation of lymphocyte activation (GO:0051249),-0.8325568113748385,-1.3623999800421729,0.10204081632653061,0.39641995030543775,1.0,4/8,8.90%,THEMIS2;CCL5;IKZF3;DCAF15
prerank,GO_Biological_Process_2021__regulation of humoral immune response (GO:0002920),-0.6854700906383323,-1.3623574680309407,0.11475409836065574,0.3960584307064613,1.0,7/21,14.85%,CD55;CLU;PHB2;C5AR1;C5AR2;SERPING1;C3
prerank,GO_Biological_Process_2021__response to type I interferon (GO:0034340),-0.878924636211174,-1.3621814724780694,0.05084745762711865,0.39621431601427926,1.0,3/6,6.14%,MX1;IFIT1;SHFL
prerank,GO_Biological_Process_2021__regulation of prostaglandin biosynthetic process (GO:0031392),0.9060459717167239,1.3620358850145478,0.07692307692307693,0.5848975831719609,1.0,2/5,2.51%,ANXA1;SIRT1
prerank,GO_Biological_Process_2021__regulation of sensory perception of pain (GO:0051930),-0.9467168512465454,-1.3616649573956219,0.0,0.39743277501193386,1.0,2/5,2.02%,CCL3;MGLL
prerank,GO_Biological_Process_2021__ionotropic glutamate receptor signaling pathway (GO:0035235),0.8276003842011304,1.361652879041271,0.10204081632653061,0.5857815745480114,1.0,3/7,6.73%,GRIN3A;CDK5R1;CPEB4
prerank,Reactome_2022__Regulated Necrosis R-HSA-5218859,-0.6535830462223818,-1.361443000028792,0.08974358974358974,0.3977825837871387,1.0,14/49,18.05%,UBC;CYCS;RPS27A;CDC37;GZMB;TNFSF10;CFLAR;IRF1;MLKL;CASP5;UBA52;FLOT1;IL18;CASP4
prerank,GO_Biological_Process_2021__membrane repolarization (GO:0086009),0.7427115853338206,1.3614007266702937,0.125,0.5858623114369272,1.0,3/11,4.38%,KCNJ2;KCNIP2;KCND3
prerank,Reactome_2022__Epigenetic Regulation Of Gene Expression R-HSA-212165,-0.5828033647497802,-1.3613546752749521,0.08333333333333333,0.3976579709339998,1.0,17/88,14.62%,H2BC4;H2BC26;H2AC20;H2AC6;CHD3;TAF1D;GTF2H5;H3-3B;H2AJ;H2BC21;H2BC5;H2BC9;H2BC11;TAF1C;DNMT1;TET1;CBX3
prerank,GO_Biological_Process_2021__L-ascorbic acid metabolic process (GO:0019852),-0.8924944753551127,-1.3608045220002372,0.07272727272727272,0.39882947811014086,1.0,2/6,4.51%,SLC2A3;CYB5A
prerank,GO_Biological_Process_2021__granulocyte activation (GO:0036230),-0.9016783475706897,-1.360761566559354,0.05454545454545454,0.39850877548763813,1.0,1/5,1.49%,CCL5
prerank,Reactome_2022__SCF-beta-TrCP Mediated Degradation Of Emi1 R-HSA-174113,-0.6540763821539971,-1.3607571967592165,0.041666666666666664,0.398086192451436,1.0,14/45,19.69%,UBC;RPS27A;PSMB3;PSMB6;PSMA7;PSMB9;PSMD12;PSMD8;PSMA5;UBA52;PSMA3;PSMC4;PSME2;PSME1
prerank,KEGG_2021_Human__Malaria,-0.6899636804177256,-1.3605596227545556,0.0625,0.398238533487777,1.0,5/22,11.27%,CD36;KLRC4-KLRK1;PECAM1;ITGB2;ITGAL
prerank,GO_Biological_Process_2021__response to copper ion (GO:0046688),-0.8440931827450684,-1.3603035845530709,0.1,0.39872837335641464,1.0,1/9,0.25%,MT2A
prerank,CellMarker_Augmented_2021__Dental Pulp Stem cell:Deciduous Tooth,-0.6607117281387715,-1.3602022108521594,0.0684931506849315,0.3986035358859849,1.0,15/46,12.82%,ABCA9;PLN;MS4A4A;PLXDC1;ABCA6;CD93;PECAM1;PCDH12;MS4A6A;PTPRB;SPARCL1;ABCA8;A2M;FLT1;PTPRC
prerank,Reactome_2022__Coenzyme A Biosynthesis R-HSA-196783,0.8740645397884524,1.3601426500954266,0.046511627906976744,0.5900646993248715,1.0,2/7,4.53%,PANK3;PANK1
prerank,Reactome_2022__Constitutive Signaling By NOTCH1 HD Domain Mutants R-HSA-2691232,-0.8194904147842736,-1.359729659524503,0.06666666666666667,0.39991922972726895,1.0,2/12,1.30%,UBC;RPS27A
prerank,CellMarker_Augmented_2021__Myeloid cell:Bone Marrow,-0.6697725642209669,-1.359664328612326,0.03278688524590164,0.3997627186503958,1.0,14/40,12.82%,CD69;MARCO;SIGLEC1;CD14;CD200R1;SELL;IL3RA;PECAM1;ITGA4;ENPP3;ITGA6;VEGFA;IL18R1;PTPRC
prerank,GO_Biological_Process_2021__regulation of cell projection organization (GO:0031344),0.7564559080641381,1.3594209400564596,0.06818181818181818,0.5922482386348891,1.0,1/10,1.76%,SPRY2
prerank,GO_Biological_Process_2021__muscle tissue morphogenesis (GO:0060415),-0.8861384930102606,-1.359415797436205,0.1509433962264151,0.40010594207939676,1.0,3/6,7.37%,MYLK;TGFBR3;TTN
prerank,GO_Biological_Process_2021__positive regulation of tau-protein kinase activity (GO:1902949),0.881463224428281,1.3593178196066489,0.058823529411764705,0.5914995498019142,1.0,1/5,0.03%,EGR1
prerank,Reactome_2022__NRAGE Signals Death Thru JNK R-HSA-193648,-0.6346730330896727,-1.359148835530946,0.10294117647058823,0.4004687506223021,1.0,6/44,6.92%,PLEKHG5;RASGRF2;VAV3;ARHGEF1;ARHGEF3;OBSCN
prerank,KEGG_2021_Human__Serotonergic synapse,0.5462236427411464,1.3590572010969437,0.034482758620689655,0.5914833149678095,1.0,7/57,6.30%,CACNA1A;TRPC1;PLA2G4C;MAP2K1;GNAQ;KCNJ5;PLCB4
prerank,KEGG_2021_Human__TGF-beta signaling pathway,0.5946152860222749,1.3587463601871559,0.13333333333333333,0.5914671398205948,1.0,17/51,16.08%,ACVR2A;SMAD1;TGFBR2;SMAD7;NEO1;SMAD2;SMAD3;TNF;PPP2R1B;BMPR1B;RGMB;MAPK1;BMPR1A;SMURF1;TGFBR1;TGIF1;RPS6KB2
prerank,KEGG_2021_Human__VEGF signaling pathway,0.5848324260203273,1.3587386587088128,0.08571428571428572,0.5904032619139472,1.0,14/41,18.52%,PLA2G4C;MAPK11;CASP9;MAP2K1;SHC2;PPP3CA;MAPK1;MAPKAPK2;PTK2;AKT2;PIK3CA;PPP3CB;MAP2K2;NFATC2
prerank,Reactome_2022__Chromosome Maintenance R-HSA-73886,-0.5871391798743623,-1.3586140697554645,0.09859154929577464,0.40156287062281554,1.0,20/70,15.66%,H2BC4;H2BC26;H2AC20;H2AC6;H3-3B;H2AJ;CHTF18;H2BC21;POLR2G;CENPU;H2BC5;H2BC9;ITGB3BP;NPM1;TERF2IP;H2BC11;RPA3;NHP2;NOP10;ANKRD28
prerank,CellMarker_Augmented_2021__Megakaryocyte:Fetal Kidney,-0.9261330864152887,-1.3585877221467217,0.05660377358490566,0.40117160227001053,1.0,2/5,5.33%,SRGN;PLEK
prerank,GO_Biological_Process_2021__protein localization to cell surface (GO:0034394),-0.6708868219291294,-1.3585280168483684,0.10909090909090909,0.40093339800048533,1.0,2/19,0.78%,FLNA;RIC3
prerank,GO_Biological_Process_2021__regulation of endothelial cell proliferation (GO:0001936),0.5320909099017719,1.3583993137749322,0.0,0.5906452489860003,1.0,6/46,5.26%,NRP1;SEMA5A;FGF2;SIRT1;WNT5A;PTPRM
prerank,Reactome_2022__Lysosphingolipid And LPA Receptors R-HSA-419408,0.8121111725802082,1.3581199442895129,0.14285714285714285,0.5903750380491175,1.0,2/6,5.54%,PLPPR1;PLPPR4
prerank,GO_Biological_Process_2021__regulation of pH (GO:0006885),0.811396487130752,1.3581160636302037,0.13157894736842105,0.5892977113373491,1.0,4/5,18.83%,PDK4;SLC9A1;SLC9A7;CLCN3
prerank,GO_Biological_Process_2021__regulation of epithelial cell proliferation (GO:0050678),-0.6504398668277894,-1.3580802401985397,0.07692307692307693,0.4021854549165482,1.0,9/42,6.88%,NR4A3;TGFBR3;RUNX3;ZFP36;NLRC3;B2M;AQP11;IGF1;C5AR1
prerank,Reactome_2022__Regulation Of NF-kappa B Signaling R-HSA-9758274,-0.7785756703722282,-1.358060249413287,0.08695652173913043,0.4018150508494245,1.0,3/16,6.58%,UBC;RPS27A;NLRC5
prerank,GO_Biological_Process_2021__regulation of T cell activation (GO:0050863),-0.7102205638515235,-1.358015258621657,0.07692307692307693,0.40146570021942146,1.0,5/27,2.84%,IL4I1;CD2;CCL5;PRKCQ;PRELID1
prerank,GO_Biological_Process_2021__nucleic acid transport (GO:0050657),-0.8218554032255765,-1.3578760124333433,0.12244897959183673,0.40149083734993435,1.0,2/8,2.95%,SIDT2;SIDT1
prerank,GO_Biological_Process_2021__positive regulation of leukocyte apoptotic process (GO:2000108),0.779783462671014,1.357680471012472,0.13157894736842105,0.5899861590360165,1.0,2/9,2.51%,ANXA1;SIRT1
prerank,Reactome_2022__Synthesis Of PE R-HSA-1483213,0.8689680631856127,1.3575535149193285,0.07317073170731707,0.5893584156462254,1.0,3/8,10.72%,ETNPPL;CHKA;SELENOI
prerank,GO_Biological_Process_2021__single strand break repair (GO:0000012),0.7248754866684075,1.357548964593685,0.14285714285714285,0.5882887996468674,1.0,2/7,7.13%,SIRT1;LIG4
prerank,PanglaoDB_Augmented_2021__Enteric Neurons,0.4795218361318198,1.357358518141666,0.047619047619047616,0.5878352995392321,1.0,49/114,22.00%,CNTN2;NCAN;NMNAT2;ZNF536;SCN3A;SNAP91;PLPPR4;LRRC4C;PCDH17;AHDC1;PLEKHA5;TAFA5;KCTD16;CA10;OLFM3;CADM2;ASXL3;RGMB;GUCY1A2;RBFOX1;NTRK2;CACNA1E;GRIA2;NFASC;CSRNP3;STXBP5;EML5;PPFIA2;KALRN;ADGRB3;MAPK4;ATRNL1;PIK3CA;GCNT2;MAP6;PCLO;CRMP1;FSTL5;MAP2;DCLK1;CNTN1;PHYHIPL;SYT4;TUB;NOVA1;CACNA1B;FBXO7;NRXN1;LSAMP
prerank,Reactome_2022__Gap-filling DNA Repair Synthesis And Ligation In TC-NER R-HSA-6782210,-0.6169172311885684,-1.3573067276594033,0.043478260869565216,0.40301915639336755,1.0,7/51,7.16%,UBC;PPIE;RPS27A;POLE3;UVSSA;GTF2H5;POLR2G
prerank,CellMarker_Augmented_2021__Stem cell:Liver,-0.8212000570274516,-1.3570297400000195,0.10909090909090909,0.40359676822605006,1.0,3/8,8.71%,GSTP1;ITGA6;CD44
prerank,GO_Biological_Process_2021__excitatory synapse assembly (GO:1904861),0.8195375027724897,1.3569851518113756,0.0784313725490196,0.5884792648863773,1.0,6/7,11.81%,GRID2;NLGN1;WNT5A;PLXNB2;SHANK3;PTEN
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA damage recognition (GO:0000715)",-0.7379072992298478,-1.3568943324167557,0.109375,0.40359931011417954,1.0,4/22,2.80%,UBC;RPS27A;XPA;COPS6
prerank,CellMarker_Augmented_2021__Dendritic cell:Synovium,-0.6090872344761558,-1.3564080744905913,0.04,0.40448669554570565,1.0,21/83,11.39%,JAML;MNDA;VNN2;CLEC12A;AIF1;FCER1G;BTK;SNX20;NCF4;PLEK;IL10RA;CD300LF;CYTIP;LILRB3;SLC11A1;MS4A6A;CSF2RB;NCKAP1L;TYROBP;ITGAL;CSF3R
prerank,GO_Biological_Process_2021__lung development (GO:0030324),0.6530625343338041,1.3563457957089207,0.1111111111111111,0.5900254330120515,1.0,4/16,4.19%,PDPN;FGF2;PKD1;RCN3
prerank,GO_Biological_Process_2021__positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),-0.7699503837468722,-1.3560613938584418,0.1111111111111111,0.4055127193219736,1.0,1/13,0.08%,NR4A3
prerank,GO_Biological_Process_2021__cellular response to hypoxia (GO:0071456),-0.5719156809652275,-1.35579228677641,0.0547945205479452,0.4057037434927777,1.0,24/90,18.04%,UBC;RPS27A;CARD16;PSMB3;RORA;ELOB;PSMB6;PSMA7;EGLN3;PSMB9;RBX1;VEGFA;HIF1A;NOP53;PSMD12;PSMD8;PSMA5;PGK1;UBA52;MT3;PSMA3;PINK1;PSMC4;FAM162A
prerank,GO_Biological_Process_2021__neural crest cell migration (GO:0001755),0.6464785040568285,1.355748730110845,0.10526315789473684,0.5911880721488803,1.0,5/18,14.14%,NRP1;SEMA5A;SEMA3B;PHACTR4;ERBB4
prerank,GO_Biological_Process_2021__peptidyl-threonine modification (GO:0018210),0.5345164797701881,1.3556817867466067,0.027777777777777776,0.5903343828230307,1.0,16/52,15.67%,CDK5R1;TGFBR2;CDK10;GALNT13;LRRK2;GALNTL6;MAP2K1;NLK;MAP3K10;DYRK1A;WNK1;MAPK1;GALNT1;TGFBR1;GALNT2;GSK3B
prerank,GO_Biological_Process_2021__positive regulation of behavior (GO:0048520),-0.8947147178112443,-1.3556665342701897,0.10416666666666667,0.4055936955358021,1.0,1/5,0.08%,NR4A3
prerank,Reactome_2022__IRF3-mediated Induction Of Type I IFN R-HSA-3270619,-0.8149396080427678,-1.3555386409380779,0.13725490196078433,0.40554395464791193,1.0,2/9,11.42%,NLRC3;STING1
prerank,Reactome_2022__Synthesis Of Very Long-Chain Fatty acyl-CoAs R-HSA-75876,0.6628561487834597,1.3553602693428972,0.13513513513513514,0.590425259044841,1.0,2/14,8.59%,HACD2;ELOVL6
prerank,GO_Biological_Process_2021__regulation of axon guidance (GO:1902667),0.7857172521681117,1.3553601187539748,0.1111111111111111,0.5893671492616065,1.0,2/8,2.84%,NRP1;ZSWIM4
prerank,Reactome_2022__Purine Catabolism R-HSA-74259,-0.8109971252892662,-1.3552685347240703,0.057692307692307696,0.4060042917590217,1.0,2/8,4.95%,ADPRM;NT5C
prerank,CellMarker_Augmented_2021__Epithelial cell:Amniotic Membrane,-0.7580669265407575,-1.3547614622138227,0.12903225806451613,0.40723270788475524,1.0,3/12,9.33%,CLDN7;OVOL2;LLGL2
prerank,Reactome_2022__TNFR2 Non-Canonical NF-kB Pathway R-HSA-5668541,-0.6056237609281712,-1.354731556267163,0.10526315789473684,0.40693188789077883,1.0,13/68,12.85%,UBC;TNFRSF11B;RPS27A;TNFRSF25;PSMB3;PSMB6;PSMA7;TNFRSF1B;PSMB9;TNFSF13B;PSMD12;PSMD8;PSMA5
prerank,KEGG_2021_Human__Wnt signaling pathway,0.5188846811517179,1.3546754581912575,0.1,0.5910021361323339,1.0,32/93,19.22%,ZNRF3;TCF7L1;CTNNBIP1;TLE2;WNT5A;INVS;FZD3;SMAD3;PLCB4;WNT2B;RYK;NLK;DVL3;CTBP2;PPP3CA;BTRC;DKK2;TBL1XR1;FBXW11;TCF7L2;CSNK1E;JUN;TLE1;NFATC3;CCND3;GSK3B;CACYBP;MAP3K7;PPP3CB;PLCB3;NFATC2;CSNK2A1
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell differentiation (GO:0030857),0.8688238528395881,1.354449579422421,0.07272727272727272,0.5906751302185584,1.0,3/5,3.94%,SPRY2;SPRED1;SPRED2
prerank,GO_Biological_Process_2021__negative regulation of leukocyte cell-cell adhesion (GO:1903038),-0.7938092502756575,-1.3542265165156182,0.09523809523809523,0.40819642919570737,1.0,1/12,0.34%,IL4I1
prerank,GO_Biological_Process_2021__positive regulation of mitotic cell cycle (GO:0045931),0.683514593022093,1.3542128329434966,0.09375,0.5906401127924744,1.0,3/20,9.60%,KLHL18;PPP1R10;MDM2
prerank,CellMarker_Augmented_2021__Macrophage:Placenta,-0.9275256902263096,-1.3541349710821706,0.06779661016949153,0.4079250752120433,1.0,2/5,3.07%,AIF1;CD14
prerank,GO_Biological_Process_2021__positive regulation of glial cell migration (GO:1903977),-0.8636538482576301,-1.3539151584570959,0.1076923076923077,0.40816147600378105,1.0,1/6,0.62%,CCL3
prerank,CellMarker_Augmented_2021__Multipotent Progenitor cell:Undefined,-0.5913081230689156,-1.3538923400674387,0.06493506493506493,0.40782122516872765,1.0,34/89,18.95%,XAF1;MS4A4A;AIF1;RGS1;CMAHP;SNX20;CD93;PLEK;IL10RA;F13A1;LILRB4;PECAM1;TRIM22;TNFRSF1B;SAMSN1;MS4A6A;CSF2RB;NCKAP1L;HLA-DRA;TYROBP;PTPRC;HAVCR2;APOL3;HLA-DPA1;CIITA;CD74;HLA-DPB1;FCGR3A;GIMAP4;EVI2B;FOLR2;PARVG;RNASE6;PPP1R16B
prerank,GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen (GO:0002483),-0.7627755775740891,-1.3528024425321392,0.08955223880597014,0.4112621436496844,1.0,8/11,14.74%,B2M;HLA-F;HLA-DRA;ERAP1;ABCB9;TAP1;HLA-E;ERAP2
prerank,GO_Biological_Process_2021__positive regulation of chondrocyte differentiation (GO:0032332),0.8436053603729541,1.3525240246047974,0.11627906976744186,0.5968882542387091,1.0,4/6,9.95%,ZBTB16;SOX5;BMPR1B;LOXL2
prerank,GO_Biological_Process_2021__negative regulation of RNA metabolic process (GO:0051253),-0.6718647995025844,-1.3524931419480544,0.13793103448275862,0.4117121501169582,1.0,2/15,6.24%,RPS13;RPS26
prerank,GO_Biological_Process_2021__polyphosphate metabolic process (GO:0006797),-0.8703269207282811,-1.3523363789347354,0.12,0.41172554310010917,1.0,2/5,9.75%,BNIP2;PRUNE1
prerank,CellMarker_Augmented_2021__GABAergic neuron:Undefined,0.8274845254144713,1.3520672586004259,0.08,0.5973391075898468,1.0,2/5,14.77%,GABBR1;GAD1
prerank,GO_Biological_Process_2021__negative regulation of DNA recombination (GO:0045910),-0.6836833970229086,-1.3520601344252807,0.05970149253731343,0.41234217991685934,1.0,6/39,8.56%,H1-4;H1-3;H1-2;H1-0;POLR2G;H1-10
prerank,Reactome_2022__CD28 Co-Stimulation R-HSA-389356,-0.6965830343297337,-1.3520481076493773,0.15384615384615385,0.41193994000944045,1.0,4/27,7.56%,GRAP2;YES1;FYN;THEM4
prerank,GO_Biological_Process_2021__positive regulation of cell-substrate junction organization (GO:0150117),0.6750314801592828,1.3520097316464708,0.09090909090909091,0.5965899340133842,1.0,2/18,0.61%,COL16A1;NRP1
prerank,GO_Biological_Process_2021__negative regulation of appetite (GO:0032099),-0.8584957395796629,-1.3519890229740055,0.11320754716981132,0.4116372611181063,1.0,1/5,3.44%,BBS2
prerank,GO_Biological_Process_2021__regulation of monocyte chemotactic protein-1 production (GO:0071637),-0.807141543274285,-1.3518514774368486,0.18518518518518517,0.4116901065959248,1.0,4/8,8.28%,OAS3;APOD;GSTP1;OAS1
prerank,GO_Biological_Process_2021__positive regulation of cytosolic calcium ion concentration (GO:0007204),-0.6307520474733808,-1.351798150195274,0.04477611940298507,0.41138836131943374,1.0,12/56,11.47%,CALCR;CD36;CXCR4;CD55;FIS1;ACKR4;TACR1;C5AR1;TRPV4;P2RY8;TRPM4;C5AR2
prerank,CellMarker_Augmented_2021__Beige Adipogenic Precursor cell:Adipose Tissue,0.5764246791057954,1.3517013262997228,0.03125,0.5957172148858804,1.0,16/36,22.52%,SVEP1;PTPRG;GUCY1A2;ENAH;RUNX1T1;COL6A1;FBXL7;JAM2;NFASC;CEP112;SLIT3;DCLK1;PRKG1;NOVA1;CXCL12;ASPN
prerank,CellMarker_Augmented_2021__Brown Adipogenic Precursor cell:Adipose Tissue,0.5764246791057954,1.3517013262997228,0.03125,0.5957172148858804,1.0,16/36,22.52%,SVEP1;PTPRG;GUCY1A2;ENAH;RUNX1T1;COL6A1;FBXL7;JAM2;NFASC;CEP112;SLIT3;DCLK1;PRKG1;NOVA1;CXCL12;ASPN
prerank,GO_Biological_Process_2021__regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),-0.7509313188900841,-1.3516644632405665,0.11940298507462686,0.41133316916482887,1.0,5/15,2.49%,CD36;SIGIRR;CD55;CARD16;TRIM5
prerank,GO_Biological_Process_2021__digestive system development (GO:0055123),0.7880316365217735,1.3515614998414274,0.13157894736842105,0.5953448237891201,1.0,4/7,19.59%,PKD1;COBL;NIPBL;FGFR2
prerank,Reactome_2022__IRAK2 Mediated Activation Of TAK1 Complex Upon TLR7/8 Or 9 Stimulation R-HSA-975163,-0.7071174681925935,-1.3512724827963019,0.13333333333333333,0.4120935793872052,1.0,3/14,4.18%,UBC;RPS27A;NDUFA2
prerank,Reactome_2022__GRB2 Events In EGFR Signaling R-HSA-179812,0.8567283440617169,1.3511684975630982,0.12195121951219512,0.5948087782450848,1.0,1/5,2.15%,TGFA
prerank,Reactome_2022__SHC1 Events In EGFR Signaling R-HSA-180336,0.8567283440617169,1.3511684975630982,0.12195121951219512,0.5948087782450848,1.0,1/5,2.15%,TGFA
prerank,Reactome_2022__Dual Incision In GG-NER R-HSA-5696400,-0.7072560855039132,-1.3510917437624035,0.034482758620689655,0.41226347105271005,1.0,9/32,14.82%,UBC;RPS27A;XPA;POLE3;GTF2H5;PARP2;RBX1;RPA3;UBA52
prerank,CellMarker_Augmented_2021__Endothelial Stem cell:Blood Vessel,-0.7867937851987827,-1.3510838973171948,0.0847457627118644,0.41182516231122746,1.0,8/13,12.82%,CD14;SELL;PECAM1;TNFRSF1B;ITGA4;ITGA6;CSF3R;PTPRC
prerank,GO_Biological_Process_2021__response to calcium ion (GO:0051592),0.5458807064326654,1.3510460303312026,0.045454545454545456,0.594215045257547,1.0,24/67,23.01%,TRPC1;PKD2;KCNIP2;NLGN1;WNT5A;ANXA11;PPP3CA;KCNMB4;ALOX5AP;SYT17;KCNMB3;AHCYL1;PRKAA1;SEC31A;ADGRV1;NEDD4;CPNE2;SYT4;HOMER1;ADD1;RYR1;CPNE3;ITPKB;RYR2
prerank,GO_Biological_Process_2021__protein localization to nuclear envelope (GO:0090435),0.9049091065944981,1.3510060301346416,0.047619047619047616,0.5933172531728291,1.0,2/5,4.41%,NUTF2;TOR1AIP2
prerank,GO_Biological_Process_2021__transcription-coupled nucleotide-excision repair (GO:0006283),-0.6025202213389395,-1.3509778087158357,0.09090909090909091,0.4116620116874056,1.0,8/61,7.16%,UBC;PPIE;RPS27A;XPA;COPS6;UVSSA;GTF2H5;POLR2G
prerank,Reactome_2022__HDL Remodeling R-HSA-8964058,-0.8582569155998476,-1.3507642329090415,0.08771929824561403,0.41193942570700876,1.0,2/5,4.17%,LIPG;PLTP
prerank,GO_Biological_Process_2021__very long-chain fatty acid biosynthetic process (GO:0042761),0.798555999207688,1.3502792063165416,0.10526315789473684,0.5938292652884611,1.0,2/8,8.59%,HACD2;ELOVL6
prerank,GO_Biological_Process_2021__fatty acid elongation (GO:0030497),0.798555999207688,1.3502792063165416,0.10526315789473684,0.5938292652884611,1.0,2/8,8.59%,HACD2;ELOVL6
prerank,GO_Biological_Process_2021__regulation of postsynapse organization (GO:0099175),0.6228436776854237,1.3500682246298794,0.02857142857142857,0.5934647046573364,1.0,8/25,9.17%,CDK5R1;SRCIN1;LRRK2;WNT5A;ABHD17B;SHANK3;PDLIM5;TANC2
prerank,Reactome_2022__Downregulation Of ERBB2:ERBB3 Signaling R-HSA-1358803,-0.784476374012434,-1.3500093282890702,0.08955223880597014,0.41425855783028764,1.0,2/11,1.30%,UBC;RPS27A
prerank,Reactome_2022__Regulation Of PTEN Stability And Activity R-HSA-8948751,-0.6121731449992724,-1.349968782932261,0.08860759493670886,0.41389807763782854,1.0,16/57,19.69%,UBC;RPS27A;PSMB3;PSMB6;PSMA7;PSMB9;PSMD12;PSMD8;PSMA5;OTUD3;UBA52;PSMA3;PSMC4;CSNK2A2;PSME2;PSME1
prerank,GO_Biological_Process_2021__negative regulation of dendritic spine development (GO:0061000),0.8326221637851337,1.3499231569175578,0.09259259259259259,0.5929392738969611,1.0,3/6,11.81%,GRIN3A;NLGN1;PTEN
prerank,Reactome_2022__Signaling By FGFR4 In Disease R-HSA-5655291,0.7597527073658427,1.3498838046539876,0.1509433962264151,0.5920110258580571,1.0,1/8,1.00%,PIGU
prerank,GO_Biological_Process_2021__primary miRNA processing (GO:0031053),0.7816920825754912,1.34972593305878,0.075,0.5915101327424265,1.0,4/10,13.55%,SMAD1;SMAD2;SMAD3;DROSHA
prerank,PanglaoDB_Augmented_2021__Fibroblasts,0.5109623165127025,1.3497034236340104,0.0,0.5905674071196725,1.0,16/92,7.07%,EGR1;KLF4;COL5A3;COL16A1;PKD2;SVEP1;GSN;COL5A2;FGF2;KLF6;ACTA2;PBX1;TIMP3;CTSK;RUNX1;NFAT5
prerank,Reactome_2022__Cytochrome C-Mediated Apoptotic Response R-HSA-111461,-0.7358133288332436,-1.349614492207313,0.16666666666666666,0.41458170539290723,1.0,2/12,1.08%,APIP;CYCS
prerank,GO_Biological_Process_2021__negative regulation of heart contraction (GO:0045822),-0.8698016021310593,-1.3495787064181013,0.10714285714285714,0.4143190568437623,1.0,2/8,6.56%,PLN;SRI
prerank,GO_Biological_Process_2021__long-term synaptic potentiation (GO:0060291),0.6881201827314608,1.349520941832751,0.1956521739130435,0.5901311192666715,1.0,6/12,16.68%,NPTN;SHANK2;PLK2;GRIN2B;SLC24A2;GRIN2A
prerank,GO_Biological_Process_2021__positive regulation of immunoglobulin production (GO:0002639),-0.7447991811439554,-1.349284176583513,0.13333333333333333,0.4146991349437549,1.0,5/20,14.31%,TFRC;DNAJB9;PHB2;PTPRC;HLA-E
prerank,Reactome_2022__Phosphorylation Of APC/C R-HSA-176412,0.698401074225618,1.3490105642336885,0.13043478260869565,0.5913238326416301,1.0,3/12,10.68%,UBE2D1;CDC23;ANAPC16
prerank,GO_Biological_Process_2021__cholesterol transport (GO:0030301),-0.645402699264427,-1.3489688233835153,0.11864406779661017,0.4153213742140241,1.0,4/30,4.82%,OSBPL5;CD36;LIPG;CLU
prerank,GO_Biological_Process_2021__negative regulation of nitrogen compound metabolic process (GO:0051172),0.8694806413006057,1.3487513613299142,0.07317073170731707,0.5912688461370623,1.0,2/7,3.01%,ABCA2;LDLR
prerank,GO_Biological_Process_2021__negative regulation of neuron projection development (GO:0010977),0.5270673605213995,1.3485742451735672,0.08,0.5907935549561341,1.0,14/45,15.36%,PTPN9;LRP4;NLGN1;CIB1;BCL11A;KANK1;LINGO1;PTEN;RTN4;DCC;ADCY6;BAG5;FKBP4;KIAA0319
prerank,PanglaoDB_Augmented_2021__Airway Epithelial Cells,-0.8453828552817829,-1.3485342056555376,0.09090909090909091,0.41638887640177263,1.0,3/7,10.61%,DUOX1;CLCA4;CFTR
prerank,GO_Biological_Process_2021__regulation of microglial cell migration (GO:1904139),-0.8636562208762271,-1.3484267263603313,0.0967741935483871,0.4162417940567694,1.0,1/6,0.62%,CCL3
prerank,CellMarker_Augmented_2021__CD4-CD28+ T cell:Peripheral Blood,-0.8557125688695798,-1.3481656506234345,0.1346153846153846,0.41625825621065504,1.0,3/6,12.82%,PRF1;ITGB2;PTPRC
prerank,CellMarker_Augmented_2021__CD4-CD28- T cell:Peripheral Blood,-0.8557125688695798,-1.3481656506234345,0.1346153846153846,0.41625825621065504,1.0,3/6,12.82%,PRF1;ITGB2;PTPRC
prerank,GO_Biological_Process_2021__melanocyte differentiation (GO:0030318),0.8056014138695268,1.3481420802032922,0.13636363636363635,0.5915592222411009,1.0,2/5,14.62%,MITF;ENPP1
prerank,GO_Biological_Process_2021__cellular senescence (GO:0090398),0.6868906818441902,1.348134794739195,0.05,0.5906061431655047,1.0,4/19,13.79%,SIRT1;MAP2K1;HMGA1;NSMCE2
prerank,Reactome_2022__G Beta:Gamma Signaling Thru BTK R-HSA-8964315,-0.7838875217564912,-1.3480602798186012,0.14754098360655737,0.4162181251893404,1.0,2/8,4.88%,BTK;GNB5
prerank,Reactome_2022__Rap1 Signaling R-HSA-392517,0.7199330055489725,1.3480536348144385,0.05128205128205128,0.5900348180923134,1.0,2/14,3.84%,RAP1GAP;RAP1A
prerank,GO_Biological_Process_2021__positive regulation of MAPK cascade (GO:0043410),-0.5626874211953696,-1.3479775314729798,0.012195121951219513,0.4161104826689057,1.0,18/146,9.28%,CCL4;CALCR;CD36;CCL3;CCL5;GPR183;PDGFD;MARCO;TRIM5;GLIPR2;IGF1;PHB2;C5AR1;EIF2AK2;MAP3K12;PRKD2;CD44;CHI3L1
prerank,Reactome_2022__Defective CFTR Causes Cystic Fibrosis R-HSA-5678895,-0.6369313253452074,-1.3478152037923194,0.0759493670886076,0.4162345851520743,1.0,15/51,19.69%,UBC;RPS27A;PSMB3;PSMB6;PSMA7;PSMB9;CFTR;PSMD12;PSMD8;PSMA5;UBA52;PSMA3;PSMC4;PSME2;PSME1
prerank,KEGG_2021_Human__Intestinal immune network for IgA production,-0.7026994007052979,-1.3474832194730932,0.08955223880597014,0.41691731869355103,1.0,9/21,18.79%,CXCR4;HLA-DRB5;ITGA4;HLA-DRA;TNFSF13B;HLA-DPA1;HLA-DMB;HLA-DPB1;HLA-DRB1
prerank,Reactome_2022__Gene Silencing By RNA R-HSA-211000,-0.6046092272305089,-1.3473905211736577,0.02857142857142857,0.4167322677450991,1.0,14/73,10.95%,MYBL1;H2BC4;H2BC26;H2AC20;H2AC6;MOV10L1;H3-3B;H2AJ;H2BC21;POLR2G;H2BC5;H2BC9;TDRKH;NUP50
prerank,GO_Biological_Process_2021__positive regulation of macrophage cytokine production (GO:0060907),0.7336412974656203,1.3472026667172898,0.17307692307692307,0.5924683538305436,1.0,3/8,10.29%,SIRT1;WNT5A;LAPTM5
prerank,Reactome_2022__DNA Replication R-HSA-69306,-0.5719523152486596,-1.3471510260448607,0.039473684210526314,0.41702839115307605,1.0,26/102,14.90%,UBC;H2BC4;H2BC26;H2AC20;RPS27A;H2AC6;PSMB3;POLE3;H3-3B;H2AJ;H2BC21;PSMB6;PSMA7;H2BC5;PSMB9;H2BC9;RBX1;PSMD12;ANAPC11;H2BC11;PSMD8;PSMA5;MCM7;RPA3;UBA52;CDC26
prerank,GO_Biological_Process_2021__tumor necrosis factor-mediated signaling pathway (GO:0033209),-0.6041746691291969,-1.3471454855959075,0.08974358974358974,0.4166226928830033,1.0,16/82,12.85%,TNFRSF11B;CARD14;TNFRSF25;PSMB3;AIM2;PSMB6;PSMA7;TNFRSF1B;TMSB4X;PSMB9;STAT1;EIF5A;TNFSF13B;PSMD12;PSMD8;PSMA5
prerank,GO_Biological_Process_2021__associative learning (GO:0008306),0.8040194214238062,1.3470964666158818,0.14,0.5918560970334783,1.0,1/5,8.58%,BRSK1
prerank,GO_Biological_Process_2021__regulation of cell adhesion mediated by integrin (GO:0033628),0.6255737577260071,1.3470018422489174,0.12195121951219512,0.5911864651879456,1.0,6/18,13.77%,ACER2;SERPINE1;CIB1;PDE3B;P2RY12;PTK2
prerank,PanglaoDB_Augmented_2021__Distal Tubule Cells,0.5393449482148421,1.3468491950054047,0.1,0.5908158901745961,1.0,21/52,18.86%,ESRRG;PPARGC1A;FGD4;LPP;JAG1;CPEB4;PLEKHA5;LARP1B;WNK1;MAP7;CMYA5;COBL;SLC8A1;CXCL14;STON2;BAZ2B;RSPH3;NIPSNAP2;SPTLC3;TSC22D2;ACOT11
prerank,"KEGG_2021_Human__Parathyroid hormone synthesis, secretion and action",0.48310336254536906,1.3466319971659328,0.06666666666666667,0.5908218593701997,1.0,6/70,6.41%,EGR1;MMP17;MAP2K1;GNAQ;PLCB4;ADCY9
prerank,Reactome_2022__TRAF6-mediated Induction Of TAK1 Complex Within TLR4 Complex R-HSA-937072,-0.7058631830232907,-1.3465947312201436,0.10526315789473684,0.4179545776186637,1.0,3/15,4.18%,UBC;RPS27A;NDUFA2
prerank,Reactome_2022__Butyrophilin (BTN) Family Interactions R-HSA-8851680,-0.9166666666666667,-1.3465046118021422,0.057692307692307696,0.41779796581105627,1.0,5/5,8.38%,BTN3A1;BTN3A3;BTN3A2;BTN2A1;BTN2A2
prerank,Reactome_2022__Nicotinamide Salvaging R-HSA-197264,-0.8039935947513319,-1.346032613263816,0.05263157894736842,0.418886405998292,1.0,4/12,8.03%,PARP14;NUDT12;PARP9;NAMPT
prerank,Reactome_2022__Inactivation Of APC/C Via Direct Inhibition Of APC/C Complex R-HSA-141430,0.6740687647162958,1.3460125079792515,0.11627906976744186,0.5923658575946126,1.0,3/13,10.68%,UBE2D1;CDC23;ANAPC16
prerank,Reactome_2022__ABC Transporter Disorders R-HSA-5619084,-0.6224303117492136,-1.3459777190458337,0.10256410256410256,0.41854741057069605,1.0,16/57,19.69%,UBC;RPS27A;PSMB3;PSMB6;PSMA7;PSMB9;ABCB4;CFTR;PSMD12;PSMD8;PSMA5;UBA52;PSMA3;PSMC4;PSME2;PSME1
prerank,GO_Biological_Process_2021__box C/D snoRNP assembly (GO:0000492),0.8812305253715784,1.345902121710548,0.12244897959183673,0.5919557977353815,1.0,2/6,1.43%,NUFIP1;RUVBL2
prerank,GO_Biological_Process_2021__manganese ion transport (GO:0006828),0.7423917061797392,1.3455812704990007,0.15555555555555556,0.5923921601185076,1.0,3/10,5.71%,TRPC1;SLC39A14;SLC39A8
prerank,CellMarker_Augmented_2021__Natural Killer T (NKT) cell:Fetal Kidney,-0.49789858089690747,-1.3454929167167091,0.0,0.41970918667527846,1.0,566/3680,13.68%,CCL4;NR4A3;ITK;GNLY;TC2N;H1-4;SPON2;MT2A;FLNA;H4C3;SAMD3;IL4I1;NKG7;BTN3A1;SKAP1;STAT4;SYAP1;THEMIS;OSBPL5;H1-3;DDX11;RPS13;TPD52;ERICH1;MYBL1;BCL11B;MIF4GD;CCL3;UBC;PDE4A;H1-2;RPS4X;SIGIRR;CEBPD;INSIG1;SLC2A3;COL18A1;PPIE;CCDC88C;DEGS2;FTH1;TOMM7;SRGN;MYO1G;CD37;H2AC20;TGFBR3;NIT2;FOSL2;CYCS;ARHGAP4;HLA-B;THEMIS2;PPP1R15A;RBIS;ACAP1;MCTP2;FOS;CD96;CD2;RPL28;DYNLT1;RPS27A;RPS8;FRG1;RPGRIP1L;RUNX3;GAPDH;SLC7A5;RPL38;CXCR4;ZFP36;CCL5;SCML4;RPS21;JUNB;DUSP1;PYHIN1;CD55;XAF1;PRKCQ;EMB;RPL31;NFKBID;SLFN12L;XPA;CARD16;IL7R;CTDSP1;RPL37A;RPS14;SMIM10L1;SYNE2;PSMG4;CD69;GADD45B;GRAP2;CCDC107;RPL12;MDH2;RPLP1;UBXN1;SIDT2;RPL3;GABARAPL1;ZCRB1;PDGFD;MDFIC;DDIT4;COX7C;DHX38;IKZF3;RAB37;RPL23A;NLRC3;RPL39;ZNF831;RPL32;CHD3;PARP14;BTG2;CSTF2T;STAG3;RPS11;TAF6L;CSRNP1;PSTPIP1;COPS6;B2M;RPL5;PRELID1;RPS15;RPS12;TNFRSF25;EDF1;PSMB3;RPS25;YES1;DNAJB9;RPS23;RPS27;PDXDC1;FAU;SRP14;DNAJC19;SELL;CDC37;FCER1G;RORA;TAF1D;GZMB;POLE3;UQCRB;RPS20;ANKZF1;RPL29;GTF3C6;SSB;ASMTL;RGS1;TCEAL8;RPLP2;BTF3;CHCHD2;USP36;SSNA1;EIF2B1;RANBP6;RPL19;RPS24;PRF1;NARS1;ANXA2;CD247;RPL13A;RGS16;CBLB;GLIPR2;RPL41;OST4;RNF213;SYNE1;SNRPD2;ARL4C;PDHX;IFITM3;SLAMF6;NDUFA2;DDRGK1;RPL7A;OGG1;SNX20;EMD;BTN3A3;RPL35;GTF2H5;ETS1;UQCRH;LSP1;RPL37;NDUFA1;CTDP1;CYB5A;GNL2;RPS18;SLC38A1;TNFSF10;ING3;SAMD9L;PTMA;HUS1;OGFR;DTX3;LPCAT1;BHLHE40;ATP6V1F;TSPAN32;BROX;NT5C;ABCB1;RPL10;ARIH2;RPL10A;HLA-C;BNIP2;ARHGEF1;ZNF331;ZRANB2;RAB11A;SP110;SLC16A3;DHX40;PHF11;SCAND1;RPL11;ADRM1;PLEK;FAM118A;SLC37A1;NR1H2;RPS3;FBXO25;RPL23;MTCH1;PIGO;SLC25A5;ISCA1;CD63;TMA7;JMJD6;ABCF1;ANKRD12;TXK;FIS1;TIPIN;LAMTOR5;IL12RB2;INPP4A;MRPL57;NDUFB9;SPAG7;WDR83;RANBP1;RPS3A;ARGLU1;RPL4;EIF1;H3-3B;H2AJ;BRD9;SHFL;ILF3;RPS26;TRAPPC4;TNFAIP8;RPL30;TXN2;WRAP73;TMSB10;PHB2;RBM22;EFHD2;RPL36AL;EIF2D;SP140;NAPA;TCF25;SRI;AURKAIP1;PRKAR1B;NACA;C4ORF33;NDUFA12;MRPS7;ARHGEF3;GSTP1;EIF2AK2;BRD3;TRMT2A;RPL36;MRPL51;TMEM128;RPL24;ODC1;RPL14;C2ORF49;BTN3A2;EXOSC10;STK39;RNF126;RPL18A;POLR2G;PSMB6;NDUFB4;RNMT;IER2;GSTK1;PSMA7;EMP3;RPS6;GIMAP2;FYN;TTN;RPS2;RPS7;PLSCR1;ZDHHC4;UQCR10;THEM4;FAM50A;ATG2A;TPT1;CRBN;PPP1CB;ERMP1;RPL34;SNF8;RPL15;SRPK1;ACTG1;HLA-F;CCL3L3;CYTIP;MRPL19;NAA38;RNF44;POLM;SPOCK2;NAMPT;TNFRSF1B;TNFAIP3;ITGA4;PNRC2;RPL21;KLRD1;PRR14;GADD45GIP1;ACAA1;PNN;EID1;CFL1;CALM1;ZNF600;LY6E;PRKD2;FERMT3;RNPEPL1;MAT2B;HMGN3;RPS5;EIF4A3;RPL27A;KXD1;COX4I1;BEX4;H1-10;PFKFB3;NOL7;APOBEC3G;CD72;CD44;SH3BP5;LSM7;UNC45A;MRPL52;MTCH2;TM9SF2;METRNL;COX5B;GBP2;PSMB9;ZNF394;SAMD9;RPL6;S100A6;SAMSN1;ETFB;PDCD7;GABARAPL2;PDCD5;LLGL2;H2BC9;PTS;CACNA2D4;RBM28;CCDC146;RPL27;P2RY8;CHTOP;ITGB3BP;ORMDL1;CRNKL1;LDHA;CCHCR1;RPL18;GLMN;HINT1;U2AF2;NDUFB1;WDR46;COMMD8;NCBP2;NSA2;EXOSC1;VPS28;CFLAR;SMDT1;JOSD1;EIF5A;SLFN5;SMARCD1;BEST1;CCDC174;LITAF;MYL12A;IDH3B;NDUFS8;LARS1;TTC38;BAIAP2L2;IRF1;POFUT2;ZNF266;RTCB;ZNF260;SMNDC1;GOLGA4;ITGB2;HNRNPAB;DCTN6;NPM1;TRMT10B;BCL7B;DDX27;CCDC137;KDM7A;EIF3K;BLOC1S2;NCKAP1L;MICOS13;ERAP1;CCDC59;KDM6B;NDUFS5;RPLP0;PTGES2;PTPRB;MXRA7;REXO4;PRR5L;TUBGCP2;RPS9;RBX1;AKAP8;TYROBP;TAP1;ITGAL;APBA2;KARS1;KLHDC2;EIF2A;ARPC5L;MRPS11;BTG1;TARS2;PARG;PRPF3;ING4;SYTL3;CSNK1G2;ANKRA2;GPX4;NOB1;TTC19;GLI4;MRPS15;ENOSF1;WDR55;ARMCX3;ATG10;MCEE;BUD31;MRPL32;GMEB1;CD47;ZNF586;PSMD12;COPS8;CYFIP2;PIM3;DGKD;CKS2;ANAPC11;PFN1;DNAJC2;IL18R1;MAX;UROS;VPS37B;CREM;PLEKHA1;TERF2IP;C19ORF53;MICU2;CYBA;CSNK1D;ATF1;GTPBP6;PTPRC;COX7A2;PSMD8;PSMA5;ATP1B3;PRDM1;KAT5;APEX1;CLTB;TRABD;COX6C;DNMT1;SRSF2;CCZ1;DDX5;USB1;PGK1;POGK;SRSF7;THYN1;RPS28;TMCO1;EEF1B2;SOD1;SEC62;RAD9A;SPG7;FAM136A;ZNF302;ELMOD3;ZNF16;RPL9;NR4A1;FTL;RGL4;HAVCR2;UXT;CWC25
prerank,GO_Biological_Process_2021__positive regulation of cell junction assembly (GO:1901890),0.6001982971634796,1.3453902005404095,0.07692307692307693,0.5920030556429335,1.0,6/37,3.53%,COL16A1;NRP1;GRID2;DLG5;NPHP1;NLGN1
prerank,GO_Biological_Process_2021__regulation of protein metabolic process (GO:0051246),0.5761663595321086,1.3453032888655971,0.05263157894736842,0.5914193989017703,1.0,5/34,9.60%,KLF4;LDLR;SPOPL;NEDD4L;MDM2
prerank,GO_Biological_Process_2021__modified amino acid transport (GO:0072337),0.7979893335317023,1.3452440035300532,0.08163265306122448,0.5906617223404788,1.0,1/8,0.66%,PDPN
prerank,GO_Biological_Process_2021__negative regulation of viral transcription (GO:0032897),-0.8090204115393373,-1.3452072074648567,0.16666666666666666,0.42041991864231937,1.0,3/10,9.65%,ZFP36;IFITM3;TRIM13
prerank,PanglaoDB_Augmented_2021__Neural Stem/Precursor Cells,0.5598444470352733,1.3449726480345632,0.07142857142857142,0.5906288389767348,1.0,12/69,5.57%,NPAS3;KCNQ2;CNTN2;IGF1R;DPYSL5;NCAN;GFAP;SLC1A3;ZNF536;ARNT2;SNAP91;CSPG5
prerank,GO_Biological_Process_2021__regulation of cartilage development (GO:0061035),0.7829043635379163,1.3445277143745307,0.11627906976744186,0.5910247963188036,1.0,5/11,11.55%,ZBTB16;BMP1;SOX5;BMPR1B;KAT2A
prerank,Reactome_2022__NOTCH2 Activation And Transmission Of Signal To Nucleus R-HSA-2979096,-0.7555226377288593,-1.34423773909028,0.10606060606060606,0.4233029638468683,1.0,2/16,1.30%,UBC;RPS27A
prerank,GO_Biological_Process_2021__inositol phosphate catabolic process (GO:0071545),0.7001319942985584,1.3440943613111156,0.11363636363636363,0.5918085361304368,1.0,5/11,16.55%,INPP1;IMPA1;NUDT3;PTEN;INPP5A
prerank,Reactome_2022__Drug ADME R-HSA-9748784,-0.7178979055887004,-1.3436092938056285,0.09230769230769231,0.42480843370782956,1.0,5/26,6.85%,VAV3;SLC38A1;ABCC3;ABCB1;GSTP1
prerank,GO_Biological_Process_2021__positive regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901838),-0.7840362482233708,-1.3434628773164228,0.1875,0.4248455459859037,1.0,1/10,0.51%,DDX11
prerank,GO_Biological_Process_2021__excitatory postsynaptic potential (GO:0060079),0.7566308826518846,1.3431292507416817,0.15384615384615385,0.5947261716039356,1.0,5/11,16.68%,GRID2;LRRK2;GRIN2B;GSK3B;GRIN2A
prerank,"GO_Biological_Process_2021__protein localization to chromosome, telomeric region (GO:0070198)",-0.8077206184560791,-1.3428526686226825,0.11864406779661017,0.4264412590154907,1.0,3/10,12.59%,TPP1;BRCA2;TERF2IP
prerank,GO_Biological_Process_2021__positive regulation of leukocyte mediated cytotoxicity (GO:0001912),-0.7059173410457844,-1.3427241866413917,0.07575757575757576,0.4263816330422484,1.0,8/20,14.31%,HLA-B;SLAMF6;HLA-F;KLRD1;CD226;HLA-DRA;TYROBP;HLA-E
prerank,GO_Biological_Process_2021__cellular response to estradiol stimulus (GO:0071392),0.752057252636692,1.34271407293141,0.13953488372093023,0.5957532208900467,1.0,3/11,4.06%,RUVBL2;NCOA3;NRIP1
prerank,GO_Biological_Process_2021__regulation of B cell activation (GO:0050864),-0.7175010906279952,-1.34270055647347,0.06666666666666667,0.42606606035181643,1.0,6/16,9.60%,IL4I1;THEMIS2;IKZF3;TNFAIP3;SAMSN1;BANK1
prerank,GO_Biological_Process_2021__regulation of DNA-directed DNA polymerase activity (GO:1900262),-0.8588047018150571,-1.3426324279321502,0.09259259259259259,0.42541797329032827,1.0,1/5,6.55%,CHTF18
prerank,GO_Biological_Process_2021__positive regulation of DNA-directed DNA polymerase activity (GO:1900264),-0.8588047018150571,-1.3426324279321502,0.09259259259259259,0.42541797329032827,1.0,1/5,6.55%,CHTF18
prerank,Reactome_2022__FLT3 Signaling By CBL Mutants R-HSA-9706377,-0.919318989905469,-1.3426292106798474,0.06557377049180328,0.4250004054846424,1.0,2/5,1.30%,UBC;RPS27A
prerank,Reactome_2022__DNA Replication Pre-Initiation R-HSA-69002,-0.5928709017222984,-1.342512009319634,0.02666666666666667,0.4248387117267109,1.0,25/88,14.90%,UBC;H2BC4;H2BC26;H2AC20;RPS27A;H2AC6;PSMB3;POLE3;H3-3B;H2AJ;H2BC21;PSMB6;PSMA7;H2BC5;PSMB9;H2BC9;PSMD12;ANAPC11;H2BC11;PSMD8;PSMA5;MCM7;RPA3;UBA52;CDC26
prerank,GO_Biological_Process_2021__negative regulation of angiogenesis (GO:0016525),0.5781772044424024,1.3424765200551965,0.0,0.5956153616372344,1.0,9/43,7.30%,KLF4;SERPINE1;YJEFN3;SPRY2;AMOT;SPRED1;PPARG;PTPRM;TNF
prerank,GO_Biological_Process_2021__negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),-0.8644313399964116,-1.3424636300999198,0.05357142857142857,0.4246301834950059,1.0,1/8,2.68%,PARP14
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell action potential (GO:0098901),-0.7118928612119912,-1.3424225416459812,0.1076923076923077,0.4243278441531407,1.0,8/18,18.55%,JUP;FGF13;CALM1;TRPM4;DSC2;NOS1AP;PKP2;AKAP9
prerank,GO_Biological_Process_2021__regulation of immune effector process (GO:0002697),-0.6970450948579129,-1.341670814648522,0.04838709677419355,0.4264739977024423,1.0,12/22,21.85%,CD55;CLU;PHB2;C5AR1;HLA-DRA;C5AR2;SERPING1;C3;HLA-DRB1;C1QBP;C1QB;C1QC
prerank,GO_Biological_Process_2021__regulation of postsynaptic membrane potential (GO:0060078),0.6660430432017505,1.3415600574595545,0.1282051282051282,0.5985701468788355,1.0,11/20,21.96%,GRID2;INSYN2A;LRRK2;GLRA1;GRIN2B;GSK3B;GRIN2A;GABRG3;GABRA4;GABRA2;GRIN1
prerank,GO_Biological_Process_2021__negative regulation of mitochondrial fusion (GO:0010637),-0.9077869828569882,-1.3414064358304316,0.03278688524590164,0.426922769075457,1.0,1/5,1.44%,TFRC
prerank,GO_Biological_Process_2021__inorganic cation transmembrane transport (GO:0098662),0.4575465101895608,1.3413928915539846,0.05263157894736842,0.5980614910353963,1.0,35/128,15.77%,CACNA1A;TRPC1;KCNQ2;PKD2;SLC39A14;SLC9C2;KCNJ2;SLC1A3;SCN3A;PKD1;KCND3;SCN3B;SLC39A8;HPN;SLC4A4;KCNC2;SLC41A1;SLC9A1;SCN8A;KCNK6;KCNK13;ITGAV;KCNN2;ANO6;SLC9A9;ABCC8;KCNH5;SLC8A1;SLC40A1;SLC25A14;HVCN1;SLC24A2;SLC12A2;ABCB8;TRPC4
prerank,GO_Biological_Process_2021__organic hydroxy compound biosynthetic process (GO:1901617),-0.6634707125350162,-1.341289917784504,0.0967741935483871,0.4270135864479348,1.0,3/31,3.13%,INSIG1;CH25H;PER2
prerank,Reactome_2022__Josephin Domain DUBs R-HSA-5689877,-0.8201146011648264,-1.34120032853978,0.09230769230769231,0.4268132654954452,1.0,2/10,1.30%,UBC;RPS27A
prerank,GO_Biological_Process_2021__B cell activation (GO:0042113),-0.6066328760964863,-1.3410026919323577,0.15384615384615385,0.42711027341302255,1.0,10/45,12.82%,TPD52;GPR183;DNAJB9;BTK;SLC25A5;PHB2;ITGA4;BANK1;TCF3;PTPRC
prerank,Reactome_2022__Biosynthesis Of N-glycan Precursor (Dolichol LLO) And Transfer To Protein R-HSA-446193,0.5488008203497674,1.3409871479840991,0.058823529411764705,0.5988065650382955,1.0,18/50,20.04%,ST6GAL2;GNPNAT1;GLB1;ST6GALNAC3;MPDU1;GFPT1;MVD;ST6GALNAC5;RENBP;NANS;ST8SIA4;ALG12;GMDS;ST8SIA5;ALG8;ALG3;NUS1;ALG5
prerank,CellMarker_Augmented_2021__Microglial cell:Embryonic Prefrontal Cortex,-0.502010335584441,-1.3406766696694998,0.010869565217391304,0.42781876716161377,1.0,53/423,8.28%,CCL4;CD36;CCL3;H1-2;CEBPD;SAT1;CH25H;SRGN;CD37;ARHGAP4;HLA-B;FOS;DYNLT1;ZFP36;JUNB;DUSP1;MNDA;GPR183;RNASET2;TPP1;SYNE2;GADD45B;RGS2;AIF1;BTG2;B2M;NAIP;CD14;FCER1G;RGS1;CTSB;RNF213;IER3;PLTP;BEX1;NCF4;GATM;HLA-C;PLEK;IL10RA;GLUL;LILRB4;IGF1;CD63;C5AR1;NNAT;IER2;GSTK1;TPT1;SGK1;TNFRSF1B;OLR1;OAS1
prerank,GO_Biological_Process_2021__positive regulation of oligodendrocyte differentiation (GO:0048714),-0.8869106613816775,-1.3406293314382816,0.14583333333333334,0.42759016560277324,1.0,3/5,10.30%,CXCR4;TNFRSF1B;PTN
prerank,"KEGG_2021_Human__Glycine, serine and threonine metabolism",-0.7084597367409778,-1.3405178352357152,0.07142857142857142,0.42751158276448864,1.0,2/16,4.89%,GLYCTK;GATM
prerank,GO_Biological_Process_2021__regulation of lamellipodium organization (GO:1902743),0.7462931680537959,1.3403723009630626,0.0975609756097561,0.600203016921912,1.0,2/10,1.04%,PDPN;FER
prerank,Reactome_2022__Fatty Acids Bound To GPR40 (FFAR1) Regulate Insulin Secretion R-HSA-434316,0.7854754788131041,1.3403133382038406,0.16666666666666666,0.5993486062925244,1.0,3/7,18.03%,GNAQ;GNA11;PLCB3
prerank,GO_Biological_Process_2021__establishment of epithelial cell apical/basal polarity (GO:0045198),0.7571738305006928,1.339927775287967,0.1346153846153846,0.5999920507876043,1.0,1/7,1.49%,MSN
prerank,GO_Biological_Process_2021__regulation of T cell mediated cytotoxicity (GO:0001914),-0.754719047243937,-1.3398314196371912,0.04054054054054054,0.42910446466403873,1.0,6/14,14.31%,HLA-B;HLA-F;KLRD1;HLA-DRA;PTPRC;HLA-E
prerank,CellMarker_Augmented_2021__Macrophage:Lung,-0.7720880907240059,-1.3393229224434917,0.14285714285714285,0.43035827189575926,1.0,3/11,11.27%,TFRC;CD14;ITGAL
prerank,GO_Biological_Process_2021__positive regulation of immune response (GO:0050778),-0.6428235736456632,-1.3390190301155858,0.05714285714285714,0.4307802229440552,1.0,16/47,16.01%,SKAP1;RSAD2;CCL5;PLSCR1;CD226;ITGB2;TASL;HLA-DRA;KARS1;CYBA;PTPRC;NOD2;IFI35;HLA-DMB;CD74;POLR3C
prerank,CellMarker_Augmented_2021__T Helper cell:Liver,-0.855828943894239,-1.3388444404836084,0.10526315789473684,0.4309313717840251,1.0,3/8,4.97%,DUSP1;CD69;ABCB1
prerank,GO_Biological_Process_2021__homotypic cell-cell adhesion (GO:0034109),-0.6453835819827567,-1.3387477300740405,0.11940298507462686,0.43089624137095023,1.0,9/32,14.58%,FLNA;PLEK;ACTG1;FERMT3;MYL12A;ACTB;DSC2;PIK3CB;TLN1
prerank,GO_Biological_Process_2021__xenobiotic catabolic process (GO:0042178),-0.87229037129976,-1.338666466756686,0.1702127659574468,0.43067540723290404,1.0,3/5,8.97%,GSTM4;ACAA1;GSTM3
prerank,GO_Biological_Process_2021__regulation of membrane depolarization (GO:0003254),0.7943559719294011,1.3385428191195485,0.10526315789473684,0.6045753496911045,1.0,4/9,8.52%,SMAD7;LRRK2;SCN3B;NEDD4L
prerank,GO_Biological_Process_2021__response to corticosteroid (GO:0031960),-0.8923589158736602,-1.3384348275090592,0.12244897959183673,0.4310210616035871,1.0,1/5,0.10%,CALCR
prerank,GO_Biological_Process_2021__cellular response to calcium ion (GO:0071277),0.5631582310762133,1.3382717544119658,0.06896551724137931,0.6046349842627113,1.0,13/44,22.43%,PKD2;NLGN1;WNT5A;ALOX5AP;SYT17;PRKAA1;ADGRV1;CPNE2;SYT4;ADD1;RYR1;CPNE3;ITPKB
prerank,Reactome_2022__LGI-ADAM Interactions R-HSA-5682910,0.7633863266794567,1.3381015198572848,0.20588235294117646,0.6045609117409847,1.0,7/9,21.06%,LGI4;ADAM11;STX1A;CACNG8;CACNG2;CACNG3;ADAM22
prerank,GO_Biological_Process_2021__synaptic vesicle localization (GO:0097479),0.756334262674998,1.3380210962302077,0.06976744186046512,0.6038777385047455,1.0,2/11,6.03%,NLGN1;TMEM230
prerank,GO_Biological_Process_2021__negative regulation of double-strand break repair via nonhomologous end joining (GO:2001033),-0.8548525720540208,-1.3377591578988712,0.10204081632653061,0.432923316945036,1.0,1/5,8.09%,CYREN
prerank,CellMarker_Augmented_2021__CD1C+ B Dendritic cell:Blood,-0.6759746860536843,-1.3376058331560245,0.07575757575757576,0.43306222937115624,1.0,10/32,7.73%,CD36;SLC2A3;MNDA;PID1;MPP7;NAIP;CD14;F13A1;NLRP12;RAB3D
prerank,GO_Biological_Process_2021__regulation of actin cytoskeleton organization (GO:0032956),0.5309366046987538,1.3375494832650139,0.034482758620689655,0.6049457968682733,1.0,5/62,7.54%,PDGFA;EPS8;HIP1R;CDK10;CRK
prerank,Reactome_2022__Caspase Activation Via Dependence Receptors In Absence Of Ligand R-HSA-418889,0.707017734829762,1.3369943966330393,0.175,0.6063709949981342,1.0,4/9,13.60%,DAPK2;CASP9;UNC5B;DCC
prerank,GO_Biological_Process_2021__positive regulation of interleukin-4 production (GO:0032753),-0.786401285657579,-1.3365958915277245,0.10344827586206896,0.43583730529309034,1.0,3/12,3.26%,SLC7A5;PRKCQ;FCER1G
prerank,GO_Biological_Process_2021__protein kinase B signaling (GO:0043491),-0.6965327301747968,-1.3365957854492179,0.10344827586206896,0.43539075067701133,1.0,4/17,7.56%,CCL3;CCL5;IGF1;THEM4
prerank,GO_Biological_Process_2021__positive regulation of actin filament polymerization (GO:0030838),0.5607823301179183,1.3365518045331637,0.05714285714285714,0.6069767481422079,1.0,6/31,4.43%,FER;GSN;CDC42EP3;NCK2;VASP;SPIRE2
prerank,GO_Biological_Process_2021__nuclear pore organization (GO:0006999),0.6929768459998055,1.336414748896474,0.15789473684210525,0.6065021907245044,1.0,7/13,25.66%,NUP153;RTN4;NDC1;NUP133;NUP205;NUP98;TPR
prerank,GO_Biological_Process_2021__zinc ion import across plasma membrane (GO:0071578),0.9273935266096578,1.3362469045121539,0.023255813953488372,0.6059347333251915,1.0,3/5,5.71%,SLC39A12;SLC39A14;SLC39A8
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Embryo,0.6512296478990943,1.3360945206926527,0.08888888888888889,0.6054256836231144,1.0,1/20,0.04%,SHROOM3
prerank,GO_Biological_Process_2021__response to UV-C (GO:0010225),-0.824242203969269,-1.3356554837974373,0.15789473684210525,0.4380285178194254,1.0,1/7,1.78%,CARD16
prerank,GO_Biological_Process_2021__cellular response to peptide hormone stimulus (GO:0071375),-0.592034052480291,-1.3354483276803621,0.075,0.43834608845331097,1.0,4/74,2.94%,NR4A3;SYAP1;INSIG1;USF1
prerank,KEGG_2021_Human__Galactose metabolism,0.6428576354724759,1.3354236375874422,0.13636363636363635,0.606819767765735,1.0,4/18,6.29%,PFKP;PFKM;GLB1;MGAM
prerank,GO_Biological_Process_2021__TORC2 signaling (GO:0038203),-0.8715765231971819,-1.33483881647134,0.1836734693877551,0.44004494528947713,1.0,1/6,0.46%,SYAP1
prerank,GO_Biological_Process_2021__copper ion homeostasis (GO:0055070),-0.8073888797569648,-1.3348037236375891,0.07352941176470588,0.439697158322626,1.0,1/11,0.25%,MT2A
prerank,Reactome_2022__DARPP-32 Events R-HSA-180024,-0.6854056865537819,-1.3344900615705175,0.12727272727272726,0.4403614332841003,1.0,3/18,8.36%,PDE4A;PRKAR1B;CALM1
prerank,GO_Biological_Process_2021__regulation of cell-cell adhesion mediated by integrin (GO:0033632),-0.8621874813692276,-1.3344693890475026,0.11290322580645161,0.4400232171062795,1.0,3/5,8.42%,SKAP1;CCL5;FERMT3
prerank,KEGG_2021_Human__Leukocyte transendothelial migration,-0.5746762839457386,-1.3343207253573177,0.057971014492753624,0.4400802317265954,1.0,15/78,11.27%,ITK;CXCR4;VAV3;CD99L2;CLDN7;NCF4;PECAM1;TXK;ACTG1;ITGA4;NCF2;MYL12A;ITGB2;ACTB;ITGAL
prerank,Reactome_2022__Heparan Sulfate/Heparin (HS-GAG) Metabolism R-HSA-1638091,0.5672685325013566,1.3343203183056098,0.12195121951219512,0.6094499079692592,1.0,8/33,6.07%,HS3ST5;HS3ST4;NCAN;GLB1;HS2ST1;CSPG5;HPSE;B4GALT7
prerank,GO_Biological_Process_2021__negative regulation of PERK-mediated unfolded protein response (GO:1903898),-0.843500151405257,-1.3341681412944015,0.10416666666666667,0.44014629654980564,1.0,1/5,1.16%,PPP1R15A
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-serine phosphorylation (GO:0033138),-0.6126053134402032,-1.334165919795809,0.11428571428571428,0.43969944751777534,1.0,8/49,14.13%,CALCR;TFRC;PRKD2;CD44;VEGFA;MTCP1;TERF2IP;CAMK1
prerank,GO_Biological_Process_2021__positive regulation of cytoskeleton organization (GO:0051495),0.5309011165036162,1.3341314409734235,0.041666666666666664,0.6091440828438913,1.0,6/47,4.28%,NRP1;FER;SEMA5A;CDC42EP3;NCK2;VASP
prerank,GO_Biological_Process_2021__cation homeostasis (GO:0055080),0.8204301434030172,1.3340532449354878,0.07692307692307693,0.6085207321210805,1.0,3/6,15.12%,SLC7A8;UNC80;ATP13A2
prerank,GO_Biological_Process_2021__transcription by RNA polymerase III (GO:0006383),-0.6546932519240801,-1.3340160051210235,0.14705882352941177,0.4398206494889515,1.0,2/23,3.40%,SNAPC1;GTF3C6
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Synovium,-0.8453355802296958,-1.333986138922432,0.0967741935483871,0.43943900344308706,1.0,3/6,12.82%,PECAM1;CD44;PTPRC
prerank,GO_Biological_Process_2021__negative regulation of lymphocyte activation (GO:0051250),-0.7597584220275323,-1.333968544637165,0.140625,0.43909464586650027,1.0,4/14,9.60%,IL4I1;TNFAIP3;SAMSN1;BANK1
prerank,KEGG_2021_Human__Steroid biosynthesis,0.7202157069485745,1.3336728373562885,0.1568627450980392,0.6090030216271743,1.0,7/12,20.27%,DHCR24;FDFT1;TM7SF2;MSMO1;LIPA;SC5D;SQLE
prerank,GO_Biological_Process_2021__protein localization to chromatin (GO:0071168),0.6640956722924384,1.3334690998542411,0.11627906976744186,0.6087180587492677,1.0,8/15,26.93%,RUVBL2;CHMP7;NIPBL;MACROH2A1;LEMD2;ESR1;WAPL;MCM9
prerank,GO_Biological_Process_2021__alpha-amino acid catabolic process (GO:1901606),-0.7924444635180402,-1.3331828117487081,0.14545454545454545,0.4411494778883697,1.0,2/10,5.45%,IL4I1;KMO
prerank,Reactome_2022__SARS-CoV-1 Infection R-HSA-9678108,-0.6482497761337361,-1.333150894193906,0.08955223880597014,0.440767646094766,1.0,5/41,6.59%,UBC;RPS27A;ZCRB1;PARP14;PARP9
prerank,Reactome_2022__RHOH GTPase Cycle R-HSA-9013407,-0.6473223585484673,-1.3331369871448018,0.2112676056338028,0.440377483559183,1.0,2/29,5.44%,TFRC;JUP
prerank,GO_Biological_Process_2021__regulation of lymphocyte migration (GO:2000401),0.793311131020006,1.3330767197293563,0.1568627450980392,0.6092357809845693,1.0,3/7,14.99%,MSN;JAM2;STK10
prerank,GO_Biological_Process_2021__iron ion transmembrane transport (GO:0034755),0.7627926518141012,1.3330266239274422,0.15555555555555556,0.6084673380240098,1.0,3/8,13.82%,SLC39A14;SLC39A8;SLC40A1
prerank,Reactome_2022__InlB-mediated Entry Of Listeria Monocytogenes Into Host Cell R-HSA-8875360,-0.7633907962055945,-1.3329900279387223,0.13846153846153847,0.44052454544850184,1.0,3/15,7.21%,UBC;RPS27A;RNMT
prerank,GO_Biological_Process_2021__positive regulation of cytoplasmic transport (GO:1903651),0.7005647931975524,1.3327693048397535,0.20454545454545456,0.6083704570906222,1.0,3/11,11.83%,MSN;PTPN23;SORL1
prerank,GO_Biological_Process_2021__negative regulation of interleukin-1 beta production (GO:0032691),-0.7443320714375443,-1.3327445108835378,0.0967741935483871,0.4409710504692885,1.0,5/14,8.14%,CARD16;LILRB4;IGF1;GSTP1;TNFAIP3
prerank,GO_Biological_Process_2021__synaptonemal complex assembly (GO:0007130),-0.9106092458804799,-1.3327247207979778,0.08064516129032258,0.44013906501440747,1.0,2/5,2.73%,SYCE2;STAG3
prerank,GO_Biological_Process_2021__synaptonemal complex organization (GO:0070193),-0.9106092458804799,-1.3327247207979778,0.08064516129032258,0.44013906501440747,1.0,2/5,2.73%,SYCE2;STAG3
prerank,GO_Biological_Process_2021__mitochondrion morphogenesis (GO:0070584),-0.7730300460662887,-1.3325569488250997,0.11475409836065574,0.44044877739668176,1.0,5/11,18.39%,PID1;FIS1;NUBPL;SLIRP;PNPT1
prerank,GO_Biological_Process_2021__cellular glucose homeostasis (GO:0001678),0.5723766992463805,1.3325081278855015,0.11764705882352941,0.6085336801248048,1.0,7/31,10.70%,PPARGC1A;IGF1R;SLC39A14;SIRT1;UNC13B;SOX4;PCK2
prerank,GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway (GO:0002484),-0.8382078487211133,-1.3319616624451664,0.1,0.4417260779473817,1.0,4/5,14.31%,HLA-B;HLA-C;HLA-F;HLA-E
prerank,"GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent (GO:0002486)",-0.8382078487211133,-1.3319616624451664,0.1,0.4417260779473817,1.0,4/5,14.31%,HLA-B;HLA-C;HLA-F;HLA-E
prerank,GO_Biological_Process_2021__regulation of cell junction assembly (GO:1901888),0.624943438904132,1.331908037139513,0.047619047619047616,0.6102156239398138,1.0,7/17,19.15%,RAP1A;RUNX1;PDLIM5;TJP1;SETD5;RAPGEF2;CBFB
prerank,KEGG_2021_Human__Viral carcinogenesis,-0.520449360501964,-1.331733403453328,0.06172839506172839,0.44201521474621536,1.0,21/138,14.85%,H2BC7;H4C3;H2BC4;HLA-B;HLA-C;RANBP1;H2BC18;EIF2AK2;H2BC21;HLA-F;H2BC5;RBPJ;H2BC9;H2BC8;H2BC11;PIK3CB;CCND1;REL;HLA-E;RASA2;C3
prerank,Reactome_2022__MECP2 Regulates Transcription Factors R-HSA-9022707,0.854814351302478,1.331628688486925,0.10869565217391304,0.6103753999693653,1.0,2/5,12.37%,PPARG;RBFOX1
prerank,GO_Biological_Process_2021__positive regulation of integrin activation (GO:0033625),-0.8439642839650674,-1.3313428131536453,0.1746031746031746,0.4426735698558868,1.0,2/7,5.33%,SKAP1;PLEK
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell proliferation (GO:0050680),-0.5866788960194023,-1.3311983216963763,0.08333333333333333,0.4426458177669986,1.0,8/42,10.09%,TGFBR3;RUNX3;NLRC3;B2M;AQP11;BRCA2;STAT1;ATP5IF1
prerank,Reactome_2022__Regulation Of PTEN Localization R-HSA-8948747,-0.831291372800758,-1.331157992159661,0.06557377049180328,0.4422940697341839,1.0,2/9,1.30%,UBC;RPS27A
prerank,GO_Biological_Process_2021__negative regulation of exocytosis (GO:0045920),0.8044133877953367,1.3309938368195302,0.125,0.6115319734721569,1.0,2/9,0.57%,ANXA1;RAB33B
prerank,GO_Biological_Process_2021__positive regulation of NLRP3 inflammasome complex assembly (GO:1900227),-0.8488944093784228,-1.3309041247459057,0.10606060606060606,0.4426624192159846,1.0,1/6,0.52%,CD36
prerank,PanglaoDB_Augmented_2021__Ciliated Cells,-0.7334360692824058,-1.330398122990855,0.12307692307692308,0.44382058248587214,1.0,6/16,17.34%,ANKUB1;ATP5MK;CCDC39;DNAH12;TUBB4B;DNAH9
prerank,Reactome_2022__ERBB2 Activates PTK6 Signaling R-HSA-8847993,0.7879208743269965,1.3299015657442381,0.1956521739130435,0.6153401559519385,1.0,4/6,14.14%,NRG1;NRG3;NRG2;ERBB4
prerank,GO_Biological_Process_2021__neuropeptide signaling pathway (GO:0007218),0.6654315919629082,1.3298664504243631,0.20689655172413793,0.6144048750758617,1.0,7/15,17.63%,GLRA1;SORT1;SORCS3;SORL1;SORCS2;MCHR2;RAPGEF2
prerank,CellMarker_Augmented_2021__Naive CD8+ T cell:Peripheral Blood,-0.6077643693541582,-1.32973290018846,0.07352941176470588,0.44544311787085533,1.0,19/74,13.55%,RIC3;TOMM7;RPS8;SCML4;GPR183;CD55;AIF1;SELL;RACK1;TXK;GIMAP2;THEM4;BEX4;ITFG2;NPM1;APBA2;GPR155;APEX1;LRRN3
prerank,GO_Biological_Process_2021__synaptic vesicle budding from presynaptic endocytic zone membrane (GO:0016185),-0.7737030504551895,-1.3293024923131278,0.14285714285714285,0.4462196578420165,1.0,2/7,1.19%,MX2;MX1
prerank,GO_Biological_Process_2021__negative regulation of pathway-restricted SMAD protein phosphorylation (GO:0060394),0.8558582381011512,1.3292553871315194,0.0851063829787234,0.6157334321927886,1.0,1/5,2.59%,SMAD7
prerank,Reactome_2022__Free Fatty Acids Regulate Insulin Secretion R-HSA-400451,-0.7627864443317254,-1.329133484740112,0.11475409836065574,0.44634081411028276,1.0,1/10,0.52%,CD36
prerank,GO_Biological_Process_2021__positive regulation of T cell mediated cytotoxicity (GO:0001916),-0.7750415636034175,-1.3290539236168493,0.08955223880597014,0.44619329460553653,1.0,4/11,14.31%,HLA-B;HLA-F;HLA-DRA;HLA-E
prerank,KEGG_2021_Human__Glycosylphosphatidylinositol (GPI)-anchor biosynthesis,0.6864584095708126,1.3290351798394493,0.1111111111111111,0.6157731471631486,1.0,3/19,1.13%,PIGQ;PIGU;PGAP1
prerank,Reactome_2022__Synthesis Of Substrates In N-glycan Biosythesis R-HSA-446219,0.5434207904661718,1.3288754410845793,0.125,0.6152996821186104,1.0,14/37,20.04%,ST6GAL2;GNPNAT1;GLB1;ST6GALNAC3;GFPT1;MVD;ST6GALNAC5;RENBP;NANS;ST8SIA4;GMDS;ST8SIA5;NUS1;ALG5
prerank,Reactome_2022__Synthesis Of UDP-N-acetyl-glucosamine R-HSA-446210,0.7773980830301734,1.3287789905599612,0.15217391304347827,0.6146813465630954,1.0,3/7,12.99%,GNPNAT1;GFPT1;RENBP
prerank,GO_Biological_Process_2021__pyrimidine deoxyribonucleotide catabolic process (GO:0009223),-0.7571442022242844,-1.3286948271370578,0.15254237288135594,0.4469578432728951,1.0,3/10,4.95%,SMUG1;OGG1;NT5C
prerank,GO_Biological_Process_2021__lymphocyte mediated immunity (GO:0002449),-0.8070332355753334,-1.3284351022394139,0.07936507936507936,0.4472565113466443,1.0,5/9,8.19%,MYO1G;CD55;BTN3A3;BTN3A2;KLRD1
prerank,CellMarker_Augmented_2021__Enteroendocrine cell:Large Intestine,0.531176807794815,1.328014692500688,0.041666666666666664,0.6167500450728892,1.0,21/71,19.54%,PGM5P2;FER;FRAS1;ZNF471;CFAP54;L2HGDH;TOR1AIP2;PLEKHA5;WDPCP;ADAMTSL3;LRRTM4;ZC3H14;BMPR1A;KPNA5;CEP112;ASB3;BRWD1;NEDD4;SPTLC3;ACOT11;TBC1D8B
prerank,CellMarker_Augmented_2021__Activated CD4+ T cell:Blood,-0.8644692780650626,-1.3279670646265243,0.13333333333333333,0.4483485838070839,1.0,3/6,3.07%,TFRC;CD69;CD14
prerank,Reactome_2022__GRB2 Events In ERBB2 Signaling R-HSA-1963640,0.742146854057846,1.3279428939303255,0.16279069767441862,0.616040188241425,1.0,4/9,14.14%,NRG1;NRG3;NRG2;ERBB4
prerank,GO_Biological_Process_2021__negative regulation of protein transport (GO:0051224),-0.7223020617845657,-1.3279375940399403,0.14516129032258066,0.4480303263175921,1.0,1/14,1.20%,RSAD2
prerank,GO_Biological_Process_2021__bone resorption (GO:0045453),-0.8609790990670093,-1.3278215609311366,0.13043478260869565,0.4480599407349483,1.0,2/6,7.73%,TPP1;RAB3D
prerank,PanglaoDB_Augmented_2021__Osteocytes,0.5441452720724931,1.3277987066101076,0.07142857142857142,0.6157877716148115,1.0,14/40,16.66%,PDPN;TCF7L1;WNT5A;GPR161;CDH11;P3H2;ENAH;FBXL7;CXCL14;FERMT2;CD276;ANTXR1;RAI14;TNC
prerank,GO_Biological_Process_2021__regulation of early endosome to late endosome transport (GO:2000641),0.635145056610949,1.3277907033661402,0.09523809523809523,0.6149180066099339,1.0,5/17,11.38%,MSN;MAP2K1;PTPN23;SNX12;MAPK1
prerank,GO_Biological_Process_2021__defense response to fungus (GO:0050832),-0.8424212062150452,-1.3276177717153792,0.13793103448275862,0.4483474488494808,1.0,1/8,1.38%,GAPDH
prerank,CellMarker_Augmented_2021__Side-population cell:Undefined,0.6472494031280993,1.3274696165765356,0.11627906976744186,0.6154123624498138,1.0,5/19,5.72%,KLF4;ANXA1;TGFBR2;TGFA;BACE2
prerank,GO_Biological_Process_2021__vasculature development (GO:0001944),0.7789317249501073,1.3273388450051402,0.23214285714285715,0.614853993263031,1.0,2/6,17.35%,FBXW7;PIK3CA
prerank,Reactome_2022__Complement Cascade R-HSA-166658,-0.6638414367135856,-1.3272200165126586,0.08771929824561403,0.44929196457143444,1.0,7/22,14.85%,CD55;CLU;C5AR1;PSMA7;C5AR2;SERPING1;C3
prerank,GO_Biological_Process_2021__proteasomal ubiquitin-independent protein catabolic process (GO:0010499),-0.747091295270789,-1.3272190329291722,0.08823529411764706,0.448849748070872,1.0,8/17,21.50%,PSMB3;PSMB6;PSMA7;PSMB9;PSMA5;PSMA3;PSMB5;NFE2L2
prerank,GO_Biological_Process_2021__negative regulation of execution phase of apoptosis (GO:1900118),0.7929164961798925,1.3271688195815643,0.09090909090909091,0.6144059328069308,1.0,1/6,5.40%,FZD3
prerank,Reactome_2022__PINK1-PRKN Mediated Mitophagy R-HSA-5205685,-0.7202457625616008,-1.3270617089217376,0.08928571428571429,0.4488695716245986,1.0,3/19,1.30%,UBC;TOMM7;RPS27A
prerank,GO_Biological_Process_2021__regulation of extracellular matrix disassembly (GO:0010715),0.8050559955165482,1.3270289670609499,0.1,0.6140857357396614,1.0,1/9,0.66%,PDPN
prerank,Reactome_2022__p75NTR Recruits Signaling Complexes R-HSA-209543,-0.8032221069228281,-1.3268619986806858,0.1746031746031746,0.44913743482643453,1.0,2/11,1.30%,UBC;RPS27A
prerank,GO_Biological_Process_2021__negative regulation of synaptic transmission (GO:0050805),0.6364268229694843,1.3267780147696573,0.13953488372093023,0.6141092853092187,1.0,9/18,20.60%,LRRK2;SHANK2;PLK2;PTEN;PRRT1;SLC24A2;ATAD1;GRIK3;SLC30A1
prerank,"GO_Biological_Process_2021__positive regulation of gene expression, epigenetic (GO:0045815)",-0.637775617581952,-1.3267704747636813,0.1044776119402985,0.4490330195790772,1.0,6/45,4.71%,H1-4;H1-3;H1-2;TAF1D;H1-0;PADI2
prerank,CellMarker_Augmented_2021__Plasma cell:Undefined,-0.8403610503600778,-1.3265486002970934,0.06818181818181818,0.4493532527799072,1.0,3/6,12.88%,CXCR4;PECAM1;PRDM1
prerank,GO_Biological_Process_2021__neutrophil activation (GO:0042119),-0.809215763245946,-1.3265461917423158,0.1746031746031746,0.4489131418565184,1.0,3/10,11.20%,CCL5;FCER1G;TYROBP
prerank,GO_Biological_Process_2021__oligosaccharide biosynthetic process (GO:0009312),0.7890817075251715,1.3262593858643827,0.09302325581395349,0.6142460867725168,1.0,3/8,11.79%,MPDU1;FUT9;ST6GALNAC5
prerank,GO_Biological_Process_2021__carbohydrate biosynthetic process (GO:0016051),0.7890817075251715,1.3262593858643827,0.09302325581395349,0.6142460867725168,1.0,3/8,11.79%,MPDU1;FUT9;ST6GALNAC5
prerank,GO_Biological_Process_2021__regulation of chondrocyte differentiation (GO:0032330),0.7429979868686474,1.3262423688424694,0.17142857142857143,0.6133894185394133,1.0,7/11,21.47%,ZBTB16;SOX5;BMPR1B;LOXL2;TGFBR1;SCIN;SOX6
prerank,GO_Biological_Process_2021__cellular copper ion homeostasis (GO:0006878),-0.8574548771308691,-1.3261796497804381,0.03076923076923077,0.44952409968029056,1.0,1/8,0.25%,MT2A
prerank,GO_Biological_Process_2021__negative regulation of B cell activation (GO:0050869),-0.7680950105717869,-1.3261213248782984,0.09090909090909091,0.44927864839570636,1.0,5/13,11.20%,MNDA;TNFAIP3;SAMSN1;BANK1;TYROBP
prerank,GO_Biological_Process_2021__digestive tract development (GO:0048565),0.6454724798975446,1.3260417524188417,0.17142857142857143,0.6130732483946112,1.0,8/17,13.48%,PKD1;SALL1;TNF;COBL;CCDC40;RARB;MEGF8;NIPBL
prerank,Reactome_2022__Cellular Hexose Transport R-HSA-189200,-0.8433763884006998,-1.326009973670233,0.1016949152542373,0.4492274533006925,1.0,3/6,10.34%,SLC2A3;SLC5A9;SLC2A8
prerank,GO_Biological_Process_2021__negative regulation of myeloid leukocyte differentiation (GO:0002762),-0.7426442899305146,-1.3258340361314294,0.10344827586206896,0.44951073692563903,1.0,4/16,9.06%,CCL3;LILRB4;GPR137B;LILRB3
prerank,Reactome_2022__Repression Of WNT Target Genes R-HSA-4641265,0.7405762112064046,1.325606016186681,0.13043478260869565,0.6140111335326446,1.0,6/11,15.26%,TCF7L1;TLE2;CTBP2;HDAC1;TCF7L2;TLE1
prerank,GO_Biological_Process_2021__regulation of histone methylation (GO:0031060),-0.7633313842195698,-1.3254899773487112,0.1,0.4501363121289561,1.0,3/9,13.98%,ZNF335;CHTOP;TET1
prerank,Reactome_2022__HDR Thru Homologous Recombination (HRR) R-HSA-5685942,-0.6227497610781759,-1.3254486893999733,0.09090909090909091,0.4497946153476965,1.0,12/44,14.82%,UBC;RPS27A;POLE3;HUS1;MUS81;BRCA2;XRCC3;KAT5;RAD9A;RPA3;BRCA1;UBA52
prerank,GO_Biological_Process_2021__carbohydrate homeostasis (GO:0033500),0.6198849795726811,1.3254028326381382,0.125,0.6139094646051253,1.0,11/41,11.06%,LEPR;IGF1R;ADIPOR2;PDK4;MCU;PPARG;BACE2;VGF;SOX4;KLF7;TCF7L2
prerank,GO_Biological_Process_2021__pattern recognition receptor signaling pathway (GO:0002221),-0.6219662891586869,-1.3252837982173795,0.07575757575757576,0.4499536878662586,1.0,5/42,3.91%,CD36;UBC;RPS27A;CD14;CTSB
prerank,KEGG_2021_Human__Fat digestion and absorption,-0.7306045116301076,-1.325262990892836,0.09836065573770492,0.44956900651102616,1.0,1/14,0.52%,CD36
prerank,GO_Biological_Process_2021__dense core granule cytoskeletal transport (GO:0099519),0.7054138381552143,1.3252442889016949,0.18604651162790697,0.6135939506079017,1.0,3/7,19.97%,TANC2;PPFIA2;SYT4
prerank,CellMarker_Augmented_2021__Progenitor cell:Skin,0.6425647686932958,1.3249532613583137,0.14634146341463414,0.6134041350707363,1.0,4/21,9.00%,SHROOM3;FRAS1;MAGI1;SHANK2
prerank,GO_Biological_Process_2021__establishment of Golgi localization (GO:0051683),0.7959630151081702,1.324941307779383,0.10810810810810811,0.6124676402080329,1.0,3/7,11.51%,STK25;COPG1;RIPOR1
prerank,Reactome_2022__Oncogenic MAPK Signaling R-HSA-6802957,0.5017371636883293,1.32473165662511,0.05714285714285714,0.6121912965275533,1.0,11/63,13.33%,DUSP6;MAP3K11;SPRED1;RAP1A;SPRED2;MAP2K1;VCL;DUSP7;MAPK1;NF1;SHOC2
prerank,GO_Biological_Process_2021__production of miRNAs involved in gene silencing by miRNA (GO:0035196),0.5961970896245276,1.3246935887552478,0.09302325581395349,0.6114191379731415,1.0,3/24,5.98%,SMAD1;SMAD2;SMAD3
prerank,KEGG_2021_Human__ErbB signaling pathway,0.49589208575854515,1.3245023379920444,0.09090909090909091,0.6111275169505618,1.0,18/68,18.09%,TGFA;GAB1;NCK2;MAP2K1;NRG1;CRK;SHC2;NRG3;MAPK1;NRG2;JUN;PTK2;ERBB4;AKT2;GSK3B;RPS6KB2;PIK3CA;MAP2K2
prerank,GO_Biological_Process_2021__calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338),-0.8721529920069369,-1.3243136985733184,0.16326530612244897,0.45210981895339164,1.0,1/5,3.74%,CLDN7
prerank,Reactome_2022__Heme Biosynthesis R-HSA-189451,0.7290015708625193,1.324221319446875,0.12244897959183673,0.611314245883797,1.0,2/9,4.35%,FLVCR1;COX10
prerank,Reactome_2022__Hh Mutants Abrogate Ligand Secretion R-HSA-5387390,-0.6230385817552789,-1.324172820273046,0.08860759493670886,0.4521262112746889,1.0,14/48,19.69%,UBC;RPS27A;PSMB3;PSMB6;PSMA7;PSMB9;PSMD12;PSMD8;PSMA5;UBA52;PSMA3;PSMC4;PSME2;PSME1
prerank,GO_Biological_Process_2021__negative regulation of immune response (GO:0050777),-0.6040104462849656,-1.3241178176932422,0.05405405405405406,0.45187163937099445,1.0,10/77,9.21%,CALCR;NLRC3;DHX58;YES1;CD247;PRKAR1B;FYN;TNFAIP3;ENPP3;SAMSN1
prerank,GO_Biological_Process_2021__negative regulation of gene silencing by miRNA (GO:0060965),0.7807933075144339,1.3241157125187968,0.14583333333333334,0.6107234969252694,1.0,2/8,7.30%,PPARG;TNF
prerank,Reactome_2022__Regulation Of TNFR1 Signaling R-HSA-5357905,-0.671620703854072,-1.3239830687272611,0.1,0.4520191999674802,1.0,5/31,9.94%,UBC;RPS27A;RACK1;TNFAIP3;CFLAR
prerank,KEGG_2021_Human__Terpenoid backbone biosynthesis,0.6529618125993145,1.323839722961477,0.12195121951219512,0.6111042062667241,1.0,8/15,28.89%,IDI1;HMGCS1;MVD;NUS1;ACAT1;PCYOX1;HMGCR;ACAT2
prerank,GO_Biological_Process_2021__cellular response to dsRNA (GO:0071359),-0.723615308319097,-1.3238318767613935,0.1111111111111111,0.4519832952565628,1.0,5/14,16.49%,IFIT1;NPM1;STING1;COLEC12;FLOT1
prerank,CellMarker_Augmented_2021__Red Blood Cell (erythrocyte):Undefined,-0.5732675201884371,-1.3238184683286656,0.0821917808219178,0.45159888296484824,1.0,16/80,10.62%,CD36;SRGN;MNDA;XAF1;CLEC12A;MS4A4A;PARP14;CD93;SAMD9L;F13A1;PECAM1;GBP2;SAMSN1;CFLAR;MS4A6A;CSF2RB
prerank,Reactome_2022__Mitophagy R-HSA-5205647,-0.7013248321984688,-1.3236019314770702,0.1,0.4518768697273058,1.0,3/22,1.30%,UBC;TOMM7;RPS27A
prerank,GO_Biological_Process_2021__regulation of embryonic development (GO:0045995),0.6438222932113522,1.323523914809412,0.06060606060606061,0.611536576670732,1.0,13/24,18.85%,PHLDB1;DAG1;TDG;WDPCP;POGLUT1;RPS6KA6;BAG6;NIPBL;CLASP1;TRIP12;RAB14;CLASP2;B4GALT5
prerank,Reactome_2022__Glycogen Storage Diseases R-HSA-3229121,-0.7965626172343501,-1.323406609362594,0.13432835820895522,0.45219780843857565,1.0,3/10,6.17%,UBC;RPS27A;G6PC3
prerank,Reactome_2022__Acetylcholine Regulates Insulin Secretion R-HSA-399997,0.7439144840910262,1.323245615628639,0.16279069767441862,0.6116336760731356,1.0,4/10,21.35%,GNAQ;GNA11;PLCB3;CHRM3
prerank,Reactome_2022__Hedgehog Off State R-HSA-5610787,-0.5680131601139321,-1.3230556084886222,0.07792207792207792,0.4530134153282961,1.0,17/82,17.75%,UBC;RPS27A;RPGRIP1L;PSMB3;PRKAR1B;PSMB6;PSMA7;PSMB9;RBX1;PSMD12;PSMD8;PSMA5;IFT52;UBA52;PSMA3;PRKAR2B;PSMC4
prerank,GO_Biological_Process_2021__peptidyl-lysine deacetylation (GO:0034983),0.7861823951798099,1.3229992002528614,0.12195121951219512,0.6117480337314019,1.0,2/8,3.65%,SIRT1;HDAC9
prerank,CellMarker_Augmented_2021__Plasma cell:Kidney,0.7533017812451899,1.322927943069217,0.23255813953488372,0.6110208795268046,1.0,2/5,8.58%,PARM1;BRSK1
prerank,GO_Biological_Process_2021__regulation of organ growth (GO:0046620),0.7546345565428944,1.3226790275072238,0.175,0.6111533119026797,1.0,1/7,0.35%,DUSP6
prerank,CellMarker_Augmented_2021__Enterocyte Progenitor cell:Small Intestine,-0.6393170783259818,-1.3223631963406233,0.0684931506849315,0.4548778380811056,1.0,17/42,19.61%,EMB;ENPP4;GCNT1;CHCHD10;SLC5A9;TMEM144;FCSK;FBP1;ZNF586;PON2;ATP1B3;AGT;PIGH;SLC2A1;RNASE6;SLC46A3;CTSA
prerank,GO_Biological_Process_2021__lipopolysaccharide-mediated signaling pathway (GO:0031663),-0.761706006202211,-1.3223331569083647,0.1864406779661017,0.45455319840559755,1.0,3/15,3.07%,CCL3;CCL5;CD14
prerank,GO_Biological_Process_2021__negative regulation of cell motility (GO:2000146),0.4956618599065521,1.3222834899950178,0.05555555555555555,0.6117570853791322,1.0,23/72,14.68%,SERPINE1;SRGAP2B;DLG5;SMAD7;MITF;DAG1;DACH1;TMEFF2;JAG1;RECK;VCL;ROBO1;CRK;KANK1;PTPRK;RNF20;CCDC125;PTEN;NF1;GTPBP4;AFDN;FRMD5;SRGAP2
prerank,GO_Biological_Process_2021__regulation of mast cell activation (GO:0033003),-0.7898147961730669,-1.3220603059691647,0.10909090909090909,0.4549916317575187,1.0,3/8,9.70%,CD300LF;PLSCR1;CD226
prerank,GO_Biological_Process_2021__entrainment of circadian clock by photoperiod (GO:0043153),-0.698660311186746,-1.322017308660372,0.14492753623188406,0.4546761618656606,1.0,7/20,18.38%,PER3;PER2;BHLHE40;PPP1CB;RBM4B;CRTC1;RBM4
prerank,GO_Biological_Process_2021__negative regulation of cell migration (GO:0030336),0.49696837594436005,1.321978035519711,0.03225806451612903,0.6119403560356793,1.0,29/91,17.58%,SERPINE1;SRGAP2B;FGF2;DLG5;SMAD7;MITF;PTPN23;DAG1;DACH1;TMEFF2;JAG1;RECK;VCL;ROBO1;KANK1;PTPRG;PTPRK;RNF20;PTEN;NF1;BMPR1A;GTPBP4;AFDN;CLASP1;SRGAP2;PTPRR;CLASP2;RAP2C;CX3CL1
prerank,GO_Biological_Process_2021__purine-containing compound metabolic process (GO:0072521),0.7786159878905593,1.3216334244919825,0.21428571428571427,0.6122624352187857,1.0,1/6,12.09%,FHIT
prerank,GO_Biological_Process_2021__regulation of platelet-derived growth factor receptor-beta signaling pathway (GO:2000586),0.7971011503586527,1.3215227020984381,0.10638297872340426,0.6118704172870112,1.0,1/5,2.09%,HIP1R
prerank,GO_Biological_Process_2021__apoptotic mitochondrial changes (GO:0008637),-0.6686221049407027,-1.3212818714019003,0.14754098360655737,0.45654913535694447,1.0,6/22,7.84%,CLU;FIS1;VPS35;THEM4;HK2;IFIT2
prerank,GO_Biological_Process_2021__negative regulation of neurotransmitter secretion (GO:0046929),0.7792333274556108,1.3209886632035492,0.13636363636363635,0.6129384488551874,1.0,1/7,3.84%,RAP1A
prerank,GO_Biological_Process_2021__modulation by symbiont of host process (GO:0044003),-0.8039849352198813,-1.3209537846680375,0.12727272727272726,0.4571658223196463,1.0,3/10,2.81%,UBC;RPS27A;B2M
prerank,Reactome_2022__Assembly Of Pre-Replicative Complex R-HSA-68867,-0.6000994144801234,-1.320826133529574,0.06756756756756757,0.4571426326204467,1.0,21/77,13.28%,UBC;H2BC4;H2BC26;H2AC20;RPS27A;H2AC6;PSMB3;H3-3B;H2AJ;H2BC21;PSMB6;PSMA7;H2BC5;PSMB9;H2BC9;PSMD12;ANAPC11;H2BC11;PSMD8;PSMA5;MCM7
prerank,GO_Biological_Process_2021__pyrimidine deoxyribonucleotide biosynthetic process (GO:0009221),-0.8724194809438266,-1.3206303998191262,0.12,0.4574299073757314,1.0,1/5,1.39%,CMPK2
prerank,GO_Biological_Process_2021__forebrain neuron differentiation (GO:0021879),0.8056765140916722,1.320346023578265,0.13043478260869565,0.6142981121327742,1.0,4/5,17.63%,SALL1;SHANK3;ERBB4;RAPGEF2
prerank,KEGG_2021_Human__Rheumatoid arthritis,-0.6192735625797098,-1.3199757815252802,0.08955223880597014,0.45965490605693776,1.0,16/50,17.61%,CCL3;FOS;CCL5;ATP6V1F;HLA-DRB5;CCL3L3;ITGB2;HLA-DRA;TNFSF13B;VEGFA;ITGAL;FLT1;HLA-DPA1;HLA-DMB;HLA-DPB1;IL18
prerank,KEGG_2021_Human__Cytokine-cytokine receptor interaction,-0.5692981212482542,-1.3195875383409663,0.0945945945945946,0.46044700856173054,1.0,17/84,8.06%,CCL4;CCL3;TNFRSF11B;CXCR4;CCL5;IL7R;TNFRSF25;TNFSF10;IL3RA;IL10RA;IL12RB2;ACKR4;OSMR;PRLR;CCL3L3;CSF2RA;TNFRSF1B
prerank,CellMarker_Augmented_2021__Macrophage:Synovium,-0.5584255255354618,-1.3194062097745722,0.05555555555555555,0.46066152675713296,1.0,25/83,11.39%,MNDA;CLEC12A;MS4A4A;MARCO;AIF1;SIGLEC1;CD14;FCER1G;CD93;PLEK;LILRB4;CD300LF;PECAM1;C5AR1;SIRPB2;TNFRSF1B;TYMP;LILRB3;NCF2;SLC11A1;MS4A6A;ITGB2;CSF2RB;TYROBP;CSF3R
prerank,KEGG_2021_Human__Natural killer cell mediated cytotoxicity,-0.5889457530966483,-1.319120549562248,0.13114754098360656,0.4611848739083461,1.0,17/67,14.31%,HLA-B;KLRC4-KLRK1;VAV3;FCER1G;GZMB;PRF1;CD247;TNFSF10;HLA-C;FYN;KLRD1;ITGB2;TYROBP;ITGAL;IFNGR2;PIK3CB;HLA-E
prerank,KEGG_2021_Human__Epstein-Barr virus infection,-0.5380023377249401,-1.3189281871970173,0.0625,0.461346791271142,1.0,36/146,18.79%,OAS3;CYCS;HLA-B;RUNX3;GADD45B;B2M;OAS2;BTK;CD247;HLA-C;ADRM1;HLA-DRB5;EIF2AK2;HLA-F;TNFAIP3;OAS1;RBPJ;CD44;STAT1;HLA-DRA;TAP1;ITGAL;PSMD12;PSMD8;PIK3CB;CCND1;HLA-E;HLA-DPA1;HLA-DMB;RAC1;HLA-DPB1;IRF7;PSMC4;IRAK4;VIM;HLA-DRB1
prerank,Reactome_2022__Myoclonic Epilepsy Of Lafora R-HSA-3785653,-0.880038548796195,-1.3188085238809553,0.15151515151515152,0.46137979678217395,1.0,2/6,1.30%,UBC;RPS27A
prerank,GO_Biological_Process_2021__regulation of low-density lipoprotein particle clearance (GO:0010988),-0.859161469221631,-1.3185699463182994,0.08771929824561403,0.4617382270669452,1.0,1/5,3.81%,ANXA2
prerank,Reactome_2022__Transport Of Mature mRNA Derived From An Intronless Transcript R-HSA-159231,0.5454138060043395,1.318238213604239,0.0967741935483871,0.6212468089003895,1.0,6/38,7.20%,NXF1;CPSF4;NUP153;NUP188;WDR33;NUP42
prerank,GO_Biological_Process_2021__positive regulation of transmembrane transport (GO:0034764),-0.813248007118564,-1.3180197626157688,0.12,0.4632255451626602,1.0,1/12,0.08%,NR4A3
prerank,GO_Biological_Process_2021__regulation of AMPA receptor activity (GO:2000311),0.6080169711501077,1.3179759576540733,0.14634146341463414,0.6213452070491454,1.0,7/16,14.74%,NLGN1;RELN;SHISA9;SHANK3;PRRT1;CACNG8;CACNG2
prerank,Reactome_2022__Cyclin A:Cdk2-associated Events At S Phase Entry R-HSA-69656,-0.5831021280522678,-1.3178740606289785,0.125,0.4632395775663918,1.0,20/65,22.96%,UBC;RPS27A;PSMB3;PSMB6;PSMA7;PSMB9;PSMD12;MAX;PSMD8;PSMA5;CCND1;UBA52;PSMA3;PSMC4;PSME2;PSME1;PSMB5;PSMC3;CDKN1B;PSME3
prerank,GO_Biological_Process_2021__lipid modification (GO:0030258),0.6154918347841474,1.3176883823063508,0.1891891891891892,0.6214087842235417,1.0,5/25,5.54%,PLA2G7;PLPPR1;PLPP1;PLPP5;PLPPR4
prerank,Reactome_2022__Oncogene Induced Senescence R-HSA-2559585,-0.6561546969762981,-1.3175348135384057,0.0847457627118644,0.46379167432161833,1.0,3/25,4.35%,UBC;RPS27A;ETS1
prerank,GO_Biological_Process_2021__amyloid fibril formation (GO:1990000),-0.6324009347652503,-1.3173729180230203,0.13114754098360656,0.4639331402536031,1.0,4/35,2.81%,CD36;UBC;RPS27A;B2M
prerank,GO_Biological_Process_2021__regulation of oligodendrocyte differentiation (GO:0048713),-0.7660166343325285,-1.3170903964141742,0.12962962962962962,0.46442386294605237,1.0,3/10,10.30%,CXCR4;TNFRSF1B;PTN
prerank,CellMarker_Augmented_2021__Fibroblast:Undefined,-0.7762656771858013,-1.3168957198769156,0.0967741935483871,0.4646837017618454,1.0,6/12,18.52%,CD44;C5AR2;CD47;PTPRC;VIM;ITGB1
prerank,Reactome_2022__Cytokine Signaling In Immune System R-HSA-1280215,-0.5081485199334546,-1.3166268011641833,0.011363636363636364,0.4651047193241037,1.0,74/465,11.49%,CCL4;MT2A;FLNA;MX2;STAT4;CD36;BCL11B;CCL3;UBC;SIGIRR;CEBPD;OAS3;TNFRSF11B;HLA-B;MX1;RSAD2;FOS;RPS27A;CCL5;XAF1;IL7R;GRAP2;TRIM5;IFIT3;B2M;IFIT1;TNFRSF25;PSMB3;YES1;RORA;OAS2;ANXA2;IFITM3;ELOB;HLA-C;IL3RA;IL10RA;F13A1;HLA-DRB5;IL12RB2;TRIM22;RHOU;AURKAIP1;NLRC5;OSMR;FGF13;PRLR;EIF2AK2;PSMB6;PSMA7;FYN;HLA-F;IFIT2;CSF2RA;TNFRSF1B;OAS1;RNASEL;EIF4A3;CD44;GBP2;PSMB9;STAT1;IRF1;ITGB2;CSF2RB;HLA-DRA;RPLP0;NUP50;TNFSF13B;RBX1;VEGFA;HIF1A;CSF3R;ALPK1
prerank,KEGG_2021_Human__Linoleic acid metabolism,0.7805916003152155,1.3160486015019777,0.26666666666666666,0.6271611002675818,1.0,1/6,0.68%,PLA2G4C
prerank,GO_Biological_Process_2021__regulation of response to interferon-gamma (GO:0060330),-0.7691447784850223,-1.3158712587391057,0.09615384615384616,0.4672506209855847,1.0,4/12,11.78%,CDC37;PARP9;STAT1;IFNGR2
prerank,CellMarker_Augmented_2021__Gonadal Mitotic Phase Fetal Germ cell:Fetal Gonad,-0.5442231765104523,-1.3157613356346631,0.025,0.4671163920015984,1.0,30/170,9.94%,FLNA;RPS13;RPS4X;RPS8;TPP1;GABARAPL1;DDIT4;MTHFD1;RPL13A;GLIPR2;RPL41;RPL10;RPL10A;MUS81;BPHL;RPL11;JUP;RPS3;RPL23;CD63;PPP1R3B;RPS26;RPS2;ATG2A;LY6E;RPL27A;TMSB4X;ZNF589;HINT1;CFLAR
prerank,GO_Biological_Process_2021__regulation of long-term synaptic depression (GO:1900452),0.7381933999007301,1.3156773407277755,0.15555555555555556,0.6274396771487762,1.0,4/8,20.52%,GRID2;SHANK3;KCNB1;AGER
prerank,Reactome_2022__Interferon Alpha/Beta Signaling R-HSA-909733,-0.5901217686414332,-1.3156014731449746,0.09375,0.46714362831098233,1.0,18/45,10.38%,MX2;OAS3;HLA-B;MX1;RSAD2;XAF1;IFIT3;IFIT1;OAS2;IFITM3;HLA-C;HLA-F;IFIT2;OAS1;RNASEL;GBP2;STAT1;IRF1
prerank,KEGG_2021_Human__Pentose phosphate pathway,0.5967992787808389,1.3152275277915126,0.08571428571428572,0.6281471402595858,1.0,2/20,1.17%,PFKP;PFKM
prerank,GO_Biological_Process_2021__negative regulation of cell activation (GO:0050866),0.783729590502662,1.3150821365426542,0.1346153846153846,0.6276854351617615,1.0,2/8,3.01%,PDGFA;LDLR
prerank,Reactome_2022__RHO GTPase Effectors R-HSA-195258,-0.5107744398235927,-1.3149666480705517,0.011764705882352941,0.46884924098064623,1.0,27/192,12.68%,FLNA;MYLK;H2BC4;H2BC26;H2AC20;H2AC6;RPS27;BTK;NCF4;H3-3B;H2AJ;H2BC21;PPP1CB;ACTG1;CENPU;H2BC5;CALM1;H2BC9;ITGB3BP;NCF2;ZWILCH;CFTR;NCKAP1L;CYFIP2;PFN1;CYBA;H2BC11
prerank,GO_Biological_Process_2021__negative regulation of RIG-I signaling pathway (GO:0039536),-0.8546148392240025,-1.3147739421969926,0.08771929824561403,0.4688409232645349,1.0,1/5,2.65%,DHX58
prerank,KEGG_2021_Human__Mitophagy,-0.6055102388341644,-1.314473352041317,0.09230769230769231,0.4693741253273233,1.0,8/57,11.34%,UBC;TOMM7;RPS27A;GABARAPL1;FIS1;GABARAPL2;CITED2;HIF1A
prerank,Reactome_2022__HDMs Demethylate Histones R-HSA-3214842,-0.6437035056674515,-1.3143809247502545,0.16923076923076924,0.46925544132773767,1.0,4/21,16.76%,JMJD6;KDM7A;KDM6B;KDM1B
prerank,CellMarker_Augmented_2021__Microglial cell:Undefined,-0.7923710220875978,-1.314366404763068,0.09090909090909091,0.4688667345224982,1.0,3/9,6.88%,ADGRE1;AIF1;C5AR1
prerank,GO_Biological_Process_2021__positive regulation of angiogenesis (GO:0045766),0.5522816595063171,1.3137902780760384,0.1111111111111111,0.6317151826418528,1.0,12/62,9.91%,KLF4;SEMA5A;SERPINE1;SMAD1;FGF2;SIRT1;GAB1;WNT5A;RUNX1;SIRT6;TMIGD2;SASH1
prerank,CellMarker_Augmented_2021__Myeloid cell:Blood,-0.6786537105419443,-1.3137577701964778,0.1,0.47052900866539454,1.0,5/26,14.59%,CD37;TSPAN32;NLRP12;C19ORF38;ALOX12
prerank,GO_Biological_Process_2021__regulation of calcium ion transmembrane transporter activity (GO:1901019),-0.7313948263390043,-1.3137040566294895,0.14285714285714285,0.47029156687535967,1.0,2/16,8.36%,PLN;CALM1
prerank,GO_Biological_Process_2021__regulation of sterol biosynthetic process (GO:0106118),0.7441174810117004,1.3136239970987915,0.1702127659574468,0.6315576208925913,1.0,1/8,1.57%,ABCA2
prerank,GO_Biological_Process_2021__regulation of cell activation (GO:0050865),-0.8215756784536126,-1.3134750314895198,0.22950819672131148,0.47066933815017337,1.0,2/6,5.75%,FCER1G;TXK
prerank,GO_Biological_Process_2021__nucleic acid phosphodiester bond hydrolysis (GO:0090305),-0.6263920141250695,-1.31312329547952,0.11290322580645161,0.4712230912012115,1.0,11/53,11.16%,UBC;RPS27A;XPA;OGG1;GTF2H5;MUS81;MEI4;PNRC2;IHO1;REXO4;RBX1
prerank,GO_Biological_Process_2021__cellular response to cytokine stimulus (GO:0071345),-0.5186369136496921,-1.3127476225997774,0.023809523809523808,0.47225494298528964,1.0,42/277,8.28%,CCL4;MT2A;STAT4;CD36;CCL3;UBC;SIGIRR;CEBPD;RIPOR2;FOS;RPS27A;GAPDH;CXCR4;ZFP36;CCL5;JUNB;DUSP1;MNDA;PYHIN1;PID1;GRAP2;AIF1;IFIT1;RORA;RPL13A;DUOX1;AIM2;IL3RA;IL10RA;F13A1;RPS3;GBP3;IL12RB2;RHOU;OSMR;PRLR;STK39;FYN;NLRP12;CSF2RA;TNFRSF1B;OAS1
prerank,GO_Biological_Process_2021__axon guidance (GO:0007411),0.4506470911959067,1.3125895469511906,0.05263157894736842,0.6343737476549006,1.0,36/133,13.77%,PLXNB1;NRP1;GRB10;CDK5R1;CNTN2;SEMA5A;PLXNA2;RAP1GAP;GAB1;VASP;WNT5A;PTPRM;DAG1;RELN;PLXNA3;SEMA3B;PLXNB2;RYK;ROBO1;PLXNC1;TNR;SHANK3;NPTN;SPTAN1;UNC5B;ALCAM;NFIB;KLF7;EPHA6;ENAH;MAPK1;PDLIM7;GAB2;PLXNA1;DCC;PTK2
prerank,GO_Biological_Process_2021__response to host defenses (GO:0052200),-0.8372641041811761,-1.3120590808263324,0.125,0.4732936926960334,1.0,3/7,2.81%,UBC;RPS27A;B2M
prerank,GO_Biological_Process_2021__modulation by symbiont of host defense response (GO:0052031),-0.8372641041811761,-1.3120590808263324,0.125,0.4732936926960334,1.0,3/7,2.81%,UBC;RPS27A;B2M
prerank,Reactome_2022__Modulation By Mtb Of Host Immune System R-HSA-9637628,-0.8372641041811761,-1.3120590808263324,0.125,0.4732936926960334,1.0,3/7,2.81%,UBC;RPS27A;B2M
prerank,GO_Biological_Process_2021__small nucleolar ribonucleoprotein complex assembly (GO:0000491),0.8019857317802714,1.3120513090033685,0.13636363636363635,0.6355436290284839,1.0,2/8,1.43%,NUFIP1;RUVBL2
prerank,CellMarker_Augmented_2021__Natural Killer cell:Kidney,-0.8844789127501381,-1.311906600560983,0.025,0.47329809013187685,1.0,3/5,8.19%,NKG7;PRF1;KLRD1
prerank,Reactome_2022__MAP3K8 (TPL2)-dependent MAPK1/3 Activation R-HSA-5684264,-0.7339584012874298,-1.3118942736054762,0.14285714285714285,0.47290923900312,1.0,2/16,1.30%,UBC;RPS27A
prerank,PanglaoDB_Augmented_2021__Plasma Cells,-0.6218083796183963,-1.311798595378883,0.136986301369863,0.47273844427228984,1.0,10/48,5.33%,H2AC8;CD37;CYCS;CXCR4;MS4A4A;GZMB;SLAMF6;CD93;NCF4;PLEK
prerank,GO_Biological_Process_2021__monosaccharide transmembrane transport (GO:0015749),-0.8474240167523907,-1.3117441077889531,0.21153846153846154,0.4725011552436379,1.0,2/5,10.34%,SLC5A9;SLC2A8
prerank,GO_Biological_Process_2021__negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),-0.6583770759053811,-1.311699221813669,0.1774193548387097,0.47223093084264783,1.0,5/20,9.32%,RPL5;RPL11;RPL23;RPS7;GABARAPL2
prerank,GO_Biological_Process_2021__GPI anchor biosynthetic process (GO:0006506),0.6697385637489919,1.3116377178560632,0.09090909090909091,0.6361478507152689,1.0,3/22,1.13%,PIGQ;PIGU;PGAP1
prerank,Reactome_2022__Telomere Maintenance R-HSA-157579,-0.5863034821560088,-1.3115379749347724,0.058823529411764705,0.47239467201560664,1.0,17/55,15.66%,H2BC4;H2BC26;H2AC20;H2AC6;H3-3B;H2AJ;CHTF18;H2BC21;POLR2G;H2BC5;H2BC9;TERF2IP;H2BC11;RPA3;NHP2;NOP10;ANKRD28
prerank,Reactome_2022__Attachment Of GPI Anchor To uPAR R-HSA-162791,0.8375084326202891,1.3114976132700247,0.14285714285714285,0.6357295478980638,1.0,3/6,8.91%,PIGU;PGAP1;PIGT
prerank,CellMarker_Augmented_2021__Luteinizing Granulosa cell:Ovarian Follicle,0.5813149245386464,1.3114862147843547,0.1,0.6349047556769092,1.0,18/38,20.28%,PDZRN4;GRID2;PCDH15;GRIA3;CLSTN2;ASXL3;HIF3A;PTPN5;COL11A1;RUNX1T1;RBFOX1;FLRT2;ERBB4;CDH8;GRIN2A;DLGAP1;GABRB2;UNC5D
prerank,GO_Biological_Process_2021__regulation of leukocyte cell-cell adhesion (GO:1903037),-0.855831892910106,-1.31141794360202,0.1,0.47237489064203125,1.0,1/6,0.40%,SKAP1
prerank,GO_Biological_Process_2021__cardiac muscle cell contraction (GO:0086003),0.6742616604199331,1.3113274747673966,0.1590909090909091,0.6346251852414422,1.0,3/14,5.10%,GSN;KCNJ2;SCN3B
prerank,GO_Biological_Process_2021__regulation of natural killer cell activation (GO:0032814),-0.8081062655621052,-1.3112727618777702,0.19642857142857142,0.4723967482972294,1.0,4/6,19.00%,DCAF15;TYROBP;PRDM1;PTPN22
prerank,Reactome_2022__G Alpha (Z) Signaling Events R-HSA-418597,-0.6460903831915913,-1.3112168491595035,0.10294117647058823,0.47216086769357124,1.0,4/28,6.62%,PRKCQ;RGS16;GNB5;RGS4
prerank,GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885),-0.7768589903497704,-1.310843439311583,0.13114754098360656,0.47283899163775917,1.0,5/7,14.74%,B2M;ERAP1;ABCB9;TAP1;ERAP2
prerank,Reactome_2022__Downregulation Of ERBB2 Signaling R-HSA-8863795,-0.6986781993243469,-1.3105587250188062,0.13432835820895522,0.47334991703028034,1.0,3/23,3.25%,UBC;RPS27A;CDC37
prerank,GO_Biological_Process_2021__ribosomal large subunit biogenesis (GO:0042273),-0.6138022923009121,-1.3104549078408991,0.08695652173913043,0.4731884200048169,1.0,22/45,19.85%,RPL3;RPL23A;RPL5;RPL7A;RPL10;RPL10A;RPL11;RPL24;RPL14;RPL6;NSA2;NPM1;RPLP0;NOP53;TRAF7;NHP2;SURF6;RPL35A;LAS1L;GTF3A;HEATR3;BRIX1
prerank,CellMarker_Augmented_2021__Neuron:Embryo,0.49551412470190365,1.3103283039308593,0.029411764705882353,0.6373276016426892,1.0,28/72,21.61%,KCNQ2;CNTN2;NCAN;OTUD7A;SNAP91;SCN3B;PSD;RUNDC3A;CA10;CTNNA2;SORCS3;SNCB;PTPN5;SLC35F1;RBFOX1;GRIA2;CACNG8;FXYD7;PNMA3;PDZD4;PNMA2;TTYH1;ZFR2;GRM3;CELF5;AMER2;CACNA1B;NRXN1
prerank,GO_Biological_Process_2021__neuron projection morphogenesis (GO:0048812),0.4661503187032942,1.3102363567074868,0.08695652173913043,0.6366224786346004,1.0,35/106,19.71%,PLXNB1;LRP4;SLITRK5;MAP1S;NLGN1;NYAP2;LRRK2;RAB10;PLPPR4;TMEM106B;RYK;DOCK10;FLRT1;CTNNA2;BRSK1;SHANK3;GPM6A;ALCAM;BTBD3;KLF7;CELSR2;PTEN;DCC;CNTN4;SRGAP2;CNTNAP1;PARD3;SHTN1;FARP1;BRSK2;MAP6;TAOK2;MAP2;FGFR2;DCLK1
prerank,GO_Biological_Process_2021__regulation of vesicle-mediated transport (GO:0060627),0.46520071531847457,1.3102104113738289,0.07142857142857142,0.6358180631074252,1.0,10/75,5.14%,RAB33B;NRP1;CD22;HIP1R;RNF139;PICALM;LRRK2;MAP2K1;TSC2;RAB10
prerank,CellMarker_Augmented_2021__Cholinergic neuron:Spinal Cord,0.6130935232215148,1.3099907436239107,0.1891891891891892,0.6356568439587816,1.0,11/30,14.20%,CNTN2;DPYSL5;NCAN;ZNF536;SNAP91;OLFM3;NRXN2;CAMKV;DCC;NELL1;GRIA2
prerank,GO_Biological_Process_2021__positive regulation of regulatory T cell differentiation (GO:0045591),-0.796170616918815,-1.309826739652505,0.06153846153846154,0.4748079149032423,1.0,3/10,10.77%,IL4I1;LILRB4;HLA-DRA
prerank,GO_Biological_Process_2021__substrate-dependent cell migration (GO:0006929),0.6823125176043454,1.3096820185264006,0.19047619047619047,0.6357992211842062,1.0,4/10,12.55%,NRP1;P2RY12;ANKS1A;ITGA2
prerank,GO_Biological_Process_2021__synapse assembly (GO:0007416),0.5555397339847816,1.309677471801921,0.10869565217391304,0.6348817619905782,1.0,12/39,11.81%,PLXNB1;GRID2;NLGN1;WNT5A;PLXNB2;RYK;DNM3;SHANK3;SHANK2;GPM6A;NRXN2;PTEN
prerank,GO_Biological_Process_2021__extracellular matrix organization (GO:0030198),0.460841540562739,1.3095564257609509,0.045454545454545456,0.6343363718080969,1.0,34/139,13.53%,COL5A3;MMP17;COL16A1;PDGFA;NCAN;SERPINE1;GSN;COL5A2;FGF2;EXOC8;COL24A1;LCP1;DAG1;SLC39A8;CTSK;BMP1;ADAMTSL2;RECK;TNR;ADAMTS17;FBN2;ADAMTSL3;MMP16;LOXL2;ITGAV;P3H2;COL11A1;NF1;ITGA2;COL6A1;FLRT2;COL25A1;JAM2;COL15A1
prerank,CellMarker_Augmented_2021__Adipose-derived Stem cell:Abdominal Adipose Tissue,-0.8170735555143055,-1.3092717380839818,0.16393442622950818,0.4762010212055291,1.0,5/8,12.82%,CD14;PECAM1;ITGA4;CD44;PTPRC
prerank,CellMarker_Augmented_2021__M1 macrophage:Peripheral Blood,-0.7933546818141559,-1.3091590601472924,0.09433962264150944,0.4760538892072687,1.0,2/11,3.24%,IL7R;SELL
prerank,Reactome_2022__Miscellaneous Transport And Binding Events R-HSA-5223345,0.673232575178539,1.3090916782358852,0.14634146341463414,0.6351507498513356,1.0,7/17,20.79%,NIPA2;NIPAL2;NIPA1;ANKH;MMGT1;MAGT1;ADD1
prerank,GO_Biological_Process_2021__glial cell migration (GO:0008347),-0.892873080441901,-1.3090742558938955,0.08196721311475409,0.4759565839831186,1.0,1/5,0.62%,CCL3
prerank,CellMarker_Augmented_2021__Serotonergic neuron:Undefined,0.6353772579048338,1.3089643208709925,0.09302325581395349,0.6346567717875283,1.0,4/17,13.12%,PDIA2;SNAP91;VGF;ABCC8
prerank,CellMarker_Augmented_2021__Oligodendrocyte Progenitor cell:Embryonic Prefrontal Cortex,0.49632489221546766,1.308933323044504,0.045454545454545456,0.6338130959640034,1.0,20/80,10.47%,DUSP6;GRID2;SEMA5A;PCDH15;LUZP2;SERPINE2;CSPG5;LRRC4C;LHFPL3;BCL11A;KANK1;BRINP3;SOX4;CA10;RAMP1;CADM2;CD82;DBI;ALCAM;OLIG1
prerank,Reactome_2022__Mitochondrial Fatty Acid Beta-Oxidation Of Saturated Fatty Acids R-HSA-77286,0.7832818523095945,1.3089094214285086,0.09523809523809523,0.6329885333673334,1.0,2/9,11.26%,ACADS;ACADVL
prerank,CellMarker_Augmented_2021__T Helper1 (Th1) cell:Undefined,-0.7508084343840301,-1.3088535881689318,0.16071428571428573,0.4762638044918076,1.0,6/14,13.66%,STAT4;IL12RB2;KLRD1;STAT1;IL18R1;HAVCR2
prerank,GO_Biological_Process_2021__regulation of interferon-gamma-mediated signaling pathway (GO:0060334),-0.7551347524724409,-1.3088230289893314,0.09259259259259259,0.47592739621225766,1.0,8/18,11.78%,PARP14;CDC37;NR1H2;TXK;NLRC5;PARP9;STAT1;IFNGR2
prerank,GO_Biological_Process_2021__superoxide anion generation (GO:0042554),-0.7856815784944444,-1.3088172188843856,0.16363636363636364,0.4755092331634586,1.0,5/7,14.59%,DUOX1;NCF4;NCF2;CYBA;ALOX12
prerank,GO_Biological_Process_2021__regulation of DNA damage checkpoint (GO:2000001),0.6996781543551405,1.3086438859737293,0.17391304347826086,0.633066614379915,1.0,2/9,18.66%,FEM1B;RFWD3
prerank,GO_Biological_Process_2021__response to amyloid-beta (GO:1904645),-0.6441707816669753,-1.3085499897791208,0.09836065573770492,0.4758900855601874,1.0,6/30,8.15%,CALCR;CD36;SNX6;IGF1;FYN;ITGA4
prerank,GO_Biological_Process_2021__positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),-0.7528664922412163,-1.3081233009397115,0.18181818181818182,0.47685399880131185,1.0,4/9,16.49%,RIPOR2;TYROBP;CAMK1;FLOT1
prerank,Reactome_2022__Axon Guidance R-HSA-422475,-0.5015050057937311,-1.307385146732964,0.03409090909090909,0.47876902854936115,1.0,93/389,13.76%,RPS13;UBC;RPS4X;RPL28;RPS27A;RPS8;RPL38;CXCR4;RPS21;PRKCQ;RPL31;RPL37A;RPS14;RPL12;VAV3;RPLP1;RPL3;RPL23A;RPL39;RPL32;RPS11;RPL5;RPS15;RPS12;PSMB3;RPS25;YES1;RPS23;RPS27;FAU;RPS20;RPL29;RPLP2;RPL19;RPS24;RPL13A;EPHB1;RPL41;RPL7A;RPL35;RPL37;ELOB;SCN9A;RPL10A;RPL11;RPS3;RPL23;SEMA6A;DOK6;RPS3A;RPL4;RPL30;RPL36AL;RPL36;RPL14;RPL18A;PSMB6;RNMT;PSMA7;RPS6;FYN;RPS2;RPS7;RPL34;RPL15;ACTG1;RPL21;RPS5;EIF4A3;RPL27A;CD72;PSMB9;RPL6;RPL27;RPL18;NCBP2;MYL12A;RPLP0;RPS9;RBX1;TYROBP;ABLIM3;EFNB2;PSMD12;PFN1;PTPRC;PSMD8;PSMA5;CLTB;RPS28;RPL9;PIK3CB;VLDLR
prerank,GO_Biological_Process_2021__calcineurin-mediated signaling (GO:0097720),0.7765654706940638,1.3073130098233778,0.23404255319148937,0.6358487579516617,1.0,6/8,18.52%,ADGRB2;NFAT5;PPP3CA;NFATC3;PPP3CB;NFATC2
prerank,GO_Biological_Process_2021__calcineurin-NFAT signaling cascade (GO:0033173),0.7765654706940638,1.3073130098233778,0.23404255319148937,0.6358487579516617,1.0,6/8,18.52%,ADGRB2;NFAT5;PPP3CA;NFATC3;PPP3CB;NFATC2
prerank,GO_Biological_Process_2021__positive regulation of ubiquitin-protein transferase activity (GO:0051443),0.652113528770841,1.3073105973327523,0.07894736842105263,0.6349595911749467,1.0,10/22,12.35%,ARRDC3;FZR1;DCUN1D4;CDC14B;BTRC;UBE2L3;FBXW7;PTEN;UBE2N;DCUN1D1
prerank,GO_Biological_Process_2021__positive regulation of cell-substrate adhesion (GO:0010811),-0.6192216542938463,-1.3073085074063342,0.1111111111111111,0.47848931983265086,1.0,3/43,0.52%,FLNA;SKAP1;CD36
prerank,Reactome_2022__Regulation Of Complement Cascade R-HSA-977606,-0.6718446328476085,-1.3073062640739155,0.10526315789473684,0.4780543295418939,1.0,7/21,14.85%,CD55;CLU;C5AR1;PSMA7;C5AR2;SERPING1;C3
prerank,GO_Biological_Process_2021__activation of Janus kinase activity (GO:0042976),-0.8445738886373495,-1.307003949460741,0.16326530612244897,0.47852125310975197,1.0,1/5,6.83%,PRLR
prerank,Reactome_2022__Formation Of Apoptosome R-HSA-111458,-0.7446083422614651,-1.3069030294837456,0.20967741935483872,0.4785617300811068,1.0,2/10,1.08%,APIP;CYCS
prerank,Reactome_2022__Downstream Signaling Events Of B Cell Receptor (BCR) R-HSA-1168372,-0.584577281937394,-1.3068962205899386,0.09333333333333334,0.47814421161120324,1.0,16/68,19.69%,UBC;RPS27A;PSMB3;PSMB6;PSMA7;CALM1;PSMB9;PSMD12;PSMD8;PSMA5;REL;UBA52;PSMA3;PSMC4;PSME2;PSME1
prerank,CellMarker_Augmented_2021__Mesenchymal Stromal cell:Bone Marrow,-0.8142269244341296,-1.3066861039014876,0.22727272727272727,0.47847089881685084,1.0,4/8,12.82%,CD14;PECAM1;CD44;PTPRC
prerank,Reactome_2022__ARMS-mediated Activation R-HSA-170984,0.7951305402395912,1.306141110587135,0.1794871794871795,0.6383001070603322,1.0,2/5,7.54%,RAP1A;CRK
prerank,GO_Biological_Process_2021__negative regulation of type I interferon-mediated signaling pathway (GO:0060339),-0.7462515365637371,-1.3058454494765497,0.1267605633802817,0.4808865637791393,1.0,3/10,8.28%,OAS3;NLRC5;OAS1
prerank,GO_Biological_Process_2021__positive regulation of lipopolysaccharide-mediated signaling pathway (GO:0031666),0.8060582342194402,1.305655163096105,0.08695652173913043,0.6391812113334673,1.0,2/6,9.91%,CD180;SASH1
prerank,Reactome_2022__Recycling Pathway Of L1 R-HSA-437239,0.5946646695392758,1.3055268020620057,0.10256410256410256,0.6387539425801321,1.0,5/25,11.38%,MSN;RPS6KA4;DNM3;RPS6KA6;MAPK1
prerank,GO_Biological_Process_2021__peptidyl-serine modification (GO:0018209),0.45195540582467403,1.3054016442861376,0.047619047619047616,0.6383608974796324,1.0,35/138,16.08%,CDK5R1;POGLUT3;TGFBR2;CSNK1G1;STK32B;PKD1;GALNT13;LRRK2;RPS6KA4;TLK1;PARP1;MAST2;CAB39;MAP3K10;STK38L;BRSK1;POGLUT1;MAST3;PLK2;DYRK1A;WNK1;RPS6KA6;MAPK1;CAMKV;MAPKAPK2;CSNK1E;PRKCI;MARK1;GALNT1;MAP3K13;TGFBR1;AKT2;GALNT2;GSK3B;RPS6KB2
prerank,GO_Biological_Process_2021__nucleoside catabolic process (GO:0009164),-0.7423436402232021,-1.3053123064732224,0.1935483870967742,0.48239265556189165,1.0,3/9,10.19%,NT5C;TYMP;DPYS
prerank,Reactome_2022__Synthesis Of Leukotrienes (LT) And Eoxins (EX) R-HSA-2142691,0.7915797400445168,1.3052558563523105,0.20930232558139536,0.638067863941208,1.0,2/8,12.49%,ALOX5AP;MAPKAPK2
prerank,GO_Biological_Process_2021__regulation of Fc-gamma receptor signaling pathway involved in phagocytosis (GO:1905449),-0.872069341313063,-1.3050140228318017,0.14285714285714285,0.48282053885605336,1.0,3/5,12.82%,APPL1;CD47;PTPRC
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell proliferation (GO:1904705),-0.6270358221599565,-1.3049494750720645,0.14754098360655737,0.4826289886103892,1.0,2/25,5.56%,NR4A3;IGF1
prerank,GO_Biological_Process_2021__response to ketone (GO:1901654),-0.7713271340842691,-1.3047763237204855,0.09090909090909091,0.4826655060918431,1.0,2/13,10.11%,TGFBR3;ABCB4
prerank,Reactome_2022__Nervous System Development R-HSA-9675108,-0.498018483155487,-1.3047574743227632,0.033707865168539325,0.48229567719546246,1.0,94/403,13.76%,RPS13;UBC;RPS4X;RPL28;RPS27A;RPS8;RPL38;CXCR4;RPS21;PRKCQ;RPL31;RPL37A;RPS14;RPL12;VAV3;RPLP1;RPL3;RPL23A;RPL39;RPL32;RPS11;RPL5;RPS15;RPS12;PSMB3;RPS25;YES1;RPS23;RPS27;FAU;RPS20;RPL29;RPLP2;RPL19;RPS24;RPL13A;EPHB1;RPL41;RPL7A;RPL35;RPL37;ELOB;SCN9A;RPL10A;RPL11;RPS3;RPL23;SEMA6A;DOK6;RPS3A;RPL4;RPL30;RPL36AL;RPL36;RPL14;RPL18A;PSMB6;RNMT;PSMA7;RPS6;FYN;RPS2;RPS7;RPL34;RPL15;ACTG1;RPL21;RPS5;EIF4A3;RPL27A;CD72;PSMB9;RPL6;RPL27;RPL18;NCBP2;MYL12A;RPLP0;RPS9;RBX1;TYROBP;ABLIM3;ADGRG6;EFNB2;PSMD12;PFN1;PTPRC;PSMD8;PSMA5;CLTB;RPS28;RPL9;PIK3CB;VLDLR
prerank,PanglaoDB_Augmented_2021__Pulmonary Alveolar Type II Cells,-0.6051027134160748,-1.3047118082111184,0.0945945945945946,0.48195086895115996,1.0,11/50,4.85%,CD36;CEBPD;SAT1;RUNX3;MS4A4A;MARCO;ZMYND15;SIGLEC1;CD14;TNFSF10;LPCAT1
prerank,GO_Biological_Process_2021__positive regulation of macrophage migration (GO:1905523),-0.737235369169866,-1.3046857949634032,0.1774193548387097,0.4816066808655702,1.0,2/13,1.49%,CCL3;CCL5
prerank,Reactome_2022__Activated TAK1 Mediates P38 MAPK Activation R-HSA-450302,0.6507812324942874,1.3046062524765374,0.08333333333333333,0.6396356382924903,1.0,8/18,16.34%,MAPK11;IRAK1;TAB2;UBE2N;MAPKAPK2;IRAK2;TRAF6;MAP3K7
prerank,GO_Biological_Process_2021__hexose transmembrane transport (GO:0008645),-0.8105882547841678,-1.3045923978681804,0.10344827586206896,0.4815143262675995,1.0,3/8,10.34%,SLC2A3;SLC5A9;SLC2A8
prerank,GO_Biological_Process_2021__inositol metabolic process (GO:0006020),0.8019114804734586,1.304591171688431,0.09523809523809523,0.6387499091562492,1.0,4/7,13.98%,IPPK;IMPA1;ISYNA1;PPIP5K1
prerank,GO_Biological_Process_2021__fatty acid transport (GO:0015908),-0.7812896962076228,-1.3045040074032879,0.14705882352941177,0.4813411731241254,1.0,1/10,0.52%,CD36
prerank,GO_Biological_Process_2021__positive regulation of type 2 immune response (GO:0002830),-0.7793071969075658,-1.3044871776610325,0.1875,0.4809418337002962,1.0,4/9,17.61%,RSAD2;NOD2;CD74;IL18
prerank,CellMarker_Augmented_2021__Bile Duct cell:Liver,0.718979957269779,1.3043696539695333,0.10869565217391304,0.6386217022317897,1.0,1/13,0.04%,SHROOM3
prerank,CellMarker_Augmented_2021__Epidermal Transit Amplifying cell:Foreskin,-0.5891276954446065,-1.3040681837433878,0.14473684210526316,0.4820222023100461,1.0,16/69,13.36%,CYCS;COX7C;SSB;SNRPD2;PLTP;UQCRH;PTMA;TMA7;GSTP1;MRPL51;PDCD5;RTCB;NDUFS5;COX7A2;ATP1B3;EEF1B2
prerank,GO_Biological_Process_2021__signal complex assembly (GO:0007172),0.841999029953147,1.3039156396544131,0.12195121951219512,0.6392150401238508,1.0,1/5,4.13%,NCK2
prerank,CellMarker_Augmented_2021__Macrophage:Brain,-0.6103172234820529,-1.3034097866443692,0.15942028985507245,0.48385158269188794,1.0,15/45,15.77%,FOSL2;EMB;AIF1;PLTP;CD93;BHLHE40;HLA-DRB5;ITGA4;METRNL;MS4A6A;CREM;CYTH1;CIITA;HLA-DMB;CD74
prerank,GO_Biological_Process_2021__positive regulation of embryonic development (GO:0040019),-0.7983075239035752,-1.3032962811530069,0.24561403508771928,0.4837899030373145,1.0,2/7,8.34%,RACK1;CFL1
prerank,GO_Biological_Process_2021__intestinal absorption (GO:0050892),-0.9126098688317981,-1.3029630041325402,0.10909090909090909,0.4845666004727596,1.0,1/6,0.52%,CD36
prerank,PanglaoDB_Augmented_2021__Germ Cells,0.5622905519437843,1.302888023869625,0.13333333333333333,0.6418690199992279,1.0,5/42,7.46%,TULP2;MYO1D;GCNA;UBE3D;STX11
prerank,GO_Biological_Process_2021__negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039532),-0.8405731518366824,-1.302843114969344,0.12962962962962962,0.48445607418264713,1.0,1/6,2.65%,DHX58
prerank,Reactome_2022__RHOU GTPase Cycle R-HSA-9013420,0.5574149962370517,1.3026683694308232,0.09302325581395349,0.6418350453245808,1.0,5/34,9.11%,ARHGAP31;DLG5;NCK2;GIT1;SPTAN1
prerank,GO_Biological_Process_2021__positive regulation of NF-kappaB transcription factor activity (GO:0051092),-0.5512102897468636,-1.3026455832690684,0.0375,0.48473999309157567,1.0,23/117,12.59%,CD36;UBC;RPS27A;TFRC;CARD14;PRKCQ;CARD16;TRIM5;BTK;DDRGK1;AIM2;CLU;RPS3;LAMTOR5;TRIM22;EIF2AK2;PRKD2;TRIM13;CFLAR;NPM1;IL18R1;HSPA1B;TERF2IP
prerank,Reactome_2022__N-Glycan Antennae Elongation R-HSA-975577,0.6933290372203237,1.3024207665678338,0.2,0.6418174874987392,1.0,5/10,22.36%,B4GALT4;MGAT4C;MGAT5;B4GALT5;MGAT4B
prerank,GO_Biological_Process_2021__positive regulation of microglial cell migration (GO:1904141),-0.8636645719625977,-1.3022056279861478,0.14285714285714285,0.4856102314934232,1.0,1/5,0.62%,CCL3
prerank,GO_Biological_Process_2021__negative regulation of release of cytochrome c from mitochondria (GO:0090201),-0.7230166718051744,-1.3021541521219653,0.15517241379310345,0.48529025088162264,1.0,3/11,5.56%,PRELID1;CLU;IGF1
prerank,GO_Biological_Process_2021__negative regulation of protein localization to cell surface (GO:2000009),0.7672248839970388,1.3021330278790424,0.15217391304347827,0.6419140707645554,1.0,3/8,13.94%,PICALM;NEDD4L;LEPROTL1
prerank,GO_Biological_Process_2021__interleukin-21-mediated signaling pathway (GO:0038114),-0.8283422724837721,-1.3020177957513173,0.14035087719298245,0.48483639343411933,1.0,2/6,9.56%,STAT4;STAT1
prerank,GO_Biological_Process_2021__cellular response to interleukin-21 (GO:0098757),-0.8283422724837721,-1.3020177957513173,0.14035087719298245,0.48483639343411933,1.0,2/6,9.56%,STAT4;STAT1
prerank,GO_Biological_Process_2021__neutrophil degranulation (GO:0043312),-0.5003668154140103,-1.301800589455943,0.043478260869565216,0.4850786630906149,1.0,71/346,15.24%,CD36;SLC2A3;PPIE;FTH1;NIT2;HLA-B;DYNLT1;MNDA;CD55;RNASET2;ENPP4;CLEC12A;CHIT1;RAB37;B2M;CD14;FCAR;SRP14;SELL;FCER1G;ANXA2;CTSB;CD93;PADI2;LPCAT1;HLA-C;GLA;JUP;NBEAL2;CD63;PECAM1;RAB3A;GSTP1;C5AR1;RAB3D;CYSTM1;AGA;TNFRSF1B;OLR1;ACAA1;OSCAR;CD44;COMMD9;LILRB3;CHI3L1;SLC11A1;ITGB2;NCKAP1L;PTGES2;PTPRB;PRDX4;TYROBP;ITGAL;STING1;CD47;PSMD12;HSPA1B;CYBA;PTPRC;PSMA5;FTL;OSTF1;TUBB4B;CRACR2A;HSPA1A;IGF2R;TIMP2;C3;TMEM179B;FPR1;GUSB
prerank,GO_Biological_Process_2021__lipoprotein transport (GO:0042953),-0.8461783737607935,-1.3015349650572003,0.10638297872340426,0.4854885667021675,1.0,1/7,0.52%,CD36
prerank,Reactome_2022__CHL1 Interactions R-HSA-447041,0.7624678670004655,1.3013737560850687,0.22857142857142856,0.6437844780939377,1.0,1/6,0.61%,NRP1
prerank,CellMarker_Augmented_2021__Natural Killer cell:Breast,0.5078301708765431,1.3013693094285255,0.09375,0.6411307283402709,1.0,18/77,12.37%,NPAS3;CNTN2;NCAN;ZNF536;CDH20;SNAP91;SCN3B;LRRC4C;GRIA4;CTNNA2;CADM2;SORCS3;PSD2;ASXL3;PTPN5;NRXN2;SLC35F1;RBFOX1
prerank,CellMarker_Augmented_2021__Chromaffin cell:Adrenal Gland,0.5078301708765431,1.3013693094285255,0.09375,0.6411307283402709,1.0,18/77,12.37%,NPAS3;CNTN2;NCAN;ZNF536;CDH20;SNAP91;SCN3B;LRRC4C;GRIA4;CTNNA2;CADM2;SORCS3;PSD2;ASXL3;PTPN5;NRXN2;SLC35F1;RBFOX1
prerank,CellMarker_Augmented_2021__Definitive Zone cell:Adrenal Gland,0.5078301708765431,1.3013693094285255,0.09375,0.6411307283402709,1.0,18/77,12.37%,NPAS3;CNTN2;NCAN;ZNF536;CDH20;SNAP91;SCN3B;LRRC4C;GRIA4;CTNNA2;CADM2;SORCS3;PSD2;ASXL3;PTPN5;NRXN2;SLC35F1;RBFOX1
prerank,Reactome_2022__FCGR Activation R-HSA-2029481,-0.8149900348816566,-1.301210842460417,0.1724137931034483,0.48600968680061557,1.0,3/10,7.36%,YES1;CD247;FYN
prerank,Reactome_2022__Interleukin-2 Family Signaling R-HSA-451927,-0.6687665245780074,-1.3010845850144954,0.109375,0.4859626743115594,1.0,7/29,13.75%,STAT4;IL3RA;CSF2RA;STAT1;CSF2RB;HAVCR2;PIK3CB
prerank,GO_Biological_Process_2021__mitochondrial cytochrome c oxidase assembly (GO:0033617),-0.7638496590645056,-1.300890033073405,0.12727272727272726,0.4860993263264124,1.0,6/13,18.82%,TIMM21;BCS1L;COX18;OXA1L;SURF1;COX20
prerank,GO_Biological_Process_2021__positive regulation of early endosome to late endosome transport (GO:2000643),0.7634641048150654,1.3008320021393398,0.20454545454545456,0.642069249438181,1.0,2/8,4.44%,MSN;PTPN23
prerank,CellMarker_Augmented_2021__Hematopoietic cell:Fetal Liver,-0.8715495477002462,-1.3007813988173689,0.12280701754385964,0.48605231771485596,1.0,4/5,12.82%,CD14;IL3RA;PECAM1;PTPRC
prerank,Reactome_2022__Neuronal System R-HSA-112316,0.4427548975629723,1.3005944633170181,0.05555555555555555,0.6421646797753781,1.0,61/240,15.11%,PRKAB2;IL1RAPL2;CACNA1A;KCNQ2;SLITRK5;GRIN3A;KCNJ2;SLC1A3;NBEA;EPB41;NLGN1;KCND3;TSPOAP1;GLRA1;KCNJ5;LIN7A;SLC1A2;NRG1;ADCY9;UNC13B;GABRR2;ALDH5A1;GRIA3;GRIA4;GIT1;KCNC2;SHANK3;PDLIM5;NPTN;SHANK2;SHARPIN;GRIA1;LRRTM2;MDM2;KCNMB4;GRM5;KCNK6;STX1A;KCNK13;LRRTM4;KCNN2;PTPRD;PPFIA3;RPS6KA6;NRXN2;MAPK1;GRIN2B;ABCC8;KCNH5;KCNMB3;PRKAB1;ADCY6;CACNA1E;ERBB4;GRIA2;CACNG8;CACNG2;GAD1;LRRC4B;CACNB4;NLGN4Y
prerank,GO_Biological_Process_2021__protein retention in ER lumen (GO:0006621),0.8235898260039289,1.3005677491026026,0.19444444444444445,0.6413236775071199,1.0,1/6,1.27%,PDIA2
prerank,GO_Biological_Process_2021__hepatocyte growth factor receptor signaling pathway (GO:0048012),0.7364178580102139,1.3004652777181895,0.18421052631578946,0.6408234903138097,1.0,3/7,9.97%,NRP1;HPN;HGF
prerank,GO_Biological_Process_2021__regulation of cellular response to growth factor stimulus (GO:0090287),0.7468629837442604,1.3003397776946088,0.21153846153846154,0.6404373585614805,1.0,3/6,14.65%,TWSG1;PCSK6;XIAP
prerank,GO_Biological_Process_2021__nuclear pore complex assembly (GO:0051292),0.7425968396778049,1.2999646511483178,0.15384615384615385,0.6412096230487876,1.0,6/9,25.66%,NUP153;RTN4;NDC1;NUP205;NUP98;TPR
prerank,GO_Biological_Process_2021__positive regulation of hydrolase activity (GO:0051345),-0.5511975422249684,-1.2998518528454894,0.05263157894736842,0.48836382939329015,1.0,8/90,5.49%,CCL4;CCL3;CCL5;RGS1;RGS16;RACK1;GNB5;RPS3
prerank,GO_Biological_Process_2021__cellular response to interleukin-1 (GO:0071347),-0.5457186058369321,-1.2998123353127309,0.0875,0.4880044393055626,1.0,17/102,12.85%,CCL4;CCL3;UBC;RPS27A;CCL5;PSMB3;GBP3;PSMB6;PSMA7;GBP2;PSMB9;RBX1;HIF1A;CD47;PSMD12;PSMD8;PSMA5
prerank,GO_Biological_Process_2021__ribonucleoprotein complex biogenesis (GO:0022613),-0.6262846461096742,-1.2997468318805927,0.09230769230769231,0.48774908039572584,1.0,12/50,7.39%,RBIS;RPL38;RPL5;RPS15;RPS25;RPS24;METTL17;RPL11;GLUL;RPL14;RPS6;RPS7
prerank,Reactome_2022__Chaperone Mediated Autophagy R-HSA-9613829,-0.6962863212438973,-1.299710700314291,0.14754098360655737,0.48745443829062596,1.0,2/19,1.30%,UBC;RPS27A
prerank,Reactome_2022__Cytoprotection By HMOX1 R-HSA-9707564,-0.6113468308026944,-1.2996319780558412,0.08571428571428572,0.4873905644267071,1.0,15/45,24.17%,CYCS;COX7C;COX4I1;COX5B;COX18;COX6C;SMARCD3;SURF1;COX20;NFE2L2;COX7B;SIN3B;COX5A;MBD4;BLVRB
prerank,KEGG_2021_Human__Measles,-0.5717273595027462,-1.299563362607911,0.09210526315789473,0.48727127433192385,1.0,12/87,9.56%,MX2;OAS3;CYCS;MX1;FOS;OAS2;CBLB;RACK1;EIF2AK2;TNFAIP3;OAS1;STAT1
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell proliferation (GO:0001938),0.55487156394036,1.2995289630162603,0.03333333333333333,0.6419476562821412,1.0,5/41,4.48%,NRP1;SEMA5A;FGF2;SIRT1;WNT5A
prerank,Reactome_2022__Cyclin A/B1/B2 Associated Events During G2/M Transition R-HSA-69273,0.7502765181431119,1.2995041107916812,0.06818181818181818,0.6411608260591756,1.0,3/12,8.13%,CDK7;XPO1;PPP2R1B
prerank,CellMarker_Augmented_2021__Effector Memory T cell:Undefined,-0.8548450013581952,-1.2994187341561543,0.11764705882352941,0.4872393764146141,1.0,4/5,12.82%,IL7R;SELL;CD44;PTPRC
prerank,Reactome_2022__Transport Of Mature mRNAs Derived From Intronless Transcripts R-HSA-159234,0.5452200139730337,1.2992685436934215,0.12903225806451613,0.6410805007965709,1.0,6/39,7.20%,NXF1;CPSF4;NUP153;NUP188;WDR33;NUP42
prerank,GO_Biological_Process_2021__regulation of complement activation (GO:0030449),-0.6898668004527424,-1.299143972391401,0.1,0.48768265806636035,1.0,7/20,14.85%,CD55;CLU;PHB2;C5AR1;C5AR2;SERPING1;C3
prerank,CellMarker_Augmented_2021__Radial Glial cell:Undefined,0.7810076486957843,1.299134090952864,0.20930232558139536,0.6406487073243321,1.0,2/5,2.97%,GFAP;SLC1A3
prerank,GO_Biological_Process_2021__axon development (GO:0061564),0.5573941164866612,1.2988435438954378,0.10344827586206896,0.6410003302098054,1.0,20/58,19.59%,SLITRK5;CDK5R1;SEMA5A;MAP1S;RAB10;PLPPR4;RYK;CTNNA2;BRSK1;KLF7;RTN4;DCC;CNTN4;PARD3;SHTN1;CAMSAP2;BRSK2;MARK2;TAOK2;FGFR2
prerank,GO_Biological_Process_2021__neutrophil activation involved in immune response (GO:0002283),-0.49952000751718895,-1.2988275998276495,0.06382978723404255,0.48827548584580943,1.0,71/349,15.24%,CD36;SLC2A3;PPIE;FTH1;NIT2;HLA-B;DYNLT1;MNDA;CD55;RNASET2;ENPP4;CLEC12A;CHIT1;RAB37;B2M;CD14;FCAR;SRP14;SELL;FCER1G;ANXA2;CTSB;CD93;PADI2;LPCAT1;HLA-C;GLA;JUP;NBEAL2;CD63;PECAM1;RAB3A;GSTP1;C5AR1;RAB3D;CYSTM1;AGA;TNFRSF1B;OLR1;ACAA1;OSCAR;CD44;COMMD9;LILRB3;CHI3L1;SLC11A1;ITGB2;NCKAP1L;PTGES2;PTPRB;PRDX4;TYROBP;ITGAL;STING1;CD47;PSMD12;HSPA1B;CYBA;PTPRC;PSMA5;FTL;OSTF1;TUBB4B;CRACR2A;HSPA1A;IGF2R;TIMP2;C3;TMEM179B;FPR1;GUSB
prerank,CellMarker_Augmented_2021__Urine-derived Stem cell:Urine,-0.8006137364853108,-1.2985698486351778,0.25396825396825395,0.4886538436554488,1.0,5/8,18.52%,CD14;PECAM1;CD44;PTPRC;ITGB1
prerank,GO_Biological_Process_2021__rRNA 3'-end processing (GO:0031125),-0.7636977202328346,-1.298239993180204,0.21052631578947367,0.48932376201960787,1.0,2/9,7.08%,RPS21;EXOSC10
prerank,PanglaoDB_Augmented_2021__Oxyphil Cells,0.5742749523782753,1.298190279295186,0.16129032258064516,0.6424828807064454,1.0,14/38,14.24%,WIPF3;L2HGDH;ADRA1A;SYCP2L;ACACB;DTNA;CADM2;LDB3;PREX2;HIF3A;CMYA5;SLC35F1;RBFOX1;HFM1
prerank,GO_Biological_Process_2021__positive regulation of autophagy of mitochondrion in response to mitochondrial depolarization (GO:1904925),-0.8235636562974606,-1.2981866164269558,0.10416666666666667,0.4891244966440625,1.0,3/6,10.09%,TOMM7;HK2;ATP5IF1
prerank,Reactome_2022__Interleukin-21 Signaling R-HSA-9020958,-0.8194597198259471,-1.2981786736999485,0.11538461538461539,0.4887205926143614,1.0,1/8,0.41%,STAT4
prerank,KEGG_2021_Human__SNARE interactions in vesicular transport,0.580889276462176,1.298118386427391,0.17142857142857143,0.6418280564565286,1.0,9/28,14.60%,VAMP1;BET1;STX11;VTI1A;STX1A;STX2;SNAP23;YKT6;STX6
prerank,Reactome_2022__Pyroptosis R-HSA-5620971,-0.678082560872103,-1.2980743512437558,0.13636363636363635,0.48872701007834607,1.0,7/22,20.58%,CYCS;GZMB;IRF1;CASP5;IL18;CASP4;CHMP6
prerank,GO_Biological_Process_2021__regulation of type I interferon-mediated signaling pathway (GO:0060338),-0.6946415938185692,-1.2978937289043369,0.09090909090909091,0.4888199902673286,1.0,5/20,8.32%,OAS3;CDC37;NLRC5;OAS1;RNASEL
prerank,Reactome_2022__RUNX3 Regulates Immune Response And Cell Migration R-HSA-8949275,-0.8292266310265216,-1.2976856974423172,0.2033898305084746,0.4890228972602023,1.0,3/5,11.27%,RUNX3;ITGA4;ITGAL
prerank,Reactome_2022__Cell Recruitment (Pro-Inflammatory Response) R-HSA-9664424,-0.6749154053906775,-1.297637808588445,0.20967741935483872,0.4887226254526748,1.0,5/22,17.61%,PSTPIP1;TXN2;ENTPD5;C3;IL18
prerank,GO_Biological_Process_2021__muscle cell differentiation (GO:0042692),-0.7513909005960342,-1.2976310459198268,0.15151515151515152,0.48830512919804986,1.0,3/16,9.67%,RORA;SYNE1;GLMN
prerank,KEGG_2021_Human__Complement and coagulation cascades,-0.6344951558593405,-1.297333917918731,0.10526315789473684,0.4888922606740849,1.0,10/31,14.85%,PROCR;CD55;F8;CLU;F13A1;C5AR1;ITGB2;A2M;SERPING1;C3
prerank,GO_Biological_Process_2021__neutrophil mediated immunity (GO:0002446),-0.4984605980442514,-1.2972775473180582,0.043478260869565216,0.48865557434276785,1.0,71/350,15.24%,CD36;SLC2A3;PPIE;FTH1;NIT2;HLA-B;DYNLT1;MNDA;CD55;RNASET2;ENPP4;CLEC12A;CHIT1;RAB37;B2M;CD14;FCAR;SRP14;SELL;FCER1G;ANXA2;CTSB;CD93;PADI2;LPCAT1;HLA-C;GLA;JUP;NBEAL2;CD63;PECAM1;RAB3A;GSTP1;C5AR1;RAB3D;CYSTM1;AGA;TNFRSF1B;OLR1;ACAA1;OSCAR;CD44;COMMD9;LILRB3;CHI3L1;SLC11A1;ITGB2;NCKAP1L;PTGES2;PTPRB;PRDX4;TYROBP;ITGAL;STING1;CD47;PSMD12;HSPA1B;CYBA;PTPRC;PSMA5;FTL;OSTF1;TUBB4B;CRACR2A;HSPA1A;IGF2R;TIMP2;C3;TMEM179B;FPR1;GUSB
prerank,GO_Biological_Process_2021__piRNA metabolic process (GO:0034587),-0.8468047729760847,-1.2972471393933993,0.16129032258064516,0.48837232273309183,1.0,3/6,10.44%,MYBL1;MOV10L1;TDRKH
prerank,GO_Biological_Process_2021__regulation of dendritic cell antigen processing and presentation (GO:0002604),-0.844680147193542,-1.297103808407905,0.1875,0.4884415783248118,1.0,2/5,14.09%,SLC11A1;NOD2
prerank,GO_Biological_Process_2021__T-helper cell differentiation (GO:0042093),-0.8347359398164224,-1.2970896724348275,0.10714285714285714,0.488073029298725,1.0,1/6,1.61%,GPR183
prerank,KEGG_2021_Human__Influenza A,-0.550581318014428,-1.2969284806843377,0.08571428571428572,0.48815804215453873,1.0,19/114,10.77%,MX2;OAS3;CYCS;MX1;RSAD2;CCL5;OAS2;TNFSF10;RAB11A;HLA-DRB5;SLC25A5;EIF2AK2;ACTG1;OAS1;RNASEL;TMPRSS11D;STAT1;ACTB;HLA-DRA
prerank,CellMarker_Augmented_2021__Multilymphoid Progenitor cell:Umbilical Cord Blood,-0.49760921658706375,-1.2969168211248148,0.03260869565217391,0.4877513646594027,1.0,71/406,13.17%,BCL2A1;H4C3;BTN3A1;ABCA9;ADGRE1;CD37;ARHGAP4;HLA-B;ACAP1;IFI44L;RUNX3;CMPK2;JUNB;DUSP1;SPATA21;RNASET2;IL7R;AIF1;CHD3;CSRNP1;LMLN;RPS27;FCAR;RGS1;DNHD1;USP36;NYNRIN;SLC38A1;DTX3;POMT1;GRIK1;ARHGEF1;SP110;IGF1;BASP1;ATP10A;SHFL;CCDC85C;TMSB10;ZSCAN30;GSTP1;C5AR1;BTN2A1;CABP4;IER2;TTN;SAT2;CSF2RA;TNFRSF1B;TNFAIP3;PRKD2;AMPD2;LSM7;DVL1;CCHCR1;EFR3B;ITGB2;KDM7A;AKAP8;BTG1;CSNK1G2;IFNGR2;TCF3;EFNB2;CYFIP2;PIM3;DGKD;VPS37B;DDX23;BMF;CCZ1
prerank,PanglaoDB_Augmented_2021__Pinealocytes,0.5215068641533993,1.2968678370291145,0.07692307692307693,0.6451019754273783,1.0,8/39,9.76%,CACNA1A;AANAT;AP3B2;SCN3B;MGAT4C;PDE10A;TNR;SV2B
prerank,GO_Biological_Process_2021__DNA duplex unwinding (GO:0032508),-0.5868063614378132,-1.2968454157684777,0.140625,0.48756366500685355,1.0,5/40,4.34%,DDX11;UBC;RPS27A;XPA;GTF2H5
prerank,GO_Biological_Process_2021__RNA metabolic process (GO:0016070),0.45562522104782294,1.2967735132255005,0.11538461538461539,0.6445088749875016,1.0,8/111,2.70%,ADARB2;POLR2D;NUFIP1;SYNCRIP;RNASEH2C;TBRG4;NOL9;WDR74
prerank,GO_Biological_Process_2021__positive regulation of extracellular matrix disassembly (GO:0090091),0.8327052060487363,1.2965960718741065,0.10638297872340426,0.6442662060799084,1.0,1/5,0.66%,PDPN
prerank,GO_Biological_Process_2021__positive regulation of cell adhesion mediated by integrin (GO:0033630),-0.8054613382898885,-1.296595334882325,0.16071428571428573,0.4880305486236942,1.0,2/9,1.49%,SKAP1;CCL5
prerank,GO_Biological_Process_2021__myeloid dendritic cell activation (GO:0001773),0.7363352743866347,1.2965264178501335,0.20454545454545456,0.6436125176610054,1.0,1/7,1.95%,TGFBR2
prerank,CellMarker_Augmented_2021__Pericyte:Brain,0.5629719202056793,1.2962460931911464,0.11764705882352941,0.6438777177866097,1.0,7/33,5.20%,COL16A1;TPM2;SVEP1;COL5A2;ACTA2;PHLDB1;TIMP3
prerank,Reactome_2022__Defective Intrinsic Pathway For Apoptosis R-HSA-9734009,0.6193582517509503,1.2962385100642133,0.14583333333333334,0.6430210456496329,1.0,1/17,1.30%,CDK5R1
prerank,GO_Biological_Process_2021__negative regulation of IRE1-mediated unfolded protein response (GO:1903895),-0.8513223396143772,-1.296236341654435,0.16666666666666666,0.48887794841681703,1.0,2/5,4.19%,DNAJB9;DDRGK1
prerank,GO_Biological_Process_2021__regulation of muscle contraction (GO:0006937),-0.794607086533029,-1.295975232966445,0.12903225806451613,0.48941287238654946,1.0,3/11,7.44%,CHRM2;SRI;MYBPC3
prerank,GO_Biological_Process_2021__regulation of neurotransmitter receptor activity (GO:0099601),0.5344580212429481,1.295688104268864,0.09090909090909091,0.6442325000561844,1.0,22/42,22.89%,NETO1;NLGN1;RELN;NPTXR;SHISA9;GRIA3;GRIA4;GRIA1;GRIN2B;NPTX1;PRRT1;GRIA2;CACNG8;CACNG2;GRIN2A;DLGAP4;DLGAP1;CACNG3;CNIH3;GRIN1;DLG2;DLGAP2
prerank,GO_Biological_Process_2021__cellular response to interleukin-7 (GO:0098761),-0.7783829486921116,-1.2956509567959358,0.1206896551724138,0.4895019478786899,1.0,1/10,1.80%,IL7R
prerank,GO_Biological_Process_2021__interleukin-7-mediated signaling pathway (GO:0038111),-0.7783829486921116,-1.2956509567959358,0.1206896551724138,0.4895019478786899,1.0,1/10,1.80%,IL7R
prerank,GO_Biological_Process_2021__adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),-0.632892463630905,-1.2956247475673186,0.18461538461538463,0.4891430944678821,1.0,4/30,3.46%,FLNA;CHRM2;MARCO;RGS1
prerank,KEGG_2021_Human__NOD-like receptor signaling pathway,-0.5402123170181741,-1.2953385404890865,0.06493506493506493,0.4896294605207227,1.0,19/125,9.56%,OAS3;CCL5;CARD16;GABARAPL1;PSTPIP1;NAIP;OAS2;CTSB;AIM2;GBP3;TXN2;NLRP12;NAMPT;TNFAIP3;OAS1;RNASEL;GBP2;GABARAPL2;STAT1
prerank,KEGG_2021_Human__Glycosphingolipid biosynthesis,0.6427407980906031,1.29508101930836,0.1388888888888889,0.645204457004252,1.0,5/20,8.69%,B3GNT2;GLB1;B4GALT4;ST6GALNAC3;FUT9
prerank,CellMarker_Augmented_2021__Progenitor cell:Bone,0.5682899774416781,1.294541077202989,0.13333333333333333,0.6444657956745197,1.0,5/43,1.95%,COL5A3;ANXA1;ARHGAP31;SERPINE1;TGFBR2
prerank,CellMarker_Augmented_2021__Amniotic Fluid Stem cell:Amniotic Fluid,0.5682899774416781,1.294541077202989,0.13333333333333333,0.6444657956745197,1.0,5/43,1.95%,COL5A3;ANXA1;ARHGAP31;SERPINE1;TGFBR2
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Synovial Fluid,0.5682899774416781,1.294541077202989,0.13333333333333333,0.6444657956745197,1.0,5/43,1.95%,COL5A3;ANXA1;ARHGAP31;SERPINE1;TGFBR2
prerank,Reactome_2022__Meiotic Recombination R-HSA-912446,-0.6501429900201429,-1.2943553730148463,0.11940298507462686,0.49263888329940064,1.0,10/27,9.35%,H2BC4;H2BC26;H2AC20;H2AC6;H3-3B;H2AJ;H2BC21;BRCA2;H2BC5;H2BC9
prerank,Reactome_2022__Signal Transduction By L1 R-HSA-445144,0.6512321580381202,1.294221672017215,0.15384615384615385,0.6447273537586016,1.0,4/16,11.38%,NRP1;MAP2K1;ITGAV;MAPK1
prerank,GO_Biological_Process_2021__adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880),0.7838869668178058,1.2941642588832887,0.20930232558139536,0.6441747984031583,1.0,3/5,17.63%,ADRA1A;ADCY9;RAPGEF2
prerank,Reactome_2022__RET Signaling R-HSA-8853659,0.6210302933885503,1.2940311451168123,0.12195121951219512,0.6437955615442096,1.0,6/22,12.71%,PIGU;GRB10;RAP1GAP;SHANK3;PDLIM7;GAB2
prerank,GO_Biological_Process_2021__chemokine (C-X-C motif) ligand 12 signaling pathway (GO:0038146),-0.8545066431701019,-1.2940242486519151,0.13725490196078433,0.49329933026433576,1.0,2/5,7.09%,CXCR4;STK39
prerank,Reactome_2022__Pre-NOTCH Transcription And Translation R-HSA-1912408,-0.6162450914662349,-1.2939834868129931,0.08450704225352113,0.49303892638806984,1.0,10/41,9.35%,H2BC4;H2BC26;H2AC20;H2AC6;H3-3B;H2AJ;H2BC21;H2BC5;RBPJ;H2BC9
prerank,GO_Biological_Process_2021__heterotypic cell-cell adhesion (GO:0034113),-0.7062615776267561,-1.293828373574523,0.14285714285714285,0.4931573519838051,1.0,9/20,18.52%,CD2;CD200R1;JUP;ITGA4;ITGB2;DSC2;CD200;PKP2;ITGB1
prerank,CellMarker_Augmented_2021__B cell:Undefined,-0.6366574347966573,-1.2937255041838611,0.10606060606060606,0.49306725625260656,1.0,11/39,12.82%,CD2;IL7R;CD69;CD14;SELL;CD63;PECAM1;ITGA4;ITGB2;IL18R1;PTPRC
prerank,GO_Biological_Process_2021__regulation of ruffle assembly (GO:1900027),0.6624377029105295,1.2936324042147769,0.2,0.6443689792987485,1.0,4/14,11.03%,EPS8;NLGN1;KANK1;P2RY12
prerank,PanglaoDB_Augmented_2021__Cholinergic Neurons,0.5276718246926937,1.2935955090091287,0.08823529411764706,0.6435854223792157,1.0,9/36,11.82%,KCNQ2;DPYSL5;NCAN;SNAP91;CSPG5;VGF;PURG;LINGO1;CAMKV
prerank,Reactome_2022__SEMA3A-Plexin Repulsion Signaling By Inhibiting Integrin Adhesion R-HSA-399955,0.657850346842406,1.2934050273094095,0.175,0.6434107581980647,1.0,3/12,5.95%,NRP1;PLXNA2;PLXNA3
prerank,Reactome_2022__Hedgehog Ligand Biogenesis R-HSA-5358346,-0.6088421966167143,-1.2931419384523437,0.14473684210526316,0.49485058053115943,1.0,14/51,19.69%,UBC;RPS27A;PSMB3;PSMB6;PSMA7;PSMB9;PSMD12;PSMD8;PSMA5;UBA52;PSMA3;PSMC4;PSME2;PSME1
prerank,GO_Biological_Process_2021__positive regulation of DNA binding (GO:0043388),-0.7438136126856394,-1.2927871502997421,0.08064516129032258,0.49561415138369913,1.0,4/17,5.56%,PYHIN1;EDF1;H1-0;IGF1
prerank,Reactome_2022__Neutrophil Degranulation R-HSA-6798695,-0.4940169669937916,-1.2924368552163286,0.044444444444444446,0.49637641921430603,1.0,69/341,15.24%,CD36;SLC2A3;PPIE;FTH1;NIT2;HLA-B;DYNLT1;MNDA;CD55;RNASET2;ENPP4;CLEC12A;CHIT1;RAB37;B2M;FCAR;SRP14;SELL;FCER1G;ANXA2;CTSB;NDUFA2;CD93;PADI2;LPCAT1;HLA-C;JUP;NBEAL2;CD63;PECAM1;RAB3A;GSTP1;C5AR1;RAB3D;CYSTM1;AGA;TNFRSF1B;OLR1;ACAA1;OSCAR;CD44;COMMD9;CHI3L1;SLC11A1;ITGB2;NCKAP1L;PTGES2;PTPRB;PRDX4;TYROBP;ITGAL;STING1;CD47;PSMD12;HSPA1B;CYBA;PTPRC;PSMA5;FTL;OSTF1;TUBB4B;CRACR2A;HSPA1A;IGF2R;TIMP2;C3;TMEM179B;FPR1;GUSB
prerank,GO_Biological_Process_2021__regulation of DNA biosynthetic process (GO:2000278),0.6367349574345555,1.292343112426681,0.14285714285714285,0.6463752844559665,1.0,4/18,9.97%,PDGFA;FGF2;DACH1;HGF
prerank,GO_Biological_Process_2021__B cell mediated immunity (GO:0019724),-0.7775714469284815,-1.2922702031115212,0.1864406779661017,0.4965222515404332,1.0,2/5,15.77%,FCER1G;CD74
prerank,GO_Biological_Process_2021__positive regulation of protein ubiquitination (GO:0031398),0.5317255473459278,1.2921303298740008,0.043478260869565216,0.6463680636222985,1.0,12/56,14.94%,UBE2D1;SMAD7;LRRK2;ARRDC3;DCUN1D4;LAPTM5;UBE2L3;FBXW7;UBE2N;DCUN1D1;XIAP;TRAF6
prerank,GO_Biological_Process_2021__negative regulation of protein import into nucleus (GO:0042308),-0.8153764839963448,-1.292123248032963,0.10714285714285714,0.4962374632900435,1.0,2/6,4.08%,MDFIC;APOD
prerank,GO_Biological_Process_2021__negative regulation of protein import (GO:1904590),-0.8153764839963448,-1.292123248032963,0.10714285714285714,0.4962374632900435,1.0,2/6,4.08%,MDFIC;APOD
prerank,CellMarker_Augmented_2021__Megakaryocyte Erythroid cell:Undefined,-0.6411231254587398,-1.2913237825911281,0.15384615384615385,0.4985765423177908,1.0,9/33,8.19%,CD2;IL7R;CD69;CD200R1;SELL;GZMB;PECAM1;ITGA4;KLRD1
prerank,Reactome_2022__Intra-Golgi Traffic R-HSA-6811438,0.6038028823554625,1.2910325523794173,0.15625,0.6492122945041051,1.0,7/35,16.04%,RAB33B;VTI1A;COG1;GOLIM4;YKT6;STX6;COG3
prerank,GO_Biological_Process_2021__sensory perception of light stimulus (GO:0050953),0.523779355679939,1.2909981011528588,0.12903225806451613,0.6484894138026109,1.0,4/38,3.93%,TULP2;PCDH15;CRYGS;RP2
prerank,Reactome_2022__G1/S Transition R-HSA-69206,-0.553743511528427,-1.2909916972054616,0.08571428571428572,0.4992717505382053,1.0,27/92,22.23%,UBC;RPS27A;PSMB3;POLE3;PSMB6;PSMA7;PSMB9;PSMD12;MAX;PSMD8;PSMA5;MCM7;RPA3;CCND1;UBA52;PSMA3;PSMC4;PSME2;PSME1;PRIM1;MCM6;PSMB5;TYMS;PSMC3;CDC7;MCM5;CDKN1B
prerank,CellMarker_Augmented_2021__Marginal Zone B cell:Undefined,0.7677863138994248,1.2908152946027986,0.19444444444444445,0.6483094039045929,1.0,1/7,0.44%,CD180
prerank,Reactome_2022__Ras Activation Upon Ca2+ Influx Thru NMDA Receptor R-HSA-442982,-0.7617759510070565,-1.2907183598922747,0.14285714285714285,0.49977436441340967,1.0,3/13,8.36%,RASGRF2;NEFL;CALM1
prerank,GO_Biological_Process_2021__glycerophospholipid catabolic process (GO:0046475),0.6224171758475437,1.2904615142099625,0.16981132075471697,0.6490096851583136,1.0,3/17,5.79%,PLA2G4C;PLA2G7;PRDX6
prerank,GO_Biological_Process_2021__inositol phosphate dephosphorylation (GO:0046855),0.6846268232982311,1.2903148854374824,0.16666666666666666,0.6478645950863146,1.0,4/10,16.55%,INPP1;IMPA1;PTEN;INPP5A
prerank,GO_Biological_Process_2021__phosphorylated carbohydrate dephosphorylation (GO:0046838),0.6846268232982311,1.2903148854374824,0.16666666666666666,0.6478645950863146,1.0,4/10,16.55%,INPP1;IMPA1;PTEN;INPP5A
prerank,GO_Biological_Process_2021__dorsal/ventral pattern formation (GO:0009953),0.7641725270391171,1.2899018150335957,0.15217391304347827,0.648332077863244,1.0,4/8,14.04%,BMPR1B;PTCH1;BMPR1A;AIDA
prerank,CellMarker_Augmented_2021__Neural Stem cell:Brain,-0.7615952400512833,-1.2897498557873213,0.17307692307692307,0.5024181444133613,1.0,4/10,18.52%,CXCR4;ITGA6;VIM;ITGB1
prerank,GO_Biological_Process_2021__presynaptic membrane organization (GO:0097090),0.7006172785588768,1.289611427500968,0.22727272727272727,0.6485833728993025,1.0,7/10,17.29%,LRP4;CNTN2;NLGN1;PTPRD;PTEN;NLGN4Y;IL1RAPL1
prerank,GO_Biological_Process_2021__negative regulation of p38MAPK cascade (GO:1903753),-0.79422291166811,-1.289482054906088,0.18181818181818182,0.5029172399651543,1.0,1/7,1.54%,DUSP1
prerank,GO_Biological_Process_2021__glycerolipid biosynthetic process (GO:0045017),0.7453786319758489,1.2894351854422996,0.2553191489361702,0.6484353280824512,1.0,2/5,21.64%,HDHD5;CPNE3
prerank,Reactome_2022__Heme Signaling R-HSA-9707616,0.578989298408404,1.289412099440548,0.11764705882352941,0.6477363812741649,1.0,6/37,10.67%,PPARGC1A;SIRT1;NRIP1;XPO1;CLOCK;TBL1XR1
prerank,CellMarker_Augmented_2021__Luminal cell:Prostate,0.5946077627212246,1.289403841356083,0.15555555555555556,0.6469016270739333,1.0,1/24,0.04%,SHROOM3
prerank,GO_Biological_Process_2021__cholesterol metabolic process (GO:0008203),-0.6192974744617927,-1.2894005241464224,0.11666666666666667,0.5027434244811245,1.0,3/42,0.88%,OSBPL5;INSIG1;CH25H
prerank,GO_Biological_Process_2021__chromatin maintenance (GO:0070827),0.79080184800116,1.288817986310189,0.25,0.6484364534982598,1.0,1/5,2.51%,SIRT1
prerank,GO_Biological_Process_2021__regulation of protein ADP-ribosylation (GO:0010835),-0.805262573437982,-1.2886723939094307,0.08928571428571429,0.5047827917455568,1.0,1/6,1.84%,WARS1
prerank,GO_Biological_Process_2021__androgen receptor signaling pathway (GO:0030521),0.706003824013307,1.2883127791011868,0.15384615384615385,0.6492198401228034,1.0,2/10,5.23%,ARID1A;PLPP1
prerank,Reactome_2022__PI3K Events In ERBB2 Signaling R-HSA-1963642,0.7622613947708721,1.2882445284845276,0.18181818181818182,0.6485539895714951,1.0,6/10,17.35%,PIGU;NRG1;NRG3;NRG2;ERBB4;PIK3CA
prerank,CellMarker_Augmented_2021__Lake Et al.Science.In1:Brain,0.5111950313111667,1.2882309469941848,0.07692307692307693,0.6477529543920193,1.0,28/67,22.48%,KCNQ2;CNTN2;NCAN;ZNF536;KHDRBS2;SNAP91;CNR1;CTNNA2;SORCS3;ASXL3;PTPN5;NRXN2;SLC35F1;RBFOX1;CACNA1E;GRIA2;LRRC4B;ADGRB3;TMEM132C;PDZD4;GRIK3;UNC5D;CNTNAP2;AMER2;CACNA1B;NRXN1;LSAMP;RAB3C
prerank,GO_Biological_Process_2021__positive regulation of transcription by RNA polymerase I (GO:0045943),-0.6974878338356022,-1.288221989684289,0.16129032258064516,0.5059648007935397,1.0,1/19,0.51%,DDX11
prerank,Reactome_2022__Metabolism Of Polyamines R-HSA-351202,-0.6298065387460006,-1.287871437194297,0.13043478260869565,0.5065506278555325,1.0,17/44,22.96%,PSMB3;SLC38A1;PSMB6;PSMA7;PSMB9;AZIN2;AZIN1;PSMD12;PSMD8;PSMA5;PSMA3;PSMC4;PSME2;PSME1;PSMB5;PSMC3;PSME3
prerank,CellMarker_Augmented_2021__Tumor-propagating cell:Undefined,0.5205169427844397,1.2876760517382129,0.07692307692307693,0.645148971057785,1.0,14/56,12.88%,COL16A1;LRP4;RASSF8;FKBP9;COL5A2;FGF2;PHLDB1;MAGI1;NUAK1;LOXL2;PTPRG;ENAH;TJP1;FBXL7
prerank,CellMarker_Augmented_2021__Progenitor cell:Fetal Liver,0.5205169427844397,1.2876760517382129,0.07692307692307693,0.645148971057785,1.0,14/56,12.88%,COL16A1;LRP4;RASSF8;FKBP9;COL5A2;FGF2;PHLDB1;MAGI1;NUAK1;LOXL2;PTPRG;ENAH;TJP1;FBXL7
prerank,CellMarker_Augmented_2021__Dental Pulp Stem cell:Molar,0.5205169427844397,1.2876760517382129,0.07692307692307693,0.645148971057785,1.0,14/56,12.88%,COL16A1;LRP4;RASSF8;FKBP9;COL5A2;FGF2;PHLDB1;MAGI1;NUAK1;LOXL2;PTPRG;ENAH;TJP1;FBXL7
prerank,CellMarker_Augmented_2021__Mesenchymal Progenitor cell:Bone Marrow,0.5205169427844397,1.2876760517382129,0.07692307692307693,0.645148971057785,1.0,14/56,12.88%,COL16A1;LRP4;RASSF8;FKBP9;COL5A2;FGF2;PHLDB1;MAGI1;NUAK1;LOXL2;PTPRG;ENAH;TJP1;FBXL7
prerank,CellMarker_Augmented_2021__Mesenchymal Progenitor cell:Bone,0.5205169427844397,1.2876760517382129,0.07692307692307693,0.645148971057785,1.0,14/56,12.88%,COL16A1;LRP4;RASSF8;FKBP9;COL5A2;FGF2;PHLDB1;MAGI1;NUAK1;LOXL2;PTPRG;ENAH;TJP1;FBXL7
prerank,CellMarker_Augmented_2021__Mesenchymal Progenitor cell:Adipose Tissue,0.5205169427844397,1.2876760517382129,0.07692307692307693,0.645148971057785,1.0,14/56,12.88%,COL16A1;LRP4;RASSF8;FKBP9;COL5A2;FGF2;PHLDB1;MAGI1;NUAK1;LOXL2;PTPRG;ENAH;TJP1;FBXL7
prerank,GO_Biological_Process_2021__macrophage activation (GO:0042116),-0.6326769871895919,-1.2875998528764954,0.203125,0.5069604055347714,1.0,6/27,10.55%,AIF1;CD93;CLU;C5AR1;SLC11A1;ITGB2
prerank,GO_Biological_Process_2021__depyrimidination (GO:0045008),-0.7622783474409678,-1.2874551317484213,0.2222222222222222,0.5070044562814515,1.0,2/6,4.21%,SMUG1;OGG1
prerank,GO_Biological_Process_2021__sphingolipid metabolic process (GO:0006665),0.4934992339797222,1.2872487328540487,0.07692307692307693,0.6461385524204747,1.0,12/78,6.69%,VAPB;ACER2;ARSA;ABCA2;PPM1L;GLB1;ST6GALNAC3;PLPP1;FA2H;PPT1;SPTLC2;HACD2
prerank,Reactome_2022__Acyl Chain Remodelling Of PG R-HSA-1482925,-0.8531141578109287,-1.2872006324174594,0.14285714285714285,0.5074435552174472,1.0,1/5,4.85%,LPCAT1
prerank,Reactome_2022__Nuclear Events Mediated By NFE2L2 R-HSA-9759194,-0.5577540177393566,-1.2868204247124064,0.05405405405405406,0.5082918889700391,1.0,20/65,22.04%,UBC;RPS27A;PSMB3;PSMB6;PSMA7;GCLM;PSMB9;RBX1;PSMD12;PSMD8;PSMA5;UBA52;TALDO1;PSMA3;PSMC4;PSME2;PSME1;PSMB5;NFE2L2;PSMC3
prerank,Reactome_2022__Regulation Of mRNA Stability By Proteins That Bind AU-rich Elements R-HSA-450531,-0.5734624149719526,-1.286787543149072,0.11688311688311688,0.5079781795876672,1.0,14/76,14.82%,UBC;RPS27A;ZFP36;PSMB3;PSMB6;PSMA7;ENPP2;PSMB9;EXOSC1;PSMD12;PSMD8;PSMA5;HSPA1A;UBA52
prerank,PanglaoDB_Augmented_2021__Spermatocytes,0.8242538699470102,1.2866258330138174,0.2894736842105263,0.6473062539454985,1.0,2/6,5.60%,SYCP3;GCNA
prerank,GO_Biological_Process_2021__necroptotic process (GO:0070266),-0.7350119706173204,-1.286572734392528,0.15789473684210525,0.5082334488485014,1.0,3/11,14.98%,CD14;MLKL;IPMK
prerank,GO_Biological_Process_2021__organic hydroxy compound transport (GO:0015850),-0.6559794622922529,-1.2865668858609236,0.14285714285714285,0.50782186648824,1.0,2/18,4.96%,SLC51A;ABCC3
prerank,GO_Biological_Process_2021__female gonad development (GO:0008585),-0.7800531466878442,-1.2865216798071755,0.11290322580645161,0.5075396074969619,1.0,4/9,19.59%,VEGFA;SOD1;EIF2B2;CYP19A1
prerank,GO_Biological_Process_2021__glycosphingolipid metabolic process (GO:0006687),0.5535574279354964,1.2864020738159845,0.15151515151515152,0.646952204304698,1.0,5/34,5.16%,ARSA;ABCA2;GLB1;LARGE1;ST6GALNAC3
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transmembrane transport (GO:1904427),-0.7181690637293141,-1.2857996533978155,0.21052631578947367,0.5092764197808366,1.0,2/11,3.66%,CALCR;CEMIP
prerank,GO_Biological_Process_2021__tight junction assembly (GO:0120192),-0.6903782258673725,-1.2856534014165355,0.125,0.5095146386438367,1.0,4/22,7.76%,MPP7;CLDN7;PECAM1;ACTG1
prerank,GO_Biological_Process_2021__regulation of ER to Golgi vesicle-mediated transport (GO:0060628),0.7563503447450985,1.2852895606247903,0.24444444444444444,0.6503234393446983,1.0,3/8,3.81%,PGAP1;RNF139;LRRK2
prerank,GO_Biological_Process_2021__negative regulation of T cell migration (GO:2000405),-0.8262749156678947,-1.2849796382070924,0.1864406779661017,0.5110959385984326,1.0,3/5,4.08%,RIPOR2;CD200R1;APOD
prerank,Reactome_2022__EPH-ephrin Mediated Repulsion Of Cells R-HSA-3928665,-0.6143980918720456,-1.2848292503174437,0.14084507042253522,0.5111361632242679,1.0,9/35,19.57%,VAV3;YES1;EPHB1;FYN;EFNB2;CLTB;AP2S1;APH1B;EPHB2
prerank,CellMarker_Augmented_2021__Osteoblast:Bone,-0.7338652558500067,-1.2847569714802483,0.09259259259259259,0.5109125946501407,1.0,3/14,8.71%,CALCR;OSCAR;CD44
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Umbilical Cord,-0.8075478211783023,-1.284726140505481,0.2786885245901639,0.5101732003582556,1.0,5/7,18.52%,CD14;PECAM1;CD44;PTPRC;ITGB1
prerank,CellMarker_Augmented_2021__Fibroblast:Vocal Fold,-0.8075478211783023,-1.284726140505481,0.2786885245901639,0.5101732003582556,1.0,5/7,18.52%,CD14;PECAM1;CD44;PTPRC;ITGB1
prerank,GO_Biological_Process_2021__regulation of hematopoietic stem cell differentiation (GO:1902036),-0.5763758890489342,-1.28449626544176,0.1625,0.5104094808097929,1.0,17/55,22.96%,PSMB3;EIF2AK2;PSMB6;PSMA7;PSMB9;TCF3;PSMD12;PSMD8;PSMA5;SETD1A;PSMA3;PSMC4;PSME2;PSME1;PSMB5;PSMC3;PSME3
prerank,GO_Biological_Process_2021__negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),0.7168803422404548,1.284437302427325,0.17073170731707318,0.6523961428401956,1.0,1/10,0.35%,BAG3
prerank,Reactome_2022__Integration Of Provirus R-HSA-162592,0.6989174427811956,1.2844256768814715,0.2,0.6516025244587724,1.0,3/10,14.26%,LIG4;HMGA1;SGIP1
prerank,GO_Biological_Process_2021__heparan sulfate proteoglycan biosynthetic process (GO:0015012),0.6990871529365843,1.2841576190088995,0.15789473684210525,0.6515290137926901,1.0,4/15,4.71%,HS3ST5;CSGALNACT1;HS2ST1;UGDH
prerank,GO_Biological_Process_2021__response to retinoic acid (GO:0032526),0.5782570621094684,1.284019700256421,0.15555555555555556,0.6512614636038676,1.0,3/27,8.25%,ACER2;WNT5A;BRINP3
prerank,GO_Biological_Process_2021__proteasome assembly (GO:0043248),-0.7673649353861356,-1.2839227289250936,0.18867924528301888,0.5118845066449499,1.0,3/9,19.33%,ADRM1;OTUD6B;PSMG1
prerank,GO_Biological_Process_2021__glutamine transport (GO:0006868),-0.7993700319012087,-1.2838694896825453,0.21052631578947367,0.5116537417900916,1.0,3/5,17.98%,SLC38A1;SLC38A6;SLC1A4
prerank,GO_Biological_Process_2021__regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844),-0.8424473012416323,-1.2838410074268454,0.07407407407407407,0.511348386112975,1.0,2/5,8.36%,SRI;CALM1
prerank,GO_Biological_Process_2021__aminophospholipid transport (GO:0015917),0.8178743874097543,1.2837074272891147,0.3090909090909091,0.6515019290925074,1.0,1/5,6.28%,SCARB2
prerank,GO_Biological_Process_2021__regulation of cGMP-mediated signaling (GO:0010752),0.8181306442898413,1.2836382689971022,0.17777777777777778,0.650966854520718,1.0,3/5,13.04%,RUNDC3A;PDE10A;CGAS
prerank,CellMarker_Augmented_2021__Adipose Multilineage-Differentiating Stress-Enduring cell:Adipose Tissue,0.5928102996747406,1.283525551983497,0.13793103448275862,0.6506415138938978,1.0,8/33,8.39%,COL5A3;COL16A1;COL5A2;ACTA2;TIMP3;CNRIP1;NTM;CDH11
prerank,GO_Biological_Process_2021__positive regulation of cytokine-mediated signaling pathway (GO:0001961),-0.6645684484237475,-1.2832839589818164,0.16666666666666666,0.5129537987730384,1.0,10/26,15.77%,CXCR4;PARP14;CD300LF;TXK;NLRC5;PARP9;HIF1A;HSPA1B;HSPA1A;CD74
prerank,PanglaoDB_Augmented_2021__Trichocytes,-0.8273642243823378,-1.2832577361777169,0.20408163265306123,0.512610446008725,1.0,1/5,12.31%,ADGRG6
prerank,GO_Biological_Process_2021__positive regulation of response to endoplasmic reticulum stress (GO:1905898),0.6245618471670844,1.2831836822705096,0.16279069767441862,0.6509115787634551,1.0,4/14,13.44%,DDIT3;BOK;RNF185;BAG6
prerank,GO_Biological_Process_2021__nuclear transport (GO:0051169),0.7226389355633904,1.2829854965279077,0.21052631578947367,0.6507207465229914,1.0,3/11,7.27%,NUTF2;XPO1;HMGA1
prerank,GO_Biological_Process_2021__malate metabolic process (GO:0006108),-0.8318149920170714,-1.282708811712663,0.1875,0.514017701093066,1.0,2/6,2.23%,ME1;MDH2
prerank,Reactome_2022__Role Of Second Messengers In Netrin-1 Signaling R-HSA-418890,0.8287762573823663,1.2825143747247651,0.1568627450980392,0.6512717281494028,1.0,1/6,0.46%,TRPC1
prerank,GO_Biological_Process_2021__cellular response to hepatocyte growth factor stimulus (GO:0035729),0.7573516254064665,1.282480531217284,0.17777777777777778,0.6498110103737312,1.0,2/6,9.97%,NRP1;HGF
prerank,GO_Biological_Process_2021__response to hepatocyte growth factor (GO:0035728),0.7573516254064665,1.282480531217284,0.17777777777777778,0.6498110103737312,1.0,2/6,9.97%,NRP1;HGF
prerank,CellMarker_Augmented_2021__Basal cell:Undefined,-0.5762148551004856,-1.2824526695938376,0.15151515151515152,0.51454085748724,1.0,22/73,9.17%,CEBPD;SAT1;FTH1;FOSL2;CD55;MGLL;IFIT3;B2M;CD14;ANXA2;CTSB;IER3;ABCC3;CD63;GBP3;PLSCR1;SGK1;TYMP;OAS1;CD44;GBP2;S100A6
prerank,CellMarker_Augmented_2021__Germinal Stem cell:Ovary,-0.5887017893720908,-1.2823402394820063,0.1643835616438356,0.5140328442646629,1.0,13/46,8.63%,MT2A;CEBPD;FTH1;PID1;IFIT3;IFIT1;IFITM3;PLTP;CLU;ENKUR;SPATS2L;IFIT2;TMEM219
prerank,CellMarker_Augmented_2021__Germline Stem cell:Ovarian Cortex,-0.5887017893720908,-1.2823402394820063,0.1643835616438356,0.5140328442646629,1.0,13/46,8.63%,MT2A;CEBPD;FTH1;PID1;IFIT3;IFIT1;IFITM3;PLTP;CLU;ENKUR;SPATS2L;IFIT2;TMEM219
prerank,GO_Biological_Process_2021__positive regulation of histone modification (GO:0031058),0.5904604307097094,1.2820723988105167,0.0975609756097561,0.6504644413742285,1.0,3/26,5.00%,PPARGC1A;RUVBL2;RPS6KA4
prerank,"GO_Biological_Process_2021__regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",-0.7282001762062562,-1.2820710876238248,0.09615384615384616,0.5140851028996749,1.0,1/12,1.48%,ZFP36
prerank,"GO_Biological_Process_2021__positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",-0.7282001762062562,-1.2820710876238248,0.09615384615384616,0.5140851028996749,1.0,1/12,1.48%,ZFP36
prerank,GO_Biological_Process_2021__negative regulation of NIK/NF-kappaB signaling (GO:1901223),-0.6883921729224498,-1.281608709736889,0.2153846153846154,0.5151567366486213,1.0,4/15,15.37%,NLRC3;NLRP12;TMSB4X;IFI35
prerank,GO_Biological_Process_2021__phosphatidylglycerol metabolic process (GO:0046471),-0.6893521407015116,-1.2815157442899192,0.21818181818181817,0.5151633072495233,1.0,1/13,4.85%,LPCAT1
prerank,GO_Biological_Process_2021__actin filament-based transport (GO:0099515),-0.7096252706549528,-1.2815030470695092,0.1864406779661017,0.5148058208844067,1.0,2/14,1.88%,MYO1G;SYNE2
prerank,CellMarker_Augmented_2021__Granulocyte:Peripheral Blood,-0.7598523623532137,-1.2813693000986235,0.14754098360655737,0.5148200928873261,1.0,7/12,12.82%,CD14;IL3RA;CD63;ITGA4;ENPP3;CD44;PTPRC
prerank,PanglaoDB_Augmented_2021__Enteric Glia Cells,0.4937999820026568,1.2813667779629556,0.15384615384615385,0.6522815861887943,1.0,25/65,20.67%,LGI4;CNTN2;GFAP;ZNF536;NDRG2;INTS6;PLPPR4;PCDH17;CHST1;NTM;SHC2;PTPN5;PTPRD;LINGO1;NTRK2;CXCL14;NFASC;MAPK4;TMEM132C;CX3CL1;DCLK1;CNTN1;PHYHIPL;GRIK3;MEGF10
prerank,Reactome_2022__Alpha-Linolenic (Omega3) And Linoleic (Omega6) Acid Metabolism R-HSA-2046104,-0.7487546646841365,-1.2811602302387344,0.1896551724137931,0.5150865293953515,1.0,3/10,17.64%,MUSK;ACAA1;FADS2
prerank,GO_Biological_Process_2021__isoprenoid biosynthetic process (GO:0008299),0.7828692579214648,1.2811503386561105,0.15555555555555556,0.6520757366352076,1.0,2/6,11.61%,IDI1;MVD
prerank,GO_Biological_Process_2021__regulation of epithelial to mesenchymal transition involved in endocardial cushion formation (GO:1905005),0.737142384841235,1.280935671060077,0.225,0.6518998353903361,1.0,1/6,1.95%,TGFBR2
prerank,GO_Biological_Process_2021__eye photoreceptor cell development (GO:0042462),-0.7938271996515839,-1.2808464534234556,0.14814814814814814,0.5155970976045355,1.0,3/9,13.29%,RPGRIP1L;VEGFA;NRL
prerank,KEGG_2021_Human__Spliceosome,-0.5514455801950786,-1.2806238353005108,0.11538461538461539,0.5159587251616738,1.0,32/111,19.10%,PPIE;RNU4-2;DHX16;DHX38;SNRNP27;SNRPD2;RBM22;EIF4A3;LSM7;CRNKL1;U2AF2;NCBP2;SMNDC1;PRPF3;BUD31;HSPA1B;DDX23;SRSF2;DDX5;SRSF7;SNRPA1;HSPA1A;EFTUD2;SLU7;SNRPA;LSM4;SNRNP200;PRPF18;HSPA2;BCAS2;SF3A1;PRPF4
prerank,GO_Biological_Process_2021__dermatan sulfate proteoglycan biosynthetic process (GO:0050651),0.7477003596516743,1.2805541581610973,0.2,0.6523856837468323,1.0,4/10,11.46%,NCAN;CSGALNACT1;CSPG5;UST
prerank,GO_Biological_Process_2021__positive regulation of ligase activity (GO:0051351),-0.787685457433269,-1.2805532257815466,0.1702127659574468,0.5157426343361783,1.0,2/8,8.69%,GCLM;TMSB4X
prerank,GO_Biological_Process_2021__cardiac muscle cell-cardiac muscle cell adhesion (GO:0086042),-0.8184714059696193,-1.2802429018387214,0.16129032258064516,0.5163623038763145,1.0,3/5,16.41%,JUP;DSC2;PKP2
prerank,GO_Biological_Process_2021__purine ribonucleotide biosynthetic process (GO:0009152),0.5528921380473408,1.2802241742055063,0.1388888888888889,0.6528849854836618,1.0,7/34,15.24%,PANK3;PANK1;ADCY9;GUCY1A1;NPR2;ADCY6;GUCY1B1
prerank,Reactome_2022__Apoptotic Factor-Mediated Response R-HSA-111471,-0.6966487834594504,-1.2801959341419438,0.2459016393442623,0.5160945280391201,1.0,2/18,1.08%,APIP;CYCS
prerank,Reactome_2022__Cell-extracellular Matrix Interactions R-HSA-446353,-0.7535006886122155,-1.2799977082822318,0.1320754716981132,0.5163733751883711,1.0,1/10,0.28%,FLNA
prerank,Reactome_2022__Listeria Monocytogenes Entry Into Host Cells R-HSA-8876384,-0.715939181096867,-1.2799824036553578,0.16923076923076924,0.5159880307642132,1.0,3/19,7.21%,UBC;RPS27A;RNMT
prerank,GO_Biological_Process_2021__detection of bacterium (GO:0016045),-0.8017315208024789,-1.279809206228511,0.16666666666666666,0.5162738781028963,1.0,2/7,3.02%,HLA-B;NAIP
prerank,KEGG_2021_Human__Primary immunodeficiency,-0.7241671399373134,-1.279331309870878,0.09836065573770492,0.5174207062459033,1.0,6/15,18.04%,IL7R;BTK;TAP1;PTPRC;CIITA;RFX5
prerank,GO_Biological_Process_2021__cellular response to glucose stimulus (GO:0071333),0.5127701179900209,1.2790823639451887,0.2413793103448276,0.6559629654586229,1.0,11/25,20.52%,IGF1R;SLC39A14;UNC13B;SOX4;PCK2;PTPRN;PRKAA1;TRA2B;ZBTB20;KCNB1;AGER
prerank,GO_Biological_Process_2021__actin filament reorganization (GO:0090527),0.8617927649948982,1.2786911252283306,0.2,0.6562954752697491,1.0,2/6,3.12%,GSN;MCU
prerank,GO_Biological_Process_2021__peptidyl-tyrosine dephosphorylation (GO:0035335),0.5673232378835283,1.278558632641421,0.12121212121212122,0.6559545417537556,1.0,3/25,2.07%,DUSP6;PTPN9;DUSP18
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:White Adipose Tissue,-0.6572102731733213,-1.2785217983432293,0.2037037037037037,0.5198383888272904,1.0,13/29,11.47%,ABCA9;CD36;FCAR;IGF1;PECAM1;ANKDD1A;C5AR1;VENTX;CFLAR;BEST1;SLC11A1;USHBP1;C5AR2
prerank,GO_Biological_Process_2021__serine family amino acid biosynthetic process (GO:0009070),-0.7675851738869326,-1.2783667739587854,0.18181818181818182,0.5200248388753198,1.0,2/7,13.89%,MTHFD1;SEPHS1
prerank,GO_Biological_Process_2021__peptidyl-lysine hydroxylation (GO:0017185),-0.7934416285932095,-1.2783045397401582,0.27906976744186046,0.5198070206098536,1.0,2/5,16.10%,JMJD6;VIPAS39
prerank,CellMarker_Augmented_2021__Germinal Center B cell:Tonsil,0.5871944972777348,1.2782807640056832,0.13953488372093023,0.6561401926640121,1.0,8/40,7.39%,KLF4;FKBP9;GSN;TSPAN15;ASAP2;BACE2;KITLG;IL13RA1
prerank,Reactome_2022__NR1H2 And NR1H3 Regulate Gene Expression To Control Bile Acid Homeostasis R-HSA-9623433,-0.7763554239425308,-1.2781178199917889,0.2222222222222222,0.5199344820793738,1.0,2/7,19.98%,NR1H2;RXRB
prerank,GO_Biological_Process_2021__DNA replication checkpoint signaling (GO:0000076),-0.7236808169299797,-1.2779464458925784,0.17857142857142858,0.5201130663775783,1.0,4/10,18.89%,HUS1;TIPIN;RAD9A;NAE1
prerank,GO_Biological_Process_2021__negative regulation of ubiquitin-protein transferase activity (GO:0051444),-0.6889913265436843,-1.2778255228658868,0.2,0.5201814568480603,1.0,5/11,7.39%,RPL5;RPL11;RPL23;DTX3L;RPS7
prerank,CellMarker_Augmented_2021__Erythroblast:Fetal Liver,-0.6414898883648015,-1.2777873615483397,0.140625,0.5194547317454832,1.0,4/24,8.19%,GRAP2;BTK;WHAMMP3;KLRD1
prerank,CellMarker_Augmented_2021__Red Blood Cell (erythrocyte):Plasma,-0.6414898883648015,-1.2777873615483397,0.140625,0.5194547317454832,1.0,4/24,8.19%,GRAP2;BTK;WHAMMP3;KLRD1
prerank,GO_Biological_Process_2021__actin filament organization (GO:0007015),0.4727473194587662,1.277703257893267,0.10526315789473684,0.6573901081413634,1.0,12/98,4.81%,SHROOM3;AVIL;TPM2;CORO6;EPS8;GSN;HIP1R;GAS2;MCU;MYO1D;SPIRE2;LCP1
prerank,Reactome_2022__Creatine Metabolism R-HSA-71288,-0.7907255405900361,-1.277411758237551,0.1896551724137931,0.520320181301934,1.0,1/5,4.89%,GATM
prerank,GO_Biological_Process_2021__positive regulation of neuron projection development (GO:0010976),0.5252757080400509,1.2770507554156587,0.16129032258064516,0.6588262711413585,1.0,17/64,18.87%,AVIL;RAP1A;WNT5A;RELN;SCARB2;PLXNB2;FUT9;NPTN;ZNF804A;COBL;NTRK2;PRKCI;CAPRIN2;CX3CL1;RAPGEF2;MARK2;SCN1B
prerank,Reactome_2022__Ubiquinol Biosynthesis R-HSA-2142789,0.7559340302034427,1.2769844362804017,0.22727272727272727,0.6581783534100609,1.0,1/7,4.98%,COQ9
prerank,Reactome_2022__TCF Dependent Signaling In Response To WNT R-HSA-201681,-0.5374813480451693,-1.2769761223939715,0.08536585365853659,0.5213448993089418,1.0,25/125,12.89%,UBC;H2BC4;H2BC26;CCDC88C;H2AC20;RPS27A;RUNX3;H2AC6;PSMB3;H3-3B;H2AJ;H2BC21;PSMB6;PSMA7;H2BC5;PSMB9;H2BC9;RBX1;CSNK1G2;FZD2;PSMD12;H2BC11;PSMD8;PSMA5;KAT5
prerank,GO_Biological_Process_2021__positive regulation of podosome assembly (GO:0071803),0.7950001064841461,1.2768434519573804,0.2926829268292683,0.6578807900081977,1.0,2/5,7.30%,LCP1;TNF
prerank,CellMarker_Augmented_2021__Pluripotent Stem cell:Skin,0.5158224751107681,1.2765930156159961,0.09090909090909091,0.6578887339804995,1.0,15/50,14.08%,TPM2;FKBP9;SERPINE1;FAM20C;PLXNA2;RCN3;JAG1;ARAP3;IL13RA1;EPAS1;TCF7L2;FAM114A1;COL6A1;MMP14;STEAP3
prerank,GO_Biological_Process_2021__positive regulation of ruffle assembly (GO:1900029),0.7286138773975933,1.2765904662929126,0.28205128205128205,0.657070464410872,1.0,3/8,11.03%,EPS8;NLGN1;P2RY12
prerank,GO_Biological_Process_2021__regulation of cysteine-type endopeptidase activity (GO:2000116),-0.6672934903660317,-1.2764949565102384,0.1875,0.5226452555536157,1.0,4/14,9.00%,AIM2;FYN;NLRP12;PSMB9
prerank,GO_Biological_Process_2021__entry into host (GO:0044409),-0.7659662345346361,-1.2764698466310673,0.2,0.5222810762290853,1.0,1/9,1.43%,CXCR4
prerank,GO_Biological_Process_2021__ovarian follicle development (GO:0001541),-0.8026656058714119,-1.2763714891228424,0.18333333333333332,0.5221579062034037,1.0,3/7,16.91%,VEGFA;SOD1;EIF2B2
prerank,Reactome_2022__ABC Transporters In Lipid Homeostasis R-HSA-1369062,-0.749503992925888,-1.2763118947921317,0.14814814814814814,0.5218675041160693,1.0,2/10,2.50%,ABCA9;ABCA6
prerank,"GO_Biological_Process_2021__heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process (GO:0015014)",0.8340719154163958,1.2761964492878166,0.20833333333333334,0.6577453198735406,1.0,3/6,10.88%,CSGALNACT1;HS2ST1;EXT1
prerank,GO_Biological_Process_2021__mRNA catabolic process (GO:0006402),-0.6211101981372725,-1.2758671134633806,0.16417910447761194,0.5229304847524988,1.0,7/39,14.43%,ZFP36;NUDT12;EXOSC10;HSPA1B;DDX5;NUDT16;HSPA1A
prerank,KEGG_2021_Human__Type I diabetes mellitus,-0.6492429170873905,-1.275847995614124,0.15254237288135594,0.5225963209023066,1.0,11/28,16.72%,HLA-B;GZMB;PRF1;HLA-C;HLA-DRB5;HLA-F;HLA-DRA;HLA-E;HLA-DPA1;HLA-DMB;HLA-DPB1
prerank,GO_Biological_Process_2021__platelet degranulation (GO:0002576),-0.5474153779876199,-1.275602701050318,0.12857142857142856,0.5229598490819153,1.0,18/81,11.68%,FLNA;CD36;SRGN;F8;CLU;PLEK;F13A1;IGF1;CD63;PECAM1;SELENOP;TTN;CALM1;FERMT3;TMSB4X;VEGFA;A2M;GTPBP2
prerank,GO_Biological_Process_2021__positive regulation of BMP signaling pathway (GO:0030513),0.6855814107840411,1.2754824521687997,0.17073170731707318,0.6595751936301142,1.0,5/14,12.30%,ACVR2A;UBE2O;SMAD2;BMPR1B;BMPR1A
prerank,Reactome_2022__Keratan Sulfate Degradation R-HSA-2022857,0.7781199317348368,1.2753876703505467,0.2608695652173913,0.6590466910530672,1.0,1/5,3.20%,GLB1
prerank,GO_Biological_Process_2021__basement membrane organization (GO:0071711),0.7846566607555735,1.2752462250907368,0.12962962962962962,0.6587646854772755,1.0,3/7,20.19%,HPN;FLRT2;NTN4
prerank,CellMarker_Augmented_2021__Macrophage:Spleen,-0.8204331597623751,-1.274979755482921,0.1791044776119403,0.5247159784604501,1.0,2/6,3.07%,ADGRE1;CD14
prerank,GO_Biological_Process_2021__ruffle organization (GO:0031529),-0.7199812827936513,-1.2749686266432807,0.23809523809523808,0.5243086817396437,1.0,8/13,20.20%,AIF1;PLEK;CORO1B;PLEKHA1;RAC1;INPP5K;CARMIL1;TPM1
prerank,GO_Biological_Process_2021__response to glucocorticoid (GO:0051384),-0.665420459393008,-1.27481532554691,0.19642857142857142,0.5244236448368501,1.0,2/16,1.48%,CALCR;ZFP36
prerank,CellMarker_Augmented_2021__Endothelial cell:Brain,-0.8337134421308057,-1.2745151196060402,0.16,0.524878642630343,1.0,3/5,12.34%,PECAM1;A2M;FLT1
prerank,GO_Biological_Process_2021__ornithine metabolic process (GO:0006591),-0.8213024496785613,-1.2744214544616215,0.29411764705882354,0.5247687443140499,1.0,3/6,11.99%,ODC1;AZIN2;AZIN1
prerank,GO_Biological_Process_2021__nucleotide-excision repair (GO:0006289),-0.5375880451583734,-1.2742554688651155,0.14102564102564102,0.524818018459442,1.0,11/88,7.58%,UBC;PPIE;RPS27A;XPA;COPS6;UVSSA;OGG1;GTF2H5;HUS1;POLR2G;BRCA2
prerank,GO_Biological_Process_2021__negative regulation of cytoskeleton organization (GO:0051494),0.6103142858501878,1.274077880308267,0.15217391304347827,0.6620990431477934,1.0,10/24,17.35%,HIP1R;MYADM;KANK1;SHANK3;TJP1;SSH2;CLASP1;FKBP4;IQCJ-SCHIP1;PIK3CA
prerank,GO_Biological_Process_2021__cellular response to unfolded protein (GO:0034620),0.5986346763943668,1.2740773920744235,0.14285714285714285,0.6612816369216851,1.0,1/23,0.35%,BAG3
prerank,GO_Biological_Process_2021__commissural neuron axon guidance (GO:0071679),0.7422736610236994,1.2740533285502844,0.13636363636363635,0.6605237245738046,1.0,3/6,9.90%,NRP1;RYK;NFIB
prerank,"Reactome_2022__FOXO-mediated Transcription Of Oxidative Stress, Metabolic And Neuronal Genes R-HSA-9615017",0.6272149575576189,1.2739204299891311,0.16216216216216217,0.6602556410047619,1.0,5/17,9.84%,PPARGC1A;FBXO32;SMAD2;SMAD3;HDAC1
prerank,PanglaoDB_Augmented_2021__Airway Goblet Cells,-0.7378594128092206,-1.2738413368055588,0.24,0.5258709772063027,1.0,2/8,8.80%,CLDN7;OVOL2
prerank,GO_Biological_Process_2021__regulation of peptidyl-serine phosphorylation (GO:0033135),-0.5739282414848089,-1.2737203102767947,0.13846153846153847,0.5258182731231955,1.0,10/66,12.59%,CALCR;TFRC;DDIT4;PAQR3;RACK1;PRKD2;CD44;VEGFA;MTCP1;TERF2IP
prerank,GO_Biological_Process_2021__regulation of actin filament-based process (GO:0032970),0.5492568534510607,1.2736531330924112,0.1724137931034483,0.6602462319986908,1.0,4/47,7.54%,PDGFA;HIP1R;CDK10;CRK
prerank,GO_Biological_Process_2021__visual perception (GO:0007601),0.5019460594354662,1.2736097455296744,0.15625,0.6595926008631571,1.0,3/39,3.93%,TULP2;CRYGS;RP2
prerank,GO_Biological_Process_2021__regulation of translational termination (GO:0006449),-0.7979084158185641,-1.2734809875733804,0.21666666666666667,0.5261117225131675,1.0,2/7,11.36%,SHFL;MTRF1
prerank,GO_Biological_Process_2021__positive regulation of interleukin-12 production (GO:0032735),0.5978234820450969,1.2733355103147774,0.14285714285714285,0.6598128124083944,1.0,7/19,21.93%,MAPK11;LGALS9;LAPTM5;IRF5;HSPD1;AGER;SYK
prerank,GO_Biological_Process_2021__toll-like receptor 2 signaling pathway (GO:0034134),0.7995256723148279,1.2731621085938116,0.2222222222222222,0.6595183512474966,1.0,3/5,13.17%,IRAK1;LGALS9;PIK3AP1
prerank,GO_Biological_Process_2021__RNA catabolic process (GO:0006401),-0.5796182272207816,-1.2731095729890474,0.16417910447761194,0.5269810244688853,1.0,4/39,2.90%,ZFP36;RNASET2;SIDT2;NUDT12
prerank,CellMarker_Augmented_2021__Primitive Endoderm cell:Germ,0.48746643057152633,1.2730510551236114,0.15,0.6574155745950009,1.0,22/67,18.96%,TRPC1;FGF2;NLGN1;KHDRBS3;NUAK1;SALL1;ROBO1;PURG;MMP16;PTPRG;PTPRD;ENAH;COL11A1;GPC6;FBXL7;FERMT2;ANTXR1;TRPC4;FAM171B;RBFOX2;KIAA1549L;CRMP1
prerank,CellMarker_Augmented_2021__Mesothelial cell:Lung,0.48746643057152633,1.2730510551236114,0.15,0.6574155745950009,1.0,22/67,18.96%,TRPC1;FGF2;NLGN1;KHDRBS3;NUAK1;SALL1;ROBO1;PURG;MMP16;PTPRG;PTPRD;ENAH;COL11A1;GPC6;FBXL7;FERMT2;ANTXR1;TRPC4;FAM171B;RBFOX2;KIAA1549L;CRMP1
prerank,CellMarker_Augmented_2021__Interstitial cell:Bladder,0.48746643057152633,1.2730510551236114,0.15,0.6574155745950009,1.0,22/67,18.96%,TRPC1;FGF2;NLGN1;KHDRBS3;NUAK1;SALL1;ROBO1;PURG;MMP16;PTPRG;PTPRD;ENAH;COL11A1;GPC6;FBXL7;FERMT2;ANTXR1;TRPC4;FAM171B;RBFOX2;KIAA1549L;CRMP1
prerank,GO_Biological_Process_2021__protein processing involved in protein targeting to mitochondrion (GO:0006627),0.7831842358291601,1.2729667918967917,0.19148936170212766,0.6568838725933673,1.0,2/5,15.45%,IMMP2L;IMMP1L
prerank,Reactome_2022__PI3K Events In ERBB4 Signaling R-HSA-1250342,0.7586307607770013,1.272797615434099,0.24444444444444444,0.6566231612583098,1.0,5/7,17.35%,NRG1;NRG3;NRG2;ERBB4;PIK3CA
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transport into cytosol (GO:0010524),-0.7000369707683856,-1.2725903478651805,0.16666666666666666,0.5280504903551467,1.0,2/12,3.66%,CALCR;CEMIP
prerank,GO_Biological_Process_2021__leptin-mediated signaling pathway (GO:0033210),0.7002054900114284,1.2724417883297767,0.23076923076923078,0.656915996115319,1.0,2/9,2.51%,LEPR;SIRT1
prerank,GO_Biological_Process_2021__regulation of sodium ion transmembrane transport (GO:1902305),0.6580140544613405,1.2724078536669832,0.11428571428571428,0.6563301992919284,1.0,6/16,18.87%,SCN3B;NEDD4L;SLMAP;FXYD5;FXYD7;SCN1B
prerank,Reactome_2022__Transcriptional Regulation By VENTX R-HSA-8853884,0.5693563240238988,1.2723821858570905,0.15384615384615385,0.6556751102235846,1.0,5/32,11.06%,UBE2D1;FZR1;CDC23;ANAPC16;TCF7L2
prerank,GO_Biological_Process_2021__regulation of ion transmembrane transport (GO:0034765),0.6090312009577914,1.2722651241751848,0.21875,0.6553323740685563,1.0,11/19,22.92%,KCNJ2;KCNJ5;NEDD4L;WNK1;ANO6;AHCYL1;P2RX7;NEDD4;CHRM3;YWHAE;KCNJ6
prerank,GO_Biological_Process_2021__positive regulation of protein localization to cell periphery (GO:1904377),0.5429057081947316,1.271874908463198,0.11428571428571428,0.6559357421254566,1.0,16/38,28.07%,PTPN9;EPB41;CIB1;TNF;ARF6;PRKCI;DPP10;PLS1;SPTBN1;STX3;PIK3R1;PRKCE;SORBS1;EFCAB7;CLIP3;EPB41L2
prerank,GO_Biological_Process_2021__positive regulation of actin nucleation (GO:0051127),0.7280016204078004,1.2718696280966113,0.175,0.6551425912885455,1.0,2/11,5.63%,GSN;WASF2
prerank,CellMarker_Augmented_2021__Plasmacytoid Dendritic cell:Lung,0.5072430370328064,1.2714964783712335,0.0967741935483871,0.6557306566473405,1.0,17/68,11.39%,KLF4;NRP1;FKBP9;SERPINE1;GSN;FAM20C;TGFBR2;PLXNA2;SIRPA;TIMP3;RIN2;PDGFC;IL13RA1;PDLIM5;SASH1;EPAS1;FAM114A1
prerank,GO_Biological_Process_2021__monocyte differentiation (GO:0030224),0.713336696519973,1.2712291356550676,0.15,0.6560923830171363,1.0,2/8,5.17%,PIR;PPARG
prerank,GO_Biological_Process_2021__gastrulation (GO:0007369),-0.8106755022196608,-1.2711458063621484,0.15,0.5327360916474913,1.0,1/8,0.08%,NR4A3
prerank,GO_Biological_Process_2021__positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),0.6489166592519546,1.2704997423816862,0.15384615384615385,0.6580117420431983,1.0,2/14,1.00%,TRPC1;PKD2
prerank,Reactome_2022__Activation Of NMDA Receptors And Postsynaptic Events R-HSA-442755,0.4968759241164532,1.2703632436208077,0.0967741935483871,0.6577668344681868,1.0,15/62,14.20%,PRKAB2;GRIN3A;NBEA;LIN7A;NRG1;GRIA3;GRIA4;GIT1;GRIA1;RPS6KA6;MAPK1;GRIN2B;PRKAB1;ERBB4;GRIA2
prerank,GO_Biological_Process_2021__regulation of regulatory T cell differentiation (GO:0045589),-0.6942658996764169,-1.2702969978685634,0.19696969696969696,0.5350425831901581,1.0,3/14,10.38%,IL4I1;LILRB4;IRF1
prerank,CellMarker_Augmented_2021__Lake Et al.Science.Ex3:Brain,0.520140252158481,1.2701364270357338,0.13793103448275862,0.6576905975464471,1.0,45/89,23.01%,NPAS3;SLITRK5;CNTN2;GRID2;ZNF536;CDH20;SNAP91;SCN3B;PCDH9;LRRC4C;GRIA4;CA10;OLFM3;CTNNA2;CADM2;GPM6A;GRIA1;SORCS3;ASXL3;PTPN5;SLC35F1;RBFOX1;NEGR1;JAM2;GRIA2;SLC24A2;CNTN4;PPFIA2;DAB1;ADGRB3;TMEM132C;ARHGEF9;DPP6;GABRB2;GRM3;GRIK3;UNC5D;AMER2;NOVA1;SYNPR;NRXN1;LSAMP;RAB3C;OPCML;RYR2
prerank,GO_Biological_Process_2021__calcium-mediated signaling (GO:0019722),-0.5770189872228204,-1.2700040820846417,0.15714285714285714,0.5355644956345165,1.0,6/54,6.11%,CCL3;MCTP2;CXCR4;BTK;FIS1;ACKR4
prerank,Reactome_2022__PCNA-Dependent Long Patch Base Excision Repair R-HSA-5651801,-0.7228082446419868,-1.2699827232080445,0.17857142857142858,0.5352030082553307,1.0,4/14,17.06%,POLE3;APEX1;RPA3;LRIG1
prerank,GO_Biological_Process_2021__epithelial cell apoptotic process (GO:1904019),0.8399581713319102,1.269959523648671,0.16666666666666666,0.6574466635124283,1.0,1/6,1.66%,GSN
prerank,GO_Biological_Process_2021__negative regulation of B cell proliferation (GO:0030889),-0.8089478473923919,-1.2698049586720774,0.13333333333333333,0.5351145425554198,1.0,2/8,11.20%,MNDA;TYROBP
prerank,GO_Biological_Process_2021__regulation of short-term neuronal synaptic plasticity (GO:0048172),0.742133110517422,1.269680078980944,0.17391304347826086,0.6577063510289896,1.0,4/10,11.06%,SYNGR1;GRIK2;SHISA9;PPFIA3
prerank,GO_Biological_Process_2021__protein heterotetramerization (GO:0051290),0.671608049337954,1.2695951933524052,0.18181818181818182,0.6571419828135806,1.0,4/11,12.14%,PKD2;PKD1;GRIN2B;CPSF7
prerank,GO_Biological_Process_2021__sprouting angiogenesis (GO:0002040),0.5723453538491298,1.2693119660704126,0.1794871794871795,0.6573317144715025,1.0,7/25,9.95%,NRP1;SEMA5A;YJEFN3;FGF2;RECK;ROBO1;LOXL2
prerank,"GO_Biological_Process_2021__substrate-dependent cell migration, cell extension (GO:0006930)",0.758194611671903,1.2693022928283704,0.275,0.6565881413862235,1.0,1/6,0.61%,NRP1
prerank,KEGG_2021_Human__beta-Alanine metabolism,0.6276281700184532,1.2692539175793678,0.16666666666666666,0.6559854083404995,1.0,3/23,9.12%,CARNS1;ACADS;ACOX3
prerank,GO_Biological_Process_2021__nitric oxide metabolic process (GO:0046209),0.764219105610822,1.2692386612449718,0.2,0.6544374117500432,1.0,1/6,10.57%,GCH1
prerank,GO_Biological_Process_2021__nitric oxide biosynthetic process (GO:0006809),0.764219105610822,1.2692386612449718,0.2,0.6544374117500432,1.0,1/6,10.57%,GCH1
prerank,GO_Biological_Process_2021__skeletal muscle tissue regeneration (GO:0043403),0.786303107004014,1.2691900303744594,0.14893617021276595,0.6538532430437615,1.0,4/6,9.28%,ANXA1;LARGE1;AKIRIN1;PPP3CA
prerank,GO_Biological_Process_2021__positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),-0.7221040308565916,-1.2690565912489848,0.20689655172413793,0.5370392908738696,1.0,3/12,6.83%,CCL5;IL10RA;PRLR
prerank,KEGG_2021_Human__Notch signaling pathway,0.5350377304385185,1.2689956797891386,0.16666666666666666,0.6537410380917948,1.0,11/39,11.55%,MFNG;MAML2;RFNG;TLE2;JAG1;MAML3;DVL3;CTBP2;HDAC1;NUMBL;KAT2A
prerank,GO_Biological_Process_2021__regulation of acute inflammatory response (GO:0002673),-0.8499563447058648,-1.2689075430715213,0.12280701754385964,0.5369638247823385,1.0,2/6,6.85%,OSMR;GSTP1
prerank,GO_Biological_Process_2021__sterol transport (GO:0015918),-0.7042774310638855,-1.268528354560255,0.18032786885245902,0.5377396378105019,1.0,2/13,0.52%,OSBPL5;CD36
prerank,CellMarker_Augmented_2021__T Helper2 (Th2) cell:Undefined,-0.7464377187905215,-1.2683594074092497,0.23636363636363636,0.5378924382084193,1.0,1/9,1.43%,CXCR4
prerank,GO_Biological_Process_2021__carnitine metabolic process (GO:0009437),0.7861521947426993,1.2683540187287896,0.16,0.6550391532359908,1.0,2/7,5.35%,CPT1C;CPT1A
prerank,GO_Biological_Process_2021__positive regulation of interferon-gamma production (GO:0032729),-0.6402790660452011,-1.2680290680185637,0.15625,0.5384520492523052,1.0,10/36,10.20%,BTN3A1;CD2;SLC7A5;CD14;SLAMF6;TXK;IL12RB2;BTN3A2;CD226;SLC11A1
prerank,GO_Biological_Process_2021__negative regulation of axonogenesis (GO:0050771),0.5675208790429057,1.2679490440134396,0.16216216216216217,0.6554919238862938,1.0,8/22,15.36%,LRP4;DIP2B;LINGO1;PTEN;RTN4;DCC;RNF6;KIAA0319
prerank,GO_Biological_Process_2021__circulatory system development (GO:0072359),0.47185018213577185,1.2678948913906494,0.05714285714285714,0.6548816898560994,1.0,21/67,15.68%,PKD2;TGFBR2;PKD1;HDAC9;TSC2;SALL1;ALPK3;SOX4;PDLIM5;TAB2;LDB3;HEG1;FBXW7;KAT2A;PTEN;SMYD4;NF1;PDLIM7;ERBB4;TGFBR1;CACYBP
prerank,GO_Biological_Process_2021__ESCRT complex disassembly (GO:1904896),0.680794861821171,1.2678512090946927,0.14285714285714285,0.6535554744032663,1.0,3/9,19.81%,CHMP7;CHMP1A;VTA1
prerank,GO_Biological_Process_2021__ESCRT III complex disassembly (GO:1904903),0.680794861821171,1.2678512090946927,0.14285714285714285,0.6535554744032663,1.0,3/9,19.81%,CHMP7;CHMP1A;VTA1
prerank,GO_Biological_Process_2021__monocarboxylic acid metabolic process (GO:0032787),-0.547027939919706,-1.2672153522298046,0.07246376811594203,0.5407304602487873,1.0,12/80,9.55%,CD36;ME1;VNN2;PER2;PDHX;GATM;SLC16A3;IGF1;GNPAT;THEM4;ACAA1;LDHA
prerank,Reactome_2022__Assembly And Cell Surface Presentation Of NMDA Receptors R-HSA-9609736,0.6129772893818628,1.2671819079699307,0.23076923076923078,0.6551897180915769,1.0,4/17,11.85%,GRIN3A;NBEA;LIN7A;GRIN2B
prerank,GO_Biological_Process_2021__regulation of MyD88-independent toll-like receptor signaling pathway (GO:0034127),-0.7821305716697047,-1.2671290535840982,0.19607843137254902,0.5406167246051925,1.0,1/6,3.07%,CD14
prerank,GO_Biological_Process_2021__regulation of cell-cell adhesion (GO:0022407),0.533039078949184,1.266930955336341,0.11764705882352941,0.6553376649568908,1.0,11/27,16.79%,SMAD7;MAGI1;JAG1;FUT9;PTPRG;CELSR2;GTPBP4;AFDN;PTK2;PTPRR;RNASE10
prerank,GO_Biological_Process_2021__positive regulation of axon extension (GO:0045773),0.6466024537651751,1.2669213457793784,0.11428571428571428,0.6545940998938774,1.0,2/16,1.58%,NRP1;SEMA5A
prerank,GO_Biological_Process_2021__gliogenesis (GO:0042063),0.6516048562629817,1.266909074025323,0.1388888888888889,0.6538796705435798,1.0,5/12,11.88%,ANXA1;RELN;NFIB;METRN;CDK6
prerank,PanglaoDB_Augmented_2021__Peritubular Myoid Cells,0.5180792078484454,1.2667529750314739,0.030303030303030304,0.6537277174459871,1.0,10/42,6.44%,COL16A1;TPM2;FKBP9;SVEP1;COL5A2;ACTA2;PHLDB1;INTS6;TIMP3;WNT2B
prerank,CellMarker_Augmented_2021__LGR5+ Stem cell:Small Intestine,0.5251614589585926,1.2667175798915518,0.13333333333333333,0.6530433028700668,1.0,16/44,14.29%,COL16A1;FKBP9;SVEP1;COL5A2;PHLDB1;TIMP3;TANC1;CDH11;PTPRG;ENAH;FAM114A1;COL6A1;TJP1;FBXL7;ADCY6;FERMT2
prerank,GO_Biological_Process_2021__neuromuscular process (GO:0050905),-0.7631013075465369,-1.266716599606157,0.1746031746031746,0.5415646969992747,1.0,1/8,1.79%,TPP1
prerank,Reactome_2022__Phenylalanine And Tyrosine Metabolism R-HSA-8963691,-0.8440411925802551,-1.2667120802721583,0.21153846153846154,0.5411443771349411,1.0,1/5,0.34%,IL4I1
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Gastrointestinal Tract,0.4980048273417076,1.2666487630526384,0.08333333333333333,0.6509996537391646,1.0,21/71,12.82%,NRP1;PKD2;EPS8;GLIS3;UBTD2;RASAL2;SCARB2;PDGFC;JAG1;KITLG;PTPN13;PLK2;ALCAM;REEP3;ITGAV;EXT1;FAM114A1;ITGA2;SCRN1;DCBLD2;SH3RF1
prerank,CellMarker_Augmented_2021__Mucous Acinar cell:Salivary Gland,0.4980048273417076,1.2666487630526384,0.08333333333333333,0.6509996537391646,1.0,21/71,12.82%,NRP1;PKD2;EPS8;GLIS3;UBTD2;RASAL2;SCARB2;PDGFC;JAG1;KITLG;PTPN13;PLK2;ALCAM;REEP3;ITGAV;EXT1;FAM114A1;ITGA2;SCRN1;DCBLD2;SH3RF1
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Intestine,0.4980048273417076,1.2666487630526384,0.08333333333333333,0.6509996537391646,1.0,21/71,12.82%,NRP1;PKD2;EPS8;GLIS3;UBTD2;RASAL2;SCARB2;PDGFC;JAG1;KITLG;PTPN13;PLK2;ALCAM;REEP3;ITGAV;EXT1;FAM114A1;ITGA2;SCRN1;DCBLD2;SH3RF1
prerank,KEGG_2021_Human__Primary bile acid biosynthesis,-0.8060026370462817,-1.266419200662337,0.16666666666666666,0.5416209726331477,1.0,1/8,0.88%,CH25H
prerank,GO_Biological_Process_2021__membrane lipid biosynthetic process (GO:0046467),0.5405658419160818,1.266300152426572,0.12903225806451613,0.6513278857135797,1.0,8/42,8.59%,VAPB;ACER2;PPM1L;PLPP1;FA2H;SPTLC2;HACD2;ELOVL6
prerank,GO_Biological_Process_2021__positive regulation of axon extension involved in axon guidance (GO:0048842),0.8191974305710419,1.2662314820812635,0.1891891891891892,0.6507181684664475,1.0,2/5,1.58%,NRP1;SEMA5A
prerank,CellMarker_Augmented_2021__Osteogenic Precursor-Like cell:Dermis,0.5033556912864529,1.2660972135269979,0.17647058823529413,0.6504083352819963,1.0,27/86,14.14%,NPAS3;RASSF8;SLITRK5;NPHP1;NLGN1;ARNT2;GULP1;PBX1;CADM1;ARHGEF26;LRRC4C;PLCB4;TMEFF2;PDE10A;PLEKHA5;NEDD4L;BMPR1B;NFIB;TACC2;RPS6KA6;ENAH;TTLL7;ENOX1;TJP1;MARK1;PTK2;ERBB4
prerank,GO_Biological_Process_2021__high-density lipoprotein particle remodeling (GO:0034375),-0.7423351814090562,-1.2658125929683497,0.2459016393442623,0.5431202982881488,1.0,2/9,4.17%,LIPG;PLTP
prerank,GO_Biological_Process_2021__inorganic cation import across plasma membrane (GO:0098659),0.5530616974075442,1.2657875505861171,0.13333333333333333,0.6506412543001906,1.0,13/39,15.33%,SLC39A12;SLC39A14;SLC9C2;KCNJ2;KCNJ5;SLC39A8;SLC12A6;SLC9A1;SLC9A9;SLC12A5;SLC8A1;SLC24A2;SLC12A2
prerank,Reactome_2022__SHC-mediated cascade:FGFR4 R-HSA-5654719,-0.7636104255662144,-1.2654786105842255,0.2033898305084746,0.5436087912238575,1.0,2/7,14.45%,FGF13;FGF20
prerank,GO_Biological_Process_2021__response to granulocyte macrophage colony-stimulating factor (GO:0097012),-0.8306697774945351,-1.2653531554269724,0.1276595744680851,0.5431156884651109,1.0,1/5,1.48%,ZFP36
prerank,GO_Biological_Process_2021__cellular response to granulocyte macrophage colony-stimulating factor stimulus (GO:0097011),-0.8306697774945351,-1.2653531554269724,0.1276595744680851,0.5431156884651109,1.0,1/5,1.48%,ZFP36
prerank,GO_Biological_Process_2021__carboxylic acid metabolic process (GO:0019752),-0.648539111701389,-1.2649499381582407,0.1774193548387097,0.5440635702529638,1.0,2/18,4.51%,SLC2A3;CYB5A
prerank,GO_Biological_Process_2021__bile acid and bile salt transport (GO:0015721),-0.7047956346963952,-1.2649260806436622,0.2318840579710145,0.5436506780139722,1.0,2/13,4.96%,SLC51A;ABCC3
prerank,CellMarker_Augmented_2021__Neuron:Brain,0.6227845353843275,1.264722554404525,0.17142857142857143,0.6536212480496146,1.0,10/20,17.15%,DPYSL5;GFAP;RELN;GRIA3;COBL;NELL1;CNTN4;NFASC;LNX1;NXPH1
prerank,GO_Biological_Process_2021__histone arginine methylation (GO:0034969),0.7700241124249336,1.2646679215241123,0.1875,0.6530252189548611,1.0,2/5,17.32%,COPRS;PRMT7
prerank,GO_Biological_Process_2021__negative regulation of calcium ion transport (GO:0051926),-0.7739664418255567,-1.2646169464064156,0.18333333333333332,0.5442570983588597,1.0,1/10,0.73%,PLN
prerank,GO_Biological_Process_2021__negative regulation of T cell mediated cytotoxicity (GO:0001915),-0.7967057824441091,-1.2644904809924007,0.17543859649122806,0.5441698534437321,1.0,3/6,12.82%,KLRD1;NCKAP1L;PTPRC
prerank,CellMarker_Augmented_2021__Basal Progenitor cell:Breast,-0.7658232093525394,-1.264327433544249,0.16363636363636364,0.5442310678054192,1.0,4/8,8.80%,CLDN7;ITGA6;CD44;OVOL2
prerank,PanglaoDB_Augmented_2021__Pancreatic Progenitor Cells,0.5331167840622283,1.2643236277364116,0.15789473684210525,0.6535243696917411,1.0,4/41,0.92%,SHROOM3;PLXNB1;MFNG;LRP4
prerank,GO_Biological_Process_2021__positive regulation of neuroinflammatory response (GO:0150078),-0.8240588092481981,-1.263967808435128,0.19607843137254902,0.5449061850501978,1.0,1/5,0.62%,CCL3
prerank,GO_Biological_Process_2021__preassembly of GPI anchor in ER membrane (GO:0016254),0.7117913510216004,1.2639651117886785,0.21052631578947367,0.6543595663961767,1.0,1/12,0.08%,PIGQ
prerank,Reactome_2022__Gastrulation R-HSA-9758941,0.7995162590248558,1.2638377911077292,0.23809523809523808,0.6542497595835656,1.0,3/6,16.37%,SMAD2;SMAD3;TRIM33
prerank,GO_Biological_Process_2021__aminoglycan biosynthetic process (GO:0006023),0.6068768297793079,1.2636357303613788,0.15,0.6542344047091866,1.0,5/24,6.07%,B3GNT2;HS3ST5;HS2ST1;UGDH;B4GALT7
prerank,GO_Biological_Process_2021__endothelial cell proliferation (GO:0001935),0.7146546762089075,1.2633062186254405,0.175,0.6545416784928152,1.0,3/9,17.57%,SEMA5A;LOXL2;PRKX
prerank,Reactome_2022__TNF Signaling R-HSA-75893,-0.6036656858295234,-1.263196529701196,0.12857142857142856,0.5468143357750604,1.0,5/39,9.94%,UBC;RPS27A;RACK1;TNFAIP3;CFLAR
prerank,GO_Biological_Process_2021__regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901836),-0.7158458182178388,-1.2624563182538697,0.2033898305084746,0.5485997157244878,1.0,1/14,0.51%,DDX11
prerank,GO_Biological_Process_2021__negative regulation of cell development (GO:0010721),-0.670721172110144,-1.2624244877570105,0.25925925925925924,0.5482911525514846,1.0,3/16,5.56%,DYNLT1;B2M;IGF1
prerank,GO_Biological_Process_2021__fat-soluble vitamin metabolic process (GO:0006775),0.7650796565329515,1.2624212812246034,0.1568627450980392,0.6566204629959413,1.0,1/8,1.92%,UBIAD1
prerank,CellMarker_Augmented_2021__Stem cell:Amniotic Membrane,0.49601561912889064,1.2622929949552903,0.11764705882352941,0.6563208136066715,1.0,15/54,14.07%,ANXA1;ARHGAP31;SVEP1;SERPINE1;TGFBR2;ATP10D;TIMP3;RIN2;TWIST2;HEG1;EPAS1;P3H2;ELK3;GPNMB;MMP14
prerank,"GO_Biological_Process_2021__regulation of synaptic transmission, GABAergic (GO:0032228)",0.7075205020650361,1.262156874906593,0.18181818181818182,0.6560352481018571,1.0,4/8,6.34%,NLGN1;ZDHHC3;ADRA1A;BAIAP3
prerank,Reactome_2022__Regulation Of TP53 Degradation R-HSA-6804757,-0.6461162470005564,-1.2620791632296928,0.15384615384615385,0.5488554648141609,1.0,3/29,7.98%,UBC;RPS27A;SGK1
prerank,GO_Biological_Process_2021__pyrimidine nucleoside catabolic process (GO:0046135),-0.7425251560143205,-1.2618683747772945,0.23728813559322035,0.5491447292582997,1.0,3/8,10.19%,NT5C;TYMP;DPYS
prerank,Reactome_2022__Presynaptic Depolarization And Calcium Channel Opening R-HSA-112308,0.73004942823825,1.2617555311070632,0.1590909090909091,0.6567939515125732,1.0,4/10,14.91%,CACNA1A;CACNA1E;CACNG2;CACNB4
prerank,CellMarker_Augmented_2021__T cell:Undefined,-0.6260360885186718,-1.261743188246929,0.2,0.5490963682230425,1.0,9/34,8.19%,CD2;IL7R;CD69;CD200R1;SELL;GZMB;PECAM1;ITGA4;KLRD1
prerank,GO_Biological_Process_2021__regulation of basement membrane assembly involved in embryonic body morphogenesis (GO:1904259),0.7991644755767338,1.2617091698769693,0.2708333333333333,0.6554227589626894,1.0,4/5,16.96%,PHLDB1;DAG1;CLASP1;CLASP2
prerank,GO_Biological_Process_2021__positive regulation of basement membrane assembly involved in embryonic body morphogenesis (GO:1904261),0.7991644755767338,1.2617091698769693,0.2708333333333333,0.6554227589626894,1.0,4/5,16.96%,PHLDB1;DAG1;CLASP1;CLASP2
prerank,Reactome_2022__Phase 1 - Inactivation Of Fast Na+ Channels R-HSA-5576894,0.8259901930490776,1.2614271354370865,0.13953488372093023,0.655566207301111,1.0,2/5,4.38%,KCNIP2;KCND3
prerank,GO_Biological_Process_2021__negative regulation of epithelial to mesenchymal transition (GO:0010719),0.6935550104347107,1.2610089952639436,0.19047619047619047,0.6562687044311041,1.0,6/14,6.57%,SPRY2;SMAD7;SPRED1;SPRED2;USF3;HPN
prerank,GO_Biological_Process_2021__apoptotic cell clearance (GO:0043277),0.5928848871485727,1.2607842439902055,0.2222222222222222,0.6565305891669387,1.0,5/20,17.07%,ANXA1;ITGAV;TYRO3;RHOBTB1;XKR6
prerank,GO_Biological_Process_2021__negative regulation of transposition (GO:0010529),-0.7559827222207033,-1.2607416676261514,0.15254237288135594,0.5519258768892834,1.0,2/12,8.67%,MYBL1;APOBEC3G
prerank,Reactome_2022__Laminin Interactions R-HSA-3000157,-0.7122844979411078,-1.2607341511347883,0.23728813559322035,0.551517737239032,1.0,2/9,8.60%,COL18A1;ITGA6
prerank,Reactome_2022__Ion Transport By P-type ATPases R-HSA-936837,-0.6105607183382933,-1.26061376637032,0.19402985074626866,0.5514536288979067,1.0,7/34,14.37%,PLN;ATP10A;SRI;ATP13A1;CALM1;ATP1B3;ATP8B1
prerank,GO_Biological_Process_2021__positive regulation of epidermal cell differentiation (GO:0045606),0.7352846725665144,1.2605056965676766,0.16666666666666666,0.6560305491600942,1.0,1/7,3.26%,NCOA3
prerank,GO_Biological_Process_2021__positive regulation of keratinocyte differentiation (GO:0045618),0.7352846725665144,1.2605056965676766,0.16666666666666666,0.6560305491600942,1.0,1/7,3.26%,NCOA3
prerank,GO_Biological_Process_2021__regulation of defense response to virus (GO:0050688),0.7124932915354124,1.2604400884118037,0.2727272727272727,0.6554565642908219,1.0,1/13,0.25%,IFNLR1
prerank,CellMarker_Augmented_2021__Granulocyte-monocyte progenitor:Umbilical Cord Blood,-0.5480531568944454,-1.2604084947022902,0.1232876712328767,0.551704739902024,1.0,13/60,12.48%,SPON2;CD96;CLEC12A;GCNT1;SELL;PLEK;F13A1;RAB3D;LDHA;TNFSF13B;CSF3R;APPL1;DENND10
prerank,GO_Biological_Process_2021__regulation of neurogenesis (GO:0050767),-0.6332346047127003,-1.2603267938159015,0.1791044776119403,0.5514866469049395,1.0,5/31,4.86%,DYNLT1;B2M;PER2;ZNF335;BHLHE40
prerank,GO_Biological_Process_2021__purine nucleotide catabolic process (GO:0006195),-0.7780896680063933,-1.2601327431995666,0.2033898305084746,0.5516744167462556,1.0,3/7,14.09%,NT5C;HINT1;GPX1
prerank,"GO_Biological_Process_2021__negative regulation of mRNA splicing, via spliceosome (GO:0048025)",0.6492224476104906,1.260099077780904,0.23684210526315788,0.6555725105192959,1.0,1/13,0.47%,PCBP4
prerank,GO_Biological_Process_2021__negative regulation of cytokine production involved in inflammatory response (GO:1900016),-0.693740533438537,-1.2600223093037848,0.20967741935483872,0.5516453176214748,1.0,3/13,5.46%,NLRC3;APOD;LILRB4
prerank,CellMarker_Augmented_2021__Pericyte:Undefined,0.7137119919402689,1.2599842101176713,0.2894736842105263,0.6551723098241993,1.0,3/7,9.71%,PDGFA;ACTA2;ALCAM
prerank,GO_Biological_Process_2021__positive regulation of cation channel activity (GO:2001259),0.5864275069279167,1.259890861568948,0.11904761904761904,0.6547201654540454,1.0,4/21,8.67%,PKD2;KCNIP2;RELN;SHANK3
prerank,GO_Biological_Process_2021__antibacterial humoral response (GO:0019731),-0.7768082939806643,-1.2596143140390197,0.15517241379310345,0.5527262396975825,1.0,5/8,18.84%,RPL39;H2BC21;H2BC11;HLA-E;RNASE6
prerank,Reactome_2022__TP53 Regulates Transcription Of Genes Involved In G2 Cell Cycle Arrest R-HSA-6804114,0.6447758829649218,1.2592163387661646,0.21951219512195122,0.6561563343664575,1.0,3/12,22.03%,ZNF385A;REXO2;E2F4
prerank,Reactome_2022__Interleukin-4 And Interleukin-13 Signaling R-HSA-6785807,-0.5762560737008898,-1.2591154689851873,0.15714285714285714,0.554042659637621,1.0,12/59,11.34%,CD36;CEBPD;FOS;RORA;F13A1;RHOU;FGF13;TNFRSF1B;STAT1;ITGB2;VEGFA;HIF1A
prerank,GO_Biological_Process_2021__positive regulation of phospholipase C activity (GO:0010863),-0.6432716303776714,-1.2589691766589584,0.22727272727272727,0.5540745295348501,1.0,4/25,6.88%,ITK;TXK;PHB2;C5AR1
prerank,GO_Biological_Process_2021__regulation of T cell receptor signaling pathway (GO:0050856),-0.6429317385891204,-1.2588199664464694,0.20588235294117646,0.5540367021126343,1.0,7/25,19.00%,LILRB4;RPS3;PRKD2;CD226;EZR;TESPA1;PTPN22
prerank,Reactome_2022__Signaling By KIT In Disease R-HSA-9669938,-0.7164670506163868,-1.2587849769458415,0.171875,0.5536996773236221,1.0,3/14,9.56%,YES1;FYN;STAT1
prerank,GO_Biological_Process_2021__regulation of endocytosis (GO:0030100),0.5237461654417351,1.2585629001157925,0.07142857142857142,0.6574706079574854,1.0,6/49,8.81%,CD22;HIP1R;PICALM;TSC2;NEDD4L;SNX12
prerank,GO_Biological_Process_2021__folic acid metabolic process (GO:0046655),-0.7111041840810782,-1.2585370731239733,0.22950819672131148,0.5542254769230238,1.0,3/14,18.15%,MTHFD1;SHMT1;FOLR2
prerank,Reactome_2022__Striated Muscle Contraction R-HSA-390522,0.666396788451461,1.2584112679985733,0.20512820512820512,0.6572939273496231,1.0,3/12,8.30%,TPM2;TMOD2;TMOD3
prerank,GO_Biological_Process_2021__regulation of focal adhesion assembly (GO:0051893),0.5045071901548145,1.2582086207211411,0.16216216216216217,0.657341248923562,1.0,8/45,14.39%,COL16A1;NRP1;VCL;SLC9A1;PTEN;PTK2;FERMT2;CLASP1
prerank,Reactome_2022__Budding And Maturation Of HIV Virion R-HSA-162588,-0.6454808918594898,-1.258107887123508,0.2,0.5552299275194359,1.0,6/26,16.16%,UBC;RPS27A;VPS28;VPS37B;UBA52;MVB12A
prerank,CellMarker_Augmented_2021__Migration Phase Fetal Germ cell:Fetal Gonad,-0.5413235387332027,-1.2580505851969048,0.10666666666666667,0.554955252775811,1.0,27/100,10.88%,SAT1;TOMM7;RPS14;PSMB3;TCEAL8;GLIPR2;SNRPD2;IFITM3;PLTP;UQCRH;ATP6V1F;TMEM144;TMSB10;GSTP1;PSMB6;CYSTM1;EID1;HMGN3;BEX4;TMSB4X;ETFB;LDHA;FKBP14;GABRA3;PTN;MICOS13;NDUFS5
prerank,CellMarker_Augmented_2021__Cortical Thymus Epithelial cell:Thymus,-0.6049929086834291,-1.2580055365638534,0.14666666666666667,0.5542338528091185,1.0,6/49,3.81%,TC2N;SKAP1;CCDC88C;CD2;CD69;CD247
prerank,CellMarker_Augmented_2021__Medullary Thymus Epithelial cell:Thymus,-0.6049929086834291,-1.2580055365638534,0.14666666666666667,0.5542338528091185,1.0,6/49,3.81%,TC2N;SKAP1;CCDC88C;CD2;CD69;CD247
prerank,GO_Biological_Process_2021__regulation of cytokine production (GO:0001817),-0.5660520417576579,-1.257372163452546,0.12162162162162163,0.5558032550112135,1.0,21/86,13.37%,ITK;BTN3A1;SRGN;HLA-B;GAPDH;BTN3A3;TXK;EIF2AK2;BTN3A2;BTN2A1;NLRP12;LURAP1;TNFRSF1B;BTN2A2;GLMN;SLC11A1;STING1;C5AR2;CD47;PTPRC;SOD1
prerank,GO_Biological_Process_2021__fructose 6-phosphate metabolic process (GO:0006002),0.765385670258848,1.2570757901290344,0.23404255319148937,0.6602526153102882,1.0,3/7,6.70%,PFKP;PFKM;GFPT1
prerank,GO_Biological_Process_2021__phosphatidylglycerol acyl-chain remodeling (GO:0036148),-0.8236096844272511,-1.2570222029115297,0.14583333333333334,0.5566711214326793,1.0,1/6,4.85%,LPCAT1
prerank,Reactome_2022__Condensation Of Prophase Chromosomes R-HSA-2299718,-0.6506252679727685,-1.2569528189312227,0.12698412698412698,0.5564724788191006,1.0,9/22,9.35%,H2BC4;H2BC26;H2AC20;H2AC6;H3-3B;H2AJ;H2BC21;H2BC5;H2BC9
prerank,Reactome_2022__SUMOylation Of RNA Binding Proteins R-HSA-4570464,0.4976029185458784,1.2569277363508036,0.21621621621621623,0.6599290400479175,1.0,9/41,17.93%,RNF2;NUP153;NUP188;NUP42;HNRNPC;PHC1;NDC1;NUP133;NUP205
prerank,GO_Biological_Process_2021__negative regulation of ERAD pathway (GO:1904293),-0.843471344768141,-1.2569203421297073,0.16363636363636364,0.5561981148012705,1.0,2/6,4.37%,UBXN1;AQP11
prerank,"GO_Biological_Process_2021__negative regulation of translation, ncRNA-mediated (GO:0040033)",-0.7825120970728386,-1.256816644072767,0.12727272727272726,0.555705853188882,1.0,1/8,1.48%,ZFP36
prerank,GO_Biological_Process_2021__miRNA mediated inhibition of translation (GO:0035278),-0.7825120970728386,-1.256816644072767,0.12727272727272726,0.555705853188882,1.0,1/8,1.48%,ZFP36
prerank,GO_Biological_Process_2021__regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267),0.7186937648437366,1.2566498912349373,0.1951219512195122,0.6600387815611908,1.0,2/9,10.07%,GSN;LGALS9
prerank,GO_Biological_Process_2021__vesicle tethering to Golgi (GO:0099041),0.8205311076646398,1.2566061746271868,0.21153846153846154,0.6594804812782763,1.0,1/5,3.83%,C17ORF75
prerank,Reactome_2022__RUNX1 Interacts With Co-Factors Whose Precise Effect On RUNX1 Targets Is Not Known R-HSA-8939243,0.5948789071878167,1.2562035468913941,0.10256410256410256,0.6600482563495308,1.0,15/28,24.07%,RNF2;CBX6;ARID1A;RYBP;RUNX1;ARID1B;PHC1;ACTL6A;YAF2;CBFB;ARID2;SMARCA2;CBX4;PHC2;SMARCC1
prerank,CellMarker_Augmented_2021__Lake Et al.Science.Ex6:Brain,0.5964303776484515,1.256146193980354,0.08108108108108109,0.659465067910094,1.0,4/19,1.84%,TSPAN18;HS3ST4;SEMA5A;LUZP2
prerank,GO_Biological_Process_2021__attachment of GPI anchor to protein (GO:0016255),0.8388648131364081,1.2558783861664264,0.19230769230769232,0.6597314378382125,1.0,3/5,8.91%,PIGU;PGAP1;PIGT
prerank,Reactome_2022__TGF-beta Receptor Signaling In EMT (Epithelial To Mesenchymal Transition) R-HSA-2173791,-0.703756391032688,-1.2556842198754563,0.23333333333333334,0.5591976955096581,1.0,2/13,1.30%,UBC;RPS27A
prerank,CellMarker_Augmented_2021__Corneal Endothelial cell:Eye,0.49141582037282694,1.2554076267661474,0.07407407407407407,0.6608184443928369,1.0,19/53,20.67%,PDPN;AMOT;LRRC4C;PARM1;NTM;PREX2;PTPRD;COL11A1;SLC35F1;LINGO1;RUNX1T1;NTRK2;FBXL7;CSRNP3;TMEM132C;CRMP1;DCLK1;KCND2;MEGF10
prerank,Reactome_2022__NCAM Signaling For Neurite Out-Growth R-HSA-375165,0.5511981316238808,1.2553362878757284,0.13157894736842105,0.6603014545911244,1.0,9/32,16.03%,CNTN2;NCAN;SPTAN1;MAPK1;COL6A1;PTK2;CACNB4;ST8SIA4;COL4A5
prerank,GO_Biological_Process_2021__positive regulation of fatty acid biosynthetic process (GO:0045723),-0.8032277230384579,-1.2551265462993213,0.18181818181818182,0.5603552745385995,1.0,1/6,5.38%,NR1H2
prerank,Reactome_2022__Nucleotide Excision Repair R-HSA-5696398,-0.5362355581317783,-1.254997967252746,0.136986301369863,0.5603681662747341,1.0,8/88,4.34%,UBC;PPIE;RPS27A;XPA;COPS6;POLE3;UVSSA;GTF2H5
prerank,GO_Biological_Process_2021__positive regulation of cellular biosynthetic process (GO:0031328),0.43551191010659407,1.2547791580020309,0.1,0.6616845444339008,1.0,12/119,7.30%,EGR1;KLF4;PPARGC1A;PKD2;FGF2;SIRT1;LDLR;SAMD4A;STARD4;SMAD3;PLXNB2;TNF
prerank,Reactome_2022__Common Pathway Of Fibrin Clot Formation R-HSA-140875,-0.7825981212728468,-1.2545023358866911,0.14754098360655737,0.561681322142437,1.0,3/8,5.43%,PROCR;F8;F13A1
prerank,GO_Biological_Process_2021__peptidyl-threonine phosphorylation (GO:0018107),0.4995136134364535,1.254463875455861,0.15151515151515152,0.6620511869253916,1.0,10/47,11.38%,CDK5R1;TGFBR2;CDK10;LRRK2;MAP2K1;NLK;MAP3K10;DYRK1A;WNK1;MAPK1
prerank,GO_Biological_Process_2021__regulation of DNA-templated transcription in response to stress (GO:0043620),0.7338095369707527,1.2542244615150582,0.30612244897959184,0.6621185332687429,1.0,1/6,5.85%,DDIT3
prerank,KEGG_2021_Human__Taste transduction,0.5598816919934644,1.2540531353599216,0.2,0.6619005451648916,1.0,4/27,6.30%,CACNA1A;SCN3A;GABBR1;PLCB4
prerank,Reactome_2022__NOTCH4 Intracellular Domain Regulates Transcription R-HSA-9013695,0.64768327524432,1.2540375112820634,0.15,0.6612168942511425,1.0,5/14,11.55%,MAML2;ACTA2;SMAD3;MAML3;KAT2A
prerank,GO_Biological_Process_2021__regulation of organelle organization (GO:0033043),0.4751969393017892,1.2537296101620095,0.09090909090909091,0.6614401522726473,1.0,10/61,15.12%,PLXNB1;RAB33B;MSN;PDE4DIP;SCARB2;RBSN;MAPK1;TJP1;PTK2;ATP13A2
prerank,Reactome_2022__Global Genome Nucleotide Excision Repair (GG-NER) R-HSA-5696399,-0.5621818108988162,-1.2537062615525008,0.16129032258064516,0.5639411661769852,1.0,6/67,4.34%,UBC;RPS27A;XPA;COPS6;POLE3;GTF2H5
prerank,GO_Biological_Process_2021__rDNA heterochromatin assembly (GO:0000183),0.799278539340767,1.2531144847002054,0.16279069767441862,0.6627481804300281,1.0,1/6,2.51%,SIRT1
prerank,CellMarker_Augmented_2021__Hepatoblast:Liver,-0.5657444929880092,-1.2529854753750964,0.17647058823529413,0.5660395733855559,1.0,13/56,14.50%,PLN;TFRC;ADGRD1;ANGPTL1;IGF1;TTN;ENPP2;ABCA8;A2M;FLT1;PTPRC;COLEC12;FILIP1L
prerank,Reactome_2022__Mitochondrial Iron-Sulfur Cluster Biogenesis R-HSA-1362409,-0.7779507875938245,-1.252773837164628,0.20634920634920634,0.5662952075678096,1.0,2/9,7.17%,ISCA1;NFS1
prerank,GO_Biological_Process_2021__negative regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002924),-0.8031315782687996,-1.2527448746657304,0.2,0.5659811658062427,1.0,1/5,1.64%,CD55
prerank,GO_Biological_Process_2021__protein hexamerization (GO:0034214),0.7712898033892417,1.25264449332864,0.2558139534883721,0.6636403350119497,1.0,1/7,4.71%,UGDH
prerank,GO_Biological_Process_2021__ATP synthesis coupled proton transport (GO:0015986),-0.6978254364513514,-1.252599410814226,0.21875,0.5659965774414687,1.0,8/15,20.98%,ATP5PD;ATP5F1E;VPS9D1;ATP5ME;STOML2;ATP5F1C;ATP5F1D;ATP5MC2
prerank,GO_Biological_Process_2021__positive regulation of smooth muscle cell migration (GO:0014911),-0.7860904854860215,-1.252529211417623,0.10909090909090909,0.565772269384687,1.0,4/10,5.56%,NR4A3;CCL5;AIF1;IGF1
prerank,GO_Biological_Process_2021__cellular response to exogenous dsRNA (GO:0071360),-0.7164505017689147,-1.252435419733284,0.19230769230769232,0.5656577940125278,1.0,4/11,16.49%,IFIT1;STING1;COLEC12;FLOT1
prerank,CellMarker_Augmented_2021__Monocyte:Peripheral Blood,-0.63720206382445,-1.252163343141942,0.171875,0.5659742913247737,1.0,6/22,8.26%,CD2;CD14;SELL;TNFRSF1B;KLRD1;ENPP3
prerank,Reactome_2022__Iron Uptake And Transport R-HSA-917937,-0.606408866194643,-1.2521526474439464,0.1267605633802817,0.5655933532269675,1.0,5/47,4.87%,UBC;FTH1;RPS27A;TFRC;ATP6V1F
prerank,KEGG_2021_Human__Osteoclast differentiation,-0.5375880489720076,-1.252114379641055,0.12658227848101267,0.5652880968808427,1.0,16/100,12.67%,CALCR;TNFRSF11B;FOSL2;FOS;JUNB;BTK;NCF4;LILRB4;FYN;OSCAR;LILRB3;STAT1;NCF2;TYROBP;IFNGR2;CYBA
prerank,CellMarker_Augmented_2021__Mesenchymal cell:Fetal Liver,0.5428351562374032,1.2521041879833659,0.17142857142857143,0.6644144946431603,1.0,12/34,13.53%,COL16A1;SEMA5A;SVEP1;COL5A2;ACTA2;NTM;CDH11;COL11A1;RUNX1T1;COL6A1;FBXL7;COL15A1
prerank,GO_Biological_Process_2021__PML body organization (GO:0030578),-0.8103248266622747,-1.251924869553191,0.23214285714285715,0.5655222848576356,1.0,1/5,4.35%,ETS1
prerank,CellMarker_Augmented_2021__Ciliated Epithelial cell:Esophagus,-0.5127330709314363,-1.2518787104767626,0.10714285714285714,0.5652243610965071,1.0,28/185,12.79%,PZP;CCDC170;CCDC88C;DNAH11;RPGRIP1L;DTHD1;WARS1;ENPP4;LMLN;ANKUB1;SYNE1;BASP1;IFT46;C5AR1;ANKRD54;OTUD1;EFHC1;DZIP1L;TMEM67;AK9;IFT81;ITGAL;DNAH1;SYTL3;CCDC39;SLC12A7;DNAH12;ZNF674
prerank,Reactome_2022__Regulation Of Ornithine Decarboxylase (ODC) R-HSA-350562,-0.61530872769268,-1.2518623288536228,0.16176470588235295,0.5648315157667085,1.0,15/40,22.96%,PSMB3;PSMB6;PSMA7;PSMB9;AZIN1;PSMD12;PSMD8;PSMA5;PSMA3;PSMC4;PSME2;PSME1;PSMB5;PSMC3;PSME3
prerank,GO_Biological_Process_2021__positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation (GO:1905007),0.7761480173237274,1.2516417348232267,0.225,0.6654702373197697,1.0,2/5,15.21%,TGFBR2;TGFBR1
prerank,GO_Biological_Process_2021__aerobic respiration (GO:0009060),-0.6664218123309466,-1.2514996513931156,0.15,0.5655896660390571,1.0,10/18,18.76%,MDH2;UQCRB;UQCRH;UQCR10;NDUFS8;OXA1L;UQCRC1;NDUFS7;SURF1;ATP5F1D
prerank,Reactome_2022__Formation Of Incision Complex In GG-NER R-HSA-5696395,-0.5953029172592399,-1.2513059767928654,0.14516129032258066,0.5657549003130203,1.0,8/37,14.82%,UBC;RPS27A;XPA;GTF2H5;PARP2;RBX1;RPA3;UBA52
prerank,GO_Biological_Process_2021__vesicle transport along microtubule (GO:0047496),0.5604813445054542,1.2512471189700696,0.21052631578947367,0.6658805103272444,1.0,7/20,25.09%,BICDL1;FBXW11;DYNC1H1;NDE1;TRAK2;PAFAH1B1;TRAK1
prerank,GO_Biological_Process_2021__response to fatty acid (GO:0070542),-0.7803136742318921,-1.2511780444509077,0.2222222222222222,0.5657975421314115,1.0,2/9,1.81%,CD36;PID1
prerank,GO_Biological_Process_2021__regulation of Golgi to plasma membrane protein transport (GO:0042996),-0.7951815406741174,-1.2509786248513004,0.21568627450980393,0.5662612075246979,1.0,1/6,4.24%,RACK1
prerank,Reactome_2022__Defective CHSY1 Causes TPBS R-HSA-3595177,0.7684762516274546,1.2507999935822205,0.2553191489361702,0.6667267310719909,1.0,2/5,5.57%,NCAN;CSPG5
prerank,Reactome_2022__Biosynthesis Of DHA-derived SPMs R-HSA-9018677,-0.8359204296237616,-1.2507129809358937,0.1346153846153846,0.5665816559597835,1.0,3/6,14.59%,GSTM4;GPX4;ALOX12
prerank,GO_Biological_Process_2021__programmed necrotic cell death (GO:0097300),-0.7261964845537041,-1.2506825006663027,0.15517241379310345,0.5662505960714239,1.0,3/12,14.98%,CD14;MLKL;IPMK
prerank,GO_Biological_Process_2021__protein mono-ADP-ribosylation (GO:0140289),-0.750022888256869,-1.2505434063757046,0.2,0.5663876073424142,1.0,6/11,16.67%,PARP14;PARP15;PARP9;PARP4;PARP11;PARP12
prerank,"GO_Biological_Process_2021__protein alpha-1,2-demannosylation (GO:0036508)",-0.6376010542844344,-1.2502419913305274,0.21311475409836064,0.5669510075003746,1.0,2/22,1.30%,UBC;RPS27A
prerank,GO_Biological_Process_2021__regulation of macrophage cytokine production (GO:0010935),0.674361249007692,1.2502243904417663,0.23404255319148937,0.6675197500939618,1.0,4/12,10.79%,SIRT1;WNT5A;LAPTM5;IRAK3
prerank,Reactome_2022__Response To Elevated Platelet Cytosolic Ca2+ R-HSA-76005,-0.5357726036478607,-1.250055252795217,0.1267605633802817,0.567094054026367,1.0,14/86,8.69%,FLNA;CD36;SRGN;F8;CLU;PLEK;F13A1;IGF1;CD63;PECAM1;SELENOP;CALM1;FERMT3;TMSB4X
prerank,Reactome_2022__Platelet Degranulation R-HSA-114608,-0.5392281019898584,-1.2496826334687947,0.1111111111111111,0.5680144230629628,1.0,20/82,14.58%,FLNA;CD36;SRGN;F8;CLU;PLEK;F13A1;IGF1;CD63;PECAM1;SELENOP;CALM1;FERMT3;TMSB4X;VEGFA;GTPBP2;PFN1;SOD1;SERPING1;TLN1
prerank,GO_Biological_Process_2021__regulation of IRE1-mediated unfolded protein response (GO:1903894),-0.7562135700079196,-1.2496514581365408,0.16071428571428573,0.5676700176124768,1.0,2/11,4.19%,DNAJB9;DDRGK1
prerank,GO_Biological_Process_2021__regulation of cellular localization (GO:0060341),0.5744868177619792,1.2496101451503094,0.21428571428571427,0.668798196870022,1.0,14/32,21.44%,FER;GSN;LRRK2;PARP1;DVL3;BRSK1;CSNK1E;STXBP2;DYNC1H1;BRSK2;PPM1F;MAP2;UNC13D;EPHA5
prerank,GO_Biological_Process_2021__negative regulation of muscle hypertrophy (GO:0014741),-0.7700081182674129,-1.2495648659740743,0.22641509433962265,0.5674881534076711,1.0,1/7,2.19%,RGS2
prerank,GO_Biological_Process_2021__negative regulation of catalytic activity (GO:0043086),-0.6363482597046974,-1.2495572899085923,0.22580645161290322,0.5670974346275931,1.0,6/17,16.40%,PLN;IFIT1;PARP9;ATP5IF1;OXA1L;MT3
prerank,GO_Biological_Process_2021__negative regulation of developmental process (GO:0051093),0.5435845626719805,1.2492120511995328,0.13333333333333333,0.6694463279892278,1.0,15/40,15.36%,GRIN3A;ZNF706;MARCHF5;ANP32B;BCL11A;KANK1;SFMBT1;NFIB;LOXL2;KLF7;RPS6KA6;CDK6;DCC;RAPGEF3;KIAA0319
prerank,GO_Biological_Process_2021__glycolipid biosynthetic process (GO:0009247),0.587934358284087,1.2490520682679633,0.16129032258064516,0.669299920726992,1.0,3/27,3.31%,PIGQ;PIGU;LARGE1
prerank,GO_Biological_Process_2021__myeloid cell activation involved in immune response (GO:0002275),-0.7342726249823627,-1.248849333161113,0.22413793103448276,0.5691947208531047,1.0,5/14,15.37%,FCER1G;ENPP3;TYROBP;KARS1;IFI35
prerank,CellMarker_Augmented_2021__Myoepithelial cell:Parotid Gland,0.5141110810983965,1.2487217050314077,0.08,0.6695116229757858,1.0,22/46,22.83%,PDPN;SLC1A3;WNT5A;TIMP3;SALL1;NTM;CDH11;UNC5B;PREX2;PTPRD;COL11A1;RUNX1T1;FBXL7;NFASC;TNC;CRMP1;DCLK1;MEGF10;HTRA1;ANOS1;CXCL12;PLPP3
prerank,GO_Biological_Process_2021__regulation of interleukin-17 production (GO:0032660),-0.6957182601654844,-1.248700596818217,0.2459016393442623,0.5692344115718987,1.0,3/16,4.14%,SLC7A5;PRKCQ;SLAMF6
prerank,GO_Biological_Process_2021__Fc receptor mediated stimulatory signaling pathway (GO:0002431),-0.5741244741153504,-1.248387944560564,0.17647058823529413,0.5697182835781662,1.0,10/66,10.76%,NR4A3;MYO1G;VAV3;YES1;FCER1G;CD247;FYN;ACTG1;ACTB;NCKAP1L
prerank,GO_Biological_Process_2021__superoxide metabolic process (GO:0006801),-0.669420167528939,-1.2482889967414035,0.21875,0.5696700880033618,1.0,7/16,16.40%,DUOX1;NCF4;NCF2;CYBA;SOD1;ALOX12;MT3
prerank,GO_Biological_Process_2021__neurotransmitter receptor diffusion trapping (GO:0099628),0.7500865784687096,1.248188904586102,0.14,0.6699081373476751,1.0,4/5,20.94%,GPHN;CACNG8;CACNG2;CACNG3
prerank,GO_Biological_Process_2021__postsynaptic neurotransmitter receptor diffusion trapping (GO:0098970),0.7500865784687096,1.248188904586102,0.14,0.6699081373476751,1.0,4/5,20.94%,GPHN;CACNG8;CACNG2;CACNG3
prerank,GO_Biological_Process_2021__chromatin remodeling at centromere (GO:0031055),-0.6578758814592527,-1.248135453936349,0.23809523809523808,0.5698907996913714,1.0,4/20,10.59%,CENPV;CENPU;ITGB3BP;NPM1
prerank,GO_Biological_Process_2021__endoplasmic reticulum mannose trimming (GO:1904380),-0.6575726785584698,-1.2478372136997526,0.20634920634920634,0.5704469767710842,1.0,2/17,1.30%,UBC;RPS27A
prerank,GO_Biological_Process_2021__cellular response to zinc ion (GO:0071294),-0.8019585818511998,-1.2478099855647564,0.1864406779661017,0.5701030676713023,1.0,1/6,0.25%,MT2A
prerank,GO_Biological_Process_2021__bicellular tight junction assembly (GO:0070830),-0.6840690706732511,-1.2477631186633957,0.16981132075471697,0.5698200230162768,1.0,3/20,5.65%,MPP7;CLDN7;PECAM1
prerank,Reactome_2022__Cross-presentation Of Particulate Exogenous Antigens (Phagosomes) R-HSA-1236973,-0.7985833705919552,-1.247722869395663,0.14754098360655737,0.5694502870638942,1.0,4/7,12.67%,CD36;NCF4;NCF2;CYBA
prerank,GO_Biological_Process_2021__positive regulation of cyclin-dependent protein kinase activity (GO:1904031),0.6092241804548072,1.2476261053817455,0.17777777777777778,0.6710482279763181,1.0,5/16,15.55%,PKD2;PKD1;SPDYA;CCNYL1;CCND3
prerank,GO_Biological_Process_2021__type I interferon signaling pathway (GO:0060337),-0.5864527776683877,-1.2475126062235788,0.13559322033898305,0.5694551586475242,1.0,18/41,10.38%,MX2;OAS3;HLA-B;MX1;RSAD2;XAF1;IFIT3;IFIT1;OAS2;IFITM3;HLA-C;HLA-F;IFIT2;OAS1;RNASEL;GBP2;STAT1;IRF1
prerank,GO_Biological_Process_2021__cellular response to type I interferon (GO:0071357),-0.5864527776683877,-1.2475126062235788,0.13559322033898305,0.5694551586475242,1.0,18/41,10.38%,MX2;OAS3;HLA-B;MX1;RSAD2;XAF1;IFIT3;IFIT1;OAS2;IFITM3;HLA-C;HLA-F;IFIT2;OAS1;RNASEL;GBP2;STAT1;IRF1
prerank,GO_Biological_Process_2021__response to manganese ion (GO:0010042),0.8222211126108159,1.2474613442280698,0.22448979591836735,0.6708245369282069,1.0,2/5,15.12%,LRRK2;ATP13A2
prerank,GO_Biological_Process_2021__DNA catabolic process (GO:0006308),-0.7599663194969031,-1.2474361725941756,0.23728813559322035,0.5693405838293116,1.0,3/9,15.97%,MUS81;REXO4;DFFB
prerank,GO_Biological_Process_2021__anoikis (GO:0043276),0.725733687429889,1.2474201309276265,0.1702127659574468,0.6702582046622759,1.0,2/9,4.14%,DAPK2;TSC2
prerank,CellMarker_Augmented_2021__Eosinophil:Undefined,-0.6839533685943331,-1.2473655564021233,0.23529411764705882,0.5691860924009542,1.0,5/18,8.15%,ADGRE1;IL3RA;C5AR1;CSF2RA;ITGA4
prerank,GO_Biological_Process_2021__negative regulation of protein secretion (GO:0050709),-0.6686225132737291,-1.247358069231754,0.203125,0.568778137379027,1.0,1/18,1.20%,RSAD2
prerank,GO_Biological_Process_2021__gland morphogenesis (GO:0022612),0.7523513364700041,1.2473271384022373,0.1875,0.6697184955182702,1.0,1/5,1.49%,MSN
prerank,Reactome_2022__Intraflagellar Transport R-HSA-5620924,-0.6300326939219523,-1.2472459275289627,0.2903225806451613,0.5686976734263222,1.0,6/28,16.14%,IFT46;DYNC2I1;IFT27;IFT81;IFT52;IFT43
prerank,GO_Biological_Process_2021__cellular respiration (GO:0045333),-0.5901106162012306,-1.2470535749161846,0.14084507042253522,0.5689573068876805,1.0,8/35,10.31%,NR4A3;CYCS;MDH2;UQCRB;UQCRH;UQCR10;ETFB;NDUFS8
prerank,GO_Biological_Process_2021__regulation of cytosolic calcium ion concentration (GO:0051480),-0.5916141581345643,-1.247047025348831,0.13432835820895522,0.568543763403191,1.0,10/61,6.88%,CALCR;CD36;PLN;CXCR4;CD55;CDH23;FIS1;ACKR4;TACR1;C5AR1
prerank,GO_Biological_Process_2021__positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),0.5171954851956582,1.2468708083673568,0.125,0.6703592779119905,1.0,11/56,12.11%,AVIL;NRP1;EPS8;CDC42EP3;NLGN1;AKIRIN1;WASF2;AUTS2;GPM6A;P2RY12;FNBP1L
prerank,"GO_Biological_Process_2021__nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",-0.6358731959086525,-1.2466962258950074,0.1774193548387097,0.5692557627741655,1.0,2/23,1.30%,UBC;RPS27A
prerank,GO_Biological_Process_2021__negative regulation of sprouting angiogenesis (GO:1903671),-0.7961110776692004,-1.2466403733359672,0.22,0.5690088965413714,1.0,2/7,5.83%,EPN1;SEMA6A
prerank,GO_Biological_Process_2021__interleukin-6-mediated signaling pathway (GO:0070102),0.6212067411626637,1.2465822732856886,0.24390243902439024,0.6707199923273022,1.0,1/16,1.04%,FER
prerank,CellMarker_Augmented_2021__Stem cell:Pancreas,0.5094674227828235,1.2465531080824686,0.1935483870967742,0.6700803134701431,1.0,18/56,16.43%,GRID2;L2HGDH;POU2F1;MGAT4C;PLEKHA5;SHISA9;WDPCP;ADAMTSL3;PREX2;HIF3A;LRRTM4;BMPR1A;KPNA5;PTBP2;TYRO3;FAM221A;CDH8;ASB3
prerank,Reactome_2022__Dectin-2 Family R-HSA-5621480,-0.7921483913380968,-1.2463970779263156,0.18032786885245902,0.569353941070226,1.0,2/6,7.36%,FCER1G;FYN
prerank,Reactome_2022__Death Receptor Signaling R-HSA-73887,-0.5146310642255497,-1.2463238023523864,0.11392405063291139,0.5691405746154973,1.0,13/118,9.94%,PLEKHG5;UBC;RPS27A;RASGRF2;VAV3;RACK1;TNFSF10;ARHGEF1;ARHGEF3;OBSCN;TNFAIP3;ITGB3BP;CFLAR
prerank,CellMarker_Augmented_2021__Lake Et al.Science.In3:Brain,-0.7438473004307211,-1.2462074792031121,0.25,0.5690337111741082,1.0,3/7,12.14%,KMO;CRIM1;SLC12A7
prerank,GO_Biological_Process_2021__forebrain neuron development (GO:0021884),0.7910627082896184,1.246161011032315,0.24,0.670718618461333,1.0,4/5,19.59%,WNT5A;ROBO2;RAPGEF2;FGFR2
prerank,GO_Biological_Process_2021__defense response to Gram-positive bacterium (GO:0050830),-0.6689360216841562,-1.2460208915001203,0.2,0.5694376637263293,1.0,10/21,20.38%,RPL39;H2BC21;GBP2;H2BC11;HLA-E;RNASE6;TNFRSF14;MPEG1;PPP1R11;TLR2
prerank,CellMarker_Augmented_2021__Zymogenic Chief cell:Gastric Epithelium,-0.5513033169544065,-1.2459242110934967,0.12307692307692308,0.5689061060181252,1.0,15/70,11.20%,CEBPD;SIGLEC1;CD14;FCER1G;CTSB;CD93;ABCC3;CD300LF;SIRPB2;TYMP;OSCAR;TNFAIP2;GBP2;CSF2RB;TYROBP
prerank,CellMarker_Augmented_2021__Thecal cell:Ovary,-0.5513033169544065,-1.2459242110934967,0.12307692307692308,0.5689061060181252,1.0,15/70,11.20%,CEBPD;SIGLEC1;CD14;FCER1G;CTSB;CD93;ABCC3;CD300LF;SIRPB2;TYMP;OSCAR;TNFAIP2;GBP2;CSF2RB;TYROBP
prerank,GO_Biological_Process_2021__positive regulation of extracellular matrix assembly (GO:1901203),0.7214826678114242,1.2458706393762249,0.17391304347826086,0.6710146417744955,1.0,5/8,16.96%,PHLDB1;DAG1;SMAD3;CLASP1;CLASP2
prerank,GO_Biological_Process_2021__oogenesis (GO:0048477),-0.8119059305704617,-1.2458674371485619,0.18,0.5687004681739721,1.0,3/7,10.30%,MEI4;IHO1;PTN
prerank,GO_Biological_Process_2021__calcium-ion regulated exocytosis (GO:0017156),-0.6591594857884442,-1.2457888844346021,0.1896551724137931,0.5685414192432421,1.0,1/16,1.34%,RIMS1
prerank,GO_Biological_Process_2021__protein poly-ADP-ribosylation (GO:0070212),-0.7484365727100134,-1.2456432170802818,0.20967741935483872,0.5686667318803319,1.0,4/9,9.48%,PARP14;PARP15;PARP9;PARP2
prerank,GO_Biological_Process_2021__positive regulation of T cell apoptotic process (GO:0070234),-0.8469661741802343,-1.2451420582727868,0.14545454545454545,0.5697624730835712,1.0,2/6,2.84%,CCL5;PRELID1
prerank,GO_Biological_Process_2021__regulation of ossification (GO:0030278),0.5898619743541558,1.245096459440386,0.16216216216216217,0.6728739382044155,1.0,3/20,4.48%,LRP4;ZBTB16;WNT5A
prerank,GO_Biological_Process_2021__mitochondrial transcription (GO:0006390),0.6812927436984149,1.2449433057709245,0.24324324324324326,0.6728394284748661,1.0,1/9,5.52%,TFB1M
prerank,GO_Biological_Process_2021__cellular response to nerve growth factor stimulus (GO:1990090),0.6282700344480197,1.244910502154295,0.18181818181818182,0.6722386697043496,1.0,10/16,28.85%,RAP1A;CIB1;NTRK2;RAPGEF2;TMEM108;MAGI2;ACAP2;NTRK3;KIDINS220;WASF1
prerank,Reactome_2022__APEX1-Independent Resolution Of AP Sites Via Single Nucleotide Replacement Pathway R-HSA-5649702,-0.75683214187879,-1.2447747184088256,0.2692307692307692,0.5706256821042868,1.0,1/6,4.21%,OGG1
prerank,GO_Biological_Process_2021__protein polyglutamylation (GO:0018095),0.7202460788420997,1.244629831611068,0.3076923076923077,0.6724437761789156,1.0,4/7,11.84%,TTLL11;TTLL1;CEP41;TTLL7
prerank,GO_Biological_Process_2021__regulation of smooth muscle contraction (GO:0006940),-0.7090435176153559,-1.2443797794636606,0.1896551724137931,0.5715865263700965,1.0,1/11,1.41%,CHRM2
prerank,CellMarker_Augmented_2021__FOXN4+ cell:Lung,-0.5686989917677524,-1.2439499461609254,0.19672131147540983,0.5724734952478076,1.0,7/44,5.97%,INSIG1;GADD45B;STIL;CHCHD2;ARL4C;PTMA;RANBP1
prerank,Reactome_2022__Wax And Plasmalogen Biosynthesis R-HSA-8848584,-0.7893164107609278,-1.2439106376453741,0.2727272727272727,0.5721741348279157,1.0,1/5,5.77%,GNPAT
prerank,GO_Biological_Process_2021__negative regulation of protein localization to nucleus (GO:1900181),-0.6687357333844104,-1.243518481696767,0.09259259259259259,0.5730462237610676,1.0,3/16,5.46%,MDFIC;APOD;LILRB4
prerank,GO_Biological_Process_2021__regulation of cellular response to heat (GO:1900034),0.48330173392952464,1.24344150169082,0.13333333333333333,0.6754613980234455,1.0,15/73,17.93%,BAG3;SIRT1;NUP153;NUP188;NUP42;MAPK1;MAPKAPK2;IER5;BAG5;FKBP4;GSK3B;NDC1;NUP133;HSPH1;NUP205
prerank,CellMarker_Augmented_2021__Myofibroblast:Lung,0.5568139766097109,1.2433356908733633,0.24242424242424243,0.6750228331773991,1.0,6/31,5.20%,COL16A1;TPM2;SVEP1;COL5A2;ACTA2;TIMP3
prerank,Reactome_2022__Signaling By Interleukins R-HSA-449147,-0.4913645188994958,-1.2432544329512136,0.03488372093023256,0.5734305707732079,1.0,49/299,14.20%,CCL4;STAT4;CD36;CCL3;UBC;SIGIRR;CEBPD;FOS;RPS27A;CCL5;IL7R;PSMB3;YES1;RORA;ANXA2;IL3RA;IL10RA;F13A1;IL12RB2;RHOU;AURKAIP1;NLRC5;OSMR;FGF13;PSMB6;PSMA7;FYN;CSF2RA;TNFRSF1B;PSMB9;STAT1;ITGB2;CSF2RB;RPLP0;RBX1;VEGFA;HIF1A;CSF3R;ALPK1;PSMD12;IL18R1;PSMD8;PSMA5;SOD1;HAVCR2;PIK3CB;SNRPA1;NOD2;CCND1
prerank,CellMarker_Augmented_2021__Gonadal Endothelial cell:Fetal Gonad,0.40437299231652024,1.2432331959091631,0.0,0.6745977423210189,1.0,59/332,13.16%,KLF4;DUSP6;TSPAN18;TUBA1C;NRP1;LHFPL2;GRB10;MAML2;MSN;COL5A2;SMAD1;TGFBR2;PLXNA2;PDK4;CRIP2;GRAMD1A;GAB1;KLF6;MAP3K11;ANKRD6;TBC1D1;TMEM184B;ASAP2;FCGRT;TIMP3;PTPRM;ITPRIP;PCDH17;FAM107B;GPR161;FKBP5;NFAT5;DIP2B;HMGA1;CCPG1;CDYL;SHANK3;ANXA11;TANC2;MMP16;NFIB;SASH1;LOXL2;CHST15;LAPTM5;RNF185;SMIM13;GNL1;FXYD5;RTKN;PDLIM7;ELK3;FLRT2;TJP1;FBXL7;PIP4K2A;LIPA;DNAJC21;RARB
prerank,GO_Biological_Process_2021__negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),0.4803914583727623,1.2430576939828801,0.16666666666666666,0.6745115339142086,1.0,17/68,10.09%,UBE2D1;ACVR2A;SPRY2;SMAD1;TGFBR2;SIRT1;SMAD7;SPRED1;SPRED2;PPARG;SMAD2;SMAD3;SPART;ADAMTSL2;LEMD3;BMPR1B;BCL9L
prerank,Reactome_2022__TCR Signaling R-HSA-202403,-0.5369879680234374,-1.2430110021436092,0.13157894736842105,0.5737749430822484,1.0,19/94,14.82%,ITK;UBC;RPS27A;PRKCQ;GRAP2;PSMB3;CD247;HLA-DRB5;PSMB6;PSMA7;PSMB9;HLA-DRA;PSMD12;PTPRC;PSMD8;PSMA5;PIK3CB;HLA-DPA1;UBA52
prerank,Reactome_2022__Translation Of Structural Proteins R-HSA-9683701,-0.678361503666719,-1.2428725582303788,0.19642857142857142,0.5737512100329311,1.0,4/23,6.59%,UBC;RPS27A;PARP14;PARP9
prerank,Reactome_2022__Regulation Of HSF1-mediated Heat Shock Response R-HSA-3371453,0.48736825560080116,1.2427275044828283,0.09375,0.6748256368798649,1.0,16/70,17.93%,BAG3;SIRT1;MRPL18;NUP153;NUP188;NUP42;MAPK1;MAPKAPK2;BAG5;HSPA14;FKBP4;GSK3B;NDC1;NUP133;HSPH1;NUP205
prerank,GO_Biological_Process_2021__stress-induced premature senescence (GO:0090400),0.8293709060484795,1.2424760070432153,0.24,0.6750891043377805,1.0,1/5,2.51%,SIRT1
prerank,Reactome_2022__Formation Of Tubulin Folding Intermediates By CCT/TriC R-HSA-389960,0.6221257219180926,1.242149003698455,0.22857142857142856,0.6753395304513562,1.0,2/18,6.90%,TUBA1C;TCP1
prerank,GO_Biological_Process_2021__inhibitory synapse assembly (GO:1904862),0.7248560579895942,1.2421209771430357,0.21052631578947367,0.6746670975019865,1.0,2/8,4.48%,PLXNB1;WNT5A
prerank,Reactome_2022__Resolution Of Abasic Sites (AP Sites) R-HSA-73933,-0.5991689218822029,-1.241884644122991,0.17391304347826086,0.5765218945637385,1.0,7/27,13.98%,SMUG1;POLE3;OGG1;PARP2;PARG;APEX1;RPA3
prerank,GO_Biological_Process_2021__regulation of cell death (GO:0010941),-0.5459020593590223,-1.2418640240543295,0.11428571428571428,0.5761619039862925,1.0,8/66,9.65%,CALCR;CD36;CCL5;EPHB1;CLU;VPS35;TNFRSF1B;TRIM13
prerank,GO_Biological_Process_2021__dolichol-linked oligosaccharide biosynthetic process (GO:0006488),0.6469579096854475,1.2417907103281942,0.2558139534883721,0.6751539991367846,1.0,6/13,18.95%,MPDU1;MVD;ALG12;ALG8;ALG3;NUS1
prerank,GO_Biological_Process_2021__positive regulation of chromosome organization (GO:2001252),-0.6995512446052923,-1.2416934098924348,0.2,0.5762478401667146,1.0,1/11,0.51%,DDX11
prerank,GO_Biological_Process_2021__positive regulation of isomerase activity (GO:0010912),-0.7447805764914324,-1.241683661645199,0.17543859649122806,0.5758427538224552,1.0,4/8,15.71%,PLSCR1;ITGB2;NOD2;UHRF1
prerank,CellMarker_Augmented_2021__Granulosa cell:Ovary,0.6619400786951286,1.2416590274058064,0.1794871794871795,0.6749558140675903,1.0,8/20,16.64%,MTCL1;FGF2;BMP1;TWIST2;LOXL2;CD276;ANTXR1;RAI14
prerank,GO_Biological_Process_2021__regulation of protein transport (GO:0051223),0.5612718768870738,1.2416082186370714,0.15789473684210525,0.6744350284354954,1.0,11/24,22.99%,LCP1;TNF;SNX12;DISP1;ATP13A2;STXBP5;ARFIP1;CHP1;PPM1F;DNAJA1;STXBP5L
prerank,GO_Biological_Process_2021__negative regulation of mRNA processing (GO:0050686),0.6114259772698061,1.241402703349724,0.1951219512195122,0.6744862458740677,1.0,1/14,0.47%,PCBP4
prerank,Reactome_2022__Bicarbonate Transporters R-HSA-425381,0.7352303099018404,1.241319148569435,0.32075471698113206,0.6740042604351119,1.0,2/6,8.62%,AHCYL2;SLC4A4
prerank,GO_Biological_Process_2021__negative regulation of binding (GO:0051100),-0.5613506829561622,-1.2413013953629164,0.15584415584415584,0.5765174469845911,1.0,9/62,10.71%,DDX11;PLN;CARD16;IFIT1;RACK1;IFIT2;BTAF1;DVL1;ACTB
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Bone Marrow,-0.798672016488355,-1.2412974174393199,0.1724137931034483,0.576145431444907,1.0,5/10,12.82%,CXCR4;CD14;ITGA6;CD44;PTPRC
prerank,GO_Biological_Process_2021__mitotic spindle assembly (GO:0090307),-0.6104919186344959,-1.2412844925110436,0.18181818181818182,0.5757674235824068,1.0,4/29,8.95%,FLNA;RAB11A;WRAP73;ABRAXAS1
prerank,GO_Biological_Process_2021__regulation of DNA binding (GO:0051101),-0.6201311427305488,-1.2412593846703885,0.18055555555555555,0.5754160682027428,1.0,3/30,5.56%,PYHIN1;EDF1;IGF1
prerank,Reactome_2022__Cyclin D Associated Events In G1 R-HSA-69231,-0.5808839235474513,-1.2412535633194381,0.22033898305084745,0.5750195694453047,1.0,2/33,1.30%,UBC;RPS27A
prerank,GO_Biological_Process_2021__regulation of B cell apoptotic process (GO:0002902),-0.8135857150209362,-1.2409328453419122,0.16666666666666666,0.575653318348217,1.0,1/6,3.54%,BTK
prerank,GO_Biological_Process_2021__epithelial cell-cell adhesion (GO:0090136),-0.7764632227666716,-1.2409168636195673,0.2413793103448276,0.5752637330754418,1.0,2/7,5.44%,PLEKHA7;JUP
prerank,Reactome_2022__Aspartate And Asparagine Metabolism R-HSA-8963693,0.7159801564618592,1.2408999321482477,0.2553191489361702,0.6745883541788094,1.0,4/7,14.37%,ASPA;FOLH1;NAALAD2;NAT8L
prerank,Reactome_2022__Linoleic Acid (LA) Metabolism R-HSA-2046105,-0.7801396365775342,-1.24062861799456,0.29310344827586204,0.5758963913135373,1.0,2/5,17.64%,MUSK;FADS2
prerank,GO_Biological_Process_2021__histone H3-K27 demethylation (GO:0071557),-0.7857941074677994,-1.2405053251524454,0.22641509433962265,0.5758778540178597,1.0,2/5,10.85%,KDM7A;KDM6B
prerank,Reactome_2022__Chondroitin Sulfate/Dermatan Sulfate Metabolism R-HSA-1793185,0.5213275443233218,1.2404696591696043,0.22857142857142856,0.6752949199177182,1.0,8/30,12.44%,NCAN;CHST7;CSGALNACT1;CSPG5;B4GALT7;CHST15;UST;GPC6
prerank,Reactome_2022__Transcriptional Regulation By Small RNAs R-HSA-5578749,-0.5789894550938576,-1.2403153823129636,0.14705882352941177,0.5760023026804978,1.0,11/54,10.95%,H2BC4;H2BC26;H2AC20;H2AC6;H3-3B;H2AJ;H2BC21;POLR2G;H2BC5;H2BC9;NUP50
prerank,GO_Biological_Process_2021__regulation of vasculogenesis (GO:2001212),0.7215969748677764,1.2402726498980445,0.23809523809523808,0.6751349206722005,1.0,2/6,6.25%,RAP1A;RIN2
prerank,GO_Biological_Process_2021__regulation of nitric-oxide synthase biosynthetic process (GO:0051769),-0.7962399393491706,-1.2400811877415003,0.23076923076923078,0.5764057913322558,1.0,5/6,20.38%,GSTP1;NAMPT;SELENOS;NOD2;TLR2
prerank,GO_Biological_Process_2021__nicotinamide nucleotide biosynthetic process (GO:0019359),0.7257142058859669,1.2399489583735892,0.24489795918367346,0.6754567154369584,1.0,1/7,1.71%,NMNAT2
prerank,GO_Biological_Process_2021__negative regulation of protein binding (GO:0032091),-0.5639524670696909,-1.2398905087837726,0.14864864864864866,0.5764712819411977,1.0,9/56,10.71%,DDX11;CARD16;B2M;IFIT1;RACK1;IFIT2;ITGA4;DVL1;ACTB
prerank,Reactome_2022__Interleukin-7 Signaling R-HSA-1266695,-0.7350727646395601,-1.23974018053446,0.22807017543859648,0.5765237101209555,1.0,1/12,1.80%,IL7R
prerank,GO_Biological_Process_2021__regulation of glucan biosynthetic process (GO:0010962),-0.7585798183078318,-1.2392255282381293,0.16176470588235295,0.577846040029032,1.0,2/5,17.44%,PPP1R3B;INPP5K
prerank,GO_Biological_Process_2021__negative regulation of amyloid precursor protein biosynthetic process (GO:0042985),0.7779053747423228,1.2391382218510538,0.2708333333333333,0.677627619741525,1.0,1/5,5.72%,BACE2
prerank,GO_Biological_Process_2021__dicarboxylic acid biosynthetic process (GO:0043650),-0.7493943201619258,-1.2390793225854528,0.21428571428571427,0.5779492046170179,1.0,1/7,3.80%,MTHFD1
prerank,KEGG_2021_Human__Diabetic cardiomyopathy,-0.5314819834318693,-1.2390228643838155,0.08433734939759036,0.5777610631582564,1.0,41/136,18.76%,CD36;PLN;GAPDH;COX7C;UQCRB;NDUFC1;NDUFA2;NCF4;UQCRH;NDUFA1;SLC25A5;NDUFB9;ATP5PD;NDUFA12;ATP5F1E;NDUFB4;UQCR10;PPP1CB;COX4I1;COX5B;NCF2;NDUFB1;NDUFS8;NDUFS5;CYBA;COX7A2;COX6C;PIK3CB;NDUFS6;NDUFB7;AGT;UQCRC1;RAC1;NDUFB3;UQCRQ;ATP5F1C;SLC2A1;NDUFS7;NDUFA3;PDK3;ATP5F1D
prerank,GO_Biological_Process_2021__negative regulation of cellular catabolic process (GO:0031330),0.5252137071322609,1.2390139052553997,0.09090909090909091,0.6772562407138222,1.0,8/48,13.96%,LEPR;ATRAID;TIMP3;TAB2;HGF;SORL1;MTMR9;NELL1
prerank,GO_Biological_Process_2021__cellular response to alkaloid (GO:0071312),0.6945046646558892,1.2388944225942657,0.21153846153846154,0.6768364224414145,1.0,5/10,24.83%,SLC8A1;BLM;RYR1;RYR2;CASP3
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Ovarian Cortex,0.46529462436346636,1.238565103235767,0.0975609756097561,0.6763064391390399,1.0,9/51,3.17%,ANXA1;EPS8;MAML2;INPP1;SERPINE1;TGFBR2;GLIS3;SERPINE2;ACTA2
prerank,CellMarker_Augmented_2021__Stem cell:Stomach,0.46529462436346636,1.238565103235767,0.0975609756097561,0.6763064391390399,1.0,9/51,3.17%,ANXA1;EPS8;MAML2;INPP1;SERPINE1;TGFBR2;GLIS3;SERPINE2;ACTA2
prerank,GO_Biological_Process_2021__immunoglobulin mediated immune response (GO:0016064),-0.7144966562200172,-1.238321843442503,0.25,0.5795775089671686,1.0,2/7,15.77%,FCER1G;CD74
prerank,Reactome_2022__Chromatin Modifying Enzymes R-HSA-3247509,-0.4879923582299341,-1.2382454557495282,0.07142857142857142,0.579427236098593,1.0,24/191,12.89%,H2AC25;H2BC4;H2BC26;H2AC20;H2AC6;CHD3;TAF6L;ING3;PADI2;ING5;JMJD6;H2BC18;H2AJ;MSL3;H2BC21;RPS2;H2BC5;H2BC9;SMARCD1;KDM7A;KDM6B;ING4;H2BC11;KAT5
prerank,Reactome_2022__Immune System R-HSA-168256,-0.45639000784425315,-1.2382144318023682,0.030303030303030304,0.5790641209912277,1.0,170/1274,11.49%,CCL4;ITK;GNLY;JAML;MT2A;FLNA;MX2;BTN3A1;STAT4;CD36;BCL11B;CCL3;UBC;SIGIRR;CEBPD;SLC2A3;PPIE;FTH1;OAS3;NIT2;TNFRSF11B;HLA-B;MX1;RSAD2;FOS;CD96;DYNLT1;RPS27A;CCL5;MNDA;CD55;XAF1;PRKCQ;RNASET2;IL7R;HERC6;ENPP4;CLEC12A;GRAP2;VAV3;TRIM5;CHIT1;IFIT3;RAB37;NLRC3;DHX58;PSTPIP1;B2M;IFIT1;SIGLEC1;TNFRSF25;PSMB3;YES1;CD200R1;FCAR;SRP14;SELL;FCER1G;RORA;OAS2;BTK;ANXA2;CD247;CBLB;CTSB;RNF213;IFITM3;SLAMF6;NDUFA2;AIM2;CD93;BTN3A3;NCF4;ELOB;PADI2;SPSB1;CLU;LPCAT1;ATP6V1F;TSPAN32;ARIH2;HLA-C;IL3RA;IL10RA;F13A1;JUP;LILRB4;CD300LF;HLA-DRB5;NBEAL2;CD63;PECAM1;DTX3L;TXK;IL12RB2;KLHL13;TRIM22;RNF144B;RAB3A;RHOU;TXN2;AURKAIP1;NLRC5;OSMR;FGF13;PRLR;GSTP1;C5AR1;EIF2AK2;BTN3A2;BTN2A1;RNF126;PSMB6;PSMA7;FYN;THEM4;RAB3D;ACTG1;HLA-F;IFIT2;CYSTM1;AGA;CSF2RA;TNFRSF1B;TNFAIP3;OLR1;ITGA4;KLRD1;ACAA1;OAS1;RNASEL;CALM1;BTN2A2;EIF4A3;OSCAR;CD44;GBP2;UBAC1;PSMB9;COMMD9;CHI3L1;STAT1;GLMN;CD226;NCF2;SLC11A1;TRIM69;IRF1;ITGB2;DCTN6;CSF2RB;NCKAP1L;HLA-DRA;ERAP1;RPLP0;NUP50;PTGES2;PTPRB;TNFSF13B;PRDX4;RBX1;VEGFA;TYROBP;ITGAL;DCTN4;HIF1A;CSF3R;STING1;C5AR2;ALPK1
prerank,GO_Biological_Process_2021__positive regulation of adaptive immune response (GO:0002821),-0.7928669554781931,-1.238202527130003,0.20689655172413793,0.578714428693585,1.0,1/7,0.40%,SKAP1
prerank,GO_Biological_Process_2021__negative regulation of regulated secretory pathway (GO:1903306),0.7383992003969628,1.2379607048209265,0.23255813953488372,0.677226052921829,1.0,1/6,3.84%,RAP1A
prerank,Reactome_2022__Synthesis Of Pyrophosphates In Cytosol R-HSA-1855167,0.7213654347674133,1.23791841201827,0.20512820512820512,0.676660982591072,1.0,6/7,27.52%,IPPK;NUDT3;PPIP5K1;NUDT4;IP6K1;ITPK1
prerank,GO_Biological_Process_2021__positive regulation of binding (GO:0051099),-0.5626988574996169,-1.2377886062896146,0.1794871794871795,0.5796868824336638,1.0,9/61,6.59%,DDX11;PYHIN1;B2M;EDF1;RPL11;IGF1;DTX3L;MED25;PARP9
prerank,GO_Biological_Process_2021__beta-catenin-TCF complex assembly (GO:1904837),0.6009815827324726,1.2375463855047983,0.19607843137254902,0.6770029527143996,1.0,8/23,18.19%,TCF7L1;TLE2;HDAC1;BCL9L;TCF7L2;TLE1;BCL9;RBBP5
prerank,GO_Biological_Process_2021__nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),-0.6307228524207986,-1.2375340637955088,0.19672131147540983,0.5801361085684124,1.0,2/24,1.30%,UBC;RPS27A
prerank,Reactome_2022__Plasma Lipoprotein Assembly R-HSA-8963898,0.704985122105858,1.2374959822987193,0.25,0.6764026171147819,1.0,2/9,16.63%,BMP1;P4HB
prerank,GO_Biological_Process_2021__poly(A)+ mRNA export from nucleus (GO:0016973),0.6885583387424196,1.2372466446390264,0.21621621621621623,0.6764631823840039,1.0,3/10,17.17%,NXF1;NUP133;IWS1
prerank,GO_Biological_Process_2021__negative regulation of endothelial cell apoptotic process (GO:2000352),0.7272811512625985,1.2363300347490045,0.34146341463414637,0.6784272587090341,1.0,2/10,1.65%,SEMA5A;SERPINE1
prerank,Reactome_2022__Zinc Transporters R-HSA-435354,0.7333746397397182,1.2362997334466919,0.2222222222222222,0.67775417689249,1.0,2/9,5.71%,SLC39A14;SLC39A8
prerank,CellMarker_Augmented_2021__Stem cell:Eye,-0.8385993010017198,-1.236231808115812,0.23214285714285715,0.5841577005710711,1.0,2/5,8.71%,CSF2RA;CD44
prerank,GO_Biological_Process_2021__positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),0.6094629872613002,1.2360065219216125,0.18604651162790697,0.6780810407194582,1.0,5/15,15.55%,PKD2;PKD1;SPDYA;CCNYL1;CCND3
prerank,GO_Biological_Process_2021__extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),-0.6544816042207735,-1.2358969604527477,0.2,0.5847896614899597,1.0,1/16,0.27%,BCL2A1
prerank,GO_Biological_Process_2021__regulation of type B pancreatic cell development (GO:2000074),0.7423821799017468,1.2358459272013802,0.25,0.6778963092260136,1.0,4/6,22.15%,RFX3;CLOCK;GSK3B;FOXO1
prerank,GO_Biological_Process_2021__peripheral nervous system axon ensheathment (GO:0032292),0.6941905756891666,1.235481163839358,0.3111111111111111,0.6776372540674986,1.0,4/7,15.71%,LGI4;NF1;CNTNAP1;PARD3
prerank,GO_Biological_Process_2021__Schwann cell development (GO:0014044),0.6941905756891666,1.235481163839358,0.3111111111111111,0.6776372540674986,1.0,4/7,15.71%,LGI4;NF1;CNTNAP1;PARD3
prerank,GO_Biological_Process_2021__defense response to tumor cell (GO:0002357),0.7636949582874777,1.2354212182847264,0.20930232558139536,0.6771382689663464,1.0,1/8,0.08%,KLF4
prerank,KEGG_2021_Human__Prostate cancer,0.46366507081715425,1.2352937121646739,0.06896551724137931,0.6768947155334407,1.0,12/66,11.81%,PDGFA;IGF1R;TGFA;TCF7L1;CASP9;E2F3;MAP2K1;PDGFC;MDM2;TCF7L2;MAPK1;PTEN
prerank,GO_Biological_Process_2021__positive regulation of T cell receptor signaling pathway (GO:0050862),-0.7507976679383261,-1.2351982246422168,0.12962962962962962,0.5864943100086845,1.0,3/11,9.70%,RPS3;PRKD2;CD226
prerank,PanglaoDB_Augmented_2021__Anterior Pituitary Gland Cells,0.4622325920667844,1.2351881145869714,0.14814814814814814,0.6765427550191093,1.0,44/86,24.55%,PDZRN4;ZNF536;SCN3A;RCN3;SNAP91;PLPPR4;CPEB4;KCTD16;NTM;GRIA3;GRIA4;CDH11;OLFM3;CADM2;GRIA1;ASXL3;PTPRD;COL11A1;RUNX1T1;PTPRN;RBFOX1;GRIA2;HFM1;SGIP1;CNTN4;NFASC;CSRNP3;ROBO2;ADGRB3;MAP6;SYT4;UNC5D;INTS6L;PRKG1;NOVA1;NRXN1;LSAMP;RAB3C;OPCML;SEMA6D;FGF14;MAGI2;COL14A1;CADPS
prerank,GO_Biological_Process_2021__cellular response to lipoteichoic acid (GO:0071223),-0.789499313103805,-1.2351499800990613,0.19230769230769232,0.5857428964539054,1.0,1/5,3.07%,CD14
prerank,GO_Biological_Process_2021__response to lipoteichoic acid (GO:0070391),-0.789499313103805,-1.2351499800990613,0.19230769230769232,0.5857428964539054,1.0,1/5,3.07%,CD14
prerank,GO_Biological_Process_2021__heme biosynthetic process (GO:0006783),0.6145982850798115,1.235050359313715,0.17391304347826086,0.6763365912780148,1.0,2/15,4.35%,FLVCR1;COX10
prerank,GO_Biological_Process_2021__regulation of telomere maintenance via telomerase (GO:0032210),-0.592484672978099,-1.2346904769306493,0.17142857142857143,0.5867632443732568,1.0,3/43,7.08%,PKIB;PRKCQ;EXOSC10
prerank,GO_Biological_Process_2021__regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),-0.5409532276312273,-1.2343526902596975,0.14925373134328357,0.5874872636325389,1.0,17/70,14.82%,UBC;RPS27A;PSMB3;ELOB;PSMB6;PSMA7;EGLN3;PSMB9;RBX1;VEGFA;HIF1A;ATF3;PSMD12;PSMD8;PSMA5;HSPA1A;UBA52
prerank,PanglaoDB_Augmented_2021__Mast Cells,0.43924290517451436,1.2342625047665947,0.038461538461538464,0.6783770564874354,1.0,22/124,8.62%,CPA1;GSN;FPR3;PDK4;MITF;TCF7L1;STK32B;NEO1;HS2ST1;SPRED1;MRC1;KCTD12;NCEH1;GRIK2;VSIG4;ST6GALNAC3;RIN2;CHST1;UNC13B;HPGDS;DNM3;SLC4A4
prerank,GO_Biological_Process_2021__positive regulation of cardiac epithelial to mesenchymal transition (GO:0062043),0.7627227342964397,1.2339376026609308,0.2571428571428571,0.678857060267853,1.0,3/7,15.21%,TGFBR2;JAG1;TGFBR1
prerank,GO_Biological_Process_2021__linoleic acid metabolic process (GO:0043651),-0.7172232707020851,-1.2338288559801676,0.23529411764705882,0.5889469265592061,1.0,3/10,17.64%,GSTP1;ALOX12;FADS2
prerank,GO_Biological_Process_2021__positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),0.5731398439764581,1.2336022675858658,0.16216216216216217,0.6791311978854772,1.0,2/18,2.15%,HIP1R;TGFA
prerank,CellMarker_Augmented_2021__Cytotoxic T cell:Undefined,-0.7737157797514008,-1.233540793962222,0.2413793103448276,0.5893547046997875,1.0,3/7,3.32%,IL7R;SELL;GZMB
prerank,CellMarker_Augmented_2021__Liver Bud Hepatic cell:Liver,-0.5391027360285428,-1.233537756264107,0.14634146341463414,0.588962309672025,1.0,14/100,7.32%,MT2A;FTH1;PID1;MGLL;POLE3;CHCHD2;IFITM3;SCN9A;SP110;H2AJ;EFHD2;OSMR;SLC16A7;EMP3
prerank,GO_Biological_Process_2021__protein secretion (GO:0009306),0.5317890659054328,1.233400683256871,0.17857142857142858,0.6791639905762538,1.0,5/40,7.65%,ANXA1;RCN3;RAB10;SEL1L;COPG1
prerank,GO_Biological_Process_2021__positive regulation of receptor signaling pathway via STAT (GO:1904894),-0.7579814507902348,-1.233389284876404,0.1320754716981132,0.5889923576610645,1.0,3/10,5.34%,CCL5;IL7R;IL10RA
prerank,PanglaoDB_Augmented_2021__Loop Of Henle Cells,0.4876588053285974,1.233382519510992,0.14705882352941177,0.67853525795872,1.0,14/58,11.39%,COL16A1;KCNT1;PLA2G7;GSN;PLXNA2;PHLDB1;TIMP3;RIN2;DACH1;JAG1;CDH11;SASH1;EPAS1;FAM114A1
prerank,GO_Biological_Process_2021__regulation of pattern recognition receptor signaling pathway (GO:0062207),-0.8212878455758652,-1.2333384119513415,0.20689655172413793,0.5887987936762503,1.0,1/6,0.52%,CD36
prerank,GO_Biological_Process_2021__central nervous system neuron development (GO:0021954),0.6456877506307303,1.233262081472135,0.19047619047619047,0.6783403294343313,1.0,8/11,27.08%,PTEN;NTRK2;RAPGEF2;B4GALT5;MAP2;ARHGAP35;B4GALT6;GBA2
prerank,GO_Biological_Process_2021__aortic valve morphogenesis (GO:0003180),0.6428518310557394,1.2332466484689533,0.2571428571428571,0.677689736636552,1.0,7/12,26.68%,JAG1;ROBO1;ROBO2;SLIT3;TGFB1;NOTCH1;SLIT2
prerank,Reactome_2022__Mitochondrial Protein Import R-HSA-1268020,-0.6023718374196005,-1.233214844270997,0.16923076923076924,0.5887842326191448,1.0,11/44,15.39%,TOMM7;DNAJC19;CHCHD2;CHCHD10;TIMM44;PITRM1;TIMM21;BCS1L;COA6;TOMM40;COA4
prerank,GO_Biological_Process_2021__integrin activation (GO:0033622),0.7431883848489095,1.2329943367289657,0.2553191489361702,0.6777238773628079,1.0,1/7,0.32%,COL16A1
prerank,"GO_Biological_Process_2021__DNA catabolic process, endonucleolytic (GO:0000737)",-0.6488037410969727,-1.2328318221509267,0.19047619047619047,0.5895032383543386,1.0,6/18,23.00%,H1-0;MUS81;REXO4;DFFB;DICER1;DNASE2
prerank,GO_Biological_Process_2021__positive regulation of deacetylase activity (GO:0090045),-0.7985972893819488,-1.232450325158405,0.2,0.5903040918380005,1.0,2/6,11.19%,PRKD2;VEGFA
prerank,CellMarker_Augmented_2021__Alveolar Epithelial Progenitor cell:Embryonic Stem Cell,-0.5341816961301326,-1.2324007319289816,0.1643835616438356,0.5897127934005223,1.0,28/84,15.28%,CD36;XAF1;MGLL;MS4A4A;MARCO;ABCA6;SIGLEC1;CD14;FCER1G;CD93;KMO;LILRB4;PECAM1;SGK1;CSF2RA;CHI3L1;CFLAR;MS4A6A;HLA-DRA;TYROBP;ALPK1;NABP1;A2M;HAVCR2;APOL6;ACSM5;C3;ADAP2
prerank,CellMarker_Augmented_2021__Anterior Foregut Endoderm cell:Lung,-0.5341816961301326,-1.2324007319289816,0.1643835616438356,0.5897127934005223,1.0,28/84,15.28%,CD36;XAF1;MGLL;MS4A4A;MARCO;ABCA6;SIGLEC1;CD14;FCER1G;CD93;KMO;LILRB4;PECAM1;SGK1;CSF2RA;CHI3L1;CFLAR;MS4A6A;HLA-DRA;TYROBP;ALPK1;NABP1;A2M;HAVCR2;APOL6;ACSM5;C3;ADAP2
prerank,GO_Biological_Process_2021__glycogen catabolic process (GO:0005980),-0.6809796831523414,-1.232355485996328,0.1774193548387097,0.5894368516813052,1.0,2/12,8.36%,PHKG1;CALM1
prerank,GO_Biological_Process_2021__ribosome disassembly (GO:0032790),-0.750875470016081,-1.232091325371062,0.23529411764705882,0.5898032737402376,1.0,2/7,11.14%,EIF2D;MTIF3
prerank,GO_Biological_Process_2021__regulation of metallopeptidase activity (GO:1905048),-0.8173429274693785,-1.2318932925705595,0.19298245614035087,0.5899024078713939,1.0,2/5,14.68%,DDRGK1;TIMP2
prerank,GO_Biological_Process_2021__positive regulation of epithelial to mesenchymal transition (GO:0010718),0.5947803777016799,1.2318475430210432,0.21428571428571427,0.680608488515159,1.0,11/27,15.21%,PDPN;TGFBR2;SMAD2;SMAD3;JAG1;LOXL2;BCL9L;TCF7L2;ZNF703;FERMT2;TGFBR1
prerank,Reactome_2022__Host Interactions Of HIV Factors R-HSA-162909,-0.5238328985496861,-1.2318438276451478,0.14473684210526316,0.5895697901146602,1.0,25/115,17.75%,UBC;RPS27A;B2M;PSMB3;CD247;ELOB;SLC25A5;RANBP1;PSMB6;PSMA7;FYN;APOBEC3G;PSMB9;NPM1;NUP50;RBX1;PSMD12;PSMD8;PSMA5;UBA52;AP2S1;SEC13;PSMA3;NUP88;PSMC4
prerank,GO_Biological_Process_2021__negative regulation of T cell mediated immunity (GO:0002710),-0.7466981546761909,-1.2316611844336398,0.1896551724137931,0.5897070056724657,1.0,4/9,8.19%,IL4I1;LILRB4;HLA-F;KLRD1
prerank,GO_Biological_Process_2021__nuclear body organization (GO:0030575),-0.7848735076680853,-1.2313269767381148,0.17543859649122806,0.5904778603432378,1.0,1/8,4.35%,ETS1
prerank,Reactome_2022__Translocation Of ZAP-70 To Immunological Synapse R-HSA-202430,-0.7404911546868993,-1.2312611955638721,0.26229508196721313,0.59027221658831,1.0,6/8,19.00%,CD247;HLA-DRB5;HLA-DRA;HLA-DPA1;HLA-DRB1;PTPN22
prerank,GO_Biological_Process_2021__late endosome to Golgi transport (GO:0034499),0.7980431941149768,1.2309557599032002,0.22807017543859648,0.6829487620353752,1.0,2/5,8.81%,SGSM2;SNX12
prerank,GO_Biological_Process_2021__regulation of cell aging (GO:0090342),0.7134202362098723,1.2308431797952042,0.2708333333333333,0.6825112566131324,1.0,2/7,7.01%,MARCHF5;NUAK1
prerank,GO_Biological_Process_2021__spindle assembly (GO:0051225),-0.5682141477526784,-1.2307572692895778,0.1791044776119403,0.5914150287216604,1.0,11/55,16.54%,FLNA;GOLGA8A;RAB11A;RPS3;WRAP73;ABRAXAS1;TUBGCP2;CSNK1D;SMC1A;GOLGA8N;TUBGCP5
prerank,Reactome_2022__Signal Attenuation R-HSA-74749,0.7672095244904721,1.2306543625520028,0.2,0.6825403173364357,1.0,2/7,11.38%,GRB10;MAPK1
prerank,Reactome_2022__Metabolism Of Folate And Pterines R-HSA-196757,-0.7414572795039426,-1.2303272591069878,0.25925925925925924,0.5924740132254039,1.0,3/12,18.15%,MTHFD1;SHMT1;FOLR2
prerank,CellMarker_Augmented_2021__Ciliated cell:Lung,-0.5162640887935526,-1.2302712951154504,0.10126582278481013,0.5922800440578342,1.0,28/113,16.37%,ANKRD37;H1-2;CCDC170;DYNLT1;SSB;BASP1;IFT46;KLHL13;ENKUR;H2AJ;SRI;CYSTM1;H2BC5;CALM1;HMGN3;TMEM254;GPX4;AZIN1;ATF3;APOO;SOD1;RPA3;TUBB4B;IFT52;AGBL5;PNMA1;IFT43;RRAGA
prerank,GO_Biological_Process_2021__positive regulation of lamellipodium organization (GO:1902745),0.5519230599437642,1.2301909762173806,0.2,0.6832372879856576,1.0,4/25,8.34%,AVIL;AKIRIN1;WASF2;AUTS2
prerank,GO_Biological_Process_2021__establishment of mitotic spindle orientation (GO:0000132),-0.6894920384013172,-1.229932694942213,0.22413793103448276,0.5930527139366941,1.0,1/15,1.29%,DYNLT1
prerank,GO_Biological_Process_2021__endocardial cushion morphogenesis (GO:0003203),0.7523014186982139,1.2298694066105982,0.22727272727272727,0.6835515268111337,1.0,2/7,12.30%,TGFBR2;BMPR1A
prerank,Reactome_2022__N-glycan Trimming In ER And Calnexin/Calreticulin Cycle R-HSA-532668,-0.611228583533905,-1.2295972621157356,0.1694915254237288,0.5937927438685975,1.0,3/33,2.25%,UBC;RPS27A;UBXN1
prerank,GO_Biological_Process_2021__central nervous system development (GO:0007417),0.4424432784758509,1.2295391238927085,0.047619047619047616,0.6839722565953716,1.0,35/160,12.41%,IL1RAPL2;PKD2;QARS1;CDK5R1;NCAN;GSN;MAP1S;AATK;TGFBR2;ZBTB16;MYRF;PKD1;ARNT2;PBX1;TPPP;RELN;PPT1;HAPLN2;PDGFC;PLXNB2;LIG4;SH3GL3;ALDH5A1;SOX4;CA10;POU6F2;NFIB;PTCH1;RPS6KA6;PTEN;GRIN2B;NF1;ELP3;NPTX1;SH3GL1
prerank,GO_Biological_Process_2021__snoRNA localization (GO:0048254),-0.7715346124923614,-1.2291136153488473,0.20833333333333334,0.5949354055410679,1.0,3/6,22.62%,ZNHIT6;FBL;PIH1D1
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902110),0.712853998876532,1.229098427488296,0.2619047619047619,0.6845705004111365,1.0,1/8,0.75%,STPG1
prerank,GO_Biological_Process_2021__positive regulation of protein tyrosine kinase activity (GO:0061098),0.569195113310412,1.229023955520381,0.275,0.6841102589366636,1.0,6/24,12.47%,SRCIN1;TGFA;RELN;GRM5;FBXW7;NTRK2
prerank,GO_Biological_Process_2021__innate immune response activating cell surface receptor signaling pathway (GO:0002220),-0.5358694042413364,-1.228584922235839,0.15,0.5961142875140184,1.0,20/80,22.96%,PSMB3;FCER1G;PSMB6;PSMA7;FYN;KLRD1;PSMB9;TYROBP;PSMD12;PSMD8;PSMA5;PSMA3;PSMC4;PSME2;PSME1;CLEC7A;PSMB5;PSMC3;LYN;PSME3
prerank,GO_Biological_Process_2021__U4 snRNA 3'-end processing (GO:0034475),0.7649100168247024,1.228510008384939,0.175,0.684188423625002,1.0,2/5,17.25%,EXOSC6;EXOSC7
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' (GO:0034427)",0.7649100168247024,1.228510008384939,0.175,0.684188423625002,1.0,2/5,17.25%,EXOSC6;EXOSC7
prerank,Reactome_2022__PI3K/AKT Signaling In Cancer R-HSA-2219528,0.4928269698523598,1.2284257226745028,0.14285714285714285,0.6837062872722914,1.0,18/61,16.08%,PDGFA;PIGU;TGFA;CASP9;TSC2;NRG1;KITLG;MDM2;NRG3;PTEN;GAB2;PIK3AP1;NRG2;VAV1;ERBB4;AKT2;GSK3B;RPS6KB2
prerank,GO_Biological_Process_2021__RNA polymerase II preinitiation complex assembly (GO:0051123),0.6950963044392546,1.228347908579576,0.20930232558139536,0.683248792172475,1.0,1/8,2.38%,DR1
prerank,GO_Biological_Process_2021__regulation of glial cell migration (GO:1903975),-0.8553297207562232,-1.2283074821864628,0.16981132075471697,0.5966049882629391,1.0,1/5,1.61%,GPR183
prerank,GO_Biological_Process_2021__dendrite extension (GO:0097484),0.7503230456271022,1.2281504417073668,0.16666666666666666,0.683241352708268,1.0,2/5,22.09%,AUTS2;TMEM108
prerank,GO_Biological_Process_2021__negative regulation of ion transport (GO:0043271),-0.6755123057651746,-1.2278777306552118,0.26229508196721313,0.5975544726178436,1.0,1/16,0.73%,PLN
prerank,KEGG_2021_Human__African trypanosomiasis,0.6220809188937046,1.2278511041680633,0.20408163265306123,0.6834228431023092,1.0,3/14,7.30%,GNAQ;PLCB4;TNF
prerank,GO_Biological_Process_2021__smooth muscle tissue development (GO:0048745),-0.8513292980562429,-1.227713616526825,0.208955223880597,0.597578046920207,1.0,1/5,0.62%,MYLK
prerank,GO_Biological_Process_2021__long-chain fatty acid biosynthetic process (GO:0042759),-0.6937784087859604,-1.2275271903607585,0.19672131147540983,0.5977964331716602,1.0,4/11,14.59%,GSTM4;GSTP1;GPX4;ALOX12
prerank,Reactome_2022__Innate Immune System R-HSA-168249,-0.4537796913003759,-1.2275063275169653,0.041237113402061855,0.5974303879056001,1.0,110/690,14.86%,ITK;GNLY;CD36;UBC;SIGIRR;SLC2A3;PPIE;FTH1;NIT2;HLA-B;FOS;DYNLT1;RPS27A;MNDA;CD55;PRKCQ;RNASET2;ENPP4;CLEC12A;GRAP2;VAV3;CHIT1;RAB37;NLRC3;DHX58;PSTPIP1;B2M;PSMB3;YES1;FCAR;SRP14;SELL;FCER1G;BTK;ANXA2;CD247;CTSB;NDUFA2;AIM2;CD93;NCF4;PADI2;CLU;LPCAT1;ATP6V1F;TSPAN32;HLA-C;JUP;NBEAL2;CD63;PECAM1;TXK;RAB3A;TXN2;NLRC5;GSTP1;C5AR1;PSMB6;PSMA7;FYN;RAB3D;ACTG1;CYSTM1;AGA;TNFRSF1B;TNFAIP3;OLR1;KLRD1;ACAA1;CALM1;OSCAR;CD44;PSMB9;COMMD9;CHI3L1;NCF2;SLC11A1;ITGB2;NCKAP1L;PTGES2;PTPRB;PRDX4;TYROBP;ITGAL;STING1;C5AR2;ALPK1;CD47;PSMD12;CYFIP2;HSPA1B;CYBA;PTPRC;PSMD8;PSMA5;FTL;PIK3CB;SERPING1;OSTF1;TUBB4B;NOD2;CRACR2A;HLA-E;HSPA1A;IGF2R;LY86;TIMP2;UBA52;C3;TMEM179B
prerank,Reactome_2022__STING Mediated Induction Of Host Immune Responses R-HSA-1834941,-0.7040919448607379,-1.2273342242291612,0.24528301886792453,0.5975732541430294,1.0,2/11,11.42%,NLRC3;STING1
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Adipose Tissue,-0.6958803419369876,-1.2271909527130775,0.16666666666666666,0.5976720162534104,1.0,6/16,12.82%,TFRC;CD14;PECAM1;ITGA4;CD44;PTPRC
prerank,GO_Biological_Process_2021__regulation of GTPase activity (GO:0043087),-0.5019255637460945,-1.227184476288116,0.11538461538461539,0.597294284882374,1.0,9/124,4.88%,CCL4;CCL3;CCL5;VAV3;RGS1;GMIP;RGS16;RACK1;GNB5
prerank,GO_Biological_Process_2021__negative regulation of endothelial cell migration (GO:0010596),0.5658017536630681,1.2271081699525948,0.1111111111111111,0.6850429833590288,1.0,5/21,9.92%,FGF2;PPARG;PTPRM;TNF;DNAJA4
prerank,GO_Biological_Process_2021__ER-associated misfolded protein catabolic process (GO:0071712),0.662108578518102,1.2270992957896099,0.20930232558139536,0.6843503210907185,1.0,3/10,13.44%,AUP1;RNF185;BAG6
prerank,GO_Biological_Process_2021__B cell differentiation (GO:0030183),-0.629726608370447,-1.2269665405121908,0.16666666666666666,0.597530900382054,1.0,6/28,12.82%,TPD52;DNAJB9;SLC25A5;ITGA4;TCF3;PTPRC
prerank,GO_Biological_Process_2021__regulation of myeloid leukocyte mediated immunity (GO:0002886),0.7200370677729805,1.2269533027604729,0.22857142857142856,0.6842358564776828,1.0,1/8,1.04%,FER
prerank,Reactome_2022__EGFR Downregulation R-HSA-182971,-0.6368117301525951,-1.2266163009869937,0.23880597014925373,0.5982303642556148,1.0,3/24,1.30%,UBC;EPN1;RPS27A
prerank,GO_Biological_Process_2021__negative regulation of natural killer cell mediated cytotoxicity (GO:0045953),-0.7322852681682535,-1.2262948239772091,0.1896551724137931,0.5987349590422852,1.0,4/10,14.31%,HLA-B;HLA-F;KLRD1;HLA-E
prerank,PanglaoDB_Augmented_2021__Stromal Cells,0.5251505693322415,1.2261122591051363,0.10810810810810811,0.685944347906386,1.0,6/44,5.20%,COL5A3;COL16A1;SVEP1;COL5A2;ACTA2;TIMP3
prerank,GO_Biological_Process_2021__fibroblast growth factor receptor signaling pathway (GO:0008543),0.5176535542349765,1.2259996405496496,0.23529411764705882,0.685687535242986,1.0,20/44,24.36%,POLR2D;FGF2;SPRED1;SPRED2;FLRT1;MAPK1;FLRT2;SHOC2;POLR2H;RAB14;RBFOX2;FGFR2;FGFR1;CBL;FRS2;ANOS1;HNRNPH1;FGFR3;POLR2F;POLR2A
prerank,CellMarker_Augmented_2021__Stem cell:Molar,0.5496530800120065,1.225848598040604,0.15625,0.6854547114886715,1.0,10/34,12.56%,COL16A1;TPM2;SERPINE1;COL5A2;TIMP3;CDH11;TWIST2;LOXL2;FAM114A1;COL6A1
prerank,CellMarker_Augmented_2021__Osteocyte:Bone,0.7717089094648582,1.2256268112759023,0.18518518518518517,0.6853864925404696,1.0,1/5,0.66%,PDPN
prerank,KEGG_2021_Human__Butanoate metabolism,0.6300570627928227,1.2256172495510076,0.18421052631578946,0.6847210863785148,1.0,5/20,14.77%,ACADS;L2HGDH;ALDH5A1;HMGCS1;GAD1
prerank,GO_Biological_Process_2021__tRNA metabolic process (GO:0006399),-0.7221466501691114,-1.2253352227484675,0.22807017543859648,0.6015515285338997,1.0,3/12,12.52%,SSB;KARS1;DARS2
prerank,"GO_Biological_Process_2021__DNA damage response, signal transduction by p53 class mediator (GO:0030330)",0.4817344456543107,1.2252809584003488,0.12,0.6851919631884443,1.0,9/57,11.20%,PCBP4;ACER2;ZNF385A;SOX4;CNOT7;PLK2;MDM2;CNOT2;RPS6KA6
prerank,GO_Biological_Process_2021__peptide catabolic process (GO:0043171),-0.702725141059356,-1.225202037120328,0.2,0.601522202399941,1.0,4/13,15.21%,TPP1;ERAP1;ERAP2;TRHDE
prerank,KEGG_2021_Human__Fatty acid biosynthesis,0.6826079444603909,1.2250774366378543,0.2,0.685124213051822,1.0,3/10,18.18%,ACACB;FASN;ACACA
prerank,GO_Biological_Process_2021__cristae formation (GO:0042407),-0.6227998551481604,-1.224892652029598,0.1774193548387097,0.6020983733278984,1.0,13/24,28.12%,ATP5PD;ATP5F1E;ATP5ME;MICOS13;APOO;SPG7;ATP5F1C;ATP5F1D;ATP5MC2;AFG3L2;DNAJC11;ATP5F1A;ATP5MC3
prerank,GO_Biological_Process_2021__eye photoreceptor cell differentiation (GO:0001754),-0.7616850834158504,-1.2247349100872968,0.2708333333333333,0.6021809846264915,1.0,2/8,11.19%,NKD1;VEGFA
prerank,GO_Biological_Process_2021__positive regulation of gliogenesis (GO:0014015),0.8018069931757942,1.2246728554827266,0.2391304347826087,0.6855003260081699,1.0,2/5,12.90%,TNF;PRKCI
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Skeletal Muscle,-0.8021577222898955,-1.2243828438058706,0.27419354838709675,0.602980298827365,1.0,4/7,18.52%,CD14;CD44;PTPRC;ITGB1
prerank,GO_Biological_Process_2021__regulation of interleukin-4 production (GO:0032673),-0.6861807813672653,-1.2239167500207628,0.2459016393442623,0.6040712667087398,1.0,3/15,3.26%,SLC7A5;PRKCQ;FCER1G
prerank,Reactome_2022__Spry Regulation Of FGF Signaling R-HSA-1295596,-0.6947155267331336,-1.2238006218503414,0.2807017543859649,0.604015404465009,1.0,2/15,1.30%,UBC;RPS27A
prerank,GO_Biological_Process_2021__positive regulation of alcohol biosynthetic process (GO:1902932),0.7592674066854024,1.2237638785698903,0.30612244897959184,0.6878471294670123,1.0,3/5,22.61%,PRKAA1;SNCA;SCAP
prerank,GO_Biological_Process_2021__stimulatory C-type lectin receptor signaling pathway (GO:0002223),-0.5374572305886535,-1.2237496270152295,0.11538461538461539,0.603338254164035,1.0,20/79,22.96%,PSMB3;FCER1G;PSMB6;PSMA7;FYN;KLRD1;PSMB9;TYROBP;PSMD12;PSMD8;PSMA5;PSMA3;PSMC4;PSME2;PSME1;CLEC7A;PSMB5;PSMC3;LYN;PSME3
prerank,GO_Biological_Process_2021__cellular response to lectin (GO:1990858),-0.5374572305886535,-1.2237496270152295,0.11538461538461539,0.603338254164035,1.0,20/79,22.96%,PSMB3;FCER1G;PSMB6;PSMA7;FYN;KLRD1;PSMB9;TYROBP;PSMD12;PSMD8;PSMA5;PSMA3;PSMC4;PSME2;PSME1;CLEC7A;PSMB5;PSMC3;LYN;PSME3
prerank,GO_Biological_Process_2021__adenosine to inosine editing (GO:0006382),0.7769976388532236,1.2236344294511319,0.16981132075471697,0.6875904685233588,1.0,1/6,0.51%,ADARB2
prerank,GO_Biological_Process_2021__negative regulation of production of molecular mediator of immune response (GO:0002701),0.8004371607881822,1.2234030391601967,0.23404255319148937,0.6876370133939175,1.0,3/5,15.40%,CD22;TNF;CR1
prerank,GO_Biological_Process_2021__retina homeostasis (GO:0001895),-0.7336184005113273,-1.2233311038434003,0.2037037037037037,0.6043203707244941,1.0,4/11,13.37%,B2M;ACTG1;ACTB;SOD1
prerank,Reactome_2022__MET Activates RAP1 And RAC1 R-HSA-8875555,0.674517092428641,1.2233091840161598,0.21428571428571427,0.6872764006655148,1.0,3/11,7.54%,PIGU;RAP1A;CRK
prerank,GO_Biological_Process_2021__folic acid-containing compound metabolic process (GO:0006760),-0.7128838300811616,-1.2231906291611212,0.2631578947368421,0.6044072622380919,1.0,3/13,18.15%,MTHFD1;SHMT1;FOLR2
prerank,GO_Biological_Process_2021__positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),0.5687033179164217,1.2231804788948328,0.17073170731707318,0.6870094575991642,1.0,3/20,5.15%,ANXA1;CDK10;UBE2E2
prerank,GO_Biological_Process_2021__epithelial cell development (GO:0002064),0.7149839540115661,1.2230276113451868,0.2708333333333333,0.6870100130808005,1.0,2/8,10.18%,ACTA2;TMEM79
prerank,GO_Biological_Process_2021__Roundabout signaling pathway (GO:0035385),0.7087235704070792,1.2230153791001341,0.2826086956521739,0.6863612081345438,1.0,4/5,28.91%,ROBO1;SLIT3;SLIT2;RHOA
prerank,GO_Biological_Process_2021__homologous chromosome segregation (GO:0045143),-0.7088357478263847,-1.2228311781287269,0.25,0.6052384162576137,1.0,4/9,17.43%,MEI4;IHO1;ZCWPW1;SGO2
prerank,PanglaoDB_Augmented_2021__Tuft Cells,-0.5624912271812837,-1.2224863955964094,0.2,0.6058762612712328,1.0,14/53,13.83%,JAML;MNDA;RGS2;AIF1;CD14;FCER1G;NCF4;CD300LF;MS4A6A;CSF2RB;TYROBP;CSF3R;PTPRC;CASP5
prerank,GO_Biological_Process_2021__nervous system development (GO:0007399),0.4314442900926116,1.2224210790974412,0.0625,0.6877988446748394,1.0,55/254,12.41%,IL1RAPL2;AVIL;KCNQ2;PKD2;DPYSL5;NCAN;SEMA5A;GSN;MAP1S;DOC2A;FGF2;ZBTB16;DPF3;PKD1;NLGN1;ARNT2;ADGRB2;CSPG5;RELN;GDF11;PPT1;NRG1;HAPLN2;PDGFC;JAG1;TMOD2;LIG4;RYK;ROBO1;SH3GL3;ZC4H2;ALDH5A1;WDPCP;DNM3;POU6F2;SHANK3;SHANK2;CYP46A1;MOBP;GPM6A;SCN8A;NUMBL;DYRK1A;BTBD3;MERTK;RPS6KA6;NRXN2;PTEN;APAF1;FKTN;NF1;ELP3;NPTX1;RBFOX1;SH3GL1
prerank,Reactome_2022__RIPK1-mediated Regulated Necrosis R-HSA-5213460,-0.6589698404866325,-1.2223844881810624,0.18571428571428572,0.6058813745288965,1.0,4/27,4.62%,UBC;RPS27A;CDC37;TNFSF10
prerank,GO_Biological_Process_2021__positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),-0.6530130024055476,-1.2223461948606094,0.20967741935483872,0.6056017218597283,1.0,5/24,11.19%,CCL5;PARP14;IGF1;PARP9;VEGFA
prerank,CellMarker_Augmented_2021__Brush Cell (Tuft cell):Lung,0.4966845708139576,1.222204372113156,0.18181818181818182,0.6870122239858844,1.0,10/49,16.78%,ANXA1;AHCY;GRAMD1A;DIP2B;SOX4;SORL1;SKAP2;NFATC3;HSPD1;NDC1
prerank,CellMarker_Augmented_2021__Neuroendocrine cell:Lung,0.4966845708139576,1.222204372113156,0.18181818181818182,0.6870122239858844,1.0,10/49,16.78%,ANXA1;AHCY;GRAMD1A;DIP2B;SOX4;SORL1;SKAP2;NFATC3;HSPD1;NDC1
prerank,Reactome_2022__Notch-HLH Transcription Pathway R-HSA-350054,0.5832646942301578,1.2221108759736283,0.19047619047619047,0.6866200830477829,1.0,6/25,11.55%,MAML2;HDAC9;MAML3;HDAC1;TBL1XR1;KAT2A
prerank,CellMarker_Augmented_2021__CD8+ Cytotoxic T cell:Undefined,-0.8073017974083109,-1.22202266469792,0.27450980392156865,0.6063431700629666,1.0,3/5,4.62%,GZMB;PRF1;TNFSF10
prerank,GO_Biological_Process_2021__regulation of toll-like receptor signaling pathway (GO:0034121),-0.6733330582672752,-1.2220195170640198,0.1935483870967742,0.605939945722812,1.0,5/18,17.04%,CD36;IRF1;APPL1;FLOT1;IRF7
prerank,Reactome_2022__MET Promotes Cell Motility R-HSA-8875878,0.5788456109846684,1.2219588824622578,0.1794871794871795,0.6863094867104338,1.0,5/19,13.77%,PIGU;RAP1A;CRK;ITGA2;PTK2
prerank,GO_Biological_Process_2021__cGMP metabolic process (GO:0046068),0.7560676889395582,1.2218838065186544,0.3541666666666667,0.6860340854618756,1.0,3/6,15.24%,GUCY1A1;NPR2;GUCY1B1
prerank,CellMarker_Augmented_2021__Luminal Progenitor cell:Breast,-0.7834108144348033,-1.221830938089007,0.24489795918367346,0.6061426874646915,1.0,4/6,19.52%,CLDN7;OVOL2;GPRC5C;CDS1
prerank,Reactome_2022__KEAP1-NFE2L2 Pathway R-HSA-9755511,-0.5198761420660318,-1.2217335727867253,0.18421052631578946,0.6060920397008084,1.0,21/82,22.04%,UBC;RPS27A;PSMB3;PSMB6;PSMA7;GCLM;PSMB9;RBX1;PSMD12;PSMD8;PSMA5;UBA52;TALDO1;PSMA3;PSMC4;CSNK2A2;PSME2;PSME1;PSMB5;NFE2L2;PSMC3
prerank,GO_Biological_Process_2021__positive regulation of macroautophagy (GO:0016239),0.5045220101664368,1.221538684429443,0.20930232558139536,0.6863004567383048,1.0,4/44,6.65%,BAG3;SIRT1;TSC2;SPTLC2
prerank,Reactome_2022__Cargo Recognition For Clathrin-Mediated Endocytosis R-HSA-8856825,-0.5424112476736129,-1.2215330299564953,0.125,0.6062327076626958,1.0,7/83,2.80%,UBC;EPN1;RPS27A;CHRM2;TFRC;IL7R;COPS6
prerank,GO_Biological_Process_2021__positive regulation of long-term synaptic potentiation (GO:1900273),0.6276540945287112,1.2214198150631095,0.1951219512195122,0.6859680875025609,1.0,2/10,8.67%,RELN;SHANK3
prerank,GO_Biological_Process_2021__chromatin assembly or disassembly (GO:0006333),0.7101085131635898,1.2212111315288527,0.2,0.6860730995340584,1.0,3/9,16.84%,MTA2;SUPT16H;CHAF1A
prerank,Reactome_2022__Activation Of Ca-permeable Kainate Receptor R-HSA-451308,-0.7875492493006062,-1.2212097153048331,0.2413793103448276,0.60683556006117,1.0,2/7,8.36%,GRIK1;CALM1
prerank,Reactome_2022__Regulation Of Necroptotic Cell Death R-HSA-5675482,-0.6672067793596164,-1.221162115294033,0.18840579710144928,0.6065997184475841,1.0,6/25,11.93%,UBC;RPS27A;CDC37;TNFSF10;CFLAR;MLKL
prerank,KEGG_2021_Human__Nitrogen metabolism,0.807260790487277,1.220948979447429,0.23404255319148937,0.6863730894451588,1.0,1/5,0.05%,CA8
prerank,GO_Biological_Process_2021__phagolysosome assembly (GO:0001845),0.6963079455911052,1.2209065797873415,0.2545454545454545,0.6858466374369151,1.0,7/8,30.41%,RAB7A;RAB14;ARL8B;RAB7B;RAB20;PIKFYVE;RAB39A
prerank,GO_Biological_Process_2021__marginal zone B cell differentiation (GO:0002315),0.7785352657680356,1.220611913381122,0.28846153846153844,0.6860889656752397,1.0,2/5,8.17%,MFNG;DOCK10
prerank,GO_Biological_Process_2021__cellular response to cAMP (GO:0071320),0.6178809814152988,1.2205926764546253,0.2222222222222222,0.6854836936894937,1.0,3/20,3.84%,PKD2;AANAT;RAP1A
prerank,GO_Biological_Process_2021__negative regulation of cell cycle phase transition (GO:1901988),-0.7163715775508991,-1.2204100472496626,0.32558139534883723,0.6083835658160532,1.0,1/6,2.73%,ATF5
prerank,GO_Biological_Process_2021__microglial cell activation (GO:0001774),-0.671678853788323,-1.220391345947787,0.2545454545454545,0.6080547039051564,1.0,5/18,11.20%,AIF1;CLU;C5AR1;ITGB2;TYROBP
prerank,CellMarker_Augmented_2021__Megakaryocyte:Undefined,-0.7628589388485202,-1.220317081641035,0.24528301886792453,0.6078861438858256,1.0,3/7,8.60%,IL3RA;PECAM1;ITGA6
prerank,Reactome_2022__Formation Of Fibrin Clot (Clotting Cascade) R-HSA-140877,-0.7180314581173539,-1.2202774168938886,0.1896551724137931,0.6075642128840846,1.0,3/14,5.43%,PROCR;F8;F13A1
prerank,GO_Biological_Process_2021__positive regulation of vascular associated smooth muscle cell apoptotic process (GO:1905461),0.8357063826801396,1.2201528563649686,0.21428571428571427,0.6865150133462767,1.0,3/5,12.13%,E2F3;PPARG;SOD2
prerank,GO_Biological_Process_2021__mitochondrial fragmentation involved in apoptotic process (GO:0043653),-0.7502753324417291,-1.2199819647910124,0.23076923076923078,0.60808387862826,1.0,2/9,6.23%,FIS1;VPS35
prerank,CellMarker_Augmented_2021__Multipotent Mesenchymal Stroma cell:Bone Marrow,-0.8420011851059215,-1.2199298458112204,0.23880597014925373,0.6078358791053795,1.0,2/5,12.82%,CD14;PTPRC
prerank,GO_Biological_Process_2021__blood vessel endothelial cell migration (GO:0043534),0.6463123640906876,1.2198578310076056,0.15789473684210525,0.6867673987611437,1.0,3/11,7.38%,NRP1;FGF2;ROBO1
prerank,GO_Biological_Process_2021__proteoglycan metabolic process (GO:0006029),0.5803032170683906,1.2198150853610419,0.23529411764705882,0.686208896712383,1.0,6/16,9.81%,HS3ST4;CSGALNACT1;HPSE;B4GALT7;CANT1;BMPR1B
prerank,Reactome_2022__Regulation Of TP53 Expression And Degradation R-HSA-6806003,-0.6205671479193543,-1.219587624934873,0.203125,0.6085263354757773,1.0,2/30,1.30%,UBC;RPS27A
prerank,GO_Biological_Process_2021__histone H3-K4 trimethylation (GO:0080182),-0.6869507662140686,-1.2195798776825193,0.23529411764705882,0.6081558257385117,1.0,2/10,14.77%,ZNF335;SETD1A
prerank,CellMarker_Augmented_2021__Dental Pulp Stem cell:Dental Pulp,-0.7700183921744779,-1.2193912128745132,0.23880597014925373,0.6084103823733565,1.0,3/7,18.52%,CD44;PTPRC;ITGB1
prerank,GO_Biological_Process_2021__positive regulation of synaptic transmission (GO:0050806),0.4590876885815971,1.219335845514487,0.11764705882352941,0.6872820906947995,1.0,17/48,14.74%,NLGN1;ZDHHC3;GRIK2;RELN;ADRA1A;BAIAP3;TNF;SHANK3;NPTN;SHANK2;PLK2;CLSTN2;CLSTN3;GRIN2B;SLC24A2;CACNG8;CACNG2
prerank,Reactome_2022__ER Quality Control Compartment (ERQC) R-HSA-901032,-0.6399418282794954,-1.2192399966601097,0.2542372881355932,0.6084810231466479,1.0,2/19,1.30%,UBC;RPS27A
prerank,Reactome_2022__RHOT1 GTPase Cycle R-HSA-9013425,0.7264647564901353,1.219165165432466,0.27906976744186046,0.6872026276504042,1.0,3/5,25.09%,TRAK2;RAP1GDS1;TRAK1
prerank,GO_Biological_Process_2021__toll-like receptor 9 signaling pathway (GO:0034162),0.6408677464245818,1.2190167287310352,0.17073170731707318,0.686998133784148,1.0,5/12,14.94%,TLR7;IRAK1;PIK3AP1;IRAK2;TRAF6
prerank,GO_Biological_Process_2021__regulation of myoblast fusion (GO:1901739),-0.8116275922567102,-1.2190024185911938,0.2549019607843137,0.608887885823214,1.0,2/5,9.94%,RIPOR2;CFLAR
prerank,GO_Biological_Process_2021__microtubule anchoring (GO:0034453),0.6834434846158068,1.2188622099247786,0.3023255813953488,0.6869191028207277,1.0,6/9,30.34%,DAG1;CLASP1;CLASP2;PCM1;BICD2;PEX14
prerank,Reactome_2022__Estrogen-dependent Gene Expression R-HSA-9018519,-0.5155444147799176,-1.218370507977398,0.13333333333333333,0.6107485495500172,1.0,19/86,14.70%,H2BC4;H2BC26;H2AC20;FOS;H2AC6;USF1;GREB1;H3-3B;H2AJ;H2BC21;POLR2G;H2BC5;H2BC9;H2BC11;KAT5;DDX5;ZNF217;CCND1;SMC1A
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Skin,0.5162206282682182,1.2183405435691166,0.1935483870967742,0.687919270422809,1.0,20/48,21.61%,GRID2;NCAN;PBX1;FZD3;ASXL3;PTPN5;PTPRD;SLC35F1;LINGO1;MARK1;ERBB4;CSRNP3;MAPK4;ADGRV1;MAP6;FGFR2;GRIK3;UNC5D;MEGF10;NRXN1
prerank,GO_Biological_Process_2021__anterograde trans-synaptic signaling (GO:0098916),0.4295046076457655,1.2180774080216772,0.11538461538461539,0.6879643167845712,1.0,49/124,22.06%,CACNA1A;KCNQ2;DOC2A;SLC1A3;KCNIP2;NLGN1;GRIK2;GLRA1;SLC1A2;UNC13B;PDE7B;GABRR2;DTNA;GRIA3;SLC12A6;GRIA4;GRIA1;KCNMB4;GRM5;SNCB;NRXN2;MAPK1;GRIN2B;NPTX1;SLC12A5;CACNA1E;GRIA2;GAD1;CACNB4;NLGN4Y;HTR7;GRIN2A;GABRD;DLGAP1;SNCA;KCND2;GABRB2;HOMER1;GRM3;GABRG3;NOVA1;CACNA1B;GABRA4;GRM1;CHRM3;NRXN1;GABRA2;GRIN1;DLG2
prerank,GO_Biological_Process_2021__positive regulation of cytokine production involved in immune response (GO:0002720),-0.6436542864480581,-1.2179651061103143,0.2535211267605634,0.611715132068155,1.0,7/19,14.31%,SLC7A5;CD55;B2M;HLA-F;CD226;NOD2;HLA-E
prerank,GO_Biological_Process_2021__positive regulation of type I interferon production (GO:0032481),-0.5522530097334604,-1.2179298473254836,0.2028985507246377,0.6114171983853515,1.0,9/65,11.42%,OAS3;GAPDH;DHX58;CD14;OAS2;OAS1;STAT1;IRF1;STING1
prerank,GO_Biological_Process_2021__adherens junction organization (GO:0034332),0.518582482022329,1.2178663563246426,0.1794871794871795,0.6880092755074974,1.0,12/32,15.66%,SMAD7;CDH20;CADM1;VCL;CDH11;CADM2;AFDN;TJP1;CDH19;ZNF703;FERMT2;CDH8
prerank,CellMarker_Augmented_2021__Endothelial cell:Embryo,-0.5692354812836471,-1.2177698070153933,0.16417910447761194,0.6114916656691299,1.0,19/70,11.39%,CD36;MNDA;MS4A4A;AIF1;SIGLEC1;CD14;FCER1G;CD93;F13A1;PECAM1;SIRPB2;TNFRSF1B;CFLAR;PCDH12;MS4A6A;CSF2RB;HLA-DRA;TYROBP;CSF3R
prerank,CellMarker_Augmented_2021__Pancreatic Progenitor cell:Pancreas,0.5526372656721255,1.2177493301138895,0.15384615384615385,0.6836488221447791,1.0,7/29,12.11%,ESRRG;FRAS1;PBX1;ASXL3;PTPRD;COBL;FNBP1L
prerank,CellMarker_Augmented_2021__Neural Stem cell:Bone Marrow,0.5526372656721255,1.2177493301138895,0.15384615384615385,0.6836488221447791,1.0,7/29,12.11%,ESRRG;FRAS1;PBX1;ASXL3;PTPRD;COBL;FNBP1L
prerank,CellMarker_Augmented_2021__Dermal Papilla cell:Hair Follicle,0.5526372656721255,1.2177493301138895,0.15384615384615385,0.6836488221447791,1.0,7/29,12.11%,ESRRG;FRAS1;PBX1;ASXL3;PTPRD;COBL;FNBP1L
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Larynx,0.5526372656721255,1.2177493301138895,0.15384615384615385,0.6836488221447791,1.0,7/29,12.11%,ESRRG;FRAS1;PBX1;ASXL3;PTPRD;COBL;FNBP1L
prerank,CellMarker_Augmented_2021__Ductal cell:Pancreas,0.5526372656721255,1.2177493301138895,0.15384615384615385,0.6836488221447791,1.0,7/29,12.11%,ESRRG;FRAS1;PBX1;ASXL3;PTPRD;COBL;FNBP1L
prerank,CellMarker_Augmented_2021__Progenitor cell:Embryonic Stem Cell,0.5526372656721255,1.2177493301138895,0.15384615384615385,0.6836488221447791,1.0,7/29,12.11%,ESRRG;FRAS1;PBX1;ASXL3;PTPRD;COBL;FNBP1L
prerank,CellMarker_Augmented_2021__Early Hematopoietic cell:Blood,0.5526372656721255,1.2177493301138895,0.15384615384615385,0.6836488221447791,1.0,7/29,12.11%,ESRRG;FRAS1;PBX1;ASXL3;PTPRD;COBL;FNBP1L
prerank,Reactome_2022__eNOS Activation R-HSA-203615,-0.7709053441357185,-1.2177305309625184,0.24561403508771928,0.6112247566337643,1.0,2/8,8.36%,TACR1;CALM1
prerank,GO_Biological_Process_2021__protein localization to endoplasmic reticulum (GO:0070972),-0.6505758042865144,-1.217661825472176,0.20634920634920634,0.6110800099183475,1.0,3/14,9.32%,PPP1R15A;DDRGK1;GABARAPL2
prerank,GO_Biological_Process_2021__positive regulation of insulin receptor signaling pathway (GO:0046628),0.6956545768316128,1.2173893089046952,0.17073170731707318,0.6840238123011882,1.0,2/8,11.83%,SIRT1;SORL1
prerank,GO_Biological_Process_2021__regulation of phospholipid metabolic process (GO:1903725),-0.7412667531754832,-1.2164528532811707,0.22413793103448276,0.6145079313885445,1.0,2/9,6.40%,DNAJC19;PHB2
prerank,Reactome_2022__Activation Of Arylsulfatases R-HSA-1663150,-0.6879801555102874,-1.2164436528681652,0.2982456140350877,0.6141118089039035,1.0,2/9,2.05%,ARSJ;ARSG
prerank,GO_Biological_Process_2021__membrane lipid metabolic process (GO:0006643),0.6651110061700306,1.2164158835541197,0.2702702702702703,0.6862186156617521,1.0,6/12,27.72%,B4GALT4;ARV1;CERK;SERINC1;TEX2;MGST2
prerank,GO_Biological_Process_2021__regulation of peptidyl-lysine acetylation (GO:2000756),0.7284255484824081,1.2162921191776677,0.2978723404255319,0.685961692626544,1.0,4/7,16.79%,SIRT1;DIP2B;SETD5;PRKAA1
prerank,GO_Biological_Process_2021__cellular response to leucine starvation (GO:1990253),0.6889653176505937,1.2161795289303423,0.25,0.6856043179260727,1.0,1/10,0.78%,RRAGD
prerank,GO_Biological_Process_2021__bleb assembly (GO:0032060),-0.80880416616754,-1.2159163715185846,0.2826086956521739,0.6153754548367665,1.0,2/6,7.32%,MYLK;EMP3
prerank,GO_Biological_Process_2021__regulation of lysosomal protein catabolic process (GO:1905165),0.7935898222533504,1.2158979153871685,0.2127659574468085,0.6858079035951051,1.0,2/5,15.12%,LDLR;ATP13A2
prerank,GO_Biological_Process_2021__protein O-linked glycosylation via serine (GO:0018242),0.7888885007326448,1.2158183153648363,0.21739130434782608,0.6854737526216537,1.0,5/6,15.60%,POGLUT3;GALNT13;POGLUT1;GALNT1;GALNT2
prerank,KEGG_2021_Human__One carbon pool by folate,-0.6907815686335462,-1.2156417966900088,0.29310344827586204,0.6157506402244368,1.0,5/13,25.30%,MTHFD1;SHMT1;TYMS;GART;MTFMT
prerank,GO_Biological_Process_2021__positive regulation of lamellipodium morphogenesis (GO:2000394),-0.7827586626097932,-1.2155224645539568,0.2708333333333333,0.6156761700881926,1.0,2/6,8.11%,CORO1B;ENPP2
prerank,GO_Biological_Process_2021__cell migration involved in sprouting angiogenesis (GO:0002042),0.6846345459571,1.215085780334273,0.225,0.6872763783422521,1.0,3/9,7.38%,NRP1;FGF2;ROBO1
prerank,GO_Biological_Process_2021__sphingoid metabolic process (GO:0046519),-0.7456754878693277,-1.2150553175211016,0.29310344827586204,0.6169119525277553,1.0,1/9,0.87%,DEGS2
prerank,GO_Biological_Process_2021__regulation of leukocyte degranulation (GO:0043300),0.720066343543363,1.2147196524181891,0.2,0.6878241454918256,1.0,1/7,1.04%,FER
prerank,GO_Biological_Process_2021__negative regulation of calcium ion transmembrane transporter activity (GO:1901020),-0.6449280289669436,-1.214698085000273,0.2698412698412698,0.6176066054404561,1.0,4/13,8.36%,PLN;GNB5;SRI;CALM1
prerank,GO_Biological_Process_2021__sphingolipid biosynthetic process (GO:0030148),0.5001924987774762,1.2145833801367525,0.09375,0.6875671611619635,1.0,12/50,12.86%,VAPB;ACER2;PPM1L;LARGE1;PLPP1;FA2H;SPTLC2;HACD2;ELOVL6;SAMD8;ST6GALNAC5;SGMS1
prerank,CellMarker_Augmented_2021__Lymphoid-primed Multipotent Progenitor cell:Umbilical Cord Blood,-0.5624772739142386,-1.2144820346000054,0.24,0.6178641944271598,1.0,10/47,12.97%,MYO1G;RPGRIP1L;OAS2;RNF213;ETS1;CYTIP;RNPEPL1;B3GAT2;CD47;QPRT
prerank,GO_Biological_Process_2021__protein O-linked glycosylation (GO:0006493),0.5221574933179948,1.2144377006889209,0.10344827586206896,0.687243757582794,1.0,15/55,15.60%,B3GNT2;POGLUT3;LARGE1;GALNT13;GALNTL6;TMTC2;FKRP;POGLUT1;C1GALT1;GALNT7;FKTN;GXYLT1;GALNT1;EOGT;GALNT2
prerank,Reactome_2022__Defective Factor VIII Causes Hemophilia A R-HSA-9662001,-0.7911017829644968,-1.214202029033104,0.23333333333333334,0.6182848769722665,1.0,1/6,1.93%,F8
prerank,Reactome_2022__Metabolism Of Water-Soluble Vitamins And Cofactors R-HSA-196849,-0.5305569913093081,-1.2139898384539147,0.14285714285714285,0.6184872222906248,1.0,23/79,18.15%,SLC2A3;VNN2;PARP14;NUDT12;MTHFD1;CYB5A;PARP9;NFS1;FLAD1;NAMPT;ENPP2;ENPP3;QPRT;NMRK1;SLC25A19;PARP4;SHMT1;NADK2;MCCC2;MOCOS;SLC2A1;PPCDC;FOLR2
prerank,"Reactome_2022__GABA Synthesis, Release, Reuptake And Degradation R-HSA-888590",-0.6608794956094951,-1.2138740622598718,0.23333333333333334,0.618435398236355,1.0,2/14,6.19%,RIMS1;RAB3A
prerank,GO_Biological_Process_2021__negative regulation of nervous system development (GO:0051961),-0.6735072201491108,-1.2136833893681795,0.23214285714285715,0.6186615362564237,1.0,2/14,2.81%,DYNLT1;B2M
prerank,GO_Biological_Process_2021__cell morphogenesis involved in differentiation (GO:0000904),0.5319732758497586,1.2136456791964265,0.16666666666666666,0.6891714919654655,1.0,11/48,16.86%,NRP1;FER;SRCIN1;RELN;TMEFF2;ITGAV;FERMT2;TYRO3;SRGAP2;ANTXR1;ATRNL1
prerank,GO_Biological_Process_2021__positive regulation of monocyte chemotactic protein-1 production (GO:0071639),-0.7578648243969558,-1.212783993509353,0.30612244897959184,0.6212297667348348,1.0,2/6,8.28%,OAS3;OAS1
prerank,PanglaoDB_Augmented_2021__Foveolar Cells,-0.8060761945021069,-1.2126575661477734,0.2413793103448276,0.6211822452602355,1.0,2/6,14.37%,ABCC3;ATP8B1
prerank,GO_Biological_Process_2021__regulation of metaphase/anaphase transition of cell cycle (GO:1902099),0.780868873699584,1.212634636292824,0.21739130434782608,0.6919748570132276,1.0,2/5,11.55%,CDC23;CENPE
prerank,GO_Biological_Process_2021__phospholipid transport (GO:0015914),-0.5664817065255237,-1.2124868954495722,0.14705882352941177,0.6213458033672221,1.0,7/44,10.11%,OSBPL5;PRELID1;PLTP;ABCB1;ATP10A;PCTP;ABCB4
prerank,PanglaoDB_Augmented_2021__Ductal Cells,-0.7248443640997934,-1.2122828321155898,0.25,0.621472992944118,1.0,6/12,17.39%,CLDN7;CFTR;SERPING1;ATP8B1;C3;GPRC5C
prerank,Reactome_2022__Developmental Biology R-HSA-1266738,-0.4536553982747104,-1.212095414508391,0.053763440860215055,0.6217023693781256,1.0,95/590,9.63%,CD36;RPS13;UBC;RPS4X;CEBPD;H2BC4;H2BC26;H2AC20;RPL28;RPS27A;RPS8;RPL38;CXCR4;RPS21;PRKCQ;RPL31;RPL37A;RPS14;H2AC6;RPL12;VAV3;RPLP1;RPL3;RPL23A;RPL39;RPL32;RPS11;RPL5;RPS15;RPS12;PSMB3;RPS25;YES1;RPS23;RPS27;FAU;RPS20;RPL29;RPLP2;RPL19;RPS24;ZNF335;RPL13A;EPHB1;RPL41;PDHX;RPL7A;RPL35;RPL37;ELOB;SCN9A;RPL10A;BNIP2;RPL11;JUP;RPS3;RPL23;SEMA6A;DOK6;RPS3A;RPL4;H3-3B;H2AJ;RPL30;MED25;RPL36AL;FGF13;RPL36;H2BC21;RPL14;RPL18A;POLR2G;PSMB6;RNMT;PSMA7;RPS6;FYN;RPS2;RPS7;RPL34;RPL15;ACTG1;RPL21;H2BC5;RBPJ;RPS5;EIF4A3;RPL27A;CD72;PSMB9;RPL6;H2BC9;RPL27;RPL18;MEIS1
prerank,GO_Biological_Process_2021__negative regulation of cyclase activity (GO:0031280),0.7581637123704574,1.2119331531963191,0.3125,0.6927441060667392,1.0,2/5,20.06%,ADGRV1;GRM3
prerank,GO_Biological_Process_2021__negative regulation of adenylate cyclase activity (GO:0007194),0.7581637123704574,1.2119331531963191,0.3125,0.6927441060667392,1.0,2/5,20.06%,ADGRV1;GRM3
prerank,GO_Biological_Process_2021__regulation of translation (GO:0006417),-0.4976054448848741,-1.21183945591812,0.14285714285714285,0.6220999147621097,1.0,33/151,18.50%,MIF4GD;RPS4X;GAPDH;BTG2;RPL5;GZMB;RPL13A;RACK1;RPL10;RPS3;EIF1;SHFL;ILF3;EIF2AK2;EIF4A3;NCBP2;NPM1;MTRF1;EIF2A;PATL2;RBM4B;PASK;RPS27L;ZCCHC4;PUM3;SHMT1;CNOT8;EIF2B2;EEF2;ZNF540;RBM4;PAIP2;VIM
prerank,GO_Biological_Process_2021__pexophagy (GO:0000425),0.7417452577447599,1.2116235494696141,0.19607843137254902,0.6928834593088009,1.0,2/7,12.36%,USP30;PEX5
prerank,GO_Biological_Process_2021__mononuclear cell differentiation (GO:1903131),0.5699297387582659,1.2116000869616248,0.22857142857142856,0.6922685509010768,1.0,3/18,9.31%,PIR;PPARG;IKZF1
prerank,GO_Biological_Process_2021__regulation of myotube differentiation (GO:0010830),0.650601261382187,1.2114858328756641,0.3023255813953488,0.6918874420289669,1.0,9/15,27.24%,HDAC9;TMEM119;HDAC1;MMP14;PIEZO1;HDAC3;MAPK14;NOTCH1;ATP11A
prerank,GO_Biological_Process_2021__regulation of T cell cytokine production (GO:0002724),-0.685654176571984,-1.2114718850068367,0.2033898305084746,0.62298397924557,1.0,6/13,10.69%,CD55;B2M;LILRB4;HLA-F;TNFRSF1B;TRPM4
prerank,GO_Biological_Process_2021__protein modification by small protein conjugation or removal (GO:0070647),0.618629841993321,1.2114595031811903,0.25,0.6912746474238022,1.0,4/13,12.79%,DESI2;SAE1;UBA1;UBA2
prerank,GO_Biological_Process_2021__ion homeostasis (GO:0050801),0.6371621984935131,1.211208740337863,0.2222222222222222,0.6912711298846544,1.0,8/16,25.84%,NEDD4L;SLC4A4;WNK1;UNC80;SLC12A5;SLC4A8;SLC4A2;CAMK2D
prerank,GO_Biological_Process_2021__porphyrin-containing compound biosynthetic process (GO:0006779),0.5901495034822526,1.2112028275946707,0.19148936170212766,0.6906600811575511,1.0,4/17,13.15%,FLVCR1;COX10;RSAD1;ALAD
prerank,GO_Biological_Process_2021__regulation of response to external stimulus (GO:0032101),-0.5421397371012805,-1.2111462763537828,0.175,0.6237526957757648,1.0,14/72,14.09%,CD36;CXCR4;CD55;MGLL;TRIM5;DHX58;CALM1;TMSB4X;IRF1;ERAP1;APPL1;EFNB2;CASP5;NOD2
prerank,Reactome_2022__Scavenging By Class A Receptors R-HSA-3000480,-0.6994249658097749,-1.2108403240065901,0.2653061224489796,0.6243462452814377,1.0,2/8,2.39%,FTH1;MARCO
prerank,GO_Biological_Process_2021__positive regulation of protein localization to nucleus (GO:1900182),-0.5723896612996193,-1.2107408387327963,0.2028985507246377,0.6243629137010668,1.0,8/47,6.59%,FLNA;TFRC;PYHIN1;JUP;DTX3L;LAMTOR5;RBM22;PARP9
prerank,GO_Biological_Process_2021__aromatic amino acid transport (GO:0015801),0.7288401307910612,1.2107317726758662,0.3111111111111111,0.6916172566316996,1.0,2/5,4.23%,SLC7A8;SLC3A2
prerank,Reactome_2022__RHOB GTPase Cycle R-HSA-9013026,-0.543760201624366,-1.2106170636309017,0.16666666666666666,0.6243975508373362,1.0,4/51,6.82%,TFRC;ARHGEF1;JUP;ARHGEF3
prerank,GO_Biological_Process_2021__positive regulation of phosphatase activity (GO:0010922),-0.730521417726258,-1.2106126488970024,0.23214285714285715,0.6240066406477797,1.0,3/12,8.36%,PPP1R15A;PLEK;CALM1
prerank,GO_Biological_Process_2021__regulation of protein localization to cell cortex (GO:1904776),0.8072199163300072,1.210423467024615,0.17777777777777778,0.6911359631903585,1.0,1/5,3.48%,EPB41
prerank,GO_Biological_Process_2021__positive regulation of protein localization to cell cortex (GO:1904778),0.8072199163300072,1.210423467024615,0.17777777777777778,0.6911359631903585,1.0,1/5,3.48%,EPB41
prerank,GO_Biological_Process_2021__cell chemotaxis (GO:0060326),-0.5936436207690354,-1.2103614454260234,0.16417910447761194,0.6244786651065282,1.0,6/27,6.72%,PLEKHG5;CXCR4;PRKCQ;EPHB1;ACKR4;CORO1B
prerank,GO_Biological_Process_2021__actin filament network formation (GO:0051639),0.6548138089157883,1.2103266302456237,0.21875,0.6908244694589487,1.0,3/10,11.62%,SPIRE2;LCP1;COBL
prerank,Reactome_2022__Association Of TriC/CCT With Target Proteins During Biosynthesis R-HSA-390471,0.5611598081488421,1.21014767208159,0.2222222222222222,0.690766426334623,1.0,5/31,13.21%,FKBP9;TCP1;SKIC2;FBXW7;CCT3
prerank,Reactome_2022__Phospholipase C-mediated Cascade; FGFR4 R-HSA-5654228,-0.7751149181920963,-1.2099757067938315,0.3157894736842105,0.625291209404518,1.0,2/5,14.45%,FGF13;FGF20
prerank,GO_Biological_Process_2021__neural crest cell development (GO:0014032),0.5577196892500816,1.2092879640837226,0.2777777777777778,0.6929821136444767,1.0,8/22,18.35%,SEMA5A;SEMA3B;NRG1;PHACTR4;ERBB4;KLHL12;NOLC1;SEMA4D
prerank,GO_Biological_Process_2021__odontogenesis of dentin-containing tooth (GO:0042475),0.7585048837212138,1.2091601642766203,0.3181818181818182,0.6929002014812319,1.0,2/5,14.43%,HDAC1;ANKRD11
prerank,GO_Biological_Process_2021__peptidyl-methionine modification (GO:0018206),0.6465169998200216,1.2090637882338857,0.21052631578947367,0.692489553102932,1.0,1/8,5.00%,NAA20
prerank,Reactome_2022__RUNX1 Regulates Estrogen Receptor Mediated Transcription R-HSA-8931987,0.7288116485670817,1.2089118409947213,0.28,0.692364447013068,1.0,4/6,25.61%,RUNX1;KCTD6;CBFB;ESR1
prerank,GO_Biological_Process_2021__positive regulation of blood vessel endothelial cell migration (GO:0043536),0.5391242969306618,1.2087199293672752,0.21621621621621623,0.6923052304033597,1.0,5/36,6.06%,ANXA1;FGF2;SIRT1;HDAC9;CIB1
prerank,GO_Biological_Process_2021__nucleotide-sugar metabolic process (GO:0009225),0.7059470851022859,1.2087002093386345,0.2857142857142857,0.691754177772849,1.0,3/7,6.70%,CSGALNACT1;EXTL2;GFPT1
prerank,GO_Biological_Process_2021__regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),0.4858177379674665,1.2084702100355855,0.1951219512195122,0.691750253671058,1.0,12/50,16.39%,PKD2;CDK5R1;CCNG2;PKD1;CDK7;CCNG1;SPDYA;PTEN;GTPBP4;CCNYL1;CCND3;BLM
prerank,KEGG_2021_Human__Salmonella infection,-0.48748722480435847,-1.2084089594856675,0.09302325581395349,0.6298169103678046,1.0,30/199,15.00%,TUBB8;FLNA;CYCS;FOS;DYNLT1;GAPDH;NAIP;CD14;ANXA2;TNFSF10;RPS3;TXN2;ACTG1;MYL12A;DCTN6;ACTB;NCKAP1L;DCTN4;ARPC5L;MLKL;CYFIP2;PFN1;PTPRC;PIK3CB;CASP5;CYTH1;TUBB4B;DYNC1LI2;STX10;SNX9
prerank,CellMarker_Augmented_2021__Spermatogonial Stem cell:Embryo,0.4738927955386464,1.2082376266817385,0.17647058823529413,0.6880554438727593,1.0,16/47,15.77%,COL16A1;SEMA5A;COL5A2;FGF2;PHLDB1;PLPPR4;NTM;CDH11;COL11A1;RUNX1T1;COL6A1;FBXL7;FERMT2;NFASC;ANTXR1;TRPC4
prerank,CellMarker_Augmented_2021__Fibroblast:Embryonic Stem Cell,0.4738927955386464,1.2082376266817385,0.17647058823529413,0.6880554438727593,1.0,16/47,15.77%,COL16A1;SEMA5A;COL5A2;FGF2;PHLDB1;PLPPR4;NTM;CDH11;COL11A1;RUNX1T1;COL6A1;FBXL7;FERMT2;NFASC;ANTXR1;TRPC4
prerank,CellMarker_Augmented_2021__Testis Somatic cell:Testis,0.4738927955386464,1.2082376266817385,0.17647058823529413,0.6880554438727593,1.0,16/47,15.77%,COL16A1;SEMA5A;COL5A2;FGF2;PHLDB1;PLPPR4;NTM;CDH11;COL11A1;RUNX1T1;COL6A1;FBXL7;FERMT2;NFASC;ANTXR1;TRPC4
prerank,CellMarker_Augmented_2021__Mesenchymal cell:Pancreas,0.4738927955386464,1.2082376266817385,0.17647058823529413,0.6880554438727593,1.0,16/47,15.77%,COL16A1;SEMA5A;COL5A2;FGF2;PHLDB1;PLPPR4;NTM;CDH11;COL11A1;RUNX1T1;COL6A1;FBXL7;FERMT2;NFASC;ANTXR1;TRPC4
prerank,CellMarker_Augmented_2021__Fibroblast:Synovium,0.4738927955386464,1.2082376266817385,0.17647058823529413,0.6880554438727593,1.0,16/47,15.77%,COL16A1;SEMA5A;COL5A2;FGF2;PHLDB1;PLPPR4;NTM;CDH11;COL11A1;RUNX1T1;COL6A1;FBXL7;FERMT2;NFASC;ANTXR1;TRPC4
prerank,CellMarker_Augmented_2021__Mesenchymal Stromal cell:Blood Vessel,0.4738927955386464,1.2082376266817385,0.17647058823529413,0.6880554438727593,1.0,16/47,15.77%,COL16A1;SEMA5A;COL5A2;FGF2;PHLDB1;PLPPR4;NTM;CDH11;COL11A1;RUNX1T1;COL6A1;FBXL7;FERMT2;NFASC;ANTXR1;TRPC4
prerank,CellMarker_Augmented_2021__Retinal Ganglion cell:Embryonic Stem Cell,0.4738927955386464,1.2082376266817385,0.17647058823529413,0.6880554438727593,1.0,16/47,15.77%,COL16A1;SEMA5A;COL5A2;FGF2;PHLDB1;PLPPR4;NTM;CDH11;COL11A1;RUNX1T1;COL6A1;FBXL7;FERMT2;NFASC;ANTXR1;TRPC4
prerank,Reactome_2022__Mitotic G1 Phase And G1/S Transition R-HSA-453279,-0.4931587402464821,-1.2082369542286888,0.16,0.6298239100634492,1.0,29/104,22.23%,UBC;RPS27A;PSMB3;POLE3;PSMB6;PSMA7;PSMB9;PSMD12;MAX;PSMD8;PSMA5;MCM7;RPA3;CCND1;UBA52;CDKN1C;PSMA3;PSMC4;PSME2;PSME1;PRIM1;MCM6;PSMB5;TYMS;PSMC3;CDC7;LYN;MCM5;CDKN1B
prerank,KEGG_2021_Human__Kaposi sarcoma-associated herpesvirus infection,-0.5114679058643814,-1.2077696011273304,0.14634146341463414,0.6309837149088435,1.0,22/131,14.85%,UBC;CYCS;HLA-B;FOS;RPS27A;ZFP36;GABARAPL1;CD200R1;GNB5;HLA-C;EIF2AK2;HLA-F;CALM1;GABARAPL2;STAT1;VEGFA;HIF1A;PIK3CB;CCND1;HLA-E;UBA52;C3
prerank,GO_Biological_Process_2021__negative regulation of cAMP-dependent protein kinase activity (GO:2000480),-0.7035556176295562,-1.2077292016879988,0.21568627450980393,0.6306914742018634,1.0,2/8,6.63%,PKIB;PRKAR1B
prerank,GO_Biological_Process_2021__translesion synthesis (GO:0019985),-0.6185751095306428,-1.207689625586964,0.20967741935483872,0.6304234809796511,1.0,2/33,1.30%,UBC;RPS27A
prerank,Reactome_2022__Neurotransmitter Receptors And Postsynaptic Signal Transmission R-HSA-112314,0.4165649335960227,1.207526191144481,0.10526315789473684,0.6897461284365958,1.0,25/121,14.74%,PRKAB2;GRIN3A;KCNJ2;NBEA;GLRA1;KCNJ5;LIN7A;NRG1;ADCY9;GABRR2;GRIA3;GRIA4;GIT1;NPTN;GRIA1;MDM2;RPS6KA6;MAPK1;GRIN2B;PRKAB1;ADCY6;ERBB4;GRIA2;CACNG8;CACNG2
prerank,"GO_Biological_Process_2021__DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",0.5102235761067038,1.2074842213101937,0.2,0.6892458976936896,1.0,7/40,9.99%,PCBP4;ZNF385A;SOX4;CNOT7;PLK2;MDM2;CNOT2
prerank,GO_Biological_Process_2021__negative regulation of response to endoplasmic reticulum stress (GO:1903573),-0.6342485320842791,-1.207442585521996,0.1694915254237288,0.6307340869568077,1.0,6/22,9.83%,UBXN1;RACK1;AQP11;CLU;NR1H2;SELENOS
prerank,GO_Biological_Process_2021__NIK/NF-kappaB signaling (GO:0038061),-0.533239189074455,-1.2072527054953517,0.21333333333333335,0.6309668370637485,1.0,19/62,22.96%,CARD14;PSMB3;PSMB6;PSMA7;PSMB9;CHI3L1;PSMD12;COPS8;PSMD8;PSMA5;REL;PSMA3;PSMC4;PSME2;PSME1;DICER1;PSMB5;PSMC3;PSME3
prerank,Reactome_2022__LDL Clearance R-HSA-8964038,0.6276619470271689,1.2071690139737408,0.2391304347826087,0.6896338770517064,1.0,2/13,4.94%,LDLR;NCEH1
prerank,PanglaoDB_Augmented_2021__Oligodendrocytes,0.4538437536199247,1.2068455069676458,0.13043478260869565,0.6900751889187883,1.0,29/118,13.18%,LGI4;SLC39A12;CNTN2;SRCIN1;NCAN;GFAP;TSPAN15;HEPACAM;MYRF;ASPA;MYO1D;NDRG2;DPY19L1;TPPP;FA2H;SLC1A2;HAPLN2;TNR;CA10;MOBP;PSD2;GRM5;SNCB;OLIG1;PTPN5;NTRK2;FASN;KIF6;MPPED1
prerank,GO_Biological_Process_2021__establishment of endothelial intestinal barrier (GO:0090557),0.7057802793585501,1.2068075500671716,0.25,0.689608445362017,1.0,5/9,17.63%,RAB1B;AFDN;TJP1;RAP2C;RAPGEF2
prerank,GO_Biological_Process_2021__glycerol ether biosynthetic process (GO:0046504),-0.7891569160471041,-1.2067044717223268,0.26229508196721313,0.6318300320236054,1.0,1/5,5.77%,GNPAT
prerank,GO_Biological_Process_2021__cellular lipid biosynthetic process (GO:0097384),-0.7891569160471041,-1.2067044717223268,0.26229508196721313,0.6318300320236054,1.0,1/5,5.77%,GNPAT
prerank,GO_Biological_Process_2021__nucleoside phosphate biosynthetic process (GO:1901293),-0.7103892945901167,-1.2066959056290711,0.3230769230769231,0.6314194779015652,1.0,2/9,1.39%,ME1;CMPK2
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),-0.7156108603092947,-1.206298089870458,0.2545454545454545,0.6322809783845443,1.0,3/9,7.65%,CLU;RPS3;TPT1
prerank,GO_Biological_Process_2021__regulation of microtubule cytoskeleton organization (GO:0070507),0.5649173224790555,1.2061041439497264,0.10810810810810811,0.6912467029377989,1.0,10/28,22.56%,PHLDB1;TPPP;CLASP1;GSK3B;PRKAA1;CLASP2;MARK2;MAP6;MAPRE2;STMN3
prerank,GO_Biological_Process_2021__regulation of isotype switching (GO:0045191),-0.7110729822084916,-1.2060695567717747,0.2631578947368421,0.6325653836712319,1.0,1/11,1.44%,TFRC
prerank,CellMarker_Augmented_2021__Leydig cell:Fetal Gonad,-0.46952221491435364,-1.2059184690291462,0.11235955056179775,0.6325645906702685,1.0,61/286,18.31%,TGFBR3;NIT2;RPS8;CXCR4;CARD16;RPS14;RPL12;RPS12;HS3ST1;RPL29;OST4;PDHX;PLTP;RPL7A;RPL35;CYB5A;RPS18;RANBP1;SULF2;RPS26;EPHX1;BRD3;SLC16A7;ODC1;RPL14;BTN3A2;RNF126;RPS2;RPS7;XYLT2;MTCH2;RPL6;S100A6;ETFB;PTS;RPL27;STAT1;EIF5A;HNRNPAB;EPSTI1;VEGFA;TSPAN9;SLC29A3;GPR155;PGK1;OXA1L;TET1;CFAP97;SURF6;SLC31A2;COA4;CDKN1C;PKP2;MATN2;S100A4;AAMDC;PRKAR2B;SLC2A1;CASP4;APH1B;GALNS
prerank,GO_Biological_Process_2021__regulation of mast cell degranulation (GO:0043304),0.6504495692445704,1.2058713299775827,0.2777777777777778,0.6912001772536486,1.0,7/13,24.34%,FER;LGALS9;GAB2;STXBP2;UNC13D;SYK;CD84
prerank,CellMarker_Augmented_2021__Mesenchymal Progenitor cell:Muscle,0.5260668601069335,1.205854677537979,0.15384615384615385,0.6905936715834446,1.0,12/38,14.07%,COL16A1;TPM2;SERPINE1;COL5A2;PHLDB1;TIMP3;CDH11;LOXL2;HEG1;COL6A1;FBXL7;MMP14
prerank,GO_Biological_Process_2021__p38MAPK cascade (GO:0038066),-0.7925375653938714,-1.2056401028586152,0.3111111111111111,0.6330915627955993,1.0,1/5,1.48%,ZFP36
prerank,GO_Biological_Process_2021__lipid droplet organization (GO:0034389),0.6237826692881732,1.2055844483749865,0.1836734693877551,0.6906769614589384,1.0,2/11,8.99%,PLA2G4C;AUP1
prerank,GO_Biological_Process_2021__regulation of dendritic cell differentiation (GO:2001198),-0.7051430506812829,-1.2055661873830144,0.3392857142857143,0.6328770877755068,1.0,1/9,1.11%,HLA-B
prerank,GO_Biological_Process_2021__purine-containing compound catabolic process (GO:0072523),-0.748347264379601,-1.2052700431762555,0.3888888888888889,0.6333676298189675,1.0,2/7,14.09%,NT5C;GPX1
prerank,GO_Biological_Process_2021__protein O-linked glycosylation via threonine (GO:0018243),0.7498440561445723,1.2052254759199377,0.26666666666666666,0.6911686215251702,1.0,5/7,15.60%,GALNT13;GALNTL6;GALNT1;EOGT;GALNT2
prerank,Reactome_2022__Role Of ABL In ROBO-SLIT Signaling R-HSA-428890,0.7208241851038675,1.2050742476976357,0.2857142857142857,0.69096122853566,1.0,7/7,27.96%,ROBO1;CLASP1;CLASP2;ABL1;SLIT2;ABL2;CAP1
prerank,Reactome_2022__IL-6-type Cytokine Receptor Ligand Interactions R-HSA-6788467,-0.7200406223394039,-1.2049662634607712,0.24528301886792453,0.6339285472315735,1.0,1/9,6.67%,OSMR
prerank,GO_Biological_Process_2021__high-density lipoprotein particle assembly (GO:0034380),0.7105762695527701,1.2047414775370213,0.24074074074074073,0.6915482988588622,1.0,1/7,6.72%,BMP1
prerank,Reactome_2022__SHC-mediated cascade:FGFR3 R-HSA-5654704,-0.695607263248446,-1.2044189203452977,0.26229508196721313,0.6349677937623152,1.0,2/8,14.45%,FGF13;FGF20
prerank,PanglaoDB_Augmented_2021__Gastric Chief Cells,0.5607015507709421,1.2043873114291936,0.21951219512195122,0.6920056375270337,1.0,4/26,5.87%,HID1;FAAH;AATK;FA2H
prerank,GO_Biological_Process_2021__selective autophagy (GO:0061912),-0.5198084842455986,-1.2043800454271572,0.13114754098360656,0.6346817253755449,1.0,10/55,14.82%,UBC;RPS27A;DDRGK1;PHB2;ACBD5;ATG2A;CFTR;STING1;DYNC1LI2;UBA52
prerank,Reactome_2022__Cellular Response To Heat Stress R-HSA-3371556,0.4516731462750728,1.2041869873983855,0.14705882352941177,0.6920336913558278,1.0,16/85,17.93%,BAG3;SIRT1;MRPL18;NUP153;NUP188;NUP42;MAPK1;MAPKAPK2;BAG5;HSPA14;FKBP4;GSK3B;NDC1;NUP133;HSPH1;NUP205
prerank,GO_Biological_Process_2021__gland development (GO:0048732),0.5352748567804236,1.2039965332183649,0.2,0.692040291126722,1.0,7/30,7.23%,ANXA1;PKD2;ZBTB1;MSN;PRKCSH;NRG1;SALL1
prerank,GO_Biological_Process_2021__positive regulation of reactive oxygen species metabolic process (GO:2000379),-0.6253071113791787,-1.2039092263602524,0.2463768115942029,0.6356068914740074,1.0,7/29,13.37%,CD36;PID1;GSTP1;ITGB2;TYROBP;CYBA;SOD1
prerank,Reactome_2022__Extracellular Matrix Organization R-HSA-1474244,0.42072119845274186,1.2038167086807743,0.16666666666666666,0.6921110274890329,1.0,27/135,13.53%,COL5A3;MMP17;COL16A1;PDGFA;LRP4;NCAN;SERPINE1;COL5A2;COL24A1;DAG1;CTSK;BMP1;FZR1;TNR;LTBP3;FBN2;MMP16;LOXL2;DMTF1;ITGAV;P3H2;COL11A1;ITGA2;COL6A1;COL25A1;JAM2;COL15A1
prerank,GO_Biological_Process_2021__regulation of anatomical structure morphogenesis (GO:0022603),0.42919369364509213,1.203796437767136,0.043478260869565216,0.6915727801002061,1.0,31/92,18.35%,CDK5R1;SRCIN1;FGF2;MARCHF5;LRRK2;PHLDB1;DAG1;LRRC4C;NEDD4L;BRSK1;SHANK3;PDLIM5;POGLUT1;TANC2;ZRANB1;KNDC1;BCL9L;NF1;STRIP1;GPNMB;FERMT2;CLASP1;GSK3B;PPFIA2;ADGRB3;CLASP2;KIF13B;BRSK2;MARK2;NEDD4;SEMA4D
prerank,GO_Biological_Process_2021__regulation of angiogenesis (GO:0045765),0.4667975279368473,1.2036974745070788,0.18181818181818182,0.6913023152317264,1.0,13/103,5.26%,KLF4;SEMA5A;SERPINE1;YJEFN3;SPRY2;AMOT;FGF2;SIRT1;GAB1;SPRED1;WNT5A;PPARG;PTPRM
prerank,Reactome_2022__SUMOylation Of DNA Damage Response And Repair Proteins R-HSA-3108214,0.45789477173502896,1.2034956491746138,0.20689655172413793,0.6912988978904001,1.0,20/67,23.88%,RNF2;NUP153;NUP188;PARP1;NUP42;TDG;NSMCE1;NSMCE2;PHC1;BLM;NDC1;NUP133;NUP205;SMC6;HERC2;PIAS1;NUP98;CBX4;PHC2;POLR1A
prerank,GO_Biological_Process_2021__regulation of homophilic cell adhesion (GO:1903385),0.8185200728254189,1.2034243557369166,0.22641509433962265,0.69085874007931,1.0,3/5,16.19%,PTPN23;PTPRG;PTPRR
prerank,GO_Biological_Process_2021__G1/S transition of mitotic cell cycle (GO:0000082),0.4772085888846258,1.2033814077054727,0.14285714285714285,0.6903342451632344,1.0,9/55,12.63%,E2F3;CDK17;CDK18;CDK7;RCC1;SPDYA;PLK2;CDK6;POLA1
prerank,GO_Biological_Process_2021__response to lipid (GO:0033993),0.4891827697659798,1.2033777124034455,0.2,0.6897256439919134,1.0,11/62,10.79%,ANXA1;ACER2;FER;ABCA2;PPARG;IRAK1;TAB2;LGALS9;GCH1;PCK2;IRAK3
prerank,CellMarker_Augmented_2021__Eosinophil:Sputum,-0.6195641539793042,-1.2027634986463098,0.21311475409836064,0.6388388287526223,1.0,8/26,14.20%,CLDN7;JUP;CD63;OVOL2;TRPV4;TSPAN9;ADGRG6;CCND1
prerank,GO_Biological_Process_2021__dermatan sulfate metabolic process (GO:0030205),0.7332615874643466,1.2025046495817626,0.2857142857142857,0.6917952057541866,1.0,3/8,11.46%,NCAN;CSPG5;UST
prerank,Reactome_2022__Adenylate Cyclase Inhibitory Pathway R-HSA-170670,0.6237396161465644,1.202060722997956,0.2857142857142857,0.692491849544217,1.0,2/10,13.60%,ADCY9;ADCY6
prerank,KEGG_2021_Human__Steroid hormone biosynthesis,-0.6948933700725075,-1.201906354966717,0.2692307692307692,0.6410283308716801,1.0,5/8,28.53%,COMT;CYP3A5;CYP19A1;HSD17B12;HSD17B7
prerank,Reactome_2022__Adenylate Cyclase Activating Pathway R-HSA-170660,0.650810821890216,1.2018519425031096,0.3541666666666667,0.6926040113270123,1.0,2/7,13.60%,ADCY9;ADCY6
prerank,Reactome_2022__PKMTs Methylate Histone Lysines R-HSA-3214841,0.4984811683442118,1.201842746821937,0.21052631578947367,0.6919955598270744,1.0,7/40,13.32%,SETD7;AEBP2;NSD3;SETD3;NSD2;SETD2;SETDB2
prerank,GO_Biological_Process_2021__organelle transport along microtubule (GO:0072384),0.5472131482265662,1.2017674762475006,0.2,0.6914940599256619,1.0,5/27,12.19%,MAP1S;COPG1;BICDL1;FBXW11;RAB6A
prerank,GO_Biological_Process_2021__establishment of protein localization to mitochondrion (GO:0072655),-0.5788700915106965,-1.201738957976653,0.25396825396825395,0.6411045424375471,1.0,7/31,7.80%,TOMM7;DNAJC19;TIMM44;FIS1;PITRM1;TIMM21;HK2
prerank,Reactome_2022__rRNA Processing In Mitochondrion R-HSA-8868766,0.7669889137584813,1.2016303565985327,0.2708333333333333,0.6913318710788121,1.0,4/5,18.78%,TFB1M;TRMT10C;MTERF4;NSUN4
prerank,Reactome_2022__Transport Of SLBP Independent Mature mRNA R-HSA-159227,0.48885203900221375,1.20136278983612,0.2647058823529412,0.6914341123272796,1.0,4/32,7.20%,NXF1;NUP153;NUP188;NUP42
prerank,GO_Biological_Process_2021__regulation of calcium ion import (GO:0090279),-0.7078689888633983,-1.2012922067275962,0.21818181818181817,0.6420937906164852,1.0,3/13,7.36%,CCL3;PLN;FYN
prerank,GO_Biological_Process_2021__negative regulation of cell division (GO:0051782),0.7763607050034286,1.201264439085648,0.24444444444444444,0.6911561570289965,1.0,2/6,16.39%,ZFYVE19;BLM
prerank,Reactome_2022__EPHA-mediated Growth Cone Collapse R-HSA-3928663,-0.6810554226812737,-1.2012214889025616,0.29310344827586204,0.6418748394360664,1.0,5/14,22.18%,YES1;FYN;MYH10;LYN;MYH9
prerank,GO_Biological_Process_2021__regulation of sprouting angiogenesis (GO:1903670),0.5267868683116054,1.2010825960424092,0.22727272727272727,0.6911845480210563,1.0,3/22,2.26%,KLF4;SMAD1;FGF2
prerank,Reactome_2022__Phosphorylation Of CD3 And TCR Zeta Chains R-HSA-202427,-0.7206295373497165,-1.2009377323880768,0.29508196721311475,0.64248574955745,1.0,7/12,19.00%,CD247;HLA-DRB5;HLA-DRA;PTPRC;HLA-DPA1;HLA-DRB1;PTPN22
prerank,GO_Biological_Process_2021__regulation of mitochondrial membrane permeability (GO:0046902),-0.7089932163721135,-1.2007980868803956,0.16363636363636364,0.6424373390427359,1.0,3/10,13.43%,SLC25A5;THEM4;SPG7
prerank,Reactome_2022__Interleukin-12 Family Signaling R-HSA-447115,-0.5802149758797494,-1.2007738697804518,0.2608695652173913,0.6421069508305454,1.0,9/39,15.40%,STAT4;ANXA2;IL12RB2;AURKAIP1;STAT1;RPLP0;SOD1;SNRPA1;TALDO1
prerank,GO_Biological_Process_2021__regulation of synapse maturation (GO:0090128),0.7084894574642884,1.2006656759587455,0.275,0.692045293437285,1.0,4/7,25.98%,RELN;NRXN1;DAB2IP;CAMK2B
prerank,GO_Biological_Process_2021__negative regulation of protein serine/threonine kinase activity (GO:0071901),-0.5320233545541825,-1.2005555808255743,0.27419354838709675,0.6423054749727847,1.0,6/56,6.85%,PKIB;DUSP1;RGS2;PAQR3;PRKAR1B;GSTP1
prerank,GO_Biological_Process_2021__regulation of ERAD pathway (GO:1904292),-0.7034743960325583,-1.2004735944007074,0.27586206896551724,0.6420753619275437,1.0,2/10,4.37%,UBXN1;AQP11
prerank,CellMarker_Augmented_2021__Circulating Precursor cell:Peripheral Blood,-0.5367939872266756,-1.1998522519923573,0.16455696202531644,0.6438101181305439,1.0,28/73,18.95%,JAML;MS4A4A;AIF1;RGS1;CD93;PLEK;IL10RA;F13A1;PECAM1;SAMSN1;MS4A6A;CSF2RB;NCKAP1L;HLA-DRA;TYROBP;A2M;PTPRC;LPAR6;HLA-DPA1;HLA-DMB;CD74;HLA-DPB1;FCGR3A;GIMAP4;PARVG;HLA-DRB1;RNASE6;PPP1R16B
prerank,GO_Biological_Process_2021__regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),0.5845043788095453,1.199836966737908,0.25,0.6938098284191564,1.0,4/17,7.92%,LRRK2;DDIT3;TXNDC12;BOK
prerank,Reactome_2022__Signaling By ALK Fusions And Activated Point Mutants R-HSA-9725370,-0.533399975719674,-1.1998133163627231,0.18181818181818182,0.6434855572105231,1.0,5/48,11.16%,BCL2A1;RNF213;RPS6;NPM1;RBX1
prerank,Reactome_2022__Nucleotide Catabolism R-HSA-8956319,-0.6720047165253812,-1.1998113236904968,0.22807017543859648,0.6430677094461007,1.0,6/21,13.80%,ADPRM;NT5C;DPYS;ENTPD4;ENTPD5;NUDT16
prerank,GO_Biological_Process_2021__sodium ion import across plasma membrane (GO:0098719),0.6668445973755228,1.1997201300535192,0.2391304347826087,0.6935517679462313,1.0,6/9,17.33%,SLC9C2;SLC9A1;SLC9A9;SLC8A1;SLC12A2;SLC9A7
prerank,GO_Biological_Process_2021__C4-dicarboxylate transport (GO:0015740),0.7290361740489302,1.1995703978108305,0.2222222222222222,0.6932521397529773,1.0,3/8,14.12%,SLC25A18;SLC1A2;SLC25A14
prerank,Reactome_2022__Pyrimidine Catabolism R-HSA-73621,-0.6895556206346702,-1.1995320803771596,0.25806451612903225,0.6435166437524452,1.0,2/8,10.19%,NT5C;DPYS
prerank,Reactome_2022__Activation Of Kainate Receptors Upon Glutamate Binding R-HSA-451326,-0.6615871394729257,-1.1994878183555655,0.2923076923076923,0.6432338488242266,1.0,4/17,15.86%,GNB5;GRIK1;CALM1;GNB2
prerank,CellMarker_Augmented_2021__Hematopoietic Stem cell:Germ,-0.7941582717850169,-1.199407287539383,0.3492063492063492,0.6431150912250678,1.0,1/6,1.43%,CXCR4
prerank,GO_Biological_Process_2021__positive regulation of GTPase activity (GO:0043547),-0.5154155852377181,-1.199114612648089,0.1794871794871795,0.643662429745408,1.0,9/135,4.88%,CCL4;CCL3;USP6;CCL5;RGS1;GMIP;RGS16;RACK1;GNB5
prerank,Reactome_2022__Transport Of SLBP Dependant Mature mRNA R-HSA-159230,0.48862944582030676,1.1990762062748972,0.2571428571428571,0.6943493933517731,1.0,4/33,7.20%,NXF1;NUP153;NUP188;NUP42
prerank,GO_Biological_Process_2021__protein import into peroxisome matrix (GO:0016558),0.6564965215570587,1.1990073700484118,0.22727272727272727,0.6939027355466502,1.0,4/10,17.23%,PEX13;PEX5;PEX16;PEX5L
prerank,GO_Biological_Process_2021__negative regulation of cell adhesion (GO:0007162),0.46089909726965994,1.1988777536313928,0.09375,0.6936874395139722,1.0,14/49,13.77%,PLXNB1;ACER2;SEMA5A;SERPINE1;PLXNA2;PLXNA3;JAG1;PLXNB2;PLXNC1;CD164;PDE3B;GTPBP4;PLXNA1;PTK2
prerank,GO_Biological_Process_2021__regulation of osteoblast proliferation (GO:0033688),0.7455707153442102,1.19887224737092,0.2571428571428571,0.6930746508717294,1.0,4/8,8.57%,PLXNB1;ATRAID;HPSE;TMEM119
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Prostate,-0.6531964588049662,-1.1986997214898756,0.2807017543859649,0.6446352204546364,1.0,5/15,8.71%,CXCR4;CSF2RA;ITGA4;ITGA6;CD44
prerank,GO_Biological_Process_2021__regulation of phospholipase activity (GO:0010517),-0.7342896370339166,-1.1986945713802728,0.26,0.6442532549649064,1.0,1/8,2.19%,RGS2
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Dental Pulp,-0.8212188989708997,-1.19850771559225,0.26666666666666666,0.6443731865762786,1.0,2/5,12.82%,CD44;PTPRC
prerank,GO_Biological_Process_2021__regulation of MHC class I biosynthetic process (GO:0045343),-0.7556781371513738,-1.1984501715653448,0.29310344827586204,0.6441258934568955,1.0,3/5,15.25%,NLRC5;NLRP12;CIITA
prerank,GO_Biological_Process_2021__heparan sulfate proteoglycan metabolic process (GO:0030201),0.6601953396097487,1.1984310362073967,0.21212121212121213,0.693634607126634,1.0,5/17,5.59%,HS3ST5;HS3ST4;HS2ST1;UGDH;HPSE
prerank,Reactome_2022__MET Activates RAS Signaling R-HSA-8851805,-0.748648369232183,-1.1981738849254804,0.25,0.6446416989628543,1.0,1/6,7.21%,RNMT
prerank,GO_Biological_Process_2021__negative regulation of type I interferon production (GO:0032480),-0.575946575044016,-1.198166981804605,0.17647058823529413,0.6442607150108344,1.0,6/34,14.23%,NLRC3;DHX58;NLRC5;TNFAIP3;HAVCR2;REL
prerank,GO_Biological_Process_2021__tRNA 5'-leader removal (GO:0001682),-0.7979735696904494,-1.198088720778769,0.25,0.64406049460714,1.0,1/5,3.42%,SSB
prerank,Reactome_2022__Negative Regulation Of FGFR3 Signaling R-HSA-5654732,-0.6240365596245389,-1.197898892155043,0.288135593220339,0.6442963937958797,1.0,3/21,6.76%,UBC;RPS27A;FGF13
prerank,GO_Biological_Process_2021__regulation of tyrosine phosphorylation of STAT protein (GO:0042509),-0.5977329912020181,-1.1976504583295513,0.2537313432835821,0.6446365286070393,1.0,5/30,11.19%,CCL5;PARP14;IGF1;PARP9;VEGFA
prerank,GO_Biological_Process_2021__heart process (GO:0003015),-0.7899580098004133,-1.1974824231341246,0.24528301886792453,0.6447498693407986,1.0,3/6,14.09%,FYN;SOD1;GPX1
prerank,GO_Biological_Process_2021__protein localization to condensed chromosome (GO:1903083),-0.7454340537950221,-1.1974055477850658,0.2777777777777778,0.6444976469224976,1.0,5/8,23.81%,ZWILCH;MIS12;IK;BUB3;CHAMP1
prerank,GO_Biological_Process_2021__protein lipidation (GO:0006497),0.5063696670160766,1.1973084570036412,0.21621621621621623,0.6963257122154517,1.0,4/44,6.37%,PIGQ;PIGU;ZDHHC3;HHAT
prerank,GO_Biological_Process_2021__negative regulation of leukocyte activation (GO:0002695),-0.6997766217867856,-1.197293900712904,0.22641509433962265,0.6444254416895342,1.0,3/10,15.81%,CD300LF;HAVCR2;CD200
prerank,GO_Biological_Process_2021__retinal rod cell development (GO:0046548),-0.8205773588751916,-1.1972855321699671,0.3076923076923077,0.6436155619740572,1.0,2/5,13.29%,RPGRIP1L;NRL
prerank,GO_Biological_Process_2021__retinal rod cell differentiation (GO:0060221),-0.8205773588751916,-1.1972855321699671,0.3076923076923077,0.6436155619740572,1.0,2/5,13.29%,RPGRIP1L;NRL
prerank,KEGG_2021_Human__PPAR signaling pathway,-0.5752765522873892,-1.19722891437674,0.15714285714285714,0.6433589288874761,1.0,6/40,8.24%,CD36;UBC;ME1;PLTP;OLR1;ACAA1
prerank,GO_Biological_Process_2021__phosphatidylinositol-mediated signaling (GO:0048015),0.4687814648974089,1.1970867712541566,0.2222222222222222,0.6963805182487246,1.0,12/46,18.03%,IGF1R;NYAP2;PLCL1;PLCB4;PIK3C2B;PI4KB;PTEN;NF1;GAB2;TYRO3;PIK3CA;PLCB3
prerank,GO_Biological_Process_2021__regulation of membrane repolarization (GO:0060306),0.6779935769360976,1.1969379008273386,0.3541666666666667,0.6963621950277895,1.0,2/8,8.52%,KCNJ2;NEDD4L
prerank,GO_Biological_Process_2021__negative regulation of cytoplasmic translation (GO:2000766),0.772468648332738,1.1966829352172963,0.23809523809523808,0.6965419546151705,1.0,2/5,18.57%,CPEB4;CPEB2
prerank,GO_Biological_Process_2021__organonitrogen compound catabolic process (GO:1901565),-0.5946951380374081,-1.1966328740182146,0.2698412698412698,0.6448544754287412,1.0,6/36,10.83%,IL4I1;TPP1;PDXDC1;TXN2;ENPP2;ERAP1
prerank,CellMarker_Augmented_2021__Epithelial cell:Blood,0.6848555294692267,1.1965684321907182,0.30952380952380953,0.695579066641605,1.0,1/10,0.04%,SHROOM3
prerank,CellMarker_Augmented_2021__Cancer cell:Lung,0.6848555294692267,1.1965684321907182,0.30952380952380953,0.695579066641605,1.0,1/10,0.04%,SHROOM3
prerank,Reactome_2022__FGFR3 Mutant Receptor Activation R-HSA-2033514,-0.7499715007293395,-1.1964395883852363,0.2631578947368421,0.6450480600269995,1.0,2/5,14.45%,FGF13;FGF20
prerank,Reactome_2022__DNA Damage Reversal R-HSA-73942,0.7186377615686524,1.1962857616914988,0.30952380952380953,0.6959877511397555,1.0,4/7,22.91%,MGMT;ASCC1;ALKBH5;FTO
prerank,GO_Biological_Process_2021__vocal learning (GO:0042297),0.7449186575727785,1.1960887910330258,0.2608695652173913,0.6952567225127795,1.0,4/5,21.61%,SHANK3;NRXN2;CNTNAP2;NRXN1
prerank,GO_Biological_Process_2021__imitative learning (GO:0098596),0.7449186575727785,1.1960887910330258,0.2608695652173913,0.6952567225127795,1.0,4/5,21.61%,SHANK3;NRXN2;CNTNAP2;NRXN1
prerank,Reactome_2022__Sphingolipid De Novo Biosynthesis R-HSA-1660661,0.5208133966517601,1.1960046290913349,0.22857142857142856,0.6948766317063145,1.0,6/33,6.65%,VAPB;ACER2;PPM1L;PLPP1;FA2H;SPTLC2
prerank,Reactome_2022__DNA Damage Recognition In GG-NER R-HSA-5696394,-0.6025696957939093,-1.1958734558773814,0.208955223880597,0.6463558332336555,1.0,6/33,12.38%,UBC;RPS27A;COPS6;PARP2;RBX1;COPS8
prerank,Reactome_2022__Interleukin-12 Signaling R-HSA-9020591,-0.5873798441206259,-1.1958211786041062,0.27419354838709675,0.6461269566445345,1.0,8/33,15.40%,STAT4;ANXA2;IL12RB2;AURKAIP1;RPLP0;SOD1;SNRPA1;TALDO1
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell migration (GO:0010633),0.622749935780723,1.1955270553123745,0.21875,0.6958749406459845,1.0,6/18,16.19%,PTPN23;PTPRM;DNAJA4;PTPRG;PTEN;PTPRR
prerank,GO_Biological_Process_2021__positive regulation of ion transmembrane transporter activity (GO:0032414),-0.6348092304920112,-1.195488633376339,0.3148148148148148,0.6466942046972385,1.0,5/18,18.55%,ABCB1;STK39;CFTR;ATP1B3;AKAP9
prerank,GO_Biological_Process_2021__postsynapse assembly (GO:0099068),0.6671718837070622,1.1953455942070916,0.20930232558139536,0.6958365136285981,1.0,5/9,15.11%,LRP4;NLGN1;WNT5A;NRXN2;NLGN4Y
prerank,GO_Biological_Process_2021__external encapsulating structure organization (GO:0045229),0.46492152077801024,1.1953115210875613,0.20833333333333334,0.6952707921466637,1.0,25/91,13.53%,COL5A3;MMP17;COL16A1;PDGFA;NCAN;SERPINE1;COL5A2;FGF2;COL24A1;DAG1;SLC39A8;ADAMTSL2;RECK;TNR;ADAMTS17;FBN2;ADAMTSL3;MMP16;ITGAV;COL11A1;NF1;ITGA2;COL6A1;JAM2;COL15A1
prerank,Reactome_2022__Maturation Of Protein 3A R-HSA-9683673,0.7722088165920751,1.1951841402667274,0.30357142857142855,0.6951606499144284,1.0,2/5,13.98%,ST6GALNAC3;GALNT1
prerank,GO_Biological_Process_2021__cell cycle G1/S phase transition (GO:0044843),0.4841095163992421,1.1951515205414036,0.1891891891891892,0.6946171734883603,1.0,7/44,11.88%,MAP3K11;E2F3;CDK7;RCC1;SPDYA;PLK2;CDK6
prerank,Reactome_2022__Signaling By NOTCH2 R-HSA-1980145,-0.5943433477771796,-1.194918534972115,0.23076923076923078,0.6481136834077175,1.0,3/24,3.32%,UBC;RPS27A;GZMB
prerank,GO_Biological_Process_2021__positive regulation of protein targeting to mitochondrion (GO:1903955),-0.5866727483572943,-1.1948488642893202,0.2459016393442623,0.6479186799686126,1.0,7/25,11.48%,TOMM7;USP36;ARIH2;RHOU;PDCD5;HPS4;ABLIM3
prerank,GO_Biological_Process_2021__protein prenylation (GO:0018342),0.7533087140552497,1.194819182076002,0.22916666666666666,0.6950440801936483,1.0,3/5,12.43%,PTAR1;PGGT1B;CHM
prerank,GO_Biological_Process_2021__UDP-N-acetylglucosamine biosynthetic process (GO:0006048),0.6323201520618504,1.1946435773187463,0.23809523809523808,0.693790000369452,1.0,3/10,12.99%,GNPNAT1;GFPT1;RENBP
prerank,GO_Biological_Process_2021__UDP-N-acetylglucosamine metabolic process (GO:0006047),0.6323201520618504,1.1946435773187463,0.23809523809523808,0.693790000369452,1.0,3/10,12.99%,GNPNAT1;GFPT1;RENBP
prerank,GO_Biological_Process_2021__amino sugar biosynthetic process (GO:0046349),0.6323201520618504,1.1946435773187463,0.23809523809523808,0.693790000369452,1.0,3/10,12.99%,GNPNAT1;GFPT1;RENBP
prerank,GO_Biological_Process_2021__peptidyl-tyrosine autophosphorylation (GO:0038083),-0.6564686410841506,-1.1945804080146227,0.24193548387096775,0.6484031166161326,1.0,2/11,5.75%,ITK;TXK
prerank,GO_Biological_Process_2021__IMP biosynthetic process (GO:0006188),-0.7571958686755879,-1.1944445084850375,0.2962962962962963,0.6484727779107959,1.0,1/5,8.61%,AMPD2
prerank,GO_Biological_Process_2021__positive regulation of Notch signaling pathway (GO:0045747),0.5361606512732505,1.1942807930901576,0.14705882352941177,0.6943600032617462,1.0,7/29,15.51%,MAML2;JAG1;ROBO1;MAML3;POGLUT1;PRKCI;ROBO2
prerank,Reactome_2022__Constitutive Signaling By Ligand-Responsive EGFR Cancer Variants R-HSA-1236382,-0.698103744466409,-1.1941443867991148,0.30357142857142855,0.6489677409359705,1.0,3/15,3.25%,UBC;RPS27A;CDC37
prerank,GO_Biological_Process_2021__cellular response to peptide (GO:1901653),-0.5478085373305137,-1.194141669492664,0.17142857142857143,0.6485716202644609,1.0,7/43,8.15%,DDX11;CD36;SNX6;RPL23;IGF1;FYN;ITGA4
prerank,GO_Biological_Process_2021__regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),-0.48196110881113274,-1.194131160186614,0.18518518518518517,0.6481817450864154,1.0,20/168,10.24%,FLNA;PLEKHG5;GAPDH;TFRC;CARD16;TRIM5;NLRC3;RORA;TNFSF10;LILRB4;LAMTOR5;TRIM22;GSTP1;NLRP12;LURAP1;TNFAIP3;STAT1;TRIM13;CFLAR;LITAF
prerank,GO_Biological_Process_2021__steroid biosynthetic process (GO:0006694),-0.5967169629912961,-1.193914638209905,0.20689655172413793,0.6484636593042541,1.0,3/31,6.83%,INSIG1;CH25H;PRLR
prerank,KEGG_2021_Human__Gastric cancer,0.44654519697009254,1.193786257130511,0.12,0.6951754231857223,1.0,22/78,16.08%,TGFBR2;FGF2;GAB1;TCF7L1;E2F3;MAP2K1;WNT5A;FZD3;SMAD2;SMAD3;WNT2B;DVL3;CTNNA2;SHC2;HGF;TCF7L2;MAPK1;RARB;TGFBR1;AKT2;GSK3B;RPS6KB2
prerank,Reactome_2022__Hedgehog On State R-HSA-5632684,-0.5344649480968929,-1.1936993818145423,0.18571428571428572,0.6486420048326893,1.0,10/66,12.85%,UBC;RPS27A;PSMB3;PSMB6;PSMA7;PSMB9;RBX1;PSMD12;PSMD8;PSMA5
prerank,Reactome_2022__SHC1 Events In ERBB2 Signaling R-HSA-1250196,0.6589619957928675,1.1936090969654392,0.2972972972972973,0.6950148479458557,1.0,5/13,18.75%,NRG1;NRG3;NRG2;ERBB4;PTPN12
prerank,GO_Biological_Process_2021__gamma-aminobutyric acid metabolic process (GO:0009448),0.7996698502342887,1.193496525405472,0.24324324324324326,0.6948238066623535,1.0,2/5,14.77%,ALDH5A1;GAD1
prerank,GO_Biological_Process_2021__glucose import (GO:0046323),-0.7990213650719684,-1.193454245777819,0.30303030303030304,0.6490321433584714,1.0,1/6,0.76%,SLC2A3
prerank,Reactome_2022__FLT3 Signaling R-HSA-9607240,-0.6136262727976504,-1.193221579678343,0.2463768115942029,0.6492671676893038,1.0,4/31,7.36%,UBC;RPS27A;GRAP2;FYN
prerank,GO_Biological_Process_2021__positive regulation of RIG-I signaling pathway (GO:1900246),-0.7299457116307462,-1.193217923345824,0.23076923076923078,0.6488723650998222,1.0,1/7,2.65%,DHX58
prerank,GO_Biological_Process_2021__sodium ion transmembrane transport (GO:0035725),0.4991431713859202,1.19300689352274,0.2,0.6956673908911808,1.0,12/38,15.33%,PKD2;SLC9C2;SCN3A;SCN3B;SLC4A4;SLC9A1;SCN8A;ANO6;SLC9A9;SLC8A1;SLC24A2;SLC12A2
prerank,Reactome_2022__Neurexins And Neuroligins R-HSA-6794361,0.4901041298697048,1.1927689952988956,0.14285714285714285,0.6958649092267595,1.0,23/42,24.02%,EPB41;NLGN1;LIN7A;SHANK3;PDLIM5;SHANK2;SHARPIN;LRRTM2;GRM5;STX1A;LRRTM4;NRXN2;GRIN2B;NLGN4Y;GRIN2A;DLGAP4;DLGAP1;HOMER1;GRM1;NRXN1;DLGAP2;HOMER2;NRXN3
prerank,Reactome_2022__Synaptic Adhesion-Like Molecules R-HSA-8849932,0.6308851355617358,1.1927121548004556,0.3684210526315789,0.6955100645848425,1.0,6/12,16.68%,GRIA3;GRIA4;GRIA1;PTPRD;GRIN2B;GRIN2A
prerank,GO_Biological_Process_2021__cellular response to topologically incorrect protein (GO:0035967),0.5588599983654049,1.1926573037522739,0.25,0.6950128519845703,1.0,1/27,0.35%,BAG3
prerank,GO_Biological_Process_2021__positive regulation of macrophage derived foam cell differentiation (GO:0010744),-0.7025874822514492,-1.1925231627192832,0.2631578947368421,0.6505999453403183,1.0,1/9,0.52%,CD36
prerank,GO_Biological_Process_2021__regulation of cardiac muscle contraction (GO:0055117),-0.6188539294971,-1.1922040794774134,0.2753623188405797,0.651336513946961,1.0,4/22,8.36%,PLN;RGS2;SRI;CALM1
prerank,Reactome_2022__Asymmetric Localization Of PCP Proteins R-HSA-4608870,-0.5500553655344875,-1.1920814869515584,0.21333333333333335,0.6513067262468938,1.0,10/48,12.85%,UBC;RPS27A;PSMB3;PSMB6;PSMA7;PSMB9;FZD2;PSMD12;PSMD8;PSMA5
prerank,GO_Biological_Process_2021__regulation of axon extension involved in axon guidance (GO:0048841),0.6357761440601353,1.1920509256276564,0.2,0.6962308870046199,1.0,3/15,6.05%,NRP1;SEMA5A;SEMA3B
prerank,GO_Biological_Process_2021__positive regulation of SMAD protein signal transduction (GO:0060391),0.6638662882167199,1.19177621607184,0.28,0.6962946770650232,1.0,3/9,15.36%,BMPR1A;TGFBR1;KIAA0319
prerank,GO_Biological_Process_2021__atrioventricular valve morphogenesis (GO:0003181),0.605723431247963,1.1915978347994438,0.30434782608695654,0.6962768613337289,1.0,3/13,12.30%,TGFBR2;SOX4;BMPR1A
prerank,Reactome_2022__Defects Of Contact Activation System (CAS) And Kallikrein/Kinin System (KKS) R-HSA-9651496,-0.706149016696038,-1.1915844117914036,0.27419354838709675,0.6524529271078809,1.0,3/10,13.78%,F8;GGCX;SERPING1
prerank,Reactome_2022__Triglyceride Biosynthesis R-HSA-75109,-0.7858219520055423,-1.1915741312642791,0.24528301886792453,0.6520744727411664,1.0,1/5,11.17%,GK
prerank,Reactome_2022__Disease R-HSA-1643685,-0.43714974242373605,-1.1914714812588512,0.02040816326530612,0.6519872622316297,1.0,184/1160,14.45%,CALCR;H2AC25;SPON2;BCL2A1;CD36;RPS13;UBC;RPS4X;CEBPD;H2BC4;H2BC26;H2AC20;HLA-B;RPL28;RPS27A;RPS8;RPL38;CXCR4;RPS21;RPL31;RPL37A;RPS14;H2AC6;F8;RPL12;VAV3;RPLP1;RPL3;ZCRB1;RPL23A;RPL39;RPL32;CHD3;PARP14;RPS11;PSTPIP1;B2M;RPL5;RPS15;RPS12;PSMB3;RPS25;YES1;RPS23;RPS27;FAU;CDC37;RPS20;RPL29;RPLP2;BTK;RPL19;RPS24;CD247;RPL13A;RPL41;RNF213;SNRPD2;NDUFA2;RPL7A;OGG1;ADAMTS19;RPL35;GTF2H5;RPL37;CTDP1;ELOB;HUS1;GNB5;POMT1;RPL10A;HLA-C;RPL11;RPS3;RPL23;SLC25A5;RANBP1;RPS3A;H2BC18;RPL4;H3-3B;H2AJ;G6PC3;RPL30;TXN2;RPL36AL;PARP9;PRKAR1B;FGF13;EIF2AK2;RPL36;H2BC21;RPL14;RPL18A;POLR2G;PSMB6;RNMT;PSMA7;RPS6;FYN;RPS2;RPS7;SV2C;BRCA2;NLRP12;CRBN;PPP1CB;RPL34;SNF8;RPL15;SRPK1;ACTG1;HLA-F;CSF2RA;ITGA4;RPL21;H2BC5;CALM1;RBPJ;RPS5;RPL27A;GCLM;APOBEC3G;GPC3;PSMB9;RPL6;H2BC9;RPL27;STAT1;RPL18;COMT;NCBP2;VPS28;ABCB4;GOLGA4;GGCX;NPM1;CFTR;CSF2RB;KDM7A;NCKAP1L;RPLP0;NUP50;RPS9;RBX1;VEGFA;STING1;SDC3;IFNGR2;ENTPD5;WDR48;SLC29A3;PSMD12;CYFIP2;ANAPC11;VPS37B;CYBA;H2BC11;PSMD8;PSMA5;ATP1B3;KAT5;DNMT1;DDX5;PEBP1;PGK1;RPS28;RAD9A;RPL9;NR4A1;KIAA1549;PIK3CB;SERPING1;ESR2;NOTCH2;ADAMTS6;RPA3;NOD2;DYNC1LI2;CCND1;BRCA1;HLA-E;HSPA1A;FGF20
prerank,CellMarker_Augmented_2021__Stem cell:Adipose Tissue,-0.7569916642907606,-1.1913176097735196,0.36666666666666664,0.6520710923333874,1.0,4/7,18.52%,PECAM1;CD44;PTPRC;ITGB1
prerank,Reactome_2022__Glycogen Breakdown (Glycogenolysis) R-HSA-70221,-0.6933440014507009,-1.1912405309911156,0.3225806451612903,0.6519270532332827,1.0,2/11,8.36%,PHKG1;CALM1
prerank,CellMarker_Augmented_2021__Mitotic Arrest Phase Fetal Germ cell:Fetal Gonad,0.3611230027698147,1.1910012535266226,0.0,0.6973379327512683,1.0,116/651,12.28%,CA8;WIPF3;DUSP6;KCNQ2;STPG1;RRAGD;GRB10;EPS8;ACVR2A;INPP1;C20ORF96;SPRY2;MYOM1;TSPAN33;SMAD1;CTSF;ZBTB33;RASGEF1B;TSPAN15;DGUOK;ZBTB16;TCF7L1;STK32B;KLF6;SERPINE2;CTNNBIP1;CDC42EP3;NEO1;MAP3K11;BBX;CHD5;NDRG2;SIRPA;NRIP1;MTUS1;NCK2;TSC2;MXD4;FOXP4;SNAP91;MRC1;UXS1;FMN1;ARRDC3;RASAL2;CDK17;UBE2E2;CADM1;PTPRM;TLK1;FSD1L;ARHGEF26;PHLPP1;CIB1;SEL1L;NRG1;GPR161;DACH1;NIPA1;USP31;RALY;PLEKHA5;TAF2;SHISA9;RYK;ELAVL2;SYCP2L;BCL11A;ROBO1;IL13RA1;TCEAL4;UBXN6;BOK;TTLL1;CLOCK;TBC1D12;GIT1;LTBP3;NEDD4L;ZFAND5;ILKAP;RAMP1;APPBP2;ANXA11;PI4KB;ZNF800;SPTAN1;ZDBF2;TANC2;CD82;PPP3CA;PLK2;CSMD3;CEP131;DUSP7;ARHGAP20;MED13L;BMPR1B;DNAJA4;JMJD1C;DYRK1A;BTBD3;RGMB;TBL1XR1;FBXW7;ZBTB38;TCF7L2;GOLIM4;COBL;MFHAS1;TBC1D22B;CDK6;SETD3;LSM6;NAALAD2;RUNX1T1
prerank,CellMarker_Augmented_2021__Dental Pulp Stem cell:Premolar,-0.8118007244423295,-1.190913809635972,0.3,0.6525571027180734,1.0,2/5,12.82%,CD14;PTPRC
prerank,GO_Biological_Process_2021__T cell mediated immunity (GO:0002456),-0.7051565038064405,-1.1906411937596975,0.23880597014925373,0.6529986898748088,1.0,4/11,7.06%,MYO1G;CD55;BTN3A3;BTN3A2
prerank,Reactome_2022__Golgi Associated Vesicle Biogenesis R-HSA-432722,-0.5716625843728261,-1.1906371710549664,0.2054794520547945,0.6526042724814825,1.0,3/42,1.44%,TPD52;FTH1;TFRC
prerank,PanglaoDB_Augmented_2021__Granulosa Cells,0.47286183119099146,1.1903797069277364,0.2,0.6985395184680503,1.0,17/45,16.64%,LRP4;FKBP9;COL5A2;MTCL1;DAG1;MAGI1;NUAK1;BOK;GNA11;ENAH;TJP1;ADCY6;FERMT2;CD276;ANTXR1;COL4A5;RAI14
prerank,Reactome_2022__Signaling By Hippo R-HSA-2028269,0.5913410198551636,1.1903761677958427,0.2549019607843137,0.6979305040665961,1.0,3/16,12.87%,AMOT;MOB1B;TJP1
prerank,Reactome_2022__Phase 4 - Resting Membrane Potential R-HSA-5576886,0.8139324535842615,1.1899760947005955,0.23636363636363636,0.6985610080222128,1.0,3/5,10.27%,KCNJ2;KCNK6;KCNK13
prerank,GO_Biological_Process_2021__positive regulation of synapse maturation (GO:0090129),0.7121381244785996,1.1898945854003742,0.2894736842105263,0.6981558840935191,1.0,4/6,25.98%,RELN;NRXN1;DAB2IP;CAMK2B
prerank,CellMarker_Augmented_2021__Goblet cell:Small Intestine,0.5415353473643526,1.189734248463717,0.2727272727272727,0.6980656074252471,1.0,2/17,3.50%,GSN;FCGBP
prerank,GO_Biological_Process_2021__positive regulation of trophoblast cell migration (GO:1901165),-0.773870154834029,-1.189701005126322,0.3333333333333333,0.6552830917780533,1.0,2/5,21.42%,VEGFA;C1QBP
prerank,Reactome_2022__RHOA GTPase Cycle R-HSA-8980692,-0.4939078112564938,-1.1896931245365423,0.1875,0.6548934093512293,1.0,12/117,6.99%,PLEKHG5;ARHGAP4;TFRC;RASGRF2;VAV3;GMIP;DDRGK1;ARHGEF1;JUP;ARHGEF3;OBSCN;ACBD5
prerank,Reactome_2022__Activation Of ATR In Response To Replication Stress R-HSA-176187,-0.6239522468564053,-1.1893918463617295,0.28125,0.6554458681573442,1.0,7/20,22.17%,HUS1;MCM7;RAD9A;RPA3;MCM6;CDC7;MCM5
prerank,GO_Biological_Process_2021__positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),0.4732651903487784,1.1893668864994889,0.2,0.698674100975459,1.0,13/49,13.77%,PLXNB1;PDGFA;IGF1R;FGF2;SIRT1;GAB1;PDGFC;TNF;UNC5B;HGF;NTRK2;PIK3AP1;PTK2
prerank,GO_Biological_Process_2021__peptide antigen assembly with MHC protein complex (GO:0002501),-0.7360199624001592,-1.1893493502417296,0.28846153846153844,0.6551812919681224,1.0,3/5,18.79%,HLA-DRA;HLA-DMB;HLA-DRB1
prerank,KEGG_2021_Human__Glyoxylate and dicarboxylate metabolism,-0.614882412763273,-1.188995487809157,0.22807017543859648,0.6560274803609091,1.0,10/22,23.99%,GLYCTK;MDH2;GLUL;MCEE;SHMT1;AFMID;ACO2;ACSS1;MDH1;GRHPR
prerank,GO_Biological_Process_2021__photoperiodism (GO:0009648),-0.6370840291607704,-1.188615250666699,0.29411764705882354,0.6567876776613444,1.0,7/21,18.38%,PER3;PER2;BHLHE40;PPP1CB;RBM4B;CRTC1;RBM4
prerank,GO_Biological_Process_2021__phosphate-containing compound metabolic process (GO:0006796),0.4380235950424638,1.188345697221639,0.2727272727272727,0.7011732380181728,1.0,34/136,18.14%,PFKP;PLA2G4C;PANK3;PFKM;INPP1;DUSP18;LRRK2;PLPPR1;PLPP1;PLPPR4;PLCB4;GFPT1;PPA2;IPPK;PPP3CA;IMPA1;ACYP1;PTPRD;NUDT3;PTEN;LCAT;PIP4K2A;ISYNA1;PPIP5K1;AGPAT2;ENPP1;PLD4;PPM1A;INPP5A;NUDT4;PIK3CA;PPP3CB;PLCB3;INPP4B
prerank,GO_Biological_Process_2021__nitric oxide mediated signal transduction (GO:0007263),-0.7070854305811695,-1.1883101546300785,0.29310344827586204,0.6575016542430157,1.0,1/9,0.52%,CD36
prerank,GO_Biological_Process_2021__transcription preinitiation complex assembly (GO:0070897),0.6429186151810884,1.188070284411867,0.34285714285714286,0.7012928319229547,1.0,1/10,2.38%,DR1
prerank,GO_Biological_Process_2021__negative regulation of cell volume (GO:0045794),0.7222247714882484,1.1878531604191849,0.3333333333333333,0.7011799528261282,1.0,4/5,18.83%,SHANK3;ANO6;P2RX7;CLCN3
prerank,Reactome_2022__Erythropoietin Activates Phosphoinositide-3-kinase (PI3K) R-HSA-9027276,0.6616584255735478,1.1878165993543222,0.2978723404255319,0.7006636785174294,1.0,1/11,1.00%,PIGU
prerank,Reactome_2022__SARS-CoV-2 Targets Host Intracellular Signaling And Regulatory Pathways R-HSA-9755779,0.6431442889676635,1.1877264861426025,0.2553191489361702,0.7004104044221878,1.0,5/11,21.45%,YWHAG;AKT2;AKT3;REXO2;YWHAE
prerank,Reactome_2022__PECAM1 Interactions R-HSA-210990,-0.7158472085134612,-1.1877236581755686,0.2807017543859649,0.6588254555060743,1.0,3/10,7.36%,YES1;PECAM1;FYN
prerank,GO_Biological_Process_2021__osteoclast differentiation (GO:0030316),-0.6888219298490504,-1.1876557558588852,0.25396825396825395,0.6586387084509618,1.0,4/16,11.20%,GPR183;ANXA2;OSCAR;TYROBP
prerank,GO_Biological_Process_2021__hippo signaling (GO:0035329),0.5772782538727315,1.187472076623307,0.22448979591836735,0.700590678138692,1.0,7/17,24.83%,AMOT;MOB1B;TJP1;YWHAE;SAV1;STK3;CASP3
prerank,Reactome_2022__Interaction Between L1 And Ankyrins R-HSA-445095,0.5591446556583288,1.1869035589369814,0.23529411764705882,0.701595857960356,1.0,5/19,9.98%,KCNQ2;SCN3A;SCN3B;SPTAN1;SCN8A
prerank,Reactome_2022__Post-translational Protein Phosphorylation R-HSA-8957275,0.48849178813679556,1.1868289542632329,0.21212121212121213,0.7012720505415244,1.0,12/53,17.75%,GOLM1;FAM20C;TRIM26;PRKCSH;VGF;ANO8;PPP3CA;DMTF1;DNAJC3;PDIA6;P4HB;NUCB1
prerank,Reactome_2022__G Alpha (12/13) Signaling Events R-HSA-416482,-0.5273540852034544,-1.186797539120493,0.2465753424657534,0.6606096291037906,1.0,8/54,6.92%,PLEKHG5;RASGRF2;VAV3;BTK;GNB5;ARHGEF1;ARHGEF3;OBSCN
prerank,Reactome_2022__Hemostasis R-HSA-109582,-0.4583460998811535,-1.1867211969964675,0.12195121951219512,0.6604332876671324,1.0,37/364,8.71%,JAML;FLNA;CD36;PROCR;SRGN;CD2;SLC7A5;PRKCQ;F8;MGLL;VAV3;YES1;CD99L2;SELL;FCER1G;ANXA2;CLU;GNB5;SLC16A3;PLEK;F13A1;IGF1;PDE5A;CD63;PECAM1;H3-3B;SELENOP;SRI;PRKAR1B;FYN;OLR1;ITGA4;CALM1;FERMT3;ITGA6;TMSB4X;CD44
prerank,GO_Biological_Process_2021__positive regulation of G protein-coupled receptor signaling pathway (GO:0045745),0.7643346370636894,1.1866453457944308,0.23404255319148937,0.7013004210875684,1.0,1/5,2.36%,SLC39A14
prerank,GO_Biological_Process_2021__plasma membrane organization (GO:0007009),-0.5893040017000829,-1.1865070670854494,0.19696969696969696,0.660832514979391,1.0,5/36,7.98%,COL5A1;CXCR4;RAB3A;PLSCR1;EPB41L3
prerank,Reactome_2022__Constitutive Signaling By AKT1 E17K In Cancer R-HSA-5674400,0.5806135422672075,1.1861486692009018,0.20689655172413793,0.7022622417316231,1.0,8/20,22.15%,CASP9;TSC2;MDM2;AKT2;GSK3B;RPS6KB2;AKT3;FOXO1
prerank,GO_Biological_Process_2021__regulation of Rac protein signal transduction (GO:0035020),0.6219918364721306,1.186136468660915,0.25,0.70169800118176,1.0,3/13,12.17%,KBTBD6;AUTS2;ARF6
prerank,CellMarker_Augmented_2021__Cholinergic neuron:Undefined,0.4999588038445035,1.1861229358150984,0.17073170731707318,0.7011146902275153,1.0,9/36,11.82%,KCNQ2;DPYSL5;NCAN;SNAP91;OLFM3;SHC2;NRXN2;LINGO1;CAMKV
prerank,"GO_Biological_Process_2021__regulation of retrograde transport, endosome to Golgi (GO:1905279)",0.7721752730538165,1.1860164576986627,0.32,0.7009228398996602,1.0,3/6,20.25%,LRRK2;ARFIP1;USP7
prerank,CellMarker_Augmented_2021__Natural Killer cell:Blood,-0.8368088174659777,-1.185900622768119,0.2608695652173913,0.662403769013036,1.0,2/5,8.19%,CD2;KLRD1
prerank,GO_Biological_Process_2021__signal transduction in response to DNA damage (GO:0042770),0.4896386438104542,1.185887241190294,0.13513513513513514,0.7006712999722082,1.0,9/39,18.30%,ACER2;CASP9;CLOCK;TIPRL;INTS7;SESN2;HINFP;BATF;NBN
prerank,GO_Biological_Process_2021__bone morphogenesis (GO:0060349),0.7264975072897694,1.1858192355833006,0.2,0.700230294475802,1.0,3/6,23.98%,BMPR1B;FGFR2;FGFR3
prerank,CellMarker_Augmented_2021__Chondrocyte:Cartilage,0.520124982261348,1.1855527744070216,0.2222222222222222,0.7005489819905484,1.0,17/41,17.53%,COL16A1;LRP4;COL5A2;PHLDB1;MAGI1;ROBO1;CDH11;PTPRG;ENAH;COL11A1;GPC6;COL6A1;FBXL7;FERMT2;ANTXR1;TNC;FARP1
prerank,Reactome_2022__RUNX3 Regulates CDKN1A Transcription R-HSA-8941855,-0.7468689975051548,-1.1854979241422623,0.2711864406779661,0.6632801246947926,1.0,1/7,1.37%,RUNX3
prerank,GO_Biological_Process_2021__mitochondrion localization (GO:0051646),0.614269673948002,1.1853950766741361,0.26666666666666666,0.7003582730236079,1.0,6/12,25.09%,LRRK2;MFN1;MARK1;MARK2;TRAK2;TRAK1
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Fat Pad,-0.7742014818720473,-1.1849966821960265,0.3064516129032258,0.6644256313598778,1.0,2/5,18.52%,CD44;ITGB1
prerank,GO_Biological_Process_2021__negative regulation of histone H4 acetylation (GO:0090241),0.7519431298525739,1.184737185033582,0.2682926829268293,0.7016731989610989,1.0,1/5,2.51%,SIRT1
prerank,Reactome_2022__Cross-presentation Of Soluble Exogenous Antigens (Endosomes) R-HSA-1236978,-0.5664048435760979,-1.1844840212156806,0.2054794520547945,0.6657891459559224,1.0,14/40,22.96%,PSMB3;PSMB6;PSMA7;PSMB9;PSMD12;PSMD8;PSMA5;PSMA3;PSMC4;PSME2;PSME1;PSMB5;PSMC3;PSME3
prerank,GO_Biological_Process_2021__positive regulation of leukocyte migration (GO:0002687),-0.6717917288928933,-1.1844747409314058,0.3,0.6654021808676978,1.0,4/13,11.19%,AIF1;PTN;NCKAP1L;VEGFA
prerank,CellMarker_Augmented_2021__Regulatory T (Treg) cell:Liver,-0.456006145226879,-1.1844647935966777,0.09195402298850575,0.6650156979789598,1.0,55/302,15.14%,PDE4A;SAT1;OAS3;MX1;GAPDH;TFRC;GOLGA8A;CARD16;TPP1;GCNT1;VAV3;GABARAPL1;DDIT4;PSMB3;GTF3C6;RGS1;PLTP;NCF4;IL12RB2;NAPA;SPATS2L;CORO1B;PSMB6;TTN;PPP1CB;ACOT9;SPOCK2;NAMPT;TNFRSF1B;TNFAIP3;TYMP;OAS1;RBPJ;TM9SF2;GBP2;SAMSN1;TRIM69;CSF2RB;ADPRH;EPSTI1;GK;TBC1D8;SLC35F2;PIM3;HSPA1B;CREM;PRDM1;PGK1;HAVCR2;GPX1;HSPA1A;SMS;TP53INP1;SNX9;RPS27L
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell apoptotic process (GO:1904036),0.6577364051664251,1.1844386780497942,0.2857142857142857,0.7019400340224113,1.0,2/14,1.65%,SEMA5A;SERPINE1
prerank,GO_Biological_Process_2021__regulation of fibroblast apoptotic process (GO:2000269),-0.7783686171145102,-1.1838369354567442,0.24528301886792453,0.6667750399975999,1.0,3/6,19.87%,BTG1;STK17B;PRDM11
prerank,GO_Biological_Process_2021__PERK-mediated unfolded protein response (GO:0036499),0.6925450037877612,1.1838050579367296,0.2765957446808511,0.7035001609885683,1.0,2/8,9.03%,DDIT3;EIF2S1
prerank,GO_Biological_Process_2021__positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),-0.48798750382272826,-1.1835529792262243,0.1875,0.6671963964782558,1.0,20/126,15.77%,FLNA;PLEKHG5;GAPDH;TFRC;CARD16;TRIM5;TNFSF10;LAMTOR5;TRIM22;LURAP1;TRIM13;CFLAR;LITAF;ALPK1;TERF2IP;NOD2;REL;APOL3;LGALS1;CD74
prerank,GO_Biological_Process_2021__regulation of actin filament length (GO:0030832),0.7525196556023682,1.1834056850718784,0.34782608695652173,0.7041229447469503,1.0,1/6,1.05%,EPS8
prerank,CellMarker_Augmented_2021__Macrophage:Serum,-0.7875292682608965,-1.1833798149816181,0.328125,0.6673760376882811,1.0,1/5,0.84%,ADGRE1
prerank,KEGG_2021_Human__Phototransduction,-0.7743189968347555,-1.1833743511522625,0.32075471698113206,0.6669836832307712,1.0,1/5,8.36%,CALM1
prerank,CellMarker_Augmented_2021__Endothelial cell:Adipose Tissue,-0.7468681809531227,-1.1824791342028842,0.3,0.6695945577131629,1.0,2/5,12.82%,PECAM1;PTPRC
prerank,GO_Biological_Process_2021__regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),0.5808015796753787,1.1824556025972024,0.2777777777777778,0.7061355577723022,1.0,4/18,15.98%,CDK17;CDK18;POLA1;HINFP
prerank,GO_Biological_Process_2021__histone mRNA catabolic process (GO:0071044),-0.6906372036837379,-1.1822192569531946,0.2413793103448276,0.6699347366965627,1.0,2/13,7.08%,SSB;EXOSC10
prerank,GO_Biological_Process_2021__positive regulation of protein kinase activity (GO:0045860),0.4234694356256036,1.18218423724927,0.10344827586206896,0.7064274621206983,1.0,13/107,10.03%,EGR1;SRCIN1;TGFBR2;BORA;RAP1A;MAP2K1;RELN;CIB1;CAB39;TNF;TAB2;SPDYA;GRM5
prerank,GO_Biological_Process_2021__regulation of interferon-gamma production (GO:0032649),-0.5636296700478974,-1.1820991454705692,0.18055555555555555,0.6698996166145111,1.0,15/52,14.79%,BTN3A1;CD2;SLC7A5;CD14;SLAMF6;LILRB4;TXK;IL12RB2;BTN3A2;CD226;SLC11A1;CD47;IL18R1;HAVCR2;HLA-DPA1
prerank,GO_Biological_Process_2021__TOR signaling (GO:0031929),-0.6352425981630989,-1.1820779785473985,0.288135593220339,0.6696073213999645,1.0,3/21,11.05%,SYAP1;RPS6;PRR5L
prerank,Reactome_2022__Regulation Of RAS By GAPs R-HSA-5658442,-0.5526271805406016,-1.181972825117572,0.23684210526315788,0.6694998005000121,1.0,12/53,14.82%,UBC;RPS27A;PSMB3;PSMB6;PSMA7;PSMB9;RBX1;PSMD12;PSMD8;PSMA5;RASA2;UBA52
prerank,CellMarker_Augmented_2021__Central Nervous System Stem cell:Fetal Brain,-0.5303872482489281,-1.1818569376944121,0.22077922077922077,0.6693756583958083,1.0,18/51,16.96%,MS4A4A;VAV3;AIF1;CD93;TNFSF10;GATM;F13A1;PECAM1;MS4A6A;CFTR;HLA-DRA;SPARCL1;PTPRC;SERPING1;HLA-DPA1;CD74;HLA-DPB1;FCGR3A
prerank,Reactome_2022__Intrinsic Pathway For Apoptosis R-HSA-109606,-0.5718503337222579,-1.1817066721723661,0.2835820895522388,0.6694302724850733,1.0,3/46,3.32%,APIP;CYCS;GZMB
prerank,Reactome_2022__Synthesis Of Bile Acids And Bile Salts R-HSA-192105,-0.6420409302659277,-1.1814899579694398,0.25,0.6696521553674625,1.0,1/18,0.88%,CH25H
prerank,GO_Biological_Process_2021__regulation of transposition (GO:0010528),-0.7763781882255311,-1.1814792256674818,0.2807017543859649,0.6692550021729623,1.0,2/7,8.67%,MYBL1;APOBEC3G
prerank,Reactome_2022__Prolonged ERK Activation Events R-HSA-169893,0.6470660882247953,1.1812550910008157,0.3333333333333333,0.7085140323393752,1.0,4/12,11.38%,RAP1A;MAP2K1;CRK;MAPK1
prerank,KEGG_2021_Human__Th1 and Th2 cell differentiation,-0.5626467156163277,-1.181107695441117,0.208955223880597,0.669961395134327,1.0,11/60,11.78%,STAT4;FOS;RUNX3;PRKCQ;CD247;HLA-DRB5;IL12RB2;RBPJ;STAT1;HLA-DRA;IFNGR2
prerank,GO_Biological_Process_2021__positive regulation of mRNA catabolic process (GO:0061014),-0.5606622516336462,-1.1810995560233033,0.20588235294117646,0.6695645413636675,1.0,4/38,11.05%,ZFP36;BTG2;POLR2G;PRR5L
prerank,Reactome_2022__Advanced Glycosylation Endproduct Receptor Signaling R-HSA-879415,0.618050955500736,1.1810277894310557,0.2682926829268293,0.7087439601848379,1.0,4/10,20.52%,PRKCSH;MAPK1;CAPZA2;AGER
prerank,GO_Biological_Process_2021__regulation of cAMP-dependent protein kinase activity (GO:2000479),-0.6733522065253533,-1.1809897144429153,0.22641509433962265,0.6694352547084909,1.0,2/12,6.63%,PKIB;PRKAR1B
prerank,GO_Biological_Process_2021__protein localization to endoplasmic reticulum exit site (GO:0070973),0.7219156290818444,1.1808976053425213,0.3269230769230769,0.7084487351563269,1.0,1/5,3.81%,LRRK2
prerank,GO_Biological_Process_2021__dendrite arborization (GO:0140059),0.7392905395536882,1.1808369672340626,0.2765957446808511,0.7080451909108234,1.0,1/5,0.61%,NRP1
prerank,GO_Biological_Process_2021__positive regulation of locomotion (GO:0040017),-0.6521950823822286,-1.1807222575502943,0.3442622950819672,0.6697787855803469,1.0,3/15,7.96%,AIF1;DUOX1;SPOCK2
prerank,GO_Biological_Process_2021__chaperone-mediated protein complex assembly (GO:0051131),-0.5771147924778618,-1.1807128381009133,0.2807017543859649,0.6693716633642706,1.0,5/16,22.53%,CLU;HSPA1A;CCT2;PSMG1;PFDN6
prerank,GO_Biological_Process_2021__regulation of protein import into nucleus (GO:0042306),-0.6028888722157519,-1.1804350628864007,0.19047619047619047,0.6698258870362338,1.0,5/27,6.41%,FLNA;MDFIC;APOD;JUP;RBM22
prerank,GO_Biological_Process_2021__cation transport (GO:0006812),0.4335025119196227,1.180132699379866,0.1111111111111111,0.709431403488702,1.0,20/71,13.70%,KCNJ2;KCNIP2;SCN3A;SLC7A8;SLC3A2;KCND3;ATP10D;SCN3B;KCNJ5;NEDD4L;SLC4A4;SLC41A1;KCNMB4;SCN8A;KCNK6;KCNN2;ANO6;ABCC8;KCNMB3;SLC8A1
prerank,GO_Biological_Process_2021__negative regulation of leukocyte proliferation (GO:0070664),-0.8149319359173196,-1.1799992595235702,0.2765957446808511,0.6709733538858829,1.0,3/5,8.26%,GSTP1;TNFAIP3;ENPP3
prerank,GO_Biological_Process_2021__cytoplasmic sequestering of transcription factor (GO:0042994),0.6708423901657152,1.1799808943188255,0.29545454545454547,0.7092153544579564,1.0,2/9,3.46%,PKD2;PKD1
prerank,CellMarker_Augmented_2021__Adipose-derived Stem cell:Subcutaneous Adipose Tissue,-0.732481249468448,-1.17997856722825,0.29508196721311475,0.6706660942272106,1.0,3/7,18.52%,PECAM1;CD44;ITGB1
prerank,GO_Biological_Process_2021__histone mRNA metabolic process (GO:0008334),-0.6103825179332477,-1.179580327494754,0.28125,0.6715011928170834,1.0,3/22,9.87%,SSB;EXOSC10;NCBP2
prerank,GO_Biological_Process_2021__extracellular matrix assembly (GO:0085029),0.6843182937633782,1.179569341345845,0.3023255813953488,0.7097594794422668,1.0,5/10,28.44%,LTBP3;NTN4;QSOX1;TGFB1;GPM6B
prerank,GO_Biological_Process_2021__presynapse assembly (GO:0099054),0.5933778229076397,1.17950352566581,0.25,0.7092575990087088,1.0,8/14,18.31%,LRP4;NLGN1;WNT5A;PTPRD;PTEN;NLGN4Y;IL1RAPL1;PCLO
prerank,Reactome_2022__Sema4D In Semaphorin Signaling R-HSA-400685,0.6138121559339028,1.1793948740087372,0.2,0.7089831390459141,1.0,1/19,0.43%,PLXNB1
prerank,KEGG_2021_Human__Inflammatory bowel disease,-0.6012373134032774,-1.1792402916393216,0.22950819672131148,0.67202501486215,1.0,15/37,18.79%,STAT4;RORA;HLA-DRB5;IL12RB2;STAT1;HLA-DRA;IFNGR2;IL18R1;NOD2;HLA-DPA1;HLA-DMB;HLA-DPB1;IL18;MAF;HLA-DRB1
prerank,GO_Biological_Process_2021__nitrogen compound transport (GO:0071705),0.44472613120784454,1.1791749239828653,0.12,0.7091225333983455,1.0,16/76,11.75%,FLVCR1;PDPN;SLC7A8;SCAMP4;RCN3;SLC3A2;ARRDC3;PPT1;SCARB2;SLC15A4;SLC44A2;RAB7A;RAMP1;LMAN2L;SLC19A2;SLC44A1
prerank,GO_Biological_Process_2021__regulation of sodium ion transport (GO:0002028),0.5126828669487566,1.1791689791584175,0.25,0.7085241177583469,1.0,9/23,18.87%,SCN3B;WNK1;SLMAP;NKAIN3;AHCYL1;NKAIN2;P2RX7;NEDD4;SCN1B
prerank,GO_Biological_Process_2021__protein sumoylation (GO:0016925),0.4864614534815626,1.1791462135323747,0.23076923076923078,0.708005319552464,1.0,15/47,22.40%,SAE1;NUP153;NUP188;NUP42;BCL11A;STX1A;UBA2;ZNF451;NSMCE2;NDC1;NUP133;NUP205;TRIM28;PIAS1;NUP98
prerank,Reactome_2022__CREB1 Phosphorylation Thru Activation Of Adenylate Cyclase R-HSA-442720,-0.6482157988435744,-1.1789654106383984,0.38181818181818183,0.6724540683773221,1.0,3/11,17.40%,PRKAR1B;CALM1;PRKAR2B
prerank,GO_Biological_Process_2021__regulation of glucocorticoid receptor signaling pathway (GO:2000322),0.7224264491873356,1.178896286166442,0.28846153846153844,0.7080960965779769,1.0,3/5,26.86%,CLOCK;PER1;LMO3
prerank,GO_Biological_Process_2021__regulation of cell-substrate adhesion (GO:0010810),0.47852196793725116,1.1785304883286571,0.22857142857142856,0.708559481610611,1.0,9/30,19.71%,PDPN;MYADM;NF1;PTK2;GCNT2;CX3CL1;RSU1;PPM1F;PTPRO
prerank,GO_Biological_Process_2021__glycosphingolipid catabolic process (GO:0046479),-0.7701618610956327,-1.1783794842349675,0.35185185185185186,0.6737126042398994,1.0,1/7,5.40%,GLA
prerank,GO_Biological_Process_2021__polyamine metabolic process (GO:0006595),-0.6785170559768633,-1.178345416716709,0.25925925925925924,0.6733880170283596,1.0,3/10,7.79%,SAT1;ODC1;SAT2
prerank,"GO_Biological_Process_2021__positive regulation of CD8-positive, alpha-beta T cell differentiation (GO:0043378)",-0.7417293721200992,-1.1780793442406536,0.3508771929824561,0.6739204522752557,1.0,3/5,10.76%,RUNX3;LILRB4;NCKAP1L
prerank,GO_Biological_Process_2021__mitochondrial outer membrane permeabilization (GO:0097345),-0.6887252011717009,-1.1780432572762387,0.265625,0.67363479790426,1.0,3/10,18.86%,BLOC1S2;BMF;RHOT2
prerank,GO_Biological_Process_2021__regulation of hippo signaling (GO:0035330),0.6479897092182259,1.177861723457177,0.20930232558139536,0.7097277768536456,1.0,5/13,16.47%,DLG5;SHANK2;MOB3B;WWC2;IQCJ-SCHIP1
prerank,Reactome_2022__Deubiquitination R-HSA-5688426,-0.46801195363211645,-1.177847063183398,0.14814814814814814,0.6737800411844628,1.0,30/203,14.26%,H2AC25;UBC;H2BC4;H2BC26;H2AC20;RPS27A;H2AC6;PSMB3;ADRM1;H2BC18;H2BC21;PSMB6;PSMA7;TNFAIP3;H2BC5;MAT2B;ABRAXAS1;PSMB9;H2BC9;JOSD1;CFTR;HIF1A;WDR48;PSMD12;H2BC11;PSMD8;PSMA5;OTUD3;NOD2;BRCA1
prerank,GO_Biological_Process_2021__regulation of posttranscriptional gene silencing (GO:0060147),0.4588406594483777,1.177713936558994,0.10810810810810811,0.7089371348342476,1.0,9/47,17.93%,POLR2D;NUP153;NUP188;NUP42;IPO8;POLR2H;NDC1;NUP133;NUP205
prerank,GO_Biological_Process_2021__regulation of gene silencing by RNA (GO:0060966),0.4588406594483777,1.177713936558994,0.10810810810810811,0.7089371348342476,1.0,9/47,17.93%,POLR2D;NUP153;NUP188;NUP42;IPO8;POLR2H;NDC1;NUP133;NUP205
prerank,GO_Biological_Process_2021__glucose 6-phosphate metabolic process (GO:0051156),-0.6420074153706313,-1.177441286969131,0.3442622950819672,0.6747194785156795,1.0,4/15,15.98%,G6PC3;HK2;TALDO1;H6PD
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Ligament,-0.6991508012603872,-1.1771913157085065,0.26865671641791045,0.6751450492446295,1.0,6/14,18.52%,CD14;PECAM1;CD44;PTPRC;CD74;ITGB1
prerank,GO_Biological_Process_2021__mesenchymal cell development (GO:0014031),0.7169994409704397,1.1767452670755256,0.34210526315789475,0.7112655856679441,1.0,5/7,26.65%,NRG1;KLHL12;NOLC1;CDH2;NOTCH1
prerank,Reactome_2022__Sealing Of Nuclear Envelope (NE) By ESCRT-III R-HSA-9668328,-0.6226727765158588,-1.1765904498279858,0.27941176470588236,0.6767216337159581,1.0,1/21,0.17%,TUBB8
prerank,CellMarker_Augmented_2021__Pericyte:Skeletal Muscle,-0.5331894219831996,-1.176569492511119,0.2222222222222222,0.6763690647807075,1.0,12/53,12.82%,PLN;PLXDC1;SYNE1;CD93;PECAM1;ENPP2;PCDH12;SPARCL1;ABCA8;A2M;FLT1;PTPRC
prerank,GO_Biological_Process_2021__cell projection assembly (GO:0030031),0.5509698325785622,1.1764096789153864,0.225,0.7116852983308851,1.0,2/17,1.66%,PDGFA;GSN
prerank,GO_Biological_Process_2021__membrane depolarization (GO:0051899),0.5616000354721287,1.176194743612167,0.2765957446808511,0.7117724611035026,1.0,9/18,18.87%,CACNA1A;SCN3A;SCN3B;SCN8A;CACNA1E;CACNG2;CACNB4;P2RX7;SCN1B
prerank,GO_Biological_Process_2021__ATF6-mediated unfolded protein response (GO:0036500),0.6693988753594586,1.1760656043227105,0.32653061224489793,0.7115961730774741,1.0,1/9,5.85%,DDIT3
prerank,GO_Biological_Process_2021__regulation of endocytic recycling (GO:2001135),0.6592318068831043,1.176030660502287,0.3269230769230769,0.7110401685203782,1.0,2/7,18.99%,SORL1;ARHGAP1
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell differentiation (GO:0030858),0.7273190292935362,1.175996028428054,0.3541666666666667,0.7105727146194167,1.0,3/6,7.45%,FGF2;VEZF1;RFX3
prerank,CellMarker_Augmented_2021__Epithelial cell:Thymus,0.6158122061380387,1.1758395241965465,0.26666666666666666,0.710514600866288,1.0,1/20,0.04%,SHROOM3
prerank,Reactome_2022__Calnexin/calreticulin Cycle R-HSA-901042,-0.5998907598412412,-1.1758198775302167,0.21212121212121213,0.6783116800946608,1.0,2/24,1.30%,UBC;RPS27A
prerank,GO_Biological_Process_2021__positive regulation of double-strand break repair (GO:2000781),-0.5478031273642179,-1.1755873972954418,0.25,0.6785745325783266,1.0,6/31,14.63%,DDX11;DTX3L;PARP9;WDR48;ZCWPW1;FANCB
prerank,GO_Biological_Process_2021__negative regulation of lipid catabolic process (GO:0050995),0.7102626557392234,1.1755005835084558,0.358974358974359,0.7110008760594274,1.0,5/9,21.70%,TNF;PDE3B;SORL1;PRKAA1;MFSD2A
prerank,GO_Biological_Process_2021__substrate adhesion-dependent cell spreading (GO:0034446),0.5815902429924054,1.1754874889906854,0.2647058823529412,0.7104472209317034,1.0,10/31,16.86%,NRP1;FER;SRCIN1;TMEFF2;ITGAV;FERMT2;TYRO3;SRGAP2;ANTXR1;ATRNL1
prerank,GO_Biological_Process_2021__negative regulation of inflammatory response (GO:0050728),-0.5247085442460369,-1.175391923304904,0.2054794520547945,0.6787271386983476,1.0,17/94,9.83%,CALCR;NLRC3;YES1;CD200R1;RORA;CD247;IGF1;VPS35;PRKAR1B;GSTP1;FYN;NLRP12;TNFRSF1B;TNFAIP3;ENPP3;METRNL;SELENOS
prerank,GO_Biological_Process_2021__neural crest cell differentiation (GO:0014033),0.6410201012219522,1.1753242632816416,0.2647058823529412,0.7103214336315835,1.0,5/10,27.82%,NRG1;KLHL12;NOLC1;CDH2;FBXL17
prerank,GO_Biological_Process_2021__mitochondrial ATP synthesis coupled proton transport (GO:0042776),-0.6801121035911852,-1.1752653460574944,0.3114754098360656,0.6787751928323,1.0,7/14,20.98%,ATP5PD;ATP5F1E;ATP5ME;STOML2;ATP5F1C;ATP5F1D;ATP5MC2
prerank,GO_Biological_Process_2021__positive regulation of smooth muscle cell apoptotic process (GO:0034393),0.8030321849597654,1.1751347561431589,0.3023255813953488,0.7101376841770661,1.0,3/6,12.13%,E2F3;PPARG;SOD2
prerank,GO_Biological_Process_2021__negative regulation of actin filament depolymerization (GO:0030835),0.7730218570121344,1.1751081826292216,0.2916666666666667,0.7096442503639319,1.0,1/5,1.66%,GSN
prerank,Reactome_2022__Negative Regulation Of FGFR4 Signaling R-HSA-5654733,-0.6305348711016316,-1.1751032391001064,0.27586206896551724,0.6788725949587845,1.0,3/20,6.76%,UBC;RPS27A;FGF13
prerank,GO_Biological_Process_2021__CENP-A containing nucleosome assembly (GO:0034080),-0.62013971911214,-1.1748396066253977,0.25806451612903225,0.678732584880466,1.0,3/18,10.59%,CENPU;ITGB3BP;NPM1
prerank,GO_Biological_Process_2021__CENP-A containing chromatin organization (GO:0061641),-0.62013971911214,-1.1748396066253977,0.25806451612903225,0.678732584880466,1.0,3/18,10.59%,CENPU;ITGB3BP;NPM1
prerank,GO_Biological_Process_2021__regulation of interferon-beta production (GO:0032648),-0.5624374315531491,-1.1746367308728811,0.18181818181818182,0.678862712994134,1.0,11/42,17.04%,OAS3;NLRC3;DHX58;OAS2;OAS1;IRF1;STING1;REL;POLR3C;FLOT1;IRF7
prerank,GO_Biological_Process_2021__adrenergic receptor signaling pathway (GO:0071875),0.7043272112387431,1.174283555188251,0.2926829268292683,0.7113294419865119,1.0,3/8,17.63%,ADRA1A;ADCY9;RAPGEF2
prerank,GO_Biological_Process_2021__peptidyl-lysine acetylation (GO:0018394),0.6538463449299943,1.1742442826940382,0.27906976744186046,0.7108551803486574,1.0,3/9,13.44%,SIRT1;KAT2A;BAG6
prerank,GO_Biological_Process_2021__monovalent inorganic cation homeostasis (GO:0055067),0.6493832607086574,1.1741724612205293,0.3,0.7104783360659044,1.0,7/11,18.83%,PDK4;SLC12A6;SLC9A1;SLC12A5;SLC12A2;SLC9A7;CLCN3
prerank,KEGG_2021_Human__Type II diabetes mellitus,0.5389260689584414,1.1741194953375067,0.21875,0.7100152205008702,1.0,5/28,13.93%,CACNA1A;TNF;MAPK1;ABCC8;CACNA1E
prerank,GO_Biological_Process_2021__negative regulation of locomotion (GO:0040013),0.6241040862493016,1.1737664135147883,0.20512820512820512,0.7104114623971124,1.0,4/9,16.45%,CRK;CCDC125;FRMD5;SPOCK3
prerank,CellMarker_Augmented_2021__Neural Stem cell:Inferior Colliculus,0.43775710497134324,1.1736355319811471,0.1935483870967742,0.7102672587988453,1.0,23/58,20.67%,LRP4;FRAS1;PBX1;MAGI1;SALL1;CACHD1;PTPRD;ENAH;LINGO1;FNBP1L;TJP1;FBXL7;MARK1;CSRNP3;MAPK4;FARP1;MAP6;RBFOX2;CRMP1;DCLK1;ZNF462;UNC5D;MEGF10
prerank,GO_Biological_Process_2021__dicarboxylic acid metabolic process (GO:0043648),-0.5646087747860085,-1.1735404119540762,0.21875,0.6817801082894084,1.0,4/38,3.80%,NIT2;ME1;MDH2;MTHFD1
prerank,GO_Biological_Process_2021__dermatan sulfate biosynthetic process (GO:0030208),0.7441980457199149,1.1733200743983623,0.30612244897959184,0.7107782111465598,1.0,3/7,11.46%,NCAN;CSPG5;UST
prerank,PanglaoDB_Augmented_2021__Tanycytes,0.46353950023754925,1.1731258810558223,0.15789473684210525,0.7109803776255537,1.0,28/69,22.83%,LRP4;PBX1;PLPPR4;PRDX6;NTM;CDH11;SHC2;ASXL3;GUCY1A2;PTPRD;COL11A1;RUNX1T1;FBXL7;COL25A1;MARK1;NFASC;CSRNP3;MAPK4;MAP6;CRMP1;MAP2;DCLK1;MEGF10;PRKG1;PRICKLE2;LRFN5;OPCML;PLPP3
prerank,GO_Biological_Process_2021__peptidyl-threonine dephosphorylation (GO:0035970),0.55283913272342,1.1725092860624322,0.30434782608695654,0.7120764285698319,1.0,2/15,2.07%,DUSP6;DUSP18
prerank,GO_Biological_Process_2021__regulation of leukocyte migration (GO:0002685),0.6917856874036626,1.1722844286940945,0.3023255813953488,0.7121715109284171,1.0,1/11,0.34%,ANXA1
prerank,GO_Biological_Process_2021__G protein-coupled glutamate receptor signaling pathway (GO:0007216),0.6779477319161225,1.1720093418830675,0.34782608695652173,0.712410427756317,1.0,7/9,27.39%,GRM5;HOMER1;GRM3;GRIK3;GRM1;HOMER2;GRM7
prerank,GO_Biological_Process_2021__positive regulation of cellular metabolic process (GO:0031325),0.4552605343728087,1.17155037132249,0.25,0.7131573011630811,1.0,10/64,7.76%,KLF4;IFNLR1;SCRIB;TGFBR2;STARD4;PPARG;RAB1B;TBC1D5;HPN;ACACB
prerank,CellMarker_Augmented_2021__Embryonic Stem cell:Undefined,-0.715607754349952,-1.1715080359785686,0.3387096774193548,0.687676723216803,1.0,3/7,18.52%,PECAM1;ITGA6;ITGB1
prerank,GO_Biological_Process_2021__carboxylic acid biosynthetic process (GO:0046394),0.7583988124654311,1.171364094009277,0.30434782608695654,0.7132033419730174,1.0,3/6,9.85%,CARNS1;UGDH;SLC35D1
prerank,GO_Biological_Process_2021__gonad development (GO:0008406),0.5604960053038951,1.1712529507867708,0.3333333333333333,0.7128950045845696,1.0,5/14,11.17%,WNT5A;WNT2B;KITLG;SALL1;NCOA4
prerank,GO_Biological_Process_2021__reverse cholesterol transport (GO:0043691),-0.7305716693038696,-1.1712354854241451,0.3409090909090909,0.6880692027512519,1.0,2/9,4.82%,LIPG;CLU
prerank,Reactome_2022__Loss Of MECP2 Binding Ability To NCoR/SMRT Complex R-HSA-9022537,0.6831277736918311,1.170992152539021,0.3404255319148936,0.713266493143832,1.0,2/7,21.59%,TBL1XR1;HDAC3
prerank,GO_Biological_Process_2021__ion transport (GO:0006811),0.4854332506137928,1.1709693870259628,0.18181818181818182,0.7127100489674161,1.0,18/59,15.33%,SLC1A3;SLC25A18;ATP10D;GLRA1;SLC1A2;LASP1;SLC15A4;SLC12A6;SLC9A1;WNK1;KCNN2;ANO6;SLC9A9;SLC12A5;SLC8A1;SLC24A2;SLC26A3;SLC12A2
prerank,PanglaoDB_Augmented_2021__Myoblasts,0.5087816182976909,1.1707682743359067,0.25,0.7128136186077966,1.0,7/44,5.20%,COL16A1;TPM2;FKBP9;COL5A2;ZBTB16;PHLDB1;TIMP3
prerank,Reactome_2022__Plasma Lipoprotein Clearance R-HSA-8964043,-0.6191745240474374,-1.1707357548396928,0.265625,0.6891007660559465,1.0,3/26,5.38%,UBC;RPS27A;NR1H2
prerank,GO_Biological_Process_2021__positive regulation of protein localization to Cajal body (GO:1904871),0.668299843125815,1.1705019237538115,0.3,0.7123717630397168,1.0,3/11,13.21%,MEPCE;TCP1;CCT3
prerank,GO_Biological_Process_2021__regulation of protein localization to Cajal body (GO:1904869),0.668299843125815,1.1705019237538115,0.3,0.7123717630397168,1.0,3/11,13.21%,MEPCE;TCP1;CCT3
prerank,KEGG_2021_Human__Ras signaling pathway,0.4139411492579413,1.1702349924587154,0.05555555555555555,0.7125134702923599,1.0,24/137,13.50%,PLA2G4C;PDGFA;RASA4B;IGF1R;TGFA;FGF2;GAB1;RAP1A;MAP2K1;RASAL2;PDGFC;RGL2;KITLG;SHC2;HGF;MAPK1;GRIN2B;ARF6;NF1;NTRK2;AFDN;GAB2;SHOC2;SYNGAP1
prerank,GO_Biological_Process_2021__nuclear export (GO:0051168),0.4584983025226389,1.1701652123362942,0.20689655172413793,0.7121217710633247,1.0,9/65,7.82%,NUTF2;NXF1;U2AF1;PKD1;NUP153;NUP188;NUP42;XPO1;RANBP3L
prerank,GO_Biological_Process_2021__positive regulation of cellular response to insulin stimulus (GO:1900078),0.6330869857296708,1.1700672219294475,0.35,0.7118638962654937,1.0,2/9,11.83%,SIRT1;SORL1
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Cartilage,-0.6492413083727784,-1.1700397499936055,0.2727272727272727,0.690759325844946,1.0,5/15,12.82%,TFRC;PECAM1;ITGA4;CD44;PTPRC
prerank,GO_Biological_Process_2021__mammary gland epithelial cell differentiation (GO:0060644),0.7197874507903483,1.1698698213218526,0.2564102564102564,0.7119581437640814,1.0,3/6,15.47%,ZNF703;ERBB4;AKT2
prerank,GO_Biological_Process_2021__positive regulation of cholesterol metabolic process (GO:0090205),0.6979868010858149,1.1698407530339956,0.3148148148148148,0.7114538823963693,1.0,2/5,22.61%,PRKAA1;SCAP
prerank,GO_Biological_Process_2021__regulation of neural precursor cell proliferation (GO:2000177),0.6664150868534949,1.1697263693196558,0.2926829268292683,0.7112256513730931,1.0,1/10,3.81%,LRRK2
prerank,GO_Biological_Process_2021__apical junction assembly (GO:0043297),-0.5934960241230954,-1.1695913839816863,0.23214285714285715,0.6917115760418052,1.0,3/25,5.65%,MPP7;CLDN7;PECAM1
prerank,GO_Biological_Process_2021__extracellular matrix disassembly (GO:0022617),0.5654503994557846,1.1694908801783999,0.15789473684210525,0.7113770816109669,1.0,7/27,9.60%,GSN;EXOC8;LCP1;CTSK;HPN;BMP1;MMP16
prerank,GO_Biological_Process_2021__limb morphogenesis (GO:0035108),0.622222415416818,1.1693725967804294,0.2222222222222222,0.711234554969082,1.0,4/12,13.48%,BMPR1B;PTCH1;MEGF8;NIPBL
prerank,GO_Biological_Process_2021__neuron cell-cell adhesion (GO:0007158),0.5765776623774526,1.1691483019081483,0.29545454545454547,0.7113478645839967,1.0,6/14,15.11%,CDK5R1;NLGN1;NRXN2;NCAM2;CNTN4;NLGN4Y
prerank,"Reactome_2022__Plasma Lipoprotein Assembly, Remodeling, And Clearance R-HSA-174824",-0.5901483534223209,-1.1689209441571988,0.23728813559322035,0.6933447240672725,1.0,5/44,5.38%,UBC;RPS27A;LIPG;PLTP;NR1H2
prerank,"GO_Biological_Process_2021__regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",0.48038547070026244,1.1689183909473033,0.12,0.7116123367572985,1.0,22/42,27.66%,KHDRBS2;KHDRBS3;RBFOX1;SRSF12;TRA2B;RBFOX2;THRAP3;HNRNPU;WTAP;CELF2;CELF5;PUF60;NOVA1;KHDRBS1;RNPS1;CELF1;MBNL1;RBM15;RBM5;MBNL3;HNRNPL;RBM8A
prerank,Reactome_2022__Transcription Of E2F Targets Under Negative Control By P107 (RBL1) And P130 (RBL2) In Complex With HDAC1 R-HSA-1362300,0.6369909725360405,1.168862705462459,0.3469387755102041,0.7111769700693078,1.0,3/10,22.03%,HDAC1;LIN52;E2F4
prerank,Reactome_2022__Metabolism Of Porphyrins R-HSA-189445,0.6287729282041871,1.1688477453198256,0.21428571428571427,0.7106195392681134,1.0,5/15,17.37%,FLVCR1;COX10;ALAD;SLCO2B1;ALAS1
prerank,GO_Biological_Process_2021__negative regulation of interleukin-6 production (GO:0032715),-0.6203277922611877,-1.168761925367819,0.31746031746031744,0.693438122852924,1.0,8/19,11.47%,NLRC3;CD200R1;LILRB4;NLRP12;TNFAIP3;SELENOS;NCKAP1L;C5AR2
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell apoptotic process (GO:0010665),0.7408349832710077,1.1685188952615888,0.3023255813953488,0.7109783205230125,1.0,2/5,12.30%,PPP1R10;BMPR1A
prerank,CellMarker_Augmented_2021__Vascular Smooth Muscle cell:Embryonic Stem Cell,0.5104349317672247,1.168184797467164,0.16129032258064516,0.711298807048704,1.0,4/37,3.17%,COL5A3;COL16A1;COL5A2;ACTA2
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Eye,-0.6785155745451164,-1.1681133289117058,0.24528301886792453,0.6948012135621338,1.0,7/12,24.18%,CLDN7;OVOL2;PKP2;CDS1;USP43;TOM1L1;EPB41L4B
prerank,Reactome_2022__Nef Mediated Downregulation Of MHC Class I Complex Cell Surface Expression R-HSA-164940,-0.7376760132776563,-1.1675725826325947,0.3508771929824561,0.696113639391261,1.0,1/7,2.81%,B2M
prerank,GO_Biological_Process_2021__positive regulation of T cell migration (GO:2000406),-0.6348855599402724,-1.1672835377328776,0.2641509433962264,0.6965644510887841,1.0,3/14,7.09%,CCL5;AIF1;STK39
prerank,CellMarker_Augmented_2021__Liver Stem cell:Fetal Liver,0.48764486216210484,1.16697706612851,0.1935483870967742,0.7141058988542102,1.0,18/45,18.51%,COL16A1;FKBP9;COL5A2;PHLDB1;NUAK1;CDH11;ITGAV;ENAH;COL6A1;TJP1;FBXL7;FERMT2;CD276;ANTXR1;RAI14;TNC;RBFOX2;SNX7
prerank,GO_Biological_Process_2021__skeletal system morphogenesis (GO:0048705),0.6116565435208657,1.1668634568830334,0.1891891891891892,0.7138303026373047,1.0,7/15,19.84%,RAB33B;FBN2;MEGF8;ANKRD11;TGFBR1;FGFR2;FGFR1
prerank,GO_Biological_Process_2021__negative regulation of cell aging (GO:0090344),0.6370880776432148,1.166781949167421,0.32608695652173914,0.7135175284297964,1.0,3/10,11.88%,SIRT1;MARCHF5;CDK6
prerank,GO_Biological_Process_2021__positive regulation of protein localization to cell surface (GO:2000010),-0.6917824603517326,-1.1666550947662422,0.24561403508771928,0.6979558294777093,1.0,1/10,0.78%,RIC3
prerank,GO_Biological_Process_2021__regulation of metal ion transport (GO:0010959),-0.701623703523481,-1.1666117297123626,0.3114754098360656,0.6976221073756846,1.0,2/14,6.56%,PLN;SRI
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Tendon,-0.658587385882613,-1.16656261557543,0.30158730158730157,0.6965039598600278,1.0,5/14,12.82%,TFRC;PECAM1;ITGA4;CD44;PTPRC
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Bone,-0.658587385882613,-1.16656261557543,0.30158730158730157,0.6965039598600278,1.0,5/14,12.82%,TFRC;PECAM1;ITGA4;CD44;PTPRC
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Muscle,-0.658587385882613,-1.16656261557543,0.30158730158730157,0.6965039598600278,1.0,5/14,12.82%,TFRC;PECAM1;ITGA4;CD44;PTPRC
prerank,GO_Biological_Process_2021__negative regulation of ossification (GO:0030279),-0.6577548594151267,-1.1664206947895188,0.31746031746031744,0.6965949534593512,1.0,4/13,10.69%,CCL3;SRGN;RBPJ;TRPM4
prerank,Reactome_2022__Ion Channel Transport R-HSA-983712,-0.49759352151424663,-1.1663851318745442,0.1951219512195122,0.6962738926219333,1.0,16/106,10.69%,UBC;PLN;RPS27A;MCOLN2;SLC9B1;ATP6V1F;ATP10A;SRI;ATP13A1;SGK1;CALM1;CLCA4;TRPV4;TRPM3;BEST1;TRPM4
prerank,Reactome_2022__G1/S DNA Damage Checkpoints R-HSA-69615,-0.5405347311426895,-1.1662838090563148,0.25,0.6957520313315967,1.0,10/53,12.85%,UBC;RPS27A;CARD16;PSMB3;PSMB6;PSMA7;PSMB9;PSMD12;PSMD8;PSMA5
prerank,Reactome_2022__p53-Dependent G1 DNA Damage Response R-HSA-69563,-0.5405347311426895,-1.1662838090563148,0.25,0.6957520313315967,1.0,10/53,12.85%,UBC;RPS27A;CARD16;PSMB3;PSMB6;PSMA7;PSMB9;PSMD12;PSMD8;PSMA5
prerank,GO_Biological_Process_2021__aorta morphogenesis (GO:0035909),-0.7545959996316146,-1.1662009680762857,0.30158730158730157,0.6956106029224728,1.0,2/7,8.45%,MYLK;RBPJ
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transmembrane transporter activity (GO:1901021),0.6069035231204595,1.1661229479864712,0.2702702702702703,0.7148217369871369,1.0,2/13,8.90%,PKD2;SLC9A1
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte activation (GO:0051251),-0.6355603802649173,-1.166095349648022,0.21666666666666667,0.6955612687267336,1.0,8/20,16.72%,PRKCQ;ZNF335;NCKAP1L;TYROBP;CD47;NOD2;HLA-DPA1;HLA-DPB1
prerank,GO_Biological_Process_2021__signal transduction by p53 class mediator (GO:0072331),0.5404431077366825,1.1660557344288156,0.3023255813953488,0.714395981269309,1.0,7/26,18.30%,ACER2;BOK;FHIT;SESN2;ZNF385B;BATF;NBN
prerank,GO_Biological_Process_2021__peptidyl-serine phosphorylation (GO:0018105),0.4184819119314803,1.1660315941849777,0.21052631578947367,0.7138676981954112,1.0,34/133,18.20%,CDK5R1;TGFBR2;CSNK1G1;STK32B;PKD1;LRRK2;RPS6KA4;TLK1;MAST2;CAB39;NLK;MAP3K10;STK38L;BRSK1;MAST3;PLK2;DYRK1A;WNK1;RPS6KA6;MAPK1;CAMKV;MAPKAPK2;CSNK1E;PRKCI;MARK1;MAP3K13;TGFBR1;AKT2;GSK3B;RPS6KB2;STK32C;PRKX;MAP2K2;MARK2
prerank,CellMarker_Augmented_2021__Cardiomyocyte:Undefined,0.4429790985955485,1.1657395347326045,0.23809523809523808,0.7139590446405749,1.0,34/93,32.09%,CEP350;UBR3;SCAF8;ZNF451;UBN2;NIPBL;CSPP1;ANKRD17;TRIP12;SCAF11;CLASP2;BRWD1;ALMS1;UBR1;CEP290;HOOK3;TTC3;ANKRD36;PCM1;TPR;BDP1;NHLRC2;TTBK2;REV3L;PIKFYVE;KIDINS220;BCLAF1;UBR5;NEK1;PDS5B;SENP6;ZNF638;CCP110;PHIP
prerank,GO_Biological_Process_2021__regulation of proteolysis (GO:0030162),0.5335430571406687,1.1656247874768182,0.1935483870967742,0.713741103179056,1.0,6/28,13.44%,RNF139;SERPINE2;SPOPL;BTRC;FBXW11;BAG6
prerank,GO_Biological_Process_2021__negative regulation of innate immune response (GO:0045824),-0.6198720842235479,-1.1656043661399138,0.2459016393442623,0.6969602901993915,1.0,8/29,13.78%,OAS3;NLRC3;DHX58;NLRC5;TNFAIP3;OAS1;A2M;SERPING1
prerank,GO_Biological_Process_2021__acylglycerol homeostasis (GO:0055090),-0.6576624683613703,-1.1655678365928206,0.25862068965517243,0.6967211769437789,1.0,1/10,3.27%,RORA
prerank,GO_Biological_Process_2021__extracellular structure organization (GO:0043062),0.46926667762358004,1.1654413976399265,0.25,0.713617115685328,1.0,26/93,13.53%,COL5A3;MMP17;COL16A1;PDGFA;NCAN;SERPINE1;COL5A2;FGF2;TEX14;COL24A1;DAG1;SLC39A8;ADAMTSL2;RECK;TNR;ADAMTS17;FBN2;ADAMTSL3;MMP16;ITGAV;COL11A1;NF1;ITGA2;COL6A1;JAM2;COL15A1
prerank,Reactome_2022__Beta-oxidation Of Very Long Chain Fatty Acids R-HSA-390247,-0.7317402292731363,-1.1652643564014669,0.37735849056603776,0.6972110290541037,1.0,2/7,14.14%,ACAA1;ECI2
prerank,Reactome_2022__FGFR3 Ligand Binding And Activation R-HSA-190239,-0.7156146768836573,-1.1651578022438516,0.2962962962962963,0.697133883713752,1.0,3/6,19.30%,FGF13;FGF20;GALNT3
prerank,CellMarker_Augmented_2021__Neuron:Embryonic Prefrontal Cortex,-0.7274608714815731,-1.1649813253405557,0.34,0.6972616950909436,1.0,1/6,2.81%,B2M
prerank,"GO_Biological_Process_2021__regulation of complement activation, classical pathway (GO:0030450)",-0.7926518006073593,-1.1648257971583338,0.2807017543859649,0.6973246983621507,1.0,1/5,1.64%,CD55
prerank,GO_Biological_Process_2021__long-term synaptic depression (GO:0060292),0.6608581437109522,1.1644024304293945,0.3673469387755102,0.7163178950821948,1.0,4/7,14.30%,SHANK2;PLK2;PRRT1;SLC24A2
prerank,Reactome_2022__Negative Regulation Of FGFR1 Signaling R-HSA-5654726,-0.6135235184884669,-1.164302818965096,0.288135593220339,0.6984376494702224,1.0,3/22,6.76%,UBC;RPS27A;FGF13
prerank,GO_Biological_Process_2021__nucleoside diphosphate metabolic process (GO:0009132),-0.7300179761186549,-1.164227827294347,0.2857142857142857,0.698209273791006,1.0,3/8,11.98%,CMPK2;ENTPD4;ENTPD5
prerank,GO_Biological_Process_2021__negative regulation of lymphocyte proliferation (GO:0050672),-0.6234340484027842,-1.1641252105275053,0.26865671641791045,0.6981532764515604,1.0,5/23,11.20%,IL4I1;MNDA;LILRB4;GLMN;TYROBP
prerank,Reactome_2022__Signaling By NTRK2 (TRKB) R-HSA-9006115,0.590992485100603,1.1639812987785576,0.2702702702702703,0.7167714532070226,1.0,2/17,1.30%,PIGU;CDK5R1
prerank,GO_Biological_Process_2021__angiotensin-activated signaling pathway (GO:0038166),0.7809096236601246,1.1637991930476954,0.3333333333333333,0.7166826871357656,1.0,2/5,13.97%,CA2;AHCYL1
prerank,GO_Biological_Process_2021__calcium ion-regulated exocytosis of neurotransmitter (GO:0048791),-0.7423355371980576,-1.163797415843615,0.2545454545454545,0.6986348565158965,1.0,1/7,1.34%,RIMS1
prerank,GO_Biological_Process_2021__positive regulation of protein processing (GO:0010954),0.6583538178665198,1.1637384523132723,0.275,0.7163141509373772,1.0,2/10,6.57%,GSN;HPN
prerank,GO_Biological_Process_2021__cardiac epithelial to mesenchymal transition (GO:0060317),-0.7258472115955146,-1.1633749611728197,0.3137254901960784,0.6994489210537104,1.0,3/9,14.83%,TGFBR3;RBPJ;SPRY1
prerank,GO_Biological_Process_2021__cellular response to hexose stimulus (GO:0071331),0.5261115637158276,1.1631771060097684,0.35294117647058826,0.717615011472811,1.0,9/19,19.09%,IGF1R;SLC39A14;UNC13B;SOX4;PCK2;PRKAA1;TRA2B;ZBTB20;KCNB1
prerank,GO_Biological_Process_2021__regulation of superoxide anion generation (GO:0032928),-0.688214405925403,-1.1628166250903595,0.265625,0.7008794178493345,1.0,4/11,13.37%,GSTP1;ITGB2;TYROBP;SOD1
prerank,GO_Biological_Process_2021__regulation of type I interferon production (GO:0032479),-0.5114463554314304,-1.1624297284158658,0.25,0.7018145854056078,1.0,7/71,11.42%,GAPDH;DHX58;CD14;NLRC5;TNFAIP3;IRF1;STING1
prerank,Reactome_2022__MyD88:MAL(TIRAP) Cascade Initiated On Plasma Membrane R-HSA-166058,-0.4950177199765462,-1.1623695284279465,0.1780821917808219,0.7015689297213222,1.0,7/91,4.18%,CD36;UBC;SIGIRR;FOS;RPS27A;BTK;NDUFA2
prerank,Reactome_2022__Syndecan Interactions R-HSA-3000170,-0.613456523349409,-1.1623103208047054,0.3064516129032258,0.7013503616518982,1.0,4/14,11.54%,TRAPPC4;FGF13;ITGA6;SDC3
prerank,GO_Biological_Process_2021__positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),0.5080276894267013,1.1622860375325557,0.2727272727272727,0.7197149246212968,1.0,9/41,15.36%,ACVR2A;UBE2O;GDF11;SMAD2;BMPR1B;BMPR1A;TWSG1;TGFBR1;KIAA0319
prerank,GO_Biological_Process_2021__regulation of cytoplasmic translation (GO:2000765),0.6373910545159994,1.1621168325849645,0.36363636363636365,0.7195682428221523,1.0,3/11,18.57%,CPEB4;ZNF385A;CPEB2
prerank,GO_Biological_Process_2021__integrated stress response signaling (GO:0140467),0.6358796927030912,1.1621064340314413,0.37209302325581395,0.7190683714755913,1.0,2/11,9.03%,DDIT3;EIF2S1
prerank,GO_Biological_Process_2021__positive regulation of heterotypic cell-cell adhesion (GO:0034116),-0.7474744587233889,-1.1620789972648757,0.39285714285714285,0.7016087331948438,1.0,2/8,8.71%,SKAP1;CD44
prerank,Reactome_2022__CD209 (DC-SIGN) Signaling R-HSA-5621575,-0.6046905870736199,-1.162066299442978,0.26666666666666666,0.7012512287346544,1.0,1/14,7.36%,FYN
prerank,GO_Biological_Process_2021__organophosphate ester transport (GO:0015748),-0.6240657944959183,-1.1620364197072084,0.36363636363636365,0.7009369451760243,1.0,4/21,9.06%,OSBPL5;PRELID1;PLTP;PCTP
prerank,PanglaoDB_Augmented_2021__Pericytes,0.5048647473174184,1.1619765196937955,0.3055555555555556,0.7188109207357547,1.0,7/47,8.39%,COL16A1;SVEP1;COL5A2;ACTA2;TIMP3;LHFPL6;CDH11
prerank,GO_Biological_Process_2021__positive regulation of fibroblast apoptotic process (GO:2000271),-0.7923110375372264,-1.1619193343253202,0.28,0.700858277170577,1.0,3/5,19.87%,BTG1;STK17B;PRDM11
prerank,Reactome_2022__Negative Regulation Of FGFR2 Signaling R-HSA-5654727,-0.620760827495549,-1.161914722109773,0.21428571428571427,0.7004484200329691,1.0,3/21,6.76%,UBC;RPS27A;FGF13
prerank,GO_Biological_Process_2021__regulation of hematopoietic progenitor cell differentiation (GO:1901532),-0.5246998954437111,-1.1618987693947076,0.28,0.7000604086205421,1.0,17/59,22.96%,PSMB3;EIF2AK2;PSMB6;PSMA7;PSMB9;TCF3;PSMD12;PSMD8;PSMA5;SETD1A;PSMA3;PSMC4;PSME2;PSME1;PSMB5;PSMC3;PSME3
prerank,Reactome_2022__Viral Messenger RNA Synthesis R-HSA-168325,0.45653916915980536,1.1618592880627105,0.15151515151515152,0.7186467382895088,1.0,4/41,7.20%,POLR2D;NUP153;NUP188;NUP42
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway (GO:1903377),-0.7377110226469814,-1.1616235604560659,0.2857142857142857,0.7004253649573023,1.0,3/5,22.45%,HIF1A;PINK1;PARK7
prerank,CellMarker_Augmented_2021__Neutrophil:Peripheral Blood,-0.7190904526954984,-1.1613483571402052,0.3050847457627119,0.7009285680347086,1.0,5/8,16.96%,CD14;IL3RA;ITGA4;FPR1;FCGR3A
prerank,GO_Biological_Process_2021__negative regulation of sodium ion transport (GO:0010766),0.6959857411368223,1.1607999691247013,0.3333333333333333,0.721238504515315,1.0,4/7,25.84%,NEDD4L;WNK1;NEDD4;CAMK2D
prerank,"KEGG_2021_Human__Alanine, aspartate and glutamate metabolism",-0.6081180007162789,-1.160774848696387,0.2571428571428571,0.7020655214853988,1.0,3/22,5.41%,IL4I1;NIT2;GLUL
prerank,GO_Biological_Process_2021__peptidyl-serine dephosphorylation (GO:0070262),-0.6312066455875557,-1.1606452775212106,0.3387096774193548,0.702039740497441,1.0,1/13,1.54%,DUSP1
prerank,"GO_Biological_Process_2021__wound healing, spreading of cells (GO:0044319)",-0.642489521249524,-1.1605260469375345,0.24074074074074073,0.7020139899474857,1.0,3/18,3.99%,FLNA;COL5A1;PLET1
prerank,Reactome_2022__Synthesis Of Glycosylphosphatidylinositol (GPI) R-HSA-162710,0.6372744975518638,1.160412760739535,0.32432432432432434,0.7216196426277603,1.0,1/13,0.08%,PIGQ
prerank,GO_Biological_Process_2021__negative chemotaxis (GO:0050919),0.5693922972718797,1.1603838584985522,0.22580645161290322,0.721147918339244,1.0,4/19,10.85%,PDGFA;SEMA3B;ROBO1;ITGAV
prerank,Reactome_2022__Phospholipase C-mediated Cascade; FGFR3 R-HSA-5654227,-0.705447445687796,-1.160184002077868,0.35,0.7026108498288424,1.0,2/6,14.45%,FGF13;FGF20
prerank,GO_Biological_Process_2021__bile acid biosynthetic process (GO:0006699),-0.6535139616174014,-1.1601082738391393,0.28846153846153844,0.7024305691810079,1.0,1/15,0.88%,CH25H
prerank,GO_Biological_Process_2021__cytoplasmic sequestering of protein (GO:0051220),-0.6385374452212957,-1.1599347089061842,0.38333333333333336,0.7025215622129717,1.0,1/10,0.28%,FLNA
prerank,GO_Biological_Process_2021__negative regulation of phagocytosis (GO:0050765),-0.6262933335410442,-1.1597971459261731,0.35714285714285715,0.7025168357478447,1.0,5/14,12.25%,RACK1;CD300LF;PLSCR1;APPL1;CD47
prerank,Reactome_2022__Diseases Of Carbohydrate Metabolism R-HSA-5663084,-0.6254272083433493,-1.1597695949314086,0.3,0.7021511253442251,1.0,3/20,6.17%,UBC;RPS27A;G6PC3
prerank,GO_Biological_Process_2021__regulation of blood circulation (GO:1903522),-0.6344782471013514,-1.1597069512584806,0.35714285714285715,0.7019821504051278,1.0,3/15,6.56%,PLN;PER2;SRI
prerank,GO_Biological_Process_2021__negative regulation of establishment of protein localization to mitochondrion (GO:1903748),0.7313864984295718,1.1597033595968713,0.2926829268292683,0.7227133292390219,1.0,1/5,3.81%,LRRK2
prerank,"Reactome_2022__Platelet Activation, Signaling And Aggregation R-HSA-76002",-0.4801461533946618,-1.1595069260064035,0.21333333333333335,0.7021050076463685,1.0,20/172,8.69%,FLNA;CD36;SRGN;PRKCQ;F8;MGLL;VAV3;FCER1G;CLU;GNB5;PLEK;F13A1;IGF1;CD63;PECAM1;SELENOP;FYN;CALM1;FERMT3;TMSB4X
prerank,GO_Biological_Process_2021__lipoprotein localization (GO:0044872),-0.7324013840032841,-1.1593419929561521,0.36,0.7022224212076027,1.0,1/8,0.52%,CD36
prerank,GO_Biological_Process_2021__positive regulation of T-helper 1 type immune response (GO:0002827),-0.773416766320151,-1.1589220368872437,0.37735849056603776,0.7029540560982339,1.0,3/5,17.61%,SLC11A1;IL18R1;IL18
prerank,CellMarker_Augmented_2021__B cell:Kidney,-0.4380124795746755,-1.1588542177657906,0.1276595744680851,0.7027638342421457,1.0,67/462,12.41%,H4C3;DDX11;RPS13;TPD52;RIC3;CD37;CXCR4;GPR183;CD55;NFKBID;RNASET2;CD69;SIDT2;PARP14;STAG3;RPS11;SIDT1;SELL;PLEKHG1;TAF1D;FAM177B;BTK;PARP15;AIM2;GTF2H5;COCH;NCF4;UQCRH;METTL17;ING5;GNB5;SP110;JUP;HLA-DRB5;IGF1;BASP1;TIPIN;TNFAIP8;MSL3;SP140;ODC1;EXOSC10;TTN;OAS1;CCDC191;LSM7;MTCH2;GPC3;EFHC1;BANK1;NSA2;SMDT1;ABCB4;NPM1;HLA-DRA;PTGES2;ABCB9;SLC35F2;IFNGR2;APPL1;TCF3;MCEE;AKAP12;SMIM14;CYFIP2;PIM3;DGKD
prerank,GO_Biological_Process_2021__regulation of stem cell proliferation (GO:0072091),-0.707050095500911,-1.1588339640510297,0.27586206896551724,0.7024045559164241,1.0,2/8,12.82%,EIF2AK2;PTPRC
prerank,GO_Biological_Process_2021__negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),-0.5596060536830807,-1.158787434751332,0.26153846153846155,0.7021355758601976,1.0,7/31,9.56%,NLRC3;RORA;LILRB4;GSTP1;NLRP12;TNFAIP3;STAT1
prerank,GO_Biological_Process_2021__positive regulation of interferon-beta production (GO:0032728),-0.5852673845737758,-1.1586990195904117,0.265625,0.7019990056940293,1.0,9/31,17.04%,OAS3;DHX58;OAS2;OAS1;IRF1;STING1;POLR3C;FLOT1;IRF7
prerank,KEGG_2021_Human__MicroRNAs in cancer,0.42230266214171425,1.1586983718094228,0.17857142857142858,0.7250069226414313,1.0,19/110,11.88%,PDGFA;SPRY2;SIRT1;E2F3;MAP2K1;TIMP3;FZD3;PIM1;RECK;CRK;TNR;SOX4;CCNG1;MMP16;MDM2;HDAC1;MAPK1;PTEN;CDK6
prerank,CellMarker_Augmented_2021__Stem cell:Muscle,-0.6833458418822226,-1.1586051508228936,0.30158730158730157,0.7018942796225123,1.0,2/8,8.71%,CXCR4;CD44
prerank,GO_Biological_Process_2021__negative regulation of telomerase activity (GO:0051974),0.6936113226323544,1.1585022027105576,0.3958333333333333,0.7250141985822014,1.0,1/5,10.90%,ERCC4
prerank,Reactome_2022__Golgi Cisternae Pericentriolar Stack Reorganization R-HSA-162658,0.6774196410819553,1.1578340327975276,0.29411764705882354,0.726702104740953,1.0,3/10,11.38%,RAB1B;BLZF1;MAPK1
prerank,GO_Biological_Process_2021__negative regulation of fatty acid biosynthetic process (GO:0045717),0.6276195447751389,1.1577376742749117,0.2857142857142857,0.7264127634874982,1.0,2/10,11.26%,SIRT1;ACADVL
prerank,GO_Biological_Process_2021__positive regulation of sodium ion transmembrane transporter activity (GO:2000651),0.6597287027680018,1.157673713284075,0.3170731707317073,0.725967145422846,1.0,4/11,22.31%,SLC9A1;WNK1;CHP1;GLRX
prerank,GO_Biological_Process_2021__cyclic-nucleotide-mediated signaling (GO:0019935),-0.606107282705356,-1.1576170646868755,0.26229508196721313,0.7045023656638792,1.0,1/23,0.52%,CD36
prerank,CellMarker_Augmented_2021__Cytotrophoblast:Placenta,0.5197626222314775,1.1576049269390083,0.20689655172413793,0.7256143558507678,1.0,7/28,8.39%,COL16A1;SVEP1;COL5A2;WNT5A;TIMP3;JAG1;CDH11
prerank,GO_Biological_Process_2021__glycoprotein biosynthetic process (GO:0009101),0.4573216478984352,1.1575819479927676,0.18421052631578946,0.7251240468226701,1.0,7/48,9.81%,B3GNT2;CSGALNACT1;LARGE1;B4GALT7;CANT1;FUT9;BMPR1B
prerank,Reactome_2022__Fanconi Anemia Pathway R-HSA-6783310,-0.6096926689585352,-1.1575273838751674,0.234375,0.7044173962050684,1.0,7/24,14.82%,UBC;RPS27A;MUS81;WDR48;RPA3;FANCB;UBA52
prerank,GO_Biological_Process_2021__protein glycosylation (GO:0006486),0.4592689626233289,1.1574081727970067,0.18518518518518517,0.7250116237666796,1.0,26/86,19.25%,B3GNT2;LARGE1;MGAT4C;SLC39A8;B4GALT7;GFPT1;FUT9;POGLUT1;GALNT7;FKTN;STT3B;MGAT5;GALNT1;EOGT;ST8SIA4;ALG12;GALNT2;COG3;ST8SIA5;GCNT2;TMEM165;ALG8;B4GALT5;ALG3;NUS1;MAGT1
prerank,KEGG_2021_Human__Base excision repair,-0.608865398597624,-1.1573786121574652,0.2903225806451613,0.7044432262468887,1.0,6/21,15.20%,SMUG1;POLE3;OGG1;PARP2;APEX1;PARP4
prerank,Reactome_2022__Diseases Associated With Glycosaminoglycan Metabolism R-HSA-3560782,0.5227522896102701,1.1567167738216582,0.3125,0.7262779680220152,1.0,5/20,12.44%,NCAN;CSPG5;B4GALT7;EXT1;GPC6
prerank,GO_Biological_Process_2021__regulation of MHC class II biosynthetic process (GO:0045346),0.6988773877541384,1.156608638708161,0.25925925925925924,0.7259719623263573,1.0,1/7,2.51%,SIRT1
prerank,GO_Biological_Process_2021__positive regulation of establishment of protein localization (GO:1904951),0.6080623992767943,1.1564700423229086,0.2619047619047619,0.7258774894397053,1.0,6/16,18.80%,TCP1;TNF;CCT3;CEP120;CHP1;CEP135
prerank,GO_Biological_Process_2021__apoptotic process (GO:0006915),-0.46597930081557776,-1.1563889015413102,0.22784810126582278,0.7069240809394312,1.0,30/160,13.87%,PPP1R15A;MX1;CD2;GAPDH;CXCR4;DDIT4;CSRNP1;TNFRSF25;CD14;GZMB;PRF1;IER3;BNIP2;SEMA6A;PLSCR1;HK2;IFIT2;EGLN3;CFLAR;BCL2L14;IRF1;ITGB2;ING4;BNIP1;GLRX2;CYFIP2;TRAF7;BMF;CASP5;NOTCH2
prerank,GO_Biological_Process_2021__DNA ligation (GO:0006266),0.6763662017900377,1.1563600709630513,0.35714285714285715,0.7255539425391523,1.0,2/7,13.61%,LIG4;MGMT
prerank,GO_Biological_Process_2021__positive regulation of myeloid leukocyte mediated immunity (GO:0002888),-0.713431960774767,-1.156337530347407,0.3404255319148936,0.7066482963919507,1.0,4/8,22.26%,ITGB2;TYROBP;STX4;CAMK4
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902253),-0.7050046544595774,-1.1562401332272307,0.38,0.7066096331216493,1.0,3/7,10.01%,PTTG1IP;RPS7;EIF5A
prerank,GO_Biological_Process_2021__positive regulation of MAP kinase activity (GO:0043406),0.5114286540265979,1.1561905345767554,0.2647058823529412,0.7255698872106233,1.0,12/43,9.91%,PDGFA;FGF2;MAP3K11;LRRK2;NEK10;PDGFC;TNF;ROBO1;DVL3;MAP3K10;IRAK1;SASH1
prerank,Reactome_2022__ChREBP Activates Metabolic Gene Expression R-HSA-163765,0.7239750259551007,1.1561018607135596,0.3090909090909091,0.7251830087555899,1.0,3/6,18.18%,ACACB;FASN;ACACA
prerank,GO_Biological_Process_2021__base-excision repair (GO:0006284),-0.5607867245695212,-1.1559349415900178,0.26153846153846155,0.7071758162937606,1.0,8/34,18.09%,SMUG1;XPA;OGG1;PARG;APEX1;RPA3;RFC1;WRN
prerank,GO_Biological_Process_2021__positive regulation of vascular endothelial growth factor production (GO:0010575),-0.6281162306316359,-1.1558128037511326,0.25806451612903225,0.7071789392925433,1.0,5/14,14.85%,RORA;SULF2;HIF1A;BRCA1;C3
prerank,GO_Biological_Process_2021__regulation of protein-containing complex assembly (GO:0043254),-0.498930473379869,-1.1557983467588968,0.2625,0.7067933354516293,1.0,13/85,12.96%,CD36;TFRC;WARS1;MPP7;RACK1;CLU;RPS3;NAPA;EIF2AK2;VEGFA;ANKRA2;NOP53;BMF
prerank,KEGG_2021_Human__Hepatocellular carcinoma,0.4305636445389312,1.155793446805812,0.2,0.7252998400299769,1.0,22/104,11.88%,IGF1R;TGFBR2;TGFA;GAB1;ARID1A;TCF7L1;DPF3;E2F3;MAP2K1;WNT5A;FZD3;GSTA4;SMAD2;SMAD3;WNT2B;DVL3;SHC2;HGF;TCF7L2;MAPK1;PTEN;CDK6
prerank,GO_Biological_Process_2021__positive regulation of fibroblast proliferation (GO:0048146),0.5383962477032994,1.1556571522919883,0.14634146341463414,0.7250874429375681,1.0,4/18,7.13%,PDGFA;WNT5A;PDGFC;LIG4
prerank,Reactome_2022__Gene And Protein Expression By JAK-STAT Signaling After Interleukin-12 Stimulation R-HSA-8950505,-0.5816801652029322,-1.1555685831301408,0.28125,0.707148424672988,1.0,7/26,15.40%,STAT4;ANXA2;AURKAIP1;RPLP0;SOD1;SNRPA1;TALDO1
prerank,GO_Biological_Process_2021__regulation of voltage-gated calcium channel activity (GO:1901385),-0.6593186711460013,-1.1555539915805928,0.3392857142857143,0.7067790279344401,1.0,5/12,21.19%,GNB5;SRI;NOS1AP;CACNB1;AHNAK
prerank,GO_Biological_Process_2021__histone H4-K12 acetylation (GO:0043983),-0.7558698765381404,-1.155299653150024,0.3076923076923077,0.7071913949737348,1.0,1/6,11.60%,ING4
prerank,Reactome_2022__Reversal Of Alkylation Damage By DNA Dioxygenases R-HSA-73943,0.6913700804983328,1.1551065538445424,0.32558139534883723,0.7262179266106302,1.0,3/6,22.91%,ASCC1;ALKBH5;FTO
prerank,GO_Biological_Process_2021__nucleoside triphosphate metabolic process (GO:0009141),-0.7608827238919044,-1.1550059421347445,0.28125,0.7076766540934261,1.0,2/7,8.26%,CMPK2;ENPP3
prerank,GO_Biological_Process_2021__regulation of nitric oxide mediated signal transduction (GO:0010749),-0.7370113180924874,-1.154857928981482,0.35714285714285715,0.7077842306357517,1.0,4/5,25.87%,VEGFA;NOS1AP;ATP2B4;EGFR
prerank,Reactome_2022__NrCAM Interactions R-HSA-447038,0.8015224786418147,1.1548465445680318,0.32432432432432434,0.7264979378700444,1.0,1/5,1.34%,CNTN2
prerank,Reactome_2022__Sialic Acid Metabolism R-HSA-4085001,0.5516951822345305,1.1548007716828794,0.23809523809523808,0.7260662534198056,1.0,7/22,17.01%,ST6GAL2;GLB1;ST6GALNAC3;ST6GALNAC5;NANS;ST8SIA4;ST8SIA5
prerank,GO_Biological_Process_2021__positive regulation of dendrite morphogenesis (GO:0050775),0.5498941991252798,1.154639554840106,0.26,0.7259814831489347,1.0,4/16,17.29%,RELN;PTPRD;CAPRIN2;IL1RAPL1
prerank,GO_Biological_Process_2021__chloride transport (GO:0006821),0.48897712059678494,1.154463121117288,0.25,0.7259787852740176,1.0,20/42,22.93%,SLC1A3;GLRA1;ANO8;ANO4;GABRR2;SLC12A6;ANO6;SLC12A5;ANO3;SLC12A2;GABRD;TTYH1;CLCN3;GABRB2;GABRG3;GABRA4;SLC4A8;GABRA2;TTYH3;GLRB
prerank,KEGG_2021_Human__Amyotrophic lateral sclerosis,-0.4582646287986317,-1.154452228916479,0.19047619047619047,0.7085879005553893,1.0,67/261,18.32%,TUBB8;CYCS;DNAH11;GABARAPL1;COX7C;PSMB3;UQCRB;NDUFC1;NDUFA2;UQCRH;NDUFA1;NEFM;CHCHD10;ADRM1;NDUFB9;ATP5PD;NDUFA12;ATP5F1E;NEFL;PSMB6;NDUFB4;PSMA7;UQCR10;ATG2A;ACTG1;TNFRSF1B;COX4I1;COX5B;DNAH17;GABARAPL2;NDUFB1;NDUFS8;DCTN6;ACTB;NDUFS5;NUP50;DCTN4;DNAH1;PSMD12;PFN1;DNAH12;COX7A2;PSMD8;PSMA5;COX6C;SRSF7;SOD1;TOMM40;TUBB4B;GPX1;NDUFS6;NDUFB7;WIPI1;SEC13;UQCRC1;RAC1;NDUFB3;PSMA3;UQCRQ;DNAH9;ATP5F1C;PINK1;NUP88;PSMC4;DCTN2;NDUFS7;NDUFA3
prerank,GO_Biological_Process_2021__mRNA export from nucleus (GO:0006406),0.4275421842731947,1.1542454358206828,0.2,0.7260124809342607,1.0,9/85,7.20%,POLR2D;NXF1;U2AF1;CPSF4;FYTTD1;NUP153;NUP188;WDR33;NUP42
prerank,CellMarker_Augmented_2021__Basophil:Undefined,-0.6059983627381929,-1.1541435464164531,0.27692307692307694,0.709155212215265,1.0,9/18,12.82%,CD69;IL3RA;CD63;C5AR1;ENPP3;CD44;ITGAL;IL18R1;PTPRC
prerank,GO_Biological_Process_2021__positive regulation of intracellular signal transduction (GO:1902533),-0.45144649106378365,-1.1539777140802587,0.19318181818181818,0.709246058569524,1.0,31/347,8.41%,CCL4;CALCR;FLNA;PLEKHG5;CCL3;GAPDH;TFRC;CCL5;CARD16;PDGFD;TRIM5;DHX58;RPS15;CD14;RPS20;RACK1;RPL37;TNFSF10;RPS3;RPL23;IGF1;FIS1;LAMTOR5;TRIM22;PHB2;EIF2AK2;FYN;THEM4;NLRP12;LURAP1;PRKD2
prerank,GO_Biological_Process_2021__meiosis I (GO:0007127),-0.6753029283693858,-1.1538671665401428,0.3225806451612903,0.7091748052782113,1.0,2/10,5.07%,MYBL1;MOV10L1
prerank,Reactome_2022__Signaling By TGFB Family Members R-HSA-9006936,0.41217149342546194,1.1532961295999131,0.14814814814814814,0.7282732314927928,1.0,23/83,15.71%,UBE2D1;ACVR2A;SERPINE1;SMAD1;TGFBR2;SMAD7;PARP1;SMAD2;SMAD3;XPO1;LTBP3;NEDD4L;BMPR1B;HDAC1;ITGAV;MAPK1;BMPR1A;SRFBP1;SMURF1;TGFBR1;PPM1A;TGIF1;PARD3
prerank,GO_Biological_Process_2021__cellular response to angiotensin (GO:1904385),0.6871664589569444,1.1529605025445733,0.3023255813953488,0.7285321650173403,1.0,2/7,13.97%,CA2;AHCYL1
prerank,GO_Biological_Process_2021__cardiac ventricle development (GO:0003231),0.6515584103833574,1.1528430103194525,0.2978723404255319,0.7284458043568719,1.0,4/7,27.02%,SALL1;TMEM65;NOTCH1;PDE2A
prerank,GO_Biological_Process_2021__negative regulation of T cell activation (GO:0050868),-0.6096876746555228,-1.1528183983153426,0.3230769230769231,0.7119760640861172,1.0,5/26,10.76%,IL4I1;RIPOR2;LILRB4;GLMN;NCKAP1L
prerank,KEGG_2021_Human__Fructose and mannose metabolism,0.5978094967287166,1.15281831339515,0.37209302325581395,0.7279877486090236,1.0,2/17,1.17%,PFKP;PFKM
prerank,GO_Biological_Process_2021__regulation of cellular protein metabolic process (GO:0032268),0.4780763438459919,1.1527703037163117,0.20588235294117646,0.727566653074462,1.0,1/35,0.08%,KLF4
prerank,GO_Biological_Process_2021__regulation of vascular endothelial growth factor production (GO:0010574),-0.6256631549183451,-1.1525766411639076,0.25757575757575757,0.7121903901292619,1.0,5/15,14.85%,RORA;SULF2;HIF1A;BRCA1;C3
prerank,Reactome_2022__Frs2-mediated Activation R-HSA-170968,0.6264245149275014,1.1524778098357387,0.2708333333333333,0.7278343857637473,1.0,5/10,21.85%,RAP1A;MAP2K1;MAPK1;MAP2K2;FRS2
prerank,GO_Biological_Process_2021__male meiosis I (GO:0007141),-0.7379191801042919,-1.1524413095967894,0.3157894736842105,0.7122375383953542,1.0,2/6,5.07%,MYBL1;MOV10L1
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Tooth,-0.794927833783025,-1.1523279743880197,0.234375,0.7121647206724455,1.0,2/6,8.60%,TFRC;ITGA6
prerank,CellMarker_Augmented_2021__Monocyte Derived Dendritic cell:Peripheral Blood,-0.7251784958626267,-1.1521639928642713,0.3333333333333333,0.7122639346010516,1.0,2/7,5.12%,CD14;IL3RA
prerank,GO_Biological_Process_2021__glycosyl compound catabolic process (GO:1901658),-0.7383417363704986,-1.1517977433850064,0.31746031746031744,0.7126181544854355,1.0,1/6,5.40%,GLA
prerank,GO_Biological_Process_2021__glycoside metabolic process (GO:0016137),-0.7383417363704986,-1.1517977433850064,0.31746031746031744,0.7126181544854355,1.0,1/6,5.40%,GLA
prerank,GO_Biological_Process_2021__presynaptic membrane assembly (GO:0097105),0.6572069790495145,1.1517182568611508,0.34146341463414637,0.7292507845890763,1.0,6/9,17.29%,LRP4;NLGN1;PTPRD;PTEN;NLGN4Y;IL1RAPL1
prerank,GO_Biological_Process_2021__regulation of execution phase of apoptosis (GO:1900117),0.724019121161007,1.151627844808248,0.358974358974359,0.7288748935961065,1.0,2/8,7.92%,FZD3;BOK
prerank,GO_Biological_Process_2021__phosphatidylinositol metabolic process (GO:0046488),0.43315498184495754,1.1514126985937918,0.18181818181818182,0.7288067366540717,1.0,18/86,18.14%,PLA2G4C;PGAP1;FGF2;PIP5K1B;PIK3C2B;PTPN13;PI4KB;IMPA1;PTEN;PIP4K2A;SBF1;MTMR9;RAB14;PIK3CA;PIP4P2;PLEKHA8;PLCB3;INPP4B
prerank,Reactome_2022__Signaling By WNT In Cancer R-HSA-4791275,0.5790908344027729,1.151248172455181,0.35294117647058826,0.7287567390267383,1.0,6/20,15.67%,PPP2R1B;CTBP2;DKK2;TCF7L2;PPP2R5E;GSK3B
prerank,GO_Biological_Process_2021__negative regulation of ion transmembrane transporter activity (GO:0032413),-0.63942275790537,-1.1511865425094086,0.35714285714285715,0.7140537249012326,1.0,2/13,7.09%,PLN;STK39
prerank,GO_Biological_Process_2021__regulation of endodeoxyribonuclease activity (GO:0032071),-0.727060499146833,-1.150964783319804,0.328125,0.7144739294529824,1.0,3/7,10.59%,DDX11;RPS3;NPM1
prerank,GO_Biological_Process_2021__positive regulation of toll-like receptor 4 signaling pathway (GO:0034145),-0.6980913023770106,-1.150798368163001,0.3728813559322034,0.7145039856316022,1.0,2/5,19.00%,IFI35;PTPN22
prerank,CellMarker_Augmented_2021__Pluripotent Stem cell:Undefined,0.6726960958072871,1.1507280134274276,0.3902439024390244,0.7299786214099504,1.0,1/8,0.08%,KLF4
prerank,GO_Biological_Process_2021__neuron projection regeneration (GO:0031102),-0.6777245581712679,-1.150412959235184,0.3275862068965517,0.7152401916182253,1.0,1/8,10.30%,PTN
prerank,GO_Biological_Process_2021__negative regulation of glycoprotein biosynthetic process (GO:0010561),0.6974493980932094,1.1500170265859877,0.391304347826087,0.7313428202095554,1.0,1/7,5.72%,BACE2
prerank,Reactome_2022__Constitutive Signaling By Overexpressed ERBB2 R-HSA-9634285,-0.7069680040788795,-1.14993465554675,0.25,0.716297302195829,1.0,1/7,3.25%,CDC37
prerank,PanglaoDB_Augmented_2021__Satellite Glial Cells,0.4259457613891686,1.1498438805627151,0.12,0.7314260676516127,1.0,23/80,14.20%,SLC39A12;TGFA;PDK4;GFAP;SLC1A3;CDH20;NDRG2;LRRK2;SIRPA;KCND3;PLXDC2;VSIG4;SLC1A2;TNF;GRIA3;CA10;GRM5;P2RY12;MAPK1;NTRK2;SLC8A1;SLCO2B1;GRIA2
prerank,CellMarker_Augmented_2021__Hematopoietic Stem cell:Undefined,-0.6807057211528427,-1.1496154158457208,0.3448275862068966,0.7169278990356371,1.0,4/9,12.82%,PECAM1;ITGA4;ITGA6;PTPRC
prerank,Reactome_2022__Regulation Of FZD By Ubiquitination R-HSA-4641263,-0.7295974559139515,-1.1495642420242265,0.30158730158730157,0.7166195431038773,1.0,2/9,1.30%,UBC;RPS27A
prerank,Reactome_2022__Constitutive Signaling By Aberrant PI3K In Cancer R-HSA-2219530,0.481174752615063,1.1495522532987006,0.2647058823529412,0.7316711681883986,1.0,11/40,14.14%,PDGFA;PIGU;TGFA;NRG1;KITLG;NRG3;GAB2;PIK3AP1;NRG2;VAV1;ERBB4
prerank,KEGG_2021_Human__Nucleotide excision repair,-0.5424406977979072,-1.149538261582782,0.25396825396825395,0.7162597353760098,1.0,7/35,17.02%,XPA;POLE3;GTF2H5;RBX1;RPA3;ERCC8;RFC1
prerank,KEGG_2021_Human__RNA degradation,0.4465301417078526,1.1494787358200906,0.17142857142857143,0.7313224160036421,1.0,10/63,12.39%,PFKP;PFKM;DCP1B;PABPC1L;EXOSC6;TOB2;CNOT7;CNOT2;LSM6;DIS3L
prerank,GO_Biological_Process_2021__positive regulation of glycolytic process (GO:0045821),-0.5740469249343639,-1.1493030274018627,0.25925925925925924,0.7161209201967513,1.0,5/17,11.98%,IGF1;PFKFB3;PFKFB4;HIF1A;ENTPD5
prerank,GO_Biological_Process_2021__positive regulation of purine nucleotide metabolic process (GO:1900544),-0.5740469249343639,-1.1493030274018627,0.25925925925925924,0.7161209201967513,1.0,5/17,11.98%,IGF1;PFKFB3;PFKFB4;HIF1A;ENTPD5
prerank,Reactome_2022__rRNA Modification In Nucleus And Cytosol R-HSA-6790901,-0.5190183570639201,-1.1491755792723437,0.20689655172413793,0.7161188639823065,1.0,13/49,17.31%,RPS14;UTP3;RPS6;RPS2;BUD23;RPS7;UTP25;WDR46;RPS9;NHP2;NOP10;RRP7A;EMG1
prerank,GO_Biological_Process_2021__regulation of dendrite morphogenesis (GO:0048814),0.542962246964119,1.1491696449098143,0.23529411764705882,0.731549248297698,1.0,12/27,23.21%,NEDD4L;KNDC1;PTPRD;CAPRIN2;GSK3B;ADGRB3;IL1RAPL1;RAPGEF2;NEDD4;SEMA4D;RAP2A;TNIK
prerank,Reactome_2022__DSCAM Interactions R-HSA-376172,0.6851474366150947,1.1490142835118733,0.3142857142857143,0.7313358001458575,1.0,2/9,13.60%,MAPK11;DCC
prerank,Reactome_2022__Formation Of ATP By Chemiosmotic Coupling R-HSA-163210,-0.6706388189912319,-1.1488193732712317,0.3442622950819672,0.7167215512019035,1.0,6/13,20.98%,ATP5PD;ATP5F1E;ATP5ME;ATP5F1C;ATP5F1D;ATP5MC2
prerank,GO_Biological_Process_2021__acyl-CoA biosynthetic process (GO:0071616),0.5674893466836607,1.148760203976159,0.3157894736842105,0.7313379911264631,1.0,5/14,20.80%,PPT1;GCDH;FASN;ACACA;SCD5
prerank,CellMarker_Augmented_2021__Macrophage:Bone Marrow,-0.7366007300848788,-1.1486516253346348,0.3389830508474576,0.7168844578774135,1.0,3/6,10.55%,ADGRE1;CD14;ITGB2
prerank,GO_Biological_Process_2021__positive regulation of intracellular protein transport (GO:0090316),-0.46696614492676697,-1.1486180154337455,0.22580645161290322,0.7165825251634951,1.0,16/115,11.48%,FLNA;TOMM7;GZMB;USP36;CEMIP;EMD;ARIH2;JUP;FIS1;RHOU;RBM22;FYN;HPS4;ITGB2;PRR5L;ABLIM3
prerank,GO_Biological_Process_2021__regulation of chemotaxis (GO:0050920),-0.6386228979832697,-1.1481824940767213,0.2903225806451613,0.7174212661622905,1.0,3/23,2.67%,CXCR4;GPR183;AIF1
prerank,Reactome_2022__Ca2+ Activated K+ Channels R-HSA-1296052,0.6972501211541009,1.1481057071690155,0.34210526315789475,0.7324786536967932,1.0,3/5,13.35%,KCNMB4;KCNN2;KCNMB3
prerank,GO_Biological_Process_2021__negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),-0.5763761678445456,-1.1480735013136345,0.2727272727272727,0.7174287861587572,1.0,6/33,7.39%,UBXN1;RPL5;DDRGK1;RPL11;RPL23;RPS7
prerank,GO_Biological_Process_2021__digestive tract morphogenesis (GO:0048546),0.6675835507625524,1.1480600183398146,0.28888888888888886,0.732032088896926,1.0,3/5,27.12%,NIPBL;FGFR2;BBS7
prerank,"GO_Biological_Process_2021__mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",-0.7174595952929691,-1.1480558718710347,0.24528301886792453,0.71709098228349,1.0,5/11,13.11%,CYCS;COX7C;COX4I1;COX5B;COX6C
prerank,GO_Biological_Process_2021__nucleotide metabolic process (GO:0009117),-0.6150825661208924,-1.1479745781912039,0.3333333333333333,0.7169596048864053,1.0,3/18,8.26%,ME1;CMPK2;ENPP3
prerank,Reactome_2022__Intracellular Signaling By Second Messengers R-HSA-9006925,0.3698790445143392,1.1476251881619735,0.0,0.7326692326178088,1.0,43/231,15.67%,EGR1;PDGFA;RRAGD;PIGU;RNF2;CBX6;TGFA;NBEA;CASP9;MTA2;TSC2;PIP5K1B;PPARG;PHLPP1;NRG1;ADCY9;KITLG;SEM1;PPP2R1B;IRAK1;MDM2;HDAC1;PREX2;NRG3;MAPK1;PTEN;GAB2;PIP4K2A;PIK3AP1;NRG2;VAV1;ADCY6;JUN;PPP2R5E;AHCYL1;ERBB4;PDE1C;XIAP;TRAF6;LAMTOR3;PHC1;AKT2;GSK3B
prerank,GO_Biological_Process_2021__ether lipid metabolic process (GO:0046485),0.5883680359021486,1.1475335655928978,0.22857142857142856,0.7323573629531248,1.0,2/11,4.94%,PLA2G7;NCEH1
prerank,GO_Biological_Process_2021__T cell activation (GO:0042110),-0.5656400896813806,-1.147507171839017,0.27941176470588236,0.7180536195157461,1.0,4/39,2.57%,ITK;JAML;CD2;NLRC3
prerank,CellMarker_Augmented_2021__Endothelial cell:Fetal Gonad,-0.4722040869142347,-1.147453324374179,0.24691358024691357,0.7177777789747247,1.0,27/157,14.94%,H1-4;H4C3;PROCR;PSMB3;ANXA2;PTMA;RANBP1;ST8SIA1;SPATS2L;BRD3;CENPU;TMSB4X;GPC3;EFHC1;ITGB3BP;LDHA;PTN;IFT27;A2M;AKAP12;PFN1;DNMT1;LRRN3;SERPING1;HLA-E;STMN1;MCUR1
prerank,Reactome_2022__Regulation Of Gene Expression In Late Stage (Branching Morphogenesis) Pancreatic Bud Precursor Cells R-HSA-210744,0.6109221977519569,1.1474211389552882,0.2857142857142857,0.7320995928463513,1.0,3/11,11.55%,MAML2;MAML3;KAT2A
prerank,CellMarker_Augmented_2021__Cardiac Progenitor cell:Undefined,0.46977603345448954,1.1473881444976006,0.3076923076923077,0.7316725473426107,1.0,16/57,14.50%,PDZRN4;SEMA5A;PLXDC2;MRC1;KCTD12;PCDH17;GRIA3;CDH11;PREX2;ASXL3;PTPRD;THSD7A;RUNX1T1;SLC8A1;SGIP1;CNTN4
prerank,GO_Biological_Process_2021__negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),0.6305631517715975,1.1473861755921877,0.38461538461538464,0.7311123080261156,1.0,4/10,12.13%,PPARG;TAFA5;PTEN;SOD2
prerank,Reactome_2022__Receptor Mediated Mitophagy R-HSA-8934903,0.665254933443307,1.1472816593476274,0.3333333333333333,0.7308739149098874,1.0,1/7,2.43%,MAP1LC3A
prerank,GO_Biological_Process_2021__regulation of astrocyte differentiation (GO:0048710),0.7120473386799201,1.1472448453691988,0.3,0.7303864191382294,1.0,4/5,26.65%,SERPINE2;BIN1;EPHA4;NOTCH1
prerank,GO_Biological_Process_2021__protein deglycosylation (GO:0006517),-0.695485332491027,-1.147087867018298,0.2698412698412698,0.718520409699974,1.0,5/8,23.24%,AGA;MAN2A1;NGLY1;PARK7;MAN2A2
prerank,GO_Biological_Process_2021__nucleobase-containing small molecule catabolic process (GO:0034656),-0.6949667242560489,-1.1465359714671088,0.39215686274509803,0.7200125283775283,1.0,4/9,13.80%,ADPRM;ENTPD4;ENTPD5;NUDT16
prerank,GO_Biological_Process_2021__actin filament polymerization (GO:0030041),-0.6064808010920428,-1.146390380748251,0.2857142857142857,0.720018542734934,1.0,3/24,2.79%,CATIP;AIF1;PSTPIP1
prerank,Reactome_2022__Signaling By ERBB2 R-HSA-1227986,-0.5696108439518439,-1.1462110674424095,0.29411764705882354,0.720137485610744,1.0,5/39,7.36%,UBC;RPS27A;YES1;CDC37;FYN
prerank,GO_Biological_Process_2021__negative regulation of platelet aggregation (GO:0090331),0.6099758790130563,1.1461806820219405,0.35714285714285715,0.7325170724243679,1.0,1/7,2.96%,SERPINE2
prerank,GO_Biological_Process_2021__neuron apoptotic process (GO:0051402),-0.5958382474773154,-1.1459707382322897,0.3157894736842105,0.7205128184516743,1.0,1/16,1.38%,GAPDH
prerank,GO_Biological_Process_2021__response to peptide (GO:1901652),-0.586278777297014,-1.145835216346361,0.2903225806451613,0.7204929001896431,1.0,3/26,3.63%,CALCR;STAT4;EIF2B1
prerank,GO_Biological_Process_2021__fatty acid alpha-oxidation (GO:0001561),0.7273354242834746,1.1457883616932556,0.3404255319148936,0.7330165158828389,1.0,1/5,10.63%,PEX13
prerank,Reactome_2022__Aquaporin-mediated Transport R-HSA-445717,-0.5967470105571273,-1.1457561689872116,0.26666666666666666,0.7202987655948332,1.0,4/25,6.63%,AQP11;GNB5;RAB11A;PRKAR1B
prerank,Reactome_2022__Cristae Formation R-HSA-8949613,-0.614971572468273,-1.1457266926430905,0.23333333333333334,0.7200075379394355,1.0,12/25,28.12%,ATP5PD;ATP5F1E;ATP5ME;MICOS13;APOO;ATP5F1C;ATP5F1D;ATP5MC2;MICOS10;DNAJC11;ATP5F1A;ATP5MC3
prerank,GO_Biological_Process_2021__negative regulation of axon extension (GO:0030517),0.5385532796494106,1.1453866217743656,0.35555555555555557,0.7335418648753881,1.0,8/19,19.55%,SEMA5A;SEMA3B;DIP2B;RTN4;RNF6;KIAA0319;SEMA4D;MAP2
prerank,Reactome_2022__IRAK1 Recruits IKK Complex R-HSA-937039,0.6749765567691463,1.14538649382816,0.3,0.732982762844233,1.0,4/8,20.08%,IRAK1;UBE2N;TRAF6;PELI1
prerank,GO_Biological_Process_2021__negative regulation of interleukin-2 production (GO:0032703),-0.6189273956935379,-1.1453864667892666,0.3333333333333333,0.7206943428453582,1.0,6/15,13.66%,ZFP36;LILRB4;TNFAIP3;PTPRC;KAT5;HAVCR2
prerank,Reactome_2022__Transmission Across Chemical Synapses R-HSA-112315,0.3940717222967189,1.1453124808448554,0.11764705882352941,0.7326464027944212,1.0,36/164,14.91%,PRKAB2;CACNA1A;GRIN3A;KCNJ2;SLC1A3;NBEA;TSPOAP1;GLRA1;KCNJ5;LIN7A;SLC1A2;NRG1;ADCY9;UNC13B;GABRR2;ALDH5A1;GRIA3;GRIA4;GIT1;NPTN;GRIA1;MDM2;STX1A;PPFIA3;RPS6KA6;MAPK1;GRIN2B;PRKAB1;ADCY6;CACNA1E;ERBB4;GRIA2;CACNG8;CACNG2;GAD1;CACNB4
prerank,Reactome_2022__Mitochondrial Biogenesis R-HSA-1592230,0.4237330468543101,1.1451591168121285,0.16666666666666666,0.7324258498748755,1.0,3/77,2.65%,PRKAB2;PPARGC1A;MAPK11
prerank,GO_Biological_Process_2021__negative regulation of circadian rhythm (GO:0042754),-0.7717120773427535,-1.1446094753048153,0.34615384615384615,0.7228332998752572,1.0,1/6,3.13%,PER2
prerank,CellMarker_Augmented_2021__Platelet:Peripheral Blood,-0.61569456034541,-1.1445736287739448,0.2777777777777778,0.7220806573686295,1.0,9/20,28.19%,TSPAN32;NLRP12;CSF3R;ALOX12;RASGRP4;GP6;RGS18;NT5M;R3HDM4
prerank,CellMarker_Augmented_2021__Platelet:Plasma,-0.61569456034541,-1.1445736287739448,0.2777777777777778,0.7220806573686295,1.0,9/20,28.19%,TSPAN32;NLRP12;CSF3R;ALOX12;RASGRP4;GP6;RGS18;NT5M;R3HDM4
prerank,GO_Biological_Process_2021__regulation of telomere maintenance (GO:0032204),0.5510623769146388,1.144413559031116,0.30434782608695654,0.7339603310876305,1.0,8/20,22.26%,PPP1R10;YLPM1;SIRT6;ERCC4;NBN;HNRNPD;USP7;ERCC1
prerank,GO_Biological_Process_2021__regulation of synapse assembly (GO:0051963),0.5233010625757963,1.143959852893813,0.26666666666666666,0.7348637482487447,1.0,12/33,15.51%,IL1RAPL2;GRID2;DLG5;NLGN1;PDLIM5;CLSTN2;CLSTN3;PTPRD;GPC6;SETD5;LRRC4B;ROBO2
prerank,KEGG_2021_Human__Long-term potentiation,0.4947586428536933,1.143926578478244,0.3,0.7343765543970611,1.0,17/53,19.21%,RAP1A;MAP2K1;GNAQ;PLCB4;PPP3CA;GRIA1;GRM5;RPS6KA6;MAPK1;GRIN2B;GRIA2;RAPGEF3;GRIN2A;PPP3CB;PLCB3;MAP2K2;PPP1CC
prerank,PanglaoDB_Augmented_2021__Osteoclasts,-0.4811483108916739,-1.1438885834858783,0.2236842105263158,0.7237402202466264,1.0,20/109,11.34%,CCL3;CEBPD;TNFRSF11B;PID1;MS4A4A;MARCO;ZMYND15;SIGLEC1;CD14;FCER1G;EPHB1;CTSB;CD93;F13A1;OSCAR;TNFAIP2;CHI3L1;OLFML2B;TYROBP;HIF1A
prerank,GO_Biological_Process_2021__cellular response to low-density lipoprotein particle stimulus (GO:0071404),-0.6499389734875464,-1.143864275007906,0.3230769230769231,0.7234225119838926,1.0,2/13,3.26%,CD36;FCER1G
prerank,CellMarker_Augmented_2021__Fibroblast:Lung,-0.7223177651625192,-1.1438433394235175,0.38095238095238093,0.7230796556850061,1.0,1/6,0.52%,CD36
prerank,GO_Biological_Process_2021__secretory granule organization (GO:0033363),-0.7261918655842605,-1.1436876689531905,0.3269230769230769,0.7232470473236352,1.0,2/5,10.75%,SRGN;BLOC1S2
prerank,Reactome_2022__Metabolism R-HSA-1430728,-0.4218896982024877,-1.143541369859058,0.07,0.7233072396459143,1.0,196/1290,12.05%,IL4I1;ARSJ;OSBPL5;CD36;RPS13;UBC;RPS4X;INSIG1;SLC2A3;DEGS2;CH25H;APIP;CYCS;RPL28;RPS27A;RPS8;SLC7A5;RPL38;RPS21;ADPRM;RPL31;GLYCTK;RPL37A;RPS14;VNN2;MGLL;ARSG;SLC51A;RPL12;MDH2;RPLP1;RPL3;COX7C;RPL23A;RPL39;RPL32;PARP14;RPS11;RPL5;RPS15;NUDT12;RPS12;PSMB3;RPS25;RPS23;RPS27;FAU;RORA;HS3ST1;GSTM4;UQCRB;RPS20;RPL29;RPLP2;PHKG1;CEMIP;RPL19;RPS24;MTHFD1;RPL13A;DUOX1;RPL41;NDUFC1;PDHX;NDUFA2;RPL7A;RPL35;UQCRH;RPL37;NDUFA1;CYB5A;SLC38A1;LPCAT1;GNB5;GATM;NT5C;ABCC3;RPL10A;TMEM126B;SLC16A3;GDPD1;BPHL;DDHD2;RPL11;SLC37A1;NR1H2;GLUL;KMO;RPS3;RPL23;ISCA1;GNPAT;INPP4A;NDUFB9;RPS3A;RPL4;G6PC3;TNFAIP8;RPL30;TXN2;MED25;RPL36AL;ATP5PD;AURKAIP1;TACR1;PARP9;CRYM;PRKAR1B;EPHX1;NDUFA12;GSTP1;MUSK;RPL36;ACBD5;RPL14;ATP5F1E;RPL18A;NFS1;PSMB6;NDUFB4;GSTK1;PSMA7;RPS6;RPS2;RPS7;UQCR10;THEM4;FLAD1;PPP1CB;RPL34;RPL15;ACOT9;NAMPT;XYLT2;ENPP2;RPL21;ACAA1;ENPP3;CALM1;PRKD2;MAT2B;RPS5;RPL27A;COX4I1;PCYT1A;PFKFB3;AMPD2;GCLM;CD44;GPC3;COX5B;GSTM3;PSMB9;PCTP;RPL6;ETFB;PTS;RPL27;ORMDL1;LDHA;RPL18;PLB1;NDUFB1;COMT;DIO2;ABCB4;PFKFB4;DPYS;IDH3B;NDUFS8;AK9;LARS1;SLC36A4;ATP5ME;NDUFS5;RPLP0;NUP50;PTGES2;COX18;RPS9;ASRGL1;GK;FBP1;KARS1;ENTPD4;SDC3;FAAH2;CSNK1G2;GPX4;MED11;DHODH;B3GAT2;AZIN2;ENTPD5;AZIN1;MCEE
prerank,GO_Biological_Process_2021__regulation of nuclear cell cycle DNA replication (GO:0033262),-0.7440224075657749,-1.1433916724653135,0.3584905660377358,0.7233571783022295,1.0,1/7,5.76%,TIPIN
prerank,Reactome_2022__p130Cas Linkage To MAPK Signaling For Integrins R-HSA-372708,0.6668538085731905,1.143312676367665,0.3902439024390244,0.7355258592682685,1.0,3/9,13.77%,RAP1A;CRK;PTK2
prerank,GO_Biological_Process_2021__DNA replication (GO:0006260),-0.50938771577892,-1.1432796086315897,0.23943661971830985,0.7233001712000939,1.0,18/76,22.17%,POLE3;HUS1;ING5;TIPIN;ING4;KAT5;MCM7;RAD9A;RPA3;BRCA1;RECQL5;RFC1;WRN;MCM6;POLG;DONSON;CDC7;MCM5
prerank,GO_Biological_Process_2021__phosphatidylinositol biosynthetic process (GO:0006661),0.3959641806834304,1.1432703125912675,0.07407407407407407,0.7351360898019964,1.0,13/98,13.78%,PIGQ;PIGU;FGF2;PIP5K1B;PIK3C2B;PTPN13;PI4KB;IMPA1;PIGC;PTEN;PIP4K2A;SBF1;MTMR9
prerank,Reactome_2022__SUMOylation Of Transcription Factors R-HSA-3232118,0.5949756908596731,1.1432558853103991,0.2826086956521739,0.734640968343725,1.0,2/13,9.60%,MITF;MDM2
prerank,Reactome_2022__Pregnenolone Biosynthesis R-HSA-196108,0.6933681999094208,1.143137192941461,0.3170731707317073,0.7344377179724628,1.0,3/8,5.38%,TSPOAP1;STARD4;CD163L1
prerank,GO_Biological_Process_2021__regulation of cell-matrix adhesion (GO:0001952),-0.5420257048381472,-1.1429924490908696,0.27941176470588236,0.7237722868383002,1.0,5/49,7.76%,SKAP1;CD36;PLET1;JUP;ACTG1
prerank,GO_Biological_Process_2021__methionine metabolic process (GO:0006555),-0.6943692071676819,-1.1428364347722704,0.3448275862068966,0.7238422158285464,1.0,2/7,14.52%,MTHFD1;SMS
prerank,Reactome_2022__RUNX3 Regulates BCL2L11 (BIM) Transcription R-HSA-8952158,-0.775411684637181,-1.1428090918189715,0.35714285714285715,0.7235055565545254,1.0,1/5,1.37%,RUNX3
prerank,GO_Biological_Process_2021__modulation by host of viral process (GO:0044788),-0.7544262460485438,-1.1427071845169496,0.26785714285714285,0.7234384372859366,1.0,2/5,14.49%,CFL1;IGF2R
prerank,Reactome_2022__Visual Phototransduction R-HSA-2187338,-0.5359246621053366,-1.1426139296597284,0.2328767123287671,0.7233257127154565,1.0,6/40,11.54%,PRKCQ;GNB5;CALM1;GPC3;PLB1;SDC3
prerank,Reactome_2022__Prostacyclin Signaling Thru Prostacyclin Receptor R-HSA-392851,-0.6982844097536404,-1.142540919393638,0.34545454545454546,0.723126877435209,1.0,2/8,15.86%,GNB5;GNB2
prerank,GO_Biological_Process_2021__death-inducing signaling complex assembly (GO:0071550),0.679330562124647,1.1423156132977934,0.35714285714285715,0.736015443396715,1.0,4/6,24.85%,TNF;TNFRSF1A;RIPK1;TRAF2
prerank,CellMarker_Augmented_2021__Hematopoietic cell:Bone Marrow,-0.7781523729044668,-1.1420830201223262,0.31666666666666665,0.7240030936417285,1.0,2/5,12.82%,IL3RA;PTPRC
prerank,Reactome_2022__Maturation Of Nucleoprotein R-HSA-9683610,-0.6744240249404523,-1.141876027826509,0.32786885245901637,0.7242297371908533,1.0,5/10,23.28%,PARP14;PARP9;PARP4;PARP8;SUMO1
prerank,GO_Biological_Process_2021__histone H2A ubiquitination (GO:0033522),0.5693499982605605,1.1417441599539075,0.34210526315789475,0.7368772930935605,1.0,2/16,5.39%,RNF2;RYBP
prerank,GO_Biological_Process_2021__fatty acid biosynthetic process (GO:0006633),-0.534511178504208,-1.1416592367522518,0.3181818181818182,0.7245017044754634,1.0,6/36,14.80%,LIPG;GSTM4;FADS3;GPX4;ALOX12;ACSM5
prerank,GO_Biological_Process_2021__positive regulation of protein deubiquitination (GO:1903003),-0.7380442519668962,-1.141643211775432,0.38,0.724150813349369,1.0,2/6,12.01%,NOP53;WDR48
prerank,GO_Biological_Process_2021__positive regulation of establishment of protein localization to mitochondrion (GO:1903749),-0.5465823650241133,-1.141461052816254,0.22950819672131148,0.7242808798938725,1.0,7/42,11.48%,TOMM7;GZMB;USP36;ARIH2;RHOU;HPS4;ABLIM3
prerank,GO_Biological_Process_2021__regulation of small GTPase mediated signal transduction (GO:0051056),-0.4914478762834419,-1.1412552355974694,0.27848101265822783,0.7244967480964579,1.0,11/109,8.02%,PLEKHG5;ARHGAP4;RASGRF2;VAV3;GMIP;CGNL1;ARHGEF1;RHOU;ARHGEF3;OBSCN;SRGAP3
prerank,GO_Biological_Process_2021__mitotic DNA replication checkpoint signaling (GO:0033314),-0.7127930492357508,-1.141088922693129,0.3620689655172414,0.724611316403145,1.0,1/6,4.73%,HUS1
prerank,GO_Biological_Process_2021__peptidyl-arginine modification (GO:0018195),-0.7119087141505522,-1.1410804195406918,0.3728813559322034,0.7242207491972452,1.0,1/5,4.71%,PADI2
prerank,GO_Biological_Process_2021__inositol phosphate metabolic process (GO:0043647),0.5145237885191614,1.140701480893366,0.25,0.7393397819048928,1.0,14/36,18.14%,INPP1;FGF2;PLCB4;IPPK;IMPA1;NUDT3;PTEN;ISYNA1;PPIP5K1;PLD4;INPP5A;NUDT4;PLCB3;INPP4B
prerank,CellMarker_Augmented_2021__Myogenic Endothelial cell:Skeletal Muscle,-0.5000799582077519,-1.1406770305340463,0.3125,0.724961202251823,1.0,20/58,19.56%,MS4A4A;PLXDC1;SIGLEC1;SYNE1;CD93;F13A1;PECAM1;PCDH12;MS4A6A;TYROBP;SPARCL1;A2M;FLT1;PTPRC;HLA-DPA1;FCGR3A;GIMAP4;FOLR2;PPP1R16B;MPEG1
prerank,GO_Biological_Process_2021__cellular response to ketone (GO:1901655),0.5457120871463875,1.1405424030252747,0.3055555555555556,0.7390984179224105,1.0,5/26,13.60%,MSN;TRERF1;PCK2;NCOA4;ADCY6
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061419),-0.7566978346858129,-1.1405345766573263,0.2916666666666667,0.7249290302918174,1.0,3/5,11.34%,RBPJ;VEGFA;HIF1A
prerank,GO_Biological_Process_2021__regulation of endoplasmic reticulum unfolded protein response (GO:1900101),-0.7031547374017303,-1.1401863661070581,0.2982456140350877,0.7255170115443472,1.0,1/7,4.24%,RACK1
prerank,GO_Biological_Process_2021__cytoplasmic translational initiation (GO:0002183),-0.6320413956426306,-1.140186236584742,0.3225806451612903,0.7251116947781212,1.0,10/17,28.10%,EIF2D;EIF2S2;EIF3I;RBM4;EIF2S3;EIF3D;DENR;EIF4H;MCTS1;EIF4A2
prerank,GO_Biological_Process_2021__regulation of cardiac conduction (GO:1903779),0.5567790492366623,1.1399316560741364,0.20689655172413793,0.7402284392467153,1.0,5/27,14.64%,TRPC1;NPR2;SLC8A1;AHCYL1;FXYD7
prerank,GO_Biological_Process_2021__positive regulation of calcium ion-dependent exocytosis (GO:0045956),0.6876800700803927,1.1396709753995524,0.2978723404255319,0.7402502286112963,1.0,3/6,19.97%,STX1A;KCNB1;SYT4
prerank,Reactome_2022__NOTCH3 Intracellular Domain Regulates Transcription R-HSA-9013508,0.586183278299311,1.1392985573435772,0.358974358974359,0.7408511590506637,1.0,5/15,11.55%,MAML2;PBX1;MAML3;IKZF1;KAT2A
prerank,GO_Biological_Process_2021__DNA metabolic process (GO:0006259),-0.46053902645337225,-1.1391771855433108,0.2222222222222222,0.7275874075807682,1.0,34/198,16.31%,UBC;RPS27A;SMUG1;XPA;BTG2;POLE3;THAP9;OGG1;HUS1;MUS81;PARP2;XRCC3;NPM1;REXO4;NABP1;PARG;NOP53;GLRX2;TERF2IP;KAT5;DDX23;APEX1;DNMT1;MCM7;RAD9A;RPA3;BRCA1;SMC1A;UBA52;PARP4;ZNF445;UHRF1;DFFB;RECQL5
prerank,GO_Biological_Process_2021__regulation of NMDA receptor activity (GO:2000310),0.5088412127920995,1.1387624243323542,0.2647058823529412,0.7417580917199328,1.0,8/26,16.68%,NLGN1;RELN;GRIA3;GRIA4;GRIA1;GRIN2B;GRIA2;GRIN2A
prerank,GO_Biological_Process_2021__cell projection organization (GO:0030030),0.496435806363659,1.1386945103344823,0.2857142857142857,0.7413493356899631,1.0,6/24,11.54%,PDGFA;GSN;NPHP1;CSPG5;P2RY12;QRICH2
prerank,GO_Biological_Process_2021__cardiac muscle cell action potential involved in contraction (GO:0086002),0.5584925673346024,1.1384932956541858,0.28205128205128205,0.7413614618429745,1.0,3/20,8.52%,KCNJ2;SCN3B;NEDD4L
prerank,Reactome_2022__Signaling By WNT R-HSA-195721,-0.46527958634372996,-1.1384671306697138,0.1951219512195122,0.729244984833432,1.0,31/190,13.01%,UBC;H2BC4;H2BC26;CCDC88C;H2AC20;RPS27A;RUNX3;H2AC6;PSMB3;RORA;GNB5;H3-3B;H2AJ;VPS35;H2BC21;PSMB6;PSMA7;H2BC5;CALM1;PSMB9;H2BC9;RBX1;CSNK1G2;FZD2;PSMD12;PFN1;H2BC11;PSMD8;PSMA5;KAT5;CLTB
prerank,Reactome_2022__Activated NTRK2 Signals Thru PI3K R-HSA-9028335,0.7736942389796753,1.138459048272532,0.2553191489361702,0.7408836252547131,1.0,3/5,17.35%,PIGU;NTRK2;PIK3CA
prerank,CellMarker_Augmented_2021__Fibroblast:Pancreas,0.4608365559001994,1.1383984139137178,0.2916666666666667,0.7405463847387241,1.0,25/59,21.43%,COL16A1;COL5A2;NLGN1;PHLDB1;PLPPR4;NTM;GRIA3;CDH11;MMP16;COL11A1;RUNX1T1;GPC6;FBXL7;CSMD2;CSRNP3;ANTXR1;TRPC4;KIAA1549L;CRMP1;DCLK1;MEGF10;NAV1;PRKG1;PRICKLE2;LRFN5
prerank,KEGG_2021_Human__Asthma,-0.6519772366227929,-1.1381394600311192,0.34,0.7298745204531937,1.0,7/12,18.79%,FCER1G;HLA-DRB5;HLA-DRA;HLA-DPA1;HLA-DMB;HLA-DPB1;HLA-DRB1
prerank,GO_Biological_Process_2021__mitochondrion distribution (GO:0048311),0.5680110595558099,1.137820920502683,0.275,0.7415287696098258,1.0,4/10,25.09%,LRRK2;CLUH;TRAK2;TRAK1
prerank,GO_Biological_Process_2021__positive regulation of T cell mediated immunity (GO:0002711),-0.5938250361015631,-1.137443847561099,0.3088235294117647,0.7316697463912003,1.0,5/20,10.77%,HLA-B;CD55;B2M;HLA-F;HLA-DRA
prerank,Reactome_2022__Metal Ion SLC Transporters R-HSA-425410,0.5711429547433851,1.1374256376751124,0.34210526315789475,0.7420557566037583,1.0,5/17,13.82%,SLC39A14;SLC39A8;SLC31A1;SLC41A1;SLC40A1
prerank,GO_Biological_Process_2021__3'-UTR-mediated mRNA stabilization (GO:0070935),-0.6816116563924942,-1.137370927541934,0.3448275862068966,0.7314681457438712,1.0,1/12,1.48%,ZFP36
prerank,GO_Biological_Process_2021__regulation of store-operated calcium entry (GO:2001256),0.6718723933773579,1.136879466969667,0.3695652173913043,0.7431489376630802,1.0,3/6,24.34%,HOMER1;HOMER2;CD84
prerank,CellMarker_Augmented_2021__Eosinophil:Peripheral Blood,-0.7100691302679724,-1.1368058163378818,0.27586206896551724,0.7325574117032696,1.0,3/9,5.12%,CD69;CD14;IL3RA
prerank,Reactome_2022__Nuclear Receptor Transcription Pathway R-HSA-383280,-0.5524089514048668,-1.1368041577734453,0.3013698630136986,0.7321547750962498,1.0,3/33,5.38%,NR4A3;RORA;NR1H2
prerank,GO_Biological_Process_2021__regulation of actin filament polymerization (GO:0030833),0.46998019721721224,1.1367598034707136,0.27586206896551724,0.7429243235485312,1.0,7/47,7.80%,FER;HIP1R;CDC42EP3;NCK2;VASP;MYADM;KANK1
prerank,CellMarker_Augmented_2021__Epithelial Hair Follicle Stem cell:Hair Follicle,-0.7704740709816391,-1.1366475273436554,0.3469387755102041,0.7322993704258702,1.0,4/7,19.52%,CLDN7;OVOL2;CD200;CDS1
prerank,Reactome_2022__Transport Of Nucleotide Sugars R-HSA-727802,0.7272499931697093,1.1362458008180987,0.3958333333333333,0.7439978018496628,1.0,1/5,9.85%,SLC35D1
prerank,GO_Biological_Process_2021__post-translational protein modification (GO:0043687),0.3840147817303279,1.1361188760489196,0.10526315789473684,0.7437554827333567,1.0,34/226,13.82%,SPSB2;FBXO30;DCAF16;GOLM1;KBTBD6;FAM20C;FBXL14;ZBTB16;FBXO32;DCAF13;FEM1B;DDA1;RAB1B;PRKCSH;VGF;ANO8;GPS1;KCTD6;BTRC;HIF3A;FBXW11;FBXW7;EPAS1;FEM1C;DCAF5;DCUN1D1;CHM;KLHL42;FBXL12;COP1;FBXL7;STT3B;DNAJC3;FBXO27
prerank,GO_Biological_Process_2021__proteasomal protein catabolic process (GO:0010498),0.39383071911353207,1.1360879911672466,0.13043478260869565,0.7433395897545725,1.0,26/173,11.31%,SPSB2;RNF122;KBTBD6;SIRT1;RNF139;SPOPL;RCN3;FEM1B;UBE3D;DDIT3;SEL1L;UBXN6;CLOCK;NEDD4L;APPBP2;RMND5A;SHARPIN;MDM2;BTRC;FBXO45;KCTD10;TBL1XR1;FBXW11;FBXW7;FEM1C;RNF185
prerank,GO_Biological_Process_2021__regulation of endothelial cell chemotaxis (GO:2001026),0.6157843478411069,1.135924784576542,0.3958333333333333,0.7430720520016033,1.0,2/11,2.26%,SEMA5A;FGF2
prerank,GO_Biological_Process_2021__protein N-linked glycosylation (GO:0006487),0.44681339119873226,1.135704601203362,0.2222222222222222,0.7431435817767374,1.0,17/48,22.36%,UBE2J1;MGAT4C;MPDU1;SLC39A8;B4GALT7;GFPT1;OSTC;STT3B;MGAT5;ALG12;TMEM165;ALG8;ALG3;MAGT1;ALG5;RPN2;MGAT4B
prerank,GO_Biological_Process_2021__action potential (GO:0001508),0.5251905408665664,1.1356065582142858,0.3225806451612903,0.7429286524881537,1.0,8/24,13.35%,KCNJ2;SCN3A;GNAQ;SCN3B;KCNMB4;SCN8A;GNA11;KCNMB3
prerank,GO_Biological_Process_2021__ganglioside biosynthetic process (GO:0001574),0.6651508830784202,1.1355041470251135,0.36585365853658536,0.742688030354692,1.0,4/10,18.85%,ST6GALNAC3;ST6GALNAC5;ST8SIA4;B4GALT5
prerank,GO_Biological_Process_2021__regulation of myeloid leukocyte differentiation (GO:0002761),-0.6923617941935505,-1.1353313971282268,0.359375,0.7358781067216268,1.0,2/7,22.26%,IRF7;CAMK4
prerank,GO_Biological_Process_2021__tetrahydrofolate metabolic process (GO:0046653),-0.7198599879276617,-1.135322779497522,0.375,0.7355143826956693,1.0,3/8,21.84%,MTHFD1;SHMT1;TYMS
prerank,GO_Biological_Process_2021__non-motile cilium assembly (GO:1905515),-0.59484535837828,-1.1352799691089,0.29310344827586204,0.7352011426991056,1.0,3/21,12.71%,RPGRIP1L;TBC1D32;CSNK1D
prerank,GO_Biological_Process_2021__snRNA 3'-end processing (GO:0034472),0.5756741077297599,1.135257432978472,0.25,0.7427250283153509,1.0,5/14,20.54%,INTS6;EXOSC6;INTS7;EXOSC7;INTS6L
prerank,PanglaoDB_Augmented_2021__Parathyroid Chief Cells,0.444112687057923,1.1351810924813082,0.25,0.7424243089334168,1.0,14/41,20.12%,GLIS3;ARNT2;SLC7A8;SPRED2;NOL4;FOXP4;LINGO1;NTRK2;ABCC8;CD276;STARD13;CRMP1;FGFR1;ZFHX2
prerank,GO_Biological_Process_2021__Rap protein signal transduction (GO:0032486),0.6869149639054801,1.1351668164960627,0.3333333333333333,0.7419423528359022,1.0,7/9,25.27%,RAP1A;PLK2;RAPGEF3;RAP2C;RAPGEF2;RAP2A;RAP2B
prerank,Reactome_2022__Dermatan Sulfate Biosynthesis R-HSA-2022923,0.7442300660748341,1.1351404701954873,0.425531914893617,0.7414611118067818,1.0,3/6,11.46%,NCAN;CSPG5;UST
prerank,GO_Biological_Process_2021__sterol biosynthetic process (GO:0016126),-0.5894422806461519,-1.1350194829076887,0.2857142857142857,0.7354588468608669,1.0,2/23,0.88%,INSIG1;CH25H
prerank,GO_Biological_Process_2021__eye morphogenesis (GO:0048592),-0.6181270640715998,-1.1348034602270145,0.3684210526315789,0.7358213167455006,1.0,2/13,3.23%,COL5A1;NKD1
prerank,GO_Biological_Process_2021__maturation of SSU-rRNA (GO:0030490),-0.5423064083089864,-1.1347542549732763,0.27419354838709675,0.7355884224519073,1.0,8/33,13.26%,RPS8;RPS14;UTP3;WDR46;MRPS11;LOC102724159;NOB1;RPS28
prerank,GO_Biological_Process_2021__regulation of toll-like receptor 3 signaling pathway (GO:0034139),-0.7524982761155332,-1.1342399872287252,0.375,0.7367499250827053,1.0,3/5,19.00%,TNFAIP3;FLOT1;PTPN22
prerank,CellMarker_Augmented_2021__FGFR1LowNME5- Epithelial cell:Esophagus,-0.5565047466340134,-1.1342032399395945,0.2898550724637681,0.7364468564678543,1.0,8/38,14.94%,SLC2A3;CD69;L3MBTL3;IL10RA;CYTIP;CCDC15;TET1;MCUR1
prerank,Reactome_2022__MAPK Targets/ Nuclear Events Mediated By MAP Kinases R-HSA-450282,0.5163157756396439,1.1340271870873289,0.24390243902439024,0.7436499595972572,1.0,7/26,13.64%,DUSP6;MAPK11;PPP2R1B;DUSP7;MAPK1;MAPKAPK2;JUN
prerank,GO_Biological_Process_2021__regulation of ubiquitin protein ligase activity (GO:1904666),-0.6319610368588854,-1.1339318925871642,0.35,0.7368079772162701,1.0,4/13,7.39%,RPL5;RPL11;RPL23;RPS7
prerank,CellMarker_Augmented_2021__Pluripotent Very Small Embryonic-Like cell:Ovary,-0.6084020052326085,-1.133829599438382,0.25,0.7366848021440565,1.0,2/13,10.61%,SEMA6A;CFTR
prerank,CellMarker_Augmented_2021__T Helper cell:Undefined,-0.6557679871286282,-1.1336623779030504,0.2962962962962963,0.7367512261033046,1.0,5/14,15.81%,IL7R;SELL;IL18R1;PTPRC;CD200
prerank,GO_Biological_Process_2021__lymphocyte proliferation (GO:0046651),0.5807969222821863,1.1333636156514169,0.3611111111111111,0.7448255789898015,1.0,1/13,1.49%,MSN
prerank,GO_Biological_Process_2021__response to dopamine (GO:1903350),0.6863525329516231,1.1331406422097179,0.32608695652173914,0.7443616153904282,1.0,2/7,11.38%,LRRK2;MAPK1
prerank,GO_Biological_Process_2021__cellular response to dopamine (GO:1903351),0.6863525329516231,1.1331406422097179,0.32608695652173914,0.7443616153904282,1.0,2/7,11.38%,LRRK2;MAPK1
prerank,PanglaoDB_Augmented_2021__Reticulocytes,-0.4892047439220657,-1.1327968320140975,0.2777777777777778,0.738985229465123,1.0,8/90,8.15%,DDX11;CD36;TFRC;DHX16;DHX38;ILF3;HDGF;ITGA4
prerank,GO_Biological_Process_2021__positive regulation of gene expression (GO:0010628),-0.4386028971308281,-1.1326591879240817,0.20930232558139536,0.7389905455160861,1.0,45/291,11.34%,CALCR;ITK;BTN3A1;CD36;CCL3;RPS4X;RIMS1;GAPDH;TFRC;PID1;WARS1;RPL5;TAF1D;DDRGK1;ETS1;CLU;RPL11;RPS3;RPL23;IGF1;TXK;LAMTOR5;VPS35;RBM22;MUSK;EIF2AK2;TTN;RPS7;PLSCR1;SNF8;ACTG1;LURAP1;RBPJ;EIF4A3;OVOL2;PDCD5;GLMN;U2AF2;SLC11A1;NPM1;CITED2;ACTB;VEGFA;TYROBP;HIF1A
prerank,GO_Biological_Process_2021__positive regulation of pattern recognition receptor signaling pathway (GO:0062208),-0.6340239218711734,-1.1325486204563224,0.35294117647058826,0.7388564826261087,1.0,1/11,2.65%,DHX58
prerank,GO_Biological_Process_2021__negative regulation of cardiac muscle hypertrophy (GO:0010614),-0.7035797658069479,-1.1324441823236693,0.3269230769230769,0.7387175927625466,1.0,1/9,2.19%,RGS2
prerank,GO_Biological_Process_2021__lipoprotein biosynthetic process (GO:0042158),-0.7011418627556527,-1.1324219061319847,0.40350877192982454,0.7383650547939759,1.0,3/8,17.68%,ATG10;WIPI1;UGCG
prerank,GO_Biological_Process_2021__regulation of high voltage-gated calcium channel activity (GO:1901841),-0.6682066073952908,-1.1323912970618906,0.3508771929824561,0.7380625991200741,1.0,3/9,16.05%,SRI;CALM1;NOS1AP
prerank,Reactome_2022__Fatty Acid Metabolism R-HSA-8978868,0.40933772478003305,1.132027669729857,0.2,0.7469466694617939,1.0,16/98,13.81%,PRKAB2;ACADS;CPT1A;FA2H;PPT1;HACD2;HPGDS;ELOVL6;ACOX3;DBI;ALOX5AP;ACADVL;MAPKAPK2;FASN;ACBD4;ECI1
prerank,GO_Biological_Process_2021__canonical glycolysis (GO:0061621),0.5929383964433728,1.13197736894569,0.2857142857142857,0.7459301701762243,1.0,2/15,1.17%,PFKP;PFKM
prerank,GO_Biological_Process_2021__glucose catabolic process to pyruvate (GO:0061718),0.5929383964433728,1.13197736894569,0.2857142857142857,0.7459301701762243,1.0,2/15,1.17%,PFKP;PFKM
prerank,GO_Biological_Process_2021__metanephros development (GO:0001656),0.6499204275142536,1.1318198136662732,0.2564102564102564,0.7460160420062028,1.0,7/9,16.14%,PKD2;PKD1;PTCH1;NF1;NIPBL;ROBO2;CTSH
prerank,GO_Biological_Process_2021__clathrin coat assembly (GO:0048268),0.5649167149538967,1.1317538382789631,0.38461538461538464,0.7457410985576537,1.0,2/14,3.41%,HIP1R;PICALM
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Liver,-0.6778217560581072,-1.1317396280004686,0.38181818181818183,0.7397471348926564,1.0,2/9,8.87%,CD44;GPC3
prerank,Reactome_2022__Processing And Activation Of SUMO R-HSA-3215018,0.6437953085116953,1.1316816689353528,0.3148148148148148,0.7454064895141218,1.0,2/8,12.79%,SAE1;UBA2
prerank,Reactome_2022__O-linked Glycosylation Of Mucins R-HSA-913709,0.5681636897439609,1.1315392292180377,0.3684210526315789,0.7452181511033696,1.0,3/21,5.16%,B3GNT2;GALNTL6;ST6GALNAC3
prerank,GO_Biological_Process_2021__regulation of autophagy (GO:0010506),0.39899235907809355,1.1312632058970011,0.058823529411764705,0.7454756715698966,1.0,10/178,3.81%,PRKAB2;LEPR;ACER2;RRAGD;DAPK2;CDK5R1;GFAP;DEPP1;EXOC8;LRRK2
prerank,CellMarker_Augmented_2021__Plasmacytoid Dendritic cell:Undefined,0.6319932258905473,1.1311594039825614,0.3157894736842105,0.7452789965052632,1.0,2/7,8.03%,NRP1;TLR7
prerank,GO_Biological_Process_2021__peptidyl-lysine modification (GO:0018205),0.4389355477423346,1.1306448759127068,0.25,0.7461264788527034,1.0,17/80,17.93%,SIRT1;SAE1;HDAC9;NUP153;NUP188;NUP42;BCL11A;VCPKMT;LOXL2;STX1A;UBA2;ZNF451;NSMCE2;HDAC10;NDC1;NUP133;NUP205
prerank,GO_Biological_Process_2021__chromosome organization (GO:0051276),-0.5064043418757378,-1.1306441626166635,0.2777777777777778,0.74249705764351,1.0,12/75,12.38%,UBC;RPS27A;XPA;COPS6;POLE3;PADI2;CENPV;FAM50A;HMGN3;GATAD1;RBX1;COPS8
prerank,GO_Biological_Process_2021__membrane fission (GO:0090148),0.6530525514878213,1.1306220808261838,0.3333333333333333,0.7456560141773008,1.0,3/7,26.23%,SLC25A46;SH3GLB1;CORO1C
prerank,GO_Biological_Process_2021__actin cytoskeleton reorganization (GO:0031532),0.47299939006444464,1.1305872977229605,0.24242424242424243,0.7452118705953319,1.0,6/46,3.12%,ANXA1;NRP1;FER;GSN;GAB1;MCU
prerank,PanglaoDB_Augmented_2021__Basal Cells,-0.5559024234806557,-1.1304743307189007,0.31746031746031744,0.7425847616210807,1.0,5/37,8.20%,MYLK;CLDN7;ANXA2;SLC16A3;TYMP
prerank,GO_Biological_Process_2021__regulation of macroautophagy (GO:0016241),0.423516025213884,1.1304282303606763,0.23529411764705882,0.7452294025040869,1.0,7/92,4.14%,PRKAB2;RRAGD;CDK5R1;SIRT1;EXOC8;LRRK2;TSC2
prerank,GO_Biological_Process_2021__import into nucleus (GO:0051170),0.4541146512583875,1.130324783188708,0.2222222222222222,0.7449653776582,1.0,9/58,6.86%,NUTF2;BACH2;E2F3;TSC2;IPO13;NUP153;NUP188;GEMIN2;PPP1R10
prerank,GO_Biological_Process_2021__regulation of PERK-mediated unfolded protein response (GO:1903897),-0.6893345865437392,-1.1303195390693717,0.3584905660377358,0.7427021198951752,1.0,1/8,1.16%,PPP1R15A
prerank,GO_Biological_Process_2021__protein insertion into mitochondrial inner membrane (GO:0045039),0.6464921080072852,1.1302494767210647,0.34782608695652173,0.7446761640834171,1.0,1/6,4.27%,TOMM70
prerank,CellMarker_Augmented_2021__FGFR1HighNME5- Epithelial cell:Esophagus,0.4037276704289867,1.1301347933206218,0.2222222222222222,0.7443788545630579,1.0,21/115,9.56%,COL5A3;COL16A1;NRP1;SVEP1;ASPA;GABBR1;ADGRB2;NOMO1;DDX31;PCDH9;HHAT;CTSK;BMP1;PLXNC1;ABHD8;ELOVL6;TRERF1;CA2;FRRS1;CDC23;SLC37A4
prerank,Reactome_2022__SHC-mediated cascade:FGFR2 R-HSA-5654699,-0.6646097987640253,-1.1300249622265492,0.288135593220339,0.7430621799819052,1.0,2/8,14.45%,FGF13;FGF20
prerank,GO_Biological_Process_2021__regulation of microtubule-based movement (GO:0060632),0.7270583974392901,1.1296073670321316,0.34545454545454546,0.745239686163168,1.0,2/5,21.26%,MAP2;LAMP1
prerank,GO_Biological_Process_2021__establishment of protein localization to chromatin (GO:0071169),0.7522751759151819,1.1294701700418655,0.3181818181818182,0.7450274627040774,1.0,2/5,13.48%,RUVBL2;NIPBL
prerank,KEGG_2021_Human__Phospholipase D signaling pathway,0.42049839144346807,1.1294311368013477,0.24242424242424243,0.74462854593468,1.0,22/109,15.47%,PLA2G4C;PDGFA;GAB1;MAP2K1;TSC2;PIP5K1B;PLPP1;PLCB4;ADCY9;PDGFC;KITLG;DNM3;SHC2;GRM5;AGPAT5;MAPK1;ARF6;GAB2;ADCY6;AGPAT2;RAPGEF3;AKT2
prerank,Reactome_2022__JNK (c-Jun Kinases) Phosphorylation And Activation Mediated By Activated Human TAK1 R-HSA-450321,0.5667163805453089,1.129417264430405,0.2682926829268293,0.7441112955674484,1.0,6/17,16.34%,IRAK1;TAB2;UBE2N;IRAK2;TRAF6;MAP3K7
prerank,KEGG_2021_Human__Adherens junction,0.47220222697610303,1.1293514853496451,0.25,0.7437221149097575,1.0,17/58,16.34%,FER;IGF1R;TGFBR2;TCF7L1;PTPRM;WASF2;SMAD3;VCL;NLK;CTNNA2;TCF7L2;MAPK1;AFDN;TJP1;TGFBR1;PARD3;MAP3K7
prerank,GO_Biological_Process_2021__autophagosome-lysosome fusion (GO:0061909),0.7187606568272814,1.1291906373561336,0.36538461538461536,0.7436133926395034,1.0,4/7,17.89%,RUBCNL;PIP4K2A;ATP13A2;ARL8B
prerank,GO_Biological_Process_2021__ether lipid biosynthetic process (GO:0008611),0.6172298775924588,1.1291313472981432,0.36585365853658536,0.743208189365702,1.0,1/9,0.68%,PLA2G4C
prerank,CellMarker_Augmented_2021__Lake Et al.Science.Ex1:Brain,-0.7168514398760808,-1.1290730583032007,0.36065573770491804,0.7455169673062704,1.0,2/8,2.35%,CCDC88C;PDGFD
prerank,Reactome_2022__Sodium/Calcium Exchangers R-HSA-425561,-0.7292149576857347,-1.1290536176867791,0.32786885245901637,0.7451523448543997,1.0,2/8,8.36%,SRI;CALM1
prerank,GO_Biological_Process_2021__mitral valve development (GO:0003174),0.7450544377929338,1.1289759469394993,0.375,0.743243975774187,1.0,2/5,12.30%,SOX4;BMPR1A
prerank,GO_Biological_Process_2021__fatty acid homeostasis (GO:0055089),0.7227736150231917,1.128914786729251,0.42592592592592593,0.7428565554958889,1.0,1/6,2.51%,SIRT1
prerank,CellMarker_Augmented_2021__Stromal cell:Embryoid Body,0.5082984583720012,1.128708852322977,0.3076923076923077,0.7429686577152097,1.0,11/31,13.53%,COL16A1;COL5A2;KLF6;ACTA2;TIMP3;CDH11;LOXL2;HEG1;FAM114A1;COL6A1;COL15A1
prerank,GO_Biological_Process_2021__spliceosomal complex assembly (GO:0000245),-0.5461043826151414,-1.1286074492298328,0.25757575757575757,0.7460547015799307,1.0,14/36,26.45%,SNRPD2;SRPK1;CRNKL1;ZRSR2;GCFC2;DDX23;SNRNP200;LUC7L3;SF3A1;SF3A3;SNRPG;DDX1;YTHDC1;SRSF5
prerank,GO_Biological_Process_2021__protein localization to basolateral plasma membrane (GO:1903361),0.6819302305788769,1.1285516182466835,0.3409090909090909,0.7427510153720595,1.0,2/5,5.96%,RAB10;LIN7A
prerank,GO_Biological_Process_2021__positive regulation of protein dephosphorylation (GO:0035307),-0.6029645544025011,-1.1284008420807174,0.27941176470588236,0.7462885124647701,1.0,3/25,8.91%,PPP1R15A;CALM1;CNEP1R1
prerank,GO_Biological_Process_2021__regulation of calcium ion transmembrane transport (GO:1903169),-0.637203015930942,-1.1282432823465127,0.3392857142857143,0.7462947280889801,1.0,3/12,17.23%,FYN;NOS1AP;CACNB1
prerank,GO_Biological_Process_2021__positive regulation of lipid storage (GO:0010884),0.6285843598104173,1.1280692302965916,0.36363636363636365,0.743335934587579,1.0,1/10,2.42%,MSR1
prerank,GO_Biological_Process_2021__positive regulation of DNA-binding transcription factor activity (GO:0051091),-0.4579890529994828,-1.1280491096825032,0.23809523809523808,0.746424423062023,1.0,31/179,12.59%,CD36;UBC;RPS27A;TFRC;CARD14;PRKCQ;CARD16;TRIM5;BTK;DDRGK1;AIM2;BEX1;CLU;JUP;RPS3;LAMTOR5;TRIM22;PHB2;EIF2AK2;PRKD2;TRIM13;CFLAR;NPM1;VEGFA;STING1;TCF3;BUD31;FZD2;IL18R1;HSPA1B;TERF2IP
prerank,GO_Biological_Process_2021__regulation of neurotransmitter secretion (GO:0046928),-0.6015063030156379,-1.1279946524083717,0.3142857142857143,0.7461343529308057,1.0,2/22,1.34%,MCTP2;RIMS1
prerank,GO_Biological_Process_2021__leucine metabolic process (GO:0006551),-0.6734527334655807,-1.1277853205968786,0.3870967741935484,0.7463380043691339,1.0,3/7,23.10%,MCCC2;HMGCL;BCAT1
prerank,GO_Biological_Process_2021__tetrahydrofolate interconversion (GO:0035999),-0.7200655392287401,-1.1277381405747307,0.3877551020408163,0.7460532300213196,1.0,3/7,21.84%,MTHFD1;SHMT1;TYMS
prerank,GO_Biological_Process_2021__Golgi to lysosome transport (GO:0090160),0.581636228855751,1.1275582957451304,0.3076923076923077,0.7442237956327035,1.0,3/9,10.29%,SORT1;RBSN;LAPTM5
prerank,GO_Biological_Process_2021__mitotic G1 DNA damage checkpoint signaling (GO:0031571),0.44418974679057416,1.1274667164248744,0.26666666666666666,0.7439466902101237,1.0,7/48,9.99%,PCBP4;ZNF385A;SOX4;CNOT7;PLK2;MDM2;CNOT2
prerank,"Reactome_2022__Gamma Carboxylation, Hypusine Formation And Arylsulfatase Activation R-HSA-163841",-0.6194019397959349,-1.1273026978998304,0.3472222222222222,0.7470699304141086,1.0,3/23,2.05%,ARSJ;F8;ARSG
prerank,GO_Biological_Process_2021__regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process (GO:1902959),0.6616620909266945,1.1272829858524742,0.36585365853658536,0.7439649087465195,1.0,5/7,24.63%,PICALM;SORL1;BIN1;AGER;EPHA4
prerank,CellMarker_Augmented_2021__Oral Keratinocyte Stem cell:Oral Mucosa,-0.5702516645217851,-1.12687543612728,0.2711864406779661,0.748051038560581,1.0,5/25,12.31%,TFRC;YES1;OSMR;ITGA6;ADGRG6
prerank,CellMarker_Augmented_2021__Theca Interna cell:Ovarian Follicle,-0.5515419323590143,-1.1268743732956883,0.3333333333333333,0.7476427137578732,1.0,11/31,19.27%,PLN;ANGPTL1;IGF1;SPARCL1;ABCA8;A2M;SERPING1;C1QTNF7;CRYAB;SERPINF1;LAMA2
prerank,"GO_Biological_Process_2021__negative regulation of retrograde protein transport, ER to cytosol (GO:1904153)",0.6335677404095642,1.1268028054053951,0.3125,0.7446819849858294,1.0,1/8,2.48%,UBE2J1
prerank,KEGG_2021_Human__Fc gamma R-mediated phagocytosis,0.4196404005322467,1.1265991149558836,0.20689655172413793,0.7446575752656643,1.0,13/81,13.55%,PLA2G4C;GSN;MAP2K1;VASP;ASAP2;PIP5K1B;PLPP1;WASF2;CRK;MAPK1;ARF6;GAB2;VAV1
prerank,CellMarker_Augmented_2021__Neural Tube cell:Germ,-0.6964359308474759,-1.1265936174108184,0.3050847457627119,0.7480172072000667,1.0,2/9,8.60%,CXCR4;ITGA6
prerank,CellMarker_Augmented_2021__Primitive Endoderm cell:Embryo,-0.536391233691285,-1.1259883327792606,0.2714285714285714,0.7492912679812689,1.0,2/44,0.78%,CALCR;COL18A1
prerank,GO_Biological_Process_2021__double-strand break repair via break-induced replication (GO:0000727),-0.7078759489622634,-1.1259348318195463,0.3103448275862069,0.7490598827889041,1.0,5/7,22.17%,MUS81;MCM7;MCM6;CDC7;MCM5
prerank,GO_Biological_Process_2021__supramolecular fiber organization (GO:0097435),0.38370802849362506,1.1258547361706563,0.16666666666666666,0.746096216960242,1.0,21/201,6.81%,SHROOM3;COL5A3;COL16A1;AVIL;TPM2;CORO6;CLIP2;GSN;COL5A2;TSPAN33;HIP1R;GFAP;TSPAN15;MYO1D;COL24A1;PGM5;TPPP;CIB1;B4GALT7;BMP1;TMOD2
prerank,GO_Biological_Process_2021__regulation of protein glycosylation (GO:0060049),0.7075296818208399,1.1257411449387706,0.36363636363636365,0.7458523688041193,1.0,3/7,12.20%,ABCA2;RAMP1;FKTN
prerank,"GO_Biological_Process_2021__regulation of CD8-positive, alpha-beta T cell differentiation (GO:0043376)",-0.722403500948674,-1.1257241160562685,0.34545454545454546,0.749216840544573,1.0,3/6,10.76%,RUNX3;LILRB4;NCKAP1L
prerank,GO_Biological_Process_2021__regulation of myoblast differentiation (GO:0045661),-0.5965010875018064,-1.1256565633691193,0.3,0.74903484647181,1.0,1/15,0.96%,RIPOR2
prerank,GO_Biological_Process_2021__plasma membrane bounded cell projection morphogenesis (GO:0120039),0.4721741684173111,1.1254898941286862,0.2608695652173913,0.7459195248858393,1.0,4/41,3.81%,PLXNB1;MAP1S;NYAP2;LRRK2
prerank,Reactome_2022__Glucagon-type Ligand Receptors R-HSA-420092,-0.6861852559380732,-1.125431962601104,0.4,0.7493633989673641,1.0,2/9,15.86%,GNB5;GNB2
prerank,Reactome_2022__KSRP (KHSRP) Binds And Destabilizes mRNA R-HSA-450604,0.5547427948283081,1.1251514245695864,0.30952380952380953,0.7464732030469697,1.0,2/14,5.05%,MAPK11;EXOSC6
prerank,GO_Biological_Process_2021__cell part morphogenesis (GO:0032990),-0.6192454742996205,-1.1251191757029249,0.375,0.749789684727074,1.0,5/13,18.39%,PID1;FIS1;NUBPL;SLIRP;PNPT1
prerank,GO_Biological_Process_2021__negative regulation of histone H3-K9 methylation (GO:0051573),-0.7307238187250051,-1.124749765437679,0.38461538461538464,0.7504262872643346,1.0,4/5,26.85%,DNMT1;BRCA1;PIH1D1;SMARCB1
prerank,GO_Biological_Process_2021__sensory perception of mechanical stimulus (GO:0050954),-0.5268809310615099,-1.1245521399685008,0.27941176470588236,0.7506457661402093,1.0,9/41,11.02%,RIPOR2;CEMIP;SLC26A5;CDH23;NDUFB9;CRYM;MYO3B;USP53;ZNF354A
prerank,GO_Biological_Process_2021__isotype switching (GO:0045190),0.6717165293017506,1.124548545132045,0.32432432432432434,0.7475291211257529,1.0,4/8,18.16%,EXOSC6;LIG4;HSPD1;BATF
prerank,GO_Biological_Process_2021__macrophage differentiation (GO:0030225),0.6042033976359014,1.1244849874861285,0.23809523809523808,0.747142519494863,1.0,2/9,5.45%,SIRT1;PARP1
prerank,Reactome_2022__Biosynthesis Of Specialized Proresolving Mediators (SPMs) R-HSA-9018678,-0.6932705436730466,-1.124257224762521,0.3508771929824561,0.7511636957242583,1.0,3/8,14.59%,GSTM4;GPX4;ALOX12
prerank,Reactome_2022__Post-translational Modification: Synthesis Of GPI-anchored Proteins R-HSA-163125,0.48516433001960807,1.1241871389850513,0.23529411764705882,0.7475685473402193,1.0,8/40,8.91%,PIGQ;PIGU;PGAP1;CPM;MDGA2;RECK;NTM;PIGT
prerank,Reactome_2022__p75NTR Regulates Axonogenesis R-HSA-193697,0.6506414401643758,1.1241081558804407,0.3783783783783784,0.7466213939082139,1.0,2/7,12.26%,LINGO1;RTN4
prerank,Reactome_2022__Axonal Growth Inhibition (RHOA Activation) R-HSA-193634,0.6506414401643758,1.1241081558804407,0.3783783783783784,0.7466213939082139,1.0,2/7,12.26%,LINGO1;RTN4
prerank,GO_Biological_Process_2021__axonogenesis (GO:0007409),0.3941632236136228,1.1240242188112055,0.16666666666666666,0.7463367982286594,1.0,33/162,12.71%,NRP1;GRB10;SLITRK5;CDK5R1;CNTN2;SEMA5A;MAP1S;RAP1GAP;GAB1;VASP;WNT5A;RAB10;DAG1;PLPPR4;RELN;SEMA3B;RYK;ROBO1;TNR;AUTS2;CTNNA2;BRSK1;SHANK3;NPTN;SPTAN1;UNC5B;KLF7;EPHA6;ENAH;MAPK1;PTEN;PDLIM7;GAB2
prerank,GO_Biological_Process_2021__short-chain fatty acid metabolic process (GO:0046459),-0.7125131068713022,-1.1237022556851182,0.4,0.7525032358314372,1.0,2/5,19.17%,MCEE;MMAA
prerank,Reactome_2022__Role Of Nef In HIV-1 Replication And Disease Pathogenesis R-HSA-164952,-0.6034381701145559,-1.1235992678751285,0.3389830508474576,0.7523348241067698,1.0,3/21,7.36%,B2M;CD247;FYN
prerank,GO_Biological_Process_2021__snRNA processing (GO:0016180),0.5651242921073973,1.123428127310364,0.3673469387755102,0.7472964486918776,1.0,3/13,20.54%,INTS6;INTS7;INTS6L
prerank,PanglaoDB_Augmented_2021__Erythroblasts,-0.5111348552649941,-1.1232876614149525,0.2876712328767123,0.7528558846296644,1.0,9/71,10.62%,TFRC;GRAP2;BTK;ETS1;TSPAN32;FERMT3;CD44;P2RY8;CSF2RB
prerank,GO_Biological_Process_2021__hematopoietic stem cell proliferation (GO:0071425),0.6708779317960304,1.123259999466836,0.41304347826086957,0.7472453513631535,1.0,4/7,6.90%,YJEFN3;WNT5A;WNT2B;RUNX1
prerank,GO_Biological_Process_2021__positive regulation of superoxide anion generation (GO:0032930),-0.6902212079413967,-1.1230087442715893,0.3333333333333333,0.7532982057250048,1.0,4/10,13.37%,GSTP1;ITGB2;TYROBP;SOD1
prerank,GO_Biological_Process_2021__regulation of T cell differentiation in thymus (GO:0033081),-0.708105300496455,-1.1230087121664027,0.3333333333333333,0.7528903561279691,1.0,5/7,24.96%,SOD1;TESPA1;TOX;CAMK4;VNN1
prerank,GO_Biological_Process_2021__I-kappaB kinase/NF-kappaB signaling (GO:0007249),-0.5404840521898147,-1.1229618234622776,0.2972972972972973,0.7526000833667137,1.0,4/52,3.07%,UBC;RPS27A;NLRC3;CD14
prerank,GO_Biological_Process_2021__negative regulation of hippo signaling (GO:0035331),0.607787384695237,1.1228348740796585,0.375,0.7480195877853062,1.0,3/10,16.31%,DLG5;SHANK2;WWC2
prerank,GO_Biological_Process_2021__establishment of spindle orientation (GO:0051294),-0.6083799535648173,-1.1227980427721038,0.31666666666666665,0.7526515848443601,1.0,2/18,9.33%,DYNLT1;LLGL2
prerank,GO_Biological_Process_2021__relaxation of cardiac muscle (GO:0055119),-0.5988610596748519,-1.1227608910207525,0.4032258064516129,0.7523520042231204,1.0,2/12,2.19%,PLN;RGS2
prerank,GO_Biological_Process_2021__positive regulation of cellular component biogenesis (GO:0044089),-0.5043593041412568,-1.122720732551301,0.29577464788732394,0.7520917291623084,1.0,11/60,12.96%,TFRC;WARS1;MPP7;RACK1;CLU;PLEK;RPS3;SNF8;VEGFA;PFN1;BMF
prerank,"Reactome_2022__PTK6 Regulates RHO GTPases, RAS GTPase And MAP Kinases R-HSA-8849471",0.6615462008371116,1.1226339473042117,0.3488372093023256,0.7479847066231006,1.0,3/9,13.50%,CRK;ELMO1;SYNGAP1
prerank,PanglaoDB_Augmented_2021__Epithelial Cells,-0.5524080246385442,-1.1226015480653115,0.3148148148148148,0.7520362794597283,1.0,7/39,14.26%,CD2;NKD1;CLDN7;ITGA4;OVOL2;ITGAL;BRCA1
prerank,Reactome_2022__Negative Regulation Of PI3K/AKT Network R-HSA-199418,0.43043589445293723,1.1225967415705689,0.2,0.7474920521208614,1.0,21/71,15.47%,PDGFA;PIGU;TGFA;PIP5K1B;PHLPP1;NRG1;KITLG;PPP2R1B;IRAK1;NRG3;MAPK1;PTEN;GAB2;PIP4K2A;PIK3AP1;NRG2;VAV1;PPP2R5E;ERBB4;TRAF6;AKT2
prerank,GO_Biological_Process_2021__cellular component disassembly (GO:0022411),0.5397954984097317,1.12242821467762,0.2564102564102564,0.7473494617858645,1.0,6/26,9.60%,GSN;EXOC8;LCP1;CTSK;BMP1;MMP16
prerank,GO_Biological_Process_2021__positive regulation of voltage-gated potassium channel activity (GO:1903818),0.6914017311144299,1.122168547990353,0.4222222222222222,0.7474315038042959,1.0,1/5,3.23%,KCNIP2
prerank,GO_Biological_Process_2021__regulation of DNA topoisomerase (ATP-hydrolyzing) activity (GO:2000371),-0.6993171556925583,-1.1221641040441426,0.39285714285714285,0.7523585310088872,1.0,2/5,15.71%,PLSCR1;UHRF1
prerank,GO_Biological_Process_2021__positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity (GO:2000373),-0.6993171556925583,-1.1221641040441426,0.39285714285714285,0.7523585310088872,1.0,2/5,15.71%,PLSCR1;UHRF1
prerank,GO_Biological_Process_2021__dendritic cell migration (GO:0036336),-0.7215250024428093,-1.1220937117844256,0.3333333333333333,0.7522009204117516,1.0,3/10,1.61%,CXCR4;CCL5;GPR183
prerank,GO_Biological_Process_2021__hypotonic response (GO:0006971),-0.7828874220154575,-1.1220722547826363,0.36363636363636365,0.7518733934407423,1.0,3/5,9.02%,MYLK;STK39;TRPV4
prerank,Reactome_2022__Costimulation By CD28 Family R-HSA-388841,-0.5558792518768567,-1.12196531400863,0.3064516129032258,0.7518036396442304,1.0,7/48,10.77%,GRAP2;YES1;CD247;HLA-DRB5;FYN;THEM4;HLA-DRA
prerank,GO_Biological_Process_2021__detection of mechanical stimulus involved in sensory perception (GO:0050974),0.6430838384158766,1.1219254509647698,0.44,0.7476380227481929,1.0,3/8,17.05%,HPN;COL11A1;ADGRV1
prerank,KEGG_2021_Human__Human immunodeficiency virus 1 infection,-0.46953353547714866,-1.1218853926866625,0.25609756097560976,0.7516271646808952,1.0,18/143,11.42%,CYCS;HLA-B;FOS;CXCR4;TRIM5;B2M;CD247;ELOB;GNB5;HLA-C;HLA-F;TNFRSF1B;CFL1;CALM1;APOBEC3G;RBX1;TAP1;STING1
prerank,GO_Biological_Process_2021__smooth muscle contraction (GO:0006939),-0.6719672178166898,-1.1218218976793521,0.38235294117647056,0.7513926584121607,1.0,1/8,0.62%,MYLK
prerank,GO_Biological_Process_2021__cellular hypotonic response (GO:0071476),-0.7566541262007254,-1.1217034966242077,0.35714285714285715,0.7513911637558959,1.0,3/5,9.02%,MYLK;STK39;TRPV4
prerank,GO_Biological_Process_2021__embryonic appendage morphogenesis (GO:0035113),0.7047052012354269,1.1216941459810126,0.3793103448275862,0.7477446433970331,1.0,2/7,13.38%,PTCH1;MEGF8
prerank,GO_Biological_Process_2021__Golgi ribbon formation (GO:0090161),0.6434326675731379,1.1215982248666936,0.3695652173913043,0.7473617406277526,1.0,3/10,14.60%,TMED5;VTI1A;STX6
prerank,GO_Biological_Process_2021__cAMP biosynthetic process (GO:0006171),0.5912822137670096,1.121420361995503,0.35555555555555557,0.747277769800616,1.0,4/8,26.69%,ADCY9;ADCY6;ADCY10;ADCY1
prerank,KEGG_2021_Human__Salivary secretion,0.4778149836680751,1.1212209429580717,0.25,0.7473098753568637,1.0,13/43,21.35%,GNAQ;ADRA1A;PLCB4;ADCY9;GUCY1A1;SLC9A1;GUCY1A2;ADCY6;GUCY1B1;SLC12A2;PLCB3;PRKG1;CHRM3
prerank,Reactome_2022__Leishmania Infection R-HSA-9658195,-0.469100594436299,-1.121139020349895,0.2857142857142857,0.7526303874149518,1.0,12/134,8.36%,CALCR;VAV3;PSTPIP1;YES1;BTK;CD247;GNB5;TXN2;PRKAR1B;FYN;ACTG1;CALM1
prerank,CellMarker_Augmented_2021__Cardiomyocyte:Heart,0.6903518454504416,1.1210780159165434,0.3333333333333333,0.7472177838807408,1.0,2/7,4.05%,KCNJ2;SIRPA
prerank,GO_Biological_Process_2021__histone H3-K36 demethylation (GO:0070544),-0.7001664380991146,-1.1209696581692956,0.36666666666666664,0.7527880798766439,1.0,1/7,10.73%,KDM7A
prerank,Reactome_2022__Elastic Fibre Formation R-HSA-1566948,0.5549204191670215,1.1209412403374472,0.4411764705882353,0.746927321819954,1.0,4/15,10.85%,LTBP3;FBN2;LOXL2;ITGAV
prerank,Reactome_2022__Sema4D Mediated Inhibition Of Cell Attachment And Migration R-HSA-416550,0.7238553446618357,1.1208100045592293,0.3695652173913043,0.7467529820668898,1.0,1/6,0.43%,PLXNB1
prerank,GO_Biological_Process_2021__negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),0.6471371357352655,1.1207588029082856,0.3018867924528302,0.7464302244732504,1.0,2/7,2.26%,SPRY2;FGF2
prerank,GO_Biological_Process_2021__positive regulation of transcription of Notch receptor target (GO:0007221),0.5794473178854113,1.1206583191644088,0.4358974358974359,0.7461574439329912,1.0,3/12,7.44%,MAML2;PBX1;MAML3
prerank,Reactome_2022__Azathioprine ADME R-HSA-9748787,-0.6846184193818475,-1.1205828014993184,0.2786885245901639,0.7535701367729656,1.0,1/12,2.19%,VAV3
prerank,Reactome_2022__HS-GAG Biosynthesis R-HSA-2022928,0.5394245311991455,1.1205725101432198,0.2619047619047619,0.7459345343377191,1.0,3/18,3.33%,HS3ST5;HS3ST4;HS2ST1
prerank,"Reactome_2022__PI5P, PP2A And IER3 Regulate PI3K/AKT Signaling R-HSA-6811558",0.44512387010768767,1.1204156007546455,0.23333333333333334,0.7458932561388677,1.0,18/64,14.94%,PDGFA;PIGU;TGFA;PIP5K1B;NRG1;KITLG;PPP2R1B;IRAK1;NRG3;MAPK1;GAB2;PIP4K2A;PIK3AP1;NRG2;VAV1;PPP2R5E;ERBB4;TRAF6
prerank,CellMarker_Augmented_2021__Hematopoietic Stem cell:Blood,-0.5986102681099132,-1.1201713351691154,0.328125,0.7543610320512533,1.0,5/19,12.82%,CXCR4;CD93;ITGA6;CD44;PTPRC
prerank,GO_Biological_Process_2021__negative regulation of cell projection organization (GO:0031345),0.4214414515344347,1.120156973545865,0.23529411764705882,0.7461155824196792,1.0,14/39,19.71%,PTPN9;SPRY2;CIB1;KANK1;PTEN;GRIN2B;DCC;ADCY6;BAG5;FKBP4;RAPGEF2;MYLIP;CRMP1;PTPRO
prerank,GO_Biological_Process_2021__negative regulation of immune system process (GO:0002683),-0.7266942216284172,-1.1201503699362216,0.4,0.754009746628049,1.0,4/6,26.56%,LILRB4;CD200;LYN;LILRB2
prerank,Reactome_2022__Cellular Response To Hypoxia R-HSA-1234174,-0.5030517245704414,-1.1200887231621797,0.3142857142857143,0.7537168404746789,1.0,15/60,12.85%,UBC;RPS27A;PSMB3;ELOB;PSMB6;PSMA7;EGLN3;PSMB9;CITED2;RBX1;VEGFA;HIF1A;PSMD12;PSMD8;PSMA5
prerank,Reactome_2022__Potassium Channels R-HSA-1296071,0.46334275415298665,1.1200071390123518,0.22580645161290322,0.7460330846620903,1.0,12/42,13.35%,KCNQ2;KCNJ2;KCND3;KCNJ5;KCNC2;KCNMB4;KCNK6;KCNK13;KCNN2;ABCC8;KCNH5;KCNMB3
prerank,"Reactome_2022__BMAL1:CLOCK,NPAS2 Activates Circadian Gene Expression R-HSA-1368108",0.48976968291124107,1.1199006343284537,0.28,0.745728650148452,1.0,4/24,10.67%,BMAL2;SERPINE1;CLOCK;TBL1XR1
prerank,GO_Biological_Process_2021__regulation of endoplasmic reticulum tubular network organization (GO:1903371),-0.7024917762666875,-1.119739605430084,0.37037037037037035,0.7543421331971277,1.0,2/5,19.79%,LNPK;TMEM33
prerank,CellMarker_Augmented_2021__Myeloid cell:Peripheral Blood,-0.6977885295857182,-1.1197119529410358,0.3620689655172414,0.7540107356061925,1.0,4/8,16.96%,CD14;IL3RA;PTPRC;FCGR3A
prerank,GO_Biological_Process_2021__intraciliary transport involved in cilium assembly (GO:0035735),-0.5702142085457316,-1.119425517959349,0.4,0.7545193826497196,1.0,6/30,16.14%,IFT46;DYNC2I1;IFT27;IFT81;IFT52;IFT43
prerank,GO_Biological_Process_2021__respiratory tube development (GO:0030323),0.5503599191713625,1.1192926169040553,0.2857142857142857,0.7468875189022404,1.0,5/15,13.44%,PDPN;FGF2;HECA;CCDC40;BAG6
prerank,GO_Biological_Process_2021__negative regulation of cell differentiation (GO:0045596),0.4040958964671199,1.1192041383514069,0.21875,0.7465993365353131,1.0,26/96,15.21%,SPRY2;COL5A2;SIRT1;SMAD7;ZBTB16;SPRED1;SPRED2;WNT5A;ANP32B;PPARG;USF3;SMAD3;HPN;JAG1;TNF;RANBP3L;TWIST2;ITGAV;PTCH1;PTEN;CDK6;RUNX1T1;FERMT2;CNTN4;ENPP1;TGFBR1
prerank,GO_Biological_Process_2021__regulation of protein localization to nucleolus (GO:1904749),-0.7263574185830848,-1.1191890553616275,0.32786885245901637,0.7547429154694401,1.0,1/5,5.41%,GLUL
prerank,Reactome_2022__Signaling By Activated Point Mutants Of FGFR1 R-HSA-1839122,-0.7168868066454446,-1.1189869748030412,0.41509433962264153,0.7549613886982851,1.0,2/5,14.45%,FGF13;FGF20
prerank,GO_Biological_Process_2021__regulation of biomineral tissue development (GO:0070167),0.5905024288790692,1.1188567683104067,0.3333333333333333,0.7470419668069951,1.0,4/12,26.65%,ANKH;ENPP1;TGFB1;NOTCH1
prerank,CellMarker_Augmented_2021__Dendritic cell:Peripheral Blood,0.6766614840527675,1.118642268649742,0.36585365853658536,0.7470739219939295,1.0,1/5,0.61%,NRP1
prerank,GO_Biological_Process_2021__myeloid leukocyte differentiation (GO:0002573),0.44182251196674127,1.1183736976722785,0.2413793103448276,0.7472123708086389,1.0,7/44,6.90%,PIR;TGFBR2;SIRT1;CBFA2T3;PPARG;PARP1;RUNX1
prerank,KEGG_2021_Human__Aminoacyl-tRNA biosynthesis,-0.5308130375165186,-1.1183570567619463,0.3384615384615385,0.7564082366173827,1.0,10/40,18.21%,HARS2;WARS1;NARS1;LARS1;KARS1;TARS2;DARS2;GARS1;TARS3;FARSA
prerank,PanglaoDB_Augmented_2021__Kidney Progenitor Cells,0.4353299604141514,1.118302355782836,0.14285714285714285,0.746883822646963,1.0,12/45,18.34%,LRP4;GPR161;MAGI1;SALL1;PTPRG;ENAH;GPC6;FERMT2;CD276;ANTXR1;RAI14;RBFOX2
prerank,GO_Biological_Process_2021__nucleosome assembly (GO:0006334),-0.5489163476369103,-1.118207422013116,0.3392857142857143,0.7564859379800359,1.0,7/30,12.68%,H2BC18;H2BC21;H2BC5;H2BC9;NPM1;HIRA;H2BC11
prerank,GO_Biological_Process_2021__pyrimidine nucleobase metabolic process (GO:0006206),0.6223739713526409,1.1181184299086706,0.3409090909090909,0.7468176163944503,1.0,1/9,1.43%,DPYSL5
prerank,GO_Biological_Process_2021__regulation of ventricular cardiac muscle cell action potential (GO:0098911),-0.6768915279911321,-1.1178691547470847,0.3559322033898305,0.7569822812373471,1.0,4/9,16.41%,JUP;TRPM4;DSC2;PKP2
prerank,GO_Biological_Process_2021__transforming growth factor beta receptor signaling pathway (GO:0007179),-0.4974022800605607,-1.1178379592412984,0.2647058823529412,0.7566603335092777,1.0,4/57,1.30%,UBC;TGFBR3;FOS;RPS27A
prerank,Reactome_2022__Protein Localization R-HSA-9609507,-0.4810591696819148,-1.1177476812375122,0.27631578947368424,0.75643969276528,1.0,19/109,11.53%,UBC;TOMM7;RPS27A;DNAJC19;CHCHD2;EMD;CYB5A;CHCHD10;TIMM44;FIS1;GNPAT;PITRM1;ACBD5;GSTK1;TIMM21;ACAA1;ZNF260;BCS1L;COA6
prerank,Reactome_2022__CREB1 Phosphorylation Thru NMDA Receptor-Mediated Activation Of RAS Signaling R-HSA-442742,-0.6074552608019038,-1.1177473328470269,0.35,0.7560366881340784,1.0,3/21,8.36%,RASGRF2;NEFL;CALM1
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte proliferation (GO:0050671),-0.5328402421319457,-1.1176516412134383,0.25757575757575757,0.7559270760329468,1.0,15/43,17.61%,TFRC;CCL5;GPR183;VAV3;AIF1;ZNF335;NCKAP1L;TNFSF13B;PTPRC;HLA-E;HLA-DPA1;HLA-DMB;CD74;HLA-DPB1;IL18
prerank,Reactome_2022__Olfactory Signaling Pathway R-HSA-381753,0.5901208870137402,1.1176162959815015,0.3170731707317073,0.7475774832387578,1.0,4/7,36.96%,LDB2;GNB1;GNAL;REEP1
prerank,GO_Biological_Process_2021__regulation of cell differentiation (GO:0045595),0.4116794201704916,1.1176137586029538,0.2,0.7470532353542987,1.0,31/99,20.73%,KLF4;CDK5R1;SMAD7;NLGN1;NSUN2;PHLDB1;ANP32B;DAG1;PLEKHB2;RUNX1;TNF;YWHAG;BMPR1B;SMYD5;CDK6;NF1;PTK2;CLASP1;TGFBR1;CLASP2;MOSMO;BIN1;CBFB;FGFR2;TIAM1;FGFR1;ZFHX2;SCIN;CDK9;MEGF10;OCIAD1
prerank,GO_Biological_Process_2021__negative regulation of telomere capping (GO:1904354),0.6811695591409511,1.1176110712865481,0.45098039215686275,0.7465378887848126,1.0,3/6,22.26%,ERCC4;NBN;ERCC1
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),-0.5481041273713156,-1.1176080447247083,0.30666666666666664,0.7556351759735569,1.0,2/41,2.37%,BCL2A1;DDIT4
prerank,GO_Biological_Process_2021__negative regulation of catabolic process (GO:0009895),-0.5303272195952292,-1.1175962859492643,0.2711864406779661,0.7552668253492203,1.0,1/29,0.28%,FLNA
prerank,GO_Biological_Process_2021__metal ion export (GO:0070839),0.5376846040250987,1.1175672664056697,0.35294117647058826,0.746137515760779,1.0,5/16,13.82%,KCNIP2;KCND3;SLC4A4;SLC9A1;SLC40A1
prerank,GO_Biological_Process_2021__protein mannosylation (GO:0035268),0.5657841604929398,1.11754178666724,0.3076923076923077,0.7456724620512779,1.0,6/18,12.20%,LARGE1;DPY19L1;TMTC2;FKRP;DPY19L3;FKTN
prerank,Reactome_2022__COPI-dependent Golgi-to-ER Retrograde Traffic R-HSA-6811434,0.4581854685272735,1.1169508731702538,0.2631578947368421,0.7466831050646408,1.0,10/55,17.41%,KIFC2;TMED3;RAB1B;COPG1;CENPE;KIF15;KIF6;COPB1;KIF13B;COPZ1
prerank,GO_Biological_Process_2021__positive regulation of myotube differentiation (GO:0010831),0.6965128718634683,1.1169089657284896,0.38461538461538464,0.7462671824538825,1.0,4/5,27.24%,MMP14;PIEZO1;MAPK14;ATP11A
prerank,GO_Biological_Process_2021__positive regulation of amyloid-beta formation (GO:1902004),0.5790848958707697,1.116862845070665,0.2631578947368421,0.7459088070568849,1.0,4/14,9.55%,ABCA2;PICALM;TNF;SLC2A13
prerank,Reactome_2022__ESR-mediated Signaling R-HSA-8939211,-0.4494083704714,-1.1166055656365963,0.2441860465116279,0.7577471070806083,1.0,22/126,14.70%,H2BC4;H2BC26;H2AC20;FOS;H2AC6;USF1;GREB1;GNB5;H3-3B;H2AJ;H2BC21;POLR2G;H2BC5;CALM1;H2BC9;H2BC11;KAT5;DDX5;ZNF217;ESR2;CCND1;SMC1A
prerank,GO_Biological_Process_2021__negative regulation of protein-containing complex disassembly (GO:0043242),0.6700710700224517,1.1166036459543451,0.38461538461538464,0.7460876680010173,1.0,3/8,10.79%,TMEM39A;TNF;IRAK3
prerank,Reactome_2022__Activation Of TFAP2 (AP-2) Family Of Transcription Factors R-HSA-8866907,-0.7113633549053253,-1.1165636403932984,0.3888888888888889,0.7574594977215474,1.0,1/6,10.60%,CITED2
prerank,GO_Biological_Process_2021__response to lead ion (GO:0010288),-0.7652022957539484,-1.1162018697089127,0.4528301886792453,0.7580774896788312,1.0,1/5,7.40%,PLSCR1
prerank,GO_Biological_Process_2021__cellular response to reactive oxygen species (GO:0034614),0.44871851682242087,1.1159354636487002,0.27586206896551724,0.7472252295033338,1.0,5/47,4.05%,ANXA1;PKD2;FER;SIRT1;SIRPA
prerank,GO_Biological_Process_2021__regulation of vesicle size (GO:0097494),0.6767867647930575,1.1156105793274744,0.3617021276595745,0.7476384337198686,1.0,1/6,3.41%,PICALM
prerank,CellMarker_Augmented_2021__Pyramidal cell:Undefined,0.7215769636124172,1.1155166776357337,0.36363636363636365,0.7474018323206334,1.0,4/7,21.29%,GRM5;PTPRG;MAP2;GRM1
prerank,GO_Biological_Process_2021__regulation of microtubule binding (GO:1904526),0.7344647078689631,1.1154315876110845,0.3617021276595745,0.7470520240132781,1.0,5/5,26.58%,MARK2;MAP2;ABL1;PPP2CB;TTBK2
prerank,Reactome_2022__Diseases Associated With N-glycosylation Of Proteins R-HSA-3781860,0.5405055605127527,1.1151471812069504,0.29545454545454547,0.7472943007598475,1.0,5/18,18.89%,GLB1;MPDU1;ALG12;ALG8;ALG3
prerank,GO_Biological_Process_2021__rRNA base methylation (GO:0070475),-0.7344075359830959,-1.1149902560232803,0.42424242424242425,0.7611316033560818,1.0,3/5,20.17%,BUD23;EMG1;NSUN5
prerank,KEGG_2021_Human__Lipid and atherosclerosis,-0.46299982652873933,-1.1149020929967068,0.3023255813953488,0.7610484044872142,1.0,14/151,8.36%,CD36;CCL3;CYCS;FOS;CCL5;VAV3;CD14;NCF4;TNFSF10;ARHGEF1;ERO1A;CCL3L3;OLR1;CALM1
prerank,GO_Biological_Process_2021__primary neural tube formation (GO:0014020),0.48344262386426806,1.1148951642830456,0.26666666666666666,0.7469685613847602,1.0,6/24,11.62%,SCRIB;TSC2;VASP;PLXNB2;PHACTR4;COBL
prerank,GO_Biological_Process_2021__tube closure (GO:0060606),0.48344262386426806,1.1148951642830456,0.26666666666666666,0.7469685613847602,1.0,6/24,11.62%,SCRIB;TSC2;VASP;PLXNB2;PHACTR4;COBL
prerank,Reactome_2022__Mitotic Prophase R-HSA-68875,-0.46708009262594835,-1.1148321538596657,0.25675675675675674,0.760826606975699,1.0,11/84,9.35%,H2BC4;H2BC26;H2AC20;H2AC6;EMD;H3-3B;H2AJ;H2BC21;H2BC5;CNEP1R1;H2BC9
prerank,Reactome_2022__Myogenesis R-HSA-525793,0.5522950898258446,1.1147502168448067,0.358974358974359,0.7468626412974569,1.0,5/20,11.06%,MAPK11;TCF7L1;NEO1;CTNNA2;TCF7L2
prerank,KEGG_2021_Human__RNA polymerase,0.49620566930611554,1.114682999367705,0.3076923076923077,0.7465871543207803,1.0,1/22,0.68%,POLR2D
prerank,KEGG_2021_Human__Glioma,0.43235483721949763,1.1146663047616059,0.18181818181818182,0.746142452984646,1.0,10/54,11.88%,PDGFA;IGF1R;TGFA;E2F3;MAP2K1;SHC2;MDM2;MAPK1;PTEN;CDK6
prerank,GO_Biological_Process_2021__regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),0.41489899844739137,1.1144931179561193,0.1875,0.7459969729701778,1.0,20/74,13.77%,PLXNB1;PDGFA;IGF1R;FGF2;SIRT1;GAB1;TSC2;PIP5K1B;PDGFC;TNF;PTPN13;UNC5B;HGF;MAPK1;PTEN;NTRK2;DIPK2A;PIP4K2A;PIK3AP1;PTK2
prerank,GO_Biological_Process_2021__polyol biosynthetic process (GO:0046173),0.6098217324150785,1.1144305992604926,0.3076923076923077,0.7456420087078821,1.0,4/13,13.98%,FGF2;IPPK;ISYNA1;PPIP5K1
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Anterior Cruciate Ligament,0.47542497251129967,1.1143683799879927,0.2727272727272727,0.7453439501810003,1.0,4/44,1.78%,ANXA1;TPM2;SERPINE1;COL5A2
prerank,CellMarker_Augmented_2021__Ureteric Bud cell:Fetal Kidney,0.5158840295661921,1.1143238504014263,0.35714285714285715,0.744941605730127,1.0,8/24,16.64%,FRAS1;B4GALNT4;GULP1;GPR161;ENAH;TYRO3;COL4A5;RAI14
prerank,Reactome_2022__FCGR3A-mediated IL10 Synthesis R-HSA-9664323,-0.5914338704374563,-1.1143121244138026,0.3442622950819672,0.7619816187460914,1.0,5/30,8.36%,YES1;CD247;PRKAR1B;FYN;CALM1
prerank,GO_Biological_Process_2021__microvillus assembly (GO:0030033),0.597061044658707,1.1141589022243583,0.3125,0.744347689612952,1.0,9/13,27.94%,RAP1A;FXYD5;RAP2C;RAPGEF2;STK26;RAP2A;TNIK;RAP2B;MAP4K4
prerank,GO_Biological_Process_2021__microvillus organization (GO:0032528),0.597061044658707,1.1141589022243583,0.3125,0.744347689612952,1.0,9/13,27.94%,RAP1A;FXYD5;RAP2C;RAPGEF2;STK26;RAP2A;TNIK;RAP2B;MAP4K4
prerank,GO_Biological_Process_2021__positive regulation of protein polymerization (GO:0032273),0.4338727601558284,1.1138316109744195,0.2857142857142857,0.744646085516987,1.0,9/47,12.17%,FER;CDK5R1;CDC42EP3;NCK2;VASP;TPPP;TOGARAM1;SLAIN2;ARF6
prerank,GO_Biological_Process_2021__iron ion transport (GO:0006826),-0.5570012441463985,-1.113651938067688,0.3382352941176471,0.7634889227379992,1.0,3/36,4.87%,FTH1;TFRC;ATP6V1F
prerank,KEGG_2021_Human__Tryptophan metabolism,-0.5823809883950907,-1.1135333771896805,0.32727272727272727,0.7635096957651847,1.0,2/22,5.45%,IL4I1;KMO
prerank,GO_Biological_Process_2021__response to nutrient levels (GO:0031667),0.6416760221601047,1.1135126724022557,0.3333333333333333,0.7448958812308124,1.0,5/10,27.29%,PRKAA1;KCNB1;ULK1;RPS6KB1;PRKAA2
prerank,GO_Biological_Process_2021__glycoside catabolic process (GO:0016139),-0.6826859251938212,-1.1131317193115589,0.3898305084745763,0.7644753393605724,1.0,3/8,23.07%,GLA;GUSB;GBA3
prerank,GO_Biological_Process_2021__regulation of viral transcription (GO:0046782),-0.5570455922622927,-1.1131071155481211,0.296875,0.7641378442072572,1.0,6/32,9.65%,ZFP36;MDFIC;IFITM3;CTDP1;POLR2G;TRIM13
prerank,GO_Biological_Process_2021__protein phosphorylation (GO:0006468),0.3461941296351766,1.1131019769019737,0.0,0.7453219037930683,1.0,75/366,16.08%,DAPK2;FER;CDK5R1;ACVR2A;IGF1R;AATK;FAM20C;TGFBR2;CSNK1G1;PDK4;SMAD7;STK32B;MAP3K11;CDK10;PKD1;LRRK2;NEK10;MAP2K1;STK36;RPS6KA4;CDK17;TLK1;PIM1;RELN;SMAD2;STK25;CDK18;MAST2;CDK7;NUAK1;CAB39;RYK;MAP4K5;NLK;TLR7;MAP3K10;STK38L;BRSK1;IRAK1;MAST3;PLK2;BMPR1B;DYRK1A;MERTK;IRAK3;CDK13;WNK1;RPS6KA6;FNIP2;MAPK1;CAMKV;CDK6;BMPR1A;NTRK2;MAPKAPK2;CILK1;CSNK1E;PRKCI;PRKAB1;MARK1;PRRT1;PTK2;ERBB4;CDKL2;TYRO3;MAP3K13;STK10;MAP3K5;ATP13A2;TGFBR1;AKT2;GSK3B;GTF2H3;ABI1;RPS6KB2
prerank,GO_Biological_Process_2021__positive regulation of fatty acid oxidation (GO:0046321),-0.6960021714023332,-1.1130701406771626,0.40350877192982454,0.7638436100741874,1.0,1/7,0.08%,NR4A3
prerank,Reactome_2022__Regulation Of Commissural Axon Pathfinding By SLIT And ROBO R-HSA-428542,0.6408597294279215,1.1127219046513879,0.38235294117647056,0.7458355646502656,1.0,4/8,19.44%,ROBO1;DCC;ROBO2;SLIT3
prerank,GO_Biological_Process_2021__regulation of receptor recycling (GO:0001919),0.548091477986824,1.1126332107473105,0.36363636363636365,0.7455951173181267,1.0,2/13,6.95%,SCRIB;TBC1D16
prerank,GO_Biological_Process_2021__regulation of cell communication by electrical coupling (GO:0010649),-0.6904945391044119,-1.1126148706209142,0.39285714285714285,0.7647789592065921,1.0,2/7,8.36%,SRI;CALM1
prerank,GO_Biological_Process_2021__oligosaccharide-lipid intermediate biosynthetic process (GO:0006490),0.6191100047367154,1.1125886040734578,0.30952380952380953,0.7452428688622057,1.0,4/11,18.89%,MPDU1;ALG12;ALG8;ALG3
prerank,Reactome_2022__RND2 GTPase Cycle R-HSA-9696270,0.49761149232787794,1.1125802125257698,0.30952380952380953,0.744755037937227,1.0,7/31,12.73%,SCRIB;PKP4;DLG5;PTPN13;LEMD3;GOLGA3;LRRC1
prerank,GO_Biological_Process_2021__epidermal growth factor receptor signaling pathway (GO:0007173),0.5292280789986903,1.1121184890691123,0.35294117647058826,0.7455956124052896,1.0,3/31,4.13%,TGFA;GAB1;NCK2
prerank,GO_Biological_Process_2021__atrioventricular valve development (GO:0003171),0.6124854950361318,1.1120535731615728,0.3076923076923077,0.7452121167117076,1.0,2/9,12.30%,TGFBR2;BMPR1A
prerank,GO_Biological_Process_2021__actin crosslink formation (GO:0051764),-0.6139599187843172,-1.1118922754421976,0.36923076923076925,0.7663466807486736,1.0,2/9,2.67%,FLNA;AIF1
prerank,"GO_Biological_Process_2021__positive regulation of synaptic transmission, glutamatergic (GO:0051968)",0.5550900657809127,1.1118270945337938,0.3157894736842105,0.7452764435749836,1.0,8/11,22.68%,NLGN1;RELN;SHANK3;CACNG8;CACNG2;CACNG3;NRXN1;TSHZ3
prerank,GO_Biological_Process_2021__peptide metabolic process (GO:0006518),-0.5291771226242981,-1.1117589793836475,0.3088235294117647,0.7662897264627233,1.0,13/45,15.68%,TPP1;GSTM4;GSTP1;GSTK1;GSTM3;ERAP1;ABCB9;GLRX2;SOD1;GPX1;ERAP2;TRHDE;PCSK5
prerank,Reactome_2022__Adaptive Immune System R-HSA-1280218,-0.4237510349208389,-1.1116826194935583,0.2391304347826087,0.7660568201934878,1.0,88/530,15.88%,ITK;JAML;BTN3A1;CD36;UBC;HLA-B;CD96;RPS27A;PRKCQ;HERC6;GRAP2;B2M;SIGLEC1;PSMB3;YES1;CD200R1;SELL;BTK;CD247;CBLB;CTSB;RNF213;SLAMF6;NDUFA2;BTN3A3;NCF4;ELOB;SPSB1;ARIH2;HLA-C;LILRB4;CD300LF;HLA-DRB5;DTX3L;KLHL13;RNF144B;BTN3A2;BTN2A1;RNF126;PSMB6;PSMA7;FYN;THEM4;HLA-F;ITGA4;KLRD1;CALM1;BTN2A2;OSCAR;UBAC1;PSMB9;GLMN;CD226;NCF2;TRIM69;ITGB2;DCTN6;HLA-DRA;ERAP1;RBX1;TYROBP;ITGAL;DCTN4;PSMD12;ANAPC11;TRAF7;CYBA;PTPRC;PSMD8;PSMA5;PIK3CB;DYNC1LI2;REL;ASB8;HLA-E;DZIP3;COLEC12;ERAP2;HLA-DPA1;UBA52;C3;CDC26;KLRF1;HLA-DMB;AP2S1;CD74;CD200;SEC13
prerank,GO_Biological_Process_2021__cholesterol import (GO:0070508),-0.7058309188801644,-1.1116612721313959,0.4,0.7653066197226116,1.0,1/5,0.52%,CD36
prerank,GO_Biological_Process_2021__sterol import (GO:0035376),-0.7058309188801644,-1.1116612721313959,0.4,0.7653066197226116,1.0,1/5,0.52%,CD36
prerank,KEGG_2021_Human__Alzheimer disease,-0.43233888477465054,-1.1116335172985359,0.2222222222222222,0.7649843573062791,1.0,53/245,18.89%,TUBB8;CYCS;GAPDH;COX7C;PSMB3;UQCRB;NDUFC1;NDUFA2;UQCRH;NDUFA1;ADRM1;SLC25A5;NDUFB9;ATP5PD;NDUFA12;EIF2AK2;ATP5F1E;PSMB6;NDUFB4;PSMA7;UQCR10;ATG2A;CALM1;COX4I1;COX5B;DVL1;NDUFB1;NDUFS8;CHRM5;NDUFS5;FZD2;PSMD12;COX7A2;PSMD8;PSMA5;COX6C;PIK3CB;TUBB4B;NDUFS6;NDUFB7;WIPI1;UQCRC1;NDUFB3;PSMA3;UQCRQ;ATP5F1C;PSMC4;CSNK2A2;APH1B;NDUFS7;NDUFA3;ATP5F1D;NAE1
prerank,GO_Biological_Process_2021__cellular transition metal ion homeostasis (GO:0046916),-0.5139516497580725,-1.1116283596109762,0.33783783783783783,0.7645959751638369,1.0,4/58,2.30%,MT2A;FTH1;TFRC;HAMP
prerank,Reactome_2022__Signaling By Erythropoietin R-HSA-9006335,0.5400093963608064,1.1114065261620634,0.2702702702702703,0.7459153843810713,1.0,1/21,1.00%,PIGU
prerank,GO_Biological_Process_2021__positive regulation of autophagosome assembly (GO:2000786),0.664923049864192,1.1112958755880642,0.3181818181818182,0.7457398465336522,1.0,4/8,25.67%,PIP4K2A;SH3GLB1;RAB3GAP2;PIP4K2B
prerank,GO_Biological_Process_2021__COPII-coated vesicle budding (GO:0090114),0.4539382314009295,1.111136193734104,0.2413793103448276,0.7456522304122037,1.0,7/57,6.50%,VAPB;TGFA;BET1;CTSC;RAB1B;SEC24B;TMED10
prerank,GO_Biological_Process_2021__positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),-0.6544500648262299,-1.111045329480722,0.42105263157894735,0.7655180993305815,1.0,5/10,14.31%,SLAMF6;HLA-F;KLRD1;CD226;HLA-E
prerank,GO_Biological_Process_2021__positive regulation of natural killer cell mediated immunity (GO:0002717),-0.6544500648262299,-1.111045329480722,0.42105263157894735,0.7655180993305815,1.0,5/10,14.31%,SLAMF6;HLA-F;KLRD1;CD226;HLA-E
prerank,GO_Biological_Process_2021__regulation of respiratory system process (GO:0044065),-0.7198328016577024,-1.1110345162023298,0.3584905660377358,0.7651442677352064,1.0,1/6,7.64%,NLGN2
prerank,Reactome_2022__PIP3 Activates AKT Signaling R-HSA-1257604,0.377935355167567,1.1109075013965986,0.21052631578947367,0.7457479429908845,1.0,38/198,15.67%,EGR1;PDGFA;RRAGD;PIGU;RNF2;CBX6;TGFA;CASP9;MTA2;TSC2;PIP5K1B;PPARG;PHLPP1;NRG1;KITLG;SEM1;PPP2R1B;IRAK1;MDM2;HDAC1;PREX2;NRG3;MAPK1;PTEN;GAB2;PIP4K2A;PIK3AP1;NRG2;VAV1;JUN;PPP2R5E;ERBB4;XIAP;TRAF6;LAMTOR3;PHC1;AKT2;GSK3B
prerank,CellMarker_Augmented_2021__Pluripotent Stem cell:Ovarian Cortex,0.5212582982776713,1.1107791624762258,0.3055555555555556,0.7456126800467584,1.0,4/26,9.19%,FLVCR1;POU2F1;SHISA9;ZNF90
prerank,GO_Biological_Process_2021__diol metabolic process (GO:0034311),-0.6733417554363681,-1.1106098022745248,0.31746031746031744,0.7659124687161759,1.0,3/12,9.36%,DEGS2;CALM1;PTS
prerank,GO_Biological_Process_2021__regulation of actin cytoskeleton reorganization (GO:2000249),0.48056639223717595,1.1105480261348133,0.375,0.7456844247640841,1.0,1/26,0.61%,NRP1
prerank,GO_Biological_Process_2021__embryonic digestive tract development (GO:0048566),0.6459439334638728,1.110468930214208,0.35135135135135137,0.7454142515008958,1.0,5/9,19.59%,SALL1;TNF;RARB;NIPBL;FGFR2
prerank,GO_Biological_Process_2021__neuromuscular synaptic transmission (GO:0007274),0.6051392570007554,1.1104582940301648,0.2830188679245283,0.7449140738793529,1.0,2/9,7.96%,TSPOAP1;DTNA
prerank,PanglaoDB_Augmented_2021__Clara Cells,0.6787404788266413,1.1103602524938794,0.37209302325581395,0.7446447934618124,1.0,1/8,0.15%,LEPR
prerank,GO_Biological_Process_2021__cellular protein modification process (GO:0006464),0.35507628639098515,1.1102223574314773,0.0,0.7445504072145805,1.0,118/716,13.82%,SPSB2;B3GNT2;ANXA1;DUSP6;FBXO30;HS3ST5;PTPN9;DAPK2;PIGU;FER;PGAP1;ACVR2A;DCAF16;GOLM1;KBTBD6;AATK;FAM20C;TGFBR2;PDK4;SIRT1;FBXL14;ZBTB16;PPM1L;MAP3K11;CDK10;LARGE1;LRRK2;FBXO32;NEK10;DCAF13;MAP2K1;STK36;FEM1B;DDA1;RPS6KA4;CDK17;UBE2E2;PTPRM;TLK1;PIM1;PARP1;RAB1B;PRKCSH;B4GALT7;STK25;CDK18;PPP4R2;MAST2;CDK7;VGF;NUAK1;UBE2D2;ANO8;RYK;PTAR1;NTAQ1;MAP4K5;NLK;PPP2R1B;STK38L;GPS1;PTPN13;BRSK1;ILKAP;FUT9;IRAK1;PIGT;CDC14B;PPP3CA;PLK2;SIRT6;DUSP7;KCTD6;BTRC;BMPR1B;LOXL2;PTPRG;PTPRK;DYRK1A;HIF3A;UBE2L3;PTPN5;MERTK;FBXW11;IRAK3;FBXW7;EPAS1;CDK13;WNK1;PTPRD;FEM1C;FNIP2;PGGT1B;MAPK1;UST;DCAF5;PTEN;CDK6;SETD3;BMPR1A;DCUN1D1;CHM;MAPKAPK2;CILK1;CSNK1E;KLHL42;FBXL12;COP1;FBXL7;PRKCI;STT3B;SBF1;PRKAB1;MARK1;PRRT1;PPP2R5E;DNAJC3;FBXO27
prerank,Reactome_2022__RAS Processing R-HSA-9648002,-0.6234473672960318,-1.1102215286838264,0.4,0.7666467209285458,1.0,2/12,8.36%,PRKCQ;CALM1
prerank,GO_Biological_Process_2021__negative regulation of Notch signaling pathway (GO:0045746),0.5857698047350774,1.10989907351194,0.3137254901960784,0.7449000991248751,1.0,3/14,14.07%,TSPAN15;FBXW7;MMP14
prerank,GO_Biological_Process_2021__telomere maintenance via telomerase (GO:0007004),-0.5725984201013101,-1.1097280447232976,0.3333333333333333,0.7675742197726106,1.0,5/19,17.02%,TERF2IP;NHP2;NOP10;ANKRD28;RFC1
prerank,KEGG_2021_Human__FoxO signaling pathway,0.41112950186066105,1.109694329584145,0.22727272727272727,0.7449165796326389,1.0,19/92,12.60%,PRKAB2;IGF1R;CCNG2;TGFBR2;SIRT1;MAPK11;SETD7;FBXO32;MAP2K1;CAT;SMAD3;NLK;PLK2;MDM2;PCK2;MAPK1;PTEN;SOD2;CSNK1E
prerank,Reactome_2022__Cell Junction Organization R-HSA-446728,-0.4892356216822812,-1.1096252261677761,0.3492063492063492,0.767531169104423,1.0,4/45,8.60%,FLNA;CLDN7;JUP;ITGA6
prerank,GO_Biological_Process_2021__regulation of lipid catabolic process (GO:0050994),0.637235219519052,1.1094221947565501,0.37735849056603776,0.7450122067748873,1.0,3/8,16.79%,TNF;PDE3B;PRKAA1
prerank,Reactome_2022__NEP/NS2 Interacts With Cellular Export Machinery R-HSA-168333,0.4610893286504423,1.1092132898722105,0.2857142857142857,0.7450285887974744,1.0,7/32,17.93%,NUP153;NUP188;NUP42;XPO1;NDC1;NUP133;NUP205
prerank,GO_Biological_Process_2021__protein autoubiquitination (GO:0051865),0.4644442510608715,1.1090523017747222,0.25925925925925924,0.7449975116285883,1.0,13/53,15.70%,RNF122;UHRF2;RNF208;MARCHF5;UBE3D;UBE2D2;MDM2;RNF19B;RNF185;RNF10;SH3RF1;TRAF6;RNF220
prerank,Reactome_2022__trans-Golgi Network Vesicle Budding R-HSA-199992,-0.4934617873583492,-1.108947948913691,0.2987012987012987,0.7692183055822466,1.0,3/58,1.44%,TPD52;FTH1;TFRC
prerank,GO_Biological_Process_2021__mitotic DNA integrity checkpoint signaling (GO:0044774),-0.6827484899172513,-1.10873858401748,0.3220338983050847,0.7694815434909528,1.0,1/8,4.73%,HUS1
prerank,GO_Biological_Process_2021__negative regulation of cellular component movement (GO:0051271),-0.6367675381280787,-1.1087382891792725,0.375,0.7690786735728947,1.0,1/11,1.03%,TGFBR3
prerank,Reactome_2022__Displacement Of DNA Glycosylase By APEX1 R-HSA-110357,-0.7065522191857518,-1.1086507544320952,0.3709677419354839,0.7688838939797646,1.0,2/6,4.21%,SMUG1;OGG1
prerank,GO_Biological_Process_2021__negative regulation of leukocyte migration (GO:0002686),-0.742719269120069,-1.1084970573040631,0.3,0.7689251818571471,1.0,2/6,15.81%,CD200R1;CD200
prerank,PanglaoDB_Augmented_2021__Pancreatic Stellate Cells,-0.5382892194961211,-1.108493381141851,0.32894736842105265,0.768527949367357,1.0,3/36,1.29%,SPON2;COL5A1;DYNLT1
prerank,GO_Biological_Process_2021__axon ensheathment in central nervous system (GO:0032291),0.6977804348663186,1.1084482253894063,0.3333333333333333,0.7460488862630362,1.0,3/5,18.85%,MYRF;CNTNAP1;B4GALT5
prerank,GO_Biological_Process_2021__negative regulation of receptor-mediated endocytosis (GO:0048261),0.5618130342486076,1.1082890001940806,0.3448275862068966,0.7458829373360284,1.0,4/18,12.17%,ABCA2;PICALM;ITGAV;ARF6
prerank,GO_Biological_Process_2021__mesenchyme morphogenesis (GO:0072132),0.6753195225537193,1.1082733282126704,0.4318181818181818,0.7454252793447282,1.0,4/7,26.65%,SMAD2;BMPR1A;ACVR1;NOTCH1
prerank,CellMarker_Augmented_2021__Goblet Progenitor cell:Large Intestine,0.7247559420650163,1.108266887497498,0.2857142857142857,0.744928816828729,1.0,1/7,2.58%,TSPAN15
prerank,GO_Biological_Process_2021__establishment of mitotic spindle localization (GO:0040001),-0.598040752960504,-1.1082211840156717,0.31746031746031744,0.768932230658159,1.0,1/18,1.29%,DYNLT1
prerank,GO_Biological_Process_2021__renal absorption (GO:0070293),0.6470065661511912,1.108216732631342,0.3333333333333333,0.7445039405543191,1.0,1/7,1.66%,GSN
prerank,GO_Biological_Process_2021__regulation of presynapse assembly (GO:1905606),0.64659741427642,1.1080767124029596,0.37209302325581395,0.7439313170278254,1.0,6/10,19.35%,IL1RAPL2;PTPRD;GPC6;LRRC4B;IL1RAPL1;SNCA
prerank,GO_Biological_Process_2021__regulation of presynapse organization (GO:0099174),0.64659741427642,1.1080767124029596,0.37209302325581395,0.7439313170278254,1.0,6/10,19.35%,IL1RAPL2;PTPRD;GPC6;LRRC4B;IL1RAPL1;SNCA
prerank,GO_Biological_Process_2021__negative regulation of protein metabolic process (GO:0051248),-0.5355140826884108,-1.107588227717023,0.3088235294117647,0.7704853015501378,1.0,2/34,4.82%,FLNA;CLU
prerank,GO_Biological_Process_2021__snRNA metabolic process (GO:0016073),0.591107845947143,1.1075423957189194,0.38095238095238093,0.7449705816025309,1.0,3/14,12.61%,MEPCE;INTS6;INTS7
prerank,Reactome_2022__NR1H2 And NR1H3-mediated Signaling R-HSA-9024446,-0.5434955558551651,-1.107524451956408,0.2727272727272727,0.7702526366954625,1.0,4/36,5.38%,ARL4C;APOD;PLTP;NR1H2
prerank,GO_Biological_Process_2021__negative regulation of alcohol biosynthetic process (GO:1902931),-0.6824673462123684,-1.10737227435714,0.34615384615384615,0.7703401525889034,1.0,2/9,13.37%,PLEK;SOD1
prerank,GO_Biological_Process_2021__muscle filament sliding (GO:0030049),0.5531109773677839,1.1071073875080344,0.2564102564102564,0.7451523636929228,1.0,1/13,0.52%,TPM2
prerank,GO_Biological_Process_2021__actin-myosin filament sliding (GO:0033275),0.5531109773677839,1.1071073875080344,0.2564102564102564,0.7451523636929228,1.0,1/13,0.52%,TPM2
prerank,GO_Biological_Process_2021__regulation of ubiquitin-dependent protein catabolic process (GO:2000058),-0.5290538632461981,-1.1069743868687576,0.3548387096774194,0.771024796968827,1.0,7/37,9.67%,PYHIN1;RPL5;CLU;RPL11;RPL23;RPS7;GLMN
prerank,GO_Biological_Process_2021__negative regulation of establishment of protein localization (GO:1904950),0.6193782955380753,1.106807614803418,0.32558139534883723,0.7453725564609308,1.0,6/10,33.13%,SNX12;PPM1F;DNAJA1;CORO2B;NDFIP2;MAPT
prerank,GO_Biological_Process_2021__galactose metabolic process (GO:0006012),0.6791366283799674,1.1067352069741054,0.39622641509433965,0.7450983870018266,1.0,3/6,26.42%,CHST1;PGM2L1;GALE
prerank,GO_Biological_Process_2021__phagosome-lysosome fusion (GO:0090385),0.6962762813476314,1.106377316794272,0.33962264150943394,0.745482897783154,1.0,6/6,30.41%,RAB7A;ARL8B;RAB7B;RAB20;PIKFYVE;RAB39A
prerank,Reactome_2022__HIV Infection R-HSA-162906,-0.43915915019887825,-1.1059885986810518,0.2987012987012987,0.7735699544030255,1.0,27/197,12.85%,UBC;RPS27A;CXCR4;B2M;PSMB3;CD247;GTF2H5;CTDP1;ELOB;SLC25A5;RANBP1;POLR2G;PSMB6;RNMT;PSMA7;FYN;APOBEC3G;PSMB9;NCBP2;VPS28;NPM1;NUP50;RBX1;PSMD12;VPS37B;PSMD8;PSMA5
prerank,Reactome_2022__Signaling By Nuclear Receptors R-HSA-9006931,-0.4426096630324368,-1.105307083918635,0.27380952380952384,0.7750554963086723,1.0,20/167,9.35%,H2BC4;H2BC26;H2AC20;FOS;H2AC6;USF1;ARL4C;APOD;PDHX;PLTP;GREB1;GNB5;NR1H2;H3-3B;H2AJ;H2BC21;POLR2G;H2BC5;CALM1;H2BC9
prerank,GO_Biological_Process_2021__regulation of cellular protein localization (GO:1903827),0.4327984065235865,1.1052091890951092,0.2222222222222222,0.7481146110770257,1.0,14/37,23.88%,ABCA2;LCP1;PARP1;DVL3;GPC6;CSNK1E;SETD2;ATP13A2;PRKAA1;PPM1F;MAP2;GBF1;TOR1A;GPC1
prerank,GO_Biological_Process_2021__cellular response to muramyl dipeptide (GO:0071225),-0.6867517159955341,-1.1051165485631202,0.38596491228070173,0.7751731960017144,1.0,5/8,25.45%,NOD2;VIM;PTPN22;TRIM41;ARHGEF2
prerank,GO_Biological_Process_2021__negative regulation of cellular amide metabolic process (GO:0034249),-0.4886910356679671,-1.1050492843946544,0.21428571428571427,0.7749153547423736,1.0,12/70,9.50%,GAPDH;BTG2;GZMB;RPL13A;RACK1;CLU;RPS3;IGF1;ILF3;EIF2AK2;EIF4A3;ORMDL1
prerank,GO_Biological_Process_2021__regulation of fat cell proliferation (GO:0070344),-0.7610579270709803,-1.1049648296448111,0.4,0.7747656583332451,1.0,2/5,3.13%,PID1;PER2
prerank,GO_Biological_Process_2021__glycosylceramide catabolic process (GO:0046477),-0.7097617362662598,-1.1049471448598525,0.35,0.7744145398610215,1.0,3/5,23.07%,GLA;GALC;GBA3
prerank,GO_Biological_Process_2021__postreplication repair (GO:0006301),-0.5463382690887737,-1.104931609664963,0.3333333333333333,0.7740309882639794,1.0,2/36,1.30%,UBC;RPS27A
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Undefined,-0.5223888190991022,-1.104682744075544,0.323943661971831,0.774336233733307,1.0,14/64,8.71%,PROCR;CD96;CD2;CXCR4;TFRC;CD55;CLEC12A;CD14;ABCB1;IL3RA;PECAM1;TNFAIP3;ITGA6;CD44
prerank,GO_Biological_Process_2021__negative regulation of histone methylation (GO:0031061),-0.6516133952008545,-1.104555776649669,0.39344262295081966,0.7742479957996317,1.0,3/11,17.91%,DNMT1;BRCA1;SUPT6H
prerank,Reactome_2022__Regulation Of IFNA/IFNB Signaling R-HSA-912694,-0.6670228407551321,-1.1041728443933243,0.3137254901960784,0.7749551309919629,1.0,4/9,29.94%,STAT1;STAT2;PTPN11;IFNAR1
prerank,GO_Biological_Process_2021__regulation of RIG-I signaling pathway (GO:0039535),-0.6379793683092618,-1.1040869854914237,0.37254901960784315,0.7747684739665025,1.0,4/13,21.42%,DHX58;NOP53;DDX60;C1QBP
prerank,GO_Biological_Process_2021__regulation of establishment of cell polarity (GO:2000114),-0.6107083273386498,-1.1039053498561158,0.3898305084745763,0.7748811002378949,1.0,2/14,4.24%,RIPOR2;RACK1
prerank,Reactome_2022__FGFR2 Ligand Binding And Activation R-HSA-190241,-0.7149181518333292,-1.1038158456331468,0.42592592592592593,0.7739724508427952,1.0,2/5,14.45%,FGF13;FGF20
prerank,Reactome_2022__FGFR2c Ligand Binding And Activation R-HSA-190375,-0.7149181518333292,-1.1038158456331468,0.42592592592592593,0.7739724508427952,1.0,2/5,14.45%,FGF13;FGF20
prerank,Reactome_2022__Activated Point Mutants Of FGFR2 R-HSA-2033519,-0.7149181518333292,-1.1038158456331468,0.42592592592592593,0.7739724508427952,1.0,2/5,14.45%,FGF13;FGF20
prerank,GO_Biological_Process_2021__release of cytochrome c from mitochondria (GO:0001836),-0.6199910324827562,-1.1036874254505227,0.3076923076923077,0.7739127020620455,1.0,2/10,5.76%,CLU;FIS1
prerank,GO_Biological_Process_2021__regulation of RNA splicing (GO:0043484),-0.5052646455385933,-1.1035754930091903,0.3142857142857143,0.7738297090193414,1.0,7/65,9.76%,RPS13;JMJD6;RPS26;RBM22;FAM50A;SRPK1;U2AF2
prerank,GO_Biological_Process_2021__regulation of transport (GO:0051049),0.49964617593956784,1.103472426568016,0.3191489361702128,0.7527072447392822,1.0,4/22,3.81%,LEPR;NRP1;EPB41;LRRK2
prerank,GO_Biological_Process_2021__positive regulation of MHC class II biosynthetic process (GO:0045348),0.7087599895028883,1.1029479427342845,0.41818181818181815,0.7536959331745264,1.0,1/5,2.51%,SIRT1
prerank,GO_Biological_Process_2021__synaptic vesicle endocytosis (GO:0048488),-0.5441943609366517,-1.1029162438442872,0.3484848484848485,0.7753866978748278,1.0,2/29,1.19%,MX2;MX1
prerank,Reactome_2022__Transport Of Small Molecules R-HSA-382551,-0.42543593658943374,-1.1029067959000747,0.21505376344086022,0.7750283025016338,1.0,66/417,13.90%,ABCA9;UBC;PLN;SLC2A3;FTH1;RPS27A;SLC7A5;TFRC;MCOLN2;EMB;SLC9B1;SLC38A4;ABCA6;LIPG;PSMB3;APOD;PLTP;AQP11;SLC38A1;ATP6V1F;GNB5;ABCC3;ABCB1;SLC5A9;RAB11A;SLC16A3;NR1H2;SLC25A5;ATP10A;ABCF1;PHB2;SRI;PRKAR1B;ATP13A1;SLC16A7;PSMB6;PSMA7;SGK1;CALM1;CLCA4;PSMB9;TRPV4;TRPM3;SMDT1;ABCB4;BEST1;SLC11A1;SLC14A1;SLC2A8;CFTR;SLC36A4;TRPM4;ABCB9;ABCA8;STEAP2;SLC12A7;SLC29A3;PSMD12;MICU2;PSMD8;PSMA5;ATP1B3;SPG7;FTL;VLDLR;MAIP1
prerank,GO_Biological_Process_2021__regulation of microglial cell activation (GO:1903978),-0.6785113776151543,-1.1027968401135628,0.38333333333333336,0.774935554309761,1.0,1/10,0.62%,CCL3
prerank,GO_Biological_Process_2021__negative regulation of nucleic acid-templated transcription (GO:1903507),0.354475683281688,1.102718771316614,0.21428571428571427,0.7537844534963558,1.0,44/305,11.06%,KLF4;QARS1;CDK5R1;GCLC;ZBTB33;SIRT1;ZBTB16;DPF3;ZNF706;SPINDOC;HDAC9;TLE2;CBFA2T3;WNT5A;SAMD1;FOXN3;ZNF12;PPARG;POU2F1;SMAD2;DDIT3;NRG1;DACH1;SALL1;HMGA1;TNF;RFX3;CLOCK;NACC2;MAP3K10;TRERF1;CNOT7;CTBP2;IKZF1;SFMBT1;MDM2;BTRC;HDAC1;TWIST2;LOXL2;PTPRK;FBXW11;ZBTB38;TCF7L2
prerank,GO_Biological_Process_2021__endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),0.3891022172235498,1.102669858085486,0.25,0.7533729653695967,1.0,17/137,10.39%,VAPB;PGAP1;TGFA;BET1;HYOU1;CTSC;TMED3;RAB1B;SEC24B;TMED10;TMED5;COPG1;SPTAN1;GRIA1;LMAN2L;VTI1A;COG1
prerank,Reactome_2022__RND3 GTPase Cycle R-HSA-9696264,0.49553673908903245,1.102653228046087,0.375,0.7528995840952639,1.0,8/30,9.38%,SCRIB;PKP4;DLG5;PICALM;RASAL2;TMOD3;PTPN13;LEMD3
prerank,GO_Biological_Process_2021__inositol lipid-mediated signaling (GO:0048017),0.4309175316923234,1.1025253246300577,0.2777777777777778,0.7526530458616143,1.0,5/36,8.96%,IGF1R;PLCL1;PLCB4;PIK3C2B;PI4KB
prerank,GO_Biological_Process_2021__positive regulation of JUN kinase activity (GO:0043507),0.5556900008965434,1.102419948762615,0.2926829268292683,0.752438017861582,1.0,8/16,16.34%,MAP3K11;TNF;DVL3;MAP3K10;SASH1;TRAF6;MAP3K5;MAP3K7
prerank,GO_Biological_Process_2021__negative regulation of ATPase activity (GO:0032780),-0.6491204303286574,-1.1020653764187602,0.3333333333333333,0.7767872655154372,1.0,2/11,2.82%,PLN;IFIT1
prerank,GO_Biological_Process_2021__regulation of plasma membrane bounded cell projection assembly (GO:0120032),0.44132204668527986,1.1018946426546832,0.2692307692307692,0.75339176135931,1.0,9/53,13.99%,FER;TBC1D1;TBC1D5;TBC1D10B;TBC1D16;TBC1D22B;ARF6;RABGAP1;EVI5
prerank,GO_Biological_Process_2021__carboxylic acid transport (GO:0046942),-0.5457705883928973,-1.1016498181898178,0.3387096774193548,0.7774887177737358,1.0,8/27,15.72%,SLC7A5;SLC38A1;SLC16A3;SLC16A7;LLGL2;SLC36A4;SLC16A6;SLC38A6
prerank,GO_Biological_Process_2021__semaphorin-plexin signaling pathway (GO:0071526),0.5035065978742675,1.1016378027515732,0.3684210526315789,0.7535579769763036,1.0,7/23,6.97%,PLXNB1;NRP1;SEMA5A;PLXNA2;PLXNA3;SEMA3B;PLXNB2
prerank,GO_Biological_Process_2021__ceramide catabolic process (GO:0046514),0.6463885081072263,1.1016305390832593,0.38095238095238093,0.7530938317336547,1.0,1/10,0.67%,ACER2
prerank,Reactome_2022__SUMO Is Proteolytically Processed R-HSA-3065679,-0.6612758819440004,-1.1016191902722607,0.41304347826086957,0.7771950331506887,1.0,3/5,29.34%,SUMO2;SUMO1;SENP1
prerank,CellMarker_Augmented_2021__Non-classical monocyte:Peripheral Blood,-0.7252437391242371,-1.1013136921508173,0.3684210526315789,0.7757450040260787,1.0,2/6,5.12%,CD14;IL3RA
prerank,CellMarker_Augmented_2021__Suppressive monocyte:Peripheral Blood,-0.7252437391242371,-1.1013136921508173,0.3684210526315789,0.7757450040260787,1.0,2/6,5.12%,CD14;IL3RA
prerank,CellMarker_Augmented_2021__CD16+ Dendritic cell:Peripheral Blood,-0.7252437391242371,-1.1013136921508173,0.3684210526315789,0.7757450040260787,1.0,2/6,5.12%,CD14;IL3RA
prerank,CellMarker_Augmented_2021__Immature Myeloid cell:Peripheral Blood,-0.7252437391242371,-1.1013136921508173,0.3684210526315789,0.7757450040260787,1.0,2/6,5.12%,CD14;IL3RA
prerank,CellMarker_Augmented_2021__Classical monocyte:Peripheral Blood,-0.7252437391242371,-1.1013136921508173,0.3684210526315789,0.7757450040260787,1.0,2/6,5.12%,CD14;IL3RA
prerank,CellMarker_Augmented_2021__Intermediate monocyte:Peripheral Blood,-0.7252437391242371,-1.1013136921508173,0.3684210526315789,0.7757450040260787,1.0,2/6,5.12%,CD14;IL3RA
prerank,GO_Biological_Process_2021__negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),0.6284079679328802,1.1012492571984938,0.34545454545454546,0.7532473055739775,1.0,1/8,7.80%,KANK1
prerank,GO_Biological_Process_2021__negative regulation of cell morphogenesis involved in differentiation (GO:0010771),0.6284079679328802,1.1012492571984938,0.34545454545454546,0.7532473055739775,1.0,1/8,7.80%,KANK1
prerank,Reactome_2022__Signaling By EGFR In Cancer R-HSA-1643713,-0.6228294974642145,-1.1011667869173076,0.36065573770491804,0.7757773766557605,1.0,3/16,3.25%,UBC;RPS27A;CDC37
prerank,GO_Biological_Process_2021__glycogen metabolic process (GO:0005977),-0.5925170711653258,-1.1010351415973914,0.4032258064516129,0.7757125339176018,1.0,3/20,8.36%,PER2;PHKG1;CALM1
prerank,Reactome_2022__Vpr-mediated Nuclear Import Of PICs R-HSA-180910,0.4740264572760786,1.1008870333703475,0.3235294117647059,0.7536926764863963,1.0,8/33,17.93%,NUP153;NUP188;NUP42;HMGA1;SGIP1;NDC1;NUP133;NUP205
prerank,GO_Biological_Process_2021__regulation of trophoblast cell migration (GO:1901163),-0.6344277007074245,-1.1004196216480606,0.4262295081967213,0.7769659819070055,1.0,2/9,21.42%,VEGFA;C1QBP
prerank,CellMarker_Augmented_2021__Mast cell:Undefined,-0.6368752515832665,-1.1003758783424515,0.3770491803278688,0.7766971854062242,1.0,4/12,12.82%,IL3RA;CSF2RA;ENPP3;PTPRC
prerank,GO_Biological_Process_2021__positive regulation of carbohydrate metabolic process (GO:0045913),-0.5515362643751206,-1.1003351639505385,0.35294117647058826,0.7764194230935701,1.0,5/19,11.98%,IGF1;PFKFB3;PFKFB4;HIF1A;ENTPD5
prerank,CellMarker_Augmented_2021__Neural Crest cell:Undefined,-0.6809229078536845,-1.1003202493005877,0.3888888888888889,0.7760588168508746,1.0,4/7,18.52%,ITGA4;NOTCH2;VIM;ITGB1
prerank,GO_Biological_Process_2021__adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),-0.6638545880405826,-1.10026634170351,0.3709677419354839,0.7758555196126317,1.0,4/13,7.06%,MYO1G;CD55;BTN3A3;BTN3A2
prerank,GO_Biological_Process_2021__postsynaptic membrane assembly (GO:0097104),0.6348081398895417,1.1002584446932346,0.3170731707317073,0.7549210906801991,1.0,4/8,15.11%,LRP4;NLGN1;NRXN2;NLGN4Y
prerank,GO_Biological_Process_2021__cellular response to hydrogen peroxide (GO:0070301),0.4889323586647909,1.099876611176214,0.42424242424242425,0.7555198275853138,1.0,3/24,4.05%,ANXA1;SIRT1;SIRPA
prerank,GO_Biological_Process_2021__cAMP metabolic process (GO:0046058),0.5912594598928429,1.099798929720475,0.4090909090909091,0.755195701806365,1.0,4/9,26.69%,ADCY9;ADCY6;ADCY10;ADCY1
prerank,Reactome_2022__Metabolism Of Carbohydrates R-HSA-71387,0.37305972611948895,1.0997806391788287,0.16666666666666666,0.7547093972612414,1.0,28/183,10.88%,B3GNT2;PFKP;HS3ST5;HS3ST4;PFKM;NCAN;CHST7;CSGALNACT1;GLB1;HS2ST1;B4GALT4;NUP153;NUP188;CSPG5;HPSE;B4GALT7;CHST1;NUP42;SLC37A2;MAP4K5;PPP2R1B;FUT9;GYS1;SLC9A1;SLC37A4;CHST15;PCK2;EXT1
prerank,GO_Biological_Process_2021__positive regulation of lipase activity (GO:0060193),0.6882559904840786,1.099742045946806,0.3617021276595745,0.7543398110557958,1.0,4/5,28.91%,FGFR2;FGFR1;FGFR3;RHOA
prerank,GO_Biological_Process_2021__mesoderm development (GO:0007498),-0.6445897374677846,-1.0995969833943262,0.37254901960784315,0.7774286350171581,1.0,3/9,11.19%,IKZF3;BTK;VEGFA
prerank,Reactome_2022__ATF4 Activates Genes In Response To Endoplasmic Reticulum Stress R-HSA-380994,0.5057894076691108,1.0994341822517015,0.3,0.7545120276514433,1.0,3/20,5.85%,NFYC;EXOSC6;DDIT3
prerank,GO_Biological_Process_2021__RNA-dependent DNA biosynthetic process (GO:0006278),-0.5552848601349705,-1.099397742143588,0.3684210526315789,0.7776075716102392,1.0,5/20,17.02%,TERF2IP;NHP2;NOP10;ANKRD28;RFC1
prerank,GO_Biological_Process_2021__glucose transmembrane transport (GO:1904659),-0.7166708376476663,-1.0992160108649318,0.3793103448275862,0.777680322849398,1.0,2/7,10.34%,SLC2A3;SLC2A8
prerank,GO_Biological_Process_2021__negative regulation of cell-substrate adhesion (GO:0010812),0.48564983104708925,1.0991393258393136,0.2894736842105263,0.7546608321282019,1.0,3/28,7.80%,ACER2;JAG1;KANK1
prerank,CellMarker_Augmented_2021__Endocrine cell:Pancreatic Islet,-0.475534476269578,-1.0991382056308272,0.2857142857142857,0.7774720063333541,1.0,15/78,15.76%,TPP1;CTDSP1;CCDC107;OST4;IFITM3;HLA-C;CD63;PTTG1IP;EMP3;TMEM219;MYL12A;PFN1;SSR4;TMEM179B;LGALS1
prerank,Reactome_2022__Nuclear Pore Complex (NPC) Disassembly R-HSA-3301854,0.4624695234946858,1.099005052418238,0.3333333333333333,0.7544928052480635,1.0,7/31,17.93%,NUP153;NUP188;NUP42;NEK9;NDC1;NUP133;NUP205
prerank,GO_Biological_Process_2021__positive regulation of vesicle fusion (GO:0031340),0.6646262024358967,1.0989198828032982,0.3333333333333333,0.7542169535493776,1.0,1/5,0.34%,ANXA1
prerank,GO_Biological_Process_2021__retinoic acid receptor signaling pathway (GO:0048384),0.6647850025099051,1.0988006460656683,0.37209302325581395,0.7540108800304904,1.0,2/6,13.16%,PPARG;RARB
prerank,GO_Biological_Process_2021__purinergic nucleotide receptor signaling pathway (GO:0035590),-0.5695661116502954,-1.0987786540916822,0.32786885245901637,0.7782906164509016,1.0,4/18,17.61%,PSTPIP1;ENTPD5;C3;IL18
prerank,GO_Biological_Process_2021__tRNA aminoacylation for protein translation (GO:0006418),-0.5348068408186094,-1.098743073240136,0.3333333333333333,0.7779993696386508,1.0,10/38,18.21%,HARS2;WARS1;NARS1;LARS1;KARS1;TARS2;DARS2;GARS1;TARS3;FARSA
prerank,"GO_Biological_Process_2021__positive regulation of mRNA splicing, via spliceosome (GO:0048026)",0.5403352110041593,1.0987410618623359,0.35135135135135137,0.7536663448016034,1.0,4/13,22.40%,PRDX6;TRA2B;THRAP3;NUP98
prerank,GO_Biological_Process_2021__chloride transmembrane transport (GO:1902476),0.5184008605884043,1.098737759690743,0.3953488372093023,0.7531682176735125,1.0,18/30,24.28%,SLC1A3;GLRA1;ANO4;GABRR2;SLC12A6;ANO6;SLC12A5;ANO3;SLC12A2;GABRD;CLCN3;GABRB2;GABRG3;GABRA4;SLC4A8;GABRA2;GLRB;GABRB1
prerank,Reactome_2022__Nef And Signal Transduction R-HSA-164944,-0.699704561068212,-1.0986094667368946,0.47368421052631576,0.7780073810474036,1.0,2/7,7.36%,CD247;FYN
prerank,GO_Biological_Process_2021__DNA replication-independent nucleosome assembly (GO:0006336),-0.5472922653760565,-1.0986080688450928,0.32786885245901637,0.7776108431365741,1.0,5/25,17.45%,CENPU;ITGB3BP;NPM1;HIRA;HAT1
prerank,GO_Biological_Process_2021__sphingomyelin metabolic process (GO:0006684),0.6545166091523095,1.098587920905111,0.3488372093023256,0.7529863370202301,1.0,3/6,12.86%,ABCA2;SAMD8;SGMS1
prerank,Reactome_2022__Clathrin-mediated Endocytosis R-HSA-8856828,-0.4675663285258404,-1.0985742066662292,0.3291139240506329,0.7773387665888705,1.0,7/117,2.80%,UBC;EPN1;RPS27A;CHRM2;TFRC;IL7R;COPS6
prerank,Reactome_2022__Late SARS-CoV-2 Infection Events R-HSA-9772573,-0.5089114009063438,-1.0985120912045514,0.3283582089552239,0.7771312603861446,1.0,5/49,7.76%,UBC;RPS27A;PARP14;PARP9;SRPK1
prerank,GO_Biological_Process_2021__regulation of epidermal growth factor receptor signaling pathway (GO:0042058),0.42818657646914887,1.098421056760799,0.26666666666666666,0.7528431574658223,1.0,4/46,2.15%,FER;SPRY2;HIP1R;TGFA
prerank,GO_Biological_Process_2021__regulation of defense response to bacterium (GO:1900424),-0.7280190811392244,-1.0983304504886837,0.39655172413793105,0.7772452681959441,1.0,1/5,12.67%,CYBA
prerank,GO_Biological_Process_2021__negative regulation of muscle cell apoptotic process (GO:0010656),0.6821590589930018,1.0982719825717813,0.4666666666666667,0.7526847925537058,1.0,1/5,0.35%,BAG3
prerank,GO_Biological_Process_2021__regulation of glial cell proliferation (GO:0060251),0.7276465623433319,1.0982176186994488,0.3673469387755102,0.7523576311712369,1.0,2/5,12.90%,TNF;PRKCI
prerank,GO_Biological_Process_2021__cellular monovalent inorganic cation homeostasis (GO:0030004),0.5958486453628052,1.097994089778913,0.375,0.7524991976183611,1.0,5/12,15.33%,KCNJ2;NEDD4L;SLC9A1;SLC8A1;SLC12A2
prerank,GO_Biological_Process_2021__inositol phosphate biosynthetic process (GO:0032958),0.6095773307061761,1.0978972171754284,0.38095238095238093,0.7522953402575269,1.0,3/9,13.98%,FGF2;IPPK;PPIP5K1
prerank,Reactome_2022__Alpha-protein Kinase 1 Signaling Pathway R-HSA-9645460,-0.6331264577296309,-1.0978463229711675,0.37037037037037035,0.778276701113635,1.0,2/11,1.30%,UBC;RPS27A
prerank,GO_Biological_Process_2021__regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),-0.5396600639028457,-1.097581851134721,0.3108108108108108,0.7786788891794787,1.0,8/46,14.43%,CARD16;RACK1;GSTP1;TNFAIP3;CFLAR;HSPA1B;H2BC11;HSPA1A
prerank,GO_Biological_Process_2021__vesicle transport along actin filament (GO:0030050),-0.6139101611813275,-1.0975510952283747,0.4067796610169492,0.7783565477023646,1.0,1/12,0.94%,MYO1G
prerank,GO_Biological_Process_2021__regulation of interleukin-18 production (GO:0032661),-0.7009049815351225,-1.0973738334515564,0.44680851063829785,0.7784926051951951,1.0,3/5,21.31%,NLRP12;TLR2;GBP5
prerank,GO_Biological_Process_2021__positive regulation of myoblast differentiation (GO:0045663),-0.6249754796181233,-1.0973479749915644,0.3541666666666667,0.7781661071384107,1.0,1/9,0.96%,RIPOR2
prerank,GO_Biological_Process_2021__positive regulation of protein metabolic process (GO:0051247),0.4005961868360557,1.0972502875131152,0.14814814814814814,0.7533031205710031,1.0,9/78,9.35%,KLF4;ABCA2;WNT5A;RAB1B;TNF;FZR1;RAB7A;NEDD4L;PLK2
prerank,GO_Biological_Process_2021__negative regulation of reactive oxygen species metabolic process (GO:2000378),-0.5700057352237196,-1.0972281534511243,0.3508771929824561,0.7781328086985663,1.0,4/13,22.45%,BRCA1;MT3;PINK1;PARK7
prerank,GO_Biological_Process_2021__transport across blood-brain barrier (GO:0150104),-0.5084585035433792,-1.0970799591277738,0.36764705882352944,0.7781818714741758,1.0,8/51,6.91%,CD36;SLC2A3;SLC7A5;TFRC;SLC38A1;ABCC3;ABCB1;SLC16A7
prerank,Reactome_2022__Tryptophan Catabolism R-HSA-71240,-0.6662449863456479,-1.0969212807243185,0.41509433962264153,0.7782948845178497,1.0,3/8,10.63%,SLC7A5;KMO;SLC36A4
prerank,KEGG_2021_Human__Transcriptional misregulation in cancer,-0.477047311956526,-1.0968342524395625,0.38461538461538464,0.7781016524948423,1.0,10/110,6.09%,NR4A3;BCL2A1;BCL11B;GADD45B;CD14;PER2;GZMB;JUP;IGF1;H3-3B
prerank,GO_Biological_Process_2021__positive regulation of fatty acid metabolic process (GO:0045923),-0.6309900489303166,-1.0965970886009275,0.3870967741935484,0.778410964087936,1.0,2/12,5.38%,NR4A3;NR1H2
prerank,Reactome_2022__Plasma Lipoprotein Remodeling R-HSA-8963899,-0.6022180767386419,-1.0959693579423135,0.3684210526315789,0.779943245478083,1.0,2/14,4.17%,LIPG;PLTP
prerank,GO_Biological_Process_2021__regulation of cytokine-mediated signaling pathway (GO:0001959),-0.5198439663194986,-1.095916520901742,0.3283582089552239,0.7796445427776197,1.0,9/60,12.82%,SIGIRR;CDC37;RACK1;TNFAIP3;RNASEL;STAT1;CFLAR;IFNGR2;PTPRC
prerank,GO_Biological_Process_2021__protein localization to kinetochore (GO:0034501),-0.6383058006055504,-1.0958573471177508,0.42592592592592593,0.7793871809595624,1.0,5/10,23.81%,ZWILCH;MIS12;IK;BUB3;CHAMP1
prerank,GO_Biological_Process_2021__inorganic anion transmembrane transport (GO:0098661),0.4776502242483335,1.095479570777668,0.28205128205128205,0.7571444618953324,1.0,20/43,21.77%,SLC1A3;XPR1;GLRA1;ANO4;GABRR2;SLC37A2;SLC12A6;SLC37A4;ANO6;SLC12A5;SLC25A14;ANO3;SLC12A2;GABRD;CLCN3;GABRB2;GABRG3;GABRA4;SLC4A8;GABRA2
prerank,Reactome_2022__Integration Of Energy Metabolism R-HSA-163685,0.4702976408787812,1.0954487055870945,0.32142857142857145,0.7567541905864439,1.0,17/73,14.74%,PRKAB2;CACNA1A;ADIPOR2;RAP1A;GNAQ;ADCY9;ACACB;PPP2R1B;KCNC2;STX1A;GNA11;FASN;ABCC8;ADCY6;CACNA1E;AHCYL1;RAPGEF3
prerank,KEGG_2021_Human__Progesterone-mediated oocyte maturation,0.4191954139947372,1.0953762832145009,0.3103448275862069,0.7564026907457803,1.0,16/66,15.47%,SPDYE16;IGF1R;MAPK11;MAP2K1;ADCY9;CPEB4;FZR1;SPDYA;CDC23;PDE3B;RPS6KA6;MAPK1;ADCY6;ANAPC1;STK10;AKT2
prerank,GO_Biological_Process_2021__cellular response to sterol (GO:0036315),-0.6991909299447461,-1.0952991822069007,0.36923076923076925,0.7805338104610331,1.0,2/9,3.27%,INSIG1;RORA
prerank,KEGG_2021_Human__Cholesterol metabolism,-0.5407378739921439,-1.0952172461588938,0.2638888888888889,0.7803855858900872,1.0,4/31,4.17%,OSBPL5;CD36;LIPG;PLTP
prerank,Reactome_2022__Signaling By NTRK3 (TRKC) R-HSA-9034015,0.6062882043450378,1.0951090795879994,0.3157894736842105,0.7565333988340102,1.0,7/11,36.97%,PIK3CA;PIK3R1;NTRK3;PLCG1;SOS1;GRB2;PTPRS
prerank,Reactome_2022__Metabolism Of Vitamins And Cofactors R-HSA-196854,-0.4622095651407645,-1.0948404039985142,0.28378378378378377,0.7812027401043709,1.0,29/113,18.15%,SLC2A3;VNN2;PARP14;NUDT12;MTHFD1;CYB5A;TACR1;PARP9;NFS1;FLAD1;NAMPT;ENPP2;ENPP3;CALM1;GPC3;PTS;PLB1;SDC3;QPRT;NMRK1;SLC25A19;PARP4;SHMT1;NADK2;MCCC2;MOCOS;SLC2A1;PPCDC;FOLR2
prerank,Reactome_2022__TBC/RABGAPs R-HSA-8854214,0.4906619765119702,1.094820828983608,0.25,0.7569008299946669,1.0,8/36,12.53%,RAB33B;TSC2;TBC1D10B;TBC1D16;RAB7A;ARF6;RAB6A;RABGAP1
prerank,GO_Biological_Process_2021__nucleocytoplasmic transport (GO:0006913),0.5072355542713449,1.094689424761301,0.3055555555555556,0.7567408438352321,1.0,4/27,7.26%,NUTF2;BACH2;GEMIN2;XPO1
prerank,CellMarker_Augmented_2021__Myeloid cell:Tonsil,-0.7183548655379502,-1.094558525250163,0.4117647058823529,0.7816277120820985,1.0,3/7,16.96%,CD14;ITGAL;FCGR3A
prerank,GO_Biological_Process_2021__regulated exocytosis (GO:0045055),-0.45331773912126866,-1.0945354460365375,0.2676056338028169,0.7812790315862863,1.0,17/119,8.69%,FLNA;CD36;SRGN;RIMS1;F8;CLU;PLEK;F13A1;IGF1;CD63;PECAM1;RAB3A;SELENOP;TTN;CALM1;FERMT3;TMSB4X
prerank,GO_Biological_Process_2021__sensory perception of sound (GO:0007605),-0.5073424349362428,-1.0944225662719889,0.3088235294117647,0.7812080136525713,1.0,9/41,11.02%,RIPOR2;CEMIP;SLC26A5;CDH23;NDUFB9;CRYM;MYO3B;USP53;ZNF354A
prerank,GO_Biological_Process_2021__hormone transport (GO:0009914),-0.7153222317107353,-1.0943548839209494,0.3898305084745763,0.7810143848653918,1.0,2/5,6.60%,SLC7A5;CRYM
prerank,GO_Biological_Process_2021__response to interleukin-6 (GO:0070741),-0.6878883336788222,-1.0941387372780345,0.35714285714285715,0.7812705600648955,1.0,2/8,9.28%,PID1;CHI3L1
prerank,GO_Biological_Process_2021__positive regulation by host of viral process (GO:0044794),-0.6650412540944233,-1.0940269950902037,0.4032258064516129,0.7811996536185093,1.0,4/9,21.07%,CFL1;TBC1D20;IGF2R;NUCKS1
prerank,PanglaoDB_Augmented_2021__Photoreceptor Cells,0.42501008675772106,1.0938338781900176,0.23333333333333334,0.7583668964810175,1.0,26/97,14.50%,CNTN2;PCDH15;AP3B2;FAM135B;ZNF536;CDH20;SNAP91;SCN3B;LIN7A;SLC1A2;NLK;TNR;GRIA4;CA10;OLFM3;CTNNA2;CADM2;GRIA1;SV2B;GRM5;PTPN5;RBFOX1;GRIA2;SGIP1;SLC24A2;CNTN4
prerank,CellMarker_Augmented_2021__Adipose-derived Stromal cell:Subcutaneous Adipose Tissue,-0.4812795880107003,-1.0937944526122114,0.26666666666666666,0.781432793222643,1.0,12/58,8.89%,CD36;CEBPD;FOSL2;PID1;CD14;IFITM3;CD93;PPP1R3B;RNF144B;SIRPB2;NAMPT;TNFAIP2
prerank,KEGG_2021_Human__Huntington disease,-0.4403452322988111,-1.0936909063976172,0.25,0.7813437378894698,1.0,55/221,18.32%,TUBB8;CYCS;DNAH11;COX7C;PSMB3;UQCRB;NDUFC1;NDUFA2;UQCRH;NDUFA1;ADRM1;SLC25A5;NDUFB9;ATP5PD;NDUFA12;ATP5F1E;POLR2G;PSMB6;NDUFB4;PSMA7;UQCR10;ATG2A;COX4I1;COX5B;DNAH17;NDUFB1;NDUFS8;DCTN6;NDUFS5;DCTN4;DNAH1;PSMD12;DNAH12;COX7A2;PSMD8;PSMA5;CLTB;COX6C;SOD1;TUBB4B;GPX1;NDUFS6;NDUFB7;WIPI1;AP2S1;UQCRC1;NDUFB3;PSMA3;UQCRQ;DNAH9;ATP5F1C;PSMC4;DCTN2;NDUFS7;NDUFA3
prerank,Reactome_2022__Inactivation Of CDC42 And RAC1 R-HSA-428543,0.6453084947314182,1.093670445675185,0.42105263157894735,0.7581603997336549,1.0,2/6,14.68%,ROBO1;SRGAP2
prerank,GO_Biological_Process_2021__negative regulation of cell growth (GO:0030308),0.41184749720298475,1.0935057028271253,0.3333333333333333,0.7581523390174462,1.0,24/79,19.75%,SERTAD2;CDKN2AIP;SIRT1;DNAJB2;SMAD3;PPT1;DIP2B;NDRG3;NME6;RTN4;DCBLD2;DCC;ENPP1;SESN2;RNF6;CAPRIN2;KIAA0319;OSGIN2;ING1;DDX3X;CGRRF1;SLIT3;MAP2;EI24
prerank,GO_Biological_Process_2021__vesicle fusion with endoplasmic reticulum-Golgi intermediate compartment (ERGIC) membrane (GO:1990668),-0.7035057571992819,-1.0934390907019618,0.4482758620689655,0.7816944125627622,1.0,2/5,22.02%,TAP1;STX4
prerank,GO_Biological_Process_2021__negative regulation of programmed cell death (GO:0043069),-0.43433417267421937,-1.0932314476797815,0.27906976744186046,0.7817955794820501,1.0,37/238,12.51%,BCL2A1;FLNA;UBC;APIP;RPS27A;TFRC;CARD14;IFIT3;ATF5;PRELID1;STIL;NAIP;DDRGK1;PTMA;RPL10;BNIP2;IGF1;RPS3A;RNF144B;TNFAIP8;PHB2;PRLR;GSTP1;TPT1;NAA38;CFL1;CD44;KANK2;CFLAR;NPM1;CITED2;NCKAP1L;VEGFA;GPX4;BNIP1;PIM3;HSPA1B
prerank,GO_Biological_Process_2021__toll-like receptor 3 signaling pathway (GO:0034138),-0.6252321524947343,-1.0930443553717746,0.37037037037037035,0.7819057004796206,1.0,2/10,14.41%,OAS1;COLEC12
prerank,"KEGG_2021_Human__Valine, leucine and isoleucine degradation",-0.5270916312856154,-1.093015202613465,0.38333333333333336,0.7816084111199529,1.0,1/40,0.34%,IL4I1
prerank,GO_Biological_Process_2021__depurination (GO:0045007),-0.7309384408900014,-1.0929509215333013,0.4528301886792453,0.7813837924929524,1.0,2/6,12.59%,OGG1;TERF2IP
prerank,GO_Biological_Process_2021__regulation of transmembrane transport (GO:0034762),0.5395499030172881,1.0927985730434144,0.35294117647058826,0.7594848429575906,1.0,4/18,8.52%,KCNJ2;KCNJ5;PIM1;NEDD4L
prerank,Reactome_2022__Regulation Of PTEN mRNA Translation R-HSA-8943723,0.6062209248061879,1.092719821498158,0.34210526315789475,0.7592475733957114,1.0,6/11,32.64%,PTEN;TNRC6C;AGO1;TNRC6A;MOV10;TNRC6B
prerank,GO_Biological_Process_2021__regulation of glycogen biosynthetic process (GO:0005979),-0.5746142141992557,-1.092652447131948,0.3793103448275862,0.7818646776974738,1.0,5/16,17.44%,IGF1;PPP1R3B;SELENOS;PASK;INPP5K
prerank,CellMarker_Augmented_2021__Cardiomyocyte:Embryonic Stem Cell,0.4405837895922915,1.0923854277203109,0.24242424242424243,0.759070436205795,1.0,15/73,9.91%,NRP1;ARHGAP31;GSN;FAM20C;GLIS3;SIRPA;KCTD12;RIN2;SCARB2;PDGFC;JAG1;IL13RA1;CDH11;ALCAM;SASH1
prerank,CellMarker_Augmented_2021__Cardiac Progenitor cell:Embryonic Stem Cell,0.4405837895922915,1.0923854277203109,0.24242424242424243,0.759070436205795,1.0,15/73,9.91%,NRP1;ARHGAP31;GSN;FAM20C;GLIS3;SIRPA;KCTD12;RIN2;SCARB2;PDGFC;JAG1;IL13RA1;CDH11;ALCAM;SASH1
prerank,"Reactome_2022__Defective B4GALT7 Causes EDS, Progeroid Type R-HSA-3560783",0.5533310575345589,1.0922797424244561,0.29545454545454547,0.7588263038895088,1.0,4/11,12.44%,NCAN;CSPG5;B4GALT7;GPC6
prerank,Reactome_2022__Downstream Signal Transduction R-HSA-186763,0.5536224682809343,1.0921311097072748,0.3125,0.758764697046432,1.0,3/22,7.54%,PDGFA;NCK2;CRK
prerank,Reactome_2022__Platelet Aggregation (Plug Formation) R-HSA-76009,0.5384318066400817,1.092062421213469,0.30952380952380953,0.75845279837436,1.0,4/21,14.74%,RAP1A;CRK;PTK2;RAPGEF3
prerank,GO_Biological_Process_2021__release of sequestered calcium ion into cytosol (GO:0051209),0.5744110505172015,1.0920591306368403,0.3055555555555556,0.7579593352654632,1.0,2/15,2.26%,PKD2;FGF2
prerank,GO_Biological_Process_2021__negative regulation of alpha-beta T cell differentiation (GO:0046639),-0.7421199067896624,-1.0918808972082588,0.4262295081967213,0.7836871503817175,1.0,1/5,1.37%,RUNX3
prerank,CellMarker_Augmented_2021__Stem cell:Fetal Liver,0.4499819466130816,1.091878969217212,0.34615384615384615,0.7577923319720523,1.0,10/44,12.88%,COL5A2;PLPPR4;NTM;GRIA3;CDH11;PTPRD;COL11A1;RUNX1T1;GPC6;FBXL7
prerank,CellMarker_Augmented_2021__Oligodendrocyte:Brain,-0.455761900615629,-1.091744470581078,0.3058823529411765,0.7837328176084672,1.0,17/100,8.69%,RPL31;PID1;COX7C;RPS23;FAU;UQCRB;RPL13A;APOD;RACK1;SEC14L5;TMSB10;NACA;ATP5F1E;RPS2;ACTG1;SGK1;TMSB4X
prerank,Reactome_2022__Integrin Signaling R-HSA-354192,0.5462013682851804,1.0916835983856457,0.37209302325581395,0.7578527129720245,1.0,4/20,14.74%,RAP1A;CRK;PTK2;RAPGEF3
prerank,GO_Biological_Process_2021__positive regulation of developmental process (GO:0051094),0.39269306513011487,1.091419674123163,0.3076923076923077,0.757965986831012,1.0,28/114,14.98%,DLG5;SIRT1;ZBTB16;MCU;NCOA3;NLGN1;MARCHF5;PHLDB1;WNT5A;DAG1;RELN;BMP1;TNF;DVL3;TMEM119;SHANK3;DDHD1;SOX5;BMPR1B;TMEM79;COBL;SORL1;RTN4;BMPR1A;ZNF703;CLASP1;RAPGEF3;MAP3K13
prerank,Reactome_2022__MAPK6/MAPK4 Signaling R-HSA-5687128,-0.48749012765692407,-1.09123077322797,0.28,0.7849205389765481,1.0,9/72,12.85%,UBC;RPS27A;PSMB3;PSMB6;PSMA7;PSMB9;PSMD12;PSMD8;PSMA5
prerank,GO_Biological_Process_2021__toll-like receptor signaling pathway (GO:0002224),-0.4941081955826346,-1.0910317930972255,0.3333333333333333,0.7851234624754616,1.0,6/67,3.91%,CD36;UBC;RPS27A;CD14;BTK;CTSB
prerank,GO_Biological_Process_2021__icosanoid transport (GO:0071715),-0.7363155820488956,-1.09102682144182,0.42592592592592593,0.7847489396020011,1.0,2/5,18.23%,ABCC3;SLCO3A1
prerank,GO_Biological_Process_2021__pyrimidine nucleoside metabolic process (GO:0006213),-0.6535509268754315,-1.0909251012402212,0.3389830508474576,0.7847173580785087,1.0,4/12,11.81%,NT5C;TYMP;DPYS;DHODH
prerank,GO_Biological_Process_2021__base conversion or substitution editing (GO:0016553),0.6355162221060712,1.090920606415829,0.38461538461538464,0.7586841068341234,1.0,1/7,0.51%,ADARB2
prerank,PanglaoDB_Augmented_2021__Epiblast Cells,0.460481794303647,1.0909199451774945,0.3125,0.758199651304852,1.0,4/31,2.55%,KCNQ2;DPYSL5;GRID2;FRAS1
prerank,GO_Biological_Process_2021__endothelial tube morphogenesis (GO:0061154),-0.6776851255955383,-1.0908554233680925,0.423728813559322,0.7845146101540559,1.0,2/7,8.45%,PRKD2;RBPJ
prerank,Reactome_2022__G1/S-Specific Transcription R-HSA-69205,0.578147731027896,1.090788066854487,0.4146341463414634,0.7580783491032191,1.0,3/14,12.63%,HDAC1;LIN52;POLA1
prerank,GO_Biological_Process_2021__positive regulation of lipid transport (GO:0032370),-0.6656103899750031,-1.0903552479827732,0.38181818181818183,0.7854423076349476,1.0,2/8,10.11%,PRELID1;ABCB4
prerank,Reactome_2022__Inositol Phosphate Metabolism R-HSA-1483249,0.4788170743263341,1.0903018294570532,0.20588235294117646,0.758915764552497,1.0,14/37,18.14%,INPP1;PLCB4;IPPK;IMPA1;NUDT3;PTEN;ISYNA1;MTMR9;PPIP5K1;PLD4;INPP5A;NUDT4;PLCB3;INPP4B
prerank,GO_Biological_Process_2021__DNA ligation involved in DNA repair (GO:0051103),0.6891399162811228,1.0900898759531008,0.32653061224489793,0.7589072984036929,1.0,1/5,7.13%,LIG4
prerank,GO_Biological_Process_2021__histone H4 deacetylation (GO:0070933),0.6503833935217638,1.089881611642419,0.3829787234042553,0.7589968366412843,1.0,4/9,22.80%,HDAC9;HDAC1;HDAC3;RCOR1
prerank,GO_Biological_Process_2021__somatic recombination of immunoglobulin genes involved in immune response (GO:0002204),0.6610026083101692,1.0898737864480026,0.34146341463414637,0.758513744749918,1.0,2/7,7.13%,EXOSC6;LIG4
prerank,GO_Biological_Process_2021__telomere maintenance in response to DNA damage (GO:0043247),-0.7406466110911445,-1.0897678069056949,0.4576271186440678,0.7865761120688917,1.0,2/6,12.95%,TERF2IP;APEX1
prerank,GO_Biological_Process_2021__positive regulation of reproductive process (GO:2000243),0.5242762101058414,1.0897395874221898,0.325,0.7583700467960048,1.0,2/16,5.25%,LHFPL2;GLRA1
prerank,GO_Biological_Process_2021__mRNA modification (GO:0016556),0.5805341293973422,1.0897235405813113,0.42857142857142855,0.7579406467952207,1.0,7/18,21.50%,NSUN2;TRUB1;PUS1;TRMT10C;PUS7;WTAP;ZC3H13
prerank,GO_Biological_Process_2021__endosome to lysosome transport via multivesicular body sorting pathway (GO:0032510),0.6832652295434468,1.0896990123190506,0.4117647058823529,0.7575193193626295,1.0,2/6,7.89%,LYST;UBXN6
prerank,GO_Biological_Process_2021__polyamine biosynthetic process (GO:0006596),-0.6738381534328646,-1.0896463541816468,0.42592592592592593,0.7865571776477898,1.0,2/6,7.79%,SAT1;SAT2
prerank,Reactome_2022__Regulation Of Localization Of FOXO Transcription Factors R-HSA-9614399,0.6103496249847322,1.0895988595610209,0.34782608695652173,0.7572638356632515,1.0,5/10,22.15%,YWHAG;AKT2;AKT3;REXO2;FOXO1
prerank,"GO_Biological_Process_2021__G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",0.5421569978093493,1.089353559241046,0.3170731707317073,0.7573916307544533,1.0,3/16,4.78%,ANXA1;NPY1R;CNR1
prerank,GO_Biological_Process_2021__regulation of interleukin-6 production (GO:0032675),-0.5060310986340923,-1.0892771760404512,0.36,0.7871722299376274,1.0,16/69,15.81%,HLA-B;NLRC3;AIF1;CD200R1;LILRB4;NLRP12;TNFAIP3;SELENOS;NCKAP1L;TYROBP;C5AR2;CD47;CYBA;NOD2;CD74;CD200
prerank,GO_Biological_Process_2021__alpha-beta T cell differentiation (GO:0046632),-0.7155425834675524,-1.0892382271060193,0.4117647058823529,0.78690584816331,1.0,2/5,1.20%,ITK;RSAD2
prerank,Reactome_2022__Defective TPR May Confer Susceptibility Towards Thyroid Papillary Carcinoma (TPC) R-HSA-5619107,0.4638530085491071,1.0892313164416851,0.32432432432432434,0.7572266060533874,1.0,9/30,22.40%,NUP153;NUP188;NUP42;MAP4K5;NDC1;NUP133;NUP205;MAP4K2;NUP98
prerank,GO_Biological_Process_2021__negative regulation of cell size (GO:0045792),0.6628863401196478,1.0890882589376005,0.4909090909090909,0.7571142877965211,1.0,2/5,11.81%,DEPTOR;PTEN
prerank,GO_Biological_Process_2021__tRNA 5'-end processing (GO:0099116),-0.7009586451220132,-1.088917610218649,0.4117647058823529,0.7874437545038434,1.0,1/6,3.42%,SSB
prerank,GO_Biological_Process_2021__sulfur amino acid metabolic process (GO:0000096),0.5717005935254266,1.0886402660797632,0.4,0.7578264901269578,1.0,2/12,1.41%,AHCY;GCLC
prerank,"Reactome_2022__SUMO Is Transferred From E1 To E2 (UBE2I, UBC9) R-HSA-3065678",0.684789137416248,1.0885505244247033,0.38,0.7576315460762392,1.0,2/5,12.79%,SAE1;UBA2
prerank,GO_Biological_Process_2021__synaptic vesicle transport (GO:0048489),0.6245550665985508,1.0885026115836973,0.40816326530612246,0.7572721889958179,1.0,1/9,6.03%,TMEM230
prerank,Reactome_2022__Pentose Phosphate Pathway R-HSA-71336,-0.6299791881865981,-1.0883876763748086,0.3387096774193548,0.7886859786755566,1.0,4/9,31.02%,TALDO1;RPE;PGLS;TKT
prerank,Reactome_2022__Stimuli-sensing Channels R-HSA-2672351,-0.5076604675503825,-1.0883225648139476,0.3333333333333333,0.7884865505479632,1.0,12/57,10.69%,UBC;RPS27A;MCOLN2;SLC9B1;SRI;SGK1;CALM1;CLCA4;TRPV4;TRPM3;BEST1;TRPM4
prerank,GO_Biological_Process_2021__dendrite morphogenesis (GO:0048813),0.47337833034302484,1.0880773404968254,0.2222222222222222,0.7579006397242873,1.0,14/29,19.55%,LRP4;TMEM106B;DOCK10;CTNNA2;SHANK3;BTBD3;KLF7;CELSR2;PTEN;FARP1;PHACTR1;MAP6;TAOK2;MAP2
prerank,GO_Biological_Process_2021__protein localization to ciliary membrane (GO:1903441),-0.6544525025418327,-1.0879155756408272,0.36363636363636365,0.7892112403752782,1.0,2/6,27.66%,BBIP1;ARL13B
prerank,CellMarker_Augmented_2021__Neural Progenitor cell:Embryonic Prefrontal Cortex,-0.47601387608603574,-1.0878567456141062,0.2857142857142857,0.7890431291446909,1.0,19/90,18.50%,H4C3;PCSK1N;RAB3A;CENPU;ITGB3BP;LDHA;CKS2;MCM7;RPA3;TUBB4B;RPS27L;UHRF1;RTN1;SGO2;HAT1;SCG3;CENPF;BUB3;VIM
prerank,KEGG_2021_Human__Fatty acid elongation,0.5265956495787509,1.087615919112093,0.30434782608695654,0.7587749625256023,1.0,3/17,8.59%,PPT1;HACD2;ELOVL6
prerank,"GO_Biological_Process_2021__base-excision repair, AP site formation (GO:0006285)",-0.6544967604261578,-1.087585274503588,0.4074074074074074,0.789381491678078,1.0,2/11,4.21%,SMUG1;OGG1
prerank,GO_Biological_Process_2021__negative regulation of striated muscle cell differentiation (GO:0051154),0.6200695613519314,1.0875152025113093,0.32653061224489793,0.7584678557142037,1.0,6/10,26.65%,TMEM119;HDAC1;SOX6;HDAC3;FRS2;NOTCH1
prerank,GO_Biological_Process_2021__phosphorylation (GO:0016310),0.34465671525413083,1.086987979716176,0.1111111111111111,0.7591913844889038,1.0,53/306,15.21%,DAPK2;PANK3;FER;ACVR2A;AATK;FAM20C;TGFBR2;PDK4;MAP3K11;CDK10;LRRK2;NEK10;MAP2K1;STK36;RPS6KA4;CDK17;TLK1;PIM1;STK25;CDK18;MAST2;CDK7;NUAK1;RYK;MAP4K5;NLK;STK38L;BRSK1;IRAK1;PLK2;FGGY;BMPR1B;DYRK1A;MERTK;IRAK3;CDK13;WNK1;FNIP2;MAPK1;CDK6;BMPR1A;MAPKAPK2;CILK1;CSNK1E;PRKCI;PRKAB1;MARK1;PRRT1;CDKL2;MAP3K13;STK10;MAP3K5;TGFBR1
prerank,GO_Biological_Process_2021__cilium movement (GO:0003341),-0.6215367356675382,-1.0868165079489762,0.3508771929824561,0.7911794654789128,1.0,5/16,12.06%,DNAH11;DNHD1;DNAH17;DNAH1;CCDC39
prerank,GO_Biological_Process_2021__positive regulation of phospholipid transport (GO:2001140),-0.6891604835341449,-1.0867160434248664,0.4583333333333333,0.7910553891850376,1.0,2/7,10.11%,PRELID1;ABCB4
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell proliferation (GO:0050679),-0.4972547966643669,-1.0864478767672667,0.42424242424242425,0.7914414632115472,1.0,11/53,14.09%,NR4A3;JAML;IGF1;C5AR1;PRKD2;PTN;VEGFA;HIF1A;NR4A1;NOTCH2;NOD2
prerank,GO_Biological_Process_2021__regulation of cell morphogenesis (GO:0022604),0.518195909913208,1.0863056695387163,0.34210526315789475,0.7605779929848218,1.0,5/25,14.29%,PDPN;ZRANB1;BCL9L;STRIP1;FERMT2
prerank,Reactome_2022__Reduction Of Cytosolic Ca++ Levels R-HSA-418359,-0.67526726438131,-1.0862190955831803,0.375,0.7917153617941948,1.0,2/8,8.36%,SRI;CALM1
prerank,KEGG_2021_Human__Olfactory transduction,-0.5397968260063821,-1.0861436916457952,0.37142857142857144,0.7915822654184508,1.0,2/28,8.36%,RGS2;CALM1
prerank,GO_Biological_Process_2021__mRNA methylation (GO:0080009),0.5844011675767832,1.086101430340056,0.42105263157894735,0.7604865451818731,1.0,4/13,21.50%,NSUN2;TRMT10C;WTAP;ZC3H13
prerank,Reactome_2022__SHC-mediated cascade:FGFR1 R-HSA-5654688,-0.6663545898838223,-1.085945790078602,0.3793103448275862,0.7916681973776727,1.0,2/8,14.45%,FGF13;FGF20
prerank,Reactome_2022__Noncanonical Activation Of NOTCH3 R-HSA-9017802,-0.6399112360104069,-1.0857876389166898,0.42424242424242425,0.7917317189367157,1.0,2/5,22.01%,APH1B;YBX1
prerank,GO_Biological_Process_2021__regulation of dendrite extension (GO:1903859),-0.611772301277004,-1.0857053662451965,0.41509433962264153,0.7912608468221426,1.0,1/12,1.34%,RIMS1
prerank,GO_Biological_Process_2021__positive regulation of dendrite extension (GO:1903861),-0.611772301277004,-1.0857053662451965,0.41509433962264153,0.7912608468221426,1.0,1/12,1.34%,RIMS1
prerank,GO_Biological_Process_2021__negative regulation of sequestering of triglyceride (GO:0010891),0.6359339573781185,1.0854872187716627,0.4166666666666667,0.7614085778587758,1.0,2/6,18.74%,PPARG;OSBPL8
prerank,GO_Biological_Process_2021__insulin-like growth factor receptor signaling pathway (GO:0048009),0.607581226675644,1.0854640356621459,0.4722222222222222,0.7610039656605748,1.0,3/10,10.48%,IGF1R;TSC2;GIGYF1
prerank,"Reactome_2022__Tetrahydrobiopterin (BH4) Synthesis, Recycling, Salvage And Regulation R-HSA-1474151",-0.7153772728065161,-1.0852961308012357,0.4098360655737705,0.7920690354154347,1.0,3/7,9.36%,TACR1;CALM1;PTS
prerank,GO_Biological_Process_2021__sensory perception of smell (GO:0007608),0.6882084821440876,1.0851918030739316,0.46808510638297873,0.761195205110017,1.0,1/5,8.47%,UBR3
prerank,GO_Biological_Process_2021__positive regulation of multicellular organismal process (GO:0051240),0.3682985357962625,1.085167902009083,0.21428571428571427,0.7607763716200163,1.0,32/190,10.09%,PRKAB2;LEPR;ESRRG;PPARGC1A;PDPN;GRB10;IGF1R;ADIPOR2;SERPINE1;TGFBR2;FGF2;SIRT1;ZBTB16;NCOA3;NLGN1;WNT5A;CADM1;SMAD2;SMAD3;ADRA1A;PDGFC;BMP1;TNF;RFX3;TMEM119;ELOVL6;SIRT6;TMIGD2;SOX5;BMPR1B;LOXL2;BCL9L
prerank,GO_Biological_Process_2021__innate immune response (GO:0045087),-0.45329572450056105,-1.0850808324653753,0.32051282051282054,0.7922525518636673,1.0,35/134,15.77%,MX1;TRIM5;RPL39;DHX58;B2M;IFIT1;YES1;FCER1G;BTK;IFITM3;TRIM22;SHFL;PHB2;NLRC5;H2BC21;FYN;SRPK1;KLRD1;OAS1;APOBEC3G;TRIM13;NCF2;SLC11A1;TYROBP;STING1;ALPK1;CYBA;H2BC11;NOD2;REL;HLA-E;COLEC12;C3;CIITA;CD74
prerank,GO_Biological_Process_2021__regulation of response to stress (GO:0080134),-0.6877703156970197,-1.0850793691699403,0.34545454545454546,0.7918835862303735,1.0,1/8,4.97%,ABCB1
prerank,Reactome_2022__Transcriptional Regulation By RUNX3 R-HSA-8878159,-0.4873568909161778,-1.0849898841754924,0.3698630136986301,0.7917375768535947,1.0,15/81,14.82%,UBC;RPS27A;RUNX3;PSMB3;PSMB6;PSMA7;ITGA4;RBPJ;PSMB9;ITGAL;PSMD12;PSMD8;PSMA5;CCND1;UBA52
prerank,GO_Biological_Process_2021__positive regulation of macrophage activation (GO:0043032),-0.7255137736228353,-1.084940998473816,0.49056603773584906,0.791467121502406,1.0,1/8,0.62%,CCL3
prerank,Reactome_2022__Amino Acid Transport Across Plasma Membrane R-HSA-352230,-0.5938555688083942,-1.0849073453000764,0.328125,0.7911835905220439,1.0,3/19,4.58%,SLC7A5;SLC38A4;SLC38A1
prerank,GO_Biological_Process_2021__regulation of monocyte chemotaxis (GO:0090025),-0.5937162312803064,-1.084848946386873,0.4406779661016949,0.7909936894424323,1.0,3/15,2.67%,CCL5;DUSP1;AIF1
prerank,"GO_Biological_Process_2021__positive regulation of CD8-positive, alpha-beta T cell activation (GO:2001187)",-0.6682722317439156,-1.0848347029728245,0.3559322033898305,0.7906262527207578,1.0,4/8,14.31%,RUNX3;LILRB4;NCKAP1L;HLA-E
prerank,GO_Biological_Process_2021__vitamin transport (GO:0051180),0.6175694799226422,1.0843115968918775,0.4473684210526316,0.7623944936007675,1.0,1/10,0.66%,PDPN
prerank,Reactome_2022__Glutathione Synthesis And Recycling R-HSA-174403,0.685316970440561,1.0839394309577985,0.4,0.7628741519800506,1.0,1/5,1.41%,GCLC
prerank,Reactome_2022__G-protein Mediated Events R-HSA-112040,0.44167871141726606,1.0839041098694837,0.2962962962962963,0.7624773175955868,1.0,11/46,18.03%,NBEA;GNAQ;PLCB4;ADCY9;GNA11;MAPK1;ADCY6;AHCYL1;PDE1C;PRKX;PLCB3
prerank,GO_Biological_Process_2021__regulation of telomere maintenance via telomere lengthening (GO:1904356),0.5445071344702919,1.0838308429813142,0.4473684210526316,0.7622219304434747,1.0,3/14,17.49%,PARP1;ERCC4;NAF1
prerank,GO_Biological_Process_2021__glycolytic process through glucose-6-phosphate (GO:0061620),0.5922589896989231,1.083727047174799,0.38461538461538464,0.7619446283627438,1.0,2/16,1.17%,PFKP;PFKM
prerank,Reactome_2022__Cell Cycle Checkpoints R-HSA-69620,-0.4367514009029133,-1.0836748078436937,0.2987012987012987,0.7935232252096277,1.0,32/185,14.90%,UBC;H2BC4;H2BC26;RPS27A;CARD16;PSMB3;RPS27;HUS1;H2BC21;PSMB6;PSMA7;CENPU;H2BC5;ABRAXAS1;PSMB9;H2BC9;ITGB3BP;ZWILCH;PSMD12;ANAPC11;H2BC11;PSMD8;PSMA5;KAT5;MCM7;RAD9A;MIS12;RPA3;DYNC1LI2;BRCA1;UBA52;CDC26
prerank,GO_Biological_Process_2021__negative regulation of blood coagulation (GO:0030195),0.5642033131735836,1.0835506733721016,0.37209302325581395,0.7620158816519758,1.0,3/13,2.96%,PDGFA;SERPINE1;SERPINE2
prerank,GO_Biological_Process_2021__positive regulation of protein glycosylation (GO:0060050),0.732220835499892,1.083242677532263,0.38461538461538464,0.7622869487101139,1.0,2/5,18.72%,RAMP1;CHP1
prerank,GO_Biological_Process_2021__regulation of neuroinflammatory response (GO:0150077),-0.6528906458545598,-1.0831310887763548,0.43103448275862066,0.7945708490948241,1.0,6/10,20.54%,CD200R1;IGF1;TNFRSF1B;CD200;IL18;NR1D1
prerank,GO_Biological_Process_2021__negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),-0.6745210768545106,-1.0828828966276196,0.4067796610169492,0.7948587988099601,1.0,1/8,4.08%,APOD
prerank,GO_Biological_Process_2021__ventricular cardiac muscle cell action potential (GO:0086005),0.5715020259028087,1.0827359667195862,0.3076923076923077,0.7631939995180187,1.0,2/11,8.52%,SCN3B;NEDD4L
prerank,"GO_Biological_Process_2021__negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371)",-0.7628715746861774,-1.0825011604380137,0.4126984126984127,0.7956652820946852,1.0,1/5,1.37%,RUNX3
prerank,GO_Biological_Process_2021__regulation of adenylate cyclase activity (GO:0045761),0.5662822617615647,1.082480954070023,0.4,0.7632495354897262,1.0,5/12,27.96%,NF1;ADGRV1;GRM3;ORAI1;CAP1
prerank,GO_Biological_Process_2021__mitochondrion organization (GO:0007005),-0.4513057812116281,-1.082437242319653,0.3246753246753247,0.7954116884895029,1.0,15/134,8.20%,MX2;TOMM7;CYCS;MX1;PID1;DNAJC19;CHCHD2;CHCHD10;TIMM44;FIS1;PHB2;PITRM1;HK2;IFIT2;TYMP
prerank,Reactome_2022__Metabolism Of Steroid Hormones R-HSA-196071,0.6087302752464091,1.0824092510720469,0.40540540540540543,0.762928122325401,1.0,3/14,5.38%,TSPOAP1;STARD4;CD163L1
prerank,GO_Biological_Process_2021__regulation of alcohol biosynthetic process (GO:1902930),0.6126548328597505,1.082356348145958,0.325,0.762577576146841,1.0,1/10,1.57%,ABCA2
prerank,PanglaoDB_Augmented_2021__Follicular Cells,-0.5654120688590918,-1.0819937024504176,0.328125,0.7962525477933146,1.0,5/14,23.15%,SLC5A9;PRLR;CYP3A5;FMO5;TG
prerank,GO_Biological_Process_2021__regulation of clathrin-dependent endocytosis (GO:2000369),0.5987988535561057,1.0819759316910003,0.40540540540540543,0.7630319395872817,1.0,2/13,4.57%,HIP1R;SNAP91
prerank,GO_Biological_Process_2021__positive regulation of immune effector process (GO:0002699),-0.5793473520770682,-1.081941717481853,0.36666666666666664,0.7960520484778603,1.0,7/18,18.79%,DHX58;HLA-DRA;PTPRC;HLA-DMB;DDX60;RPS19;HLA-DRB1
prerank,GO_Biological_Process_2021__alpha-linolenic acid metabolic process (GO:0036109),-0.6968840091324755,-1.0819371184372009,0.3829787234042553,0.7956791464499292,1.0,3/10,22.54%,ACAA1;FADS2;SCP2
prerank,GO_Biological_Process_2021__morphogenesis of an epithelial sheet (GO:0002011),0.6820930104561804,1.0817569044768083,0.41304347826086957,0.7630431830475071,1.0,2/5,26.65%,PHACTR4;NOTCH1
prerank,GO_Biological_Process_2021__negative regulation of proteasomal protein catabolic process (GO:1901799),-0.5560848385434655,-1.081707072125404,0.34328358208955223,0.7959789756604161,1.0,6/31,11.92%,UBXN1;DDRGK1;AQP11;RPL11;GABARAPL2;NOP53
prerank,GO_Biological_Process_2021__cell junction maintenance (GO:0034331),-0.6555610383839154,-1.0815110473045992,0.43859649122807015,0.7961370296832271,1.0,2/6,7.64%,CHCHD10;NLGN2
prerank,GO_Biological_Process_2021__chromatin organization involved in regulation of transcription (GO:0034401),0.6280117568989216,1.081508634120973,0.3902439024390244,0.763260802581492,1.0,2/8,2.77%,SERTAD2;ARID1A
prerank,GO_Biological_Process_2021__positive regulation of cell motility (GO:2000147),-0.45432897654563964,-1.0813681932523855,0.352112676056338,0.7961535169091332,1.0,18/124,8.60%,CCL3;MYLK;CCL5;SYNE2;PDGFD;AIF1;CEMIP;DUOX1;PLET1;DDRGK1;RACK1;IGF1;PECAM1;SEMA6A;ACTG1;SPOCK2;FERMT3;ITGA6
prerank,Reactome_2022__SUMOylation R-HSA-2990846,0.4043432172825677,1.0813046016094299,0.3125,0.7632866200059908,1.0,16/140,10.21%,PPARGC1A;RNF2;UHRF2;MITF;SAE1;NRIP1;NUP153;NUP188;PPARG;PARP1;NUP42;TDG;SATB2;MDM2;HDAC1;NSMCE1
prerank,KEGG_2021_Human__Pathways of neurodegeneration,-0.415379460583174,-1.0810160105324123,0.25274725274725274,0.7967927791099905,1.0,69/325,18.32%,TUBB8;UBC;CYCS;DNAH11;RPS27A;GABARAPL1;COX7C;PSMB3;UQCRB;NDUFC1;NDUFA2;UQCRH;NDUFA1;NEFM;ADRM1;SLC25A5;NDUFB9;ATP5PD;NDUFA12;ATP5F1E;NEFL;PSMB6;NDUFB4;PSMA7;UQCR10;ATG2A;TNFRSF1B;CALM1;COX4I1;COX5B;DNAH17;GABARAPL2;DVL1;ZFYVE1;NDUFB1;NDUFS8;CHRM5;DCTN6;NDUFS5;DCTN4;DNAH1;FZD2;PSMD12;DNAH12;COX7A2;PSMD8;PSMA5;COX6C;SOD1;TOMM40;TUBB4B;GPX1;NDUFS6;NDUFB7;UBA52;WIPI1;UQCRC1;RAC1;NDUFB3;PSMA3;UQCRQ;DNAH9;ATP5F1C;PINK1;PSMC4;DCTN2;CSNK2A2;NDUFS7;NDUFA3
prerank,Reactome_2022__Interleukin-6 Family Signaling R-HSA-6783589,-0.6206904514792665,-1.0808838867259443,0.42857142857142855,0.7967559516660276,1.0,2/15,9.56%,OSMR;STAT1
prerank,KEGG_2021_Human__Leishmaniasis,-0.4664707142420407,-1.080828720061672,0.33783783783783783,0.7965426547990417,1.0,20/57,20.38%,FOS;NCF4;HLA-DRB5;ITGA4;STAT1;NCF2;ITGB2;HLA-DRA;IFNGR2;CYBA;HLA-DPA1;C3;HLA-DMB;HLA-DPB1;FCGR3A;IRAK4;ITGB1;HLA-DRB1;NCF1;TLR2
prerank,GO_Biological_Process_2021__regulation of primary metabolic process (GO:0080090),0.38170846262735175,1.0805384204329387,0.25925925925925924,0.7646890556589251,1.0,16/105,13.43%,PRKAB2;NFYC;IDI1;LDLR;PPARG;PLPP1;FDFT1;ACACB;TM7SF2;ELOVL6;HMGCS1;TBL1XR1;MVD;RUBCNL;FASN;PRKAB1
prerank,GO_Biological_Process_2021__cellular response to leucine (GO:0071233),0.6580606997688888,1.0805012210914446,0.4,0.7638050256124622,1.0,1/10,0.78%,RRAGD
prerank,GO_Biological_Process_2021__response to leucine (GO:0043201),0.6580606997688888,1.0805012210914446,0.4,0.7638050256124622,1.0,1/10,0.78%,RRAGD
prerank,"GO_Biological_Process_2021__regulation of wound healing, spreading of epidermal cells (GO:1903689)",0.7110055885947408,1.0804645423382055,0.4473684210526316,0.7633969119815444,1.0,6/7,28.82%,PTEN;FERMT2;CLASP1;CLASP2;RREB1;PHLDB2
prerank,GO_Biological_Process_2021__negative regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045869),-0.6480615539175701,-1.0803710518456486,0.4117647058823529,0.7974630595546093,1.0,5/8,22.78%,APOBEC3G;INPP5K;RESF1;SETDB1;MORC2
prerank,GO_Biological_Process_2021__CD40 signaling pathway (GO:0023035),-0.6613628838680146,-1.0803039722935142,0.4230769230769231,0.7972364006148859,1.0,3/6,22.77%,PHB2;ITGB1;ITGA5
prerank,GO_Biological_Process_2021__regulation of protein targeting to mitochondrion (GO:1903214),-0.5207373933752051,-1.0801431619386979,0.43548387096774194,0.7972919579754822,1.0,7/31,11.48%,TOMM7;USP36;ARIH2;RHOU;HPS4;ATP5IF1;ABLIM3
prerank,GO_Biological_Process_2021__positive regulation of myeloid leukocyte differentiation (GO:0002763),0.5140773144884463,1.0800293520161632,0.3404255319148936,0.7640247058525999,1.0,3/20,7.30%,CTNNBIP1;RUNX1;TNF
prerank,GO_Biological_Process_2021__N-terminal protein amino acid modification (GO:0031365),0.6133279016160914,1.0799441849558187,0.34210526315789475,0.7637417239086354,1.0,1/10,1.55%,AANAT
prerank,Reactome_2022__Nicotinate Metabolism R-HSA-196807,-0.5855719909099013,-1.079919402920838,0.2923076923076923,0.7974927936752412,1.0,8/20,16.77%,PARP14;NUDT12;PARP9;NAMPT;QPRT;NMRK1;PARP4;NADK2
prerank,CellMarker_Augmented_2021__Endometrial Stromal Stem cell:Endometrium Stroma,-0.5510538026718473,-1.0798950247493564,0.4084507042253521,0.7971740128399768,1.0,2/28,0.65%,MYLK;COL5A1
prerank,Reactome_2022__MET Receptor Recycling R-HSA-8875656,0.6102382567922159,1.0797830343354984,0.4489795918367347,0.7637157871429627,1.0,3/9,12.17%,PIGU;CRK;ARF6
prerank,Reactome_2022__Negative Feedback Regulation Of MAPK Pathway R-HSA-5674499,0.7014989922167124,1.0797225567623894,0.4583333333333333,0.7633673912092614,1.0,3/5,18.09%,MAP2K1;MAPK1;MAP2K2
prerank,GO_Biological_Process_2021__negative regulation of sequestering of calcium ion (GO:0051283),0.5768735703174352,1.0797199019177812,0.3142857142857143,0.7628875876949879,1.0,2/14,2.26%,PKD2;FGF2
prerank,GO_Biological_Process_2021__positive regulation of mitochondrion organization (GO:0010822),0.4568751652002891,1.0797197564512484,0.2647058823529412,0.7624083869489483,1.0,6/41,9.11%,PPARGC1A;HIP1R;MCU;MARCHF5;BOK;DDHD1
prerank,CellMarker_Augmented_2021__Leydig Precursor cell:Fetal Gonad,-0.45366490238492496,-1.0796822716121903,0.3333333333333333,0.7973307129225891,1.0,36/131,11.40%,COL5A1;INSIG1;MCTP2;RPS27A;RPL31;RPL12;RPL5;RPS12;RPS23;RPS24;RPL13A;RPS18;RPL10;RPL10A;ANGPTL1;RPL23;IGF1;PDE5A;RPS3A;SPATS2L;RPL24;NEFL;RPL18A;RPS6;RPS7;RPL34;RPL15;RPS5;TMSB4X;KANK2;GPC3;RPL6;LITAF;NPM1;RPLP0;SPARCL1
prerank,Reactome_2022__SUMO E3 Ligases SUMOylate Target Proteins R-HSA-3108232,0.3947808910784168,1.0795302245236207,0.35294117647058826,0.7626320812113629,1.0,15/135,10.21%,PPARGC1A;RNF2;UHRF2;MITF;NRIP1;NUP153;NUP188;PPARG;PARP1;NUP42;TDG;SATB2;MDM2;HDAC1;NSMCE1
prerank,GO_Biological_Process_2021__positive regulation of cell cycle phase transition (GO:1901989),-0.5949825747598734,-1.0794689695478212,0.3582089552238806,0.7974828626253603,1.0,6/11,17.56%,DDRGK1;PHB2;NPM1;ZNF16;STXBP4;ATAD5
prerank,CellMarker_Augmented_2021__Epithelial Progenitor cell:Breast,0.5044797363809502,1.079087134807124,0.3783783783783784,0.7629325005954224,1.0,3/27,2.15%,KLF4;ANXA1;TGFA
prerank,CellMarker_Augmented_2021__Intestinal Epithelial Stem cell:Jejunum,0.5044797363809502,1.079087134807124,0.3783783783783784,0.7629325005954224,1.0,3/27,2.15%,KLF4;ANXA1;TGFA
prerank,GO_Biological_Process_2021__positive regulation of innate immune response (GO:0045089),-0.5393703080014737,-1.078959200710626,0.45614035087719296,0.7984260420067645,1.0,8/23,18.57%,CCL5;NLRC5;PLSCR1;TASL;HLA-E;IFI35;POLR3C;RPS19
prerank,Reactome_2022__RSK Activation R-HSA-444257,0.6229457589986647,1.078817829678298,0.42,0.7630970315483038,1.0,2/7,11.38%,RPS6KA6;MAPK1
prerank,GO_Biological_Process_2021__regulation of protein targeting (GO:1903533),-0.674524254948589,-1.078764819321667,0.4117647058823529,0.7985467569162037,1.0,4/5,29.58%,ATP5IF1;PINK1;SREBF1;HAX1
prerank,GO_Biological_Process_2021__positive regulation of chemokine production (GO:0032722),0.47930150728360166,1.0787582808512461,0.3548387096774194,0.7627359556933346,1.0,4/34,8.03%,EGR1;WNT5A;TNF;TLR7
prerank,GO_Biological_Process_2021__peptidyl-lysine dimethylation (GO:0018027),0.544699238534228,1.078389858835238,0.35,0.7631337690400342,1.0,4/16,15.35%,SETD7;SETD3;SETD2;SETD4
prerank,GO_Biological_Process_2021__positive regulation by symbiont of host autophagy (GO:0075044),-0.6806252549290298,-1.0783266390051776,0.509090909090909,0.7992250307540959,1.0,1/6,6.40%,PHB2
prerank,Reactome_2022__MAPK3 (ERK1) Activation R-HSA-110056,0.6374666515060683,1.0783004752792165,0.46938775510204084,0.7629699006854122,1.0,1/8,4.14%,MAP2K1
prerank,GO_Biological_Process_2021__positive regulation of striated muscle contraction (GO:0045989),-0.7155599318590656,-1.0781734258602536,0.45454545454545453,0.7993145162616924,1.0,1/5,2.19%,RGS2
prerank,Reactome_2022__Phospholipase C-mediated Cascade: FGFR1 R-HSA-5654219,-0.6755192428533543,-1.0781635944998802,0.46296296296296297,0.7989608396638556,1.0,2/6,14.45%,FGF13;FGF20
prerank,KEGG_2021_Human__Glycosaminoglycan degradation,0.5953194737554263,1.078091610839558,0.36585365853658536,0.7630028930280064,1.0,2/10,5.59%,GLB1;HPSE
prerank,Reactome_2022__Constitutive Signaling By NOTCH1 t(7;9)(NOTCH1:M1580 K2555) Translocation Mutant R-HSA-2660826,0.7035131583897644,1.0779819089747926,0.3333333333333333,0.7627956371209392,1.0,3/5,26.65%,JAG1;ADAM10;NOTCH1
prerank,GO_Biological_Process_2021__adiponectin-activated signaling pathway (GO:0033211),0.734985570113088,1.0779639899944162,0.5,0.7623340339525712,1.0,1/5,1.53%,ADIPOR2
prerank,CellMarker_Augmented_2021__Progenitor cell:Bone Marrow,0.425718841761117,1.0778099961980747,0.3157894736842105,0.7622873921105309,1.0,20/55,19.23%,PDZRN4;PLPPR4;PCDH17;CNRIP1;PREX2;ASXL3;PTPRD;THSD7A;RUNX1T1;NTRK2;FBXL7;JAM2;SGIP1;NFASC;KALRN;SORBS2;TMEM132C;CX3CL1;MAP6;BAALC
prerank,Reactome_2022__FRS-mediated FGFR4 Signaling R-HSA-5654712,-0.6290801938579906,-1.077725109689101,0.41379310344827586,0.7996554619758817,1.0,2/9,14.45%,FGF13;FGF20
prerank,GO_Biological_Process_2021__nucleobase-containing compound catabolic process (GO:0034655),-0.535228333084864,-1.0777216008897912,0.3333333333333333,0.7992756677075636,1.0,10/28,20.23%,ADPRM;RNASET2;SIDT2;ENTPD4;ENTPD5;NUDT16;DFFB;PNPT1;RNASE6;PABPC4
prerank,GO_Biological_Process_2021__regulation of fatty acid oxidation (GO:0046320),-0.6250367702169229,-1.0771943742253436,0.43859649122807015,0.8004206528670229,1.0,1/11,0.08%,NR4A3
prerank,GO_Biological_Process_2021__membrane raft assembly (GO:0001765),-0.7490298368287216,-1.07717495629134,0.4339622641509434,0.8001196664228026,1.0,3/5,21.67%,ANXA2;FLOT1;EMP2
prerank,GO_Biological_Process_2021__positive regulation of cation transmembrane transport (GO:1904064),-0.5625917223155981,-1.0768446452037015,0.36923076923076925,0.8006242000602921,1.0,1/23,0.28%,FLNA
prerank,GO_Biological_Process_2021__establishment of endothelial barrier (GO:0061028),0.5314391108213348,1.0768080206944743,0.38,0.7643477706462994,1.0,9/22,17.63%,MSN;RAP1A;RAB1B;MYADM;AFDN;TJP1;RAPGEF3;RAP2C;RAPGEF2
prerank,GO_Biological_Process_2021__neuron projection development (GO:0031175),0.3763967800034124,1.0766899626417408,0.23076923076923078,0.7641111498938862,1.0,40/120,23.37%,PLXNB1;CDK5R1;MAP1S;NLGN1;NYAP2;LRRK2;PTPRM;RYK;DOCK10;BICDL1;SHANK3;GPM6A;PTEN;CNTN4;SRGAP2;CNTNAP1;GSK3B;MANF;ADGRV1;SHTN1;RAPGEF2;CAMSAP2;MARK2;NEDD4;TAOK2;MAP2;DCLK1;AGER;ZFYVE27;CNTNAP2;ULK1;CTTN;TMEM108;DTNBP1;STMN3;TOR1A;UHMK1;TNIK;STX3;DAB2IP
prerank,GO_Biological_Process_2021__maintenance of protein localization in endoplasmic reticulum (GO:0035437),-0.6479948316292773,-1.0765440110324629,0.3484848484848485,0.8011413666848771,1.0,1/10,0.72%,INSIG1
prerank,GO_Biological_Process_2021__positive regulation of potassium ion transport (GO:0043268),-0.5599352440672472,-1.0764126827330576,0.3582089552238806,0.801098416377325,1.0,1/24,0.28%,FLNA
prerank,GO_Biological_Process_2021__epithelial cilium movement involved in extracellular fluid movement (GO:0003351),0.5669306186592991,1.07638413873114,0.4523809523809524,0.7644770999630236,1.0,3/10,12.89%,NEK10;RFX3;CCDC40
prerank,GO_Biological_Process_2021__positive regulation of amyloid precursor protein catabolic process (GO:1902993),0.5404403019944094,1.076209263877109,0.34210526315789475,0.7645742771099757,1.0,4/17,9.55%,ABCA2;PICALM;TNF;SLC2A13
prerank,GO_Biological_Process_2021__negative regulation of signal transduction (GO:0009968),-0.44522011672946765,-1.0761076572662205,0.2727272727272727,0.8015886328454671,1.0,18/144,8.87%,SIGIRR;RPGRIP1L;CCL5;PRKCQ;CARD16;PID1;RGS2;DDIT4;NKD1;APOD;RACK1;PLEK;SEMA6A;SULF2;NLRP12;TNFAIP3;KANK2;GPC3
prerank,GO_Biological_Process_2021__interleukin-12-mediated signaling pathway (GO:0035722),-0.5408898154244453,-1.076086884104066,0.34782608695652173,0.8012703385255509,1.0,8/34,15.40%,STAT4;ANXA2;IL12RB2;CFL1;RPLP0;SOD1;SNRPA1;TALDO1
prerank,Reactome_2022__Cooperation Of PDCL (PhLP1) And TRiC/CCT In G-protein Beta Folding R-HSA-6814122,0.46925903717634804,1.0759293121701297,0.2777777777777778,0.7647075699591633,1.0,5/25,13.21%,RGS11;GNAQ;TCP1;GNA11;CCT3
prerank,CellMarker_Augmented_2021__Progenitor cell:Prostate,-0.650209674977253,-1.0759238287527777,0.4,0.801375820193457,1.0,2/7,8.80%,CLDN7;OVOL2
prerank,Reactome_2022__MECP2 Regulates Neuronal Receptors And Channels R-HSA-9022699,-0.6121491719666872,-1.0759137450683065,0.35714285714285715,0.8010012108400331,1.0,2/15,7.21%,SLC2A3;RNMT
prerank,GO_Biological_Process_2021__sarcomere organization (GO:0045214),-0.6937455215140726,-1.075904069489244,0.46153846153846156,0.8006269637780533,1.0,2/7,7.37%,OBSCN;TTN
prerank,Reactome_2022__Signaling By EGFR R-HSA-177929,-0.5293787952295783,-1.0757681723336279,0.35384615384615387,0.8005669493763482,1.0,3/38,1.30%,UBC;EPN1;RPS27A
prerank,GO_Biological_Process_2021__transferrin transport (GO:0033572),-0.5747773238775158,-1.0757425953019848,0.4461538461538462,0.8002499174501851,1.0,2/27,4.87%,TFRC;ATP6V1F
prerank,GO_Biological_Process_2021__cell-cell junction organization (GO:0045216),0.45299296913317416,1.0755343460945732,0.35135135135135137,0.7651304095095366,1.0,11/40,13.17%,PKP4;CDH20;CADM1;SMAD3;MYADM;CDH11;CADM2;AFDN;TJP1;PRKCI;CDH19
prerank,GO_Biological_Process_2021__SNARE complex assembly (GO:0035493),0.6258199368109736,1.07525089506165,0.4166666666666667,0.7652921445976636,1.0,1/8,1.33%,VAMP1
prerank,CellMarker_Augmented_2021__Inflammatory cell:Muscle,-0.49117370763078827,-1.0752148220137043,0.30985915492957744,0.8002068621448766,1.0,28/69,19.61%,MS4A4A;AIF1;SIGLEC1;FCER1G;CD93;PLEK;F13A1;PECAM1;TNFRSF1B;CFLAR;PCDH12;MS4A6A;CSF2RB;NCKAP1L;HLA-DRA;TYROBP;PTPRC;APOL3;HLA-DPA1;HLA-DPB1;FCGR3A;LST1;GIMAP4;FOLR2;PARVG;RNASE6;MPEG1;LILRB5
prerank,CellMarker_Augmented_2021__Endothelial cell:Lymph Node,-0.49117370763078827,-1.0752148220137043,0.30985915492957744,0.8002068621448766,1.0,28/69,19.61%,MS4A4A;AIF1;SIGLEC1;FCER1G;CD93;PLEK;F13A1;PECAM1;TNFRSF1B;CFLAR;PCDH12;MS4A6A;CSF2RB;NCKAP1L;HLA-DRA;TYROBP;PTPRC;APOL3;HLA-DPA1;HLA-DPB1;FCGR3A;LST1;GIMAP4;FOLR2;PARVG;RNASE6;MPEG1;LILRB5
prerank,CellMarker_Augmented_2021__Immature Endothelial cell:Subcutaneous Adipose Tissue,-0.49117370763078827,-1.0752148220137043,0.30985915492957744,0.8002068621448766,1.0,28/69,19.61%,MS4A4A;AIF1;SIGLEC1;FCER1G;CD93;PLEK;F13A1;PECAM1;TNFRSF1B;CFLAR;PCDH12;MS4A6A;CSF2RB;NCKAP1L;HLA-DRA;TYROBP;PTPRC;APOL3;HLA-DPA1;HLA-DPB1;FCGR3A;LST1;GIMAP4;FOLR2;PARVG;RNASE6;MPEG1;LILRB5
prerank,CellMarker_Augmented_2021__Mature Endothelial cell:Subcutaneous Adipose Tissue,-0.49117370763078827,-1.0752148220137043,0.30985915492957744,0.8002068621448766,1.0,28/69,19.61%,MS4A4A;AIF1;SIGLEC1;FCER1G;CD93;PLEK;F13A1;PECAM1;TNFRSF1B;CFLAR;PCDH12;MS4A6A;CSF2RB;NCKAP1L;HLA-DRA;TYROBP;PTPRC;APOL3;HLA-DPA1;HLA-DPB1;FCGR3A;LST1;GIMAP4;FOLR2;PARVG;RNASE6;MPEG1;LILRB5
prerank,GO_Biological_Process_2021__regulation of interleukin-8 production (GO:0032677),0.44903096463452274,1.0752081409778471,0.3333333333333333,0.764896674916147,1.0,8/48,10.07%,KLF4;ANXA1;SERPINE1;DDIT3;TNF;TLR7;CD33;LGALS9
prerank,PanglaoDB_Augmented_2021__Merkel Cells,-0.5705397931720196,-1.0751647055042812,0.4074074074074074,0.79994292823969,1.0,3/13,10.61%,OVOL2;TRPV4;CFTR
prerank,GO_Biological_Process_2021__positive regulation of non-canonical Wnt signaling pathway (GO:2000052),-0.6767875557177547,-1.0751056681589273,0.42592592592592593,0.7997487625088912,1.0,2/7,12.71%,NKD1;CSNK1D
prerank,GO_Biological_Process_2021__protein K48-linked ubiquitination (GO:0070936),0.463024906757174,1.0750881627654008,0.2857142857142857,0.7646751998227859,1.0,5/47,8.52%,UBE2D1;KBTBD6;UBE2E2;UBE2D2;NEDD4L
prerank,GO_Biological_Process_2021__regulation of multicellular organism growth (GO:0040014),-0.6110084121979916,-1.07496581115982,0.39285714285714285,0.7997328273586881,1.0,3/12,13.37%,BBS2;IGF1;SOD1
prerank,CellMarker_Augmented_2021__Endothelial cell:Undefined,-0.6163025297819804,-1.0749544755815201,0.43548387096774194,0.7993826938667491,1.0,4/14,5.65%,PROCR;F8;IL3RA;PECAM1
prerank,Reactome_2022__Hyaluronan Metabolism R-HSA-2142845,-0.6529381561115506,-1.0744403057292207,0.39655172413793105,0.8004255074360157,1.0,3/8,15.24%,CEMIP;CD44;GUSB
prerank,Reactome_2022__Degradation Of Cysteine And Homocysteine R-HSA-1614558,-0.7044072258827451,-1.0742907799135493,0.42105263157894735,0.8003962611193979,1.0,2/6,17.58%,TXN2;GOT2
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Ovary,-0.6447709061781324,-1.0742745281674608,0.4426229508196721,0.8000593161201937,1.0,3/7,27.27%,CD44;ABCG2;MYD88
prerank,GO_Biological_Process_2021__mitophagy (GO:0000423),-0.6492502885756006,-1.0741385059302182,0.4642857142857143,0.8000346058808274,1.0,1/8,6.40%,PHB2
prerank,PanglaoDB_Augmented_2021__Enteroendocrine Cells,0.39407884100820956,1.0740104859977555,0.29411764705882354,0.7670043708772616,1.0,15/72,15.06%,NCAN;SCN3A;PLPPR1;NOL4;SNAP91;GRIA4;CA10;OLFM3;ALCAM;ASXL3;PTPRN;ABCC8;GRIA2;NFASC;CSRNP3
prerank,GO_Biological_Process_2021__multivesicular body organization (GO:0036257),-0.5449675008999352,-1.0739762553724572,0.3442622950819672,0.8001008497591474,1.0,5/25,16.16%,RAB11A;SNF8;VPS28;VPS37B;MVB12A
prerank,CellMarker_Augmented_2021__Amnion Epithelial cell:Amniotic Membrane,0.4724886136322906,1.0735787001937376,0.3142857142857143,0.7670575305523206,1.0,5/29,11.76%,FLVCR1;MGAT4C;SHISA9;ZNF90;ZNF665
prerank,CellMarker_Augmented_2021__Embryonic Stem cell:Hair Follicle,0.4724886136322906,1.0735787001937376,0.3142857142857143,0.7670575305523206,1.0,5/29,11.76%,FLVCR1;MGAT4C;SHISA9;ZNF90;ZNF665
prerank,GO_Biological_Process_2021__modulation of chemical synaptic transmission (GO:0050804),0.42419976368957407,1.0733847791009792,0.24,0.7670011295312266,1.0,19/81,12.34%,CACNA1A;GRID2;EIF4EBP2;NLGN1;LRRK2;GRID1;GRIK2;RELN;LRRC4C;BAIAP3;NPTXR;TNF;CLSTN2;KCNMB4;GRM5;CLSTN3;NRG3;PTEN;NPTX1
prerank,GO_Biological_Process_2021__membrane lipid catabolic process (GO:0046466),-0.671486933607349,-1.0732477800696818,0.4,0.8017380726196317,1.0,2/7,8.11%,PDXDC1;ENPP2
prerank,KEGG_2021_Human__N-Glycan biosynthesis,0.4552456313751101,1.0732438111586977,0.2777777777777778,0.7669087633886446,1.0,10/37,22.36%,ST6GAL2;MGAT4C;STT3B;MGAT5;ALG12;ALG8;ALG3;ALG5;RPN2;MGAT4B
prerank,Reactome_2022__mRNA Splicing R-HSA-72172,-0.4427200092363289,-1.0730965360915103,0.325,0.8017991100790626,1.0,40/164,19.10%,PPIE;DHX16;ZCRB1;DHX38;CSTF2T;SNRNP27;SNRPD2;RNPC3;RBM22;POLR2G;EIF4A3;LSM7;PDCD7;CRNKL1;ZRSR2;U2AF2;NCBP2;SMNDC1;PRPF3;BUD31;GCFC2;DDX23;SRSF2;DDX5;SRSF7;CWC25;SNRPA1;COLEC12;CCAR1;PPWD1;EFTUD2;SLU7;SNRPA;LSM4;SNRNP200;GTF2F1;HNRNPH2;BCAS2;SF3A1;PRPF4
prerank,GO_Biological_Process_2021__regulation of adipose tissue development (GO:1904177),0.6589268831131907,1.0730723846225239,0.4222222222222222,0.7668237139413547,1.0,3/6,11.83%,SIRT1;KLF7;SORL1
prerank,"GO_Biological_Process_2021__phagocytosis, engulfment (GO:0006911)",-0.5376122213346984,-1.0730288722713053,0.35294117647058826,0.8015487760356637,1.0,3/29,2.67%,CD36;MARCO;AIF1
prerank,GO_Biological_Process_2021__heart trabecula morphogenesis (GO:0061384),-0.6464232241187016,-1.0727104570360928,0.3939393939393939,0.8019166877992442,1.0,3/9,12.31%,TGFBR3;RBPJ;ADGRG6
prerank,"GO_Biological_Process_2021__energy coupled proton transport, down electrochemical gradient (GO:0015985)",-0.6766357688811835,-1.0726660761077231,0.4074074074074074,0.8016751765279448,1.0,5/9,20.98%,ATP5PD;VPS9D1;ATP5F1C;ATP5F1D;ATP5MC2
prerank,Reactome_2022__WNT Mediated Activation Of DVL R-HSA-201688,0.716865205454429,1.0723601557139397,0.42857142857142855,0.7681927803679511,1.0,3/5,12.60%,PIP5K1B;DVL3;CSNK1E
prerank,GO_Biological_Process_2021__relaxation of muscle (GO:0090075),-0.5990433746289738,-1.0723191325323245,0.4098360655737705,0.8021549326797907,1.0,2/11,2.19%,PLN;RGS2
prerank,GO_Biological_Process_2021__bile acid metabolic process (GO:0008206),-0.585542966886549,-1.0721684232919177,0.41818181818181815,0.8021249988215088,1.0,2/18,8.24%,CH25H;ACAA1
prerank,GO_Biological_Process_2021__apoptotic nuclear changes (GO:0030262),-0.5907726972744484,-1.072104339592379,0.4107142857142857,0.8020001976424073,1.0,8/16,29.88%,H1-0;DFFB;DEDD2;DICER1;DNASE2;CECR2;ACIN1;HMGB2
prerank,GO_Biological_Process_2021__response to peptide hormone (GO:0043434),-0.5472680142837398,-1.0719952894796154,0.3387096774193548,0.8019315638523645,1.0,3/32,3.63%,STAT4;TGFBR3;EIF2B1
prerank,GO_Biological_Process_2021__regulation of histone deacetylase activity (GO:1901725),-0.6706542560317025,-1.0714629529582433,0.3387096774193548,0.8028153577030174,1.0,2/7,11.19%,PRKD2;VEGFA
prerank,GO_Biological_Process_2021__regulation of dendritic spine maintenance (GO:1902950),-0.691092030787779,-1.0714505571233421,0.4222222222222222,0.8024578129158296,1.0,2/7,7.36%,VPS35;FYN
prerank,Reactome_2022__PERK Regulates Gene Expression R-HSA-381042,0.4585359241143167,1.0714004811694806,0.3902439024390244,0.7698838699417955,1.0,4/25,9.03%,NFYC;EXOSC6;DDIT3;EIF2S1
prerank,GO_Biological_Process_2021__regulation of brown fat cell differentiation (GO:0090335),0.6296509255933771,1.0712575158304758,0.375,0.7697755749668658,1.0,3/9,5.93%,SIRT1;PIM1;NAPEPLD
prerank,KEGG_2021_Human__p53 signaling pathway,0.43799990317513043,1.0712133653245124,0.36363636363636365,0.7693656536051593,1.0,18/50,15.55%,ZMAT3;CCNG2;SERPINE1;CASP9;TSC2;TNFRSF10A;SIVA1;CCNG1;CD82;MDM2;PTEN;CDK6;APAF1;GORAB;COP1;STEAP3;SESN2;CCND3
prerank,CellMarker_Augmented_2021__Granulosa cell:Undefined,0.4496622519100252,1.0711264233189333,0.22580645161290322,0.7691213850461451,1.0,14/43,16.66%,COL16A1;COL5A2;PHLDB1;TIMP3;PTPRM;NTM;CDH11;LOXL2;COL6A1;FBXL7;FERMT2;ANTXR1;RAI14;TNC
prerank,GO_Biological_Process_2021__response to steroid hormone (GO:0048545),0.559656665723688,1.070838780584331,0.38461538461538464,0.7694156106924527,1.0,4/17,18.31%,ABCA2;UBE2L3;PAQR7;NR3C1
prerank,Reactome_2022__E3 Ubiquitin Ligases Ubiquitinate Target Proteins R-HSA-8866654,-0.5182268445999293,-1.0708016320110034,0.43661971830985913,0.8037710335216626,1.0,4/44,1.30%,UBC;H2BC4;HLA-B;RPS27A
prerank,Reactome_2022__Signaling By ERBB4 R-HSA-1236394,-0.4912343471700942,-1.0705587902805023,0.323943661971831,0.8041320021114613,1.0,2/43,1.30%,UBC;RPS27A
prerank,Reactome_2022__Signaling By Hedgehog R-HSA-5358351,-0.4518709939346806,-1.0702906325754944,0.3974358974358974,0.8043635931123999,1.0,14/108,14.82%,UBC;RPS27A;RPGRIP1L;PSMB3;PRKAR1B;PSMB6;PSMA7;PSMB9;RBX1;PSMD12;PSMD8;PSMA5;IFT52;UBA52
prerank,Reactome_2022__Postmitotic Nuclear Pore Complex (NPC) Reformation R-HSA-9615933,0.47399112132448923,1.0702499995294865,0.34210526315789475,0.77047682426698,1.0,7/26,23.19%,NUP188;RCC1;NDC1;NUP133;NUP205;NUP98;KPNB1
prerank,GO_Biological_Process_2021__oxidative RNA demethylation (GO:0035513),-0.7192622233965311,-1.0702283627180869,0.4339622641509434,0.8041951507155081,1.0,1/5,5.68%,JMJD6
prerank,GO_Biological_Process_2021__response to sterol (GO:0036314),-0.6791372358077027,-1.0701768441107595,0.40298507462686567,0.8039753046683685,1.0,3/9,3.27%,CCL3;INSIG1;RORA
prerank,GO_Biological_Process_2021__RNA destabilization (GO:0050779),0.5535453773231235,1.070006406670247,0.3888888888888889,0.7706050114467687,1.0,8/14,29.84%,YTHDF1;RIDA;YTHDF2;FTO;CELF1;METTL16;YTHDF3;PUM1
prerank,Reactome_2022__Signaling By NOTCH R-HSA-157118,-0.4455988519823901,-1.0699563676548174,0.3333333333333333,0.804159394815338,1.0,24/150,12.85%,UBC;H2BC4;H2BC26;H2AC20;RPS27A;H2AC6;PSMB3;GZMB;H3-3B;H2AJ;H2BC21;PSMB6;PSMA7;H2BC5;RBPJ;PSMB9;H2BC9;STAT1;RBX1;HIF1A;PSMD12;H2BC11;PSMD8;PSMA5
prerank,GO_Biological_Process_2021__inner mitochondrial membrane organization (GO:0007007),-0.5228545661087449,-1.0698608663531033,0.3548387096774194,0.804038512267691,1.0,16/38,24.04%,ATP5PD;ATP5F1E;ATP5ME;MICOS13;APOO;SPG7;MAIP1;ATP5F1C;ATP5F1D;MTX3;TIMM29;ATP5MC2;GHITM;TIMM9;AFG3L2;MICOS10
prerank,GO_Biological_Process_2021__regulation of rRNA processing (GO:2000232),-0.5937986301269971,-1.0697216146957167,0.36538461538461536,0.8040335984855478,1.0,3/13,13.80%,USP36;BUD23;NUDT16
prerank,GO_Biological_Process_2021__regulation of platelet activation (GO:0010543),-0.5920767290898086,-1.0696891655493603,0.41379310344827586,0.8037156041131486,1.0,4/13,5.75%,PRKCQ;FCER1G;PLEK;TXK
prerank,GO_Biological_Process_2021__cardiac conduction system development (GO:0003161),0.6632560613028353,1.0696810293034094,0.4186046511627907,0.7709908975391304,1.0,2/7,12.30%,SMAD1;BMPR1A
prerank,Reactome_2022__Class C/3 (Metabotropic Glutamate/Pheromone Receptors) R-HSA-420499,0.6622904082563383,1.0696175786184843,0.4897959183673469,0.7706819563588522,1.0,4/6,27.39%,GRM5;GRM3;GRM1;GRM7
prerank,GO_Biological_Process_2021__synapse organization (GO:0050808),0.4403704988026183,1.0696142714337638,0.2222222222222222,0.7702231628690035,1.0,27/82,18.43%,LRP4;CNTN2;NLGN1;LRRK2;LRRC4C;UNC13B;RYK;ZC4H2;DNM3;SHANK3;SHANK2;GPM6A;GRM5;SNCB;PTPRD;PPFIA3;NRXN2;GPHN;PTEN;GPC6;LRRC4B;CACNB4;PPFIA2;FARP1;CX3CL1;NEDD4;PPFIBP1
prerank,Reactome_2022__MASTL Facilitates Mitotic Progression R-HSA-2465910,0.6467842451180079,1.0694134058824862,0.40476190476190477,0.7701653041681417,1.0,3/7,24.26%,PPP2R1B;PPP2CB;PPP2R2D
prerank,"GO_Biological_Process_2021__positive regulation of protein localization to chromosome, telomeric region (GO:1904816)",0.603087918428292,1.069409836223249,0.42857142857142855,0.7697002449262837,1.0,3/11,13.21%,TCP1;GNL3L;CCT3
prerank,CellMarker_Augmented_2021__Oviduct-derived Stem cell:Oviduct,-0.6337670584111594,-1.0693555361028715,0.47540983606557374,0.80420811736846,1.0,5/11,18.52%,PECAM1;ITGA4;CD44;PTPRC;ITGB1
prerank,KEGG_2021_Human__Inositol phosphate metabolism,0.4429404323018735,1.0692140501983194,0.3333333333333333,0.7696570590175418,1.0,14/62,18.14%,INPP1;PIP5K1B;PLCB4;PIK3C2B;IPPK;PI4KB;IMPA1;PTEN;PIP4K2A;ISYNA1;INPP5A;PIK3CA;PLCB3;INPP4B
prerank,GO_Biological_Process_2021__fatty acid catabolic process (GO:0009062),0.43920397114524895,1.0691988389880227,0.375,0.7692000169491877,1.0,7/49,16.90%,FAAH;ACADS;PEX13;ACADVL;ECI1;ECHDC1;AUH
prerank,PanglaoDB_Augmented_2021__Myofibroblasts,0.46241729254371755,1.069158349042209,0.4482758620689655,0.7688219862466911,1.0,10/41,8.39%,COL16A1;TPM2;SVEP1;COL5A2;GFAP;ACTA2;PHLDB1;TIMP3;NTM;CDH11
prerank,GO_Biological_Process_2021__O-glycan processing (GO:0016266),0.5413111640187013,1.069070616070692,0.34210526315789475,0.7685798430027023,1.0,7/22,15.60%,B3GNT2;GALNT13;C1GALT1;GALNT7;GXYLT1;GALNT1;GALNT2
prerank,GO_Biological_Process_2021__regulation of chemokine production (GO:0032642),0.4720614080992699,1.068878488274229,0.375,0.7686086802923316,1.0,4/27,8.03%,EGR1;WNT5A;TNF;TLR7
prerank,GO_Biological_Process_2021__negative regulation of leukocyte mediated cytotoxicity (GO:0001911),-0.6489095997564542,-1.0684297480049278,0.43333333333333335,0.8063026645324897,1.0,4/10,14.31%,HLA-F;KLRD1;PTPRC;HLA-E
prerank,Reactome_2022__PLC Beta Mediated Events R-HSA-112043,0.44718756269796106,1.0684173181284304,0.32142857142857145,0.7693208991778047,1.0,11/42,18.03%,NBEA;GNAQ;PLCB4;ADCY9;GNA11;MAPK1;ADCY6;AHCYL1;PDE1C;PRKX;PLCB3
prerank,GO_Biological_Process_2021__positive regulation of signal transduction by p53 class mediator (GO:1901798),-0.5790117328644285,-1.0681817905261763,0.38461538461538464,0.8066735652066935,1.0,7/14,13.17%,RPS15;RPS20;RPL37;RPL23;RPS7;EIF5A;DDX5
prerank,GO_Biological_Process_2021__negative regulation of myeloid leukocyte mediated immunity (GO:0002887),0.7208835274684767,1.06798778366456,0.4583333333333333,0.7699184151762608,1.0,2/5,24.34%,LGALS9;CD84
prerank,GO_Biological_Process_2021__sulfur compound catabolic process (GO:0044273),0.5693461346573779,1.0679485651701406,0.38235294117647056,0.7695410993946217,1.0,3/17,5.57%,NCAN;GLB1;CSPG5
prerank,Reactome_2022__Activation Of BAD And Translocation To Mitochondria R-HSA-111447,0.5577805531735248,1.0677982686521081,0.3333333333333333,0.7693987385487057,1.0,5/13,21.45%,YWHAG;AKT2;AKT3;REXO2;YWHAE
prerank,GO_Biological_Process_2021__heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),-0.5592112333211173,-1.067772474893425,0.375,0.8073352012217048,1.0,1/20,0.19%,JAML
prerank,GO_Biological_Process_2021__response to ionizing radiation (GO:0010212),0.39656467172700316,1.067769244950202,0.3235294117647059,0.7689937930202049,1.0,12/55,19.46%,ANXA1;SIRT1;LIG4;CLOCK;BRSK1;INTS7;COP1;BLM;PRKAA1;IKBIP;RFWD3;EEF1D
prerank,GO_Biological_Process_2021__negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),0.5144799089006833,1.0677192502519706,0.38461538461538464,0.7686674104507365,1.0,4/21,9.99%,SIRT1;CLOCK;HDAC1;CNOT2
prerank,GO_Biological_Process_2021__axonal transport of mitochondrion (GO:0019896),-0.6405910165726153,-1.0676164474703926,0.38333333333333336,0.8073586881966581,1.0,2/9,11.34%,NEFL;HIF1A
prerank,GO_Biological_Process_2021__calcium ion import (GO:0070509),0.5094938343977274,1.0674349357015087,0.29411764705882354,0.7689514169896904,1.0,6/19,15.77%,CACNA1A;MCU;MICU1;SLC8A1;CACNA1E;TRPC4
prerank,PanglaoDB_Augmented_2021__Luteal Cells,0.39407661069307975,1.0674057204988079,0.21428571428571427,0.7685403938927268,1.0,18/65,14.88%,PLXNB1;FKBP9;SLC39A14;DAG1;MAGI1;DHCR24;UNC13B;TBC1D16;FKBP5;CHKA;BOK;GNA11;RTKN;GPC6;COL6A1;ADCY6;FERMT2;CD276
prerank,GO_Biological_Process_2021__regulation of G2/M transition of mitotic cell cycle (GO:0010389),-0.4575868185860805,-1.0670548924416698,0.379746835443038,0.8085881647271616,1.0,32/115,23.46%,PSMB3;SSNA1;RAB11A;PSMB6;PSMA7;CEP72;PSMB9;CEP164;RBX1;PSMD12;CSNK1D;PSMD8;PSMA5;TUBB4B;CCND1;PSMA3;PRKAR2B;PSMC4;DCTN2;CENPF;AKAP9;PSME2;PSME1;DYNC1I2;NINL;PSMB5;SFI1;PSMC3;CDC7;HAUS5;PSME3;TUBB4A
prerank,"GO_Biological_Process_2021__positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)",-0.6241087193492969,-1.0669146308025614,0.453125,0.808568289509536,1.0,4/9,10.77%,CD55;PRKCQ;NCKAP1L;HLA-DRA
prerank,Reactome_2022__RUNX1 Regulates Transcription Of Genes Involved In Differentiation Of Myeloid Cells R-HSA-8939246,0.6780191992092526,1.0668354541291838,0.42,0.7695325627862375,1.0,3/5,26.12%,RUNX1;CBFB;CREBBP
prerank,GO_Biological_Process_2021__organonitrogen compound biosynthetic process (GO:1901566),0.3869820591830508,1.0667396417507562,0.3103448275862069,0.7692703660532155,1.0,24/101,13.67%,VAPB;ACER2;PLA2G4C;PPM1L;LARGE1;PLPP1;GSTA4;FA2H;SPTLC2;HACD2;CHKA;HPGDS;SLC44A2;ELOVL6;GPAT4;GCH1;SAMD8;SLC44A5;GPHN;SLC44A1;LCAT;SGMS1;CHPT1;ESD
prerank,GO_Biological_Process_2021__ubiquitin-dependent protein catabolic process (GO:0006511),0.36282837096017617,1.066714799301537,0.2222222222222222,0.7688952764861339,1.0,39/288,11.31%,UBE2D1;SPSB2;RNF122;ZNRF3;KBTBD6;SIRT1;FBXL14;SPOPL;OTUD7A;PTPN23;FEM1B;UBE3D;DDIT3;UBE2D2;FZR1;CLOCK;UBR3;NEDD4L;APPBP2;RMND5A;SHARPIN;ZRANB1;CDC23;MDM2;KCTD6;BTRC;FBXO45;RNF19B;KCTD10;UBA1;RNF20;UBE2L3;TBL1XR1;ANAPC16;FBXW11;FBXW7;RNF217;FEM1C;RNF185
prerank,GO_Biological_Process_2021__endosome to melanosome transport (GO:0035646),-0.6520794604008586,-1.0665265731294065,0.46808510638297873,0.808938569578365,1.0,1/6,5.63%,CD63
prerank,GO_Biological_Process_2021__endosome to pigment granule transport (GO:0043485),-0.6520794604008586,-1.0665265731294065,0.46808510638297873,0.808938569578365,1.0,1/6,5.63%,CD63
prerank,GO_Biological_Process_2021__regulation of ATP biosynthetic process (GO:2001169),0.532859036302067,1.0665071680051632,0.34210526315789475,0.7688812839425441,1.0,2/12,5.45%,PPARGC1A;PARP1
prerank,GO_Biological_Process_2021__ureteric bud development (GO:0001657),0.6193723419765231,1.0660522770262,0.42857142857142855,0.7694680135604998,1.0,2/6,7.23%,PKD2;SALL1
prerank,GO_Biological_Process_2021__positive regulation of aspartic-type peptidase activity (GO:1905247),0.666739543825553,1.06576354974082,0.44680851063829785,0.7696020104367063,1.0,1/6,3.41%,PICALM
prerank,GO_Biological_Process_2021__positive regulation of dendritic spine morphogenesis (GO:0061003),0.6124807467966671,1.065612721735093,0.44,0.7695240882246738,1.0,4/8,25.98%,RELN;CAPRIN2;CAPRIN1;CAMK2B
prerank,GO_Biological_Process_2021__negative regulation of glial cell apoptotic process (GO:0034351),0.6721414286977755,1.0656080732078455,0.5,0.769058274611947,1.0,1/6,12.90%,PRKCI
prerank,GO_Biological_Process_2021__positive regulation of telomerase RNA localization to Cajal body (GO:1904874),0.5507186419006743,1.0655789664864048,0.30952380952380953,0.7686846748384794,1.0,5/15,18.36%,RUVBL2;TCP1;CCT3;NAF1;SHQ1
prerank,GO_Biological_Process_2021__acetyl-CoA metabolic process (GO:0006084),0.5859741032269998,1.0654333745939462,0.37777777777777777,0.7685792655523499,1.0,4/11,18.18%,ACACB;HMGCS1;MVD;ACACA
prerank,GO_Biological_Process_2021__multivesicular body assembly (GO:0036258),-0.5451097868825544,-1.0653346960908172,0.3389830508474576,0.8118851933188209,1.0,5/24,16.16%,RAB11A;SNF8;VPS28;VPS37B;MVB12A
prerank,CellMarker_Augmented_2021__Neuroendocrine cell:Fetal Pancreas,0.426199187117131,1.0652923564533043,0.42857142857142855,0.7684669421501328,1.0,13/69,12.32%,PCBP4;KCNQ2;NCAN;ADGRB2;SNAP91;PSD;NPTXR;BRSK1;PSD2;SNCB;STX1A;TMCC2;PTPRN
prerank,GO_Biological_Process_2021__mitotic DNA replication (GO:1902969),0.652513378501824,1.0652093985388953,0.43478260869565216,0.7682210467150347,1.0,3/7,12.91%,GINS3;POLA1;GINS1
prerank,GO_Biological_Process_2021__proton-transporting ATP synthase complex assembly (GO:0043461),-0.7323753293598639,-1.0651324822677228,0.4642857142857143,0.8120515230886033,1.0,3/5,18.76%,TMEM70;OXA1L;ATP5F1D
prerank,GO_Biological_Process_2021__blood circulation (GO:0008015),-0.5391013920604327,-1.0651182343896262,0.4153846153846154,0.8117144839371548,1.0,8/23,14.09%,PLN;OLR1;GCLM;STAT1;TBC1D8;SOD1;SERPING1;GPX1
prerank,GO_Biological_Process_2021__COPI coating of Golgi vesicle (GO:0048205),0.6569134827677999,1.06497423190618,0.45098039215686275,0.7674289428688358,1.0,2/6,21.27%,TMED10;GBF1
prerank,GO_Biological_Process_2021__COPI-coated vesicle budding (GO:0035964),0.6569134827677999,1.06497423190618,0.45098039215686275,0.7674289428688358,1.0,2/6,21.27%,TMED10;GBF1
prerank,GO_Biological_Process_2021__Golgi transport vesicle coating (GO:0048200),0.6569134827677999,1.06497423190618,0.45098039215686275,0.7674289428688358,1.0,2/6,21.27%,TMED10;GBF1
prerank,GO_Biological_Process_2021__negative regulation of gene expression (GO:0010629),-0.4107854019239059,-1.0647858175338178,0.35443037974683544,0.8122089489027167,1.0,37/236,14.43%,RPS13;CCL3;SRGN;GAPDH;SLC7A5;ZFP36;PARP14;BTG2;NUDT12;GZMB;PARP15;RPL13A;DDRGK1;RACK1;RPS3;IGF1;ILF3;RPS26;PARP9;EIF2AK2;CENPV;NLRP12;BTN2A2;EIF4A3;OVOL2;SLC11A1;CITED2;VEGFA;HIF1A;PATL2;HSPA1B;DNMT1;HAVCR2;NUDT16;NOTCH2;REL;HSPA1A
prerank,GO_Biological_Process_2021__neuromuscular junction development (GO:0007528),0.5334155075306298,1.0647035813961025,0.40425531914893614,0.7677107869718979,1.0,8/20,18.43%,LRP4;LRRK2;UNC13B;ZC4H2;GPHN;CACNB4;NEDD4;PPFIBP1
prerank,GO_Biological_Process_2021__pyrimidine nucleotide metabolic process (GO:0006220),-0.6787321378180711,-1.064610413593817,0.42857142857142855,0.812204470972716,1.0,1/5,8.26%,ENPP3
prerank,GO_Biological_Process_2021__positive regulation of protein sumoylation (GO:0033235),0.6822467711081316,1.0645340684102234,0.5333333333333333,0.7676835849347414,1.0,3/6,21.07%,SAE1;UBA2;PIAS1
prerank,GO_Biological_Process_2021__protein polyufmylation (GO:1990564),-0.709996871644522,-1.0643189762981544,0.46511627906976744,0.8119272867789704,1.0,3/5,20.28%,DDRGK1;UFL1;UFC1
prerank,GO_Biological_Process_2021__protein ufmylation (GO:0071569),-0.709996871644522,-1.0643189762981544,0.46511627906976744,0.8119272867789704,1.0,3/5,20.28%,DDRGK1;UFL1;UFC1
prerank,GO_Biological_Process_2021__protein K69-linked ufmylation (GO:1990592),-0.709996871644522,-1.0643189762981544,0.46511627906976744,0.8119272867789704,1.0,3/5,20.28%,DDRGK1;UFL1;UFC1
prerank,GO_Biological_Process_2021__regulation of intracellular protein transport (GO:0033157),0.47770047700633816,1.0642394331510803,0.38636363636363635,0.7678176879879102,1.0,9/27,25.72%,LCP1;CEP131;RIPOR1;ATP13A2;CEP290;UHMK1;PCM1;TPR;TGFB1
prerank,Reactome_2022__TP53 Regulates Transcription Of Cell Cycle Genes R-HSA-6791312,0.4615866280071821,1.0640410091070753,0.34375,0.7678535230098861,1.0,5/34,9.99%,PCBP4;ZNF385A;CNOT7;PLK2;CNOT2
prerank,Reactome_2022__Muscle Contraction R-HSA-397014,0.3653651430473334,1.0638308910160392,0.23809523809523808,0.7679523456858492,1.0,18/102,10.52%,ANXA1;TRPC1;TPM2;KCNJ2;ACTA2;KCNIP2;SCN3A;KCND3;SCN3B;TMOD2;GUCY1A1;VCL;TMOD3;MYL11;SCN8A;KCNK6;KCNK13;GUCY1A2
prerank,Reactome_2022__Interleukin-2 Signaling R-HSA-9020558,0.6521605326295763,1.0638254857227882,0.4375,0.7665772986814342,1.0,4/6,32.32%,SYK;PTK2B;STAT5A;JAK3
prerank,GO_Biological_Process_2021__cellular response to interleukin-2 (GO:0071352),0.6521605326295763,1.0638254857227882,0.4375,0.7665772986814342,1.0,4/6,32.32%,SYK;PTK2B;STAT5A;JAK3
prerank,GO_Biological_Process_2021__interleukin-2-mediated signaling pathway (GO:0038110),0.6521605326295763,1.0638254857227882,0.4375,0.7665772986814342,1.0,4/6,32.32%,SYK;PTK2B;STAT5A;JAK3
prerank,Reactome_2022__Regulation Of RUNX2 Expression And Activity R-HSA-8939902,-0.4778117923007548,-1.0635792478894592,0.4142857142857143,0.8134410717848956,1.0,11/59,12.85%,UBC;RPS27A;PSMB3;PSMB6;PSMA7;PSMB9;STAT1;RBX1;PSMD12;PSMD8;PSMA5
prerank,CellMarker_Augmented_2021__Bone Marrow Stem cell:Bone Marrow,-0.681333587025093,-1.0635478587898288,0.47692307692307695,0.8131639957483413,1.0,4/7,18.52%,CD14;CD44;PTPRC;ITGB1
prerank,GO_Biological_Process_2021__cellular response to lipopolysaccharide (GO:0071222),-0.4760877023612592,-1.0632639850277954,0.3472222222222222,0.8136603960235209,1.0,9/65,9.83%,CCL3;ZFP36;CCL5;CARD16;CD14;GSTP1;TNFRSF1B;TNFAIP3;SELENOS
prerank,Reactome_2022__Signaling By FGFR2 In Disease R-HSA-5655253,0.5045217592134896,1.0632037851284772,0.4146341463414634,0.7676128564575841,1.0,2/26,1.00%,POLR2D;PIGU
prerank,Reactome_2022__Regulation Of IFNG Signaling R-HSA-877312,-0.6047855982599737,-1.0631604447576781,0.4074074074074074,0.813587306528629,1.0,5/12,26.22%,STAT1;IFNGR2;SUMO1;PTPN2;PTPN11
prerank,KEGG_2021_Human__Chronic myeloid leukemia,0.4353761704558935,1.0630720606057886,0.34782608695652173,0.767516019153702,1.0,17/61,18.09%,TGFBR2;E2F3;MAP2K1;SMAD3;RUNX1;CRK;CTBP2;SHC2;MDM2;HDAC1;MAPK1;CDK6;GAB2;TGFBR1;AKT2;PIK3CA;MAP2K2
prerank,GO_Biological_Process_2021__atrial septum development (GO:0003283),-0.7362110508468245,-1.06289092789847,0.3541666666666667,0.8139259962248854,1.0,2/6,17.77%,NOTCH2;ZFPM1
prerank,GO_Biological_Process_2021__snRNA modification (GO:0040031),0.6427967803923862,1.0628797029050325,0.4318181818181818,0.7674472108302979,1.0,1/6,1.88%,MEPCE
prerank,CellMarker_Augmented_2021__M1 macrophage:Brain,-0.48155258748029645,-1.0628363347204193,0.33783783783783783,0.8136576982868653,1.0,19/69,17.20%,JUNB;CTDSP1;SSNA1;SCAND1;NR1H2;EFHD2;EMP3;RNPEPL1;TMEM219;VPS28;COPE;STX10;TMEM179B;IFI35;TALDO1;LGALS1;MVB12A;S100A4;NME3
prerank,"GO_Biological_Process_2021__positive regulation of DNA-templated transcription, elongation (GO:0032786)",0.5107679896864227,1.062742663755714,0.375,0.7672947959528993,1.0,5/20,18.47%,SCAF8;SUPT16H;CDK13;CDK12;EAPP
prerank,GO_Biological_Process_2021__membrane depolarization during action potential (GO:0086010),0.5494504176316797,1.0627070687323878,0.4,0.7670031652954776,1.0,5/13,13.70%,KCNJ2;SCN3A;SCN3B;SCN8A;SLC8A1
prerank,KEGG_2021_Human__Insulin signaling pathway,0.3964964859386628,1.062677629928562,0.3684210526315789,0.7665934657136414,1.0,24/101,18.18%,PRKAB2;PPARGC1A;MAP2K1;TSC2;CRK;ACACB;EIF4E2;GYS1;SHC2;PCK2;PDE3B;MAPK1;FASN;PRKCI;PRKAB1;AKT2;GSK3B;RPS6KB2;INPP5A;PRKAA1;PHKB;PIK3CA;MAP2K2;ACACA
prerank,GO_Biological_Process_2021__replication fork processing (GO:0031297),-0.5437770159430748,-1.0626769383086427,0.4262295081967213,0.8137119265319269,1.0,2/27,7.58%,DDX11;BRCA2
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway (GO:0097193),-0.48714913523382414,-1.062451483921668,0.34177215189873417,0.8139780264818491,1.0,5/77,9.72%,BCL2A1;PPP1R15A;ERO1A;TNFRSF1B;HINT1
prerank,GO_Biological_Process_2021__acute inflammatory response (GO:0002526),-0.6822793801092357,-1.0623117958863189,0.49019607843137253,0.8139388511476549,1.0,2/8,7.40%,SIGIRR;PLSCR1
prerank,Reactome_2022__Surfactant Metabolism R-HSA-5683826,-0.6359428816684725,-1.062211935925042,0.46551724137931033,0.8139378228607217,1.0,3/9,10.84%,CSF2RA;CSF2RB;CCDC59
prerank,"GO_Biological_Process_2021__establishment of mitochondrion localization, microtubule-mediated (GO:0034643)",0.6794467838011226,1.0621889518350818,0.5238095238095238,0.7673189927464303,1.0,1/6,1.80%,MAP1S
prerank,GO_Biological_Process_2021__positive regulation of cysteine-type endopeptidase activity (GO:2001056),-0.5203623656304484,-1.0619958163206786,0.3384615384615385,0.8141357224078296,1.0,7/41,12.39%,CYCS;AIM2;TNFSF10;FIS1;FYN;PDCD5;CYFIP2
prerank,GO_Biological_Process_2021__neural tube closure (GO:0001843),0.4650280830680768,1.0619645050208288,0.3076923076923077,0.7673757410323292,1.0,7/27,11.62%,SCRIB;TSC2;VASP;PLXNB2;DVL3;PHACTR4;COBL
prerank,GO_Biological_Process_2021__positive regulation of glial cell differentiation (GO:0045687),-0.5956855722029137,-1.0618917246367847,0.45614035087719296,0.8140584537200136,1.0,3/11,10.30%,CXCR4;TNFRSF1B;PTN
prerank,GO_Biological_Process_2021__positive regulation of DNA repair (GO:0045739),-0.49689460724373935,-1.0618750495543687,0.4375,0.8137148608490704,1.0,7/36,14.47%,DDX11;EYA2;RPS3;ABRAXAS1;BRCA1;ERCC8;ZCWPW1
prerank,GO_Biological_Process_2021__motile cilium assembly (GO:0044458),-0.6702949387781135,-1.0618016345277743,0.4642857142857143,0.8135068391637782,1.0,2/5,12.06%,BBOF1;CCDC39
prerank,Reactome_2022__Oxygen-dependent Proline Hydroxylation Of Hypoxia-inducible Factor Alpha R-HSA-1234176,-0.49201797571743766,-1.0616572666413295,0.38571428571428573,0.8135355875305403,1.0,13/54,12.85%,UBC;RPS27A;PSMB3;ELOB;PSMB6;PSMA7;EGLN3;PSMB9;RBX1;HIF1A;PSMD12;PSMD8;PSMA5
prerank,GO_Biological_Process_2021__regulation of mRNA catabolic process (GO:0061013),-0.452366712419315,-1.061638641191427,0.3670886075949367,0.8131884994423281,1.0,24/104,20.89%,UBC;RPS27A;ZFP36;PSMB3;PSMB6;PSMA7;PSMB9;EXOSC1;PRR5L;PSMD12;PSMD8;PSMA5;APEX1;HSPA1A;UBA52;CNOT8;PSMA3;PSMC4;PNPT1;VIM;PSME2;PSME1;CARHSP1;PSMB5
prerank,Reactome_2022__RUNX3 Regulates p14-ARF R-HSA-8951936,-0.6409154651954683,-1.0614198643537813,0.45901639344262296,0.8135254738979347,1.0,1/10,1.37%,RUNX3
prerank,GO_Biological_Process_2021__regulation of multicellular organismal development (GO:2000026),0.5648546186333431,1.061286855345673,0.41379310344827586,0.768593617707212,1.0,8/17,16.51%,DUSP6;HPSE;TDG;KAT2A;BAG6;NIPBL;TRIP12;RAB14
prerank,Reactome_2022__MicroRNA (miRNA) Biogenesis R-HSA-203927,0.5207915732342137,1.06120589432811,0.38461538461538464,0.7683437768027532,1.0,1/19,0.68%,POLR2D
prerank,CellMarker_Augmented_2021__Germinal Center B cell:Undefined,0.6375214926408779,1.0609554204272547,0.4318181818181818,0.7684067578966279,1.0,1/5,3.07%,BACH2
prerank,Reactome_2022__NOD1/2 Signaling Pathway R-HSA-168638,0.47734021012887023,1.0607863844243528,0.34146341463414637,0.7683447287375273,1.0,8/29,16.34%,MAPK11;CASP9;IRAK1;TAB2;UBE2N;IRAK2;TRAF6;MAP3K7
prerank,Reactome_2022__PCP/CE Pathway R-HSA-4086400,-0.4886935119997817,-1.060645205328603,0.37333333333333335,0.8153091228904463,1.0,13/70,13.01%,UBC;RPS27A;PSMB3;RORA;PSMB6;PSMA7;PSMB9;FZD2;PSMD12;PFN1;PSMD8;PSMA5;CLTB
prerank,GO_Biological_Process_2021__negative regulation of dephosphorylation (GO:0035305),-0.6275176177144618,-1.0605133599778471,0.44642857142857145,0.8152990250032618,1.0,1/15,1.16%,PPP1R15A
prerank,KEGG_2021_Human__Bladder cancer,0.5115153129178591,1.0602134608168967,0.3076923076923077,0.7694966984953366,1.0,5/28,11.38%,DAPK2;E2F3;MAP2K1;MDM2;MAPK1
prerank,GO_Biological_Process_2021__protein de-ADP-ribosylation (GO:0051725),-0.7269022659150677,-1.0601860025738516,0.5714285714285714,0.8158705632760823,1.0,1/5,10.67%,ADPRH
prerank,GO_Biological_Process_2021__apoptotic DNA fragmentation (GO:0006309),-0.5876413820144071,-1.0598610402838353,0.43859649122807015,0.8164331422147959,1.0,4/12,23.00%,H1-0;DFFB;DICER1;DNASE2
prerank,GO_Biological_Process_2021__plasma membrane invagination (GO:0099024),-0.5234549343408835,-1.0591706913374792,0.3484848484848485,0.8180141976395882,1.0,3/25,2.67%,CD36;MARCO;AIF1
prerank,GO_Biological_Process_2021__spermidine metabolic process (GO:0008216),-0.6895786730464977,-1.0591692582788474,0.48936170212765956,0.8176366919145529,1.0,2/6,7.79%,SAT1;SAT2
prerank,GO_Biological_Process_2021__chromatin-mediated maintenance of transcription (GO:0048096),0.6294081606307045,1.0590541247070873,0.42857142857142855,0.7719644894268759,1.0,2/7,2.77%,SERTAD2;ARID1A
prerank,GO_Biological_Process_2021__carbohydrate phosphorylation (GO:0046835),0.6703964156710667,1.0589133537778652,0.4090909090909091,0.7719143126562069,1.0,2/7,9.49%,IPPK;FGGY
prerank,GO_Biological_Process_2021__regulation of miRNA mediated inhibition of translation (GO:1905616),0.6583193993676756,1.058725956536554,0.43902439024390244,0.7714819664706511,1.0,1/7,8.06%,EIF4E2
prerank,GO_Biological_Process_2021__positive regulation of miRNA mediated inhibition of translation (GO:1905618),0.6583193993676756,1.058725956536554,0.43902439024390244,0.7714819664706511,1.0,1/7,8.06%,EIF4E2
prerank,GO_Biological_Process_2021__regulation of mitotic cell cycle (GO:0007346),0.38939446741791306,1.0587016238356803,0.3333333333333333,0.7710794427193813,1.0,16/121,10.82%,UBE2D1;SCRIB;BORA;SIRT1;CDK10;SMAD3;RCC1;FZR1;BRINP3;CDC23;MDM2;BTRC;HECA;RNF20;ANAPC16;CDK13
prerank,CellMarker_Augmented_2021__Fibroblast:Peripheral Blood,0.47952814747309624,1.0585570068598678,0.36666666666666664,0.7710368219596782,1.0,10/33,13.53%,COL16A1;SVEP1;COL5A2;WNT5A;TIMP3;CDH11;COL11A1;COL6A1;FBXL7;COL15A1
prerank,GO_Biological_Process_2021__ruffle assembly (GO:0097178),-0.7006204826085993,-1.0584907078176777,0.4716981132075472,0.819308261226939,1.0,3/5,17.44%,AIF1;RAC1;INPP5K
prerank,Reactome_2022__Resolution Of AP Sites Via Multiple-Nucleotide Patch Replacement Pathway R-HSA-110373,-0.5997473050513098,-1.0580813408692085,0.41379310344827586,0.8200111537174051,1.0,6/18,17.06%,POLE3;PARP2;PARG;APEX1;RPA3;LRIG1
prerank,GO_Biological_Process_2021__regulation of double-strand break repair (GO:2000779),-0.5244878479930059,-1.0580064924571757,0.44776119402985076,0.8198812164292423,1.0,1/30,0.51%,DDX11
prerank,GO_Biological_Process_2021__zinc ion transport (GO:0006829),0.5744647867952188,1.0578715330367718,0.4594594594594595,0.7721409683827437,1.0,2/14,5.71%,SLC39A14;SLC39A8
prerank,GO_Biological_Process_2021__regulation of cellular ketone metabolic process (GO:0010565),-0.49679441781397504,-1.0577310354947367,0.3333333333333333,0.8202009012955573,1.0,16/47,22.96%,PSMB3;ODC1;PSMB6;PSMA7;PSMB9;AZIN1;PSMD12;PSMD8;PSMA5;PSMA3;PSMC4;PSME2;PSME1;PSMB5;PSMC3;PSME3
prerank,GO_Biological_Process_2021__regulation of chromatin assembly or disassembly (GO:0001672),0.5680560232247709,1.0574063155652709,0.4318181818181818,0.772995268361519,1.0,2/7,5.44%,MAP1S;TLK1
prerank,GO_Biological_Process_2021__regulation of organelle assembly (GO:1902115),0.4033560485123241,1.057097759730562,0.3142857142857143,0.7733241756031837,1.0,12/63,13.99%,MSN;GSN;TBC1D1;RAB1B;TBC1D5;TBC1D10B;TBC1D16;TBC1D12;PLK2;TBC1D22B;RABGAP1;EVI5
prerank,GO_Biological_Process_2021__neuron differentiation (GO:0030182),0.4069495474719924,1.0568209087060771,0.19230769230769232,0.7735078845554201,1.0,24/73,18.00%,CDK5R1;MAP2K1;WNT5A;UGDH;PBX1;FZD3;PPT1;WNT2B;RUNX1;RYK;SOX4;BRSK1;FUT9;OLIG1;WNK1;PTPRD;NTRK2;TGFBR1;MANF;PBX3;MTPN;IL1RAPL1;ERCC2;BRSK2
prerank,GO_Biological_Process_2021__regulation of cellular respiration (GO:0043457),0.6172141682305757,1.0566908881110086,0.44680851063829785,0.7733812546257525,1.0,2/9,3.96%,IFNLR1;CBFA2T3
prerank,GO_Biological_Process_2021__protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),0.4900055191556391,1.0566702316759298,0.30303030303030304,0.7729930486874256,1.0,5/21,22.72%,AUP1;RNF185;BAG6;KLHL15;TOR1A
prerank,GO_Biological_Process_2021__negative regulation of cation transmembrane transport (GO:1904063),-0.5846504814766937,-1.0565681499984239,0.42424242424242425,0.8229011154030935,1.0,2/11,7.09%,HAMP;STK39
prerank,PanglaoDB_Augmented_2021__Airway Smooth Muscle Cells,0.47007359771617174,1.0565637051446741,0.4857142857142857,0.7727773875980758,1.0,7/22,9.95%,TPM2;COL5A2;ACTA2;TIMP3;CDH11;TWIST2;LOXL2
prerank,CellMarker_Augmented_2021__Endothelial Progenitor cell:Blood,-0.49457297389669325,-1.0565583732643078,0.38461538461538464,0.8225475718418174,1.0,16/43,17.23%,MS4A4A;CD93;F13A1;PECAM1;MS4A6A;HLA-DRA;SPARCL1;A2M;FLT1;PTPRC;SERPING1;HLA-DPA1;CD74;CD200;HLA-DPB1;GIMAP4
prerank,"GO_Biological_Process_2021__base-excision repair, gap-filling (GO:0006287)",-0.525850466557046,-1.0564363512315504,0.3880597014925373,0.8224292818176987,1.0,8/26,21.41%,SMUG1;OGG1;PARG;APEX1;RPA3;RFC1;POLG;MPG
prerank,GO_Biological_Process_2021__regulation of epidermal cell differentiation (GO:0045604),-0.5754554980839088,-1.056435501831047,0.4406779661016949,0.8220469344063469,1.0,1/12,1.48%,ZFP36
prerank,GO_Biological_Process_2021__negative regulation of response to stimulus (GO:0048585),0.47974373109186913,1.056195095618435,0.3,0.773188005296014,1.0,2/38,2.51%,KLF4;SIRT1
prerank,GO_Biological_Process_2021__metallo-sulfur cluster assembly (GO:0031163),-0.5697263181745569,-1.056188884930066,0.4307692307692308,0.8223816348736126,1.0,4/18,15.50%,ISCA1;NFS1;NUBPL;CIAO2B
prerank,GO_Biological_Process_2021__inorganic anion transport (GO:0015698),0.46815172216629203,1.0561700142994337,0.39285714285714285,0.7727524731643306,1.0,7/26,14.62%,XPR1;GLRA1;ANO8;ANO4;ANO6;SLC25A14;ENPP1
prerank,GO_Biological_Process_2021__negative regulation of mRNA 3'-end processing (GO:0031441),0.5992514166801571,1.0561568170510642,0.46808510638297873,0.7723380684538481,1.0,4/9,20.63%,RNF20;ZC3H14;BARD1;CDK9
prerank,Reactome_2022__Killing Mechanisms R-HSA-9664420,0.5719102510190837,1.0561083127434134,0.4666666666666667,0.7719722227146707,1.0,3/8,13.64%,WNT5A;DVL3;JUN
prerank,GO_Biological_Process_2021__positive regulation of production of molecular mediator of immune response (GO:0002702),-0.609088640383478,-1.0561062162020924,0.44776119402985076,0.822213315894722,1.0,9/19,19.57%,SLC7A5;DNAJB9;PHB2;PTPRC;NOD2;HLA-E;TNFRSF14;PTPN22;EPHB2
prerank,GO_Biological_Process_2021__protein kinase A signaling (GO:0010737),0.6039514405480282,1.0559805463003593,0.4897959183673469,0.7718470192110033,1.0,2/7,4.81%,MYOM1;LCP1
prerank,CellMarker_Augmented_2021__Muller cell:Retina,-0.4877578591790897,-1.0557957591242695,0.4117647058823529,0.8227737421640144,1.0,24/77,16.96%,MNDA;MS4A4A;AIF1;SIGLEC1;CD14;CD93;PADI2;CDH23;GLUL;F13A1;CD300LF;RHOU;BEX4;CHI3L1;MS4A6A;TYROBP;CSF3R;FCGR1CP;SERPING1;LRRC4;TMIGD3;RTN1;ALDH2;FCGR3A
prerank,GO_Biological_Process_2021__regulation of ubiquitin-protein transferase activity (GO:0051438),0.5357373040871325,1.0557144312339262,0.4,0.7721197932750062,1.0,9/22,13.66%,SMAD7;FEM1B;ARRDC3;DCUN1D4;UBE2L3;FBXW7;UBE2N;DCUN1D1;BAG5
prerank,Reactome_2022__Protein Ubiquitination R-HSA-8852135,-0.4909617936306273,-1.05553452976078,0.4305555555555556,0.8230448591776888,1.0,4/58,1.30%,UBC;H2BC4;HLA-B;RPS27A
prerank,Reactome_2022__Transferrin Endocytosis And Recycling R-HSA-917977,-0.5548039811934193,-1.0554680270679497,0.417910447761194,0.8228806501995037,1.0,2/23,4.87%,TFRC;ATP6V1F
prerank,KEGG_2021_Human__Prion disease,-0.41934870882476694,-1.0554511374568563,0.34146341463414637,0.8225409717751585,1.0,52/189,18.32%,TUBB8;CYCS;CCL5;COX7C;PSMB3;UQCRB;NDUFC1;NDUFA2;NCF4;UQCRH;NDUFA1;ADRM1;SLC25A5;NDUFB9;ATP5PD;NDUFA12;ATP5F1E;PSMB6;NDUFB4;PSMA7;FYN;UQCR10;COX4I1;COX5B;NCF2;NDUFB1;NDUFS8;NDUFS5;PSMD12;HSPA1B;CYBA;COX7A2;PSMD8;PSMA5;COX6C;SOD1;PIK3CB;TUBB4B;HSPA1A;NDUFS6;NDUFB7;UQCRC1;RAC1;NDUFB3;PSMA3;UQCRQ;ATP5F1C;PSMC4;CSNK2A2;NDUFS7;HSPA2;NDUFA3
prerank,GO_Biological_Process_2021__hydrogen peroxide metabolic process (GO:0042743),-0.6212490275634694,-1.0554349500520148,0.41509433962264153,0.822193249096444,1.0,5/12,14.09%,DUOX1;PRDX4;CYBA;SOD1;GPX1
prerank,GO_Biological_Process_2021__positive regulation of defense response to virus by host (GO:0002230),-0.597634964020239,-1.0553500515857142,0.4482758620689655,0.82203801792965,1.0,6/19,11.42%,AIM2;DTX3L;PARP9;APOBEC3G;STAT1;STING1
prerank,GO_Biological_Process_2021__mitochondrial translational termination (GO:0070126),-0.4943379534039224,-1.0550156150588188,0.425,0.8225218067083653,1.0,20/62,17.46%,MRPL57;AURKAIP1;MRPS7;MRPL51;MRPL19;GADD45GIP1;MRPL52;MRPL50;MTRF1;MRPS11;MRPS10;MRPS15;MRPL16;MRPL32;CHCHD1;OXA1L;MRPL43;MRPS18C;MRPL45;MRPS25
prerank,Reactome_2022__Downstream TCR Signaling R-HSA-202424,-0.46399551260506533,-1.0549908452810106,0.3625,0.8221912705399043,1.0,16/75,14.82%,UBC;RPS27A;PRKCQ;PSMB3;CD247;HLA-DRB5;PSMB6;PSMA7;PSMB9;HLA-DRA;PSMD12;PSMD8;PSMA5;PIK3CB;HLA-DPA1;UBA52
prerank,GO_Biological_Process_2021__mitochondrial translational elongation (GO:0070125),-0.48391670224375094,-1.0548136615020756,0.38372093023255816,0.8222740482161772,1.0,19/61,17.46%,MRPL57;AURKAIP1;MRPS7;MRPL51;MRPL19;GADD45GIP1;MRPL52;MRPL50;MRPS11;MRPS10;MRPS15;MRPL16;MRPL32;CHCHD1;OXA1L;MRPL43;MRPS18C;MRPL45;MRPS25
prerank,GO_Biological_Process_2021__pinocytosis (GO:0006907),0.6439458015175896,1.0544924589483575,0.5,0.7745104742728028,1.0,2/7,12.49%,PPT1;MAPKAPK2
prerank,Reactome_2022__Beta-oxidation Of pristanoyl-CoA R-HSA-389887,0.6895278179925286,1.0543195062320367,0.4888888888888889,0.7743977015277177,1.0,1/5,9.12%,ACOX3
prerank,GO_Biological_Process_2021__nuclear polyadenylation-dependent ncRNA catabolic process (GO:0071046),-0.6856790353530947,-1.0543176588979168,0.40625,0.8219922726792751,1.0,1/5,7.08%,EXOSC10
prerank,GO_Biological_Process_2021__nuclear polyadenylation-dependent rRNA catabolic process (GO:0071035),-0.6856790353530947,-1.0543176588979168,0.40625,0.8219922726792751,1.0,1/5,7.08%,EXOSC10
prerank,GO_Biological_Process_2021__tRNA surveillance (GO:0106354),-0.6856790353530947,-1.0543176588979168,0.40625,0.8219922726792751,1.0,1/5,7.08%,EXOSC10
prerank,GO_Biological_Process_2021__nuclear polyadenylation-dependent tRNA catabolic process (GO:0071038),-0.6856790353530947,-1.0543176588979168,0.40625,0.8219922726792751,1.0,1/5,7.08%,EXOSC10
prerank,GO_Biological_Process_2021__regulation of cholesterol biosynthetic process (GO:0045540),0.5328465557300577,1.054176233936956,0.37209302325581395,0.7742097437402212,1.0,1/16,1.57%,ABCA2
prerank,Reactome_2022__Interleukin Receptor SHC Signaling R-HSA-912526,-0.5993837138760911,-1.0541617482552512,0.43333333333333335,0.822020842941578,1.0,5/16,18.94%,IL3RA;CSF2RA;CSF2RB;PIK3CB;INPP5D
prerank,GO_Biological_Process_2021__positive regulation of morphogenesis of an epithelium (GO:1905332),0.5836161093038367,1.0540929376626722,0.3829787234042553,0.7739467333560723,1.0,2/9,9.36%,FGF2;SIRT6
prerank,GO_Biological_Process_2021__regulation of chaperone-mediated autophagy (GO:1904714),0.6428940202122034,1.0540216096993054,0.43478260869565216,0.7736361585680996,1.0,4/8,19.35%,GFAP;EEF1A2;ATP13A2;SNCA
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),-0.5867194890784624,-1.0539363135305113,0.42857142857142855,0.8222282777341797,1.0,2/23,5.35%,PPP1R15A;ERO1A
prerank,CellMarker_Augmented_2021__Migrating Cancer Stem cell:Lung,-0.5472229325541209,-1.053658483101048,0.40625,0.8221895241131069,1.0,3/26,4.96%,ZNF185;CLDN7;ABCC3
prerank,CellMarker_Augmented_2021__Migrating Cancer Stem cell:Liver,-0.5472229325541209,-1.053658483101048,0.40625,0.8221895241131069,1.0,3/26,4.96%,ZNF185;CLDN7;ABCC3
prerank,GO_Biological_Process_2021__peroxisome fission (GO:0016559),-0.6684950543052279,-1.053519843761758,0.4528301886792453,0.8221888693479091,1.0,1/5,5.76%,FIS1
prerank,GO_Biological_Process_2021__tRNA aminoacylation for mitochondrial protein translation (GO:0070127),-0.6795889820896238,-1.0535066273860383,0.47619047619047616,0.8218518552685071,1.0,3/7,15.79%,TARS2;DARS2;GARS1
prerank,GO_Biological_Process_2021__regulation of protein ubiquitination (GO:0031396),0.39795064877180275,1.0534985989052563,0.3181818181818182,0.7744810636554823,1.0,19/83,15.21%,UBE2D1;SPRY2;SMAD7;SPOPL;LRRK2;DNAJB2;GNL3L;SOX4;SASH1;LAPTM5;UBE2L3;FBXW7;UBE2N;DCUN1D1;GTPBP4;BAG5;XIAP;TRAF6;TGFBR1
prerank,GO_Biological_Process_2021__mitochondrial DNA replication (GO:0006264),-0.6172790078440975,-1.053390226750444,0.45614035087719296,0.8217185347204918,1.0,3/7,25.28%,MGME1;POLG;SSBP1
prerank,GO_Biological_Process_2021__positive regulation of glycogen biosynthetic process (GO:0045725),-0.5945067185886086,-1.0533144066919322,0.43137254901960786,0.8215438491090955,1.0,1/9,5.56%,IGF1
prerank,GO_Biological_Process_2021__response to ethanol (GO:0045471),0.6029546605391194,1.0531921126537844,0.3958333333333333,0.774764836487658,1.0,4/9,16.68%,GRIN3A;GLRA1;GRIN2B;GRIN2A
prerank,Reactome_2022__Signaling By NOTCH4 R-HSA-9013694,-0.48370537668443153,-1.0531865988810716,0.4444444444444444,0.8214522614052835,1.0,18/67,19.69%,UBC;RPS27A;PSMB3;PSMB6;PSMA7;RBPJ;PSMB9;RBX1;PSMD12;PSMD8;PSMA5;NOTCH2;UBA52;PSMA3;PSMC4;APH1B;PSME2;PSME1
prerank,Reactome_2022__Regulation Of KIT Signaling R-HSA-1433559,-0.5975594032202621,-1.053121221914697,0.47540983606557374,0.821215684346832,1.0,2/13,7.36%,YES1;FYN
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),-0.5591389082554591,-1.0530542854771319,0.421875,0.8210290412804709,1.0,6/23,12.82%,PARP14;LILRB4;SH3BP5;SAMSN1;SH3BP5L;PTPRC
prerank,GO_Biological_Process_2021__metal ion transport (GO:0030001),0.4356720273412499,1.0529322975153268,0.34210526315789475,0.7748776019600764,1.0,11/58,8.80%,CACNA1A;TRPC1;PKD2;GRIN3A;NIPA2;NIPAL2;SLC3A2;SLC39A8;NIPA1;RAMP1;SLC41A1
prerank,GO_Biological_Process_2021__protein localization to cytoplasmic stress granule (GO:1903608),-0.6831390000555698,-1.0527940180313617,0.46153846153846156,0.8213850605054545,1.0,1/6,3.42%,SSB
prerank,GO_Biological_Process_2021__positive regulation of cytokine production (GO:0001819),-0.42406017272668994,-1.0523509062203715,0.3780487804878049,0.8221298425927992,1.0,49/214,16.72%,ITK;BTN3A1;CD2;GAPDH;SLC7A5;PRKCQ;DHX58;AIF1;CD14;FCER1G;RORA;SLAMF6;RPS3;TXK;LAMTOR5;IL12RB2;SULF2;EIF2AK2;BTN3A2;LURAP1;PRKD2;CHI3L1;GLMN;CD226;SLC11A1;IRF1;TYROBP;HIF1A;STING1;APPL1;IL18R1;HSPA1B;CYBA;PTPRC;SOD1;HAVCR2;NOD2;BRCA1;HLA-E;HSPA1A;HLA-DPA1;C3;CD74;CD200;AGT;POLR3C;FLOT1;STOML2;HLA-DPB1
prerank,GO_Biological_Process_2021__positive regulation of cell cycle (GO:0045787),0.4456880983355394,1.0522629751988204,0.3076923076923077,0.776013685098598,1.0,8/47,15.66%,PKD2;PKD1;CCPG1;SPDYA;MDM2;CCNYL1;CCND3;ANKRD17
prerank,Reactome_2022__Platelet Adhesion To Exposed Collagen R-HSA-75892,-0.6643289651999045,-1.0521625031190955,0.5172413793103449,0.8223029867210561,1.0,5/7,22.16%,FCER1G;FYN;ITGB1;GP6;LYN
prerank,CellMarker_Augmented_2021__Exhausted CD4+ T cell:Liver,-0.4497328734258802,-1.052091410481945,0.39705882352941174,0.822103781061034,1.0,11/84,8.45%,SRGN;GAPDH;WARS1;RGS2;IKZF3;RGS1;OGG1;UQCRH;ST8SIA1;SPOCK2;RBPJ
prerank,GO_Biological_Process_2021__protein targeting to mitochondrion (GO:0006626),-0.5082781977582939,-1.0519037759491563,0.36923076923076925,0.8222395763869432,1.0,6/36,7.54%,TOMM7;DNAJC19;TIMM44;FIS1;PITRM1;TIMM21
prerank,GO_Biological_Process_2021__icosanoid biosynthetic process (GO:0046456),0.5957223938444426,1.0518048235971544,0.425531914893617,0.7767870314066614,1.0,3/8,27.72%,ALOX5AP;MGST3;MGST2
prerank,GO_Biological_Process_2021__proteolysis involved in cellular protein catabolic process (GO:0051603),-0.49915860105260246,-1.0517439305280352,0.3888888888888889,0.8223091406304563,1.0,4/57,3.91%,UBC;RPS27A;GZMB;CTSB
prerank,GO_Biological_Process_2021__neuronal ion channel clustering (GO:0045161),0.5948801474021098,1.0516918205257817,0.46153846153846156,0.7765235904874377,1.0,2/7,3.23%,CNTN2;KCNIP2
prerank,GO_Biological_Process_2021__regulation of plasma membrane bounded cell projection organization (GO:0120035),0.49944910209418997,1.0516269488949548,0.3157894736842105,0.7762536464712773,1.0,10/23,21.32%,CTNNA2;BRSK1;ZNF804A;PTEN;MARK1;GSK3B;IL1RAPL1;BRSK2;HOMER1;FBXO7
prerank,GO_Biological_Process_2021__leukocyte tethering or rolling (GO:0050901),-0.621396151687279,-1.0513972131869511,0.4444444444444444,0.822903122612236,1.0,3/12,8.15%,GCNT1;SELL;ITGA4
prerank,CellMarker_Augmented_2021__Vascular Smooth Muscle cell:Placenta,-0.5458826281615006,-1.0513928760324611,0.4507042253521127,0.8225471473361862,1.0,2/30,0.73%,MYLK;PLN
prerank,GO_Biological_Process_2021__ISG15-protein conjugation (GO:0032020),0.6944189121609701,1.0513208354677464,0.5,0.7765081611594113,1.0,1/5,5.15%,UBE2E2
prerank,GO_Biological_Process_2021__positive regulation of synapse assembly (GO:0051965),0.4968122273451635,1.0512511607476644,0.5172413793103449,0.7762657536523874,1.0,9/20,18.35%,GRID2;DLG5;NLGN1;CLSTN2;CLSTN3;PTPRD;LRRC4B;IL1RAPL1;SEMA4D
prerank,GO_Biological_Process_2021__peptidyl-tyrosine phosphorylation (GO:0018108),-0.5061980253683522,-1.050714266611015,0.36764705882352944,0.8239615503509831,1.0,5/46,7.36%,ITK;BTK;TXK;PRLR;FYN
prerank,GO_Biological_Process_2021__regulation of endothelial cell apoptotic process (GO:2000351),0.5424003118502656,1.0505399493511842,0.36,0.7774922375372589,1.0,5/19,12.90%,SEMA5A;SERPINE1;TNF;ANO6;PRKCI
prerank,GO_Biological_Process_2021__cellular response to thyroid hormone stimulus (GO:0097067),-0.6109348792832731,-1.0505148767142252,0.4307692307692308,0.8241745438492587,1.0,1/10,3.91%,CTSB
prerank,KEGG_2021_Human__Chemical carcinogenesis,0.3892914783562277,1.0505107881638087,0.23529411764705882,0.7771476116793146,1.0,19/109,16.08%,KLF4;CACNA1A;FGF2;MAP2K1;GSTA4;ADCY9;JAG1;HPGDS;KPNA4;RPS6KA6;MAPK1;KPNA5;ADCY6;JUN;XIAP;AKT2;CCND3;PAQR7;RPS6KB2
prerank,Reactome_2022__Downregulation Of TGF-beta Receptor Signaling R-HSA-2173788,-0.5664344348665016,-1.0503601356903722,0.4090909090909091,0.8242430647707064,1.0,3/25,1.30%,UBC;PPP1R15A;RPS27A
prerank,GO_Biological_Process_2021__neuron development (GO:0048666),0.38071887146753736,1.0503034738497912,0.3333333333333333,0.7771429469440967,1.0,34/96,23.29%,LGI4;CDK5R1;NLGN1;UGDH;PBX1;PTPRM;PPT1;RUNX1;RYK;BICDL1;GPM6A;WNK1;NTRK2;CNTN4;GSK3B;MANF;PBX3;RAPGEF2;NEDD4;B4GALT5;MAP2;HS6ST1;AGER;ZFYVE27;CNTNAP2;ULK1;EPHA5;TMEM108;DTNBP1;STMN3;TOR1A;TENM2;UHMK1;STX3
prerank,GO_Biological_Process_2021__regulation of secretion (GO:0051046),-0.6701283345153414,-1.0502608276376402,0.39344262295081966,0.8241302280343445,1.0,3/8,10.40%,OAS2;SGK1;POFUT2
prerank,CellMarker_Augmented_2021__Cardiovascular Progenitor cell:Heart,0.48540336464238015,1.0501865589970534,0.3902439024390244,0.7769753940275897,1.0,11/26,13.54%,ST6GALNAC3;PCDH17;CACHD1;SHC2;PREX2;ASXL3;PTPRD;LINGO1;RUNX1T1;COL25A1;MARK1
prerank,KEGG_2021_Human__Pathogenic Escherichia coli infection,-0.43244980330118377,-1.0501687421456287,0.4,0.8239433620529949,1.0,12/146,7.76%,TUBB8;MYO1G;CYCS;FOS;GAPDH;NAIP;CLDN7;TNFSF10;ARHGEF1;RPS3;FYN;ACTG1
prerank,Reactome_2022__Serine Biosynthesis R-HSA-977347,0.6230697878706463,1.0501250243927325,0.43137254901960786,0.776658803934415,1.0,4/6,34.37%,SERINC1;PSPH;SRR;PSAT1
prerank,GO_Biological_Process_2021__extracellular transport (GO:0006858),0.6671969630410732,1.0500801456257032,0.5348837209302325,0.7762883474855711,1.0,4/7,26.62%,CCDC40;DNAAF2;CABYR;ADCY10
prerank,GO_Biological_Process_2021__positive regulation of cellular respiration (GO:1901857),0.6528522438739367,1.0500789909470303,0.4444444444444444,0.7758370170509865,1.0,1/7,0.25%,IFNLR1
prerank,GO_Biological_Process_2021__pulmonary valve morphogenesis (GO:0003184),0.5580755111656012,1.0499643469711293,0.4444444444444444,0.7756773838452623,1.0,3/9,15.51%,JAG1;ROBO1;ROBO2
prerank,GO_Biological_Process_2021__response to hydrogen peroxide (GO:0042542),0.43144366278714524,1.0497613817209779,0.3142857142857143,0.7757209618400843,1.0,5/37,6.12%,ANXA1;SIRT1;SIRPA;CAT;STK25
prerank,GO_Biological_Process_2021__AMP metabolic process (GO:0046033),-0.680306566273271,-1.0497579385515063,0.5,0.8246458481355045,1.0,2/6,10.32%,AMPD2;AK9
prerank,GO_Biological_Process_2021__positive regulation of nucleic acid-templated transcription (GO:1903508),0.3500288125729599,1.0496158313534263,0.3333333333333333,0.7755886356827716,1.0,45/316,11.93%,EGR1;KLF4;ESRRG;PPARGC1A;NPAS3;FGF2;ZBTB16;ARID1A;MITF;MYRF;KLF6;ACTA2;PICALM;ARNT2;MAP2K1;WNT5A;PPARG;RYBP;PHF5A;SMAD2;DDIT3;SMAD3;RUNX1;SALL1;HMGA1;TNF;RFX3;DVL3;MMS19;CLOCK;SOX4;TRERF1;ZBTB48;BTRC;HDAC1;NFIB;DYRK1A;RNF20;RGMB;TBL1XR1;FBXW11;NSD3;KAT2A;SETD3;RNF10
prerank,GO_Biological_Process_2021__growth hormone receptor signaling pathway via JAK-STAT (GO:0060397),-0.6177849435636774,-1.0490269273620123,0.43636363636363634,0.8260060457371846,1.0,1/10,6.83%,PRLR
prerank,Reactome_2022__Regulation Of IGF Transport And Uptake By IGFBPs R-HSA-381426,0.42767427218797105,1.048570791610654,0.3333333333333333,0.7777547527328366,1.0,8/58,10.09%,GOLM1;FAM20C;TRIM26;PRKCSH;VGF;ANO8;PPP3CA;DMTF1
prerank,Reactome_2022__Neurotoxicity Of Clostridium Toxins R-HSA-168799,0.6442294004926274,1.0482723922472867,0.48936170212765956,0.7780807924589223,1.0,3/7,10.16%,VAMP1;SV2B;STX1A
prerank,GO_Biological_Process_2021__heat acclimation (GO:0010286),-0.6828076996762761,-1.0482004612056905,0.47368421052631576,0.8273332193589678,1.0,2/5,14.43%,HSPA1B;HSPA1A
prerank,GO_Biological_Process_2021__cellular heat acclimation (GO:0070370),-0.6828076996762761,-1.0482004612056905,0.47368421052631576,0.8273332193589678,1.0,2/5,14.43%,HSPA1B;HSPA1A
prerank,GO_Biological_Process_2021__regulation of protein kinase activity (GO:0045859),0.37258729720582523,1.0479855070553739,0.36,0.7783659433300614,1.0,24/84,19.37%,QARS1;SIRT1;SPRED1;RAP1A;TSC2;GNAQ;CEP85;RELN;TNF;YWHAG;TAB2;SPDYA;DEPTOR;CENPE;NF1;PTK2;MMD;RAP2C;RAPGEF2;CHP1;SMCR8;PPM1F;SNCA;PPM1E
prerank,Reactome_2022__Prolactin Receptor Signaling R-HSA-1170546,-0.5759267453096832,-1.0479605314223377,0.423728813559322,0.8275808822162428,1.0,2/10,11.16%,PRLR;RBX1
prerank,GO_Biological_Process_2021__receptor recycling (GO:0001881),0.6839615300343644,1.0479251301643613,0.5652173913043478,0.7781109293155287,1.0,2/5,27.92%,SORL1;PLEKHJ1
prerank,"GO_Biological_Process_2021__RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",-0.4289006501638174,-1.047780661462114,0.3625,0.8276804600253819,1.0,48/208,19.10%,PPIE;FRG1;RAVER2;DHX16;ZCRB1;DHX38;CSTF2T;SNRNP27;SNRPD2;RNPC3;WDR83;RBM22;POLR2G;PNN;EIF4A3;LSM7;PDCD7;CRNKL1;ZRSR2;U2AF2;NCBP2;ZCCHC8;SMNDC1;PRPF3;BUD31;GCFC2;RBM4B;DDX23;SRSF2;DDX5;SRSF7;CWC25;SNRPA1;CWF19L2;CCAR1;PPWD1;EFTUD2;SLU7;SNRPA;LSM4;IK;SNRNP200;GTF2F1;HNRNPH2;RBM4;BCAS2;SF3A1;PRPF4
prerank,Reactome_2022__Caspase Activation Via Extrinsic Apoptotic Signaling Pathway R-HSA-5357769,0.4614492926520802,1.0476481543056524,0.375,0.7783282924288117,1.0,7/22,13.60%,DAPK2;TMED7-TICAM2;CASP9;TNFRSF10A;UNC5B;FASN;DCC
prerank,GO_Biological_Process_2021__tRNA aminoacylation (GO:0043039),-0.5130125154960303,-1.0475284330236112,0.4117647058823529,0.8280591102099473,1.0,6/35,12.52%,HARS2;WARS1;NARS1;LARS1;KARS1;DARS2
prerank,GO_Biological_Process_2021__cardiac muscle hypertrophy (GO:0003300),-0.6662318751348238,-1.0474048635519417,0.4727272727272727,0.8280393791831521,1.0,1/6,7.37%,TTN
prerank,CellMarker_Augmented_2021__Adipose-derived Stromal cell:Adipose Tissue,0.5297189882545345,1.047346163231769,0.4857142857142857,0.7785993251310793,1.0,1/10,0.08%,KLF4
prerank,KEGG_2021_Human__Pyrimidine metabolism,-0.5076160509223401,-1.0472929305668883,0.4411764705882353,0.8279294307968766,1.0,9/42,11.98%,CMPK2;NT5C;TYMP;ENPP3;DPYS;AK9;ENTPD4;DHODH;ENTPD5
prerank,GO_Biological_Process_2021__regulation of vesicle fusion (GO:0031338),0.5783229522798309,1.047155145206643,0.35714285714285715,0.7785803865412061,1.0,1/7,0.34%,ANXA1
prerank,GO_Biological_Process_2021__regulation of cytoplasmic transport (GO:1903649),0.5970895637871603,1.0471359108274685,0.4186046511627907,0.778144064747361,1.0,5/10,20.25%,LRRK2;MAP2K1;MAPK1;MAP2K2;USP7
prerank,PanglaoDB_Augmented_2021__Noradrenergic Neurons,0.7021820491434639,1.0469117872812894,0.5,0.778381092095175,1.0,1/6,4.25%,PLPPR1
prerank,PanglaoDB_Augmented_2021__Smooth Muscle Cells,-0.4980744030684622,-1.0468889751817854,0.358974358974359,0.8286231314828519,1.0,5/63,2.35%,SPON2;MYLK;COL5A1;PLN;PDGFD
prerank,GO_Biological_Process_2021__positive regulation of translation in response to stress (GO:0032056),0.679880509441676,1.04688057706575,0.46153846153846156,0.7780395328332405,1.0,2/5,26.72%,DDX3X;EIF2AK4
prerank,KEGG_2021_Human__Thyroid hormone signaling pathway,0.38543165042710326,1.0465791188231173,0.3157894736842105,0.7782965091541293,1.0,14/91,11.55%,PFKP;PFKM;NCOA3;CASP9;MAP2K1;TSC2;PLCB4;SLC9A1;MDM2;MED13L;HDAC1;ITGAV;MAPK1;KAT2A
prerank,KEGG_2021_Human__Metabolism of xenobiotics by cytochrome P450,-0.5867692944788296,-1.046547374591565,0.4642857142857143,0.8290908185430895,1.0,6/17,13.93%,GSTM4;EPHX1;GSTP1;GSTK1;GSTM3;CBR3
prerank,GO_Biological_Process_2021__positive regulation of T cell differentiation (GO:0045582),-0.5526143002336023,-1.0460334357011132,0.41935483870967744,0.8301888673993011,1.0,4/23,10.77%,IL4I1;LILRB4;NCKAP1L;HLA-DRA
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, preincision complex stabilization (GO:0006293)",-0.5458271657865502,-1.045965610110567,0.41935483870967744,0.8296319503629387,1.0,4/18,13.98%,XPA;GTF2H5;RBX1;RPA3
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",-0.5458271657865502,-1.045965610110567,0.41935483870967744,0.8296319503629387,1.0,4/18,13.98%,XPA;GTF2H5;RBX1;RPA3
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Corneal Endothelium,0.417564829557845,1.0458825490796508,0.32432432432432434,0.7793793579667588,1.0,11/59,7.32%,ANXA1;TPM2;NRP1;PKD2;MSN;SERPINE1;COL5A2;BNC2;PDGFC;RECK;VCL
prerank,Reactome_2022__RND1 GTPase Cycle R-HSA-9696273,-0.5103491461297117,-1.0457297069013802,0.4032258064516129,0.8299306232954864,1.0,2/29,1.44%,PLEKHG5;TFRC
prerank,Reactome_2022__Pre-NOTCH Expression And Processing R-HSA-1912422,-0.49157772837639313,-1.0457248277081934,0.45714285714285713,0.8295666739135149,1.0,10/52,9.35%,H2BC4;H2BC26;H2AC20;H2AC6;H3-3B;H2AJ;H2BC21;H2BC5;RBPJ;H2BC9
prerank,"Reactome_2022__SMAC, XIAP-regulated Apoptotic Response R-HSA-111469",-0.6227369864733959,-1.0456928098816605,0.40625,0.8292929625624968,1.0,1/7,1.08%,CYCS
prerank,GO_Biological_Process_2021__primary alcohol metabolic process (GO:0034308),-0.5976339559147166,-1.0454493962866396,0.43548387096774194,0.8296077227616012,1.0,2/13,5.56%,GDPD1;IGF1
prerank,Reactome_2022__Post NMDA Receptor Activation Events R-HSA-438064,0.4173785222630572,1.0453018651884198,0.3142857142857143,0.7802125801184215,1.0,13/51,17.57%,PRKAB2;NRG1;GIT1;GRIA1;RPS6KA6;MAPK1;GRIN2B;PRKAB1;ERBB4;GRIA2;GRIN2A;PRKAA1;PRKX
prerank,Reactome_2022__Glycosphingolipid Metabolism R-HSA-1660662,-0.5491415457505562,-1.0449908267211687,0.3968253968253968,0.8304080793922826,1.0,2/28,2.05%,ARSJ;ARSG
prerank,GO_Biological_Process_2021__translational termination (GO:0006415),-0.4849972069266803,-1.0449530460354435,0.3974358974358974,0.8301221153000465,1.0,20/66,17.46%,MRPL57;AURKAIP1;MRPS7;MRPL51;MRPL19;GADD45GIP1;MRPL52;MRPL50;MTRF1;MRPS11;MRPS10;MRPS15;MRPL16;MRPL32;CHCHD1;OXA1L;MRPL43;MRPS18C;MRPL45;MRPS25
prerank,GO_Biological_Process_2021__regulation of respiratory burst (GO:0060263),-0.6901283873955903,-1.0447504000801313,0.4528301886792453,0.8303136930930023,1.0,4/6,25.96%,RAC1;CLEC7A;RAC2;NOXA1
prerank,GO_Biological_Process_2021__regulation of p38MAPK cascade (GO:1900744),-0.5267185565490731,-1.0447264166343095,0.4406779661016949,0.830015797729436,1.0,2/29,2.08%,DUSP1;GADD45B
prerank,GO_Biological_Process_2021__centromere complex assembly (GO:0034508),-0.5534287368263743,-1.0445865874446643,0.3709677419354839,0.8299464083796487,1.0,6/24,18.36%,CENPV;CENPU;ITGB3BP;NPM1;MIS12;CENPF
prerank,Reactome_2022__Carboxyterminal Post-Translational Modifications Of Tubulin R-HSA-8955332,-0.5465166649625322,-1.0444638441061753,0.44285714285714284,0.8298648602638423,1.0,1/25,0.17%,TUBB8
prerank,Reactome_2022__Activation Of Caspases Thru Apoptosome-Mediated Cleavage R-HSA-111459,-0.6395512114206738,-1.044430938050752,0.4126984126984127,0.8291891472672127,1.0,1/6,1.08%,CYCS
prerank,Reactome_2022__SMAC (DIABLO) Binds To IAPs R-HSA-111463,-0.6395512114206738,-1.044430938050752,0.4126984126984127,0.8291891472672127,1.0,1/6,1.08%,CYCS
prerank,GO_Biological_Process_2021__positive regulation of DNA-dependent DNA replication (GO:2000105),-0.624996502791727,-1.0443234391101417,0.47368421052631576,0.8291080510708738,1.0,4/9,31.29%,STOML2;CDC7;SSBP1;DBF4B
prerank,GO_Biological_Process_2021__negative regulation of Rho protein signal transduction (GO:0035024),-0.5881252960588279,-1.0442261095019987,0.4426229508196721,0.8289904297764262,1.0,1/13,0.96%,RIPOR2
prerank,GO_Biological_Process_2021__DNA repair (GO:0006281),-0.416614692727225,-1.0441363100054493,0.39759036144578314,0.8288160095807383,1.0,31/218,15.20%,UBC;RPS27A;SMUG1;XPA;UBXN1;BTG2;OGG1;GTF2H5;HUS1;MUS81;DTX3L;PARP9;BRCA2;ABRAXAS1;PARP2;XRCC3;NPM1;REXO4;NABP1;NOP53;WDR48;KAT5;APEX1;RAD9A;RPA3;BRCA1;ERCC8;FANCB;SMC1A;UBA52;PARP4
prerank,GO_Biological_Process_2021__regulation of cellular extravasation (GO:0002691),0.6604223460126409,1.04412434822868,0.6136363636363636,0.7826550232966445,1.0,3/5,29.64%,FUT9;ICAM1;PLVAP
prerank,GO_Biological_Process_2021__BMP signaling pathway (GO:0030509),0.48374688463863,1.0440061589005236,0.34375,0.782083269591982,1.0,10/30,14.49%,ACVR2A;SMAD1;SMAD7;SMAD2;SMAD3;BMPR1B;RGMB;BMPR1A;MEGF8;SMURF1
prerank,GO_Biological_Process_2021__cellular response to BMP stimulus (GO:0071773),0.48374688463863,1.0440061589005236,0.34375,0.782083269591982,1.0,10/30,14.49%,ACVR2A;SMAD1;SMAD7;SMAD2;SMAD3;BMPR1B;RGMB;BMPR1A;MEGF8;SMURF1
prerank,Reactome_2022__PD-1 Signaling R-HSA-389948,-0.6501560050403358,-1.043879961388675,0.4909090909090909,0.8291170947996294,1.0,5/12,18.79%,CD247;HLA-DRB5;HLA-DRA;HLA-DPA1;HLA-DRB1
prerank,GO_Biological_Process_2021__regulation of protein dephosphorylation (GO:0035304),-0.5329380707616025,-1.043792942183071,0.4142857142857143,0.8289752624501717,1.0,3/33,8.91%,PPP1R15A;CALM1;CNEP1R1
prerank,Reactome_2022__Amine Ligand-Binding Receptors R-HSA-375280,-0.6093814827455873,-1.043752590583466,0.4423076923076923,0.8286955466994919,1.0,2/9,10.46%,CHRM2;CHRM5
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-threonine phosphorylation (GO:0010800),-0.5943605870142208,-1.043448766535595,0.5254237288135594,0.8291545153794188,1.0,3/15,9.28%,CEMIP;CALM1;CHI3L1
prerank,PanglaoDB_Augmented_2021__Mller Cells,0.4085656513698776,1.043428653646963,0.36666666666666664,0.7829866950122898,1.0,18/79,12.88%,COL16A1;LRP4;SEMA5A;KCNJ2;SLC1A3;TIMP3;PLPPR4;PCDH17;PRDX6;NTM;CDH11;CA2;DBI;PTPRD;COL11A1;NTRK2;COL6A1;FBXL7
prerank,GO_Biological_Process_2021__positive regulation of histone H3-K9 acetylation (GO:2000617),-0.714073240923248,-1.0430547252026736,0.4444444444444444,0.8298847897239955,1.0,4/5,28.16%,BRCA1;PIH1D1;SMARCB1;SPHK2
prerank,GO_Biological_Process_2021__synaptic membrane adhesion (GO:0099560),0.6182221754774139,1.0428549175463186,0.41304347826086957,0.7841635231079355,1.0,5/8,21.43%,LRRC4C;PTPRD;GPC6;LRRC4B;LRFN5
prerank,GO_Biological_Process_2021__positive regulation of intracellular transport (GO:0032388),0.4993527995304974,1.0427829838656615,0.40625,0.7839006870209242,1.0,6/29,18.25%,PGAP1;CEP131;RIPOR1;SORL1;DYNC1H1;NEDD4
prerank,GO_Biological_Process_2021__histone deacetylation (GO:0016575),0.46646143433068316,1.0427817683075982,0.3333333333333333,0.7834509448023237,1.0,11/39,16.09%,SIRT1;HDAC9;MTA2;MIER3;TRERF1;SIRT6;HDAC1;TBL1XR1;BRMS1L;SFPQ;HDAC10
prerank,GO_Biological_Process_2021__positive regulation of B cell differentiation (GO:0045579),-0.6606035801588989,-1.042179040397492,0.38,0.8318994229040866,1.0,2/6,10.76%,BTK;NCKAP1L
prerank,PanglaoDB_Augmented_2021__Hemangioblasts,0.4010564646285037,1.0420718194992071,0.46153846153846156,0.7848326291867024,1.0,6/33,16.08%,MFNG;NOSIP;CNPY3;FAM110A;CCND3;RPS6KB2
prerank,GO_Biological_Process_2021__regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),0.5170471377022337,1.0420390254240488,0.29545454545454547,0.7844229383299685,1.0,5/14,16.63%,SIRT1;SOD2;BAG5;SFPQ;P4HB
prerank,GO_Biological_Process_2021__positive regulation of autophagy of mitochondrion (GO:1903599),-0.6175469918396358,-1.0418467627804688,0.5161290322580645,0.8324900449402945,1.0,1/9,5.57%,SLC25A5
prerank,GO_Biological_Process_2021__myelination in peripheral nervous system (GO:0022011),0.5667124772122345,1.041839854166629,0.4418604651162791,0.7843541163720285,1.0,4/10,15.71%,LGI4;NF1;CNTNAP1;PARD3
prerank,GO_Biological_Process_2021__mitotic spindle organization (GO:0007052),-0.45367586224733775,-1.0417480040391365,0.3472222222222222,0.8323673303224935,1.0,20/107,18.44%,FLNA;STIL;RPS27;RAB11A;WRAP73;CENPU;ABRAXAS1;EFHC1;ITGB3BP;ZWILCH;DCTN6;MIS12;DYNC1LI2;STMN1;SMC1A;SEC13;SGO2;DCTN2;CENPF;BUB3
prerank,Reactome_2022__Synthesis Of PIPs At Early Endosome Membrane R-HSA-1660516,-0.5488494831460029,-1.0416688732020503,0.46774193548387094,0.83216376150876,1.0,1/15,5.81%,INPP4A
prerank,GO_Biological_Process_2021__negative regulation of mast cell activation involved in immune response (GO:0033007),0.6407556689007776,1.041631183206958,0.4827586206896552,0.784392104107894,1.0,2/5,10.07%,FER;LGALS9
prerank,GO_Biological_Process_2021__negative regulation of protein-containing complex assembly (GO:0031333),-0.5192766826865107,-1.0414840240645007,0.3835616438356164,0.8323164586796968,1.0,3/37,4.82%,NLRC3;RPL13A;CLU
prerank,GO_Biological_Process_2021__positive regulation of phosphoprotein phosphatase activity (GO:0032516),-0.6206573402855807,-1.0412820928802058,0.43548387096774194,0.8324932864241719,1.0,3/12,12.82%,PPP1R15A;CALM1;PTPRC
prerank,Reactome_2022__Tight Junction Interactions R-HSA-420029,-0.6045712249379316,-1.041116823577924,0.3888888888888889,0.8325688862987652,1.0,1/10,3.74%,CLDN7
prerank,GO_Biological_Process_2021__negative regulation of response to interferon-gamma (GO:0060331),-0.7142288710291482,-1.041089345936902,0.4153846153846154,0.8318595433016316,1.0,2/5,5.38%,PARP14;NR1H2
prerank,GO_Biological_Process_2021__negative regulation of interferon-gamma-mediated signaling pathway (GO:0060336),-0.7142288710291482,-1.041089345936902,0.4153846153846154,0.8318595433016316,1.0,2/5,5.38%,PARP14;NR1H2
prerank,GO_Biological_Process_2021__maintenance of protein location in nucleus (GO:0051457),-0.5918442602558471,-1.041086746025543,0.45161290322580644,0.8314871800324724,1.0,2/18,4.77%,SYNE1;CHCHD10
prerank,GO_Biological_Process_2021__DNA synthesis involved in DNA repair (GO:0000731),-0.5402140652871316,-1.0405178144653995,0.423728813559322,0.832475126500235,1.0,2/32,1.30%,UBC;RPS27A
prerank,GO_Biological_Process_2021__positive regulation of leukocyte activation (GO:0002696),-0.6297932255859132,-1.0405003492995593,0.4838709677419355,0.8321713944629394,1.0,3/11,11.32%,CD2;CD226;KARS1
prerank,PanglaoDB_Augmented_2021__Adipocyte Progenitor Cells,0.43505017053519734,1.0404524104311133,0.3333333333333333,0.7868234530537072,1.0,6/31,5.20%,FKBP9;SVEP1;COL5A2;TCF7L1;PPARG;TIMP3
prerank,Reactome_2022__TNFs Bind Their Physiological Receptors R-HSA-5669034,-0.633611739766377,-1.0404349341127048,0.43137254901960786,0.8320130834824462,1.0,4/9,11.00%,TNFRSF11B;TNFRSF25;TNFRSF1B;TNFSF13B
prerank,PanglaoDB_Augmented_2021__Retinal Ganglion Cells,0.38161339522776605,1.0403091102025777,0.29411764705882354,0.7866734199938679,1.0,32/96,18.25%,KCNQ2;CNTN2;NCAN;GALNTL6;SNAP91;PURG;TTLL1;CA10;OLFM3;POU6F2;BRSK1;KCTD8;PSD2;SNCB;PTPN5;NKAIN3;GPHN;SLC35F1;LINGO1;CAMKV;RBFOX1;NELL1;GRIA2;FXYD7;LRRC4B;SYT16;DPP10;ADGRB3;MAPK4;NXPH1;BRSK2;MAP6
prerank,GO_Biological_Process_2021__regulation of protein lipidation (GO:1903059),0.638475065070399,1.0402177926540193,0.4634146341463415,0.7863770549858976,1.0,1/5,9.52%,DBI
prerank,GO_Biological_Process_2021__C-terminal protein amino acid modification (GO:0018410),0.5719098528356847,1.039963408216572,0.42,0.7866999846866074,1.0,1/9,7.06%,FOLH1
prerank,GO_Biological_Process_2021__ceramide metabolic process (GO:0006672),0.47879373682151827,1.0399534962978936,0.4,0.7862642583034504,1.0,6/27,6.65%,ACER2;ABCA2;ST6GALNAC3;PLPP1;FA2H;SPTLC2
prerank,Reactome_2022__Phospholipase C-mediated Cascade; FGFR2 R-HSA-5654221,-0.6737349289616417,-1.0397194385717723,0.4716981132075472,0.8336201105158929,1.0,2/6,14.45%,FGF13;FGF20
prerank,GO_Biological_Process_2021__membrane depolarization during cardiac muscle cell action potential (GO:0086012),0.5676678420612081,1.0395860800726815,0.40476190476190477,0.7867464323133585,1.0,4/11,18.87%,KCNJ2;SCN3B;SLC8A1;SCN1B
prerank,CellMarker_Augmented_2021__Regulatory T (Treg) cell:Peripheral Blood,0.4706427092673705,1.0395677816082842,0.45,0.7863443965850633,1.0,3/28,8.40%,B3GNT2;SELPLG;CLDND1
prerank,Reactome_2022__Paradoxical Activation Of RAF Signaling By Kinase Inactive BRAF R-HSA-6802955,0.4362077163816455,1.0395469760546585,0.4411764705882353,0.7859494592910441,1.0,8/33,18.60%,MAP3K11;RAP1A;MAP2K1;VCL;MAPK1;PHB1;MAP2K2;KSR1
prerank,KEGG_2021_Human__Glycerolipid metabolism,-0.508135712830047,-1.0394566239315366,0.4426229508196721,0.833944693404336,1.0,4/41,5.40%,GLYCTK;MGLL;LIPG;GLA
prerank,GO_Biological_Process_2021__regulation of cation channel activity (GO:2001257),0.4082344257854048,1.0394290607637122,0.3548387096774194,0.7858137950162712,1.0,14/57,14.91%,NETO1;NLGN1;RELN;SHISA9;GRIA3;GRIA4;GRIA1;SLMAP;GRIN2B;PRRT1;GRIA2;CACNG8;CACNG2;CACNB4
prerank,GO_Biological_Process_2021__negative regulation of cell-matrix adhesion (GO:0001953),0.48753776854337716,1.0393888792385655,0.4146341463414634,0.7854461401348573,1.0,3/26,6.62%,ACER2;SERPINE1;JAG1
prerank,GO_Biological_Process_2021__positive regulation of kinase activity (GO:0033674),0.3873292968343011,1.0393471213905863,0.375,0.7851054192878878,1.0,21/71,19.84%,IGF1R;RAP1A;RELN;RYK;TNF;TAB2;SPDYA;MERTK;EPHA6;CENPE;EEF1A2;NTRK2;PTK2;ERBB4;TYRO3;ZNF622;MMD;RAPGEF2;NBN;FGFR2;FGFR1
prerank,GO_Biological_Process_2021__regulation of interleukin-1 beta production (GO:0032651),-0.4829904373737979,-1.0392002634367814,0.463768115942029,0.8341522170947664,1.0,11/52,8.14%,CD36;CCL3;MNDA;PYHIN1;CARD16;AIM2;LILRB4;IGF1;GSTP1;NLRP12;TNFAIP3
prerank,Reactome_2022__Early Phase Of HIV Life Cycle R-HSA-162594,-0.5491160567456012,-1.039168564636891,0.4262295081967213,0.8338806122331518,1.0,1/13,1.43%,CXCR4
prerank,GO_Biological_Process_2021__regulation of macrophage derived foam cell differentiation (GO:0010743),-0.5757243457634454,-1.0390246822261204,0.38333333333333336,0.8339069471340195,1.0,2/18,5.38%,CD36;NR1H2
prerank,GO_Biological_Process_2021__keratan sulfate catabolic process (GO:0042340),0.6553249740609378,1.0390115119032728,0.4523809523809524,0.7854806046131989,1.0,1/6,3.20%,GLB1
prerank,GO_Biological_Process_2021__formation of translation preinitiation complex (GO:0001731),-0.6273121408579045,-1.0389454540088912,0.4838709677419355,0.8337482858696259,1.0,6/9,28.01%,EIF2D;EIF2S2;EIF2S3;DENR;EIF4H;MCTS1
prerank,GO_Biological_Process_2021__endoderm formation (GO:0001706),-0.5759224316154319,-1.0388247989127488,0.4444444444444444,0.8336701530813031,1.0,3/14,10.55%,DUSP1;ITGA4;ITGB2
prerank,GO_Biological_Process_2021__regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091),-0.5988711551903091,-1.0388039833078238,0.45098039215686275,0.8333952293130388,1.0,5/10,22.78%,APOBEC3G;INPP5K;RESF1;SETDB1;MORC2
prerank,GO_Biological_Process_2021__regulation of oxidative phosphorylation (GO:0002082),-0.6098631877291393,-1.0387881237140908,0.45454545454545453,0.8330683452918732,1.0,3/9,19.90%,COX7A2;PINK1;UQCC2
prerank,GO_Biological_Process_2021__myeloid leukocyte mediated immunity (GO:0002444),-0.6800509632153403,-1.0386407860225157,0.5098039215686274,0.8330749131468991,1.0,2/5,25.08%,IRAK4;CARD9
prerank,GO_Biological_Process_2021__lipid droplet formation (GO:0140042),0.6554653725770014,1.0385967239750145,0.5319148936170213,0.7859414419148841,1.0,2/6,8.99%,PLA2G4C;AUP1
prerank,GO_Biological_Process_2021__ATP synthesis coupled electron transport (GO:0042773),-0.6839349381651365,-1.0381765346736198,0.5,0.83398823268926,1.0,2/6,11.53%,NDUFA12;COA6
prerank,CellMarker_Augmented_2021__Limbal Mesenchymal cell:Sclerocorneal Tissue,0.4198230095756397,1.0380791313647164,0.4482758620689655,0.7868716089467971,1.0,11/38,13.53%,ARHGAP31;STK32B;BNC2;ACTA2;CNRIP1;RECK;CDH11;HEG1;COL6A1;FBXL7;COL15A1
prerank,GO_Biological_Process_2021__serine transport (GO:0032329),-0.7192692643849045,-1.0380588545711986,0.49019607843137253,0.8338941252462315,1.0,2/5,17.98%,SFXN3;SLC1A4
prerank,Reactome_2022__Cobalamin (Cbl) Metabolism R-HSA-9759218,-0.6869957637408103,-1.0379595254820397,0.559322033898305,0.8338121273594483,1.0,2/5,29.63%,MMAB;MTRR
prerank,GO_Biological_Process_2021__membrane assembly (GO:0071709),0.4662544511150166,1.0377932335929039,0.39285714285714285,0.7872385392060851,1.0,11/31,17.29%,LRP4;PICALM;NLGN1;STX2;PTPRD;CHMP7;NRXN2;PTEN;NLGN4Y;UBXN2A;IL1RAPL1
prerank,Reactome_2022__Metabolism Of Nitric Oxide: NOS3 Activation And Regulation R-HSA-202131,-0.5941396220959524,-1.03743120305254,0.5,0.8349082174731282,1.0,2/11,8.36%,TACR1;CALM1
prerank,GO_Biological_Process_2021__regulation of cellular carbohydrate metabolic process (GO:0010675),0.5447638810209043,1.0373630288941709,0.40540540540540543,0.7879025096076737,1.0,3/11,6.28%,PDK4;SIRT1;SCARB2
prerank,GO_Biological_Process_2021__positive regulation of chemotaxis (GO:0050921),0.45939094177488793,1.0373019303960294,0.3684210526315789,0.7876011935451686,1.0,3/26,2.26%,NRP1;SEMA5A;FGF2
prerank,GO_Biological_Process_2021__positive regulation of cell cycle G2/M phase transition (GO:1902751),-0.5870611298535133,-1.0372136110742225,0.43103448275862066,0.8350861719759144,1.0,5/14,22.11%,RAB11A;NPM1;CCND1;ATAD5;CDC7
prerank,Reactome_2022__Glucose Metabolism R-HSA-70326,0.40426540251918774,1.037065198659942,0.36666666666666664,0.7877690072059829,1.0,10/70,10.70%,PFKP;PFKM;NUP153;NUP188;NUP42;SLC37A2;MAP4K5;PPP2R1B;SLC37A4;PCK2
prerank,Reactome_2022__SUMOylation Of DNA Methylation Proteins R-HSA-4655427,0.5951519472236886,1.0370541211912507,0.425,0.7873493275432334,1.0,1/11,1.33%,RNF2
prerank,GO_Biological_Process_2021__positive regulation of cilium assembly (GO:0045724),-0.5554409725657754,-1.0370294491704397,0.5208333333333334,0.8352199322368982,1.0,2/15,7.65%,WRAP73;ENTR1
prerank,GO_Biological_Process_2021__negative regulation of long-term synaptic potentiation (GO:1900272),-0.6088124279833591,-1.0368533783801899,0.4583333333333333,0.8353855859808401,1.0,2/7,11.20%,PTN;TYROBP
prerank,GO_Biological_Process_2021__DNA-dependent DNA replication maintenance of fidelity (GO:0045005),-0.5356863928733618,-1.036740067230341,0.3870967741935484,0.8353271069863103,1.0,2/30,5.76%,DDX11;TIPIN
prerank,GO_Biological_Process_2021__cellular response to transforming growth factor beta stimulus (GO:0071560),-0.44333327023046387,-1.0366697847560638,0.3333333333333333,0.8350967669615396,1.0,4/71,1.30%,UBC;TGFBR3;FOS;RPS27A
prerank,GO_Biological_Process_2021__regulation of cholesterol efflux (GO:0010874),0.49226996807378826,1.0365124697697428,0.41935483870967744,0.7884140380991028,1.0,4/24,5.17%,ABCA2;YJEFN3;SIRT1;PPARG
prerank,GO_Biological_Process_2021__negative regulation of lyase activity (GO:0051350),0.6140054278171458,1.0358000315636309,0.4791666666666667,0.7895500501632089,1.0,2/7,20.06%,ADGRV1;GRM3
prerank,KEGG_2021_Human__Staphylococcus aureus infection,-0.5071685694462713,-1.0357738976712951,0.4153846153846154,0.837012591754343,1.0,16/33,21.85%,FCAR;HLA-DRB5;C5AR1;ITGB2;HLA-DRA;ITGAL;HLA-DPA1;C3;FPR1;HLA-DMB;HLA-DPB1;FCGR3A;HLA-DRB1;KRT10;C1QB;C1QC
prerank,GO_Biological_Process_2021__B cell activation involved in immune response (GO:0002312),0.5343865066960525,1.0357062041861975,0.4888888888888889,0.7893342948066542,1.0,3/11,7.13%,CD180;EXOSC6;LIG4
prerank,GO_Biological_Process_2021__dephosphorylation (GO:0016311),0.39586374785489026,1.0356103411913216,0.3333333333333333,0.7891253672418571,1.0,23/107,11.81%,DUSP6;PTPN9;DUSP18;PPM1L;PLPPR1;PLPP1;PTPRM;PLPP5;PLPPR4;PPP4R2;PPP2R1B;PTPN13;ILKAP;CDC14B;PPP3CA;DUSP7;BTRC;PTPRG;PTPRK;PTPN5;FBXW11;PTPRD;PTEN
prerank,GO_Biological_Process_2021__epithelial structure maintenance (GO:0010669),-0.6526637298280358,-1.0355143707836347,0.48214285714285715,0.837324952138846,1.0,3/6,19.95%,CRACD;NOD2;PBLD
prerank,GO_Biological_Process_2021__carboxylic acid transmembrane transport (GO:1905039),-0.5428366329926784,-1.0353262213989056,0.4264705882352941,0.8375332267013595,1.0,6/28,10.63%,SLC7A5;SLC38A4;SLC38A1;ABCB1;SLC16A7;SLC36A4
prerank,GO_Biological_Process_2021__protein modification by small protein conjugation (GO:0032446),0.3342658515870413,1.0351317104890105,0.2857142857142857,0.7897457912428616,1.0,47/300,13.23%,UBE2D1;SPSB2;MKRN3;ZNRF3;MSL2;ZNF598;RNF25;UHRF2;SIRT1;RNF139;KLHL18;SAE1;FBXO32;TRIM26;NUP153;NUP188;UBE2D2;NUP42;BCL11A;DCUN1D4;UBR3;NEDD4L;CDC23;MDM2;BTRC;FBXO45;STX1A;KCTD10;HIF3A;UBA1;RNF20;UBE2L3;PEX13;ANAPC16;FBXW11;FBXW7;EPAS1;TSPAN17;UBE2N;DCUN1D1;PEX5;RNF38;TRIM35;UBA2;FBXL7;BARD1;ZNF451
prerank,GO_Biological_Process_2021__regulation of smooth muscle cell migration (GO:0014910),0.5724711669029976,1.03462278858684,0.5,0.7904181275449832,1.0,3/13,1.65%,NRP1;PDGFA;SERPINE1
prerank,GO_Biological_Process_2021__axon choice point recognition (GO:0016198),0.6638511232806822,1.0346075692244285,0.4634146341463415,0.7900314749779973,1.0,2/5,15.51%,ROBO1;ROBO2
prerank,GO_Biological_Process_2021__intra-Golgi vesicle-mediated transport (GO:0006891),0.4993781940140025,1.0344131828607808,0.4594594594594595,0.7900788225413269,1.0,8/26,17.41%,RAB33B;COPG1;VTI1A;COG1;RAB6A;COG3;COPB1;COPZ1
prerank,GO_Biological_Process_2021__tRNA transcription (GO:0009304),-0.656225033779751,-1.034404490125962,0.5185185185185185,0.8396928659441538,1.0,1/7,3.40%,GTF3C6
prerank,GO_Biological_Process_2021__response to axon injury (GO:0048678),-0.5994577968941939,-1.0343743424226146,0.4576271186440678,0.8393893000110105,1.0,3/14,13.37%,APOD;TYROBP;SOD1
prerank,Reactome_2022__Degradation Of Beta-Catenin By Destruction Complex R-HSA-195253,-0.45962000938878084,-1.034134288910688,0.4246575342465753,0.839572461512122,1.0,10/69,12.85%,UBC;RPS27A;PSMB3;PSMB6;PSMA7;PSMB9;RBX1;PSMD12;PSMD8;PSMA5
prerank,GO_Biological_Process_2021__positive regulation of dendritic cell cytokine production (GO:0002732),-0.6060060953127622,-1.034068548614906,0.44642857142857145,0.8393569004273436,1.0,2/6,22.26%,CLEC7A;CAMK4
prerank,Reactome_2022__FRS-mediated FGFR3 Signaling R-HSA-5654706,-0.5791765039528598,-1.0340615043827692,0.4426229508196721,0.8389941274403072,1.0,2/10,14.45%,FGF13;FGF20
prerank,Reactome_2022__Mitochondrial Translation R-HSA-5368287,-0.48937641143059857,-1.033978341222492,0.43209876543209874,0.8388068866462404,1.0,20/63,17.46%,MRPL57;AURKAIP1;MRPS7;MRPL51;MRPL19;GADD45GIP1;MRPL52;MRPL50;MTIF3;MRPS11;MRPS10;MRPS15;MRPL16;MRPL32;CHCHD1;OXA1L;MRPL43;MRPS18C;MRPL45;MRPS25
prerank,GO_Biological_Process_2021__negative regulation of protein exit from endoplasmic reticulum (GO:0070862),-0.6791376336572038,-1.0336641836551128,0.5178571428571429,0.8393203492793552,1.0,1/9,0.72%,INSIG1
prerank,GO_Biological_Process_2021__leucine catabolic process (GO:0006552),-0.6864762359872516,-1.0336279533193187,0.4807692307692308,0.8390654940029952,1.0,2/5,22.30%,MCCC2;HMGCL
prerank,Reactome_2022__DEx/H-box Helicases Activate Type I IFN And Inflammatory Cytokines Production R-HSA-3134963,-0.6375357884249427,-1.0335049192001267,0.5,0.8389739131071416,1.0,3/7,27.27%,IRF7;DHX36;MYD88
prerank,GO_Biological_Process_2021__positive regulation of protein import into nucleus (GO:0042307),-0.5499613683516634,-1.0334741898686368,0.45161290322580644,0.8386637842046396,1.0,3/21,6.41%,FLNA;JUP;RBM22
prerank,GO_Biological_Process_2021__endosome transport via multivesicular body sorting pathway (GO:0032509),0.4959878626227918,1.0334670552888647,0.4117647058823529,0.7919447474895155,1.0,6/19,14.09%,LYST;SORT1;UBXN6;CHMP7;LEPROTL1;CHMP1A
prerank,GO_Biological_Process_2021__positive regulation of response to cytokine stimulus (GO:0060760),0.532116067092087,1.0333208254318116,0.40816326530612246,0.7918794145688932,1.0,2/11,14.11%,WNT5A;AGPAT2
prerank,GO_Biological_Process_2021__long-chain fatty acid transport (GO:0015909),0.4978522111799581,1.0332787461792106,0.40540540540540543,0.7914862519526932,1.0,4/19,7.76%,PRKAB2;PPARG;CPT1A;ACACB
prerank,Reactome_2022__Diseases Of Mismatch Repair (MMR) R-HSA-5423599,-0.6994111679279778,-1.0331229096044647,0.5892857142857143,0.8393234178160759,1.0,3/5,28.25%,MSH6;MSH3;PMS2
prerank,GO_Biological_Process_2021__regulation of programmed necrotic cell death (GO:0062098),-0.6130219826944191,-1.0330640896757348,0.5172413793103449,0.8391007826117891,1.0,9/16,28.63%,CDC37;CFLAR;MLKL;FLOT1;SDCBP;OGT;HSP90AA1;ASAH1;BIRC2
prerank,CellMarker_Augmented_2021__Primordial Germ cell:Ovary,0.6075257801285694,1.033031913844483,0.47058823529411764,0.7916768710616472,1.0,1/7,1.44%,GRID2
prerank,GO_Biological_Process_2021__cellular response to interleukin-12 (GO:0071349),-0.5103264058549724,-1.0330159794933562,0.4142857142857143,0.8388902528463555,1.0,9/36,15.40%,STAT4;ANXA2;IL12RB2;CFL1;RPLP0;CD47;SOD1;SNRPA1;TALDO1
prerank,GO_Biological_Process_2021__protein targeting (GO:0006605),-0.46137421510189053,-1.0329830253849028,0.38571428571428573,0.838596578801498,1.0,13/90,9.39%,TOMM7;SRP14;DNAJC19;CDC37;AQP11;TIMM44;RPL11;FIS1;NACA;PITRM1;ZDHHC4;ZDHHC19;HPS4
prerank,GO_Biological_Process_2021__bicarbonate transport (GO:0015701),0.5333027713280425,1.032958071351236,0.5,0.7913759739870474,1.0,3/12,9.38%,SLC39A8;SLC4A4;CA2
prerank,CellMarker_Augmented_2021__Endothelial cell:Fetal Liver,-0.4681351130371302,-1.0329371578388715,0.40540540540540543,0.8383705906138068,1.0,11/51,12.34%,ABCA9;PLN;ABCA6;CD93;PECAM1;EPB41L3;ENPP2;SPARCL1;ABCA8;A2M;FLT1
prerank,GO_Biological_Process_2021__lipid translocation (GO:0034204),-0.5382124962070941,-1.0327722687850474,0.41379310344827586,0.8384857553319625,1.0,4/21,14.37%,ABCB1;ATP10A;ABCB4;ATP8B1
prerank,GO_Biological_Process_2021__receptor-mediated endocytosis (GO:0006898),-0.4503903684443834,-1.0322999562434154,0.39473684210526316,0.8392348736058081,1.0,7/101,5.46%,MX2;CD36;MX1;TFRC;MARCO;FCER1G;LILRB4
prerank,GO_Biological_Process_2021__positive regulation of toll-like receptor 9 signaling pathway (GO:0034165),-0.705427665480451,-1.0322703165054157,0.5263157894736842,0.838933641905106,1.0,1/5,1.20%,RSAD2
prerank,PanglaoDB_Augmented_2021__Cardiomyocytes,-0.4789993920951964,-1.0321314399877084,0.38235294117647056,0.8389573424398178,1.0,8/49,7.44%,CD36;PLN;CXCR4;HAMP;OBSCN;COL21A1;TTN;MYBPC3
prerank,Reactome_2022__Synthesis Of PG R-HSA-1483148,0.6183721847024413,1.0320169990564234,0.5,0.7933013989525339,1.0,2/6,15.17%,PRKCSH;PLD4
prerank,Reactome_2022__Neddylation R-HSA-8951664,0.3500005869962984,1.0319694083058666,0.35,0.7929606676174469,1.0,27/177,12.88%,UBE2D1;SPSB2;FBXO30;DCAF16;KBTBD6;FBXL14;ZBTB16;FBXO32;DCAF13;FEM1B;DDA1;UBE2D2;SEM1;DCUN1D4;GPS1;KCTD6;BTRC;HIF3A;FBXW11;FBXW7;EPAS1;FEM1C;DCAF5;DCUN1D1;KLHL42;FBXL12;FBXL7
prerank,GO_Biological_Process_2021__regulation of amyloid-beta formation (GO:1902003),0.46670450242318257,1.0318753031546763,0.35714285714285715,0.7927380326433184,1.0,8/29,12.47%,ABCA2;PICALM;TMED10;TNF;SLC2A13;SORL1;RTN4;NTRK2
prerank,PanglaoDB_Augmented_2021__Osteoblasts,0.4358559443218907,1.0314848571456319,0.4375,0.7933261108921054,1.0,14/64,12.56%,COL16A1;LRP4;SVEP1;COL5A2;ACTA2;WNT5A;TNFRSF10A;TIMP3;BMP1;CDH11;COL11A1;FAM114A1;ITGA2;COL6A1
prerank,GO_Biological_Process_2021__protein ubiquitination (GO:0016567),0.34459500134141846,1.031426634326166,0.3333333333333333,0.7930643266704922,1.0,57/390,13.01%,UBE2D1;SPSB2;MKRN3;FBXO30;RNF122;ZNRF3;MSL2;ZNF598;RNF25;UHRF2;UBE2J1;SIRT1;FBXL14;RNF139;UBE2O;RNF208;KLHL18;MARCHF5;FBXO32;TRIM26;DDA1;UBE2E2;UBE3D;UBE2D2;UBR3;NEDD4L;RMND5A;CDC23;MDM2;BTRC;FBXO45;SASH1;RNF19B;KCTD10;HIF3A;MARCHF1;UBA1;RNF20;UBE2L3;PEX13;ANAPC16;FBXW11;FBXW7;EPAS1;RNF217;RNF185;TSPAN17;RNF10;UBE2N;PEX5;RNF38;TRIM35;KLHL42;FBXL12;SH3RF1;FBXL7;BARD1
prerank,CellMarker_Augmented_2021__Lake Et al.Science.Ex8:Brain,-0.4931784284707946,-1.0313035046037213,0.3968253968253968,0.840833190986301,1.0,9/43,11.82%,THEMIS;MCTP2;ATP10A;PECAM1;PRLR;SNTB1;OLFML2B;TRPM4;B3GAT2
prerank,GO_Biological_Process_2021__mitochondrial transport (GO:0006839),-0.49688239535010387,-1.031094633825482,0.453125,0.8410261408596365,1.0,13/43,15.12%,TOMM7;DNAJC19;TIMM44;SLC25A5;FIS1;PITRM1;BCS1L;COX18;SPG7;TOMM40;MAIP1;OXA1L;STARD3
prerank,GO_Biological_Process_2021__morphogenesis of a polarized epithelium (GO:0001738),0.6092443511865344,1.0310582028473347,0.42857142857142855,0.7935405757750859,1.0,2/7,5.14%,SCRIB;RAB10
prerank,CellMarker_Augmented_2021__Clara cell:Undefined,0.3871703987914764,1.0309908895123872,0.36,0.7932659145893995,1.0,35/92,28.64%,SIRPA;LENG8;TMEM170B;DIP2B;SGSM2;SPTAN1;CLSTN3;TMEM131;WNK1;RCBTB1;MEGF8;MGAT5;DYNC1H1;CLASP2;ATG2B;SIK2;WDR7;STK35;TRIM9;ADD1;UBAP1L;PAFAH1B1;SIK3;RGL1;ZBTB18;PHF2;PIP4K2B;TTBK2;PIKFYVE;KIDINS220;ZMIZ1;DOCK4;NR2C2;SNX30;ZNF318
prerank,Reactome_2022__TP53 Regulates Transcription Of Additional Cell Death Genes With Uncertain Roles In P53-Dependent Apoptosis R-HSA-6803205,-0.6418547025642038,-1.0309682176146513,0.4423076923076923,0.8409816722178176,1.0,4/8,29.69%,BCL2L14;RABGGTB;TP53BP2;NDRG1
prerank,Reactome_2022__Export Of Viral Ribonucleoproteins From Nucleus R-HSA-168274,0.42154505663387487,1.030895697394976,0.45714285714285713,0.7929915608029136,1.0,7/33,17.93%,NUP153;NUP188;NUP42;XPO1;NDC1;NUP133;NUP205
prerank,CellMarker_Augmented_2021__Stromal cell:Amniotic Membrane,0.3698558750487523,1.030870977444546,0.2222222222222222,0.7926132304036819,1.0,14/76,8.17%,ANXA1;ARHGAP31;MSN;STK32B;BNC2;CDC42EP3;RCN3;JAZF1;KCTD12;ITPRIP;CNRIP1;RECK;PPP1R18;DOCK10
prerank,GO_Biological_Process_2021__MyD88-independent toll-like receptor signaling pathway (GO:0002756),-0.5205397939674071,-1.0307833956177876,0.4583333333333333,0.8407269227565747,1.0,4/25,5.48%,UBC;RPS27A;CD14;CD300LF
prerank,GO_Biological_Process_2021__TRIF-dependent toll-like receptor signaling pathway (GO:0035666),-0.5205397939674071,-1.0307833956177876,0.4583333333333333,0.8407269227565747,1.0,4/25,5.48%,UBC;RPS27A;CD14;CD300LF
prerank,Reactome_2022__Mitochondrial Translation Initiation R-HSA-5368286,-0.49059143406548517,-1.0307763674236674,0.4050632911392405,0.840374624504735,1.0,20/58,17.46%,MRPL57;AURKAIP1;MRPS7;MRPL51;MRPL19;GADD45GIP1;MRPL52;MRPL50;MTIF3;MRPS11;MRPS10;MRPS15;MRPL16;MRPL32;CHCHD1;OXA1L;MRPL43;MRPS18C;MRPL45;MRPS25
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell migration (GO:0010595),0.4569297235223488,1.0304768694785094,0.38095238095238093,0.793173349798336,1.0,6/60,6.25%,NRP1;SEMA5A;FGF2;SIRT1;WNT5A;RIN2
prerank,GO_Biological_Process_2021__positive regulation of cell population proliferation (GO:0008284),-0.40200716829701777,-1.0304303182834174,0.3493975903614458,0.8408357647419847,1.0,41/236,14.51%,NR4A3;RPS4X;TGFBR3;CCL5;IL7R;PID1;PDGFD;AIF1;DDRGK1;AQP11;TSPAN31;RPL23;IGF1;SLC25A5;TIPIN;IL12RB2;OSMR;PRLR;C5AR1;RPS6;NAMPT;RBPJ;S100A6;CHTOP;STAT1;MEIS1;PTN;NPM1;TRPM4;RPS9;VEGFA;TBC1D8;CD47;EFNB2;FLT1;PTPRC;ZNF16;TET1;NOD2;FGF20;CCAR1
prerank,Reactome_2022__Adherens Junctions Interactions R-HSA-418990,0.47370474705768295,1.0302704434736487,0.40476190476190477,0.7931794562890288,1.0,11/20,24.75%,CADM1;FZR1;CDH11;CADM2;AFDN;CDH19;CDH8;CDH4;NECTIN3;CDH2;CDH10
prerank,GO_Biological_Process_2021__regulation of carbohydrate catabolic process (GO:0043470),0.40544924954638845,1.0302580013467983,0.3684210526315789,0.7927561070907061,1.0,4/36,7.20%,NUP153;NUP188;SCARB2;NUP42
prerank,GO_Biological_Process_2021__cellular response to growth factor stimulus (GO:0071363),0.390250697655631,1.030073084630241,0.4,0.7927949554526124,1.0,11/101,6.06%,KLF4;ANXA1;NRP1;ACVR2A;SPRY2;TGFBR2;SMAD7;RAP1A;WNT5A;SMAD3;CIB1
prerank,GO_Biological_Process_2021__pyrimidine nucleobase catabolic process (GO:0006208),0.6574277668854637,1.0300340512510882,0.5609756097560976,0.792430788811742,1.0,1/6,1.43%,DPYSL5
prerank,PanglaoDB_Augmented_2021__Mesothelial Cells,0.4420065982914652,1.0299583940461619,0.40540540540540543,0.7921839547159326,1.0,12/43,13.56%,COL16A1;FKBP9;SVEP1;COL5A2;FRAS1;TIMP3;CDH11;EPAS1;FAM114A1;TJP1;TWSG1;PCSK6
prerank,Reactome_2022__FGFR1 Ligand Binding And Activation R-HSA-190242,-0.6455053014428904,-1.0298287195162648,0.48214285714285715,0.8416306343875114,1.0,2/6,14.45%,FGF13;FGF20
prerank,Reactome_2022__FGFR1c Ligand Binding And Activation R-HSA-190373,-0.6455053014428904,-1.0298287195162648,0.48214285714285715,0.8416306343875114,1.0,2/6,14.45%,FGF13;FGF20
prerank,GO_Biological_Process_2021__polyol metabolic process (GO:0019751),0.4680891209198775,1.029758077221731,0.28125,0.7922814876090747,1.0,13/35,18.14%,INPP1;PLCB4;IPPK;IMPA1;NUDT3;PTEN;ISYNA1;PPIP5K1;PLD4;INPP5A;NUDT4;PLCB3;INPP4B
prerank,Reactome_2022__FOXO-mediated Transcription Of Cell Death Genes R-HSA-9614657,0.5174758633834671,1.0295108402189566,0.42105263157894735,0.7923854005773343,1.0,2/13,5.85%,NFYC;DDIT3
prerank,GO_Biological_Process_2021__odontogenesis (GO:0042476),0.5604665370943789,1.029456804236281,0.3888888888888889,0.7920741530611272,1.0,3/10,19.59%,HDAC1;ANKRD11;FGFR2
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-serine phosphorylation (GO:0033137),-0.5676427102195201,-1.0293716099653507,0.43137254901960786,0.8423941594996882,1.0,3/15,4.24%,DDIT4;PAQR3;RACK1
prerank,Reactome_2022__G-protein Beta:Gamma Signaling R-HSA-397795,-0.5470452906278802,-1.0291456064301672,0.4520547945205479,0.8426644754981438,1.0,2/22,4.88%,BTK;GNB5
prerank,GO_Biological_Process_2021__purine ribonucleoside monophosphate catabolic process (GO:0009169),0.6503399005778576,1.0289377513744369,0.4888888888888889,0.7929817678731697,1.0,4/5,33.42%,PNP;PRTFDC1;HPRT1;AMPD3
prerank,Reactome_2022__G Beta:Gamma Signaling Thru PLC Beta R-HSA-418217,-0.6048029007436202,-1.0288895157608735,0.42105263157894735,0.8429463712584635,1.0,2/10,15.86%,GNB5;GNB2
prerank,Reactome_2022__M Phase R-HSA-68886,-0.4040679929713102,-1.028834029271342,0.4222222222222222,0.8427201613364792,1.0,52/280,18.55%,TUBB8;UBC;H2BC4;H2BC26;H2AC20;RPS27A;H2AC6;PSMB3;RPS27;SSNA1;EMD;H3-3B;H2AJ;H2BC21;PSMB6;PSMA7;CENPU;H2BC5;CNEP1R1;CEP72;PSMB9;H2BC9;ITGB3BP;CEP164;ZWILCH;NUP50;TUBGCP2;PSMD12;ANAPC11;H2BC11;CSNK1D;PSMD8;PSMA5;MIS12;TUBB4B;DYNC1LI2;SMC1A;UBA52;CDC26;SEC13;TUBGCP5;PSMA3;PRKAR2B;SGO2;NUP88;PSMC4;DCTN2;CSNK2A2;CC2D1B;CENPF;BUB3;AKAP9
prerank,GO_Biological_Process_2021__regulation of glial cell apoptotic process (GO:0034350),0.7005911993296322,1.0286873833909387,0.5609756097560976,0.793182286284062,1.0,1/5,12.90%,PRKCI
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-lysine acetylation (GO:2000757),0.5829893850149792,1.0286172671295102,0.48717948717948717,0.7928775890664879,1.0,1/7,2.51%,SIRT1
prerank,CellMarker_Augmented_2021__Endothelial cell:Skin,-0.49003856111326066,-1.028585216224827,0.44,0.8430844255650813,1.0,13/46,12.34%,MS4A4A;SIGLEC1;CD14;CD93;F13A1;PECAM1;PCDH12;MS4A6A;CSF2RB;TYROBP;SPARCL1;A2M;FLT1
prerank,CellMarker_Augmented_2021__1-Cell Stage Cell (Blastomere):Embryo,-0.5449695956809555,-1.0285729416479543,0.4696969696969697,0.8427364154119535,1.0,6/29,17.21%,TMEM163;BNIP1;USB1;FTL;YPEL1;PPIL2
prerank,Reactome_2022__PP2A-mediated Dephosphorylation Of Key Metabolic Factors R-HSA-163767,0.6457249703408008,1.0284751893440018,0.5098039215686274,0.7927608797082517,1.0,2/5,23.58%,PPP2R1B;PPP2CB
prerank,Reactome_2022__Regulation Of TP53 Activity Thru Association With Co-factors R-HSA-6804759,0.5853666993239088,1.0283413845954505,0.40476190476190477,0.7926248986389297,1.0,4/10,20.47%,ZNF385A;AKT2;AKT3;BANP
prerank,Reactome_2022__MET Activates PTPN11 R-HSA-8865999,0.6570683501644283,1.0283203121319964,0.46808510638297873,0.7921982111529376,1.0,1/5,1.00%,PIGU
prerank,GO_Biological_Process_2021__isocitrate metabolic process (GO:0006102),-0.6413476107083541,-1.0283087138992624,0.5102040816326531,0.8431003549751099,1.0,1/5,10.29%,IDH3B
prerank,GO_Biological_Process_2021__regulation of RNA polymerase II regulatory region sequence-specific DNA binding (GO:1903025),-0.6893594869953165,-1.0280703446360921,0.4444444444444444,0.8434443272077348,1.0,3/7,8.69%,DDRGK1;LAMTOR5;TMSB4X
prerank,Reactome_2022__Mitochondrial Translation Termination R-HSA-5419276,-0.4851911940412871,-1.0280183682844615,0.4691358024691358,0.8432380346368409,1.0,19/58,17.46%,MRPL57;AURKAIP1;MRPS7;MRPL51;MRPL19;GADD45GIP1;MRPL52;MRPL50;MRPS11;MRPS10;MRPS15;MRPL16;MRPL32;CHCHD1;OXA1L;MRPL43;MRPS18C;MRPL45;MRPS25
prerank,GO_Biological_Process_2021__cardiac right ventricle morphogenesis (GO:0003215),0.6916011042446232,1.0280094717646768,0.46511627906976744,0.7925019667344665,1.0,3/5,12.30%,JAG1;SOX4;BMPR1A
prerank,GO_Biological_Process_2021__cell-matrix adhesion (GO:0007160),-0.4869192868346486,-1.0279772320419103,0.4594594594594595,0.8429730224977326,1.0,9/53,11.27%,CD96;SIGLEC1;CD63;ITGA4;FERMT3;CD44;SGCE;ITGB2;ITGAL
prerank,GO_Biological_Process_2021__glycerol metabolic process (GO:0006071),-0.6511104510756536,-1.0279714985750308,0.543859649122807,0.8426179682175622,1.0,5/6,34.91%,GK;GK5;TPI1;PGP;GOT1
prerank,GO_Biological_Process_2021__protein localization to microtubule cytoskeleton (GO:0072698),-0.6695261427225849,-1.027912608899769,0.484375,0.8424201506768902,1.0,3/6,32.16%,MID1;CHAMP1;MAPRE1
prerank,Reactome_2022__Removal Of Flap Intermediate From C-strand R-HSA-174437,-0.5988657869163072,-1.0278187445553448,0.45,0.8423009349678943,1.0,3/10,18.09%,TERF2IP;RPA3;WRN
prerank,GO_Biological_Process_2021__regulation of granulocyte chemotaxis (GO:0071622),-0.5896506320960768,-1.0277990864675413,0.44642857142857145,0.8420015126976378,1.0,1/11,1.49%,CCL5
prerank,CellMarker_Augmented_2021__Primordial Germ cell:Undefined,-0.6038129559203269,-1.0276551647801386,0.4888888888888889,0.8420353876906641,1.0,4/10,12.88%,SLC2A3;IFITM3;ITGA6;PRDM1
prerank,GO_Biological_Process_2021__positive regulation of helicase activity (GO:0051096),-0.6562457234502265,-1.02750555716478,0.49056603773584906,0.8420770660305386,1.0,4/7,26.23%,CHTOP;MSH6;SSBP1;MSH3
prerank,GO_Biological_Process_2021__regulation of establishment of protein localization (GO:0070201),0.5802855785029728,1.0273501137226069,0.46153846153846156,0.7938061173281695,1.0,4/11,23.04%,CEP120;CEP135;DNAJA1;CEP290
prerank,GO_Biological_Process_2021__glycosaminoglycan metabolic process (GO:0030203),0.4644982847445688,1.0272704133823856,0.3888888888888889,0.7936763114345701,1.0,6/31,6.07%,HS3ST5;GLB1;HS2ST1;UGDH;HPSE;B4GALT7
prerank,Reactome_2022__Signaling By Receptor Tyrosine Kinases R-HSA-9006934,0.3477664780378184,1.0272169413722048,0.2727272727272727,0.7933402752307671,1.0,59/342,14.14%,EGR1;DUSP6;NRP1;POLR2D;PDGFA;PIGU;GRB10;FER;CDK5R1;IGF1R;SPRY2;TGFA;GFAP;MAPK11;SPRED1;RAP1A;SPRED2;NCK2;MAP2K1;MXD4;WASF2;NRG1;PDGFC;HPN;VGF;KITLG;CRK;ELMO1;SH3GL3;PPP2R1B;FLRT1;DNM3;SHC2;TAB2;ATP6V1B2;DUSP7;HDAC1;PTPRK;NRG3;ITGAV;PDE3B;MAPK1;GRIN2B;ARF6;SH3GL1;NTRK2;MAPKAPK2;ITGA2;COL6A1;GAB2;MEMO1;FLRT2;SYNGAP1;NRG2;VAV1;PCSK6;PTK2;AHCYL1;ERBB4
prerank,GO_Biological_Process_2021__positive regulation of toll-like receptor signaling pathway (GO:0034123),-0.5400572094583407,-1.0271485392756163,0.46774193548387094,0.8424906030456492,1.0,7/19,20.38%,RSAD2;TASL;CYBA;IFI35;FLOT1;PTPN22;TLR2
prerank,GO_Biological_Process_2021__negative regulation of mitotic cell cycle phase transition (GO:1901991),0.41955834721859553,1.0271128651143242,0.3333333333333333,0.7931399687653814,1.0,2/68,1.00%,KLF4;PKD2
prerank,GO_Biological_Process_2021__endoplasmic reticulum calcium ion homeostasis (GO:0032469),-0.5394286602897997,-1.027065723556674,0.41935483870967744,0.8423011816560372,1.0,7/17,29.99%,FIS1;TMCO1;BCAP31;HERPUD1;WFS1;CCDC47;THADA
prerank,GO_Biological_Process_2021__JNK cascade (GO:0007254),-0.48571128264799457,-1.0270561251603147,0.3888888888888889,0.8419593843410658,1.0,2/36,1.30%,UBC;RPS27A
prerank,KEGG_2021_Human__Cysteine and methionine metabolism,-0.5144693338713705,-1.0269428791064554,0.4383561643835616,0.8417938149821498,1.0,6/29,9.55%,IL4I1;APIP;MDH2;MAT2B;GCLM;LDHA
prerank,GO_Biological_Process_2021__regulation of MDA-5 signaling pathway (GO:0039533),-0.6936852732924348,-1.0268808996054535,0.62,0.8416166654031524,1.0,1/5,2.65%,DHX58
prerank,GO_Biological_Process_2021__R-loop disassembly (GO:0062176),-0.6690001038880481,-1.0268386183748033,0.5192307692307693,0.8413654513591369,1.0,1/5,12.91%,DDX23
prerank,GO_Biological_Process_2021__entry of bacterium into host cell (GO:0035635),0.6269414608702704,1.0268271085855643,0.47368421052631576,0.7935647632621868,1.0,3/5,35.15%,CBL;CTNNB1;GRB2
prerank,GO_Biological_Process_2021__mRNA polyadenylation (GO:0006378),0.502642565329699,1.0265574926300503,0.3783783783783784,0.7932417853568718,1.0,6/21,16.20%,WDR33;SSU72;PCF11;SCAF8;AHCYL1;PAPOLA
prerank,GO_Biological_Process_2021__RNA polyadenylation (GO:0043631),0.502642565329699,1.0265574926300503,0.3783783783783784,0.7932417853568718,1.0,6/21,16.20%,WDR33;SSU72;PCF11;SCAF8;AHCYL1;PAPOLA
prerank,"GO_Biological_Process_2021__mRNA splicing, via spliceosome (GO:0000398)",-0.41607270545119684,-1.0264897810584306,0.40963855421686746,0.8419383074119169,1.0,50/226,19.10%,PPIE;FRG1;RAVER2;DHX16;ZCRB1;DHX38;CSTF2T;SNRNP27;SNRPD2;RNPC3;WDR83;RBM22;POLR2G;SRPK1;PNN;EIF4A3;LSM7;PDCD7;CRNKL1;ZRSR2;U2AF2;NCBP2;ZCCHC8;SMNDC1;PRPF3;BUD31;GCFC2;RBM4B;DDX23;SRSF2;DDX5;SRSF7;CWC25;SNRPA1;CWF19L2;CCAR1;PPWD1;EFTUD2;SLU7;SNRPA;SCNM1;LSM4;IK;SNRNP200;GTF2F1;HNRNPH2;RBM4;BCAS2;SF3A1;PRPF4
prerank,Reactome_2022__Diseases Of DNA Repair R-HSA-9675135,-0.49112242113386073,-1.0264603540757777,0.4153846153846154,0.8416403376947795,1.0,9/34,18.99%,OGG1;HUS1;BRCA2;KAT5;RAD9A;RPA3;BRCA1;WRN;MSH6
prerank,"GO_Biological_Process_2021__regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",0.5337992256282516,1.0261716841628399,0.3939393939393939,0.7937622912280609,1.0,5/16,10.28%,SIRT1;SPRED1;SPRED2;MDM2;DYRK1A
prerank,Reactome_2022__Acyl Chain Remodelling Of PC R-HSA-1482788,0.5328574839063015,1.0261610657998033,0.47619047619047616,0.7933630412517552,1.0,1/13,0.68%,PLA2G4C
prerank,CellMarker_Augmented_2021__Kupffer cell:Liver,-0.5881146004382152,-1.0259149317007723,0.45901639344262296,0.8427392328053142,1.0,2/8,10.55%,CD14;ITGB2
prerank,GO_Biological_Process_2021__positive regulation of protein import (GO:1904591),-0.537969402152354,-1.025908193900835,0.47540983606557374,0.8423943810593729,1.0,4/22,9.33%,FLNA;JUP;RBM22;PDCD5
prerank,GO_Biological_Process_2021__presynaptic active zone organization (GO:1990709),-0.7146397166784025,-1.0257985921856623,0.5357142857142857,0.8423382620019596,1.0,1/6,6.19%,RAB3A
prerank,Reactome_2022__mRNA Splicing - Minor Pathway R-HSA-72165,-0.49520101129729677,-1.0255389886973396,0.375,0.8426484230973107,1.0,13/39,17.66%,ZCRB1;SNRPD2;RNPC3;POLR2G;PDCD7;ZRSR2;NCBP2;DDX23;SRSF2;SRSF7;EFTUD2;SNRNP200;GTF2F1
prerank,GO_Biological_Process_2021__kidney development (GO:0001822),0.48515294008601034,1.0254167422165719,0.42857142857142855,0.7946024280328123,1.0,13/30,17.57%,LRP4;ZBTB16;PKD1;SALL1;SOX4;C1GALT1;NF1;BAG6;NIPBL;TGFBR1;ROBO2;CTSH;PRKX
prerank,GO_Biological_Process_2021__Arp2/3 complex-mediated actin nucleation (GO:0034314),-0.5828884541183647,-1.0251504713221178,0.42105263157894735,0.8433321786879646,1.0,2/11,20.30%,ARPC5L;IQGAP2
prerank,Reactome_2022__Signaling By NOTCH3 R-HSA-9012852,-0.48854929566421973,-1.0251471158198295,0.3611111111111111,0.8429954518099037,1.0,4/33,9.56%,UBC;RPS27A;RBPJ;STAT1
prerank,Reactome_2022__Activation Of Pre-Replicative Complex R-HSA-68962,-0.5256500526456801,-1.0251122402936188,0.42424242424242425,0.8427134900130323,1.0,7/20,22.17%,POLE3;MCM7;RPA3;PRIM1;MCM6;CDC7;MCM5
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),0.6222374405396037,1.0250593179705094,0.45454545454545453,0.794702733434783,1.0,3/8,7.81%,SIRT1;TAF9B;ZNF385A
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),0.6222374405396037,1.0250593179705094,0.45454545454545453,0.794702733434783,1.0,3/8,7.81%,SIRT1;TAF9B;ZNF385A
prerank,GO_Biological_Process_2021__glutathione derivative metabolic process (GO:1901685),-0.5833127217248539,-1.0250162054132563,0.44776119402985076,0.8422280493281494,1.0,4/12,8.97%,GSTM4;GSTP1;GSTK1;GSTM3
prerank,GO_Biological_Process_2021__glutathione derivative biosynthetic process (GO:1901687),-0.5833127217248539,-1.0250162054132563,0.44776119402985076,0.8422280493281494,1.0,4/12,8.97%,GSTM4;GSTP1;GSTK1;GSTM3
prerank,KEGG_2021_Human__Arginine and proline metabolism,-0.5198840572350847,-1.0249557459552374,0.46153846153846156,0.8419973007425771,1.0,9/28,17.58%,SAT1;GATM;ODC1;SAT2;AZIN2;P4HA3;SMS;ALDH2;GOT2
prerank,GO_Biological_Process_2021__peptidyl-glutamic acid modification (GO:0018200),0.5463040185976318,1.0248889772822307,0.40625,0.7946822527038602,1.0,6/14,15.60%,TTLL11;PARP1;TTLL1;CEP41;TTLL7;VKORC1L1
prerank,PanglaoDB_Augmented_2021__Hepatocytes,0.41117974069807156,1.024755686117417,0.45454545454545453,0.7944823098727873,1.0,7/48,10.52%,LEPR;SAMD5;PRRG4;TM7SF2;MSMO1;HMGCS1;GPAT4
prerank,GO_Biological_Process_2021__regulation of interleukin-5 production (GO:0032674),-0.632363147587285,-1.0247388055407674,0.48,0.842159068873166,1.0,1/5,5.46%,LILRB4
prerank,GO_Biological_Process_2021__Golgi to plasma membrane transport (GO:0006893),-0.47925816374460556,-1.0246986483984672,0.421875,0.8418780740121194,1.0,5/39,12.09%,OSBPL5;BBS2;STXBP6;GOLGA4;STEAP2
prerank,GO_Biological_Process_2021__maturation of 5.8S rRNA (GO:0000460),0.5019749686353601,1.0245403316016173,0.47619047619047616,0.7945836990254705,1.0,2/15,2.35%,NOL9;RPF1
prerank,GO_Biological_Process_2021__endoplasmic reticulum organization (GO:0007029),0.4326323251547975,1.0245331489982397,0.39285714285714285,0.794153517696719,1.0,13/55,18.23%,VAPB;LRRK2;TOR1AIP2;RAB10;LMAN2L;STX1A;REEP3;RTN4;SEC61G;UBE2J2;SEC31A;SHTN1;SEC31B
prerank,GO_Biological_Process_2021__regulation of cytoplasmic mRNA processing body assembly (GO:0010603),0.6590905430530735,1.0242223541166953,0.4418604651162791,0.7944533638046454,1.0,2/6,26.04%,CNOT2;ATXN2
prerank,GO_Biological_Process_2021__calcium ion transmembrane transport (GO:0070588),0.41749933115615095,1.0241706360458078,0.4166666666666667,0.7941772324400115,1.0,5/62,3.46%,CACNA1A;TRPC1;PKD2;MCU;PKD1
prerank,GO_Biological_Process_2021__protein polymerization (GO:0051258),-0.4990487011322472,-1.0241144931877872,0.43478260869565216,0.8428392388903571,1.0,6/41,11.71%,CATIP;AIF1;PSTPIP1;FGF13;TRPV4;GPX4
prerank,GO_Biological_Process_2021__regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),-0.5682959999139405,-1.0241043978844264,0.45161290322580644,0.842496124011025,1.0,2/15,8.36%,SRI;CALM1
prerank,GO_Biological_Process_2021__regulation of apoptotic process (GO:0042981),-0.3845839571641274,-1.0238811638823397,0.4,0.8426418888693245,1.0,61/482,10.76%,BCL2A1;FLNA;PLEKHG5;UBC;APIP;RPS27A;TFRC;MNDA;CARD14;RASGRF2;GADD45B;VAV3;IKZF3;IFIT3;ATF5;PRELID1;STIL;TNFRSF25;NAIP;USP36;CTSB;DDRGK1;RACK1;TNFSF10;ING3;PTMA;CLU;ING5;RPL10;BNIP2;ARHGEF1;RPS3;MTCH1;IGF1;RPS3A;RNF144B;TNFAIP8;PHB2;ARHGEF3;PRLR;GSTP1;OBSCN;RPS6;TPT1;IFIT2;NAA38;SGK1;CFL1;ITGA6;TMEM219;CD44;MTCH2;EGLN3;PDCD5;ITGB3BP;STAT1;CFLAR;BCL2L14;NPM1;CITED2;NCKAP1L
prerank,CellMarker_Augmented_2021__Endoderm Progenitor cell:Adipose Tissue,-0.4990171751822444,-1.0238186938242582,0.4,0.8424348133500625,1.0,20/53,18.15%,MS4A4A;AIF1;SIGLEC1;CD93;F13A1;PECAM1;MS4A6A;HLA-DRA;TYROBP;SPARCL1;A2M;FLT1;SERPING1;HLA-DPA1;CD74;ALDH2;HLA-DPB1;FCGR3A;GIMAP4;FOLR2
prerank,Reactome_2022__SUMOylation Of Ubiquitinylation Proteins R-HSA-3232142,0.43065369625009114,1.0233290390050216,0.3125,0.7958063940598163,1.0,9/37,22.40%,NUP153;NUP188;NUP42;MDM2;NDC1;NUP133;NUP205;PIAS1;NUP98
prerank,GO_Biological_Process_2021__regulation of nitrogen compound metabolic process (GO:0051171),0.6000157046966749,1.0232871395541276,0.42857142857142855,0.7954723219639298,1.0,2/7,7.30%,LDLR;TNF
prerank,GO_Biological_Process_2021__positive regulation of ATP biosynthetic process (GO:2001171),0.5614444312134025,1.0231846207698019,0.5,0.7948818604670892,1.0,1/8,0.24%,PPARGC1A
prerank,GO_Biological_Process_2021__positive regulation of purine nucleotide biosynthetic process (GO:1900373),0.5614444312134025,1.0231846207698019,0.5,0.7948818604670892,1.0,1/8,0.24%,PPARGC1A
prerank,GO_Biological_Process_2021__phosphatidylinositol 3-kinase signaling (GO:0014065),0.46157500492642894,1.0229434601834306,0.45454545454545453,0.7950463728508402,1.0,7/21,17.35%,IGF1R;NYAP2;PIK3C2B;PTEN;NF1;TYRO3;PIK3CA
prerank,GO_Biological_Process_2021__regulation of endothelial cell development (GO:1901550),0.5992132603416362,1.02279047016012,0.5238095238095238,0.7949939518820265,1.0,3/9,18.17%,TNF;VCL;TNFRSF1A
prerank,GO_Biological_Process_2021__iron ion homeostasis (GO:0055072),-0.5023956587510904,-1.0227394712150657,0.49230769230769234,0.8448237135638104,1.0,4/41,2.81%,FTH1;TFRC;HAMP;B2M
prerank,GO_Biological_Process_2021__regulation of acyl-CoA biosynthetic process (GO:0050812),0.6398998872868827,1.022643676991807,0.4888888888888889,0.7944817213985867,1.0,1/5,2.30%,PDK4
prerank,GO_Biological_Process_2021__regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510),0.6398998872868827,1.022643676991807,0.4888888888888889,0.7944817213985867,1.0,1/5,2.30%,PDK4
prerank,GO_Biological_Process_2021__establishment of epithelial cell polarity (GO:0090162),0.5232364947754499,1.0223591046101523,0.43902439024390244,0.7947288334211159,1.0,3/14,15.71%,MSN;CLASP1;PARD3
prerank,GO_Biological_Process_2021__nucleobase catabolic process (GO:0046113),0.6613342449871801,1.0223145189016745,0.5869565217391305,0.7943968083434638,1.0,1/5,1.43%,DPYSL5
prerank,Reactome_2022__Canonical Retinoid Cycle In Rods (Twilight Vision) R-HSA-2453902,0.6403350375427362,1.0223004313632094,0.5531914893617021,0.7940015684503066,1.0,1/6,5.93%,NAPEPLD
prerank,GO_Biological_Process_2021__ribose phosphate biosynthetic process (GO:0046390),-0.6434036281715074,-1.0222733534214488,0.5454545454545454,0.8455646811549256,1.0,2/5,31.02%,PRPSAP1;TKT
prerank,GO_Biological_Process_2021__mitochondrial translation (GO:0032543),-0.46179089992541256,-1.0222468645076686,0.47058823529411764,0.8452714558497072,1.0,21/75,17.46%,MRPL57;AURKAIP1;MRPS7;MRPL51;MRPL19;GADD45GIP1;MRPL52;MRPL50;MTIF3;MTRF1;MRPS11;MRPS10;MRPS15;MRPL16;MRPL32;CHCHD1;OXA1L;MRPL43;MRPS18C;MRPL45;MRPS25
prerank,Reactome_2022__Toll Like Receptor 3 (TLR3) Cascade R-HSA-168164,0.38286005909972015,1.0222110432833804,0.38461538461538464,0.7938418665427541,1.0,15/89,12.49%,UBE2D1;DUSP6;TIFA;MAPK11;MAP2K1;UBE2D2;PPP2R1B;IRAK1;TAB2;DUSP7;BTRC;FBXW11;MAPK1;UBE2N;MAPKAPK2
prerank,GO_Biological_Process_2021__positive regulation of steroid metabolic process (GO:0045940),0.6336441761250952,1.0222068044242385,0.5106382978723404,0.7934092551713412,1.0,1/5,4.97%,STARD4
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Brain,-0.5717697202052047,-1.0221929055507546,0.4852941176470588,0.8450752156036166,1.0,2/16,8.71%,SLC2A3;CD44
prerank,GO_Biological_Process_2021__regulation of toll-like receptor 9 signaling pathway (GO:0034163),-0.63385173419072,-1.022130847195727,0.5409836065573771,0.8448907466985032,1.0,1/8,1.20%,RSAD2
prerank,GO_Biological_Process_2021__negative regulation of reactive oxygen species biosynthetic process (GO:1903427),-0.6646274078845303,-1.022071541396128,0.5,0.8446755077576847,1.0,1/6,7.36%,FYN
prerank,Reactome_2022__Methylation R-HSA-156581,0.6358704267009794,1.021723286717206,0.5526315789473685,0.7941005908076781,1.0,1/8,0.65%,AHCY
prerank,GO_Biological_Process_2021__protein import (GO:0017038),0.36824762659712273,1.0216912243352152,0.3125,0.7937571237085815,1.0,12/67,13.09%,NUTF2;E2F3;GDAP1;TSC2;IPO13;NUP153;NUP188;PPP1R10;PEX13;PEX5;IPO8;PEX11B
prerank,GO_Biological_Process_2021__mitochondrial gene expression (GO:0140053),-0.5516148899895512,-1.0215866181937074,0.5,0.8456313559767414,1.0,6/28,12.07%,MRPL57;MRPS7;MRPL51;MRPS11;MRPS15;MRPL16
prerank,GO_Biological_Process_2021__negative regulation of osteoblast differentiation (GO:0045668),0.4899990924498352,1.0215659966740385,0.45454545454545453,0.7935852215240851,1.0,5/18,11.88%,PPARG;RANBP3L;TWIST2;PTCH1;CDK6
prerank,Reactome_2022__SMAD2/SMAD3:SMAD4 Heterotrimer Regulates Transcription R-HSA-2173796,-0.5068260074805695,-1.0215043873253296,0.4461538461538462,0.8454971011366793,1.0,2/27,1.30%,UBC;RPS27A
prerank,GO_Biological_Process_2021__nuclear DNA replication (GO:0033260),-0.6527833637801486,-1.0213490280679374,0.5423728813559322,0.8455212645732076,1.0,6/8,30.04%,MCM7;MCM6;DONSON;MCM5;MCM3;MCMDC2
prerank,GO_Biological_Process_2021__cardiac myofibril assembly (GO:0055003),-0.6347203593722162,-1.021332832341516,0.484375,0.8452134985226591,1.0,2/7,19.65%,TTN;MEF2A
prerank,GO_Biological_Process_2021__regulation of DNA recombination at telomere (GO:0072695),0.5497388399564758,1.0213228713830638,0.46153846153846156,0.7932039765729839,1.0,1/15,0.68%,POLR2D
prerank,GO_Biological_Process_2021__negative regulation of DNA recombination at telomere (GO:0048239),0.5497388399564758,1.0213228713830638,0.46153846153846156,0.7932039765729839,1.0,1/15,0.68%,POLR2D
prerank,GO_Biological_Process_2021__fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539),0.5672250597646996,1.0212828861883247,0.42857142857142855,0.7928617427615741,1.0,3/8,12.29%,ACADS;ACADVL;GCDH
prerank,Reactome_2022__TP53 Regulates Transcription Of Genes Involved In Cytochrome C Release R-HSA-6803204,-0.56870456443159,-1.021139151240178,0.417910447761194,0.8452763401305423,1.0,1/14,2.84%,PRELID1
prerank,GO_Biological_Process_2021__pre-replicative complex assembly involved in nuclear cell cycle DNA replication (GO:0006267),-0.6440026344222498,-1.0209776892386984,0.5,0.8453198474811965,1.0,5/6,30.04%,MCM7;MCM6;MCM5;MCM3;MCMDC2
prerank,Reactome_2022__SUMOylation Of Intracellular Receptors R-HSA-4090294,-0.5517177175023806,-1.0208703404033603,0.4482758620689655,0.8452785195967001,1.0,2/20,5.38%,RORA;NR1H2
prerank,GO_Biological_Process_2021__protein-containing complex assembly (GO:0065003),0.3487492531562011,1.0207334723253862,0.4074074074074074,0.7937472497335348,1.0,25/201,10.09%,PPARGC1A;COL16A1;TSPAN33;TGFA;MITF;TCF7L1;MCU;PICALM;TLE2;LRRK2;BET1;CTSC;PDE4DIP;RAB1B;SEC24B;LIN7A;TMED10;MAGI1;TNF;BOK;SLC9A1;GRIA1;MDM2;HDAC1;BCL9L
prerank,GO_Biological_Process_2021__regulation of axon extension (GO:0030516),0.4277218525942405,1.0206549756624388,0.38095238095238093,0.7935189103589236,1.0,11/28,22.75%,DIP2B;RTN4;RNF6;MAP3K13;KIAA0319;GSK3B;SHTN1;MAP2;ZFYVE27;CTTN;ABL1
prerank,GO_Biological_Process_2021__collagen fibril organization (GO:0030199),0.4204059313835922,1.02063582152537,0.4,0.7931201844875188,1.0,12/44,13.53%,COL5A3;COL16A1;COL5A2;COL24A1;BMP1;LOXL2;P3H2;COL11A1;NF1;COL6A1;COL25A1;COL15A1
prerank,KEGG_2021_Human__Apoptosis,-0.45302575916486126,-1.0205463772057386,0.4189189189189189,0.8456995642548817,1.0,14/106,10.71%,BCL2A1;CYCS;FOS;GADD45B;GZMB;PRF1;CTSB;TNFSF10;IL3RA;ACTG1;PARP2;CFLAR;CSF2RB;ACTB
prerank,GO_Biological_Process_2021__short-chain fatty acid catabolic process (GO:0019626),0.6214997741814101,1.0205077927041606,0.5319148936170213,0.7929871778795526,1.0,2/7,10.70%,ACADS;PCK2
prerank,Reactome_2022__CREB Phosphorylation R-HSA-199920,0.6519569306269735,1.0201163553890416,0.5849056603773585,0.7934287925915773,1.0,1/6,12.49%,MAPKAPK2
prerank,CellMarker_Augmented_2021__Mesenchymal Progenitor cell:Cartilage,0.4156984403105769,1.019937986659175,0.4230769230769231,0.7933967152181941,1.0,22/64,18.51%,COL16A1;RASSF8;FKBP9;COL5A2;NUAK1;KITLG;TANC1;ALCAM;PTPRG;ITGAV;ENAH;FAM114A1;DCBLD2;TJP1;FERMT2;ANTXR1;STARD13;RAI14;TNC;RBFOX2;PPFIBP1;SNX7
prerank,"Reactome_2022__Interleukin-3, Interleukin-5 And GM-CSF Signaling R-HSA-512988",-0.5140887947911325,-1.0197537253654807,0.44285714285714284,0.8473526222158206,1.0,6/33,13.75%,YES1;IL3RA;FYN;CSF2RA;CSF2RB;PIK3CB
prerank,GO_Biological_Process_2021__regulation of mitotic metaphase/anaphase transition (GO:0030071),-0.537841548663124,-1.0196494422309679,0.4918032786885246,0.8472681349165326,1.0,1/17,1.54%,DUSP1
prerank,GO_Biological_Process_2021__negative regulation of cellular protein localization (GO:1903828),-0.5015813519928469,-1.019315390768444,0.4153846153846154,0.8477839888635037,1.0,2/28,5.46%,RIPOR2;LILRB4
prerank,GO_Biological_Process_2021__negative regulation of fat cell differentiation (GO:0045599),0.47220151185134496,1.0192914837145621,0.48484848484848486,0.7945439140597509,1.0,7/21,14.62%,SIRT1;WNT5A;SMAD3;TNF;RUNX1T1;FERMT2;ENPP1
prerank,CellMarker_Augmented_2021__Enterocyte:Large Intestine,-0.5473393521085624,-1.0192232295774373,0.4074074074074074,0.8476263111416427,1.0,2/17,4.15%,MCF2L2;RNPC3
prerank,GO_Biological_Process_2021__positive regulation of stress fiber assembly (GO:0051496),0.4388770993514572,1.0189883052876436,0.3870967741935484,0.7949020352999605,1.0,9/29,23.43%,NRP1;FERMT2;RAPGEF3;TGFBR1;PPM1F;PPM1E;LIMCH1;ABL1;ARHGEF10L
prerank,GO_Biological_Process_2021__nerve growth factor signaling pathway (GO:0038180),0.6237844655794496,1.0186793065769109,0.47058823529411764,0.7952156743740275,1.0,4/5,27.64%,RAP1A;RAPGEF2;MAGI2;KIDINS220
prerank,GO_Biological_Process_2021__regulation of lipid transport (GO:0032368),-0.6592085211515966,-1.0186666772219959,0.5357142857142857,0.8485913907049202,1.0,1/6,5.38%,NR1H2
prerank,Reactome_2022__Reactions Specific To Complex N-glycan Synthesis Pathway R-HSA-975578,-0.666097704594486,-1.018567483942001,0.5454545454545454,0.848471932941512,1.0,3/6,23.24%,CHST10;MAN2A1;MAN2A2
prerank,Reactome_2022__Gluconeogenesis R-HSA-70263,-0.551669148474103,-1.018475715267669,0.3968253968253968,0.8483756248752332,1.0,5/19,13.22%,MDH2;SLC37A1;G6PC3;FBP1;PGK1
prerank,GO_Biological_Process_2021__androgen metabolic process (GO:0008209),-0.6081668051115481,-1.018468189357737,0.5483870967741935,0.8480259793502399,1.0,3/8,28.53%,CYP19A1;MED1;HSD17B7
prerank,GO_Biological_Process_2021__respiratory chain complex III assembly (GO:0017062),-0.6238262366695435,-1.0182675939961645,0.5,0.8477534235107136,1.0,4/7,25.83%,BCS1L;TTC19;UQCC2;LYRM7
prerank,GO_Biological_Process_2021__mitochondrial respiratory chain complex III assembly (GO:0034551),-0.6238262366695435,-1.0182675939961645,0.5,0.8477534235107136,1.0,4/7,25.83%,BCS1L;TTC19;UQCC2;LYRM7
prerank,GO_Biological_Process_2021__regulation of skeletal muscle cell differentiation (GO:2001014),-0.6663706992289731,-1.0182567977618195,0.5384615384615384,0.8474351668331049,1.0,3/6,19.90%,DDX5;NR1D2;UQCC2
prerank,GO_Biological_Process_2021__tetrapyrrole metabolic process (GO:0033013),-0.6166967074056644,-1.0182301645958791,0.43859649122807015,0.8467573178034148,1.0,4/9,30.78%,MMAA;MMAB;MTRR;LMBRD1
prerank,GO_Biological_Process_2021__cobalamin metabolic process (GO:0009235),-0.6166967074056644,-1.0182301645958791,0.43859649122807015,0.8467573178034148,1.0,4/9,30.78%,MMAA;MMAB;MTRR;LMBRD1
prerank,GO_Biological_Process_2021__negative regulation of DNA replication (GO:0008156),0.6038339201028172,1.0179982596070651,0.5,0.7964670612308083,1.0,5/11,26.09%,SLFN11;GTPBP4;GMNN;RAD17;WAPL
prerank,GO_Biological_Process_2021__positive regulation of signal transduction (GO:0009967),0.34983445367354943,1.017839154301186,0.391304347826087,0.7963327501787344,1.0,25/156,9.91%,CD180;NRP1;PKD2;GRB10;MAML2;CDKN2AIP;SLC39A14;DLG5;SIRT1;SPRING1;NLGN1;LRRK2;STK36;RELN;JAG1;SALL1;ROBO1;MAML3;KANK1;SHANK3;CTBP2;NPTN;POGLUT1;ZRANB1;SASH1
prerank,Reactome_2022__G Beta:Gamma Signaling Thru CDC42 R-HSA-8964616,-0.6097368930777596,-1.0177153734861049,0.46153846153846156,0.847504603421683,1.0,2/10,15.86%,GNB5;GNB2
prerank,KEGG_2021_Human__Dopaminergic synapse,0.3733260162982441,1.017586968457272,0.4666666666666667,0.7964124130963447,1.0,21/90,19.21%,CACNA1A;MAPK11;GNAQ;KCNJ5;PLCB4;CLOCK;GRIA3;PPP2R1B;GRIA4;PPP3CA;GRIA1;GRIN2B;PPP2R5E;GRIA2;AKT2;GSK3B;GRIN2A;PPP3CB;PLCB3;CREB3L2;PPP1CC
prerank,Reactome_2022__Chk1/Chk2(Cds1) Mediated Inactivation Of Cyclin B:Cdk1 Complex R-HSA-75035,0.600302697891975,1.0171745115248627,0.45098039215686275,0.7969508458980402,1.0,3/8,21.45%,YWHAG;REXO2;YWHAE
prerank,GO_Biological_Process_2021__positive regulation of cellular protein catabolic process (GO:1903364),0.5186751377257187,1.0170226553437658,0.4897959183673469,0.7969044435673982,1.0,3/14,4.79%,MSN;ABCA2;CTSC
prerank,GO_Biological_Process_2021__positive regulation of toll-like receptor 7 signaling pathway (GO:0034157),-0.6628848611187487,-1.0169905554248067,0.49122807017543857,0.8485916467940243,1.0,2/5,10.70%,RSAD2;TASL
prerank,GO_Biological_Process_2021__regulation of toll-like receptor 7 signaling pathway (GO:0034155),-0.6628848611187487,-1.0169905554248067,0.49122807017543857,0.8485916467940243,1.0,2/5,10.70%,RSAD2;TASL
prerank,GO_Biological_Process_2021__Rho protein signal transduction (GO:0007266),-0.5040156727834504,-1.0168984332307405,0.43478260869565216,0.848461271088565,1.0,6/32,8.34%,PLEKHG5;ARHGAP4;ARHGEF1;RHOU;ARHGEF3;CFL1
prerank,GO_Biological_Process_2021__regulation of histone H3-K9 methylation (GO:0051570),0.5775070062520192,1.0165014478038832,0.45652173913043476,0.7978689978084076,1.0,1/8,2.51%,SIRT1
prerank,GO_Biological_Process_2021__unsaturated fatty acid biosynthetic process (GO:0006636),-0.6475142849409684,-1.016331305266253,0.5,0.8495697914031729,1.0,2/7,14.59%,FADS3;ALOX12
prerank,GO_Biological_Process_2021__positive regulation of fat cell differentiation (GO:0045600),-0.5216294511099602,-1.016261422508698,0.4423076923076923,0.8494085373823287,1.0,2/31,1.48%,SYAP1;ZFP36
prerank,GO_Biological_Process_2021__positive regulation of peptidase activity (GO:0010952),-0.535424708026561,-1.0162324515028514,0.5245901639344263,0.8491137138980953,1.0,6/16,19.69%,PRELID1;DDRGK1;PINK1;APH1B;PSME2;PSME1
prerank,GO_Biological_Process_2021__positive regulation of neuron death (GO:1901216),0.43506826695918055,1.0161992762512553,0.36363636363636365,0.7981986835200977,1.0,6/38,7.30%,EGR1;CDK5R1;PICALM;WNT5A;DDIT3;TNF
prerank,GO_Biological_Process_2021__negative regulation of toll-like receptor signaling pathway (GO:0034122),-0.5242344044608108,-1.015971240378308,0.4714285714285714,0.8494339275425852,1.0,3/23,8.14%,CD14;CD300LF;TNFAIP3
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-threonine phosphorylation (GO:0010801),0.5352580915211159,1.0153528755517889,0.4166666666666667,0.7998138079678465,1.0,4/14,3.94%,SPRY2;SMAD7;SPRED1;SPRED2
prerank,CellMarker_Augmented_2021__Delta cell:Pancreas,-0.5951786075936297,-1.0151042163343675,0.49122807017543857,0.8513684357247889,1.0,2/10,12.64%,RGS2;SST
prerank,GO_Biological_Process_2021__regulation of biosynthetic process (GO:0009889),-0.6050172112181421,-1.0148400507798843,0.559322033898305,0.8516187488324295,1.0,1/7,6.85%,GSTP1
prerank,GO_Biological_Process_2021__interleukin-18-mediated signaling pathway (GO:0035655),-0.7122520265944688,-1.014792422162296,0.5106382978723404,0.8510132312369075,1.0,3/5,22.29%,IL18R1;IL18;PDGFB
prerank,GO_Biological_Process_2021__cellular response to interleukin-18 (GO:0071351),-0.7122520265944688,-1.014792422162296,0.5106382978723404,0.8510132312369075,1.0,3/5,22.29%,IL18R1;IL18;PDGFB
prerank,GO_Biological_Process_2021__homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),0.45109566132683815,1.0147398485013204,0.43333333333333335,0.8008567348941413,1.0,9/36,11.01%,CNTN2;IGSF11;PKD1;CADM1;PTPRM;PLXNB2;ROBO1;NPTN;CELSR2
prerank,GO_Biological_Process_2021__protein peptidyl-prolyl isomerization (GO:0000413),-0.5694614160801923,-1.0147349484011459,0.4852941176470588,0.850848033789542,1.0,1/16,0.79%,PPIE
prerank,GO_Biological_Process_2021__mitochondrial membrane organization (GO:0007006),-0.5178121833449395,-1.0144996300738243,0.5,0.8510295839873466,1.0,9/26,26.37%,SLC25A5;MICOS13;APOO;SPG7;MAIP1;MTX3;GHITM;MICOS10;DNAJC11
prerank,GO_Biological_Process_2021__cardiac muscle tissue morphogenesis (GO:0055008),-0.6032737151075395,-1.0141111581625442,0.47540983606557374,0.8517744572645635,1.0,3/12,7.44%,TGFBR3;TTN;MYBPC3
prerank,GO_Biological_Process_2021__myeloid cell development (GO:0061515),-0.534712609696653,-1.0140169276910198,0.46875,0.8517309290538019,1.0,5/14,20.60%,ANXA2;NCKAP1L;EVI2B;TLR2;MED1
prerank,GO_Biological_Process_2021__postsynaptic membrane organization (GO:0001941),0.5141763080826173,1.0139731122233382,0.4883720930232558,0.8025000206877068,1.0,6/15,15.11%,LRP4;NLGN1;SHANK3;NRXN2;GPHN;NLGN4Y
prerank,GO_Biological_Process_2021__negative regulation of response to DNA damage stimulus (GO:2001021),-0.5381734250558373,-1.0139258742249284,0.4507042253521127,0.8515847279102807,1.0,5/18,8.71%,CLU;RPS3;PTTG1IP;TPT1;CD44
prerank,GO_Biological_Process_2021__negative regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903799),0.6378936404014927,1.0138671144480762,0.5714285714285714,0.802275448652422,1.0,3/6,25.72%,TNF;ESR1;TGFB1
prerank,GO_Biological_Process_2021__positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),-0.5154291517381349,-1.0138206387126094,0.47368421052631576,0.8515108967293111,1.0,7/28,13.37%,RACK1;RPS3;FIS1;RPS7;EIF5A;BMF;SOD1
prerank,GO_Biological_Process_2021__negative regulation of smoothened signaling pathway (GO:0045879),0.48353341898021807,1.0136778564673312,0.48717948717948717,0.8023077241212588,1.0,8/20,14.62%,TULP3;PTCH2;GPR161;KCTD6;BTRC;PTCH1;MEGF8;ENPP1
prerank,GO_Biological_Process_2021__transcription initiation from RNA polymerase II promoter (GO:0006367),0.373573045622912,1.0135836018961002,0.38461538461538464,0.8020960070521751,1.0,12/97,7.63%,ESRRG;PPARGC1A;POLR2D;MAML2;DR1;HDAC9;E2F3;PPARG;CDK7;TAF2;MAML3;TAF9B
prerank,GO_Biological_Process_2021__regulation of microtubule polymerization or depolymerization (GO:0031110),0.4827161187995622,1.0134847501561217,0.40540540540540543,0.8018907691219518,1.0,9/21,22.75%,MAP1S;CLASP1;FKBP4;CLASP2;CAMSAP2;MAP2;MAPRE2;STMN3;ABL1
prerank,CellMarker_Augmented_2021__Neural Crest cell:Germ,-0.4393173654504878,-1.0134026258575513,0.42857142857142855,0.8521934979171603,1.0,7/73,8.15%,BCL11B;EPHB1;CDH23;INPP4A;FYN;SPOCK2;ITGA4
prerank,Reactome_2022__TAK1-dependent IKK And NF-kappa-B Activation R-HSA-445989,-0.47999306971607164,-1.0130517129102754,0.4605263157894737,0.8528071374696379,1.0,3/38,6.58%,UBC;RPS27A;NLRC5
prerank,GO_Biological_Process_2021__gene silencing by miRNA (GO:0035195),-0.496202927524674,-1.013035383831628,0.4262295081967213,0.8524784420143283,1.0,1/25,1.48%,ZFP36
prerank,GO_Biological_Process_2021__regulation of nitric oxide biosynthetic process (GO:0045428),0.4665495856647492,1.0129905997688116,0.4722222222222222,0.8025168180596367,1.0,5/26,7.30%,KLF4;PKD2;SIRPA;SMAD3;TNF
prerank,GO_Biological_Process_2021__cleavage furrow formation (GO:0036089),0.6110347737284332,1.0128572882723759,0.6,0.8023428009591783,1.0,2/5,12.03%,SPIRE2;SNX18
prerank,GO_Biological_Process_2021__negative regulation of interleukin-10 production (GO:0032693),-0.6109853369880573,-1.0128375574985147,0.5079365079365079,0.8525941617824554,1.0,2/10,11.20%,LILRB4;TYROBP
prerank,GO_Biological_Process_2021__cyclic purine nucleotide metabolic process (GO:0052652),0.5038074291281727,1.0128137500883594,0.45098039215686275,0.8020004382001039,1.0,5/13,15.24%,ADCY9;GUCY1A1;NPR2;ADCY6;GUCY1B1
prerank,GO_Biological_Process_2021__glutathione biosynthetic process (GO:0006750),0.5941539807895799,1.0127844763561114,0.5102040816326531,0.8011858715272753,1.0,1/6,1.41%,GCLC
prerank,GO_Biological_Process_2021__nonribosomal peptide biosynthetic process (GO:0019184),0.5941539807895799,1.0127844763561114,0.5102040816326531,0.8011858715272753,1.0,1/6,1.41%,GCLC
prerank,GO_Biological_Process_2021__stress-activated MAPK cascade (GO:0051403),-0.46134220054085684,-1.0127115447361368,0.36619718309859156,0.8525162667786602,1.0,3/57,1.48%,UBC;RPS27A;ZFP36
prerank,Reactome_2022__Scavenging By Class F Receptors R-HSA-3000484,0.6465716683636404,1.0125870012763813,0.5476190476190477,0.8012372873252392,1.0,2/5,17.42%,HYOU1;HSPH1
prerank,GO_Biological_Process_2021__energy derivation by oxidation of organic compounds (GO:0015980),-0.5601106948509544,-1.012509743323549,0.45454545454545453,0.852696351991197,1.0,3/16,1.81%,NR4A3;CYCS;PID1
prerank,GO_Biological_Process_2021__cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),-0.5191437047388054,-1.0121817293988675,0.4745762711864407,0.8532175000156527,1.0,6/25,14.82%,UBC;RPS27A;TNFAIP3;ALPK1;NOD2;UBA52
prerank,PanglaoDB_Augmented_2021__Neurons,0.34824617254511697,1.012017066944744,0.2727272727272727,0.8020111639085226,1.0,42/199,15.82%,KCNQ2;CNTN2;NCAN;LUZP2;NBEA;PNMA8A;CHODL;NOL4;SNAP91;SCN3B;CNRIP1;VGF;GNL3L;COPG1;GRIA3;GRIA4;CA10;DNM3;OLFM3;CTNNA2;CADM2;SCN8A;PSD2;GRM5;SNCB;STX1A;CLSTN3;PTPN5;FBXW7;RGS17;RBFOX1;SLC12A5;CSPP1;GRIA2;SGIP1;CACNG2;GAD1;CACNB4;CSRNP3;EML5;RNF220;PPFIA2
prerank,GO_Biological_Process_2021__zinc ion homeostasis (GO:0055069),-0.5535059031224965,-1.0119706308043355,0.4827586206896552,0.8533744012042422,1.0,1/16,0.25%,MT2A
prerank,KEGG_2021_Human__mTOR signaling pathway,0.36456373819007165,1.0119533827416896,0.4,0.801719694790702,1.0,19/108,11.81%,RRAGD;GRB10;IGF1R;MAP2K1;TSC2;SLC3A2;WNT5A;FZD3;WNT2B;CAB39;TNF;DVL3;EIF4E2;DEPTOR;ATP6V1B2;RPS6KA6;FNIP2;MAPK1;PTEN
prerank,GO_Biological_Process_2021__integrin-mediated signaling pathway (GO:0007229),0.4220900321577393,1.0116552350371721,0.2903225806451613,0.8019387354195148,1.0,2/49,0.61%,COL16A1;NRP1
prerank,GO_Biological_Process_2021__regulation of keratinocyte proliferation (GO:0010837),-0.6090027248915637,-1.0116496200956262,0.4909090909090909,0.8538417935169368,1.0,3/11,15.71%,ZFP36;NOTCH2;STXBP4
prerank,Reactome_2022__Endogenous Sterols R-HSA-211976,0.6024631697640844,1.0112672288841547,0.4722222222222222,0.8024995659934252,1.0,2/11,9.07%,ARNT2;CYP46A1
prerank,GO_Biological_Process_2021__protein autoprocessing (GO:0016540),0.5586923523210557,1.0110934026937486,0.4523809523809524,0.8023823310434998,1.0,1/10,2.82%,MYRF
prerank,GO_Biological_Process_2021__glial cell differentiation (GO:0010001),0.5077735542771346,1.0109758235418076,0.3939393939393939,0.8022527971109008,1.0,6/14,11.35%,MYRF;TPPP;RELN;SOX4;NFIB;METRN
prerank,GO_Biological_Process_2021__cellular response to pH (GO:0071467),0.5936368780483307,1.0107351198230041,0.5121951219512195,0.8023841654996479,1.0,3/7,18.72%,SLC9A1;HVCN1;CHP1
prerank,GO_Biological_Process_2021__regulation of histone H3-K4 methylation (GO:0051569),-0.5473846669706107,-1.0107349878644472,0.46551724137931033,0.8555886283903973,1.0,3/15,14.26%,ZNF335;DNMT1;BRCA1
prerank,GO_Biological_Process_2021__regulation of mast cell activation involved in immune response (GO:0033006),0.5742075120355413,1.0104766646724115,0.45714285714285713,0.8024843671470395,1.0,1/9,1.04%,FER
prerank,GO_Biological_Process_2021__response to hexose (GO:0009746),-0.5856705566821436,-1.0104013932679952,0.47540983606557374,0.855997925677854,1.0,4/13,19.72%,EIF2B1;SELENOS;EIF2B2;PFKL
prerank,CellMarker_Augmented_2021__Cancer cell:Brain,0.3713934105430878,1.0103336256550655,0.48,0.8023673898547223,1.0,25/86,20.66%,SYNCRIP;NSUN2;NUP188;DDX31;PARP1;EIF2S1;CDC23;GTF3C4;SUPT16H;INTS7;POLA1;CCT3;DROSHA;USP14;HSPD1;PDIA6;ACTL6A;NDC1;NOLC1;URB2;NUP205;XPO5;PUS7;GEMIN5;IPO7
prerank,Reactome_2022__Mitochondrial Translation Elongation R-HSA-5389840,-0.4847732871073927,-1.0100438906404228,0.46153846153846156,0.8565884788344724,1.0,19/57,17.46%,MRPL57;AURKAIP1;MRPS7;MRPL51;MRPL19;GADD45GIP1;MRPL52;MRPL50;MRPS11;MRPS10;MRPS15;MRPL16;MRPL32;CHCHD1;OXA1L;MRPL43;MRPS18C;MRPL45;MRPS25
prerank,GO_Biological_Process_2021__phospholipid translocation (GO:0045332),-0.5079692586843927,-1.0100170978702634,0.47540983606557374,0.8562936116698069,1.0,5/24,14.37%,ABCB1;ATP10A;PLSCR1;ABCB4;ATP8B1
prerank,KEGG_2021_Human__Riboflavin metabolism,-0.6815936280498692,-1.0099850223107452,0.5517241379310345,0.8559952115233481,1.0,2/5,8.26%,FLAD1;ENPP3
prerank,Reactome_2022__RNA Polymerase III Abortive And Retractive Initiation R-HSA-749476,-0.4942820552286829,-1.0097539482861357,0.46875,0.856097589031892,1.0,3/33,3.42%,SNAPC1;GTF3C6;SSB
prerank,KEGG_2021_Human__Arginine biosynthesis,-0.6407141292888755,-1.009688076728659,0.46774193548387094,0.8559014993556695,1.0,2/8,17.58%,GLUL;GOT2
prerank,GO_Biological_Process_2021__negative regulation of protein tyrosine kinase activity (GO:0061099),-0.5704320068588382,-1.0095155662788091,0.453125,0.8559698517897691,1.0,6/16,12.82%,SNX6;CBLB;LILRB4;SH3BP5;SH3BP5L;PTPRC
prerank,Reactome_2022__Transcriptional Regulation Of White Adipocyte Differentiation R-HSA-381340,0.39727110606154914,1.0094249801583461,0.4,0.8039985891109821,1.0,4/62,5.17%,KLF4;PPARGC1A;NCOA3;PPARG
prerank,GO_Biological_Process_2021__regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),0.5425350312756454,1.009279977609708,0.4864864864864865,0.8039366904252039,1.0,1/11,0.08%,KLF4
prerank,GO_Biological_Process_2021__mitotic cell cycle phase transition (GO:0044772),0.3462665762850395,1.0091608949598971,0.4117647058823529,0.8037262452254127,1.0,34/152,19.38%,EPS8;CCNG2;BORA;E2F3;CDK7;TAF2;RCC1;CEP41;BRSK1;YWHAG;CCNG1;SPDYA;PLK2;CDC23;CEP131;BTRC;FBXW11;CHMP7;CDK6;CSNK1E;FBXL12;FBXL7;CLASP1;ANAPC1;DYNC1H1;CCND3;HINFP;CLASP2;ALMS1;TPD52L1;BRSK2;CEP135;ODF2;NDE1
prerank,Reactome_2022__Nef Mediated CD4 Down-regulation R-HSA-167590,-0.6469585643589488,-1.0091436267928544,0.5094339622641509,0.8565476126737023,1.0,4/7,27.39%,AP2S1;AP2M1;CD4;AP2A1
prerank,Reactome_2022__Protein Methylation R-HSA-8876725,-0.5538995563820451,-1.0089766512425966,0.515625,0.856672221324926,1.0,3/14,9.26%,RPS2;CALM1;ETFB
prerank,GO_Biological_Process_2021__neutral amino acid transport (GO:0015804),-0.5485106840019704,-1.0087811613000623,0.5081967213114754,0.8568495150878299,1.0,4/16,10.63%,SLC7A5;SLC38A1;LLGL2;SLC36A4
prerank,GO_Biological_Process_2021__negative regulation of DNA repair (GO:0045738),-0.7264471798976948,-1.0087649166049606,0.5370370370370371,0.8565027573659654,1.0,1/5,5.49%,RPS3
prerank,GO_Biological_Process_2021__negative regulation of stem cell differentiation (GO:2000737),0.5538562009512862,1.0083732284040492,0.4772727272727273,0.8051994017463666,1.0,4/9,26.65%,JAG1;HNRNPU;YTHDF2;NOTCH1
prerank,Reactome_2022__Regulation Of RUNX1 Expression And Activity R-HSA-8934593,0.4883064184528157,1.0083115033074885,0.46153846153846156,0.8049080968491279,1.0,7/16,25.96%,RUNX1;CDK6;CCND3;TNRC6C;CBFB;AGO1;TNRC6A
prerank,GO_Biological_Process_2021__sphingosine-1-phosphate receptor signaling pathway (GO:0003376),-0.6924457451692604,-1.0082948975559576,0.5573770491803278,0.8574485466884856,1.0,3/5,17.60%,PIK3CB;RAC1;EZR
prerank,Reactome_2022__Interleukin-9 Signaling R-HSA-8985947,-0.6647413611607247,-1.0082267844584516,0.5714285714285714,0.8565447205140697,1.0,1/6,9.56%,STAT1
prerank,GO_Biological_Process_2021__cellular response to interleukin-9 (GO:0071355),-0.6647413611607247,-1.0082267844584516,0.5714285714285714,0.8565447205140697,1.0,1/6,9.56%,STAT1
prerank,GO_Biological_Process_2021__interleukin-9-mediated signaling pathway (GO:0038113),-0.6647413611607247,-1.0082267844584516,0.5714285714285714,0.8565447205140697,1.0,1/6,9.56%,STAT1
prerank,GO_Biological_Process_2021__regulation of lipid metabolic process (GO:0019216),0.38389296856243255,1.0080996044171868,0.32142857142857145,0.8049323995515576,1.0,13/69,12.66%,NFYC;IDI1;PPARG;PLPP1;FDFT1;ACACB;TM7SF2;ELOVL6;HMGCS1;TBL1XR1;MVD;RUBCNL;FASN
prerank,KEGG_2021_Human__Melanoma,0.450871263441182,1.0079303012316045,0.43333333333333335,0.8049937507581131,1.0,12/43,11.88%,PDGFA;IGF1R;FGF2;MITF;E2F3;MAP2K1;PDGFC;MDM2;HGF;MAPK1;PTEN;CDK6
prerank,GO_Biological_Process_2021__positive regulation of vacuole organization (GO:0044090),-0.6092472268455384,-1.007815031757492,0.48936170212765956,0.8571917775585903,1.0,1/10,3.81%,ANXA2
prerank,GO_Biological_Process_2021__negative regulation of transcription regulatory region DNA binding (GO:2000678),-0.6270205957116615,-1.0077846716179615,0.5084745762711864,0.8569209376615001,1.0,2/7,8.69%,PER2;TMSB4X
prerank,CellMarker_Augmented_2021__Circulating Fetal cell:Blood,-0.5420914106241536,-1.0076174143384675,0.5344827586206896,0.8570073425245007,1.0,3/23,2.30%,JUNB;IL7R;HAMP
prerank,GO_Biological_Process_2021__negative regulation of axon extension involved in axon guidance (GO:0048843),0.5735839023679191,1.0075416966464483,0.43478260869565216,0.8053947043684619,1.0,2/11,6.05%,SEMA5A;SEMA3B
prerank,"GO_Biological_Process_2021__mRNA cis splicing, via spliceosome (GO:0045292)",-0.5942776681580717,-1.0074499897999358,0.5,0.857044840521496,1.0,4/14,17.33%,RBM22;NCBP2;DDX23;SNRNP200
prerank,GO_Biological_Process_2021__regulation of epidermis development (GO:0045682),0.605723508406122,1.0072738762972677,0.4444444444444444,0.8055791957268836,1.0,2/6,10.46%,TMEM79;KLF7
prerank,GO_Biological_Process_2021__positive regulation of p38MAPK cascade (GO:1900745),-0.53439841978805,-1.0068941223671155,0.4666666666666667,0.857964724360641,1.0,2/16,11.19%,GADD45B;VEGFA
prerank,Reactome_2022__Mismatch Repair R-HSA-5358508,-0.603040286407727,-1.006814925839926,0.47368421052631576,0.8578403963817549,1.0,5/10,28.25%,RPA3;LRIG1;MSH6;MSH3;PMS2
prerank,Reactome_2022__G Alpha (Q) Signaling Events R-HSA-416476,-0.44047798467196564,-1.006691585768019,0.47368421052631576,0.8578324789484206,1.0,10/90,7.63%,PRKCQ;MGLL;CD200R1;RGS1;BTK;RGS16;GNB5;TACR1;RGS4;GNRHR
prerank,GO_Biological_Process_2021__cellular glucan metabolic process (GO:0006073),0.6306471635868951,1.0063511105093337,0.5,0.807416846134673,1.0,5/7,32.02%,GSK3B;PHKB;PRKAG2;PHKG2;UGP2
prerank,GO_Biological_Process_2021__maturation of LSU-rRNA (GO:0000470),-0.4975462230062089,-1.006147856132517,0.4603174603174603,0.8589234008079126,1.0,7/23,18.49%,RPL7A;RPL35;RPL10A;NSA2;NHP2;ZNHIT6;LAS1L
prerank,Reactome_2022__TGF-beta Receptor Signaling Activates SMADs R-HSA-2173789,-0.5206567291666517,-1.0060999342260564,0.4782608695652174,0.85867512152153,1.0,3/36,1.30%,UBC;PPP1R15A;RPS27A
prerank,GO_Biological_Process_2021__receptor signaling pathway via STAT (GO:0097696),-0.5528445332571326,-1.0059968724548691,0.48214285714285715,0.8585619465137369,1.0,1/17,0.41%,STAT4
prerank,KEGG_2021_Human__Sphingolipid metabolism,0.4575002770856287,1.005988814315171,0.3870967741935484,0.8077973833438048,1.0,5/34,6.65%,ACER2;ARSA;GLB1;PLPP1;SPTLC2
prerank,Reactome_2022__MyD88-independent TLR4 Cascade R-HSA-166166,0.378777647031759,1.0059777259308953,0.4583333333333333,0.8073948541737609,1.0,16/92,12.49%,UBE2D1;DUSP6;TIFA;MAPK11;TMED7-TICAM2;MAP2K1;UBE2D2;PPP2R1B;IRAK1;TAB2;DUSP7;BTRC;FBXW11;MAPK1;UBE2N;MAPKAPK2
prerank,KEGG_2021_Human__Estrogen signaling pathway,0.3788326154031624,1.0059637736240092,0.48,0.8070173883129826,1.0,20/80,19.12%,TGFA;NCOA3;GABBR1;MAP2K1;GNAQ;KCNJ5;PLCB4;ADCY9;FKBP5;SHC2;MAPK1;ADCY6;JUN;FKBP4;AKT2;PIK3CA;PLCB3;MAP2K2;NCOA2;CREB3L2
prerank,GO_Biological_Process_2021__regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),0.5284885143285104,1.005792357741116,0.47619047619047616,0.8069542872949419,1.0,6/11,25.72%,MAP2K1;TNF;MAP2K2;RIPK1;ESR1;TGFB1
prerank,GO_Biological_Process_2021__regulation of cell motility (GO:2000145),0.36709228535925087,1.0054365223308042,0.42105263157894735,0.8072542767537745,1.0,20/80,14.52%,PLXNB1;SRCIN1;AMOT;PLXNA2;FGF2;SERPINE2;PLXNA3;TBCCD1;NRG1;PLXNB2;CRK;PLXNC1;DOCK10;CCDC125;CDK6;MEMO1;PLXNA1;NRG2;ERBB4;FRMD5
prerank,CellMarker_Augmented_2021__Pancreatic Endoderm cell:Embryonic Stem Cell,0.4182474346645749,1.005363664269966,0.41935483870967744,0.8069697281412639,1.0,17/50,15.62%,COL16A1;EPS8;FKBP9;RASAL2;TIMP3;JAG1;KITLG;PLK2;EPAS1;ITGAV;FAM114A1;ITGA2;SH3RF1;TJP1;MMP14;CD276;ANTXR1
prerank,GO_Biological_Process_2021__regulation of histone H4-K16 acetylation (GO:2000618),0.6614044275681186,1.0053069270858472,0.45454545454545453,0.8066731867733892,1.0,2/5,8.34%,SIRT1;AUTS2
prerank,GO_Biological_Process_2021__autophagosome membrane docking (GO:0016240),-0.6283794099445519,-1.0050666516946218,0.5283018867924528,0.8605314246671214,1.0,1/7,8.36%,CALM1
prerank,GO_Biological_Process_2021__response to leptin (GO:0044321),-0.6095554625742616,-1.004912028246695,0.5,0.8605486149801973,1.0,1/7,0.08%,NR4A3
prerank,Reactome_2022__Metabolism Of Proteins R-HSA-392499,-0.37122496672584315,-1.0039054202456354,0.5,0.8626690769342714,1.0,170/1281,12.85%,H2AC25;TUBB8;SPON2;ARSJ;RPS13;UBC;RPS4X;H2BC4;H2BC26;H2AC20;HLA-B;RPL28;RPS27A;RPS8;RPL38;RPS21;CD55;RPL31;CARD16;WARS1;RPL37A;RPS14;H2AC6;VNN2;F8;ARSG;GCNT1;RPL12;RPLP1;UBXN1;RPL3;RAB37;RPL23A;RPL39;RPL32;CHD3;RPS11;COPS6;B2M;RPL5;RPS15;RPS12;PSMB3;RPS25;RPS23;RPS27;FAU;SRP14;RORA;RPS20;RPL29;RPLP2;EIF2B1;RPL19;RPS24;NARS1;RPL13A;RPL41;PLET1;PIGL;RPL7A;ADAMTS19;RPL35;RPL37;ELOB;ING3;SPSB1;GNB5;POMT1;RPL10A;RAB11A;RPL11;ADRM1;ERO1A;NR1H2;RPS3;RPL23;PIGO;IGF1;MRPL57;KLHL13;RPS3A;H2BC18;RPL4;H3-3B;ST8SIA1;RAB3A;TRAPPC4;RPL30;TXN2;RPL36AL;AURKAIP1;MRPS7;RPL36;MRPL51;H2BC21;RPL14;RPL18A;PSMB6;PSMA7;RPS6;RPS2;RPS7;RPL34;RAB3D;RPL15;MRPL19;CSF2RA;TNFAIP3;RPL21;GADD45GIP1;H2BC5;CALM1;LY6E;MAT2B;RPS5;RPL27A;MRPL52;GPC3;ABRAXAS1;PSMB9;COMMD9;RPL6;ETFB;H2BC9;MRPL50;RPL27;RPL18;TRIM13;SELENOS;COMMD8;JOSD1;FCSK;LARS1;POFUT2;DCTN6;GGCX;NPM1;CFTR;CSF2RB;EIF3K;CCDC59;RPLP0;NUP50;PTGES2;MTIF3;RPS9;RBX1;DCTN4;KARS1;HIF1A;SPARCL1;MRPS11;TARS2;MRPS10;AGBL3;MRPS15;WDR48;MRPL16;MRPL32;CHST10;TBC1D20;PSMD12;COPS8;DARS2;H2BC11;CSNK1D;CHCHD1;PSMD8;PSMA5
prerank,GO_Biological_Process_2021__positive regulation of nitric oxide metabolic process (GO:1904407),0.5017450210584095,1.00374648550837,0.42105263157894735,0.8099154504474693,1.0,4/18,7.30%,KLF4;PKD2;SMAD3;TNF
prerank,GO_Biological_Process_2021__lipoxygenase pathway (GO:0019372),-0.6128640269630559,-1.0037345504728943,0.49056603773584906,0.8626928482614012,1.0,4/8,14.59%,GPX4;PON2;GPX1;ALOX12
prerank,Reactome_2022__G2/M Transition R-HSA-69275,-0.4195659152279807,-1.0036170691461488,0.48717948717948717,0.8626418119100785,1.0,35/141,22.15%,UBC;RPS27A;PSMB3;SSNA1;PSMB6;PSMA7;PPP1CB;CEP72;PSMB9;CEP164;TUBGCP2;RBX1;PSMD12;CSNK1D;PSMD8;PSMA5;TUBB4B;UBA52;TUBGCP5;PSMA3;PRKAR2B;PSMC4;DCTN2;CENPF;AKAP9;MZT2B;PSME2;PSME1;DYNC1I2;NINL;PSMB5;SFI1;CDK11B;PSMC3;HAUS5
prerank,PanglaoDB_Augmented_2021__Urothelial Cells,-0.4845597030397727,-1.003253293286513,0.46153846153846156,0.8631365437686389,1.0,6/41,10.26%,CARD14;NBEAL2;PRKD2;LLGL2;SSH3;SLC14A1
prerank,GO_Biological_Process_2021__regulation of erythrocyte differentiation (GO:0045646),-0.4845962348837456,-1.0032128278084753,0.4603174603174603,0.862876133084023,1.0,9/32,14.43%,ZFP36;ETS1;ANKRD54;STAT1;NCKAP1L;HIF1A;HSPA1B;ZNF16;HSPA1A
prerank,GO_Biological_Process_2021__glycerophospholipid biosynthetic process (GO:0046474),0.3626023913396411,1.0031587810362337,0.375,0.8108272454641409,1.0,32/132,18.14%,PLA2G4C;FGF2;ETNPPL;PIP5K1B;CHKA;PIK3C2B;ABHD8;SLC44A2;PTPN13;PI4KB;DDHD1;IMPA1;GPAT4;SELENOI;AGPAT5;SLC44A5;SLC44A1;PTEN;LCAT;GPAT3;PIP4K2A;CHPT1;SBF1;MTMR9;HDHD5;AGPAT2;RAB14;STARD7;PEMT;PIK3CA;PLEKHA8;INPP4B
prerank,GO_Biological_Process_2021__positive regulation of glycogen metabolic process (GO:0070875),-0.564970545246997,-1.0029268600802659,0.42857142857142855,0.8632508460981411,1.0,1/10,5.56%,IGF1
prerank,GO_Biological_Process_2021__regulation of fibroblast proliferation (GO:0048145),-0.49761146100841863,-1.0028672215295062,0.46875,0.8630167361259672,1.0,7/34,9.17%,FTH1;NLRC3;EMD;IGF1;MED25;GSTP1;S100A6
prerank,PanglaoDB_Augmented_2021__Interneurons,0.34490892347040364,1.0028500072858302,0.4,0.8111059953508004,1.0,73/199,21.61%,KCNQ2;CNTN2;NCAN;NBEA;KCNIP2;NOL4;SLC22A15;SNAP91;CDK17;RELN;PARM1;PLCB4;PCF11;CHST1;NPTXR;VGF;SHISA9;ELMO1;GRIA4;DNAJC6;CA10;DNM3;OLFM3;CTNNA2;KCNC2;CADM2;DEPTOR;SV2B;SCN8A;PSD2;GRM5;SNCB;PTPN5;FBXW11;RGS17;SLC35F1;LINGO1;CAMKV;RBFOX1;SLC12A5;OXR1;CXCL14;CACNA1E;GRIA2;CACNG2;GAD1;CSRNP3;FBXO11;EML5;PPFIA2;SPOCK3;ADGRB3;MAPK4;NXPH1;CDH4;DLGAP1;TMEM132D;HIVEP2;TRIM9;MAP2;PTPRO;PHYHIPL;SYT4;GRM3;KCNQ5;CELF5;HLF;AMER2;CACNA1B;GABRA4;GRM1;SYNPR;NRXN1
prerank,GO_Biological_Process_2021__negative regulation of mitochondrial membrane potential (GO:0010917),0.5797692350973638,1.0025663265900129,0.475,0.8113537842357436,1.0,1/6,0.62%,RNF122
prerank,GO_Biological_Process_2021__5S class rRNA transcription by RNA polymerase III (GO:0042791),-0.6577490381493026,-1.0024901581137033,0.5535714285714286,0.8632764703971378,1.0,1/6,3.40%,GTF3C6
prerank,GO_Biological_Process_2021__tRNA transcription by RNA polymerase III (GO:0042797),-0.6577490381493026,-1.0024901581137033,0.5535714285714286,0.8632764703971378,1.0,1/6,3.40%,GTF3C6
prerank,GO_Biological_Process_2021__regulation of cholesterol metabolic process (GO:0090181),0.4955394397271431,1.0023170766764593,0.425531914893617,0.8115093580821623,1.0,5/15,23.19%,ABCA2;ACADVL;ARV1;DGKQ;KPNB1
prerank,Reactome_2022__TYSND1 Cleaves Peroxisomal Proteins R-HSA-9033500,-0.6785724729182684,-1.0022094188147133,0.5294117647058824,0.8635310838189422,1.0,1/6,8.24%,ACAA1
prerank,GO_Biological_Process_2021__regulation of anion channel activity (GO:0010359),-0.6489217206690514,-1.002181041071115,0.4897959183673469,0.8632599746373804,1.0,1/5,4.97%,ABCB1
prerank,GO_Biological_Process_2021__myelin assembly (GO:0032288),0.5701745425453401,1.00206317001759,0.5681818181818182,0.8115851164728699,1.0,2/10,5.32%,ABCA2;TPPP
prerank,GO_Biological_Process_2021__UV protection (GO:0009650),-0.6215325704451325,-1.0020125967073936,0.5306122448979592,0.8632647762183648,1.0,1/5,1.76%,XPA
prerank,Reactome_2022__DNA Replication Initiation R-HSA-68952,-0.6309299585422874,-1.0016378723467692,0.4918032786885246,0.8638393395734222,1.0,1/6,3.35%,POLE3
prerank,CellMarker_Augmented_2021__Morula Cell (Blastomere):Embryo,-0.4465522688400977,-1.0015853333297486,0.4473684210526316,0.8635796061072777,1.0,13/73,9.94%,RBIS;RPS27A;RPL39;UQCRB;UQCRH;GDPD1;RPL11;RPL23;RPL34;OLR1;RPL21;LDHA;CFLAR
prerank,GO_Biological_Process_2021__negative regulation of protein K63-linked ubiquitination (GO:1900045),0.6085766883625569,1.0013618435933622,0.48,0.8128120784654582,1.0,2/6,29.00%,TRIP12;UBR5
prerank,CellMarker_Augmented_2021__Epithelial cell:Endometrium,-0.47276546358657234,-1.0013599210834352,0.4605263157894737,0.8638186857343735,1.0,11/58,13.94%,THEMIS2;CLEC12A;CD300LF;TNFRSF1B;FERMT3;OSCAR;CACNA2D4;CSF2RB;MLKL;CYBA;MYO1F
prerank,GO_Biological_Process_2021__positive regulation of apoptotic signaling pathway (GO:2001235),-0.49235921954300715,-1.0010124826175555,0.4925373134328358,0.8642658519010614,1.0,9/40,16.09%,RACK1;TNFSF10;ING5;RPS3;FIS1;TRAF7;BMF;AGT;DEDD2
prerank,GO_Biological_Process_2021__negative regulation of response to reactive oxygen species (GO:1901032),0.6100350675441499,1.0007477429045044,0.4772727272727273,0.8138969771281981,1.0,1/6,3.81%,LRRK2
prerank,GO_Biological_Process_2021__regulation of myelination (GO:0031641),0.48157908817608663,1.0006808250074595,0.4878048780487805,0.8136226700627457,1.0,6/21,15.71%,LGI4;MYRF;TPPP;RNF10;JAM2;PARD3
prerank,GO_Biological_Process_2021__regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),0.498397357234472,1.0006425494947475,0.46153846153846156,0.8132508235025233,1.0,1/13,1.00%,PKD2
prerank,GO_Biological_Process_2021__protein stabilization (GO:0050821),-0.3946666699936797,-1.0005912335288556,0.47435897435897434,0.8649096938298129,1.0,21/137,12.87%,FLNA;GAPDH;PYHIN1;RPL5;PER3;CDC37;USP36;CLU;RPL11;RPL23;IGF1;IFT46;PHB2;RPS7;HPS4;DVL1;TYROBP;NOP53;PFN1;HSPA1B;ATP1B3
prerank,GO_Biological_Process_2021__heart morphogenesis (GO:0003007),-0.5280212325818803,-1.000589141511752,0.4406779661016949,0.8645607565261241,1.0,4/23,11.19%,TGFBR3;TTN;MYBPC3;VEGFA
prerank,GO_Biological_Process_2021__regulation of proton transport (GO:0010155),-0.6420152341847049,-1.0005568443758062,0.5272727272727272,0.8643384083726916,1.0,2/6,19.58%,PHB2;SLC30A5
prerank,GO_Biological_Process_2021__substantia nigra development (GO:0021762),-0.5071593252168164,-1.0004584416086553,0.4657534246575342,0.8642499194766897,1.0,6/34,14.67%,PADI2;BASP1;CALM1;ACTB;CASP5;INA
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Periosteum,0.38559690448163136,1.0003774136626922,0.4666666666666667,0.8134415791013494,1.0,14/57,11.39%,COL16A1;EPS8;FKBP9;SERPINE1;COL5A2;GLIS3;KITLG;CDH11;ALCAM;PTPRK;RGMB;ITGAV;EXT1;FAM114A1
prerank,GO_Biological_Process_2021__protein oxidation (GO:0018158),0.6560880529278609,1.0002869973447712,0.5365853658536586,0.8131984810100644,1.0,1/5,9.95%,LOXL2
prerank,KEGG_2021_Human__Cell adhesion molecules,-0.4164464746163101,-1.0001671541140935,0.4782608695652174,0.8645809254128737,1.0,23/88,15.55%,HLA-B;CD2;SIGLEC1;CD99L2;SELL;CLDN7;HLA-C;HLA-DRB5;PECAM1;NLGN2;HLA-F;ITGA4;ITGA6;CD226;ITGB2;HLA-DRA;ITGAL;SDC3;PTPRC;HLA-E;HLA-DPA1;LRRC4;HLA-DMB
prerank,CellMarker_Augmented_2021__Intermediate Progenitor cell:Undefined,0.40594209959226407,1.0000745344096995,0.4583333333333333,0.8132425537878066,1.0,7/56,6.27%,KCNQ2;CDK5R1;NCAN;OTUD7A;NOL4;CNR1;RUNDC3A
prerank,GO_Biological_Process_2021__positive regulation of histone ubiquitination (GO:0033184),0.7064008555822123,1.0000059604298595,0.52,0.8130181186617517,1.0,2/5,20.63%,RNF20;CDK9
prerank,Reactome_2022__CD28 Dependent PI3K/Akt Signaling R-HSA-389357,-0.5641237844136914,-0.9999256573109526,0.5081967213114754,0.8647409911019367,1.0,2/16,7.56%,FYN;THEM4
prerank,GO_Biological_Process_2021__regulation of T cell proliferation (GO:0042129),-0.4785706839351949,-0.9998411960397355,0.4264705882352941,0.8645893988312848,1.0,8/39,10.76%,IL4I1;TFRC;CCL5;AIF1;LILRB4;TNFRSF1B;GLMN;NCKAP1L
prerank,Reactome_2022__Impaired BRCA2 Binding To RAD51 R-HSA-9709570,-0.5082053250926,-0.9998038062761387,0.5409836065573771,0.8643155961336769,1.0,7/24,18.09%,HUS1;BRCA2;KAT5;RAD9A;RPA3;BRCA1;WRN
prerank,GO_Biological_Process_2021__platelet-derived growth factor receptor signaling pathway (GO:0048008),-0.5827744115967791,-0.9996126633766262,0.5645161290322581,0.8643681111631017,1.0,2/12,2.35%,NR4A3;PDGFD
prerank,Reactome_2022__Transcriptional Activity Of SMAD2/SMAD3:SMAD4 Heterotrimer R-HSA-2173793,0.4091623277702164,0.9990758417771635,0.4,0.8148002297522232,1.0,9/41,11.38%,UBE2D1;SERPINE1;SMAD7;PARP1;SMAD2;SMAD3;NEDD4L;HDAC1;MAPK1
prerank,GO_Biological_Process_2021__negative regulation of secretion (GO:0051048),0.5833925637827961,0.9989027563382906,0.43902439024390244,0.8147154001964266,1.0,1/5,6.19%,NRG1
prerank,Reactome_2022__Growth Hormone Receptor Signaling R-HSA-982772,-0.5404900533784973,-0.9986527066501797,0.5370370370370371,0.8664763461116857,1.0,4/15,22.16%,PRLR;STAT1;MAPK3;LYN
prerank,GO_Biological_Process_2021__ventricular cardiac muscle tissue development (GO:0003229),-0.5964597460849014,-0.9985572973887807,0.4716981132075472,0.8663428031671899,1.0,2/10,7.44%,TGFBR3;MYBPC3
prerank,"GO_Biological_Process_2021__regulation of synaptic transmission, glutamatergic (GO:0051966)",0.47967943656269685,0.9984929746645376,0.5161290322580645,0.8153251285385102,1.0,17/31,23.83%,NLGN1;LRRK2;RELN;TNF;SHANK3;GRM5;CACNG8;CACNG2;ATAD1;HOMER1;GRM3;GRIK3;CACNG3;GRM1;NRXN1;TSHZ3;CDH2
prerank,GO_Biological_Process_2021__myelin maintenance (GO:0043217),-0.6343287733992241,-0.9982950058452819,0.5,0.8666349891550232,1.0,4/7,13.37%,CXCR4;CLU;EPB41L3;SOD1
prerank,"Reactome_2022__Regulation Of Glycolysis By Fructose 2,6-Bisphosphate Metabolism R-HSA-9634600",-0.5493587372244481,-0.9980868350709986,0.40816326530612246,0.8667863537032565,1.0,2/9,10.14%,PFKFB3;PFKFB4
prerank,GO_Biological_Process_2021__positive regulation of supramolecular fiber organization (GO:1902905),0.37831752422653037,0.9979668135276814,0.4444444444444444,0.816116879327953,1.0,6/60,4.28%,FER;CDK5R1;SEMA5A;CDC42EP3;NCK2;VASP
prerank,GO_Biological_Process_2021__energy reserve metabolic process (GO:0006112),0.564328678198541,0.9977778513570168,0.3902439024390244,0.8161349481590764,1.0,2/11,6.70%,LEPR;GFPT1
prerank,PanglaoDB_Augmented_2021__Adipocytes,0.3796014338402502,0.9976396377468952,0.47058823529411764,0.8160191875992756,1.0,9/72,5.20%,COL5A3;PPARGC1A;SVEP1;GSN;ZBTB16;ACTA2;GULP1;PPARG;TIMP3
prerank,Reactome_2022__Dissolution Of Fibrin Clot R-HSA-75205,0.6046122111927064,0.9975390931840116,0.5405405405405406,0.815830598324163,1.0,2/8,2.96%,SERPINE1;SERPINE2
prerank,"GO_Biological_Process_2021__neurotransmitter receptor transport, endosome to postsynaptic membrane (GO:0098887)",0.6600414414168899,0.9972289880165577,0.5294117647058824,0.8162498011493199,1.0,1/5,0.84%,SCRIB
prerank,Reactome_2022__Mismatch Repair (MMR) Directed By MSH2:MSH6 (MutSalpha) R-HSA-5358565,-0.6102144630533148,-0.997093766148762,0.5087719298245614,0.868860555599998,1.0,3/9,18.99%,RPA3;LRIG1;MSH6
prerank,GO_Biological_Process_2021__regulation of mitotic sister chromatid separation (GO:0010965),0.5669901945859791,0.9969935789416847,0.5,0.8162920542043333,1.0,3/11,14.97%,CDC23;CENPE;ANAPC1
prerank,Reactome_2022__Collagen Chain Trimerization R-HSA-8948216,0.4804255056155346,0.9969904362263285,0.475,0.8158729717181317,1.0,4/20,4.30%,COL5A3;COL16A1;COL5A2;COL24A1
prerank,GO_Biological_Process_2021__negative regulation of nucleocytoplasmic transport (GO:0046823),-0.5810523861297645,-0.996986288125082,0.5,0.8687410403923237,1.0,2/12,4.08%,MDFIC;APOD
prerank,GO_Biological_Process_2021__positive regulation of receptor-mediated endocytosis (GO:0048260),-0.4853327327314143,-0.9967464065403766,0.4626865671641791,0.8688765762390261,1.0,8/30,14.85%,B2M;ANXA2;CLU;CD63;VEGFA;DGKD;PICK1;C3
prerank,GO_Biological_Process_2021__regulation of protein secretion (GO:0050708),0.35678664066502663,0.9966466197006697,0.4722222222222222,0.8162187002329078,1.0,20/73,15.33%,CACNA1A;MYOM1;GOLPH3L;RAP1A;TMED10;UNC13B;TNF;RFX3;CLOCK;KCNC2;CD33;DISP1;STX1A;ARF6;ABCC8;CACNA1E;RAPGEF3;ATP13A2;STXBP5;SLC12A2
prerank,GO_Biological_Process_2021__negative regulation of purine nucleotide metabolic process (GO:1900543),0.6455740625335743,0.9965678931450409,0.5208333333333334,0.8155455433633116,1.0,2/6,8.31%,CBFA2T3;GIT1
prerank,GO_Biological_Process_2021__negative regulation of glycolytic process (GO:0045820),0.6455740625335743,0.9965678931450409,0.5208333333333334,0.8155455433633116,1.0,2/6,8.31%,CBFA2T3;GIT1
prerank,Reactome_2022__Interleukin-1 Signaling R-HSA-9020702,-0.43109693332884463,-0.9965573852203826,0.527027027027027,0.8690341618406994,1.0,14/96,14.82%,UBC;RPS27A;PSMB3;NLRC5;PSMB6;PSMA7;PSMB9;RBX1;ALPK1;PSMD12;PSMD8;PSMA5;NOD2;UBA52
prerank,Reactome_2022__Nef-mediated Downmodulation Of Cell Surface Receptors By Recruitment To Clathrin Adapters R-HSA-164938,-0.5620353368470892,-0.9964516556032025,0.4406779661016949,0.8689221062307164,1.0,6/14,27.39%,B2M;AP2S1;AP2M1;CD4;HLA-A;AP2A1
prerank,GO_Biological_Process_2021__cellular response to osmotic stress (GO:0071470),-0.5534494862598907,-0.9962278971530799,0.55,0.8690869251206803,1.0,3/16,9.02%,MYLK;STK39;TRPV4
prerank,GO_Biological_Process_2021__positive regulation of cell-cell adhesion (GO:0022409),-0.5114303886324996,-0.9959047170615598,0.5454545454545454,0.8695873016348113,1.0,2/26,1.49%,SKAP1;CCL5
prerank,GO_Biological_Process_2021__negative regulation of myotube differentiation (GO:0010832),0.596093637706178,0.9958130785233301,0.52,0.8168842520637564,1.0,4/8,26.65%,TMEM119;HDAC1;HDAC3;NOTCH1
prerank,GO_Biological_Process_2021__regulation of Ras protein signal transduction (GO:0046578),0.4002827316996559,0.9958130178922596,0.3870967741935484,0.8164598966081389,1.0,10/64,16.28%,EPS8;SPRY2;KBTBD6;KANK1;ARF6;SHOC2;SYNGAP1;VAV1;LZTR1;STARD13
prerank,Reactome_2022__ROS And RNS Production In Phagocytes R-HSA-1222556,-0.5127056363832846,-0.9957230532929074,0.5238095238095238,0.869659528310793,1.0,5/23,12.67%,NCF4;ATP6V1F;NCF2;SLC11A1;CYBA
prerank,GO_Biological_Process_2021__transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),-0.4325460396549823,-0.9955960131182814,0.43661971830985913,0.8696063749150267,1.0,4/74,1.30%,UBC;TGFBR3;FOS;RPS27A
prerank,KEGG_2021_Human__Herpes simplex virus 1 infection,-0.39456437856482407,-0.9955952426552818,0.5238095238095238,0.8692511435527248,1.0,74/305,20.76%,OAS3;CYCS;HLA-B;CCL5;B2M;ZNF790;OAS2;EIF2B1;ZNF689;HLA-C;ZNF331;HLA-DRB5;EIF2AK2;ZNF805;PPP1CB;SRPK1;HLA-F;ZNF649;ZNF570;OAS1;RNASEL;ZNF600;ZFP30;ZNF589;STAT1;HLA-DRA;ZNF546;ZNF354A;ZNF528;TAP1;STING1;IFNGR2;ZNF432;ZNF674;SRSF2;SRSF7;ZNF549;ZNF302;ZNF558;PIK3CB;HLA-E;ZNF333;ZFP82;HLA-DPA1;C3;ZNF461;ZNF484;HLA-DMB;CD74;ZNF20;ZNF559-ZNF177;HLA-DPB1;ZNF699;EIF2B2;IRF7;ZNF529;ZNF616;ZFP14;ZNF234;ZNF540;ZNF766;IRAK4;ZNF100;ZNF182;HLA-DRB1;TNFRSF14;ZNF431;ZNF519;ZNF480;ZNF14;TLR2;ZNF490;BST2;ZNF875
prerank,GO_Biological_Process_2021__mitochondrial RNA metabolic process (GO:0000959),0.48903402773238863,0.995572451847095,0.4473684210526316,0.8165018870116236,1.0,2/12,16.21%,TFB1M;FASTKD1
prerank,PanglaoDB_Augmented_2021__Olfactory Epithelial Cells,-0.4123241652679077,-0.9954704955036411,0.5180722891566265,0.8692423951541874,1.0,6/113,7.02%,PKIB;PDE4A;ATF5;SEZ6L2;SCN9A;H2BC21
prerank,GO_Biological_Process_2021__regulation of protein neddylation (GO:2000434),-0.6027802500448299,-0.9954694906264051,0.5490196078431373,0.8688876023398387,1.0,3/9,11.34%,RPL5;RPL11;HIF1A
prerank,Reactome_2022__ADP Signaling Thru P2Y Purinoceptor 12 R-HSA-392170,-0.5396154077751502,-0.9951359120697063,0.5076923076923077,0.8693389965969904,1.0,2/11,15.86%,GNB5;GNB2
prerank,GO_Biological_Process_2021__regulation of protein-containing complex disassembly (GO:0043244),0.5011089546501047,0.9949097763577284,0.4166666666666667,0.8176505404077731,1.0,3/15,10.79%,IGF1R;TNF;IRAK3
prerank,Reactome_2022__Antigen Activates B Cell Receptor Leading To Second Messenger Generation R-HSA-983695,0.4851328032120128,0.9948270168793051,0.5588235294117647,0.8174984476126418,1.0,2/25,1.61%,TRPC1;CD22
prerank,Reactome_2022__PI5P Regulates TP53 Acetylation R-HSA-6811555,-0.589948907844309,-0.9946009982683782,0.5272727272727272,0.8703859229469033,1.0,1/9,4.67%,ING3
prerank,GO_Biological_Process_2021__ERBB signaling pathway (GO:0038127),0.4431677612641681,0.9943041398306571,0.41935483870967744,0.818367493347057,1.0,16/47,21.66%,TGFA;GAB1;NCK2;NRG1;MAPK1;NRG2;PTK2;ERBB4;PTPRR;PIK3CA;ERBIN;PTPN12;GAREM1;PTPN18;CPNE3;CBL
prerank,GO_Biological_Process_2021__DNA strand elongation (GO:0022616),0.5460384490514705,0.9942201545855301,0.5306122448979592,0.8181427285645054,1.0,4/11,18.30%,GINS3;POLA1;GINS1;NBN
prerank,GO_Biological_Process_2021__endomembrane system organization (GO:0010256),0.35916827841800486,0.99418294123388,0.4090909090909091,0.8177914605374768,1.0,14/144,11.11%,SYNGR1;VAPB;EXOC8;GOLPH3L;LRRK2;TOR1AIP2;TMED3;TMED10;TMED5;LEMD3;LMAN2L;COG1;REEP3;BLZF1
prerank,GO_Biological_Process_2021__respiratory chain complex IV assembly (GO:0008535),-0.5684728752575863,-0.9937606796938382,0.5357142857142857,0.8720386837501102,1.0,7/15,18.82%,TIMM21;BCS1L;COX18;COA6;OXA1L;SURF1;COX20
prerank,GO_Biological_Process_2021__positive regulation of histone phosphorylation (GO:0033129),0.6118815738019178,0.9936958827626634,0.5,0.8184720154583538,1.0,1/6,5.00%,RPS6KA4
prerank,GO_Biological_Process_2021__regulation of necroptotic process (GO:0060544),-0.5824726013915251,-0.9934531847757808,0.5333333333333333,0.8724441373345456,1.0,10/18,29.20%,CDC37;CFLAR;MLKL;FLOT1;SDCBP;OGT;ARHGEF2;HSP90AA1;BIRC2;YBX3
prerank,GO_Biological_Process_2021__Golgi inheritance (GO:0048313),0.5394925507626789,0.9934320822011002,0.46153846153846156,0.8185972161453835,1.0,1/9,6.12%,STK25
prerank,GO_Biological_Process_2021__positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),-0.5255277911220959,-0.9933204313305044,0.5166666666666667,0.8720421600348628,1.0,1/18,3.32%,GZMB
prerank,GO_Biological_Process_2021__regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),-0.5255277911220959,-0.9933204313305044,0.5166666666666667,0.8720421600348628,1.0,1/18,3.32%,GZMB
prerank,GO_Biological_Process_2021__neurotransmitter receptor transport to postsynaptic membrane (GO:0098969),0.6355480130207926,0.9931484495369767,0.47619047619047616,0.8187945956157628,1.0,1/7,0.84%,SCRIB
prerank,GO_Biological_Process_2021__regulation of spindle organization (GO:0090224),0.5505502099366546,0.9930758702653095,0.5,0.818522010304045,1.0,1/13,2.24%,BORA
prerank,GO_Biological_Process_2021__negative regulation of protein localization to cell periphery (GO:1904376),-0.5595699694342879,-0.9928923552300286,0.48333333333333334,0.8727150936648149,1.0,1/14,1.81%,PID1
prerank,GO_Biological_Process_2021__response to acidic pH (GO:0010447),0.6038313631309706,0.9928762755661634,0.5777777777777777,0.818586796526259,1.0,2/8,18.72%,SLC9A1;CHP1
prerank,GO_Biological_Process_2021__regulation of neuron apoptotic process (GO:0043523),0.3853043734553975,0.9927431131214252,0.38095238095238093,0.8185552541663321,1.0,13/57,12.90%,PPARGC1A;CDK5R1;GRID2;DDIT3;PPT1;CPEB4;LIG4;TNF;UNC5B;SOD2;NF1;NTRK2;PRKCI
prerank,GO_Biological_Process_2021__IMP metabolic process (GO:0046040),-0.6366106877619648,-0.9925885543584877,0.5,0.8731306205049109,1.0,1/6,8.61%,AMPD2
prerank,KEGG_2021_Human__MAPK signaling pathway,0.34137876073806667,0.9924669421565203,0.47058823529411764,0.8187702876543538,1.0,44/203,15.54%,DUSP6;CACNA1A;PLA2G4C;PDGFA;IGF1R;TGFBR2;TGFA;FGF2;MAPK11;MAP3K11;RAP1A;MAP2K1;RPS6KA4;DDIT3;PDGFC;KITLG;TNF;CRK;NLK;IRAK1;TAB2;PPP3CA;DUSP7;HGF;PTPN5;RPS6KA6;MAPK1;NF1;NTRK2;MAPKAPK2;JUN;CACNA1E;ERBB4;CACNG8;CACNG2;CACNB4;TRAF6;MAP3K13;MAP3K5;LAMTOR3;TGFBR1;NFATC3;AKT2;PPM1A
prerank,GO_Biological_Process_2021__proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),0.3314028684649486,0.9924394986805276,0.4117647058823529,0.8184141351015016,1.0,40/258,13.44%,UBE2D1;SPSB2;RNF122;KBTBD6;UBE2J1;SIRT1;FBXL14;SPOPL;FEM1B;DNAJB2;UBE3D;DDIT3;SEL1L;FZR1;CLOCK;DNAJC18;UBR3;NEDD4L;APPBP2;AUP1;RMND5A;FAM8A1;SHARPIN;CDC23;MDM2;BTRC;FBXO45;KCTD10;TBL1XR1;ANAPC16;FBXW11;FBXW7;FEM1C;RNF185;KLHL42;FBXL12;COP1;FBXL7;STT3B;BAG6
prerank,GO_Biological_Process_2021__liver development (GO:0001889),0.5017352349557063,0.9924074719092058,0.4878048780487805,0.8180703638200418,1.0,7/19,12.89%,ANXA1;PKD2;PRKCSH;PCK2;COBL;NF1;CCDC40
prerank,GO_Biological_Process_2021__cellular response to brain-derived neurotrophic factor stimulus (GO:1990416),0.6685664276766807,0.9923844021393932,0.4583333333333333,0.8177389546735426,1.0,4/5,33.13%,NTRK2;TMEM108;WASF1;MAPT
prerank,GO_Biological_Process_2021__mismatch repair (GO:0006298),0.4766119119893463,0.9921769924765655,0.4444444444444444,0.8177439352991143,1.0,7/19,22.75%,MSH4;TDG;SETD2;MLH3;ERCC1;PMS1;ABL1
prerank,GO_Biological_Process_2021__positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process (GO:1902961),0.6667561289427768,0.9921255050539978,0.5238095238095238,0.8174670152792712,1.0,1/5,3.41%,PICALM
prerank,GO_Biological_Process_2021__regulation of vascular wound healing (GO:0061043),0.6016640727075617,0.9919747232529231,0.45652173913043476,0.8174541465921116,1.0,2/6,7.30%,SERPINE1;TNF
prerank,CellMarker_Augmented_2021__Cardiomyocyte:Pluripotent Stem Cell,-0.42569083901384847,-0.9919413620912265,0.4857142857142857,0.8743637567750567,1.0,15/84,9.28%,CEBPD;MNDA;PID1;MS4A4A;MARCO;SIGLEC1;CD14;CTSB;CD300LF;CCDC149;SIRPB2;EPB41L3;OSCAR;TNFAIP2;CHI3L1
prerank,Reactome_2022__Homologous DNA Pairing And Strand Exchange R-HSA-5693579,-0.48615476094465554,-0.9917394687490622,0.46153846153846156,0.8745619559642492,1.0,7/28,14.26%,HUS1;BRCA2;XRCC3;KAT5;RAD9A;RPA3;BRCA1
prerank,GO_Biological_Process_2021__cellular response to acidic pH (GO:0071468),0.614452910569262,0.991546681265189,0.5531914893617021,0.8179146282969773,1.0,2/5,18.72%,SLC9A1;CHP1
prerank,CellMarker_Augmented_2021__Neuroendocrine cell:Pancreas,0.3840105665966799,0.9913151083531576,0.39285714285714285,0.8180332904935306,1.0,16/62,14.85%,CPT1C;NCAN;ADGRB2;GDF11;PURG;DNAJC18;BRSK1;SCN8A;PSD2;SNCB;NRXN2;SLC35F1;CAMKV;PTPRN;CNTNAP1;LRRC4B
prerank,CellMarker_Augmented_2021__Purkinje cell:Brain,0.3950423562388037,0.9912750644863284,0.35,0.8177208780446678,1.0,17/83,13.42%,PCBP4;SCRIB;MTCL1;DLG5;PKD1;ADGRB2;MAST2;AHDC1;ANO8;MAP3K10;SPTAN1;GOLGA3;CSNK1E;ANKRD52;PLXNA1;MEGF8;SBF1
prerank,CellMarker_Augmented_2021__Stem cell:Dental Pulp,-0.5787841567792201,-0.9911328154334423,0.4461538461538462,0.8756249210288374,1.0,4/8,18.52%,CD44;PTPRC;VIM;ITGB1
prerank,Reactome_2022__Signaling By FGFR In Disease R-HSA-1226099,0.4172327167259426,0.9910853693173797,0.42857142857142855,0.8176779935507806,1.0,2/43,1.00%,POLR2D;PIGU
prerank,GO_Biological_Process_2021__response to amino acid (GO:0043200),0.48931245158842646,0.9910460689858632,0.4642857142857143,0.8173421667350887,1.0,3/25,6.73%,RRAGD;GLRA1;CPEB4
prerank,"GO_Biological_Process_2021__Wnt signaling pathway, calcium modulating pathway (GO:0007223)",0.48462639436197896,0.9907560439538687,0.41379310344827586,0.8174907603245979,1.0,9/28,18.04%,WNT5A;FZD3;NLK;PPP3CA;TCF7L2;MAP3K7;PPP3CB;PLCB3;TNRC6C
prerank,Reactome_2022__Post-transcriptional Silencing By Small RNAs R-HSA-426496,0.6178933206886003,0.9906593190026881,0.5,0.8172449714880563,1.0,4/7,32.64%,TNRC6C;AGO1;TNRC6A;TNRC6B
prerank,Reactome_2022__Signaling By B Cell Receptor (BCR) R-HSA-983705,-0.42497564979074576,-0.9901432073080687,0.5,0.8777750690543535,1.0,14/92,14.82%,UBC;RPS27A;PSMB3;BTK;PSMB6;PSMA7;FYN;CALM1;PSMB9;PSMD12;PSMD8;PSMA5;REL;UBA52
prerank,GO_Biological_Process_2021__negative regulation of centrosome duplication (GO:0010826),-0.577143138808616,-0.9901101292664661,0.5,0.8774955858783924,1.0,5/9,24.71%,TMEM67;NPM1;BRCA1;CENATAC;MDM1
prerank,GO_Biological_Process_2021__negative regulation of natural killer cell mediated immunity (GO:0002716),-0.6219942631480426,-0.989376410319079,0.5740740740740741,0.879006305499879,1.0,3/6,14.31%,HLA-F;KLRD1;HLA-E
prerank,GO_Biological_Process_2021__carbohydrate catabolic process (GO:0016052),-0.5044490422468031,-0.9893519913872183,0.4918032786885246,0.8787082546101097,1.0,5/25,13.22%,GAPDH;HK2;LDHA;ENOSF1;PGK1
prerank,Reactome_2022__NS1 Mediated Effects On Host Pathways R-HSA-168276,0.4189931711737214,0.989229358094101,0.3333333333333333,0.8200919583580012,1.0,10/37,18.74%,CPSF4;NUP153;NUP188;NUP42;KPNA4;KPNA5;NDC1;NUP133;NUP205;KPNA3
prerank,GO_Biological_Process_2021__glycosphingolipid biosynthetic process (GO:0006688),0.528497598916251,0.9890314648570839,0.4782608695652174,0.8201732779792226,1.0,5/10,17.01%,LARGE1;ST6GALNAC3;ST6GALNAC5;ST8SIA4;ST8SIA5
prerank,GO_Biological_Process_2021__regulation of nervous system development (GO:0051960),-0.5224175712494039,-0.9888982295837219,0.5211267605633803,0.8794894120025533,1.0,6/22,10.30%,PER2;BHLHE40;TNFRSF1B;TYMP;PRUNE1;PTN
prerank,GO_Biological_Process_2021__endocardial cushion development (GO:0003197),0.6037500013049089,0.9888237509984746,0.5116279069767442,0.8202783704169988,1.0,3/7,26.65%,BMPR1A;ACVR1;NOTCH1
prerank,CellMarker_Augmented_2021__CD14+ Endothelial Progenitor cell:Blood,-0.43833136761884617,-0.9886992097293911,0.4520547945205479,0.8796995952476855,1.0,22/59,18.75%,PID1;MS4A4A;MARCO;SIGLEC1;CD14;CD93;F13A1;PECAM1;MS4A6A;TYROBP;SPARCL1;A2M;FLT1;RASSF4;SERPING1;C3;TMIGD3;ALDH2;FCGR3A;GIMAP4;FOLR2;MAF
prerank,Reactome_2022__Signaling By FGFR3 R-HSA-5654741,-0.4945466814409824,-0.988493558733943,0.4642857142857143,0.8798328626203897,1.0,3/28,6.76%,UBC;RPS27A;FGF13
prerank,GO_Biological_Process_2021__ribosomal small subunit export from nucleus (GO:0000056),-0.6140949818672732,-0.9884371845954406,0.625,0.8796372457748981,1.0,3/6,17.60%,RPS15;NPM1;NUP88
prerank,GO_Biological_Process_2021__regulation of intracellular transport (GO:0032386),-0.5062499869800696,-0.9880422839828701,0.5223880597014925,0.8801830602241801,1.0,1/27,0.35%,MX2
prerank,GO_Biological_Process_2021__sensory organ morphogenesis (GO:0090596),-0.6421264859729809,-0.9880203278129163,0.55,0.8798670062612304,1.0,1/6,0.65%,COL5A1
prerank,GO_Biological_Process_2021__negative regulation of anoikis (GO:2000811),0.5684029041854227,0.9878942967417382,0.5142857142857142,0.8218020642978277,1.0,4/11,17.35%,PDK4;PTK2;TLE1;PIK3CA
prerank,GO_Biological_Process_2021__activation of GTPase activity (GO:0090630),0.3753972189260842,0.9875579272666503,0.46153846153846156,0.8222041122896372,1.0,14/72,12.53%,SCRIB;RAP1GAP;SGSM1;TBC1D1;ARHGEF26;TBC1D5;TBC1D10B;TBC1D16;SGSM2;TBC1D12;TBC1D22B;CCDC125;ARHGAP42;RABGAP1
prerank,GO_Biological_Process_2021__protein-containing complex disassembly (GO:0032984),-0.46034978572733914,-0.987459290377387,0.4782608695652174,0.8809559329738728,1.0,5/36,12.28%,GABARAPL1;RPL23;GABARAPL2;DVL1;FZD2
prerank,GO_Biological_Process_2021__negative regulation of membrane potential (GO:0045837),0.5705540708269475,0.9873666270152024,0.475,0.8223020510266872,1.0,1/7,0.62%,RNF122
prerank,GO_Biological_Process_2021__negative regulation of multicellular organismal process (GO:0051241),0.3479082137043642,0.9873219916177536,0.4444444444444444,0.822042779999011,1.0,26/116,11.81%,HS3ST5;LRP4;SPRY2;SMAD7;ZNF706;SPRED1;HDAC9;PLCL1;SPRED2;PTPN23;ARRDC3;RPS6KA4;USF3;DDIT3;HPN;TNF;ROBO1;NPTN;SFMBT1;NFIB;LOXL2;PTPRG;KLF7;PTCH1;RPS6KA6;PTEN
prerank,GO_Biological_Process_2021__negative regulation of stress-activated protein kinase signaling cascade (GO:0070303),0.6160347226518087,0.9872132808943151,0.5306122448979592,0.8218313639930993,1.0,1/5,1.26%,QARS1
prerank,Reactome_2022__Nuclear Envelope (NE) Reassembly R-HSA-2995410,-0.4533030221533157,-0.9871911090279671,0.44594594594594594,0.8813546656253003,1.0,2/59,4.25%,TUBB8;EMD
prerank,GO_Biological_Process_2021__skeletal system development (GO:0001501),0.3845813783258914,0.9871285682920266,0.48,0.821643946739638,1.0,18/72,15.21%,RAB33B;NCAN;ZBTB16;PKD1;WNT5A;GDF11;HAPLN2;BMP1;SOX4;CDH11;MMP16;SOX5;BMPR1B;EXT1;ANKH;MMP14;ANKRD11;TGFBR1
prerank,GO_Biological_Process_2021__ATP transport (GO:0015867),-0.6402449580349973,-0.9870077466700313,0.5714285714285714,0.8814322555089408,1.0,3/8,18.29%,SLC25A5;CD47;SLC17A9
prerank,GO_Biological_Process_2021__cellular amino acid catabolic process (GO:0009063),-0.46238116266758444,-0.9867952402735573,0.47761194029850745,0.881600888035995,1.0,4/50,6.60%,IL4I1;GLUL;KMO;CRYM
prerank,KEGG_2021_Human__Propanoate metabolism,0.4508308706638646,0.9867734682989107,0.4358974358974359,0.8220688211467405,1.0,8/29,21.81%,ACADS;ACACB;ACOX3;DBT;ECHDC1;ACACA;SUCLG1;SUCLG2
prerank,PanglaoDB_Augmented_2021__Hematopoietic Stem Cells,-0.4232926551667035,-0.9864011568719302,0.46835443037974683,0.8822975819216128,1.0,24/114,11.39%,CD36;PROCR;CXCR4;MNDA;CLEC12A;MS4A4A;AIF1;SIGLEC1;CD14;FCER1G;CD93;ABCB1;IL3RA;F13A1;CD300LF;PECAM1;ITGA4;ITGA6;CD44;MEIS1;MS4A6A;CSF2RB;TYROBP;CSF3R
prerank,GO_Biological_Process_2021__nucleotide biosynthetic process (GO:0009165),-0.5480441165961611,-0.9863801876843625,0.4915254237288136,0.8819741573265689,1.0,2/15,3.80%,ME1;MTHFD1
prerank,KEGG_2021_Human__Insulin resistance,0.3360546387944731,0.9862361080958397,0.4,0.82290310137409,1.0,17/80,17.35%,PRKAB2;PPARGC1A;CPT1A;GFPT1;TNF;ACACB;GYS1;PCK2;RPS6KA6;PTEN;PRKAB1;PTPA;AKT2;GSK3B;RPS6KB2;PRKAA1;PIK3CA
prerank,CellMarker_Augmented_2021__Astrocyte:Undefined,0.6648375433415252,0.9861936789602389,0.5652173913043478,0.8225432611833629,1.0,3/5,6.03%,GFAP;SLC1A3;SLC1A2
prerank,Reactome_2022__Aspirin ADME R-HSA-9749641,-0.6407996451611904,-0.9860163195548048,0.5272727272727272,0.8825281860048743,1.0,2/6,14.80%,ABCC3;ACSM5
prerank,GO_Biological_Process_2021__organic cation transport (GO:0015695),0.5620940941184057,0.9858990530387193,0.5333333333333333,0.8229195595297493,1.0,3/9,18.82%,SLC44A2;SLC44A1;SLC25A26
prerank,GO_Biological_Process_2021__organelle disassembly (GO:1903008),-0.4871079888807667,-0.9857614540025307,0.4915254237288136,0.8828234460230537,1.0,5/29,11.42%,DDRGK1;EIF2D;ATG2A;MTIF3;STING1
prerank,Reactome_2022__RNA Polymerase II Transcribes snRNA Genes R-HSA-6807505,0.38642870671289703,0.9857384440485585,0.4074074074074074,0.8228388166494627,1.0,6/63,6.76%,POLR2D;INTS6;POU2F1;SSU72;PCF11;CDK7
prerank,Reactome_2022__Beta-catenin Independent WNT Signaling R-HSA-3858494,-0.42100954701975013,-0.9857086479337686,0.5,0.8825911222876472,1.0,18/105,15.86%,UBC;RPS27A;PSMB3;RORA;GNB5;PSMB6;PSMA7;CALM1;PSMB9;FZD2;PSMD12;PFN1;PSMD8;PSMA5;CLTB;UBA52;AP2S1;GNB2
prerank,GO_Biological_Process_2021__cardiac atrium morphogenesis (GO:0003209),-0.6226930293458183,-0.9854896001379402,0.5384615384615384,0.8828279525119784,1.0,2/7,17.77%,NOTCH2;ZFPM1
prerank,Reactome_2022__mRNA Splicing - Major Pathway R-HSA-72163,-0.4083444094859922,-0.9854694052279064,0.46153846153846156,0.8825122336422214,1.0,36/157,19.10%,PPIE;DHX16;DHX38;CSTF2T;SNRNP27;SNRPD2;RBM22;POLR2G;EIF4A3;LSM7;CRNKL1;U2AF2;NCBP2;SMNDC1;PRPF3;BUD31;GCFC2;DDX23;SRSF2;DDX5;SRSF7;CWC25;SNRPA1;COLEC12;CCAR1;PPWD1;EFTUD2;SLU7;SNRPA;LSM4;SNRNP200;GTF2F1;HNRNPH2;BCAS2;SF3A1;PRPF4
prerank,Reactome_2022__Transport Of Mature Transcript To Cytoplasm R-HSA-72202,0.37759474277450067,0.9853856520400065,0.42857142857142855,0.8233034960021087,1.0,8/68,7.20%,NXF1;U2AF1;CPSF4;FYTTD1;NUP153;NUP188;WDR33;NUP42
prerank,GO_Biological_Process_2021__regulation of muscle system process (GO:0090257),-0.6530748721971071,-0.9851284141102782,0.6181818181818182,0.882919631077976,1.0,2/5,20.20%,SRI;TPM1
prerank,GO_Biological_Process_2021__melanosome assembly (GO:1903232),-0.6655588770034641,-0.9850797267985995,0.5510204081632653,0.8827239528332187,1.0,2/5,14.35%,HPS4;TRAPPC6A
prerank,CellMarker_Augmented_2021__Meiotic Prophase Fetal Germ cell:Fetal Gonad,-0.36559801271109493,-0.9850790063239829,0.48484848484848486,0.8823723614754947,1.0,80/745,15.00%,TC2N;H1-4;H4C3;SKAP1;USP6;SYCE2;APIP;HLA-B;CD55;WARS1;RAVER2;SLC9B1;SNAPC1;ZNF185;B2M;C5ORF58;LMLN;DNAJB9;CCDC150;UVSSA;RANBP6;SHOC1;GATM;POMT1;ARIH2;MOV10L1;ZRANB2;DHX40;DDHD2;HESX1;FBXO25;ANKRD12;GOLGA1;SLC35G2;VPS35;MSL3;CCDC136;NFS1;ZDHHC4;ZNF76;CYSTM1;CENPU;BTAF1;FEZ1;ITGB3BP;ORMDL1;IHO1;SMDT1;AK9;C11ORF65;CCDC15;TRIM23;SCRN3;IFT81;SCML1;RBM44;MXI1;SMIM14;RBM4B;ADGRG6;TERF2IP;DNAH12;ATF1;EMC2;TMCO1;FSIP2;CCDC18;TMEM70;PAPOLG;NOTCH2;ZNF681;FRA10AC1;REL;DZIP3;C19ORF38;ZCWPW1;RASA2;FAM169A;PAXBP1;SNX9
prerank,CellMarker_Augmented_2021__Lake Et al.Science.In6:Brain,0.4453524650128936,0.9848058562620985,0.4642857142857143,0.8241705754202022,1.0,8/60,3.75%,WDR13;GSN;AATK;FAM20C;PLXNA2;PDK4;RNF208;NDRG2
prerank,GO_Biological_Process_2021__response to epinephrine (GO:0071871),0.5535820019060772,0.9847165608284754,0.5,0.8235642536306484,1.0,4/8,28.58%,SLC9A1;SNCA;RYR2;SIRT2
prerank,GO_Biological_Process_2021__cellular response to epinephrine stimulus (GO:0071872),0.5535820019060772,0.9847165608284754,0.5,0.8235642536306484,1.0,4/8,28.58%,SLC9A1;SNCA;RYR2;SIRT2
prerank,GO_Biological_Process_2021__female gamete generation (GO:0007292),-0.5425450353980912,-0.9846467884022229,0.5185185185185185,0.8830224054982966,1.0,3/13,10.30%,MEI4;IHO1;PTN
prerank,GO_Biological_Process_2021__negative regulation of alpha-beta T cell proliferation (GO:0046642),0.5799604158399867,0.9844723723044259,0.4473684210526316,0.8237495892537604,1.0,4/6,23.17%,LGALS9;TWSG1;CD274;ZBTB7B
prerank,GO_Biological_Process_2021__cellular response to amyloid-beta (GO:1904646),-0.4802959673858924,-0.9842815828485065,0.5,0.8835341148263599,1.0,5/27,8.15%,CD36;SNX6;IGF1;FYN;ITGA4
prerank,GO_Biological_Process_2021__negative regulation of fatty acid oxidation (GO:0046322),0.6649246237083204,0.9842054959443456,0.5714285714285714,0.8240293379767792,1.0,3/5,25.41%,ACADVL;MFSD2A;SIRT4
prerank,Reactome_2022__Signaling By FGFR4 R-HSA-5654743,-0.5073057221950332,-0.984173909665132,0.47368421052631576,0.8834798859207865,1.0,3/26,6.76%,UBC;RPS27A;FGF13
prerank,KEGG_2021_Human__Ferroptosis,-0.48511291133017664,-0.9839977446783048,0.5076923076923077,0.8834691851809323,1.0,3/35,1.44%,SAT1;FTH1;TFRC
prerank,KEGG_2021_Human__alpha-Linolenic acid metabolism,0.5527089173142421,0.9836391138401128,0.55,0.8249529465875258,1.0,2/10,9.12%,PLA2G4C;ACOX3
prerank,GO_Biological_Process_2021__regulation of neuron death (GO:1901214),0.41185871000830954,0.9832093931476398,0.4230769230769231,0.8254975978835881,1.0,6/66,4.48%,EGR1;PPARGC1A;GRID2;PICALM;LRRK2;WNT5A
prerank,GO_Biological_Process_2021__negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),-0.5088675357003124,-0.9830204061236862,0.46774193548387094,0.8855811377463954,1.0,4/31,7.11%,EPN1;SNX6;CBLB;RNF126
prerank,Reactome_2022__Mitochondrial Fatty Acid Beta-Oxidation Of Unsaturated Fatty Acids R-HSA-77288,0.637804406266312,0.9828018408082999,0.5319148936170213,0.8261420583332818,1.0,1/5,13.81%,ECI1
prerank,GO_Biological_Process_2021__adenine nucleotide transport (GO:0051503),-0.5920256173198092,-0.9826602513572235,0.5166666666666667,0.8860077196421023,1.0,2/11,18.29%,SLC25A5;SLC17A9
prerank,KEGG_2021_Human__Choline metabolism in cancer,0.3971668402437173,0.9825936181309949,0.4642857142857143,0.826219408773925,1.0,15/73,13.64%,PLA2G4C;PDGFA;MAP2K1;TSC2;PIP5K1B;PLPP1;WASF2;PDGFC;CHKA;SLC44A2;MAPK1;SLC44A5;SLC44A1;CHPT1;JUN
prerank,GO_Biological_Process_2021__negative regulation of tumor necrosis factor production (GO:0032720),-0.5075948239223176,-0.9825573539801304,0.5344827586206896,0.8859019142142035,1.0,7/23,13.66%,NLRC3;IGF1;GSTP1;TNFAIP3;SELENOS;C5AR2;HAVCR2
prerank,GO_Biological_Process_2021__positive regulation of activated T cell proliferation (GO:0042104),-0.6495913004516689,-0.9825233137166419,0.55,0.8856225343876682,1.0,2/8,5.56%,RPS3;IGF1
prerank,GO_Biological_Process_2021__protein insertion into membrane (GO:0051205),-0.5524083040298562,-0.982513561310261,0.5666666666666667,0.8852891318371247,1.0,6/22,17.24%,EMD;CYB5A;COX18;MAIP1;OXA1L;SERP1
prerank,GO_Biological_Process_2021__regulation of T cell mediated immunity (GO:0002709),0.5210152277326063,0.9822081019816585,0.44642857142857145,0.8268215683649782,1.0,1/7,1.16%,ZBTB1
prerank,"Reactome_2022__Glutamate Binding, Activation Of AMPA Receptors And Synaptic Plasticity R-HSA-399721",0.45996042621493494,0.9819540750696524,0.47058823529411764,0.8270635464478174,1.0,7/25,14.74%,GRIA3;GRIA4;GRIA1;MDM2;GRIA2;CACNG8;CACNG2
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Gall Bladder,0.47426087090799146,0.9819261572994149,0.5483870967741935,0.8267220066614787,1.0,6/27,12.30%,GRID2;FRAS1;PLEKHA5;FAM124A;PREX2;BMPR1A
prerank,GO_Biological_Process_2021__epiboly involved in wound healing (GO:0090505),-0.5365360409594001,-0.9818690560417639,0.532258064516129,0.8865140622148848,1.0,1/13,0.28%,FLNA
prerank,Reactome_2022__APC Truncation Mutants Have Impaired AXIN Binding R-HSA-5467337,0.5696267139587551,0.9818485001876741,0.55,0.8265103628099154,1.0,4/11,23.58%,PPP2R1B;PPP2R5E;GSK3B;PPP2CB
prerank,GO_Biological_Process_2021__negative regulation of leukocyte degranulation (GO:0043301),-0.5893105749715559,-0.9818477171305412,0.5357142857142857,0.8862167051636043,1.0,2/8,10.76%,HLA-F;NCKAP1L
prerank,KEGG_2021_Human__Pertussis,-0.45481489243540446,-0.9815985102642556,0.4857142857142857,0.886439729559689,1.0,15/51,22.77%,FOS;CD14;CFL1;CALM1;IRF1;ITGB2;SERPING1;C3;IRAK4;ITGB1;MAPK3;C1QB;C1QC;IRF3;ITGA5
prerank,GO_Biological_Process_2021__epidermis development (GO:0008544),0.49020805998574984,0.9815085695905612,0.4722222222222222,0.826916930958836,1.0,3/16,9.84%,SVEP1;EDA2R;HDAC1
prerank,GO_Biological_Process_2021__membrane raft organization (GO:0031579),0.5396002048195718,0.9815016931743247,0.5526315789473685,0.8264995069654192,1.0,4/13,6.24%,YJEFN3;FA2H;PPT1;MYADM
prerank,GO_Biological_Process_2021__endothelial cell differentiation (GO:0045446),-0.6569707260039751,-0.9814827155345199,0.543859649122807,0.8863303946657216,1.0,2/6,10.85%,EDF1;KDM6B
prerank,GO_Biological_Process_2021__positive regulation of protein secretion (GO:0050714),0.426317034901674,0.9813707491701796,0.5,0.8263588528210318,1.0,10/45,12.17%,MYOM1;MCU;GOLPH3L;PTPN23;TMED10;UNC13B;SOX4;CD33;TCF7L2;ARF6
prerank,"Reactome_2022__Tristetraprolin (TTP, ZFP36) Binds And Destabilizes mRNA R-HSA-450513",-0.5479720126010013,-0.9813276938071102,0.5161290322580645,0.8863871711757829,1.0,2/14,9.90%,ZFP36;EXOSC1
prerank,CellMarker_Augmented_2021__Spermatogonial Stem cell:Testis,0.5848036667282348,0.9812544741412217,0.5319148936170213,0.8261889565711482,1.0,2/5,23.98%,ETV5;FGFR3
prerank,Reactome_2022__WNT Ligand Biogenesis And Trafficking R-HSA-3238698,0.5419480812842213,0.9811189383748898,0.45652173913043476,0.8260486007426295,1.0,3/9,7.17%,WNT5A;WNT2B;TMED5
prerank,GO_Biological_Process_2021__embryonic organ development (GO:0048568),0.46424568506917135,0.9810631111500526,0.5714285714285714,0.8257616145333629,1.0,9/30,13.16%,PDGFA;TGFBR2;PBX1;KITLG;SALL1;TNF;COBL;BMPR1A;RARB
prerank,Reactome_2022__NR1H2 And NR1H3 Regulate Gene Expression To Limit Cholesterol Uptake R-HSA-9031525,-0.6696140401871532,-0.9810286171578235,0.5740740740740741,0.8868118949632936,1.0,1/5,5.38%,NR1H2
prerank,Reactome_2022__FRS-mediated FGFR2 Signaling R-HSA-5654700,-0.5560572723189787,-0.9809012104017706,0.5423728813559322,0.8867746689925776,1.0,2/10,14.45%,FGF13;FGF20
prerank,GO_Biological_Process_2021__negative regulation of cell cycle process (GO:0010948),0.3916288406038002,0.9808976192936969,0.38461538461538464,0.8256568227219041,1.0,8/43,16.85%,RNF2;RYBP;PPP1R10;NME6;ZFYVE19;APAF1;PHC1;YAF2
prerank,GO_Biological_Process_2021__cellular zinc ion homeostasis (GO:0006882),-0.5568344187292841,-0.980855403359781,0.5272727272727272,0.8865211795201118,1.0,1/14,0.25%,MT2A
prerank,KEGG_2021_Human__Basal cell carcinoma,0.4628876967598708,0.9808321382802115,0.5454545454545454,0.8253644575844753,1.0,8/27,11.06%,TCF7L1;PTCH2;WNT5A;FZD3;WNT2B;DVL3;PTCH1;TCF7L2
prerank,GO_Biological_Process_2021__late nucleophagy (GO:0044805),-0.6017501523163835,-0.9805214559689552,0.543859649122807,0.8869453407108557,1.0,1/5,7.60%,ATG2A
prerank,Reactome_2022__Glutamate And Glutamine Metabolism R-HSA-8964539,-0.6204463962830091,-0.9803033606776992,0.5370370370370371,0.8870485843722576,1.0,3/6,24.26%,GLUL;GOT2;OAT
prerank,GO_Biological_Process_2021__determination of bilateral symmetry (GO:0009855),-0.5622264770212154,-0.98028801011898,0.5192307692307693,0.8867412805763216,1.0,2/11,2.84%,DNAH11;STIL
prerank,GO_Biological_Process_2021__negative regulation of protein catabolic process (GO:0042177),-0.49575168556171445,-0.9799493179474068,0.49122807017543857,0.887247626236264,1.0,1/27,0.28%,FLNA
prerank,GO_Biological_Process_2021__regulation of vasculature development (GO:1901342),-0.5641377104922785,-0.9797893151782603,0.5217391304347826,0.8873074533985938,1.0,2/14,4.35%,WARS1;ETS1
prerank,GO_Biological_Process_2021__mRNA pseudouridine synthesis (GO:1990481),0.5978668718757656,0.9795915751110708,0.5769230769230769,0.8280209788259187,1.0,3/5,19.27%,TRUB1;PUS1;PUS7
prerank,GO_Biological_Process_2021__dendritic spine maintenance (GO:0097062),0.5611022302911606,0.9795589601744935,0.5476190476190477,0.8277042827942618,1.0,1/7,1.37%,IGF1R
prerank,GO_Biological_Process_2021__T cell proliferation (GO:0042098),-0.6072235769481247,-0.9790976114303364,0.5555555555555556,0.888507248385239,1.0,1/11,0.38%,BTN3A1
prerank,GO_Biological_Process_2021__regulation of cell migration (GO:0030334),0.32596947513606467,0.9789541697493009,0.5217391304347826,0.828769949595123,1.0,61/252,14.68%,ANXA1;PLXNB1;PDPN;PDGFA;FER;IGF1R;SRCIN1;SEMA5A;SERPINE1;SRGAP2B;SPRY2;AMOT;PLXNA2;FGF2;DLG5;SMAD7;MITF;SERPINE2;DAG1;PLXNA3;SEMA3B;CIB1;TBCCD1;MYADM;DACH1;TMEFF2;PDGFC;JAG1;PLXNB2;RECK;VCL;ROBO1;PLXNC1;KANK1;DOCK10;CTNNA2;PPP3CA;TWIST2;SASH1;HGF;PTPRK;RNF20;RIPOR1;PTEN;SORL1;SOD2;NF1;ELP3;GTPBP4;AFDN;TJP1;PLXNA1;ZNF703;MGAT5;GPNMB;PTK2;MMP14;ERBB4;FERMT2;FRMD5;SRGAP2
prerank,Reactome_2022__Signaling By High-Kinase Activity BRAF Mutants R-HSA-6802948,0.45706712377974906,0.9789245547653412,0.48717948717948717,0.8284239296145991,1.0,6/25,18.60%,RAP1A;MAP2K1;VCL;MAPK1;MAP2K2;KSR1
prerank,GO_Biological_Process_2021__regulation of ERBB signaling pathway (GO:1901184),0.5044020893936345,0.978650072607455,0.5135135135135135,0.8286281797272181,1.0,1/11,1.04%,FER
prerank,Reactome_2022__Competing Endogenous RNAs (ceRNAs) Regulate PTEN Translation R-HSA-8948700,0.5664176495204518,0.9785677970332164,0.5428571428571428,0.8284053715402115,1.0,5/10,32.64%,TNRC6C;AGO1;TNRC6A;MOV10;TNRC6B
prerank,GO_Biological_Process_2021__regulation of membrane tubulation (GO:1903525),-0.6280775549648215,-0.978563036936986,0.6122448979591837,0.889382552263892,1.0,1/6,5.64%,ATP10A
prerank,GO_Biological_Process_2021__leukocyte adhesion to vascular endothelial cell (GO:0061756),-0.5515526790404063,-0.9785107765878809,0.5081967213114754,0.8891611723103527,1.0,3/13,8.15%,GCNT1;SELL;ITGA4
prerank,Reactome_2022__Signaling By Rho GTPases R-HSA-194315,-0.36636885295701227,-0.9784760973065828,0.5222222222222223,0.8888753132807128,1.0,45/489,10.91%,FLNA;PLEKHG5;MYLK;H2BC4;H2BC26;H2AC20;ARHGAP4;TFRC;H2AC6;RASGRF2;VAV3;MPP7;RPS27;CDC37;PLEKHG1;BTK;GMIP;DDRGK1;EMD;NCF4;ARHGEF1;JUP;PDE5A;BASP1;H3-3B;H2AJ;RHOU;EFHD2;ARHGEF3;OBSCN;ACBD5;H2BC21;PPP1CB;ACTG1;CENPU;H2BC5;CALM1;H2BC9;ITGB3BP;NCF2;ZWILCH;BAIAP2L2;CFTR;NCKAP1L;EPSTI1
prerank,CellMarker_Augmented_2021__Leydig cell:Testis,-0.4619885933561557,-0.9784681687053278,0.49295774647887325,0.8885358237911724,1.0,14/39,23.10%,TMEM266;RBM28;ZKSCAN3;PDCD6IPP2;ZNF445;ATAD5;SCG3;PLCXD1;ZNF431;HIC2;ZNF519;ZRANB3;WDR12;BCAT1
prerank,GO_Biological_Process_2021__regulation of NIK/NF-kappaB signaling (GO:1901222),-0.44288624334424664,-0.9784669544151976,0.5352112676056338,0.8881858371636743,1.0,14/54,20.43%,NLRC3;CD14;RPS3;PHB2;EIF2AK2;NLRP12;TMSB4X;TERF2IP;NOD2;IFI35;EZR;PTPN22;TLR2;ILK
prerank,GO_Biological_Process_2021__maintenance of protein localization in organelle (GO:0072595),-0.5427576172794346,-0.9781523477523684,0.49122807017543857,0.8885536650751534,1.0,2/17,7.80%,CHCHD10;HK2
prerank,Reactome_2022__Netrin-1 Signaling R-HSA-373752,0.41468370566470414,0.9781500171515785,0.5483870967741935,0.8289425553828286,1.0,8/41,13.77%,TRPC1;MAPK11;NEO1;ROBO1;UNC5B;RGMB;DCC;PTK2
prerank,GO_Biological_Process_2021__chemical synaptic transmission (GO:0007268),0.34812785394671747,0.9781256756297141,0.47368421052631576,0.8286205084333448,1.0,39/166,15.11%,CACNA1A;KCNQ2;GRID2;DOC2A;SLC1A3;KCNIP2;NLGN1;TSPOAP1;GRID1;GRIK2;GLRA1;LIN7A;SLC1A2;UNC13B;PDE7B;GABRR2;DTNA;GRIA3;SLC12A6;GRIA4;BRSK1;GRIA1;KCNMB4;GRM5;SNCB;STX1A;PPFIA3;NRXN2;MAPK1;PTEN;GRIN2B;NPTX1;SLC12A5;CACNA1E;GRIA2;STXBP2;GAD1;CACNB4;NLGN4Y
prerank,GO_Biological_Process_2021__mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),0.3668194006386568,0.977728154501044,0.38095238095238093,0.8290753069882134,1.0,8/81,7.20%,NXF1;U2AF1;CPSF4;FYTTD1;NUP153;NUP188;WDR33;NUP42
prerank,GO_Biological_Process_2021__regulation of cytokine production involved in immune response (GO:0002718),-0.5813788871340371,-0.9776506309329307,0.5081967213114754,0.8893551372171321,1.0,5/12,14.09%,SLC7A5;BTK;TNFRSF1B;TRPM4;NOD2
prerank,Reactome_2022__G0 And Early G1 R-HSA-1538133,0.5237081897711446,0.9776463480430091,0.5116279069767442,0.8287943652501354,1.0,3/13,10.33%,HDAC1;DYRK1A;LIN52
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell apoptotic process (GO:1904037),0.5415465166535466,0.9774224437889231,0.5490196078431373,0.828840334424242,1.0,3/10,12.90%,GSN;ANO6;PRKCI
prerank,Reactome_2022__PIWI-interacting RNA (piRNA) Biogenesis R-HSA-5601884,-0.5522617267730836,-0.9774135874125608,0.5166666666666667,0.8895465513879829,1.0,4/17,10.44%,MYBL1;MOV10L1;POLR2G;TDRKH
prerank,GO_Biological_Process_2021__regulation of lysosomal lumen pH (GO:0035751),0.6117745624712145,0.9773901907802922,0.5490196078431373,0.8284898342507803,1.0,2/7,6.14%,LRRK2;PPT1
prerank,Reactome_2022__Activation Of GABAB Receptors R-HSA-991365,0.44546898339852115,0.9772256237421005,0.5925925925925926,0.8284485071159801,1.0,3/23,6.41%,KCNJ2;KCNJ5;ADCY9
prerank,CellMarker_Augmented_2021__Endothelial cell:Blood Vessel,-0.46157921874146574,-0.9771496508636972,0.43283582089552236,0.8899384841084658,1.0,12/37,12.34%,CD36;PROCR;PLXDC1;SELL;CD93;PECAM1;TNFRSF1B;ITGA4;TYMP;ITGB2;VEGFA;FLT1
prerank,GO_Biological_Process_2021__regulation of cellular protein catabolic process (GO:1903362),0.5291636577086076,0.9771160509613536,0.5227272727272727,0.8282790948631992,1.0,2/15,1.49%,ATRAID;MSN
prerank,GO_Biological_Process_2021__aspartate family amino acid metabolic process (GO:0009066),-0.5476366246951996,-0.9771114968385027,0.5151515151515151,0.8896566930416131,1.0,2/14,3.80%,NIT2;MTHFD1
prerank,Reactome_2022__MAP Kinase Activation R-HSA-450294,-0.42689353714270584,-0.976946766193863,0.4782608695652174,0.8897081177225888,1.0,3/57,1.30%,UBC;FOS;RPS27A
prerank,GO_Biological_Process_2021__negative regulation of supramolecular fiber organization (GO:1902904),0.4100460387593946,0.9768779334553757,0.4864864864864865,0.8284358289358804,1.0,16/56,19.55%,HIP1R;LDLR;PFDN4;CIB1;MYADM;KANK1;SHANK3;DYRK1A;SSH2;CLASP1;CLASP2;PIK3CA;CAMSAP2;ATXN7;SNCA;MAP2
prerank,KEGG_2021_Human__Morphine addiction,0.34970140445489856,0.9768331168482672,0.5517241379310345,0.8281036850021967,1.0,7/63,7.36%,CACNA1A;GABBR1;KCNJ5;ADCY9;PDE10A;PDE7B;GABRR2
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell action potential involved in regulation of contraction (GO:0098909),-0.6715222625684436,-0.9768038391558568,0.5471698113207547,0.889720131067399,1.0,2/5,18.55%,FGF13;AKAP9
prerank,GO_Biological_Process_2021__positive regulation of heart rate (GO:0010460),0.5433807340870431,0.9767705282454273,0.5121951219512195,0.8278183942289161,1.0,2/8,6.22%,SCN3B;ADRA1A
prerank,Reactome_2022__APC/C:Cdc20 Mediated Degradation Of Mitotic Proteins R-HSA-176409,-0.44877754792879626,-0.9766464371557385,0.5,0.8887139167013729,1.0,17/54,19.69%,UBC;RPS27A;PSMB3;PSMB6;PSMA7;PSMB9;PSMD12;ANAPC11;PSMD8;PSMA5;UBA52;CDC26;PSMA3;PSMC4;BUB3;PSME2;PSME1
prerank,Reactome_2022__Activation Of APC/C And APC/C:Cdc20 Mediated Degradation Of Mitotic Proteins R-HSA-176814,-0.44877754792879626,-0.9766464371557385,0.5,0.8887139167013729,1.0,17/54,19.69%,UBC;RPS27A;PSMB3;PSMB6;PSMA7;PSMB9;PSMD12;ANAPC11;PSMD8;PSMA5;UBA52;CDC26;PSMA3;PSMC4;BUB3;PSME2;PSME1
prerank,Reactome_2022__APC:Cdc20 Mediated Degradation Of Cell Cycle Proteins Before Cycle Checkpoint Satisfied R-HSA-179419,-0.44877754792879626,-0.9766464371557385,0.5,0.8887139167013729,1.0,17/54,19.69%,UBC;RPS27A;PSMB3;PSMB6;PSMA7;PSMB9;PSMD12;ANAPC11;PSMD8;PSMA5;UBA52;CDC26;PSMA3;PSMC4;BUB3;PSME2;PSME1
prerank,Reactome_2022__Cdc20:Phospho-APC/C Mediated Degradation Of Cyclin A R-HSA-174184,-0.44877754792879626,-0.9766464371557385,0.5,0.8887139167013729,1.0,17/54,19.69%,UBC;RPS27A;PSMB3;PSMB6;PSMA7;PSMB9;PSMD12;ANAPC11;PSMD8;PSMA5;UBA52;CDC26;PSMA3;PSMC4;BUB3;PSME2;PSME1
prerank,Reactome_2022__EPHB-mediated Forward Signaling R-HSA-3928662,-0.4982744919490989,-0.9765648581402636,0.5277777777777778,0.8885548415501993,1.0,3/27,7.76%,YES1;FYN;ACTG1
prerank,GO_Biological_Process_2021__protein localization to endosome (GO:0036010),0.5473871555047215,0.9764358007260278,0.5769230769230769,0.8281146189924503,1.0,1/9,0.61%,NRP1
prerank,GO_Biological_Process_2021__NAD biosynthetic process (GO:0009435),-0.5391732565774747,-0.9763479508474953,0.4918032786885246,0.8886636901191178,1.0,4/15,12.97%,NUDT12;PARP9;NAMPT;QPRT
prerank,GO_Biological_Process_2021__cellular response to metal ion (GO:0071248),-0.4275293678906183,-0.976236166682581,0.5352112676056338,0.8886046990145479,1.0,3/79,2.81%,MT2A;FOS;B2M
prerank,GO_Biological_Process_2021__regulation of canonical Wnt signaling pathway (GO:0060828),0.32740803238160093,0.9761792898029529,0.4117647058823529,0.8282943601749871,1.0,32/171,15.94%,LRP4;ZNRF3;RUVBL2;SEMA5A;CSNK1G1;ANKRD6;TLE2;LRRK2;GNAQ;WNT5A;INVS;TMEM170B;DDIT3;DVL3;KANK1;SOX4;BTRC;HDAC1;DKK2;TBL1XR1;WNK1;TCF7L2;CSNK1E;ZNF703;XIAP;GID8;CAPRIN2;TLE1;PPM1A;GSK3B;RNF220;KLHL12
prerank,Reactome_2022__FCERI Mediated NF-kB Activation R-HSA-2871837,-0.4379490794811406,-0.9761583188864418,0.5135135135135135,0.8884351524062836,1.0,10/68,12.85%,UBC;RPS27A;PRKCQ;PSMB3;PSMB6;PSMA7;PSMB9;PSMD12;PSMD8;PSMA5
prerank,GO_Biological_Process_2021__regulation of sequestering of calcium ion (GO:0051282),0.5701176567521617,0.9760196333778886,0.5681818181818182,0.8282648876118932,1.0,3/7,35.90%,RYR2;PTK2B;ANXA6
prerank,GO_Biological_Process_2021__mitochondrial RNA processing (GO:0000963),0.6032256286884119,0.975930097118683,0.46938775510204084,0.8280265138735058,1.0,1/6,1.40%,TBRG4
prerank,GO_Biological_Process_2021__positive regulation of T cell chemotaxis (GO:0010820),-0.6304764375766528,-0.9758454091262647,0.5531914893617021,0.888531390258556,1.0,2/7,7.09%,CCL5;STK39
prerank,GO_Biological_Process_2021__regulation of T cell chemotaxis (GO:0010819),-0.6304764375766528,-0.9758454091262647,0.5531914893617021,0.888531390258556,1.0,2/7,7.09%,CCL5;STK39
prerank,CellMarker_Augmented_2021__Neutrophil:Sputum,-0.5161784534606844,-0.9756541651810733,0.48333333333333334,0.8882641341542513,1.0,4/16,9.33%,TNFSF10;ANKRD22;ABCC3;LLGL2
prerank,CellMarker_Augmented_2021__Neutrophil:Bronchoalveolar System,-0.5161784534606844,-0.9756541651810733,0.48333333333333334,0.8882641341542513,1.0,4/16,9.33%,TNFSF10;ANKRD22;ABCC3;LLGL2
prerank,GO_Biological_Process_2021__iron-sulfur cluster assembly (GO:0016226),-0.5232245271017194,-0.9756441029055891,0.5230769230769231,0.8879348220497024,1.0,4/19,15.50%,ISCA1;NFS1;NUBPL;CIAO2B
prerank,GO_Biological_Process_2021__negative regulation of neuron differentiation (GO:0045665),-0.6392804068970269,-0.9755556148499686,0.625,0.8877872974343135,1.0,1/7,2.81%,B2M
prerank,GO_Biological_Process_2021__response to progesterone (GO:0032570),0.5178840540218359,0.9753008191849346,0.4782608695652174,0.8290819417991576,1.0,1/11,8.61%,TRERF1
prerank,GO_Biological_Process_2021__positive regulation of neuroblast proliferation (GO:0002052),-0.5452466763952122,-0.9752544775780331,0.47540983606557374,0.8882233946678288,1.0,3/9,15.22%,ZNF335;VEGFA;SMARCD3
prerank,GO_Biological_Process_2021__negative regulation of phosphatase activity (GO:0010923),-0.550195298867503,-0.9752079988287704,0.5245901639344263,0.8880011849065214,1.0,1/19,1.16%,PPP1R15A
prerank,GO_Biological_Process_2021__regulation of double-strand break repair via homologous recombination (GO:0010569),0.4194781725620162,0.9751535638491229,0.5517241379310345,0.8289709514780029,1.0,8/33,19.52%,PARP1;PPP4R2;MMS19;SIRT6;CGAS;SETD2;KLHL15;ARID2
prerank,Reactome_2022__Vasopressin Regulates Renal Water Homeostasis Via Aquaporins R-HSA-432040,-0.5179698452973911,-0.9751464961858582,0.5517241379310345,0.887747153923111,1.0,3/24,6.63%,GNB5;RAB11A;PRKAR1B
prerank,GO_Biological_Process_2021__regulation of peroxisome proliferator activated receptor signaling pathway (GO:0035358),0.5983349394205967,0.9750816281535333,0.5957446808510638,0.8286978124353704,1.0,1/6,2.51%,SIRT1
prerank,GO_Biological_Process_2021__response to muscle stretch (GO:0035994),0.5469451937830285,0.9749952500567444,0.4666666666666667,0.8284191528148985,1.0,5/11,17.35%,GSN;SLC9A1;SLC8A1;PTK2;PIK3CA
prerank,Reactome_2022__Molecules Associated With Elastic Fibres R-HSA-2129379,0.488086423781538,0.9749443918460354,0.5483870967741935,0.8281581376858993,1.0,2/10,10.85%,LTBP3;ITGAV
prerank,"Reactome_2022__Synthesis Of IP2, IP, And Ins In Cytosol R-HSA-1855183",0.5559570289017459,0.9748804743606502,0.5,0.8279089544296174,1.0,6/12,18.14%,INPP1;IMPA1;ISYNA1;MTMR9;INPP5A;INPP4B
prerank,GO_Biological_Process_2021__metal ion homeostasis (GO:0055065),0.5080189558297008,0.9747866504862289,0.475,0.8277062862165585,1.0,8/20,21.96%,SLC7A8;TMTC2;SLC12A6;SLC12A5;SLC8A1;SLC12A2;SNCA;GRIN1
prerank,GO_Biological_Process_2021__regulation of anoikis (GO:2000209),0.5107136461784024,0.9746356421839126,0.47058823529411764,0.8276252115705021,1.0,4/14,17.35%,PDK4;PTK2;TLE1;PIK3CA
prerank,Reactome_2022__Synthesis Of DNA R-HSA-69239,-0.4175115800455645,-0.9745889922669783,0.5333333333333333,0.8886767233659786,1.0,24/85,20.89%,UBC;RPS27A;PSMB3;POLE3;PSMB6;PSMA7;PSMB9;RBX1;PSMD12;ANAPC11;PSMD8;PSMA5;MCM7;RPA3;UBA52;CDC26;LRIG1;PSMA3;PSMC4;PSME2;PSME1;PRIM1;MCM6;PSMB5
prerank,KEGG_2021_Human__Relaxin signaling pathway,0.3615697303091024,0.9745721828343397,0.5,0.8273419967781263,1.0,17/80,18.09%,TGFBR2;MAPK11;ACTA2;MAP2K1;SMAD2;PLCB4;ADCY9;SHC2;MAPK1;ADCY6;JUN;TGFBR1;AKT2;COL4A5;PIK3CA;PLCB3;MAP2K2
prerank,KEGG_2021_Human__Bacterial invasion of epithelial cells,0.40301730066475216,0.9745349204066551,0.6,0.8270417380746959,1.0,9/61,8.95%,GAB1;ARHGEF26;WASF2;VCL;CRK;ELMO1;DNM3;CTNNA2;SHC2
prerank,GO_Biological_Process_2021__regulation of rhodopsin mediated signaling pathway (GO:0022400),-0.6258636529548656,-0.9744761293593305,0.6507936507936508,0.8885398541300409,1.0,1/9,8.36%,CALM1
prerank,GO_Biological_Process_2021__regulation of protein kinase C signaling (GO:0090036),0.5392136845526747,0.9744010519245796,0.5,0.8269437970244723,1.0,3/11,6.24%,WNT5A;ADRA1A;MYADM
prerank,Reactome_2022__EPH-Ephrin Signaling R-HSA-2682334,-0.4314826357655256,-0.9743960362181618,0.5342465753424658,0.888328522583792,1.0,18/69,24.34%,VAV3;YES1;EPHB1;FYN;ACTG1;MYL12A;EFNB2;CLTB;AP2S1;APH1B;ITSN1;EPHB2;MYH10;LYN;MYH9;SDCBP;AP2M1;CLTA
prerank,GO_Biological_Process_2021__mitotic nuclear division (GO:0140014),-0.4474219976761737,-0.9741756945379133,0.5,0.8884865114891427,1.0,5/50,8.95%,FLNA;CTDP1;RAB11A;WRAP73;ABRAXAS1
prerank,"Reactome_2022__Signaling By Rho GTPases, Miro GTPases And RHOBTB3 R-HSA-9716542",-0.36193794853913064,-0.9739405821077382,0.6129032258064516,0.8887401764771775,1.0,45/503,10.91%,FLNA;PLEKHG5;MYLK;H2BC4;H2BC26;H2AC20;ARHGAP4;TFRC;H2AC6;RASGRF2;VAV3;MPP7;RPS27;CDC37;PLEKHG1;BTK;GMIP;DDRGK1;EMD;NCF4;ARHGEF1;JUP;PDE5A;BASP1;H3-3B;H2AJ;RHOU;EFHD2;ARHGEF3;OBSCN;ACBD5;H2BC21;PPP1CB;ACTG1;CENPU;H2BC5;CALM1;H2BC9;ITGB3BP;NCF2;ZWILCH;BAIAP2L2;CFTR;NCKAP1L;EPSTI1
prerank,Reactome_2022__APC/C:Cdc20 Mediated Degradation Of Securin R-HSA-174154,-0.4515485672393031,-0.9739126540466737,0.5138888888888888,0.8884403462876235,1.0,12/53,14.90%,UBC;RPS27A;PSMB3;PSMB6;PSMA7;PSMB9;PSMD12;ANAPC11;PSMD8;PSMA5;UBA52;CDC26
prerank,Reactome_2022__Recycling Of eIF2:GDP R-HSA-72731,-0.5911538891401159,-0.9737535902865841,0.4915254237288136,0.8885059252316826,1.0,4/8,22.09%,EIF2B1;EIF2S2;EIF2B2;EIF2S3
prerank,GO_Biological_Process_2021__L-amino acid transport (GO:0015807),0.49558098317663574,0.9737441910049278,0.5121951219512195,0.8280401667596531,1.0,5/16,6.03%,SLC1A3;SLC25A18;SLC7A8;SLC3A2;SLC1A2
prerank,GO_Biological_Process_2021__cholesterol efflux (GO:0033344),-0.5721820572268249,-0.9736761158751494,0.5344827586206896,0.8883623578251252,1.0,5/12,24.24%,ABCA8;ABCA5;NPC1;STX12;ABCA7
prerank,GO_Biological_Process_2021__purine nucleoside monophosphate biosynthetic process (GO:0009127),0.515749366132232,0.9735714422612379,0.5483870967741935,0.8281148174334996,1.0,1/10,5.19%,PPAT
prerank,GO_Biological_Process_2021__regulation of natural killer cell mediated cytotoxicity (GO:0042269),-0.5449238006508454,-0.9734222438273409,0.5254237288135594,0.8886263008101662,1.0,5/14,14.31%,SLAMF6;HLA-F;KLRD1;CD226;HLA-E
prerank,Reactome_2022__Collagen Biosynthesis And Modifying Enzymes R-HSA-1650814,0.44254091700545367,0.9734132591928032,0.45714285714285713,0.8281663404989693,1.0,4/34,4.30%,COL5A3;COL16A1;COL5A2;COL24A1
prerank,GO_Biological_Process_2021__replication fork protection (GO:0048478),-0.6015290161350475,-0.9731581431525691,0.5333333333333333,0.8889148249166251,1.0,3/8,21.03%,TIPIN;ZRANB3;DONSON
prerank,Reactome_2022__Rev-mediated Nuclear Export Of HIV RNA R-HSA-165054,0.41615251270227194,0.9731291163896868,0.59375,0.8283618274652347,1.0,5/33,7.72%,NUP153;NUP188;NUP42;XPO1;RCC1
prerank,GO_Biological_Process_2021__regulation of toll-like receptor 4 signaling pathway (GO:0034143),-0.5425965206896195,-0.9724234222599412,0.5873015873015873,0.8902756841506559,1.0,7/16,22.16%,TNFAIP3;APPL1;IFI35;FLOT1;PTPN22;NR1D1;LYN
prerank,Reactome_2022__Interleukin-17 Signaling R-HSA-448424,-0.4240319182619846,-0.9723586359770144,0.4714285714285714,0.8901422629965006,1.0,3/58,1.30%,UBC;FOS;RPS27A
prerank,GO_Biological_Process_2021__positive regulation of amyloid-beta clearance (GO:1900223),-0.5775384306094437,-0.9723131372940466,0.5344827586206896,0.8898639282179818,1.0,3/6,31.99%,LRPAP1;ABCA7;TREM2
prerank,GO_Biological_Process_2021__negative regulation of MAP kinase activity (GO:0043407),-0.485506753039759,-0.9722486927317742,0.5,0.8896918809879604,1.0,4/34,6.85%,DUSP1;RGS2;PAQR3;GSTP1
prerank,GO_Biological_Process_2021__negative regulation of cellular response to insulin stimulus (GO:1900077),-0.4889242024518076,-0.9721971663617024,0.4931506849315068,0.8894598861887199,1.0,2/21,1.81%,PRKCQ;PID1
prerank,GO_Biological_Process_2021__regulation of bone mineralization (GO:0030500),-0.46423060542014316,-0.9720626524620388,0.4925373134328358,0.889468308606098,1.0,2/33,0.93%,CCL3;SRGN
prerank,GO_Biological_Process_2021__regulation of endothelial cell migration (GO:0010594),0.3876309242273711,0.9718400256442035,0.47368421052631576,0.830704761035401,1.0,9/52,13.77%,NRP1;FGF2;WNT5A;PTPRM;RIN2;SASH1;DNAJA4;NF1;PTK2
prerank,GO_Biological_Process_2021__protein K11-linked ubiquitination (GO:0070979),0.4776378088864012,0.9718145432015569,0.42857142857142855,0.8303751051187254,1.0,10/20,25.93%,UBE2E2;FZR1;CDC23;UBE2L3;ANAPC1;ANAPC4;UBE2D4;UBE2D3;UBE2E3;RNF4
prerank,GO_Biological_Process_2021__positive regulation of lipid localization (GO:1905954),-0.5828689224281202,-0.9715236003778497,0.5645161290322581,0.8904231641077868,1.0,1/5,14.85%,C3
prerank,GO_Biological_Process_2021__oligosaccharide metabolic process (GO:0009311),0.4409368383593837,0.9714376301500667,0.5111111111111111,0.8307532784407692,1.0,7/25,17.01%,ST6GAL2;ST6GALNAC3;MPDU1;FUT9;ST6GALNAC5;ST8SIA4;ST8SIA5
prerank,GO_Biological_Process_2021__plasma membrane repair (GO:0001778),-0.6011655901758648,-0.9709193578110635,0.55,0.8914514044610052,1.0,1/7,6.19%,RAB3A
prerank,GO_Biological_Process_2021__peptidyl-proline modification (GO:0018208),-0.5271361144451051,-0.9708421883370882,0.5757575757575758,0.8913214174448224,1.0,1/19,0.79%,PPIE
prerank,GO_Biological_Process_2021__cellular iron ion homeostasis (GO:0006879),-0.4827504721031509,-0.9707672249666037,0.46875,0.891149203923895,1.0,3/39,2.30%,FTH1;TFRC;HAMP
prerank,Reactome_2022__Regulation Of Gene Expression In Beta Cells R-HSA-210745,-0.6035365637242112,-0.9705409857419599,0.5161290322580645,0.891364981648001,1.0,1/6,4.10%,PDHX
prerank,GO_Biological_Process_2021__ribosomal subunit export from nucleus (GO:0000054),-0.5596993879904593,-0.9704668813108148,0.5535714285714286,0.8911611643767182,1.0,4/10,21.82%,RPS15;NPM1;NUP88;NMD3
prerank,Reactome_2022__FGFR2 Alternative Splicing R-HSA-6803529,0.4867375550231301,0.9704120214049718,0.5384615384615384,0.8323614129481387,1.0,1/19,0.68%,POLR2D
prerank,GO_Biological_Process_2021__regulation of establishment of protein localization to telomere (GO:0070203),0.5485155869338045,0.9703783252163098,0.5434782608695652,0.832008442235135,1.0,2/10,13.21%,TCP1;CCT3
prerank,GO_Biological_Process_2021__regulation of RNA metabolic process (GO:0051252),-0.4489580897474603,-0.9702247236069621,0.4533333333333333,0.8913168742074615,1.0,6/50,8.28%,OAS3;OAS2;USP36;FAM50A;TNFRSF1B;OAS1
prerank,GO_Biological_Process_2021__phosphatidylcholine catabolic process (GO:0034638),0.6103226583414418,0.9696880776455908,0.625,0.8331089398109109,1.0,1/7,1.59%,PLA2G7
prerank,GO_Biological_Process_2021__positive regulation of cellular carbohydrate metabolic process (GO:0010676),0.6192513063061088,0.9694255797729271,0.5277777777777778,0.8332898364473879,1.0,3/5,25.01%,AKT2;SNCA;PRKCE
prerank,Reactome_2022__Defective B3GALTL Causes PpS R-HSA-5083635,-0.5057862220369391,-0.9693306616987821,0.546875,0.8931065955902086,1.0,2/17,4.26%,SPON2;ADAMTS19
prerank,GO_Biological_Process_2021__positive regulation of vasculature development (GO:1904018),0.41585495403910777,0.9693191645214055,0.4857142857142857,0.8330975912627813,1.0,9/54,9.91%,SEMA5A;SERPINE1;FGF2;SIRT1;GAB1;WNT5A;RUNX1;TMIGD2;SASH1
prerank,CellMarker_Augmented_2021__Pigment Epithelial cell:Retina,0.41331194907718305,0.9691731332865712,0.4166666666666667,0.8330431771938797,1.0,11/39,14.88%,MTCL1;B4GALNT4;ADGRB2;GPR161;TBC1D16;VGF;BRSK1;ENAH;PLXNA1;FRMD5;CD276
prerank,GO_Biological_Process_2021__activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c (GO:0008635),-0.6166178842868135,-0.9690755097086998,0.5,0.8933494361279548,1.0,1/5,1.08%,CYCS
prerank,PanglaoDB_Augmented_2021__Motor Neurons,0.457160192278538,0.969000831414801,0.5384615384615384,0.8330060134300596,1.0,6/20,12.60%,ADGRB2;CSPG5;VGF;ENAH;LINGO1;CSNK1E
prerank,GO_Biological_Process_2021__positive regulation of cardiocyte differentiation (GO:1905209),-0.586833090412838,-0.968774359132145,0.5689655172413793,0.8936976598828625,1.0,2/5,25.54%,EFNB2;DHX36
prerank,GO_Biological_Process_2021__negative regulation of cell-substrate junction organization (GO:0150118),-0.5404765548117375,-0.9687125775370542,0.5,0.8931414734640638,1.0,1/14,4.08%,APOD
prerank,GO_Biological_Process_2021__negative regulation of focal adhesion assembly (GO:0051895),-0.5404765548117375,-0.9687125775370542,0.5,0.8931414734640638,1.0,1/14,4.08%,APOD
prerank,Reactome_2022__PTEN Regulation R-HSA-6807070,0.36911013408746185,0.9687098220977113,0.47368421052631576,0.8332037932434924,1.0,6/117,5.17%,EGR1;RRAGD;RNF2;CBX6;MTA2;PPARG
prerank,GO_Biological_Process_2021__metaphase/anaphase transition of cell cycle (GO:0044784),0.6025034176265727,0.9685890249074851,0.5957446808510638,0.832717303014601,1.0,2/6,14.97%,CDC23;ANAPC1
prerank,GO_Biological_Process_2021__metaphase/anaphase transition of mitotic cell cycle (GO:0007091),0.6025034176265727,0.9685890249074851,0.5957446808510638,0.832717303014601,1.0,2/6,14.97%,CDC23;ANAPC1
prerank,GO_Biological_Process_2021__thyroid hormone generation (GO:0006590),-0.591625258700486,-0.9685625274411428,0.5185185185185185,0.8931484184540449,1.0,2/6,10.07%,DUOX1;DIO2
prerank,GO_Biological_Process_2021__adherens junction assembly (GO:0034333),0.53527828587549,0.9683123339938755,0.5319148936170213,0.8328748862674502,1.0,3/9,13.62%,SMAD7;VCL;ZNF703
prerank,Reactome_2022__Defective B3GALT6 Causes EDSP2 And SEMDJL1 R-HSA-4420332,0.5037971884373482,0.9683105164696161,0.43902439024390244,0.8324719317995554,1.0,3/10,12.44%,NCAN;CSPG5;GPC6
prerank,CellMarker_Augmented_2021__Progenitor cell:Corneal Epithelium,-0.49614752972054627,-0.9680627267275349,0.509090909090909,0.8939915964730574,1.0,3/27,6.67%,ARSJ;ANXA2;OSMR
prerank,GO_Biological_Process_2021__store-operated calcium entry (GO:0002115),-0.6840785597634554,-0.9680580243432897,0.6031746031746031,0.8936504933816648,1.0,3/5,19.28%,CRACR2A;STIM2;ORAI2
prerank,Reactome_2022__Transcriptional Regulation By E2F6 R-HSA-8953750,0.42297270243174434,0.967977567559807,0.5348837209302325,0.832795227139183,1.0,5/28,16.85%,RNF2;RYBP;APAF1;PHC1;YAF2
prerank,KEGG_2021_Human__Pyruvate metabolism,-0.46798288793918774,-0.9678696771852622,0.5,0.8937028734517026,1.0,2/31,2.23%,ME1;MDH2
prerank,GO_Biological_Process_2021__cellular response to oxygen-containing compound (GO:1901701),0.3294149629557882,0.9677927577301678,0.5,0.8328097257394221,1.0,15/188,5.25%,EGR1;CD180;RRAGD;PKD2;FER;RUVBL2;AANAT;SERPINE1;PDK4;NCOA3;RAP1A;SIRPA;NRIP1;WNT5A;GLRA1
prerank,CellMarker_Augmented_2021__Cancer cell:Undefined,0.5670875002825897,0.9672246806479667,0.5957446808510638,0.8336920981607507,1.0,2/6,4.66%,GFAP;TNFRSF10A
prerank,GO_Biological_Process_2021__regulation of protein binding (GO:0043393),-0.43045544916012096,-0.9666613880991172,0.5466666666666666,0.8964119083499823,1.0,11/88,11.42%,DDX11;CARD16;B2M;IFIT1;RACK1;RPL11;DTX3L;IFIT2;DVL1;ACTB;STING1
prerank,GO_Biological_Process_2021__positive regulation of small molecule metabolic process (GO:0062013),0.5855459350800841,0.966566692539486,0.53125,0.834716281195497,1.0,4/9,26.76%,PPARG;AKT2;PRKCE;PPM1K
prerank,GO_Biological_Process_2021__acylglycerol metabolic process (GO:0006639),-0.487429047666533,-0.9664821225356518,0.4444444444444444,0.8964245840665063,1.0,4/25,16.99%,MGLL;GK;DGKD;LMF1
prerank,GO_Biological_Process_2021__mitotic sister chromatid segregation (GO:0000070),0.37093028608527395,0.9663578894100009,0.28,0.8347982685957925,1.0,11/64,14.09%,NCAPH2;NSL1;TEX14;BOD1;CDC23;CHMP7;SMC4;CENPE;ZNF207;NIPBL;CHMP1A
prerank,GO_Biological_Process_2021__positive regulation of cell death (GO:0010942),-0.4300507792403714,-0.9663263584289382,0.546875,0.8964863447958639,1.0,5/45,4.82%,CALCR;CD36;FOS;DDIT4;CLU
prerank,GO_Biological_Process_2021__regulation of gene expression (GO:0010468),-0.3628138610703305,-0.9658439402983966,0.648936170212766,0.8972596564552413,1.0,96/645,14.51%,CALCR;BTN3A1;CD36;MYBL1;CCL3;PPIE;RIMS1;RUNX3;SLC7A5;TFRC;PRKCQ;NFKBID;PID1;WARS1;TRIM5;AIF1;CHD3;PARP14;ATF5;TAF6L;RPL5;EDF1;RORA;USP36;PARP15;ZNF335;DDRGK1;OGG1;RACK1;BTN3A3;ETS1;CLU;BHLHE40;ZNF331;RPL11;RPS3;RPL23;IGF1;TXK;LAMTOR5;TRIM22;VPS35;MSL3;PARP9;MUSK;BTN3A2;BTN2A1;TTN;RPS7;PLSCR1;PLAG1;FAM50A;BRCA2;SNF8;ACTG1;BTN2A2;RBPJ;OVOL2;RPL6;PDCD5;DVL1;GLMN;HINT1;ZNF513;SLC11A1;HNRNPAB;CITED2;KDM6B;REXO4;MLX;VEGFA;TYROBP;HIF1A;BTG1;ANKRA2;TCF3;GLI4;GLRX2;GCFC2;HSPA1B;CREM;TERF2IP;PTPRC;PRDM1;DNMT1;HAVCR2;ZNF217;PIK3CB;ESR2;NOTCH2;GPX1;REL;BRCA1;HSPA1A;FGF20;CCAR1
prerank,GO_Biological_Process_2021__negative regulation of protein localization to plasma membrane (GO:1903077),-0.5459502735906526,-0.9657087127749494,0.5357142857142857,0.8972369475314615,1.0,1/16,1.81%,PID1
prerank,GO_Biological_Process_2021__delamination (GO:0060232),-0.6346659085950487,-0.9656635723689722,0.5964912280701754,0.8969830786508646,1.0,2/5,16.09%,TRPV4;AKNA
prerank,GO_Biological_Process_2021__regulation of establishment of planar polarity (GO:0090175),-0.4544268938020789,-0.9656137824413492,0.5194805194805194,0.8967013962247132,1.0,19/63,22.96%,PSMB3;PSMB6;PSMA7;PSMB9;DVL1;FZD2;PSMD12;PFN1;PSMD8;PSMA5;AP2S1;RAC1;PSMA3;PSMC4;PSME2;PSME1;PSMB5;PSMC3;PSME3
prerank,Reactome_2022__Constitutive Signaling By NOTCH1 HD+PEST Domain Mutants R-HSA-2894862,-0.4455543502169587,-0.9655092853065281,0.4461538461538462,0.8966159308659338,1.0,2/46,1.30%,UBC;RPS27A
prerank,GO_Biological_Process_2021__somatic hypermutation of immunoglobulin genes (GO:0016446),-0.6361536766091256,-0.9651995472431815,0.609375,0.897006343420101,1.0,6/7,36.38%,MSH6;POLQ;PMS2;SAMHD1;POLL;MCM3AP
prerank,Reactome_2022__Signaling By ERBB2 In Cancer R-HSA-1227990,0.484947546961835,0.9648347049366539,0.4444444444444444,0.8379361311815795,1.0,8/17,18.75%,PIGU;NRG1;NRG3;NRG2;ERBB4;PIK3CA;ERBIN;PTPN12
prerank,GO_Biological_Process_2021__arachidonic acid metabolic process (GO:0019369),0.4456033032577968,0.9647701235082164,0.4634146341463415,0.8376631493750086,1.0,2/21,0.68%,FAAH;PLA2G4C
prerank,GO_Biological_Process_2021__RNA export from nucleus (GO:0006405),0.3620077417610529,0.9647267494327855,0.4,0.8373448677238784,1.0,8/83,7.20%,NXF1;U2AF1;CPSF4;FYTTD1;NUP153;NUP188;WDR33;NUP42
prerank,Reactome_2022__Mitotic G2-G2/M Phases R-HSA-453274,-0.40174783680147463,-0.9646196867677428,0.5569620253164557,0.897924539199193,1.0,35/142,22.15%,UBC;RPS27A;PSMB3;SSNA1;PSMB6;PSMA7;PPP1CB;CEP72;PSMB9;CEP164;TUBGCP2;RBX1;PSMD12;CSNK1D;PSMD8;PSMA5;TUBB4B;UBA52;TUBGCP5;PSMA3;PRKAR2B;PSMC4;DCTN2;CENPF;AKAP9;MZT2B;PSME2;PSME1;DYNC1I2;NINL;PSMB5;SFI1;CDK11B;PSMC3;HAUS5
prerank,GO_Biological_Process_2021__negative regulation of insulin receptor signaling pathway (GO:0046627),-0.4889269461261115,-0.9645446815248655,0.4788732394366197,0.8977268302468726,1.0,2/20,1.81%,PRKCQ;PID1
prerank,KEGG_2021_Human__TNF signaling pathway,-0.4197369606933692,-0.9643300068134228,0.5753424657534246,0.8978647511245473,1.0,11/79,14.09%,FOS;CCL5;JUNB;TNFRSF1B;TNFAIP3;CFLAR;IRF1;MLKL;IL18R1;PIK3CB;NOD2
prerank,GO_Biological_Process_2021__synaptic vesicle fusion to presynaptic active zone membrane (GO:0031629),0.5298900619106114,0.9643239525132291,0.4444444444444444,0.8378637759241688,1.0,4/10,10.74%,STX11;STX1A;STX2;SNAP23
prerank,KEGG_2021_Human__cGMP-PKG signaling pathway,-0.4093393423534811,-0.9642108121775497,0.5066666666666667,0.8977475619516301,1.0,7/101,8.36%,MYLK;PLN;RGS2;SLC25A5;PDE5A;PPP1CB;CALM1
prerank,GO_Biological_Process_2021__erythrocyte differentiation (GO:0030218),-0.47125610799085904,-0.9641394985873476,0.5081967213114754,0.8975361837730417,1.0,6/34,11.19%,TGFBR3;RPS14;SLC25A5;ATP5IF1;NCKAP1L;VEGFA
prerank,GO_Biological_Process_2021__positive regulation of potassium ion transmembrane transporter activity (GO:1901018),0.5676796357780627,0.9641028034340242,0.48936170212765956,0.8379952387612556,1.0,1/7,3.23%,KCNIP2
prerank,GO_Biological_Process_2021__RNA biosynthetic process (GO:0032774),-0.4938891265160932,-0.9640737115665922,0.5070422535211268,0.8973005357624629,1.0,1/21,3.69%,TCEA2
prerank,GO_Biological_Process_2021__regulation of signal transduction (GO:0009966),-0.4070421127799588,-0.9640385272675249,0.48148148148148145,0.8970022655375806,1.0,19/127,9.33%,CD36;DYNLT1;CD55;MGLL;RGS2;MDFIC;TRIM5;RORA;RGS16;CLU;MTCH1;CD63;RGS4;FYN;PLSCR1;NLRP12;ANKRD54;OVOL2;LLGL2
prerank,GO_Biological_Process_2021__negative regulation of MAPK cascade (GO:0043409),0.374760517093311,0.9639572161788649,0.42424242424242425,0.8379275108955154,1.0,14/60,12.21%,DUSP6;QARS1;SPRY2;SPRED1;SPRED2;SIRPA;TIMP3;DAG1;DUSP7;IRAK3;RPS6KA6;PTEN;SORL1;NF1
prerank,Reactome_2022__SUMOylation Of Chromatin Organization Proteins R-HSA-4551638,0.37897604197151047,0.9638916560526485,0.4473684210526316,0.8376495143809547,1.0,10/48,17.93%,RNF2;NUP153;NUP188;NUP42;SATB2;HDAC1;PHC1;NDC1;NUP133;NUP205
prerank,GO_Biological_Process_2021__negative regulation of histone acetylation (GO:0035067),0.5193910508704559,0.9638135865090285,0.5333333333333333,0.8373888348020947,1.0,3/10,19.35%,SIRT1;ZNF451;SNCA
prerank,GO_Biological_Process_2021__response to cAMP (GO:0051591),0.4629747373765444,0.9636948192189109,0.5217391304347826,0.8372306345661761,1.0,4/25,6.96%,PKD2;AANAT;RAP1A;VGF
prerank,GO_Biological_Process_2021__positive regulation of protein localization to plasma membrane (GO:1903078),0.40010554168856216,0.9636305419191868,0.5405405405405406,0.8369704129702545,1.0,11/37,23.61%,PTPN9;CIB1;TNF;ARF6;PRKCI;DPP10;PLS1;SPTBN1;STX3;ATP2C1;PIK3R1
prerank,CellMarker_Augmented_2021__Astrocyte:Brain,-0.39511532887380935,-0.9634977755585024,0.6216216216216216,0.897816831490554,1.0,24/111,14.31%,MT2A;FTH1;FOS;ZFP36;JUNB;GADD45B;BTG2;PLTP;CLU;GLUL;SEMA6A;TACR1;C5AR1;IER2;PFKFB3;EGLN3;SLC14A1;HIF1A;SPARCL1;ATF3;PON2;RASSF4;PEA15;HLA-E
prerank,CellMarker_Augmented_2021__Trophoblast cell:Placenta,0.3998958934739672,0.9634316712925296,0.5161290322580645,0.8369317171729701,1.0,6/44,2.26%,ANXA1;TPM2;FKBP9;SERPINE1;COL5A2;FGF2
prerank,GO_Biological_Process_2021__positive regulation of RNA export from nucleus (GO:0046833),-0.6223755870143066,-0.9633681838525722,0.5714285714285714,0.8974505999034418,1.0,2/5,17.54%,NCBP2;NRDE2
prerank,GO_Biological_Process_2021__positive regulation of nucleobase-containing compound transport (GO:0032241),-0.6223755870143066,-0.9633681838525722,0.5714285714285714,0.8974505999034418,1.0,2/5,17.54%,NCBP2;NRDE2
prerank,GO_Biological_Process_2021__autophagosome maturation (GO:0097352),-0.47952207915850575,-0.9632092820728657,0.5454545454545454,0.8974871725484206,1.0,3/25,9.32%,GABARAPL1;CALM1;GABARAPL2
prerank,GO_Biological_Process_2021__macromolecule modification (GO:0043412),0.5836661831844066,0.9625184557423365,0.5102040816326531,0.8386170098543636,1.0,2/7,14.78%,PARP1;SETD5
prerank,Reactome_2022__Activation Of AP-1 Family Of Transcription Factors R-HSA-450341,-0.5621465030806804,-0.9624747519588693,0.5344827586206896,0.8988365836280474,1.0,1/9,1.22%,FOS
prerank,GO_Biological_Process_2021__positive regulation by host of viral genome replication (GO:0044829),-0.6605829798310666,-0.9623173639549175,0.5964912280701754,0.8988865173639332,1.0,4/5,31.12%,TBC1D20;NUCKS1;YTHDC2;PPIB
prerank,Reactome_2022__Processive Synthesis On C-strand Of Telomere R-HSA-174414,-0.5368148526359162,-0.962200494165367,0.5454545454545454,0.8988111427250259,1.0,4/12,18.09%,TERF2IP;RPA3;LRIG1;WRN
prerank,CellMarker_Augmented_2021__Beta cell:Pancreas,-0.5762311181453293,-0.9619287131910611,0.5849056603773585,0.8992645393704825,1.0,1/8,1.03%,TGFBR3
prerank,GO_Biological_Process_2021__positive regulation of endopeptidase activity (GO:0010950),-0.477592498121567,-0.9618588984537845,0.4722222222222222,0.8990673808904682,1.0,3/21,7.36%,PRELID1;AIM2;FYN
prerank,Reactome_2022__CREB1 Phosphorylation Thru Activation Of CaMKII/CaMKK/CaMKIV Cascasde R-HSA-442729,-0.589400460022478,-0.9618376768876328,0.5692307692307692,0.8987765305942554,1.0,2/8,22.26%,CALM1;CAMK4
prerank,Reactome_2022__Cytochrome P450 - Arranged By Substrate Type R-HSA-211897,0.5064832994141598,0.9617790891230917,0.48717948717948717,0.8400569334426823,1.0,4/17,18.67%,ARNT2;CYP46A1;TBXAS1;NCOA2
prerank,GO_Biological_Process_2021__regulation of centriole elongation (GO:1903722),0.6125054566628407,0.9614973439377127,0.6,0.8403680469648797,1.0,2/5,31.84%,CEP120;CCP110
prerank,GO_Biological_Process_2021__regulation of sequestering of triglyceride (GO:0010889),0.5450805409109096,0.9614722395797518,0.5365853658536586,0.8400106684805815,1.0,4/10,27.88%,PPARG;OSBPL8;LPL;ABHD5
prerank,Reactome_2022__TFAP2 (AP-2) Family Regulates Transcription Of Growth Factors And Their Receptors R-HSA-8866910,0.5795559933728955,0.9613654327077297,0.5094339622641509,0.839840412978309,1.0,1/7,2.15%,TGFA
prerank,"GO_Biological_Process_2021__negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515)",-0.6114105130728406,-0.9608613178755758,0.59375,0.900601787344958,1.0,1/8,1.37%,RUNX3
prerank,CellMarker_Augmented_2021__Plasmacytoid Dendritic cell:Blood,-0.3829530881815757,-0.9606806478182613,0.5476190476190477,0.9006370339334866,1.0,30/256,9.39%,SPON2;MIF4GD;ADGRE1;IFI44L;SLC7A5;MCOLN2;GPR183;EMB;RNASET2;MDFIC;SIDT1;SELL;GZMB;EPHB1;CTSB;SCN9A;SLC38A1;IL3RA;LILRB4;SULF2;CRYM;ZDHHC4;TNFAIP3;ITGA4;EIF4A3;BEX4;BTAF1;EGLN3;EFHC1;HPS4
prerank,GO_Biological_Process_2021__anaphase-promoting complex-dependent catabolic process (GO:0031145),-0.44369215836866477,-0.9606711796943833,0.5428571428571428,0.9003077268166698,1.0,17/59,19.69%,UBC;RPS27A;PSMB3;PSMB6;PSMA7;PSMB9;PSMD12;ANAPC11;PSMD8;PSMA5;UBA52;CDC26;PSMA3;PSMC4;BUB3;PSME2;PSME1
prerank,GO_Biological_Process_2021__MAPK cascade (GO:0000165),-0.39316928964675,-0.9605453958803241,0.5833333333333334,0.9002805932002562,1.0,33/209,14.82%,CCL3;UBC;RPS27A;ZFP36;CCL5;PRKCQ;RASGRF2;PAQR3;PSMB3;IL3RA;IGF1;WDR83;FGF13;NEFL;PSMB6;PSMA7;FYN;PPP1CB;CSF2RA;CALM1;PSMB9;CSF2RB;RBX1;KARS1;PSMD12;PSMD8;PSMA5;PEBP1;PIK3CB;PEA15;FGF20;RASA2;UBA52
prerank,GO_Biological_Process_2021__cellular response to leptin stimulus (GO:0044320),-0.6034848052514417,-0.9604860511720776,0.5333333333333333,0.9000279947336384,1.0,1/7,0.08%,NR4A3
prerank,KEGG_2021_Human__Cholinergic synapse,0.36298524581223934,0.9604467190065816,0.55,0.8415880886738576,1.0,7/72,6.41%,CACNA1A;KCNQ2;KCNJ2;MAP2K1;GNAQ;PLCB4;ADCY9
prerank,CellMarker_Augmented_2021__Hematopoietic Stem cell:Corneal Endothelium,0.4114840185176573,0.9601749920222327,0.5517241379310345,0.8414669570290781,1.0,10/40,12.47%,SPON1;PDZRN4;PCDH17;MMRN1;PREX2;ASXL3;PTPRD;THSD7A;RUNX1T1;NTRK2
prerank,CellMarker_Augmented_2021__Hematopoietic Stem cell:Breast,0.4114840185176573,0.9601749920222327,0.5517241379310345,0.8414669570290781,1.0,10/40,12.47%,SPON1;PDZRN4;PCDH17;MMRN1;PREX2;ASXL3;PTPRD;THSD7A;RUNX1T1;NTRK2
prerank,Reactome_2022__Sphingolipid Metabolism R-HSA-428157,0.38516410582797755,0.96005393987642,0.5172413793103449,0.8413697614310859,1.0,9/61,6.65%,VAPB;ACER2;ARSA;PPM1L;GLB1;PLPP1;FA2H;ARSD;SPTLC2
prerank,"GO_Biological_Process_2021__regulation of retrograde protein transport, ER to cytosol (GO:1904152)",0.4886656611343107,0.9599995751100802,0.4782608695652174,0.8410863366316272,1.0,1/12,2.48%,UBE2J1
prerank,GO_Biological_Process_2021__positive regulation of lipid metabolic process (GO:0045834),0.5276066325660478,0.9599924801589924,0.5217391304347826,0.8406959611863303,1.0,5/14,26.79%,PPARG;EEF1A2;ZBTB20;SIRT4;SORBS1
prerank,GO_Biological_Process_2021__regulation of centriole replication (GO:0046599),-0.5397259065328937,-0.9599663962892395,0.5245901639344263,0.9009650038432399,1.0,3/13,14.26%,STIL;NPM1;BRCA1
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Endometrium,-0.6892008334353505,-0.959917851300722,0.5833333333333334,0.9007573989822498,1.0,2/5,12.82%,CD14;PTPRC
prerank,GO_Biological_Process_2021__positive regulation of macrophage chemotaxis (GO:0010759),-0.5939867657566051,-0.9598251905864921,0.6666666666666666,0.900664299062884,1.0,1/8,1.49%,CCL5
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Endometrium,-0.45677486958278946,-0.9597963601102347,0.5303030303030303,0.9003980865303866,1.0,17/59,11.05%,SAT1;FOSL2;FOS;MDFIC;PARP14;ANXA2;SAMD9L;GBP3;SNTB1;PLSCR1;SGK1;CLCA4;ITGA6;CD44;S100A6;CFTR;PRR5L
prerank,GO_Biological_Process_2021__regulation of receptor catabolic process (GO:2000644),-0.6064812628280106,-0.9596627848193835,0.6086956521739131,0.9002948089625079,1.0,1/5,5.72%,DTX3L
prerank,GO_Biological_Process_2021__cellular protein-containing complex assembly (GO:0034622),0.33573877107345185,0.9595729765932546,0.5,0.8412084752195016,1.0,12/118,6.90%,VAMP1;SMAD1;HIP1R;IMMP2L;PICALM;NCK2;NUP153;PDE4DIP;SMAD2;SMAD3;NRG1;TCP1
prerank,Reactome_2022__SUMOylation Of SUMOylation Proteins R-HSA-4085377,0.391377965298677,0.9595346518774172,0.4864864864864865,0.8408860740270708,1.0,6/32,17.93%,NUP153;NUP188;NUP42;NDC1;NUP133;NUP205
prerank,GO_Biological_Process_2021__mitotic intra-S DNA damage checkpoint signaling (GO:0031573),-0.5530220301730637,-0.9593958010421398,0.49019607843137253,0.9005930894553438,1.0,3/12,5.76%,HUS1;MUS81;TIPIN
prerank,GO_Biological_Process_2021__positive regulation of nervous system development (GO:0051962),0.4345499063158784,0.9593007240115485,0.48148148148148145,0.8410598859409161,1.0,8/31,11.05%,GRID2;DLG5;NLGN1;LIG4;CLSTN2;NUMBL;CLSTN3;PTPRD
prerank,KEGG_2021_Human__Legionellosis,-0.45391655147549786,-0.9592754079149715,0.5633802816901409,0.900482896925606,1.0,9/44,18.22%,CYCS;NAIP;CD14;ITGB2;HSPA1B;HSPA1A;C3;IL18;HSPA2
prerank,GO_Biological_Process_2021__cellular response to cold (GO:0070417),0.605418981692236,0.958808983221707,0.5277777777777778,0.8418756369440341,1.0,3/5,26.72%,DNAJC3;FOXO1;EIF2AK4
prerank,GO_Biological_Process_2021__anterograde synaptic vesicle transport (GO:0048490),0.5573263505648531,0.9587877727993843,0.6,0.8411245211612173,1.0,2/8,9.74%,AP3B2;AP3S1
prerank,GO_Biological_Process_2021__synaptic vesicle transport along microtubule (GO:0099517),0.5573263505648531,0.9587877727993843,0.6,0.8411245211612173,1.0,2/8,9.74%,AP3B2;AP3S1
prerank,Reactome_2022__CTNNB1 S33 Mutants Not Phosphorylated R-HSA-5358747,0.551124852635185,0.9587868405218354,0.5526315789473685,0.8403186382081904,1.0,3/12,15.67%,PPP2R1B;PPP2R5E;GSK3B
prerank,Reactome_2022__Beta-catenin Phosphorylation Cascade R-HSA-196299,0.551124852635185,0.9587868405218354,0.5526315789473685,0.8403186382081904,1.0,3/12,15.67%,PPP2R1B;PPP2R5E;GSK3B
prerank,CellMarker_Augmented_2021__Mesothelial cell:Undefined,-0.5330325910080254,-0.9587118989376406,0.5344827586206896,0.9012857985721218,1.0,3/15,9.97%,JUP;LLGL2;SSH3
prerank,KEGG_2021_Human__Non-small cell lung cancer,0.38035678762181385,0.9586270587448799,0.5384615384615384,0.8402899390609074,1.0,12/56,18.09%,TGFA;CASP9;E2F3;MAP2K1;HGF;MAPK1;CDK6;FHIT;RARB;AKT2;PIK3CA;MAP2K2
prerank,GO_Biological_Process_2021__dendritic cell differentiation (GO:0097028),0.5323340864355743,0.9583735278654347,0.5483870967741935,0.8404466032202833,1.0,2/12,10.07%,TGFBR2;LGALS9
prerank,GO_Biological_Process_2021__positive regulation of histone deacetylation (GO:0031065),-0.5632928373904201,-0.9582548853058573,0.5818181818181818,0.9019705452222754,1.0,5/10,23.03%,PRKD2;AKAP8;VEGFA;CTBP1;AKAP8L
prerank,GO_Biological_Process_2021__translational elongation (GO:0006414),-0.438684278024374,-0.9581601013946164,0.5875,0.9018772301891914,1.0,23/75,17.99%,RACK1;MRPL57;AURKAIP1;MRPS7;MRPL51;MRPL19;GADD45GIP1;MRPL52;MRPL50;MRPS11;GTPBP2;MRPS10;MRPS15;MRPL16;MRPL32;CHCHD1;EEF1B2;OXA1L;MRPL43;MRPS18C;MRPL45;MRPS25;EEF2
prerank,Reactome_2022__Signaling By TGF-beta Receptor Complex R-HSA-170834,0.3617924335258214,0.9580491783053103,0.5357142857142857,0.8406985463987062,1.0,20/72,16.37%,UBE2D1;SERPINE1;TGFBR2;SMAD7;PARP1;SMAD2;SMAD3;XPO1;LTBP3;NEDD4L;HDAC1;ITGAV;MAPK1;SRFBP1;SMURF1;TGFBR1;PPM1A;TGIF1;PARD3;TRIM33
prerank,Reactome_2022__Regulation Of TP53 Activity Thru Acetylation R-HSA-6804758,-0.49484176176907857,-0.9579173301109095,0.5166666666666667,0.9020361575685696,1.0,3/28,4.84%,CHD3;ING3;ING5
prerank,GO_Biological_Process_2021__vascular process in circulatory system (GO:0003018),0.599398020677861,0.9578160930191453,0.6388888888888888,0.8404333923731411,1.0,3/7,15.46%,GCLC;ADCY6;SCPEP1
prerank,GO_Biological_Process_2021__regulation of tube diameter (GO:0035296),0.599398020677861,0.9578160930191453,0.6388888888888888,0.8404333923731411,1.0,3/7,15.46%,GCLC;ADCY6;SCPEP1
prerank,GO_Biological_Process_2021__positive regulation of protein serine/threonine kinase activity (GO:0071902),0.3968487158285514,0.9576727101170546,0.5789473684210527,0.8403598636423999,1.0,16/74,9.13%,PDGFA;PKD2;FGF2;SIRT1;PKD1;LRRK2;NEK10;MAP2K1;WNT5A;CIB1;PDGFC;CAB39;TNF;ROBO1;IRAK1;SPDYA
prerank,GO_Biological_Process_2021__positive regulation of nitric oxide biosynthetic process (GO:0045429),0.5040376327898615,0.9573719608384269,0.5588235294117647,0.8405497339742795,1.0,4/17,7.30%,KLF4;PKD2;SMAD3;TNF
prerank,Reactome_2022__GRB2:SOS Provides Linkage To MAPK Signaling For Integrins R-HSA-354194,0.5642062756840281,0.9573484521726815,0.6046511627906976,0.8401738179096537,1.0,2/10,13.77%,RAP1A;PTK2
prerank,GO_Biological_Process_2021__positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway (GO:0051482),-0.5704823464333966,-0.9573357129062323,0.5576923076923077,0.9030789501626264,1.0,2/10,13.82%,P2RY8;LPAR6
prerank,KEGG_2021_Human__Regulation of actin cytoskeleton,-0.38302786066437194,-0.9573121927832228,0.5875,0.902778212935451,1.0,22/151,12.45%,MYLK;CHRM2;CXCR4;VAV3;PDGFD;ARHGEF1;PPP1CB;ACTG1;ITGA4;CFL1;ITGA6;TMSB4X;SSH3;MYL12A;CHRM5;ITGB2;ACTB;NCKAP1L;ITGAL;ARPC5L;CYFIP2;PFN1
prerank,Reactome_2022__Downstream Signaling Of Activated FGFR1 R-HSA-5654687,0.4589797987541006,0.9572748756443117,0.42857142857142855,0.8399717807757471,1.0,7/16,23.61%,PIGU;FLRT1;FLRT2;PIK3CA;FGFR1;FRS2;PIK3R1
prerank,CellMarker_Augmented_2021__Epithelial cell:Epithelium,-0.45832845427701085,-0.9572561781471113,0.4868421052631579,0.9025708674659066,1.0,9/41,11.65%,MS4A4A;SIGLEC1;CD93;TNFSF10;F13A1;PECAM1;MS4A6A;SPARCL1;A2M
prerank,GO_Biological_Process_2021__regulation of protein autoubiquitination (GO:1902498),0.5634421821153689,0.9572174468792499,0.5238095238095238,0.8396972070240767,1.0,2/6,9.91%,LRRK2;SASH1
prerank,GO_Biological_Process_2021__response to metal ion (GO:0010038),-0.45164094843910657,-0.9571670038952274,0.5081967213114754,0.9024430101628551,1.0,5/43,8.36%,MT2A;HAMP;TTN;PLSCR1;CALM1
prerank,GO_Biological_Process_2021__negative regulation of protein modification by small protein conjugation or removal (GO:1903321),-0.445547163828893,-0.9569741011398704,0.5588235294117647,0.9025324616268495,1.0,8/39,9.91%,UBXN1;RPL5;PER2;RPL11;RPS3;TNFAIP3;U2AF2;VPS28
prerank,GO_Biological_Process_2021__regulation of mitochondrial fission (GO:0090140),0.4575549088581974,0.9568226761860305,0.5555555555555556,0.8400547902140273,1.0,4/20,9.11%,MCU;MARCHF5;LRRK2;DDHD1
prerank,GO_Biological_Process_2021__cadmium ion transport (GO:0015691),0.6445921640165527,0.9567816980600167,0.6666666666666666,0.8393108213296777,1.0,2/5,5.71%,SLC39A14;SLC39A8
prerank,GO_Biological_Process_2021__cadmium ion transmembrane transport (GO:0070574),0.6445921640165527,0.9567816980600167,0.6666666666666666,0.8393108213296777,1.0,2/5,5.71%,SLC39A14;SLC39A8
prerank,Reactome_2022__Switching Of Origins To A Post-Replicative State R-HSA-69052,-0.4360307471167473,-0.9565301222109647,0.5945945945945946,0.9031146908623959,1.0,14/67,14.90%,UBC;RPS27A;PSMB3;PSMB6;PSMA7;PSMB9;RBX1;PSMD12;ANAPC11;PSMD8;PSMA5;MCM7;UBA52;CDC26
prerank,GO_Biological_Process_2021__activation of NF-kappaB-inducing kinase activity (GO:0007250),-0.5240340968572377,-0.9563742164312895,0.5087719298245614,0.903103907788041,1.0,3/12,12.38%,CARD14;CHI3L1;COPS8
prerank,GO_Biological_Process_2021__intracellular sterol transport (GO:0032366),0.512997563020437,0.9563390772322636,0.5652173913043478,0.8400645353129484,1.0,1/11,4.97%,STARD4
prerank,GO_Biological_Process_2021__DNA replication initiation (GO:0006270),-0.4993941773975008,-0.956034812755641,0.484375,0.9034926189165245,1.0,7/24,22.17%,POLE3;MCM7;RPA3;PRIM1;MCM6;CDC7;MCM5
prerank,GO_Biological_Process_2021__cellular response to growth hormone stimulus (GO:0071378),0.5827376250900727,0.9558731091171327,0.5652173913043478,0.8407282271127281,1.0,3/6,27.36%,PTK2;PIK3R1;PXN
prerank,GO_Biological_Process_2021__response to cytokine (GO:0034097),-0.42501250990332673,-0.9557417685171435,0.5921052631578947,0.9037708723554301,1.0,15/106,10.20%,MX2;SIGIRR;MX1;CXCR4;XAF1;PID1;IFITM3;SHFL;OSMR;EIF2AK2;PLSCR1;NLRP12;CHI3L1;STAT1;SLC11A1
prerank,GO_Biological_Process_2021__monocarboxylic acid catabolic process (GO:0072329),0.5398001539160555,0.9556056606422727,0.5769230769230769,0.8409617318386357,1.0,2/11,8.50%,FAAH;FAH
prerank,GO_Biological_Process_2021__negative regulation of transforming growth factor beta production (GO:0071635),-0.6458173149946125,-0.955582968920901,0.6666666666666666,0.9038114695180304,1.0,2/5,25.48%,TYROBP;LILRB1
prerank,Reactome_2022__Post-translational Protein Modification R-HSA-597592,0.29044404460232026,0.9554493031100337,0.5,0.8408660336120962,1.0,133/940,13.01%,PIGQ;UBE2D1;SPSB2;B3GNT2;PPARGC1A;FBXO30;TUBA1C;RAB33B;ARSA;SPON1;PIGU;PGAP1;RNF2;DCAF16;SEMA5A;GOLM1;KBTBD6;FAM20C;SMAD1;TGFBR2;UHRF2;TGFA;ST6GAL2;STAMBPL1;SMAD7;FBXL14;ZBTB16;MITF;RNF139;GNPNAT1;GLB1;LARGE1;SAE1;OTUD7A;FBXO32;GALNTL6;B4GALT4;DCAF13;NRIP1;TRIM26;BET1;TOMM70;TTLL11;FEM1B;NUP153;NUP188;DDA1;CTSC;USP30;CPM;RAB10;ST6GALNAC3;PPARG;MGAT4C;MPDU1;PARP1;TMED3;DAG1;RAB1B;SEC24B;SMAD2;PRKCSH;SMAD3;SEL1L;ARSD;MDGA2;GFPT1;ADAMTSL2;VGF;INO80E;UBE2D2;RECK;ANO8;NUP42;DPH5;SEM1;TAF9B;COPG1;TDG;TTLL1;NTM;DCUN1D4;GPS1;RAB7A;ADAMTS17;PIGT;SPTAN1;VCPKMT;PPP3CA;ZRANB1;ADAMTSL3;GRIA1;SATB2;MDM2;LMAN2L;KCTD6;BTRC;HDAC1;C1GALT1;DMTF1;NSMCE1;HIF3A;UBA1;COG1;RNF20;UBE2L3;PEX13;PIGC;FBXW11;FBXW7;EPAS1;FEM1C;RNF185;THSD7A;KAT2A;MVD;DCAF5;ST6GALNAC5;PTEN;TTLL7;HNRNPC;UBE2N;RAB6A;DCUN1D1;PEX5;THSD7B;KLHL42;NEGR1;FBXL12;UBA2;FBXL7;RENBP;BARD1
prerank,GO_Biological_Process_2021__membrane organization (GO:0061024),-0.3910178029349926,-0.9551578703747444,0.573170731707317,0.9045056175175957,1.0,9/187,1.80%,MX2;UBC;EPN1;MX1;RPS27A;RIMS1;CHRM2;TFRC;IL7R
prerank,Reactome_2022__TRAF6 Mediated IRF7 Activation In TLR7/8 Or 9 Signaling R-HSA-975110,0.5775745219926802,0.9551027176096267,0.6097560975609756,0.8412553002909366,1.0,4/7,14.94%,TLR7;IRAK1;UBE2N;TRAF6
prerank,GO_Biological_Process_2021__L-serine biosynthetic process (GO:0006564),0.6031548536829083,0.9550785941818442,0.6346153846153846,0.8408977353508269,1.0,3/5,34.37%,PSPH;SRR;PSAT1
prerank,GO_Biological_Process_2021__import into cell (GO:0098657),-0.4867534286388775,-0.9550671475243993,0.5846153846153846,0.9044014827119112,1.0,4/27,5.41%,SLC7A5;SLC38A1;IL10RA;GLUL
prerank,GO_Biological_Process_2021__positive regulation of cell cycle process (GO:0090068),-0.46329026591314554,-0.9549269384532147,0.5606060606060606,0.9044211694418985,1.0,8/55,13.80%,DDX11;IGF1;RANBP1;CENPV;PLSCR1;XRCC3;ZNF16;NUDT16
prerank,Reactome_2022__Separation Of Sister Chromatids R-HSA-2467813,-0.4076087283626057,-0.9549159520673909,0.5,0.9040972438814757,1.0,28/123,19.77%,UBC;RPS27A;PSMB3;RPS27;PSMB6;PSMA7;CENPU;PSMB9;ITGB3BP;ZWILCH;PSMD12;ANAPC11;PSMD8;PSMA5;MIS12;DYNC1LI2;SMC1A;UBA52;CDC26;SEC13;PSMA3;SGO2;PSMC4;CENPF;BUB3;PSME2;PSME1;DYNC1I2
prerank,GO_Biological_Process_2021__peptidyl-proline hydroxylation to 4-hydroxy-L-proline (GO:0018401),-0.6447664554312403,-0.9548215080195528,0.5555555555555556,0.9039521675797474,1.0,2/5,12.90%,EGLN3;P4HA3
prerank,Reactome_2022__FRS-mediated FGFR1 Signaling R-HSA-5654693,-0.5573649236149825,-0.9547772528575805,0.559322033898305,0.9036904675895489,1.0,2/10,14.45%,FGF13;FGF20
prerank,Reactome_2022__Mitotic Anaphase R-HSA-68882,-0.3912388779912633,-0.954687076135896,0.5301204819277109,0.9032294182823876,1.0,22/170,14.90%,TUBB8;UBC;RPS27A;PSMB3;RPS27;EMD;PSMB6;PSMA7;CENPU;PSMB9;ITGB3BP;ZWILCH;PSMD12;ANAPC11;PSMD8;PSMA5;MIS12;TUBB4B;DYNC1LI2;SMC1A;UBA52;CDC26
prerank,Reactome_2022__Mitotic Metaphase And Anaphase R-HSA-2555396,-0.3912388779912633,-0.954687076135896,0.5301204819277109,0.9032294182823876,1.0,22/170,14.90%,TUBB8;UBC;RPS27A;PSMB3;RPS27;EMD;PSMB6;PSMA7;CENPU;PSMB9;ITGB3BP;ZWILCH;PSMD12;ANAPC11;PSMD8;PSMA5;MIS12;TUBB4B;DYNC1LI2;SMC1A;UBA52;CDC26
prerank,Reactome_2022__HIV Life Cycle R-HSA-162587,-0.37992739611714194,-0.9546517813947208,0.52,0.9029717210595488,1.0,12/130,10.95%,UBC;RPS27A;CXCR4;GTF2H5;CTDP1;ELOB;RANBP1;POLR2G;RNMT;NCBP2;VPS28;NUP50
prerank,GO_Biological_Process_2021__protein modification process (GO:0036211),-0.4352211210457713,-0.9545247159175388,0.5,0.9029404767827756,1.0,11/58,17.24%,USP6;YES1;ERO1A;GGCX;ADPRH;SEPHS1;UBA52;RPN1;PARP4;PIGH;SERP1
prerank,GO_Biological_Process_2021__chromatin disassembly (GO:0031498),0.49525930448921807,0.9545238644206031,0.5348837209302325,0.8412688581571807,1.0,3/11,10.75%,ARID1A;HMGA1;SUPT16H
prerank,GO_Biological_Process_2021__nucleosome disassembly (GO:0006337),0.49525930448921807,0.9545238644206031,0.5348837209302325,0.8412688581571807,1.0,3/11,10.75%,ARID1A;HMGA1;SUPT16H
prerank,GO_Biological_Process_2021__negative regulation of cellular process (GO:0048523),0.30258765026355766,0.9544732221182282,0.5454545454545454,0.8409729875486358,1.0,40/332,8.92%,KLF4;IFNLR1;PLXNB1;SERTAD2;PDPN;PKD2;SEMA5A;CDKN2AIP;PLXNA2;FGF2;DLG5;SIRT1;RNF139;CDK10;CHD5;MARCHF5;CBFA2T3;SIRPA;NCK2;MAP2K1;TSC2;ANP32B;PLPP1;DNAJB2;PLXNA3;SMAD3;CIB1;PPT1;ADRA1A;TXNDC12;PLXNB2;HMGA1;PLXNC1;NACC2;SOX4;NDRG3;CNOT7;CTBP2;CD33;NME6
prerank,GO_Biological_Process_2021__positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),0.33923302933872185,0.9543692735220536,0.56,0.8407607986918476,1.0,14/83,10.29%,ACER2;GSN;HIP1R;SIRT1;CASP9;TNFRSF10A;ANP32B;PPARG;SMAD3;TNF;ROBO1;BOK;LGALS9;LAPTM5
prerank,GO_Biological_Process_2021__regulation of release of sequestered calcium ion into cytosol (GO:0051279),0.45621144976241346,0.9543171479267293,0.5405405405405406,0.8404987964118044,1.0,1/23,0.46%,TRPC1
prerank,GO_Biological_Process_2021__negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),-0.4964227627346399,-0.9537769288263356,0.5571428571428572,0.9042902706255643,1.0,3/27,5.31%,UBXN1;DDRGK1;RPL11
prerank,CellMarker_Augmented_2021__Hematopoietic Stem cell:Embryo,-0.4514436932491598,-0.9535623161546057,0.5211267605633803,0.904392145097612,1.0,11/48,12.34%,CH25H;MS4A4A;SIDT2;SIGLEC1;CTSB;CD93;VILL;OLFML2B;FBP1;A2M;FLT1
prerank,GO_Biological_Process_2021__regulation of catecholamine secretion (GO:0050433),0.488597653227656,0.9535276285228916,0.5555555555555556,0.8419923170607513,1.0,6/15,22.41%,STX1A;SYT17;KCNB1;SNCA;SYT4;DTNBP1
prerank,GO_Biological_Process_2021__DNA geometric change (GO:0032392),-0.4624569835503459,-0.9534161160868005,0.5245901639344263,0.9043672456069318,1.0,1/21,0.51%,DDX11
prerank,KEGG_2021_Human__Renin secretion,0.40426110468739,0.9533010274537858,0.5365853658536586,0.8420742026746797,1.0,12/39,18.03%,KCNJ2;GNAQ;PLCB4;GUCY1A1;PPP3CA;GUCY1A2;PDE3B;ADCY6;PDE1C;GUCY1B1;PPP3CB;PLCB3
prerank,GO_Biological_Process_2021__positive regulation of apoptotic process (GO:0043065),-0.37922870445790147,-0.9532005822792872,0.5584415584415584,0.9045306263393478,1.0,25/217,9.49%,PLEKHG5;CCL3;UBC;RPS27A;MNDA;RASGRF2;GADD45B;VAV3;RACK1;TNFSF10;ING3;CLU;ING5;ARHGEF1;RPS3;MTCH1;TNFAIP8;ARHGEF3;OBSCN;RPS6;IFIT2;ITGA6;MTCH2;PDCD5;ITGB3BP
prerank,GO_Biological_Process_2021__negative regulation of mRNA polyadenylation (GO:1900364),0.5492087558740282,0.953170678173934,0.5283018867924528,0.8418951898295518,1.0,3/8,20.63%,RNF20;ZC3H14;CDK9
prerank,GO_Biological_Process_2021__positive regulation of cell migration (GO:0030335),-0.3902133914190895,-0.9531566190190746,0.5675675675675675,0.9042627571470911,1.0,19/166,8.60%,CCL3;MYLK;CCL5;SYNE2;PDGFD;AIF1;CEMIP;GLIPR2;PLET1;DDRGK1;RACK1;RAB11A;IGF1;PECAM1;SEMA6A;ACTG1;ENPP2;FERMT3;ITGA6
prerank,GO_Biological_Process_2021__peroxisome proliferator activated receptor signaling pathway (GO:0035357),0.608751487518119,0.9531441464506373,0.6326530612244898,0.841544398747424,1.0,1/5,5.17%,PPARG
prerank,GO_Biological_Process_2021__inner dynein arm assembly (GO:0036159),-0.6273040953479039,-0.9529829157890604,0.5882352941176471,0.9043713281960699,1.0,2/5,12.06%,DNAH1;CCDC39
prerank,GO_Biological_Process_2021__regulation of mRNA stability (GO:0043488),-0.4065023601489696,-0.9528707343527476,0.6103896103896104,0.9042815125818037,1.0,16/120,14.82%,UBC;RPS27A;ZFP36;PSMB3;PSMB6;PSMA7;PSMB9;EXOSC1;SLC11A1;NPM1;PSMD12;PSMD8;PSMA5;APEX1;HSPA1A;UBA52
prerank,CellMarker_Augmented_2021__Endocrine cell:Undefined,-0.535343593266184,-0.952844244617391,0.547945205479452,0.9036545304855701,1.0,3/23,3.92%,LIPG;HS3ST1;DUOX1
prerank,CellMarker_Augmented_2021__Endocrine cell:Embryonic Stem Cell,-0.535343593266184,-0.952844244617391,0.547945205479452,0.9036545304855701,1.0,3/23,3.92%,LIPG;HS3ST1;DUOX1
prerank,Reactome_2022__Diseases Associated With Glycosylation Precursor Biosynthesis R-HSA-5609975,0.55627907829325,0.9525822603517642,0.5121951219512195,0.842308303860536,1.0,3/8,26.42%,GFPT1;NUS1;GALE
prerank,GO_Biological_Process_2021__protein complex oligomerization (GO:0051259),0.3693627853542277,0.9525772460917576,0.5555555555555556,0.8419133183050614,1.0,10/67,8.90%,TIFA;PKD2;ZBTB1;MCU;UGDH;TMEM120B;BOK;NACC2;KCNC2;SLC9A1
prerank,Reactome_2022__Regulation Of PLK1 Activity At G2/M Transition R-HSA-2565942,-0.4268210062828301,-0.9523792119529464,0.5131578947368421,0.9045076715611283,1.0,9/70,14.82%,UBC;RPS27A;SSNA1;PPP1CB;CEP72;CEP164;CSNK1D;TUBB4B;UBA52
prerank,"GO_Biological_Process_2021__DNA-templated transcription, initiation (GO:0006352)",0.3436277462346816,0.9522492909209682,0.5652173913043478,0.842271987952055,1.0,13/119,7.63%,ESRRG;PPARGC1A;POLR2D;MAML2;HDAC9;E2F3;PPARG;TFB1M;CDK7;TAF2;MAML3;RRN3;TAF9B
prerank,GO_Biological_Process_2021__regulation of translational initiation (GO:0006446),-0.4301463561013112,-0.9519985142153127,0.5454545454545454,0.904970986302296,1.0,7/58,12.13%,MIF4GD;CCL5;EIF1;POLR2G;NCBP2;NPM1;ATF3
prerank,Reactome_2022__Defective B3GAT3 Causes JDSSDHD R-HSA-3560801,0.49351516541400386,0.9518314094331831,0.5,0.8427244320563247,1.0,3/11,12.44%,NCAN;CSPG5;GPC6
prerank,GO_Biological_Process_2021__protein O-linked mannosylation (GO:0035269),0.482343492743328,0.9518115397589294,0.4883720930232558,0.842385147182449,1.0,4/14,12.20%,LARGE1;TMTC2;FKRP;FKTN
prerank,GO_Biological_Process_2021__regulation of cyclin-dependent protein kinase activity (GO:1904029),0.4256240909299897,0.9517239134743238,0.5116279069767442,0.8422010505521815,1.0,7/27,16.39%,CDK5R1;CCNG2;CDK7;CCNG1;GTPBP4;CCND3;BLM
prerank,Reactome_2022__Downstream Signaling Of Activated FGFR4 R-HSA-5654716,0.4991246452970952,0.951375700950305,0.5111111111111111,0.8425589031162362,1.0,1/13,1.00%,PIGU
prerank,GO_Biological_Process_2021__positive regulation of signaling (GO:0023056),0.46404381319614973,0.9513359728555231,0.5128205128205128,0.8422367564242736,1.0,7/25,10.53%,SCRIB;CDKN2AIP;PTPN23;GRIK2;TNF;CLSTN2;CLSTN3
prerank,GO_Biological_Process_2021__negative regulation of kinase activity (GO:0033673),0.35461775772733234,0.9511886467178569,0.5405405405405406,0.842180022512819,1.0,7/51,9.33%,QARS1;SPRED1;TSC2;GNAQ;CEP85;YWHAG;DEPTOR
prerank,GO_Biological_Process_2021__glutathione metabolic process (GO:0006749),-0.4724233509976564,-0.9511325719218274,0.5909090909090909,0.9065976376388301,1.0,8/20,14.09%,GSTM4;GSTP1;GSTK1;GCLM;GSTM3;GLRX2;SOD1;GPX1
prerank,Reactome_2022__RNA Polymerase III Transcription Initiation R-HSA-76046,-0.4784042544413343,-0.9510649029653409,0.5245901639344263,0.9063912002401567,1.0,2/29,3.40%,SNAPC1;GTF3C6
prerank,GO_Biological_Process_2021__negative regulation of transcription by RNA polymerase II (GO:0000122),0.2904183781085951,0.9505995660534822,0.8571428571428571,0.8431722288194499,1.0,50/426,9.99%,KLF4;UBE2D1;BAG3;ZNF175;ZBTB1;TFEC;RNF2;CBX6;GLIS3;DR1;SIRT1;SMAD7;ZBTB16;MITF;ZNF536;HDAC9;MTA2;NRIP1;MIER3;MXD4;JAZF1;FOXP4;MOSPD1;PPARG;PARP1;ZNF555;ZNF75A;CXXC5;SMAD2;DDIT3;SMAD3;DACH1;RUNX1;ZBTB2;SALL1;TNF;BCL11A;NFIX;TAF9B;ZNF3;NACC2;NEDD4L;HSF4;CTBP2;SIRT6;MDM2;HDAC1;NFIB;LOXL2;CNOT2
prerank,GO_Biological_Process_2021__axonemal dynein complex assembly (GO:0070286),-0.5497436931850683,-0.9505401220933082,0.625,0.9072658864076483,1.0,5/12,22.38%,DNAH17;DNAH1;CCDC39;TTC12;DNAI4
prerank,GO_Biological_Process_2021__negative regulation of protein localization to membrane (GO:1905476),-0.5100243929343007,-0.9505318051291655,0.5,0.9069570913972472,1.0,1/19,1.81%,PID1
prerank,GO_Biological_Process_2021__protein kinase C signaling (GO:0070528),-0.6113418690132342,-0.950399904569932,0.5818181818181818,0.906999493502658,1.0,3/7,22.29%,PLEK;FLOT1;PDGFB
prerank,KEGG_2021_Human__Pancreatic cancer,0.3767082821598109,0.9501402262871135,0.5625,0.843771728808776,1.0,7/62,5.98%,TGFBR2;TGFA;CASP9;E2F3;MAP2K1;SMAD2;SMAD3
prerank,Reactome_2022__RA Biosynthesis Pathway R-HSA-5365859,-0.5261429841095154,-0.9500944178554104,0.5272727272727272,0.907307541623592,1.0,6/8,37.54%,RDH14;RDH11;RDH10;DHRS4;ALDH1A1;ALDH1A2
prerank,GO_Biological_Process_2021__rRNA transcription (GO:0009303),-0.528318838980967,-0.9499966563932659,0.5714285714285714,0.9072408244466793,1.0,1/15,3.40%,GTF3C6
prerank,GO_Biological_Process_2021__lipid catabolic process (GO:0016042),-0.5527828352792474,-0.949831508369025,0.5254237288135594,0.9072660536902756,1.0,1/10,2.51%,LIPG
prerank,GO_Biological_Process_2021__bone cell development (GO:0098751),-0.6074467122377287,-0.9495783311185213,0.6610169491525424,0.9075022049001524,1.0,1/6,3.81%,ANXA2
prerank,GO_Biological_Process_2021__cellular response to acid chemical (GO:0071229),0.4614701122053257,0.9495186501898174,0.45161290322580644,0.8446023010126424,1.0,3/23,6.73%,RRAGD;GLRA1;CPEB4
prerank,GO_Biological_Process_2021__glycosaminoglycan catabolic process (GO:0006027),0.435998623936393,0.9494892323935149,0.5882352941176471,0.8442689244125284,1.0,6/31,8.90%,NCAN;FGF2;GLB1;CSPG5;HPSE;SLC9A1
prerank,PanglaoDB_Augmented_2021__Pulmonary Vascular Smooth Muscle Cells,-0.482952280948417,-0.949437052467932,0.4794520547945205,0.9074660987142851,1.0,2/35,0.65%,MYLK;COL5A1
prerank,GO_Biological_Process_2021__negative regulation of G0 to G1 transition (GO:0070317),0.40996917767363583,0.949308303681664,0.5384615384615384,0.8438234129360753,1.0,5/30,16.85%,RNF2;RYBP;APAF1;PHC1;YAF2
prerank,GO_Biological_Process_2021__regulation of G0 to G1 transition (GO:0070316),0.40996917767363583,0.949308303681664,0.5384615384615384,0.8438234129360753,1.0,5/30,16.85%,RNF2;RYBP;APAF1;PHC1;YAF2
prerank,GO_Biological_Process_2021__regulation of phosphatase activity (GO:0010921),0.4948230744436195,0.9491810479448481,0.625,0.8437385930904592,1.0,4/16,18.72%,TIPRL;PTPA;MTMR9;CHP1
prerank,GO_Biological_Process_2021__positive regulation of receptor recycling (GO:0001921),0.569353161070441,0.9491761421372806,0.6666666666666666,0.8433402273713417,1.0,1/8,0.84%,SCRIB
prerank,GO_Biological_Process_2021__cardiac left ventricle morphogenesis (GO:0003214),0.5931405074728725,0.9491557492998245,0.58,0.8430137326199016,1.0,1/6,1.95%,TGFBR2
prerank,Reactome_2022__Trafficking Of GluR2-containing AMPA Receptors R-HSA-416993,0.49114118013728414,0.9490975487583697,0.4883720930232558,0.8427480130935452,1.0,4/14,14.20%,GRIA3;GRIA4;GRIA1;GRIA2
prerank,GO_Biological_Process_2021__positive regulation of interleukin-1 beta production (GO:0032731),-0.45312363043521786,-0.949065836049316,0.5915492957746479,0.9080113700453174,1.0,5/38,4.19%,CD36;CCL3;MNDA;PYHIN1;AIM2
prerank,CellMarker_Augmented_2021__B cell:Fetal Liver,-0.639036328433378,-0.9489882061660123,0.5660377358490566,0.9078459589421393,1.0,2/6,20.27%,BANK1;NCF1
prerank,GO_Biological_Process_2021__regulation of fat cell differentiation (GO:0045598),-0.45467499915025095,-0.9488345437817609,0.5,0.9078471327119372,1.0,3/49,3.27%,SYAP1;ZFP36;RORA
prerank,Reactome_2022__GABA Receptor Activation R-HSA-977443,0.4025179018427132,0.9483237513664337,0.5172413793103449,0.8442187832133524,1.0,14/35,24.98%,KCNJ2;KCNJ5;ADCY9;GABRR2;NPTN;ADCY6;ARHGEF9;GABRB2;GABRG3;GABRA4;GABRA2;KCNJ6;GABRB1;GNG7
prerank,GO_Biological_Process_2021__parallel actin filament bundle assembly (GO:0030046),-0.6199400974633564,-0.9476801930181319,0.625,0.9100148702179667,1.0,1/5,2.67%,AIF1
prerank,GO_Biological_Process_2021__positive regulation of protein kinase C signaling (GO:0090037),0.592827104924253,0.9471903911141588,0.5777777777777777,0.8463416958698144,1.0,2/6,6.22%,WNT5A;ADRA1A
prerank,GO_Biological_Process_2021__phospholipid efflux (GO:0033700),-0.6105079298659433,-0.9471184108750238,0.5777777777777777,0.9109928690766324,1.0,3/5,38.78%,ABCA7;APOE;APOC1
prerank,GO_Biological_Process_2021__glycogen biosynthetic process (GO:0005978),-0.5859393658744054,-0.9470855628247137,0.59375,0.9103856713053972,1.0,1/9,3.13%,PER2
prerank,GO_Biological_Process_2021__glucan biosynthetic process (GO:0009250),-0.5859393658744054,-0.9470855628247137,0.59375,0.9103856713053972,1.0,1/9,3.13%,PER2
prerank,KEGG_2021_Human__JAK-STAT signaling pathway,0.3773965672929575,0.9469090567092551,0.5862068965517241,0.8465358813712169,1.0,5/77,2.51%,LEPR;IFNLR1;PDGFA;GFAP;IL20RB
prerank,GO_Biological_Process_2021__protein localization to chromosome (GO:0034502),-0.4940164529506607,-0.946838260368422,0.5555555555555556,0.9106673213972056,1.0,1/25,1.79%,TPP1
prerank,GO_Biological_Process_2021__mRNA transcription by RNA polymerase II (GO:0042789),0.5633314015011751,0.9468244785693958,0.5365853658536586,0.8463019239981279,1.0,1/6,1.16%,ZBTB1
prerank,GO_Biological_Process_2021__negative regulation of calcineurin-NFAT signaling cascade (GO:0070885),0.5568970141580641,0.9467824114587646,0.5813953488372093,0.8455441497351397,1.0,4/6,27.48%,GSK3B;CHP1;HOMER2;DYRK2
prerank,GO_Biological_Process_2021__negative regulation of calcineurin-mediated signaling (GO:0106057),0.5568970141580641,0.9467824114587646,0.5813953488372093,0.8455441497351397,1.0,4/6,27.48%,GSK3B;CHP1;HOMER2;DYRK2
prerank,Reactome_2022__Interleukin-1 Processing R-HSA-448706,-0.6033140491035284,-0.9467430070202101,0.6153846153846154,0.910569137090023,1.0,4/8,34.98%,IL18;IL1B;IL1A;RELA
prerank,PanglaoDB_Augmented_2021__Juxtaglomerular Cells,0.41531804391338945,0.9464829341134817,0.5,0.8458040921582635,1.0,5/28,5.20%,COL16A1;SEMA5A;SVEP1;ACTA2;TIMP3
prerank,GO_Biological_Process_2021__regulation of hydrogen peroxide-induced cell death (GO:1903205),0.5120338353648178,0.9464355362945036,0.48,0.8454997258423338,1.0,1/8,3.81%,LRRK2
prerank,PanglaoDB_Augmented_2021__Cholangiocytes,-0.5380020388599219,-0.9460796347845464,0.5084745762711864,0.9117145015321851,1.0,3/13,10.61%,CLDN7;OVOL2;CFTR
prerank,GO_Biological_Process_2021__sequestering of extracellular ligand from receptor (GO:0035581),0.6049245136935766,0.9458456292150543,0.5777777777777777,0.8464655627459858,1.0,2/5,20.80%,FBN2;CD46
prerank,GO_Biological_Process_2021__RNA transport (GO:0050658),-0.4245309701558452,-0.9458453620479035,0.5352112676056338,0.9118666315044771,1.0,10/57,13.24%,ZFP36;SIDT2;DHX38;SIDT1;EIF4A3;CHTOP;U2AF2;NCBP2;SRSF2;SRSF7
prerank,GO_Biological_Process_2021__glutamine family amino acid catabolic process (GO:0009065),-0.6178538404454819,-0.9457087079442967,0.5689655172413793,0.9118493636898403,1.0,1/5,5.41%,GLUL
prerank,GO_Biological_Process_2021__positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),-0.4762441923536668,-0.9456582014660918,0.5454545454545454,0.9115918163572049,1.0,4/25,10.09%,PYHIN1;DDRGK1;CLU;ATP5IF1
prerank,GO_Biological_Process_2021__positive regulation of establishment of protein localization to telomere (GO:1904851),0.5489596297360225,0.9455473553610425,0.6363636363636364,0.8467301776763478,1.0,2/9,13.21%,TCP1;CCT3
prerank,GO_Biological_Process_2021__regulation of receptor-mediated endocytosis (GO:0048259),0.43125038747737826,0.9454034963109887,0.4583333333333333,0.8466664256091873,1.0,5/29,6.14%,SERPINE1;HIP1R;PICALM;SNAP91;PPT1
prerank,GO_Biological_Process_2021__embryonic heart tube morphogenesis (GO:0003143),0.4598507255163155,0.9453870286374407,0.5227272727272727,0.8463348954697701,1.0,5/18,13.38%,PKD2;TGFBR2;CCDC40;SETDB2;MEGF8
prerank,Reactome_2022__Signaling By FGFR3 In Disease R-HSA-5655332,0.4979916994374628,0.945339695992199,0.5652173913043478,0.8460364572874393,1.0,1/13,1.00%,PIGU
prerank,GO_Biological_Process_2021__acetyl-CoA biosynthetic process from pyruvate (GO:0006086),-0.6169178921511964,-0.944699538458143,0.6326530612244898,0.9136383748639729,1.0,3/5,20.82%,PDHX;PDHB;PDHA1
prerank,Reactome_2022__Downstream Signaling Of Activated FGFR2 R-HSA-5654696,0.4790372389667064,0.9446946555747261,0.5111111111111111,0.8471089988293244,1.0,1/14,1.00%,PIGU
prerank,GO_Biological_Process_2021__regulation of heart rate by cardiac conduction (GO:0086091),0.45824488705400607,0.9446466669745486,0.6296296296296297,0.8468541448243174,1.0,4/23,5.43%,KCNJ2;KCND3;SCN3B;KCNJ5
prerank,Reactome_2022__C-type Lectin Receptors (CLRs) R-HSA-5621481,-0.40700503833034185,-0.9445765859196913,0.6301369863013698,0.9135528248904726,1.0,12/99,12.85%,UBC;RPS27A;PSMB3;FCER1G;PSMB6;PSMA7;FYN;CALM1;PSMB9;PSMD12;PSMD8;PSMA5
prerank,Reactome_2022__Transport Of Nucleosides And Free Purine And Pyrimidine Bases Across Plasma Membrane R-HSA-83936,-0.6153179538235424,-0.9444324803007242,0.6226415094339622,0.913514667384884,1.0,2/6,12.36%,SLC25A5;SLC29A3
prerank,Reactome_2022__APC/C:Cdh1 Mediated Degradation Of Cdc20 And APC/C:Cdh1 Targets In Late Mitosis/Early G1 R-HSA-174178,-0.43440247822373806,-0.9443530192822267,0.5492957746478874,0.913378537933713,1.0,12/56,14.90%,UBC;RPS27A;PSMB3;PSMB6;PSMA7;PSMB9;PSMD12;ANAPC11;PSMD8;PSMA5;UBA52;CDC26
prerank,GO_Biological_Process_2021__mitral valve morphogenesis (GO:0003183),0.5201276665657795,0.9442061641294925,0.5531914893617021,0.8474233617431666,1.0,2/7,12.30%,SOX4;BMPR1A
prerank,GO_Biological_Process_2021__retinal ganglion cell axon guidance (GO:0031290),0.5998717181370264,0.9439466216354154,0.6190476190476191,0.8476757551176533,1.0,3/6,9.71%,NRP1;PTPRM;ALCAM
prerank,GO_Biological_Process_2021__regulation of dendrite development (GO:0050773),0.41704271794362485,0.9438499706834714,0.6129032258064516,0.8475245576790551,1.0,17/31,23.37%,BCL11A;NEDD4L;KNDC1;CSMD3;COBL;MARK1;DCC;KIAA0319;GSK3B;ADGRB3;CAMSAP2;NEDD4;SEMA4D;MFSD2A;RAP2A;TNIK;DAB2IP
prerank,GO_Biological_Process_2021__positive regulation of alpha-beta T cell activation (GO:0046635),-0.6333165969674579,-0.9437337792967491,0.6551724137931034,0.9145363086785202,1.0,4/10,18.79%,CD55;HLA-DRA;HLA-E;HLA-DRB1
prerank,GO_Biological_Process_2021__positive regulation of phagocytosis (GO:0050766),-0.475485041597566,-0.943459424464132,0.5303030303030303,0.91476796970525,1.0,8/32,14.85%,FCER1G;CD300LF;SLC11A1;NCKAP1L;CD47;CYBA;PTPRC;C3
prerank,Reactome_2022__Autodegradation Of Cdh1 By Cdh1:APC/C R-HSA-174084,-0.43822574136672937,-0.9433487901372952,0.5277777777777778,0.914749667760492,1.0,12/53,14.90%,UBC;RPS27A;PSMB3;PSMB6;PSMA7;PSMB9;PSMD12;ANAPC11;PSMD8;PSMA5;UBA52;CDC26
prerank,GO_Biological_Process_2021__cAMP-mediated signaling (GO:0019933),0.4927502796378875,0.9432727696157862,0.4878048780487805,0.8483977615336021,1.0,10/17,27.96%,PDE7B;RAPGEF3;RAPGEF2;KSR1;RIMS2;DGKQ;EPHA5;ADCY1;PDE2A;CAP1
prerank,GO_Biological_Process_2021__regulation of androgen receptor signaling pathway (GO:0060765),0.45637387038446053,0.9430088300445346,0.54,0.848507758983765,1.0,5/23,21.18%,SIRT1;HDAC1;RNF6;NCOA2;SAFB2
prerank,GO_Biological_Process_2021__heart looping (GO:0001947),0.48835947297416793,0.9428935453723045,0.5581395348837209,0.848448917528497,1.0,2/15,1.95%,PKD2;TGFBR2
prerank,Reactome_2022__Transport Of Ribonucleoproteins Into Host Nucleus R-HSA-168271,0.3998287055845424,0.942870931981396,0.6060606060606061,0.8480909001836582,1.0,10/32,25.85%,NUP153;NUP188;NUP42;NDC1;NUP133;NUP205;NUP98;KPNB1;TPR;KPNA1
prerank,GO_Biological_Process_2021__protein deacetylation (GO:0006476),-0.426922879223049,-0.9428444969913393,0.639344262295082,0.915493964967522,1.0,2/38,6.30%,FLNA;MSL3
prerank,GO_Biological_Process_2021__regulation of non-motile cilium assembly (GO:1902855),-0.6673071554442894,-0.9427000667965169,0.6444444444444445,0.9154754052099845,1.0,1/5,6.35%,WRAP73
prerank,Reactome_2022__Formation Of Annular Gap Junctions R-HSA-196025,-0.5468777805714852,-0.9422581019139818,0.5416666666666666,0.9161042351594151,1.0,4/9,30.19%,CLTB;AP2M1;CLTA;DAB2
prerank,CellMarker_Augmented_2021__Epithelial Progenitor cell:Lung,-0.5778247193563609,-0.9422331833987162,0.6,0.9158191925794256,1.0,2/8,8.48%,ANKRD22;CLCA4
prerank,GO_Biological_Process_2021__regulation of carbohydrate biosynthetic process (GO:0043255),-0.591684625458835,-0.9420738051887968,0.5892857142857143,0.9158140090517032,1.0,2/8,11.31%,SELENOS;FBP1
prerank,GO_Biological_Process_2021__regulation of stem cell population maintenance (GO:2000036),0.47551464047433306,0.94175460170543,0.5681818181818182,0.8502238309462471,1.0,7/15,12.63%,ZNF706;NCOA3;TAF5L;LOXL2;CNOT2;KAT2A;WDR43
prerank,CellMarker_Augmented_2021__Unrestricted Somatic Stem cell:Embryo,-0.631964930521101,-0.9416632082285582,0.5689655172413793,0.9164521120380926,1.0,2/5,12.82%,PECAM1;PTPRC
prerank,CellMarker_Augmented_2021__Limbal Stem cell:Corneal Epithelium,-0.47855942930722734,-0.9415970604202546,0.5079365079365079,0.9162581601004531,1.0,13/34,17.61%,DUOX1;ABCC3;RNF144B;TMPRSS11D;CFLAR;ALPK1;NABP1;TBC1D8;APOL6;C3;TTC39B;CDCP1;IL18
prerank,CellMarker_Augmented_2021__Oogenesis Phase Fetal Germ cell:Fetal Gonad,-0.3636686698814451,-0.9415580907066127,0.6458333333333334,0.9159869473566328,1.0,64/569,10.40%,TUBB8;CD36;TMEM163;INSIG1;MRO;CCDC88C;DEGS2;TGFBR3;EPN1;MCTP2;DNAH11;EMB;PSMG4;HERC6;RASGRF2;VAV3;RGS2;MPP7;DHX58;STAG3;PSTPIP1;PER3;H1-0;CTSB;L3MBTL3;COCH;MB21D2;EYA2;ING3;SLC37A1;GLUL;PECAM1;NIPSNAP3A;RNF144B;CCDC85C;TXN2;NAPA;IQSEC1;ZNF330;EPHX1;PITRM1;STK39;FAM227B;GSTK1;MYO3B;ZDHHC4;CRBN;CYSTM1;EPB41L3;SGK1;ITGA4;PRKD2;MAT2B;GSTM3;DNAH17;GABARAPL2;PDCD5;HPS4;STAT1;SMDT1;C3ORF70;ABCB4;SLC2A8;POFUT2
prerank,GO_Biological_Process_2021__positive regulation of viral process (GO:0048524),-0.4360001575279305,-0.941476577099397,0.5074626865671642,0.9158639618774859,1.0,7/52,7.76%,PPIE;CCL5;MDFIC;IFIT1;CTDP1;POLR2G;SRPK1
prerank,KEGG_2021_Human__Dilated cardiomyopathy,-0.43945513240883743,-0.9413354100263861,0.5735294117647058,0.9157612458033688,1.0,10/57,10.71%,PLN;EMD;IGF1;TTN;MYBPC3;ACTG1;ITGA4;ITGA6;CACNA2D4;ACTB
prerank,GO_Biological_Process_2021__phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),-0.44114801523588487,-0.9411143805859924,0.5396825396825397,0.9158434995470024,1.0,8/34,15.92%,CHRM2;TACR1;C5AR1;P2RY8;C5AR2;LPAR6;FPR1;AGT
prerank,GO_Biological_Process_2021__protein localization to organelle (GO:0033365),0.3637092775752812,0.9410933487411556,0.4642857142857143,0.851322029808612,1.0,6/106,3.95%,TULP2;RAB33B;BBS9;MARCHF5;LRRK2;TULP3
prerank,GO_Biological_Process_2021__non-canonical Wnt signaling pathway (GO:0035567),-0.4163425882976554,-0.9410280872168021,0.5925925925925926,0.9156736587771719,1.0,18/89,19.69%,CCDC88C;PSMB3;PSMB6;PSMA7;CALM1;PSMB9;DVL1;FZD2;PSMD12;PFN1;PSMD8;PSMA5;AP2S1;RAC1;PSMA3;PSMC4;PSME2;PSME1
prerank,GO_Biological_Process_2021__cellular response to misfolded protein (GO:0071218),0.42768208693522625,0.9409709520763108,0.5,0.8512130895042613,1.0,7/18,23.10%,DNAJC18;AUP1;RNF185;BAG6;KLHL15;TOR1A;DNAJB14
prerank,GO_Biological_Process_2021__positive regulation of nucleocytoplasmic transport (GO:0046824),-0.46071724503920974,-0.9409479994175507,0.5806451612903226,0.9154837893698023,1.0,4/38,6.41%,FLNA;EMD;JUP;RBM22
prerank,GO_Biological_Process_2021__purine nucleotide metabolic process (GO:0006163),-0.505283465318372,-0.9408475252815769,0.5,0.9153175669248436,1.0,2/16,4.95%,MTHFD1;NT5C
prerank,GO_Biological_Process_2021__positive regulation of DNA recombination (GO:0045911),-0.5067252334824727,-0.9406680266278784,0.5666666666666667,0.915376366504608,1.0,4/22,14.63%,TFRC;WDR48;ZCWPW1;FANCB
prerank,GO_Biological_Process_2021__positive regulation of interleukin-1 production (GO:0032732),-0.4436244439436288,-0.9404067784895611,0.5694444444444444,0.9156834250645072,1.0,5/41,4.19%,CD36;CCL3;MNDA;PYHIN1;AIM2
prerank,GO_Biological_Process_2021__protein deneddylation (GO:0000338),-0.5561367370782229,-0.9402230080168712,0.6031746031746031,0.9157789409925333,1.0,2/10,12.38%,COPS6;COPS8
prerank,GO_Biological_Process_2021__regulation of epithelial cell differentiation (GO:0030856),0.5910596189002439,0.9399154618296139,0.6666666666666666,0.853146088539579,1.0,2/8,17.57%,KLF7;PRKX
prerank,Reactome_2022__CDK-mediated Phosphorylation And Removal Of Cdc6 R-HSA-69017,-0.43753396222229013,-0.9398388091028764,0.5416666666666666,0.9163203279281199,1.0,12/54,14.90%,UBC;RPS27A;PSMB3;PSMB6;PSMA7;PSMB9;PSMD12;ANAPC11;PSMD8;PSMA5;UBA52;CDC26
prerank,GO_Biological_Process_2021__negative regulation of smooth muscle cell proliferation (GO:0048662),-0.4957093670746598,-0.9397668924562474,0.5625,0.9161474000635732,1.0,3/18,8.14%,AIF1;APOD;TNFAIP3
prerank,GO_Biological_Process_2021__negative regulation of cellular senescence (GO:2000773),0.5390879358810607,0.9396671775034487,0.5416666666666666,0.8533023667615733,1.0,2/9,11.88%,SIRT1;CDK6
prerank,GO_Biological_Process_2021__positive regulation of defense response (GO:0031349),-0.39850162378351395,-0.9394930536592013,0.5135135135135135,0.9164537159534134,1.0,11/62,16.01%,CCL3;CCL5;ETS1;PLSCR1;NLRP12;TASL;CD47;CYBA;IFI35;AGT;POLR3C
prerank,Reactome_2022__Downstream Signaling Of Activated FGFR3 R-HSA-5654708,0.4856564607555152,0.9389128683234256,0.5555555555555556,0.8546683555232019,1.0,1/14,1.00%,PIGU
prerank,GO_Biological_Process_2021__pteridine-containing compound metabolic process (GO:0042558),-0.6053663294686641,-0.938845843469047,0.6129032258064516,0.9175066787093483,1.0,2/8,9.36%,CALM1;PTS
prerank,GO_Biological_Process_2021__positive regulation of cell differentiation (GO:0045597),0.3291679985832521,0.938527662207291,0.5833333333333334,0.855165418789647,1.0,27/144,10.09%,PDPN;ATRAID;ACVR2A;TGFBR2;MSR1;MAPK11;ZBTB16;CTNNBIP1;RAP1A;AKIRIN1;PPARG;SMAD2;SMAD3;RIN2;KITLG;ZC4H2;ZNF385A;RANBP3L;BRINP3;CTNNA2;TMEM119;FBN2;SOX5;BMPR1B;LOXL2;HGF;BCL9L
prerank,CellMarker_Augmented_2021__Stem cell:Endometrium,-0.6227950360391694,-0.9381020297363444,0.6129032258064516,0.9187162143057642,1.0,1/5,5.65%,PECAM1
prerank,"GO_Biological_Process_2021__regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370)",-0.6196481607800612,-0.9380122708396099,0.640625,0.9185660811823313,1.0,3/9,10.77%,RUNX3;NCKAP1L;HLA-DRA
prerank,GO_Biological_Process_2021__positive regulation of monocyte differentiation (GO:0045657),0.565388025075771,0.9379867282792314,0.6136363636363636,0.8558571510693866,1.0,1/7,3.13%,CTNNBIP1
prerank,KEGG_2021_Human__Hepatitis B,-0.3982886821470785,-0.9379057678594389,0.6133333333333333,0.9184695872015044,1.0,3/114,1.22%,STAT4;CYCS;FOS
prerank,GO_Biological_Process_2021__positive regulation of mitotic cell cycle phase transition (GO:1901992),0.38196450574794155,0.9378787400469226,0.5172413793103449,0.855692228298085,1.0,5/41,9.82%,ANXA1;KLHL18;UBE2E2;CDC23;RAD51B
prerank,Reactome_2022__MET Activates PI3K/AKT Signaling R-HSA-8851907,0.6129453108486065,0.9378452711740995,0.6304347826086957,0.8553758309849654,1.0,1/6,1.00%,PIGU
prerank,GO_Biological_Process_2021__detection of mechanical stimulus (GO:0050982),0.46026041058291534,0.9377881229781877,0.5405405405405406,0.8551084424600044,1.0,2/14,3.46%,PKD2;PKD1
prerank,GO_Biological_Process_2021__mitochondrial calcium ion transmembrane transport (GO:0006851),-0.49609965060479155,-0.9377696337158221,0.5483870967741935,0.9184367054330789,1.0,7/17,16.70%,PHB2;SMDT1;MICU2;SPG7;MAIP1;MCUR1;STOML2
prerank,GO_Biological_Process_2021__cellular response to UV (GO:0034644),0.3894550835430306,0.9375165004272201,0.5,0.8553174042964381,1.0,8/49,10.90%,ZBTB1;RUVBL2;SIRT1;CASP9;PARP1;EIF2S1;PTPRK;ERCC4
prerank,CellMarker_Augmented_2021__Nucleus Pulposus cell:Intervertebral Disc,0.39911219722315544,0.9373267114948517,0.5,0.8553098625822549,1.0,13/44,12.87%,SVEP1;BNC2;PHLDB1;WNT5A;PDE10A;TANC1;CDH11;ARHGAP20;GUCY1A2;ENOX1;RUNX1T1;COL6A1;TJP1
prerank,Reactome_2022__Presynaptic Function Of Kainate Receptors R-HSA-500657,-0.5467050260548754,-0.9373112617733269,0.6181818181818182,0.9191894543364005,1.0,2/11,15.86%,GNB5;GNB2
prerank,KEGG_2021_Human__Arachidonic acid metabolism,0.4539146814610329,0.9373055387921986,0.5555555555555556,0.854940177304382,1.0,2/20,7.66%,PLA2G4C;HPGDS
prerank,GO_Biological_Process_2021__Fc-gamma receptor signaling pathway (GO:0038094),-0.4318942003559673,-0.9372854023273482,0.6029411764705882,0.91892574830087,1.0,11/65,13.75%,MYO1G;VAV3;YES1;FCER1G;CD247;FYN;ACTG1;ACTB;NCKAP1L;CYFIP2;PIK3CB
prerank,CellMarker_Augmented_2021__Bipolar cell:Eye,0.3573005469169749,0.9369973499247247,0.5384615384615384,0.8552839946795674,1.0,17/84,14.79%,GLIS3;FGF2;GFAP;DPY19L1;PCDH9;PDE7B;KCTD16;GRIA3;DNM3;SPTAN1;SATB2;SCN8A;ZC3H12B;NEGR1;ANKH;PDE1C;CNTNAP1
prerank,GO_Biological_Process_2021__glucan catabolic process (GO:0009251),-0.5470129050791359,-0.93693645568051,0.6923076923076923,0.9193503866220567,1.0,2/12,8.36%,PHKG1;CALM1
prerank,GO_Biological_Process_2021__regulation of sodium ion transmembrane transporter activity (GO:2000649),0.4375371182531243,0.9369137281169709,0.5,0.8550820709123924,1.0,9/26,18.87%,NETO1;SCN3B;NEDD4L;WNK1;SLMAP;FXYD5;FXYD7;NEDD4;SCN1B
prerank,GO_Biological_Process_2021__cellular divalent inorganic cation homeostasis (GO:0072503),-0.45090632315696044,-0.936772350368024,0.582089552238806,0.9193906918818444,1.0,7/54,10.20%,MT2A;CCL3;CCL5;ATP13A1;TPT1;TRPV4;SLC11A1
prerank,CellMarker_Augmented_2021__PDX1+ Pancreatic Progenitor cell:Embryonic Stem Cell,-0.5156270913032989,-0.9367304097001791,0.5740740740740741,0.9191272041588826,1.0,7/15,24.18%,CLDN7;OVOL2;PKP2;GPRC5C;CDS1;TOM1L1;EPB41L4B
prerank,GO_Biological_Process_2021__regulation of generation of precursor metabolites and energy (GO:0043467),0.3569321171995035,0.9367013853591412,0.5609756097560976,0.855036868121487,1.0,7/37,17.93%,NUP153;NUP188;NUP42;RUBCNL;NDC1;NUP133;NUP205
prerank,Reactome_2022__Processing Of Capped Intron-Containing Pre-mRNA R-HSA-72203,-0.3783867412024699,-0.9366680991800537,0.6547619047619048,0.9189439951147126,1.0,41/207,17.81%,PPIE;DHX16;ZCRB1;DHX38;CSTF2T;SNRNP27;SNRPD2;RNPC3;RBM22;POLR2G;EIF4A3;LSM7;PDCD7;CHTOP;CRNKL1;ZRSR2;U2AF2;NCBP2;SMNDC1;NUP50;PRPF3;BUD31;GCFC2;DDX23;SRSF2;DDX5;SRSF7;CWC25;SNRPA1;COLEC12;CCAR1;PPWD1;EFTUD2;SLU7;SEC13;SNRPA;LSM4;SNRNP200;NUP88;GTF2F1;HNRNPH2
prerank,GO_Biological_Process_2021__vesicle organization (GO:0016050),-0.4741398325177877,-0.9366176241638714,0.5757575757575758,0.9187609215801907,1.0,1/31,0.93%,SRGN
prerank,GO_Biological_Process_2021__positive regulation of cell-matrix adhesion (GO:0001954),-0.4711081591797628,-0.9365853277662591,0.4918032786885246,0.9185079619607914,1.0,2/26,0.52%,SKAP1;CD36
prerank,GO_Biological_Process_2021__regulation of mitochondrion organization (GO:0010821),0.39828650918065905,0.9365197843743657,0.5,0.8550618450781056,1.0,3/35,3.81%,PPARGC1A;MARCHF5;LRRK2
prerank,GO_Biological_Process_2021__negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),-0.4970948155917016,-0.9363619329295667,0.5636363636363636,0.918665163343811,1.0,7/24,13.66%,NLRC3;IGF1;GSTP1;TNFAIP3;SELENOS;C5AR2;HAVCR2
prerank,GO_Biological_Process_2021__DNA dealkylation involved in DNA repair (GO:0006307),0.5515891898943489,0.9363549581669792,0.525,0.8546373892951661,1.0,4/9,22.91%,MGMT;ASCC1;ALKBH5;FTO
prerank,GO_Biological_Process_2021__DNA dealkylation (GO:0035510),0.5515891898943489,0.9363549581669792,0.525,0.8546373892951661,1.0,4/9,22.91%,MGMT;ASCC1;ALKBH5;FTO
prerank,GO_Biological_Process_2021__regulation of cell population proliferation (GO:0042127),-0.36148292433145324,-0.9362769158363763,0.625,0.918482395702298,1.0,57/400,12.64%,NR4A3;STAT4;RPS4X;COL18A1;FTH1;TFRC;JUNB;IL7R;WARS1;H2AC6;PDGFD;IFIT3;AIF1;BTG2;ATF5;DDRGK1;ETS1;AQP11;TSPAN31;CLU;ING5;JUP;RPL23;IGF1;SLC25A5;TIPIN;IL12RB2;OSMR;PRLR;EIF2AK2;RNF126;RPS6;SGK1;NAMPT;BEX4;KANK2;EGLN3;PDCD5;CHTOP;STAT1;MEIS1;GLMN;PTN;IRF1;NPM1;TRPM4;RPS9;VEGFA;BTG1;ING4;TBC1D8;CD47;EFNB2;FLT1;COPS8;HSPA1B;SST
prerank,GO_Biological_Process_2021__respiratory system development (GO:0060541),0.4637569543837129,0.9362421949209065,0.4117647058823529,0.8545008841098645,1.0,5/18,13.44%,PDPN;FGF2;DISP1;CCDC40;BAG6
prerank,GO_Biological_Process_2021__modification-dependent protein catabolic process (GO:0019941),0.32797689098754135,0.9362406500409381,0.7142857142857143,0.8541060130913295,1.0,22/162,11.31%,UBE2D1;SPSB2;ZNRF3;FBXL14;UBE2D2;FZR1;UBR3;NEDD4L;CDC23;MDM2;KCTD6;BTRC;FBXO45;RNF19B;KCTD10;UBA1;RNF20;UBE2L3;ANAPC16;RNF217;FEM1C;RNF185
prerank,"GO_Biological_Process_2021__regulation of CD4-positive, alpha-beta T cell activation (GO:2000514)",-0.6467921765973318,-0.9362312656318865,0.6379310344827587,0.9182564644565491,1.0,2/6,10.77%,CD55;HLA-DRA
prerank,Reactome_2022__SHC-related Events Triggered By IGF1R R-HSA-2428933,0.5936633536121002,0.9361034360431544,0.6097560975609756,0.8539106690602541,1.0,1/5,1.37%,IGF1R
prerank,"Reactome_2022__Transport Of Vitamins, Nucleosides, And Related Molecules R-HSA-425397",-0.5001487285797995,-0.9358872887591051,0.5538461538461539,0.9187232216830539,1.0,3/19,12.36%,APOD;SLC25A5;SLC29A3
prerank,Reactome_2022__Defects In Cobalamin (B12) Metabolism R-HSA-3296469,-0.5860767572229751,-0.9358723530391928,0.625,0.918397522234298,1.0,3/7,30.78%,MMAB;MTRR;LMBRD1
prerank,CellMarker_Augmented_2021__Pluripotent Stem cell:Embryo,-0.5063572481978735,-0.9356993676203045,0.5873015873015873,0.9184313763520762,1.0,2/20,5.83%,COL18A1;SEMA6A
prerank,Reactome_2022__Mismatch Repair (MMR) Directed By MSH2:MSH3 (MutSbeta) R-HSA-5358606,-0.5765582313253308,-0.9356114403319072,0.5636363636363636,0.9183122210903873,1.0,4/9,28.25%,RPA3;LRIG1;MSH3;PMS2
prerank,GO_Biological_Process_2021__regulation of Wnt signaling pathway (GO:0030111),0.3789733934723238,0.9355940818112618,0.4642857142857143,0.8546409131030753,1.0,12/62,9.77%,GRB10;TCF7L1;CTNNBIP1;LRRK2;TSC2;GNAQ;RUNX1;SALL1;NLK;KANK1;ZRANB1;BTRC
prerank,GO_Biological_Process_2021__regulation of neuron migration (GO:2001222),0.4616666411057395,0.9355257595321518,0.5294117647058824,0.8544024801668174,1.0,9/25,18.01%,PLXNB2;CTNNA2;NIPBL;SRGAP2;ZNF609;SHTN1;CX3CL1;RAPGEF2;PHACTR1
prerank,GO_Biological_Process_2021__positive regulation of blood coagulation (GO:0030194),-0.5412572230381648,-0.9355247201954437,0.6,0.918189829146662,1.0,2/9,2.94%,ENPP4;USF1
prerank,Reactome_2022__Cargo Concentration In ER R-HSA-5694530,0.42646235201919147,0.9352381386076434,0.6097560975609756,0.854567415735263,1.0,5/24,9.61%,TGFA;CTSC;SEC24B;GRIA1;LMAN2L
prerank,Reactome_2022__Telomere Extension By Telomerase R-HSA-171319,0.4698435143931808,0.9351621299063793,0.5581395348837209,0.8543399822110086,1.0,1/14,1.43%,RUVBL2
prerank,GO_Biological_Process_2021__regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),0.5971200667275502,0.9349120579940357,0.62,0.8545316463648491,1.0,1/6,2.26%,FGF2
prerank,KEGG_2021_Human__Calcium signaling pathway,-0.4056457400558176,-0.9348645239667145,0.6103896103896104,0.9192539445342345,1.0,9/121,6.57%,MYLK;PLN;CHRM2;CXCR4;MCOLN2;PDGFD;PHKG1;SLC25A5;TACR1
prerank,Reactome_2022__DDX58/IFIH1-mediated Induction Of Interferon-Alpha/Beta R-HSA-168928,-0.4300104737338981,-0.9347131017145557,0.56,0.9193638410187415,1.0,5/59,8.14%,UBC;RPS27A;DHX58;NLRC5;TNFAIP3
prerank,GO_Biological_Process_2021__nucleus localization (GO:0051647),-0.5752378483055833,-0.93468228156545,0.5333333333333333,0.919078475415354,1.0,1/9,1.88%,SYNE2
prerank,KEGG_2021_Human__Hypertrophic cardiomyopathy,0.39373613647202144,0.9344314003373025,0.5384615384615384,0.855286761990337,1.0,11/51,14.91%,PRKAB2;TPM2;DAG1;TNF;ITGAV;ITGA2;PRKAB1;SLC8A1;CACNG8;CACNG2;CACNB4
prerank,GO_Biological_Process_2021__negative regulation of DNA binding (GO:0043392),-0.5114702784797354,-0.9342458479519605,0.5714285714285714,0.9196862997649512,1.0,1/17,3.13%,PER2
prerank,GO_Biological_Process_2021__negative regulation of apoptotic process (GO:0043066),-0.36714112724565706,-0.9340646116633363,0.6511627906976745,0.9196797716520381,1.0,31/294,8.71%,BCL2A1;FLNA;UBC;APIP;RPS27A;TFRC;CARD14;CARD16;SNX6;IFIT3;ATF5;PRELID1;STIL;NAIP;RNF213;DDRGK1;PTMA;RPL10;BNIP2;IGF1;LAMTOR5;RPS3A;RNF144B;TNFAIP8;PHB2;PRLR;GSTP1;TPT1;NAA38;CFL1;CD44
prerank,Reactome_2022__tRNA Processing In Nucleus R-HSA-6784531,0.3780387743355586,0.9339214389211933,0.5384615384615384,0.8560465477122555,1.0,5/46,7.20%,CPSF4;NUP153;NUP188;ZBTB8OS;NUP42
prerank,GO_Biological_Process_2021__positive regulation of translation (GO:0045727),-0.41888529564756244,-0.9337592331495655,0.5303030303030303,0.9200049669466618,1.0,13/75,15.93%,RPS4X;CCL5;RPL5;POLR2G;EIF4A3;EIF5A;NPM1;RPS9;PASK;RPS27L;ZCCHC4;RPUSD4;TRUB2
prerank,GO_Biological_Process_2021__DNA biosynthetic process (GO:0071897),0.5291591385312006,0.9336130173600209,0.5151515151515151,0.8563980502751928,1.0,3/11,19.02%,SIRT1;POLA1;WRNIP1
prerank,GO_Biological_Process_2021__mitochondrial DNA metabolic process (GO:0032042),0.5484872433246613,0.93337479362985,0.574468085106383,0.856524089363232,1.0,1/7,5.45%,PARP1
prerank,GO_Biological_Process_2021__negative regulation of translation (GO:0017148),-0.4237114858535842,-0.9332119874338035,0.5915492957746479,0.9209367449971815,1.0,9/73,8.47%,GAPDH;BTG2;GZMB;RPL13A;RACK1;RPS3;ILF3;EIF2AK2;EIF4A3
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Umbilical Vein,-0.48587037797609145,-0.9331905370683752,0.5757575757575758,0.9206480109612876,1.0,6/34,14.50%,MYLK;ABCA8;A2M;PTPRC;SERPING1;FILIP1L
prerank,GO_Biological_Process_2021__positive regulation of programmed cell death (GO:0043068),-0.3689998228532504,-0.9331575673095506,0.5974025974025974,0.9203826837844283,1.0,24/204,9.49%,PLEKHG5;UBC;RPS27A;MNDA;RASGRF2;GADD45B;VAV3;PRF1;RACK1;TNFSF10;ING3;CLU;ING5;ARHGEF1;MTCH1;TNFAIP8;ARHGEF3;OBSCN;RPS6;IFIT2;ITGA6;MTCH2;PDCD5;ITGB3BP
prerank,GO_Biological_Process_2021__pentose-phosphate shunt (GO:0006098),-0.5490145350424728,-0.9329896293454791,0.6031746031746031,0.9204421581813642,1.0,5/10,31.02%,TALDO1;H6PD;RPE;PGLS;TKT
prerank,CellMarker_Augmented_2021__Blast cell:Bone Marrow,-0.43022438572731875,-0.9329868955792107,0.5492957746478874,0.9201075683394798,1.0,12/59,11.65%,CD36;MS4A4A;SIGLEC1;CD14;FCER1G;CD93;F13A1;PECAM1;MS4A6A;CSF2RB;TYROBP;A2M
prerank,GO_Biological_Process_2021__regulation of phospholipase C activity (GO:1900274),0.5276094522560926,0.9328840903805253,0.5333333333333333,0.857239394105785,1.0,1/10,2.26%,FGF2
prerank,KEGG_2021_Human__Th17 cell differentiation,-0.40782629396882286,-0.9326045072001976,0.5675675675675675,0.9206470329586204,1.0,9/68,11.78%,FOS;PRKCQ;RORA;CD247;HLA-DRB5;STAT1;HLA-DRA;HIF1A;IFNGR2
prerank,"Reactome_2022__Cell Cycle, Mitotic R-HSA-69278",-0.35719934531978215,-0.9324681715128306,0.6373626373626373,0.9206302455665597,1.0,46/370,14.90%,TUBB8;UBC;H2BC4;H2BC26;H2AC20;RPS27A;H2AC6;PSMB3;RPS27;POLE3;SSNA1;EMD;H3-3B;H2AJ;H2BC21;PSMB6;PSMA7;PPP1CB;CENPU;H2BC5;CNEP1R1;CEP72;PSMB9;H2BC9;ITGB3BP;CEP164;ZWILCH;NUP50;TUBGCP2;RBX1;PSMD12;ANAPC11;MAX;H2BC11;CSNK1D;PSMD8;PSMA5;MCM7;MIS12;RPA3;TUBB4B;DYNC1LI2;CCND1;SMC1A;UBA52;CDC26
prerank,GO_Biological_Process_2021__regulation of protein localization to cell periphery (GO:1904375),0.47990070002876306,0.9322786061360705,0.5217391304347826,0.8581950412297302,1.0,1/13,1.57%,ABCA2
prerank,GO_Biological_Process_2021__regulation of cell killing (GO:0031341),-0.5752865541698374,-0.931909674336254,0.5714285714285714,0.9215064832477387,1.0,3/9,16.58%,CD55;CYBA;RAC1
prerank,GO_Biological_Process_2021__negative regulation of cilium assembly (GO:1902018),0.5468401567372082,0.9318607988117631,0.6538461538461539,0.858641266690595,1.0,1/9,3.28%,CDK10
prerank,GO_Biological_Process_2021__determination of heart left/right asymmetry (GO:0061371),0.4534855587015273,0.9318136593920076,0.5531914893617021,0.8583272923764418,1.0,5/17,13.38%,PKD2;TGFBR2;CCDC40;SETDB2;MEGF8
prerank,GO_Biological_Process_2021__membrane biogenesis (GO:0044091),0.6300045765726972,0.9318118607434034,0.6666666666666666,0.8579387317469427,1.0,4/5,27.18%,PEX16;SPTBN1;SERINC1;CLIP3
prerank,GO_Biological_Process_2021__negative regulation of neuron apoptotic process (GO:0043524),0.412354532124444,0.9317363847793558,0.5,0.8577055536227145,1.0,9/40,14.52%,PPARGC1A;PPT1;CPEB4;LIG4;UNC5B;SOD2;NTRK2;PRKCI;TYRO3
prerank,GO_Biological_Process_2021__cytoskeleton organization (GO:0007010),-0.4084486098916035,-0.9317224086146986,0.5405405405405406,0.9215257617802637,1.0,7/88,8.34%,CCL3;ARHGAP4;SEMA6A;RHOU;EPB41L3;TNFAIP3;CFL1
prerank,GO_Biological_Process_2021__cellular biogenic amine biosynthetic process (GO:0042401),-0.634054873326875,-0.9315769287554034,0.6885245901639344,0.9215351110919273,1.0,2/5,7.79%,SAT1;SAT2
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, deadenylation-independent decay (GO:0031086)",-0.6112178079255726,-0.9315207106364172,0.5789473684210527,0.9213230976071938,1.0,2/6,8.16%,ZFP36;PNRC2
prerank,GO_Biological_Process_2021__negative regulation of cysteine-type endopeptidase activity (GO:2000117),0.37990116168386606,0.9314211379139048,0.5625,0.8580176032781335,1.0,1/35,0.08%,KLF4
prerank,GO_Biological_Process_2021__determination of left/right symmetry (GO:0007368),-0.5124327310510567,-0.9313246991082593,0.603448275862069,0.9213292116704727,1.0,5/18,12.06%,DNAH11;STIL;ENKUR;CITED2;CCDC39
prerank,Reactome_2022__Nef Mediated CD8 Down-regulation R-HSA-182218,-0.6301570377375237,-0.9312556479569727,0.6078431372549019,0.9211636483800407,1.0,3/6,27.39%,AP2S1;AP2M1;AP2A1
prerank,GO_Biological_Process_2021__2-oxoglutarate metabolic process (GO:0006103),0.5210644525577028,0.931100219987165,0.5128205128205128,0.858302662785615,1.0,1/9,4.39%,L2HGDH
prerank,GO_Biological_Process_2021__protein methylation (GO:0006479),0.4100400073123356,0.9306463058375074,0.47368421052631576,0.8588917487157954,1.0,6/27,17.32%,VCPKMT;NSD3;SETD3;RAB6A;SNRPB;PRMT7
prerank,GO_Biological_Process_2021__mRNA processing (GO:0006397),-0.3701239013386214,-0.9305884513502068,0.6707317073170732,0.9222456793986092,1.0,54/248,19.10%,PPIE;FRG1;RAVER2;DHX16;ZCRB1;DHX38;CSTF2T;SNRNP27;SNRPD2;RNPC3;GTF2H5;WDR83;RBM22;AURKAIP1;POLR2G;RNMT;PNN;EIF4A3;LSM7;PDCD7;CHTOP;CRNKL1;ZRSR2;U2AF2;NCBP2;ZCCHC8;SMNDC1;PRPF3;BUD31;GCFC2;RBM4B;DDX23;SRSF2;DDX5;SRSF7;CWC25;SNRPA1;CWF19L2;CCAR1;PPWD1;EFTUD2;SLU7;SNRPA;LSM4;IK;SNRNP200;PRPF18;GTF2F1;HNRNPH2;RBM4;BCAS2;SRRM4;SF3A1;PRPF4
prerank,GO_Biological_Process_2021__histone lysine methylation (GO:0034968),0.4352948929721128,0.9305312458246838,0.5853658536585366,0.8587866237198969,1.0,12/23,34.98%,SETD3;SETDB2;RBBP5;SUV39H2;SETD1B;KDM6A;CXXC1;WDR82;EZH2;SMYD2;DOT1L;DPY30
prerank,GO_Biological_Process_2021__amyloid-beta metabolic process (GO:0050435),0.5301980296746979,0.9304714894453586,0.5681818181818182,0.8584949227173962,1.0,3/10,17.77%,BACE2;DYRK1A;IDE
prerank,GO_Biological_Process_2021__regulation of peptide hormone secretion (GO:0090276),0.4007757485102394,0.9304681346299359,0.5609756097560976,0.8581128607039827,1.0,10/36,14.74%,CACNA1A;RAP1A;TNF;RFX3;CLOCK;KCNC2;STX1A;ABCC8;CACNA1E;RAPGEF3
prerank,GO_Biological_Process_2021__negative regulation of ATP metabolic process (GO:1903579),-0.5166380802053702,-0.9304269773919379,0.5645161290322581,0.9222217584275137,1.0,3/12,11.31%,PID1;FIS1;FBP1
prerank,GO_Biological_Process_2021__positive regulation of potassium ion transmembrane transport (GO:1901381),-0.4641294790895766,-0.930352499033268,0.5277777777777778,0.922029668157925,1.0,1/30,0.28%,FLNA
prerank,GO_Biological_Process_2021__regulation of feeding behavior (GO:0060259),-0.6626778011817469,-0.9302800483713539,0.6491228070175439,0.9218344217303133,1.0,1/5,0.08%,NR4A3
prerank,GO_Biological_Process_2021__internal protein amino acid acetylation (GO:0006475),0.5473688381640056,0.9301280842108284,0.6,0.8584398538605807,1.0,2/7,13.44%,KAT2A;BAG6
prerank,Reactome_2022__Nuclear Import Of Rev Protein R-HSA-180746,0.4002957084042283,0.9298392826884576,0.5675675675675675,0.8587026339665916,1.0,7/32,17.93%,NUP153;NUP188;NUP42;RCC1;NDC1;NUP133;NUP205
prerank,CellMarker_Augmented_2021__Embryonic Stem cell:Periodontal Ligament,0.3895745648722276,0.9296144598181599,0.6206896551724138,0.8584771687635419,1.0,12/54,12.47%,TSPAN18;SPON1;PLPPR4;CNRIP1;DACH1;AUTS2;PREX2;ASXL3;PTPN5;PTPRD;RUNX1T1;NTRK2
prerank,CellMarker_Augmented_2021__Retinal Progenitor cell:Retina,0.3895745648722276,0.9296144598181599,0.6206896551724138,0.8584771687635419,1.0,12/54,12.47%,TSPAN18;SPON1;PLPPR4;CNRIP1;DACH1;AUTS2;PREX2;ASXL3;PTPN5;PTPRD;RUNX1T1;NTRK2
prerank,GO_Biological_Process_2021__regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),0.5187816922897013,0.9295729889919957,0.5384615384615384,0.8582023644762689,1.0,3/10,8.88%,SPRY2;FGF2;NPTN
prerank,GO_Biological_Process_2021__response to histamine (GO:0034776),0.6007742961911291,0.9295675441019325,0.6086956521739131,0.8574196901812609,1.0,3/6,28.96%,GABRB2;GABRB1;GABRB3
prerank,GO_Biological_Process_2021__cellular response to histamine (GO:0071420),0.6007742961911291,0.9295675441019325,0.6086956521739131,0.8574196901812609,1.0,3/6,28.96%,GABRB2;GABRB1;GABRB3
prerank,GO_Biological_Process_2021__positive regulation of lipid kinase activity (GO:0090218),0.4592403695335359,0.9294592674384867,0.5952380952380952,0.8572891572113448,1.0,4/18,13.77%,FGF2;P2RY12;EEF1A2;PTK2
prerank,KEGG_2021_Human__Central carbon metabolism in cancer,0.3811820048380734,0.9293407665456996,0.625,0.857116269626558,1.0,3/44,4.14%,PFKP;PFKM;MAP2K1
prerank,CellMarker_Augmented_2021__Astrocyte:Embryonic Prefrontal Cortex,0.32669174395119,0.9291510021344453,0.7142857142857143,0.8570762089054372,1.0,40/213,9.91%,PDPN;SPON1;LRP4;SLC39A12;NCAN;SPRY2;LUZP2;RAP1GAP;GFAP;IDI1;SERPINE2;SLC1A3;SLC25A18;NDRG2;GULP1;SIRPA;SLC3A2;TEX264;TIMP3;DAG1;CSPG5;ARHGEF26;TECPR2;SLC1A2;BCL11A;TM7SF2;DTNA;MSMO1;BRINP3;SOX4;SLC4A4;RAMP1;PDLIM5;CD82;HMGCS1;DBI;ALCAM;PHACTR2;BMPR1B;SASH1
prerank,GO_Biological_Process_2021__cell junction organization (GO:0034330),-0.4298474106916874,-0.9291251397839637,0.6231884057971014,0.9240482337646939,1.0,7/47,14.60%,FLNA;NLGN2;ACTG1;DVL1;ACTB;MYOT;PPFIA4
prerank,Reactome_2022__RHO GTPases Activate WASPs And WAVEs R-HSA-5663213,0.3992630108423664,0.9289421768023507,0.5483870967741935,0.8570680108177386,1.0,6/32,15.86%,WIPF3;WASF2;NCKIPSD;MAPK1;PTK2;ABI1
prerank,CellMarker_Augmented_2021__Mesodermal Embryonic Stem cell:Germ,-0.4372230575695085,-0.9287635473910059,0.5416666666666666,0.924570521093466,1.0,10/42,13.78%,SYNE1;CD93;PECAM1;ENPP2;PCDH12;SPARCL1;ABCA8;A2M;FLT1;SERPING1
prerank,GO_Biological_Process_2021__post-Golgi vesicle-mediated transport (GO:0006892),-0.41728416569893556,-0.9287182416358964,0.6129032258064516,0.9243613890034933,1.0,7/73,13.62%,OSBPL5;FTH1;NAPA;STXBP6;STEAP2;AP4M1;FTL
prerank,GO_Biological_Process_2021__fat cell differentiation (GO:0045444),-0.4614234211128363,-0.9286433608274666,0.6197183098591549,0.9241655766141535,1.0,5/41,3.44%,NR4A3;PID1;ATF5;PER2;BBS2
prerank,GO_Biological_Process_2021__regulation of leukocyte activation (GO:0002694),-0.5779155613675713,-0.9285754208458572,0.6181818181818182,0.9239600354171206,1.0,5/10,15.81%,LILRB4;PLSCR1;GPR137B;CD74;CD200
prerank,Reactome_2022__Insulin Receptor Signaling Cascade R-HSA-74751,0.44374798052752634,0.9283959155256273,0.6052631578947368,0.8577702811602775,1.0,9/29,19.84%,PIGU;GRB10;PDE3B;MAPK1;GAB2;AKT2;PIK3CA;FGFR2;FGFR1
prerank,CellMarker_Augmented_2021__Regulatory T (Treg) cell:Undefined,-0.5119659238455818,-0.9283195985032492,0.6071428571428571,0.9241987079262743,1.0,2/12,5.81%,SELL;IL12RB2
prerank,Reactome_2022__Degradation Of Extracellular Matrix R-HSA-1474228,0.40770513295300376,0.9282922754879218,0.625,0.8575444939026454,1.0,6/45,9.60%,MMP17;COL16A1;CTSK;BMP1;FZR1;MMP16
prerank,PanglaoDB_Augmented_2021__Sebocytes,-0.44602064627124943,-0.9281445642664894,0.5454545454545454,0.924256357491974,1.0,9/32,11.31%,CEBPD;ZMYND15;CLDN7;ANKRD22;ABCC3;TNFAIP2;LLGL2;SSH3;FBP1
prerank,GO_Biological_Process_2021__regulation of phagocytosis (GO:0050764),-0.46302903362704895,-0.9281440953841529,0.6376811594202898,0.9239195293733544,1.0,7/37,12.82%,FCER1G;RACK1;PLSCR1;SLC11A1;CD47;CYBA;PTPRC
prerank,GO_Biological_Process_2021__positive regulation of vascular permeability (GO:0043117),-0.5819198106091896,-0.928128805254148,0.5714285714285714,0.9236256616306149,1.0,2/6,11.19%,TRPV4;VEGFA
prerank,GO_Biological_Process_2021__humoral immune response mediated by circulating immunoglobulin (GO:0002455),-0.5844219069221553,-0.9280878643870446,0.625,0.9233648536199843,1.0,4/6,29.52%,C1QB;C1QC;ZP3;C1QA
prerank,Reactome_2022__TNF Receptor Superfamily (TNFSF) Members Mediating Non-Canonical NF-kB Pathway R-HSA-5676594,-0.5659253131096522,-0.9280061743411175,0.5576923076923077,0.9232125868431899,1.0,5/9,31.80%,TNFSF13B;TNFRSF13C;BIRC2;TNFRSF11A;LTBR
prerank,Reactome_2022__Rab Regulation Of Trafficking R-HSA-9007101,0.3428264159185319,0.9279172932444179,0.5185185185185185,0.8579227844513991,1.0,30/99,23.97%,RAB33B;TSC2;RAB10;RAB1B;RIN2;TBC1D10B;TBC1D16;RAB7A;ARF6;RAB6A;RABGAP1;RAB3IP;SBF1;AKT2;RAB14;TRAPPC12;RAB3IL1;TBC1D2;TRAPPC8;RIN3;AKT3;RAB38;ULK1;DENND5B;YWHAE;RAB7B;TBC1D7;TRAPPC6B;DENND2D;GGA1
prerank,Reactome_2022__Telomere C-strand (Lagging Strand) Synthesis R-HSA-174417,-0.49270820513681984,-0.9277850022879123,0.5614035087719298,0.9233164408767556,1.0,7/22,21.40%,CHTF18;TERF2IP;RPA3;LRIG1;WRN;PRIM1;CTC1
prerank,GO_Biological_Process_2021__histone exchange (GO:0043486),-0.475302453339425,-0.9277425159723897,0.5076923076923077,0.9230691539139025,1.0,3/25,10.59%,CENPU;ITGB3BP;NPM1
prerank,GO_Biological_Process_2021__protein-DNA complex subunit organization (GO:0071824),-0.6218241975122402,-0.927688324875443,0.6290322580645161,0.9228581245116683,1.0,2/5,17.91%,RPL23;SUPT6H
prerank,GO_Biological_Process_2021__negative regulation of homotypic cell-cell adhesion (GO:0034111),0.5101328128000888,0.9275316076241137,0.5833333333333334,0.858427804557466,1.0,2/9,13.62%,SERPINE2;ZNF703
prerank,GO_Biological_Process_2021__toll-like receptor 4 signaling pathway (GO:0034142),-0.5297821540928311,-0.9275047317961654,0.5517241379310345,0.9229029793377584,1.0,3/13,10.55%,CD14;OAS1;ITGB2
prerank,CellMarker_Augmented_2021__Dendritic cell:Undefined,-0.5246605349830809,-0.9274608819371548,0.5737704918032787,0.9226561121868341,1.0,3/16,5.81%,CD14;CLU;IL12RB2
prerank,GO_Biological_Process_2021__cellular polysaccharide catabolic process (GO:0044247),-0.5344001208390037,-0.927220536830704,0.6792452830188679,0.922825504099899,1.0,2/13,8.36%,PHKG1;CALM1
prerank,GO_Biological_Process_2021__regulation of protein kinase B signaling (GO:0051896),0.33353099636138606,0.9272061865043589,0.7272727272727273,0.858747134897579,1.0,33/114,14.29%,PDGFA;IGF1R;SEMA5A;SPRY2;TGFA;FGF2;SIRT1;GAB1;TSC2;RCN3;DAG1;HPSE;PHLPP1;DDIT3;CIB1;NRG1;KITLG;TNF;HGF;P2RY12;TCF7L2;MFHAS1;PTEN;RTN4;NTRK2;GAB2;MTDH;PIK3AP1;NRG2;VAV1;PTK2;ERBB4;FERMT2
prerank,GO_Biological_Process_2021__proteoglycan biosynthetic process (GO:0030166),0.4339766620300931,0.9271717159171275,0.5483870967741935,0.8584525453005116,1.0,6/23,10.88%,CSGALNACT1;UGDH;B4GALT7;CANT1;BMPR1B;EXT1
prerank,GO_Biological_Process_2021__regulation of T-helper 17 cell differentiation (GO:2000319),-0.6259644977092294,-0.9271327415735293,0.603448275862069,0.9226836452764903,1.0,1/6,1.70%,NFKBID
prerank,Reactome_2022__RAF Activation R-HSA-5673000,0.42145488665569036,0.9270301330640124,0.4166666666666667,0.8583644360693257,1.0,9/29,19.21%,MAP3K11;MAP2K1;PPP2R1B;SHOC2;PPP2R5E;PHB1;MAP2K2;KSR1;PPP1CC
prerank,GO_Biological_Process_2021__regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),-0.4092646294272457,-0.926804345856557,0.6301369863013698,0.9230624299779252,1.0,4/68,2.43%,UBC;TGFBR3;RPS27A;SNX6
prerank,Reactome_2022__Synthesis Of 5-Eicosatetraenoic Acids R-HSA-2142688,-0.6060587961010071,-0.9267720435499816,0.5961538461538461,0.922812590616941,1.0,3/6,14.09%,GPX4;PON2;GPX1
prerank,GO_Biological_Process_2021__positive regulation of microtubule polymerization (GO:0031116),0.39272171755576285,0.9266574866397518,0.5555555555555556,0.8587996332361126,1.0,5/24,14.39%,CDK5R1;GIT1;TOGARAM1;SLAIN2;CLASP1
prerank,Reactome_2022__Cell Cycle R-HSA-1640170,-0.35138020684202437,-0.926479885505333,0.6630434782608695,0.9231452532584613,1.0,63/462,15.06%,TUBB8;UBC;SYCE2;H2BC4;H2BC26;H2AC20;RPS27A;CARD16;SYNE2;H2AC6;STAG3;PSMB3;RPS27;POLE3;SSNA1;SYNE1;EMD;HUS1;H3-3B;H2AJ;CHTF18;H2BC21;POLR2G;PSMB6;PSMA7;BRCA2;PPP1CB;CENPU;H2BC5;CNEP1R1;ABRAXAS1;CEP72;PSMB9;H2BC9;ITGB3BP;CEP164;ZWILCH;NPM1;NUP50;TUBGCP2;RBX1;PSMD12;ANAPC11;MAX;TERF2IP;H2BC11;CSNK1D;PSMD8;PSMA5;KAT5;MCM7;RAD9A;MIS12;RPA3;TUBB4B;DYNC1LI2;CCND1;BRCA1;SMC1A;UBA52;CDC26;NHP2;NOP10
prerank,GO_Biological_Process_2021__neural tube development (GO:0021915),0.4909316259870191,0.9260783566106777,0.6153846153846154,0.8596147916975047,1.0,4/10,10.96%,PKD2;PKD1;SOX4;PTCH1
prerank,GO_Biological_Process_2021__regulation of myosin-light-chain-phosphatase activity (GO:0035507),0.5429757625650296,0.926033208586988,0.5853658536585366,0.8593203428804953,1.0,2/7,7.30%,NUAK1;TNF
prerank,Reactome_2022__Aflatoxin Activation And Detoxification R-HSA-5423646,0.5650130418967061,0.9259954579617246,0.6578947368421053,0.8590525504498637,1.0,1/7,5.24%,ACY3
prerank,GO_Biological_Process_2021__sensory perception of pain (GO:0019233),-0.6287471853585259,-0.9259930683090647,0.625,0.9238210539377001,1.0,1/7,4.57%,SCN9A
prerank,GO_Biological_Process_2021__purine nucleotide biosynthetic process (GO:0006164),-0.5572012372478088,-0.9258720657822239,0.5178571428571429,0.9237542805107095,1.0,2/9,8.61%,MTHFD1;AMPD2
prerank,PanglaoDB_Augmented_2021__Ependymal Cells,-0.46686624143536537,-0.9254942666939624,0.5588235294117647,0.924269243275399,1.0,5/32,9.34%,CATIP;PLTP;ENKUR;NME9;EFHC1
prerank,GO_Biological_Process_2021__regulation of cytokine production involved in inflammatory response (GO:1900015),-0.47835071281678265,-0.9252960781464911,0.603448275862069,0.9243068911022853,1.0,6/29,14.09%,NLRC3;APOD;LILRB4;HIF1A;APPL1;NOD2
prerank,CellMarker_Augmented_2021__Ovarian Germ Stem cell:Ovary,0.46034459637577924,0.9252628038722386,0.5128205128205128,0.8598043433464349,1.0,1/18,0.56%,FLVCR1
prerank,CellMarker_Augmented_2021__Gonocyte:Gonad,0.46034459637577924,0.9252628038722386,0.5128205128205128,0.8598043433464349,1.0,1/18,0.56%,FLVCR1
prerank,GO_Biological_Process_2021__positive regulation of telomerase activity (GO:0051973),-0.45650313539773013,-0.9251618035306534,0.5873015873015873,0.9242302176740096,1.0,2/26,1.65%,PKIB;PRKCQ
prerank,GO_Biological_Process_2021__regulation of glycogen metabolic process (GO:0070873),-0.5783538267236907,-0.9251596307208293,0.6363636363636364,0.9239022439643111,1.0,2/6,17.44%,PPP1R3B;INPP5K
prerank,GO_Biological_Process_2021__regulation of cellular response to stress (GO:0080135),0.34222597500608426,0.925153279415296,0.5,0.8596526523867098,1.0,17/104,17.93%,BAG3;SIRT1;CASP9;NUP153;NUP188;NUAK1;NUP42;MAPK1;MAPKAPK2;BAG5;FKBP4;GSK3B;MANF;NDC1;NUP133;HSPH1;NUP205
prerank,GO_Biological_Process_2021__response to insulin (GO:0032868),-0.44016054623068024,-0.9249133403562239,0.5142857142857142,0.9241194585946372,1.0,3/59,2.94%,SYAP1;INSIG1;USF1
prerank,GO_Biological_Process_2021__modulation by symbiont of host apoptotic process (GO:0052150),-0.5977266963125984,-0.92487117798464,0.6470588235294118,0.9239124561599404,1.0,1/6,3.95%,RNF213
prerank,GO_Biological_Process_2021__activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),0.35348926122108,0.9248701081799626,0.68,0.8598646175526893,1.0,10/59,7.92%,ACER2;HIP1R;CASP9;TNFRSF10A;ANP32B;PPARG;SMAD3;TNF;ROBO1;BOK
prerank,GO_Biological_Process_2021__anterograde axonal protein transport (GO:0099641),0.5544958647044821,0.9248328502505384,0.6041666666666666,0.8587789341927827,1.0,3/8,31.01%,DLG2;KIF5B;HSPB1
prerank,GO_Biological_Process_2021__axo-dendritic protein transport (GO:0099640),0.5544958647044821,0.9248328502505384,0.6041666666666666,0.8587789341927827,1.0,3/8,31.01%,DLG2;KIF5B;HSPB1
prerank,GO_Biological_Process_2021__protein localization to presynapse (GO:1905383),0.5544958647044821,0.9248328502505384,0.6041666666666666,0.8587789341927827,1.0,3/8,31.01%,DLG2;KIF5B;HSPB1
prerank,GO_Biological_Process_2021__acylglycerol catabolic process (GO:0046464),-0.533645524227455,-0.9248258280679624,0.543859649122807,0.9236827776596792,1.0,2/11,2.51%,MGLL;LIPG
prerank,GO_Biological_Process_2021__protein homotrimerization (GO:0070207),0.5602283424238228,0.9247307632764468,0.56,0.8582039599023567,1.0,3/7,10.35%,SLC1A2;DISP1;ALOX5AP
prerank,GO_Biological_Process_2021__protein trimerization (GO:0070206),0.5602283424238228,0.9247307632764468,0.56,0.8582039599023567,1.0,3/7,10.35%,SLC1A2;DISP1;ALOX5AP
prerank,GO_Biological_Process_2021__receptor clustering (GO:0043113),-0.4953337343978531,-0.9247244845308874,0.5789473684210527,0.9235543140681818,1.0,7/22,11.27%,FLNA;MUSK;ITGA4;DVL1;PTN;ITGB2;ITGAL
prerank,Reactome_2022__Binding Of TCF/LEF:CTNNB1 To Target Gene Promoters R-HSA-4411364,-0.6217444382851988,-0.92464538633992,0.660377358490566,0.9233705494059022,1.0,1/5,1.37%,RUNX3
prerank,GO_Biological_Process_2021__cellular response to starvation (GO:0009267),0.3259794352866675,0.9245527858401119,0.5909090909090909,0.8581270271707334,1.0,22/115,18.33%,RRAGD;PDK4;MAP1LC3A;SIRT1;XPR1;LRRK2;CPEB4;NUAK1;BRSK1;EIF2S1;ATP6V1B2;MAPK1;RIPOR1;SESN2;TBL2;MAP3K5;LAMTOR3;PRKAA1;SH3GLB1;BRSK2;SIK2;TCIRG1
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell chemotaxis (GO:2001028),0.54770273944126,0.9244812437952545,0.5714285714285714,0.8579661354369925,1.0,2/10,2.26%,SEMA5A;FGF2
prerank,KEGG_2021_Human__Vibrio cholerae infection,-0.42668644292165747,-0.9243976273581181,0.6338028169014085,0.9236168794141281,1.0,5/39,10.71%,ATP6V1F;ERO1A;ACTG1;CFTR;ACTB
prerank,Reactome_2022__S Phase R-HSA-69242,-0.38485041035536305,-0.9242830719743267,0.6623376623376623,0.9235309081925124,1.0,19/116,14.90%,UBC;RPS27A;PSMB3;POLE3;PSMB6;PSMA7;PSMB9;RBX1;PSMD12;ANAPC11;MAX;PSMD8;PSMA5;MCM7;RPA3;CCND1;SMC1A;UBA52;CDC26
prerank,GO_Biological_Process_2021__brain development (GO:0007420),0.3375598952674302,0.9242034732280757,0.6428571428571429,0.8582463387312114,1.0,21/93,13.48%,QARS1;CDK5R1;MAP1S;AATK;TGFBR2;ARNT2;PBX1;RELN;PPT1;PLXNB2;CA10;CTNNA2;SHANK3;NFIB;FBXW11;PTCH1;PTEN;GRIN2B;NF1;BAG6;NIPBL
prerank,GO_Biological_Process_2021__aflatoxin metabolic process (GO:0046222),0.5800374453383235,0.9241156059920197,0.6122448979591837,0.8572715928059861,1.0,1/5,5.24%,ACY3
prerank,GO_Biological_Process_2021__mycotoxin metabolic process (GO:0043385),0.5800374453383235,0.9241156059920197,0.6122448979591837,0.8572715928059861,1.0,1/5,5.24%,ACY3
prerank,GO_Biological_Process_2021__organic heteropentacyclic compound metabolic process (GO:1901376),0.5800374453383235,0.9241156059920197,0.6122448979591837,0.8572715928059861,1.0,1/5,5.24%,ACY3
prerank,Reactome_2022__Regulation Of Gene Expression By Hypoxia-inducible Factor R-HSA-1234158,-0.5170709263253819,-0.9240695814181669,0.5636363636363636,0.9236468050811604,1.0,3/8,11.34%,CITED2;VEGFA;HIF1A
prerank,Reactome_2022__Intra-Golgi And Retrograde Golgi-to-ER Traffic R-HSA-6811442,0.33238931045147685,0.9240565273136653,0.6666666666666666,0.856985688282807,1.0,23/143,17.41%,RAB33B;KIFC2;TMED3;RAB1B;COPG1;RABEPK;VTI1A;COG1;GOLIM4;CENPE;RAB6A;KIF15;KIF6;NAA35;YKT6;GALNT1;STX6;DYNC1H1;GALNT2;COG3;COPB1;KIF13B;COPZ1
prerank,Reactome_2022__Signaling By ERBB2 KD Mutants R-HSA-9664565,0.4791470291937189,0.9239411612042954,0.5111111111111111,0.8568309809850156,1.0,7/16,18.36%,PIGU;NRG1;NRG3;NRG2;ERBB4;PIK3CA;ERBIN
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),-0.46785341556298776,-0.923930363590084,0.5666666666666667,0.9236845280567114,1.0,7/20,23.60%,RBPJ;VEGFA;HIF1A;ATF3;MT3;NFE2L2;KLF2
prerank,Reactome_2022__Transcriptional Regulation By RUNX2 R-HSA-8878166,-0.39298269950586134,-0.9239302728473986,0.6301369863013698,0.9233514286957103,1.0,14/85,14.82%,UBC;RPS27A;PSMB3;YES1;PSMB6;PSMA7;PSMB9;STAT1;RBX1;PSMD12;PSMD8;PSMA5;CCND1;UBA52
prerank,GO_Biological_Process_2021__leukocyte cell-cell adhesion (GO:0007159),-0.48357923116055884,-0.9239037675131717,0.6206896551724138,0.9230738435704079,1.0,7/17,11.27%,CCL5;PECAM1;OLR1;ITGA4;FERMT3;ITGB2;ITGAL
prerank,GO_Biological_Process_2021__negative regulation of complement activation (GO:0045916),-0.5819212229274959,-0.9237590046656327,0.6071428571428571,0.923053227833378,1.0,3/7,13.78%,CD55;A2M;SERPING1
prerank,Reactome_2022__Downregulation Of SMAD2/3:SMAD4 Transcriptional Activity R-HSA-2173795,0.42587886584691703,0.9237326950823572,0.6111111111111112,0.8568858229426162,1.0,9/29,11.38%,UBE2D1;SERPINE1;SMAD7;PARP1;SMAD2;SMAD3;NEDD4L;HDAC1;MAPK1
prerank,KEGG_2021_Human__Glycolysis / Gluconeogenesis,0.4231028865156133,0.9236510395178289,0.5714285714285714,0.8567156007089659,1.0,2/37,1.17%,PFKP;PFKM
prerank,Reactome_2022__HIV Transcription Initiation R-HSA-167161,0.42470227016079537,0.9233075352069218,0.59375,0.857131353647042,1.0,10/37,19.66%,POLR2D;CDK7;TAF2;TAF9B;TAF3;GTF2E1;POLR2H;GTF2H3;ERCC2;TAF4
prerank,KEGG_2021_Human__cAMP signaling pathway,-0.391493150216902,-0.9231652425288942,0.6455696202531646,0.9240495870508247,1.0,5/121,2.19%,PDE4A;PLN;FOS;CHRM2;VAV3
prerank,GO_Biological_Process_2021__cellular calcium ion homeostasis (GO:0006874),-0.4035800359662814,-0.9228545063774991,0.5974025974025974,0.9244313748680579,1.0,8/76,9.96%,CCL3;PLN;CCL5;CDH23;ATP13A1;TPT1;TRPV4;SMDT1
prerank,Reactome_2022__RNA Polymerase I Transcription Termination R-HSA-73863,-0.452404811101851,-0.922767351798871,0.5223880597014925,0.9242804233356235,1.0,2/24,4.34%,TAF1D;GTF2H5
prerank,Reactome_2022__Nucleotide Biosynthesis R-HSA-8956320,-0.5477196567794849,-0.9227017012383847,0.6268656716417911,0.9240938792106341,1.0,3/10,25.74%,DHODH;GART;IMPDH2
prerank,CellMarker_Augmented_2021__Basal cell:Airway Epithelium,0.40321617392105913,0.9226173766308172,0.5526315789473685,0.8582891394039566,1.0,17/40,24.58%,FKBP9;DAG1;BMP1;BOK;GNA11;FAM114A1;SH3GL1;STEAP3;CD276;P4HB;FAM234A;CD151;CTTN;MGAT4B;QSOX1;GPC1;SLC4A2
prerank,GO_Biological_Process_2021__regulation of gene silencing by miRNA (GO:0060964),0.35411929731230973,0.9225997196008521,0.71875,0.8579303857107208,1.0,5/56,7.20%,POLR2D;NUP153;NUP188;PPARG;NUP42
prerank,GO_Biological_Process_2021__negative regulation of neuroinflammatory response (GO:0150079),-0.55215404531685,-0.9223377807791079,0.6271186440677966,0.924510927481883,1.0,5/12,15.81%,CD200R1;IGF1;TNFRSF1B;PTPRC;CD200
prerank,GO_Biological_Process_2021__regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043619),-0.5588305149372577,-0.9223227735530534,0.6363636363636364,0.924204435034428,1.0,2/7,16.40%,HIF1A;MT3
prerank,GO_Biological_Process_2021__regulation of potassium ion transmembrane transporter activity (GO:1901016),0.4648873938811964,0.9222668431737071,0.5526315789473685,0.85824578814361,1.0,3/19,8.52%,NETO1;CAB39;NEDD4L
prerank,GO_Biological_Process_2021__positive regulation of macromolecule metabolic process (GO:0010604),-0.36644435253152063,-0.9221730006452112,0.6419753086419753,0.924225611638968,1.0,34/215,11.34%,CALCR;CD36;CCL3;RIMS1;TFRC;PID1;WARS1;RPL5;ANXA2;DDRGK1;ETS1;CLU;RPL11;RPS3;RPL23;IGF1;CD63;DTX3L;LAMTOR5;VPS35;MUSK;TTN;RPS7;PLSCR1;SNF8;ACTG1;RBPJ;OVOL2;PDCD5;SLC11A1;CITED2;VEGFA;TYROBP;HIF1A
prerank,GO_Biological_Process_2021__regulation of stem cell differentiation (GO:2000736),-0.41466643756842125,-0.922172427558366,0.6056338028169014,0.9238935147609089,1.0,18/66,22.96%,PSMB3;EIF2AK2;PSMB6;PSMA7;PSMB9;PTN;TCF3;PSMD12;PSMD8;PSMA5;SETD1A;PSMA3;PSMC4;PSME2;PSME1;PSMB5;PSMC3;PSME3
prerank,GO_Biological_Process_2021__regulation of neutrophil migration (GO:1902622),-0.5476870070535528,-0.9221665988178452,0.5932203389830508,0.9235810948825219,1.0,3/8,23.99%,NCKAP1L;RAC1;RAC2
prerank,Reactome_2022__Nitric Oxide Stimulates Guanylate Cyclase R-HSA-392154,0.4630006348371627,0.9219356852484398,0.65,0.8586757739862138,1.0,6/15,15.24%,PDE10A;GUCY1A1;KCNMB4;GUCY1A2;KCNMB3;GUCY1B1
prerank,GO_Biological_Process_2021__regulation of platelet aggregation (GO:0090330),0.482046560928388,0.9219355776566907,0.5945945945945946,0.8582912349024759,1.0,2/14,2.96%,PDPN;SERPINE2
prerank,GO_Biological_Process_2021__chromatin organization (GO:0006325),0.3181187385329117,0.9219061423270671,0.5666666666666667,0.857990504220408,1.0,16/98,13.32%,ZBTB1;RUVBL2;DR1;SIRT1;ARID1A;TCF7L1;SETD7;MTA2;HP1BP3;SATB2;HDAC1;LOXL2;KAT2A;HMGN4;SETD2;SETDB2
prerank,GO_Biological_Process_2021__striated muscle cell differentiation (GO:0051146),0.4498874948503543,0.9218860275248048,0.59375,0.8576639717745262,1.0,2/10,7.87%,NRG1;SORT1
prerank,GO_Biological_Process_2021__regulation of microtubule-based process (GO:0032886),0.41693148575126576,0.9218718473374704,0.5813953488372093,0.8573325195541334,1.0,10/29,18.25%,PHLDB1;TPPP;KLHL42;MEMO1;CLASP1;GSK3B;PRKAA1;CLASP2;MARK2;MAP6
prerank,Reactome_2022__Negative Regulation Of MAPK Pathway R-HSA-5675221,-0.48483843850217356,-0.9214089050348282,0.6724137931034483,0.9247424505819095,1.0,3/31,2.98%,UBC;RPS27A;PAQR3
prerank,GO_Biological_Process_2021__regulation of vascular endothelial cell proliferation (GO:1905562),0.514172204591644,0.9213026824944862,0.6363636363636364,0.85830374193314,1.0,3/13,9.36%,FGF2;PPARG;SIRT6
prerank,GO_Biological_Process_2021__cellular response to DNA damage stimulus (GO:0006974),-0.3705277519865371,-0.9210710391203236,0.7,0.9251098067159261,1.0,32/274,15.71%,BCL2A1;DDX11;PPP1R15A;MNDA;XPA;VAV3;BTG2;POLE3;OGG1;HUS1;MUS81;RPS3;DTX3L;TNFRSF1B;PARP2;XRCC3;NPM1;REXO4;NABP1;NOP53;WDR48;APEX1;MCM7;RAD9A;CCND1;BRCA1;ERCC8;CBX3;SMC1A;PARP4;PIDD1;STXBP4
prerank,KEGG_2021_Human__Cardiac muscle contraction,-0.4455450477534514,-0.9208115453688367,0.6567164179104478,0.9253118504762112,1.0,14/47,17.32%,COX7C;UQCRB;UQCRH;UQCR10;COX4I1;COX5B;CACNA2D4;COX7A2;ATP1B3;COX6C;ATP1A1;UQCRC1;CACNB1;UQCRQ
prerank,GO_Biological_Process_2021__placenta development (GO:0001890),0.5847348705381384,0.9205566672563297,0.6122448979591837,0.8597531574218099,1.0,2/5,13.77%,PPARG;PTK2
prerank,GO_Biological_Process_2021__negative regulation of cytokine production (GO:0001818),-0.389339581365356,-0.9204498396123816,0.6282051282051282,0.9256916792082883,1.0,21/117,13.66%,SIGIRR;SRGN;ZFP36;NLRC3;DHX58;CD200R1;APOD;LILRB4;NLRC5;NLRP12;TNFAIP3;BTN2A2;TMSB4X;SELENOS;SLC11A1;NCKAP1L;TYROBP;C5AR2;PTPRC;KAT5;HAVCR2
prerank,CellMarker_Augmented_2021__Secretory cell:Lung,-0.45798626818365773,-0.9204395267013069,0.6176470588235294,0.9253953443350604,1.0,12/27,18.95%,IFITM3;HLA-DRB5;HLA-DRA;PRR5L;CYFIP2;HLA-DPA1;C3;HLA-DMB;CD74;HLA-DPB1;HLA-DRB1;PPP1R16B
prerank,GO_Biological_Process_2021__negative regulation of extracellular matrix organization (GO:1903054),-0.5901371982642233,-0.9202694989778512,0.6491228070175439,0.9255130164752717,1.0,1/5,8.06%,TNFRSF1B
prerank,Reactome_2022__Signaling By RAF1 Mutants R-HSA-9656223,0.39617296569995364,0.9200179144892036,0.5714285714285714,0.8604621881449394,1.0,4/30,11.38%,RAP1A;MAP2K1;VCL;MAPK1
prerank,GO_Biological_Process_2021__Wnt signaling pathway (GO:0016055),-0.4130128006211035,-0.9199279047931516,0.5652173913043478,0.9259020596947981,1.0,8/55,12.28%,UBC;CCDC88C;RPS27A;VPS35;DVL1;RBX1;CSNK1G2;FZD2
prerank,Reactome_2022__E2F Mediated Regulation Of DNA Replication R-HSA-113510,0.46115508672628847,0.9198126910889669,0.6,0.8604838510495254,1.0,4/14,23.58%,PPP2R1B;POLA1;PRIM2;PPP2CB
prerank,KEGG_2021_Human__Insulin secretion,0.36479515083660086,0.9196942931048018,0.5862068965517241,0.8603390877568181,1.0,14/52,19.12%,GNAQ;PLCB4;ADCY9;KCNMB4;STX1A;KCNN2;GNA11;ABCC8;KCNMB3;ADCY6;PLCB3;PCLO;RIMS2;CREB3L2
prerank,KEGG_2021_Human__Yersinia infection,0.3407865958638599,0.9192543005083851,0.5925925925925926,0.8608961694332318,1.0,25/113,16.34%,WIPF3;MAPK11;MAP2K1;GNAQ;PIP5K1B;WASF2;TNF;CRK;ELMO1;IRAK1;TAB2;RPS6KA6;MAPK1;ARF6;VAV1;JUN;PTK2;SKAP2;TRAF6;NLRC4;GIT2;NFATC3;AKT2;GSK3B;MAP3K7
prerank,CellMarker_Augmented_2021__Smooth Muscle cell:Undefined,0.44428999418950355,0.919163415461074,0.5,0.8607513513960758,1.0,3/20,3.17%,TPM2;SVEP1;ACTA2
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",0.3813329019385351,0.9187558185442667,0.5625,0.8612610134854705,1.0,7/45,12.18%,POLR2D;DCP1B;SAMD4A;EXOSC6;CNOT7;CNOT2;LSM6
prerank,GO_Biological_Process_2021__plus-end-directed vesicle transport along microtubule (GO:0072383),-0.5975258901638945,-0.9184277847853342,0.6111111111111112,0.9286587473587928,1.0,2/5,32.69%,KIFAP3;FYCO1
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Peripheral Blood,-0.42685579476671004,-0.9181727370689662,0.5555555555555556,0.9288267934491562,1.0,14/49,9.17%,FOSL2;CD55;PARP14;ANXA2;ANKRD22;ABCC3;ERO1A;GBP3;DTX3L;PARP9;PLSCR1;CD44;SAMD9;S100A6
prerank,GO_Biological_Process_2021__negative regulation of autophagy (GO:0010507),0.40270003524837394,0.9180921196713029,0.7407407407407407,0.8622114522052091,1.0,4/47,9.97%,LEPR;LRRK2;TAB2;HGF
prerank,KEGG_2021_Human__Breast cancer,0.35698662013311344,0.918064659959055,0.5652173913043478,0.8618950169411238,1.0,16/76,11.88%,IGF1R;FGF2;TCF7L1;NCOA3;E2F3;MAP2K1;WNT5A;FZD3;WNT2B;JAG1;DVL3;SHC2;TCF7L2;MAPK1;PTEN;CDK6
prerank,GO_Biological_Process_2021__detection of calcium ion (GO:0005513),0.5093559494873938,0.9180197083052128,0.5,0.8616255402870995,1.0,3/9,13.35%,KCNIP2;KCNMB4;KCNMB3
prerank,KEGG_2021_Human__Thyroid cancer,0.42817076383150215,0.9178858718635287,0.6206896551724138,0.8614703518575664,1.0,7/27,11.38%,TCF7L1;MAP2K1;PPARG;CCDC6;TCF7L2;NCOA4;MAPK1
prerank,GO_Biological_Process_2021__regulation of peptidase activity (GO:0052547),0.5037483011098316,0.9175342343888055,0.5789473684210527,0.8617661107813264,1.0,4/12,16.14%,RCN3;HDAC1;ATP13A2;CTSH
prerank,Reactome_2022__O-linked Glycosylation R-HSA-5173105,0.3849271687646335,0.9174900721125524,0.5263157894736842,0.8615022301347774,1.0,11/47,9.87%,B3GNT2;SPON1;SEMA5A;LARGE1;GALNTL6;ST6GALNAC3;DAG1;ADAMTSL2;ADAMTS17;ADAMTSL3;C1GALT1
prerank,GO_Biological_Process_2021__negative regulation of translational initiation (GO:0045947),0.5481688977835564,0.9174782797118259,0.5945945945945946,0.8611402188032165,1.0,1/11,3.39%,EIF4EBP2
prerank,GO_Biological_Process_2021__sulfate transport (GO:0008272),0.5251912063089981,0.9172777296275006,0.5555555555555556,0.8611200666851138,1.0,1/8,14.12%,SLC25A14
prerank,GO_Biological_Process_2021__positive regulation of neural precursor cell proliferation (GO:2000179),-0.4944267497664475,-0.9172262747404052,0.5423728813559322,0.9306604405468111,1.0,4/13,20.59%,ZNF335;VEGFA;SMARCD3;TOX
prerank,GO_Biological_Process_2021__vascular transport (GO:0010232),-0.4331183243395306,-0.9172066331996194,0.5909090909090909,0.9303694180548634,1.0,7/50,6.91%,SLC2A3;SLC7A5;TFRC;SLC38A1;ABCC3;ABCB1;SLC16A7
prerank,Reactome_2022__Selective Autophagy R-HSA-9663891,-0.4161131880052256,-0.9168947382711423,0.5555555555555556,0.9306818344925167,1.0,3/51,1.30%,UBC;TOMM7;RPS27A
prerank,CellMarker_Augmented_2021__Intestinal Stem cell:Small Intestine,0.6135708667950032,0.916742316708425,0.6511627906976745,0.8617982222449607,1.0,3/5,19.71%,ALCAM;BMPR1A;DCLK1
prerank,GO_Biological_Process_2021__regulation of cholesterol storage (GO:0010885),0.4868722073364242,0.9167310500258538,0.5531914893617021,0.8614520720864154,1.0,2/13,5.17%,MSR1;PPARG
prerank,CellMarker_Augmented_2021__Muscle Satellite cell:Muscle,0.3973055026377876,0.9163475716241494,0.65625,0.8618969221261222,1.0,10/44,14.53%,PDPN;GSN;PLXNA2;MAP1LC3A;RIN2;CD82;RBFOX1;NTRK2;CXCL14;NFASC
prerank,CellMarker_Augmented_2021__Hepatocyte:Fetal Liver,0.41808520958238354,0.9163188686894148,0.631578947368421,0.8615665320041589,1.0,11/33,21.51%,FKBP9;MAGI1;PTPRK;FAM114A1;ITGA2;TJP1;CD276;RAI14;SNX7;NTN4;CTTN
prerank,GO_Biological_Process_2021__positive regulation of T-helper cell differentiation (GO:0045624),0.5658741341990076,0.9162446746808464,0.6341463414634146,0.8613810084483356,1.0,1/8,0.34%,ANXA1
prerank,Reactome_2022__mTORC1-mediated Signaling R-HSA-166208,0.4476367977465213,0.9155304961683793,0.5454545454545454,0.8626097805339076,1.0,1/20,0.78%,RRAGD
prerank,GO_Biological_Process_2021__lipid biosynthetic process (GO:0008610),-0.43129534383150386,-0.9154587481948917,0.5970149253731343,0.9332932241031219,1.0,4/45,6.83%,LIPG;LPCAT1;GNPAT;PRLR
prerank,GO_Biological_Process_2021__regulation of protein export from nucleus (GO:0046825),0.4729661415740075,0.9154330057368226,0.6046511627906976,0.8624342769692209,1.0,6/21,15.67%,BAG3;ANP32B;TCF7L2;BARD1;RAPGEF3;GSK3B
prerank,Reactome_2022__Basigin Interactions R-HSA-210991,-0.5037259751042455,-0.9152468635497086,0.5666666666666667,0.9333690547838788,1.0,6/18,18.52%,SLC7A5;SLC16A3;ITGA6;ATP1B3;PPIL2;ITGB1
prerank,GO_Biological_Process_2021__cholesterol homeostasis (GO:0042632),-0.4651334552415409,-0.915120596072418,0.578125,0.9330083789391844,1.0,4/33,5.38%,INSIG1;LIPG;RORA;NR1H2
prerank,GO_Biological_Process_2021__sterol homeostasis (GO:0055092),-0.4651334552415409,-0.915120596072418,0.578125,0.9330083789391844,1.0,4/33,5.38%,INSIG1;LIPG;RORA;NR1H2
prerank,GO_Biological_Process_2021__negative regulation of amyloid-beta formation (GO:1902430),-0.4917947249497368,-0.9150951869494875,0.5737704918032787,0.9327235817433225,1.0,2/15,5.56%,CLU;IGF1
prerank,GO_Biological_Process_2021__positive regulation of cellular process (GO:0048522),-0.355460604771728,-0.9150380033693613,0.6823529411764706,0.9325226798884662,1.0,46/336,14.51%,CALCR;CD36;RPS4X;ZFP36;CCL5;IL7R;PDGFD;AIF1;FCER1G;DDRGK1;ETS1;AQP11;TSPAN31;RPL23;IGF1;SLC25A5;TIPIN;IL12RB2;OSMR;PRLR;RPS6;NAMPT;TNFRSF1B;PRKD2;CHTOP;MEIS1;TRIM13;SLC11A1;PTN;POFUT2;NPM1;CITED2;TRPM4;RPS9;VEGFA;TBC1D8;CD47;EFNB2;FLT1;CYBA;ZNF16;TET1;CCND1;COLEC12;FGF20;CCAR1
prerank,KEGG_2021_Human__Sulfur metabolism,0.5619676418066789,0.914443377107536,0.7027027027027027,0.86416167569859,1.0,5/7,37.53%,MPST;PAPSS1;BPNT2;SQOR;BPNT1
prerank,GO_Biological_Process_2021__negative regulation of smooth muscle contraction (GO:0045986),-0.6156050934947466,-0.9143028804392255,0.68,0.9339018498809326,1.0,2/5,24.74%,SOD1;KCNMA1
prerank,Reactome_2022__MAPK1 (ERK2) Activation R-HSA-112411,0.5506774902810838,0.9142600585894731,0.5918367346938775,0.8641866553975799,1.0,3/8,25.21%,MAPK1;MAP2K2;IL6ST
prerank,GO_Biological_Process_2021__positive regulation of vascular endothelial cell proliferation (GO:1905564),0.5046997248081537,0.9141816029009082,0.6410256410256411,0.8640879665306365,1.0,2/10,9.36%,FGF2;SIRT6
prerank,GO_Biological_Process_2021__positive regulation of cellular component organization (GO:0051130),-0.4036144279059267,-0.914131528877012,0.6075949367088608,0.9338582859544344,1.0,14/78,14.13%,PPP1R15A;TFRC;WARS1;MPP7;RACK1;CLU;RPS3;ATP10A;GPC3;ABCB4;VEGFA;BMF;GPX1;CAMK1
prerank,GO_Biological_Process_2021__alpha-amino acid metabolic process (GO:1901605),-0.46017722030938446,-0.9139936176543079,0.5846153846153846,0.933795460193541,1.0,3/25,5.45%,MTHFD1;GLUL;KMO
prerank,GO_Biological_Process_2021__negative regulation of protein polymerization (GO:0032272),0.45988078570795843,0.9139388080336154,0.5609756097560976,0.8642365485656911,1.0,7/22,19.55%,HIP1R;MYADM;KANK1;DYRK1A;SSH2;SNCA;MAP2
prerank,GO_Biological_Process_2021__natural killer cell mediated immunity (GO:0002228),-0.5370573685388228,-0.9138807335644696,0.5964912280701754,0.9336683924774615,1.0,3/9,13.99%,GZMB;KLRD1;TUBB4B
prerank,Reactome_2022__Gap Junction Degradation R-HSA-190873,-0.5261951306917665,-0.9138282467769234,0.6274509803921569,0.9331125961089644,1.0,4/10,30.19%,CLTB;AP2M1;CLTA;DAB2
prerank,Reactome_2022__Gap Junction Trafficking R-HSA-190828,-0.5261951306917665,-0.9138282467769234,0.6274509803921569,0.9331125961089644,1.0,4/10,30.19%,CLTB;AP2M1;CLTA;DAB2
prerank,Reactome_2022__Regulation Of APC/C Activators Between G1/S And Early Anaphase R-HSA-176408,-0.4219279411140294,-0.9135172984855134,0.5915492957746479,0.9334418555446913,1.0,17/58,19.69%,UBC;RPS27A;PSMB3;PSMB6;PSMA7;PSMB9;PSMD12;ANAPC11;PSMD8;PSMA5;UBA52;CDC26;PSMA3;PSMC4;BUB3;PSME2;PSME1
prerank,GO_Biological_Process_2021__neuromuscular process controlling balance (GO:0050885),-0.603093635575697,-0.9134407953447646,0.676923076923077,0.933247689561299,1.0,2/6,5.06%,TPP1;CDH23
prerank,GO_Biological_Process_2021__positive regulation of transcription elongation from RNA polymerase II promoter (GO:0032968),0.5042621595638468,0.9133918781977385,0.6,0.8651210754663352,1.0,4/10,18.47%,SUPT16H;CDK13;CDK12;EAPP
prerank,GO_Biological_Process_2021__cellular sodium ion homeostasis (GO:0006883),0.5040053818330987,0.9128922479945051,0.5909090909090909,0.8654529341766923,1.0,4/9,15.33%,NEDD4L;SLC9A1;SLC8A1;SLC12A2
prerank,GO_Biological_Process_2021__sodium ion homeostasis (GO:0055078),0.5040053818330987,0.9128922479945051,0.5909090909090909,0.8654529341766923,1.0,4/9,15.33%,NEDD4L;SLC9A1;SLC8A1;SLC12A2
prerank,Reactome_2022__Synthesis Of Active Ubiquitin: Roles Of E1 And E2 Enzymes R-HSA-8866652,-0.4594636873112232,-0.9126431529004677,0.5507246376811594,0.934606633472636,1.0,2/24,1.30%,UBC;RPS27A
prerank,GO_Biological_Process_2021__regulation of actin filament-based movement (GO:1903115),-0.6134674046395117,-0.9123842682659705,0.6530612244897959,0.9347842588495299,1.0,3/7,7.44%,PLN;SRI;MYBPC3
prerank,GO_Biological_Process_2021__response to DNA damage checkpoint signaling (GO:0072423),-0.6184785902892912,-0.9123768910724349,0.6984126984126984,0.9344647755422796,1.0,2/5,14.70%,MUS81;SMC1A
prerank,CellMarker_Augmented_2021__Cancer cell:Esophagus,0.40388897309437766,0.9123031390323453,0.6470588235294118,0.8662432236627485,1.0,9/47,11.39%,NRP1;FKBP9;SERPINE1;GSN;SAMD4A;RIN2;PDLIM5;EPAS1;FAM114A1
prerank,GO_Biological_Process_2021__positive regulation of viral release from host cell (GO:1902188),-0.5705122047774972,-0.9122462494209655,0.6190476190476191,0.9343698832047598,1.0,1/8,12.55%,VPS37B
prerank,GO_Biological_Process_2021__rRNA pseudouridine synthesis (GO:0031118),-0.5891681427830939,-0.9121813583899452,0.6808510638297872,0.9341853446064201,1.0,4/7,22.19%,NHP2;NOP10;RPUSD4;RPUSD3
prerank,CellMarker_Augmented_2021__PROM1High Progenitor cell:Large Intestine,-0.40037501508121326,-0.9120714157592379,0.56,0.9340906188937621,1.0,2/62,1.36%,ARSJ;RPGRIP1L
prerank,GO_Biological_Process_2021__positive regulation of execution phase of apoptosis (GO:1900119),0.6148325770826382,0.9118978488412853,0.6170212765957447,0.8667296561205273,1.0,1/5,7.92%,BOK
prerank,Reactome_2022__O-glycosylation Of TSR Domain-Containing Proteins R-HSA-5173214,-0.48636597064935616,-0.91187181789828,0.576271186440678,0.934210480041937,1.0,2/18,4.26%,SPON2;ADAMTS19
prerank,GO_Biological_Process_2021__protein import into nucleus (GO:0006606),0.3590054429666814,0.9117340571466165,0.4375,0.8667123276381181,1.0,7/58,6.86%,NUTF2;E2F3;TSC2;IPO13;NUP153;NUP188;PPP1R10
prerank,KEGG_2021_Human__Endometrial cancer,0.36383377206546086,0.9116935240384848,0.7037037037037037,0.8664177903007708,1.0,11/45,18.09%,TCF7L1;CASP9;MAP2K1;CTNNA2;TCF7L2;MAPK1;PTEN;AKT2;GSK3B;PIK3CA;MAP2K2
prerank,GO_Biological_Process_2021__negative regulation of macromolecule biosynthetic process (GO:0010558),-0.5285776403284658,-0.9116898168820459,0.5892857142857143,0.9342662431418259,1.0,2/8,9.83%,GSTP1;SELENOS
prerank,GO_Biological_Process_2021__negative regulation of transport (GO:0051051),-0.4250345116523353,-0.9116199012508516,0.6231884057971014,0.9340820031580503,1.0,4/37,7.40%,HAMP;RACK1;NR1H2;PLSCR1
prerank,GO_Biological_Process_2021__response to misfolded protein (GO:0051788),-0.5786582252859509,-0.911577422424074,0.66,0.9338435213972751,1.0,1/7,4.82%,CLU
prerank,GO_Biological_Process_2021__negative regulation of neural precursor cell proliferation (GO:2000178),0.5137704449885758,0.9115666116288336,0.6097560975609756,0.8662620633788846,1.0,2/6,12.21%,WNT5A;NF1
prerank,GO_Biological_Process_2021__neurotrophin TRK receptor signaling pathway (GO:0048011),-0.5693112990805073,-0.9113890604588815,0.603448275862069,0.9339664974273333,1.0,1/8,2.37%,DDIT4
prerank,Reactome_2022__Presynaptic Phase Of Homologous DNA Pairing And Strand Exchange R-HSA-5693616,-0.45877815077172374,-0.9111268489015293,0.6461538461538462,0.9341820735586355,1.0,7/26,18.09%,HUS1;BRCA2;KAT5;RAD9A;RPA3;BRCA1;WRN
prerank,Reactome_2022__PI-3K cascade:FGFR1 R-HSA-5654689,0.49513246226790736,0.9110009186968465,0.5609756097560976,0.8670964208885531,1.0,1/11,1.00%,PIGU
prerank,GO_Biological_Process_2021__negative regulation of protein phosphorylation (GO:0001933),0.3131332651001837,0.9107930208949554,0.6666666666666666,0.8670225644965474,1.0,16/112,9.33%,QARS1;SPRY2;SMAD7;SPRED1;LRRK2;SPRED2;SIRPA;NCK2;TSC2;GNAQ;CEP85;CIB1;MYADM;PTPN13;YWHAG;DEPTOR
prerank,PanglaoDB_Augmented_2021__Epsilon Cells,-0.4770108989983128,-0.9107262138648226,0.6166666666666667,0.934707410033522,1.0,7/33,11.65%,CALCR;CGNL1;SLC6A16;ITGA4;S100A6;ABCA8;A2M
prerank,GO_Biological_Process_2021__T cell homeostasis (GO:0043029),-0.5803050890078574,-0.9105028522167306,0.6610169491525424,0.9349161834301762,1.0,4/6,32.78%,NCKAP1L;PPP2R3C;AKT1;ZC3H8
prerank,GO_Biological_Process_2021__regulation of stem cell division (GO:2000035),0.5534929117558632,0.9104181745465976,0.5531914893617021,0.8673946262810943,1.0,2/6,10.26%,NCOA3;SMYD5
prerank,"GO_Biological_Process_2021__synaptic transmission, glutamatergic (GO:0035249)",0.478473021928553,0.9103020973208971,0.6666666666666666,0.8672284987923121,1.0,4/16,6.64%,GRID2;GRID1;GRIK2;UNC13B
prerank,Reactome_2022__HDR Thru Single Strand Annealing (SSA) R-HSA-5685938,-0.44634457842182335,-0.9100781829786763,0.5625,0.9354632371508679,1.0,6/26,18.09%,HUS1;KAT5;RAD9A;RPA3;BRCA1;WRN
prerank,CellMarker_Augmented_2021__Epithelial cell:Undefined,-0.540827526497561,-0.9100005793241832,0.6842105263157895,0.9353269037910158,1.0,3/11,24.92%,ITGA6;KRT10;THBD
prerank,GO_Biological_Process_2021__phospholipid metabolic process (GO:0006644),0.39567039027825895,0.9099144556834077,0.6333333333333333,0.8676769468477727,1.0,10/43,14.11%,PLA2G4C;ABCA2;PLPPR1;PLPP1;PLPPR4;FDFT1;AGPAT5;LCAT;PIP4K2A;AGPAT2
prerank,Reactome_2022__PI-3K cascade:FGFR4 R-HSA-5654720,0.5161516761968794,0.9097945327882732,0.5813953488372093,0.8675569032679454,1.0,1/10,1.00%,PIGU
prerank,GO_Biological_Process_2021__nucleotide catabolic process (GO:0009166),-0.5596869485274125,-0.9094284692957689,0.5737704918032787,0.9362211852871097,1.0,2/10,14.09%,NT5C;GPX1
prerank,GO_Biological_Process_2021__low-density lipoprotein receptor particle metabolic process (GO:0032799),-0.5471542602725064,-0.9094172223546031,0.6065573770491803,0.935584816626995,1.0,5/9,27.39%,VLDLR;AP2S1;AP2M1;CLTA;AP2A1
prerank,GO_Biological_Process_2021__low-density lipoprotein particle receptor catabolic process (GO:0032802),-0.5471542602725064,-0.9094172223546031,0.6065573770491803,0.935584816626995,1.0,5/9,27.39%,VLDLR;AP2S1;AP2M1;CLTA;AP2A1
prerank,GO_Biological_Process_2021__glycolytic process (GO:0006096),-0.505276058905732,-0.9093817215294189,0.6129032258064516,0.9353370852964221,1.0,4/16,13.22%,GAPDH;HK2;LDHA;PGK1
prerank,GO_Biological_Process_2021__regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),-0.37454821186614123,-0.9092655033302922,0.6103896103896104,0.9352775001216571,1.0,14/85,12.71%,UBXN1;DDRGK1;RACK1;ELOB;CLU;ARIH2;RPL11;RNF144B;DVL1;GLMN;RBX1;NOP53;HSPA1B;CSNK1D
prerank,GO_Biological_Process_2021__negative regulation of autophagosome maturation (GO:1901097),0.5671042764055427,0.909100171937896,0.5714285714285714,0.8687159028231377,1.0,1/5,4.89%,TMEM39A
prerank,Reactome_2022__Potential Therapeutics For SARS R-HSA-9679191,-0.39342823937324306,-0.908973746050723,0.6025641025641025,0.9355842120840908,1.0,12/76,18.52%,CHD3;BTK;CRBN;ITGA4;COMT;RBX1;VEGFA;IFNGR2;ATP1B3;AP2S1;CHD4;ITGB1
prerank,GO_Biological_Process_2021__pyrimidine ribonucleotide metabolic process (GO:0009218),-0.6041654521195192,-0.9089398537171116,0.5967741935483871,0.9353112736823653,1.0,2/5,11.81%,ENTPD4;DHODH
prerank,GO_Biological_Process_2021__muscle contraction (GO:0006936),0.3505571438937007,0.9087426064551599,0.5555555555555556,0.8692449239996889,1.0,10/54,8.30%,TPM2;MYOM1;ACTA2;KCNIP2;GLRA1;ADRA1A;TMOD2;VCL;DTNA;TMOD3
prerank,GO_Biological_Process_2021__negative regulation of cellular macromolecule biosynthetic process (GO:2000113),0.30577307397772113,0.9086893198129015,0.7272727272727273,0.8689710127587464,1.0,50/369,11.06%,KLF4;SYNCRIP;QARS1;CDK5R1;GCLC;ZBTB33;SIRT1;ZBTB16;RNF139;DPF3;ZNF706;SPINDOC;SAMD4A;HDAC9;TLE2;CBFA2T3;WNT5A;SAMD1;FOXN3;ZNF12;PPARG;POU2F1;SMAD2;DDIT3;NRG1;DACH1;SALL1;HMGA1;TNF;RFX3;EIF4E2;CLOCK;NACC2;MAP3K10;TRERF1;CNOT7;CTBP2;IKZF1;SFMBT1;DBI;MDM2;BTRC;HDAC1;TWIST2;SLFN11;LOXL2;PTPRK;FBXW11;ZBTB38;TCF7L2
prerank,GO_Biological_Process_2021__protein exit from endoplasmic reticulum (GO:0032527),0.43503988074708977,0.9086610402990968,0.5789473684210527,0.8686513604815055,1.0,3/22,8.99%,TECPR2;SEL1L;AUP1
prerank,GO_Biological_Process_2021__negative regulation by symbiont of host apoptotic process (GO:0033668),-0.5767470410935308,-0.9085264266891472,0.6415094339622641,0.9358564507009616,1.0,1/7,3.95%,RNF213
prerank,Reactome_2022__tRNA Aminoacylation R-HSA-379724,-0.4336130842527526,-0.908354504786163,0.6666666666666666,0.9358158551377052,1.0,6/37,12.52%,WARS1;NARS1;LARS1;KARS1;TARS2;DARS2
prerank,GO_Biological_Process_2021__negative regulation of double-strand break repair (GO:2000780),-0.4863049283696005,-0.9082561363274764,0.65625,0.935727583184391,1.0,3/24,14.63%,OGG1;CYREN;FANCB
prerank,GO_Biological_Process_2021__intraciliary retrograde transport (GO:0035721),-0.5591531127398257,-0.9082259195953988,0.6206896551724138,0.9354676959275584,1.0,2/11,16.14%,DYNC2I1;IFT43
prerank,KEGG_2021_Human__Retinol metabolism,-0.5273469909351401,-0.9081625925172297,0.6346153846153846,0.9352334165655896,1.0,9/12,37.54%,CYP3A5;RDH11;ADH5;RDH10;DHRS4;CYP2S1;RETSAT;ALDH1A1;ALDH1A2
prerank,GO_Biological_Process_2021__UV-damage excision repair (GO:0070914),-0.5363373379649936,-0.9077933519039197,0.5740740740740741,0.9357617759820658,1.0,1/11,1.76%,XPA
prerank,GO_Biological_Process_2021__negative regulation of oxidoreductase activity (GO:0051354),-0.5999268692071287,-0.9077257599287801,0.625,0.935572020029643,1.0,2/5,16.40%,OXA1L;MT3
prerank,GO_Biological_Process_2021__presynaptic endocytosis (GO:0140238),0.45897990530200633,0.9077146243547922,0.5882352941176471,0.8704002358059765,1.0,6/18,19.35%,NLGN1;SNCB;STX1A;NLGN4Y;STON2;SNCA
prerank,Reactome_2022__Glyoxylate Metabolism And Glycine Degradation R-HSA-389661,-0.5244657307118814,-0.9077134868744959,0.6833333333333333,0.9352744565903107,1.0,8/13,26.42%,PDHX;GOT2;DLST;PDHB;PDHA1;NDUFAB1;GRHPR;DHTKD1
prerank,GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen (GO:0002478),-0.39006168561887244,-0.9075770351446383,0.6285714285714286,0.9352500339009095,1.0,18/77,19.77%,FCER1G;HLA-DRB5;MFSD6;HLA-F;DCTN6;HLA-DRA;DCTN4;DYNC1LI2;HLA-E;HLA-DPA1;HLA-DMB;AP2S1;CD74;SEC13;HLA-DPB1;DCTN2;HLA-DRB1;DYNC1I2
prerank,GO_Biological_Process_2021__estrogen metabolic process (GO:0008210),-0.5829854742294153,-0.9074110853990475,0.6530612244897959,0.9352732159525244,1.0,3/6,28.53%,CYP3A5;CYP19A1;HSD17B7
prerank,GO_Biological_Process_2021__epithelial cell differentiation (GO:0030855),0.3618532360999566,0.9073930598989189,0.7096774193548387,0.8707234104448162,1.0,10/43,11.26%,ANXA1;SCRIB;RAB10;PPARG;CPT1A;PTER;JAG1;HDAC1;PCK2;ACADVL
prerank,CellMarker_Augmented_2021__Interneuron:Embryonic Prefrontal Cortex,-0.490054874166746,-0.9072287177790492,0.6166666666666667,0.9353376097521878,1.0,6/17,18.75%,CXCR4;LDHA;CKS2;INA;VIM;MAF
prerank,Reactome_2022__Diseases Of Glycosylation R-HSA-3781865,0.3664672357542799,0.9072256989800778,0.6296296296296297,0.8707299587471706,1.0,18/73,12.52%,SPON1;NCAN;SEMA5A;GLB1;LARGE1;MPDU1;DAG1;CSPG5;B4GALT7;GFPT1;ADAMTSL2;ADAMTS17;ADAMTSL3;C1GALT1;EXT1;THSD7A;GPC6;THSD7B
prerank,GO_Biological_Process_2021__endothelial cell migration (GO:0043542),-0.46895524436621566,-0.9072202393877657,0.6031746031746031,0.9350151848833037,1.0,5/21,13.60%,PLEKHG5;CORO1B;STAT1;VEGFA;NR4A1
prerank,Reactome_2022__HDR Thru MMEJ (alt-NHEJ) R-HSA-5685939,-0.5490678087145049,-0.9072133637097618,0.5454545454545454,0.9346961557553286,1.0,2/8,9.48%,BRCA2;PARP2
prerank,GO_Biological_Process_2021__glucose metabolic process (GO:0006006),-0.42949735322202065,-0.9071519662823239,0.6216216216216216,0.9344787282370104,1.0,6/40,8.28%,GAPDH;MDH2;PER2;APOD;G6PC3;OAS1
prerank,KEGG_2021_Human__Renal cell carcinoma,0.3621224774901631,0.9069373552999233,0.7307692307692307,0.870848703057728,1.0,10/58,11.38%,TGFA;GAB1;ARNT2;RAP1A;MAP2K1;CRK;PRCC;HGF;EPAS1;MAPK1
prerank,GO_Biological_Process_2021__positive regulation of gene silencing by miRNA (GO:2000637),-0.48516598010849527,-0.9067777621026053,0.5806451612903226,0.9349835144271378,1.0,1/21,1.48%,ZFP36
prerank,KEGG_2021_Human__Thiamine metabolism,-0.5877018134445493,-0.9067381412237674,0.631578947368421,0.9347503095665669,1.0,1/6,7.17%,NFS1
prerank,GO_Biological_Process_2021__glial cell development (GO:0021782),0.4496642261642292,0.9066234154100452,0.5853658536585366,0.8712936057567495,1.0,6/16,12.21%,MYRF;TPPP;CSPG5;SOX4;CDK6;NF1
prerank,Reactome_2022__Negative Regulators Of DDX58/IFIH1 Signaling R-HSA-936440,-0.4646293381404204,-0.9063386492151706,0.5789473684210527,0.9353116110431106,1.0,4/32,8.14%,UBC;RPS27A;NLRC5;TNFAIP3
prerank,GO_Biological_Process_2021__negative regulation of autophagosome assembly (GO:1902902),0.4714033686500011,0.9061972045460077,0.660377358490566,0.8718247449080937,1.0,2/11,4.89%,LRRK2;TMEM39A
prerank,GO_Biological_Process_2021__positive regulation of I-kappaB phosphorylation (GO:1903721),-0.5683919490418363,-0.9059447474567173,0.5964912280701754,0.935885173169462,1.0,1/6,4.19%,DDRGK1
prerank,GO_Biological_Process_2021__translational readthrough (GO:0006451),-0.5657407502941333,-0.9056587663033313,0.6140350877192983,0.9357696989295823,1.0,1/7,10.07%,DIO2
prerank,GO_Biological_Process_2021__selenocysteine incorporation (GO:0001514),-0.5657407502941333,-0.9056587663033313,0.6140350877192983,0.9357696989295823,1.0,1/7,10.07%,DIO2
prerank,Reactome_2022__Inhibition Of Replication Initiation Of Damaged DNA By RB1/E2F1 R-HSA-113501,0.5023668801157678,0.9056369719136139,0.574468085106383,0.8727883580895949,1.0,4/10,23.58%,PPP2R1B;POLA1;PRIM2;PPP2CB
prerank,Reactome_2022__Regulation Of Cholesterol Biosynthesis By SREBP (SREBF) R-HSA-1655829,0.37422398527202544,0.9053509915194624,0.5882352941176471,0.8731911009770348,1.0,11/48,12.66%,NFYC;IDI1;SEC24B;FDFT1;ACACB;TM7SF2;ELOVL6;HMGCS1;TBL1XR1;MVD;FASN
prerank,GO_Biological_Process_2021__central nervous system myelination (GO:0022010),0.5409296261386523,0.9047204387533588,0.6097560975609756,0.8742448768965819,1.0,4/9,14.79%,ABCA2;MYRF;PTEN;CNTNAP1
prerank,GO_Biological_Process_2021__histone H3-K14 acetylation (GO:0044154),-0.570937943195621,-0.9046119266957118,0.6153846153846154,0.9376097684876403,1.0,1/6,4.84%,ING5
prerank,GO_Biological_Process_2021__deadenylation-dependent decapping of nuclear-transcribed mRNA (GO:0000290),0.5518732859416824,0.9045931170814424,0.6444444444444445,0.87410743988069,1.0,2/7,14.32%,DCP1B;LSM1
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),0.5003874471699246,0.9044320513691547,0.6363636363636364,0.8739853763011521,1.0,4/12,9.60%,SIRT1;TAF9B;ZNF385A;MDM2
prerank,GO_Biological_Process_2021__regulation of cell growth (GO:0001558),0.32931613265672904,0.9043969872577738,0.5384615384615384,0.8737007860512415,1.0,28/142,17.55%,SERTAD2;RAB33B;CDKN2AIP;SIRT1;PTCH2;DNAJB2;SMAD3;CIB1;PPT1;HPN;TAF9B;NDRG3;NME6;NRG3;ATAD3A;RTN4;DCBLD2;CHPT1;MMP14;ENPP1;SESN2;CAPRIN2;TGFBR1;OSGIN2;ING1;MTPN;DDX3X;CGRRF1
prerank,GO_Biological_Process_2021__positive regulation of interleukin-2 production (GO:0032743),0.42090387918925776,0.9042969175138901,0.5526315789473685,0.8734977250391956,1.0,2/22,6.90%,ANXA1;RUNX1
prerank,KEGG_2021_Human__Focal adhesion,-0.3782479036484457,-0.9041235329779626,0.6538461538461539,0.9382954521670711,1.0,17/124,14.58%,FLNA;MYLK;VAV3;PDGFD;IGF1;FYN;PPP1CB;ACTG1;ITGA4;ITGA6;MYL12A;ACTB;VEGFA;FLT1;PIK3CB;CCND1;TLN1
prerank,Reactome_2022__Uptake And Actions Of Bacterial Toxins R-HSA-5339562,0.4148966381444506,0.9038936954839031,0.5609756097560976,0.8739041837682144,1.0,4/23,10.16%,VAMP1;MAP2K1;SV2B;STX1A
prerank,Reactome_2022__PI-3K cascade:FGFR3 R-HSA-5654710,0.5017802757484991,0.9037198729919363,0.5581395348837209,0.8739143881366603,1.0,1/11,1.00%,PIGU
prerank,Reactome_2022__Depolymerisation Of Nuclear Lamina R-HSA-4419969,-0.5328742684562316,-0.903620525405892,0.6363636363636364,0.9390248685625672,1.0,2/10,8.91%,EMD;CNEP1R1
prerank,GO_Biological_Process_2021__fatty acid metabolic process (GO:0006631),0.3649501193839833,0.9035087124612416,0.56,0.8739398039258097,1.0,7/69,5.87%,PPARGC1A;FAAH;CPT1C;ADIPOR2;PPARG;CPT1A;FA2H
prerank,GO_Biological_Process_2021__regulation of regulated secretory pathway (GO:1903305),-0.44803107690157795,-0.9032678602863872,0.6440677966101694,0.939412822881491,1.0,3/22,7.73%,RIMS1;RAB3A;RAB3D
prerank,GO_Biological_Process_2021__membrane protein ectodomain proteolysis (GO:0006509),-0.49668715881457026,-0.9031763147861457,0.5892857142857143,0.9393050367370984,1.0,2/17,10.83%,PRKCQ;ERAP1
prerank,Reactome_2022__Pyrimidine Salvage R-HSA-73614,0.5037934699589123,0.9024967636303157,0.6341463414634146,0.8757046286130091,1.0,4/8,25.52%,UCK2;UPP1;DCK;UCKL1
prerank,GO_Biological_Process_2021__intracellular protein transport (GO:0006886),0.2958179339170303,0.9024414226910901,0.7894736842105263,0.8754555164205456,1.0,41/257,12.53%,BAG3;NUTF2;ARL5A;SGSM1;PKD1;NLGN1;TBC1D1;E2F3;C17ORF75;TSC2;IPO13;NUP153;NUP188;TLK1;TMED3;RAB1B;TECPR2;TMED10;TBC1D5;PPP1R10;TBC1D10B;TBC1D16;TMED5;NUP42;XPO1;STX11;RANBP3L;SGSM2;TBC1D12;RAB7A;STX1A;LAPTM5;STX2;SNX27;TBC1D22B;SORL1;ARF6;RAB6A;AP4E1;IPO8;RABGAP1
prerank,GO_Biological_Process_2021__negative regulation of protein dephosphorylation (GO:0035308),-0.5193061499960725,-0.9024391193410333,0.6229508196721312,0.9405538682892486,1.0,1/18,1.16%,PPP1R15A
prerank,Reactome_2022__APC/C-mediated Degradation Of Cell Cycle Proteins R-HSA-174143,-0.4125885311239533,-0.9023290352795034,0.6666666666666666,0.94045521949225,1.0,17/61,19.69%,UBC;RPS27A;PSMB3;PSMB6;PSMA7;PSMB9;PSMD12;ANAPC11;PSMD8;PSMA5;UBA52;CDC26;PSMA3;PSMC4;BUB3;PSME2;PSME1
prerank,Reactome_2022__Signaling By MET R-HSA-6806834,-0.42017799404375117,-0.9021804660152,0.6060606060606061,0.9404764363350147,1.0,2/49,1.30%,UBC;RPS27A
prerank,GO_Biological_Process_2021__positive regulation of response to external stimulus (GO:0032103),-0.3818513668681684,-0.9021749290761295,0.589041095890411,0.9401667368720507,1.0,16/87,16.01%,CCL3;CCL5;DHX58;AIF1;USF1;ETS1;PLSCR1;NLRP12;PTN;TASL;CD47;CYBA;LY86;IFI35;AGT;POLR3C
prerank,GO_Biological_Process_2021__regulation of mRNA export from nucleus (GO:0010793),0.5684828192582239,0.9019305200480993,0.6451612903225806,0.8756771170387572,1.0,3/6,17.17%,NSUN2;SETD2;IWS1
prerank,GO_Biological_Process_2021__regulation of ribonucleoprotein complex localization (GO:2000197),0.5684828192582239,0.9019305200480993,0.6451612903225806,0.8756771170387572,1.0,3/6,17.17%,NSUN2;SETD2;IWS1
prerank,PanglaoDB_Augmented_2021__Mesangial Cells,-0.4090999711219495,-0.9017780598330266,0.6619718309859155,0.9406479895746409,1.0,4/71,3.11%,FLNA;MYLK;COL5A1;PER3
prerank,GO_Biological_Process_2021__focal adhesion assembly (GO:0048041),0.48032111093987595,0.9013987563282926,0.5294117647058824,0.8764104500693596,1.0,5/17,21.51%,PTPRK;FERMT2;TAOK2;PEAK1;CTTN
prerank,GO_Biological_Process_2021__regulation of amyloid fibril formation (GO:1905906),0.47981835422397434,0.9013273717606689,0.5454545454545454,0.8761766447242284,1.0,2/12,4.68%,LDLR;PFDN4
prerank,GO_Biological_Process_2021__regulation of neuron projection arborization (GO:0150011),0.4794413423111052,0.9012638802120467,0.5526315789473685,0.875948100356262,1.0,3/14,14.98%,WNT5A;DVL3;MAP3K13
prerank,Reactome_2022__Mucopolysaccharidoses R-HSA-2206281,0.5103793067129677,0.901212359634196,0.5531914893617021,0.8756540285434654,1.0,1/7,3.20%,GLB1
prerank,Reactome_2022__PPARA Activates Gene Expression R-HSA-1989781,0.32254211089800144,0.9011813499977979,0.6538461538461539,0.8753501045113412,1.0,11/86,10.67%,PPARGC1A;NFYC;NCOA3;ARNT2;PPARG;CPT1A;FDFT1;CLOCK;HMGCS1;MED13L;TBL1XR1
prerank,GO_Biological_Process_2021__autophagy of mitochondrion (GO:0000422),-0.4347325565804283,-0.9010112316180193,0.6440677966101694,0.9416359341577027,1.0,5/32,9.32%,GABARAPL1;FIS1;PHB2;ATG2A;GABARAPL2
prerank,GO_Biological_Process_2021__lysosome organization (GO:0007040),-0.4537798454834456,-0.9008117995920859,0.6,0.9416787462605666,1.0,5/28,17.49%,TPP1;HPS4;TASL;ZKSCAN3;HOOK2
prerank,GO_Biological_Process_2021__regulation of blood coagulation (GO:0030193),0.5140495327387519,0.9007932697453249,0.5416666666666666,0.8757485946383149,1.0,3/9,5.59%,SERPINE1;SERPINE2;HPSE
prerank,Reactome_2022__Signaling By CSF3 (G-CSF) R-HSA-9674555,-0.45980675929094117,-0.9006003512208387,0.6176470588235294,0.9417655871074067,1.0,3/26,4.49%,UBC;RPS27A;ELOB
prerank,CellMarker_Augmented_2021__Endothelial cell:Embryonic Brain,-0.42684354386547485,-0.9001122681614628,0.6376811594202898,0.9424060539754231,1.0,15/55,12.34%,MS4A4A;SIGLEC1;CD14;FCER1G;CD93;F13A1;PECAM1;TNFRSF1B;CFLAR;PCDH12;MS4A6A;CSF2RB;TYROBP;A2M;FLT1
prerank,KEGG_2021_Human__Autophagy,0.3192447211277684,0.9000624829419003,0.6363636363636364,0.8768637336729203,1.0,23/114,18.09%,RAB33B;RRAGD;DAPK2;IGF1R;MAP2K1;TSC2;ATG4C;RAB7A;EIF2S1;DEPTOR;MAPK1;PTEN;TRAF6;AKT2;RPS6KB2;MAP3K7;PRKAA1;SH3GLB1;PIK3CA;ATG2B;ATG16L1;ATG13;MAP2K2
prerank,GO_Biological_Process_2021__termination of RNA polymerase I transcription (GO:0006363),-0.4439211797366336,-0.9000216438960982,0.5735294117647058,0.9422724411919928,1.0,2/24,4.34%,TAF1D;GTF2H5
prerank,Reactome_2022__Collagen Formation R-HSA-1474290,0.3955725120454217,0.8998787179027387,0.6363636363636364,0.8768625047074164,1.0,11/43,13.53%,COL5A3;COL16A1;COL5A2;COL24A1;BMP1;LOXL2;P3H2;COL11A1;COL6A1;COL25A1;COL15A1
prerank,GO_Biological_Process_2021__regulation of JUN kinase activity (GO:0043506),0.4094527293703943,0.8998251818869191,0.6216216216216216,0.8765989428681691,1.0,9/25,16.34%,MAP3K11;TNF;DVL3;MAP3K10;SASH1;AIDA;TRAF6;MAP3K5;MAP3K7
prerank,GO_Biological_Process_2021__negative regulation of cellular protein metabolic process (GO:0032269),-0.3983792071633012,-0.899724784074942,0.5769230769230769,0.942522459482102,1.0,9/69,8.47%,GAPDH;BTG2;GZMB;RPL13A;RACK1;RPS3;ILF3;EIF2AK2;EIF4A3
prerank,GO_Biological_Process_2021__SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),-0.3982251788407997,-0.8995838816013655,0.5972222222222222,0.9425366041822354,1.0,17/69,22.96%,PSMB3;PSMB6;PSMA7;PSMB9;RBX1;PSMD12;PSMD8;PSMA5;PSMA3;PSMC4;FBXO4;PSME2;PSME1;PSMB5;PSMC3;CUL4A;PSME3
prerank,GO_Biological_Process_2021__glutamine family amino acid metabolic process (GO:0009064),-0.47342402427070013,-0.8995823244948647,0.5972222222222222,0.9422083086043245,1.0,3/20,8.63%,NIT2;GLUL;GCLM
prerank,GO_Biological_Process_2021__positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),0.519891211065256,0.8994772917579055,0.5510204081632653,0.8770567152839819,1.0,1/8,1.03%,GRB10
prerank,GO_Biological_Process_2021__regulation of extracellular matrix constituent secretion (GO:0003330),-0.5541914969382139,-0.8992056972317699,0.6842105263157895,0.9426370948346744,1.0,2/5,21.23%,TNFRSF1B;RGCC
prerank,KEGG_2021_Human__Protein processing in endoplasmic reticulum,0.3126112927657614,0.8990716049962308,0.7391304347826086,0.8775594563768914,1.0,24/151,17.42%,UBE2D1;UBE2J1;HYOU1;DNAJB2;DNAJB11;SEC24B;DDIT3;PRKCSH;SEL1L;UBE2D2;UBXN6;EIF2S1;RNF185;STT3B;DNAJC3;MAP3K5;SEC61G;UBE2J2;SSR2;UBXN2A;PDIA6;P4HB;SEC31A;HSPH1
prerank,"Reactome_2022__Adrenaline,noradrenaline Inhibits Insulin Secretion R-HSA-400042",-0.5014608775251156,-0.8988837358487619,0.6290322580645161,0.9429839587804555,1.0,2/14,15.86%,GNB5;GNB2
prerank,Reactome_2022__N-glycan Antennae Elongation In medial/trans-Golgi R-HSA-975576,0.4459381288366563,0.8985305260023003,0.6129032258064516,0.8783741398481272,1.0,5/16,22.36%,B4GALT4;MGAT4C;MGAT5;B4GALT5;MGAT4B
prerank,GO_Biological_Process_2021__ribonucleoside monophosphate biosynthetic process (GO:0009156),0.47450043322223,0.8985201449356414,0.6206896551724138,0.8780298017431296,1.0,2/11,15.81%,PPAT;ADK
prerank,GO_Biological_Process_2021__positive regulation of mRNA 3'-end processing (GO:0031442),-0.540744338566515,-0.8984787760643762,0.6415094339622641,0.9434184533041736,1.0,3/8,25.54%,NCBP2;LEO1;DHX36
prerank,CellMarker_Augmented_2021__Neural Crest Stem cell:Hair Follicle,0.348689311392446,0.8984166743568904,0.6071428571428571,0.877887120616152,1.0,4/55,7.88%,SYNGR1;STK32B;CNRIP1;PURG
prerank,Reactome_2022__TP53 Regulates Transcription Of Death Receptors And Ligands R-HSA-6803211,0.5339030401859259,0.8983067480072294,0.6818181818181818,0.8777043081924011,1.0,3/8,12.66%,TNFRSF10A;TNFRSF10D;FASN
prerank,GO_Biological_Process_2021__negative regulation of transferase activity (GO:0051348),-0.44556555218306027,-0.8982082291776652,0.5689655172413793,0.9436110817362484,1.0,2/23,5.72%,ZFP36;DTX3L
prerank,Reactome_2022__Cytosolic tRNA Aminoacylation R-HSA-379716,-0.48612161267169596,-0.8981109158669529,0.6557377049180327,0.9434491967047336,1.0,4/23,11.32%,WARS1;NARS1;LARS1;KARS1
prerank,GO_Biological_Process_2021__heart development (GO:0007507),0.3519149304915499,0.8980541480622388,0.8076923076923077,0.8778435506626932,1.0,25/83,15.68%,PKD2;TGFBR2;PKD1;HDAC9;TSC2;SALL1;ALPK3;SOX4;PDLIM5;TAB2;LDB3;HEG1;KAT2A;PTEN;SMYD4;NF1;PDLIM7;FLRT2;MEGF8;NIPBL;PTK2;ERBB4;TGFBR1;TBX19;CACYBP
prerank,GO_Biological_Process_2021__tetrahydrobiopterin metabolic process (GO:0046146),-0.6190821677139263,-0.8980425993373293,0.6949152542372882,0.9432309939985811,1.0,2/7,9.36%,CALM1;PTS
prerank,Reactome_2022__Defective Homologous Recombination Repair (HRR) Due To BRCA2 Loss Of Function R-HSA-9701190,-0.4495147341649274,-0.8979940830985987,0.640625,0.9430098090049105,1.0,7/27,18.09%,HUS1;BRCA2;KAT5;RAD9A;RPA3;BRCA1;WRN
prerank,GO_Biological_Process_2021__cytoskeleton-dependent intracellular transport (GO:0030705),-0.46467645591416745,-0.8979257323596341,0.6231884057971014,0.9428263716724595,1.0,1/21,0.86%,CCDC88C
prerank,GO_Biological_Process_2021__positive regulation of interleukin-8 production (GO:0032757),-0.4545776749842533,-0.8976954179837264,0.6176470588235294,0.9429405776105255,1.0,9/35,15.77%,CD2;CD14;LAMTOR5;PRKD2;CHI3L1;HSPA1B;NOD2;HSPA1A;CD74
prerank,GO_Biological_Process_2021__central nervous system projection neuron axonogenesis (GO:0021952),-0.5184881259593316,-0.8976890433702428,0.5909090909090909,0.9426226733096076,1.0,1/9,3.87%,EPHB1
prerank,Reactome_2022__Apoptotic Cleavage Of Cellular Proteins R-HSA-111465,0.40591052748060724,0.8976359014541359,0.6216216216216216,0.8784351454961642,1.0,6/27,13.77%,GSN;GAS2;FZR1;SPTAN1;TJP1;PTK2
prerank,GO_Biological_Process_2021__cellular response to glucose starvation (GO:0042149),0.40238057922145076,0.8974016688883886,0.6176470588235294,0.8785588768132274,1.0,9/33,18.07%,CPEB4;NUAK1;BRSK1;SESN2;TBL2;PRKAA1;SH3GLB1;BRSK2;SIK2
prerank,CellMarker_Augmented_2021__Stem cell:Submandibular Gland,0.40603630099017474,0.8972518308103333,0.6538461538461539,0.87844641396847,1.0,7/32,13.92%,PDK4;MRC1;TIMP3;HPGDS;PREX2;EPAS1;SLCO2B1
prerank,GO_Biological_Process_2021__positive regulation of protein targeting to membrane (GO:0090314),-0.45228764627020024,-0.8972145053738788,0.56,0.9432595093347292,1.0,4/18,10.55%,CEMIP;FIS1;FYN;ITGB2
prerank,Reactome_2022__Nuclear Envelope Breakdown R-HSA-2980766,0.34654298690485574,0.897132688070797,0.6842105263157895,0.8783089431625757,1.0,6/44,9.38%,NUP153;NUP188;TMPO;NUP42;NEK9;LEMD3
prerank,GO_Biological_Process_2021__histone monoubiquitination (GO:0010390),0.4593395791203277,0.8970681679176491,0.6842105263157895,0.8780461204721725,1.0,3/21,10.42%,RNF2;RYBP;RNF20
prerank,Reactome_2022__XBP1(S) Activates Chaperone Genes R-HSA-381038,-0.44501426202013317,-0.8968850341530098,0.5915492957746479,0.943570540893506,1.0,4/36,9.62%,DDX11;DNAJB9;HDGF;FKBP14
prerank,GO_Biological_Process_2021__cellular protein complex disassembly (GO:0043624),0.5332303721998414,0.8968235119490168,0.6296296296296297,0.8781948894574423,1.0,3/5,30.34%,APEH;ETF1;PEX14
prerank,Reactome_2022__Response Of EIF2AK1 (HRI) To Heme Deficiency R-HSA-9648895,-0.5041863780263851,-0.8968150018944019,0.6557377049180327,0.943412246378629,1.0,2/13,2.73%,PPP1R15A;ATF5
prerank,Reactome_2022__Signaling By Non-Receptor Tyrosine Kinases R-HSA-9006927,-0.4364107312945402,-0.8967856996609905,0.609375,0.9431446404522879,1.0,2/37,1.30%,UBC;RPS27A
prerank,Reactome_2022__Integrin Cell Surface Interactions R-HSA-216083,-0.4468058865099438,-0.8967338750075348,0.5833333333333334,0.9428990966236853,1.0,8/32,12.25%,COL18A1;PECAM1;ITGA4;ITGA6;CD44;ITGB2;ITGAL;CD47
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced cell death (GO:1903202),0.4231000038762769,0.8966262208826888,0.6190476190476191,0.8781880811451228,1.0,4/20,13.66%,SIRT1;LRRK2;SOD2;BAG5
prerank,GO_Biological_Process_2021__negative regulation of RNA splicing (GO:0033119),-0.4710866581610784,-0.8964507525403951,0.5932203389830508,0.9431442148744658,1.0,4/18,13.24%,RPS13;RPS26;U2AF2;SRSF7
prerank,GO_Biological_Process_2021__plasma membrane bounded cell projection assembly (GO:0120031),0.29132826013568136,0.8964404304876699,0.96,0.8782063403683359,1.0,29/189,12.64%,AVIL;NRP1;GSN;BBS9;EXOC8;PKD1;RAP1A;CFAP54;RP2;FGD4;PTPN23;STK36;VCL;RFX3;CEP83;CEP41;WDPCP;DNM3;CDC14B;RFX2;CEP131;P2RY12;POC1B;ANO6;FXYD5;FNBP1L;ARF6;CILK1;RAB3IP
prerank,GO_Biological_Process_2021__DNA modification (GO:0006304),-0.515707057160017,-0.8962406324461784,0.6071428571428571,0.9432173944737993,1.0,4/14,12.59%,SMUG1;OGG1;PARP2;TERF2IP
prerank,PanglaoDB_Augmented_2021__Myoepithelial Cells,0.4518787475363436,0.8961775859909482,0.6764705882352942,0.8784500420304774,1.0,3/21,3.17%,COL16A1;FKBP9;ACTA2
prerank,GO_Biological_Process_2021__wound healing (GO:0042060),-0.45526806073725445,-0.8961148438368068,0.6712328767123288,0.943090716057185,1.0,6/36,10.20%,JAML;IGF1;RAB3A;CORO1B;CFLAR;SLC11A1
prerank,GO_Biological_Process_2021__regulation of MAPK cascade (GO:0043408),-0.3719716657841555,-0.8960601638717419,0.6285714285714286,0.9428798607467432,1.0,8/97,6.85%,APIP;TGFBR3;DUSP1;TRIM5;EPHB1;LILRB4;IGF1;GSTP1
prerank,Reactome_2022__TP53 Regulates Transcription Of DNA Repair Genes R-HSA-6796648,-0.4071500592750359,-0.8959214003753624,0.640625,0.9428563411139015,1.0,5/52,7.16%,FOS;GTF2H5;CTDP1;ELOB;POLR2G
prerank,KEGG_2021_Human__Phosphatidylinositol signaling system,0.34459312737717246,0.8956482240026864,0.6521739130434783,0.8791242246280185,1.0,15/79,18.14%,INPP1;PIP5K1B;PLCB4;PIK3C2B;IPPK;PI4KB;IMPA1;PTEN;PIP4K2A;PPIP5K1;INPP5A;PIK3CA;PIP4P2;PLCB3;INPP4B
prerank,GO_Biological_Process_2021__transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),0.28842438311986246,0.8955922493414271,0.9375,0.878871740862045,1.0,45/256,13.77%,NRP1;POLR2D;PDGFA;GRB10;FER;CDK5R1;IGF1R;FGF2;PDK4;SLC39A14;GAB1;MAPK11;SPRED1;SPRED2;NCK2;TSC2;WASF2;NRG1;PDGFC;HPN;RYK;CRK;ELMO1;SORT1;GIT1;FLRT1;SHC2;ATP6V1B2;AP3S1;HGF;PTPRG;GIGYF1;MPZL1;MERTK;EPHA6;ITGAV;MAPK1;ANKS1A;GRIN2B;NTRK2;MAPKAPK2;FLRT2;SHOC2;VAV1;PTK2
prerank,GO_Biological_Process_2021__mitochondrial DNA repair (GO:0043504),0.5845951047698351,0.8951900159397117,0.6888888888888889,0.8794000553598613,1.0,1/5,5.45%,PARP1
prerank,GO_Biological_Process_2021__actin filament depolymerization (GO:0030042),0.5177454837705106,0.89517482488448,0.5952380952380952,0.8790726462403836,1.0,1/9,1.66%,GSN
prerank,GO_Biological_Process_2021__negative regulation of telomere maintenance (GO:0032205),0.4632722795414636,0.8948226014341127,0.5853658536585366,0.8795254297451333,1.0,5/12,24.03%,PARP1;ERCC4;NBN;ERCC1;TNKS2
prerank,CellMarker_Augmented_2021__Endothelial Progenitor cell:Adipose Tissue,-0.44826493670627415,-0.8947692668734176,0.6282051282051282,0.9402614948750155,1.0,8/30,12.34%,CD93;PECAM1;PCDH12;PTPRB;SPARCL1;ABCA8;A2M;FLT1
prerank,CellMarker_Augmented_2021__Endothelial cell:Bladder,-0.44826493670627415,-0.8947692668734176,0.6282051282051282,0.9402614948750155,1.0,8/30,12.34%,CD93;PECAM1;PCDH12;PTPRB;SPARCL1;ABCA8;A2M;FLT1
prerank,CellMarker_Augmented_2021__Mature Endothelial cell:Blood,-0.44826493670627415,-0.8947692668734176,0.6282051282051282,0.9402614948750155,1.0,8/30,12.34%,CD93;PECAM1;PCDH12;PTPRB;SPARCL1;ABCA8;A2M;FLT1
prerank,CellMarker_Augmented_2021__Endothelial cell:Corpus Luteum,-0.44826493670627415,-0.8947692668734176,0.6282051282051282,0.9402614948750155,1.0,8/30,12.34%,CD93;PECAM1;PCDH12;PTPRB;SPARCL1;ABCA8;A2M;FLT1
prerank,CellMarker_Augmented_2021__Keratinocyte:Epithelium,-0.44826493670627415,-0.8947692668734176,0.6282051282051282,0.9402614948750155,1.0,8/30,12.34%,CD93;PECAM1;PCDH12;PTPRB;SPARCL1;ABCA8;A2M;FLT1
prerank,CellMarker_Augmented_2021__Submandibular Gland Stem cell:Submandibular Gland,-0.44826493670627415,-0.8947692668734176,0.6282051282051282,0.9402614948750155,1.0,8/30,12.34%,CD93;PECAM1;PCDH12;PTPRB;SPARCL1;ABCA8;A2M;FLT1
prerank,CellMarker_Augmented_2021__Cardiomyocyte Progenitor cell:Myocardium,-0.44826493670627415,-0.8947692668734176,0.6282051282051282,0.9402614948750155,1.0,8/30,12.34%,CD93;PECAM1;PCDH12;PTPRB;SPARCL1;ABCA8;A2M;FLT1
prerank,CellMarker_Augmented_2021__Monocyte:Umbilical Cord Blood,-0.44826493670627415,-0.8947692668734176,0.6282051282051282,0.9402614948750155,1.0,8/30,12.34%,CD93;PECAM1;PCDH12;PTPRB;SPARCL1;ABCA8;A2M;FLT1
prerank,CellMarker_Augmented_2021__Hematopoietic Progenitor cell:Bone Marrow,-0.44826493670627415,-0.8947692668734176,0.6282051282051282,0.9402614948750155,1.0,8/30,12.34%,CD93;PECAM1;PCDH12;PTPRB;SPARCL1;ABCA8;A2M;FLT1
prerank,CellMarker_Augmented_2021__Stromal Vascular Fraction cell:Adipose Tissue,-0.44826493670627415,-0.8947692668734176,0.6282051282051282,0.9402614948750155,1.0,8/30,12.34%,CD93;PECAM1;PCDH12;PTPRB;SPARCL1;ABCA8;A2M;FLT1
prerank,CellMarker_Augmented_2021__Hematopoietic Progenitor cell:Umbilical Cord Blood,-0.44826493670627415,-0.8947692668734176,0.6282051282051282,0.9402614948750155,1.0,8/30,12.34%,CD93;PECAM1;PCDH12;PTPRB;SPARCL1;ABCA8;A2M;FLT1
prerank,CellMarker_Augmented_2021__Hematopoietic Stem cell:Peripheral Blood,-0.44826493670627415,-0.8947692668734176,0.6282051282051282,0.9402614948750155,1.0,8/30,12.34%,CD93;PECAM1;PCDH12;PTPRB;SPARCL1;ABCA8;A2M;FLT1
prerank,CellMarker_Augmented_2021__Hematopoietic Stem cell:Periodontal Ligament,-0.44826493670627415,-0.8947692668734176,0.6282051282051282,0.9402614948750155,1.0,8/30,12.34%,CD93;PECAM1;PCDH12;PTPRB;SPARCL1;ABCA8;A2M;FLT1
prerank,CellMarker_Augmented_2021__Dendritic cell:Umbilical Cord Blood,-0.44826493670627415,-0.8947692668734176,0.6282051282051282,0.9402614948750155,1.0,8/30,12.34%,CD93;PECAM1;PCDH12;PTPRB;SPARCL1;ABCA8;A2M;FLT1
prerank,CellMarker_Augmented_2021__Progenitor-like Angiogenesis-Promoting cell:Blood,-0.44826493670627415,-0.8947692668734176,0.6282051282051282,0.9402614948750155,1.0,8/30,12.34%,CD93;PECAM1;PCDH12;PTPRB;SPARCL1;ABCA8;A2M;FLT1
prerank,Reactome_2022__Glycerophospholipid Biosynthesis R-HSA-1483206,-0.39808092504656883,-0.8946700533389119,0.6142857142857143,0.9401242070313434,1.0,8/80,9.64%,OSBPL5;MGLL;LPCAT1;DDHD2;GNPAT;PCYT1A;PCTP;PLB1
prerank,GO_Biological_Process_2021__response to UV (GO:0009411),0.3093847764040783,0.8946513558361774,0.7692307692307693,0.8795230715215394,1.0,9/71,10.90%,ZBTB1;RUVBL2;CASP9;CAT;PARP1;BRSK1;EIF2S1;PTPRK;ERCC4
prerank,Reactome_2022__Insertion Of Tail-Anchored Proteins Into Endoplasmic Reticulum Membrane R-HSA-9609523,-0.5159846556913468,-0.8946390816367707,0.5964912280701754,0.9398443403867112,1.0,2/16,4.51%,EMD;CYB5A
prerank,Reactome_2022__Signaling By PDGF R-HSA-186797,0.3898061625797105,0.8946181614198571,0.6451612903225806,0.8792260015771078,1.0,9/33,18.75%,PDGFA;NCK2;PDGFC;CRK;COL6A1;SYNGAP1;COL4A5;PIK3CA;PTPN12
prerank,GO_Biological_Process_2021__histone H3 acetylation (GO:0043966),-0.44907041200437214,-0.8946075456794221,0.6181818181818182,0.9395801687842699,1.0,5/34,11.60%,TAF6L;POLE3;ING5;BRCA2;ING4
prerank,GO_Biological_Process_2021__regulation of telomerase activity (GO:0051972),-0.43709421523151415,-0.8945221807742025,0.6615384615384615,0.9394029636258447,1.0,2/33,1.65%,PKIB;PRKCQ
prerank,GO_Biological_Process_2021__response to organophosphorus (GO:0046683),-0.5289592587681938,-0.8944055711502615,0.6140350877192983,0.9393157336814659,1.0,2/10,9.56%,DUOX1;STAT1
prerank,Reactome_2022__Signaling By Insulin Receptor R-HSA-74752,0.36981605970074416,0.8943849367288982,0.5526315789473685,0.8794035219523706,1.0,17/46,23.98%,PIGU;GRB10;ATP6V1B2;PDE3B;MAPK1;GAB2;AKT2;PIK3CA;TCIRG1;FGFR2;ATP6V0B;FGFR1;ATP6V0D1;FRS2;ATP6V0E2;PIK3R1;FGFR3
prerank,GO_Biological_Process_2021__T cell activation involved in immune response (GO:0002286),-0.5734771698710125,-0.8941008420680588,0.6363636363636364,0.939628119391801,1.0,4/8,15.77%,FCER1G;SLC11A1;ITGAL;CD74
prerank,Reactome_2022__VEGFA-VEGFR2 Pathway R-HSA-4420097,-0.37429459381527314,-0.8939057164709351,0.6493506493506493,0.9396956854476131,1.0,12/76,13.75%,VAV3;NCF4;JUP;FYN;THEM4;CALM1;NCF2;NCKAP1L;VEGFA;CYFIP2;CYBA;PIK3CB
prerank,GO_Biological_Process_2021__regulation of protein catabolic process (GO:0042176),-0.3945776190490619,-0.8937126262348769,0.6212121212121212,0.9396548729367761,1.0,9/75,11.99%,FLNA;NKD1;ODC1;SNF8;TNFAIP3;GPC3;VPS28;AZIN2;AZIN1
prerank,GO_Biological_Process_2021__cellular response to drug (GO:0035690),-0.49680860987994113,-0.8936064299286607,0.6206896551724138,0.9395119816855262,1.0,4/17,11.31%,TFRC;AIM2;RBM22;FBP1
prerank,"GO_Biological_Process_2021__Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",-0.4201633129125037,-0.893497818784952,0.631578947368421,0.9394001192653423,1.0,19/65,22.96%,PSMB3;PSMB6;PSMA7;PSMB9;DVL1;FZD2;PSMD12;PFN1;PSMD8;PSMA5;AP2S1;RAC1;PSMA3;PSMC4;PSME2;PSME1;PSMB5;PSMC3;PSME3
prerank,Reactome_2022__SLC-mediated Transmembrane Transport R-HSA-425407,-0.3902092035623906,-0.893258442756237,0.6578947368421053,0.9396068118332879,1.0,18/118,12.36%,SLC2A3;SLC7A5;EMB;SLC38A4;APOD;SLC38A1;SLC5A9;SLC16A3;SLC25A5;SRI;SLC16A7;CALM1;SLC11A1;SLC14A1;SLC2A8;SLC36A4;SLC12A7;SLC29A3
prerank,GO_Biological_Process_2021__negative regulation of response to cytokine stimulus (GO:0060761),0.5453740752772792,0.893241783365194,0.5714285714285714,0.8815872198863952,1.0,1/7,0.08%,KLF4
prerank,GO_Biological_Process_2021__protein destabilization (GO:0031648),-0.47284694369258506,-0.8932140414914933,0.6666666666666666,0.9393589912306473,1.0,2/25,1.60%,CCDC88C;PYHIN1
prerank,GO_Biological_Process_2021__heterochromatin organization (GO:0070828),0.5154775230917042,0.8931208454321871,0.525,0.8814991746212316,1.0,5/10,13.32%,SIRT1;SETD7;HP1BP3;LOXL2;SETDB2
prerank,GO_Biological_Process_2021__protein dephosphorylation (GO:0006470),0.33515698498882085,0.8930042303024666,0.782608695652174,0.8813663253185204,1.0,21/109,11.81%,DUSP6;PTPN9;DUSP18;PPM1L;PTPRM;SSU72;PPP4R2;PPP2R1B;PTPN13;ILKAP;CDC14B;PPP3CA;DUSP7;BTRC;PTPRG;PTPRK;PTPN5;FBXW11;PTPRD;PPP1R15B;PTEN
prerank,GO_Biological_Process_2021__cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),-0.3696587369912761,-0.8927322343725522,0.6153846153846154,0.9400723004757564,1.0,7/86,5.65%,JAML;EMB;SELL;CLDN7;MMP24;CDH23;PECAM1
prerank,GO_Biological_Process_2021__cellular component assembly (GO:0022607),-0.3503682730435736,-0.892622328449544,0.6329113924050633,0.9399696659382974,1.0,17/165,11.06%,FLNA;SYCE2;RIMS1;AIF1;STAG3;CD247;ELOB;CHCHD10;RHOU;CORO1B;NLGN2;ACTG1;DVL1;BAIAP2L2;ACTB;NCKAP1L;TUBGCP2
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Periodontal Ligament,-0.6035782273255408,-0.89253120826295,0.6451612903225806,0.939839311581967,1.0,2/5,12.82%,CD44;PTPRC
prerank,GO_Biological_Process_2021__nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),-0.47430675683318524,-0.8924977364498747,0.603448275862069,0.9396071843150914,1.0,1/19,1.48%,ZFP36
prerank,KEGG_2021_Human__Amphetamine addiction,0.38981360483032224,0.8922452435134728,0.6111111111111112,0.8824497992787839,1.0,15/40,19.21%,GRIN3A;SIRT1;GRIA3;GRIA4;PPP3CA;GRIA1;HDAC1;STX1A;GRIN2B;JUN;GRIA2;GRIN2A;PPP3CB;CREB3L2;PPP1CC
prerank,GO_Biological_Process_2021__negative regulation of T cell receptor signaling pathway (GO:0050860),-0.5304142664813698,-0.8922196356317421,0.6379310344827587,0.9398565812224088,1.0,3/12,19.00%,LILRB4;EZR;PTPN22
prerank,Reactome_2022__Toll Like Receptor 4 (TLR4) Cascade R-HSA-166016,-0.3676766263862349,-0.8918897331983887,0.6753246753246753,0.9402816308837754,1.0,7/114,4.18%,CD36;UBC;SIGIRR;FOS;RPS27A;BTK;NDUFA2
prerank,GO_Biological_Process_2021__peptide cross-linking (GO:0018149),0.5505638573140337,0.8916888235988721,0.6739130434782609,0.883203512711486,1.0,1/8,0.34%,ANXA1
prerank,GO_Biological_Process_2021__negative regulation of Wnt signaling pathway (GO:0030178),0.34002442264398425,0.8914996629607406,0.6,0.8832444125687049,1.0,14/118,7.68%,LRP4;GRB10;ZNRF3;RUVBL2;CTNNBIP1;ANKRD6;TLE2;TSC2;WNT5A;INVS;TMEM170B;DDIT3;NLK;DVL3
prerank,GO_Biological_Process_2021__positive regulation of cholesterol transport (GO:0032376),-0.47939981774135926,-0.8914241562665884,0.6515151515151515,0.940872902446224,1.0,5/22,11.64%,LIPG;PLTP;NR1H2;ABCB4;ABCA8
prerank,Reactome_2022__Signaling By FLT3 ITD And TKD Mutants R-HSA-9703648,0.48815674141080845,0.8913893097799624,0.6060606060606061,0.88306624204984,1.0,6/12,30.20%,GAB2;PIK3CA;PIK3R1;BCL2L1;STAT5A;SOS1
prerank,GO_Biological_Process_2021__negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),0.3747958763648034,0.8912104658358825,0.7083333333333334,0.8830574060675929,1.0,1/37,0.08%,KLF4
prerank,KEGG_2021_Human__Sphingolipid signaling pathway,0.34315846546764617,0.8911528916190041,0.72,0.8827849647054858,1.0,20/91,18.56%,ACER2;MAPK11;MAP2K1;GNAQ;PLCB4;SPTLC2;TNF;PPP2R1B;MAPK1;PTEN;GAB2;SGMS1;PPP2R5E;MAP3K5;AKT2;PIK3CA;PLCB3;MAP2K2;TNFRSF1A;SPTLC3
prerank,GO_Biological_Process_2021__protein ADP-ribosylation (GO:0006471),-0.4606957353294388,-0.8911456363747062,0.6231884057971014,0.9411370236309133,1.0,7/24,16.67%,PARP14;PARP15;PARP9;PARP2;PARP4;PARP11;PARP12
prerank,GO_Biological_Process_2021__cellular response to amino acid stimulus (GO:0071230),0.42458593128187994,0.8911075146177699,0.6551724137931034,0.8825226992154435,1.0,3/28,6.73%,RRAGD;GLRA1;CPEB4
prerank,Reactome_2022__RHO GTPase Cycle R-HSA-9012999,0.2813548735818133,0.8910545379054332,0.9230769230769231,0.8822556878193383,1.0,57/351,15.86%,VAPB;WIPF3;PLXNB1;ARHGAP31;SCRIB;SLITRK5;PKP4;DLG5;CDC42EP3;MAP3K11;NCOA3;PICALM;NCK2;FGD4;RASAL2;ARHGEF26;WASF2;PRKCSH;JAG1;ARAP3;TMPO;DOCK10;TMOD3;GIT1;GPS1;PTPN13;RAB7A;SPTAN1;ARHGAP15;LEMD3;ARHGAP20;PREX2;RNF20;GOLGA3;SNAP23;HNRNPC;FNBP1L;CPSF7;RTKN;ARHGAP42;LRRC1;SH3RF1;DBT;NDUFA5;PLXNA1;VAV1;YKT6;STEAP3;FERMT2;DOCK8;SRGAP2;STK10;GIT2;RHOBTB1;MSI2;COPS4;ABI1
prerank,CellMarker_Augmented_2021__MKI67+ Progenitor cell:Large Intestine,-0.434738168868059,-0.8908823890889681,0.6811594202898551,0.9413300907989273,1.0,3/38,5.65%,H4C3;CD93;PECAM1
prerank,Reactome_2022__Toll-like Receptor Cascades R-HSA-168898,-0.3660545151594498,-0.890714337087224,0.6923076923076923,0.9413813274125645,1.0,8/132,4.18%,CD36;UBC;SIGIRR;FOS;RPS27A;BTK;CTSB;NDUFA2
prerank,GO_Biological_Process_2021__postsynaptic density organization (GO:0097106),0.4933292333812777,0.8905821853370885,0.5084745762711864,0.8828333736702041,1.0,4/8,11.81%,NLGN1;SHANK3;NRXN2;PTEN
prerank,KEGG_2021_Human__Human T-cell leukemia virus 1 infection,0.30484208046147554,0.8904556164571683,0.9130434782608695,0.8827750022134423,1.0,10/153,7.30%,EGR1;NRP1;TGFBR2;E2F3;MAP2K1;SMAD2;SMAD3;ADCY9;XPO1;TNF
prerank,GO_Biological_Process_2021__muscle cell development (GO:0055001),-0.4934552327486016,-0.8904104174482304,0.625,0.9416634806166501,1.0,3/19,11.19%,IGF1;TTN;VEGFA
prerank,GO_Biological_Process_2021__negative regulation of transporter activity (GO:0032410),0.5010356591121903,0.8902065776784952,0.5,0.8828903937751351,1.0,4/6,35.88%,SNCA;CTTNBP2NL;NDFIP2;PPIF
prerank,GO_Biological_Process_2021__regulation of keratinocyte differentiation (GO:0045616),-0.46967332626394875,-0.8894840015770876,0.6060606060606061,0.9431213531139313,1.0,1/17,1.48%,ZFP36
prerank,Reactome_2022__Activation Of G Protein Gated Potassium Channels R-HSA-1296041,0.45091778322956966,0.889237683631558,0.5384615384615384,0.8845932468268783,1.0,2/13,5.43%,KCNJ2;KCNJ5
prerank,Reactome_2022__Transcriptional Activation Of Mitochondrial Biogenesis R-HSA-2151201,0.34416372327498473,0.8891073722880712,0.7894736842105263,0.8845143649524242,1.0,2/47,5.52%,PPARGC1A;TFB1M
prerank,CellMarker_Augmented_2021__Secretory Progenitor cell:Small Intestine,0.41897396309901747,0.889022660869878,0.6585365853658537,0.8842917999744042,1.0,9/23,15.91%,KCNQ2;GLIS3;CHD5;OGFRL1;PTPN13;SV2B;CHM;CACNB4;SYT16
prerank,CellMarker_Augmented_2021__Dental Pulp cell:Dental Pulp,0.36301886651906906,0.8887879556166918,0.7407407407407407,0.8839264805925381,1.0,11/46,12.56%,COL16A1;NRP1;SERPINE1;COL5A2;TIMP3;CDH11;ALCAM;HEG1;EPAS1;FAM114A1;COL6A1
prerank,CellMarker_Augmented_2021__Mesenchymal Stromal cell:Amniotic Membrane,0.36301886651906906,0.8887879556166918,0.7407407407407407,0.8839264805925381,1.0,11/46,12.56%,COL16A1;NRP1;SERPINE1;COL5A2;TIMP3;CDH11;ALCAM;HEG1;EPAS1;FAM114A1;COL6A1
prerank,GO_Biological_Process_2021__endothelial cell chemotaxis (GO:0035767),-0.5639479112411856,-0.8885377616120612,0.640625,0.9447043981937582,1.0,4/5,13.60%,PLEKHG5;CORO1B;VEGFA;NR4A1
prerank,GO_Biological_Process_2021__phosphatidylcholine metabolic process (GO:0046470),0.395098181995287,0.888371616171498,0.5666666666666667,0.8844767404947765,1.0,10/42,13.00%,PLA2G4C;PLA2G7;CHKA;SLC44A2;DBI;GPAT4;SLC44A5;SLC44A1;LCAT;CHPT1
prerank,GO_Biological_Process_2021__receptor catabolic process (GO:0032801),0.45093110400434694,0.8883300618235699,0.6666666666666666,0.8841654968041502,1.0,5/21,18.25%,ZNRF3;SMURF1;SH3GLB1;MYLIP;NEDD4
prerank,Reactome_2022__Disorders Of Transmembrane Transporters R-HSA-5619115,-0.3829538154092593,-0.8882909272738052,0.6547619047619048,0.9448497763632275,1.0,19/112,17.75%,UBC;RPS27A;PSMB3;PSMB6;PSMA7;PSMB9;ABCB4;CFTR;NUP50;SLC29A3;PSMD12;PSMD8;PSMA5;UBA52;SEC13;PSMA3;NUP88;SLC2A1;PSMC4
prerank,GO_Biological_Process_2021__positive regulation of protein export from nucleus (GO:0046827),0.4962124455773157,0.8882260200088318,0.6444444444444445,0.8840226943830918,1.0,2/14,4.84%,BAG3;ANP32B
prerank,GO_Biological_Process_2021__negative regulation of cell cycle (GO:0045786),-0.40160438983492736,-0.8880644460243394,0.6333333333333333,0.9450227317927236,1.0,3/49,2.69%,RUNX3;DUSP1;BTG2
prerank,"GO_Biological_Process_2021__retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",0.3791721703103804,0.8879978543953678,0.5925925925925926,0.8841618374031058,1.0,12/66,17.41%,GOLPH3L;TMED3;RAB1B;TMED10;COPG1;CENPE;RAB6A;KIF15;SCYL1;COG3;COPB1;COPZ1
prerank,Reactome_2022__Antigen Processing: Ubiquitination And Proteasome Degradation R-HSA-983168,0.2993690786976347,0.8876922632679464,0.8888888888888888,0.8844441858744315,1.0,39/242,15.70%,UBE2D1;SPSB2;FBXO30;KBTBD6;RNF25;UBE2J1;FBXL14;ZBTB16;UBE2O;FBXO32;UBE2E2;UBE3D;UBE2D2;SEM1;FZR1;NEDD4L;CDC23;KCTD6;BTRC;RNF19B;UBA1;UBE2L3;FBXW11;FBXW7;RNF217;UBE2N;KLHL42;FBXL12;SH3RF1;FBXL7;FBXO27;SMURF1;RNF6;ANAPC1;FBXO11;BLMH;UBE2J2;LNX1;RNF220
prerank,GO_Biological_Process_2021__maintenance of epithelial cell apical/basal polarity (GO:0045199),0.5249437351836816,0.8876358861730869,0.6739130434782609,0.8838230449110376,1.0,1/6,5.96%,LIN7A
prerank,GO_Biological_Process_2021__maintenance of apical/basal cell polarity (GO:0035090),0.5249437351836816,0.8876358861730869,0.6739130434782609,0.8838230449110376,1.0,1/6,5.96%,LIN7A
prerank,GO_Biological_Process_2021__positive regulation of cell division (GO:0051781),0.42025540442023424,0.8876217581353745,0.5161290322580645,0.8834635099670232,1.0,11/23,28.91%,PKP4;CDC14B;CSPP1;CDC14A;FGFR2;PRKCE;CIT;ECT2;GIPC1;SIRT2;RHOA
prerank,GO_Biological_Process_2021__membrane raft distribution (GO:0031580),-0.5661245359026923,-0.8875484070414448,0.6721311475409836,0.9456474630012847,1.0,1/5,1.25%,CD2
prerank,GO_Biological_Process_2021__secondary alcohol biosynthetic process (GO:1902653),-0.4552465881221758,-0.8875283906371075,0.625,0.9453652160208933,1.0,1/19,0.72%,INSIG1
prerank,GO_Biological_Process_2021__divalent inorganic cation homeostasis (GO:0072507),0.48012986396944135,0.8875141145453824,0.6097560975609756,0.8834003086012254,1.0,5/14,21.96%,TMTC2;SLC8A1;ATP13A2;SNCA;GRIN1
prerank,"GO_Biological_Process_2021__maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",-0.4876113032302661,-0.8874177936042834,0.6363636363636364,0.9452275458973576,1.0,2/17,7.08%,RPS21;EXOSC10
prerank,GO_Biological_Process_2021__negative regulation of actin filament polymerization (GO:0030837),0.48929367276414226,0.8870742107615874,0.6410256410256411,0.883998012701453,1.0,4/16,7.80%,GSN;HIP1R;MYADM;KANK1
prerank,CellMarker_Augmented_2021__Vascular Endothelial cell:Placenta,-0.44151128254825134,-0.8869795441458073,0.6285714285714286,0.9458331434385495,1.0,16/39,21.92%,MS4A4A;SIGLEC1;CD93;PECAM1;PCDH12;MS4A6A;A2M;FLT1;SERPING1;APOL3;GIMAP4;FOLR2;LILRB5;C1QB;C1QC;CLEC1A
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Colorectum,-0.5064368382981908,-0.8869264940005419,0.6909090909090909,0.9456186597311516,1.0,3/9,18.52%,ITGA6;CD44;ITGB1
prerank,Reactome_2022__PI-3K cascade:FGFR2 R-HSA-5654695,0.49472643192142524,0.8868988478642944,0.5952380952380952,0.8840085833789978,1.0,1/11,1.00%,PIGU
prerank,Reactome_2022__Deactivation Of Beta-Catenin Transactivating Complex R-HSA-3769402,-0.45505500839347446,-0.8868665420262903,0.671875,0.9453951153503098,1.0,2/31,1.30%,UBC;RPS27A
prerank,Reactome_2022__Netrin Mediated Repulsion Signals R-HSA-418886,0.5131080926066993,0.8867823219997103,0.5609756097560976,0.8838811734219172,1.0,3/6,20.28%,UNC5B;DCC;UNC5D
prerank,CellMarker_Augmented_2021__SLC16A7+ cell:Lung,-0.33317315211390885,-0.8866910210828557,0.8541666666666666,0.945475438503053,1.0,109/662,15.71%,ABCA9;SLC2A3;CCDC88C;RSAD2;CD96;DNAH11;IFI44L;GOLGA8A;CEP85L;CCL5;XAF1;XPA;PLXDC1;IKZF3;SNAPC1;SIDT1;TNFRSF25;FCAR;NKD1;PHKG1;UVSSA;SYNE1;SLAMF6;RNPC3;GTF2H5;METTL17;GREB1;GNB5;GDAP1L1;CDH23;GDPD1;PIGO;JMJD6;PPP1R3B;ARGLU1;ACKR4;SHFL;C5AR1;SLC16A7;COL21A1;BTN3A2;SIRPB2;NFS1;CABP4;MYO3B;THEM4;NLRP12;ARL17A;TBC1D32;C3ORF62;SRGAP3;PRKD2;BTAF1;GSTM3;LILRB3;PDCD7;EFHC1;NEK3;FKBP14;CEP164;DZIP1L;CFLAR;TMEM67;LARS1;MKRN2OS;POFUT2;TASL;COX18;AKAP8;ITGAL;ENTPD4;DNAH1;ALPK1;TARS2;FAAH2;TBC1D8;GMEB1;SLC29A3;PDPR;DNAH12;GPR155;QPRT;CNTROB;FAM219B;DDX5;RAD9A;ZNF549;SPG7;ZNF302;ELMOD3;CWC25;MYO1F;DYNC1LI2;APOL6;ZC3H6;CYB5D2;WDR73;ZCWPW1;CCAR1;ERAP2;AASDH;PAXBP1;NMRK1;GON4L;ZNF461;RBMS2;ZNF445;PCSK5;STXBP4
prerank,GO_Biological_Process_2021__positive regulation of Rho protein signal transduction (GO:0035025),-0.5068624259718398,-0.886625434629174,0.609375,0.9453042302667531,1.0,4/15,16.58%,ARHGEF3;P2RY8;LPAR6;RAC1
prerank,"Reactome_2022__WNT5A-dependent Internalization Of FZD2, FZD5 And ROR2 R-HSA-5140745",-0.5338580686348053,-0.8865788696917725,0.6779661016949152,0.9450748892186204,1.0,4/11,15.66%,RORA;FZD2;CLTB;AP2S1
prerank,GO_Biological_Process_2021__C21-steroid hormone metabolic process (GO:0008207),0.5196876065120873,0.886259093306586,0.6222222222222222,0.8845567240623141,1.0,2/8,9.07%,TSPOAP1;CYP46A1
prerank,GO_Biological_Process_2021__positive regulation of viral genome replication (GO:0045070),-0.4891857624276958,-0.8861537084066264,0.6727272727272727,0.9456272039804458,1.0,3/25,2.82%,PPIE;CCL5;IFIT1
prerank,KEGG_2021_Human__Gastric acid secretion,-0.4120444266828255,-0.8860768065471503,0.6338028169014085,0.9454898189700313,1.0,10/49,17.94%,MYLK;ACTG1;CALM1;CFTR;ACTB;SST;ATP1B3;ATP1A1;EZR;HRH2
prerank,GO_Biological_Process_2021__regulation of purine nucleotide metabolic process (GO:1900542),0.3525378840095535,0.8858679496087438,0.6756756756756757,0.8850593850002616,1.0,6/35,17.93%,NUP153;NUP188;NUP42;NDC1;NUP133;NUP205
prerank,GO_Biological_Process_2021__negative regulation of metabolic process (GO:0009892),-0.44542425068772645,-0.8858345281008573,0.609375,0.9456220382082496,1.0,7/38,12.47%,NR1H2;FIS1;GSTP1;BTN2A2;RBPJ;PCTP;IL18R1
prerank,GO_Biological_Process_2021__prostanoid metabolic process (GO:0006692),-0.5131001990243511,-0.8858272088002238,0.7,0.945313299470078,1.0,1/7,6.85%,GSTP1
prerank,GO_Biological_Process_2021__regulation of cilium assembly (GO:1902017),0.35960207574623027,0.88560160994995,0.6129032258064516,0.8852811062753532,1.0,8/50,13.99%,CDK10;TBC1D1;TBC1D5;TBC1D10B;TBC1D16;TBC1D22B;RABGAP1;EVI5
prerank,Reactome_2022__Ethanol Oxidation R-HSA-71384,-0.5905357768499305,-0.8854912878845348,0.6530612244897959,0.9450214429180971,1.0,3/5,30.36%,ALDH2;ACSS1;ADH5
prerank,GO_Biological_Process_2021__ethanol oxidation (GO:0006069),-0.5905357768499305,-0.8854912878845348,0.6530612244897959,0.9450214429180971,1.0,3/5,30.36%,ALDH2;ACSS1;ADH5
prerank,GO_Biological_Process_2021__ethanol metabolic process (GO:0006067),-0.5905357768499305,-0.8854912878845348,0.6530612244897959,0.9450214429180971,1.0,3/5,30.36%,ALDH2;ACSS1;ADH5
prerank,GO_Biological_Process_2021__regulation of chemokine-mediated signaling pathway (GO:0070099),-0.5499421686984021,-0.8854449558551752,0.6065573770491803,0.9448081068395158,1.0,2/6,11.34%,PADI2;HIF1A
prerank,GO_Biological_Process_2021__natural killer cell activation (GO:0030101),-0.5013105638701544,-0.8848875004406243,0.711864406779661,0.9456310340836781,1.0,1/16,1.25%,CD2
prerank,Reactome_2022__Cell-Cell Communication R-HSA-1500931,-0.3746770620419773,-0.8846469479659294,0.7285714285714285,0.9457873348535116,1.0,8/72,13.75%,FLNA;CLDN7;JUP;FYN;ITGA6;TYROBP;CD47;PIK3CB
prerank,CellMarker_Augmented_2021__Decidual cell:Placenta,-0.45600806721785614,-0.8845640476739094,0.6911764705882353,0.9456961292428774,1.0,4/29,8.85%,ARSJ;TNFRSF11B;OSMR;SGCE
prerank,KEGG_2021_Human__Mismatch repair,-0.5158472421519307,-0.8844252393534946,0.6785714285714286,0.945620251850139,1.0,8/16,33.65%,RPA3;RFC1;MSH6;SSBP1;MSH3;PMS2;LIG1;RFC2
prerank,GO_Biological_Process_2021__phosphate ion transmembrane transport (GO:0035435),0.4868623518053854,0.8844229199901602,0.627906976744186,0.8869090242350236,1.0,4/11,14.12%,XPR1;SLC37A2;SLC37A4;SLC25A14
prerank,GO_Biological_Process_2021__phosphate ion transport (GO:0006817),0.4868623518053854,0.8844229199901602,0.627906976744186,0.8869090242350236,1.0,4/11,14.12%,XPR1;SLC37A2;SLC37A4;SLC25A14
prerank,GO_Biological_Process_2021__negative regulation of myeloid cell differentiation (GO:0045638),-0.4612928434581482,-0.8843198027968483,0.6226415094339622,0.9455077986902672,1.0,2/15,9.63%,ZFP36;MEIS1
prerank,PanglaoDB_Augmented_2021__Enterochromaffin Cells,0.37126589244872943,0.8840634774621128,0.6296296296296297,0.8872083263148821,1.0,16/44,17.64%,PPARGC1A;SEMA5A;NTM;GRIA3;CDH11;SLC4A4;PTPRD;PDE1C;SGIP1;SLC26A3;CNTN4;NFASC;KALRN;GRIN2A;SORBS2;CNTN3
prerank,GO_Biological_Process_2021__negative regulation of chemokine production (GO:0032682),-0.5223387484872098,-0.8840511152380123,0.5964912280701754,0.9456822370127552,1.0,6/10,8.28%,SIGIRR;OAS3;APOD;LILRB4;GSTP1;OAS1
prerank,Reactome_2022__Metabolism Of Cofactors R-HSA-8978934,-0.507740146429832,-0.8839217274744193,0.6875,0.9456552444311859,1.0,3/15,9.36%,TACR1;CALM1;PTS
prerank,Reactome_2022__Sulfur Amino Acid Metabolism R-HSA-1614635,-0.5107464488802345,-0.8838487072886522,0.7076923076923077,0.9455398443267603,1.0,2/13,6.33%,APIP;TXN2
prerank,Reactome_2022__Interleukin-37 Signaling R-HSA-9008059,0.46312476519818513,0.8837262279543773,0.59375,0.8875319411263294,1.0,6/19,10.61%,PTPN20;PTPN9;PTPN23;SMAD3;PTPN13;PTPN5
prerank,GO_Biological_Process_2021__regulation of establishment of protein localization to mitochondrion (GO:1903747),-0.5353028985314022,-0.8836579598323773,0.7192982456140351,0.9455708326599372,1.0,4/7,29.58%,ATP5IF1;PINK1;SREBF1;HAX1
prerank,GO_Biological_Process_2021__cellular modified amino acid biosynthetic process (GO:0042398),-0.452664639350656,-0.8834568439675836,0.6,0.9456505537247195,1.0,3/14,8.63%,GATM;PLSCR1;GCLM
prerank,Reactome_2022__Mitotic Spindle Checkpoint R-HSA-69618,0.3427490622935224,0.8832345158052446,0.5862068965517241,0.8882334262218462,1.0,17/74,20.09%,UBE2D1;XPO1;PPP2R1B;CDC23;ANAPC16;CENPE;PPP2R5E;CLASP1;ANAPC1;DYNC1H1;NUP133;CLASP2;DYNLL2;PPP1CC;NDE1;ANAPC4;CENPT
prerank,PanglaoDB_Augmented_2021__Trophoblast Cells,-0.43163663218134607,-0.8831997088825554,0.6716417910447762,0.9458886168563986,1.0,6/26,4.96%,FOSL2;CD55;ANXA2;IER3;BHLHE40;ABCC3
prerank,GO_Biological_Process_2021__response to exogenous dsRNA (GO:0043330),-0.46072315130558966,-0.8831341393237148,0.6949152542372882,0.945684987444148,1.0,4/16,16.49%,IFIT1;STING1;COLEC12;FLOT1
prerank,Reactome_2022__Regulation Of Lipid Metabolism By PPARalpha R-HSA-400206,0.3192071333877433,0.8830256255397961,0.68,0.8883452547655895,1.0,11/88,10.67%,PPARGC1A;NFYC;NCOA3;ARNT2;PPARG;CPT1A;FDFT1;CLOCK;HMGCS1;MED13L;TBL1XR1
prerank,KEGG_2021_Human__ECM-receptor interaction,-0.44944862134896746,-0.8828829939032338,0.6721311475409836,0.9458102495535984,1.0,5/33,8.71%,CD36;SV2C;ITGA4;ITGA6;CD44
prerank,GO_Biological_Process_2021__positive regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090267),-0.5546412970438318,-0.8828362742556929,0.6181818181818182,0.9452543993279278,1.0,1/5,9.58%,XRCC3
prerank,GO_Biological_Process_2021__positive regulation of spindle checkpoint (GO:0090232),-0.5546412970438318,-0.8828362742556929,0.6181818181818182,0.9452543993279278,1.0,1/5,9.58%,XRCC3
prerank,GO_Biological_Process_2021__positive regulation of cytokinesis (GO:0032467),0.4549325061596172,0.8827657575536177,0.5789473684210527,0.8884815232025539,1.0,4/18,15.48%,PKP4;CDC14B;CSPP1;CDC14A
prerank,GO_Biological_Process_2021__regulation of monocyte differentiation (GO:0045655),0.46643510728080984,0.8827653418820347,0.5227272727272727,0.8881124879153045,1.0,2/10,11.88%,CTNNBIP1;CDK6
prerank,GO_Biological_Process_2021__positive regulation of myelination (GO:0031643),0.5291541618671648,0.8826058431975572,0.6170212765957447,0.8879938000349356,1.0,4/10,15.71%,MYRF;TPPP;RNF10;PARD3
prerank,GO_Biological_Process_2021__regulation of insulin secretion (GO:0050796),0.3554309201051073,0.8825641002162933,0.696969696969697,0.8877134914282158,1.0,13/56,14.74%,CACNA1A;MCU;RAP1A;TNF;RFX3;CLOCK;SOX4;KCNC2;STX1A;TCF7L2;ABCC8;CACNA1E;RAPGEF3
prerank,GO_Biological_Process_2021__regulation of actin filament depolymerization (GO:0030834),0.47722599121342923,0.8823750282626273,0.6363636363636364,0.8876538537961108,1.0,1/8,1.58%,SEMA5A
prerank,GO_Biological_Process_2021__chromatin remodeling (GO:0006338),0.34492195464223785,0.8823727457009582,0.6764705882352942,0.8872808899919948,1.0,6/79,3.74%,ZBTB1;RUVBL2;DR1;SIRT1;ARID1A;MTA2
prerank,GO_Biological_Process_2021__termination of RNA polymerase II transcription (GO:0006369),0.41602370240711173,0.8823633796578928,0.5405405405405406,0.8869425006072369,1.0,7/24,12.20%,CPSF4;WDR33;SSU72;PCF11;SCAF8;CPSF7;SNRPB
prerank,GO_Biological_Process_2021__monoacylglycerol metabolic process (GO:0046462),0.5127371705262751,0.8822389401386078,0.64,0.8867560595349885,1.0,1/7,0.63%,FAAH
prerank,GO_Biological_Process_2021__oxoacid metabolic process (GO:0043436),0.4502854299128273,0.8821829373243081,0.631578947368421,0.8864964198356646,1.0,2/12,14.62%,PPA2;ENPP1
prerank,GO_Biological_Process_2021__positive regulation of Arp2/3 complex-mediated actin nucleation (GO:2000601),0.5382059074349762,0.8821269802005468,0.5952380952380952,0.8862565511104133,1.0,1/8,5.63%,WASF2
prerank,CellMarker_Augmented_2021__Alpha cell:Pancreatic Islet,-0.43667655218415435,-0.8818954111855389,0.7,0.9470157057879823,1.0,4/60,4.82%,CD36;RSAD2;SLC38A4;CLU
prerank,Reactome_2022__NOTCH4 Activation And Transmission Of Signal To Nucleus R-HSA-9013700,0.5197757276049648,0.8817553495696262,0.6857142857142857,0.8866618671187226,1.0,1/7,6.62%,JAG1
prerank,GO_Biological_Process_2021__antifungal innate immune response (GO:0061760),-0.5542219404210351,-0.8816286044963052,0.6610169491525424,0.9471403505173241,1.0,3/6,27.95%,CLEC7A;CARD9;BCL10
prerank,GO_Biological_Process_2021__sensory perception (GO:0007600),-0.4753679385154296,-0.8815980063607406,0.6865671641791045,0.9468820109712515,1.0,3/18,6.88%,SCN9A;CDH23;C5AR1
prerank,CellMarker_Augmented_2021__LGR5+ Stem cell:Large Intestine,-0.4613164898102634,-0.8815093832257035,0.609375,0.9467727009619374,1.0,2/16,2.51%,SLC38A4;LIPG
prerank,CellMarker_Augmented_2021__Trophectoderm cell:Embryo,-0.41284635262162395,-0.8813426064594108,0.6301369863013698,0.9466968698542377,1.0,5/51,5.60%,TGFBR3;SLC7A5;TFRC;GLIPR2;BASP1
prerank,GO_Biological_Process_2021__establishment of protein localization to organelle (GO:0072594),0.35310066468270784,0.8813255857291129,0.6206896551724138,0.8872719794209486,1.0,7/58,6.86%,NUTF2;E2F3;TSC2;IPO13;NUP153;NUP188;PPP1R10
prerank,Reactome_2022__CDC42 GTPase Cycle R-HSA-9013148,0.32932628718802376,0.8813011066913019,0.7916666666666666,0.8869393264951674,1.0,23/119,15.15%,WIPF3;ARHGAP31;SCRIB;CDC42EP3;MAP3K11;FGD4;ARHGEF26;PRKCSH;ARAP3;TMPO;DOCK10;GIT1;RAB7A;ARHGAP20;PREX2;SNAP23;FNBP1L;ARHGAP42;YKT6;STEAP3;DOCK8;SRGAP2;GIT2
prerank,"GO_Biological_Process_2021__positive regulation of transcription, DNA-templated (GO:0045893)",-0.3275417173411258,-0.8812559242628215,0.8602150537634409,0.9465785882779327,1.0,73/739,11.42%,NR4A3;H1-4;IL4I1;SKAP1;H1-3;MYBL1;BCL11B;UBC;H1-2;FOSL2;FOS;RPS27A;RUNX3;JUNB;PYHIN1;PID1;MDFIC;ATF5;TAF6L;CSRNP1;USF1;EDF1;RORA;CHCHD2;H1-0;ZNF335;DDRGK1;BEX1;ETS1;PADI2;CHCHD10;ING5;NR1H2;JUP;IGF1;JMJD6;DTX3L;TXK;ILF3;MED25;NLRC5;PARP9;IER2;PLSCR1;ZNF76;MAP3K12;PLAG1;BRCA2;NAMPT;RNASEL;PRKD2;RBPJ;H1-10;ITGA6;VENTX;DVL1;STAT1;MEIS1;ZNF513;EIF5A;SMARCD1;SLC11A1;LITAF;IRF1;HNRNPAB;NPM1;CITED2;KDM6B;MLX;VEGFA;KARS1;HIF1A;STING1
prerank,KEGG_2021_Human__Fluid shear stress and atherosclerosis,-0.3760925600908839,-0.881161828189092,0.6447368421052632,0.9464452122933874,1.0,15/94,13.75%,FOS;DUSP1;GSTM4;PECAM1;TXN2;GSTP1;ACTG1;CALM1;GSTM3;TRPV4;NCF2;ACTB;VEGFA;CYBA;PIK3CB
prerank,"GO_Biological_Process_2021__regulation of mRNA splicing, via spliceosome (GO:0048024)",0.33171162546033484,0.8811507812667678,0.8181818181818182,0.8868509572129099,1.0,26/73,27.66%,PCBP4;KHDRBS2;PRDX6;KHDRBS3;RBFOX1;SRSF12;TRA2B;RBFOX2;THRAP3;HNRNPU;WTAP;CELF2;CELF5;PUF60;NOVA1;NUP98;KHDRBS1;RNPS1;CELF1;MBNL1;RBM15;RBM5;MBNL3;METTL16;HNRNPL;RBM8A
prerank,GO_Biological_Process_2021__negative regulation of organelle assembly (GO:1902116),0.40512757464142646,0.8809336850544945,0.5789473684210527,0.8869480281169545,1.0,3/29,4.89%,CDK10;LRRK2;TMEM39A
prerank,GO_Biological_Process_2021__cell-cell adhesion mediated by cadherin (GO:0044331),-0.5804774376859743,-0.8808786131802128,0.6481481481481481,0.9467457566193191,1.0,2/5,4.61%,PLEKHA7;MMP24
prerank,GO_Biological_Process_2021__positive regulation of organelle assembly (GO:1902117),0.3846698323925631,0.8808464575340595,0.6,0.8867378287173335,1.0,11/36,25.67%,LCP1;TNF;CNOT2;PIP4K2A;DYNC1H1;CEP120;SH3GLB1;ARHGAP35;G3BP1;RAB3GAP2;PIP4K2B
prerank,GO_Biological_Process_2021__positive regulation of cellular amide metabolic process (GO:0034250),-0.3883690827061026,-0.8807635962115522,0.6857142857142857,0.9466063485990812,1.0,14/66,20.17%,RPS4X;RPL5;RACK1;CLU;EIF4A3;NPM1;PASK;RPS27L;ZCCHC4;GSAP;EEF2;VIM;NSMAF;NSUN5
prerank,Reactome_2022__Late Phase Of HIV Life Cycle R-HSA-162599,-0.3641418848793004,-0.8806608038288225,0.6901408450704225,0.946524637373776,1.0,11/119,10.95%,UBC;RPS27A;GTF2H5;CTDP1;ELOB;RANBP1;POLR2G;RNMT;NCBP2;VPS28;NUP50
prerank,PanglaoDB_Augmented_2021__Undefined Placental Cells,0.38607310200310274,0.8804251881872506,0.6129032258064516,0.8872686497547028,1.0,2/35,0.65%,TUBA1C;AHCY
prerank,Reactome_2022__Synthesis Of PIPs At ER Membrane R-HSA-1483248,0.5826598418054127,0.8803439117490663,0.6818181818181818,0.8870828517683967,1.0,1/5,13.42%,SBF1
prerank,GO_Biological_Process_2021__purine nucleobase biosynthetic process (GO:0009113),-0.5842944243844752,-0.8802605653033726,0.7419354838709677,0.9470188182557616,1.0,2/5,23.50%,SHMT1;GART
prerank,GO_Biological_Process_2021__positive regulation of JNK cascade (GO:0046330),0.3729917948093201,0.8802076241915979,0.59375,0.8870140867669286,1.0,22/48,27.93%,MAP3K11;ANKRD6;EDA2R;MAP3K10;MFHAS1;SH3RF1;TRAF6;MAP3K5;ZNF622;TPD52L1;TAOK2;MTURN;MAP4K2;AGER;DAB2IP;RIPK1;TRAF2;SERPINF2;PTK2B;HIPK2;MAPK8IP1;DUSP22
prerank,GO_Biological_Process_2021__cellular macromolecule catabolic process (GO:0044265),-0.42796114156060244,-0.8801869699736259,0.6349206349206349,0.9468521916605912,1.0,2/36,2.26%,RNASET2;SIDT2
prerank,GO_Biological_Process_2021__regulation of potassium ion transmembrane transport (GO:1901379),-0.430226591221201,-0.8799628682555588,0.6268656716417911,0.9469824882636344,1.0,3/37,7.09%,FLNA;CD63;STK39
prerank,Reactome_2022__Voltage Gated Potassium Channels R-HSA-1296072,0.43254368972844254,0.8799352225471443,0.5833333333333334,0.887140094011872,1.0,8/18,21.33%,KCNQ2;KCND3;KCNC2;KCNH5;KCNB1;KCND2;KCNQ5;KCNB2
prerank,GO_Biological_Process_2021__regulation of endothelial cell differentiation (GO:0045601),0.5394469845491507,0.879919631170486,0.6938775510204082,0.8867891439612577,1.0,1/6,3.51%,VEZF1
prerank,GO_Biological_Process_2021__positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),-0.372854783715498,-0.8798574231246681,0.6388888888888888,0.9468947051509372,1.0,12/64,12.71%,PYHIN1;DDRGK1;RACK1;ELOB;CLU;ARIH2;RNF144B;DVL1;RBX1;NOP53;HSPA1B;CSNK1D
prerank,CellMarker_Augmented_2021__Preadipocyte Progenitor cell:Adipose Tissue,0.3595920706230453,0.8797607874352878,0.65625,0.8867984085482595,1.0,16/32,29.77%,ACTA2;CDH11;RUNX1T1;JAM2;COL15A1;SLIT3;CXCL12;ASPN;ABI3BP;COL14A1;ADAMTS2;LDB2;DAAM2;C1S;VWF;SPARC
prerank,GO_Biological_Process_2021__fatty acid transmembrane transport (GO:1902001),0.468309953369218,0.8796120399120644,0.5882352941176471,0.8867930800725716,1.0,3/14,7.76%,PRKAB2;CPT1A;ACACB
prerank,"Reactome_2022__Cobalamin (Cbl, Vitamin B12) Transport And Metabolism R-HSA-196741",-0.5182775987225874,-0.879555071306585,0.5833333333333334,0.9472276858576194,1.0,3/10,30.78%,MMAB;MTRR;LMBRD1
prerank,GO_Biological_Process_2021__cell-cell junction assembly (GO:0007043),0.36626543283418644,0.8793828499791291,0.65625,0.8867488780403242,1.0,10/39,15.66%,PKP4;SMAD7;CDH20;VCL;CDH11;TJP1;CDH19;ZNF703;CNTNAP1;CDH8
prerank,KEGG_2021_Human__Purine metabolism,-0.3888717743453078,-0.8793797879410494,0.6428571428571429,0.9472215716307412,1.0,11/91,11.98%,PDE4A;ADPRM;ENPP4;NT5C;PDE5A;ENPP3;AMPD2;PRUNE1;AK9;ENTPD4;ENTPD5
prerank,GO_Biological_Process_2021__positive regulation of response to wounding (GO:1903036),-0.47291658620140015,-0.878529267855433,0.5901639344262295,0.9485553699545447,1.0,4/15,10.30%,MYLK;DUOX1;ACTG1;PTN
prerank,GO_Biological_Process_2021__exit from mitosis (GO:0010458),0.4947284209388756,0.8784200065542799,0.6341463414634146,0.8882883309941135,1.0,4/10,16.96%,EPS8;CHMP7;CLASP1;CLASP2
prerank,GO_Biological_Process_2021__regulation of axon regeneration (GO:0048679),-0.5286565784700423,-0.8782527891700558,0.6938775510204082,0.9487725618899587,1.0,2/9,23.95%,PTN;SCARF1
prerank,Reactome_2022__Polymerase Switching On C-strand Of Telomere R-HSA-174411,-0.5015452454656903,-0.8780368945984758,0.6379310344827587,0.948862659188243,1.0,4/15,21.40%,CHTF18;TERF2IP;PRIM1;CTC1
prerank,GO_Biological_Process_2021__mRNA cleavage involved in gene silencing by miRNA (GO:0035279),0.5845302351352193,0.8778368871986335,0.7142857142857143,0.8889961763207327,1.0,2/5,29.29%,AGO1;MOV10
prerank,GO_Biological_Process_2021__positive regulation of granulocyte differentiation (GO:0030854),0.5448197948415295,0.8778309400333609,0.6730769230769231,0.8886356228784482,1.0,1/5,6.90%,RUNX1
prerank,GO_Biological_Process_2021__negative regulation of microglial cell activation (GO:1903979),0.5050373190944405,0.8771066450977762,0.6808510638297872,0.8897745317352732,1.0,1/7,3.01%,LDLR
prerank,GO_Biological_Process_2021__regulation of smoothened signaling pathway (GO:0008589),0.36242100345557177,0.8770984670800795,0.6774193548387096,0.8894091048309712,1.0,8/32,13.38%,DLG5;TULP3;PTCH2;STK36;KCTD6;BTRC;PTCH1;MEGF8
prerank,GO_Biological_Process_2021__positive regulation of developmental growth (GO:0048639),-0.4259918913943666,-0.8770816053040051,0.6229508196721312,0.9503819054546159,1.0,1/30,1.34%,RIMS1
prerank,GO_Biological_Process_2021__regulation of RNA biosynthetic process (GO:2001141),0.5372793284584776,0.8770431168589503,0.7272727272727273,0.8891360867399241,1.0,2/7,6.74%,MITF;RALY
prerank,GO_Biological_Process_2021__regulation of tumor necrosis factor superfamily cytokine production (GO:1903555),-0.5575558172607064,-0.8770218688060891,0.6470588235294118,0.9501995519363758,1.0,1/8,1.48%,ZFP36
prerank,"GO_Biological_Process_2021__DNA-templated transcription, elongation (GO:0006354)",-0.389018448945221,-0.8768565745647651,0.6666666666666666,0.950198494179889,1.0,7/58,9.87%,TCEA2;GTF2H5;CTDP1;ELOB;ADRM1;POLR2G;NCBP2
prerank,GO_Biological_Process_2021__positive regulation of cell morphogenesis involved in differentiation (GO:0010770),-0.4255158589421664,-0.8767674175858484,0.6119402985074627,0.9500344354045015,1.0,1/37,0.28%,FLNA
prerank,GO_Biological_Process_2021__positive regulation of T cell proliferation (GO:0042102),-0.4437776175292701,-0.8766978267015806,0.6714285714285714,0.9498523811604686,1.0,5/36,5.56%,TFRC;CCL5;AIF1;RPS3;IGF1
prerank,Reactome_2022__GPER1 Signaling R-HSA-9634597,-0.4443176588285059,-0.8766683640919067,0.6451612903225806,0.9495829692812238,1.0,5/26,18.52%,GNB5;PRKAR1B;GNB2;PRKAR2B;ITGB1
prerank,GO_Biological_Process_2021__regulation of protein autophosphorylation (GO:0031952),0.38242453283151673,0.8762351996176644,0.6333333333333333,0.8904574998279671,1.0,12/31,18.72%,PDGFA;NEK10;PDGFC;MOB1B;PPP2R5E;GPNMB;ENPP1;DDX3X;RAP2C;NBN;TAOK2;CHP1
prerank,KEGG_2021_Human__Rap1 signaling pathway,0.30923428609062314,0.8761830961347998,0.8421052631578947,0.8901600549861701,1.0,26/136,13.60%,PDGFA;IGF1R;FGF2;RAP1GAP;MAPK11;RAP1A;MAP2K1;VASP;GNAQ;CNR1;PLCB4;ADCY9;PDGFC;MAGI1;ARAP3;KITLG;CRK;HGF;MAGI3;ENAH;MAPK1;GRIN2B;AFDN;PRKCI;VAV1;ADCY6
prerank,GO_Biological_Process_2021__blood vessel morphogenesis (GO:0048514),0.40678595663503275,0.875895108151636,0.6875,0.8904293220393921,1.0,3/22,2.59%,NRP1;TGFBR2;SMAD7
prerank,GO_Biological_Process_2021__negative regulation of collateral sprouting (GO:0048671),-0.5767295321993664,-0.8757861536523651,0.6415094339622641,0.9509692596031285,1.0,1/5,6.76%,FGF13
prerank,GO_Biological_Process_2021__positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),-0.461149990717315,-0.8757640177190853,0.6612903225806451,0.9506936254937831,1.0,1/25,0.28%,FLNA
prerank,GO_Biological_Process_2021__regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),-0.469724300837039,-0.8756700583214905,0.5555555555555556,0.9505748779766291,1.0,1/16,1.03%,TGFBR3
prerank,GO_Biological_Process_2021__regulation of epithelial cell migration (GO:0010632),-0.4264148400697876,-0.8755356877105159,0.6811594202898551,0.9504983848013175,1.0,7/39,12.45%,GLIPR2;RAB11A;GLUL;ENPP2;PTN;HIF1A;PFN1
prerank,GO_Biological_Process_2021__cellular response to steroid hormone stimulus (GO:0071383),0.479689467316784,0.87536599370882,0.5609756097560976,0.8913420280455552,1.0,3/9,18.31%,TRERF1;UBE2L3;NR3C1
prerank,GO_Biological_Process_2021__regulation of DNA replication (GO:0006275),0.4211061797575131,0.8752043701844521,0.6176470588235294,0.8913541902485728,1.0,9/35,22.88%,SLFN11;ZBTB38;BRPF3;GTPBP4;ANKRD17;FAF1;BLM;GMNN;RAD17
prerank,GO_Biological_Process_2021__negative regulation of intracellular signal transduction (GO:1902532),-0.3571812107170582,-0.8751489039948932,0.725,0.9510332762840193,1.0,22/142,13.97%,DUSP1;DDIT4;NLRC3;RORA;RACK1;CGNL1;PLEK;LILRB4;GSTP1;THEM4;NLRP12;TNFAIP3;TMSB4X;STAT1;BANK1;NOP53;DGKD;PLEKHA1;PEBP1;PRDM15;PIK3CB;OTUD3
prerank,CellMarker_Augmented_2021__Periosteum-derived Progenitor cell:Periosteum,-0.3971278811341868,-0.8749674640642078,0.6973684210526315,0.951043985387017,1.0,4/57,3.91%,MYLK;CH25H;MGLL;CTSB
prerank,CellMarker_Augmented_2021__Stem cell:Amniotic Fluid,-0.5512463837005308,-0.874955251771982,0.6911764705882353,0.9507567482510476,1.0,3/7,18.52%,CD44;FLT1;ITGB1
prerank,GO_Biological_Process_2021__amino acid import across plasma membrane (GO:0089718),0.4836368677923453,0.8748788805908501,0.6862745098039216,0.8916081199663113,1.0,4/11,6.03%,SLC1A3;SLC7A8;SLC3A2;SLC1A2
prerank,GO_Biological_Process_2021__RNA processing (GO:0006396),0.3064862373318843,0.8748524869499316,0.7222222222222222,0.8912818134571087,1.0,6/151,2.54%,PPARGC1A;ADARB2;NUFIP1;SYNCRIP;NOL9;U2AF1
prerank,GO_Biological_Process_2021__regulation of T-helper 17 type immune response (GO:2000316),-0.6060755222131914,-0.8748426424176572,0.6923076923076923,0.9506953388805625,1.0,1/5,1.65%,PRKCQ
prerank,GO_Biological_Process_2021__regulation of T cell differentiation (GO:0045580),-0.45058163162734344,-0.8746504399415647,0.6229508196721312,0.9508475014573387,1.0,2/20,2.84%,CD2;PRELID1
prerank,Reactome_2022__RNA Polymerase I Transcription Initiation R-HSA-73762,-0.4058451549689807,-0.8746240986163016,0.6268656716417911,0.9505756494346297,1.0,3/40,4.34%,CHD3;TAF1D;GTF2H5
prerank,GO_Biological_Process_2021__regulation of peptidyl-cysteine S-nitrosylation (GO:2000169),-0.5811687801533268,-0.8745977580729035,0.6470588235294118,0.9502979676372683,1.0,2/5,25.69%,NOS1AP;ATP2B4
prerank,GO_Biological_Process_2021__regulation of exocytosis (GO:0017157),0.3809637415884772,0.8744948915125645,0.6666666666666666,0.8916418565631988,1.0,15/39,24.55%,ANXA1;RAB10;CLASP1;STXBP5;CLASP2;IL1RAPL1;RALA;RIMS2;SNCA;UNC13D;SEPTIN4;RAB3C;STXBP5L;CADPS2;CADPS
prerank,GO_Biological_Process_2021__regulation of chromosome separation (GO:1905818),-0.6075693298627316,-0.874474356567942,0.7551020408163265,0.9502337884430679,1.0,2/5,18.08%,PLSCR1;CSNK2A2
prerank,Reactome_2022__IRE1alpha Activates Chaperones R-HSA-381070,-0.43753042783566887,-0.8741660127233872,0.6376811594202898,0.9504910235843576,1.0,4/38,9.62%,DDX11;DNAJB9;HDGF;FKBP14
prerank,Reactome_2022__Inactivation Of CSF3 (G-CSF) Signaling R-HSA-9705462,-0.4734520354710975,-0.8739374589428952,0.7166666666666667,0.9506580132739353,1.0,3/22,4.49%,UBC;RPS27A;ELOB
prerank,GO_Biological_Process_2021__regulation of retinoic acid receptor signaling pathway (GO:0048385),0.5097775284571805,0.8736612089913787,0.6,0.8930641001115904,1.0,1/9,8.76%,CTBP2
prerank,GO_Biological_Process_2021__regulation of receptor internalization (GO:0002090),-0.453330163332505,-0.8735715088693263,0.5967741935483871,0.9510560053079549,1.0,6/23,17.17%,CD63;VEGFA;ANKRD13D;PICK1;FLOT1;LRPAP1
prerank,Reactome_2022__Signaling To ERKs R-HSA-187687,-0.42470164569486596,-0.8735030590534686,0.6923076923076923,0.9508626389004791,1.0,1/28,0.60%,BCL11B
prerank,Reactome_2022__Signaling By FGFR2 IIIa TM R-HSA-8851708,0.4263937268161445,0.873380367744913,0.5555555555555556,0.8932686253406336,1.0,1/16,0.68%,POLR2D
prerank,GO_Biological_Process_2021__protein localization to axon (GO:0099612),0.5779121107030992,0.8733324417250032,0.7450980392156863,0.89302420590908,1.0,1/5,1.34%,CNTN2
prerank,GO_Biological_Process_2021__positive regulation of hormone secretion (GO:0046887),-0.5731961594275871,-0.8728782908414514,0.6615384615384615,0.9517192182342233,1.0,1/6,19.59%,CYP19A1
prerank,GO_Biological_Process_2021__RNA 3'-end processing (GO:0031123),-0.38533665756525076,-0.8728413288848997,0.7123287671232876,0.9514507979031012,1.0,8/53,13.24%,DHX38;CSTF2T;EIF4A3;CHTOP;U2AF2;NCBP2;SRSF2;SRSF7
prerank,GO_Biological_Process_2021__positive regulation of secretion by cell (GO:1903532),0.36218284173572934,0.8725061251711284,0.7272727272727273,0.8942752872453817,1.0,18/52,22.41%,MYOM1;GOLPH3L;BAIAP3;TMED10;UNC13B;CD33;STX1A;ARF6;CLASP1;ATP13A2;STXBP5;SLC12A2;CLASP2;KCNB1;SNCA;UNC13D;CD2AP;DTNBP1
prerank,GO_Biological_Process_2021__establishment of protein localization to chromosome (GO:0070199),0.5356394511068852,0.8724159125361924,0.65,0.8941319060726655,1.0,1/7,1.43%,RUVBL2
prerank,GO_Biological_Process_2021__positive regulation of cell communication (GO:0010647),0.4557585978045116,0.8724157231150496,0.6041666666666666,0.8937621244737934,1.0,6/18,10.53%,CDKN2AIP;PTPN23;GRIK2;TNF;CLSTN2;CLSTN3
prerank,Reactome_2022__Class I MHC Mediated Antigen Processing And Presentation R-HSA-983169,-0.34306685283526867,-0.8722810011403462,0.75,0.9522316753292728,1.0,42/299,14.90%,CD36;UBC;HLA-B;RPS27A;HERC6;B2M;PSMB3;BTK;CBLB;RNF213;NDUFA2;NCF4;ELOB;SPSB1;ARIH2;HLA-C;DTX3L;KLHL13;RNF144B;RNF126;PSMB6;PSMA7;HLA-F;UBAC1;PSMB9;GLMN;NCF2;TRIM69;ERAP1;RBX1;PSMD12;ANAPC11;TRAF7;CYBA;PSMD8;PSMA5;ASB8;HLA-E;DZIP3;ERAP2;UBA52;CDC26
prerank,"GO_Biological_Process_2021__endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)",-0.5154016864863544,-0.8722268919145911,0.6346153846153846,0.9520112069070495,1.0,1/8,1.52%,RPS21
prerank,PanglaoDB_Augmented_2021__Satellite Cells,-0.4000591429251912,-0.8721934673723174,0.6615384615384615,0.9517579345057726,1.0,2/60,1.43%,CALCR;CXCR4
prerank,GO_Biological_Process_2021__membrane protein intracellular domain proteolysis (GO:0031293),0.3870204266373071,0.872072086968267,0.6744186046511628,0.8940863774279022,1.0,5/17,25.72%,TRAF6;SPPL2B;RHBDD1;ADAM10;TGFB1
prerank,Reactome_2022__Peroxisomal Lipid Metabolism R-HSA-390918,-0.4836308775822966,-0.872052677166894,0.6909090909090909,0.9517084561646655,1.0,3/16,14.14%,ACBD5;ACAA1;ECI2
prerank,GO_Biological_Process_2021__detection of muscle stretch (GO:0035995),-0.5731957614528854,-0.8719806013207976,0.6964285714285714,0.9515183159579477,1.0,1/5,7.37%,TTN
prerank,GO_Biological_Process_2021__progesterone receptor signaling pathway (GO:0050847),0.5374954352689232,0.8719799072384469,0.64,0.8939191742096683,1.0,2/6,18.25%,TRERF1;NEDD4
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle tissue growth (GO:0055023),-0.5268670465232855,-0.871913036747181,0.6170212765957447,0.9513402719675432,1.0,3/12,8.45%,TGFBR3;IGF1;RBPJ
prerank,GO_Biological_Process_2021__potassium ion import across plasma membrane (GO:1990573),0.4393022661270001,0.8716941280308445,0.6756756756756757,0.8940553647503724,1.0,5/18,15.33%,KCNJ2;KCNJ5;SLC12A6;SLC12A5;SLC12A2
prerank,GO_Biological_Process_2021__regulation of delayed rectifier potassium channel activity (GO:1902259),-0.557117224822637,-0.8716578721120054,0.6545454545454545,0.9515273113643355,1.0,3/6,30.60%,NOS1AP;SUMO1;ANK3
prerank,KEGG_2021_Human__Tuberculosis,-0.3621698044952229,-0.8716324288997227,0.7125,0.9512716287603599,1.0,26/123,20.69%,CYCS;CD14;FCER1G;LSP1;IL10RA;HLA-DRB5;CALM1;STAT1;ITGB2;HLA-DRA;IFNGR2;NOD2;HLA-DPA1;C3;CIITA;HLA-DMB;CD74;HLA-DPB1;FCGR3A;IL18;RFX5;IRAK4;HLA-DRB1;NFYB;TLR2;CLEC7A
prerank,Reactome_2022__Molybdenum Cofactor Biosynthesis R-HSA-947581,-0.585165343144072,-0.8716039977268804,0.7142857142857143,0.9506681269719162,1.0,2/5,17.37%,NFS1;MOCOS
prerank,GO_Biological_Process_2021__molybdopterin cofactor biosynthetic process (GO:0032324),-0.585165343144072,-0.8716039977268804,0.7142857142857143,0.9506681269719162,1.0,2/5,17.37%,NFS1;MOCOS
prerank,GO_Biological_Process_2021__histone H3-K4 methylation (GO:0051568),-0.43482602163983053,-0.8714180167382086,0.6666666666666666,0.950750576761655,1.0,2/21,14.77%,ZNF335;SETD1A
prerank,GO_Biological_Process_2021__cellular response to alcohol (GO:0097306),0.36390319703985957,0.8712676893032613,0.6538461538461539,0.8945619355687968,1.0,6/30,16.39%,GRAMD1A;GLRA1;GRAMD1C;PTCH1;ADCY6;BLM
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Oral Cavity,0.3913132282915325,0.8712213916028019,0.675,0.8942504548559628,1.0,7/35,7.39%,KLF4;GSN;PDK4;BACE2;ARSD;RIN2;IL13RA1
prerank,Reactome_2022__Ephrin Signaling R-HSA-3928664,-0.5004884649615446,-0.8709768970335297,0.6896551724137931,0.9512958896567462,1.0,4/15,12.32%,EPHB1;FYN;MYL12A;EFNB2
prerank,CellMarker_Augmented_2021__Myeloid Conventional Dendritic cell:Bone Marrow,-0.5447625030998328,-0.8708649632533232,0.6666666666666666,0.9511720722317933,1.0,2/9,9.70%,CD2;CD226
prerank,GO_Biological_Process_2021__calcium ion homeostasis (GO:0055074),-0.4176125118460829,-0.8707498360338426,0.7,0.9510722134653316,1.0,5/45,9.02%,CCL3;CCL5;ATP13A1;TPT1;TRPV4
prerank,CellMarker_Augmented_2021__Stem cell:Salivary Gland,-0.362836152534202,-0.8705877587697133,0.6901408450704225,0.9510887812434251,1.0,15/93,9.17%,MDFIC;PARP14;B2M;ANXA2;ETS1;SAMD9L;BNIP2;PHF11;ERO1A;GBP3;TNFAIP8;TNFAIP3;CD44;SAMD9;S100A6
prerank,GO_Biological_Process_2021__RNA stabilization (GO:0043489),0.41606091802838246,0.8705846899044729,0.6756756756756757,0.8951411371529641,1.0,5/23,19.56%,NSUN2;TENT5A;NAF1;THRAP3;HNRNPU
prerank,GO_Biological_Process_2021__negative regulation of T cell proliferation (GO:0042130),-0.4732799971324275,-0.8705194930431102,0.6666666666666666,0.9508995376032403,1.0,4/22,9.67%,IL4I1;LILRB4;BTN2A2;GLMN
prerank,GO_Biological_Process_2021__calcium ion transmembrane import into cytosol (GO:0097553),0.4080220130691238,0.8701679190092285,0.6388888888888888,0.8955216868649978,1.0,2/24,2.26%,PKD2;FGF2
prerank,GO_Biological_Process_2021__cellular response to organic cyclic compound (GO:0071407),-0.3817238237444057,-0.8701512866539163,0.68,0.9513753224356019,1.0,5/99,3.27%,NR4A3;CCL3;INSIG1;CCL5;RORA
prerank,Reactome_2022__Signal Transduction R-HSA-162582,-0.31936767480896333,-0.8701273920141067,0.95,0.9510877479271955,1.0,105/1525,8.45%,CCL4;CALCR;FLNA;PLEKHG5;BCL11B;CCL3;MYLK;UBC;PDE4A;H2BC4;ADGRE1;H2BC26;CCDC88C;H2AC20;EPN1;ARHGAP4;PPP1R15A;FOS;RPS27A;RPGRIP1L;RUNX3;CHRM2;CXCR4;TFRC;CCL5;GPR183;CD55;PRKCQ;H2AC6;MGLL;RASGRF2;GRAP2;VAV3;PDGFD;MPP7;CHD3;USF1;PAQR3;PSMB3;YES1;RPS27;CD200R1;CDC37;PLEKHG1;RORA;GZMB;RGS1;BTK;GMIP;RGS16;ARL4C;APOD;PDHX;IER3;PLTP;DDRGK1;RACK1;EMD;NCF4;TNFSF10;GREB1;ATP6V1F;GNB5;ARHGEF1;IL3RA;NR1H2;JUP;IGF1;PDE5A;BASP1;LAMTOR5;WDR83;H3-3B;H2AJ;ACKR4;VPS35;RHOU;EFHD2;TACR1;RGS4;PRKAR1B;FGF13;ARHGEF3;C5AR1;OBSCN;ACBD5;H2BC21;NEFL;POLR2G;PSMB6;RNMT;PSMA7;RPS6;FYN;THEM4;GNRHR;PPP1CB;ACTG1;SGK1;CENPU;CSF2RA;TNFAIP3;H2BC5;CALM1;RBPJ
prerank,GO_Biological_Process_2021__negative regulation of protein modification process (GO:0031400),-0.3889268214955397,-0.8700349837674751,0.6794871794871795,0.9509225294589121,1.0,4/65,2.98%,PPP1R15A;PID1;WARS1;PAQR3
prerank,GO_Biological_Process_2021__regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),0.44975068682142383,0.8699172189271208,0.5869565217391305,0.8957097764256177,1.0,1/15,1.03%,GRB10
prerank,GO_Biological_Process_2021__positive regulation of sodium ion transport (GO:0010765),0.5091904051701399,0.8697707871711188,0.5853658536585366,0.8956384201943978,1.0,3/7,18.87%,SCN3B;AHCYL1;SCN1B
prerank,GO_Biological_Process_2021__spermatid development (GO:0007286),0.45558839358436276,0.8697298016241379,0.5483870967741935,0.8953127384423732,1.0,5/14,13.41%,SYCP3;CIB1;CDYL;RFX2;JAM2
prerank,GO_Biological_Process_2021__positive regulation of alpha-beta T cell differentiation (GO:0046638),-0.5234419299472114,-0.8696560297048188,0.6833333333333333,0.9513829419363214,1.0,3/9,10.76%,RUNX3;LILRB4;NCKAP1L
prerank,Reactome_2022__Cardiac Conduction R-HSA-5576891,0.3358072651428099,0.869525238165889,0.6666666666666666,0.8952751885163527,1.0,13/64,14.64%,TRPC1;KCNJ2;KCNIP2;SCN3A;KCND3;SCN3B;SCN8A;KCNK6;KCNK13;SLC8A1;AHCYL1;CACNG8;FXYD7
prerank,GO_Biological_Process_2021__interleukin-1-mediated signaling pathway (GO:0070498),0.3408132668220484,0.8694491916370193,0.6551724137931034,0.8950698181275479,1.0,1/82,0.03%,EGR1
prerank,GO_Biological_Process_2021__positive regulation of neuron apoptotic process (GO:0043525),-0.4998629783015299,-0.8694159448713619,0.7017543859649122,0.9515303927569908,1.0,1/19,0.62%,CCL3
prerank,GO_Biological_Process_2021__regulation of substrate adhesion-dependent cell spreading (GO:1900024),0.40167010499586775,0.8692794467402521,0.6060606060606061,0.8950659554845591,1.0,7/35,7.80%,NRP1;PDPN;CSPG5;CIB1;MYADM;CRK;KANK1
prerank,GO_Biological_Process_2021__regulation of cell cycle phase transition (GO:1901987),0.3410982996575218,0.8692061391647216,0.5862068965517241,0.8948033383052271,1.0,7/70,10.80%,UBE2D1;NEK10;FZR1;CDC23;BTRC;ANAPC16;FBXW7
prerank,KEGG_2021_Human__Lysine degradation,0.3504530259652591,0.8691254071050873,0.7222222222222222,0.8945648862051578,1.0,6/52,13.32%,SETD7;NSD3;GCDH;NSD2;SETD2;SETDB2
prerank,GO_Biological_Process_2021__nuclear migration (GO:0007097),-0.5123909423108135,-0.8687692839734842,0.6557377049180327,0.9524963412815356,1.0,1/12,1.88%,SYNE2
prerank,PanglaoDB_Augmented_2021__Hepatoblasts,-0.5019528808568776,-0.8687096723961801,0.6666666666666666,0.9522802887615899,1.0,5/14,24.18%,ADGRG6;PKP2;GPRC5C;TOM1L1;EPB41L4B
prerank,GO_Biological_Process_2021__mitotic chromosome condensation (GO:0007076),0.4545571004840748,0.8686186603641457,0.6,0.8954565678556423,1.0,3/18,14.09%,NCAPH2;SMC4;CHMP1A
prerank,Reactome_2022__APC/C:Cdc20 Mediated Degradation Of Cyclin B R-HSA-174048,-0.466745639234385,-0.8684906249539807,0.6666666666666666,0.9524034997635268,1.0,2/16,1.30%,UBC;RPS27A
prerank,GO_Biological_Process_2021__positive regulation of cellular catabolic process (GO:0031331),-0.3677989663788922,-0.8684247568459733,0.734375,0.9522084366760831,1.0,20/98,18.39%,TRIM5;IGF1;DTX3L;TRIM22;VPS35;PTTG1IP;TNFRSF1B;PFKFB3;PFKFB4;PRR5L;HIF1A;ENTPD5;KAT5;PIK3CB;TP53INP1;SNX9;CNOT8;EZR;TPCN1;PNPT1
prerank,Reactome_2022__CTLA4 Inhibitory Signaling R-HSA-389513,-0.47959156148985016,-0.8682125146326183,0.6666666666666666,0.9522929439385766,1.0,2/17,7.36%,YES1;FYN
prerank,GO_Biological_Process_2021__Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),-0.4017351583467937,-0.8681683140926216,0.6764705882352942,0.9520445533262578,1.0,10/64,13.75%,MYO1G;VAV3;YES1;CD247;FYN;ACTG1;ACTB;NCKAP1L;CYFIP2;PIK3CB
prerank,Reactome_2022__SUMOylation Of DNA Replication Proteins R-HSA-4615885,0.3630656569360866,0.8680188668131243,0.6363636363636364,0.896309229872089,1.0,6/37,17.93%,NUP153;NUP188;NUP42;NDC1;NUP133;NUP205
prerank,"GO_Biological_Process_2021__protein localization to chromosome, centromeric region (GO:0071459)",-0.4775847354728334,-0.8679688499886157,0.5818181818181818,0.9520429049336306,1.0,6/11,25.39%,ZWILCH;MIS12;IK;BUB3;CHAMP1;RB1
prerank,CellMarker_Augmented_2021__Beta cell:Pancreatic Islet,0.3341153402613964,0.8676692260127046,0.75,0.8966780137791366,1.0,7/56,9.71%,RASA4B;CDK5R1;SEMA5A;CADM1;ELMO1;GPM6A;ALCAM
prerank,GO_Biological_Process_2021__protein acetylation (GO:0006473),0.4222586110989827,0.8676626897749736,0.5625,0.8963339802911222,1.0,3/23,8.08%,AANAT;SIRT1;CLOCK
prerank,GO_Biological_Process_2021__negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),-0.39993452573782085,-0.8676344836505439,0.7746478873239436,0.9523204233544116,1.0,12/56,14.43%,EYA2;TNFSF10;IGF1;GSTP1;TNFAIP3;ITGA6;CFLAR;HSPA1B;GPX1;PEA15;BRCA1;HSPA1A
prerank,GO_Biological_Process_2021__triglyceride biosynthetic process (GO:0019432),0.5113490133166876,0.8675212805402599,0.5625,0.8962483499305278,1.0,3/9,12.41%,GPAT4;PCK2;GPAT3
prerank,GO_Biological_Process_2021__negative regulation of apoptotic signaling pathway (GO:2001234),-0.38473327043981476,-0.8674490680939381,0.6818181818181818,0.9523750937819431,1.0,9/56,14.43%,PRELID1;CLU;IGF1;SLC25A5;GSTP1;ITGA6;CFLAR;GPX1;HSPA1A
prerank,GO_Biological_Process_2021__regulation of small molecule metabolic process (GO:0062012),0.41288677120171835,0.8674184429254462,0.6190476190476191,0.8960767847639324,1.0,2/19,2.51%,PDK4;SIRT1
prerank,Reactome_2022__Peroxisomal Protein Import R-HSA-9033241,-0.41538653646421275,-0.8667990113613867,0.6956521739130435,0.9532963531843466,1.0,6/40,10.48%,UBC;RPS27A;GNPAT;GSTK1;ACAA1;ZNF260
prerank,GO_Biological_Process_2021__ceramide biosynthetic process (GO:0046513),-0.4676346433976951,-0.8664547600972671,0.6296296296296297,0.953712630537448,1.0,1/22,0.87%,DEGS2
prerank,GO_Biological_Process_2021__positive regulation of cytoplasmic translation (GO:2000767),-0.5990137415368191,-0.8664505841043045,0.7954545454545454,0.9534049443247679,1.0,3/5,31.65%,DHX36;YBX3;PKM
prerank,Reactome_2022__Interactions Of Rev With Host Cellular Proteins R-HSA-177243,0.3724711627758788,0.8663674651983617,0.75,0.8977871430912759,1.0,5/35,7.72%,NUP153;NUP188;NUP42;XPO1;RCC1
prerank,GO_Biological_Process_2021__aortic valve development (GO:0003176),0.41971564295873803,0.8663229985691993,0.6052631578947368,0.8975339276851524,1.0,8/15,26.68%,JAG1;ROBO1;ROBO2;TNFRSF1A;SLIT3;TGFB1;NOTCH1;SLIT2
prerank,GO_Biological_Process_2021__positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),-0.5232636076706554,-0.8661995640156331,0.6909090909090909,0.9535718550859907,1.0,2/12,14.20%,RAB11A;CCND1
prerank,GO_Biological_Process_2021__immune response-activating cell surface receptor signaling pathway (GO:0002429),-0.4748734366175878,-0.8661460737806908,0.6,0.9533444451558839,1.0,5/14,15.16%,FCER1G;C5AR1;SPG21;C5AR2;FPR1
prerank,Reactome_2022__Factors Involved In Megakaryocyte Development And Platelet Production R-HSA-983231,0.32483657289955997,0.8661193236637498,0.7297297297297297,0.8975672508837268,1.0,13/83,14.42%,KIFC2;DOCK10;RBSN;RAD51B;HDAC1;JMJD1C;CENPE;MFN1;KIF15;KIF6;AK3;MAFK;DOCK8
prerank,GO_Biological_Process_2021__positive regulation of nervous system process (GO:0031646),-0.456926584847424,-0.8658526625153103,0.6538461538461539,0.9535883046124917,1.0,3/15,8.06%,RIMS1;NLGN2;TNFRSF1B
prerank,GO_Biological_Process_2021__neuron projection arborization (GO:0140058),0.5281764544164014,0.8657016513524934,0.6382978723404256,0.8980203273590087,1.0,1/5,3.53%,NLGN1
prerank,GO_Biological_Process_2021__extrinsic apoptotic signaling pathway (GO:0097191),0.35885342509683404,0.8656717747331439,0.6538461538461539,0.8977101079813543,1.0,9/52,7.92%,BAG3;CASP9;TNFRSF10A;SMAD3;CIB1;SIVA1;TNF;SORT1;BOK
prerank,GO_Biological_Process_2021__negative regulation of chemokine-mediated signaling pathway (GO:0070100),-0.53641243915276,-0.8655075660707716,0.6271186440677966,0.9538408900355206,1.0,1/5,4.71%,PADI2
prerank,PanglaoDB_Augmented_2021__Proximal Tubule Cells,0.43906738628216235,0.8650947988062522,0.631578947368421,0.8984106046555035,1.0,6/24,13.34%,HPN;FAH;SLC4A4;FUT9;GCDH;NME4
prerank,GO_Biological_Process_2021__pentose metabolic process (GO:0019321),0.5422851492565142,0.8650912994328256,0.6666666666666666,0.8980433067795199,1.0,1/5,9.49%,FGGY
prerank,Reactome_2022__IKK Complex Recruitment Mediated By RIP1 R-HSA-937041,-0.46142052424740265,-0.8650726757237768,0.6923076923076923,0.9543746115628102,1.0,3/19,4.18%,UBC;RPS27A;NDUFA2
prerank,GO_Biological_Process_2021__regulation of filopodium assembly (GO:0051489),0.37160363243135897,0.8650465063615527,0.5945945945945946,0.8977906075682264,1.0,5/31,12.17%,NRP1;NLGN1;GPM6A;FNBP1L;ARF6
prerank,KEGG_2021_Human__Citrate cycle (TCA cycle),-0.432893187913563,-0.8648010657601758,0.6379310344827587,0.954573491308848,1.0,6/25,20.82%,MDH2;IDH3B;DLST;PDHB;ACO2;PDHA1
prerank,GO_Biological_Process_2021__'de novo' posttranslational protein folding (GO:0051084),-0.43515736106631725,-0.864733447608663,0.6231884057971014,0.954393471889124,1.0,6/24,19.11%,ERO1A;ENTPD5;HSPA1B;HSPA1A;HSPA2;CCT2
prerank,GO_Biological_Process_2021__negative regulation of biomineralization (GO:0110150),0.5742658977159596,0.8643112176181358,0.7619047619047619,0.8988805731261985,1.0,4/5,37.07%,TGFB1;NOTCH1;ROCK2;ROCK1
prerank,KEGG_2021_Human__Chagas disease,-0.38185899181237876,-0.8643005377011894,0.7051282051282052,0.9550004410306415,1.0,4/75,3.81%,CCL3;FOS;CCL5;CD247
prerank,GO_Biological_Process_2021__positive regulation of wound healing (GO:0090303),-0.4463751662090049,-0.864021519807616,0.6666666666666666,0.955175262448871,1.0,4/21,7.76%,MYLK;ENPP4;DUOX1;ACTG1
prerank,"GO_Biological_Process_2021__regulation of gene expression, epigenetic (GO:0040029)",-0.3857644364302184,-0.863820328760092,0.6833333333333333,0.9552021582403322,1.0,9/67,16.76%,TAF1D;ZNF335;GLMN;ACTB;TAF1C;DNMT1;GPX1;CGGBP1;KDM1B
prerank,GO_Biological_Process_2021__protein modification by small protein removal (GO:0070646),-0.34322098007817103,-0.8636340401267385,0.7654320987654321,0.9552319916586957,1.0,26/210,14.82%,UBC;USP6;RPS27A;COPS6;PSMB3;USP36;ADRM1;PSMB6;PSMA7;TNFAIP3;OTUD1;ABRAXAS1;PSMB9;JOSD1;CFTR;ACTB;HIF1A;WDR48;PSMD12;COPS8;PSMD8;PSMA5;OTUD6B;OTUD3;BRCA1;UBA52
prerank,GO_Biological_Process_2021__negative regulation of telomere maintenance via telomere lengthening (GO:1904357),0.39284890712924136,0.8634634748566182,0.7222222222222222,0.9001790246047836,1.0,4/19,11.89%,PARP1;GNL3L;ERCC4;HNRNPC
prerank,GO_Biological_Process_2021__cellular response to insulin stimulus (GO:0032869),0.3252106335366861,0.8632088457830328,0.6111111111111112,0.9003491008881431,1.0,10/90,5.45%,GRB10;FER;IGF1R;PDK4;SLC39A14;GAB1;HDAC9;RAB10;PPARG;PARP1
prerank,GO_Biological_Process_2021__aminoglycan catabolic process (GO:0006026),0.4231844358760604,0.8631188878156077,0.631578947368421,0.9001909665959396,1.0,3/17,5.59%,CTBS;GLB1;HPSE
prerank,Reactome_2022__RUNX3 Regulates WNT Signaling R-HSA-8951430,-0.573116931606886,-0.8629484332988259,0.6346153846153846,0.9562839877788746,1.0,1/6,1.37%,RUNX3
prerank,GO_Biological_Process_2021__fatty acid beta-oxidation (GO:0006635),0.3799699550258006,0.8627993169713352,0.7441860465116279,0.9004512010516881,1.0,7/36,16.90%,ACADS;ACOX3;ACADVL;GCDH;ECI1;ECHDC1;AUH
prerank,GO_Biological_Process_2021__positive regulation of glycoprotein biosynthetic process (GO:0010560),0.52525330617136,0.8627780101516246,0.6521739130434783,0.9001316273076704,1.0,2/8,8.66%,ABCA2;RAMP1
prerank,GO_Biological_Process_2021__regulation of phosphoprotein phosphatase activity (GO:0043666),-0.44779775303469527,-0.8626717197075054,0.6119402985074627,0.9566087790860697,1.0,2/27,8.36%,PPP1R15A;CALM1
prerank,KEGG_2021_Human__Ether lipid metabolism,0.416593030442302,0.8626700108605279,0.6410256410256411,0.8999500306980133,1.0,3/26,5.23%,PLA2G4C;PLA2G7;PLPP1
prerank,GO_Biological_Process_2021__regulation of protein targeting to membrane (GO:0090313),-0.42245430748279905,-0.8626630252100145,0.7346938775510204,0.9563192689885321,1.0,4/22,10.55%,CEMIP;FIS1;FYN;ITGB2
prerank,GO_Biological_Process_2021__double-strand break repair via classical nonhomologous end joining (GO:0097680),0.5430915176664574,0.8624961056441411,0.6666666666666666,0.8999489648662502,1.0,1/6,7.13%,LIG4
prerank,GO_Biological_Process_2021__regulation of cellular pH (GO:0030641),0.404515574978062,0.8624841050885084,0.525,0.899606261054614,1.0,7/17,18.72%,SLC9C2;SLC4A4;SLC9A1;CA2;SLC9A9;SLC9A7;CHP1
prerank,GO_Biological_Process_2021__macromolecule catabolic process (GO:0009057),-0.4689763674556098,-0.8623546428319806,0.6666666666666666,0.9566143223530863,1.0,1/20,1.79%,TPP1
prerank,Reactome_2022__DCC Mediated Attractive Signaling R-HSA-418885,-0.47675274608416035,-0.8622093025074764,0.625,0.9565433308079501,1.0,2/13,11.48%,FYN;ABLIM3
prerank,GO_Biological_Process_2021__positive regulation of monocyte chemotaxis (GO:0090026),-0.5032541644939613,-0.8621613777894541,0.6557377049180327,0.9562806712135418,1.0,2/10,2.67%,CCL5;AIF1
prerank,CellMarker_Augmented_2021__Endothelial Precursor cell:Peripheral Blood,-0.4073101377492841,-0.8621144805911354,0.6027397260273972,0.956050616730923,1.0,15/48,18.15%,MS4A4A;SIGLEC1;CD93;F13A1;PECAM1;PCDH12;MS4A6A;SPARCL1;A2M;FLT1;SERPING1;HLA-DPB1;FCGR3A;GIMAP4;FOLR2
prerank,GO_Biological_Process_2021__protein deubiquitination involved in ubiquitin-dependent protein catabolic process (GO:0071947),0.5487372242452087,0.8620386277694716,0.6888888888888889,0.900179245392051,1.0,2/5,9.29%,OTUD7A;ZRANB1
prerank,GO_Biological_Process_2021__regulation of transcription by RNA polymerase III (GO:0006359),-0.44981369137459865,-0.861694157459166,0.7014925373134329,0.9565870693136699,1.0,8/19,32.78%,ZNF76;POLR3C;DHX36;POLR3F;MAF1;ZNF345;PRDX5;ZC3H8
prerank,GO_Biological_Process_2021__cellular response to nitrogen levels (GO:0043562),-0.542007829658031,-0.861507624590812,0.6792452830188679,0.9563010014441629,1.0,2/8,9.32%,GABARAPL1;GABARAPL2
prerank,GO_Biological_Process_2021__cellular response to nitrogen starvation (GO:0006995),-0.542007829658031,-0.861507624590812,0.6792452830188679,0.9563010014441629,1.0,2/8,9.32%,GABARAPL1;GABARAPL2
prerank,CellMarker_Augmented_2021__Stromal cell:Bone Marrow,-0.5600861930265275,-0.8613949335670152,0.6774193548387096,0.956136022809814,1.0,3/6,18.52%,CD44;PTPRC;ITGB1
prerank,Reactome_2022__Acetylcholine Neurotransmitter Release Cycle R-HSA-264642,-0.4909745588975619,-0.8613797237273747,0.6909090909090909,0.9558416300390967,1.0,2/14,6.19%,RIMS1;RAB3A
prerank,GO_Biological_Process_2021__negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067),-0.49471108802003905,-0.8613730530290561,0.5862068965517241,0.9555533148029042,1.0,2/8,11.92%,NLRC3;NOP53
prerank,Reactome_2022__Norepinephrine Neurotransmitter Release Cycle R-HSA-181430,-0.4995168261169291,-0.8610530091627969,0.6909090909090909,0.9558682479530948,1.0,2/13,6.19%,RIMS1;RAB3A
prerank,CellMarker_Augmented_2021__Mesenchymal cell:Liver,-0.4594217766671877,-0.860912518972627,0.6617647058823529,0.9557683231510181,1.0,6/24,12.82%,TFRC;GADD45B;PLTP;PTGES2;AKAP12;PTPRC
prerank,Reactome_2022__Neurotransmitter Release Cycle R-HSA-112310,0.37921071721809896,0.8607174233639512,0.6285714285714286,0.9022072883159429,1.0,8/35,11.06%,SLC1A3;TSPOAP1;LIN7A;SLC1A2;UNC13B;ALDH5A1;STX1A;PPFIA3
prerank,Reactome_2022__mRNA Decay By 3 To 5 Exoribonuclease R-HSA-429958,0.49608047387267584,0.8606717394638238,0.6666666666666666,0.9019067369704574,1.0,3/12,17.25%,EXOSC6;SKIC2;EXOSC7
prerank,"Reactome_2022__TICAM1, RIP1-mediated IKK Complex Recruitment R-HSA-168927",-0.4858275926402682,-0.8605724463955042,0.6875,0.9562005745153213,1.0,2/16,1.30%,UBC;RPS27A
prerank,Reactome_2022__RAC1 GTPase Cycle R-HSA-9013149,-0.36290151882825694,-0.8598528425024198,0.7654320987654321,0.9573584480473576,1.0,9/144,4.41%,ARHGAP4;TFRC;RASGRF2;VAV3;MPP7;PLEKHG1;GMIP;EMD;NCF4
prerank,GO_Biological_Process_2021__negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),0.4628162099105386,0.8596686838649799,0.6666666666666666,0.9036102945834279,1.0,2/12,6.68%,LRRK2;TXNDC12
prerank,Reactome_2022__Diseases Associated With O-glycosylation Of Proteins R-HSA-3906995,-0.44411646148670325,-0.8595655744120311,0.6785714285714286,0.9575901209777669,1.0,3/28,4.92%,SPON2;ADAMTS19;POMT1
prerank,CellMarker_Augmented_2021__Lake Et al.Science.Ex2:Brain,0.5364481425647162,0.859460832793042,0.6818181818181818,0.9036882448845237,1.0,1/7,1.78%,COL5A2
prerank,GO_Biological_Process_2021__negative regulation of mast cell activation (GO:0033004),0.5008306778574908,0.8593223560809392,0.6521739130434783,0.9035957287332563,1.0,1/6,1.04%,FER
prerank,GO_Biological_Process_2021__protein processing (GO:0016485),-0.4005081624788764,-0.8593159464099034,0.6911764705882353,0.9576836055318725,1.0,19/57,25.42%,SRGN;PITRM1;SPG7;XPNPEP3;TMEM208;PCSK2;PIDD1;PCSK5;STOML2;CASP4;APH1B;C1RL;LONP2;CASP2;SEC11A;AFG3L2;SPCS2;PCSK7;OGT
prerank,GO_Biological_Process_2021__regulation of DNA methylation-dependent heterochromatin assembly (GO:0090308),-0.4901999707608374,-0.8592093219248182,0.7,0.9575773804070922,1.0,5/11,22.78%,DNMT1;TET1;RESF1;SETDB1;MORC2
prerank,GO_Biological_Process_2021__cellular response to corticosteroid stimulus (GO:0071384),0.5176405394938085,0.8588601172509682,0.6666666666666666,0.9041562344937144,1.0,1/9,0.34%,ANXA1
prerank,Reactome_2022__CaMK IV-mediated Phosphorylation Of CREB R-HSA-111932,-0.5178629583727303,-0.8588154527168418,0.6774193548387096,0.9580288851681228,1.0,1/10,8.36%,CALM1
prerank,Reactome_2022__RHOJ GTPase Cycle R-HSA-9013409,-0.3890761623959957,-0.8584476481334135,0.6521739130434783,0.9584390187469921,1.0,3/46,5.44%,TFRC;MPP7;JUP
prerank,KEGG_2021_Human__B cell receptor signaling pathway,-0.40667656518394146,-0.8583881092883644,0.8,0.958218258837009,1.0,6/64,9.06%,FOS;VAV3;BTK;LILRB4;CD72;LILRB3
prerank,Reactome_2022__VEGFR2 Mediated Cell Proliferation R-HSA-5218921,-0.49240289504257156,-0.8583863788687882,0.6984126984126984,0.9579096766426176,1.0,2/15,11.19%,CALM1;VEGFA
prerank,GO_Biological_Process_2021__negative regulation of amyloid fibril formation (GO:1905907),0.4847469807183532,0.8583390666070472,0.6176470588235294,0.9047635810802502,1.0,2/10,4.68%,LDLR;PFDN4
prerank,GO_Biological_Process_2021__protein localization to plasma membrane (GO:0072659),-0.3786345979905716,-0.8580116806432061,0.704225352112676,0.9582578930297829,1.0,9/101,7.98%,FLNA;TMEM150A;TSPAN32;RAB11A;JUP;RAB3A;FGF13;RAB3D;EPB41L3
prerank,Reactome_2022__Folding Of Actin By CCT/TriC R-HSA-390450,0.5017815934550992,0.8578342632564248,0.7380952380952381,0.9053467965930897,1.0,2/9,13.21%,TCP1;CCT3
prerank,KEGG_2021_Human__Drug metabolism,-0.41815982973671717,-0.8578237812134168,0.7,0.958403693229134,1.0,13/39,22.80%,GSTM4;GSTP1;GSTK1;TYMP;GSTM3;DPYS;FMO4;GUSB;NME3;CYP3A5;FMO5;TK2;IMPDH1
prerank,Reactome_2022__APC-Cdc20 Mediated Degradation Of Nek2A R-HSA-179409,-0.4594680014356762,-0.8578176111616289,0.6885245901639344,0.9581012101480807,1.0,2/17,1.30%,UBC;RPS27A
prerank,Reactome_2022__Mitochondrial tRNA Aminoacylation R-HSA-379726,0.4146791727758814,0.8577677052295384,0.7142857142857143,0.9051403401239605,1.0,2/17,7.54%,QARS1;PPA2
prerank,KEGG_2021_Human__Oxytocin signaling pathway,0.3212499937983676,0.8577630732898736,0.75,0.9047734409183975,1.0,21/106,15.41%,PRKAB2;PLA2G4C;KCNJ2;MAP2K1;GNAQ;KCNJ5;PLCB4;ADCY9;GUCY1A1;PPP3CA;GUCY1A2;MAPK1;PRKAB1;NPR2;ADCY6;JUN;CACNG8;CACNG2;CACNB4;GUCY1B1;NFATC3
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Kidney,0.3352211380566922,0.8576899011904607,0.6176470588235294,0.9045248868570211,1.0,12/73,10.17%,PDZRN4;RASGEF1B;PPM1L;KHDRBS2;TSPOAP1;ST6GALNAC3;DACH1;RFX3;ELMO1;AUTS2;SORCS3;ASXL3
prerank,Reactome_2022__Transcriptional Regulation By MECP2 R-HSA-8986944,-0.393781131125738,-0.8576724006684814,0.7241379310344828,0.9580624782248658,1.0,4/50,8.36%,SLC2A3;RNMT;SGK1;CALM1
prerank,GO_Biological_Process_2021__amino acid import (GO:0043090),-0.4933921434904991,-0.8576414593044358,0.68,0.9578012863432956,1.0,1/12,1.42%,SLC7A5
prerank,PanglaoDB_Augmented_2021__Vascular Smooth Muscle Cells,-0.4242993802449882,-0.8575374473308497,0.631578947368421,0.9576865882411534,1.0,2/37,0.65%,MYLK;COL5A1
prerank,GO_Biological_Process_2021__positive regulation of protein autophosphorylation (GO:0031954),0.40246073898217705,0.8573571491124581,0.5675675675675675,0.9048193341680034,1.0,3/17,6.42%,PDGFA;NEK10;PDGFC
prerank,GO_Biological_Process_2021__lipid homeostasis (GO:0055088),0.37134497752819406,0.857158398296055,0.6923076923076923,0.9047927129842236,1.0,7/33,10.80%,ABCA2;SIRT1;RCN3;PPARG;ABHD8;ACOX3;FBXW7
prerank,GO_Biological_Process_2021__response to alcohol (GO:0097305),-0.4741542229719159,-0.856973988221156,0.6507936507936508,0.9584320722633941,1.0,2/18,1.03%,CCL3;TGFBR3
prerank,GO_Biological_Process_2021__eye development (GO:0001654),-0.44562760581487454,-0.8567259232373614,0.7384615384615385,0.9586214011439711,1.0,1/26,0.65%,COL5A1
prerank,GO_Biological_Process_2021__neurotransmitter uptake (GO:0001504),-0.57982278529066,-0.85650920012496,0.7115384615384616,0.9587316690074476,1.0,2/6,5.41%,SLC38A1;GLUL
prerank,GO_Biological_Process_2021__regulation of glucose import (GO:0046324),-0.4161893586427245,-0.8560812419570457,0.6470588235294118,0.9592013565784997,1.0,5/24,14.20%,PID1;IGF1;SELENOS;APPL1;PEA15
prerank,GO_Biological_Process_2021__positive regulation of exocytosis (GO:0045921),-0.421149914003738,-0.856067926094408,0.7413793103448276,0.9589198512115766,1.0,4/30,10.61%,RAB3A;RAB3D;SNF8;CFTR
prerank,GO_Biological_Process_2021__steroid catabolic process (GO:0006706),-0.5295551079500487,-0.8560647461137696,0.6440677966101694,0.9586093201716764,1.0,1/6,19.59%,CYP19A1
prerank,CellMarker_Augmented_2021__Germ cell:Undefined,-0.5536245435596483,-0.8558855963591832,0.6545454545454545,0.958602654999857,1.0,2/7,12.88%,TDRKH;PRDM1
prerank,GO_Biological_Process_2021__response to lipopolysaccharide (GO:0032496),0.3245254408626895,0.8557931792392092,0.7857142857142857,0.9071477842305067,1.0,11/84,10.79%,CD180;FER;SERPINE1;SIRPA;WNT5A;GIT1;IRAK1;TAB2;LGALS9;GCH1;IRAK3
prerank,Reactome_2022__Golgi-to-ER Retrograde Transport R-HSA-8856688,0.33353069284241693,0.8556405728868124,0.7096774193548387,0.9070778142061225,1.0,16/86,19.49%,KIFC2;TMED3;RAB1B;COPG1;CENPE;RAB6A;KIF15;KIF6;GALNT1;DYNC1H1;GALNT2;COPB1;KIF13B;COPZ1;DYNLL2;CAPZA2
prerank,Reactome_2022__CLEC7A (Dectin-1) Signaling R-HSA-5607764,-0.37374495362373955,-0.8554919011344373,0.7368421052631579,0.9590542628590618,1.0,10/86,12.85%,UBC;RPS27A;PSMB3;PSMB6;PSMA7;CALM1;PSMB9;PSMD12;PSMD8;PSMA5
prerank,GO_Biological_Process_2021__epithelial cell migration (GO:0010631),-0.4411528447253449,-0.8553991104881038,0.7090909090909091,0.9589219855699481,1.0,3/22,9.56%,PLEKHG5;KANK2;STAT1
prerank,GO_Biological_Process_2021__nucleic acid metabolic process (GO:0090304),0.34992572448391646,0.8553338989853446,0.8,0.907333054011171,1.0,11/57,20.03%,POLR2D;WDR74;MMS19;HNRNPC;LSM1;ENPP1;POLR2H;RBFOX2;HNRNPU;HNRNPD;WTAP
prerank,GO_Biological_Process_2021__positive regulation of receptor internalization (GO:0002092),-0.4883295205246201,-0.8553265272520962,0.6792452830188679,0.9587752087368937,1.0,3/12,14.27%,CD63;VEGFA;PICK1
prerank,GO_Biological_Process_2021__mucosal immune response (GO:0002385),0.5788987338546168,0.8551602304145148,0.7619047619047619,0.9073761167301222,1.0,1/5,0.25%,IFNLR1
prerank,GO_Biological_Process_2021__negative regulation of protein ubiquitination (GO:0031397),-0.39240900179514865,-0.8548375691338237,0.7014925373134329,0.9593837909842889,1.0,9/40,14.43%,UBXN1;PER2;RPS3;DTX3L;TNFAIP3;U2AF2;VPS28;HSPA1B;HSPA1A
prerank,GO_Biological_Process_2021__positive regulation of brown fat cell differentiation (GO:0090336),0.5060176344410323,0.8547807369622165,0.6190476190476191,0.9077864121638127,1.0,2/7,5.93%,PIM1;NAPEPLD
prerank,GO_Biological_Process_2021__mRNA transcription (GO:0009299),0.481520199681786,0.8545095562585909,0.6388888888888888,0.9079563367144465,1.0,1/10,1.16%,ZBTB1
prerank,CellMarker_Augmented_2021__Goblet cell:Large Intestine,-0.47987767413037075,-0.8544073763486925,0.6862745098039216,0.9598141565779341,1.0,2/15,7.77%,SLC37A1;HLA-F
prerank,GO_Biological_Process_2021__negative regulation of interferon-beta production (GO:0032688),-0.5344146398587043,-0.8543781316273089,0.7192982456140351,0.9595652369818385,1.0,1/8,2.57%,NLRC3
prerank,CellMarker_Augmented_2021__8-Cell Stage Cell (Blastomere):Embryo,-0.46650060238461344,-0.8543724461680001,0.6101694915254238,0.9592669528986902,1.0,2/10,16.93%,C19ORF53;FAM32A
prerank,GO_Biological_Process_2021__mitochondrion-endoplasmic reticulum membrane tethering (GO:1990456),-0.5612713426796991,-0.8543533987800711,0.6538461538461539,0.9589950722473031,1.0,1/6,8.36%,CALM1
prerank,GO_Biological_Process_2021__protein hydroxylation (GO:0018126),-0.49374271839747513,-0.8543203035095542,0.7037037037037037,0.9587641263169436,1.0,2/10,16.10%,EGLN3;VIPAS39
prerank,GO_Biological_Process_2021__histone H3 deacetylation (GO:0070932),0.4776780890060489,0.8538833646274748,0.6341463414634146,0.9088835897847501,1.0,4/14,9.84%,SIRT1;HDAC9;SIRT6;HDAC1
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Germ,-0.5792297322305873,-0.8538702621139218,0.711864406779661,0.9590009598139227,1.0,2/5,12.82%,CD44;PTPRC
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Meniscus,-0.5792297322305873,-0.8538702621139218,0.711864406779661,0.9590009598139227,1.0,2/5,12.82%,CD44;PTPRC
prerank,GO_Biological_Process_2021__nucleoside phosphate catabolic process (GO:1901292),-0.5436380500825444,-0.8538220873748563,0.7017543859649122,0.9588051380683065,1.0,3/8,11.98%,ENPP3;ENTPD4;ENTPD5
prerank,GO_Biological_Process_2021__negative regulation of actin nucleation (GO:0051126),-0.5645239672028228,-0.8537880041356009,0.7090909090909091,0.9585716435528444,1.0,2/6,14.27%,CORO1B;PICK1
prerank,GO_Biological_Process_2021__regulation of intracellular pH (GO:0051453),0.39770428618621534,0.853542506853199,0.6052631578947368,0.9091705058570626,1.0,10/23,18.72%,SLC9C2;LRRK2;SLC4A4;SLC9A1;CA2;SLC9A9;SLC26A3;SLC9A7;TMEM165;CHP1
prerank,GO_Biological_Process_2021__protein autophosphorylation (GO:0046777),-0.34668885630570473,-0.8532895381788634,0.7380952380952381,0.9592771572617045,1.0,9/125,8.41%,ITK;EPHB1;TXK;MAK;MUSK;EIF2AK2;STK39;MAP3K12;PRKD2
prerank,GO_Biological_Process_2021__regulation of striated muscle contraction (GO:0006942),-0.48099304120180275,-0.8531218281529386,0.6507936507936508,0.9592674034016117,1.0,3/14,8.36%,SRI;MYBPC3;CALM1
prerank,GO_Biological_Process_2021__positive regulation of neuron projection arborization (GO:0150012),0.5395099234252947,0.8530348251385889,0.6486486486486487,0.9098097624780559,1.0,3/7,14.98%,WNT5A;DVL3;MAP3K13
prerank,GO_Biological_Process_2021__positive regulation of stem cell proliferation (GO:2000648),0.4860963755676746,0.8529791455079707,0.7368421052631579,0.9095509821932042,1.0,3/9,19.56%,LTBP3;FERMT2;HNRNPU
prerank,GO_Biological_Process_2021__ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),-0.43802537109198386,-0.8528844406704991,0.625,0.9594145154570446,1.0,5/20,16.16%,RNF126;SNF8;VPS28;VPS37B;MVB12A
prerank,GO_Biological_Process_2021__dephosphorylation of RNA polymerase II C-terminal domain (GO:0070940),-0.5706025456856395,-0.8528816730105155,0.7258064516129032,0.9591056247566399,1.0,1/5,4.48%,CTDP1
prerank,GO_Biological_Process_2021__myelination (GO:0042552),0.35767007849231364,0.8527431581234323,0.7666666666666667,0.9097198530587182,1.0,8/31,15.71%,LGI4;MYRF;TPPP;SCN8A;NF1;NFASC;CNTNAP1;PARD3
prerank,KEGG_2021_Human__Shigellosis,-0.3509557595264422,-0.8525819999819041,0.7560975609756098,0.9593426852672009,1.0,26/189,14.85%,UBC;CYCS;RPS27A;CCL5;PRKCQ;GABARAPL1;NAIP;CD14;H3-3B;ACTG1;HK2;CD44;GABARAPL2;GLMN;MYL12A;ACTB;RBX1;STING1;ARPC5L;PFN1;PIK3CB;CYTH1;TLN1;CBX3;UBA52;C3
prerank,GO_Biological_Process_2021__very long-chain fatty acid metabolic process (GO:0000038),0.4289856767418523,0.8525245281233459,0.6,0.9097148625513295,1.0,2/16,8.59%,HACD2;ELOVL6
prerank,GO_Biological_Process_2021__negative regulation of DNA biosynthetic process (GO:2000279),0.4029788771066313,0.8524081447852909,0.8125,0.9096066215427995,1.0,4/19,11.89%,DACH1;GNL3L;ERCC4;HNRNPC
prerank,GO_Biological_Process_2021__negative regulation of phosphoprotein phosphatase activity (GO:0032515),-0.4672613573719517,-0.8522785470438993,0.6811594202898551,0.95957088721673,1.0,1/17,1.16%,PPP1R15A
prerank,GO_Biological_Process_2021__positive regulation of histone exchange (GO:1900051),-0.5501247166415275,-0.8520633078777436,0.7,0.959307616654024,1.0,1/7,12.59%,TERF2IP
prerank,GO_Biological_Process_2021__regulation of histone exchange (GO:1900049),-0.5501247166415275,-0.8520633078777436,0.7,0.959307616654024,1.0,1/7,12.59%,TERF2IP
prerank,GO_Biological_Process_2021__receptor signaling pathway via JAK-STAT (GO:0007259),-0.4578881813793158,-0.8517496139039588,0.6290322580645161,0.959547206639014,1.0,1/20,0.41%,STAT4
prerank,Reactome_2022__Interleukin-27 Signaling R-HSA-9020956,-0.5250070566830585,-0.8515919250893812,0.6538461538461539,0.9595750686391576,1.0,1/9,9.56%,STAT1
prerank,GO_Biological_Process_2021__negative regulation of peptidase activity (GO:0010466),-0.424989954265591,-0.8513443682562452,0.6271186440677966,0.9597477798909664,1.0,8/25,19.40%,GAPDH;UBXN1;SPOCK2;SERPING1;TIMP2;AGT;SERPINF1;SPOCK1
prerank,GO_Biological_Process_2021__positive regulation of receptor catabolic process (GO:2000646),0.5438604541878592,0.8512948241433985,0.6122448979591837,0.911375066831001,1.0,2/6,10.29%,ABCA2;LAPTM5
prerank,Reactome_2022__Serotonin Neurotransmitter Release Cycle R-HSA-181429,-0.47854908755571524,-0.8512550671208625,0.6842105263157895,0.9595901891788018,1.0,2/16,6.19%,RIMS1;RAB3A
prerank,GO_Biological_Process_2021__cholesterol biosynthetic process (GO:0006695),-0.44348312718577626,-0.8512333696878954,0.7377049180327869,0.9593284622680601,1.0,1/20,0.72%,INSIG1
prerank,CellMarker_Augmented_2021__Endometrial Stem cell:Endometrium,-0.4940202642479394,-0.8509189924855934,0.6875,0.9595937120940193,1.0,4/12,12.82%,PECAM1;ITGA4;CD44;PTPRC
prerank,Reactome_2022__Smooth Muscle Contraction R-HSA-445355,0.38668280921248155,0.8508302860522968,0.7096774193548387,0.9119509278987671,1.0,7/31,10.52%,ANXA1;TPM2;ACTA2;GUCY1A1;VCL;MYL11;GUCY1A2
prerank,GO_Biological_Process_2021__calcium-mediated signaling using intracellular calcium source (GO:0035584),-0.4881934980448303,-0.8507671692869386,0.6949152542372882,0.9595491738575017,1.0,4/11,24.26%,FIS1;PTPRC;TRPM2;BCAP31
prerank,Reactome_2022__Glutathione Conjugation R-HSA-156590,-0.4652148106896371,-0.8507546001100607,0.696969696969697,0.959279033832388,1.0,5/17,8.97%,GSTM4;GSTP1;GSTK1;GCLM;GSTM3
prerank,Reactome_2022__Regulation Of Cytoskeletal Remodeling And Cell Spreading By IPP Complex Components R-HSA-446388,0.5675366113649047,0.8507109090574523,0.75,0.9118184794301366,1.0,3/5,27.45%,RSU1;ARHGEF6;LIMS1
prerank,GO_Biological_Process_2021__protein transport (GO:0015031),-0.3370228740376814,-0.8506024433973919,0.8,0.9592953522042053,1.0,37/272,16.10%,CD36;USP6;TFRC;ARL5C;SNX6;BBS2;ARL4C;CLU;ATP6V1F;IL10RA;RAB3A;VPS35;EIF2D;NAPA;ARL17A;RAB3D;GOLGA4;NPM1;ADPRH;TRIM23;IFT27;STX19;TBC1D8;DENND10;AP4M1;VLDLR;PICK1;TMEM167A;STX10;TBC1D2B;SNX9;SCAMP3;VPS26A;CD74;SLU7;SEC13;VIPAS39
prerank,"GO_Biological_Process_2021__transcription, DNA-templated (GO:0006351)",-0.3424282497878438,-0.8504377167044344,0.7654320987654321,0.9592972059025654,1.0,10/168,7.21%,CEBPD;GTF3C6;BTF3;TCEA2;GTF2H5;CTDP1;ELOB;PTMA;POLR2G;RNMT
prerank,GO_Biological_Process_2021__B cell homeostasis (GO:0001782),-0.5096408050410611,-0.8504297214511448,0.6862745098039216,0.9590013970302975,1.0,5/9,23.82%,TNFAIP3;NCKAP1L;LYN;CAMLG;PPP2R3C
prerank,GO_Biological_Process_2021__cellular response to glucocorticoid stimulus (GO:0071385),0.48857675875446394,0.8501596191600042,0.76,0.9124967875588651,1.0,1/11,0.34%,ANXA1
prerank,CellMarker_Augmented_2021__Mesenchymal cell:Ovary,0.46240737011812405,0.8500927630937288,0.6808510638297872,0.9122845989236015,1.0,2/12,4.48%,ACTA2;WNT5A
prerank,GO_Biological_Process_2021__positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),0.48753988003680704,0.8500875437356725,0.6470588235294118,0.9115658807887603,1.0,3/8,8.90%,CIB1;TNF;SLC9A1
prerank,GO_Biological_Process_2021__positive regulation of calcineurin-mediated signaling (GO:0106058),0.48753988003680704,0.8500875437356725,0.6470588235294118,0.9115658807887603,1.0,3/8,8.90%,CIB1;TNF;SLC9A1
prerank,Reactome_2022__Interleukin-1 Family Signaling R-HSA-446652,-0.35843523926581966,-0.8500432734950888,0.7654320987654321,0.9594193583544569,1.0,14/120,12.85%,UBC;SIGIRR;RPS27A;PSMB3;NLRC5;PSMB6;PSMA7;PSMB9;RBX1;ALPK1;PSMD12;IL18R1;PSMD8;PSMA5
prerank,GO_Biological_Process_2021__regulation of inflammatory response (GO:0050727),-0.3693751562360777,-0.8499403374168061,0.7261904761904762,0.9593114240717044,1.0,16/113,9.83%,CCL3;CCL5;MGLL;SNX6;NLRC3;CD200R1;RORA;ETS1;VPS35;NLRP12;TNFRSF1B;TNFAIP3;ENPP3;TMSB4X;METRNL;SELENOS
prerank,Reactome_2022__GAG Synthesis Requires Tetrasaccharide Linker Sequence R-HSA-1971475,0.42542761471879503,0.849854130622355,0.5789473684210527,0.9117145516020698,1.0,3/16,6.07%,NCAN;CSPG5;B4GALT7
prerank,Reactome_2022__RUNX2 Regulates Genes Involved In Cell Migration R-HSA-8941332,0.5248593936374644,0.8498222703983174,0.7073170731707317,0.9113907829723253,1.0,3/6,20.41%,AKT2;CBFB;AKT3
prerank,GO_Biological_Process_2021__peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity (GO:1990264),-0.5460922270234123,-0.8496088446266322,0.6885245901639344,0.959500934425347,1.0,1/6,10.98%,PTPRB
prerank,Reactome_2022__mRNA 3-End Processing R-HSA-72187,-0.38450763040698094,-0.849522385411559,0.7887323943661971,0.9593901568989484,1.0,10/45,15.85%,DHX38;CSTF2T;EIF4A3;CHTOP;U2AF2;NCBP2;SRSF2;SRSF7;COLEC12;SLU7
prerank,GO_Biological_Process_2021__negative regulation of protein kinase B signaling (GO:0051898),0.4041702810071399,0.8495017687661509,0.675,0.9115861503613133,1.0,6/25,6.06%,SIRT1;TSC2;DAG1;PHLPP1;DDIT3;CIB1
prerank,CellMarker_Augmented_2021__Epithelial cell:Bone,-0.4045294511371416,-0.8494898336633293,0.75,0.9588515335658199,1.0,6/57,4.70%,SRGN;TPP1;MGLL;CTSB;CD93;SAMD9L
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Whartons Jelly,-0.4045294511371416,-0.8494898336633293,0.75,0.9588515335658199,1.0,6/57,4.70%,SRGN;TPP1;MGLL;CTSB;CD93;SAMD9L
prerank,GO_Biological_Process_2021__protein localization to lysosome (GO:0061462),0.40777328545570063,0.8493435550299508,0.7209302325581395,0.9116037989847483,1.0,8/24,18.25%,SCARB2;RAB7A;LAPTM5;NCOA4;SORL1;RTN4;ATP13A2;NEDD4
prerank,Reactome_2022__Phase I - Functionalization Of Compounds R-HSA-211945,-0.42050343132647555,-0.8491891098049154,0.6875,0.9591389858732048,1.0,9/34,21.68%,BPHL;AURKAIP1;EPHX1;FMO4;CBR3;ALDH2;CYP3A5;CYP19A1;ACSS1
prerank,GO_Biological_Process_2021__protein localization to cell-cell junction (GO:0150105),-0.5092429261365514,-0.8491331698712361,0.6730769230769231,0.9589102820042756,1.0,4/11,10.71%,MPP7;CGNL1;ACTG1;ACTB
prerank,GO_Biological_Process_2021__production of small RNA involved in gene silencing by RNA (GO:0070918),0.44006175264607084,0.8490753320460322,0.6666666666666666,0.9118503033424272,1.0,8/15,30.25%,DROSHA;AGO1;MRPL44;HENMT1;SNIP1;ZC3H7A;PUM1;TSN
prerank,GO_Biological_Process_2021__lymphocyte differentiation (GO:0030098),0.3689562727326978,0.8490040259865665,0.75,0.9116297159218683,1.0,6/44,9.31%,LEPR;KLF6;HDAC9;PBX1;SOX4;IKZF1
prerank,Reactome_2022__Transport Of Mature mRNA Derived From An Intron-Containing Transcript R-HSA-159236,0.3325789966177409,0.8489680263311677,0.6666666666666666,0.9113299649462356,1.0,6/60,7.20%,NXF1;U2AF1;FYTTD1;NUP153;NUP188;NUP42
prerank,GO_Biological_Process_2021__vesicle cytoskeletal trafficking (GO:0099518),-0.4250267821158533,-0.8486448198096667,0.6825396825396826,0.9594972189606601,1.0,1/28,0.94%,MYO1G
prerank,GO_Biological_Process_2021__negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315),0.5229981055587486,0.8485785836697857,0.7111111111111111,0.9112674665108107,1.0,1/6,1.00%,PKD2
prerank,GO_Biological_Process_2021__negative regulation of release of sequestered calcium ion into cytosol (GO:0051280),0.5229981055587486,0.8485785836697857,0.7111111111111111,0.9112674665108107,1.0,1/6,1.00%,PKD2
prerank,Reactome_2022__Cargo Trafficking To Periciliary Membrane R-HSA-5620920,0.3378230121953086,0.8476629207022023,0.6857142857142857,0.9125671051278322,1.0,4/38,6.90%,BBS9;EXOC8;PKD1;TCP1
prerank,GO_Biological_Process_2021__lytic vacuole organization (GO:0080171),-0.4418481784785363,-0.8474123237173559,0.6721311475409836,0.961501078669939,1.0,4/24,17.49%,TPP1;HPS4;ZKSCAN3;HOOK2
prerank,Reactome_2022__Metabolism Of Fat-Soluble Vitamins R-HSA-6806667,0.43551446368235325,0.8473529307731138,0.6410256410256411,0.9127800156841627,1.0,2/21,3.01%,UBIAD1;LDLR
prerank,GO_Biological_Process_2021__cellular response to radiation (GO:0071478),0.3949444067372102,0.8472400669831907,0.5882352941176471,0.9125502701703928,1.0,7/23,19.46%,SIRT1;LIG4;CLOCK;INTS7;BLM;OPN3;EEF1D
prerank,GO_Biological_Process_2021__regulation of defense response to virus by host (GO:0050691),0.38585180369263467,0.8471517660091679,0.6511627906976745,0.9123719229701275,1.0,2/24,4.27%,IFNLR1;TOMM70
prerank,CellMarker_Augmented_2021__Ectoderm cell:Germ,0.3175996929731113,0.8470929698854647,0.8823529411764706,0.9121145997804614,1.0,18/72,19.06%,ABCA2;AATK;GABBR1;TSPOAP1;TMOD2;SORCS3;OLIG1;NRXN2;MVB12B;CACNA1E;LRRC4B;PNMA3;TMEM132C;PDZD4;PREX1;TNRC6C;TTYH1;TMEM132D
prerank,GO_Biological_Process_2021__natural killer cell differentiation (GO:0001779),0.47778501755922087,0.846885371428504,0.6511627906976745,0.9121319599470992,1.0,1/8,4.87%,PBX1
prerank,GO_Biological_Process_2021__protein targeting to membrane (GO:0006612),-0.371673245474081,-0.8468311395894109,0.684931506849315,0.9621213708230303,1.0,9/60,13.39%,SRP14;AQP11;FIS1;NACA;ACBD5;ZDHHC4;ZDHHC19;VPS37B;SEC62
prerank,Reactome_2022__Ovarian Tumor Domain Proteases R-HSA-5689896,-0.40772744917846493,-0.8464718218772267,0.71875,0.962462018805516,1.0,2/33,1.30%,UBC;RPS27A
prerank,GO_Biological_Process_2021__connective tissue development (GO:0061448),-0.4330687982419811,-0.8464298017791554,0.6461538461538462,0.9622441312103478,1.0,5/20,9.28%,DDRGK1;SULF2;NAMPT;CD44;CHI3L1
prerank,Reactome_2022__NOTCH1 Intracellular Domain Regulates Transcription R-HSA-2122947,-0.40390335815629297,-0.8463852515633389,0.7142857142857143,0.961988981477903,1.0,2/41,1.30%,UBC;RPS27A
prerank,GO_Biological_Process_2021__snRNA transcription (GO:0009301),0.3273665936259255,0.8463109364114717,0.7692307692307693,0.9129445095307228,1.0,4/62,6.76%,POLR2D;INTS6;POU2F1;CDK7
prerank,GO_Biological_Process_2021__cellular response to virus (GO:0098586),-0.4471102362440753,-0.8462786913105976,0.6666666666666666,0.9618691708580961,1.0,4/22,11.34%,CCL5;OAS1;EIF5A;HIF1A
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Undefined,-0.40056097813528546,-0.8459379182355612,0.7230769230769231,0.9621864634618523,1.0,8/43,10.55%,TFRC;CD55;CD14;CD63;PECAM1;ITGA6;CD44;ITGB2
prerank,Reactome_2022__Inwardly Rectifying K+ Channels R-HSA-1296065,0.4136089486190634,0.8459116783580527,0.675,0.9133798859050615,1.0,2/14,5.43%,KCNJ2;KCNJ5
prerank,GO_Biological_Process_2021__synaptic vesicle cycle (GO:0099504),-0.48346985711471413,-0.8457655596778852,0.6825396825396826,0.9622190020677799,1.0,2/16,6.19%,RIMS1;RAB3A
prerank,Reactome_2022__Miro GTPase Cycle R-HSA-9715370,0.49275833100644,0.8457356368574616,0.6956521739130435,0.9133549013775591,1.0,4/8,25.09%,MFN1;TRAK2;RAP1GDS1;TRAK1
prerank,Reactome_2022__Platelet Calcium Homeostasis R-HSA-418360,-0.4823046273743631,-0.8456525511202816,0.71875,0.9621193460875048,1.0,2/16,8.36%,SRI;CALM1
prerank,Reactome_2022__Negative Regulation Of Activity Of TFAP2 (AP-2) Family Transcription Factors R-HSA-8866904,-0.5841929101702289,-0.8454997534467587,0.7291666666666666,0.9620944367515182,1.0,1/5,23.28%,SUMO1
prerank,GO_Biological_Process_2021__sodium ion export across plasma membrane (GO:0036376),0.46251658540099466,0.8454783300566804,0.631578947368421,0.9134228317894783,1.0,2/7,8.90%,SLC4A4;SLC9A1
prerank,GO_Biological_Process_2021__reticulophagy (GO:0061709),-0.45956578478236526,-0.8451138135125112,0.7192982456140351,0.9624715553884975,1.0,3/13,11.42%,DDRGK1;ATG2A;STING1
prerank,GO_Biological_Process_2021__positive regulation of catalytic activity (GO:0043085),-0.4019077224780187,-0.8450724635571705,0.6619718309859155,0.9622398665265361,1.0,12/28,26.23%,CHTOP;AZIN2;SOD1;NOD2;MT3;WRN;MSH6;MAPK3;STX4;YWHAB;SSBP1;MSH3
prerank,GO_Biological_Process_2021__endothelial cell development (GO:0001885),-0.43545760128488276,-0.8449491977924025,0.6440677966101694,0.9621632882397294,1.0,3/17,8.97%,COL18A1;PECAM1;GSTM3
prerank,GO_Biological_Process_2021__cellular potassium ion homeostasis (GO:0030007),0.4828201903246004,0.8447587251418491,0.6862745098039216,0.9144796459176435,1.0,1/8,2.68%,KCNJ2
prerank,GO_Biological_Process_2021__alpha-beta T cell activation (GO:0046631),0.49043771597629116,0.8446748141194695,0.6923076923076923,0.914268611197255,1.0,1/6,0.34%,ANXA1
prerank,GO_Biological_Process_2021__filopodium assembly (GO:0046847),0.4818587906780648,0.8446117120828236,0.6458333333333334,0.9140484660899423,1.0,3/9,14.68%,FGD4;DNM3;SRGAP2
prerank,GO_Biological_Process_2021__positive regulation of excitatory postsynaptic potential (GO:2000463),-0.45647640572104753,-0.8444080439269541,0.6984126984126984,0.962864196716728,1.0,2/14,7.64%,RIMS1;NLGN2
prerank,Reactome_2022__Sensory Perception R-HSA-9709957,-0.3534867118603722,-0.8442735218833086,0.7142857142857143,0.9628333544199379,1.0,14/99,11.54%,RIPOR2;PRKCQ;SLC26A5;SCN9A;GNB5;CDH23;RAB3A;MYO3B;EPB41L3;CALM1;GPC3;PLB1;TRPM4;SDC3
prerank,GO_Biological_Process_2021__regulation of cell development (GO:0060284),-0.4455195262377527,-0.844223018163376,0.6811594202898551,0.962656317212554,1.0,4/21,13.87%,PER2;BHLHE40;PRUNE1;NOTCH2
prerank,Reactome_2022__Abortive Elongation Of HIV-1 Transcript In Absence Of Tat R-HSA-167242,0.38798910105280404,0.8439836017122273,0.7073170731707317,0.914964648901906,1.0,1/19,0.68%,POLR2D
prerank,KEGG_2021_Human__Cell cycle,0.3227492111877756,0.8436169670966084,0.90625,0.9152125889190854,1.0,16/77,15.67%,E2F3;SMAD2;SMAD3;CDK7;FZR1;YWHAG;CDC14B;CDC23;MDM2;HDAC1;CDK6;STAG1;ANAPC1;CDC14A;CCND3;GSK3B
prerank,GO_Biological_Process_2021__establishment of protein localization to extracellular region (GO:0035592),0.39260086017533574,0.843548037881296,0.7105263157894737,0.9150108657522857,1.0,4/30,7.65%,RCN3;RAB10;SEL1L;COPG1
prerank,GO_Biological_Process_2021__positive regulation of TORC1 signaling (GO:1904263),0.4269579651149456,0.843528769651934,0.6153846153846154,0.9146657162519036,1.0,2/15,5.75%,RRAGD;GPR137C
prerank,GO_Biological_Process_2021__muscle organ development (GO:0007517),-0.4298735877082998,-0.8433663321421804,0.7575757575757576,0.9638808862336334,1.0,4/26,8.85%,EMD;IGF1;SRI;SGCE
prerank,Reactome_2022__Metabolism Of Steroids R-HSA-8957322,-0.3612449322754767,-0.8433608446319389,0.8142857142857143,0.9635832932858673,1.0,4/94,4.96%,INSIG1;CH25H;SLC51A;ABCC3
prerank,GO_Biological_Process_2021__snRNA transcription by RNA polymerase II (GO:0042795),0.3281745750259218,0.8433434315871751,0.8148148148148148,0.9146495701796241,1.0,4/61,6.76%,POLR2D;INTS6;POU2F1;CDK7
prerank,GO_Biological_Process_2021__ceramide transport (GO:0035627),-0.49913843337277874,-0.8431398936639691,0.7321428571428571,0.9637097939111143,1.0,3/10,10.11%,PLTP;ABCB1;ABCB4
prerank,GO_Biological_Process_2021__modulation by host of viral genome replication (GO:0044827),-0.5158502046930421,-0.8430963517757862,0.71875,0.9634840269952324,1.0,6/10,34.05%,TBC1D20;NUCKS1;YTHDC2;CCNK;PPIB;FBXL2
prerank,GO_Biological_Process_2021__negative regulation of developmental growth (GO:0048640),-0.43609423327794117,-0.8429893746540501,0.7166666666666667,0.9633185138211764,1.0,3/22,6.76%,NKD1;BBS2;FGF13
prerank,GO_Biological_Process_2021__positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725),-0.593599523049877,-0.8429242278370896,0.7777777777777778,0.963130213716676,1.0,4/5,34.84%,IL18;CARD9;IL1B;RASGRP1
prerank,GO_Biological_Process_2021__induction of positive chemotaxis (GO:0050930),-0.5588087088567426,-0.8428437286053027,0.7,0.9629992447818494,1.0,1/5,11.19%,VEGFA
prerank,GO_Biological_Process_2021__positive regulation of adenylate cyclase activity (GO:0045762),0.5361857707577482,0.8425905442233849,0.717391304347826,0.9157488209859311,1.0,2/5,23.24%,NF1;ORAI1
prerank,GO_Biological_Process_2021__central nervous system neuron axonogenesis (GO:0021955),-0.5061424664471122,-0.8419609099378598,0.7230769230769231,0.9643639712327692,1.0,1/11,3.87%,EPHB1
prerank,GO_Biological_Process_2021__telomere maintenance via telomere lengthening (GO:0010833),-0.43277681901883364,-0.841934976759849,0.7213114754098361,0.9640954731675774,1.0,6/22,21.40%,TERF2IP;NHP2;NOP10;ANKRD28;RFC1;CTC1
prerank,CellMarker_Augmented_2021__Basal cell:Epithelium,0.47204365183094654,0.8419283323614496,0.6176470588235294,0.9167639254031272,1.0,1/12,1.36%,FKBP9
prerank,GO_Biological_Process_2021__early endosome to Golgi transport (GO:0034498),0.45768980176955193,0.8418387590452313,0.696969696969697,0.9166174805885983,1.0,3/11,19.96%,RBSN;RAB6A;SNX1
prerank,Reactome_2022__Signaling By PDGFRA Extracellular Domain Mutants R-HSA-9673770,-0.535874783844035,-0.8414884653025898,0.6949152542372882,0.964658784608955,1.0,2/8,13.75%,STAT1;PIK3CB
prerank,KEGG_2021_Human__Acute myeloid leukemia,-0.40887563957297407,-0.8412842106975843,0.7058823529411765,0.9647389126150878,1.0,4/51,5.44%,BCL2A1;CD14;PER2;JUP
prerank,CellMarker_Augmented_2021__Smooth Muscle cell:Adipose Tissue,-0.4303368628102848,-0.8407665290374247,0.6666666666666666,0.9653445044146035,1.0,9/37,12.34%,CD93;PECAM1;PCDH12;MS4A6A;PTPRB;SPARCL1;ABCA8;A2M;FLT1
prerank,CellMarker_Augmented_2021__Sertoli cell:Fetal Gonad,-0.32282863180395155,-0.840664510158862,0.8901098901098901,0.9651959523678996,1.0,27/303,8.99%,SAT1;RIC3;THEMIS2;PPP1R15A;ME1;CD55;SYNE2;F8;BTG2;PLEKHG1;GSTM4;EPHB1;NYNRIN;BEX1;SCN9A;CLU;GATM;JUP;SLC25A5;VPS35;MED25;HK2;SPOCK2;BEX4;ITGA6;APOBEC3G;GBP2
prerank,GO_Biological_Process_2021__regulation of non-membrane spanning protein tyrosine kinase activity (GO:1903995),-0.5553618513665819,-0.8405745329879188,0.7666666666666667,0.9650703283386648,1.0,1/5,7.36%,FYN
prerank,GO_Biological_Process_2021__regulation of apoptotic signaling pathway (GO:2001233),0.41102268683408066,0.8405653025793788,0.7297297297297297,0.9185744541029326,1.0,9/29,19.22%,DAPK2;QARS1;TNF;DEPTOR;SGMS1;TGFBR1;CX3CL1;TPD52L1;CSNK2A1
prerank,GO_Biological_Process_2021__regulation of protein localization to centrosome (GO:1904779),-0.5076576975818177,-0.8405018836394863,0.6206896551724138,0.9648877168593464,1.0,4/8,27.78%,CEP72;CEP250;UBXN2B;MARK4
prerank,Reactome_2022__RHO GTPases Activate CIT R-HSA-5625900,-0.4710404549529908,-0.8404166351354555,0.7666666666666667,0.9647708271027976,1.0,8/14,31.89%,PPP1CB;MYH10;MYH9;CDKN1B;RNASE1;MYH14;MYL6;DHDDS
prerank,GO_Biological_Process_2021__regulation of mononuclear cell migration (GO:0071675),-0.4721027838590346,-0.8403763276327751,0.7241379310344828,0.9645428010999177,1.0,2/14,2.67%,CCL5;AIF1
prerank,GO_Biological_Process_2021__T cell differentiation in thymus (GO:0033077),0.4848483530745705,0.8403745827375346,0.6792452830188679,0.9185383069480677,1.0,1/7,7.13%,LIG4
prerank,KEGG_2021_Human__Endocytosis,-0.33164829024607506,-0.840328524199854,0.8395061728395061,0.9643263217998069,1.0,25/206,14.49%,EPN1;HLA-B;ACAP1;CXCR4;TFRC;SNX6;CBLB;HLA-C;RAB11A;VPS35;IQSEC1;SNF8;HLA-F;WASHC2A;VPS28;SPG21;ARPC5L;HSPA1B;VPS37B;CLTB;PSD3;CYTH1;HLA-E;HSPA1A;IGF2R
prerank,Reactome_2022__MAPK1/MAPK3 Signaling R-HSA-5684996,-0.3466114685485926,-0.8402829808830905,0.8235294117647058,0.9640843316303759,1.0,30/181,14.82%,UBC;RPS27A;PRKCQ;RASGRF2;PAQR3;PSMB3;IL3RA;WDR83;FGF13;NEFL;PSMB6;RNMT;PSMA7;FYN;PPP1CB;CSF2RA;CALM1;PSMB9;CSF2RB;RBX1;PSMD12;PSMD8;PSMA5;PEBP1;PIK3CB;PEA15;FGF20;TLN1;RASA2;UBA52
prerank,Reactome_2022__Signaling By FGFR1 R-HSA-5654736,-0.4100251953259726,-0.8399566979430264,0.6935483870967742,0.9644151112609959,1.0,2/32,1.30%,UBC;RPS27A
prerank,GO_Biological_Process_2021__negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),0.4319971889631333,0.8399455215061636,0.6578947368421053,0.9189317533719553,1.0,2/17,10.29%,CD22;LAPTM5
prerank,GO_Biological_Process_2021__negative regulation of monooxygenase activity (GO:0032769),-0.535989919889147,-0.8398570101627524,0.6909090909090909,0.9642843155713676,1.0,1/6,5.40%,GLA
prerank,CellMarker_Augmented_2021__DCLK1+ Progenitor cell:Large Intestine,-0.4008246724438987,-0.8394345613071412,0.7272727272727273,0.9647030815505818,1.0,4/49,2.53%,SPON2;COL5A1;MX1;IFIT3
prerank,CellMarker_Augmented_2021__Myeloid Dendritic cell:Stomach,-0.5010882780592724,-0.8393189204732151,0.7258064516129032,0.963410310955984,1.0,2/10,8.15%,ADGRE1;ITGA4
prerank,CellMarker_Augmented_2021__Myeloid Dendritic cell:Lung,-0.5010882780592724,-0.8393189204732151,0.7258064516129032,0.963410310955984,1.0,2/10,8.15%,ADGRE1;ITGA4
prerank,CellMarker_Augmented_2021__Myeloid Dendritic cell:Skin,-0.5010882780592724,-0.8393189204732151,0.7258064516129032,0.963410310955984,1.0,2/10,8.15%,ADGRE1;ITGA4
prerank,CellMarker_Augmented_2021__Myeloid Dendritic cell:Blood,-0.5010882780592724,-0.8393189204732151,0.7258064516129032,0.963410310955984,1.0,2/10,8.15%,ADGRE1;ITGA4
prerank,CellMarker_Augmented_2021__Myeloid Dendritic cell:Intestine,-0.5010882780592724,-0.8393189204732151,0.7258064516129032,0.963410310955984,1.0,2/10,8.15%,ADGRE1;ITGA4
prerank,GO_Biological_Process_2021__positive regulation of stress-activated MAPK cascade (GO:0032874),0.3361625093832629,0.8392839436053129,0.78125,0.9199251172276367,1.0,17/66,20.52%,MAP3K11;ANKRD6;EDA2R;STK25;MAP3K10;SASH1;KLHDC10;MFHAS1;SH3RF1;TRAF6;MAP3K5;ZNF622;TPD52L1;TAOK2;MTURN;MAP4K2;AGER
prerank,Reactome_2022__Deadenylation-dependent mRNA Decay R-HSA-429914,0.3400763413298134,0.8389213610354085,0.6111111111111112,0.9202484729926759,1.0,7/47,14.32%,DCP1B;EXOSC6;CNOT7;CNOT2;SKIC2;LSM6;LSM1
prerank,GO_Biological_Process_2021__protein localization to cell periphery (GO:1990778),-0.3746603220921992,-0.8389034349898924,0.704225352112676,0.963888235541185,1.0,9/103,7.98%,FLNA;TMEM150A;TSPAN32;RAB11A;JUP;RAB3A;FGF13;RAB3D;EPB41L3
prerank,CellMarker_Augmented_2021__Endothelial cell:Heart,-0.40207811327491566,-0.8387755743901474,0.6883116883116883,0.9638317952507198,1.0,11/42,13.78%,SIGLEC1;APOD;CD93;F13A1;PECAM1;PCDH12;PTPRB;SPARCL1;A2M;FLT1;SERPING1
prerank,GO_Biological_Process_2021__negative regulation of cell population proliferation (GO:0008285),-0.33590713510372494,-0.8385659385447808,0.7906976744186046,0.9638719461009334,1.0,32/203,12.64%,COL18A1;FTH1;TGFBR3;RUNX3;WARS1;H2AC6;IFIT3;NLRC3;AIF1;BTG2;ATF5;B2M;PER2;APOD;EMD;ETS1;AQP11;ING5;MED25;GSTP1;EIF2AK2;TNFAIP3;KANK2;PDCD5;GLMN;IRF1;NPM1;BTG1;ING4;COPS8;HSPA1B;SST
prerank,GO_Biological_Process_2021__positive regulation of T cell activation (GO:0050870),-0.3982606298325807,-0.8384876472864001,0.7536231884057971,0.9636934704714087,1.0,4/44,2.67%,TFRC;CCL5;PRKCQ;AIF1
prerank,Reactome_2022__Caspase Activation Via Death Receptors In Presence Of Ligand R-HSA-140534,-0.44437960826245226,-0.8384768003587898,0.7,0.9634186123274237,1.0,3/13,9.94%,NDUFA2;TNFSF10;CFLAR
prerank,Reactome_2022__Interactions Of Vpr With Host Cellular Proteins R-HSA-176033,0.3565558340035595,0.8384606941407917,0.6944444444444444,0.9206961370187233,1.0,8/36,17.93%,NUP153;NUP188;NUP42;HMGA1;SGIP1;NDC1;NUP133;NUP205
prerank,GO_Biological_Process_2021__cyclic nucleotide transport (GO:0070729),0.5496589745838775,0.8384183304122332,0.7111111111111111,0.9204009684684447,1.0,3/5,35.29%,LRRC8D;ABCC5;ABCC4
prerank,KEGG_2021_Human__Synaptic vesicle cycle,0.35699387524035064,0.837836357013237,0.7272727272727273,0.9212170053711871,1.0,8/50,10.31%,CACNA1A;SLC1A3;SLC1A2;UNC13B;DNM3;ATP6V1B2;STX1A;STX2
prerank,GO_Biological_Process_2021__cellular response to ionizing radiation (GO:0071479),0.361228113180528,0.8377338446363283,0.7419354838709677,0.9210785369444628,1.0,9/36,20.87%,SIRT1;LIG4;CLOCK;MDM2;INTS7;NIPBL;BLM;EEF1D;TMEM109
prerank,GO_Biological_Process_2021__ear morphogenesis (GO:0042471),0.4950432673273254,0.8374605300270187,0.6666666666666666,0.9212533994364317,1.0,3/6,21.78%,NIPBL;FGFR2;CHD7
prerank,GO_Biological_Process_2021__ERAD pathway (GO:0036503),0.3271395692028707,0.8373925543877079,0.7777777777777778,0.9210413560004722,1.0,13/76,13.82%,UBE2J1;RNF139;RCN3;DNAJB2;SEL1L;UBXN6;DNAJC18;AUP1;FAM8A1;RNF185;STT3B;BAG6;FBXO27
prerank,CellMarker_Augmented_2021__Oxyntic Stem cell:Stomach,-0.40065133384990315,-0.837293898058795,0.676923076923077,0.964761325531014,1.0,6/30,18.36%,STIL;CENPU;BRCA1;SGO2;FANCI;CENPF
prerank,CellMarker_Augmented_2021__Oxyntic Progenitor cell:Stomach,-0.40065133384990315,-0.837293898058795,0.676923076923077,0.964761325531014,1.0,6/30,18.36%,STIL;CENPU;BRCA1;SGO2;FANCI;CENPF
prerank,CellMarker_Augmented_2021__Progenitor cell:Stomach,-0.40065133384990315,-0.837293898058795,0.676923076923077,0.964761325531014,1.0,6/30,18.36%,STIL;CENPU;BRCA1;SGO2;FANCI;CENPF
prerank,GO_Biological_Process_2021__regulation of exit from mitosis (GO:0007096),-0.40601764537395985,-0.8372013718094646,0.7083333333333334,0.9645630092341411,1.0,3/26,6.40%,UBC;RPS27A;PHB2
prerank,GO_Biological_Process_2021__regulation of developmental growth (GO:0048638),-0.4314002668591129,-0.8370180922434549,0.6909090909090909,0.9646368455624347,1.0,3/23,13.37%,IGF1;MUSK;SOD1
prerank,Reactome_2022__Uptake And Function Of Diphtheria Toxin R-HSA-5336415,-0.5627640957224034,-0.8369326674310243,0.7272727272727273,0.9644896821652345,1.0,3/5,29.27%,EEF2;HSP90AA1;CD9
prerank,GO_Biological_Process_2021__negative regulation of chemotaxis (GO:0050922),-0.4224248500597303,-0.836854432455259,0.6268656716417911,0.9643539385615504,1.0,3/21,6.72%,AIF1;SEMA6A;CORO1B
prerank,KEGG_2021_Human__Bile secretion,-0.39804745896279903,-0.8367157113848815,0.6716417910447762,0.9642579135679255,1.0,7/38,12.87%,SLC51A;ABCC3;ABCB1;EPHX1;ABCB4;CFTR;ATP1B3
prerank,Reactome_2022__Diseases Of Signal Transduction By Growth Factor Receptors And Second Messengers R-HSA-5663202,0.2933689990008858,0.8365261915298221,1.0,0.9223529272555859,1.0,48/316,13.74%,DUSP6;POLR2D;PDGFA;PIGU;MAML2;MSN;TGFBR2;TGFA;MAP3K11;CASP9;SPRED1;HDAC9;RAP1A;SPRED2;MAP2K1;TSC2;SMAD2;SMAD3;SEL1L;NRG1;HHAT;JAG1;KITLG;VCL;BCL11A;MAML3;SEM1;KANK1;PPP2R1B;CTBP2;MDM2;DUSP7;HDAC1;DKK2;TBL1XR1;NRG3;FBXW7;TCF7L2;MAPK1;KAT2A;PTEN;NF1;GAB2;PIK3AP1;SHOC2;NRG2;VAV1;PPP2R5E
prerank,KEGG_2021_Human__Gap junction,-0.3655993328260246,-0.8365194147039334,0.72,0.964283641788044,1.0,2/62,2.35%,TUBB8;PDGFD
prerank,GO_Biological_Process_2021__positive regulation of erythrocyte differentiation (GO:0045648),-0.42825440148353117,-0.836382621609144,0.7580645161290323,0.9642273076197648,1.0,8/23,14.43%,ETS1;ANKRD54;STAT1;NCKAP1L;HIF1A;HSPA1B;ZNF16;HSPA1A
prerank,Reactome_2022__Cytosolic Iron-Sulfur Cluster Assembly R-HSA-2564830,0.45017944361304896,0.8363285957865151,0.6956521739130435,0.922412060969336,1.0,2/9,17.92%,MMS19;ERCC2
prerank,KEGG_2021_Human__Starch and sucrose metabolism,-0.44488417415268977,-0.8360492386206728,0.6885245901639344,0.9645075757425139,1.0,3/21,8.26%,G6PC3;HK2;ENPP3
prerank,GO_Biological_Process_2021__ventricular cardiac muscle tissue morphogenesis (GO:0055010),-0.47714186123020785,-0.8354319396967209,0.6875,0.9654407992060267,1.0,3/19,8.45%,TGFBR3;MYBPC3;RBPJ
prerank,GO_Biological_Process_2021__negative regulation of immune effector process (GO:0002698),-0.4883806446635234,-0.8352858964865075,0.7704918032786885,0.9654237266640491,1.0,5/13,13.66%,CD55;ENPP3;APPL1;CD47;HAVCR2
prerank,CellMarker_Augmented_2021__Mast Cell progenitor:Bone Marrow,-0.36759002364628063,-0.8351615190270494,0.7733333333333333,0.9644860647756784,1.0,6/65,12.52%,TFRC;STIL;ZWILCH;NPM1;XPOT;DARS2
prerank,CellMarker_Augmented_2021__Megakaryocyte Progenitor cell:Subcutaneous Adipose Tissue,-0.36759002364628063,-0.8351615190270494,0.7733333333333333,0.9644860647756784,1.0,6/65,12.52%,TFRC;STIL;ZWILCH;NPM1;XPOT;DARS2
prerank,CellMarker_Augmented_2021__Erythroblast:Blood,-0.36759002364628063,-0.8351615190270494,0.7733333333333333,0.9644860647756784,1.0,6/65,12.52%,TFRC;STIL;ZWILCH;NPM1;XPOT;DARS2
prerank,CellMarker_Augmented_2021__Circulating Fetal cell:Peripheral Blood,-0.36759002364628063,-0.8351615190270494,0.7733333333333333,0.9644860647756784,1.0,6/65,12.52%,TFRC;STIL;ZWILCH;NPM1;XPOT;DARS2
prerank,GO_Biological_Process_2021__positive regulation of immune system process (GO:0002684),0.43127421298200735,0.8351375401009069,0.6511627906976745,0.9243429112484061,1.0,1/12,0.34%,ANXA1
prerank,Reactome_2022__RHOBTB2 GTPase Cycle R-HSA-9013418,-0.44498688898406413,-0.8349984849339592,0.6885245901639344,0.96451447125728,1.0,2/21,7.76%,CDC37;ACTG1
prerank,KEGG_2021_Human__Aldosterone-regulated sodium reabsorption,-0.4694735733667359,-0.8349642565182397,0.64,0.964274844408451,1.0,5/20,16.02%,IGF1;SGK1;ATP1B3;PIK3CB;ATP1A1
prerank,GO_Biological_Process_2021__regulation of toll-like receptor 2 signaling pathway (GO:0034135),-0.508776485222714,-0.8348309293346623,0.746031746031746,0.9642271501481545,1.0,2/8,12.67%,TNFAIP3;CYBA
prerank,GO_Biological_Process_2021__positive regulation of phosphate metabolic process (GO:0045937),-0.44508883821178113,-0.8348110862478187,0.6515151515151515,0.9639595684027703,1.0,4/18,10.76%,CCL5;ITGA6;GLMN;NCKAP1L
prerank,GO_Biological_Process_2021__epithelium development (GO:0060429),-0.3825990785175213,-0.8341713008685337,0.6818181818181818,0.964816763935533,1.0,9/44,11.19%,TPP1;STIL;MTHFD1;CTSB;GSTK1;KANK2;DVL1;STAT1;VEGFA
prerank,GO_Biological_Process_2021__regulation of lymphocyte proliferation (GO:0050670),-0.49773423210584683,-0.834048420210501,0.7090909090909091,0.9647013204937075,1.0,3/7,8.06%,IKZF3;ZNF335;TNFRSF1B
prerank,GO_Biological_Process_2021__nucleic acid-templated transcription (GO:0097659),0.3965697987690161,0.8340357874253458,0.7647058823529411,0.9260239940883314,1.0,2/27,7.93%,POLR2D;MMS19
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),0.49094442380176223,0.8340079871694017,0.7058823529411765,0.9257047956707005,1.0,1/9,5.85%,DDIT3
prerank,KEGG_2021_Human__Inflammatory mediator regulation of TRP channels,0.32869876598000675,0.833651331310879,0.76,0.9259967828776752,1.0,5/60,6.41%,PLA2G4C;MAPK11;GNAQ;PLCB4;ADCY9
prerank,GO_Biological_Process_2021__cellular response to retinoic acid (GO:0071300),0.3945512979800092,0.833613843262509,0.7272727272727273,0.9256824383957195,1.0,2/19,8.25%,WNT5A;BRINP3
prerank,GO_Biological_Process_2021__regulation of autophagosome assembly (GO:2000785),0.36969002652364225,0.8334585568051844,0.8,0.9256207843932184,1.0,4/32,8.16%,LRRK2;TMEM39A;RAB1B;TBC1D12
prerank,GO_Biological_Process_2021__protein K63-linked deubiquitination (GO:0070536),0.38562869349388806,0.8334112532618518,0.7714285714285715,0.92533895190037,1.0,3/24,9.29%,STAMBPL1;OTUD7A;ZRANB1
prerank,CellMarker_Augmented_2021__Acinar cell:Pancreas,0.3211742408845322,0.8333875192666156,0.7037037037037037,0.9249931336283866,1.0,18/83,16.79%,GPR180;ZBTB33;MIER3;TRUB1;LIG4;APPBP2;ZNF800;MBLAC2;CD164;TBL1XR1;SLC25A46;MTDH;STT3B;RNF6;SLC12A2;EML5;SLC10A7;PRKAA1
prerank,GO_Biological_Process_2021__positive regulation of protein transport (GO:0051222),0.3518557967679972,0.8333512174679545,0.7692307692307693,0.924711769788469,1.0,9/53,12.17%,MYOM1;GOLPH3L;TMED10;UNC13B;TNF;CD33;CEP131;RIPOR1;ARF6
prerank,Reactome_2022__Signaling By Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) R-HSA-2404192,0.392074865577853,0.8333248779953502,0.75,0.9236858429595501,1.0,2/27,1.37%,PIGU;IGF1R
prerank,Reactome_2022__IRS-related Events Triggered By IGF1R R-HSA-2428928,0.392074865577853,0.8333248779953502,0.75,0.9236858429595501,1.0,2/27,1.37%,PIGU;IGF1R
prerank,Reactome_2022__IGF1R Signaling Cascade R-HSA-2428924,0.392074865577853,0.8333248779953502,0.75,0.9236858429595501,1.0,2/27,1.37%,PIGU;IGF1R
prerank,GO_Biological_Process_2021__regulation of peptidyl-threonine phosphorylation (GO:0010799),0.3880794685299111,0.8333240117827205,0.625,0.923327621371859,1.0,5/27,7.11%,SPRY2;SMAD7;SPRED1;SPRED2;CAB39
prerank,GO_Biological_Process_2021__regulation of supramolecular fiber organization (GO:1902903),0.3916663807324111,0.8329077369444194,0.6666666666666666,0.9236468482279955,1.0,1/18,1.80%,MAP1S
prerank,Reactome_2022__Metabolism Of Nucleotides R-HSA-15869,-0.3927623631553546,-0.8327725567326935,0.6811594202898551,0.9668365811646021,1.0,10/63,13.80%,ADPRM;NT5C;TXN2;AMPD2;DPYS;AK9;ENTPD4;DHODH;ENTPD5;NUDT16
prerank,GO_Biological_Process_2021__purine nucleobase metabolic process (GO:0006144),-0.5027771068517363,-0.8326716845134713,0.703125,0.9667431066583883,1.0,1/7,15.99%,SHMT1
prerank,GO_Biological_Process_2021__positive regulation of heart contraction (GO:0045823),-0.49959461835196906,-0.8326555492191896,0.7,0.9664582669164012,1.0,2/10,10.69%,RGS2;TRPM4
prerank,GO_Biological_Process_2021__mitotic cytokinesis (GO:0000281),-0.40198730064213484,-0.8325558499327943,0.7361111111111112,0.9663143136405352,1.0,8/34,21.61%,EFHC1;TTC19;CNTROB;STMN1;SNX9;MITD1;CKAP2;MYH10
prerank,GO_Biological_Process_2021__protein deubiquitination (GO:0016579),-0.33080509595411717,-0.8325274832775735,0.775,0.9660579183032232,1.0,25/200,14.82%,UBC;USP6;RPS27A;PSMB3;USP36;ADRM1;PSMB6;PSMA7;TNFAIP3;OTUD1;ABRAXAS1;PSMB9;JOSD1;CFTR;ACTB;HIF1A;WDR48;PSMD12;PSMD8;PSMA5;OTUD6B;MINDY1;OTUD3;BRCA1;UBA52
prerank,Reactome_2022__RAF/MAP Kinase Cascade R-HSA-5673001,-0.34869204067526416,-0.8325177753876868,0.8536585365853658,0.9657707462502579,1.0,30/177,14.82%,UBC;RPS27A;PRKCQ;RASGRF2;PAQR3;PSMB3;IL3RA;WDR83;FGF13;NEFL;PSMB6;RNMT;PSMA7;FYN;PPP1CB;CSF2RA;CALM1;PSMB9;CSF2RB;RBX1;PSMD12;PSMD8;PSMA5;PEBP1;PIK3CB;PEA15;FGF20;TLN1;RASA2;UBA52
prerank,GO_Biological_Process_2021__regulation of synapse structural plasticity (GO:0051823),0.573004294597483,0.8323328448184006,0.7441860465116279,0.9244186166600175,1.0,2/5,8.67%,CTNNA2;SHANK3
prerank,GO_Biological_Process_2021__positive regulation of NIK/NF-kappaB signaling (GO:1901224),-0.3965078535801433,-0.8320720251888792,0.7692307692307693,0.9662569274667722,1.0,8/38,15.37%,CD14;RPS3;PHB2;EIF2AK2;NLRP12;TERF2IP;NOD2;IFI35
prerank,Reactome_2022__Mitochondrial Calcium Ion Transport R-HSA-8949215,-0.4356188745981282,-0.8315258361834191,0.6896551724137931,0.9669564163283799,1.0,6/20,16.70%,PHB2;SMDT1;MICU2;SPG7;MAIP1;STOML2
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),0.4188485168910602,0.8312625505999935,0.6904761904761905,0.9257749781059414,1.0,3/15,13.66%,SIRT1;SOD2;BAG5
prerank,GO_Biological_Process_2021__cellular response to molecule of bacterial origin (GO:0071219),-0.36560462638438035,-0.8311162522320523,0.75,0.9674391154696915,1.0,7/60,9.83%,ZFP36;CARD16;CD14;GSTP1;TNFRSF1B;TNFAIP3;SELENOS
prerank,KEGG_2021_Human__Peroxisome,-0.3863700906609633,-0.8309598719756425,0.7681159420289855,0.9674299536786457,1.0,6/51,14.14%,NUDT12;GNPAT;GSTK1;ACAA1;SOD1;ECI2
prerank,CellMarker_Augmented_2021__Endothelial cell:Liver,-0.3800459807933473,-0.8308622107233942,0.7083333333333334,0.9673253241856594,1.0,9/51,14.55%,TFRC;F8;PECAM1;ARGLU1;CRBN;BNIP1;EFNB2;PTPRC;PPWD1
prerank,Reactome_2022__Ion Homeostasis R-HSA-5578775,-0.4126886009427745,-0.8304427316263516,0.7,0.9677288571227494,1.0,3/31,8.36%,PLN;SRI;CALM1
prerank,GO_Biological_Process_2021__response to molecule of bacterial origin (GO:0002237),0.3596026790129825,0.8304407496769893,0.7352941176470589,0.9269337626919081,1.0,11/38,20.08%,FER;IRAK1;TAB2;LGALS9;GCH1;IRAK3;MAPKAPK2;IRF5;ERBIN;SNCA;PELI1
prerank,Reactome_2022__Opioid Signaling R-HSA-111885,-0.36371230190290116,-0.8304392507718793,0.7763157894736842,0.9674305654524837,1.0,4/65,8.36%,PDE4A;GNB5;PRKAR1B;CALM1
prerank,CellMarker_Augmented_2021__Pluripotent Stem cell:Embryoid Body,-0.38191270215706313,-0.8302518965704098,0.7272727272727273,0.9671262116997765,1.0,11/38,17.44%,COL18A1;EPHB1;SLC5A9;SULF2;ZDHHC19;SERPING1;LRRC4;FPR1;PPP1R14A;ALDH2;VCAN
prerank,CellMarker_Augmented_2021__Osteoblast:Bone Marrow,-0.38191270215706313,-0.8302518965704098,0.7272727272727273,0.9671262116997765,1.0,11/38,17.44%,COL18A1;EPHB1;SLC5A9;SULF2;ZDHHC19;SERPING1;LRRC4;FPR1;PPP1R14A;ALDH2;VCAN
prerank,GO_Biological_Process_2021__negative regulation of NF-kappaB transcription factor activity (GO:0032088),0.37373403849321407,0.830059682419577,0.7142857142857143,0.927255643657003,1.0,3/49,5.85%,KLF4;SIRT1;DDIT3
prerank,GO_Biological_Process_2021__regulation of mRNA metabolic process (GO:1903311),-0.5050848316162622,-0.8297368155792295,0.7321428571428571,0.9676863106917325,1.0,3/11,21.90%,SRPK1;SUPT6H;CDK11B
prerank,PanglaoDB_Augmented_2021__Myocytes,-0.3708132595853906,-0.8297222010522375,0.7297297297297297,0.9674024170505392,1.0,4/42,7.37%,CXCR4;PRKCQ;IQSEC1;TTN
prerank,Reactome_2022__Constitutive Signaling By EGFRvIII R-HSA-5637810,0.4528206117121637,0.8296800249404639,0.6521739130434783,0.9275590064070819,1.0,1/11,1.00%,PIGU
prerank,GO_Biological_Process_2021__amino acid transport (GO:0006865),0.39913233182625,0.8294267915042626,0.7333333333333333,0.9276475905757702,1.0,4/27,4.23%,PDPN;SLC38A10;SLC7A8;SLC3A2
prerank,GO_Biological_Process_2021__exonucleolytic catabolism of deadenylated mRNA (GO:0043928),0.398131644557107,0.8293174930558065,0.6764705882352942,0.9274897080545561,1.0,6/24,17.25%,DCP1B;EXOSC6;CNOT7;LSM6;LSM1;EXOSC7
prerank,CellMarker_Augmented_2021__Dendritic Cell progenitor:Bone Marrow,-0.514883407691302,-0.8291150145668601,0.7586206896551724,0.9681217925393324,1.0,4/9,12.82%,SIGLEC1;IL3RA;CSF2RA;PTPRC
prerank,GO_Biological_Process_2021__macrophage activation involved in immune response (GO:0002281),-0.5061170640880546,-0.8288626077318295,0.6666666666666666,0.9683085188853228,1.0,2/10,15.37%,TYROBP;IFI35
prerank,GO_Biological_Process_2021__positive regulation of transport (GO:0051050),0.3239232681779749,0.8288489680057137,0.8064516129032258,0.9278929677998211,1.0,6/59,8.52%,ANXA1;HIP1R;SIRPA;TNF;BOK;NEDD4L
prerank,KEGG_2021_Human__Oocyte meiosis,0.33740007296321783,0.828711605694118,0.7666666666666667,0.9277533501888608,1.0,15/79,11.38%,SPDYE16;IGF1R;MAPK11;MAP2K1;ADCY9;CPEB4;PPP2R1B;YWHAG;SPDYA;PPP3CA;CDC23;BTRC;FBXW11;RPS6KA6;MAPK1
prerank,GO_Biological_Process_2021__cellular response to organic substance (GO:0071310),-0.36247591787513983,-0.8286937061341743,0.8,0.9683103164019606,1.0,7/81,4.25%,CCL3;SIGIRR;CXCR4;CCL5;PID1;RACK1;EMD
prerank,GO_Biological_Process_2021__transition metal ion homeostasis (GO:0055076),0.3965061965133865,0.8284645575019131,0.6486486486486487,0.9278371622178722,1.0,3/23,3.41%,SLC39A14;NEO1;PICALM
prerank,GO_Biological_Process_2021__hemopoiesis (GO:0030097),0.322980242471885,0.8282905925809846,0.8888888888888888,0.9278070142619345,1.0,10/60,7.17%,YJEFN3;TGFBR2;ZBTB16;WNT5A;ARMC6;SELPLG;WNT2B;JAG1;RUNX1;KITLG
prerank,KEGG_2021_Human__Mucin type O-glycan biosynthesis,0.42449637964882225,0.8282131724435381,0.6923076923076923,0.927567405963605,1.0,8/19,15.84%,GALNT13;GALNTL6;ST6GALNAC3;C1GALT1;GALNT7;GALNT1;GALNT2;GALNT17
prerank,Reactome_2022__FGFR2 Mutant Receptor Activation R-HSA-1839126,0.4006175088929928,0.8282040885936803,0.6590909090909091,0.9272232838217407,1.0,1/18,0.68%,POLR2D
prerank,"GO_Biological_Process_2021__RNA splicing, via transesterification reactions (GO:0000375)",-0.42314952710676546,-0.8276947330898947,0.71875,0.9697453677969244,1.0,8/24,20.36%,WDR83;SMNDC1;PRPF3;DDX23;SLU7;BCAS2;PRPF4;SF3A3
prerank,GO_Biological_Process_2021__regulation of hippocampal neuron apoptotic process (GO:0110089),-0.5256718243752103,-0.8276355230534668,0.75,0.9695452294389334,1.0,1/5,11.20%,TYROBP
prerank,GO_Biological_Process_2021__cellular amide metabolic process (GO:0043603),-0.3670987747433691,-0.8274930741932933,0.7058823529411765,0.9694683091789007,1.0,11/64,18.15%,VNN2;MTHFD1;NIT1;THEM4;ACOT9;ORMDL1;ABCB9;ACSM5;SHMT1;MCCC2;FOLR2
prerank,Reactome_2022__Transport Of Inorganic Cations/Anions And Amino Acids/Oligopeptides R-HSA-425393,0.31189743591189883,0.8274888695802933,0.7666666666666667,0.9279624354988245,1.0,16/58,15.38%,SLC1A3;SLC25A18;SLC7A8;AHCYL2;SLC3A2;SLC1A2;SLC15A4;SLC12A6;SLC4A4;SLC9A1;SLC9A9;SLC12A5;SLC8A1;SLC26A3;SLC12A2;SLC7A11
prerank,GO_Biological_Process_2021__positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),-0.45817423408840097,-0.8274560603459366,0.7121212121212122,0.9692516005145538,1.0,6/18,25.54%,MED12;MED30;PSMC4;MED1;PSMC3;DHX36
prerank,GO_Biological_Process_2021__negative regulation of DNA-binding transcription factor activity (GO:0043433),-0.3567021955433338,-0.827385101299487,0.7532467532467533,0.9690629847535593,1.0,10/86,8.69%,FLNA;SIGIRR;NLRC3;AIM2;BHLHE40;PHB2;NLRC5;NLRP12;TNFAIP3;TMSB4X
prerank,GO_Biological_Process_2021__transition metal ion transport (GO:0000041),-0.4416395543380901,-0.8273255974723861,0.71875,0.9688828708575135,1.0,2/23,1.44%,FTH1;TFRC
prerank,GO_Biological_Process_2021__regulation of secretion by cell (GO:1903530),-0.4166897880353637,-0.8272711243638805,0.7391304347826086,0.9687252215398136,1.0,5/41,9.33%,MCTP2;RIMS1;RAB3A;RAB3D;LLGL2
prerank,GO_Biological_Process_2021__negative regulation of bone resorption (GO:0045779),-0.5400533751175265,-0.8271455597286572,0.6875,0.968348783108858,1.0,2/6,8.75%,TNFAIP3;GPR137B
prerank,GO_Biological_Process_2021__negative regulation of bone remodeling (GO:0046851),-0.5400533751175265,-0.8271455597286572,0.6875,0.968348783108858,1.0,2/6,8.75%,TNFAIP3;GPR137B
prerank,GO_Biological_Process_2021__vasculogenesis (GO:0001570),-0.5081648340906757,-0.8270461961661477,0.7777777777777778,0.968247276042311,1.0,3/13,11.19%,TGFBR3;GLMN;VEGFA
prerank,CellMarker_Augmented_2021__Endothelial Precursor cell:Fetal Liver,-0.39388212993737337,-0.8270291717665019,0.7083333333333334,0.9679756012319287,1.0,7/40,13.78%,NYNRIN;CGNL1;COL21A1;PTN;SPARCL1;FLT1;SERPING1
prerank,Reactome_2022__Signaling By NOTCH1 R-HSA-1980143,-0.365405481173934,-0.8269209057038355,0.7878787878787878,0.9678686927853114,1.0,2/59,1.30%,UBC;RPS27A
prerank,GO_Biological_Process_2021__mesoderm formation (GO:0001707),0.4670154227972222,0.8267838194657642,0.65,0.9290057707447568,1.0,3/6,15.58%,SMAD2;ITGA2;TBX19
prerank,GO_Biological_Process_2021__regulation of cell size (GO:0008361),-0.43903339065004987,-0.8266545112177436,0.7090909090909091,0.9680379554199777,1.0,4/20,10.33%,VAV3;PLEK;LAMTOR5;LARS1
prerank,GO_Biological_Process_2021__positive regulation of phospholipase activity (GO:0010518),-0.4658521839229888,-0.826473375362606,0.7719298245614035,0.9680760737940454,1.0,1/15,1.49%,CCL5
prerank,GO_Biological_Process_2021__enzyme linked receptor protein signaling pathway (GO:0007167),0.32846912314782495,0.8263367857383994,0.625,0.929379898915758,1.0,15/76,14.52%,FER;ACVR2A;IGF1R;RYK;SHC2;PTPRG;MPZL1;MERTK;EPHA6;PTPRD;NTRK2;NPR2;PTK2;ERBB4;TYRO3
prerank,GO_Biological_Process_2021__positive regulation of transforming growth factor beta production (GO:0071636),0.4946253021013354,0.8263230385163259,0.6818181818181818,0.9290401518426583,1.0,4/7,25.56%,LGALS9;BMPR1A;CD46;SERPINF2
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Venous Blood,0.3560776788636415,0.8262523017956765,0.75,0.9288187966573893,1.0,4/46,10.53%,FAAH;RGL2;SLC44A2;CLSTN3
prerank,GO_Biological_Process_2021__regulation of wound healing (GO:0061041),0.3997267308300101,0.8262394114531586,0.7428571428571429,0.9284840746338229,1.0,5/21,7.80%,ANXA1;SERPINE1;FGF2;CRK;KANK1
prerank,Reactome_2022__Transcriptional Regulation By TP53 R-HSA-3700989,-0.3246085398216926,-0.8262012015314835,0.8148148148148148,0.9682200827926564,1.0,22/277,8.90%,UBC;CYCS;FOS;RPS27A;DDIT4;COX7C;CHD3;BTG2;PRELID1;GTF2H5;CTDP1;ELOB;ING3;HUS1;ING5;LAMTOR5;TXN2;POLR2G;SGK1;COX4I1;TMEM219;COX5B
prerank,GO_Biological_Process_2021__protein K11-linked deubiquitination (GO:0035871),0.5317765529891141,0.8261966443559556,0.7209302325581395,0.9282358697030896,1.0,2/8,4.84%,OTUD7A;USP30
prerank,GO_Biological_Process_2021__Golgi organization (GO:0007030),0.32105357023164277,0.8261952837641572,0.8695652173913043,0.9278834832123154,1.0,22/98,18.97%,GOLPH3L;LRRK2;BET1;TMED3;STK25;TMED10;TMED5;LMAN2L;VTI1A;COG1;BLZF1;BAG5;CLASP1;STX6;COG3;UBXN2A;PLEKHM2;CLASP2;ATP8B2;TRAPPC12;HACE1;TRAPPC8
prerank,GO_Biological_Process_2021__regulation of Rho protein signal transduction (GO:0035023),0.3394457009074234,0.8261192189847751,0.7241379310344828,0.9276629229236487,1.0,7/47,11.76%,NRP1;EPS8;ROBO1;KANK1;KCTD10;HEG1;CCDC125
prerank,GO_Biological_Process_2021__microtubule cytoskeleton organization involved in mitosis (GO:1902850),-0.3606039082295344,-0.8260125599032638,0.7534246575342466,0.9682609077051139,1.0,17/85,19.89%,STIL;RPS27;CENPU;EFHC1;ITGB3BP;ZWILCH;DCTN6;MIS12;DYNC1LI2;STMN1;SEC13;SGO2;DCTN2;CENPF;BUB3;DYNC1I2;RMDN1
prerank,Reactome_2022__Activated NTRK2 Signals Thru FRS2 And FRS3 R-HSA-9028731,0.4945353467504873,0.8259673063842279,0.6875,0.927569500448255,1.0,3/6,30.20%,NTRK2;FRS2;SOS1
prerank,Reactome_2022__Regulation Of FOXO Transcriptional Activity By Acetylation R-HSA-9617629,0.47238982584567263,0.8259020250031825,0.6410256410256411,0.9273492338598378,1.0,1/9,2.51%,SIRT1
prerank,GO_Biological_Process_2021__mitochondrion disassembly (GO:0061726),-0.3986075140653454,-0.8257684849736509,0.7543859649122807,0.9684354111033128,1.0,4/29,9.32%,GABARAPL1;FIS1;ATG2A;GABARAPL2
prerank,KEGG_2021_Human__Circadian rhythm,0.36694063789799397,0.8255889702590503,0.7368421052631579,0.9275867675372218,1.0,1/26,0.12%,PRKAB2
prerank,GO_Biological_Process_2021__regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),-0.38621751603252774,-0.8255812334868015,0.7638888888888888,0.968451082623324,1.0,10/58,11.19%,CYCS;CARD16;NAIP;TNFSF10;FIS1;LAMTOR5;NLRP12;CD44;PDCD5;VEGFA
prerank,Reactome_2022__Signaling By PDGFR In Disease R-HSA-9671555,-0.48911737192513965,-0.8253631610397202,0.7142857142857143,0.9685502577000081,1.0,4/14,13.75%,STAT1;GOLGA4;WDR48;PIK3CB
prerank,GO_Biological_Process_2021__constitutive secretory pathway (GO:0045054),-0.5249063736069581,-0.8249970527578199,0.7192982456140351,0.9688330439943715,1.0,2/5,14.42%,RAB3A;TMEM167A
prerank,KEGG_2021_Human__Ubiquitin mediated proteolysis,0.3167648631629279,0.8248185419879069,0.875,0.9286167299183505,1.0,24/117,15.39%,UBE2D1;UBE2J1;UBE2O;SAE1;UBE2E2;UBE2D2;FZR1;NEDD4L;CDC23;MDM2;BTRC;UBA1;UBE2L3;FBXW11;FBXW7;UBE2N;UBA2;COP1;SMURF1;XIAP;TRAF6;ANAPC1;UBE2J2;RHOBTB1
prerank,GO_Biological_Process_2021__histone lysine demethylation (GO:0070076),-0.41336676024891766,-0.8246431244719257,0.6896551724137931,0.9692102457759731,1.0,3/20,16.76%,KDM7A;KDM6B;KDM1B
prerank,GO_Biological_Process_2021__aminoglycan metabolic process (GO:0006022),-0.4954615127260046,-0.8244360547539233,0.6909090909090909,0.9692924078209844,1.0,2/6,11.82%,XYLT2;B3GAT2
prerank,GO_Biological_Process_2021__regulation of protein deubiquitination (GO:0090085),-0.5289685147244747,-0.8241185283318692,0.7115384615384616,0.9695524610881858,1.0,1/5,12.01%,WDR48
prerank,GO_Biological_Process_2021__sodium ion transport (GO:0006814),0.3606404080837675,0.8241059089007937,0.7647058823529411,0.9294421563413765,1.0,10/37,15.33%,PKD2;SCN3A;SCN3B;NEDD4L;SLC4A4;SCN8A;ANO6;SLC8A1;SLC24A2;SLC12A2
prerank,Reactome_2022__Regulation Of Signaling By CBL R-HSA-912631,-0.47013889390134367,-0.823953038550678,0.7246376811594203,0.9694927132987674,1.0,3/16,13.75%,YES1;FYN;PIK3CB
prerank,GO_Biological_Process_2021__RNA secondary structure unwinding (GO:0010501),0.48628126635207186,0.8233212479441503,0.7045454545454546,0.9304841753161079,1.0,2/7,22.24%,DDX3X;AGO1
prerank,GO_Biological_Process_2021__cardiac muscle tissue development (GO:0048738),0.37860660397196094,0.8232426170534491,0.75,0.9302767766237182,1.0,3/17,12.30%,SMAD1;NRG1;BMPR1A
prerank,GO_Biological_Process_2021__positive regulation of maintenance of mitotic sister chromatid cohesion (GO:0034184),0.5124297845928397,0.8230294844912336,0.7272727272727273,0.929678138975319,1.0,2/5,25.05%,NSMCE2;MACROH2A1
prerank,GO_Biological_Process_2021__regulation of maintenance of mitotic sister chromatid cohesion (GO:0034182),0.5124297845928397,0.8230294844912336,0.7272727272727273,0.929678138975319,1.0,2/5,25.05%,NSMCE2;MACROH2A1
prerank,GO_Biological_Process_2021__positive regulation of maintenance of sister chromatid cohesion (GO:0034093),0.5124297845928397,0.8230294844912336,0.7272727272727273,0.929678138975319,1.0,2/5,25.05%,NSMCE2;MACROH2A1
prerank,GO_Biological_Process_2021__response to glucose (GO:0009749),0.3618990497771544,0.8229865790722215,0.7857142857142857,0.9293810356384167,1.0,6/30,11.06%,IGF1R;SLC39A14;UNC13B;SOX4;PCK2;TCF7L2
prerank,GO_Biological_Process_2021__positive regulation of autophagosome maturation (GO:1901098),0.5438541237278687,0.8229818734342477,0.74,0.9290344955401814,1.0,2/5,29.88%,SMCR8;CALCOCO2
prerank,Reactome_2022__CD28 Dependent Vav1 Pathway R-HSA-389359,-0.4934434021048806,-0.8227730054209997,0.7192982456140351,0.9713474775240972,1.0,1/9,7.36%,FYN
prerank,GO_Biological_Process_2021__positive regulation of viral transcription (GO:0050434),-0.4245619444001999,-0.8226831736538789,0.7142857142857143,0.9712122138428244,1.0,3/22,7.16%,MDFIC;CTDP1;POLR2G
prerank,"GO_Biological_Process_2021__retrograde transport, endosome to Golgi (GO:0042147)",0.30377660859569855,0.8225695806211946,0.9655172413793104,0.9294058595128696,1.0,13/77,14.60%,UBE2O;BAIAP3;TBC1D5;TBC1D10B;SGSM2;RAB7A;SNX12;RBSN;VTI1A;RAB6A;YKT6;EVI5;STX6
prerank,CellMarker_Augmented_2021__Intestinal Stem cell:Intestinal Crypt,-0.4213135499535808,-0.8225348057585966,0.7213114754098361,0.9711631179025958,1.0,7/29,11.34%,ARSJ;ANXA2;ABCC3;OSMR;CD44;S100A6;HIF1A
prerank,CellMarker_Augmented_2021__Multipotent Progenitor cell:Stomach,-0.4096059527060727,-0.822524035954288,0.6333333333333333,0.9708753107612144,1.0,3/28,7.98%,ANKRD37;DTX3L;SGK1
prerank,GO_Biological_Process_2021__regulation of dendritic cell apoptotic process (GO:2000668),0.4633226017465381,0.822263641675363,0.6304347826086957,0.9297047489911294,1.0,3/7,22.44%,LGALS9;RAPGEF2;CXCL12
prerank,GO_Biological_Process_2021__peptidyl-asparagine modification (GO:0018196),0.3739570435906262,0.8222479367615333,0.7647058823529411,0.9293900555151178,1.0,8/23,22.09%,UBE2J1;OSTC;STT3B;MGAT5;ALG8;MAGT1;ALG5;RPN2
prerank,GO_Biological_Process_2021__white fat cell differentiation (GO:0050872),0.4914743231257298,0.8221665817075097,0.6410256410256411,0.9291657693895529,1.0,3/6,8.76%,SIRT1;PPARG;CTBP2
prerank,CellMarker_Augmented_2021__Colony-forming cell:Prostate,0.3283079378556615,0.8218095995388703,0.7647058823529411,0.9294644049705538,1.0,15/53,12.73%,TGFBR2;TGFA;KIAA1671;MTUS1;ASAP2;PTPRM;BACE2;LPP;JAG1;RYK;CACHD1;PTPRK;ITGAV;ITGA2;LRRC1
prerank,GO_Biological_Process_2021__cellular response to purine-containing compound (GO:0071415),0.495755022926444,0.8216883010770716,0.6595744680851063,0.929330357668626,1.0,3/6,23.01%,SLC8A1;RYR1;RYR2
prerank,GO_Biological_Process_2021__renal system development (GO:0072001),0.39462272843273694,0.8216122287957304,0.7096774193548387,0.9291378753765644,1.0,6/23,15.21%,LRP4;PKD1;SALL1;C1GALT1;BAG6;TGFBR1
prerank,GO_Biological_Process_2021__response to cholesterol (GO:0070723),0.42991335906941486,0.821541768594102,0.6875,0.9289050307200013,1.0,6/13,10.96%,ABCA2;TGFBR2;GRAMD1A;SMAD2;GRAMD1C;PTCH1
prerank,GO_Biological_Process_2021__negative regulation of cellular component organization (GO:0051129),0.3289342717837708,0.8215355515916555,0.8214285714285714,0.9285553791102235,1.0,12/57,17.16%,SPRY2;DNAJB2;TMEFF2;TNF;DNAJA4;IRAK3;SORL1;PEX5;AIDA;RAPGEF3;GSK3B;DDX3X
prerank,GO_Biological_Process_2021__endosome organization (GO:0007032),0.37498108042155803,0.8214443720338306,0.7096774193548387,0.9283679165426436,1.0,1/28,2.76%,EXOC8
prerank,GO_Biological_Process_2021__positive regulation of response to biotic stimulus (GO:0002833),-0.39785004038304106,-0.8213477057499284,0.7049180327868853,0.972702389905202,1.0,9/30,17.22%,CCL5;DHX58;PLSCR1;TASL;CYBA;LY86;IFI35;POLR3C;DDX60
prerank,"GO_Biological_Process_2021__DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)",-0.5022652330905667,-0.8212358143583844,0.7192982456140351,0.9723232786205753,1.0,3/8,15.14%,ING4;KAT5;RPS27L
prerank,"GO_Biological_Process_2021__DNA damage response, signal transduction resulting in transcription (GO:0042772)",-0.5022652330905667,-0.8212358143583844,0.7192982456140351,0.9723232786205753,1.0,3/8,15.14%,ING4;KAT5;RPS27L
prerank,GO_Biological_Process_2021__homocysteine metabolic process (GO:0050667),0.5435539582390289,0.8211192726164704,0.6923076923076923,0.9286346965196621,1.0,2/5,26.96%,BLMH;MPST
prerank,GO_Biological_Process_2021__protein K63-linked ubiquitination (GO:0070534),-0.4141520529205194,-0.8208442258409938,0.7424242424242424,0.9727092225667422,1.0,3/33,7.11%,TRIM5;ARIH2;RNF126
prerank,GO_Biological_Process_2021__regulation of pinocytosis (GO:0048548),-0.5303783878735833,-0.8206772360545374,0.625,0.9727179648482651,1.0,1/6,5.38%,NR1H2
prerank,Reactome_2022__Regulation Of TP53 Activity Thru Phosphorylation R-HSA-6804756,0.33182170296984365,0.8202371081355427,0.75,0.9297641734245623,1.0,11/63,13.71%,PRKAB2;CDK5R1;MAPK11;NUAK1;TAF2;TAF9B;MDM2;SUPT16H;BARD1;PRKAB1;TAF3
prerank,GO_Biological_Process_2021__regulation of lamellipodium morphogenesis (GO:2000392),0.4739358097393007,0.8201139033883051,0.6304347826086957,0.9296168946348035,1.0,2/9,7.80%,PDPN;KANK1
prerank,CellMarker_Augmented_2021__Endothelial cell:Embryoid Body,0.36719610940960856,0.8199780476652905,0.7586206896551724,0.9294966742811777,1.0,3/26,12.88%,COL5A2;CDH11;FBXL7
prerank,GO_Biological_Process_2021__positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),-0.44565433279845434,-0.8198890786257024,0.7142857142857143,0.9734224168286023,1.0,6/16,30.31%,CITED2;CDKN1C;RNF111;SDCBP;DAB2;SNW1
prerank,GO_Biological_Process_2021__positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),-0.44565433279845434,-0.8198890786257024,0.7142857142857143,0.9734224168286023,1.0,6/16,30.31%,CITED2;CDKN1C;RNF111;SDCBP;DAB2;SNW1
prerank,GO_Biological_Process_2021__carbohydrate derivative transport (GO:1901264),-0.49476603048765994,-0.8196206845708874,0.7096774193548387,0.9735666250586787,1.0,4/12,15.59%,PLTP;VLDLR;SLC25A19;SLC15A3
prerank,Reactome_2022__Interleukin-20 Family Signaling R-HSA-8854691,-0.4536131870394712,-0.8195963639165351,0.7288135593220338,0.9732982540005807,1.0,1/14,0.41%,STAT4
prerank,GO_Biological_Process_2021__positive regulation of filopodium assembly (GO:0051491),0.3953664067309054,0.8195906029200256,0.7941176470588235,0.9297042502032209,1.0,4/18,12.11%,NRP1;NLGN1;GPM6A;FNBP1L
prerank,GO_Biological_Process_2021__regulation of phosphatidylinositol dephosphorylation (GO:0060304),0.5162311926702094,0.8195695732145966,0.7021276595744681,0.9293911322042888,1.0,1/5,13.78%,MTMR9
prerank,CellMarker_Augmented_2021__Corneal Endothelial cell:Corneal Endothelium,0.3506339007324265,0.8194497124178035,0.7878787878787878,0.9292845944779087,1.0,10/45,12.28%,PLXNB1;TIMP3;MAGI1;JAG1;UNC13B;ALPK3;UNC5B;PREX2;PTPRD;RUNX1T1
prerank,CellMarker_Augmented_2021__Mesenchymal cell:Bone Marrow,-0.4111948575790743,-0.8194117207204359,0.7313432835820896,0.9732486836863676,1.0,7/42,11.86%,ARSJ;COL5A1;RGS4;OSMR;SGCE;PTN;CRIM1
prerank,GO_Biological_Process_2021__regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),0.38581415852658263,0.819267376134664,0.8222222222222222,0.9291557191878367,1.0,2/20,4.79%,PKD1;CTSC
prerank,Reactome_2022__Processing Of SMDT1 R-HSA-8949664,-0.44993188117557215,-0.8188459516920046,0.6666666666666666,0.9738880510819419,1.0,6/15,16.70%,PHB2;SMDT1;MICU2;SPG7;MAIP1;STOML2
prerank,CellMarker_Augmented_2021__Follicular Helper (Tfh) T cell:Undefined,-0.5149163363920847,-0.8184298947931651,0.7741935483870968,0.974325119476086,1.0,4/8,28.41%,IL12RB2;MAF;CD4;STAT3
prerank,Reactome_2022__Synthesis Of PA R-HSA-1483166,-0.419834140927847,-0.8181799000353815,0.6923076923076923,0.9744743599299452,1.0,3/23,5.77%,LPCAT1;DDHD2;GNPAT
prerank,Reactome_2022__Sensory Processing Of Sound R-HSA-9659379,0.3323485986645846,0.8180601962037751,0.8461538461538461,0.9312859642139959,1.0,9/46,10.99%,EPS8;MSN;GSN;PCDH15;TPRN;CTBP2;SPTAN1;STX1A;KCNN2
prerank,GO_Biological_Process_2021__organelle organization (GO:0006996),0.26989079350078476,0.8180053623697358,1.0,0.9310399265566437,1.0,63/304,18.97%,VAPB;PPARGC1A;PKD2;ATAD3B;GOLPH3L;LRRK2;FGD4;TOR1AIP2;SYNE3;PARP1;TMED3;TFB1M;CSPG5;TMED10;MAST2;ARAP3;LIG4;TMED5;SORT1;WDPCP;RAB7A;AUP1;MAST3;ZRANB1;LMAN2L;NCKIPSD;COG1;BLZF1;CHMP7;ATAD3A;FNBP1L;PRKCI;PEX11B;CLUH;STRIP1;MARK1;BAG5;CHMP1A;ESRRA;CLASP1;PPRC1;CNTNAP1;NRF1;COG3;PEX16;UBXN2A;RAB14;PLEKHM2;SEC31A;CLASP2;BRWD1;ALAS1;ATP8B2;TRAPPC12;NIPSNAP2;SEC31B;PCLO;HACE1;BIN1;GABPB1;YTHDF1;ODF2;TRAPPC8
prerank,Reactome_2022__MAP2K And MAPK Activation R-HSA-5674135,0.36769151520214133,0.8179560880011519,0.7435897435897436,0.9307268969180658,1.0,7/29,18.60%,RAP1A;MAP2K1;VCL;MAPK1;LAMTOR3;MAP2K2;KSR1
prerank,KEGG_2021_Human__Neuroactive ligand-receptor interaction,0.3122427618368091,0.8175545351436087,0.8333333333333334,0.9311304308487935,1.0,16/94,10.03%,LEPR;NPY1R;GRIN3A;GRID2;FPR3;GABBR1;CNR1;GRID1;GRIK2;GLRA1;ADRA1A;GABRR2;GRIA3;GRIA4;GRIA1;GRM5
prerank,GO_Biological_Process_2021__regulation of osteoclast development (GO:2001204),-0.4942541658162071,-0.8175430308723163,0.7169811320754716,0.9751514619948457,1.0,2/6,13.87%,TYROBP;NOTCH2
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Mammary Gland,-0.3558932758994872,-0.817264008592525,0.7702702702702703,0.975347334025813,1.0,9/71,9.17%,FLNA;CTDSP1;ZNF185;IFITM3;ETS1;HLA-C;RNPEPL1;ITGA6;S100A6
prerank,GO_Biological_Process_2021__positive regulation of protein kinase B signaling (GO:0051897),-0.36019013821548124,-0.8170077204269076,0.8115942028985508,0.9755099365649805,1.0,2/89,0.62%,CALCR;CCL3
prerank,Reactome_2022__RNA Polymerase II Transcription Termination R-HSA-73856,-0.36753688466878776,-0.8168522623804426,0.8194444444444444,0.9755398820950437,1.0,10/50,15.85%,DHX38;CSTF2T;EIF4A3;CHTOP;U2AF2;NCBP2;SRSF2;SRSF7;COLEC12;SLU7
prerank,GO_Biological_Process_2021__positive regulation of tumor necrosis factor-mediated signaling pathway (GO:1903265),-0.508278477835719,-0.8168296386374244,0.7457627118644068,0.9752771678904089,1.0,3/9,18.05%,HSPA1B;HSPA1A;CASP4
prerank,GO_Biological_Process_2021__cellular response to reactive nitrogen species (GO:1902170),0.5249780266809249,0.8166914560672157,0.6976744186046512,0.931856044792344,1.0,3/5,22.15%,KCNC2;GUCY1B1;FOXO1
prerank,GO_Biological_Process_2021__cellular response to nitric oxide (GO:0071732),0.5249780266809249,0.8166914560672157,0.6976744186046512,0.931856044792344,1.0,3/5,22.15%,KCNC2;GUCY1B1;FOXO1
prerank,GO_Biological_Process_2021__natural killer cell mediated cytotoxicity (GO:0042267),-0.4605291075504113,-0.8166638554452801,0.7272727272727273,0.9753126861669199,1.0,2/10,13.99%,GZMB;TUBB4B
prerank,"GO_Biological_Process_2021__neurotransmitter receptor transport, endosome to plasma membrane (GO:0099639)",0.5130665735787543,0.8166259211950176,0.7037037037037037,0.9316102604380267,1.0,1/6,0.84%,SCRIB
prerank,KEGG_2021_Human__Arrhythmogenic right ventricular cardiomyopathy,-0.3634608679227107,-0.8164927547642609,0.8260869565217391,0.9753178328452885,1.0,12/48,19.27%,EMD;JUP;ACTG1;ITGA4;ITGA6;CACNA2D4;ACTB;DSC2;PKP2;CACNB1;ITGB1;LAMA2
prerank,GO_Biological_Process_2021__potassium ion homeostasis (GO:0055075),0.4429639922289608,0.8164650725301787,0.75,0.9314942989870238,1.0,4/14,15.33%,KCNJ2;SLC12A6;SLC12A5;SLC12A2
prerank,GO_Biological_Process_2021__gluconeogenesis (GO:0006094),-0.405701729217425,-0.816326843634266,0.7397260273972602,0.9753560751974513,1.0,4/27,6.17%,GAPDH;MDH2;PER2;G6PC3
prerank,GO_Biological_Process_2021__cardiac muscle contraction (GO:0060048),0.3978118212993444,0.8162363161622896,0.6923076923076923,0.9315482270258267,1.0,2/16,5.10%,GSN;SCN3B
prerank,GO_Biological_Process_2021__positive regulation of focal adhesion disassembly (GO:0120183),-0.4991423669916515,-0.8161462360734967,0.7254901960784313,0.9750686252845954,1.0,1/6,6.65%,IQSEC1
prerank,GO_Biological_Process_2021__regulation of focal adhesion disassembly (GO:0120182),-0.4991423669916515,-0.8161462360734967,0.7254901960784313,0.9750686252845954,1.0,1/6,6.65%,IQSEC1
prerank,Reactome_2022__CD163 Mediating An Anti-Inflammatory Response R-HSA-9662834,0.4908687669033503,0.8160521505079575,0.675,0.9315574464931256,1.0,4/6,29.42%,PLK2;MAPK14;RHBDF2;CD163
prerank,GO_Biological_Process_2021__regulation of vasoconstriction (GO:0019229),-0.48763336329555884,-0.8157104268757791,0.6935483870967742,0.9754844405784789,1.0,3/10,15.92%,PER2;TRPM4;AGT
prerank,Reactome_2022__Signaling By FGFR2 R-HSA-5654738,-0.39032956016094106,-0.8156078337431723,0.71875,0.9753600482691962,1.0,5/46,9.87%,UBC;RPS27A;FGF13;POLR2G;NCBP2
prerank,GO_Biological_Process_2021__negative regulation of Arp2/3 complex-mediated actin nucleation (GO:0034316),-0.564536760414365,-0.8155625279365581,0.7719298245614035,0.9751448491297735,1.0,2/5,14.27%,CORO1B;PICK1
prerank,GO_Biological_Process_2021__establishment of spindle localization (GO:0051293),-0.5223176673649855,-0.8154399526213598,0.6842105263157895,0.9750674405406293,1.0,2/7,9.33%,CFL1;LLGL2
prerank,GO_Biological_Process_2021__response to thyroid hormone (GO:0097066),-0.46333270173731655,-0.815387812426316,0.7692307692307693,0.9748607190614671,1.0,1/11,3.91%,CTSB
prerank,GO_Biological_Process_2021__L-alpha-amino acid transmembrane transport (GO:1902475),0.42525276934083367,0.8150820512254492,0.7105263157894737,0.932915092447688,1.0,5/16,6.03%,SLC1A3;SLC25A18;SLC7A8;SLC3A2;SLC1A2
prerank,Reactome_2022__Activation Of SMO R-HSA-5635838,0.45983856003752543,0.8149201181274581,0.7551020408163265,0.93283451531663,1.0,5/10,33.78%,PTCH1;EFCAB7;ARRB2;ARRB1;CDON
prerank,Reactome_2022__Early SARS-CoV-2 Infection Events R-HSA-9772572,0.34877839615795964,0.8149174883374227,0.8275862068965517,0.9324773811224046,1.0,1/26,0.61%,NRP1
prerank,KEGG_2021_Human__GABAergic synapse,0.3140927501605366,0.8146697999812534,0.8275862068965517,0.9325442093983922,1.0,5/56,7.36%,CACNA1A;GABBR1;PLCL1;ADCY9;GABRR2
prerank,GO_Biological_Process_2021__cellular response to oxidative stress (GO:0034599),-0.3422933160631955,-0.814388232354195,0.8095238095238095,0.9763380439284989,1.0,18/93,14.43%,CYCS;FOS;AIF1;CHCHD2;NCF4;ERO1A;RPS3;GSTP1;ERMP1;NCF2;SELENOS;PRR5L;HIF1A;HSPA1B;CYBA;SOD1;GPX1;HSPA1A
prerank,CellMarker_Augmented_2021__Mesenchymal Stromal cell:Undefined,-0.4170201159640613,-0.8142280222421941,0.7619047619047619,0.9763318595485876,1.0,7/26,12.82%,TFRC;CD55;CD63;ITGA6;CD44;ITGB2;PTPRC
prerank,GO_Biological_Process_2021__negative regulation of biosynthetic process (GO:0009890),-0.4818086663948724,-0.8139945061733682,0.7636363636363637,0.9764576705819126,1.0,3/9,22.45%,GSTP1;CIITA;PARK7
prerank,GO_Biological_Process_2021__cellular protein localization (GO:0034613),-0.3185444221497956,-0.813954301456676,0.9012345679012346,0.9762232875260936,1.0,37/240,16.63%,FLNA;USP6;RIC3;ARL5C;SNX6;BBS2;ARL4C;CD63;VPS35;EIF2D;NAPA;CORO1B;ARL17A;EPB41L3;TM9SF2;NPM1;ADPRH;TRIM23;IFT27;COX18;STX19;TBC1D8;ARMCX3;AP4M1;OXA1L;PICK1;STX10;TBC1D2B;SNX9;WIPI1;VPS26A;CD74;SLU7;SEC13;VIPAS39;RRAGA;PIGK
prerank,GO_Biological_Process_2021__small GTPase mediated signal transduction (GO:0007264),0.3049345827563179,0.8136766014297675,0.875,0.9339885639479164,1.0,22/84,19.78%,ARHGAP31;FGF2;MAPK11;RIN2;RUNDC3A;RGL2;SHC2;PLK2;NF1;SHOC2;JUN;TIAM2;SHTN1;RAPGEF2;NUCB1;KSR1;CHP1;ARHGAP1;RALA;ARHGAP33;TRIM28;TIAM1
prerank,GO_Biological_Process_2021__negative regulation of viral life cycle (GO:1903901),-0.47283180666037733,-0.813498396169313,0.7142857142857143,0.9766513514929072,1.0,3/10,8.41%,TRIM5;IFITM3;LY6E
prerank,GO_Biological_Process_2021__regulation of macrophage chemotaxis (GO:0010758),-0.46811330922630723,-0.8134559010527399,0.7272727272727273,0.9764060629755122,1.0,1/12,1.49%,CCL5
prerank,GO_Biological_Process_2021__regulation of mitotic nuclear division (GO:0007088),-0.401205146627704,-0.8133909522469416,0.696969696969697,0.9762158533724923,1.0,3/24,6.57%,DUSP1;IGF1;AURKAIP1
prerank,GO_Biological_Process_2021__positive regulation of keratinocyte migration (GO:0051549),-0.5034317193056479,-0.8133817115745474,0.7058823529411765,0.975935153439451,1.0,1/7,6.65%,IQSEC1
prerank,GO_Biological_Process_2021__regulation of heterotypic cell-cell adhesion (GO:0034114),0.4227050171702863,0.8133314404607759,0.6571428571428571,0.9342686739960301,1.0,3/14,7.30%,KLF4;MYADM;TNF
prerank,GO_Biological_Process_2021__regulation of cell cycle G1/S phase transition (GO:1902806),-0.423898598926962,-0.813232376609884,0.7090909090909091,0.9759016567930338,1.0,9/21,22.96%,DDRGK1;PHB2;APPL1;STXBP4;PSME2;PSME1;CDKN1B;TAF1;PSME3
prerank,GO_Biological_Process_2021__photoreceptor cell development (GO:0042461),-0.5012208441618027,-0.8131537669509806,0.7037037037037037,0.9757282380656827,1.0,1/7,11.19%,VEGFA
prerank,KEGG_2021_Human__mRNA surveillance pathway,0.30300328015099814,0.8130855998949271,0.8620689655172413,0.934383743369102,1.0,7/70,8.13%,NXF1;PABPC1L;CPSF4;WDR33;SSU72;PCF11;PPP2R1B
prerank,GO_Biological_Process_2021__leucine transport (GO:0015820),-0.5383113829606211,-0.8130737167734085,0.75,0.9756015581243906,1.0,2/5,9.33%,SLC7A5;LLGL2
prerank,GO_Biological_Process_2021__positive regulation of transcription by RNA polymerase II (GO:0045944),-0.3032736569092193,-0.8130133224814293,0.9347826086956522,0.975376232369748,1.0,54/564,11.42%,NR4A3;IL4I1;SKAP1;MYBL1;BCL11B;UBC;FOSL2;FOS;RPS27A;JUNB;PID1;ATF5;TAF6L;CSRNP1;USF1;RORA;CHCHD2;ZNF335;DDRGK1;BEX1;ETS1;NR1H2;JUP;IGF1;JMJD6;TXK;MED25;NLRC5;IER2;PLSCR1;ZNF76;PLAG1;NAMPT;RNASEL;PRKD2;RBPJ;ITGA6;VENTX;DVL1;STAT1;MEIS1;ZNF513;EIF5A;SMARCD1;SLC11A1;LITAF;IRF1;NPM1;CITED2;KDM6B;MLX;VEGFA;HIF1A;STING1
prerank,GO_Biological_Process_2021__generation of neurons (GO:0048699),0.3022052775574171,0.8129561512860335,0.8181818181818182,0.93421372840767,1.0,22/95,13.54%,NRP1;CDK5R1;MAP2K1;WNT5A;FZD3;RELN;WNT2B;RUNX1;PLXNB2;RYK;AUTS2;BRSK1;FUT9;GPM6A;OLIG1;PEX13;PTPRD;CDK6;ELP3;NTRK2;SH3RF1;MARK1
prerank,GO_Biological_Process_2021__mitochondrial protein processing (GO:0034982),0.46210675129531287,0.8126084879974697,0.7142857142857143,0.9344667232614408,1.0,1/9,2.93%,IMMP2L
prerank,CellMarker_Augmented_2021__Endothelial cell:Cornea,-0.49828178346296215,-0.8125723945267279,0.7096774193548387,0.9759131716250021,1.0,2/8,12.25%,CD44;CD47
prerank,GO_Biological_Process_2021__positive regulation of macromolecule biosynthetic process (GO:0010557),0.29180323207940767,0.8125271872799179,0.8918918918918919,0.9342167124227552,1.0,4/89,3.55%,KLF4;FGF2;SIRT1;SAMD4A
prerank,GO_Biological_Process_2021__negative regulation of cellular protein catabolic process (GO:1903363),0.501002615548626,0.8121315070136794,0.723404255319149,0.9345718163155806,1.0,1/7,0.96%,ATRAID
prerank,GO_Biological_Process_2021__positive regulation of nuclear cell cycle DNA replication (GO:0010571),-0.5433174278243558,-0.8119014353857348,0.7647058823529411,0.9767512543926363,1.0,2/6,31.29%,CDC7;DBF4B
prerank,Reactome_2022__COPII-mediated Vesicle Transport R-HSA-204005,0.32514599930796473,0.811895910611093,0.9354838709677419,0.9346198564251464,1.0,7/54,9.61%,TGFA;BET1;CTSC;RAB1B;SEC24B;GRIA1;LMAN2L
prerank,KEGG_2021_Human__Toxoplasmosis,-0.35703526551502923,-0.811394163813261,0.7922077922077922,0.9772381333135861,1.0,21/78,21.50%,CYCS;IL10RA;HLA-DRB5;ITGA6;STAT1;HLA-DRA;IFNGR2;HSPA1B;HSPA1A;HLA-DPA1;CIITA;HLA-DMB;HLA-DPB1;HSPA2;IRAK4;ITGB1;HLA-DRB1;LAMA2;TLR2;PIK3R6;MAPK3
prerank,GO_Biological_Process_2021__regulation of actin nucleation (GO:0051125),0.4854371323091903,0.811309369233577,0.7045454545454546,0.9353389910065381,1.0,1/9,1.66%,GSN
prerank,GO_Biological_Process_2021__regulation of autophagosome maturation (GO:1901096),0.44287052164187507,0.8110990127457496,0.6226415094339622,0.9353022872395631,1.0,1/11,4.89%,TMEM39A
prerank,KEGG_2021_Human__Ribosome biogenesis in eukaryotes,0.341514118999706,0.8109943383829972,0.7222222222222222,0.9351234933907319,1.0,11/57,14.72%,NXF1;EFL1;AK6;WDR3;XPO1;GNL3L;RCL1;WDR43;GTPBP4;DROSHA;UTP18
prerank,PanglaoDB_Augmented_2021__Endothelial Cells (Aorta),-0.374151341619851,-0.8109795220143619,0.8028169014084507,0.9776398084527593,1.0,4/70,3.11%,COL5A1;PROCR;ENPP4;PER3
prerank,GO_Biological_Process_2021__negative regulation of secretion by cell (GO:1903531),0.3971016866574979,0.8104636524740121,0.725,0.9356240788693062,1.0,1/22,0.34%,ANXA1
prerank,GO_Biological_Process_2021__unsaturated fatty acid metabolic process (GO:0033559),0.39335070322020005,0.8103406991120901,0.7631578947368421,0.935489676720035,1.0,2/30,0.68%,FAAH;PLA2G4C
prerank,Reactome_2022__Circadian Clock R-HSA-400253,-0.36172374724263484,-0.8100976298689526,0.78125,0.9788079185459546,1.0,7/62,8.03%,UBC;RPS27A;PER2;RORA;BHLHE40;PPP1CB;NAMPT
prerank,GO_Biological_Process_2021__negative regulation of neuron death (GO:1901215),0.3215856892819632,0.80997419950998,0.8518518518518519,0.9357856802928695,1.0,15/59,16.55%,PPARGC1A;LRRK2;PPT1;CPEB4;LIG4;UNC5B;SORL1;SOD2;NTRK2;PRKCI;GPNMB;TYRO3;ATP13A2;GSK3B;INPP5A
prerank,GO_Biological_Process_2021__negative regulation of protein autophosphorylation (GO:0031953),-0.5033248793425604,-0.8099144695106287,0.7619047619047619,0.9788092265369468,1.0,1/7,7.60%,NLRP12
prerank,GO_Biological_Process_2021__ERBB2 signaling pathway (GO:0038128),0.4208404649320656,0.8096425737643651,0.7073170731707317,0.9360991963145794,1.0,11/22,23.61%,GAB1;NRG1;NRG2;ERBB4;PTPRR;PIK3CA;ERBIN;PTPN12;PTPN18;CPNE3;PIK3R1
prerank,GO_Biological_Process_2021__mRNA transport (GO:0051028),0.3086596731950565,0.8094249241804133,0.95,0.9360622871528893,1.0,8/85,7.20%,NXF1;U2AF1;CPSF4;FYTTD1;NUP153;NUP188;WDR33;NUP42
prerank,GO_Biological_Process_2021__positive regulation of microtubule polymerization or depolymerization (GO:0031112),0.365544849168821,0.8094195109962935,0.8076923076923077,0.9357108009907391,1.0,4/21,14.39%,CDK5R1;TOGARAM1;SLAIN2;CLASP1
prerank,GO_Biological_Process_2021__regulation of epidermal growth factor-activated receptor activity (GO:0007176),-0.4421603554578236,-0.8092574194826592,0.765625,0.9796561051925677,1.0,2/14,3.88%,SNX6;CBLB
prerank,GO_Biological_Process_2021__amino acid transmembrane transport (GO:0003333),-0.42549206142186663,-0.8092391433903153,0.7619047619047619,0.979383590407856,1.0,3/26,4.58%,SLC7A5;SLC38A4;SLC38A1
prerank,GO_Biological_Process_2021__NLS-bearing protein import into nucleus (GO:0006607),-0.43591808257975956,-0.809097785788146,0.6212121212121212,0.9793573744798907,1.0,1/13,3.88%,CBLB
prerank,GO_Biological_Process_2021__renal water homeostasis (GO:0003091),-0.45536056881610715,-0.8088946780329642,0.7222222222222222,0.9794460019727135,1.0,2/17,6.63%,RAB11A;PRKAR1B
prerank,GO_Biological_Process_2021__regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),-0.4170312808293163,-0.8086331625974615,0.7285714285714285,0.9795728399956743,1.0,1/19,1.03%,TGFBR3
prerank,PanglaoDB_Augmented_2021__Chondrocytes,-0.3584259532604686,-0.808523353020707,0.7567567567567568,0.9794782822549187,1.0,8/59,11.54%,COL5A1;RUNX3;GADD45B;IL10RA;STAT1;OLFML2B;VEGFA;SDC3
prerank,GO_Biological_Process_2021__regulation of transforming growth factor beta production (GO:0071634),0.4170677808249018,0.8083484746958252,0.7435897435897436,0.9372553537152947,1.0,3/13,10.85%,SMAD3;LGALS9;ITGAV
prerank,Reactome_2022__Cell-cell Junction Organization R-HSA-421270,0.35229339595408826,0.8079585565947144,0.8108108108108109,0.9375988287139706,1.0,10/31,17.78%,CADM1;FZR1;CDH11;CADM2;AFDN;PRKCI;CDH19;CDH8;PARD3;CDH4
prerank,CellMarker_Augmented_2021__Lymphoid cell:Peripheral Blood,-0.36703365302516333,-0.8079362180384759,0.7468354430379747,0.980132214105616,1.0,6/63,7.96%,CD37;MNDA;BTK;PLEK;IL10RA;SPOCK2
prerank,Reactome_2022__Vesicle-mediated Transport R-HSA-5653656,-0.3081575094998499,-0.8077794406914915,0.9777777777777777,0.9800675817233669,1.0,53/493,16.21%,CD36;TPD52;UBC;FTH1;EPN1;RPS27A;CHRM2;TFRC;CD55;IL7R;F8;MARCO;COPS6;RAB11A;GOLGA1;RAB3A;TRAPPC4;TACR1;SNF8;NAA38;CALM1;GABARAPL2;HPS4;VPS28;SLC2A8;GOLGA4;DCTN6;CFTR;PTGES2;DCTN4;BNIP1;TBC1D20;COPS8;VPS37B;CSNK1D;CLTB;AP4M1;FTL;COPE;CYTH1;DYNC1LI2;TRAPPC6A;COLEC12;IGF2R;STX10;UBA52;SNX9;AP2S1;ANKRD28;DENND3;SEC13;MVB12A;DENND6A
prerank,GO_Biological_Process_2021__protein monoubiquitination (GO:0006513),0.3719191346484747,0.8076760876465737,0.8285714285714286,0.937654352252204,1.0,4/31,10.42%,ZNF598;UBE2O;UBE3D;RNF20
prerank,GO_Biological_Process_2021__regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),0.3400553937665224,0.8076051386696186,0.7941176470588235,0.9374045549798014,1.0,3/31,4.66%,SERPINE1;FEM1B;TNFRSF10A
prerank,GO_Biological_Process_2021__regulation of leukocyte chemotaxis (GO:0002688),0.4398245717756101,0.8074639182702832,0.675,0.9372566682389323,1.0,1/9,4.07%,MTUS1
prerank,GO_Biological_Process_2021__phosphatidic acid metabolic process (GO:0046473),-0.38722002297778907,-0.8073866457279357,0.7352941176470589,0.9803878975063922,1.0,3/32,5.77%,LPCAT1;DDHD2;GNPAT
prerank,GO_Biological_Process_2021__protein N-linked glycosylation via asparagine (GO:0018279),0.38035558554132576,0.8073009233449786,0.8387096774193549,0.9371265775892137,1.0,8/22,22.09%,UBE2J1;OSTC;STT3B;MGAT5;ALG8;MAGT1;ALG5;RPN2
prerank,GO_Biological_Process_2021__protein localization to Golgi apparatus (GO:0034067),0.3836639988847456,0.8072096588640585,0.7777777777777778,0.9369170382966213,1.0,6/26,12.19%,RAB33B;ARL5A;TMED10;RIPOR1;SORL1;RAB6A
prerank,GO_Biological_Process_2021__positive regulation of protein binding (GO:0032092),0.3354538774948353,0.8071192731648761,0.7428571428571429,0.9367120754859403,1.0,4/42,3.81%,HIP1R;PKD1;EPB41;LRRK2
prerank,KEGG_2021_Human__Vasopressin-regulated water reabsorption,-0.3810775679428057,-0.8070483784769287,0.7868852459016393,0.9806234196654796,1.0,7/32,22.02%,RAB11A;DCTN6;DCTN4;DYNC1LI2;DCTN2;DYNC1I2;STX4
prerank,GO_Biological_Process_2021__cellular response to lipid (GO:0071396),-0.34680616502706857,-0.8067225265018083,0.7894736842105263,0.9808178763443348,1.0,13/113,11.38%,INSIG1;ZFP36;CARD16;PID1;CD14;RORA;GSTP1;TNFRSF1B;TNFAIP3;SELENOS;ABCB4;CFTR;BRINP2
prerank,KEGG_2021_Human__Glycerophospholipid metabolism,0.31847027904359704,0.8063916321667012,0.8666666666666667,0.9377172371302729,1.0,13/66,15.17%,PLA2G4C;ETNPPL;PLPP1;PLPP5;CHKA;GPAT4;SELENOI;AGPAT5;LCAT;GPAT3;CHPT1;AGPAT2;PLD4
prerank,GO_Biological_Process_2021__lysosomal microautophagy (GO:0016237),-0.4944787799480118,-0.8062021659439594,0.7407407407407407,0.9810128519175322,1.0,1/7,7.60%,ATG2A
prerank,GO_Biological_Process_2021__piecemeal microautophagy of the nucleus (GO:0034727),-0.4944787799480118,-0.8062021659439594,0.7407407407407407,0.9810128519175322,1.0,1/7,7.60%,ATG2A
prerank,GO_Biological_Process_2021__negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),-0.44431333401050976,-0.8060792171094986,0.7183098591549296,0.9805890388925358,1.0,3/13,14.43%,EYA2;HSPA1B;HSPA1A
prerank,GO_Biological_Process_2021__negative regulation of signal transduction in absence of ligand (GO:1901099),-0.44431333401050976,-0.8060792171094986,0.7183098591549296,0.9805890388925358,1.0,3/13,14.43%,EYA2;HSPA1B;HSPA1A
prerank,GO_Biological_Process_2021__Ras protein signal transduction (GO:0007265),-0.3531734797419287,-0.8059958016811072,0.7866666666666666,0.9804617708623954,1.0,8/107,8.34%,PLEKHG5;ARHGAP4;GRAP2;AIF1;ARHGEF1;IGF1;ARHGEF3;CFL1
prerank,GO_Biological_Process_2021__monoubiquitinated protein deubiquitination (GO:0035520),0.4823626747085029,0.805934008831385,0.8043478260869565,0.9381080533426873,1.0,2/6,26.97%,USP7;BAP1
prerank,GO_Biological_Process_2021__positive regulation of phosphorylation (GO:0042327),0.2729453104582919,0.8058757118739811,1.0,0.9379205227910661,1.0,18/161,10.77%,LEPR;NRP1;ACVR2A;IGF1R;FGF2;SIRT1;LRRK2;CIB1;RYK;TNF;DVL3;TMEM119;SLC4A4;NPTN;KNDC1;HGF;MERTK;EPHA6
prerank,GO_Biological_Process_2021__N-acetylneuraminate catabolic process (GO:0019262),0.4899130090334374,0.8058630653067613,0.6944444444444444,0.937591984396439,1.0,2/6,20.15%,RENBP;GNPDA1
prerank,Reactome_2022__Intrinsic Pathway Of Fibrin Clot Formation R-HSA-140837,-0.49006831177701093,-0.8056186488277411,0.7413793103448276,0.9808002567199431,1.0,1/11,1.93%,F8
prerank,KEGG_2021_Human__Adrenergic signaling in cardiomyocytes,0.3034629820584918,0.8054481504011728,0.9523809523809523,0.9379294932443906,1.0,17/102,15.47%,TPM2;MAPK11;GNAQ;ADRA1A;PLCB4;ADCY9;PPP2R1B;SLC9A1;MAPK1;ADCY6;SLC8A1;PPP2R5E;CACNG8;RAPGEF3;CACNG2;CACNB4;AKT2
prerank,GO_Biological_Process_2021__protein depolymerization (GO:0051261),0.4102681343194555,0.8052539542131256,0.6756756756756757,0.9378259873088847,1.0,1/17,1.66%,GSN
prerank,KEGG_2021_Human__Pathways in cancer,-0.32030980185995583,-0.8052258956756404,0.9333333333333333,0.9810895344000952,1.0,41/315,14.45%,STAT4;PLEKHG5;CYCS;FOS;CXCR4;IL7R;GADD45B;GSTM4;ETS1;ELOB;GNB5;ARHGEF1;IL3RA;JUP;IGF1;IL12RB2;GSTP1;BRCA2;CSF2RA;CALM1;ITGA6;EGLN3;GSTM3;DVL1;STAT1;CSF2RB;RBX1;VEGFA;HIF1A;CSF3R;IFNGR2;APPL1;FZD2;CKS2;MAX;PIK3CB;LPAR6;ESR2;NOTCH2;CCND1;FGF20
prerank,GO_Biological_Process_2021__regulation of DNA repair (GO:0006282),-0.40378790054713876,-0.8050422807825377,0.828125,0.9811173625543955,1.0,6/34,14.44%,EYA2;RPS3;ABRAXAS1;PARG;BRCA1;ERCC8
prerank,"GO_Biological_Process_2021__regulation of CD8-positive, alpha-beta T cell proliferation (GO:2000564)",-0.5065441630698181,-0.8048777632011529,0.7777777777777778,0.9810717125076998,1.0,3/7,19.00%,IRF1;HLA-E;PTPN22
prerank,GO_Biological_Process_2021__regulation of Rab protein signal transduction (GO:0032483),-0.5570686771450883,-0.8047459848336665,0.7924528301886793,0.9809907303513961,1.0,1/6,15.84%,DENND3
prerank,GO_Biological_Process_2021__fatty acid derivative biosynthetic process (GO:1901570),0.3513736224662679,0.804588179654372,0.7419354838709677,0.9384407259728454,1.0,6/25,20.80%,PPT1;ALOX5AP;GCDH;FASN;ACACA;SCD5
prerank,GO_Biological_Process_2021__negative regulation of RNA catabolic process (GO:1902369),-0.4855715857843256,-0.804453565432293,0.7692307692307693,0.9812089038001771,1.0,2/7,17.88%,NRDE2;SLIRP
prerank,GO_Biological_Process_2021__protein localization to membrane (GO:0072657),-0.340759613539887,-0.8043796476601889,0.7808219178082192,0.9810355057881789,1.0,18/148,11.27%,FLNA;ARL5C;TMEM150A;TSPAN32;RAB11A;JUP;RAB3A;FGF13;NLGN2;RAB3D;EPB41L3;ITGA4;TM9SF2;DVL1;PTN;EFR3B;ITGB2;ITGAL
prerank,GO_Biological_Process_2021__ketone body metabolic process (GO:1902224),-0.47051834637031875,-0.8043484521545478,0.6607142857142857,0.9808051444707762,1.0,4/8,27.15%,HMGCL;BDH1;AACS;SLC27A5
prerank,GO_Biological_Process_2021__organic acid transport (GO:0015849),-0.3837947467436158,-0.8043265652587114,0.7066666666666667,0.9805233047117317,1.0,4/54,4.96%,SLC51A;SLC38A4;SLC38A1;ABCC3
prerank,GO_Biological_Process_2021__monoacylglycerol catabolic process (GO:0052651),0.5192302177055645,0.8042781060759535,0.7708333333333334,0.9385661267551857,1.0,1/5,0.63%,FAAH
prerank,GO_Biological_Process_2021__negative regulation of macrophage activation (GO:0043031),0.40563914929665823,0.8040527343617317,0.7674418604651163,0.9386165885978112,1.0,1/11,3.01%,LDLR
prerank,Reactome_2022__Microbial Modulation Of RIPK1-mediated Regulated Necrosis R-HSA-9686347,-0.4942092507532452,-0.8039816276870452,0.7090909090909091,0.9808119689412867,1.0,4/5,35.55%,MLKL;GNL3;RRM1;CASP8
prerank,GO_Biological_Process_2021__regulation of long-term synaptic potentiation (GO:1900271),0.37193191634202194,0.8037297327130152,0.6923076923076923,0.9388078423054819,1.0,10/20,26.72%,RELN;SHANK3;CYP46A1;GSK3B;YTHDF1;AGER;ABL1;EPHA4;ADCY1;EIF2AK4
prerank,KEGG_2021_Human__Homologous recombination,-0.3846060909463653,-0.8036667375614378,0.703125,0.981048873243887,1.0,6/30,14.26%,MUS81;BRCA2;ABRAXAS1;XRCC3;RPA3;BRCA1
prerank,GO_Biological_Process_2021__negative regulation of activated T cell proliferation (GO:0046007),0.4681181705271814,0.8036039196280051,0.775,0.9386646066811641,1.0,1/9,0.84%,SCRIB
prerank,GO_Biological_Process_2021__positive regulation of proteasomal protein catabolic process (GO:1901800),-0.33923504162756934,-0.8035260418685094,0.8055555555555556,0.9810060679515012,1.0,11/69,12.71%,DDRGK1;RACK1;ELOB;CLU;ARIH2;RNF144B;DVL1;RBX1;NOP53;HSPA1B;CSNK1D
prerank,GO_Biological_Process_2021__response to nitric oxide (GO:0071731),0.4905596233579451,0.8034790648123161,0.7674418604651163,0.9384862982363434,1.0,3/6,22.15%,KCNC2;GUCY1B1;FOXO1
prerank,KEGG_2021_Human__Biosynthesis of unsaturated fatty acids,0.412568869649121,0.8034718979245365,0.7575757575757576,0.9381366820094333,1.0,3/19,9.12%,HACD2;ELOVL6;ACOX3
prerank,Reactome_2022__Transcription Of E2F Targets Under Negative Control By DREAM Complex R-HSA-1362277,0.4270907778989007,0.8033315041915263,0.7872340425531915,0.9380114386890219,1.0,2/12,10.33%,HDAC1;LIN52
prerank,GO_Biological_Process_2021__regulation of protein tyrosine kinase activity (GO:0061097),0.3764591082477887,0.8031768435716373,0.7575757575757576,0.9379170382828678,1.0,4/26,10.03%,SRCIN1;NCK2;RELN;GRM5
prerank,GO_Biological_Process_2021__cell junction assembly (GO:0034329),-0.3696989442284895,-0.8029762070571894,0.7377049180327869,0.9816687792420393,1.0,7/56,10.71%,FLNA;NLGN2;ACTG1;SPOCK2;ITGA6;TRPV4;ACTB
prerank,GO_Biological_Process_2021__regulation of interferon-alpha production (GO:0032647),-0.4423076929132732,-0.8028847987193958,0.8507462686567164,0.9815173088516206,1.0,4/19,17.04%,NLRC3;STAT1;HAVCR2;IRF7
prerank,KEGG_2021_Human__Amoebiasis,0.3432368563322403,0.8026166158064661,0.7878787878787878,0.9385911318190281,1.0,10/47,18.03%,GNAQ;PLCB4;TNF;VCL;RAB7A;GNA11;PTK2;COL4A5;PIK3CA;PLCB3
prerank,GO_Biological_Process_2021__negative regulation of glycogen biosynthetic process (GO:0045719),-0.5321127829531845,-0.8025252970654971,0.7924528301886793,0.9815860454317958,1.0,3/5,17.44%,SELENOS;PASK;INPP5K
prerank,GO_Biological_Process_2021__negative regulation of glycogen metabolic process (GO:0070874),-0.5321127829531845,-0.8025252970654971,0.7924528301886793,0.9815860454317958,1.0,3/5,17.44%,SELENOS;PASK;INPP5K
prerank,GO_Biological_Process_2021__regulation of cellular component biogenesis (GO:0044087),-0.3929675371839896,-0.8025252926040765,0.7352941176470589,0.9812910977017982,1.0,1/31,0.52%,CD36
prerank,CellMarker_Augmented_2021__Specialist Antigen Presenting cell:Undefined,-0.4223708844697524,-0.8023914006834295,0.7352941176470589,0.981172434974271,1.0,4/22,8.15%,IL7R;SIGLEC1;IL3RA;ITGA4
prerank,Reactome_2022__MyD88 Cascade Initiated On Plasma Membrane R-HSA-975871,-0.3423613219322624,-0.8023529528812703,0.8108108108108109,0.9809482105647008,1.0,3/84,1.30%,UBC;FOS;RPS27A
prerank,"GO_Biological_Process_2021__positive regulation of phagocytosis, engulfment (GO:0060100)",-0.49032398404596744,-0.8022207236708256,0.7627118644067796,0.9808919996765706,1.0,4/7,24.91%,NCKAP1L;C3;ABCA7;RAB31
prerank,GO_Biological_Process_2021__carbohydrate derivative biosynthetic process (GO:1901137),-0.44115639158620196,-0.8019712136603079,0.7627118644067796,0.9810334270629449,1.0,2/19,11.17%,GCNT1;GK
prerank,GO_Biological_Process_2021__protein localization to centrosome (GO:0071539),-0.436277101860917,-0.8018862088576376,0.7681159420289855,0.9808608620683236,1.0,5/17,21.63%,STIL;CSNK1D;GOLGB1;DCTN2;SNX10
prerank,Reactome_2022__Pyruvate Metabolism And Citric Acid (TCA) Cycle R-HSA-71406,-0.37588787783585575,-0.8018700099704252,0.8208955223880597,0.980601831388505,1.0,11/37,20.82%,MDH2;PDHX;SLC16A3;LDHA;IDH3B;PDPR;DLST;PDK3;PDHB;ACO2;PDHA1
prerank,"GO_Biological_Process_2021__positive regulation of DNA-templated transcription, initiation (GO:2000144)",0.40282195260360765,0.8013996306590134,0.7567567567567568,0.9402918216249363,1.0,4/15,22.38%,MITF;JUN;MED24;MED13
prerank,Reactome_2022__Signaling By ALK R-HSA-201556,-0.41835273314637894,-0.8012625870434373,0.7,0.9813382033750699,1.0,4/20,13.75%,PTN;HIF1A;PRDM1;PIK3CB
prerank,GO_Biological_Process_2021__regulation of centrosome cycle (GO:0046605),-0.43116539729857095,-0.8012595592516982,0.7818181818181819,0.9810494445784279,1.0,3/16,10.59%,ATF5;XRCC3;NPM1
prerank,GO_Biological_Process_2021__protein insertion into ER membrane (GO:0045048),-0.4127374494006995,-0.8012213646376564,0.7936507936507936,0.9808338359458815,1.0,5/27,17.24%,EMD;CYB5A;EMC2;EMC1;SERP1
prerank,KEGG_2021_Human__Nicotinate and nicotinamide metabolism,-0.38808053058707215,-0.8011297309623254,0.7534246575342466,0.9806913117343236,1.0,7/24,16.77%,NUDT12;NT5C;NAMPT;ENPP3;QPRT;NMRK1;NADK2
prerank,GO_Biological_Process_2021__regulation of cell cycle (GO:0051726),-0.31868929159142356,-0.8010633735977554,0.8846153846153846,0.9805029518705691,1.0,25/190,15.42%,MX2;PPP1R15A;RUNX3;JUNB;DUSP1;GADD45B;PER2;RACK1;RPL23;MED25;GADD45GIP1;IRF1;CITED2;ING4;NOP53;PIM3;CKS2;PTPRC;NR4A1;NOTCH2;CCND1;BRCA1;CDC26;TP53INP1;NUDT6
prerank,GO_Biological_Process_2021__vascular endothelial growth factor receptor signaling pathway (GO:0048010),0.30102998826413696,0.8002730748983575,0.8125,0.9418552126803778,1.0,11/53,13.77%,NRP1;MAPK11;NCK2;WASF2;CRK;ELMO1;SHC2;ITGAV;MAPKAPK2;VAV1;PTK2
prerank,GO_Biological_Process_2021__regulation of microtubule depolymerization (GO:0031114),0.4046597138284786,0.8002203950799844,0.7857142857142857,0.9416103827235697,1.0,6/20,19.20%,MAP1S;CIB1;CLASP1;CLASP2;CAMSAP2;ATXN7
prerank,GO_Biological_Process_2021__cellular lipid catabolic process (GO:0044242),-0.41422060628055135,-0.7999116572406153,0.7931034482758621,0.9821563965642399,1.0,3/18,8.11%,LIPG;ACBD5;ENPP2
prerank,GO_Biological_Process_2021__reelin-mediated signaling pathway (GO:0038026),0.48991314407994496,0.7998886926556714,0.7674418604651163,0.9418129436964362,1.0,1/5,5.60%,RELN
prerank,GO_Biological_Process_2021__regulation of interleukin-10 production (GO:0032653),-0.4220053558250121,-0.7998799094686759,0.7205882352941176,0.9819218174079952,1.0,6/24,20.69%,LILRB4;TYROBP;CD47;NOD2;HLA-DRB1;CLEC7A
prerank,GO_Biological_Process_2021__regulation of transmembrane transporter activity (GO:0022898),0.49865204001863744,0.7997704266248992,0.7272727272727273,0.941691030245244,1.0,4/6,21.35%,PIM1;AHCYL1;SNCA;CHRM3
prerank,GO_Biological_Process_2021__negative regulation of neurogenesis (GO:0050768),-0.4064465621140466,-0.7995249305779872,0.7391304347826086,0.9822622255382852,1.0,2/27,2.81%,DYNLT1;B2M
prerank,GO_Biological_Process_2021__pathway-restricted SMAD protein phosphorylation (GO:0060389),-0.5032535223039231,-0.799467681726936,0.7818181818181819,0.9820763191458258,1.0,1/8,1.03%,TGFBR3
prerank,GO_Biological_Process_2021__phosphatidic acid biosynthetic process (GO:0006654),-0.3874030275788685,-0.7991606387229121,0.7384615384615385,0.9823220755628678,1.0,3/31,5.77%,LPCAT1;DDHD2;GNPAT
prerank,KEGG_2021_Human__Circadian entrainment,-0.35874713201737357,-0.7991515833167552,0.7857142857142857,0.982047281520015,1.0,5/64,8.36%,FOS;PER3;PER2;GNB5;CALM1
prerank,Reactome_2022__Signal Regulatory Protein Family Interactions R-HSA-391160,0.40780965562460636,0.7990847276782322,0.717391304347826,0.9425023791307072,1.0,3/11,14.02%,SIRPA;PTK2;SKAP2
prerank,GO_Biological_Process_2021__positive regulation of cell cycle G1/S phase transition (GO:1902808),0.3783567057426986,0.7989988608161775,0.7368421052631579,0.9422445356869711,1.0,2/24,5.15%,ANXA1;UBE2E2
prerank,PanglaoDB_Augmented_2021__Luminal Epithelial Cells,-0.4271124633205441,-0.7988745286750184,0.7368421052631579,0.9821581204476243,1.0,7/21,13.66%,CEBPD;CLDN7;TNFSF10;OVOL2;HIF1A;BTG1;UXT
prerank,GO_Biological_Process_2021__negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),-0.36662768469250107,-0.7988082077054303,0.7205882352941176,0.9819589934355704,1.0,3/46,2.43%,UBC;RPS27A;SNX6
prerank,Reactome_2022__RNA Polymerase III Transcription Initiation From Type 3 Promoter R-HSA-76071,-0.41793625812907503,-0.7987411936260082,0.8032786885245902,0.9817761492273863,1.0,1/21,2.61%,SNAPC1
prerank,PanglaoDB_Augmented_2021__Sertoli Cells,-0.36993672267530214,-0.7987126816551776,0.8059701492537313,0.9815368576264745,1.0,21/69,17.39%,COL18A1;MRO;CD55;PADI2;CLU;SLC16A3;NR1H2;EPHX1;PRLR;PFKFB3;ABLIM3;TSPAN9;SERPING1;NOTCH2;C3;AGT;VASN;DOCK6;MATN2;CRYAB;GPRC5C
prerank,GO_Biological_Process_2021__regulation of gastrulation (GO:0010470),0.4796897948409498,0.7986067963030098,0.65,0.9424990875582288,1.0,5/8,16.96%,PHLDB1;DAG1;POGLUT1;CLASP1;CLASP2
prerank,GO_Biological_Process_2021__small RNA loading onto RISC (GO:0070922),-0.5015884375967494,-0.7984443732370673,0.7692307692307693,0.981642331840772,1.0,2/7,20.58%,ADAR;DICER1
prerank,Reactome_2022__Sensory Processing Of Sound By Outer Hair Cells Of Cochlea R-HSA-9662361,0.3646826022839323,0.7983086334326469,0.7142857142857143,0.9426527968610339,1.0,4/30,1.68%,EPS8;MSN;GSN;PCDH15
prerank,GO_Biological_Process_2021__dosage compensation (GO:0007549),-0.46761991077484955,-0.7982736408458572,0.8,0.9816023986816238,1.0,5/9,26.07%,BRCA1;LRIF1;SMCHD1;YTHDC1;METTL3
prerank,GO_Biological_Process_2021__regulation of viral release from host cell (GO:1902186),-0.46729254191625946,-0.7981719736015211,0.7910447761194029,0.9815006018595516,1.0,3/16,12.55%,TRIM5;TRIM13;VPS37B
prerank,GO_Biological_Process_2021__endoplasmic reticulum to cytosol transport (GO:1903513),0.41323193217663406,0.7980351243195336,0.7631578947368421,0.9427932672521655,1.0,2/15,8.99%,SEL1L;AUP1
prerank,GO_Biological_Process_2021__mitochondrion transport along microtubule (GO:0047497),0.40469790297153807,0.7979404797096721,0.7878787878787878,0.9425881760238235,1.0,1/12,1.80%,MAP1S
prerank,GO_Biological_Process_2021__positive regulation of natural killer cell activation (GO:0032816),0.46227887120460875,0.7976924327650632,0.7317073170731707,0.9425712012442645,1.0,1/10,1.16%,ZBTB1
prerank,Reactome_2022__Citric Acid Cycle (TCA Cycle) R-HSA-71403,-0.43081409001124493,-0.797581183391162,0.71875,0.9821224644364343,1.0,2/16,10.29%,MDH2;IDH3B
prerank,GO_Biological_Process_2021__regulation of mitochondrial depolarization (GO:0051900),-0.5195256930980681,-0.7974863238852996,0.75,0.9819694792956395,1.0,1/5,4.24%,RACK1
prerank,CellMarker_Augmented_2021__Adipose Progenitor cell:Adipose Tissue,0.32885636252235806,0.7974102714095407,0.8125,0.942702805052362,1.0,13/57,12.95%,NRP1;FKBP9;SERPINE1;VCL;LOXL2;REEP3;ITGAV;EXT1;FAM114A1;ANO6;ITGA2;DCBLD2;TWSG1
prerank,CellMarker_Augmented_2021__Mesenchymal Stromal cell:Placenta,-0.37951131129291826,-0.7974021760250983,0.8082191780821918,0.9818273387705932,1.0,16/50,18.15%,MS4A4A;SIGLEC1;CD93;F13A1;PECAM1;ENPP2;MS4A6A;A2M;FLT1;PTPRC;SERPING1;APOL3;HLA-DPA1;HLA-DPB1;GIMAP4;FOLR2
prerank,Reactome_2022__G Beta:Gamma Signaling Thru PI3Kgamma R-HSA-392451,-0.45438665832849423,-0.7973775298654128,0.7761194029850746,0.9815697181617679,1.0,3/15,20.71%,GNB5;GNB2;PIK3R6
prerank,GO_Biological_Process_2021__regulation of protein localization to early endosome (GO:1902965),0.47667773674369274,0.7972773766803853,0.7291666666666666,0.9418269047430529,1.0,1/6,1.49%,MSN
prerank,GO_Biological_Process_2021__positive regulation of protein localization to early endosome (GO:1902966),0.47667773674369274,0.7972773766803853,0.7291666666666666,0.9418269047430529,1.0,1/6,1.49%,MSN
prerank,GO_Biological_Process_2021__positive regulation of protein localization to endosome (GO:1905668),0.47667773674369274,0.7972773766803853,0.7291666666666666,0.9418269047430529,1.0,1/6,1.49%,MSN
prerank,GO_Biological_Process_2021__stabilization of membrane potential (GO:0030322),-0.4968187685700267,-0.7971676554294856,0.7083333333333334,0.9816588421367541,1.0,1/5,4.77%,CHCHD10
prerank,GO_Biological_Process_2021__negative regulation of smooth muscle cell migration (GO:0014912),-0.4479701553387111,-0.7969589172339855,0.6909090909090909,0.9817129956461353,1.0,2/11,6.72%,AIF1;CORO1B
prerank,GO_Biological_Process_2021__amino sugar catabolic process (GO:0046348),0.4664839925951875,0.7969346037692303,0.7435897435897436,0.9420676661320978,1.0,2/7,20.15%,RENBP;GNPDA1
prerank,Reactome_2022__POLB-Dependent Long Patch Base Excision Repair R-HSA-110362,-0.519670278313953,-0.7965783898977445,0.75,0.9820007252216955,1.0,4/7,17.06%,PARP2;PARG;APEX1;LRIG1
prerank,GO_Biological_Process_2021__membrane protein proteolysis (GO:0033619),-0.3906893077509866,-0.7965520443314227,0.7377049180327869,0.9817675188854839,1.0,1/27,1.65%,PRKCQ
prerank,GO_Biological_Process_2021__positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),-0.3382579468568983,-0.7964751667422612,0.835820895522388,0.9815827553141245,1.0,11/63,12.71%,DDRGK1;RACK1;ELOB;CLU;ARIH2;RNF144B;DVL1;RBX1;NOP53;HSPA1B;CSNK1D
prerank,Reactome_2022__SARS-CoV-2 Activates/Modulates Innate And Adaptive Immune Responses R-HSA-9705671,-0.3419107824288827,-0.7964121710990232,0.821917808219178,0.9813766396000029,1.0,13/92,17.60%,HLA-B;B2M;HLA-C;NLRP12;HLA-F;STAT1;NUP50;STING1;NOD2;HLA-E;SEC13;IRF7;NUP88
prerank,Reactome_2022__Signaling By ERBB2 ECD Mutants R-HSA-9665348,0.44776539905350043,0.7963536528988409,0.7111111111111111,0.9427531108700884,1.0,1/11,1.00%,PIGU
prerank,Reactome_2022__Cation-coupled Chloride Cotransporters R-HSA-426117,0.509962751253404,0.7963233297226715,0.6666666666666666,0.9424614529647002,1.0,3/5,15.33%,SLC12A6;SLC12A5;SLC12A2
prerank,GO_Biological_Process_2021__protein polyubiquitination (GO:0000209),0.2991002998455797,0.7961427039448986,0.8888888888888888,0.9424009949070258,1.0,41/254,15.29%,UBE2D1;MKRN3;FBXO30;KBTBD6;UBE2J1;FBXL14;UBE2O;MARCHF5;FBXO32;DDA1;UBE2E2;UBE3D;UBE2D2;FZR1;NEDD4L;RMND5A;SHARPIN;CDC23;MDM2;BTRC;SASH1;RNF19B;MARCHF1;RNF20;UBE2L3;FBXW11;FBXW7;RNF217;UBE2N;KLHL42;FBXL12;FBXL7;BARD1;FBXO27;SMURF1;TRAF6;RNF6;ANAPC1;FBXO11;BLMH;UBE2J2
prerank,GO_Biological_Process_2021__negative regulation of mitotic metaphase/anaphase transition (GO:0045841),0.44665734102794563,0.7961362747368069,0.6578947368421053,0.9410107823391253,1.0,2/11,12.59%,TEX14;ZNF207
prerank,GO_Biological_Process_2021__mitotic spindle checkpoint signaling (GO:0071174),0.44665734102794563,0.7961362747368069,0.6578947368421053,0.9410107823391253,1.0,2/11,12.59%,TEX14;ZNF207
prerank,GO_Biological_Process_2021__mitotic spindle assembly checkpoint signaling (GO:0007094),0.44665734102794563,0.7961362747368069,0.6578947368421053,0.9410107823391253,1.0,2/11,12.59%,TEX14;ZNF207
prerank,GO_Biological_Process_2021__spindle assembly checkpoint signaling (GO:0071173),0.44665734102794563,0.7961362747368069,0.6578947368421053,0.9410107823391253,1.0,2/11,12.59%,TEX14;ZNF207
prerank,GO_Biological_Process_2021__pyrimidine nucleobase biosynthetic process (GO:0019856),-0.5579320436031353,-0.7959790761731285,0.7758620689655172,0.9818277264755787,1.0,1/5,11.81%,DHODH
prerank,GO_Biological_Process_2021__modulation by symbiont of entry into host (GO:0052372),-0.4599609594480476,-0.7957890837650926,0.7428571428571429,0.9818924578417254,1.0,2/12,5.98%,TRIM5;TRIM22
prerank,GO_Biological_Process_2021__negative regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902548),0.47727202634833255,0.7956858585602596,0.7441860465116279,0.941377279738444,1.0,1/6,1.76%,SPRY2
prerank,GO_Biological_Process_2021__cellular component maintenance (GO:0043954),0.4109998741785444,0.7956181115339018,0.696969696969697,0.9411608195973579,1.0,1/10,1.37%,IGF1R
prerank,GO_Biological_Process_2021__regulation of hepatocyte proliferation (GO:2000345),0.5007392134990023,0.7955604564595657,0.7222222222222222,0.9409010532695151,1.0,2/5,10.80%,HPN;FBXW7
prerank,Reactome_2022__Non-integrin membrane-ECM Interactions R-HSA-3000171,0.3648309126986624,0.7955557848926976,0.8648648648648649,0.9405502325934264,1.0,4/25,12.55%,PDGFA;DAG1;ITGAV;ITGA2
prerank,"GO_Biological_Process_2021__exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000467)",-0.48329376325517537,-0.7955151248923946,0.6949152542372882,0.9817565278680844,1.0,3/8,25.53%,EXOSC10;ERI2;ERI3
prerank,GO_Biological_Process_2021__exonucleolytic trimming involved in rRNA processing (GO:0000459),-0.48329376325517537,-0.7955151248923946,0.6949152542372882,0.9817565278680844,1.0,3/8,25.53%,EXOSC10;ERI2;ERI3
prerank,Reactome_2022__Other Semaphorin Interactions R-HSA-416700,0.42876189965674016,0.7954122321053134,0.7631578947368421,0.9404689720532332,1.0,3/15,7.75%,SEMA5A;PLXNA2;PLXNC1
prerank,CellMarker_Augmented_2021__Glial cell:Undefined,-0.49104803867903546,-0.7953468176970454,0.6964285714285714,0.9817462170588899,1.0,3/9,12.82%,CD14;NEFL;PTPRC
prerank,CellMarker_Augmented_2021__Pericyte:Subcutaneous Adipose Tissue,-0.3974711559663042,-0.7952886708663629,0.8,0.9815297080897165,1.0,8/35,12.34%,CD93;PECAM1;PCDH12;PTPRB;SPARCL1;ABCA8;A2M;FLT1
prerank,Reactome_2022__Formation Of HIV-1 Elongation Complex Containing HIV-1 Tat R-HSA-167200,-0.3665332370002906,-0.7951495879061166,0.7833333333333333,0.9814418324255578,1.0,5/37,9.87%,GTF2H5;CTDP1;ELOB;POLR2G;NCBP2
prerank,GO_Biological_Process_2021__response to purine-containing compound (GO:0014074),-0.4753522134018604,-0.7951229568396949,0.6896551724137931,0.9812148367166268,1.0,2/11,9.56%,DUOX1;STAT1
prerank,CellMarker_Augmented_2021__Stromal cell:Undefined,0.4486024932467256,0.7951193281642872,0.75,0.9406352608129085,1.0,1/13,0.66%,PDPN
prerank,GO_Biological_Process_2021__neurotransmitter transport (GO:0006836),-0.3851648309858322,-0.7950408344419835,0.7794117647058824,0.9810468387611719,1.0,6/47,9.43%,RIMS1;SLC38A1;GLUL;RAB3A;SLC6A16;DVL1
prerank,GO_Biological_Process_2021__regulation of stress fiber assembly (GO:0051492),0.32850164375616886,0.794604051843932,0.7692307692307693,0.9410965654794445,1.0,18/54,23.61%,NRP1;WASF2;TMEFF2;SLC9A1;TJP1;FERMT2;CLASP1;RAPGEF3;TGFBR1;CLASP2;ALMS1;PPM1F;PPM1E;ARAP1;LIMCH1;ABL1;ARHGEF10L;PIK3R1
prerank,Reactome_2022__mRNA Decay By 5 To 3 Exoribonuclease R-HSA-430039,0.40437371082690965,0.794591497040368,0.723404255319149,0.9407635491567756,1.0,3/13,14.32%,DCP1B;LSM6;LSM1
prerank,GO_Biological_Process_2021__negative regulation of vascular endothelial growth factor signaling pathway (GO:1900747),0.4944086169428473,0.794522259347407,0.7142857142857143,0.9405608925116561,1.0,1/5,1.76%,SPRY2
prerank,GO_Biological_Process_2021__protein homotetramerization (GO:0051289),-0.42111815992649604,-0.7944926007155289,0.78125,0.9817241775568235,1.0,2/30,2.81%,APIP;B2M
prerank,GO_Biological_Process_2021__lactation (GO:0007595),-0.524651775318099,-0.7944421183686229,0.7358490566037735,0.9812197659037879,1.0,2/5,11.19%,PRLR;VEGFA
prerank,GO_Biological_Process_2021__body fluid secretion (GO:0007589),-0.524651775318099,-0.7944421183686229,0.7358490566037735,0.9812197659037879,1.0,2/5,11.19%,PRLR;VEGFA
prerank,GO_Biological_Process_2021__positive regulation of protein depolymerization (GO:1901881),0.4511275516736208,0.793872305531022,0.8260869565217391,0.9411907924168493,1.0,1/6,1.58%,SEMA5A
prerank,GO_Biological_Process_2021__regulation of viral entry into host cell (GO:0046596),0.37280260035860846,0.7938417756077357,0.6363636363636364,0.9409187862659163,1.0,3/22,4.08%,HS3ST5;GSN;TRIM26
prerank,GO_Biological_Process_2021__regulation of dendritic cell chemotaxis (GO:2000508),0.4985778277207759,0.7937952175514853,0.7380952380952381,0.9406903045831165,1.0,2/5,23.45%,LGALS9;SLAMF8
prerank,GO_Biological_Process_2021__mitochondrial protein catabolic process (GO:0035694),-0.5282270072402966,-0.7937937424872817,0.7636363636363637,0.9819552446970754,1.0,4/5,40.37%,BNIP3;PISD;AFG1L;BNIP3L
prerank,GO_Biological_Process_2021__microtubule polymerization or depolymerization (GO:0031109),-0.4375274893280836,-0.7937421614730408,0.765625,0.9817525450254607,1.0,4/15,15.54%,FGF13;TRPV4;STMN1;MAP7D3
prerank,Reactome_2022__FCGR3A-mediated Phagocytosis R-HSA-9664422,-0.3632616526643394,-0.7937036118383207,0.8472222222222222,0.9814912069066422,1.0,8/52,12.39%,VAV3;YES1;BTK;CD247;FYN;ACTG1;NCKAP1L;CYFIP2
prerank,GO_Biological_Process_2021__response to estrogen (GO:0043627),-0.4225809431921952,-0.7936258333678587,0.7758620689655172,0.9813208052172058,1.0,4/20,20.70%,GSTM3;CITED2;BRCA1;WBP2
prerank,GO_Biological_Process_2021__positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),0.4195528971008072,0.7934747179957112,0.7567567567567568,0.9408820622132259,1.0,3/16,13.77%,FGF2;P2RY12;PTK2
prerank,Reactome_2022__BH3-only Proteins Associate With And Inactivate Anti-Apoptotic BCL-2 Members R-HSA-111453,-0.5251375389216311,-0.793280153870066,0.7272727272727273,0.9816469867111582,1.0,1/6,12.96%,BMF
prerank,Reactome_2022__RHOT2 GTPase Cycle R-HSA-9013419,0.4935791339940754,0.7931907930429921,0.7659574468085106,0.9410433743455108,1.0,4/7,25.09%,MFN1;TRAK2;RAP1GDS1;TRAK1
prerank,GO_Biological_Process_2021__stem cell development (GO:0048864),0.4961468446748549,0.7931784929880175,0.7272727272727273,0.9407285529831773,1.0,3/7,16.85%,NRG1;KLHL12;NOLC1
prerank,GO_Biological_Process_2021__negative regulation of protein kinase activity (GO:0006469),0.3025219115207857,0.7929603083758632,0.8484848484848485,0.940712444913666,1.0,10/67,12.21%,QARS1;SRCIN1;SPRED1;TSC2;GNAQ;CEP85;YWHAG;DEPTOR;SORL1;NF1
prerank,GO_Biological_Process_2021__actin nucleation (GO:0045010),0.4043480041119837,0.7928527364133758,0.7727272727272727,0.9405277055524776,1.0,1/14,4.43%,SPIRE2
prerank,GO_Biological_Process_2021__negative regulation of response to external stimulus (GO:0032102),-0.37683825733146714,-0.792845577618394,0.8028169014084507,0.9819836490786511,1.0,11/67,9.83%,SIGIRR;CARD16;NLRC3;DHX58;RORA;VPS35;NLRP12;TNFAIP3;ENPP3;METRNL;SELENOS
prerank,GO_Biological_Process_2021__endodermal cell fate commitment (GO:0001711),-0.4901247819482361,-0.792620018617913,0.7142857142857143,0.9820053259585375,1.0,2/5,32.34%,LEO1;CTR9
prerank,GO_Biological_Process_2021__phospholipid catabolic process (GO:0009395),-0.4317494439675868,-0.7924581941289921,0.7222222222222222,0.981965651502469,1.0,3/13,8.11%,LIPG;GDPD1;ENPP2
prerank,GO_Biological_Process_2021__positive regulation of rRNA processing (GO:2000234),-0.483490920751518,-0.7923337521258869,0.7818181818181819,0.9818353529750724,1.0,1/8,7.38%,BUD23
prerank,GO_Biological_Process_2021__histone acetylation (GO:0016573),-0.36891518718933486,-0.7921710829573854,0.8032786885245902,0.9817984175115525,1.0,8/59,12.89%,TAF6L;POLE3;ING3;ING5;MSL3;BRCA2;ING4;KAT5
prerank,GO_Biological_Process_2021__maintenance of DNA methylation (GO:0010216),0.4991033673755273,0.7921315956097321,0.7142857142857143,0.9412422002654124,1.0,1/6,2.05%,UHRF2
prerank,GO_Biological_Process_2021__synaptic vesicle exocytosis (GO:0016079),-0.3934995105403055,-0.7920223572902992,0.765625,0.9817321940578262,1.0,3/24,11.60%,RIMS1;RAB3A;STX19
prerank,KEGG_2021_Human__Platelet activation,-0.3357887168943167,-0.7920208674036178,0.7866666666666666,0.9814449191714797,1.0,10/89,10.71%,MYLK;FCER1G;BTK;ARHGEF1;FYN;PPP1CB;ACTG1;FERMT3;MYL12A;ACTB
prerank,GO_Biological_Process_2021__chordate embryonic development (GO:0043009),0.38170456539812414,0.7919226584137115,0.78125,0.9412907343491792,1.0,5/28,7.13%,PKD2;PKD1;ARNT2;WNT5A;LIG4
prerank,GO_Biological_Process_2021__regulation of attachment of spindle microtubules to kinetochore (GO:0051988),0.4143843967593517,0.7917689532764715,0.6666666666666666,0.9411448604642426,1.0,4/7,36.44%,ECT2;SIRT2;CDC42;APC
prerank,Reactome_2022__ZBP1(DAI) Mediated Induction Of Type I IFNs R-HSA-1606322,-0.43078942091524824,-0.7916717401385878,0.7638888888888888,0.9817276863081472,1.0,8/16,34.98%,IRF3;NKIRAS2;MYD88;NFKBIA;CHUK;IKBKB;TLR3;RELA
prerank,CellMarker_Augmented_2021__PROCR+ Progenitor cell:Small Intestine,0.49984326448130917,0.7914870551541022,0.7708333333333334,0.9412797501929101,1.0,3/6,17.03%,RCN3;FLRT2;CUEDC2
prerank,GO_Biological_Process_2021__ketone body biosynthetic process (GO:0046951),-0.4710845551818177,-0.7911476923707937,0.7017543859649122,0.9822605304168517,1.0,4/7,27.15%,HMGCL;BDH1;AACS;SLC27A5
prerank,KEGG_2021_Human__PD-L1 expression and PD-1 checkpoint pathway in cancer,-0.36556407888035525,-0.7911046523054576,0.835820895522388,0.9820452112898129,1.0,7/66,13.75%,FOS;PRKCQ;CD247;STAT1;HIF1A;IFNGR2;PIK3CB
prerank,GO_Biological_Process_2021__establishment of vesicle localization (GO:0051650),-0.44320732187602596,-0.7910266563235854,0.75,0.9818858917630445,1.0,1/14,5.18%,RAB11A
prerank,KEGG_2021_Human__Prolactin signaling pathway,-0.3791962400683026,-0.7910070749622178,0.782608695652174,0.9816309129024694,1.0,7/46,14.20%,FOS;PRLR;STAT1;IRF1;PIK3CB;ESR2;CCND1
prerank,GO_Biological_Process_2021__histone H2B ubiquitination (GO:0033523),-0.4806179814871971,-0.7908565280148084,0.7924528301886793,0.9815515803462495,1.0,1/9,5.72%,DTX3L
prerank,GO_Biological_Process_2021__transcription initiation from RNA polymerase I promoter (GO:0006361),-0.3862564653651594,-0.7907863280668468,0.7903225806451613,0.9813952054167143,1.0,2/26,4.34%,TAF1D;GTF2H5
prerank,Reactome_2022__Pyruvate Metabolism R-HSA-70268,-0.4250256152500389,-0.7907201484868749,0.7413793103448276,0.9812123480066172,1.0,7/19,20.82%,PDHX;SLC16A3;LDHA;PDPR;PDK3;PDHB;PDHA1
prerank,GO_Biological_Process_2021__cytosolic transport (GO:0016482),0.2865523983692605,0.7906783193698107,1.0,0.9421526064474453,1.0,15/101,14.60%,UBE2O;MYO1D;PTPN23;BAIAP3;TBC1D5;TBC1D10B;SORT1;RAB7A;RBSN;VTI1A;LAPTM5;RAB6A;YKT6;EVI5;STX6
prerank,Reactome_2022__RHOQ GTPase Cycle R-HSA-9013406,-0.3713541715105049,-0.7906476573948218,0.875,0.9810295983181164,1.0,4/51,6.92%,TFRC;MPP7;JUP;OBSCN
prerank,CellMarker_Augmented_2021__Granulocyte:Undefined,0.4514132566942405,0.7906208314159175,0.6511627906976745,0.9418771380895826,1.0,1/6,8.83%,CD33
prerank,GO_Biological_Process_2021__negative regulation of protein polyubiquitination (GO:1902915),-0.48984233066716915,-0.7905272265798176,0.76,0.9809372567808501,1.0,2/5,37.23%,PPIA;PARP10
prerank,GO_Biological_Process_2021__neuron maturation (GO:0042551),0.3938779967963934,0.79032855763417,0.7647058823529411,0.9419598512397219,1.0,1/14,0.85%,LGI4
prerank,GO_Biological_Process_2021__positive regulation of Ras protein signal transduction (GO:0046579),-0.36857456049691445,-0.7903244778434257,0.782608695652174,0.9809432089003266,1.0,10/38,22.82%,IGF1;ARHGEF3;P2RY8;PIK3CB;LPAR6;NOTCH2;RAC1;RASGRP4;LYN;RAPGEF1
prerank,GO_Biological_Process_2021__endosomal vesicle fusion (GO:0034058),-0.4691296992911499,-0.7900441615074419,0.7450980392156863,0.9810314418883461,1.0,1/8,9.09%,SAMD9
prerank,Reactome_2022__Gene Expression (Transcription) R-HSA-74160,-0.2926250035790965,-0.7900348388501848,0.96875,0.9807613932153049,1.0,121/1014,14.41%,NR4A3;MYBL1;UBC;SLC2A3;H2BC4;H2BC26;H2AC20;CYCS;FOS;RPS27A;RUNX3;PRKCQ;H2AC6;DDIT4;COX7C;DHX38;ABCA6;SNAPC1;CHD3;BTG2;CSTF2T;PRELID1;PSMB3;YES1;RORA;ZNF790;TAF1D;GTF3C6;SSB;ZNF689;GTF2H5;CTDP1;ELOB;ING3;HUS1;ING5;MOV10L1;ZNF331;NR1H2;LAMTOR5;H3-3B;H2AJ;TXN2;MED25;H2BC21;POLR2G;PSMB6;RNMT;PSMA7;SGK1;ITGA4;ZNF649;ZNF570;H2BC5;CALM1;ZNF600;RBPJ;EIF4A3;COX4I1;TMEM219;ZFP30;COX5B;PSMB9;ZNF394;VENTX;H2BC9;ZNF589;CHTOP;STAT1;U2AF2;NCBP2;SMARCD1;BCL2L14;ZNF266;ZNF70;TDRKH;NPM1;CITED2;ZNF546;NUP50;COX18;ZNF354A;RBX1;VEGFA;ZNF528;ITGAL;NABP1;BTG1;ZNF432;ZNF586;PSMD12;ANAPC11;MAX;SST;H2BC11;PSMD8;PSMA5;PRDM1;KAT5;TAF1C;COX6C;DNMT1;SRSF2;SRSF7;RAD9A;ZNF549;ZNF302;NR4A1;UXT;ZNF558;ZNF18;ESR2;NOTCH2;TET1;RPA3;ZNF681;CCND1;BRCA1;ZNF333;ZKSCAN3;COLEC12
prerank,GO_Biological_Process_2021__protein import into mitochondrial matrix (GO:0030150),-0.4870121853576696,-0.7898895025310715,0.7017543859649122,0.9806878086114127,1.0,3/10,7.54%,DNAJC19;TIMM44;TIMM21
prerank,GO_Biological_Process_2021__regulation of endopeptidase activity (GO:0052548),-0.3786215658655324,-0.7898531210973939,0.746268656716418,0.9804524956943772,1.0,13/35,19.69%,GAPDH;PRELID1;SPOCK2;PSMB9;SERPING1;TIMP2;AGT;PSMA3;APH1B;SERPINF1;PSME2;SPOCK1;PSME1
prerank,GO_Biological_Process_2021__histone H4-K5 acetylation (GO:0043981),-0.43530416864246213,-0.7898172729521794,0.7931034482758621,0.9799451786681403,1.0,4/15,25.42%,ING4;KAT8;KANSL1;OGT
prerank,GO_Biological_Process_2021__histone H4-K8 acetylation (GO:0043982),-0.43530416864246213,-0.7898172729521794,0.7931034482758621,0.9799451786681403,1.0,4/15,25.42%,ING4;KAT8;KANSL1;OGT
prerank,CellMarker_Augmented_2021__Basophil:Blood,0.5007571548121417,0.7895525248387498,0.75,0.9427840618570077,1.0,2/6,1.92%,CD22;SMAD1
prerank,GO_Biological_Process_2021__hexose biosynthetic process (GO:0019319),-0.38753658789508133,-0.7893041803603026,0.7702702702702703,0.9804760418725854,1.0,4/30,6.17%,GAPDH;MDH2;PER2;G6PC3
prerank,Reactome_2022__Nucleotide Salvage R-HSA-8956321,0.4381117495979611,0.7892311735377563,0.7105263157894737,0.9429956722227026,1.0,4/14,18.49%,DGUOK;UCK2;ADK;UPP1
prerank,CellMarker_Augmented_2021__Cancer cell:Blood,-0.4840224165127839,-0.7891686132576664,0.6833333333333333,0.9803867558593042,1.0,3/6,18.52%,CD44;PTPRC;ITGB1
prerank,GO_Biological_Process_2021__negative regulation of growth (GO:0045926),-0.3399481562237476,-0.7889315317279723,0.8133333333333334,0.980461704479941,1.0,14/77,16.40%,MT2A;RACK1;ING5;TP53TG5;FBP1;BTG1;ING4;HSPA1B;ESR2;NOTCH2;HSPA1A;TCHP;PSRC1;MT3
prerank,GO_Biological_Process_2021__regulation of protein localization to cell surface (GO:2000008),-0.3902254227708881,-0.7886700647038005,0.8095238095238095,0.9805763189462157,1.0,1/25,0.78%,RIC3
prerank,GO_Biological_Process_2021__embryonic axis specification (GO:0000578),-0.5227814951980492,-0.7886414629384851,0.7457627118644068,0.9803494617119118,1.0,1/6,2.84%,STIL
prerank,Reactome_2022__BBSome-mediated Cargo-Targeting To Cilium R-HSA-5620922,0.39671825297951824,0.7883793903373826,0.7631578947368421,0.9439007463117217,1.0,4/17,13.21%,BBS9;TCP1;RAB3IP;CCT3
prerank,Reactome_2022__MET Activates PTK2 Signaling R-HSA-8874081,-0.4654616104756343,-0.7882697552351512,0.7894736842105263,0.9806809949762818,1.0,3/9,19.27%,RNMT;ITGB1;LAMA2
prerank,GO_Biological_Process_2021__regulation of glycoprotein biosynthetic process (GO:0010559),0.4809039401581962,0.7880727358071933,0.6590909090909091,0.944029962058628,1.0,1/5,1.57%,ABCA2
prerank,CellMarker_Augmented_2021__Extravillous Trophoblast cell:Placenta,-0.40856086673909914,-0.7878172848592953,0.7941176470588235,0.9810705236567869,1.0,5/27,8.11%,CH25H;PID1;GABARAPL1;EPB41L3;ENPP2
prerank,Reactome_2022__Interleukin-6 Signaling R-HSA-1059683,-0.47380632180178006,-0.7875169798584896,0.7735849056603774,0.9812139116325115,1.0,1/10,9.56%,STAT1
prerank,GO_Biological_Process_2021__regulation of heart contraction (GO:0008016),0.3277901682015862,0.7874863093193306,0.875,0.9445163987388229,1.0,3/44,3.23%,TRPC1;SMAD7;KCNIP2
prerank,GO_Biological_Process_2021__negative regulation of hydrolase activity (GO:0051346),0.3749852298583302,0.7874686242449495,0.7619047619047619,0.9442020387118075,1.0,4/28,10.86%,SLC39A14;LRRK2;LRCH1;WNK1
prerank,Reactome_2022__Anchoring Of Basal Body To Plasma Membrane R-HSA-5620912,-0.3452166550513024,-0.7873039483297686,0.8055555555555556,0.9812620515965291,1.0,21/78,24.63%,RPGRIP1L;SSNA1;RAB11A;CEP72;CEP164;TMEM67;CSNK1D;TUBB4B;PRKAR2B;CC2D2A;DCTN2;AKAP9;DYNC1I2;NINL;SFI1;HAUS5;TUBB4A;SCLT1;CEP250;TCTN1;CEP162
prerank,GO_Biological_Process_2021__positive regulation of myeloid cell differentiation (GO:0045639),-0.38371714707886456,-0.7872563585870503,0.8285714285714286,0.9810617524760281,1.0,8/30,14.43%,ETS1;ANKRD54;STAT1;NCKAP1L;HIF1A;HSPA1B;ZNF16;HSPA1A
prerank,PanglaoDB_Augmented_2021__Spermatozoa,-0.35532873546364685,-0.7872256879390753,0.7761194029850746,0.9808536450109385,1.0,19/72,16.72%,CCDC170;MGLL;ANKUB1;CD14;SGK1;CFLAR;MS4A6A;HLA-DRA;SMIM14;DNAH12;RASSF4;APOL6;HLA-DPA1;C3;HLA-DMB;CD74;ALDH2;GSAP;HLA-DPB1
prerank,GO_Biological_Process_2021__regulation of receptor signaling pathway via JAK-STAT (GO:0046425),-0.4049736564976232,-0.7871618558875315,0.7121212121212122,0.980658865030292,1.0,2/21,5.34%,CCL5;IL10RA
prerank,GO_Biological_Process_2021__pre-mRNA cleavage required for polyadenylation (GO:0098789),-0.49344885630131763,-0.7870766996989368,0.7796610169491526,0.9805196463981888,1.0,2/9,9.87%,CSTF2T;NCBP2
prerank,GO_Biological_Process_2021__macroautophagy (GO:0016236),0.28134621277933763,0.7865451991030888,0.967741935483871,0.9453849505942938,1.0,24/97,21.01%,PRKAB2;MAP1LC3A;TOMM70;TBC1D5;UBXN6;MFN1;RUBCNL;PIP4K2A;PRKAB1;ILRUN;ATP13A2;HDAC10;PRKAA1;ATG16L1;ATG13;ARL8B;TCIRG1;DYNLL2;CSNK2A1;EI24;VTA1;MTERF3;SNAP29;ULK1
prerank,KEGG_2021_Human__Glutathione metabolism,-0.4002356540576941,-0.7865347866364946,0.7457627118644068,0.9810324843574715,1.0,9/28,14.52%,GSTM4;GSTP1;ODC1;GSTK1;GCLM;GSTM3;GPX4;GPX1;SMS
prerank,GO_Biological_Process_2021__late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),-0.4454793163599803,-0.7863920630634262,0.7333333333333333,0.980951291545581,1.0,5/12,24.43%,SNF8;VPS28;TMEM50B;CHMP6;VPS36
prerank,GO_Biological_Process_2021__ciliary basal body-plasma membrane docking (GO:0097711),-0.34655433496095767,-0.7861067599895091,0.8082191780821918,0.981126035261279,1.0,21/76,24.63%,RPGRIP1L;SSNA1;RAB11A;CEP72;CEP164;TMEM67;CSNK1D;TUBB4B;PRKAR2B;CC2D2A;DCTN2;AKAP9;DYNC1I2;NINL;SFI1;HAUS5;TUBB4A;SCLT1;CEP250;TCTN1;CEP162
prerank,GO_Biological_Process_2021__RNA splicing (GO:0008380),-0.3491678225236679,-0.7857890753285007,0.8589743589743589,0.981342872946213,1.0,24/84,19.10%,DHX16;ZCRB1;SNRPD2;RNPC3;WDR83;SRPK1;PDCD7;ZRSR2;NCBP2;SMNDC1;PRPF3;DDX23;SRSF2;USB1;SRSF7;SNRPA1;SLU7;SCNM1;LSM4;LUC7L3;PRPF18;NRDE2;BCAS2;PRPF4
prerank,KEGG_2021_Human__Regulation of lipolysis in adipocytes,0.327669544382915,0.7857015412943873,0.6896551724137931,0.9465884907349806,1.0,8/34,20.93%,NPY1R;ADCY9;PDE3B;ADCY6;AKT2;PIK3CA;AKT3;PRKG1
prerank,GO_Biological_Process_2021__N-acetylneuraminate metabolic process (GO:0006054),0.42728193267334175,0.7854269077355482,0.6842105263157895,0.9466476981033107,1.0,2/9,20.15%,RENBP;GNPDA1
prerank,GO_Biological_Process_2021__protein-containing complex subunit organization (GO:0043933),0.2998988472868569,0.7852896212712946,0.9142857142857143,0.9465478698519688,1.0,5/83,6.51%,PPARGC1A;MITF;PICALM;LIN7A;MAGI1
prerank,Reactome_2022__Signaling By FGFR1 In Disease R-HSA-5655302,0.35221622420422133,0.7852549822121452,0.7380952380952381,0.9462677043603767,1.0,1/28,1.00%,PIGU
prerank,GO_Biological_Process_2021__regulation of mitochondrial membrane potential (GO:0051881),0.34050832307325657,0.7852084136045892,0.8076923076923077,0.946013508808051,1.0,4/28,7.54%,RNF122;LRRK2;SPART;PPA2
prerank,GO_Biological_Process_2021__telomeric loop disassembly (GO:0090657),-0.49011677100669954,-0.7851734109662366,0.7454545454545455,0.9821053370867404,1.0,3/7,25.12%,XRCC3;WRN;SLX4
prerank,Reactome_2022__Hyaluronan Uptake And Degradation R-HSA-2160916,-0.5157948291908252,-0.7850810366558281,0.8035714285714286,0.981979118450014,1.0,2/6,15.24%,CD44;GUSB
prerank,GO_Biological_Process_2021__negative regulation of canonical Wnt signaling pathway (GO:0090090),0.298039444009964,0.7846210072869356,0.9230769230769231,0.9465278278914476,1.0,13/104,11.06%,LRP4;ZNRF3;RUVBL2;ANKRD6;TLE2;WNT5A;INVS;TMEM170B;DDIT3;DVL3;HDAC1;DKK2;TCF7L2
prerank,Reactome_2022__Sensory Perception Of Taste R-HSA-9717189,0.4635922578008178,0.7844789668255722,0.7446808510638298,0.9463938647865108,1.0,2/9,3.34%,KCNJ2;SCN3A
prerank,Reactome_2022__Ca2+ Pathway R-HSA-4086398,0.34586182658015585,0.7844680182607535,0.84375,0.946088433407118,1.0,9/39,18.04%,TCF7L1;WNT5A;NLK;PPP3CA;TCF7L2;MAP3K7;PPP3CB;PLCB3;TNRC6C
prerank,GO_Biological_Process_2021__negative regulation of viral entry into host cell (GO:0046597),-0.4925024361353082,-0.7843493664495478,0.8076923076923077,0.9827725706048209,1.0,3/8,8.41%,TRIM5;IFITM3;LY6E
prerank,Reactome_2022__RNA Polymerase II Transcription R-HSA-73857,-0.28747026738045844,-0.7840036311039882,0.9693877551020408,0.9829570639460788,1.0,116/904,14.99%,NR4A3;UBC;SLC2A3;H2BC4;H2BC26;H2AC20;CYCS;FOS;RPS27A;RUNX3;PRKCQ;H2AC6;DDIT4;COX7C;DHX38;ABCA6;SNAPC1;CHD3;BTG2;CSTF2T;PRELID1;PSMB3;YES1;RORA;ZNF790;ZNF689;GTF2H5;CTDP1;ELOB;ING3;HUS1;ING5;ZNF331;NR1H2;LAMTOR5;H3-3B;H2AJ;TXN2;MED25;H2BC21;POLR2G;PSMB6;RNMT;PSMA7;SGK1;ITGA4;ZNF649;ZNF570;H2BC5;CALM1;ZNF600;RBPJ;EIF4A3;COX4I1;TMEM219;ZFP30;COX5B;PSMB9;ZNF394;VENTX;H2BC9;ZNF589;CHTOP;STAT1;U2AF2;NCBP2;SMARCD1;BCL2L14;ZNF266;ZNF70;NPM1;CITED2;ZNF546;COX18;ZNF354A;RBX1;VEGFA;ZNF528;ITGAL;NABP1;BTG1;ZNF432;ZNF586;PSMD12;ANAPC11;MAX;SST;H2BC11;PSMD8;PSMA5;PRDM1;KAT5;COX6C;SRSF2;SRSF7;RAD9A;ZNF549;ZNF302;NR4A1;UXT;ZNF558;ZNF18;ESR2;NOTCH2;RPA3;ZNF681;CCND1;BRCA1;ZNF333;ZKSCAN3;COLEC12;CBX3;SETD1A;UBA52;CDC26;TP53INP1
prerank,GO_Biological_Process_2021__positive regulation of cell growth (GO:0030307),0.3056247590913908,0.783871093127162,0.8095238095238095,0.9467050595011456,1.0,20/67,22.55%,CDKN2AIP;CIB1;HPN;TAF9B;NEDD4L;SYT17;MMP14;SMURF1;MAP3K13;TGFBR1;MTPN;DDX3X;SHTN1;SEMA4D;RIMS2;CSNK2A1;SYT4;ZFYVE27;MFSD2A;ADAM10
prerank,Reactome_2022__FGFR1 Mutant Receptor Activation R-HSA-1839124,-0.4088261947575203,-0.7838597923159787,0.7833333333333333,0.9828991758437047,1.0,3/23,14.45%,FGF13;STAT1;FGF20
prerank,GO_Biological_Process_2021__regulation of mitotic cell cycle phase transition (GO:1901990),-0.3260654659206848,-0.7838395112319239,0.9,0.9826307102355253,1.0,34/144,22.15%,UBC;RPS27A;PSMB3;SSNA1;PSMB6;PSMA7;CEP72;PSMB9;CEP164;APPL1;PSMD12;ANAPC11;CSNK1D;PSMD8;PSMA5;TUBB4B;UBA52;CDC26;PSMA3;PRKAR2B;PSMC4;DCTN2;CENPF;BUB3;AKAP9;PSME2;PSME1;DYNC1I2;NINL;PSMB5;RGCC;SFI1;PSMC3;HAUS5
prerank,GO_Biological_Process_2021__phosphatidylcholine acyl-chain remodeling (GO:0036151),0.39391014508717875,0.783781648257309,0.7058823529411765,0.946481172660664,1.0,1/17,0.68%,PLA2G4C
prerank,GO_Biological_Process_2021__mitotic G2 DNA damage checkpoint signaling (GO:0007095),0.38411751616119294,0.783709429470916,0.7878787878787878,0.9462788726500243,1.0,7/24,18.65%,FOXN3;FZR1;BRSK1;CDC14B;BLM;NBN;TAOK2
prerank,GO_Biological_Process_2021__IRE1-mediated unfolded protein response (GO:0036498),-0.38425198967107144,-0.7836088006048526,0.8088235294117647,0.9827519185131756,1.0,4/42,6.27%,DDX11;TPP1;DNAJB9;HDGF
prerank,GO_Biological_Process_2021__peroxisomal transport (GO:0043574),0.47513886492741764,0.7834700838806476,0.74,0.9459646257127692,1.0,2/6,16.09%,ZFAND6;PEX16
prerank,GO_Biological_Process_2021__establishment of protein localization to peroxisome (GO:0072663),0.47513886492741764,0.7834700838806476,0.74,0.9459646257127692,1.0,2/6,16.09%,ZFAND6;PEX16
prerank,Reactome_2022__Biotin Transport And Metabolism R-HSA-196780,0.45563733792491873,0.7834438770721764,0.6538461538461539,0.9456557452502522,1.0,5/8,31.77%,ACACB;ACACA;PCCA;SLC5A6;HLCS
prerank,GO_Biological_Process_2021__negative regulation of cAMP-mediated signaling (GO:0043951),0.46494873657040015,0.783379673684149,0.7727272727272727,0.9453855949225385,1.0,1/7,10.95%,PDE3B
prerank,GO_Biological_Process_2021__positive regulation of ATP metabolic process (GO:1903580),-0.3859012505512759,-0.7831936827781355,0.7692307692307693,0.9831203799702251,1.0,7/25,11.98%,PID1;IGF1;PFKFB3;TMSB4X;PFKFB4;HIF1A;ENTPD5
prerank,GO_Biological_Process_2021__glucosamine-containing compound catabolic process (GO:1901072),0.4939225090973093,0.7831834282630661,0.75,0.9453080889735587,1.0,1/6,0.62%,CTBS
prerank,Reactome_2022__Dopamine Neurotransmitter Release Cycle R-HSA-212676,-0.4235928702428713,-0.7831080237253129,0.7213114754098361,0.9829599285869314,1.0,2/21,6.19%,RIMS1;RAB3A
prerank,GO_Biological_Process_2021__histone H4 acetylation (GO:0043967),0.3477809577446488,0.7828807174475358,0.7222222222222222,0.945405915350515,1.0,3/43,3.65%,RUVBL2;MSL2;CHD5
prerank,GO_Biological_Process_2021__actin polymerization or depolymerization (GO:0008154),-0.3791667770651026,-0.782853632594376,0.8194444444444444,0.983088823582798,1.0,5/43,8.34%,CATIP;AIF1;PSTPIP1;VILL;CFL1
prerank,Reactome_2022__Negative Regulation Of NMDA Receptor-Mediated Neuronal Transmission R-HSA-9617324,-0.4502705878213067,-0.7828128125848582,0.7540983606557377,0.9828758988335412,1.0,3/15,14.13%,NEFL;CALM1;CAMK1
prerank,GO_Biological_Process_2021__positive regulation of double-strand break repair via homologous recombination (GO:1905168),0.426817400988283,0.7827567613382606,0.8536585365853658,0.9452686305829444,1.0,2/11,7.93%,PARP1;MMS19
prerank,Reactome_2022__Generic Transcription Pathway R-HSA-212436,-0.28773489516842066,-0.7826487666227817,0.9896907216494846,0.9828549449929008,1.0,105/803,14.99%,NR4A3;UBC;SLC2A3;H2BC4;H2BC26;H2AC20;CYCS;FOS;RPS27A;RUNX3;PRKCQ;H2AC6;DDIT4;COX7C;ABCA6;CHD3;BTG2;PRELID1;PSMB3;YES1;RORA;ZNF790;ZNF689;GTF2H5;CTDP1;ELOB;ING3;HUS1;ING5;ZNF331;NR1H2;LAMTOR5;H3-3B;H2AJ;TXN2;MED25;H2BC21;POLR2G;PSMB6;RNMT;PSMA7;SGK1;ITGA4;ZNF649;ZNF570;H2BC5;CALM1;ZNF600;RBPJ;COX4I1;TMEM219;ZFP30;COX5B;PSMB9;ZNF394;VENTX;H2BC9;ZNF589;STAT1;SMARCD1;BCL2L14;ZNF266;ZNF70;NPM1;CITED2;ZNF546;COX18;ZNF354A;RBX1;VEGFA;ZNF528;ITGAL;BTG1;ZNF432;ZNF586;PSMD12;ANAPC11;MAX;SST;H2BC11;PSMD8;PSMA5;PRDM1;KAT5;COX6C;RAD9A;ZNF549;ZNF302;NR4A1;UXT;ZNF558;ZNF18;ESR2;NOTCH2;RPA3;ZNF681;CCND1;BRCA1;ZNF333;ZKSCAN3;CBX3;SETD1A;UBA52;CDC26;TP53INP1
prerank,KEGG_2021_Human__Non-alcoholic fatty liver disease,-0.34292219597752127,-0.782634620746976,0.8974358974358975,0.9826106851377379,1.0,23/113,14.79%,CYCS;FOS;COX7C;UQCRB;NDUFC1;NDUFA2;UQCRH;NDUFA1;NDUFB9;NDUFA12;NDUFB4;UQCR10;COX4I1;COX5B;NDUFB1;NDUFS8;NDUFS5;MLX;COX7A2;COX6C;PIK3CB;NDUFS6;NDUFB7
prerank,GO_Biological_Process_2021__regulation of nucleic acid-templated transcription (GO:1903506),-0.3023521111647663,-0.7826103570956576,0.9333333333333333,0.9823534350016393,1.0,29/281,12.59%,MYBL1;PPIE;RUNX3;PRKCQ;CHD3;ATF5;TAF6L;EDF1;RORA;OGG1;BHLHE40;ZNF331;TRIM22;MSL3;PLAG1;BRCA2;RPL6;DVL1;HINT1;REXO4;MLX;HIF1A;BTG1;TCF3;GLI4;GLRX2;GCFC2;CREM;TERF2IP
prerank,GO_Biological_Process_2021__protein homooligomerization (GO:0051260),-0.33850467791117383,-0.7823503374079837,0.8108108108108109,0.9824613129924106,1.0,6/77,5.68%,APIP;B2M;PRF1;RNF213;AQP11;JMJD6
prerank,Reactome_2022__Synthesis Of Bile Acids And Bile Salts Via 27-Hydroxycholesterol R-HSA-193807,0.5128869834611657,0.7821384984054897,0.7441860465116279,0.9459003843399756,1.0,1/5,18.67%,NCOA2
prerank,GO_Biological_Process_2021__regulation of cation transmembrane transport (GO:1904062),0.4017376163842224,0.7820735712844438,0.7948717948717948,0.9456391799536119,1.0,7/19,20.05%,KCNIP2;WNK1;SLMAP;KCNN2;DPP10;DPP6;HOMER1
prerank,GO_Biological_Process_2021__regulation of centrosome duplication (GO:0010824),-0.3848677104142789,-0.7819416331654984,0.7857142857142857,0.982810626286376,1.0,4/23,10.59%,STIL;XRCC3;TMEM67;NPM1
prerank,GO_Biological_Process_2021__insulin secretion involved in cellular response to glucose stimulus (GO:0035773),0.44704684189923405,0.7815677333584381,0.8292682926829268,0.9460867790121508,1.0,1/5,12.32%,PTPRN
prerank,PanglaoDB_Augmented_2021__Paneth Cells,-0.40498134497866156,-0.7815023853634674,0.8103448275862069,0.9832568322897663,1.0,4/18,14.09%,TNFSF10;FBP1;CASP5;NOD2
prerank,GO_Biological_Process_2021__cellular response to decreased oxygen levels (GO:0036294),-0.37393671219639874,-0.7813729467508794,0.8135593220338984,0.9831807117193194,1.0,11/39,18.04%,CARD16;RORA;EGLN3;VEGFA;HIF1A;NOP53;PGK1;PICK1;MT3;PINK1;FAM162A
prerank,Reactome_2022__Aberrant Regulation Of Mitotic G1/S Transition In Cancer Due To RB1 Defects R-HSA-9659787,0.44486961296356897,0.7812927317557719,0.7954545454545454,0.9461115990200908,1.0,3/10,15.55%,E2F3;CDK6;CCND3
prerank,GO_Biological_Process_2021__maintenance of blood-brain barrier (GO:0035633),-0.42136362523925247,-0.781282918987466,0.7333333333333333,0.9830312001143446,1.0,5/17,19.27%,PECAM1;ACTG1;ACTB;ITGB1;LAMA2
prerank,KEGG_2021_Human__Lysosome,0.29558530184584175,0.7810626792200593,0.8846153846153846,0.9461150727456356,1.0,13/95,10.29%,ARSA;ABCA2;CTSF;AP3B2;GLB1;CTSC;PPT1;SCARB2;CTSK;SORT1;AP3S1;CD164;LAPTM5
prerank,GO_Biological_Process_2021__dendritic spine organization (GO:0097061),0.3767985665527272,0.7810466934895617,0.7931034482758621,0.9457859471144774,1.0,4/21,11.81%,IGF1R;DOCK10;SHANK3;PTEN
prerank,GO_Biological_Process_2021__fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540),-0.4705394603760241,-0.7803267007638273,0.7543859649122807,0.9841324346149236,1.0,3/9,22.54%,ACAA1;ECI2;SCP2
prerank,GO_Biological_Process_2021__regulation of collateral sprouting (GO:0048670),-0.4990099554029619,-0.780308868279481,0.7407407407407407,0.9838778867253708,1.0,1/6,6.76%,FGF13
prerank,Reactome_2022__SARS-CoV-2 Modulates Autophagy R-HSA-9754560,-0.4587628856443872,-0.7800283793924845,0.7547169811320755,0.9839851024274553,1.0,1/8,24.01%,VPS11
prerank,GO_Biological_Process_2021__chemical homeostasis (GO:0048878),0.32321165219383574,0.7798320116247991,0.8125,0.9472217381110054,1.0,8/35,10.86%,PPARG;VGF;ABHD8;NEDD4L;SLC4A4;ACOX3;FBXW7;WNK1
prerank,CellMarker_Augmented_2021__Hepatic Progenitor-Like cell:Pluripotent Stem Cell,0.34784301248198507,0.7797497069851412,0.7804878048780488,0.9469861892846904,1.0,5/44,6.29%,DUSP6;GSN;FCGRT;ARSD;MGAM
prerank,GO_Biological_Process_2021__L-serine metabolic process (GO:0006563),-0.4660071974276787,-0.7795776801949935,0.7142857142857143,0.9843306433103313,1.0,1/6,15.99%,SHMT1
prerank,Reactome_2022__Phospholipid Metabolism R-HSA-1483257,-0.3234754802229656,-0.7795776727080733,0.8625,0.9840448330190102,1.0,11/148,9.64%,OSBPL5;MGLL;LPCAT1;GDPD1;DDHD2;GNPAT;INPP4A;TNFAIP8;PCYT1A;PCTP;PLB1
prerank,Reactome_2022__Macroautophagy R-HSA-1632852,-0.33355530627214536,-0.7791744478123952,0.8767123287671232,0.9843849197160706,1.0,4/94,2.29%,UBC;TOMM7;RPS27A;GABARAPL1
prerank,GO_Biological_Process_2021__signal release from synapse (GO:0099643),-0.4010700188139249,-0.7791166781447106,0.7727272727272727,0.9842065713889433,1.0,3/31,9.43%,RIMS1;RAB3A;DVL1
prerank,GO_Biological_Process_2021__actin-mediated cell contraction (GO:0070252),0.4938483300960578,0.7790853732181073,0.8372093023255814,0.9476282462044903,1.0,2/7,1.66%,PDPN;GSN
prerank,CellMarker_Augmented_2021__Paneth cell:Pyloric Gland,-0.49003696364600907,-0.7790676621230619,0.7692307692307693,0.983986460901803,1.0,1/5,8.92%,MEP1B
prerank,Reactome_2022__TRIF-mediated Programmed Cell Death R-HSA-2562578,-0.45443211317715704,-0.7790068136875574,0.7659574468085106,0.9837847889944757,1.0,1/6,4.18%,NDUFA2
prerank,Reactome_2022__Platelet Homeostasis R-HSA-418346,-0.3399647104127189,-0.7789667587842762,0.7941176470588235,0.9835466228393588,1.0,5/54,8.36%,GNB5;PDE5A;PECAM1;SRI;CALM1
prerank,GO_Biological_Process_2021__homeostasis of number of cells (GO:0048872),0.4529492657431455,0.7787351905738157,0.6530612244897959,0.9478568244463533,1.0,4/7,27.76%,NAPEPLD;OCIAD1;NOTCH1;UBAP2L
prerank,GO_Biological_Process_2021__regulation of cell cycle process (GO:0010564),-0.37389759592499594,-0.778622691244492,0.7857142857142857,0.9838366888488277,1.0,7/64,9.53%,ATF5;RAB11A;TIPIN;KLHL13;ENTR1;CALM1;IHO1
prerank,GO_Biological_Process_2021__regulation of cell division (GO:0051302),-0.3728324397431408,-0.7786000878830598,0.7611940298507462,0.9835908049729891,1.0,6/47,9.34%,RACK1;RAB11A;KLHL13;ENTR1;CALM1;EFHC1
prerank,GO_Biological_Process_2021__regulation of telomerase RNA localization to Cajal body (GO:1904872),0.3946936499332189,0.7785959954775065,0.8333333333333334,0.9477489900031915,1.0,5/18,18.36%,RUVBL2;TCP1;CCT3;NAF1;SHQ1
prerank,KEGG_2021_Human__HIF-1 signaling pathway,-0.34168667798687274,-0.7781249704766044,0.8169014084507042,0.9840374588790883,1.0,16/75,13.75%,GAPDH;TFRC;ELOB;IGF1;RPS6;HK2;PFKFB3;EGLN3;LDHA;RBX1;VEGFA;HIF1A;IFNGR2;FLT1;PGK1;PIK3CB
prerank,GO_Biological_Process_2021__negative regulation of coagulation (GO:0050819),0.5020461718722137,0.7780790265420201,0.75,0.9482454046757486,1.0,3/6,2.96%,HS3ST5;SERPINE1;SERPINE2
prerank,GO_Biological_Process_2021__miRNA loading onto RISC involved in gene silencing by miRNA (GO:0035280),-0.5071053882051778,-0.7778872794763458,0.8695652173913043,0.9841286144832266,1.0,2/6,20.58%,ADAR;DICER1
prerank,GO_Biological_Process_2021__midbody abscission (GO:0061952),0.40256951386963247,0.7777431861050383,0.7555555555555555,0.9484054567189404,1.0,2/11,14.09%,CHMP7;CHMP1A
prerank,KEGG_2021_Human__Spinocerebellar ataxia,-0.32537939186562365,-0.777564621896001,0.8765432098765432,0.9843111127914457,1.0,16/116,13.76%,CYCS;PSMB3;RORA;KCNC3;ADRM1;SLC25A5;PSMB6;PSMA7;ATG2A;RBPJ;PSMD12;PSMD8;PSMA5;KAT5;PIK3CB;VLDLR
prerank,GO_Biological_Process_2021__regulation of helicase activity (GO:0051095),-0.48011224894811744,-0.7769649744874519,0.8148148148148148,0.9850103931324694,1.0,2/9,9.47%,IFIT1;CHTOP
prerank,GO_Biological_Process_2021__positive regulation of histone methylation (GO:0031062),0.372169119658179,0.776563963711919,0.825,0.9498876446953267,1.0,2/18,8.34%,SIRT1;AUTS2
prerank,GO_Biological_Process_2021__regulation of transforming growth factor beta2 production (GO:0032909),0.5435080533130016,0.7765560936613581,0.875,0.9495582234984251,1.0,2/5,12.30%,SMAD3;BMPR1A
prerank,GO_Biological_Process_2021__cellular response to chemical stress (GO:0062197),-0.33441250662145006,-0.7765088882021242,0.8734177215189873,0.9854117529138894,1.0,16/76,14.43%,CYCS;AIF1;CHCHD2;NCF4;ERO1A;GSTP1;ERMP1;TRPV4;NCF2;SELENOS;PRR5L;HSPA1B;CYBA;SOD1;GPX1;HSPA1A
prerank,GO_Biological_Process_2021__regulation of defense response (GO:0031347),-0.35669409790922274,-0.7764301621578408,0.7746478873239436,0.9852493292531584,1.0,14/52,20.21%,MGLL;DHX58;TMSB4X;IRF1;ERAP1;APPL1;CASP5;NOD2;AKNA;CASP4;PTPN22;NR1D2;UFL1;HERC5
prerank,GO_Biological_Process_2021__nucleoside diphosphate catabolic process (GO:0009134),-0.500159632334477,-0.7762893994978152,0.7551020408163265,0.9851730727412558,1.0,2/6,11.98%,ENTPD4;ENTPD5
prerank,GO_Biological_Process_2021__positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),0.4544443397237041,0.776214273817857,0.7391304347826086,0.9497728526010836,1.0,4/7,25.72%,MAP2K1;MAP2K2;RIPK1;TGFB1
prerank,GO_Biological_Process_2021__regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514),-0.45873423213495734,-0.7761807454347694,0.7586206896551724,0.985034279721604,1.0,2/7,17.23%,NOS1AP;CACNB1
prerank,Reactome_2022__Assembly Of Collagen Fibrils And Other Multimeric Structures R-HSA-2022090,-0.39741581849724483,-0.7761602796319871,0.8,0.9847782622181513,1.0,3/23,3.91%,COL5A1;COL18A1;CTSB
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),-0.35063598432122195,-0.7761594581945785,0.8732394366197183,0.9844963324772297,1.0,15/70,18.87%,CCL5;PARP14;IGF1;PECAM1;PARP9;ENPP2;CD44;BANK1;VEGFA;PTPRC;CD74;AGT;IL18;NEDD9;TNFRSF14
prerank,GO_Biological_Process_2021__embryonic skeletal system development (GO:0048706),-0.46879058194709755,-0.7759077527796016,0.7540983606557377,0.984576697500897,1.0,3/9,15.68%,SULF2;DYNC2I1;PCSK5
prerank,Reactome_2022__Formation Of HIV Elongation Complex In Absence Of HIV Tat R-HSA-167152,-0.3619338075998999,-0.7758988002505813,0.8448275862068966,0.9843132203809457,1.0,5/39,9.87%,GTF2H5;CTDP1;ELOB;POLR2G;NCBP2
prerank,GO_Biological_Process_2021__intermediate filament organization (GO:0045109),0.45268933849359894,0.7758310346334315,0.7906976744186046,0.9500297949503791,1.0,1/7,2.32%,GFAP
prerank,GO_Biological_Process_2021__regulation of cellular metabolic process (GO:0031323),0.32917210006196307,0.7756778887121715,0.8333333333333334,0.9498789896742924,1.0,4/36,7.76%,ABCA2;PDK4;TBC1D16;ACACB
prerank,GO_Biological_Process_2021__negative regulation of Ras protein signal transduction (GO:0046580),-0.3632190965313622,-0.7755968789686533,0.803030303030303,0.984495138553778,1.0,1/29,0.96%,RIPOR2
prerank,GO_Biological_Process_2021__regulation of macrophage migration (GO:1905521),-0.45809790777202447,-0.7753400174711998,0.746031746031746,0.9845780373516853,1.0,1/7,3.15%,CD200R1
prerank,GO_Biological_Process_2021__positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002824),-0.4758310082912376,-0.7752673901016517,0.7272727272727273,0.9844188782487725,1.0,2/7,10.20%,PRKCQ;SLC11A1
prerank,GO_Biological_Process_2021__positive regulation of pinocytosis (GO:0048549),0.4800610783538142,0.7750234654875673,0.7708333333333334,0.9504794601061585,1.0,1/6,6.14%,PPT1
prerank,"Reactome_2022__Gamma-carboxylation, Transport, And Amino-Terminal Cleavage Of Proteins R-HSA-159854",-0.5429575633532053,-0.7746194694020679,0.8148148148148148,0.9847874355277296,1.0,1/5,10.57%,GGCX
prerank,Reactome_2022__Gamma-carboxylation Of Protein Precursors R-HSA-159740,-0.5429575633532053,-0.7746194694020679,0.8148148148148148,0.9847874355277296,1.0,1/5,10.57%,GGCX
prerank,GO_Biological_Process_2021__nuclear membrane organization (GO:0071763),-0.4507732898756962,-0.7745933712596982,0.7543859649122807,0.984547753445164,1.0,1/16,4.25%,EMD
prerank,GO_Biological_Process_2021__rescue of stalled ribosome (GO:0072344),0.49660694511549897,0.7742092273573121,0.7647058823529411,0.9513806987901795,1.0,1/5,1.81%,ZNF598
prerank,GO_Biological_Process_2021__hexose metabolic process (GO:0019318),-0.41414302858970287,-0.7741796932849359,0.78125,0.9848930427931791,1.0,3/23,11.31%,APOD;OAS1;FBP1
prerank,GO_Biological_Process_2021__positive regulation of ceramide biosynthetic process (GO:2000304),-0.4711239739348956,-0.7741348866582188,0.7833333333333333,0.9843802610884199,1.0,1/9,4.24%,RACK1
prerank,GO_Biological_Process_2021__positive regulation of sphingolipid biosynthetic process (GO:0090154),-0.4711239739348956,-0.7741348866582188,0.7833333333333333,0.9843802610884199,1.0,1/9,4.24%,RACK1
prerank,GO_Biological_Process_2021__cellular response to X-ray (GO:0071481),0.48337244976459504,0.7740768086923308,0.7391304347826086,0.9512465296985102,1.0,1/5,13.48%,NIPBL
prerank,GO_Biological_Process_2021__signal peptide processing (GO:0006465),-0.4715299945227075,-0.7739502853591445,0.7413793103448276,0.9843747035387508,1.0,3/8,23.96%,PCSK5;SEC11A;SPCS2
prerank,Reactome_2022__STAT5 Activation R-HSA-9645135,0.48329607389294316,0.7738909355165574,0.7727272727272727,0.9511887646049281,1.0,1/5,12.71%,GAB2
prerank,GO_Biological_Process_2021__growth hormone receptor signaling pathway (GO:0060396),-0.43122708173575053,-0.7738312222967846,0.7192982456140351,0.9842834724029486,1.0,1/13,6.83%,PRLR
prerank,GO_Biological_Process_2021__ncRNA 3'-end processing (GO:0043628),-0.44951759118674406,-0.773536761666248,0.7761194029850746,0.9844544412038446,1.0,1/11,3.42%,SSB
prerank,GO_Biological_Process_2021__positive regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045899),-0.4918688753574123,-0.7735034545323851,0.7090909090909091,0.9842231219105677,1.0,2/7,22.04%,PSMC4;PSMC3
prerank,KEGG_2021_Human__PI3K-Akt signaling pathway,-0.30332445740684316,-0.7732053571944522,0.9285714285714286,0.9843836336212527,1.0,26/189,14.45%,CHRM2;IL7R;PDGFD;DDIT4;CDC37;GNB5;IL3RA;IGF1;G6PC3;OSMR;PRLR;RPS6;THEM4;SGK1;ITGA4;ITGA6;VEGFA;MTCP1;CSF3R;FLT1;NR4A1;PIK3CB;LPAR6;CCND1;BRCA1;FGF20
prerank,GO_Biological_Process_2021__dopaminergic neuron differentiation (GO:0071542),0.44332760107954144,0.7731598839123123,0.6888888888888889,0.9518980655973325,1.0,2/6,15.75%,RYK;MANF
prerank,GO_Biological_Process_2021__positive regulation of inflammatory response (GO:0050729),-0.35152142557711774,-0.7729557507532442,0.8055555555555556,0.9845051538262588,1.0,6/53,12.25%,CCL3;ETS1;OSMR;NLRP12;KARS1;CD47
prerank,GO_Biological_Process_2021__ventricular trabecula myocardium morphogenesis (GO:0003222),0.441878600282008,0.7728213996608134,0.8055555555555556,0.9521789985953901,1.0,3/7,15.21%,NRG1;BMPR1A;TGFBR1
prerank,GO_Biological_Process_2021__chondrocyte differentiation (GO:0002062),-0.39973709698778054,-0.771847282568272,0.8275862068965517,0.9859487969668242,1.0,2/18,6.07%,RUNX3;SULF2
prerank,Reactome_2022__RAC3 GTPase Cycle R-HSA-9013423,0.29353996770183766,0.7716185941338464,0.95,0.9537131756415986,1.0,18/75,15.86%,SLITRK5;NCOA3;WASF2;JAG1;ARAP3;TMPO;DOCK10;GIT1;RAB7A;ARHGAP15;LEMD3;SNAP23;ARHGAP42;YKT6;FERMT2;SRGAP2;GIT2;ABI1
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),-0.396878892025156,-0.771507774625226,0.8166666666666667,0.9861734691694716,1.0,2/23,4.77%,GZMB;CHCHD10
prerank,GO_Biological_Process_2021__regulation of ion transmembrane transporter activity (GO:0032412),0.3433570112143661,0.7714742262526643,0.8484848484848485,0.9536249669045538,1.0,10/26,21.45%,SCN3B;NEDD4L;FXYD5;AHCYL1;FXYD7;NEDD4;SCN1B;HOMER1;CHRM3;YWHAE
prerank,Reactome_2022__CLEC7A (Dectin-1) Induces NFAT Activation R-HSA-5607763,0.4418347728665844,0.7713660989488449,0.6829268292682927,0.953452191284256,1.0,5/9,18.52%,PPP3CA;AHCYL1;NFATC3;PPP3CB;NFATC2
prerank,GO_Biological_Process_2021__regulation of protein localization to plasma membrane (GO:1903076),0.310917923184923,0.771272856657841,0.9285714285714286,0.9532626210463355,1.0,7/57,14.07%,PTPN9;PICALM;CIB1;TNF;ARF6;PRKCI;MMP14
prerank,GO_Biological_Process_2021__aspartate family amino acid catabolic process (GO:0009068),0.4025180460923852,0.7709705518160384,0.7111111111111111,0.9533480393373787,1.0,3/13,12.29%,ASPA;SLC25A21;GCDH
prerank,GO_Biological_Process_2021__response to organic cyclic compound (GO:0014070),-0.40973185777681187,-0.7703492095493099,0.8507462686567164,0.9876365319680334,1.0,2/28,1.49%,CCL3;CCL5
prerank,Reactome_2022__Formation Of Cornified Envelope R-HSA-6809371,0.4305906934376369,0.7702719450988695,0.6842105263157895,0.9540378484529353,1.0,1/8,1.94%,PKP4
prerank,GO_Biological_Process_2021__neurotransmitter secretion (GO:0007269),-0.39139425782033055,-0.7702441698898143,0.7761194029850746,0.9875186706575529,1.0,3/32,9.43%,RIMS1;RAB3A;DVL1
prerank,GO_Biological_Process_2021__mRNA 3'-end processing (GO:0031124),0.3075803388496452,0.7701868308417602,0.92,0.9538186942007514,1.0,7/61,8.84%,POLR2D;U2AF1;CPSF4;WDR33;SSU72;PCF11;SCAF8
prerank,GO_Biological_Process_2021__negative regulation of protein kinase activity by regulation of protein phosphorylation (GO:0044387),-0.5066452675674208,-0.770007899887007,0.7843137254901961,0.9875588400346491,1.0,3/5,25.76%,NPM1;ADAR;ADARB1
prerank,GO_Biological_Process_2021__monovalent inorganic anion homeostasis (GO:0055083),0.4759651247652672,0.7698817581305788,0.7272727272727273,0.9535497560418253,1.0,3/7,15.33%,SLC12A6;SLC12A5;SLC12A2
prerank,GO_Biological_Process_2021__chloride ion homeostasis (GO:0055064),0.4759651247652672,0.7698817581305788,0.7272727272727273,0.9535497560418253,1.0,3/7,15.33%,SLC12A6;SLC12A5;SLC12A2
prerank,Reactome_2022__TRAF6 Mediated Induction Of NFkB And MAP Kinases Upon TLR7/8 Or 9 Activation R-HSA-975138,-0.32583158412017804,-0.7698624584785132,0.868421052631579,0.9875316771815904,1.0,5/87,6.58%,UBC;FOS;RPS27A;NDUFA2;NLRC5
prerank,KEGG_2021_Human__Proximal tubule bicarbonate reclamation,0.4209338391565665,0.7696584215416369,0.7111111111111111,0.9534956286286044,1.0,3/11,10.70%,SLC4A4;CA2;PCK2
prerank,Reactome_2022__Dimerization Of Procaspase-8 R-HSA-69416,-0.45938132806789334,-0.7696003482904411,0.8095238095238095,0.9873661430804374,1.0,2/9,9.94%,TNFSF10;CFLAR
prerank,Reactome_2022__CASP8 Activity Is Inhibited R-HSA-5218900,-0.45938132806789334,-0.7696003482904411,0.8095238095238095,0.9873661430804374,1.0,2/9,9.94%,TNFSF10;CFLAR
prerank,GO_Biological_Process_2021__regulation of nitric-oxide synthase activity (GO:0050999),-0.3804229074227372,-0.7695948020641388,0.7741935483870968,0.9870855733316012,1.0,5/27,16.05%,GLA;CALM1;HIF1A;PIK3CB;NOS1AP
prerank,GO_Biological_Process_2021__negative regulation of mitotic cell cycle (GO:0045930),0.3737835608486078,0.7695914026278544,0.8666666666666667,0.9532263565880285,1.0,9/30,12.62%,SCRIB;FZD3;SMAD3;PRCC;BRINP3;NME6;PLK2;HECA;TRIM35
prerank,GO_Biological_Process_2021__coronary vasculature morphogenesis (GO:0060977),0.437546555274584,0.7695883623063359,0.7674418604651163,0.9528855774798525,1.0,2/7,3.63%,NRP1;SPRED1
prerank,GO_Biological_Process_2021__regulation of insulin receptor signaling pathway (GO:0046626),-0.38693109041746476,-0.7694585651190677,0.7714285714285715,0.9870482339311114,1.0,2/30,1.81%,PRKCQ;PID1
prerank,GO_Biological_Process_2021__regulation of mitotic spindle organization (GO:0060236),0.34825569928389655,0.7693752476710537,0.8055555555555556,0.9528233166366049,1.0,4/26,19.56%,BORA;CHMP1A;DYNC1H1;HNRNPU
prerank,Reactome_2022__RAB GEFs Exchange GTP For GDP On RABs R-HSA-8876198,0.28493803415058655,0.7690953175755201,0.9393939393939394,0.9529634070393512,1.0,21/73,23.70%,RAB10;RAB1B;RIN2;RAB7A;RAB6A;RAB3IP;SBF1;AKT2;RAB14;TRAPPC12;RAB3IL1;TRAPPC8;RIN3;AKT3;RAB38;ULK1;DENND5B;YWHAE;RAB7B;TRAPPC6B;DENND2D
prerank,GO_Biological_Process_2021__mRNA cleavage involved in mRNA processing (GO:0098787),-0.46800953356432873,-0.768741958744814,0.8333333333333334,0.9879105322296925,1.0,2/10,9.87%,CSTF2T;NCBP2
prerank,GO_Biological_Process_2021__negative regulation by symbiont of host programmed cell death (GO:0052041),-0.47766029216563055,-0.768499549653969,0.8301886792452831,0.987989274210261,1.0,1/7,3.95%,RNF213
prerank,CellMarker_Augmented_2021__Endothelial cell:Intervertebral Disc,-0.3647075669212045,-0.7684969628075451,0.7702702702702703,0.9877114310660523,1.0,18/49,19.61%,MS4A4A;SIGLEC1;CD93;F13A1;PECAM1;PCDH12;MS4A6A;TYROBP;SPARCL1;A2M;FLT1;SERPING1;ALDH2;FCGR3A;GIMAP4;FOLR2;MPEG1;LILRB5
prerank,GO_Biological_Process_2021__positive regulation of mononuclear cell migration (GO:0071677),-0.417504443170647,-0.7683979409134127,0.71875,0.987591302941459,1.0,2/17,2.67%,CCL5;AIF1
prerank,GO_Biological_Process_2021__transcription by RNA polymerase II (GO:0006366),-0.30310981631051803,-0.76836320562275,0.9195402298850575,0.9873550471204039,1.0,14/238,7.21%,NR4A3;CEBPD;SNAPC1;CSTF2T;RORA;BTF3;GTF2H5;CTDP1;ELOB;ADRM1;NR1H2;C5AR1;POLR2G;RNMT
prerank,GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),-0.33386287475744836,-0.7680624481356906,0.8208955223880597,0.9875267885163069,1.0,15/73,19.77%,FCER1G;HLA-DRB5;DCTN6;HLA-DRA;DCTN4;DYNC1LI2;HLA-DPA1;HLA-DMB;AP2S1;CD74;SEC13;HLA-DPB1;DCTN2;HLA-DRB1;DYNC1I2
prerank,GO_Biological_Process_2021__transcription by RNA polymerase I (GO:0006360),-0.37978717059371064,-0.7678508961061139,0.859375,0.9876106889780165,1.0,2/28,4.34%,TAF1D;GTF2H5
prerank,GO_Biological_Process_2021__positive regulation of response to DNA damage stimulus (GO:2001022),0.33479028631488095,0.7675504371241056,0.8888888888888888,0.9549782652402373,1.0,6/36,12.03%,SIRT1;SPRED1;SPRED2;NACC2;NSMCE1;UBE2N
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),0.30830855265401474,0.7673811964247576,0.8780487804878049,0.9549026805996194,1.0,7/45,13.66%,SIRT1;LRRK2;HYOU1;TXNDC12;MDM2;SOD2;BAG5
prerank,GO_Biological_Process_2021__cardiocyte differentiation (GO:0035051),0.42351595669045516,0.7672488194003279,0.8205128205128205,0.9547345273874451,1.0,1/5,6.19%,NRG1
prerank,GO_Biological_Process_2021__positive regulation of response to stimulus (GO:0048584),-0.39932025947818284,-0.7670337192716651,0.8947368421052632,0.9885459177384495,1.0,2/28,2.81%,RSAD2;B2M
prerank,PanglaoDB_Augmented_2021__Beta Cells,-0.3258582799672298,-0.7667079067197876,0.9066666666666666,0.9888048637346982,1.0,4/90,3.85%,TGFBR3;RIMS1;HAMP;RGS16
prerank,GO_Biological_Process_2021__regulation of ceramide biosynthetic process (GO:2000303),-0.4505898229627119,-0.7665276213216211,0.7936507936507936,0.9888187086342014,1.0,2/12,9.50%,RACK1;ORMDL1
prerank,GO_Biological_Process_2021__regulation of necrotic cell death (GO:0010939),-0.4914277247457473,-0.7664291076937224,0.7818181818181819,0.988688193514395,1.0,3/5,27.45%,MT3;HEBP2;ASAH1
prerank,KEGG_2021_Human__Ascorbate and aldarate metabolism,0.46035319667814895,0.766341306811948,0.7755102040816326,0.9556733638213198,1.0,1/7,4.71%,UGDH
prerank,GO_Biological_Process_2021__regulation of macrophage apoptotic process (GO:2000109),0.4623716837466941,0.7663236187785751,0.75,0.9553746335411225,1.0,1/6,2.51%,SIRT1
prerank,GO_Biological_Process_2021__regulation of dopamine secretion (GO:0014059),0.41704424070301804,0.7662315873378044,0.7906976744186046,0.9552106976466648,1.0,4/11,22.41%,SYT17;SNCA;SYT4;DTNBP1
prerank,GO_Biological_Process_2021__purine ribonucleotide metabolic process (GO:0009150),0.332686556015553,0.7660330414441292,0.8888888888888888,0.9552696957164083,1.0,7/40,14.62%,EFL1;LRRK2;DBI;GPAT4;MFN1;AK3;ENPP1
prerank,GO_Biological_Process_2021__long-chain fatty acid metabolic process (GO:0001676),-0.37210493289378943,-0.766023113977097,0.8524590163934426,0.9889752236832182,1.0,9/36,14.59%,MGLL;GSTM4;EPHX1;GSTP1;ACAA1;FAAH2;GPX4;GPX1;ALOX12
prerank,GO_Biological_Process_2021__negative regulation of protein targeting to membrane (GO:0090315),-0.5152363964490668,-0.7659388194034803,0.8571428571428571,0.9887906373004952,1.0,2/5,30.75%,INPP5K;DMTN
prerank,GO_Biological_Process_2021__regulation of postsynaptic neurotransmitter receptor activity (GO:0098962),0.49400260983675026,0.7656305162022261,0.7272727272727273,0.9554295125169863,1.0,5/7,22.89%,NPTXR;NPTX1;DLGAP4;DLGAP1;DLGAP2
prerank,GO_Biological_Process_2021__cytoplasmic microtubule organization (GO:0031122),-0.3551105748866317,-0.7653830691122883,0.90625,0.9893221475493585,1.0,8/48,17.60%,CCDC88C;RAB11A;TRPV4;TUBGCP2;WDR73;TUBGCP5;HOOK2;EZR
prerank,KEGG_2021_Human__Various types of N-glycan biosynthesis,0.3480469124429196,0.7651375941239723,0.75,0.9558832867852048,1.0,7/29,22.36%,B4GALNT4;MGAT4C;STT3B;ALG12;ALG3;RPN2;MGAT4B
prerank,GO_Biological_Process_2021__regulation of transcription by RNA polymerase II (GO:0006357),-0.2812291736757941,-0.7648112156429433,1.0,0.9898662282018601,1.0,147/1260,14.39%,NR4A3;IL4I1;SKAP1;STAT4;MYBL1;BCL11B;UBC;CEBPD;FOSL2;FOS;RPS27A;RUNX3;ZFP36;JUNB;PID1;CTDSP1;RPS14;ZSCAN9;HAMP;IKZF3;CHD3;ATF5;TAF6L;CSRNP1;USF1;PER3;PER2;RORA;ZNF790;CHCHD2;PARP15;H1-0;ZNF335;ZNF689;DDRGK1;BEX1;GTF2H5;ETS1;CTDP1;BHLHE40;RPL10;SP110;HESX1;NR1H2;JUP;RPL23;IGF1;JMJD6;TXK;BRD9;HDGF;ZSCAN30;ZNF32;MED25;SP140;TCF25;NLRC5;PARP9;CRYM;BRD3;IER2;PLSCR1;ZNF76;PLAG1;ZNF805;SNF8;ZNF449;NAMPT;ZNF789;ZNF649;ZNF570;EID1;RNASEL;ZNF600;PRKD2;RBPJ;ITGA6;ZFP30;OVOL2;KANK2;ZNF394;VENTX;ZNF589;DVL1;STAT1;MEIS1;ZNF513;EIF5A;ZNF821;SMARCD1;SLC11A1;LITAF;IRF1;ZNF266;ZNF70;ZNF260;NPM1;CITED2;KDM7A;ZNF546;KDM6B;ZNF354A;MLX;VEGFA;ZNF528;FBP1;HIF1A;STING1;MXI1;ZSCAN29;TCF3;ZNF432;NOP53;BUD31;ATF3;TEF;GMEB1;ZNF586;HIRA;MAX;CREM;ATF1;ZNF674;PRDM1;KAT5;APEX1;DDX5;NRL;ZNF549;ZNF302;ZNF16;PRDM15;NR4A1;UXT;ZNF217;ZNF558;ZNF18;ESR2;TET1;ZNF681;NOD2;CAMK1;CCND1;REL;BRCA1;ZNF333;ZKSCAN3
prerank,GO_Biological_Process_2021__regulation of calcineurin-NFAT signaling cascade (GO:0070884),0.409468854849052,0.7646399566955512,0.7948717948717948,0.9563157363860273,1.0,6/16,18.72%,CIB1;TNF;SLC9A1;GSK3B;CAMTA1;CHP1
prerank,GO_Biological_Process_2021__regulation of histone H2B ubiquitination (GO:2001166),0.5334354140054343,0.7643960088928324,0.8571428571428571,0.9563238752340885,1.0,2/5,20.63%,RNF20;CDK9
prerank,GO_Biological_Process_2021__long-term memory (GO:0007616),0.4434120428011269,0.7643149079253744,0.7555555555555555,0.9560928077164804,1.0,2/10,11.55%,LDLR;KAT2A
prerank,CellMarker_Augmented_2021__Epidermal Stem cell:Skin,-0.4565588394605652,-0.7638572236770191,0.7068965517241379,0.9909943049149849,1.0,4/6,18.52%,ITGA6;FZD2;CD200;ITGB1
prerank,GO_Biological_Process_2021__negative regulation of cell death (GO:0060548),0.3100620093080497,0.7636912448670198,0.9629629629629629,0.956570859771565,1.0,13/60,17.34%,PPARGC1A;FGF2;LRRK2;TXNDC12;SOX4;SORL1;GPNMB;FERMT2;SRGAP2;ATP13A2;GSK3B;INPP5A;TM7SF3
prerank,GO_Biological_Process_2021__regulation of reactive oxygen species metabolic process (GO:2000377),-0.377581923943745,-0.7635781789733932,0.78125,0.9911258694645314,1.0,7/35,18.40%,PID1;BRCA1;AGT;MT3;RAC1;PINK1;PDK3
prerank,GO_Biological_Process_2021__COPII vesicle coating (GO:0048208),0.31873549210601804,0.7633340423376808,0.9310344827586207,0.9560166731553185,1.0,7/50,9.45%,TGFA;BET1;CTSC;RAB1B;SEC24B;TMED10;GRIA1
prerank,GO_Biological_Process_2021__vesicle coating (GO:0006901),0.31873549210601804,0.7633340423376808,0.9310344827586207,0.9560166731553185,1.0,7/50,9.45%,TGFA;BET1;CTSC;RAB1B;SEC24B;TMED10;GRIA1
prerank,"GO_Biological_Process_2021__vesicle targeting, rough ER to cis-Golgi (GO:0048207)",0.31873549210601804,0.7633340423376808,0.9310344827586207,0.9560166731553185,1.0,7/50,9.45%,TGFA;BET1;CTSC;RAB1B;SEC24B;TMED10;GRIA1
prerank,"Reactome_2022__Transport Of Bile Salts And Organic Acids, Metal Ions And Amine Compounds R-HSA-425366",0.3457954778769718,0.762845750698997,0.8571428571428571,0.9563013731666391,1.0,11/37,13.82%,SLC39A14;SLC22A15;SLC39A8;SLC31A1;RUNX1;SLC44A2;SLC41A1;SLC2A13;SLC44A5;SLC44A1;SLC40A1
prerank,KEGG_2021_Human__Ubiquinone and other terpenoid-quinone biosynthesis,-0.4799091791410941,-0.762841435135931,0.6896551724137931,0.9920085492754562,1.0,1/6,10.57%,GGCX
prerank,GO_Biological_Process_2021__protein transmembrane import into intracellular organelle (GO:0044743),-0.4093080730571386,-0.7627492899244079,0.7419354838709677,0.9918722786445405,1.0,3/20,7.54%,DNAJC19;TIMM44;TIMM21
prerank,GO_Biological_Process_2021__negative regulation of microtubule polymerization or depolymerization (GO:0031111),0.3570860004498087,0.7625454248423468,0.8333333333333334,0.9563388088728269,1.0,9/26,19.55%,CIB1;DYRK1A;CLASP1;FKBP4;CLASP2;CAMSAP2;ATXN7;SNCA;MAP2
prerank,GO_Biological_Process_2021__regulation of protein phosphorylation (GO:0001932),-0.3053592585784822,-0.76251372441113,0.9166666666666666,0.9920523313587127,1.0,30/180,16.58%,CCDC88C;TFRC;CARD14;PID1;WARS1;MARCO;PAQR3;RACK1;PECAM1;MUSK;FYN;TTN;ANKRD54;ITGB2;NPM1;PRR5L;AKAP8;VEGFA;NOP53;ATF3;TERF2IP;CSNK1D;SOD1;CCND1;FGF20;C3;CD74;MT3;FLOT1;RAC1
prerank,GO_Biological_Process_2021__regulation of autophagy of mitochondrion (GO:1903146),-0.42945377759940684,-0.7624976758592515,0.8297872340425532,0.9918184518538754,1.0,7/17,29.58%,USP36;PINK1;CSNK2A2;PARK7;SREBF1;HTRA2;HAX1
prerank,GO_Biological_Process_2021__histone H3-K4 demethylation (GO:0034720),-0.4899979725727217,-0.7623222573314787,0.7678571428571429,0.991808264107535,1.0,2/7,27.53%,KDM1B;KDM5C
prerank,GO_Biological_Process_2021__RNA phosphodiester bond hydrolysis (GO:0090501),-0.4003773616460237,-0.7621374238421307,0.8688524590163934,0.9918289090362606,1.0,8/21,21.97%,NYNRIN;NUDT16;NHP2;RNASE6;TRIR;DICER1;ERN1;PARN
prerank,GO_Biological_Process_2021__negative regulation of leukocyte apoptotic process (GO:2000107),-0.4700049696720683,-0.7621105570784337,0.7735849056603774,0.9915798838843575,1.0,3/9,17.04%,SELENOS;NOD2;IRF7
prerank,Reactome_2022__Organelle Biogenesis And Maintenance R-HSA-1852241,0.25082308310405943,0.7621081242192541,1.0,0.9566817919279789,1.0,7/219,3.46%,PRKAB2;PPARGC1A;BBS9;MAPK11;EXOC8;NPHP1;PKD1
prerank,GO_Biological_Process_2021__positive regulation of nuclear division (GO:0051785),0.43692968142554434,0.7617998703100364,0.7560975609756098,0.9567776463916509,1.0,1/9,2.15%,TGFA
prerank,CellMarker_Augmented_2021__Adipose-derived Stem cell:Adipose Tissue,-0.43317245659280124,-0.7616655266066372,0.7301587301587301,0.991977996258856,1.0,7/15,12.82%,TFRC;CD55;PECAM1;ITGA4;CD44;ITGAL;PTPRC
prerank,GO_Biological_Process_2021__stress granule assembly (GO:0034063),-0.4144263241848738,-0.7612858908113781,0.7761194029850746,0.9922013455743963,1.0,1/19,3.06%,RPS23
prerank,GO_Biological_Process_2021__regulation of cell adhesion (GO:0030155),-0.3268377261982124,-0.761037130167273,0.9,0.992324494484449,1.0,4/82,1.54%,RIPOR2;CXCR4;CCL5;DUSP1
prerank,GO_Biological_Process_2021__serine family amino acid metabolic process (GO:0009069),0.467166728585775,0.76069321574039,0.8,0.9579777291378982,1.0,1/7,1.41%,GCLC
prerank,Reactome_2022__Toll Like Receptor 7/8 (TLR7/8) Cascade R-HSA-168181,-0.3224540285379467,-0.7606180830828232,0.8947368421052632,0.9924013236664788,1.0,5/88,6.58%,UBC;FOS;RPS27A;NDUFA2;NLRC5
prerank,Reactome_2022__MyD88 Dependent Cascade Initiated On Endosome R-HSA-975155,-0.3224540285379467,-0.7606180830828232,0.8947368421052632,0.9924013236664788,1.0,5/88,6.58%,UBC;FOS;RPS27A;NDUFA2;NLRC5
prerank,GO_Biological_Process_2021__nucleus organization (GO:0006997),-0.3569550357638169,-0.760380806289111,0.8125,0.9924627796492573,1.0,2/36,3.97%,USP36;SYNE1
prerank,GO_Biological_Process_2021__ncRNA catabolic process (GO:0034661),-0.39163824754756726,-0.7602600900880696,0.7794117647058824,0.9924011735409244,1.0,7/21,21.97%,EXOSC10;ZCCHC8;NUDT16;DEDD2;TRIR;TENT4B;PARN
prerank,GO_Biological_Process_2021__transcription elongation from RNA polymerase II promoter (GO:0006368),-0.3380930246916371,-0.7598418327077451,0.8888888888888888,0.9926701440061299,1.0,6/57,9.87%,GTF2H5;CTDP1;ELOB;ADRM1;POLR2G;NCBP2
prerank,Reactome_2022__Long-term Potentiation R-HSA-9620244,0.37554937595029475,0.7597332758346704,0.7837837837837838,0.958997148649308,1.0,6/17,16.68%,NRG1;GRIA1;GRIN2B;ERBB4;GRIA2;GRIN2A
prerank,KEGG_2021_Human__Colorectal cancer,-0.34951596810138513,-0.759575022856948,0.8888888888888888,0.9927468409389352,1.0,3/68,2.08%,CYCS;FOS;GADD45B
prerank,GO_Biological_Process_2021__negative regulation of cation channel activity (GO:2001258),-0.4385970587901267,-0.7594966466820489,0.734375,0.9925622842827257,1.0,3/11,8.36%,GNB5;SRI;CALM1
prerank,Reactome_2022__Activation Of RAC1 Downstream Of NMDARs R-HSA-9619229,-0.4664164989521681,-0.7591905061241118,0.7727272727272727,0.992728573743763,1.0,2/7,14.13%,CALM1;CAMK1
prerank,CellMarker_Augmented_2021__Hematopoietic cell:Liver,0.286390956887976,0.7591022251585947,0.9705882352941176,0.9595894826979545,1.0,17/89,16.88%,B3GNT2;ZBTB1;OSBPL3;SLC39A8;RUNX1;TMED5;TMOD3;ZNF800;CD164;AP4E1;MTDH;SRFBP1;EOGT;RNF6;TRIP12;SCAF11;PTBP3
prerank,GO_Biological_Process_2021__regulation of programmed cell death (GO:0043067),-0.3203602720919077,-0.7590617875957699,0.88,0.9926465041863205,1.0,19/122,15.92%,IKZF3;PRELID1;TNFRSF25;USP36;CTSB;CLU;RPS3;TPT1;SGK1;TMEM219;KANK2;STAT1;BCL2L14;NOP53;APEX1;TP53INP1;PIDD1;LGALS1;AGT
prerank,KEGG_2021_Human__Basal transcription factors,-0.3615845523674092,-0.7587289017936,0.8245614035087719,0.9929124648325585,1.0,2/35,4.34%,TAF6L;GTF2H5
prerank,GO_Biological_Process_2021__regulation of nitric oxide metabolic process (GO:0080164),-0.45930682860479133,-0.7585777730688992,0.8333333333333334,0.992799693942547,1.0,4/8,16.58%,SELENOS;CD47;NOS1AP;RAC1
prerank,GO_Biological_Process_2021__regulation of cellular component organization (GO:0051128),-0.31841993536801816,-0.7585575493316461,0.9113924050632911,0.9925488953751302,1.0,5/103,4.79%,CD36;TFRC;PRKCQ;ATF5;OGFR
prerank,GO_Biological_Process_2021__intracellular protein transmembrane transport (GO:0065002),-0.37023171094583884,-0.758552033048831,0.7384615384615385,0.9922701171816818,1.0,5/32,13.88%,DNAJC19;TIMM44;TIMM21;SEC62;TOMM40
prerank,Reactome_2022__RHOBTB GTPase Cycle R-HSA-9706574,-0.3657143161454486,-0.7583916180757984,0.6935483870967742,0.9922061844353954,1.0,3/33,7.76%,CDC37;PDE5A;ACTG1
prerank,GO_Biological_Process_2021__regulation of cellular macromolecule biosynthetic process (GO:2000112),-0.29460007300444624,-0.7582865727667083,0.9655172413793104,0.992078410936496,1.0,32/310,12.59%,MYBL1;PPIE;RUNX3;PRKCQ;CHD3;ATF5;TAF6L;EDF1;RORA;OGG1;BHLHE40;RPL10;ZNF331;TRIM22;MSL3;PLAG1;BRCA2;RPL6;DVL1;HINT1;REXO4;MLX;HIF1A;EIF2A;BTG1;TCF3;GLI4;GLRX2;GCFC2;RBM4B;CREM;TERF2IP
prerank,Reactome_2022__Synthesis Of PIPs At Plasma Membrane R-HSA-1660499,0.32630722227671416,0.7582565199606038,0.9259259259259259,0.9604404555186191,1.0,11/45,18.14%,PIP5K1B;PLEKHA5;PIK3C2B;PTPN13;PTEN;PIP4K2A;MTMR9;RAB14;PIK3CA;PLEKHA8;INPP4B
prerank,GO_Biological_Process_2021__ephrin receptor signaling pathway (GO:0048013),-0.3531140474910855,-0.7582538757594883,0.8076923076923077,0.991848535594337,1.0,12/63,19.57%,VAV3;YES1;EPHB1;FYN;ACTG1;ACTB;EFNB2;AP2S1;RAC1;APH1B;ITSN1;EPHB2
prerank,GO_Biological_Process_2021__amide transport (GO:0042886),-0.4029159097346272,-0.758014361848501,0.78125,0.9918920290635518,1.0,5/17,11.24%,PLTP;AQP11;SLC14A1;ABCB9;TAP1
prerank,Reactome_2022__Metabolism Of Lipids R-HSA-556833,-0.2849874556254039,-0.7578892836331722,1.0,0.9917823233478646,1.0,39/467,12.05%,ARSJ;OSBPL5;CD36;INSIG1;DEGS2;CH25H;MGLL;ARSG;SLC51A;RORA;GSTM4;LPCAT1;ABCC3;GDPD1;DDHD2;NR1H2;GNPAT;INPP4A;TNFAIP8;MED25;MUSK;ACBD5;THEM4;PPP1CB;ACOT9;ACAA1;PRKD2;PCYT1A;PCTP;ORMDL1;PLB1;ABCB4;PTGES2;GK;FAAH2;CSNK1G2;GPX4;MED11;MCEE
prerank,GO_Biological_Process_2021__establishment of protein localization to plasma membrane (GO:0061951),0.3497729374405958,0.7573278099384141,0.9069767441860465,0.9614662500753623,1.0,6/29,12.69%,GOLPH3L;RAB10;GOLGA7;RAB7A;BLZF1;AFDN
prerank,GO_Biological_Process_2021__protein targeting to lysosome (GO:0006622),0.38336215418519076,0.7570860839747197,0.8292682926829268,0.9614307452819376,1.0,5/20,11.83%,SCARB2;RAB7A;LAPTM5;NCOA4;SORL1
prerank,Reactome_2022__RHOBTB1 GTPase Cycle R-HSA-9013422,0.34364800212701196,0.7569852043966363,0.8157894736842105,0.961236655654371,1.0,7/22,18.22%,GPS1;RNF20;HNRNPC;CPSF7;RHOBTB1;COPS4;TRA2B
prerank,GO_Biological_Process_2021__positive regulation of protein phosphorylation (GO:0001934),-0.29699843319629965,-0.7569460941219222,0.9647058823529412,0.9928722076121169,1.0,32/226,16.58%,CALCR;TFRC;CARD14;PDGFD;MARCO;CEMIP;DDRGK1;RACK1;IGF1;PECAM1;MUSK;ENPP2;CALM1;PRKD2;CD44;CHI3L1;BANK1;VEGFA;MTCP1;TERF2IP;CSNK1D;PTPRC;CAMK1;CCND1;FGF20;C3;SNX9;CD74;AGT;MT3;FLOT1;RAC1
prerank,GO_Biological_Process_2021__regulation of interleukin-2 production (GO:0032663),-0.36472644143592897,-0.7568572305207397,0.8253968253968254,0.9927265661760454,1.0,9/36,13.66%,ZFP36;LILRB4;RPS3;TNFAIP3;PRKD2;GLMN;PTPRC;KAT5;HAVCR2
prerank,GO_Biological_Process_2021__positive regulation of tissue remodeling (GO:0034105),-0.5054864011046853,-0.7564470044798811,0.7592592592592593,0.9930018797879101,1.0,1/5,17.61%,IL18
prerank,GO_Biological_Process_2021__erythrocyte development (GO:0048821),-0.46432327758053715,-0.7564390829093782,0.78,0.9927287829281075,1.0,2/8,20.60%,NCKAP1L;MED1
prerank,GO_Biological_Process_2021__regulation of oxidoreductase activity (GO:0051341),-0.4456622669872772,-0.7563254542761131,0.7241379310344828,0.9926011506359629,1.0,4/10,23.53%,OXA1L;NOD2;MT3;SZT2
prerank,GO_Biological_Process_2021__positive regulation of ERBB signaling pathway (GO:1901186),0.35422355264771876,0.7562189978218798,0.7894736842105263,0.9618855419237546,1.0,1/16,2.09%,HIP1R
prerank,GO_Biological_Process_2021__positive regulation of glucose import (GO:0046326),-0.39285929599955116,-0.7562104214878601,0.8135593220338984,0.992483784797658,1.0,2/16,11.83%,IGF1;APPL1
prerank,GO_Biological_Process_2021__pulmonary valve development (GO:0003177),0.3680813334470534,0.7561578975176716,0.7948717948717948,0.9615996671878362,1.0,4/12,18.17%,JAG1;ROBO1;ROBO2;TNFRSF1A
prerank,GO_Biological_Process_2021__regulation of extracellular matrix organization (GO:1903053),0.45416294718998973,0.7561464087753607,0.8461538461538461,0.9612681327960312,1.0,1/8,6.90%,RUNX1
prerank,Reactome_2022__Purine Salvage R-HSA-74217,0.4873411475938123,0.7560923229344142,0.8076923076923077,0.9609826833671938,1.0,1/7,2.67%,DGUOK
prerank,GO_Biological_Process_2021__post-transcriptional gene silencing by RNA (GO:0035194),-0.4050114988665765,-0.7560711864475657,0.7540983606557377,0.9923970596029521,1.0,3/17,17.54%,MOV10L1;CNOT8;NRDE2
prerank,GO_Biological_Process_2021__negative regulation of signal transduction by p53 class mediator (GO:1901797),0.4222965679870201,0.7559921621875343,0.8378378378378378,0.9607891008937397,1.0,3/13,10.28%,SIRT1;MDM2;DYRK1A
prerank,GO_Biological_Process_2021__negative regulation of B cell apoptotic process (GO:0002903),-0.492669748330291,-0.7557838375581081,0.7407407407407407,0.9925243432975537,1.0,3/5,36.74%,BCL10;NOC2L;BCL6
prerank,Reactome_2022__Diseases Of Metabolism R-HSA-5668914,-0.31789627598016135,-0.7557797982882951,0.9333333333333333,0.9922466739258967,1.0,9/123,8.87%,SPON2;UBC;RPS27A;ADAMTS19;POMT1;G6PC3;CSF2RA;GCLM;GPC3
prerank,GO_Biological_Process_2021__regulation of response to DNA damage stimulus (GO:2001020),0.3441141030435969,0.7557491123311647,0.7575757575757576,0.9607914119720142,1.0,11/31,26.39%,CASP9;FEM1B;NSMCE1;UBE2N;RFWD3;WRNIP1;CDK9;ABL1;NEK4;UBE2V2;POLH
prerank,Reactome_2022__Estrogen-dependent Nuclear Events Downstream Of ESR-membrane Signaling R-HSA-9634638,-0.4025319144474343,-0.7557416972794909,0.8448275862068966,0.9920302581901618,1.0,1/17,1.22%,FOS
prerank,GO_Biological_Process_2021__regulation of granulocyte differentiation (GO:0030852),0.4473030219699438,0.7557048995745227,0.8181818181818182,0.960498111777802,1.0,1/7,6.90%,RUNX1
prerank,CellMarker_Augmented_2021__HES1High Progenitor cell:Stomach,-0.36845465766659374,-0.755571991047212,0.8208955223880597,0.9920150184458703,1.0,8/41,12.09%,PLEKHG5;PLXDC1;APOD;OSMR;DIO2;PTPRB;SPARCL1;STEAP2
prerank,GO_Biological_Process_2021__positive regulation of macrophage differentiation (GO:0045651),0.45614765093039134,0.7555559305415556,0.78,0.9603465300636287,1.0,2/6,25.72%,RIPK1;TGFB1
prerank,Reactome_2022__Metabolism Of Non-Coding RNA R-HSA-194441,0.2955974708027219,0.7555461046635096,0.8787878787878788,0.9600078321523948,1.0,8/42,17.93%,NUP153;NUP188;GEMIN2;NUP42;SNRPB;NDC1;NUP133;NUP205
prerank,GO_Biological_Process_2021__positive regulation of leukocyte degranulation (GO:0043302),-0.464734243666479,-0.7554042685026358,0.765625,0.9919616232844163,1.0,2/10,10.55%,HLA-F;ITGB2
prerank,Reactome_2022__MAPK Family Signaling Cascades R-HSA-5683057,-0.30802933516098163,-0.7554008014959074,0.9418604651162791,0.9916920564745659,1.0,30/212,14.82%,UBC;RPS27A;PRKCQ;RASGRF2;PAQR3;PSMB3;IL3RA;WDR83;FGF13;NEFL;PSMB6;RNMT;PSMA7;FYN;PPP1CB;CSF2RA;CALM1;PSMB9;CSF2RB;RBX1;PSMD12;PSMD8;PSMA5;PEBP1;PIK3CB;PEA15;FGF20;TLN1;RASA2;UBA52
prerank,Reactome_2022__Interleukin-15 Signaling R-HSA-8983432,0.45382048873800007,0.7552740179051567,0.8461538461538461,0.960056168395588,1.0,6/11,35.15%,GAB2;STAT5A;SOS1;JAK3;IL15;GRB2
prerank,Reactome_2022__Butyrate Response Factor 1 Binds And Destabilizes mRNA R-HSA-450385,0.38936542497098386,0.7551609833146729,0.7948717948717948,0.9598425429704122,1.0,5/14,25.04%,EXOSC6;MAPKAPK2;EXOSC7;DCP1A;DCP2
prerank,GO_Biological_Process_2021__peripheral nervous system development (GO:0007422),0.41550989471991584,0.7551336263619332,0.717948717948718,0.9595459480862124,1.0,4/12,14.53%,ADGRB2;SCN8A;NF1;NFASC
prerank,CellMarker_Augmented_2021__Type II pneumocyte:Lung,-0.3911150505916354,-0.7548795203887703,0.8181818181818182,0.9921600632512205,1.0,7/19,14.85%,DUOX1;BHLHE40;ABCC3;CD44;CFTR;ARHGEF38;C3
prerank,"GO_Biological_Process_2021__negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",0.43046925308548084,0.754853060229995,0.75,0.9596276341764353,1.0,3/9,10.28%,SIRT1;MDM2;DYRK1A
prerank,"GO_Biological_Process_2021__regulation of CD4-positive, alpha-beta T cell proliferation (GO:2000561)",-0.5011733498130467,-0.7546142604361478,0.8833333333333333,0.9922846205032069,1.0,1/7,1.64%,CD55
prerank,GO_Biological_Process_2021__peroxisome organization (GO:0007031),-0.3932117029371995,-0.7545355146857381,0.7931034482758621,0.9921295535533736,1.0,1/18,5.76%,FIS1
prerank,GO_Biological_Process_2021__granulocyte migration (GO:0097530),-0.49077749113896924,-0.7543244866581716,0.8571428571428571,0.9920863640697378,1.0,1/6,0.62%,CCL3
prerank,Reactome_2022__Membrane Trafficking R-HSA-199991,-0.28848390071793695,-0.7542490813860127,0.9888888888888889,0.9918908007887624,1.0,50/476,16.21%,TPD52;UBC;FTH1;EPN1;RPS27A;CHRM2;TFRC;CD55;IL7R;F8;COPS6;RAB11A;GOLGA1;RAB3A;TRAPPC4;TACR1;SNF8;NAA38;CALM1;GABARAPL2;HPS4;VPS28;SLC2A8;GOLGA4;DCTN6;CFTR;PTGES2;DCTN4;BNIP1;TBC1D20;COPS8;VPS37B;CSNK1D;CLTB;AP4M1;FTL;COPE;CYTH1;DYNC1LI2;TRAPPC6A;IGF2R;STX10;UBA52;SNX9;AP2S1;ANKRD28;DENND3;SEC13;MVB12A;DENND6A
prerank,GO_Biological_Process_2021__cell proliferation in forebrain (GO:0021846),0.43994675758121604,0.7540622920638266,0.7777777777777778,0.9604319065350874,1.0,4/7,25.45%,NUMBL;CEP120;HOOK3;PCM1
prerank,CellMarker_Augmented_2021__AXL+SIGLEC6+ Dendritic cell:Blood,-0.35832235775106186,-0.7538125339331943,0.8589743589743589,0.9922031983479603,1.0,8/56,8.68%,MGLL;ATF5;SIGLEC1;SCN9A;BHLHE40;ZNF789;RNASEL;CD72
prerank,GO_Biological_Process_2021__regulation of peptidyl-tyrosine phosphorylation (GO:0050730),0.30094905153496865,0.75377225790502,0.96875,0.9604924605504555,1.0,5/58,9.97%,NRP1;PDGFA;RELN;CNOT7;HGF
prerank,GO_Biological_Process_2021__removal of superoxide radicals (GO:0019430),-0.49973115949362285,-0.7536689658525095,0.8135593220338984,0.9921143309030692,1.0,2/5,16.40%,SOD1;MT3
prerank,GO_Biological_Process_2021__RNA modification (GO:0009451),0.3044166470336761,0.7533865087130787,0.8333333333333334,0.9607148281125392,1.0,4/44,5.52%,MEPCE;NSUN2;TRUB1;TFB1M
prerank,GO_Biological_Process_2021__COPII-coated vesicle cargo loading (GO:0090110),0.3758534900207533,0.7530438183157231,0.7636363636363637,0.9608748069435482,1.0,5/14,22.61%,SEC24B;SEC31A;SEC31B;SEC23B;SCAP
prerank,GO_Biological_Process_2021__ventricular septum development (GO:0003281),0.3510169506453699,0.7528965067863286,0.8421052631578947,0.9606821584375597,1.0,8/23,15.51%,TGFBR2;SMAD7;SALL1;ROBO1;SOX4;BMPR1A;TGFBR1;ROBO2
prerank,GO_Biological_Process_2021__regulation of interleukin-23 production (GO:0032667),-0.5067572251176143,-0.752885298088709,0.75,0.9929239034023197,1.0,3/5,27.27%,RAC1;CLEC7A;MYD88
prerank,GO_Biological_Process_2021__negative regulation of inclusion body assembly (GO:0090084),0.4287205319169094,0.7527599073133757,0.75,0.960522812934984,1.0,3/9,11.83%,DNAJB2;DNAJA4;SORL1
prerank,GO_Biological_Process_2021__protein localization to nucleus (GO:0034504),-0.3313489074076451,-0.7525290259353281,0.8591549295774648,0.9931748560702043,1.0,12/80,11.92%,XPA;RANBP6;CHCHD10;RPL11;PHB2;PTTG1IP;CNEP1R1;GBP2;DVL1;NUP50;APPL1;NOP53
prerank,CellMarker_Augmented_2021__Alpha cell:Pancreas,0.47846902700895155,0.752348478982424,0.7368421052631579,0.9606619680373999,1.0,1/5,12.79%,UBA2
prerank,Reactome_2022__Toll Like Receptor 9 (TLR9) Cascade R-HSA-168138,-0.3161809260377685,-0.7523428497108609,0.925,0.9931897826436056,1.0,5/92,6.58%,UBC;FOS;RPS27A;NDUFA2;NLRC5
prerank,CellMarker_Augmented_2021__Alveolar Epithelial Progenitor cell:Lung,-0.3551433924020217,-0.7519927360737725,0.8769230769230769,0.9933847344061971,1.0,7/43,14.20%,ARSJ;OSMR;SPATS2L;CRIM1;ADGRG6;PON2;CCND1
prerank,GO_Biological_Process_2021__positive regulation of DNA biosynthetic process (GO:2000573),-0.3631274862966433,-0.7519117511420386,0.7936507936507936,0.9932069357612112,1.0,4/45,8.41%,PKIB;PRKCQ;CHTF18;PRKD2
prerank,Reactome_2022__Signaling By VEGF R-HSA-194138,-0.31374524811302806,-0.7517499628106036,0.9113924050632911,0.9931914296270894,1.0,13/81,13.75%,VAV3;NCF4;JUP;FYN;THEM4;CALM1;NCF2;NCKAP1L;VEGFA;FLT1;CYFIP2;CYBA;PIK3CB
prerank,Reactome_2022__Phase II - Conjugation Of Compounds R-HSA-156580,-0.36108723026036216,-0.7513147549657035,0.855072463768116,0.993510360466443,1.0,8/41,9.85%,GSTM4;SLC38A1;GSTP1;GSTK1;MAT2B;GCLM;GSTM3;COMT
prerank,Reactome_2022__GPVI-mediated Activation Cascade R-HSA-114604,-0.3925636719122242,-0.7511083400585238,0.7746478873239436,0.9935302375370403,1.0,3/27,7.36%,VAV3;FCER1G;FYN
prerank,GO_Biological_Process_2021__cartilage development (GO:0051216),-0.3875827724078899,-0.7507510657669245,0.8032786885245902,0.9937146915654201,1.0,6/25,9.28%,RUNX3;DDRGK1;SULF2;CD44;TRPV4;CHI3L1
prerank,Reactome_2022__Digestion R-HSA-8935690,0.4987590797108544,0.750717000447755,0.8363636363636363,0.9625948541856325,1.0,2/5,6.29%,PIR;MGAM
prerank,Reactome_2022__Collagen Degradation R-HSA-1442490,-0.42020176417353894,-0.7506161961498534,0.82,0.993620586490289,1.0,2/18,3.91%,COL18A1;CTSB
prerank,GO_Biological_Process_2021__nucleobase-containing compound biosynthetic process (GO:0034654),0.4188374274058482,0.7505923960029806,0.74,0.9624142922428547,1.0,1/11,2.67%,DGUOK
prerank,GO_Biological_Process_2021__neuronal action potential (GO:0019228),0.466897208626463,0.7505143202582544,0.7857142857142857,0.9622007397772718,1.0,4/9,13.35%,SCN3A;KCNMB4;SCN8A;KCNMB3
prerank,Reactome_2022__Unattached Kinetochores Signal Amplification Via A MAD2 Inhibitory Signal R-HSA-141444,-0.3321137156812059,-0.7505009976122375,0.9253731343283582,0.9935164114080297,1.0,13/62,22.58%,RPS27;CENPU;ITGB3BP;ZWILCH;MIS12;DYNC1LI2;SEC13;SGO2;CENPF;BUB3;DYNC1I2;PPP2R5C;KANSL1
prerank,GO_Biological_Process_2021__protein localization to microtubule organizing center (GO:1905508),-0.41754301713626363,-0.7504469414835082,0.796875,0.9932807350769495,1.0,4/15,21.63%,STIL;CSNK1D;DCTN2;SNX10
prerank,GO_Biological_Process_2021__positive regulation of actin filament bundle assembly (GO:0032233),0.33760897632452735,0.7502456989940991,0.8,0.9622025347908119,1.0,1/32,0.61%,NRP1
prerank,Reactome_2022__Cilium Assembly R-HSA-5617833,-0.31835828459374976,-0.7500126833075974,0.9113924050632911,0.9936850999296876,1.0,28/142,22.15%,RPGRIP1L;BBS2;SSNA1;RAB11A;IFT46;DYNC2I1;PRKD2;CEP72;CEP164;TMEM67;PTGES2;IFT27;IFT81;CSNK1D;TUBB4B;IFT52;IFT43;PRKAR2B;CC2D2A;DCTN2;AKAP9;CCT2;DYNC1I2;NINL;BBIP1;DYNLT2;SFI1;HAUS5
prerank,GO_Biological_Process_2021__oligodendrocyte differentiation (GO:0048709),0.4139834896653211,0.7497708224402674,0.8125,0.9625559660376759,1.0,2/10,5.32%,MYRF;TPPP
prerank,GO_Biological_Process_2021__secondary palate development (GO:0062009),-0.5034858858541836,-0.7496930041215779,0.7551020408163265,0.9938414376557659,1.0,1/7,1.03%,TGFBR3
prerank,Reactome_2022__RNA Polymerase III Transcription Initiation From Type 2 Promoter R-HSA-76066,-0.3917337897965074,-0.7494223226817193,0.7833333333333333,0.9939092124091549,1.0,1/22,3.40%,GTF3C6
prerank,GO_Biological_Process_2021__regulation of viral life cycle (GO:1903900),-0.41771231646799645,-0.7492746630997165,0.7636363636363637,0.9938708085234766,1.0,2/16,5.98%,TRIM5;TRIM22
prerank,GO_Biological_Process_2021__regulation of histone H3-K27 methylation (GO:0061085),-0.48485783558086626,-0.7491738529072569,0.7547169811320755,0.9937263152244784,1.0,2/5,25.42%,SUPT6H;OGT
prerank,GO_Biological_Process_2021__protein targeting to peroxisome (GO:0006625),0.3478107694475639,0.7489693860936536,0.7674418604651163,0.9633475034915869,1.0,7/22,18.58%,GDAP1;ZFAND6;PEX13;PEX5;PEX11B;PEX16;ATAD1
prerank,GO_Biological_Process_2021__positive regulation of dendrite development (GO:1900006),-0.49005187861561167,-0.7489332351926248,0.8070175438596491,0.993718292983051,1.0,2/8,13.76%,PTN;VLDLR
prerank,"GO_Biological_Process_2021__negative regulation of DNA-templated transcription, elongation (GO:0032785)",-0.411509550198797,-0.748867759978151,0.7924528301886793,0.9935587730683769,1.0,6/13,30.85%,RECQL5;NELFE;LARP7;NELFCD;RNF8;HEXIM1
prerank,Reactome_2022__Synthesis Of PIPs At Golgi Membrane R-HSA-1660514,0.3758475157937705,0.748679005508089,0.8378378378378378,0.9634853110323592,1.0,1/12,8.96%,PI4KB
prerank,"GO_Biological_Process_2021__regulation of phagocytosis, engulfment (GO:0060099)",-0.47835599843618515,-0.7485678638675183,0.7833333333333333,0.9937199322773219,1.0,2/7,14.85%,NCKAP1L;C3
prerank,Reactome_2022__TNFR1-mediated Ceramide Production R-HSA-5626978,-0.4997408091829436,-0.7484818069324766,0.8571428571428571,0.9935554539246954,1.0,1/5,4.24%,RACK1
prerank,GO_Biological_Process_2021__C21-steroid hormone biosynthetic process (GO:0006700),0.45490495532112607,0.7484598090100109,0.7346938775510204,0.9635899607502014,1.0,1/6,4.90%,TSPOAP1
prerank,GO_Biological_Process_2021__regulation of cell-substrate junction assembly (GO:0090109),0.36322734597526196,0.7481137228031521,0.7222222222222222,0.9637110604585982,1.0,9/20,28.91%,VCL;SLC9A1;PTK2;CLASP1;PEAK1;LIMCH1;CORO1C;GPM6B;RHOA
prerank,GO_Biological_Process_2021__protein localization to perinuclear region of cytoplasm (GO:1905719),-0.466103678197104,-0.7477548051130677,0.7857142857142857,0.9943522990303312,1.0,2/5,22.20%,HOOK2;AKTIP
prerank,CellMarker_Augmented_2021__Paneth cell:Undefined,0.32069065616666315,0.7477286133146136,1.0,0.9639187955657317,1.0,8/62,9.61%,GNPNAT1;UGDH;COQ9;PLPP1;DHCR24;MRPS35;SLC37A4;LMAN2L
prerank,GO_Biological_Process_2021__regulation of glucose metabolic process (GO:0010906),0.3506412384607776,0.7476441626122377,0.8823529411764706,0.9637053153340851,1.0,2/22,2.51%,PDK4;SIRT1
prerank,GO_Biological_Process_2021__purine ribonucleotide catabolic process (GO:0009154),-0.40755763101888,-0.7475374491833593,0.796875,0.9944122126690481,1.0,3/15,13.80%,HINT1;ENTPD4;NUDT16
prerank,GO_Biological_Process_2021__positive regulation of membrane invagination (GO:1905155),-0.48117791682582445,-0.7473991550732576,0.7931034482758621,0.9943712325468413,1.0,2/6,14.85%,NCKAP1L;C3
prerank,KEGG_2021_Human__Aldosterone synthesis and secretion,0.30498730163598076,0.7472051088345513,0.9166666666666666,0.9640655916808514,1.0,5/60,6.41%,LDLR;GNAQ;KCNJ5;PLCB4;ADCY9
prerank,GO_Biological_Process_2021__purine-containing compound salvage (GO:0043101),0.45302839941644735,0.7471643776870609,0.7735849056603774,0.963777957081697,1.0,1/8,2.67%,DGUOK
prerank,GO_Biological_Process_2021__positive regulation of membrane protein ectodomain proteolysis (GO:0051044),-0.4370829873566091,-0.7470442414913196,0.8125,0.9945672307018225,1.0,3/8,21.94%,TNFRSF1B;SNX9;NRDC
prerank,GO_Biological_Process_2021__regulation of immunoglobulin production (GO:0002637),-0.4326369152101017,-0.7469851673698139,0.828125,0.9943573836354052,1.0,7/15,22.02%,DNAJB9;PHB2;PTPRC;HLA-E;SUPT6H;EPHB2;STX4
prerank,GO_Biological_Process_2021__regulation of synaptic vesicle exocytosis (GO:2000300),-0.3921480444494898,-0.7469704189733787,0.7966101694915254,0.994094746537555,1.0,1/15,1.34%,RIMS1
prerank,GO_Biological_Process_2021__mitotic DNA damage checkpoint signaling (GO:0044773),-0.3500199771633786,-0.746834986286999,0.8695652173913043,0.9940085644233414,1.0,9/45,15.14%,HUS1;MUS81;TIPIN;ABRAXAS1;NOP53;RAD9A;CCND1;BRCA1;RPS27L
prerank,GO_Biological_Process_2021__positive regulation of protein modification process (GO:0031401),0.270880567559964,0.74666028910289,1.0,0.9641090865921842,1.0,24/141,16.10%,LEPR;ACVR2A;FGF2;SIRT1;LRRK2;CIB1;TNF;DVL3;TMEM119;RAMP1;NPTN;KNDC1;HGF;DYRK1A;UBE2N;NTRK2;PTPA;GPNMB;PTK2;ERBB4;RAPGEF3;AKT2;CCND3;WDFY2
prerank,GO_Biological_Process_2021__retinol metabolic process (GO:0042572),-0.46817999413654043,-0.7465848577968288,0.7586206896551724,0.9941213513896509,1.0,3/5,35.62%,RDH11;RDH10;RETSAT
prerank,GO_Biological_Process_2021__negative regulation of macroautophagy (GO:0016242),0.36982686111690244,0.7464008763502631,0.9047619047619048,0.9640854659084657,1.0,3/23,4.89%,LRRK2;TSC2;TMEM39A
prerank,GO_Biological_Process_2021__cilium organization (GO:0044782),-0.30391676037102633,-0.7463325926211773,0.9418604651162791,0.9942718346605647,1.0,13/144,11.48%,FLNA;CATIP;BBS2;RAB11A;IFT46;MAK;DYNC2I1;CEP164;TMEM138;DZIP1L;TMEM67;IFT81;ABLIM3
prerank,GO_Biological_Process_2021__DNA integrity checkpoint signaling (GO:0031570),-0.3898119301724658,-0.7463245276779249,0.8142857142857143,0.9940019648090036,1.0,3/26,13.39%,HUS1;TIPIN;RAD9A
prerank,GO_Biological_Process_2021__peptidyl-proline hydroxylation (GO:0019511),-0.4750782816895224,-0.7463000679343019,0.7962962962962963,0.9937548884301627,1.0,2/8,12.90%,EGLN3;P4HA3
prerank,GO_Biological_Process_2021__regulation of extrinsic apoptotic signaling pathway (GO:2001236),-0.33980602328231413,-0.7462907178179944,0.9,0.9934903436047342,1.0,6/48,10.28%,TNFSF10;IGF1;GSTP1;ITGA6;CFLAR;BCL2L14
prerank,Reactome_2022__Leading Strand Synthesis R-HSA-69109,0.4493917255536243,0.7462589545159527,0.8571428571428571,0.9639052707462663,1.0,2/8,19.40%,POLA1;PRIM2
prerank,GO_Biological_Process_2021__lysine metabolic process (GO:0006553),-0.41036100533790965,-0.7462505417059356,0.75,0.9929767789935328,1.0,3/10,20.62%,CRYM;DLST;PHYKPL
prerank,GO_Biological_Process_2021__lysine catabolic process (GO:0006554),-0.41036100533790965,-0.7462505417059356,0.75,0.9929767789935328,1.0,3/10,20.62%,CRYM;DLST;PHYKPL
prerank,Reactome_2022__RORA Activates Gene Expression R-HSA-1368082,-0.39834473638963497,-0.7460411177727069,0.8070175438596491,0.9930117281167429,1.0,1/17,3.27%,RORA
prerank,GO_Biological_Process_2021__endochondral bone morphogenesis (GO:0060350),0.44088744250841305,0.7459960283985334,0.8461538461538461,0.9639064549905788,1.0,2/7,9.81%,TMEM119;BMPR1B
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Gingiva,-0.4719158295340821,-0.7458880963265931,0.8333333333333334,0.9929712864976393,1.0,3/6,22.77%,CD44;ITGB1;ITGA5
prerank,KEGG_2021_Human__Non-homologous end-joining,-0.43494648764461125,-0.7456820816505387,0.7735849056603774,0.9929785892483834,1.0,1/9,7.94%,POLM
prerank,GO_Biological_Process_2021__regulation of receptor signaling pathway via STAT (GO:1904892),-0.4379808514608976,-0.7454699790213237,0.7419354838709677,0.993013508678491,1.0,1/8,1.80%,IL7R
prerank,GO_Biological_Process_2021__regulation of microtubule polymerization (GO:0031113),0.31822206698325795,0.7452904779097601,0.9090909090909091,0.9644759097535442,1.0,8/34,19.55%,CDK5R1;TOGARAM1;DYRK1A;SLAIN2;CLASP1;CAMSAP2;SNCA;MAP2
prerank,GO_Biological_Process_2021__ATP-dependent chromatin remodeling (GO:0043044),0.3049439407812369,0.745163722979122,0.9117647058823529,0.9642710689034096,1.0,7/37,16.76%,ARID1A;MTA2;HDAC1;HNRNPC;ARID1B;ACTL6A;VPS72
prerank,CellMarker_Augmented_2021__CD141+CLEC9A+ Dendritic cell:Blood,0.2999341003298216,0.7450744055142917,0.896551724137931,0.9640663727148926,1.0,13/70,14.62%,FHIP1B;PRELID2;NDRG2;PDE4DIP;OSBPL3;CADM1;TRERF1;KCNK6;PDLIM7;SLC9A9;PTK2;WDFY4;ENPP1
prerank,GO_Biological_Process_2021__positive regulation of cellular protein metabolic process (GO:0032270),-0.324029577475674,-0.7450709046651047,0.9117647058823529,0.9932768439699982,1.0,18/76,18.50%,RPS4X;RPL5;NR1H2;VPS35;AURKAIP1;PTTG1IP;EIF4A3;NPM1;ATG10;CYFIP2;PASK;RPS27L;ZCCHC4;UHRF1;AGT;EZR;EEF2;VIM
prerank,Reactome_2022__ROBO Receptors Bind AKAP5 R-HSA-9010642,0.46302933004556557,0.744899349987036,0.8214285714285714,0.9639811139187541,1.0,2/6,17.84%,ROBO2;PPP3CB
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial fission (GO:0090141),0.39800605517736093,0.7447597892717231,0.8157894736842105,0.9638424580402314,1.0,3/14,9.11%,MCU;MARCHF5;DDHD1
prerank,CellMarker_Augmented_2021__T Helper17 (Th17) cell:Undefined,-0.44396923581794284,-0.7446731264063534,0.7931034482758621,0.9935274848221548,1.0,1/11,3.27%,RORA
prerank,GO_Biological_Process_2021__pyrimidine-containing compound metabolic process (GO:0072527),-0.4612967545827128,-0.744637227990072,0.7735849056603774,0.9932987898747453,1.0,3/10,15.19%,TYMP;ENPP3;SLC25A19
prerank,PanglaoDB_Augmented_2021__Principal Cells,-0.39028590351751224,-0.7446007996019447,0.7966101694915254,0.9930626975700577,1.0,3/26,8.80%,PLEKHA7;CLDN7;OVOL2
prerank,CellMarker_Augmented_2021__Tuft Progenitor cell:Small Intestine,0.47884293827996705,0.7445483157582393,0.8205128205128205,0.9638724364546051,1.0,1/6,0.52%,TPM2
prerank,GO_Biological_Process_2021__positive regulation of cell killing (GO:0031343),-0.45614526655268683,-0.7442775424423189,0.819672131147541,0.9931978445370224,1.0,4/9,20.69%,PRF1;CYBA;RAC1;CLEC7A
prerank,KEGG_2021_Human__Cellular senescence,0.2925423131046606,0.7442470470659522,1.0,0.9639517040832041,1.0,19/109,12.49%,SERPINE1;TGFBR2;SIRT1;MAPK11;MCU;E2F3;MAP2K1;TSC2;SMAD2;SMAD3;PPP3CA;MDM2;BTRC;LIN52;FBXW11;MAPK1;PTEN;CDK6;MAPKAPK2
prerank,GO_Biological_Process_2021__positive regulation of stem cell differentiation (GO:2000738),0.4336079215803347,0.7440806921317883,0.7755102040816326,0.9638871446551674,1.0,4/7,21.47%,LTBP3;SOX5;NUDT21;SOX6
prerank,GO_Biological_Process_2021__negative regulation of cellular biosynthetic process (GO:0031327),0.3271683431564456,0.7440119207216491,0.8275862068965517,0.9636296346020661,1.0,4/27,11.26%,ABCA2;SIRPA;FBXW7;ACADVL
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte differentiation (GO:0045621),0.3796277866163387,0.7440064701835258,0.813953488372093,0.9632984185847334,1.0,1/14,1.16%,ZBTB1
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle cell proliferation (GO:0060045),-0.4721844830274294,-0.7439486699733524,0.8888888888888888,0.9934106268574097,1.0,2/10,8.45%,TGFBR3;RBPJ
prerank,GO_Biological_Process_2021__positive regulation of osteoclast differentiation (GO:0045672),0.4635963658502422,0.7437762768515751,0.8085106382978723,0.9632341573833808,1.0,2/5,14.94%,TNF;TRAF6
prerank,"Reactome_2022__Defective EXT1 Causes Exostoses 1, TRPS2 And CHDS R-HSA-3656253",-0.4582852385970479,-0.7437325597838479,0.7627118644067796,0.9934303217676641,1.0,2/7,11.54%,GPC3;SDC3
prerank,GO_Biological_Process_2021__histone H4-K16 acetylation (GO:0043984),0.37142180552065074,0.7436859664992767,0.7674418604651163,0.9630550864188704,1.0,1/19,1.75%,MSL2
prerank,GO_Biological_Process_2021__positive regulation of mast cell degranulation (GO:0043306),0.41349999019545125,0.7436374346311123,0.8333333333333334,0.9627818294888012,1.0,2/7,21.93%,GAB2;SYK
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),-0.4167899735643361,-0.7435872399482026,0.8513513513513513,0.9933548006535879,1.0,1/19,2.37%,DDIT4
prerank,GO_Biological_Process_2021__establishment of skin barrier (GO:0061436),0.42381101967603674,0.7433006090644553,0.8478260869565217,0.9626005818465507,1.0,2/7,10.18%,FA2H;TMEM79
prerank,GO_Biological_Process_2021__regulation of water loss via skin (GO:0033561),0.42381101967603674,0.7433006090644553,0.8478260869565217,0.9626005818465507,1.0,2/7,10.18%,FA2H;TMEM79
prerank,GO_Biological_Process_2021__response to endoplasmic reticulum stress (GO:0034976),-0.3295655404029296,-0.7431680884661079,0.9066666666666666,0.9936525219573511,1.0,10/91,13.27%,PPP1R15A;RASGRF2;DNAJB9;DDRGK1;ERO1A;SELENOS;CFTR;ATG10;ATF3;TMCO1
prerank,GO_Biological_Process_2021__ameboidal-type cell migration (GO:0001667),-0.3713189138030284,-0.7431551174685163,0.765625,0.9933916846590098,1.0,5/28,8.87%,PDXDC1;SEMA6A;CENPV;ITGA4;GPC3
prerank,Reactome_2022__Digestion And Absorption R-HSA-8963743,0.4846748685622961,0.7431360488440893,0.88,0.9625366788676041,1.0,2/6,6.29%,PIR;MGAM
prerank,KEGG_2021_Human__Small cell lung cancer,-0.3465640694291232,-0.743108959163174,0.9041095890410958,0.9931685418119388,1.0,7/55,14.20%,CYCS;GADD45B;ITGA6;CKS2;MAX;PIK3CB;CCND1
prerank,GO_Biological_Process_2021__regulation of actin filament bundle assembly (GO:0032231),-0.4085975309571021,-0.74265802665441,0.782608695652174,0.9935086114470112,1.0,4/18,16.58%,PLEK;ACTG1;PFN1;RAC1
prerank,GO_Biological_Process_2021__negative regulation of cholesterol biosynthetic process (GO:0045541),-0.4960718900092655,-0.7426358540308335,0.7446808510638298,0.9927373060966396,1.0,1/5,13.37%,SOD1
prerank,GO_Biological_Process_2021__negative regulation of sterol biosynthetic process (GO:0106119),-0.4960718900092655,-0.7426358540308335,0.7446808510638298,0.9927373060966396,1.0,1/5,13.37%,SOD1
prerank,GO_Biological_Process_2021__negative regulation of cholesterol metabolic process (GO:0090206),-0.4960718900092655,-0.7426358540308335,0.7446808510638298,0.9927373060966396,1.0,1/5,13.37%,SOD1
prerank,Reactome_2022__RNA Pol II CTD Phosphorylation And Interaction With CE R-HSA-77075,0.34506694218073797,0.742497462248279,0.7894736842105263,0.9631156977704178,1.0,2/23,6.76%,POLR2D;CDK7
prerank,GO_Biological_Process_2021__glycerolipid catabolic process (GO:0046503),-0.4230561054344996,-0.742449675081778,0.7368421052631579,0.9927171410302725,1.0,2/12,5.25%,MGLL;GDPD1
prerank,GO_Biological_Process_2021__protein localization to vacuole (GO:0072665),-0.43252444881727814,-0.7422185023595441,0.864406779661017,0.9927669633119286,1.0,1/9,5.78%,LAMTOR5
prerank,Reactome_2022__Keratinization R-HSA-6805567,0.40385125147101125,0.7421715438868776,0.7297297297297297,0.9633013512412749,1.0,1/9,1.94%,PKP4
prerank,"GO_Biological_Process_2021__negative regulation of transcription, DNA-templated (GO:0045892)",-0.2783523739118363,-0.7420880736768276,1.0,0.9926643521291049,1.0,78/599,16.40%,NR4A3;FLNA;UBC;RPS27A;RUNX3;ZFP36;SCML4;RPS14;HAMP;MDFIC;SNX6;ZMYND15;CHD3;ATF5;PER3;PER2;PARP15;H1-0;L3MBTL3;BHLHE40;RPL10;HESX1;NR1H2;RPL23;BASP1;ILF3;HDGF;MED25;PHB2;TCF25;PARP9;CRYM;EID1;RBPJ;BTAF1;KANK2;ZNF589;STAT1;IRF1;ZNF266;CITED2;MLX;VEGFA;SCML1;FBP1;MXI1;ING4;TCF3;NOP53;GCFC2;ATF3;MAX;CREM;ZNF674;PRDM1;KAT5;DDX5;UXT;ZNF217;ZNF558;ESR2;CCND1;BRCA1;ATP8B1;ZKSCAN3;CBX3;UBA52;CIITA;ZFPM2;CGGBP1;UHRF1;SP2;ZNF20;DEDD2;KAT8;PRMT2;CDKN1C;MT3
prerank,GO_Biological_Process_2021__positive regulation of Wnt signaling pathway (GO:0030177),-0.30604699751026193,-0.7420336534125088,0.9764705882352941,0.9924668827143774,1.0,15/109,13.53%,PSMB3;JUP;SULF2;PSMB6;PSMA7;TNFAIP3;GPC3;PSMB9;TRPM4;CSNK1G2;PSMD12;CSNK1D;PSMD8;PSMA5;PRDM15
prerank,GO_Biological_Process_2021__regulation of macromolecule metabolic process (GO:0060255),-0.311700880557966,-0.7411328558632451,0.9382716049382716,0.9932558666080261,1.0,14/113,12.88%,NFKBID;TRIM5;AIF1;ZNF335;IGF1;TXK;TRIM22;ZNF513;HNRNPAB;KDM6B;HIF1A;ANKRA2;PTPRC;PRDM1
prerank,GO_Biological_Process_2021__organelle assembly (GO:0070925),-0.2872946028341275,-0.7411170617412911,0.9885057471264368,0.9930059187592242,1.0,39/285,16.62%,FLNA;GOLGA8A;GABARAPL1;RPS23;BBS2;RAB11A;RPS3;IFT46;MAK;DYNC2I1;ATG2A;SNF8;GABARAPL2;HPS4;ZFYVE1;CEP164;TMEM138;DZIP1L;VPS28;TMEM67;NPM1;TUBGCP2;IFT81;EIF2A;STING1;ABLIM3;PATL2;VPS37B;CSNK1D;MIS12;IFT52;TRAPPC6A;TP53INP1;WIPI1;GOLGA8N;IFT43;MVB12A;TUBGCP5;LSM4
prerank,GO_Biological_Process_2021__triglyceride homeostasis (GO:0070328),-0.4041288326936314,-0.7410122112018468,0.7777777777777778,0.9928484498159504,1.0,1/12,3.27%,RORA
prerank,GO_Biological_Process_2021__positive regulation of cytokine production involved in inflammatory response (GO:1900017),-0.44557609472076953,-0.7407635270903559,0.7543859649122807,0.9928557380634203,1.0,8/11,28.41%,HIF1A;APPL1;NOD2;CLEC7A;GBP5;CARD9;MYD88;STAT3
prerank,GO_Biological_Process_2021__DNA recombination (GO:0006310),-0.3552220189174678,-0.7406812922737012,0.847457627118644,0.9927033863702458,1.0,4/25,18.09%,THAP9;XRCC3;RECQL5;WRN
prerank,GO_Biological_Process_2021__regulation of protein acetylation (GO:1901983),0.41010054794033235,0.7404725216018903,0.7608695652173914,0.965111351597676,1.0,4/10,17.16%,SIRT1;RAPGEF3;GSK3B;DDX3X
prerank,GO_Biological_Process_2021__cilium assembly (GO:0060271),-0.30189597386471306,-0.74040230267267,0.9534883720930233,0.9928478598750637,1.0,20/207,12.71%,FLNA;RPGRIP1L;BBOF1;BBS2;SSNA1;RAB11A;IFT46;MAK;DYNC2I1;TBC1D32;CEP72;CEP164;TMEM138;DZIP1L;TMEM67;IFT27;IFT81;ABLIM3;CCDC39;CSNK1D
prerank,GO_Biological_Process_2021__autophagy of nucleus (GO:0044804),-0.39751614614312036,-0.7401853263996494,0.75,0.9928750857002859,1.0,2/13,15.41%,ATG2A;WIPI1
prerank,GO_Biological_Process_2021__regulation of RNA export from nucleus (GO:0046831),0.41467860082468494,0.7400956439792967,0.9166666666666666,0.9653002647104877,1.0,4/12,17.17%,NSUN2;NUP153;SETD2;IWS1
prerank,Reactome_2022__Resolution Of Sister Chromatid Cohesion R-HSA-2500257,-0.3327240204450488,-0.7400562309647538,0.9558823529411765,0.9927851610393468,1.0,12/70,19.77%,RPS27;CENPU;ITGB3BP;ZWILCH;MIS12;DYNC1LI2;SMC1A;SEC13;SGO2;CENPF;BUB3;DYNC1I2
prerank,Reactome_2022__Regulation Of Beta-Cell Development R-HSA-186712,0.36094831536149286,0.7398606171109541,0.8611111111111112,0.9653377518541629,1.0,7/17,22.15%,MAML2;MAML3;KAT2A;AKT2;MAP4K2;AKT3;FOXO1
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Bone Marrow,-0.3270493947358186,-0.7398144045781322,0.8428571428571429,0.9928422878020963,1.0,17/66,18.05%,DTX3L;SIRPB2;IFIT2;NAMPT;RNASEL;SAMD9;PLB1;NCF2;CFLAR;CSF3R;ALPK1;NABP1;APOL6;FPR1;CARD6;FAM151B;CASP4
prerank,GO_Biological_Process_2021__chaperone cofactor-dependent protein refolding (GO:0051085),-0.38859199067104094,-0.7396208316655847,0.873015873015873,0.9928072209381114,1.0,4/20,18.22%,ERO1A;HSPA1B;HSPA1A;HSPA2
prerank,Reactome_2022__Regulation Of Actin Dynamics For Phagocytic Cup Formation R-HSA-2029482,0.2914927487823315,0.7394935111718199,0.9642857142857143,0.9654733145371074,1.0,8/54,13.77%,WIPF3;WASF2;CRK;ELMO1;NCKIPSD;MAPK1;VAV1;PTK2
prerank,Reactome_2022__RHO GTPases Activate Formins R-HSA-5663220,-0.3208858749633482,-0.7394497119188623,0.974025974025974,0.9927398011084099,1.0,15/83,19.77%,RPS27;ACTG1;CENPU;ITGB3BP;ZWILCH;PFN1;MIS12;DYNC1LI2;SEC13;SGO2;CENPF;BUB3;ITGB1;EVL;DYNC1I2
prerank,GO_Biological_Process_2021__presynapse organization (GO:0099172),-0.4167291854234434,-0.7394366522167396,0.7213114754098361,0.9924782381338958,1.0,3/9,9.43%,C5AR1;NLGN2;DVL1
prerank,CellMarker_Augmented_2021__Plasmablast:Peripheral Blood,-0.3797832389676888,-0.739316754545086,0.8461538461538461,0.9921322015169893,1.0,3/32,4.41%,VNN2;BTK;NCF4
prerank,CellMarker_Augmented_2021__Immature Transitional B cell:Blood,-0.3797832389676888,-0.739316754545086,0.8461538461538461,0.9921322015169893,1.0,3/32,4.41%,VNN2;BTK;NCF4
prerank,GO_Biological_Process_2021__negative regulation of ERBB signaling pathway (GO:1901185),-0.38898997787710804,-0.7392437576477744,0.7868852459016393,0.9919531077762979,1.0,2/29,7.11%,EPN1;RNF126
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Uterus,0.3168072030622538,0.7392345197558003,0.918918918918919,0.965424905706461,1.0,7/34,12.55%,COL16A1;TIMP3;TANC1;NFIB;EPAS1;FAM114A1;ITGA2
prerank,CellMarker_Augmented_2021__Myoepithelial cell:Salivary Gland,-0.35655699828038756,-0.7392166554938038,0.7777777777777778,0.9917343248504016,1.0,3/41,6.67%,ARSJ;ANXA2;OSMR
prerank,"GO_Biological_Process_2021__regulation of DNA-templated transcription, elongation (GO:0032784)",-0.3680185467391607,-0.7391982920643664,0.9122807017543859,0.9914783716192468,1.0,1/22,3.69%,TCEA2
prerank,GO_Biological_Process_2021__regulation of DNA-dependent DNA replication (GO:0090329),-0.4301566213346274,-0.7390905667585018,0.8333333333333334,0.9913269452328939,1.0,1/8,5.76%,TIPIN
prerank,"GO_Biological_Process_2021__RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)",-0.44505299633861356,-0.7390042934967539,0.8490566037735849,0.9911905104239803,1.0,2/10,13.80%,NYNRIN;NUDT16
prerank,GO_Biological_Process_2021__anion transmembrane transport (GO:0098656),0.322200973608248,0.738807248106698,0.8387096774193549,0.9656665452975446,1.0,6/42,6.03%,SLC1A3;SLC25A18;SLC7A8;SLC3A2;SLC39A8;SLC1A2
prerank,CellMarker_Augmented_2021__Ionocyte cell:Lung,-0.2972114192901013,-0.7387283854181195,0.975609756097561,0.9913422955601794,1.0,20/207,10.92%,PKIB;TPD52;CCDC107;GABARAPL1;RAB37;H1-0;ETS1;CGNL1;ATP6V1F;NT5C;SP110;IGF1;H3-3B;CCDC85C;SNTB1;TMSB4X;COX5B;SLC14A1;CFTR;USP53
prerank,GO_Biological_Process_2021__modulation of excitatory postsynaptic potential (GO:0098815),-0.3745210019375721,-0.7386613777901969,0.8245614035087719,0.9911612318413798,1.0,2/20,7.64%,RIMS1;NLGN2
prerank,GO_Biological_Process_2021__ncRNA export from nucleus (GO:0097064),-0.361486200666383,-0.7386159396212835,0.8709677419354839,0.9909281323727253,1.0,7/36,17.60%,SSB;NCBP2;NPM1;XPOT;NUP50;SEC13;NUP88
prerank,GO_Biological_Process_2021__histone deubiquitination (GO:0016578),-0.41618172271280307,-0.7382507912538754,0.8032786885245902,0.9911592870045434,1.0,1/14,3.61%,USP36
prerank,Reactome_2022__Polo-like Kinase Mediated Events R-HSA-156711,0.4408989067019151,0.7380896202050293,0.7843137254901961,0.9662959271405888,1.0,1/6,10.33%,LIN52
prerank,GO_Biological_Process_2021__endocytic recycling (GO:0032456),-0.3663299299306437,-0.7380540142318842,0.8461538461538461,0.9911918125798672,1.0,4/42,7.74%,ARL4C;VPS35;ENTR1;SNF8
prerank,Reactome_2022__RHOG GTPase Cycle R-HSA-9013408,-0.35170255707637255,-0.7377182369547806,0.8529411764705882,0.9913285050864817,1.0,4/60,4.25%,TFRC;VAV3;MPP7;EMD
prerank,"GO_Biological_Process_2021__retrograde protein transport, ER to cytosol (GO:0030970)",0.3834216138246711,0.7375936823535685,0.7941176470588235,0.9665166831225287,1.0,2/17,8.99%,SEL1L;AUP1
prerank,GO_Biological_Process_2021__neurogenesis (GO:0022008),0.37202775661689563,0.7374482890815593,0.8461538461538461,0.9663537249946845,1.0,4/23,11.88%,ANXA1;RYK;BTBD3;CDK6
prerank,CellMarker_Augmented_2021__Hematopoietic Stem cell:Umbilical Cord Blood,-0.4153222119297332,-0.7371807799446737,0.8235294117647058,0.9918842270396654,1.0,4/15,14.37%,CMAHP;CLCA4;CFTR;ATP8B1
prerank,Reactome_2022__EGR2 And SOX10-mediated Initiation Of Schwann Cell Myelination R-HSA-9619665,0.3708832071429355,0.7371372379785609,0.8205128205128205,0.9664070675295046,1.0,5/16,20.80%,DAG1;ADGRV1;NAB2;NAB1;SCD5
prerank,GO_Biological_Process_2021__regulation of smooth muscle cell apoptotic process (GO:0034391),0.45778648672683453,0.7370570889256565,0.8541666666666666,0.9662075637073179,1.0,2/5,12.51%,SIRT1;DIPK2A
prerank,CellMarker_Augmented_2021__Myofibroblast:Liver,-0.36515987689255947,-0.7367033935578947,0.7397260273972602,0.9922487429817622,1.0,5/37,13.78%,COL5A1;OLFML2B;PTN;CALD1;SERPING1
prerank,GO_Biological_Process_2021__regulation of protein serine/threonine kinase activity (GO:0071900),-0.3086741763595727,-0.7364053710738425,0.9342105263157895,0.9924246890894476,1.0,8/69,14.20%,SYAP1;CDC37;SNF8;CALM1;ACTB;MTCP1;CAMK1;CCND1
prerank,GO_Biological_Process_2021__double-strand break repair (GO:0006302),-0.3156764374989818,-0.7362995848288503,0.971830985915493,0.9923007168488516,1.0,14/125,14.26%,UBXN1;HUS1;DTX3L;PARP9;BRCA2;POLM;CYREN;ABRAXAS1;PARP2;XRCC3;NABP1;KAT5;RPA3;BRCA1
prerank,GO_Biological_Process_2021__epithelial to mesenchymal transition (GO:0001837),-0.4058381538235324,-0.7359536172805876,0.8985507246376812,0.992508755433733,1.0,7/28,16.94%,TGFBR3;RBPJ;HNRNPAB;HIF1A;DDX5;AKNA;S100A4
prerank,GO_Biological_Process_2021__mitochondrial calcium ion homeostasis (GO:0051560),-0.4183103086679798,-0.7356166804644906,0.8360655737704918,0.9926968677395702,1.0,5/17,14.94%,FIS1;SMDT1;MICU2;MAIP1;MCUR1
prerank,GO_Biological_Process_2021__ectoderm development (GO:0007398),0.475912156289356,0.7355492686591307,0.85,0.9677813198050779,1.0,5/7,23.17%,EDA2R;STX2;SMURF1;AMER2;ZBTB7B
prerank,Reactome_2022__TRAIL Signaling R-HSA-75158,-0.45022586043162516,-0.7353058534243455,0.7903225806451613,0.9928799251229837,1.0,2/7,9.94%,TNFSF10;CFLAR
prerank,GO_Biological_Process_2021__cellular metal ion homeostasis (GO:0006875),-0.3579435908853522,-0.7350791318263719,0.8805970149253731,0.9929143733274491,1.0,11/52,16.90%,CCL3;CCL5;ATP13A1;TPT1;TRPV4;ATP1B3;TMCO1;ATP1A1;MT3;STOML2;STIM2
prerank,Reactome_2022__VxPx Cargo-Targeting To Cilium R-HSA-5620916,0.37999069401408525,0.7349830752032459,0.8285714285714286,0.9681763831637401,1.0,2/17,3.46%,EXOC8;PKD1
prerank,CellMarker_Augmented_2021__Smooth Muscle cell:Blood Vessel,-0.3749884169365465,-0.734921712540236,0.782608695652174,0.9918059627711342,1.0,1/27,0.62%,MYLK
prerank,CellMarker_Augmented_2021__Fibroblast:Corneal Endothelium,-0.3749884169365465,-0.734921712540236,0.782608695652174,0.9918059627711342,1.0,1/27,0.62%,MYLK
prerank,CellMarker_Augmented_2021__Myofibroblast:Undefined,-0.3749884169365465,-0.734921712540236,0.782608695652174,0.9918059627711342,1.0,1/27,0.62%,MYLK
prerank,CellMarker_Augmented_2021__Peritubular Myoid cell:Testis,-0.3749884169365465,-0.734921712540236,0.782608695652174,0.9918059627711342,1.0,1/27,0.62%,MYLK
prerank,CellMarker_Augmented_2021__Mesenchymal cell:Undefined,-0.3749884169365465,-0.734921712540236,0.782608695652174,0.9918059627711342,1.0,1/27,0.62%,MYLK
prerank,GO_Biological_Process_2021__pyrimidine ribonucleotide biosynthetic process (GO:0009220),-0.4893546369611823,-0.734857338084032,0.7903225806451613,0.991618251707968,1.0,1/7,11.81%,DHODH
prerank,GO_Biological_Process_2021__regulation of cell cycle G2/M phase transition (GO:1902749),-0.3359945488290971,-0.7346648154231049,0.9027777777777778,0.9915862786459283,1.0,16/64,22.15%,ATF5;SSNA1;CEP72;CEP164;NPM1;CSNK1D;TUBB4B;PRKAR2B;ATAD5;DCTN2;CENPF;AKAP9;DYNC1I2;NINL;SFI1;HAUS5
prerank,KEGG_2021_Human__Pentose and glucuronate interconversions,0.40098645844071534,0.7346154669330699,0.7659574468085106,0.9682941866782364,1.0,1/11,4.71%,UGDH
prerank,GO_Biological_Process_2021__positive regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000343),0.4726777758006273,0.734476889397942,0.9117647058823529,0.9681024460487597,1.0,1/6,7.30%,TNF
prerank,GO_Biological_Process_2021__positive regulation of DNA methylation-dependent heterochromatin assembly (GO:0090309),-0.4181341321553827,-0.7343703326954264,0.8064516129032258,0.9916852184199302,1.0,4/10,22.78%,DNMT1;RESF1;SETDB1;MORC2
prerank,CellMarker_Augmented_2021__Primitive Streak cell:Primitive Streak,0.36074755151155685,0.7343265751296671,0.8461538461538461,0.9679474733576475,1.0,3/20,12.91%,DPYSL5;MAP3K15;GINS1
prerank,GO_Biological_Process_2021__covalent chromatin modification (GO:0016569),0.3973339944949208,0.7341048840192368,0.8409090909090909,0.9679065415202074,1.0,3/12,14.78%,SIRT1;HDAC1;SETD5
prerank,GO_Biological_Process_2021__telomere organization (GO:0032200),-0.3710141035981165,-0.7340692372375583,0.8676470588235294,0.991771758789609,1.0,6/30,21.40%,HUS1;TERF2IP;APEX1;RPA3;WRN;CTC1
prerank,GO_Biological_Process_2021__response to muramyl dipeptide (GO:0032495),-0.4063744605048163,-0.7338910569894054,0.7931034482758621,0.9917545801953954,1.0,5/11,25.45%,NOD2;VIM;PTPN22;TRIM41;ARHGEF2
prerank,KEGG_2021_Human__Endocrine and other factor-regulated calcium reabsorption,0.3286213412584421,0.7335263590032416,0.8888888888888888,0.9682195196598603,1.0,6/36,13.70%,GNAQ;PLCB4;ADCY9;DNM3;ADCY6;SLC8A1
prerank,GO_Biological_Process_2021__negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244),-0.41515615032347974,-0.7334068082717121,0.8301886792452831,0.9921371777536176,1.0,6/12,30.85%,RECQL5;NELFE;LARP7;NELFCD;RNF8;HEXIM1
prerank,GO_Biological_Process_2021__protein tetramerization (GO:0051262),-0.3537521258778798,-0.7333178048572735,0.8823529411764706,0.9919718873445528,1.0,3/46,3.43%,APIP;B2M;KCNC3
prerank,Reactome_2022__HS-GAG Degradation R-HSA-2024096,0.42481788488734995,0.7332544449677011,0.8857142857142857,0.9681988523795944,1.0,3/11,12.44%,GLB1;HPSE;GPC6
prerank,GO_Biological_Process_2021__beta-catenin destruction complex disassembly (GO:1904886),-0.4180614156490119,-0.7328223578565162,0.8032786885245902,0.9923320191214614,1.0,2/11,12.28%,DVL1;FZD2
prerank,Reactome_2022__Trafficking And Processing Of Endosomal TLR R-HSA-1679131,-0.4322588855730475,-0.7327467001929598,0.7636363636363637,0.9921840255253193,1.0,1/10,3.91%,CTSB
prerank,GO_Biological_Process_2021__positive regulation of homotypic cell-cell adhesion (GO:0034112),0.4741321392099381,0.73261645984194,0.8958333333333334,0.96875539611908,1.0,1/7,0.66%,PDPN
prerank,GO_Biological_Process_2021__positive regulation of hemostasis (GO:1900048),-0.45903225323956875,-0.7325276004906102,0.7857142857142857,0.9919769966394745,1.0,1/5,2.01%,ENPP4
prerank,GO_Biological_Process_2021__positive regulation of coagulation (GO:0050820),-0.45903225323956875,-0.7325276004906102,0.7857142857142857,0.9919769966394745,1.0,1/5,2.01%,ENPP4
prerank,GO_Biological_Process_2021__synapse pruning (GO:0098883),-0.4567786765056532,-0.7321540801375969,0.7575757575757576,0.9922061600013321,1.0,6/8,34.67%,C3;C1QB;C1QC;C1QA;TREM2;ITGAM
prerank,GO_Biological_Process_2021__pancreas development (GO:0031016),0.43151019414627834,0.7319376876194299,0.7272727272727273,0.9691896513270425,1.0,2/6,12.89%,TCF7L2;CCDC40
prerank,GO_Biological_Process_2021__foam cell differentiation (GO:0090077),0.4311154375170929,0.7317639546421697,0.6888888888888889,0.9687010415742335,1.0,1/5,5.17%,PPARG
prerank,GO_Biological_Process_2021__macrophage derived foam cell differentiation (GO:0010742),0.4311154375170929,0.7317639546421697,0.6888888888888889,0.9687010415742335,1.0,1/5,5.17%,PPARG
prerank,Reactome_2022__Activation Of BH3-only Proteins R-HSA-114452,0.3593500288927146,0.7309309456651301,0.9411764705882353,0.9694514718721781,1.0,6/23,21.45%,YWHAG;AKT2;DYNLL2;AKT3;REXO2;YWHAE
prerank,GO_Biological_Process_2021__negative regulation of phosphorylation (GO:0042326),-0.32075661242164555,-0.7308963386902546,0.9027777777777778,0.9936322059719197,1.0,3/61,2.98%,PID1;WARS1;PAQR3
prerank,Reactome_2022__Formation Of RNA Pol II Elongation Complex R-HSA-112382,-0.32586475561626466,-0.730506453366894,0.9354838709677419,0.9938066215937807,1.0,5/51,9.87%,GTF2H5;CTDP1;ELOB;POLR2G;NCBP2
prerank,KEGG_2021_Human__Fanconi anemia pathway,-0.34644520955721403,-0.7302073229594082,0.9178082191780822,0.9939021697059035,1.0,7/37,17.50%,MUS81;BRCA2;WDR48;RPA3;BRCA1;FANCB;FANCI
prerank,GO_Biological_Process_2021__positive regulation of muscle cell differentiation (GO:0051149),0.3624872633315225,0.7301411898491343,0.8709677419354839,0.9700837066266589,1.0,3/18,8.54%,MAPK11;NRG1;CTNNA2
prerank,GO_Biological_Process_2021__microtubule-based transport (GO:0099111),0.41600969272636473,0.7300214494010894,0.8461538461538461,0.9698515144900464,1.0,4/8,26.62%,CCDC40;DNAAF2;CABYR;ADCY10
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell apoptotic process (GO:1905459),0.4507070900484916,0.7296258783549461,0.76,0.9700128057953081,1.0,3/7,12.13%,E2F3;PPARG;SOD2
prerank,Reactome_2022__Disassembly Of Destruction Complex And Recruitment Of AXIN To Membrane R-HSA-4641262,0.37450130651172925,0.7294579881744995,0.7368421052631579,0.9698861896528674,1.0,4/17,15.67%,DVL3;PPP2R1B;PPP2R5E;GSK3B
prerank,GO_Biological_Process_2021__positive regulation of collagen metabolic process (GO:0010714),0.39784435332295065,0.729453087530281,0.8095238095238095,0.9695611113679022,1.0,1/8,6.90%,RUNX1
prerank,Reactome_2022__Autophagy R-HSA-9612973,-0.3080714133426039,-0.7294229774117625,0.9444444444444444,0.9946276721698067,1.0,16/107,16.37%,UBC;TOMM7;RPS27A;GABARAPL1;LAMTOR5;GABARAPL2;VPS28;CFTR;ATG10;VPS37B;TOMM40;DYNC1LI2;UBA52;WIPI1;MVB12A;RRAGA
prerank,GO_Biological_Process_2021__amide biosynthetic process (GO:0043604),-0.39191269643934434,-0.7293578395656038,0.8793103448275862,0.9944326297866586,1.0,1/25,0.87%,DEGS2
prerank,KEGG_2021_Human__Thermogenesis,-0.3056160559580045,-0.7293390974939035,0.9240506329113924,0.9941835821265035,1.0,39/154,18.82%,MGLL;COX7C;UQCRB;NDUFC1;NDUFA2;UQCRH;NDUFA1;NDUFB9;ATP5PD;NDUFA12;ATP5F1E;NDUFB4;RPS6;UQCR10;ACTG1;COX4I1;COX5B;NDUFB1;SMARCD1;NDUFS8;ACTB;ATP5ME;NDUFS5;COX18;COA6;COX7A2;COX6C;NDUFS6;NDUFB7;SMARCD3;COA4;UQCRC1;NDUFB3;UQCRQ;ATP5F1C;NDUFS7;NDUFA3;ATP5F1D;COX20
prerank,GO_Biological_Process_2021__positive regulation of chromosome segregation (GO:0051984),0.4433029421627057,0.7293070576905765,0.8108108108108109,0.96943068961059,1.0,2/6,28.58%,SMC6;SIRT2
prerank,Reactome_2022__Arachidonic Acid Metabolism R-HSA-2142753,-0.3619345695832825,-0.728958110259762,0.8387096774193549,0.9944510497776736,1.0,6/23,14.59%,PTGES2;FAAH2;GPX4;PON2;GPX1;ALOX12
prerank,Reactome_2022__Neurofascin Interactions R-HSA-447043,0.43267323879742675,0.7288704093577514,0.7906976744186046,0.9697255275185903,1.0,3/6,19.86%,NFASC;CNTNAP1;CNTN1
prerank,GO_Biological_Process_2021__regulation of stress-activated MAPK cascade (GO:0032872),-0.33446612099442774,-0.7287916502191635,0.8548387096774194,0.9943889621259318,1.0,4/42,6.90%,TGFBR3;EPHB1;GSTP1;EIF2AK2
prerank,Reactome_2022__RHOC GTPase Cycle R-HSA-9013106,-0.32554050558779196,-0.7287112818227568,0.8970588235294118,0.9942531800078802,1.0,4/58,6.99%,TFRC;ARHGEF1;JUP;ACBD5
prerank,Reactome_2022__Aryl Hydrocarbon Receptor Signaling R-HSA-8937144,0.4724091465297081,0.7282411549902246,0.8541666666666666,0.970165882213426,1.0,1/5,3.54%,ARNT2
prerank,GO_Biological_Process_2021__dendrite self-avoidance (GO:0070593),-0.45465789875279783,-0.7279523683630019,0.7777777777777778,0.9949995135355025,1.0,1/10,1.68%,EMB
prerank,GO_Biological_Process_2021__positive regulation of positive chemotaxis (GO:0050927),-0.45260094644840365,-0.7278014501957909,0.8939393939393939,0.9949545211455848,1.0,1/7,11.19%,VEGFA
prerank,GO_Biological_Process_2021__T-tubule organization (GO:0033292),0.45924509303052885,0.7277133047332217,0.8695652173913043,0.970440028013125,1.0,2/5,31.67%,BIN1;MYOF
prerank,GO_Biological_Process_2021__purine nucleoside bisphosphate metabolic process (GO:0034032),-0.3923869040859988,-0.727693867569526,0.8688524590163934,0.9945012795554109,1.0,3/16,14.80%,THEM4;ACOT9;ACSM5
prerank,GO_Biological_Process_2021__ribonucleoside bisphosphate metabolic process (GO:0033875),-0.3923869040859988,-0.727693867569526,0.8688524590163934,0.9945012795554109,1.0,3/16,14.80%,THEM4;ACOT9;ACSM5
prerank,GO_Biological_Process_2021__regulation of neuroblast proliferation (GO:1902692),-0.3977738591531745,-0.7275975295640102,0.8275862068965517,0.9943975570751045,1.0,4/13,15.22%,ZNF335;PTN;VEGFA;SMARCD3
prerank,GO_Biological_Process_2021__regulation of activated T cell proliferation (GO:0046006),-0.42230387159135707,-0.7272615139731144,0.8253968253968254,0.9946030444655634,1.0,4/17,8.38%,LILRB4;RPS3;IGF1;BTN2A2
prerank,GO_Biological_Process_2021__positive regulation of cell migration by vascular endothelial growth factor signaling pathway (GO:0038089),0.4335649395238625,0.7270729058829379,0.7962962962962963,0.9709849993300557,1.0,1/7,2.61%,GAB1
prerank,GO_Biological_Process_2021__regulation of cellular component size (GO:0032535),-0.3562876575505317,-0.727017929734694,0.8857142857142857,0.9946538854065341,1.0,3/26,5.78%,PPP1R15A;VAV3;LAMTOR5
prerank,Reactome_2022__RUNX2 Regulates Osteoblast Differentiation R-HSA-8940973,-0.4408503071630707,-0.7268874766816867,0.7962962962962963,0.9945477537725305,1.0,1/13,3.03%,YES1
prerank,GO_Biological_Process_2021__negative regulation of lipid storage (GO:0010888),0.34930233278678247,0.726688572538036,0.9090909090909091,0.9710686210487325,1.0,3/16,10.85%,PPARG;TNF;ITGAV
prerank,GO_Biological_Process_2021__cytosolic calcium ion transport (GO:0060401),0.354717169122082,0.7266731549863312,0.8918918918918919,0.9707479641294615,1.0,4/22,13.70%,MCU;ADRA1A;MICU1;SLC8A1
prerank,GO_Biological_Process_2021__regulation of fibroblast migration (GO:0010762),0.3469082029030716,0.7264727929310426,0.8571428571428571,0.970682100274612,1.0,1/18,2.26%,FGF2
prerank,"GO_Biological_Process_2021__regulation of transcription, DNA-templated (GO:0006355)",-0.2681090139636466,-0.7262274383388541,1.0,0.9951085144791045,1.0,168/1271,16.47%,NR4A3;SKAP1;STAT4;MYBL1;BCL11B;CEBPD;PPIE;FOSL2;FOS;RUNX3;SCML4;JUNB;PYHIN1;PRKCQ;CTDSP1;ZSCAN9;MDFIC;SNX6;IKZF3;ZMYND15;CHD3;ATF5;TAF6L;CSRNP1;USF1;EDF1;PER2;RORA;ZNF790;TCEA2;ZNF689;L3MBTL3;OGG1;ETS1;ING5;BHLHE40;ZNF331;SP110;HESX1;NR1H2;IGF1;BASP1;JMJD6;DTX3L;TRIM22;BRD9;ILF3;HDGF;MSL3;ZSCAN30;ZNF32;PHB2;SP140;PARP9;BRD3;ZNF76;MAP3K12;PLAG1;ZNF805;BRCA2;SNF8;ZNF449;ZNF789;ZNF649;ZNF570;EID1;ZNF600;RBPJ;BTAF1;ZFP30;OVOL2;ZNF394;RPL6;VENTX;ZNF589;DVL1;STAT1;MEIS1;HINT1;ZNF821;SMARCD1;LITAF;IRF1;ZNF266;ZNF70;ZNF260;HNRNPAB;NPM1;CITED2;KDM7A;ZNF546;ZNF354A;REXO4;MLX;VEGFA;ZNF528;SCML1;KARS1;HIF1A;MXI1;BTG1;ING4;ZSCAN29;TCF3;ZNF432;GLI4;GLRX2;GCFC2;ATF3;TEF;GMEB1;FZD2;ZNF586;HIRA;DNAJC2;MAX;CREM;TERF2IP;ATF1;ZNF674;PRDM1;KAT5;DDX5;NRL;ZNF549;ZNF302;ZNF16;PRDM15;NR4A1;UXT;ZNF217;ZNF558;ZNF18;ESR2;ZNF681;REL;BRCA1;ZNF333;ATP8B1;ZKSCAN3;CCAR1;ZFP82;CBX3;ZNF232;TP53INP1;HMGN5;GON4L;SMARCD3;CIITA;ZFPM2;ZNF461;ZNF484;PSRC1;ZNF445;CD74;MED12;SP2;AGT;POLR3C;ZNF20;DEDD2;KAT8;PRMT2;CDKN1C;MED30;CREBRF;MT3;ZNF35
prerank,GO_Biological_Process_2021__prostaglandin metabolic process (GO:0006693),-0.39219371428306793,-0.7261209983587874,0.8214285714285714,0.9949827095307222,1.0,2/13,15.77%,GSTP1;CD74
prerank,GO_Biological_Process_2021__protein maturation (GO:0051604),0.2868281181348247,0.7260482273987304,1.0,0.9707617006252478,1.0,16/63,16.40%,AANAT;TSPAN33;TSPAN15;CPM;DNAJB11;MMS19;MMP16;PTCH1;TSPAN17;SORL1;PCSK6;NAA35;MMP14;GALNT2;GLRX3;HSPD1
prerank,GO_Biological_Process_2021__posttranscriptional regulation of gene expression (GO:0010608),-0.3483348850315113,-0.7259646754598328,0.863013698630137,0.9948937269249712,1.0,5/35,15.70%,RPL10;PARP9;EIF2A;RBM4B;PUM3
prerank,GO_Biological_Process_2021__in utero embryonic development (GO:0001701),0.3808216506349655,0.724731020350846,0.7894736842105263,0.9722464713438962,1.0,9/14,22.55%,PKD1;ARNT2;LIG4;TGFBR1;HINFP;PTPRR;FGFR2;CHD7;ADAM10
prerank,GO_Biological_Process_2021__histone H2A acetylation (GO:0043968),-0.39420549568983365,-0.7242781768064854,0.8208955223880597,0.9968306122323494,1.0,2/16,6.30%,ING3;MSL3
prerank,GO_Biological_Process_2021__histone H3-K9 demethylation (GO:0033169),-0.4166266135480782,-0.7242026122058027,0.803921568627451,0.9966799528251574,1.0,1/8,10.73%,KDM7A
prerank,GO_Biological_Process_2021__cellular response to increased oxygen levels (GO:0036295),0.45213304353616507,0.7241642019553,0.7948717948717948,0.9725515246031912,1.0,5/8,34.82%,ATP6V0D1;FOXO1;ATP6V1G1;ATP6V1A;FAS
prerank,GO_Biological_Process_2021__antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),-0.3161948184880267,-0.7239733057688365,0.9076923076923077,0.9966517887391512,1.0,15/75,19.77%,FCER1G;HLA-DRB5;DCTN6;HLA-DRA;DCTN4;DYNC1LI2;HLA-DPA1;HLA-DMB;AP2S1;CD74;SEC13;HLA-DPB1;DCTN2;HLA-DRB1;DYNC1I2
prerank,GO_Biological_Process_2021__nucleobase-containing small molecule interconversion (GO:0015949),0.3747386622731472,0.7236972816431886,0.8235294117647058,0.9727191695348408,1.0,6/20,24.53%,AK6;NME4;NUDT13;DUT;GLRX;CTPS2
prerank,GO_Biological_Process_2021__Golgi to plasma membrane protein transport (GO:0043001),0.3413524534413715,0.7235980777920041,0.8863636363636364,0.9725034863404465,1.0,4/23,11.11%,GOLPH3L;RAB10;GOLGA7;BLZF1
prerank,Reactome_2022__Unfolded Protein Response (UPR) R-HSA-381119,-0.32965252640025344,-0.723440755626519,0.918918918918919,0.9970250473575992,1.0,11/68,17.24%,DDX11;DNAJB9;HDGF;FKBP14;EXOSC1;ATF3;TLN1;WIPI1;EIF2S2;CREBRF;SERP1
prerank,CellMarker_Augmented_2021__Stem cell:Cartilage,-0.4648401316758568,-0.7229403155075695,0.7368421052631579,0.9974299136966972,1.0,1/6,8.71%,CD44
prerank,Reactome_2022__RNA Polymerase III Transcription Initiation From Type 1 Promoter R-HSA-76061,-0.367362209643874,-0.7228930271904397,0.8253968253968254,0.997200974281837,1.0,1/23,3.40%,GTF3C6
prerank,GO_Biological_Process_2021__positive regulation of interleukin-10 production (GO:0032733),0.39563239615363366,0.7228847127995777,0.9142857142857143,0.9730702410082442,1.0,5/13,21.93%,LGALS9;HSPD1;CD274;CD46;SYK
prerank,KEGG_2021_Human__C-type lectin receptor signaling pathway,-0.33058618688575936,-0.7228159160778757,0.863013698630137,0.9970504187073422,1.0,6/72,10.38%,FCER1G;CBLB;LSP1;CALM1;STAT1;IRF1
prerank,Reactome_2022__Biological Oxidations R-HSA-211859,-0.329624993755848,-0.7226902572795395,0.8484848484848485,0.9969072796136862,1.0,11/77,9.85%,GSTM4;SLC38A1;BPHL;AURKAIP1;EPHX1;GSTP1;GSTK1;MAT2B;GCLM;GSTM3;COMT
prerank,GO_Biological_Process_2021__Rac protein signal transduction (GO:0016601),0.35563397751147696,0.7226515474232703,0.8421052631578947,0.9730037333519783,1.0,2/19,7.62%,EPS8;ELMO1
prerank,Reactome_2022__Phosphate Bond Hydrolysis By NTPDase Proteins R-HSA-8850843,-0.5023569959837706,-0.7226343648803274,0.8163265306122449,0.9967251094674474,1.0,2/5,11.98%,ENTPD4;ENTPD5
prerank,GO_Biological_Process_2021__nuclear envelope organization (GO:0006998),-0.4329417311887861,-0.7224232306843635,0.8771929824561403,0.9967214228349353,1.0,1/14,4.25%,EMD
prerank,GO_Biological_Process_2021__pseudouridine synthesis (GO:0001522),0.38773434876482554,0.7221779474120716,0.8260869565217391,0.9731830789245746,1.0,4/10,19.27%,TRUB1;PUS7L;PUS1;PUS7
prerank,"Reactome_2022__Unblocking Of NMDA Receptors, Glutamate Binding And Activation R-HSA-438066",0.388360351518231,0.7221299665625104,0.8947368421052632,0.9729071100796178,1.0,6/15,16.68%,GRIA3;GRIA4;GRIA1;GRIN2B;GRIA2;GRIN2A
prerank,Reactome_2022__Lysine Catabolism R-HSA-71064,-0.4103847348794975,-0.7221163406689509,0.8076923076923077,0.996844772409215,1.0,3/9,20.62%,CRYM;DLST;PHYKPL
prerank,GO_Biological_Process_2021__hematopoietic progenitor cell differentiation (GO:0002244),-0.41976766222234824,-0.7217875626880998,0.847457627118644,0.9969900359181955,1.0,3/15,12.82%,PLEK;FLT1;PTPRC
prerank,GO_Biological_Process_2021__regulation of monooxygenase activity (GO:0032768),-0.3827397151802535,-0.7216098241303123,0.8518518518518519,0.9969398893464743,1.0,9/16,31.72%,CALM1;NOS1AP;ZDHHC21;EGFR;HSP90AA1;POR;IL1B;AKT1;IL1A
prerank,GO_Biological_Process_2021__response to reactive oxygen species (GO:0000302),-0.32102640968798174,-0.7213274140962993,0.88,0.9970337878620534,1.0,9/45,14.09%,FOS;APOD;RPS3;GSTP1;FYN;HIF1A;GLRX2;SOD1;GPX1
prerank,GO_Biological_Process_2021__regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898),-0.4327108082830218,-0.7213126554768512,0.8245614035087719,0.9967835502114168,1.0,2/10,22.04%,PSMC4;PSMC3
prerank,GO_Biological_Process_2021__regulation of leukocyte adhesion to vascular endothelial cell (GO:1904994),0.3943202532035252,0.7212444752288927,0.8666666666666667,0.9736541498161733,1.0,4/10,8.84%,NFAT5;TNF;FUT9;IRAK1
prerank,Reactome_2022__tRNA Processing R-HSA-72306,0.2904924279191063,0.7211207659548781,0.9393939393939394,0.9734305397677167,1.0,6/77,7.20%,CPSF4;NSUN2;NUP153;NUP188;ZBTB8OS;NUP42
prerank,KEGG_2021_Human__Epithelial cell signaling in Helicobacter pylori infection,-0.3358998816697023,-0.720979132089331,0.8767123287671232,0.9969506300655852,1.0,2/53,4.87%,CCL5;ATP6V1F
prerank,GO_Biological_Process_2021__negative regulation of keratinocyte proliferation (GO:0010839),0.4964087310060361,0.7204579996479112,0.8666666666666667,0.9738871504575203,1.0,2/5,19.59%,PTPRK;FGFR2
prerank,GO_Biological_Process_2021__positive regulation of transferase activity (GO:0051347),-0.3110198379146475,-0.7202713203681803,0.8717948717948718,0.9975517618890545,1.0,7/97,7.38%,PKIB;PRKCQ;EPHB1;DTX3L;CHTF18;MUSK;RPS2
prerank,KEGG_2021_Human__Selenocompound metabolism,-0.4265249527035151,-0.7201914495446814,0.8688524590163934,0.9973844908026623,1.0,2/11,21.47%,SEPHS1;TXNRD2
prerank,GO_Biological_Process_2021__regulation of TOR signaling (GO:0032006),0.31851532955713924,0.72007960363214,0.9,0.9740497908634755,1.0,15/51,22.65%,RRAGD;SIRT1;TSC2;DEPTOR;GPAT3;LAMTOR3;PRKAA1;PIK3CA;TBCK;SMCR8;MIOS;DGKQ;HDAC3;UBR1;TBC1D7
prerank,Reactome_2022__Fertilization R-HSA-1187000,0.4354154356955486,0.7200269427751256,0.8913043478260869,0.9737619352311457,1.0,1/6,14.15%,HVCN1
prerank,GO_Biological_Process_2021__regulation of proteasomal protein catabolic process (GO:0061136),-0.3330940215057964,-0.7194550505863534,0.8823529411764706,0.998002244214736,1.0,12/44,22.96%,DDRGK1;GABARAPL2;GLMN;GPX1;PINK1;PSME2;UFL1;PSME1;RAD23A;USP19;PSMC3;PSME3
prerank,GO_Biological_Process_2021__positive regulation of cellular component movement (GO:0051272),-0.40667405483307884,-0.7191967158100635,0.8524590163934426,0.9980372148623633,1.0,4/15,11.19%,DUOX1;ETS1;SPOCK2;VEGFA
prerank,KEGG_2021_Human__Retrograde endocannabinoid signaling,-0.30572117178554603,-0.7190804437849939,0.96,0.9979211118923806,1.0,13/98,10.88%,RIMS1;MGLL;NDUFC1;NDUFA2;NDUFA1;GNB5;NDUFB9;NDUFA12;NDUFB4;NDUFB1;GABRA3;NDUFS8;NDUFS5
prerank,Reactome_2022__Impaired BRCA2 Binding To PALB2 R-HSA-9709603,-0.39550430206263587,-0.7189551762476345,0.864406779661017,0.9978172501728388,1.0,4/16,18.09%,BRCA2;KAT5;BRCA1;WRN
prerank,GO_Biological_Process_2021__regulation of steroid metabolic process (GO:0019218),0.35333090008353346,0.7188274756288204,0.8,0.9748892818467778,1.0,1/13,1.57%,ABCA2
prerank,Reactome_2022__IRS-mediated Signaling R-HSA-112399,0.3483248713461313,0.7187430839278093,0.8918918918918919,0.9746334833406076,1.0,10/25,23.98%,PIGU;PDE3B;GAB2;AKT2;PIK3CA;FGFR2;FGFR1;FRS2;PIK3R1;FGFR3
prerank,GO_Biological_Process_2021__cellular response to estrogen stimulus (GO:0071391),0.40869572064592585,0.7186849490444711,0.8163265306122449,0.9743899125624985,1.0,1/10,11.17%,NCOA4
prerank,GO_Biological_Process_2021__regulation of protein modification process (GO:0031399),-0.33290976464949296,-0.7180675048992196,0.9117647058823529,0.9986217185555955,1.0,2/38,1.84%,CCDC88C;WARS1
prerank,GO_Biological_Process_2021__regulation of glycolytic process (GO:0006110),0.2755695598665562,0.7180130485138672,0.9736842105263158,0.9748091069314158,1.0,12/57,18.92%,CBFA2T3;NUP153;NUP188;NUP42;GIT1;SLC4A4;NDC1;PRKAA1;NUP133;P2RX7;NUP205;ZBTB20
prerank,GO_Biological_Process_2021__cilium-dependent cell motility (GO:0060285),-0.43690487418591845,-0.7176775431274597,0.8703703703703703,0.9987782039366917,1.0,4/9,12.06%,DNAH17;EFHC1;DNAH1;CCDC39
prerank,GO_Biological_Process_2021__regulation of signal transduction by p53 class mediator (GO:1901796),0.283221353569075,0.7175279161517332,1.0,0.9749831366736381,1.0,17/120,13.71%,PRKAB2;CDK5R1;MAPK11;CHD5;MTA2;NUAK1;TAF2;TAF9B;ZNF385A;CCNG1;MDM2;HDAC1;SUPT16H;PIP4K2A;BARD1;PRKAB1;TAF3
prerank,GO_Biological_Process_2021__negative regulation of viral release from host cell (GO:1902187),-0.47683888658270956,-0.7175093273766889,0.8524590163934426,0.998705833601032,1.0,2/8,9.65%,TRIM5;TRIM13
prerank,GO_Biological_Process_2021__positive regulation of translational initiation (GO:0045948),-0.396965859034477,-0.7173686737378961,0.8208955223880597,0.998618903828453,1.0,2/16,7.16%,CCL5;POLR2G
prerank,GO_Biological_Process_2021__positive regulation of dephosphorylation (GO:0035306),-0.3820036851131647,-0.716878838728701,0.8904109589041096,0.9989455330555014,1.0,6/21,26.56%,CALM1;CNEP1R1;PPP1R16B;SYMPK;ANKLE2;LILRB2
prerank,GO_Biological_Process_2021__cardiac ventricle morphogenesis (GO:0003208),-0.4056671133439906,-0.7165195807856632,0.8153846153846154,0.9990798764533076,1.0,3/18,8.45%,TGFBR3;MYBPC3;RBPJ
prerank,Reactome_2022__Ca-dependent Events R-HSA-111996,0.3140592126960365,0.7163135394026269,0.9090909090909091,0.9761442385205917,1.0,6/31,17.57%,NBEA;ADCY9;MAPK1;ADCY6;PDE1C;PRKX
prerank,GO_Biological_Process_2021__regulation of JNK cascade (GO:0046328),-0.30848557992728587,-0.7161964288867274,0.88,0.9992773563644051,1.0,3/74,3.87%,TGFBR3;GADD45B;EPHB1
prerank,GO_Biological_Process_2021__negative regulation of stress-activated MAPK cascade (GO:0032873),-0.3462703501158828,-0.7161074854290729,0.90625,0.9990980088873144,1.0,2/26,6.85%,DUSP1;GSTP1
prerank,GO_Biological_Process_2021__response to ATP (GO:0033198),0.452770007058111,0.7160144386660487,0.8604651162790697,0.9761090859607997,1.0,5/9,28.67%,P2RY12;P2RX7;DGKQ;HSP90B1;P2RX4
prerank,Reactome_2022__Activation Of PUMA And Translocation To Mitochondria R-HSA-139915,-0.47877949393134933,-0.7159139432922418,0.8103448275862069,0.9990499674056283,1.0,3/5,41.03%,TP53BP2;TFDP1;TFDP2
prerank,GO_Biological_Process_2021__hepaticobiliary system development (GO:0061008),-0.41415381575314536,-0.7159009148788336,0.8032786885245902,0.9987906158699831,1.0,1/14,1.03%,TGFBR3
prerank,GO_Biological_Process_2021__bone development (GO:0060348),-0.3787118484032641,-0.7158586024871558,0.8493150684931506,0.9985605459309277,1.0,3/21,15.82%,SULF2;PTPRC;RPL13
prerank,GO_Biological_Process_2021__regulation of neutrophil chemotaxis (GO:0090022),-0.3858723049443133,-0.7157736727142926,0.8245614035087719,0.9983791566695713,1.0,5/17,16.58%,RIPOR2;NCKAP1L;C5AR2;CD74;RAC1
prerank,GO_Biological_Process_2021__mRNA destabilization (GO:0061157),-0.36976614110598804,-0.7157504357693801,0.8,0.9981420397209393,1.0,1/32,1.48%,ZFP36
prerank,GO_Biological_Process_2021__negative regulation of endopeptidase activity (GO:0010951),0.3118974210860621,0.7156735060579831,0.9230769230769231,0.976186243574667,1.0,4/26,7.10%,SERPINE1;SERPINE2;TIMP3;RECK
prerank,GO_Biological_Process_2021__negative regulation of interleukin-12 production (GO:0032695),0.4217105921419271,0.715270126279057,0.7916666666666666,0.9762753746067885,1.0,1/7,10.79%,IRAK3
prerank,GO_Biological_Process_2021__pyrimidine-containing compound biosynthetic process (GO:0072528),-0.46509937985073757,-0.7151845161608502,0.7931034482758621,0.9985747738907279,1.0,1/7,11.81%,DHODH
prerank,GO_Biological_Process_2021__negative regulation of GTPase activity (GO:0034260),0.3804978440718558,0.7149011436462377,0.8571428571428571,0.9762321983056614,1.0,3/13,10.86%,LRRK2;LRCH1;WNK1
prerank,GO_Biological_Process_2021__organic cyclic compound biosynthetic process (GO:1901362),-0.40263833981495983,-0.7147846417757521,0.8524590163934426,0.9988204823766095,1.0,5/14,22.54%,PRLR;NFS1;MOCOS;CYP19A1;SCP2
prerank,GO_Biological_Process_2021__actin filament bundle assembly (GO:0051017),-0.35913219094866744,-0.7147151607309236,0.7761194029850746,0.9986416435453388,1.0,6/19,18.85%,AIF1;CORO1B;BAIAP2L2;CALD1;EZR;NEDD9
prerank,KEGG_2021_Human__Other glycan degradation,-0.38122106989747784,-0.7146171043709457,0.8333333333333334,0.9985162415724587,1.0,2/14,9.14%,AGA;HEXD
prerank,Reactome_2022__RAB Geranylgeranylation R-HSA-8873719,0.3169454148364659,0.7144802977915689,0.9,0.9763973677415164,1.0,4/42,8.42%,RAB33B;RAB10;RAB1B;RAB7A
prerank,GO_Biological_Process_2021__regulation of systemic arterial blood pressure (GO:0003073),0.4617729841485617,0.7141587751959858,0.8095238095238095,0.976474320230904,1.0,2/5,24.68%,PLCB3;PRCP
prerank,GO_Biological_Process_2021__regulation of interleukin-12 production (GO:0032655),-0.35767897169924967,-0.7141220111753326,0.8513513513513513,0.9988296376196794,1.0,1/30,1.11%,HLA-B
prerank,Reactome_2022__Transcription Of HIV Genome R-HSA-167172,-0.3153337014832843,-0.7136988741074672,0.8813559322033898,0.9990556273713367,1.0,6/58,9.87%,GTF2H5;CTDP1;ELOB;POLR2G;RNMT;NCBP2
prerank,Reactome_2022__Regulation Of TP53 Activity R-HSA-5633007,-0.2923368243189462,-0.7135614242287075,0.9444444444444444,0.9989859356016616,1.0,6/119,4.84%,UBC;RPS27A;CHD3;ING3;HUS1;ING5
prerank,GO_Biological_Process_2021__regulation of catabolic process (GO:0009894),-0.40788198934678394,-0.7134027864250899,0.8,0.9989235471805915,1.0,5/13,20.58%,ODC1;SNF8;ITGB1;CENATAC;CHMP6
prerank,GO_Biological_Process_2021__negative regulation of cholesterol storage (GO:0010887),-0.42802264468877615,-0.7133798153389357,0.7692307692307693,0.9986916996332491,1.0,2/9,16.68%,NR1H2;TTC39B
prerank,Reactome_2022__Synthesis Of IP3 And IP4 In Cytosol R-HSA-1855204,0.33592621355136676,0.713353346730974,0.8484848484848485,0.9769635623825655,1.0,10/19,31.02%,PLCB4;PTEN;PLD4;PLCB3;ITPKB;ITPK1;PLCG1;PLCH1;OCRL;ITPKC
prerank,GO_Biological_Process_2021__diterpenoid metabolic process (GO:0016101),-0.367935956725141,-0.713167382802062,0.84375,0.9986923611756562,1.0,3/22,11.54%,GPC3;PLB1;SDC3
prerank,Reactome_2022__Sensory Processing Of Sound By Inner Hair Cells Of Cochlea R-HSA-9662360,-0.33095088250045906,-0.7131436503794045,0.9285714285714286,0.9984316597872717,1.0,5/41,7.98%,RIPOR2;CDH23;RAB3A;MYO3B;EPB41L3
prerank,Reactome_2022__Signaling By Retinoic Acid R-HSA-5362517,0.362119861803595,0.7130130020431179,0.8888888888888888,0.9770122539294724,1.0,4/20,13.16%,PDK4;CPT1A;DLAT;RARB
prerank,GO_Biological_Process_2021__negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048),-0.47795680329683315,-0.7129702629767691,0.8545454545454545,0.9983622288615966,1.0,2/5,21.23%,VEGFA;RGCC
prerank,GO_Biological_Process_2021__cellular response to mechanical stimulus (GO:0071260),0.30776759688070326,0.7125714407108589,0.9615384615384616,0.9771649270469407,1.0,3/34,8.90%,TNFRSF10A;TLR7;SLC9A1
prerank,GO_Biological_Process_2021__negative regulation of defense response (GO:0031348),-0.3575756896022886,-0.7125506817053157,0.8507462686567164,0.998575826104821,1.0,9/48,9.83%,NLRC3;DHX58;RORA;VPS35;NLRP12;TNFAIP3;ENPP3;METRNL;SELENOS
prerank,GO_Biological_Process_2021__clathrin-dependent endocytosis (GO:0072583),0.3243791192919694,0.7122919490893229,0.8918918918918919,0.9771855216437302,1.0,6/25,14.26%,PICALM;SNAP91;DNAJC6;FNBP1L;GPR107;SGIP1
prerank,GO_Biological_Process_2021__G2/M transition of mitotic cell cycle (GO:0000086),0.2594903320576714,0.7119129923121859,1.0,0.9772500782640123,1.0,28/98,23.93%,BORA;CDK7;TAF2;CEP41;BRSK1;YWHAG;CEP131;BTRC;FBXW11;CSNK1E;FBXL12;FBXL7;CLASP1;DYNC1H1;ALMS1;TPD52L1;BRSK2;CEP135;ODF2;NDE1;NEDD1;YWHAE;CEP152;PAFAH1B1;CEP290;KHDRBS1;HAUS2;PPP1R12B
prerank,GO_Biological_Process_2021__intracellular estrogen receptor signaling pathway (GO:0030520),-0.4127834522921568,-0.7116752936709113,0.8307692307692308,0.9994300993429545,1.0,4/13,13.87%,PADI2;DDX54;DDX5;ESR2
prerank,GO_Biological_Process_2021__regulation of cholesterol transport (GO:0032374),-0.3706398893579018,-0.7116234168361321,0.8615384615384616,0.9992178283070648,1.0,6/18,16.98%,LIPG;NR1H2;ABCB4;ABCA8;TTC39B;ABCA5
prerank,GO_Biological_Process_2021__establishment of protein localization to endoplasmic reticulum (GO:0072599),-0.3742287897083676,-0.711599323326054,0.8524590163934426,0.9989766696493662,1.0,1/17,3.22%,SRP14
prerank,GO_Biological_Process_2021__regulation of muscle cell differentiation (GO:0051147),0.33963518490136474,0.7114809719296189,0.8387096774193549,0.9773905233685246,1.0,3/23,8.54%,MAPK11;HDAC9;CTNNA2
prerank,GO_Biological_Process_2021__negative regulation of amyloid precursor protein catabolic process (GO:1902992),-0.37855992090112,-0.7109598408825624,0.8548387096774194,0.9994242384362391,1.0,2/17,5.56%,CLU;IGF1
prerank,GO_Biological_Process_2021__regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),-0.41859722110665953,-0.7106807697569129,0.7538461538461538,0.999489920532704,1.0,2/10,18.55%,NOS1AP;AKAP9
prerank,Reactome_2022__Pausing And Recovery Of Tat-mediated HIV Elongation R-HSA-167238,-0.340541592954526,-0.7105023861158769,0.8524590163934426,0.9994299957573072,1.0,3/26,7.16%,CTDP1;ELOB;POLR2G
prerank,Reactome_2022__IkBA Variant Leads To EDA-ID R-HSA-5603029,-0.4653356952754699,-0.7105005113166654,0.864406779661017,0.9991624823751452,1.0,4/7,34.98%,NFKBIA;CHUK;IKBKB;RELA
prerank,GO_Biological_Process_2021__anterior/posterior pattern specification (GO:0009952),-0.41598267321941323,-0.7103663687723878,0.8333333333333334,0.9990302708513,1.0,2/14,5.60%,BHLHE40;BASP1
prerank,GO_Biological_Process_2021__double-strand break repair via homologous recombination (GO:0000724),-0.3184207459415185,-0.7100969495468137,0.9054054054054054,0.9990597945223688,1.0,24/67,26.15%,HUS1;MUS81;BRCA2;XRCC3;NABP1;MCM7;RPA3;BRCA1;FANCB;RECQL5;ZSWIM7;WRN;MCM6;NUCKS1;CDC7;MCM5;FANCM;AP5Z1;EXD2;SLX4;RECQL;POLQ;LIG3;MMS22L
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Liver,-0.4819616871629119,-0.7099164472287725,0.8333333333333334,0.9989493914956882,1.0,2/5,18.52%,CD44;ITGB1
prerank,GO_Biological_Process_2021__regulation of mRNA polyadenylation (GO:1900363),0.3568252863979773,0.7097775361048217,0.875,0.9789651098786765,1.0,5/17,20.63%,RNF20;ZC3H14;CPSF7;NUDT21;CDK9
prerank,GO_Biological_Process_2021__glutamate metabolic process (GO:0006536),0.36920543125663285,0.709665736976727,0.9142857142857143,0.9787614108907203,1.0,2/13,7.83%,GCLC;ALDH5A1
prerank,GO_Biological_Process_2021__actin filament bundle organization (GO:0061572),-0.3642958225306892,-0.7094471782368489,0.8153846153846154,0.999200789308407,1.0,6/18,18.85%,AIF1;CORO1B;BAIAP2L2;CALD1;EZR;NEDD9
prerank,CellMarker_Augmented_2021__Neuron:Undefined,-0.3747082834564776,-0.709106699804116,0.8833333333333333,0.999304983710852,1.0,2/22,4.63%,FOS;NEFM
prerank,Reactome_2022__tRNA Modification In Mitochondrion R-HSA-6787450,-0.45662876027472343,-0.7090599707684523,0.8431372549019608,0.9991030113955882,1.0,1/7,7.53%,GTPBP3
prerank,GO_Biological_Process_2021__response to light stimulus (GO:0009416),-0.360493044622568,-0.7089086718743794,0.9041095890410958,0.9990119922391567,1.0,2/34,3.67%,USF1;UVSSA
prerank,Reactome_2022__PI3K Cascade R-HSA-109704,0.353634231730328,0.7088553909270044,0.8648648648648649,0.9793163986895171,1.0,10/23,23.98%,PIGU;PDE3B;GAB2;AKT2;PIK3CA;FGFR2;FGFR1;FRS2;PIK3R1;FGFR3
prerank,GO_Biological_Process_2021__positive regulation of striated muscle cell differentiation (GO:0051155),-0.3918396319306213,-0.7084685407635051,0.7796610169491526,0.9992173330698032,1.0,2/12,12.32%,IGF1;EFNB2
prerank,Reactome_2022__Synthesis Of PIPs At Late Endosome Membrane R-HSA-1660517,0.3581462900570909,0.7083802189147945,0.9142857142857143,0.9795357634902997,1.0,6/11,39.65%,MTMR9;PIKFYVE;VAC14;MTM1;MTMR2;FIG4
prerank,GO_Biological_Process_2021__negative regulation of TORC1 signaling (GO:1904262),-0.4340156744717355,-0.7082600388669621,0.8363636363636363,0.9991889501931431,1.0,1/8,9.93%,ITFG2
prerank,GO_Biological_Process_2021__regulation of establishment of endothelial barrier (GO:1903140),0.40456679357136377,0.7080369501201225,0.8333333333333334,0.9796273102452326,1.0,4/12,20.79%,TNF;VCL;TNFRSF1A;ADD1
prerank,GO_Biological_Process_2021__activation of protein kinase activity (GO:0032147),-0.296417571891042,-0.7078649206952198,0.9736842105263158,0.9993965419018659,1.0,13/85,17.61%,CARD14;IGF1;PHB2;PRKAR1B;PRLR;CHI3L1;SLC11A1;VEGFA;COPS8;MT3;PRKAR2B;PINK1;IL18
prerank,GO_Biological_Process_2021__intracellular steroid hormone receptor signaling pathway (GO:0030518),0.3130787639537469,0.7078208122982906,0.8620689655172413,0.9795313463614594,1.0,7/30,18.34%,ARID1A;PLPP1;TRERF1;NCOA4;NEDD4;NR3C1;RBFOX2
prerank,GO_Biological_Process_2021__positive regulation of microtubule nucleation (GO:0090063),-0.4277909684286551,-0.7077776477510104,0.8518518518518519,0.9992068501971781,1.0,2/7,14.43%,HSPA1B;HSPA1A
prerank,KEGG_2021_Human__Amino sugar and nucleotide sugar metabolism,0.3236422397487023,0.7077072023387025,0.9473684210526315,0.9793078676454734,1.0,4/32,6.70%,GNPNAT1;UGDH;UXS1;GFPT1
prerank,GO_Biological_Process_2021__detection of visible light (GO:0009584),0.43028631238825193,0.7076131047791406,0.8205128205128205,0.9790685996800488,1.0,2/6,11.13%,GNAQ;GNA11
prerank,Reactome_2022__SLBP Dependent Processing Of Replication-Dependent Histone Pre-mRNAs R-HSA-77588,-0.4644760469664938,-0.7074043591057498,0.85,0.9994047004974226,1.0,1/7,9.87%,NCBP2
prerank,GO_Biological_Process_2021__postsynaptic density assembly (GO:0097107),0.4427838725778116,0.7072422405882147,0.7647058823529411,0.9790884659988222,1.0,3/5,11.81%,SHANK3;NRXN2;PTEN
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell proliferation (GO:0060043),-0.4139796759276704,-0.7060847743291242,0.9,1.0,1.0,2/13,8.45%,TGFBR3;RBPJ
prerank,GO_Biological_Process_2021__negative regulation of cytokine production involved in immune response (GO:0002719),0.3771939091352858,0.7058819294672863,0.8333333333333334,0.98025536591578,1.0,3/11,10.79%,SMAD7;TNF;IRAK3
prerank,GO_Biological_Process_2021__negative regulation of protein depolymerization (GO:1901880),0.36537834776246386,0.7058628419188497,0.8837209302325582,0.9799284277522952,1.0,6/19,19.20%,CIB1;CLASP1;CLASP2;PIK3CA;CAMSAP2;ATXN7
prerank,GO_Biological_Process_2021__cellular biogenic amine catabolic process (GO:0042402),-0.41705647542161833,-0.7058580913640463,0.8301886792452831,1.0,1.0,1/7,9.85%,COMT
prerank,KEGG_2021_Human__Mannose type O-glycan biosynthesis,0.38390225494384494,0.7058275033872043,0.875,0.9796972348801595,1.0,4/16,12.20%,LARGE1;FUT9;FKRP;FKTN
prerank,GO_Biological_Process_2021__mRNA stabilization (GO:0048255),-0.3480129336354894,-0.7053399890469109,0.875,1.0,1.0,1/27,1.48%,ZFP36
prerank,GO_Biological_Process_2021__negative regulation of macromolecule metabolic process (GO:0010605),-0.290948745021124,-0.7051800587865014,1.0,1.0,1.0,18/127,14.23%,CCL3;SLC7A5;PARP14;PARP15;DDRGK1;RACK1;IGF1;PARP9;OVOL2;CITED2;VEGFA;HIF1A;DNMT1;HAVCR2;NOTCH2;TET1;ANKRD13D;REL
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),-0.38812216787865955,-0.7047945607253938,0.9019607843137255,1.0,1.0,3/14,8.71%,CLU;TPT1;CD44
prerank,GO_Biological_Process_2021__positive regulation of ATPase activity (GO:0032781),-0.3575779384192805,-0.7047634146894738,0.828125,1.0,1.0,9/31,20.20%,PLSCR1;MYBPC3;GABARAPL2;CHTOP;PFN1;ATP1B3;UHRF1;MSH6;TPM1
prerank,GO_Biological_Process_2021__ER overload response (GO:0006983),-0.4529364697971834,-0.7046933857373128,0.864406779661017,1.0,1.0,3/8,13.27%,SELENOS;ATG10;TMCO1
prerank,GO_Biological_Process_2021__cellular response to superoxide (GO:0071451),-0.4529289823520094,-0.7043728358296474,0.873015873015873,1.0,1.0,2/6,16.40%,SOD1;MT3
prerank,GO_Biological_Process_2021__sphingolipid catabolic process (GO:0030149),-0.41715445739082607,-0.7036746880861615,0.8813559322033898,1.0,1.0,3/10,8.11%,PDXDC1;GLA;ENPP2
prerank,CellMarker_Augmented_2021__Progenitor cell:Undefined,-0.32469293410504285,-0.703375936082151,0.948051948051948,1.0,1.0,2/65,1.38%,PROCR;GAPDH
prerank,GO_Biological_Process_2021__negative regulation of glucose transmembrane transport (GO:0010829),-0.4276952783224064,-0.703138655099757,0.8360655737704918,1.0,1.0,4/9,17.44%,PID1;SELENOS;PEA15;INPP5K
prerank,GO_Biological_Process_2021__negative regulation of potassium ion transport (GO:0043267),0.39697875471570593,0.7031158297940737,0.7872340425531915,0.9823507743028508,1.0,2/7,8.52%,CAB39;NEDD4L
prerank,GO_Biological_Process_2021__regulation of lipoprotein lipase activity (GO:0051004),0.35078639994341926,0.7030282604217176,0.8,0.982103003040409,1.0,3/10,13.56%,HDAC9;SORT1;PCSK6
prerank,GO_Biological_Process_2021__regulation of microtubule nucleation (GO:0010968),-0.3941634940398127,-0.702913440259548,0.8813559322033898,1.0,1.0,2/9,14.43%,HSPA1B;HSPA1A
prerank,"Reactome_2022__Sensory Perception Of Sweet, Bitter, And Umami (Glutamate) Taste R-HSA-9717207",-0.4261561120505285,-0.7028003327977516,0.8363636363636363,1.0,1.0,2/8,10.69%,SCN9A;TRPM4
prerank,CellMarker_Augmented_2021__Follicular B cell:Undefined,-0.40163763362227367,-0.7027465681894078,0.8805970149253731,1.0,1.0,1/10,1.90%,CD69
prerank,GO_Biological_Process_2021__DNA topological change (GO:0006265),0.4120558208767313,0.7026378111572265,0.8627450980392157,0.982197337572073,1.0,3/8,31.00%,TOP2B;TOP3A;TOP1
prerank,Reactome_2022__HIV Elongation Arrest And Recovery R-HSA-167287,-0.3349411973580074,-0.702551448541451,0.9016393442622951,1.0,1.0,3/28,7.16%,CTDP1;ELOB;POLR2G
prerank,Reactome_2022__Gain-of-function MRAS Complexes Activate RAF Signaling R-HSA-9726842,-0.4408306650332703,-0.7023554123818053,0.7884615384615384,1.0,1.0,1/7,7.67%,PPP1CB
prerank,GO_Biological_Process_2021__positive regulation of triglyceride metabolic process (GO:0090208),-0.4215506920981872,-0.7023471768117,0.8169014084507042,1.0,1.0,2/11,8.91%,NR1H2;CNEP1R1
prerank,GO_Biological_Process_2021__tricarboxylic acid metabolic process (GO:0072350),-0.39131605700376676,-0.7019498236344778,0.896551724137931,1.0,1.0,2/11,20.66%,IDH3B;ACO2
prerank,GO_Biological_Process_2021__regulation of glutamate receptor signaling pathway (GO:1900449),-0.45513786431778025,-0.7018110336336809,0.7924528301886793,1.0,1.0,1/5,7.36%,FYN
prerank,Reactome_2022__TP53 Regulates Metabolic Genes R-HSA-5628897,-0.3191201037533008,-0.7017278277115462,0.9333333333333333,1.0,1.0,7/66,8.90%,CYCS;DDIT4;COX7C;LAMTOR5;TXN2;COX4I1;COX5B
prerank,GO_Biological_Process_2021__regulation of extent of cell growth (GO:0061387),0.3921508800269065,0.7015823592464555,0.82,0.9831779552301062,1.0,3/8,22.75%,GSK3B;CTTN;ABL1
prerank,GO_Biological_Process_2021__pore complex assembly (GO:0046931),-0.387700741673578,-0.7014650506214678,0.8709677419354839,1.0,1.0,1/16,1.24%,PLEKHA7
prerank,GO_Biological_Process_2021__plasma membrane bounded cell projection organization (GO:0120036),-0.30082380544161513,-0.7014389915339756,0.95,1.0,1.0,5/83,6.72%,CATIP;BTG2;RAB11A;PLEK;CORO1B
prerank,Reactome_2022__RAC2 GTPase Cycle R-HSA-9013404,-0.31517853353950104,-0.7013005673051368,0.9714285714285714,1.0,1.0,5/72,4.41%,TFRC;VAV3;MPP7;EMD;NCF4
prerank,GO_Biological_Process_2021__positive regulation of collagen biosynthetic process (GO:0032967),0.40065875473337176,0.7011433201380545,0.813953488372093,0.9833831112545356,1.0,1/7,6.90%,RUNX1
prerank,GO_Biological_Process_2021__mesenchymal cell differentiation (GO:0048762),-0.3706650562526961,-0.7009965447822825,0.9210526315789473,1.0,1.0,7/32,16.94%,TGFBR3;RBPJ;HNRNPAB;HIF1A;DDX5;AKNA;S100A4
prerank,GO_Biological_Process_2021__regulation of skeletal muscle tissue development (GO:0048641),-0.43507458558489326,-0.7009515418252796,0.7540983606557377,0.9999230987423257,1.0,2/5,21.55%,FLOT1;USP19
prerank,CellMarker_Augmented_2021__Endothelial Progenitor cell:Blood Vessel,-0.3586507673819045,-0.7008688937405693,0.8636363636363636,0.9995319148159836,1.0,7/33,14.83%,NYNRIN;CGNL1;CFTR;SPARCL1;A2M;SERPING1;SPRY1
prerank,CellMarker_Augmented_2021__Circulating Progenitor cell:Blood,-0.3586507673819045,-0.7008688937405693,0.8636363636363636,0.9995319148159836,1.0,7/33,14.83%,NYNRIN;CGNL1;CFTR;SPARCL1;A2M;SERPING1;SPRY1
prerank,CellMarker_Augmented_2021__Villous cytotrophoblast:Placenta,-0.30834011759148017,-0.7008392478111312,0.9452054794520548,0.9993006489498885,1.0,14/68,22.20%,MTHFD1;RANBP1;ILF3;NPM1;DNMT1;MCM7;STMN1;SMC1A;FANCI;MSH6;MCM6;NCL;CDC7;CCT7
prerank,Reactome_2022__SUMOylation Of Immune Response Proteins R-HSA-4755510,-0.4304588711925884,-0.700795253440658,0.864406779661017,0.9991005493817243,1.0,4/9,34.98%,SUMO2;SUMO1;NFKBIA;RELA
prerank,GO_Biological_Process_2021__methylguanosine-cap decapping (GO:0110156),0.3899531200045264,0.7005034936587619,0.8809523809523809,0.9837430332077859,1.0,1/9,2.41%,DCP1B
prerank,CellMarker_Augmented_2021__Fibroblast:Heart,-0.3372559009553142,-0.700163325232882,0.8787878787878788,0.9994878451830016,1.0,7/52,14.68%,ARSJ;PTTG1IP;CRIM1;TSPAN9;CALD1;CCND1;TIMP2
prerank,GO_Biological_Process_2021__regulation of intracellular signal transduction (GO:1902531),-0.2725197056132409,-0.7000854894442643,1.0,0.9993259895590347,1.0,23/332,8.69%,PLEKHG5;ARHGAP4;RASGRF2;VAV3;DDIT4;CHD3;RPL5;GMIP;IER3;HUS1;ING5;ARHGEF1;RPL11;RHOU;PRKAR1B;ARHGEF3;OBSCN;NLRP12;SGK1;SRGAP3;ANKRD54;PRKD2;TMSB4X
prerank,GO_Biological_Process_2021__regulation of TORC1 signaling (GO:1903432),0.3339341365189001,0.6998752879454839,0.9487179487179487,0.9840669745919779,1.0,2/26,5.75%,RRAGD;GPR137C
prerank,GO_Biological_Process_2021__protein neddylation (GO:0045116),0.40866353475889317,0.6998625820942993,0.9019607843137255,0.983739740391298,1.0,2/8,12.35%,DCUN1D4;DCUN1D1
prerank,GO_Biological_Process_2021__protein catabolic process (GO:0030163),-0.3425821061494926,-0.6998441723882549,0.9420289855072463,0.999352720864553,1.0,1/41,1.79%,TPP1
prerank,GO_Biological_Process_2021__organic substance transport (GO:0071702),-0.2999407680181575,-0.6997480111340423,0.9466666666666667,0.9991766738262076,1.0,8/71,12.48%,ABCA9;ABCA6;PLTP;PCTP;ABCB9;TAP1;ABCA8;DENND10
prerank,CellMarker_Augmented_2021__Oocyte:Embryo,0.2624331711704336,0.6995328450366669,1.0,0.9837380956647784,1.0,15/74,18.88%,TIFA;IGSF11;LRCH1;CLSTN2;CHIC1;PTPRK;TMEM131;CENPE;KIF15;DNAJC3;PPM1A;RAI14;NUP133;METTL9;ARV1
prerank,GO_Biological_Process_2021__regulation of mitotic spindle assembly (GO:1901673),-0.3680080857263538,-0.6991818958144447,0.8676470588235294,0.9994609921685046,1.0,2/15,14.43%,HSPA1B;HSPA1A
prerank,GO_Biological_Process_2021__hydrogen peroxide catabolic process (GO:0042744),0.38847759345904664,0.6991047956520272,0.8085106382978723,0.9838237158343791,1.0,1/7,5.29%,CAT
prerank,"GO_Biological_Process_2021__positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",-0.45745544605386956,-0.6989212694786788,0.8833333333333333,0.999442366787422,1.0,1/7,1.60%,PYHIN1
prerank,GO_Biological_Process_2021__myoblast differentiation (GO:0045445),0.3975016406485957,0.6989088662238677,0.8974358974358975,0.9836515406702995,1.0,5/12,15.98%,NRG1;JAG1;EPAS1;TCF7L2;HINFP
prerank,CellMarker_Augmented_2021__Intestinal Epithelial Stem cell:Intestine,-0.327932936253255,-0.6986551156659113,0.8615384615384616,0.9994499705206464,1.0,3/44,6.71%,ARSJ;OSMR;SPATS2L
prerank,Reactome_2022__TP53 Regulates Transcription Of Additional Cell Cycle Genes With Uncertain Roles In P53 Pathway R-HSA-6804115,-0.39987121161458905,-0.6985515320158522,0.8275862068965517,0.9992931473580228,1.0,3/18,16.28%,BTG2;NPM1;CNOT8
prerank,Reactome_2022__Signaling By SCF-KIT R-HSA-1433557,-0.3463399229153622,-0.6977381075944395,0.9047619047619048,0.9998415710515458,1.0,4/30,9.56%,GRAP2;YES1;FYN;STAT1
prerank,GO_Biological_Process_2021__positive regulation of triglyceride biosynthetic process (GO:0010867),-0.4484298330628099,-0.6975303538874358,0.8615384615384616,0.9998347732561733,1.0,2/8,8.91%,NR1H2;CNEP1R1
prerank,GO_Biological_Process_2021__autophagosome organization (GO:1905037),-0.32715204483724114,-0.6975141582331215,0.9354838709677419,0.9995993979587625,1.0,6/40,15.41%,GABARAPL1;ATG2A;GABARAPL2;STING1;TP53INP1;WIPI1
prerank,Reactome_2022__RIP-mediated NFkB Activation Via ZBP1 R-HSA-1810476,-0.37974539111429917,-0.6970561163484265,0.8888888888888888,0.9998188080053292,1.0,7/14,34.98%,NKIRAS2;MYD88;NFKBIA;CHUK;IKBKB;TLR3;RELA
prerank,GO_Biological_Process_2021__establishment of protein localization to membrane (GO:0090150),-0.315597421936169,-0.6968227664866239,0.9850746268656716,0.9998167811899593,1.0,8/51,13.91%,AQP11;RAB11A;NACA;ZDHHC4;ZDHHC19;COX18;VPS37B;OXA1L
prerank,"Reactome_2022__Nucleotide-binding Domain, Leucine Rich Repeat Containing NLR Signaling Pathways R-HSA-168643",-0.32965548687773705,-0.696813042813786,0.921875,0.99956970105834,1.0,4/48,8.14%,PSTPIP1;AIM2;TXN2;TNFAIP3
prerank,GO_Biological_Process_2021__negative regulation of potassium ion transmembrane transport (GO:1901380),0.4145407736773825,0.6967525194973849,0.7659574468085106,0.9857269781953019,1.0,2/7,8.52%,CAB39;NEDD4L
prerank,GO_Biological_Process_2021__positive regulation of cell aging (GO:0090343),-0.4107922946564695,-0.6964868424405417,0.8909090909090909,0.9993589034416978,1.0,1/8,2.81%,B2M
prerank,GO_Biological_Process_2021__positive regulation of cellular senescence (GO:2000774),-0.4107922946564695,-0.6964868424405417,0.8909090909090909,0.9993589034416978,1.0,1/8,2.81%,B2M
prerank,Reactome_2022__Ketone Body Metabolism R-HSA-74182,-0.42598388052581626,-0.6963904336720169,0.7924528301886793,0.9991787034173599,1.0,3/7,26.76%,HMGCL;BDH1;AACS
prerank,GO_Biological_Process_2021__regulation of protein localization to chromatin (GO:1905634),0.44186917227299666,0.6963861344748138,0.868421052631579,0.9857325849827224,1.0,2/6,26.09%,SETD2;WAPL
prerank,KEGG_2021_Human__Human papillomavirus infection,-0.27454050524778106,-0.6962631714851797,0.9886363636363636,0.9990627682098975,1.0,20/190,14.31%,MX2;HLA-B;MX1;ATP6V1F;HLA-C;EIF2AK2;HLA-F;ITGA4;RBPJ;ITGA6;LLGL2;DVL1;STAT1;IRF1;VEGFA;FZD2;PIK3CB;NOTCH2;CCND1;HLA-E
prerank,GO_Biological_Process_2021__DNA strand elongation involved in DNA replication (GO:0006271),-0.3887439355705802,-0.6962214266056269,0.8727272727272727,0.9988684849300138,1.0,2/13,13.28%,POLE3;MCM7
prerank,Reactome_2022__Unwinding Of DNA R-HSA-176974,0.4276478838692155,0.6960803803641779,0.8431372549019608,0.9857817605240855,1.0,2/6,12.91%,GINS3;GINS1
prerank,Reactome_2022__STAT5 Activation Downstream Of FLT3 ITD Mutants R-HSA-9702518,0.38203737098005874,0.6960755525098357,0.8717948717948718,0.9854586817886349,1.0,3/8,29.02%,GAB2;BCL2L1;STAT5A
prerank,GO_Biological_Process_2021__rRNA modification (GO:0000154),-0.3659989202361521,-0.6960372784820981,0.8769230769230769,0.9987811974011308,1.0,4/17,15.36%,BUD23;NHP2;NOP10;ZCCHC4
prerank,Reactome_2022__STAT3 Nuclear Events Downstream Of ALK Signaling R-HSA-9701898,-0.3857561721775948,-0.6958180757726569,0.8301886792452831,0.9988150698112631,1.0,2/9,12.88%,HIF1A;PRDM1
prerank,GO_Biological_Process_2021__sno(s)RNA 3'-end processing (GO:0031126),-0.44487560668200926,-0.6956801243190986,0.84,0.998692229915138,1.0,5/8,21.97%,EXOSC10;LARP7;FBL;TENT4B;PARN
prerank,GO_Biological_Process_2021__cytochrome complex assembly (GO:0017004),-0.4674127128717521,-0.6955897905655126,0.8775510204081632,0.9985219839932281,1.0,4/5,18.64%,COX18;COA6;CYBA;SURF1
prerank,Reactome_2022__Signaling By ERBB2 TMD/JMD Mutants R-HSA-9665686,-0.38787494872217093,-0.695186138361603,0.8135593220338984,0.9987243744373706,1.0,1/13,3.25%,CDC37
prerank,CellMarker_Augmented_2021__Neural Stem cell:Hippocampus,0.27568097018172844,0.6949125948539853,0.9696969696969697,0.9863075241279053,1.0,4/41,12.40%,BORA;TMPO;SMC4;KIF15
prerank,Reactome_2022__CLEC7A/inflammasome Pathway R-HSA-5660668,-0.4482035915866677,-0.6947283764804898,0.8,0.9989408921283423,1.0,4/6,35.55%,IL1B;RELA;PYCARD;CASP8
prerank,GO_Biological_Process_2021__regulation of mRNA processing (GO:0050684),0.3216464301963865,0.6946476101551866,0.972972972972973,0.986253569562678,1.0,3/32,6.48%,KHDRBS2;CPSF4;KHDRBS3
prerank,CellMarker_Augmented_2021__Conventional Dendritic cell:Undefined,-0.4391473955068028,-0.6940442959471288,0.8148148148148148,0.999339913892163,1.0,2/10,8.15%,CD14;ITGA4
prerank,GO_Biological_Process_2021__protein localization to synapse (GO:0035418),0.43273326335252715,0.6939985831324436,0.85,0.9866229183728006,1.0,4/8,21.61%,NLGN1;NRXN2;PCLO;NRXN1
prerank,GO_Biological_Process_2021__positive regulation of protein catabolic process (GO:0045732),-0.3062759171602939,-0.6937795702390723,0.9491525423728814,0.9994044094948824,1.0,8/61,9.91%,NKD1;VPS35;PTTG1IP;SNF8;TNFRSF1B;TNFAIP3;GPC3;VPS28
prerank,"KEGG_2021_Human__Growth hormone synthesis, secretion and action",-0.2981264008844173,-0.6935829871993408,0.972972972972973,0.9993313871299937,1.0,3/83,5.56%,FOS;JUNB;IGF1
prerank,GO_Biological_Process_2021__positive regulation of canonical Wnt signaling pathway (GO:0090263),-0.2939323108826054,-0.693389936232912,0.9759036144578314,0.9992512937609179,1.0,13/96,13.53%,PSMB3;JUP;PSMB6;PSMA7;GPC3;PSMB9;TRPM4;CSNK1G2;PSMD12;CSNK1D;PSMD8;PSMA5;PRDM15
prerank,GO_Biological_Process_2021__regulation of MAP kinase activity (GO:0043405),-0.3145280704911448,-0.6933688513314522,0.9402985074626866,0.9990125081016392,1.0,12/61,15.92%,DUSP1;RGS2;PDGFD;PAQR3;GSTP1;SNF8;VEGFA;FLT1;PIK3CB;NOD2;SPRY1;AGT
prerank,"GO_Biological_Process_2021__tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)",0.39779608978634157,0.6931041758254304,0.8461538461538461,0.9871857831844723,1.0,2/12,6.43%,CPSF4;ZBTB8OS
prerank,GO_Biological_Process_2021__acetylcholine receptor signaling pathway (GO:0095500),-0.3949148838894242,-0.6930441184188376,0.8392857142857143,0.9991125501478221,1.0,1/11,1.41%,CHRM2
prerank,GO_Biological_Process_2021__negative regulation of lipid metabolic process (GO:0045833),-0.39108005732159756,-0.6930346370831402,0.8571428571428571,0.9988620866650957,1.0,1/12,4.08%,APOD
prerank,KEGG_2021_Human__Proteoglycans in cancer,-0.2882276532084787,-0.6928612459411829,0.9629629629629629,0.9987893024720323,1.0,17/139,14.20%,FLNA;VAV3;ARHGEF1;IGF1;CD63;RPS6;PPP1CB;ACTG1;CD44;GPC3;ACTB;VEGFA;HIF1A;FZD2;DDX5;PIK3CB;CCND1
prerank,GO_Biological_Process_2021__camera-type eye morphogenesis (GO:0048593),-0.43979704063158886,-0.6922209843229626,0.864406779661017,0.9992537935154198,1.0,1/7,11.19%,VEGFA
prerank,GO_Biological_Process_2021__defense response to Gram-negative bacterium (GO:0050829),-0.3674902844367,-0.6919747534113965,0.8636363636363636,0.999254292679409,1.0,7/17,19.56%,RPL30;SLC11A1;H2BC11;RPS19;RNASE6;TNFRSF14;MPEG1
prerank,GO_Biological_Process_2021__miRNA catabolic process (GO:0010587),-0.4586502388177554,-0.691935726343561,0.8367346938775511,0.9990513636024454,1.0,2/5,21.97%,TENT4B;PARN
prerank,GO_Biological_Process_2021__negative regulation of cellular carbohydrate metabolic process (GO:0010677),-0.3903863378796481,-0.6918135807704602,0.8301886792452831,0.9989242152235916,1.0,2/11,11.31%,PLEK;FBP1
prerank,GO_Biological_Process_2021__regulation of mitophagy (GO:1901524),-0.44991668601001095,-0.6917505221271053,0.8235294117647058,0.998728571657054,1.0,1/5,5.57%,SLC25A5
prerank,GO_Biological_Process_2021__sequestering of actin monomers (GO:0042989),0.4577344469147794,0.6912145560623825,0.8979591836734694,0.9886337561191602,1.0,1/5,1.66%,GSN
prerank,Reactome_2022__Regulation Of Insulin Secretion R-HSA-422356,-0.33037493644386523,-0.691207609667509,0.967741935483871,0.9989797476259178,1.0,3/51,6.63%,CD36;GNB5;PRKAR1B
prerank,GO_Biological_Process_2021__cellular response to interleukin-6 (GO:0071354),-0.37363237413634953,-0.6911248462374814,0.8888888888888888,0.9987747401712943,1.0,2/23,9.56%,PID1;STAT1
prerank,GO_Biological_Process_2021__regulation of oxidative stress-induced cell death (GO:1903201),-0.4112725428667909,-0.6909961506261317,0.8444444444444444,0.9986596091736321,1.0,4/9,26.34%,FYN;PINK1;PARK7;REST
prerank,GO_Biological_Process_2021__dendritic spine morphogenesis (GO:0060997),-0.39356743118586335,-0.6909518219641725,0.8095238095238095,0.998447707732807,1.0,1/12,3.87%,EPHB1
prerank,Reactome_2022__Amino Acids Regulate mTORC1 R-HSA-9639288,0.28477222861339946,0.6908020954613076,0.9705882352941176,0.9887964316063715,1.0,9/39,20.62%,RRAGD;ATP6V1B2;FNIP2;SESN2;LAMTOR3;TCIRG1;ATP6V0B;MIOS;ATP6V0D1
prerank,GO_Biological_Process_2021__neuron migration (GO:0001764),0.3189732096126883,0.6907029034670499,0.9130434782608695,0.9885560559809944,1.0,10/39,13.54%,NRP1;CDK5R1;RELN;AUTS2;GPM6A;PEX13;ELP3;NTRK2;SH3RF1;MARK1
prerank,GO_Biological_Process_2021__regulation of phosphatidylinositol 3-kinase activity (GO:0043551),0.35378988436295417,0.6906561201817385,0.8918918918918919,0.9882724035896315,1.0,3/22,13.77%,FGF2;P2RY12;PTK2
prerank,GO_Biological_Process_2021__microtubule polymerization (GO:0046785),-0.36134881682068853,-0.6904967523820958,0.8870967741935484,0.9986349443247217,1.0,7/25,18.55%,FGF13;TRPV4;TUBGCP2;CSNK1D;MAP7D3;TUBGCP5;AKAP9
prerank,GO_Biological_Process_2021__heterocycle biosynthetic process (GO:0018130),-0.4235185603337813,-0.6904802020964218,0.7903225806451613,0.9983971948728927,1.0,2/8,17.37%,NFS1;MOCOS
prerank,GO_Biological_Process_2021__protein-DNA complex disassembly (GO:0032986),0.35691184386195374,0.690368411525921,0.813953488372093,0.988253440870195,1.0,3/12,10.75%,ARID1A;HMGA1;SUPT16H
prerank,Reactome_2022__TRP Channels R-HSA-3295583,-0.4127393545802971,-0.690137393611188,0.875,0.9984970314571665,1.0,4/12,10.69%,MCOLN2;TRPV4;TRPM3;TRPM4
prerank,GO_Biological_Process_2021__defense response to protozoan (GO:0042832),-0.41493234885208957,-0.6901095643288928,0.7936507936507936,0.9982618017125465,1.0,2/8,10.20%,GBP2;SLC11A1
prerank,GO_Biological_Process_2021__regulation of long-chain fatty acid import across plasma membrane (GO:0010746),0.4309079602537046,0.6896526765093911,0.8205128205128205,0.9886133441420942,1.0,1/6,15.47%,AKT2
prerank,Reactome_2022__Resolution Of D-loop Structures Thru Synthesis-Dependent Strand Annealing (SDSA) R-HSA-5693554,-0.3814059995730028,-0.6895786710892903,0.9464285714285714,0.9985220088209887,1.0,5/18,18.09%,BRCA2;XRCC3;KAT5;BRCA1;WRN
prerank,GO_Biological_Process_2021__endoplasmic reticulum tubular network organization (GO:0071786),0.36548149945606745,0.6895530974856048,0.825,0.9884128064980786,1.0,3/13,12.26%,RAB10;REEP3;RTN4
prerank,GO_Biological_Process_2021__protein K6-linked ubiquitination (GO:0085020),0.41514068078647454,0.689475456225677,0.7837837837837838,0.988180854853964,1.0,4/6,25.93%,BARD1;RNF6;UBE2D4;RNF4
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway (GO:2001242),0.3173046573444454,0.6894675097305332,0.8888888888888888,0.9878465582183571,1.0,3/37,7.92%,DAPK2;DDIT3;BOK
prerank,GO_Biological_Process_2021__pyrimidine-containing compound catabolic process (GO:0072529),-0.3985963712933114,-0.6894112052439878,0.8709677419354839,0.9984543150066227,1.0,3/12,10.19%,NT5C;TYMP;DPYS
prerank,Reactome_2022__Vitamin B5 (Pantothenate) Metabolism R-HSA-199220,-0.3986501284687166,-0.6894051668227672,0.9056603773584906,0.998205136446622,1.0,3/15,8.26%,VNN2;ENPP2;ENPP3
prerank,GO_Biological_Process_2021__production of siRNA involved in RNA interference (GO:0030422),0.4347846181306662,0.6889287578566148,0.8372093023255814,0.9880878807829969,1.0,4/7,30.25%,DROSHA;MRPL44;HENMT1;TSN
prerank,Reactome_2022__Formation Of Early Elongation Complex R-HSA-113418,-0.3377724592758877,-0.6887937680288407,0.8983050847457628,0.9986371999315506,1.0,4/28,9.87%,GTF2H5;CTDP1;POLR2G;NCBP2
prerank,GO_Biological_Process_2021__negative regulation of potassium ion transmembrane transporter activity (GO:1901017),0.4603655180576679,0.6887033981908562,0.8936170212765957,0.9879705260019247,1.0,2/6,8.52%,CAB39;NEDD4L
prerank,CellMarker_Augmented_2021__Cancer Stem-Like cell:Brain,-0.32849602764031094,-0.6886145890459451,0.9436619718309859,0.9985742414223334,1.0,10/53,12.34%,MS4A4A;SIGLEC1;CD93;PECAM1;TNFRSF1B;PCDH12;MS4A6A;CSF2RB;PTPRB;FLT1
prerank,GO_Biological_Process_2021__glycoprotein metabolic process (GO:0009100),0.29994608706742854,0.6886106379914907,0.9714285714285714,0.9877469141511416,1.0,11/39,17.01%,LARGE1;ST6GALNAC3;HPSE;PRKCSH;B4GALT7;STT3B;PCSK6;FBXO27;ST8SIA4;ERP44;ST8SIA5
prerank,Reactome_2022__Class I Peroxisomal Membrane Protein Import R-HSA-9603798,-0.39034152184033105,-0.6885493173930263,0.847457627118644,0.9984029601625651,1.0,2/13,6.99%,FIS1;ACBD5
prerank,GO_Biological_Process_2021__positive regulation of catabolic process (GO:0009896),0.2899489094544136,0.688299548465957,0.9393939393939394,0.9876927467239058,1.0,15/46,19.22%,WNT5A;TNF;FZR1;RAB7A;NEDD4L;PLK2;SORL1;BARD1;SMURF1;GSK3B;IDE;NEDD4;HACE1;TIPARP;CSNK2A1
prerank,Reactome_2022__AKT Phosphorylates Targets In Nucleus R-HSA-198693,0.38123455474537216,0.6881845626844799,0.8780487804878049,0.9874772511731481,1.0,4/8,22.15%,AKT2;RPS6KB2;AKT3;FOXO1
prerank,GO_Biological_Process_2021__myeloid cell differentiation (GO:0030099),0.32892903173058086,0.6875230970168449,0.8571428571428571,0.9877812413898421,1.0,5/38,11.63%,FLVCR1;ZBTB16;RUNX1;IKZF1;MFHAS1
prerank,GO_Biological_Process_2021__mitotic G1/S transition checkpoint signaling (GO:0044819),-0.40140471270016687,-0.6873960954821264,0.8833333333333333,0.9993503659222843,1.0,2/10,15.14%,CCND1;RPS27L
prerank,GO_Biological_Process_2021__calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),-0.3824024498483541,-0.6870400954117486,0.8360655737704918,0.9994638451254628,1.0,2/14,5.06%,SELL;CDH23
prerank,GO_Biological_Process_2021__nucleotide transport (GO:0006862),-0.458253274288342,-0.6870237087419109,0.8771929824561403,0.9992242081251685,1.0,2/5,24.47%,SLC25A19;SLC25A36
prerank,GO_Biological_Process_2021__regulation of fibrinolysis (GO:0051917),-0.44496093210514687,-0.6865542682226995,0.8793103448275862,0.9994011947062191,1.0,1/6,2.94%,USF1
prerank,GO_Biological_Process_2021__steroid hormone mediated signaling pathway (GO:0043401),0.39554318506788005,0.6864294060837254,0.875,0.988450801746411,1.0,4/8,25.61%,PLPP1;NR3C1;NR3C2;ESR1
prerank,GO_Biological_Process_2021__endodermal cell differentiation (GO:0035987),0.34503946719742584,0.6863893098620816,0.9347826086956522,0.9881684289553594,1.0,5/17,14.07%,ITGAV;COL11A1;COL6A1;SETD2;MMP14
prerank,GO_Biological_Process_2021__early endosome to late endosome transport (GO:0045022),0.3160058135240189,0.6863766455195548,0.9148936170212766,0.9878508728993175,1.0,2/19,8.42%,PTPN23;RAB7A
prerank,GO_Biological_Process_2021__histone modification (GO:0016570),0.27030400015130224,0.6862935941493926,0.96875,0.9876199709523314,1.0,13/86,12.90%,RUVBL2;SIRT1;HDAC9;MTA2;MIER3;RPS6KA4;TRERF1;HDAC1;TBL1XR1;NSD3;KAT2A;UBE2N;BRMS1L
prerank,KEGG_2021_Human__IL-17 signaling pathway,-0.3276695153549208,-0.6862131500749299,0.8857142857142857,0.9994933994893683,1.0,2/44,8.14%,FOS;TNFAIP3
prerank,"GO_Biological_Process_2021__negative regulation of gene expression, epigenetic (GO:0045814)",0.3224545519425167,0.6860288951618249,0.926829268292683,0.9875149131530433,1.0,2/25,10.26%,AEBP2;SMYD5
prerank,GO_Biological_Process_2021__negative regulation of fibrinolysis (GO:0051918),-0.45289808500467305,-0.6859410336803533,0.8867924528301887,0.9995055925406321,1.0,1/5,2.94%,USF1
prerank,GO_Biological_Process_2021__neurotrophin signaling pathway (GO:0038179),-0.38427109402114457,-0.6856456470757951,0.8852459016393442,0.9995248330112293,1.0,1/13,2.37%,DDIT4
prerank,Reactome_2022__RUNX3 Regulates NOTCH Signaling R-HSA-8941856,-0.4108452526067534,-0.6851432710262635,0.8333333333333334,0.9997438683670482,1.0,2/13,8.45%,RUNX3;RBPJ
prerank,GO_Biological_Process_2021__cellular protein catabolic process (GO:0044257),0.28481976019356336,0.6849551858644063,0.9090909090909091,0.9882462583538226,1.0,5/46,9.60%,CTSF;CTSC;CTSK;RAB7A;MDM2
prerank,GO_Biological_Process_2021__organelle fusion (GO:0048284),0.33988119727104926,0.6849469564891741,0.8863636363636364,0.9879173285533321,1.0,3/17,11.82%,GDAP1;USP30;MFN1
prerank,GO_Biological_Process_2021__regulation of cytoplasmic translational elongation (GO:1900247),0.4437257581969243,0.6846870459024946,0.8571428571428571,0.9878122767526287,1.0,2/5,18.57%,DPH5;CPEB2
prerank,GO_Biological_Process_2021__cardiac muscle cell differentiation (GO:0055007),-0.3978084710480606,-0.6843962035605755,0.8787878787878788,1.0,1.0,3/12,11.19%,TTN;KDM6B;VEGFA
prerank,Reactome_2022__Initiation Of Nuclear Envelope (NE) Reformation R-HSA-2995383,-0.40048143888808785,-0.6840767256979152,0.8620689655172413,1.0,1.0,1/14,4.25%,EMD
prerank,KEGG_2021_Human__Synthesis and degradation of ketone bodies,0.40627925451184155,0.6840122249648874,0.7906976744186046,0.9880956209440728,1.0,1/7,9.47%,HMGCS1
prerank,Reactome_2022__Signaling By FGFR R-HSA-190236,-0.32036765111112064,-0.6838301998427934,0.890625,1.0,1.0,4/54,7.16%,UBC;RPS27A;FGF13;POLR2G
prerank,GO_Biological_Process_2021__regulation of cellular senescence (GO:2000772),0.36092651562539524,0.6837627137325388,0.868421052631579,0.9880533183702782,1.0,5/22,13.04%,SIRT1;NUAK1;HMGA1;CDK6;CGAS
prerank,GO_Biological_Process_2021__sulfur compound transport (GO:0072348),0.36016418638664166,0.6833726051470531,0.8518518518518519,0.9881991965158363,1.0,4/18,18.82%,SLC19A2;SLC25A14;SLC35F3;SLC25A26
prerank,GO_Biological_Process_2021__negative regulation of nitric oxide biosynthetic process (GO:0045019),-0.4499185840739288,-0.6832118518514848,0.8333333333333334,1.0,1.0,1/5,5.40%,GLA
prerank,GO_Biological_Process_2021__negative regulation of nitric oxide metabolic process (GO:1904406),-0.4499185840739288,-0.6832118518514848,0.8333333333333334,1.0,1.0,1/5,5.40%,GLA
prerank,GO_Biological_Process_2021__regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway (GO:0070432),-0.4387698430540142,-0.6831570976371893,0.8448275862068966,1.0,1.0,4/6,19.00%,HSPA1B;HSPA1A;SLC15A3;PTPN22
prerank,GO_Biological_Process_2021__positive regulation of neutrophil chemotaxis (GO:0090023),-0.39372019360096266,-0.6829332854274686,0.9090909090909091,0.9997796483178008,1.0,1/13,0.96%,RIPOR2
prerank,GO_Biological_Process_2021__positive regulation of granulocyte chemotaxis (GO:0071624),-0.39372019360096266,-0.6829332854274686,0.9090909090909091,0.9997796483178008,1.0,1/13,0.96%,RIPOR2
prerank,GO_Biological_Process_2021__regulation of mitotic centrosome separation (GO:0046602),-0.4308930444169844,-0.6824768499720569,0.7931034482758621,1.0,1.0,1/6,5.97%,RANBP1
prerank,Reactome_2022__Centrosome Maturation R-HSA-380287,-0.3056240405623282,-0.681949461204733,0.9452054794520548,1.0,1.0,19/67,24.36%,SSNA1;CEP72;CEP164;TUBGCP2;CSNK1D;TUBB4B;TUBGCP5;PRKAR2B;DCTN2;AKAP9;MZT2B;DYNC1I2;NINL;SFI1;CDK11B;HAUS5;TUBB4A;CEP250;NME7
prerank,GO_Biological_Process_2021__calcium ion transport (GO:0006816),-0.3256496084761277,-0.6817868356492702,0.9726027397260274,1.0,1.0,10/69,10.69%,CCL3;CCL5;MCOLN2;CDH23;FYN;TPT1;TRPV4;TRPM3;CACNA2D4;TRPM4
prerank,GO_Biological_Process_2021__genitalia development (GO:0048806),0.46120988745016045,0.6812507046434704,0.8444444444444444,0.9898300959216911,1.0,2/5,4.48%,PKD1;WNT5A
prerank,GO_Biological_Process_2021__positive regulation of neuron migration (GO:2001224),-0.38175885991818287,-0.6812367154415961,0.8490566037735849,1.0,1.0,1/12,5.83%,SEMA6A
prerank,Reactome_2022__RHO GTPases Activate NADPH Oxidases R-HSA-5668599,-0.36030316583954125,-0.6810455240752104,0.9552238805970149,1.0,1.0,3/18,12.67%,NCF4;NCF2;CYBA
prerank,Reactome_2022__SLBP Independent Processing Of Histone Pre-mRNAs R-HSA-111367,-0.4659577514144547,-0.68103495541901,0.8688524590163934,1.0,1.0,1/6,9.87%,NCBP2
prerank,GO_Biological_Process_2021__G protein-coupled acetylcholine receptor signaling pathway (GO:0007213),-0.38349799026240966,-0.6810238933499282,0.85,0.9999273231099526,1.0,1/12,1.41%,CHRM2
prerank,GO_Biological_Process_2021__microtubule nucleation (GO:0007020),0.34335192056421127,0.6810074107243239,0.9024390243902439,0.989685405695663,1.0,6/17,19.38%,TPPP;SLAIN2;CLASP1;TUBGCP6;CLASP2;NDE1
prerank,GO_Biological_Process_2021__embryonic organ morphogenesis (GO:0048562),0.36208082544432496,0.6808384367297927,0.8695652173913043,0.989505569721709,1.0,6/10,25.10%,FBN2;MEGF8;NIPBL;FGFR2;RYR2;ACVR1
prerank,GO_Biological_Process_2021__regulation of cytokinesis (GO:0032465),-0.3319192503060932,-0.6808324835632966,0.9242424242424242,0.999880824461045,1.0,5/50,8.36%,RAB11A;KLHL13;CENPV;ENTR1;CALM1
prerank,GO_Biological_Process_2021__regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),-0.3913546587208221,-0.6803828312468662,0.8070175438596491,1.0,1.0,2/9,5.57%,CHCHD10;SLC25A5
prerank,GO_Biological_Process_2021__mitochondrial tRNA processing (GO:0090646),-0.4490264181338273,-0.6803812173812522,0.8431372549019608,0.9997551441508956,1.0,1/5,10.63%,TRMT10B
prerank,GO_Biological_Process_2021__phosphatidylinositol dephosphorylation (GO:0046856),0.3094206342335685,0.6803045572856689,0.875,0.9896546786085383,1.0,8/21,33.18%,PTEN;MTMR9;PIP4P2;SYNJ2;OCRL;MTMR3;SYNJ1;INPP5F
prerank,CellMarker_Augmented_2021__Glomerular Epithelial cell:Renal Glomerulus,-0.3659392760286248,-0.6802997048703029,0.8852459016393442,0.9993139024773214,1.0,11/28,17.63%,CLDN7;ANXA2;SLC25A5;OVOL2;LLGL2;SLC35F2;TUBB4B;RPL8;CDCP1;EZR;SLC2A1
prerank,CellMarker_Augmented_2021__Podocyte:Renal Glomerulus,-0.3659392760286248,-0.6802997048703029,0.8852459016393442,0.9993139024773214,1.0,11/28,17.63%,CLDN7;ANXA2;SLC25A5;OVOL2;LLGL2;SLC35F2;TUBB4B;RPL8;CDCP1;EZR;SLC2A1
prerank,GO_Biological_Process_2021__negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),-0.34371615573965675,-0.6801232715819079,0.9242424242424242,0.9992325553267412,1.0,6/26,14.26%,TNFSF10;TNFAIP3;CFLAR;GPX1;PEA15;BRCA1
prerank,GO_Biological_Process_2021__negative regulation of smooth muscle cell differentiation (GO:0051151),0.4554572171987952,0.6800012197893494,0.8518518518518519,0.9896275907696561,1.0,2/5,18.52%,NFATC3;NFATC2
prerank,GO_Biological_Process_2021__telomere capping (GO:0016233),-0.40811867662839657,-0.6798667577985908,0.8421052631578947,0.9991769600321021,1.0,2/11,21.40%,TERF2IP;CTC1
prerank,GO_Biological_Process_2021__camera-type eye development (GO:0043010),0.37538555796072526,0.6793045530973286,0.8367346938775511,0.989890004960752,1.0,2/10,12.21%,FBN2;NF1
prerank,GO_Biological_Process_2021__phosphatidylcholine biosynthetic process (GO:0006656),0.3244080131308587,0.6789301359263433,0.875,0.9898745882263726,1.0,10/21,19.22%,CHKA;SLC44A2;GPAT4;SLC44A5;SLC44A1;LCAT;CHPT1;STARD7;PEMT;CSNK2A1
prerank,GO_Biological_Process_2021__heart contraction (GO:0060047),-0.39476898918240766,-0.6788550084834412,0.8787878787878788,0.9999322074874519,1.0,4/18,14.09%,TTN;MYBPC3;SOD1;GPX1
prerank,Reactome_2022__Transcriptional Regulation By AP-2 (TFAP2) Family Of Transcription Factors R-HSA-8864260,0.3201221749322161,0.6788388430931854,0.8809523809523809,0.9896363506378177,1.0,1/22,2.15%,TGFA
prerank,GO_Biological_Process_2021__response to forskolin (GO:1904321),-0.4098050917017843,-0.678556995315217,0.8571428571428571,0.9996946277494057,1.0,1/7,10.61%,CFTR
prerank,GO_Biological_Process_2021__cellular response to forskolin (GO:1904322),-0.4098050917017843,-0.678556995315217,0.8571428571428571,0.9996946277494057,1.0,1/7,10.61%,CFTR
prerank,Reactome_2022__EML4 And NUDC In Mitotic Spindle Formation R-HSA-9648025,-0.30049454621251154,-0.6784669802435959,0.9850746268656716,0.999491876433221,1.0,11/66,19.77%,RPS27;CENPU;ITGB3BP;ZWILCH;MIS12;DYNC1LI2;SEC13;SGO2;CENPF;BUB3;DYNC1I2
prerank,GO_Biological_Process_2021__late endosome to lysosome transport (GO:1902774),0.48278433582690083,0.6782026121472579,0.9318181818181818,0.9898086137026602,1.0,1/5,17.89%,ARL8B
prerank,GO_Biological_Process_2021__megakaryocyte differentiation (GO:0030219),0.4418014085762555,0.6779712136856866,0.8837209302325582,0.9896916656049962,1.0,1/6,7.81%,ZNF385A
prerank,GO_Biological_Process_2021__cellular response to ATP (GO:0071318),0.4128522924358082,0.6779572634703579,0.851063829787234,0.9893678102751673,1.0,4/8,28.67%,P2RY12;P2RX7;HSP90B1;P2RX4
prerank,GO_Biological_Process_2021__mitochondrial fusion (GO:0008053),0.3411221543042765,0.6776006811562912,0.875,0.9893369779815139,1.0,3/15,11.82%,GDAP1;USP30;MFN1
prerank,GO_Biological_Process_2021__mRNA metabolic process (GO:0016071),-0.2975722562518547,-0.6775368731103284,0.971830985915493,1.0,1.0,13/78,14.43%,ZFP36;NUDT12;SSB;AURKAIP1;U2AF2;NCBP2;PRPF3;HSPA1B;SRSF2;DDX5;SRSF7;NUDT16;HSPA1A
prerank,CellMarker_Augmented_2021__Bulge Stem cell:Scalp,-0.2972474496386312,-0.6774269208768269,0.921875,1.0,1.0,5/63,8.83%,RIC3;FYN;SPOCK2;BEX4;FEZ1
prerank,GO_Biological_Process_2021__complement receptor mediated signaling pathway (GO:0002430),0.4003508122239436,0.6773365191334371,0.8596491228070176,0.9892359164219628,1.0,1/7,2.10%,FPR3
prerank,GO_Biological_Process_2021__melanosome organization (GO:0032438),-0.3624426448320146,-0.6770876987423315,0.9047619047619048,1.0,1.0,3/15,14.35%,HPS4;BLOC1S2;TRAPPC6A
prerank,GO_Biological_Process_2021__tRNA wobble base modification (GO:0002097),-0.4140457258537425,-0.6770672291676502,0.8909090909090909,0.9998154709787272,1.0,1/9,7.53%,GTPBP3
prerank,GO_Biological_Process_2021__positive regulation of actin filament depolymerization (GO:0030836),0.4003455222598597,0.6766866550419451,0.8409090909090909,0.989454842790208,1.0,1/8,1.58%,SEMA5A
prerank,GO_Biological_Process_2021__regulation of I-kappaB phosphorylation (GO:1903719),0.4137801371412503,0.6766308435412739,0.8863636363636364,0.9891744020292573,1.0,2/7,7.30%,SIRPA;TNF
prerank,Reactome_2022__Nephrin Family Interactions R-HSA-373753,0.32936018540725076,0.6764664769740971,0.8888888888888888,0.9889955191738473,1.0,7/17,24.21%,NCK2;SPTAN1;PIK3CA;CD2AP;SPTBN1;PIK3R1;MAGI2
prerank,Reactome_2022__Glutamate Neurotransmitter Release Cycle R-HSA-210500,-0.3737057351083014,-0.6764525430865198,0.9310344827586207,1.0,1.0,2/18,6.19%,RIMS1;RAB3A
prerank,GO_Biological_Process_2021__positive regulation of regulated secretory pathway (GO:1903307),-0.378810591968538,-0.6760900209876118,0.8,1.0,1.0,2/11,7.73%,RAB3A;RAB3D
prerank,CellMarker_Augmented_2021__Adipose-derived Stromal cell:Abdominal Adipose Tissue,-0.34402340001445797,-0.6759599603100479,0.8769230769230769,0.9998890867984646,1.0,5/21,14.88%,BEX1;GPC3;QPRT;TET1;ASTN1
prerank,CellMarker_Augmented_2021__Adipose Progenitor cell:Abdominal Adipose Tissue,-0.34402340001445797,-0.6759599603100479,0.8769230769230769,0.9998890867984646,1.0,5/21,14.88%,BEX1;GPC3;QPRT;TET1;ASTN1
prerank,Reactome_2022__Regulation Of MECP2 Expression And Activity R-HSA-9022692,0.30061940008518157,0.6759140897871723,0.9333333333333333,0.9891090723779808,1.0,10/28,29.29%,HDAC1;TBL1XR1;TNRC6C;HDAC3;AGO1;CAMK2D;TNRC6A;CAMK2B;HIPK2;MOV10
prerank,GO_Biological_Process_2021__RNA methylation (GO:0001510),0.2883476423898395,0.6757285244046122,0.9696969696969697,0.9889264347297472,1.0,3/47,5.52%,MEPCE;NSUN2;TFB1M
prerank,GO_Biological_Process_2021__positive regulation of acute inflammatory response (GO:0002675),-0.4352487117911569,-0.6755363213073826,0.84,1.0,1.0,1/5,6.67%,OSMR
prerank,GO_Biological_Process_2021__cell cycle checkpoint signaling (GO:0000075),-0.42618454347557294,-0.675507241912123,0.8333333333333334,0.9997965894796267,1.0,3/6,16.30%,ZWILCH;NABP1;CHFR
prerank,Reactome_2022__Metabolism Of Amine-Derived Hormones R-HSA-209776,0.41677446833651133,0.6754893099115726,0.8888888888888888,0.9887906585265899,1.0,1/6,1.55%,AANAT
prerank,GO_Biological_Process_2021__internal peptidyl-lysine acetylation (GO:0018393),-0.3773805486537958,-0.6753989407077883,0.8723404255319149,0.9996712179920619,1.0,4/23,16.14%,TAF6L;MSL3;KAT5;KAT8
prerank,"GO_Biological_Process_2021__regulation of CD8-positive, alpha-beta T cell activation (GO:2001185)",-0.4125124162754704,-0.675128781340789,0.864406779661017,0.9996995324527882,1.0,4/8,26.10%,IRF1;HLA-E;LILRB1;HLA-A
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell differentiation (GO:2000725),-0.4190034283947755,-0.6748231935754821,0.8275862068965517,0.9997324862914443,1.0,1/5,12.32%,EFNB2
prerank,KEGG_2021_Human__Porphyrin and chlorophyll metabolism,0.34778312342938167,0.6746587496780784,0.9,0.9891611469552742,1.0,3/15,17.37%,COX10;ALAD;ALAS1
prerank,GO_Biological_Process_2021__positive regulation of histone H3-K4 methylation (GO:0051571),-0.3903084315448112,-0.674375815324564,0.8490566037735849,0.9999375762740478,1.0,2/11,14.26%,DNMT1;BRCA1
prerank,Reactome_2022__Extra-nuclear Estrogen Signaling R-HSA-9009391,-0.31124235758350416,-0.6742633887307731,0.987012987012987,0.9997890398071816,1.0,6/44,15.86%,FOS;GNB5;CALM1;ESR2;CCND1;GNB2
prerank,GO_Biological_Process_2021__Notch signaling involved in heart development (GO:0061314),-0.4460755921439792,-0.674208638578657,0.9019607843137255,0.9995940760382173,1.0,2/5,13.87%,RBPJ;NOTCH2
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell differentiation (GO:1905063),0.4293475640048443,0.6741940655136875,0.8367346938775511,0.9892628160970527,1.0,2/6,18.52%,NFATC3;NFATC2
prerank,GO_Biological_Process_2021__mitotic nuclear membrane disassembly (GO:0007077),-0.4256277402892802,-0.6740437412783383,0.8793103448275862,0.9995224163049841,1.0,1/7,8.91%,CNEP1R1
prerank,GO_Biological_Process_2021__positive regulation of neutrophil migration (GO:1902624),-0.38692927672373195,-0.6739228080469711,0.8928571428571429,0.9993950175936882,1.0,1/14,0.96%,RIPOR2
prerank,GO_Biological_Process_2021__transepithelial transport (GO:0070633),0.39554479610114135,0.6736109571772047,0.8157894736842105,0.9894305651164863,1.0,2/9,6.03%,SLC1A3;SLC1A2
prerank,GO_Biological_Process_2021__positive regulation of RNA metabolic process (GO:0051254),-0.33906598694144935,-0.6732455476134511,0.9130434782608695,0.9997509511869429,1.0,9/35,22.88%,RBM22;BUD23;U2AF2;DDX5;HSPA1A;PNPT1;ERN1;NMD3;HEATR1
prerank,Reactome_2022__Phase 0 - Rapid Depolarisation R-HSA-5576892,-0.36512564624856747,-0.6731753237248482,0.8939393939393939,0.9995585208644335,1.0,3/19,8.36%,SCN9A;FGF13;CALM1
prerank,GO_Biological_Process_2021__regulation of non-canonical Wnt signaling pathway (GO:2000050),0.3820079212429889,0.6728885479814877,0.8409090909090909,0.989687666324841,1.0,1/8,1.07%,ZNRF3
prerank,CellMarker_Augmented_2021__Retinoid Acid Signaling-Responsive Fetal Germ cell:Fetal Gonad,-0.2981358786159677,-0.6728315859520156,0.9875,0.999614665143297,1.0,25/126,17.28%,SIGIRR;GPATCH11;B2M;PER3;SPATS2L;RNMT;NNAT;MEIS1;DCTN4;GPX4;GLRX2;UROS;DNMT1;MYO1F;ECI2;CCND1;PEA15;CFAP97;AGBL5;MAP7D3;CD74;SMC1B;KDM1B;YPEL1;AAMDC
prerank,GO_Biological_Process_2021__positive regulation by host of viral transcription (GO:0043923),-0.3643827885214391,-0.672667425093394,0.8076923076923077,0.9995221979067339,1.0,6/15,26.85%,CTDP1;TAF11;NUCKS1;TFAP4;CHD1;SMARCB1
prerank,"GO_Biological_Process_2021__RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)",0.37390500392236603,0.6726048270483139,0.825,0.9896140778229124,1.0,2/13,6.43%,CPSF4;ZBTB8OS
prerank,GO_Biological_Process_2021__activation of protein kinase B activity (GO:0032148),0.2935121726739779,0.6725602596071714,0.9722222222222222,0.9893345193743623,1.0,2/23,6.19%,WNT5A;NRG1
prerank,Reactome_2022__Synthesis Of PC R-HSA-1483191,-0.36421401774373496,-0.6719606230046945,0.9090909090909091,0.999917189497009,1.0,3/17,9.06%,LPCAT1;PCYT1A;PCTP
prerank,GO_Biological_Process_2021__positive regulation of leukocyte differentiation (GO:1902107),-0.4355249194950679,-0.671925562570953,0.8363636363636363,0.9997133123873981,1.0,2/7,15.76%,NCKAP1L;LGALS1
prerank,GO_Biological_Process_2021__regulation of intracellular estrogen receptor signaling pathway (GO:0033146),-0.3622692715918413,-0.6716592138502913,0.9272727272727272,0.9997508005963677,1.0,6/23,20.70%,DDRGK1;KANK2;BRCA1;UFSP2;UFL1;WBP2
prerank,GO_Biological_Process_2021__negative regulation of sodium ion transmembrane transport (GO:1902306),-0.41837902014422534,-0.6715417337425107,0.8333333333333334,0.9996073707210651,1.0,2/8,15.13%,STK39;HECW1
prerank,GO_Biological_Process_2021__positive regulation of interferon-alpha production (GO:0032727),0.3489841360860152,0.671484306966349,0.9411764705882353,0.9899683234069218,1.0,5/16,17.16%,TLR7;SETD2;IRF5;HSPD1;DDX3X
prerank,GO_Biological_Process_2021__positive regulation of cell development (GO:0010720),-0.38555667462986964,-0.6710595027987261,0.9032258064516129,0.9997561606143289,1.0,5/17,20.69%,ZNF335;TYROBP;SERPINF1;OPRM1;CLEC7A
prerank,GO_Biological_Process_2021__hemostasis (GO:0007599),-0.46064894608879847,-0.6709470240513841,0.9107142857142857,0.9996081670386808,1.0,1/5,9.39%,HPS4
prerank,GO_Biological_Process_2021__chondroitin sulfate proteoglycan metabolic process (GO:0050654),0.3974587939982646,0.6709441162987135,0.8936170212765957,0.9902015951995063,1.0,1/8,2.80%,CSGALNACT1
prerank,GO_Biological_Process_2021__regulation of extracellular matrix assembly (GO:1901201),0.44422867655331827,0.6708133557722961,0.8157894736842105,0.9899648363662988,1.0,1/5,5.98%,SMAD3
prerank,GO_Biological_Process_2021__tRNA wobble uridine modification (GO:0002098),-0.40969357933038486,-0.670365716851579,0.9107142857142857,0.9998843387954525,1.0,1/9,7.53%,GTPBP3
prerank,GO_Biological_Process_2021__positive regulation of cholesterol efflux (GO:0010875),-0.3780745594357693,-0.6703238924820908,0.8769230769230769,0.9996599328529006,1.0,3/17,11.64%,PLTP;NR1H2;ABCA8
prerank,GO_Biological_Process_2021__regulation of vascular endothelial growth factor signaling pathway (GO:1900746),0.37582647715534945,0.6699309773982275,0.9038461538461539,0.9904929838006149,1.0,2/8,7.38%,SPRY2;ROBO1
prerank,GO_Biological_Process_2021__regulation of cell communication (GO:0010646),-0.3431532622167414,-0.6699135186236126,0.8571428571428571,0.9997807615575746,1.0,5/25,12.03%,MGLL;MTCH1;SRI;TYMP;GLRX2
prerank,GO_Biological_Process_2021__cell-cell junction maintenance (GO:0045217),0.444897764645676,0.6696969733584226,0.8478260869565217,0.9903533026052718,1.0,3/5,14.29%,MYADM;TJP1;FERMT2
prerank,CellMarker_Augmented_2021__Mesenchymal Progenitor cell:Osteoarthritic Cartilage,-0.45174657690957526,-0.669675151839634,0.8301886792452831,0.9997394332199849,1.0,1/5,8.71%,CD44
prerank,GO_Biological_Process_2021__regulation of amyloid-beta clearance (GO:1900221),-0.37175886627827837,-0.6696626046152051,0.8431372549019608,0.9994990319286607,1.0,1/11,4.82%,CLU
prerank,GO_Biological_Process_2021__autophagosome assembly (GO:0000045),-0.3177927898789422,-0.6693648345220161,0.9655172413793104,0.9994832560940425,1.0,6/42,15.41%,GABARAPL1;ATG2A;GABARAPL2;STING1;TP53INP1;WIPI1
prerank,"Reactome_2022__Synthesis, Secretion, And Inactivation Of Glucagon-like Peptide-1 (GLP-1) R-HSA-381771",0.3772516225114688,0.6692175811534944,0.8823529411764706,0.9900897314990991,1.0,2/10,18.39%,TCF7L2;SPCS3
prerank,"Reactome_2022__Incretin Synthesis, Secretion, And Inactivation R-HSA-400508",0.3772516225114688,0.6692175811534944,0.8823529411764706,0.9900897314990991,1.0,2/10,18.39%,TCF7L2;SPCS3
prerank,GO_Biological_Process_2021__hyaluronan catabolic process (GO:0030214),-0.38508150574245786,-0.6691897640568971,0.8771929824561403,0.9994096418370162,1.0,3/10,15.24%,CEMIP;CD44;GUSB
prerank,GO_Biological_Process_2021__negative regulation of neuron projection regeneration (GO:0070571),0.4123383823766962,0.6689933483733265,0.8913043478260869,0.9900278599876683,1.0,3/6,36.97%,EPHA4;INPP5F;PTPRS
prerank,GO_Biological_Process_2021__nucleobase biosynthetic process (GO:0046112),-0.4072154893745527,-0.6689762173329425,0.8709677419354839,0.9993985235554982,1.0,1/6,15.99%,SHMT1
prerank,Reactome_2022__RNA Polymerase III Transcription Termination R-HSA-73980,-0.35840386004998437,-0.6685398583452078,0.9193548387096774,0.9995492981608445,1.0,1/17,3.42%,SSB
prerank,Reactome_2022__Synthesis Of Ketone Bodies R-HSA-77111,-0.4266038936164961,-0.6684547211073114,0.8545454545454545,0.999385552418057,1.0,3/6,26.76%,HMGCL;BDH1;AACS
prerank,CellMarker_Augmented_2021__M1 macrophage:Undefined,-0.36650648015798715,-0.668291086802714,0.8679245283018868,0.9992796778217846,1.0,3/10,20.69%,STAT1;FCGR3A;CLEC7A
prerank,GO_Biological_Process_2021__Notch signaling pathway (GO:0007219),-0.3075952829552612,-0.6682216577704458,0.9305555555555556,0.9990837325164512,1.0,6/32,13.87%,DTX3;DTX3L;RBPJ;STAT1;TRAF7;NOTCH2
prerank,GO_Biological_Process_2021__negative regulation of JUN kinase activity (GO:0043508),-0.4012196376966852,-0.6681477927218118,0.9193548387096774,0.998887887592934,1.0,1/9,6.85%,GSTP1
prerank,GO_Biological_Process_2021__mitotic cell cycle checkpoint signaling (GO:0007093),0.3774978461919003,0.6679741661395396,0.8444444444444444,0.9905938634400034,1.0,3/11,10.22%,PRCC;PLK2;ZFYVE19
prerank,GO_Biological_Process_2021__regulation of DNA metabolic process (GO:0051052),0.28585827580954926,0.6675863101551677,0.8461538461538461,0.9905861046748659,1.0,4/34,12.48%,PDGFA;YLPM1;UBE2N;WDR18
prerank,KEGG_2021_Human__Vascular smooth muscle contraction,-0.30107402730591715,-0.6674933356285236,0.9565217391304348,0.999271880912926,1.0,5/76,8.36%,MYLK;PRKCQ;ARHGEF1;PPP1CB;CALM1
prerank,GO_Biological_Process_2021__regulation of cellular response to oxidative stress (GO:1900407),0.4307733437138932,0.667229918995286,0.8888888888888888,0.9905202569456423,1.0,2/6,21.23%,GCH1;AIFM2
prerank,Reactome_2022__Signal Amplification R-HSA-392518,0.3195242267502038,0.667159014006982,1.0,0.9902918434709557,1.0,3/20,11.13%,GNAQ;P2RY12;GNA11
prerank,GO_Biological_Process_2021__positive regulation of ERAD pathway (GO:1904294),0.36432476889467963,0.6670435349884205,0.7906976744186046,0.9900635817156147,1.0,4/11,22.80%,RNF185;BAG6;SGTA;UBQLN1
prerank,Reactome_2022__TP53 Regulates Transcription Of Cell Death Genes R-HSA-5633008,-0.34471689328825894,-0.6659791970333706,0.9206349206349206,1.0,1.0,5/32,15.60%,PRELID1;TMEM219;BCL2L14;TP53INP1;PIDD1
prerank,GO_Biological_Process_2021__telomere maintenance (GO:0000723),-0.3496928716646319,-0.6659773475408155,0.967741935483871,1.0,1.0,8/35,21.40%,HUS1;XRCC3;TERF2IP;APEX1;RPA3;WRN;TEP1;CTC1
prerank,GO_Biological_Process_2021__positive regulation of leukocyte chemotaxis (GO:0002690),-0.35022770419124744,-0.665682036349804,0.9523809523809523,1.0,1.0,4/26,11.19%,CCL5;AIF1;PTN;VEGFA
prerank,KEGG_2021_Human__RNA transport,-0.2714016984726106,-0.6656029086438237,1.0,0.9998875644604581,1.0,25/128,22.75%,RNU4-2;SNORD3A;EIF2B1;EIF1;PNN;EIF4A3;NCBP2;XPOT;NUP50;CYFIP2;EIF2S2;EIF3G;SEC13;EIF2B2;NUP88;EIF3I;SUMO3;PABPC4;EIF5B;NMD3;NUP155;EIF2S3;TARDBP;EIF3D;SUMO2
prerank,GO_Biological_Process_2021__hyaluronan metabolic process (GO:0030212),-0.36772990485817914,-0.6650589475792481,0.8771929824561403,1.0,1.0,3/12,15.24%,CEMIP;CD44;GUSB
prerank,GO_Biological_Process_2021__synaptic vesicle recycling (GO:0036465),0.3193277284420415,0.6650335731126328,0.9393939393939394,0.9914179268423633,1.0,6/21,19.35%,NLGN1;SNCB;STX1A;NLGN4Y;STON2;SNCA
prerank,GO_Biological_Process_2021__calcium ion transport into cytosol (GO:0060402),0.35107656981480734,0.6649168243490194,0.9032258064516129,0.9912049140624387,1.0,6/14,23.01%,ADRA1A;GRIN2B;SLC8A1;GRIN2A;GRIN1;RYR2
prerank,GO_Biological_Process_2021__smoothened signaling pathway (GO:0007224),0.3540593539009087,0.6648957860795128,0.8484848484848485,0.9908799136532268,1.0,4/17,10.96%,PTCH2;STK36;MAP3K10;PTCH1
prerank,GO_Biological_Process_2021__chromatin organization involved in negative regulation of transcription (GO:0097549),-0.4676786203106256,-0.6644135714699436,0.8936170212765957,1.0,1.0,1/5,3.35%,POLE3
prerank,GO_Biological_Process_2021__mature B cell differentiation involved in immune response (GO:0002313),-0.4282260135425109,-0.6641062961120662,0.8571428571428571,1.0,1.0,1/7,1.61%,GPR183
prerank,GO_Biological_Process_2021__retrograde axonal transport (GO:0008090),-0.37202203534125655,-0.6636309325116561,0.9076923076923077,1.0,1.0,2/14,13.37%,NEFL;SOD1
prerank,GO_Biological_Process_2021__microtubule anchoring at centrosome (GO:0034454),0.3723095101418543,0.6634969755992843,0.8679245283018868,0.9916721814769974,1.0,3/7,25.45%,NIN;HOOK3;PCM1
prerank,GO_Biological_Process_2021__regulation of histone modification (GO:0031056),-0.39749758937115376,-0.6633040569942876,0.8936170212765957,1.0,1.0,5/9,25.13%,AKAP8;PARG;PARK7;AKAP8L;HPF1
prerank,GO_Biological_Process_2021__peptidyl-tyrosine modification (GO:0018212),0.2707200197244639,0.66312579443405,1.0,0.9916254462347732,1.0,12/39,24.63%,FER;RELN;DYRK1A;PTK2;ERBB4;ABI1;FGFR2;FGFR1;SYK;ABL1;FGFR3;EPHA4
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",0.3247657850846372,0.6630919167083248,0.967741935483871,0.9913160802941877,1.0,6/26,17.25%,DCP1B;EXOSC6;CNOT7;LSM6;LSM1;EXOSC7
prerank,CellMarker_Augmented_2021__Lake Et al.Science.In8:Brain,-0.36466510625890847,-0.6623006819124294,0.9152542372881356,1.0,1.0,3/17,19.11%,CENPU;CENPF;CCT2
prerank,GO_Biological_Process_2021__negative regulation of intracellular estrogen receptor signaling pathway (GO:0033147),-0.4494649412492695,-0.6621726474654598,0.9411764705882353,1.0,1.0,2/7,14.26%,KANK2;BRCA1
prerank,GO_Biological_Process_2021__positive regulation of alpha-beta T cell proliferation (GO:0046641),-0.42588296961766026,-0.661310762992353,0.9032258064516129,1.0,1.0,1/11,1.64%,CD55
prerank,GO_Biological_Process_2021__V(D)J recombination (GO:0033151),0.3714076340095986,0.6607126337132361,0.8666666666666667,0.9929530608756375,1.0,1/9,7.13%,LIG4
prerank,GO_Biological_Process_2021__positive regulation of endocytosis (GO:0045807),-0.31868341233148,-0.6604125539568174,0.921875,1.0,1.0,5/36,10.76%,B2M;CLU;GPC3;VPS28;NCKAP1L
prerank,GO_Biological_Process_2021__valine metabolic process (GO:0006573),-0.4422095913470421,-0.66034746566347,0.8688524590163934,1.0,1.0,1/5,23.10%,BCAT1
prerank,Reactome_2022__Retinoid Metabolism And Transport R-HSA-975634,-0.3461913222681405,-0.6603182022004455,0.9193548387096774,1.0,1.0,3/19,11.54%,GPC3;PLB1;SDC3
prerank,GO_Biological_Process_2021__ERK1 and ERK2 cascade (GO:0070371),0.35930845842589104,0.6592258596238476,0.875,0.9936663900334686,1.0,6/14,18.09%,MAP2K1;LGALS9;ITGAV;MAPK1;CTSH;MAP2K2
prerank,GO_Biological_Process_2021__detection of virus (GO:0009597),-0.41734211415062483,-0.6590582524193402,0.8666666666666667,1.0,1.0,5/5,58.29%,TLR3;IFIH1;SERINC3;ZCCHC3;SERINC5
prerank,Reactome_2022__Asparagine N-linked Glycosylation R-HSA-446203,-0.25856041261527585,-0.6590107566612677,1.0,1.0,1.0,22/216,15.88%,UBC;RPS27A;CD55;F8;UBXN1;ST8SIA1;TRAPPC4;TRIM13;FCSK;DCTN6;PTGES2;DCTN4;CHST10;TBC1D20;CSNK1D;COPE;DYNC1LI2;TRAPPC6A;UBA52;RPN1;ANKRD28;SEC13
prerank,GO_Biological_Process_2021__cation transmembrane transport (GO:0098655),-0.3464182982235362,-0.6588518776341301,0.8615384615384616,1.0,1.0,6/23,15.19%,SLC7A5;TRPM3;SLC36A4;TRPM4;SFXN3;SLC25A19
prerank,Reactome_2022__Recruitment Of NuMA To Mitotic Centrosomes R-HSA-380320,-0.29830231833708315,-0.6586173802183952,0.9861111111111112,1.0,1.0,18/67,24.36%,SSNA1;CEP72;CEP164;TUBGCP2;CSNK1D;TUBB4B;TUBGCP5;PRKAR2B;DCTN2;AKAP9;MZT2B;DYNC1I2;NINL;SFI1;HAUS5;TUBB4A;CEP250;NME7
prerank,GO_Biological_Process_2021__regulation of ATP metabolic process (GO:1903578),-0.3057329802790452,-0.6584768459395915,0.873015873015873,1.0,1.0,9/43,19.90%,FIS1;ATP5IF1;NUP50;HIF1A;COX7A2;SEC13;PINK1;NUP88;UQCC2
prerank,GO_Biological_Process_2021__negative regulation of glucose import (GO:0046325),-0.45284973499496467,-0.658323271159496,0.9137931034482759,1.0,1.0,3/6,14.20%,PID1;SELENOS;PEA15
prerank,GO_Biological_Process_2021__regulation of keratinocyte migration (GO:0051547),-0.4013642806363999,-0.6582653106913965,0.8846153846153846,1.0,1.0,1/8,6.65%,IQSEC1
prerank,GO_Biological_Process_2021__phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092),0.39725106595998405,0.6581301091611037,0.9210526315789473,0.9941207048651215,1.0,2/7,17.35%,PIK3C2B;PIK3CA
prerank,GO_Biological_Process_2021__calcium ion import across plasma membrane (GO:0098703),-0.38248188936877653,-0.6581067985060567,0.8888888888888888,1.0,1.0,4/9,25.69%,TRPV4;TRPM2;TRPV2;ATP2B4
prerank,GO_Biological_Process_2021__calcium ion import into cytosol (GO:1902656),-0.38248188936877653,-0.6581067985060567,0.8888888888888888,1.0,1.0,4/9,25.69%,TRPV4;TRPM2;TRPV2;ATP2B4
prerank,GO_Biological_Process_2021__positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),-0.36110842347026306,-0.6580631546639703,0.8636363636363636,1.0,1.0,3/17,16.09%,TNFSF10;AGT;DEDD2
prerank,Reactome_2022__RHO GTPases Activate ROCKs R-HSA-5627117,-0.3480599548918746,-0.6578797007162367,0.921875,1.0,1.0,6/17,31.47%,PPP1CB;MYH10;MYH9;LIMK2;MYH14;MYL6
prerank,GO_Biological_Process_2021__phosphorylation of RNA polymerase II C-terminal domain (GO:0070816),-0.38183390171704695,-0.6578156818122224,0.8653846153846154,1.0,1.0,1/8,4.34%,GTF2H5
prerank,Reactome_2022__Retrograde Transport At Trans-Golgi-Network R-HSA-6811440,-0.31819519991397066,-0.6576840501606339,0.9242424242424242,1.0,1.0,5/39,14.72%,GOLGA1;NAA38;GOLGA4;IGF2R;STX10
prerank,GO_Biological_Process_2021__nucleoside metabolic process (GO:0009116),-0.40113869212690434,-0.6576748885719031,0.8387096774193549,1.0,1.0,1/8,8.20%,TYMP
prerank,GO_Biological_Process_2021__positive regulation of lipid biosynthetic process (GO:0046889),-0.3346868959985633,-0.6572278687225874,0.9076923076923077,1.0,1.0,2/22,8.91%,NR1H2;CNEP1R1
prerank,GO_Biological_Process_2021__regulation of kinase activity (GO:0043549),-0.3056569902298288,-0.6572236472589276,0.9577464788732394,1.0,1.0,20/65,25.87%,EPHB1;NLRC5;MUSK;TTN;ANKRD54;FLT1;SOD1;ZNF16;CD74;CDKN1C;HLA-DRB1;EPHB2;EMP2;CDKN1B;FGR;CD4;EEF1A1;NPRL2;RB1;EGFR
prerank,GO_Biological_Process_2021__adipose tissue development (GO:0060612),-0.41531990416672415,-0.6572074608959727,0.94,1.0,1.0,1/7,8.03%,NAMPT
prerank,GO_Biological_Process_2021__embryonic cranial skeleton morphogenesis (GO:0048701),-0.4059172890613793,-0.6572001964466186,0.7959183673469388,0.9999908145385965,1.0,2/7,8.47%,MTHFD1;EIF4A3
prerank,GO_Biological_Process_2021__protein localization to cell junction (GO:1902414),-0.38506073315002765,-0.6568939803410593,0.9215686274509803,0.9999842411711016,1.0,2/14,7.64%,CGNL1;NLGN2
prerank,Reactome_2022__Establishment Of Sister Chromatid Cohesion R-HSA-2468052,-0.4081074978939084,-0.6561866553463226,0.8852459016393442,1.0,1.0,1/9,14.70%,SMC1A
prerank,GO_Biological_Process_2021__cell cycle G2/M phase transition (GO:0044839),0.24208146357210708,0.6560062518747992,1.0,0.9954233815384897,1.0,28/99,23.93%,BORA;CDK7;TAF2;CEP41;BRSK1;YWHAG;CEP131;BTRC;FBXW11;CSNK1E;FBXL12;FBXL7;CLASP1;DYNC1H1;ALMS1;TPD52L1;BRSK2;CEP135;ODF2;NDE1;NEDD1;YWHAE;CEP152;PAFAH1B1;CEP290;KHDRBS1;HAUS2;PPP1R12B
prerank,GO_Biological_Process_2021__plus-end-directed organelle transport along microtubule (GO:0072386),-0.4263022726326432,-0.6556601170873313,0.8421052631578947,1.0,1.0,2/6,32.69%,KIFAP3;FYCO1
prerank,KEGG_2021_Human__Pantothenate and CoA biosynthesis,-0.3587758584148397,-0.6552538275653165,0.9032258064516129,1.0,1.0,3/17,10.19%,VNN2;ENPP3;DPYS
prerank,CellMarker_Augmented_2021__Lymphoid Stem cell:Peripheral Blood,-0.3006347830740322,-0.6552341207007678,0.9705882352941176,1.0,1.0,11/75,16.17%,POLE3;SNRPD2;SLC25A5;PDCD5;COA6;CKS2;PSMA5;SNRPA1;RPA3;NHP2;MRPL45
prerank,Reactome_2022__HuR (ELAVL1) Binds And Stabilizes mRNA R-HSA-450520,-0.4360681084768552,-0.6549978612856578,0.9523809523809523,1.0,1.0,1/8,8.11%,ENPP2
prerank,GO_Biological_Process_2021__carbohydrate derivative catabolic process (GO:1901136),0.3576674003917998,0.654583603256816,0.9142857142857143,0.9961930293271377,1.0,2/12,13.82%,STT3B;FBXO27
prerank,Reactome_2022__Fcgamma Receptor (FCGR) Dependent Phagocytosis R-HSA-2029480,-0.2896647663779377,-0.6545046819215167,0.972972972972973,1.0,1.0,9/76,13.75%,VAV3;YES1;BTK;CD247;FYN;ACTG1;NCKAP1L;CYFIP2;PIK3CB
prerank,GO_Biological_Process_2021__myofibril assembly (GO:0030239),-0.37083011039051017,-0.6543428141634117,0.9054054054054054,1.0,1.0,3/14,9.94%,OBSCN;TTN;CFLAR
prerank,GO_Biological_Process_2021__regulation of cellular amide metabolic process (GO:0034248),0.3140886441388409,0.6543416981309538,0.8620689655172413,0.9960600967059845,1.0,6/25,17.10%,PICALM;TMED10;GRM5;SAMD8;NOLC1;MTPN
prerank,GO_Biological_Process_2021__negative regulation of phosphate metabolic process (GO:0045936),0.34422230357447714,0.654319354443403,0.9387755102040817,0.9957653953268751,1.0,1/12,2.51%,SIRT1
prerank,GO_Biological_Process_2021__positive regulation of peptide hormone secretion (GO:0090277),0.3041383278182711,0.6540507959313234,0.8837209302325582,0.9956519542438145,1.0,3/18,11.06%,MCU;SOX4;TCF7L2
prerank,GO_Biological_Process_2021__negative regulation of cellular metabolic process (GO:0031324),0.30864306498613775,0.6536766168359139,0.9666666666666667,0.9955616952382003,1.0,1/24,1.57%,ABCA2
prerank,GO_Biological_Process_2021__amyloid-beta formation (GO:0034205),0.3769108203124316,0.6534750042376368,0.7906976744186046,0.9954175971140673,1.0,1/7,10.28%,DYRK1A
prerank,CellMarker_Augmented_2021__4-Cell Stage Cell (Blastomere):Embryo,0.31490705615660963,0.6534538185981388,0.9117647058823529,0.9950927081060037,1.0,8/25,21.00%,SLC35D1;FNIP2;RNF38;NSD2;GIT2;ARIH1;GEMIN5;CSDE1
prerank,GO_Biological_Process_2021__negative regulation of receptor internalization (GO:0002091),-0.38895280214928785,-0.6532467231881876,0.9508196721311475,1.0,1.0,3/9,23.34%,ANKRD13D;LRPAP1;SDCBP
prerank,GO_Biological_Process_2021__embryonic skeletal system morphogenesis (GO:0048704),0.38703424195645275,0.6532423225278419,0.8936170212765957,0.994941165221879,1.0,4/7,19.59%,TGFBR2;MEGF8;TGFBR1;FGFR2
prerank,Reactome_2022__Elevation Of Cytosolic Ca2+ Levels R-HSA-139853,0.38050153103933787,0.6532245115910346,0.8536585365853658,0.9946358783964548,1.0,5/8,31.42%,P2RX7;ORAI1;ITPR2;P2RX4;P2RX1
prerank,GO_Biological_Process_2021__protein retention in Golgi apparatus (GO:0045053),0.41506187526381766,0.6531555851600924,0.875,0.994357706826238,1.0,1/5,11.83%,SORL1
prerank,GO_Biological_Process_2021__oligodendrocyte development (GO:0014003),0.3664601276796328,0.652807003607761,0.9534883720930233,0.9943141760428609,1.0,2/12,5.32%,MYRF;TPPP
prerank,GO_Biological_Process_2021__response to angiotensin (GO:1990776),0.40821099296126295,0.652530475166547,0.9166666666666666,0.9941823011795368,1.0,3/6,37.07%,SLC30A10;ROCK2;ROCK1
prerank,"GO_Biological_Process_2021__DNA-templated transcription, termination (GO:0006353)",-0.30464741101479575,-0.6523654338770966,0.9852941176470589,1.0,1.0,3/51,4.34%,CSTF2T;TAF1D;GTF2H5
prerank,GO_Biological_Process_2021__neuron remodeling (GO:0016322),0.37245333389334134,0.6523643755813134,0.8648648648648649,0.9939736926760587,1.0,3/8,17.58%,ANKS1A;ADGRB3;CX3CL1
prerank,GO_Biological_Process_2021__negative regulation of myosin-light-chain-phosphatase activity (GO:0035509),0.40498648785980423,0.6521900845826877,0.9069767441860465,0.9938189783230831,1.0,1/5,7.30%,TNF
prerank,Reactome_2022__NOTCH2 Intracellular Domain Regulates Transcription R-HSA-2197563,-0.39205684744885566,-0.6521838710710384,0.8596491228070176,1.0,1.0,3/9,13.87%,GZMB;RBPJ;NOTCH2
prerank,GO_Biological_Process_2021__peroxisomal membrane transport (GO:0015919),-0.336847854995703,-0.6519833391033891,0.9375,1.0,1.0,2/20,6.99%,FIS1;ACBD5
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),-0.33031580275364825,-0.6518383921721486,0.935064935064935,1.0,1.0,4/30,15.14%,DDIT4;HINT1;DDX5;RPS27L
prerank,GO_Biological_Process_2021__negative regulation of vascular permeability (GO:0043116),-0.38851785307974507,-0.6514721436732772,0.8909090909090909,1.0,1.0,1/9,11.19%,VEGFA
prerank,Reactome_2022__ER To Golgi Anterograde Transport R-HSA-199977,-0.27916259079530664,-0.651408941590895,0.9848484848484849,1.0,1.0,18/108,19.77%,CD55;F8;TRAPPC4;DCTN6;PTGES2;DCTN4;TBC1D20;CSNK1D;COPE;DYNC1LI2;TRAPPC6A;ANKRD28;SEC13;GOLGB1;DCTN2;FOLR2;ANK1;DYNC1I2
prerank,GO_Biological_Process_2021__regulation of vacuole organization (GO:0044088),0.30511148843071406,0.6513999425145252,0.8717948717948718,0.9940674082065897,1.0,3/20,8.16%,RAB1B;SCARB2;TBC1D12
prerank,GO_Biological_Process_2021__mitotic sister chromatid cohesion (GO:0007064),0.39842772233343837,0.6512664744097908,0.8648648648648649,0.9938398574294848,1.0,2/10,13.48%,BOD1;NIPBL
prerank,GO_Biological_Process_2021__heterochromatin assembly (GO:0031507),-0.35393073893715626,-0.651078502249227,0.9454545454545454,1.0,1.0,2/17,6.97%,POLE3;CENPV
prerank,Reactome_2022__Signaling By FLT3 Fusion Proteins R-HSA-9703465,0.3294500594284888,0.6504710664552603,0.90625,0.9941610003460336,1.0,6/16,30.20%,GAB2;PIK3CA;SPTBN1;PIK3R1;STAT5A;SOS1
prerank,PanglaoDB_Augmented_2021__Goblet Cells,0.36575339527621803,0.6503783760987015,0.8867924528301887,0.9939220643985839,1.0,5/12,15.88%,FCGBP;BACE2;SLC26A3;MANF;OTOGL
prerank,Reactome_2022__cGMP Effects R-HSA-418457,0.322748773293991,0.6500787654402814,0.9210526315789473,0.9939056256065154,1.0,3/12,13.35%,PDE10A;KCNMB4;KCNMB3
prerank,GO_Biological_Process_2021__brain morphogenesis (GO:0048854),-0.38718081176633207,-0.6498828067884248,0.9104477611940298,1.0,1.0,1/10,3.44%,BBS2
prerank,GO_Biological_Process_2021__negative regulation of lipid localization (GO:1905953),-0.432133386631679,-0.6498285853408788,0.8771929824561403,1.0,1.0,1/6,5.38%,NR1H2
prerank,GO_Biological_Process_2021__positive regulation of TOR signaling (GO:0032008),0.31268569248568623,0.6496536607734952,0.9166666666666666,0.9938815332518651,1.0,2/33,5.75%,RRAGD;GPR137C
prerank,"GO_Biological_Process_2021__synaptic transmission, GABAergic (GO:0051932)",-0.3811409825306875,-0.6494349517634376,0.9,1.0,1.0,1/7,9.88%,GABRA3
prerank,Reactome_2022__Calcineurin Activates NFAT R-HSA-2025928,0.3944847997302504,0.6493497139622304,0.8222222222222222,0.9938153165372658,1.0,4/7,18.52%,PPP3CA;NFATC3;PPP3CB;NFATC2
prerank,GO_Biological_Process_2021__negative regulation of lipid kinase activity (GO:0090219),0.3962977604857172,0.6492640039038665,0.8863636363636364,0.9935500005907083,1.0,3/8,25.67%,PIP4K2A;DAB2IP;PIP4K2B
prerank,GO_Biological_Process_2021__regulation of ion transport (GO:0043269),-0.3219595195089381,-0.6491184476975411,0.9558823529411765,1.0,1.0,2/39,2.81%,SNX6;B2M
prerank,GO_Biological_Process_2021__protein import into peroxisome membrane (GO:0045046),-0.35525262544905056,-0.6489719013902192,0.9166666666666666,1.0,1.0,2/15,6.99%,FIS1;ACBD5
prerank,CellMarker_Augmented_2021__Pit Progenitor cell:Stomach,0.30082233885850324,0.6488222148374084,0.9473684210526315,0.9935605045003021,1.0,6/29,15.78%,FBXO32;BCL11A;NFIX;LDB3;MVB12B;TIMM17A
prerank,GO_Biological_Process_2021__regulation of membrane protein ectodomain proteolysis (GO:0051043),0.3667686510350092,0.6485457114443794,0.8775510204081632,0.9934370511579295,1.0,2/11,7.30%,TIMP3;TNF
prerank,GO_Biological_Process_2021__double-strand break repair via nonhomologous end joining (GO:0006303),-0.28699872627351464,-0.6483901517524491,0.9538461538461539,1.0,1.0,6/52,14.44%,POLM;CYREN;ABRAXAS1;KAT5;BRCA1;ERCC8
prerank,GO_Biological_Process_2021__regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645),-0.4268003601818179,-0.6483073337546672,0.8837209302325582,1.0,1.0,4/6,34.84%,IL18;CARD9;IL1B;RASGRP1
prerank,GO_Biological_Process_2021__regulation of cellular component movement (GO:0051270),-0.31517472773084343,-0.6482926865190993,0.9545454545454546,1.0,1.0,2/43,4.35%,TGFBR3;ETS1
prerank,GO_Biological_Process_2021__peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),0.3271430860186491,0.6482773396844679,0.9473684210526315,0.9930144540918133,1.0,3/17,11.74%,ZDHHC3;GOLGA7;ZDHHC11B
prerank,GO_Biological_Process_2021__peptidyl-L-cysteine S-palmitoylation (GO:0018230),0.3271430860186491,0.6482773396844679,0.9473684210526315,0.9930144540918133,1.0,3/17,11.74%,ZDHHC3;GOLGA7;ZDHHC11B
prerank,Reactome_2022__Platelet Sensitization By LDL R-HSA-432142,-0.34055702789208486,-0.648236770475775,0.9272727272727272,1.0,1.0,1/15,5.65%,PECAM1
prerank,KEGG_2021_Human__Fc epsilon RI signaling pathway,-0.29467226372050237,-0.6481116815838068,0.9705882352941176,1.0,1.0,4/49,7.36%,VAV3;FCER1G;BTK;FYN
prerank,GO_Biological_Process_2021__negative regulation of microtubule depolymerization (GO:0007026),0.3463574344299529,0.6480842959328679,0.8837209302325582,0.9928071869158079,1.0,5/16,19.20%,CIB1;CLASP1;CLASP2;CAMSAP2;ATXN7
prerank,GO_Biological_Process_2021__regulation of protein localization (GO:0032880),-0.2970253717118157,-0.6478095655242704,0.9861111111111112,1.0,1.0,7/44,14.72%,TRIM5;RACK1;TRIM22;DVL1;DZIP1L;CAMK1;STX10
prerank,Reactome_2022__Erythropoietin Activates STAT5 R-HSA-9027283,-0.40552063856272796,-0.6475843784454889,0.8928571428571429,1.0,1.0,1/6,22.16%,LYN
prerank,KEGG_2021_Human__Thyroid hormone synthesis,0.27570594037871043,0.6474428126151991,0.9444444444444444,0.9929593361123614,1.0,3/43,6.41%,GNAQ;PLCB4;ADCY9
prerank,GO_Biological_Process_2021__protein insertion into ER membrane by stop-transfer membrane-anchor sequence (GO:0045050),-0.38035596656761417,-0.6473522073770708,0.8703703703703703,1.0,1.0,2/8,14.65%,EMC2;EMC1
prerank,Reactome_2022__Processing Of Capped Intronless Pre-mRNA R-HSA-75067,0.30626431025007544,0.6473300996780549,0.9166666666666666,0.9927445811628924,1.0,5/22,12.20%,CPSF4;WDR33;PCF11;CPSF7;SNRPB
prerank,GO_Biological_Process_2021__ventricular septum morphogenesis (GO:0060412),-0.3399001262554764,-0.6472468599129302,0.890625,1.0,1.0,1/19,1.03%,TGFBR3
prerank,GO_Biological_Process_2021__macropinocytosis (GO:0044351),0.40168801326841286,0.6472418000209773,0.82,0.9925070492307009,1.0,1/5,12.49%,MAPKAPK2
prerank,GO_Biological_Process_2021__regulation of phosphorylation (GO:0042325),-0.28310623297429177,-0.6472028085424975,0.9863013698630136,1.0,1.0,10/90,13.28%,CCDC88C;CCL5;NLRC5;ITGA6;GLMN;NCKAP1L;NUP50;HIF1A;NOP53;MCM7
prerank,CellMarker_Augmented_2021__Hematopoietic Progenitor cell:Undefined,-0.3190505178190374,-0.6466920844632204,0.953125,1.0,1.0,5/33,13.78%,CGNL1;GATM;SPARCL1;FLT1;SERPING1
prerank,GO_Biological_Process_2021__nuclear membrane reassembly (GO:0031468),0.27968645206626686,0.6466201977427691,1.0,0.9927278779628552,1.0,8/46,17.93%,NUP188;RCC1;REEP3;CHMP7;UBXN2A;NDC1;NUP133;NUP205
prerank,Reactome_2022__Extension Of Telomeres R-HSA-180786,-0.31929852126264463,-0.6463341153459614,0.9655172413793104,1.0,1.0,10/32,21.40%,CHTF18;TERF2IP;RPA3;NHP2;NOP10;ANKRD28;LRIG1;WRN;PRIM1;CTC1
prerank,GO_Biological_Process_2021__urate metabolic process (GO:0046415),-0.41444329943148694,-0.6460706446170891,0.9152542372881356,1.0,1.0,2/5,24.98%,CARMIL1;ABCG2
prerank,GO_Biological_Process_2021__organophosphate biosynthetic process (GO:0090407),-0.3390825175036857,-0.6460350536973193,0.9552238805970149,0.9999511405612691,1.0,6/28,17.37%,LPCAT1;GNPAT;NFS1;GK;IPMK;MOCOS
prerank,GO_Biological_Process_2021__triglyceride metabolic process (GO:0006641),0.31683114000029056,0.6454807931092379,0.9117647058823529,0.993276834727284,1.0,4/21,12.41%,SIRT1;SEL1L;GPAT4;GPAT3
prerank,GO_Biological_Process_2021__regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),-0.37579310315283054,-0.6454759674243732,0.9032258064516129,1.0,1.0,1/12,8.36%,CALM1
prerank,GO_Biological_Process_2021__lipoxin metabolic process (GO:2001300),0.40148919037883757,0.6453946210885935,0.8478260869565217,0.9926761617909878,1.0,1/5,10.35%,ALOX5AP
prerank,Reactome_2022__Synthesis Of Lipoxins (LX) R-HSA-2142700,0.40148919037883757,0.6453946210885935,0.8478260869565217,0.9926761617909878,1.0,1/5,10.35%,ALOX5AP
prerank,GO_Biological_Process_2021__tRNA processing (GO:0008033),-0.3070545982110272,-0.6453402152331618,0.9672131147540983,1.0,1.0,5/46,11.32%,SSB;C2ORF49;RTCB;TRMT10B;KARS1
prerank,CellMarker_Augmented_2021__Epiblast cell:Embryo,-0.3103274874850811,-0.6451773517523083,0.9253731343283582,0.9999021438215036,1.0,5/45,11.31%,SAT1;VENTX;CFLAR;GK;FBP1
prerank,GO_Biological_Process_2021__cellular response to fibroblast growth factor stimulus (GO:0044344),-0.30424349733614253,-0.6449090010598515,0.96875,0.9998344223219211,1.0,5/52,9.87%,ZFP36;CCL5;POLR2G;CD44;NCBP2
prerank,Reactome_2022__MHC Class II Antigen Presentation R-HSA-2132295,0.2504002485467444,0.6446808716463628,1.0,0.9929424066687189,1.0,16/78,20.11%,CTSF;CTSC;SEC24B;CTSK;RAB7A;DNM3;CENPE;KIF15;AP1M1;DYNC1H1;CTSH;SEC31A;ACTR1B;DYNLL2;CAPZA2;HLA-DQA1
prerank,GO_Biological_Process_2021__positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103),0.37871460699165516,0.6446281079989966,0.8913043478260869,0.9926366578943714,1.0,3/10,23.61%,BOK;DAB2IP;PIK3R1
prerank,GO_Biological_Process_2021__protein insertion into mitochondrial membrane (GO:0051204),-0.3584513335810888,-0.6443232125756935,0.9032258064516129,1.0,1.0,6/15,26.68%,COX18;BMF;MAIP1;TIMM29;TIMM9;HSP90AA1
prerank,GO_Biological_Process_2021__regulation of 3'-UTR-mediated mRNA stabilization (GO:1905868),-0.4513055464650834,-0.6438414637527348,0.8846153846153846,1.0,1.0,1/5,21.44%,TENT4B
prerank,GO_Biological_Process_2021__morphogenesis of an epithelium (GO:0002009),0.3286301388342624,0.6436279861543165,0.9024390243902439,0.9930361224707812,1.0,2/13,7.32%,DAG1;VCL
prerank,Reactome_2022__mRNA Capping R-HSA-72086,-0.3255548820293985,-0.6433261284302837,0.9322033898305084,1.0,1.0,4/25,9.87%,GTF2H5;POLR2G;RNMT;NCBP2
prerank,KEGG_2021_Human__Vitamin digestion and absorption,0.3685848016536223,0.6433048775667797,0.95,0.9929781693901553,1.0,2/10,11.70%,FOLH1;SLC19A2
prerank,GO_Biological_Process_2021__rRNA-containing ribonucleoprotein complex export from nucleus (GO:0071428),0.387511543848764,0.6432606044311511,0.8627450980392157,0.9926689002899595,1.0,1/6,7.26%,XPO1
prerank,GO_Biological_Process_2021__autophagy of peroxisome (GO:0030242),0.35029002174928325,0.6431693255890334,0.9777777777777777,0.9924321690765507,1.0,3/12,18.97%,USP30;PEX5;TRAPPC8
prerank,Reactome_2022__PKA Activation R-HSA-163615,0.3424878837522328,0.6429759489192638,0.8095238095238095,0.9922146220126897,1.0,2/14,6.41%,NBEA;ADCY9
prerank,Reactome_2022__Activation Of Matrix Metalloproteinases R-HSA-1592389,-0.4026796975666623,-0.6428770491983689,0.9591836734693877,1.0,1.0,2/10,4.61%,COL18A1;MMP24
prerank,GO_Biological_Process_2021__regulation of lipid kinase activity (GO:0043550),0.38348590069036526,0.6428371890592743,0.8913043478260869,0.9919934123348656,1.0,2/8,23.61%,EEF1A2;PIK3R1
prerank,GO_Biological_Process_2021__regulation of protein localization to membrane (GO:1905475),-0.34899010866693586,-0.6427161329244733,0.90625,1.0,1.0,4/20,11.83%,FYN;GPC3;ACTB;APPL1
prerank,"GO_Biological_Process_2021__maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)",0.3516813069565406,0.6424456283736819,0.9523809523809523,0.9919929454441888,1.0,1/13,2.02%,NOL9
prerank,GO_Biological_Process_2021__positive regulation of mitotic nuclear division (GO:0045840),0.3198843439955392,0.6418741399548623,0.8888888888888888,0.9921065442483605,1.0,3/18,13.79%,TGFA;CDC23;NSMCE2
prerank,GO_Biological_Process_2021__negative regulation of cell junction assembly (GO:1901889),-0.34041294449850235,-0.6414598480700641,0.9821428571428571,1.0,1.0,1/22,4.08%,APOD
prerank,Reactome_2022__Beta Oxidation Of octanoyl-CoA To hexanoyl-CoA R-HSA-77348,-0.41894630192502536,-0.641260225955705,0.8913043478260869,1.0,1.0,5/5,58.13%,HADHB;ECHS1;HADHA;HADH;ACADM
prerank,Reactome_2022__Loss Of Nlp From Mitotic Centrosomes R-HSA-380259,-0.29204550186540346,-0.6412202395142763,0.9733333333333334,1.0,1.0,14/56,24.23%,SSNA1;CEP72;CEP164;CSNK1D;TUBB4B;PRKAR2B;DCTN2;AKAP9;DYNC1I2;NINL;SFI1;HAUS5;TUBB4A;CEP250
prerank,Reactome_2022__AURKA Activation By TPX2 R-HSA-8854518,-0.29204550186540346,-0.6412202395142763,0.9733333333333334,1.0,1.0,14/56,24.23%,SSNA1;CEP72;CEP164;CSNK1D;TUBB4B;PRKAR2B;DCTN2;AKAP9;DYNC1I2;NINL;SFI1;HAUS5;TUBB4A;CEP250
prerank,GO_Biological_Process_2021__anterograde axonal transport (GO:0008089),0.29262086790942526,0.6408701747368779,0.9743589743589743,0.9925887600877786,1.0,2/27,9.74%,AP3B2;AP3S1
prerank,GO_Biological_Process_2021__7-methylguanosine RNA capping (GO:0009452),-0.3185229664172461,-0.6407021129691641,0.9310344827586207,1.0,1.0,4/27,9.87%,GTF2H5;POLR2G;RNMT;NCBP2
prerank,GO_Biological_Process_2021__7-methylguanosine mRNA capping (GO:0006370),-0.3185229664172461,-0.6407021129691641,0.9310344827586207,1.0,1.0,4/27,9.87%,GTF2H5;POLR2G;RNMT;NCBP2
prerank,Reactome_2022__Resolution Of D-Loop Structures R-HSA-5693537,-0.32743431826016156,-0.6406540857165854,0.9393939393939394,0.9997573518848717,1.0,5/23,14.26%,MUS81;BRCA2;XRCC3;KAT5;BRCA1
prerank,Reactome_2022__Resolution Of D-loop Structures Thru Holliday Junction Intermediates R-HSA-5693568,-0.32743431826016156,-0.6406540857165854,0.9393939393939394,0.9997573518848717,1.0,5/23,14.26%,MUS81;BRCA2;XRCC3;KAT5;BRCA1
prerank,GO_Biological_Process_2021__attachment of mitotic spindle microtubules to kinetochore (GO:0051315),0.38922159125910594,0.6405508364087464,0.88,0.9924665091314331,1.0,2/8,11.55%,BOD1;CENPE
prerank,GO_Biological_Process_2021__negative regulation of DNA-dependent DNA replication (GO:2000104),-0.3847688675198211,-0.6400934909640374,0.9056603773584906,0.9999249382022154,1.0,5/12,26.23%,TIPIN;ZRANB3;DONSON;LIG3;MSH3
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Placenta,0.40871397324766723,0.6397265215103749,0.8918918918918919,0.9926748040429523,1.0,1/5,3.17%,ACTA2
prerank,CellMarker_Augmented_2021__Vascular Stem cell:Blood,-0.3148332217718077,-0.63952175290729,0.9523809523809523,0.9998555320016974,1.0,12/32,29.41%,CENPU;UHRF1;FANCI;CENPF;MSH6;MCM6;TYMS;CDC7;POLQ;MCM3;NUF2;WDHD1
prerank,CellMarker_Augmented_2021__Vascular Progenitor cell:Blood,-0.3148332217718077,-0.63952175290729,0.9523809523809523,0.9998555320016974,1.0,12/32,29.41%,CENPU;UHRF1;FANCI;CENPF;MSH6;MCM6;TYMS;CDC7;POLQ;MCM3;NUF2;WDHD1
prerank,GO_Biological_Process_2021__regulation of exosomal secretion (GO:1903541),-0.3486327272351881,-0.6395205170858909,0.9464285714285714,0.9996051926096088,1.0,4/15,23.79%,SNF8;CHMP6;SDCBP;SMPD3
prerank,GO_Biological_Process_2021__negative regulation of histone modification (GO:0031057),-0.37346719681115215,-0.6394786311267797,0.9242424242424242,0.9993775553370875,1.0,4/10,31.16%,BRCA1;CTBP1;SPHK2;NOC2L
prerank,GO_Biological_Process_2021__negative regulation of sodium ion transmembrane transporter activity (GO:2000650),-0.40668329239978135,-0.6391863531283902,0.8846153846153846,0.9993260869153822,1.0,2/8,15.13%,STK39;HECW1
prerank,GO_Biological_Process_2021__positive regulation of mRNA metabolic process (GO:1903313),-0.3516289409115213,-0.6389912935075174,0.84375,0.9992046912085367,1.0,4/12,23.44%,PRR5L;CNOT8;PNPT1;GTPBP1
prerank,GO_Biological_Process_2021__telomere maintenance via telomere trimming (GO:0090737),-0.36308578241259765,-0.6387798788703005,0.8867924528301887,0.9985815596945716,1.0,3/9,25.12%,XRCC3;WRN;SLX4
prerank,GO_Biological_Process_2021__t-circle formation (GO:0090656),-0.36308578241259765,-0.6387798788703005,0.8867924528301887,0.9985815596945716,1.0,3/9,25.12%,XRCC3;WRN;SLX4
prerank,GO_Biological_Process_2021__formation of extrachromosomal circular DNA (GO:0001325),-0.36308578241259765,-0.6387798788703005,0.8867924528301887,0.9985815596945716,1.0,3/9,25.12%,XRCC3;WRN;SLX4
prerank,Reactome_2022__Translation Of Replicase And Assembly Of Replication Transcription Complex R-HSA-9679504,0.34648171681569206,0.6384169893004049,0.8974358974358975,0.993331035654537,1.0,1/11,11.18%,CHMP7
prerank,GO_Biological_Process_2021__negative regulation of TOR signaling (GO:0032007),0.29851555176987565,0.6383687137415489,0.9574468085106383,0.9930264549925937,1.0,3/24,9.33%,SIRT1;TSC2;DEPTOR
prerank,GO_Biological_Process_2021__positive regulation of circadian rhythm (GO:0042753),-0.40754919136857487,-0.638356687073933,0.8153846153846154,0.9986656121604125,1.0,1/5,3.27%,RORA
prerank,KEGG_2021_Human__Carbohydrate digestion and absorption,-0.3243627912414998,-0.6380718477014227,0.9696969696969697,0.9986076376085324,1.0,5/25,16.02%,G6PC3;HK2;ATP1B3;PIK3CB;ATP1A1
prerank,GO_Biological_Process_2021__rRNA methylation (GO:0031167),-0.34092471180399375,-0.6377343635345809,0.9130434782608695,0.9985722236956709,1.0,6/15,24.74%,BUD23;ZCCHC4;EMG1;NSUN5;FBL;METTL5
prerank,GO_Biological_Process_2021__ncRNA metabolic process (GO:0034660),-0.32293088869855713,-0.6375010581588849,0.9117647058823529,0.9984624915196973,1.0,3/23,10.44%,MOV10L1;ZCCHC8;TDRKH
prerank,GO_Biological_Process_2021__anion transport (GO:0006820),0.3500136478817152,0.6365563211793288,0.9722222222222222,0.9938642927778399,1.0,6/17,24.86%,SLCO2B1;SLC26A3;SLC17A5;SLC13A3;SLC4A2;LRRC8D
prerank,GO_Biological_Process_2021__protein localization to mitochondrion (GO:0070585),0.35621562906198057,0.6364964678586392,0.9487179487179487,0.9935749108877036,1.0,2/11,3.81%,MARCHF5;LRRK2
prerank,GO_Biological_Process_2021__axonal transport (GO:0098930),0.2838443202197654,0.636093343349328,1.0,0.9934639545610461,1.0,3/26,10.79%,AP3B2;AP3S1;FBXW11
prerank,GO_Biological_Process_2021__postsynaptic density protein 95 clustering (GO:0097119),0.40694896426193417,0.6358411897906101,0.9649122807017544,0.9933379062336932,1.0,2/5,11.28%,NLGN1;NRXN2
prerank,Reactome_2022__Erythropoietin Activates Phospholipase C Gamma (PLCG) R-HSA-9027277,-0.3772475810391474,-0.6354611971030342,0.9298245614035088,0.9997558364128855,1.0,1/6,22.16%,LYN
prerank,GO_Biological_Process_2021__regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),-0.31931150574067696,-0.6354426097245972,0.9607843137254902,0.9995242836407179,1.0,6/28,22.45%,DDRGK1;DDX5;PRMT2;UFSP2;UFL1;PARK7
prerank,Reactome_2022__Purine Ribonucleoside Monophosphate Biosynthesis R-HSA-73817,-0.3876341048895887,-0.6353790847722323,0.8235294117647058,0.9993108537876053,1.0,2/8,25.74%,GART;IMPDH2
prerank,GO_Biological_Process_2021__pyrimidine nucleoside biosynthetic process (GO:0046134),-0.3802481501815528,-0.6351284194595146,0.8939393939393939,0.999180793627254,1.0,2/11,11.81%,TYMP;DHODH
prerank,CellMarker_Augmented_2021__Erythroid cell:Umbilical Cord Blood,0.2443185839106628,0.6348019687747593,1.0,0.993738724154675,1.0,9/73,13.23%,DPY19L1P1;NUP153;SASS6;FRRS1;RCL1;SMC4;CENPE;DCUN1D1;ZNF451
prerank,GO_Biological_Process_2021__embryo development ending in birth or egg hatching (GO:0009792),0.36072159448497537,0.6346018618316182,0.9523809523809523,0.9935179538863663,1.0,4/9,25.34%,UBR3;FGFR1;USP22;CELF1
prerank,GO_Biological_Process_2021__lamellipodium organization (GO:0097581),0.2791260208932024,0.6343663371552521,1.0,0.9933389879821171,1.0,7/23,22.19%,VCL;P2RY12;ARHGEF6;PTPRO;SNX1;CTTN;ABLIM1
prerank,GO_Biological_Process_2021__cortical actin cytoskeleton organization (GO:0030866),-0.35260516373299633,-0.6341499689345564,0.9558823529411765,0.9996514936648561,1.0,3/18,10.76%,PLEK;LLGL2;NCKAP1L
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell migration (GO:0010634),-0.3056377582697721,-0.6339089182357703,1.0,0.9995843919806459,1.0,12/63,16.58%,GLIPR2;ETS1;RAB11A;IQSEC1;ENPP2;PRKD2;VEGFA;HIF1A;PFN1;PIK3CB;AGT;RAC1
prerank,GO_Biological_Process_2021__regulation of chromatin organization (GO:1902275),0.3426241256545608,0.6337428758802653,0.8723404255319149,0.9934630280517536,1.0,4/12,20.63%,TLK1;SETD5;HNRNPU;CDK9
prerank,GO_Biological_Process_2021__positive regulation of autophagy (GO:0010508),-0.28053469178458257,-0.6337181197778277,0.9848484848484849,0.9995015830416735,1.0,10/65,17.95%,TRIM5;TRIM22;PHB2;TRIM13;STING1;KAT5;PIK3CB;TP53INP1;PINK1;TPCN1
prerank,GO_Biological_Process_2021__SCF complex assembly (GO:0010265),-0.41062781879921717,-0.6334258280143529,0.9090909090909091,0.9994885068827174,1.0,1/6,11.16%,RBX1
prerank,GO_Biological_Process_2021__vasodilation (GO:0042311),-0.41543172144115903,-0.6330373227736116,0.8421052631578947,0.9995069029781246,1.0,3/5,24.74%,SOD1;KLF2;KCNMA1
prerank,GO_Biological_Process_2021__amyloid precursor protein metabolic process (GO:0042982),0.3398610090375417,0.632579809286592,0.9047619047619048,0.993867069515183,1.0,2/11,22.55%,TMCC2;ADAM10
prerank,GO_Biological_Process_2021__regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),-0.3383192533523774,-0.6324785938206033,0.9054054054054054,0.9996758384216508,1.0,3/16,14.43%,EYA2;HSPA1B;HSPA1A
prerank,Reactome_2022__RUNX2 Regulates Bone Development R-HSA-8941326,0.32881086565089274,0.632289112400759,0.9782608695652174,0.9937524868427338,1.0,3/18,11.38%,SMAD1;SATB2;MAPK1
prerank,GO_Biological_Process_2021__regulation of actin polymerization or depolymerization (GO:0008064),-0.34430543650290024,-0.6322806385494987,0.890625,0.9995706248750639,1.0,5/18,23.88%,PFN1;FCHSD1;WAS;BRK1;WDR1
prerank,GO_Biological_Process_2021__acylglycerol biosynthetic process (GO:0046463),0.3486310541273332,0.6321921084344448,0.8666666666666667,0.9934980284739298,1.0,2/12,12.41%,GPAT4;GPAT3
prerank,Reactome_2022__WNT5A-dependent Internalization Of FZD4 R-HSA-5099900,0.35630236883065014,0.632009730626244,0.9090909090909091,0.993292890924661,1.0,1/13,4.48%,WNT5A
prerank,Reactome_2022__Insulin Receptor Recycling R-HSA-77387,-0.3552291124071877,-0.6317985074429093,0.9180327868852459,0.9996563629924782,1.0,1/18,4.87%,ATP6V1F
prerank,CellMarker_Augmented_2021__Endothelial cell:White Adipose Tissue,-0.32466218102829303,-0.6317695687710516,0.9594594594594594,0.9994277143733609,1.0,4/27,11.48%,CD93;PTPRB;SPARCL1;ABLIM3
prerank,GO_Biological_Process_2021__positive regulation of protein localization to membrane (GO:1905477),-0.26599815614349787,-0.6314753802605341,1.0,0.9993832495437182,1.0,6/71,10.55%,GZMB;CEMIP;FIS1;FYN;PDCD5;ITGB2
prerank,Reactome_2022__TNFR1-induced NFkappaB Signaling Pathway R-HSA-5357956,-0.3296146621474621,-0.6313265224836252,0.9230769230769231,0.9992221085825622,1.0,2/23,8.14%,RACK1;TNFAIP3
prerank,"GO_Biological_Process_2021__negative regulation of CD8-positive, alpha-beta T cell activation (GO:2001186)",0.45633380476294966,0.631190697274167,0.9375,0.9934999043553285,1.0,2/5,23.17%,CD274;ZBTB7B
prerank,GO_Biological_Process_2021__protein kinase C-activating G protein-coupled receptor signaling pathway (GO:0007205),0.3612057416698524,0.6306639265581905,0.9090909090909091,0.9935140670264492,1.0,3/8,17.62%,PLPP1;PARD3;PRKD3
prerank,GO_Biological_Process_2021__leukocyte aggregation (GO:0070486),-0.417696919084772,-0.6306094060234131,0.9285714285714286,0.9995209937915804,1.0,1/5,8.71%,CD44
prerank,Reactome_2022__ALK Mutants Bind TKIs R-HSA-9700645,0.35581247982831316,0.6303943208240249,0.9545454545454546,0.9933884518981679,1.0,1/11,7.37%,BCL11A
prerank,Reactome_2022__Insulin Processing R-HSA-264876,-0.3233717225522638,-0.6298029632581683,0.9841269841269841,0.9997771117985834,1.0,5/23,19.58%,ERO1A;MYRIP;PCSK2;ERO1B;SLC30A5
prerank,Reactome_2022__Activated NTRK2 Signals Thru FYN R-HSA-9032500,-0.4256661743900291,-0.6296267168677484,0.9137931034482759,0.9996361758152064,1.0,1/6,7.36%,FYN
prerank,GO_Biological_Process_2021__medium-chain fatty acid metabolic process (GO:0051791),-0.4189816769399646,-0.6293865808934438,0.9090909090909091,0.9996051662269354,1.0,6/6,58.13%,CROT;ACOT7;ABHD2;ABHD3;ACAD9;ACADM
prerank,GO_Biological_Process_2021__mitotic G2/M transition checkpoint (GO:0044818),-0.3157644490071092,-0.6285744575773446,0.9393939393939394,0.9999327974541126,1.0,9/31,22.42%,HUS1;ABRAXAS1;NABP1;NOP53;BRCA1;CHFR;NAE1;DONSON;RINT1
prerank,GO_Biological_Process_2021__sterol catabolic process (GO:0016127),0.38418691691405743,0.6284520279768244,0.8297872340425532,0.9937932837432314,1.0,1/6,9.07%,CYP46A1
prerank,GO_Biological_Process_2021__cholesterol catabolic process (GO:0006707),0.38418691691405743,0.6284520279768244,0.8297872340425532,0.9937932837432314,1.0,1/6,9.07%,CYP46A1
prerank,GO_Biological_Process_2021__alcohol catabolic process (GO:0046164),0.38418691691405743,0.6284520279768244,0.8297872340425532,0.9937932837432314,1.0,1/6,9.07%,CYP46A1
prerank,GO_Biological_Process_2021__negative regulation of necroptotic process (GO:0060546),0.34306224310087413,0.628217381599957,0.9024390243902439,0.9933084513878317,1.0,3/7,23.66%,PELI1;SLC25A4;RIPK1
prerank,GO_Biological_Process_2021__negative regulation of programmed necrotic cell death (GO:0062099),0.34306224310087413,0.628217381599957,0.9024390243902439,0.9933084513878317,1.0,3/7,23.66%,PELI1;SLC25A4;RIPK1
prerank,GO_Biological_Process_2021__regulation of striated muscle tissue development (GO:0016202),0.3986503871368541,0.6281551376117115,0.9347826086956522,0.9930361089089194,1.0,4/6,28.58%,MTPN;MEGF10;TGFB1;SIRT2
prerank,GO_Biological_Process_2021__regulation of blood vessel endothelial cell migration (GO:0043535),-0.3153635760066137,-0.6280052864399122,0.9841269841269841,1.0,1.0,6/41,11.34%,ETS1;JUP;PRKD2;TMSB4X;VEGFA;HIF1A
prerank,GO_Biological_Process_2021__endocrine system development (GO:0035270),-0.3973448965289671,-0.6279263831405756,0.9193548387096774,0.9998527547761156,1.0,1/7,5.36%,HESX1
prerank,GO_Biological_Process_2021__regulation of inclusion body assembly (GO:0090083),0.37912703530324904,0.6270568182699978,0.9714285714285714,0.9934348207149816,1.0,3/10,13.66%,DNAJB2;DNAJA4;BAG5
prerank,GO_Biological_Process_2021__positive regulation of lipid catabolic process (GO:0050996),0.33931344073637526,0.626879503740937,0.9090909090909091,0.9932228976369075,1.0,2/9,27.88%,AKT2;ABHD5
prerank,GO_Biological_Process_2021__telomere maintenance via recombination (GO:0000722),0.3199836428746632,0.6261335151750096,0.8695652173913043,0.9933990653662076,1.0,4/8,22.26%,ERCC4;NSMCE2;SMC6;ERCC1
prerank,GO_Biological_Process_2021__chromatin silencing at telomere (GO:0006348),0.3775844492299521,0.6251749036364603,0.8421052631578947,0.9937445588777164,1.0,4/6,34.98%,SIRT2;EZH2;DOT1L;DPY30
prerank,Reactome_2022__Signaling By BRAF And RAF1 Fusions R-HSA-6802952,0.25125593605062657,0.6244830909473927,1.0,0.9939166801995883,1.0,4/50,11.38%,RAP1A;MAP2K1;VCL;MAPK1
prerank,GO_Biological_Process_2021__nuclear membrane disassembly (GO:0051081),-0.3737723737725691,-0.6243600258624717,0.9298245614035088,1.0,1.0,1/9,8.91%,CNEP1R1
prerank,GO_Biological_Process_2021__positive regulation of CREB transcription factor activity (GO:0032793),0.33029119248217287,0.6236752915942021,0.9714285714285714,0.9940623501144448,1.0,2/16,5.60%,RPS6KA4;RELN
prerank,GO_Biological_Process_2021__regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell (GO:2001188),-0.41608651477120306,-0.6236684351146344,0.8545454545454545,1.0,1.0,2/5,15.55%,HAVCR2;HLA-DMB
prerank,GO_Biological_Process_2021__negative regulation of axon regeneration (GO:0048681),0.42218100265058867,0.6233298739026963,0.9148936170212766,0.9939558935132997,1.0,3/5,36.97%,EPHA4;INPP5F;PTPRS
prerank,GO_Biological_Process_2021__negative regulation of alpha-beta T cell activation (GO:0046636),0.3667232225770901,0.6231471077398747,0.8918918918918919,0.9937254102745873,1.0,2/6,20.47%,TWSG1;CD274
prerank,GO_Biological_Process_2021__negative regulation of toll-like receptor 4 signaling pathway (GO:0034144),-0.398645227928064,-0.6230727523580372,0.8928571428571429,1.0,1.0,3/8,22.16%,TNFAIP3;NR1D1;LYN
prerank,GO_Biological_Process_2021__left/right pattern formation (GO:0060972),0.37736773227960163,0.6230218302043367,0.875,0.993468760971873,1.0,2/5,13.38%,SETDB2;MEGF8
prerank,GO_Biological_Process_2021__protein palmitoylation (GO:0018345),-0.322003288938404,-0.6229360827122614,0.9491525423728814,1.0,1.0,3/24,9.18%,GLUL;ZDHHC4;ZDHHC19
prerank,GO_Biological_Process_2021__calcium import into the mitochondrion (GO:0036444),-0.37505344815786407,-0.6226982568928883,0.9122807017543859,1.0,1.0,4/9,14.94%,SMDT1;MICU2;MAIP1;MCUR1
prerank,GO_Biological_Process_2021__neuron projection maintenance (GO:1990535),0.37693152072954506,0.6225968041591479,0.8222222222222222,0.9933851470160461,1.0,6/6,62.33%,INSR;PRNP;APP;DCTN1;MAP1A;PSEN1
prerank,GO_Biological_Process_2021__retinoid metabolic process (GO:0001523),-0.31669729542052755,-0.6222566463901889,0.9545454545454546,1.0,1.0,6/26,23.01%,GPC3;PLB1;SDC3;CYP3A5;AKR1B1;RDH11
prerank,GO_Biological_Process_2021__steroid metabolic process (GO:0008202),0.2768179955428466,0.6219640784596367,0.9761904761904762,0.9934819147176657,1.0,5/31,12.96%,DHCR24;FDFT1;MSMO1;CYP46A1;LIPA
prerank,"GO_Biological_Process_2021__SRP-dependent cotranslational protein targeting to membrane, translocation (GO:0006616)",0.41419416453378594,0.6218763766215123,0.9318181818181818,0.9932293476335021,1.0,2/5,37.13%,SEC61A1;SEC61A2
prerank,GO_Biological_Process_2021__histone phosphorylation (GO:0016572),0.3871329031831738,0.6214048293819773,0.9130434782608695,0.9932247341769848,1.0,1/7,5.00%,RPS6KA4
prerank,GO_Biological_Process_2021__mitotic nuclear membrane reassembly (GO:0007084),0.2677934399240534,0.6210522579170585,1.0,0.9928740850930716,1.0,7/43,17.93%,NUP188;RCC1;REEP3;CHMP7;NDC1;NUP133;NUP205
prerank,GO_Biological_Process_2021__mitotic nuclear membrane organization (GO:0101024),0.2677934399240534,0.6210522579170585,1.0,0.9928740850930716,1.0,7/43,17.93%,NUP188;RCC1;REEP3;CHMP7;NDC1;NUP133;NUP205
prerank,GO_Biological_Process_2021__resolution of meiotic recombination intermediates (GO:0000712),-0.3784367121865501,-0.6205821266759513,0.9642857142857143,1.0,1.0,2/11,5.13%,SHOC1;MUS81
prerank,Reactome_2022__Mitochondrial Fatty Acid Beta-Oxidation R-HSA-77289,-0.31301220059411033,-0.6205739094538196,0.9814814814814815,1.0,1.0,4/26,12.05%,THEM4;ACOT9;PCTP;MCEE
prerank,GO_Biological_Process_2021__positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774),-0.39256253080265285,-0.6205598189357473,0.9298245614035088,1.0,1.0,4/9,22.02%,CFTR;TRPM4;HLA-DRB1;STX4
prerank,GO_Biological_Process_2021__TORC1 signaling (GO:0038202),0.3574565107245399,0.6204493016145852,0.9142857142857143,0.992899596692393,1.0,7/7,64.28%,NPRL3;LARP1;MTOR;CLEC16A;SMG1;CARD11;RPTOR
prerank,GO_Biological_Process_2021__3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),0.3211102088720095,0.6202235521715813,0.9230769230769231,0.9927001173441411,1.0,3/10,29.55%,ENPP1;PAPSS1;BPNT2
prerank,Reactome_2022__Glucagon Signaling In Metabolic Regulation R-HSA-163359,-0.3221911711056648,-0.6197000094205779,0.9032258064516129,1.0,1.0,3/19,17.40%,PRKAR1B;GNB2;PRKAR2B
prerank,GO_Biological_Process_2021__self proteolysis (GO:0097264),0.3960663714246102,0.6195748584980386,0.8461538461538461,0.9927444103355623,1.0,2/6,28.85%,ADGRV1;NLRP1
prerank,GO_Biological_Process_2021__positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),-0.37023752265079923,-0.6191029748247575,0.9636363636363636,1.0,1.0,2/9,10.55%,ETS1;ITGB2
prerank,GO_Biological_Process_2021__biotin metabolic process (GO:0006768),-0.3747427794978911,-0.6188620998685853,0.8888888888888888,1.0,1.0,2/8,24.48%,MCCC2;BTD
prerank,GO_Biological_Process_2021__RNA interference (GO:0016246),0.31868471998585357,0.6188162230132457,0.9545454545454546,0.9929722858891067,1.0,5/13,25.34%,DROSHA;AGO1;MRPL44;HENMT1;CELF1
prerank,Reactome_2022__Thrombin Signaling Thru Proteinase Activated Receptors (PARs) R-HSA-456926,0.30453912080487283,0.6185018686260009,0.9459459459459459,0.9928928462487214,1.0,3/19,11.38%,GNAQ;GNA11;MAPK1
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),-0.3221322905602316,-0.6181436265534714,0.9622641509433962,1.0,1.0,6/17,21.50%,RBPJ;VEGFA;HIF1A;MT3;CARF;NFE2L2
prerank,GO_Biological_Process_2021__positive regulation of leukocyte proliferation (GO:0070665),0.38507610178668683,0.6180907509507009,0.875,0.9928284366861223,1.0,2/6,13.77%,MAPK1;PTK2
prerank,GO_Biological_Process_2021__positive regulation of voltage-gated calcium channel activity (GO:1901387),0.3928222488765025,0.6177782696507881,0.9019607843137255,0.9926966845493402,1.0,2/5,29.78%,NIPSNAP2;CACNA2D1
prerank,GO_Biological_Process_2021__cyclooxygenase pathway (GO:0019371),0.35143141098894154,0.6172877783530124,0.8431372549019608,0.9922912703708991,1.0,2/6,17.76%,HPGDS;TBXAS1
prerank,Reactome_2022__Synthesis Of Prostaglandins (PG) And Thromboxanes (TX) R-HSA-2162123,0.35143141098894154,0.6172877783530124,0.8431372549019608,0.9922912703708991,1.0,2/6,17.76%,HPGDS;TBXAS1
prerank,GO_Biological_Process_2021__regulation of tubulin deacetylation (GO:0090043),0.364395141821645,0.6170267713387304,0.9767441860465116,0.9921672973689439,1.0,2/7,16.79%,TPPP;PRKAA1
prerank,Reactome_2022__FBXW7 Mutants And NOTCH1 In Cancer R-HSA-2644605,-0.3914778036457506,-0.6169475886658677,0.8679245283018868,1.0,1.0,1/5,11.16%,RBX1
prerank,GO_Biological_Process_2021__phosphatidylinositol phosphate biosynthetic process (GO:0046854),-0.3028624430764939,-0.6164647353514479,0.9545454545454546,1.0,1.0,3/28,13.75%,TMEM150A;EFR3B;PIK3CB
prerank,Reactome_2022__Phase 2 - Plateau Phase R-HSA-5576893,-0.3868704683428065,-0.6162703511585239,0.8852459016393442,1.0,1.0,3/8,25.70%,CACNB1;AKAP9;CACNA1C
prerank,Reactome_2022__CaM Pathway R-HSA-111997,0.2840665431969059,0.6161203822270104,0.9655172413793104,0.9923537200820703,1.0,5/29,17.57%,NBEA;ADCY9;ADCY6;PDE1C;PRKX
prerank,Reactome_2022__TRAF3-dependent IRF Activation Pathway R-HSA-918233,-0.3368980916825355,-0.6159204089742655,0.8888888888888888,1.0,1.0,2/13,21.89%,IRF7;IRF3
prerank,GO_Biological_Process_2021__striated muscle tissue development (GO:0014706),0.3371821110897006,0.6156715912204321,0.9166666666666666,0.9922559694217368,1.0,1/12,4.42%,PGM5
prerank,GO_Biological_Process_2021__sensory organ development (GO:0007423),0.2861012876454724,0.614730426098634,0.9722222222222222,0.9924796076813518,1.0,3/24,15.89%,PBX1;BMPR1B;PBX3
prerank,GO_Biological_Process_2021__purine ribonucleoside monophosphate biosynthetic process (GO:0009168),0.3102138250378257,0.6146960687887437,0.9117647058823529,0.992183916167411,1.0,1/13,5.19%,PPAT
prerank,GO_Biological_Process_2021__mannose trimming involved in glycoprotein ERAD pathway (GO:1904382),-0.41052360836909474,-0.6145713285091886,0.9090909090909091,1.0,1.0,3/5,31.68%,EDEM1;MAN1B1;EDEM2
prerank,GO_Biological_Process_2021__ubiquitin-dependent glycoprotein ERAD pathway (GO:0097466),-0.41052360836909474,-0.6145713285091886,0.9090909090909091,1.0,1.0,3/5,31.68%,EDEM1;MAN1B1;EDEM2
prerank,GO_Biological_Process_2021__protein deglycosylation involved in glycoprotein catabolic process (GO:0035977),-0.41052360836909474,-0.6145713285091886,0.9090909090909091,1.0,1.0,3/5,31.68%,EDEM1;MAN1B1;EDEM2
prerank,GO_Biological_Process_2021__positive regulation of exosomal secretion (GO:1903543),-0.33390167892876443,-0.6145227508383742,0.9464285714285714,1.0,1.0,1/12,7.74%,SNF8
prerank,GO_Biological_Process_2021__glomerular visceral epithelial cell differentiation (GO:0072112),-0.4003903662043069,-0.6137414405991741,0.9344262295081968,1.0,1.0,1/6,5.60%,BASP1
prerank,GO_Biological_Process_2021__chemical homeostasis within a tissue (GO:0048875),-0.40214409859319306,-0.6131777569382478,0.9272727272727272,1.0,1.0,2/5,11.19%,OAS1;VEGFA
prerank,GO_Biological_Process_2021__surfactant homeostasis (GO:0043129),-0.40214409859319306,-0.6131777569382478,0.9272727272727272,1.0,1.0,2/5,11.19%,OAS1;VEGFA
prerank,GO_Biological_Process_2021__negative regulation of actin filament bundle assembly (GO:0032232),0.29707435625039025,0.6128952389552477,1.0,0.992930188222094,1.0,6/21,16.96%,WASF2;TMEFF2;SHANK3;TJP1;CLASP1;CLASP2
prerank,GO_Biological_Process_2021__regulation of triglyceride biosynthetic process (GO:0010866),-0.37706606777575724,-0.6124792743099531,0.8852459016393442,1.0,1.0,3/10,14.85%,NR1H2;CNEP1R1;C3
prerank,GO_Biological_Process_2021__response to gamma radiation (GO:0010332),0.30885857206306633,0.6118708870824205,0.975609756097561,0.993228050850823,1.0,4/17,20.87%,LIG4;MDM2;PRKAA1;TMEM109
prerank,GO_Biological_Process_2021__regulation of histone phosphorylation (GO:0033127),0.3547281364014653,0.611217852077198,0.9387755102040817,0.9932607815375758,1.0,1/9,5.00%,RPS6KA4
prerank,Reactome_2022__Acyl Chain Remodeling Of CL R-HSA-1482798,-0.400333659941057,-0.6109152288692098,0.8909090909090909,1.0,1.0,3/6,34.02%,PLA2G4A;TAFAZZIN;HADHB
prerank,Reactome_2022__PKA-mediated Phosphorylation Of CREB R-HSA-111931,0.3230056593969382,0.6108276328941369,0.8888888888888888,0.9932151534675988,1.0,2/16,6.41%,NBEA;ADCY9
prerank,GO_Biological_Process_2021__toxin transport (GO:1901998),0.38556520922960447,0.610152993476977,0.9454545454545454,0.9933000758234003,1.0,3/5,23.39%,ANTXR1;ADAM10;RAB40B
prerank,GO_Biological_Process_2021__regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),0.284002853823061,0.6100640686848063,0.9761904761904762,0.9930345132686799,1.0,6/25,19.56%,SUPT16H;CDK13;WDR43;CDK12;EAPP;HNRNPU
prerank,GO_Biological_Process_2021__phospholipid biosynthetic process (GO:0008654),0.3046556009645335,0.6097725261354502,1.0,0.9928324760407804,1.0,6/24,13.86%,IDI1;AGPAT5;SAMD8;MVD;SGMS1;HDHD5
prerank,GO_Biological_Process_2021__phosphatidylglycerol biosynthetic process (GO:0006655),0.37482056911255607,0.6096930247977252,0.8292682926829268,0.9925486047652812,1.0,6/6,62.54%,CDS2;SLC27A1;PGS1;PLA2G6;GPAM;TAMM41
prerank,GO_Biological_Process_2021__cardiac muscle cell development (GO:0055013),0.3466298159744784,0.6095601422791289,0.8787878787878788,0.9922909858091922,1.0,4/10,17.01%,ALPK3;PDLIM5;SLC8A1;SORBS2
prerank,Reactome_2022__RHO GTPases Activate IQGAPs R-HSA-5626467,-0.3720843122729938,-0.6095279676101022,0.9130434782608695,1.0,1.0,3/9,22.27%,CALM1;IQGAP2;IQGAP1
prerank,Reactome_2022__HSP90 Chaperone Cycle For Steroid Hormone Receptors (SHR) In Presence Of Ligand R-HSA-3371497,-0.28466927768625383,-0.6089669935643361,0.9491525423728814,1.0,1.0,8/33,19.77%,DCTN6;DCTN4;HSPA1B;DYNC1LI2;HSPA1A;DCTN2;HSPA2;DYNC1I2
prerank,GO_Biological_Process_2021__DNA damage induced protein phosphorylation (GO:0006975),-0.36600052541670747,-0.6083530396004208,0.8867924528301887,1.0,1.0,3/6,32.49%,MAPK3;MAP2K6;CHEK2
prerank,CellMarker_Augmented_2021__Basal cell:Lung,-0.31242078430103787,-0.6083205225060954,0.9661016949152542,1.0,1.0,4/25,12.87%,JUP;CLCA4;ITGA6;ATP1B3
prerank,GO_Biological_Process_2021__regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),-0.3564221101049503,-0.6080292410661584,0.9152542372881356,1.0,1.0,7/17,22.02%,CFTR;TRPM4;PIM3;STXBP4;HLA-DRB1;NR1D1;STX4
prerank,GO_Biological_Process_2021__lamellipodium assembly (GO:0030032),0.2846531626337055,0.6075497501433311,0.95,0.9930983725775256,1.0,6/20,22.19%,VCL;P2RY12;SRGAP2;ARHGEF6;PTPRO;ABLIM1
prerank,GO_Biological_Process_2021__microtubule anchoring at microtubule organizing center (GO:0072393),0.3496578422638574,0.6073745962550201,0.9574468085106383,0.9928816849397932,1.0,4/9,30.05%,NIN;HOOK3;PCM1;BICD2
prerank,GO_Biological_Process_2021__regulation of potassium ion transport (GO:0043266),0.31993832837783515,0.6072018481696406,0.975609756097561,0.9926130438683148,1.0,4/17,19.50%,KCNIP2;KCNN2;DPP10;DPP6
prerank,GO_Biological_Process_2021__response to hydroperoxide (GO:0033194),0.37622424856467407,0.6070149166816788,0.9318181818181818,0.9923817708431562,1.0,5/5,62.39%,PRKD1;SP1;PRKCD;DAPK1;XRCC1
prerank,"GO_Biological_Process_2021__Notch receptor processing, ligand-dependent (GO:0035333)",-0.37529422312658745,-0.6069839206709582,0.90625,1.0,1.0,1/5,18.14%,APH1B
prerank,GO_Biological_Process_2021__protein acylation (GO:0043543),-0.2942232882805633,-0.6069820909811035,0.9473684210526315,1.0,1.0,3/31,11.60%,ING5;GLUL;ING4
prerank,GO_Biological_Process_2021__negative regulation of small GTPase mediated signal transduction (GO:0051058),0.30457675695655406,0.6063776137194137,0.9487179487179487,0.9924146566806599,1.0,1/19,1.76%,SPRY2
prerank,Reactome_2022__Regulation Of Pyruvate Dehydrogenase (PDH) Complex R-HSA-204174,-0.3622206905593411,-0.6062598810031588,0.8703703703703703,1.0,1.0,5/10,20.82%,PDHX;PDPR;PDK3;PDHB;PDHA1
prerank,GO_Biological_Process_2021__negative regulation of endocytosis (GO:0045806),0.295118560346764,0.6059148041513509,0.9444444444444444,0.9923211339327106,1.0,2/17,12.17%,PICALM;ARF6
prerank,GO_Biological_Process_2021__cellular amino acid biosynthetic process (GO:0008652),0.41173227509193766,0.6058470686854238,0.9210526315789473,0.9920530142627925,1.0,1/5,14.77%,GAD1
prerank,GO_Biological_Process_2021__cardiac cell development (GO:0055006),0.36279801764371405,0.6050075490353367,0.9210526315789473,0.9922754339908442,1.0,3/8,13.70%,JAG1;ALPK3;SLC8A1
prerank,GO_Biological_Process_2021__purine ribonucleoside monophosphate metabolic process (GO:0009167),0.2955902518128041,0.6042342982691956,1.0,0.9924865707738515,1.0,2/16,13.57%,PPAT;AK3
prerank,GO_Biological_Process_2021__ubiquitin-dependent ERAD pathway (GO:0030433),-0.26369924741752826,-0.6042065202004385,0.9871794871794872,1.0,1.0,5/64,10.12%,DNAJB9;ANKZF1;TRIM13;SELENOS;TMEM67
prerank,GO_Biological_Process_2021__negative regulation of small molecule metabolic process (GO:0062014),-0.37512664640324217,-0.6039888671613737,0.8367346938775511,1.0,1.0,5/5,62.51%,PGP;NCOR1;CRY1;EP300;CLK2
prerank,GO_Biological_Process_2021__positive regulation of protein exit from endoplasmic reticulum (GO:0070863),0.30995485306990384,0.6039060596154214,0.8780487804878049,0.9923671564719089,1.0,1/10,11.83%,SORL1
prerank,GO_Biological_Process_2021__lipoxin biosynthetic process (GO:2001301),0.35974080153516597,0.6036193591636133,0.9387755102040817,0.9921958591441181,1.0,1/5,10.35%,ALOX5AP
prerank,GO_Biological_Process_2021__nuclear RNA surveillance (GO:0071027),-0.37699968857635496,-0.603601022494453,0.896551724137931,1.0,1.0,1/6,7.08%,EXOSC10
prerank,GO_Biological_Process_2021__cell-substrate junction assembly (GO:0007044),0.29178713089779984,0.6028092070802823,0.9444444444444444,0.9923511668771517,1.0,6/22,21.51%,PTPRK;FERMT2;TAOK2;PEAK1;CD151;CTTN
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Colon,-0.37602781031084287,-0.6020527803135756,0.9272727272727272,1.0,1.0,1/8,8.71%,CD44
prerank,Reactome_2022__RNA Polymerase II Pre-transcription Events R-HSA-674695,-0.2568895962642652,-0.6018382286188892,1.0,1.0,1.0,5/68,9.87%,GTF2H5;CTDP1;ELOB;POLR2G;NCBP2
prerank,Reactome_2022__G-protein Activation R-HSA-202040,-0.34240922651927985,-0.6012938824932266,0.984375,1.0,1.0,3/12,19.15%,GNB5;GNB2;OPRM1
prerank,GO_Biological_Process_2021__stem cell differentiation (GO:0048863),0.2940753984083854,0.60099055467342,1.0,0.9930219268703728,1.0,4/22,19.59%,GPM6A;SETD2;BATF;FGFR2
prerank,GO_Biological_Process_2021__cellular response to gamma radiation (GO:0071480),0.30161075953932204,0.600921377700921,0.975,0.9927467657379528,1.0,2/13,20.87%,MDM2;TMEM109
prerank,GO_Biological_Process_2021__protein maturation by iron-sulfur cluster transfer (GO:0097428),-0.34408751234111024,-0.6008331471729913,0.9180327868852459,1.0,1.0,2/12,15.50%,ISCA1;CIAO2B
prerank,GO_Biological_Process_2021__ribosomal large subunit export from nucleus (GO:0000055),-0.393395578140897,-0.6007622344010723,0.8571428571428571,1.0,1.0,3/6,21.82%,NPM1;NUP88;NMD3
prerank,GO_Biological_Process_2021__activation of protein kinase A activity (GO:0034199),0.308138183939503,0.6005898601074813,0.9555555555555556,0.9925607390390597,1.0,3/14,13.60%,ADCY9;PRRC1;ADCY6
prerank,Reactome_2022__DAG And IP3 Signaling R-HSA-1489509,0.29000212226796507,0.6004671870486733,0.9629629629629629,0.9923081323086372,1.0,6/34,17.57%,NBEA;ADCY9;ADCY6;AHCYL1;PDE1C;PRKX
prerank,GO_Biological_Process_2021__protein K48-linked deubiquitination (GO:0071108),-0.32462324739195203,-0.6000086035918559,0.9482758620689655,1.0,1.0,3/20,13.97%,TNFAIP3;MINDY1;OTUD3
prerank,KEGG_2021_Human__Collecting duct acid secretion,-0.33676652113217875,-0.5997710299911514,0.9344262295081968,1.0,1.0,2/16,12.14%,ATP6V1F;SLC12A7
prerank,KEGG_2021_Human__DNA replication,-0.3111740863598721,-0.5996577114580653,0.9384615384615385,1.0,1.0,7/23,22.17%,POLE3;MCM7;RPA3;RFC1;PRIM1;MCM6;MCM5
prerank,GO_Biological_Process_2021__regulation of fatty acid beta-oxidation (GO:0031998),0.35216123822444345,0.5996313644281912,0.9069767441860465,0.9924298189551773,1.0,2/8,21.70%,AKT2;MFSD2A
prerank,Reactome_2022__Vitamin D (Calciferol) Metabolism R-HSA-196791,-0.370174833593648,-0.5990454361332727,0.9322033898305084,1.0,1.0,1/7,22.75%,SUMO2
prerank,GO_Biological_Process_2021__mitochondrial tRNA modification (GO:0070900),0.4025787159489444,0.5989237889569015,0.9615384615384616,0.992436631920459,1.0,3/6,24.51%,PUS1;TRMT10C;TRIT1
prerank,CellMarker_Augmented_2021__Circulating Progenitor cell:Peripheral Blood,-0.304154101655667,-0.598870214969071,1.0,1.0,1.0,6/29,16.42%,CD14;SPARCL1;ABCA8;A2M;SERPING1;ALDH2
prerank,Reactome_2022__Glucagon-like Peptide-1 (GLP1) Regulates Insulin Secretion R-HSA-381676,-0.30746593138822365,-0.598488402059684,0.9824561403508771,1.0,1.0,6/25,22.27%,GNB5;PRKAR1B;GNB2;PRKAR2B;KCNG2;IQGAP1
prerank,GO_Biological_Process_2021__tRNA modification (GO:0006400),-0.28796700399376074,-0.5978775724565235,0.9565217391304348,1.0,1.0,10/49,22.80%,SSB;GTPBP3;OSGEP;TRMT44;THUMPD3;METTL2A;TYW5;FTSJ1;WDR6;URM1
prerank,GO_Biological_Process_2021__astral microtubule organization (GO:0030953),-0.3705111572845914,-0.5977307956678425,0.9555555555555556,1.0,1.0,1/8,5.18%,RAB11A
prerank,GO_Biological_Process_2021__positive regulation of bone resorption (GO:0045780),0.3490890139180213,0.5970182632139427,0.9,0.9930024322299008,1.0,2/7,31.40%,SYK;DEF8
prerank,GO_Biological_Process_2021__regulation of histone H4 acetylation (GO:0090239),-0.35490976581631395,-0.5970093616082589,0.9354838709677419,1.0,1.0,3/8,26.85%,CTBP1;PIH1D1;SMARCB1
prerank,GO_Biological_Process_2021__regulation of macrophage differentiation (GO:0045649),-0.3618178287345957,-0.5968416088731119,0.9629629629629629,1.0,1.0,5/7,38.41%,C1QC;PTPN2;ID2;CASP8;HSF1
prerank,GO_Biological_Process_2021__regulation of chromosome segregation (GO:0051983),-0.34941380005460776,-0.5967300109689385,0.9354838709677419,1.0,1.0,2/10,18.08%,IHO1;CSNK2A2
prerank,GO_Biological_Process_2021__DNA double-strand break processing (GO:0000729),0.29992755350302674,0.5965439162829288,0.9183673469387755,0.9928943355918693,1.0,5/17,19.93%,UBE2N;BARD1;BLM;NBN;RNF138
prerank,GO_Biological_Process_2021__dicarboxylic acid catabolic process (GO:0043649),-0.3429714285899059,-0.5961505538840739,0.9206349206349206,1.0,1.0,3/10,17.58%,GLUL;QPRT;GOT2
prerank,Reactome_2022__RHOBTB3 ATPase Cycle R-HSA-9706019,0.3383596403413104,0.5959705254839635,0.975609756097561,0.9928233033983626,1.0,1/8,16.23%,HTR7
prerank,Reactome_2022__TP53 Regulates Transcription Of Caspase Activators And Caspases R-HSA-6803207,0.33195302253811615,0.5957500601955679,0.926829268292683,0.9925821895648351,1.0,2/10,15.09%,APAF1;NLRC4
prerank,GO_Biological_Process_2021__glycerolipid metabolic process (GO:0046486),0.3427305810163903,0.5954292612257788,0.9555555555555556,0.9924817236038259,1.0,3/8,32.12%,DGKQ;DGKB;PLA2G15
prerank,Reactome_2022__COPI-mediated Anterograde Transport R-HSA-6807878,-0.2723740204811631,-0.5954243557201592,0.984375,1.0,1.0,13/65,22.05%,CD55;DCTN6;PTGES2;DCTN4;COPE;DYNC1LI2;GOLGB1;DCTN2;FOLR2;ANK1;DYNC1I2;KDELR1;GORASP1
prerank,GO_Biological_Process_2021__mRNA 5'-splice site recognition (GO:0000395),0.38789968628128346,0.5953264385136335,0.9038461538461539,0.9922039104364846,1.0,1/5,15.98%,SRSF12
prerank,GO_Biological_Process_2021__regulation of actomyosin structure organization (GO:0110020),-0.34353171253043785,-0.5938038641031613,0.9710144927536232,1.0,1.0,3/12,21.93%,ACTG1;RAC1;WAS
prerank,GO_Biological_Process_2021__regulation of cell-cell adhesion mediated by cadherin (GO:2000047),-0.3413454055529838,-0.5934191138163741,0.9152542372881356,1.0,1.0,4/10,21.23%,VEGFA;DENND6A;FLOT1;RGCC
prerank,GO_Biological_Process_2021__response to increased oxygen levels (GO:0036296),0.4080250621325894,0.5932143745669343,0.925,0.9930236555423012,1.0,3/5,31.45%,ATP6V0D1;ATP6V1G1;ATP6V1A
prerank,GO_Biological_Process_2021__transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery (GO:0000972),0.3614075029372602,0.5931104283839534,0.9512195121951219,0.9927458467154974,1.0,1/6,16.80%,NUP133
prerank,Reactome_2022__Mitotic Prometaphase R-HSA-68877,-0.24760696611400462,-0.5930436317388174,1.0,1.0,1.0,29/136,22.58%,RPS27;SSNA1;CENPU;CEP72;ITGB3BP;CEP164;ZWILCH;TUBGCP2;CSNK1D;MIS12;TUBB4B;DYNC1LI2;SMC1A;SEC13;TUBGCP5;PRKAR2B;SGO2;DCTN2;CSNK2A2;CENPF;BUB3;AKAP9;MZT2B;DYNC1I2;NINL;SFI1;HAUS5;PPP2R5C;KANSL1
prerank,GO_Biological_Process_2021__purine-containing compound biosynthetic process (GO:0072522),0.3099635028051193,0.5930268757833175,0.972972972972973,0.9924682139399147,1.0,2/18,5.19%,DGUOK;PPAT
prerank,Reactome_2022__ADP Signaling Thru P2Y Purinoceptor 1 R-HSA-418592,-0.32886562462773666,-0.5925198791731657,0.95,1.0,1.0,1/14,4.88%,GNB5
prerank,GO_Biological_Process_2021__negative regulation of cold-induced thermogenesis (GO:0120163),-0.2998252611911205,-0.592135335568003,0.9696969696969697,1.0,1.0,4/31,12.47%,NR1H2;RBPJ;PCTP;IL18R1
prerank,GO_Biological_Process_2021__regulation of mammary gland epithelial cell proliferation (GO:0033599),0.3503036353576773,0.5910058217662256,0.8837209302325582,0.9931505153572187,1.0,3/7,13.62%,ROBO1;RTN4;ZNF703
prerank,GO_Biological_Process_2021__peptidyl-lysine trimethylation (GO:0018023),0.2880141140494579,0.5901838622152186,0.9714285714285714,0.9932677826549606,1.0,6/22,15.35%,VCPKMT;SMYD5;SETD3;SETD2;SETD5;SETD4
prerank,GO_Biological_Process_2021__protein alkylation (GO:0008213),0.2897603305677402,0.590075758511558,1.0,0.9930086935216303,1.0,2/16,12.20%,VCPKMT;SNRPB
prerank,Reactome_2022__Transport To Golgi And Subsequent Modification R-HSA-948021,-0.24680715875725806,-0.5895931024515445,1.0,1.0,1.0,21/128,19.82%,CD55;F8;TRAPPC4;DCTN6;PTGES2;DCTN4;CHST10;TBC1D20;CSNK1D;COPE;DYNC1LI2;TRAPPC6A;ANKRD28;SEC13;GOLGB1;DCTN2;FOLR2;MAN2A1;ANK1;DYNC1I2;MANEA
prerank,Reactome_2022__Disorders Of Developmental Biology R-HSA-9675151,0.3095960045330661,0.5894430974989627,1.0,0.9929489135452434,1.0,2/12,10.67%,HDAC1;TBL1XR1
prerank,GO_Biological_Process_2021__skeletal muscle tissue development (GO:0007519),-0.35397065349703327,-0.5892834736976649,0.9824561403508771,1.0,1.0,5/11,31.47%,CFLAR;SVIL;MYL6B;MYH14;MYL6
prerank,GO_Biological_Process_2021__very-low-density lipoprotein particle assembly (GO:0034379),0.355077299306239,0.58897394632442,0.9285714285714286,0.9928891713923149,1.0,3/7,25.59%,P4HB;MFSD2A;SOAT1
prerank,GO_Biological_Process_2021__cortical cytoskeleton organization (GO:0030865),-0.30927602671799725,-0.5885662660417434,0.9565217391304348,1.0,1.0,5/33,10.76%,PLEK;EPB41L3;TRPV4;LLGL2;NCKAP1L
prerank,GO_Biological_Process_2021__embryonic heart tube development (GO:0035050),-0.38041662187445785,-0.5885411771736487,0.9215686274509803,1.0,1.0,1/6,10.60%,CITED2
prerank,Reactome_2022__APOBEC3G Mediated Resistance To HIV-1 R-HSA-180689,0.3674991292368937,0.5884140841934862,0.9583333333333334,0.9928515802730652,1.0,2/6,14.26%,HMGA1;SGIP1
prerank,GO_Biological_Process_2021__protein localization to microtubule (GO:0035372),-0.37328949297818914,-0.5884136333654765,0.90625,1.0,1.0,3/7,32.16%,MID1;CHAMP1;MAPRE1
prerank,Reactome_2022__Lagging Strand Synthesis R-HSA-69186,-0.3323670045405953,-0.5880224512827423,0.9272727272727272,1.0,1.0,3/13,20.14%,RPA3;LRIG1;PRIM1
prerank,KEGG_2021_Human__Protein export,-0.31525111762810665,-0.5879342476306366,0.9682539682539683,1.0,1.0,3/23,13.91%,SRP14;SEC62;OXA1L
prerank,GO_Biological_Process_2021__regulation of macrophage activation (GO:0043030),-0.33911407202643246,-0.587915647198079,0.9830508474576272,1.0,1.0,4/16,15.81%,GPR137B;KARS1;CD74;CD200
prerank,GO_Biological_Process_2021__positive regulation of proteolysis (GO:0045862),-0.2919387280826979,-0.5876518845133665,0.9642857142857143,1.0,1.0,7/30,17.55%,AURKAIP1;TNFRSF1B;ATP5IF1;WDR48;CYFIP2;SNX9;PINK1
prerank,GO_Biological_Process_2021__positive regulation of transcription by RNA polymerase III (GO:0045945),0.32787162162162153,0.5874937901062018,0.918918918918919,0.9930240223444589,1.0,9/9,67.24%,ICE2;ELL;ZNF143;CHD8;CEBPA;ICE1;MTOR;RPTOR;ZC3H8
prerank,GO_Biological_Process_2021__regulation of histone H3-K9 acetylation (GO:2000615),-0.36564427036121616,-0.5874328732691433,0.9629629629629629,1.0,1.0,5/10,28.16%,CAMK1;BRCA1;PIH1D1;SMARCB1;SPHK2
prerank,GO_Biological_Process_2021__negative regulation of receptor signaling pathway via STAT (GO:1904893),0.35161519611332614,0.5872031589252478,0.9512195121951219,0.9929016985056264,1.0,3/8,39.26%,ADIPOR1;SH2B3;HGS
prerank,GO_Biological_Process_2021__glycoprotein catabolic process (GO:0006516),0.36000505646435255,0.5865447341999767,0.9024390243902439,0.99292673386919,1.0,2/9,13.82%,STT3B;FBXO27
prerank,GO_Biological_Process_2021__nuclear mRNA surveillance (GO:0071028),-0.3714825230247558,-0.5860295210056642,0.9821428571428571,1.0,1.0,1/7,7.08%,EXOSC10
prerank,GO_Biological_Process_2021__somatic recombination of immunoglobulin gene segments (GO:0016447),0.33543259120928937,0.5859601515478755,0.9555555555555556,0.9929407107637644,1.0,1/7,7.13%,LIG4
prerank,GO_Biological_Process_2021__steroid hormone biosynthetic process (GO:0120178),0.3217102857863602,0.5856583444287999,0.9487179487179487,0.9928111696599182,1.0,1/12,4.90%,TSPOAP1
prerank,GO_Biological_Process_2021__myotube differentiation (GO:0014902),-0.36768645744187267,-0.5844948308207069,0.9322033898305084,1.0,1.0,1/9,5.56%,IGF1
prerank,GO_Biological_Process_2021__positive regulation of lyase activity (GO:0051349),0.33672904508386703,0.5843214222139226,0.9069767441860465,0.9931157805145733,1.0,2/7,23.24%,NF1;ORAI1
prerank,GO_Biological_Process_2021__regulation of potassium ion import (GO:1903286),-0.3543557671979046,-0.5839767143502395,0.9591836734693877,1.0,1.0,1/7,12.87%,ATP1B3
prerank,GO_Biological_Process_2021__positive regulation of DNA metabolic process (GO:0051054),-0.2646163297320464,-0.5835939845063403,1.0,1.0,1.0,12/45,22.29%,EYA2;RPS3;PRKD2;ABRAXAS1;BRCA1;ERCC8;ZCWPW1;WRN;TOX;SMCHD1;RGCC;PDGFB
prerank,GO_Biological_Process_2021__skeletal muscle organ development (GO:0060538),-0.32621211845803316,-0.582748417664788,0.9672131147540983,1.0,1.0,2/12,9.94%,BASP1;CFLAR
prerank,GO_Biological_Process_2021__negative regulation of endothelial cell proliferation (GO:0001937),0.2929935575198799,0.5825032094012265,0.9459459459459459,0.9935709725263425,1.0,3/19,12.21%,PPARG;PTPRM;NF1
prerank,GO_Biological_Process_2021__positive regulation of cell adhesion (GO:0045785),-0.2901866456463308,-0.5824911168274868,0.9833333333333333,1.0,1.0,6/42,12.25%,CCL5;PRKD2;CITED2;NCKAP1L;VEGFA;CD47
prerank,Reactome_2022__Signaling By Leptin R-HSA-2586552,-0.37041098412433404,-0.5823845467963921,0.9555555555555556,1.0,1.0,2/7,28.41%,PTPN11;STAT3
prerank,Reactome_2022__Attenuation Phase R-HSA-3371568,0.2876581189804429,0.5820672037208393,1.0,0.9934707651155973,1.0,1/19,2.99%,MRPL18
prerank,GO_Biological_Process_2021__protein deglutamylation (GO:0035608),-0.3806824692329004,-0.5820645524724632,0.9107142857142857,1.0,1.0,2/6,14.71%,AGBL3;AGBL5
prerank,Reactome_2022__Gastrin-CREB Signaling Pathway Via PKC And MAPK R-HSA-881907,0.32564291024475517,0.5815246256287256,0.8936170212765957,0.9933889963104371,1.0,1/11,11.38%,MAPK1
prerank,GO_Biological_Process_2021__tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),-0.2907490529787063,-0.5808746205447969,1.0,1.0,1.0,5/32,17.60%,SSB;XPOT;NUP50;SEC13;NUP88
prerank,GO_Biological_Process_2021__tRNA export from nucleus (GO:0006409),-0.2907490529787063,-0.5808746205447969,1.0,1.0,1.0,5/32,17.60%,SSB;XPOT;NUP50;SEC13;NUP88
prerank,GO_Biological_Process_2021__protein auto-ADP-ribosylation (GO:0070213),-0.3537045827686893,-0.5800550478847681,0.9193548387096774,1.0,1.0,4/11,20.56%,PARP2;PARP11;PARP12;PARP8
prerank,"GO_Biological_Process_2021__posttranslational protein targeting to membrane, translocation (GO:0031204)",-0.3793941931221168,-0.5797493627422982,0.9649122807017544,1.0,1.0,1/7,13.39%,SEC62
prerank,GO_Biological_Process_2021__peptidyl-serine autophosphorylation (GO:0036289),0.35549673569603435,0.5790679179021379,0.92,0.9941045201436763,1.0,4/8,27.25%,DYRK1A;MAP2K2;RIPK1;PIKFYVE
prerank,Reactome_2022__PI Metabolism R-HSA-1483255,0.23738335101345368,0.5785190497384547,1.0,0.9940189303810263,1.0,13/69,18.14%,PIP5K1B;PLEKHA5;PIK3C2B;PTPN13;PI4KB;PTEN;PIP4K2A;SBF1;MTMR9;RAB14;PIK3CA;PLEKHA8;INPP4B
prerank,GO_Biological_Process_2021__regulation of chromosome organization (GO:0033044),-0.3184076098022458,-0.5774260688531108,0.9672131147540983,1.0,1.0,2/15,12.59%,CENPV;TERF2IP
prerank,GO_Biological_Process_2021__negative regulation of fatty acid metabolic process (GO:0045922),0.2894997729903398,0.577206111695538,0.9354838709677419,0.994326256501859,1.0,4/11,29.71%,ACADVL;SIRT4;WDTC1;ERLIN1
prerank,Reactome_2022__LRR FLII-interacting Protein 1 (LRRFIP1) Activates Type I IFN Production R-HSA-3134973,-0.3638995730884119,-0.577024419294682,0.9411764705882353,1.0,1.0,2/5,28.96%,IRF3;LRRFIP1
prerank,GO_Biological_Process_2021__P-body assembly (GO:0033962),-0.3305620112147888,-0.5768423638791589,0.9298245614035088,1.0,1.0,2/12,16.62%,PATL2;LSM4
prerank,GO_Biological_Process_2021__negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894),0.3355158226103183,0.5762773335287991,0.9811320754716981,0.9944388551489226,1.0,3/10,15.41%,PPARG;NFIB;NFATC3
prerank,GO_Biological_Process_2021__actomyosin structure organization (GO:0031032),0.2570949928231444,0.5757705536321283,0.9615384615384616,0.9943679181435374,1.0,6/46,14.52%,EPB41;PGM5;TMOD2;TMOD3;TJP1;FRMD5
prerank,GO_Biological_Process_2021__positive regulation of mitotic metaphase/anaphase transition (GO:0045842),0.34160257394827975,0.5754211376689339,0.9722222222222222,0.9935761734041464,1.0,3/10,19.61%,CDC23;NSMCE2;ANAPC4
prerank,GO_Biological_Process_2021__positive regulation of mitotic sister chromatid separation (GO:1901970),0.34160257394827975,0.5754211376689339,0.9722222222222222,0.9935761734041464,1.0,3/10,19.61%,CDC23;NSMCE2;ANAPC4
prerank,GO_Biological_Process_2021__positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),0.34160257394827975,0.5754211376689339,0.9722222222222222,0.9935761734041464,1.0,3/10,19.61%,CDC23;NSMCE2;ANAPC4
prerank,GO_Biological_Process_2021__positive regulation of potassium ion import across plasma membrane (GO:1903288),-0.36176010278970655,-0.574950659867008,0.9333333333333333,1.0,1.0,1/6,12.87%,ATP1B3
prerank,GO_Biological_Process_2021__positive regulation of insulin secretion (GO:0032024),-0.29786094356935733,-0.5742673576358753,0.9696969696969697,1.0,1.0,5/23,14.38%,NNAT;NLGN2;CFTR;TRPM4;MYRIP
prerank,Reactome_2022__P2Y Receptors R-HSA-417957,0.3745580694063786,0.5741513756310122,0.9772727272727273,0.9937694538327227,1.0,1/5,11.03%,P2RY12
prerank,GO_Biological_Process_2021__organic anion transport (GO:0015711),-0.2903298790280023,-0.5740994272864355,1.0,1.0,1.0,6/32,18.29%,SLC35B1;SLC2A8;CFTR;SLC25A19;SLCO3A1;SLC17A9
prerank,CellMarker_Augmented_2021__Memory B cell:Undefined,-0.40898644445651955,-0.572649205404879,0.9649122807017544,1.0,1.0,2/5,20.38%,RBPJ;TLR2
prerank,CellMarker_Augmented_2021__Large Granular lymphocyte:Peripheral Blood,-0.25165920667791386,-0.5720939972531778,1.0,1.0,1.0,7/48,17.64%,DTX3;CCDC136;NLGN2;CHST10;STMN1;UBFD1;FADS2
prerank,GO_Biological_Process_2021__response to magnesium ion (GO:0032026),0.3436435813556697,0.5710905932401614,0.9183673469387755,0.9946953182219012,1.0,2/7,19.35%,SLC41A1;SNCA
prerank,GO_Biological_Process_2021__positive regulation of cyclase activity (GO:0031281),0.3495633581659562,0.5709373754903302,0.9767441860465116,0.9944486403257151,1.0,3/8,26.56%,NF1;ORAI1;MAPK14
prerank,GO_Biological_Process_2021__regulation of nervous system process (GO:0031644),0.31256130274855576,0.5698879806988054,0.9512195121951219,0.9946048522292572,1.0,6/12,22.89%,NPTXR;NPTX1;DLGAP4;DLGAP1;TMEM108;DLGAP2
prerank,GO_Biological_Process_2021__amyloid precursor protein catabolic process (GO:0042987),0.3084421276822775,0.5693047351248947,0.9285714285714286,0.9944791401888526,1.0,2/10,22.55%,DYRK1A;ADAM10
prerank,GO_Biological_Process_2021__regulation of protein polymerization (GO:0032271),-0.2872630501375143,-0.5692666345718393,0.971830985915493,1.0,1.0,3/22,13.08%,PRUNE1;PFN1;FCHSD1
prerank,Reactome_2022__Telomere C-strand Synthesis Initiation R-HSA-174430,-0.3553551887229727,-0.5678521130645596,0.9166666666666666,1.0,1.0,3/9,21.40%,TERF2IP;PRIM1;CTC1
prerank,GO_Biological_Process_2021__regulation of hyaluronan biosynthetic process (GO:1900125),-0.39272226147896566,-0.567615255227534,0.9302325581395349,1.0,1.0,2/5,27.39%,PDGFB;AP2A1
prerank,Reactome_2022__Gap Junction Trafficking And Regulation R-HSA-157858,-0.31665409956925383,-0.5670697041382807,1.0,1.0,1.0,3/12,24.34%,CLTB;AP2M1;CLTA
prerank,GO_Biological_Process_2021__DNA replication-independent nucleosome organization (GO:0034724),-0.3214165110092553,-0.5664656097066936,0.9433962264150944,1.0,1.0,2/10,17.45%,HIRA;HAT1
prerank,GO_Biological_Process_2021__phagosome acidification (GO:0090383),0.2699407267998706,0.5658157227708295,0.9743589743589743,0.9955792474444596,1.0,10/21,26.64%,RAB7A;ATP6V1B2;TCIRG1;ATP6V0B;ATP6V0D1;RAB38;ATP6V0E2;SLAMF8;RAB20;ATP6V1G1
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial calcium ion concentration (GO:0051561),0.3475554518775002,0.5656553216694595,0.9333333333333333,0.9953179706969149,1.0,2/6,12.23%,MCU;MICU1
prerank,Reactome_2022__Physiological Factors R-HSA-5578768,-0.4270373848689026,-0.5652339225254316,0.98,1.0,1.0,2/5,26.31%,NPRL2;WWTR1
prerank,GO_Biological_Process_2021__tRNA transport (GO:0051031),-0.28170262734567003,-0.5649936180622339,0.9841269841269841,1.0,1.0,7/34,22.06%,SSB;XPOT;NUP50;SEC13;NUP88;YBX1;NUP155
prerank,Reactome_2022__Processive Synthesis On Lagging Strand R-HSA-69183,-0.3580065343020846,-0.5649254923393697,0.9230769230769231,1.0,1.0,3/9,20.14%,RPA3;LRIG1;PRIM1
prerank,Reactome_2022__Retrograde Neurotrophin Signaling R-HSA-177504,0.31846904094912154,0.5644134366899082,1.0,0.9954956535468645,1.0,1/11,8.46%,DNM3
prerank,Reactome_2022__RHOF GTPase Cycle R-HSA-9035034,-0.2763329500329843,-0.5643705809532651,1.0,1.0,1.0,4/31,14.75%,BASP1;BAIAP2L2;AKAP12;FAM169A
prerank,GO_Biological_Process_2021__copper ion transport (GO:0006825),0.30895436747473864,0.5642625191745435,0.90625,0.9952418778999435,1.0,2/8,14.08%,SLC31A1;STEAP3
prerank,GO_Biological_Process_2021__cognition (GO:0050890),0.26181118273338805,0.563665973888933,1.0,0.9952038672929898,1.0,10/30,21.78%,TNF;GRM5;NF1;NIPBL;RP9;SETD5;MAGT1;LINS1;MFSD2A;CHD7
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell apoptotic process (GO:2000353),-0.34856559371325857,-0.563208874354841,0.9361702127659575,1.0,1.0,1/8,8.15%,ITGA4
prerank,Reactome_2022__Regulation Of HMOX1 Expression And Activity R-HSA-9707587,0.3778627996108519,0.562292009502079,0.9772727272727273,0.9954289103009093,1.0,1/5,14.05%,MAFK
prerank,GO_Biological_Process_2021__response to glucagon (GO:0033762),-0.2960658538090265,-0.5622189682964077,0.9821428571428571,1.0,1.0,1/15,6.63%,PRKAR1B
prerank,GO_Biological_Process_2021__positive regulation of RNA splicing (GO:0033120),-0.28823382307954165,-0.5621109029487648,1.0,1.0,1.0,5/25,21.12%,RBM22;U2AF2;HSPA1A;ERN1;NCL
prerank,GO_Biological_Process_2021__cellular biogenic amine metabolic process (GO:0006576),0.3604726773179531,0.5620612459437189,0.96,0.9951900023421666,1.0,2/6,14.33%,AMD1;SRM
prerank,GO_Biological_Process_2021__regulation of stress-activated protein kinase signaling cascade (GO:0070302),0.3484545566266835,0.5616556972827882,0.9555555555555556,0.9950315639295599,1.0,3/9,18.09%,MAP2K1;MAPK1;MAP2K2
prerank,GO_Biological_Process_2021__visual system development (GO:0150063),0.28233146644827883,0.5611401456051133,1.0,0.9948878237943151,1.0,3/20,15.89%,PBX1;BMPR1B;PBX3
prerank,GO_Biological_Process_2021__positive regulation of protein acetylation (GO:1901985),-0.3181519452681359,-0.561131908058242,0.9818181818181818,1.0,1.0,3/11,14.13%,TERF2IP;KAT5;CAMK1
prerank,GO_Biological_Process_2021__positive regulation of B cell receptor signaling pathway (GO:0050861),-0.3233977877227054,-0.5609538736062868,0.9310344827586207,1.0,1.0,6/6,67.69%,SLC39A10;FOXP1;PRKCH;CD81;NFAM1;PRKCB
prerank,GO_Biological_Process_2021__regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),-0.26668580184992513,-0.560857589615079,1.0,1.0,1.0,5/49,16.35%,MED25;VENTX;CCND1;MED12;MED30
prerank,GO_Biological_Process_2021__DNA unwinding involved in DNA replication (GO:0006268),-0.31517650813510567,-0.5607457511036842,0.9777777777777777,1.0,1.0,6/11,25.28%,MCM7;RECQL5;WRN;MCM6;RECQL;SSBP1
prerank,GO_Biological_Process_2021__striated muscle contraction (GO:0006941),-0.3080308556118025,-0.5606130212991581,0.9558823529411765,1.0,1.0,2/19,7.44%,TTN;MYBPC3
prerank,GO_Biological_Process_2021__vacuolar acidification (GO:0007035),0.32844570768431336,0.5605633544201016,0.9705882352941176,0.9948718752384966,1.0,4/14,22.90%,PPT1;TCIRG1;ATP6V0D1;ATP6V0E2
prerank,GO_Biological_Process_2021__cell communication by electrical coupling involved in cardiac conduction (GO:0086064),-0.33955266269584017,-0.5604563015544624,0.9836065573770492,1.0,1.0,2/10,16.41%,ATP1A1;PKP2
prerank,GO_Biological_Process_2021__negative regulation of macrophage derived foam cell differentiation (GO:0010745),-0.36404540267028607,-0.5602327501035383,0.9607843137254902,1.0,1.0,1/9,5.38%,NR1H2
prerank,Reactome_2022__Heme Degradation R-HSA-189483,-0.37304531530637597,-0.5600979965459827,0.8928571428571429,1.0,1.0,4/7,30.97%,GUSB;BLVRB;ABCG2;HMOX2
prerank,GO_Biological_Process_2021__inner ear morphogenesis (GO:0042472),-0.3368809981186587,-0.5589984971593782,0.9830508474576272,1.0,1.0,1/8,7.41%,MYO3B
prerank,GO_Biological_Process_2021__blood vessel diameter maintenance (GO:0097746),-0.3210759711688768,-0.5587340321213712,0.9696969696969697,1.0,1.0,2/14,8.63%,PER2;GCLM
prerank,Reactome_2022__Defective HDR Thru Homologous Recombination (HRR) Due To BRCA1 Loss-Of-Function R-HSA-9701192,-0.307729380501096,-0.5583446753080555,0.9661016949152542,1.0,1.0,4/17,18.09%,BRCA2;KAT5;BRCA1;WRN
prerank,GO_Biological_Process_2021__atrial septum morphogenesis (GO:0060413),0.32867093984040163,0.5582265773517527,0.9347826086956522,0.9956073163918582,1.0,1/6,8.29%,SOX4
prerank,Reactome_2022__Role Of LAT2/NTAL/LAB On Calcium Mobilization R-HSA-2730905,0.31065395016801745,0.5564740520099118,0.9743589743589743,0.9958865056774117,1.0,5/11,23.61%,SLC7A8;GAB2;PIK3CA;SYK;PIK3R1
prerank,GO_Biological_Process_2021__negative regulation of tubulin deacetylation (GO:1904428),0.36714932473234674,0.5564192658284146,0.9545454545454546,0.9955822894921499,1.0,2/5,16.79%,TPPP;PRKAA1
prerank,GO_Biological_Process_2021__positive regulation of mRNA processing (GO:0050685),0.25852924474874805,0.5559941858859601,1.0,0.9954167375654501,1.0,4/17,22.40%,PRDX6;TRA2B;THRAP3;NUP98
prerank,Reactome_2022__Assembly Of Active LPL And LIPC Lipase Complexes R-HSA-8963889,-0.3238779439765186,-0.5557800164108995,0.9152542372881356,1.0,1.0,2/8,16.99%,PCSK5;LMF1
prerank,Reactome_2022__NR1H2 And NR1H3 Regulate Gene Expression Linked To Lipogenesis R-HSA-9029558,-0.35346987475674524,-0.5554730845054563,1.0,1.0,1.0,1/8,5.38%,NR1H2
prerank,GO_Biological_Process_2021__purine ribonucleoside bisphosphate metabolic process (GO:0034035),0.33229855510895834,0.5554598412566375,0.8913043478260869,0.9953095757591055,1.0,1/6,14.62%,ENPP1
prerank,GO_Biological_Process_2021__proton transmembrane transport (GO:1902600),-0.29756779402434386,-0.5550154383199686,0.9523809523809523,1.0,1.0,1/18,4.87%,ATP6V1F
prerank,GO_Biological_Process_2021__response to UV-A (GO:0070141),-0.35239210584482566,-0.553837963985917,0.9807692307692307,1.0,1.0,3/6,31.45%,CCND1;EGFR;AKT1
prerank,PanglaoDB_Augmented_2021__Serotonergic Neurons,0.2904850050137548,0.553480001572925,0.9743589743589743,0.9957305383355026,1.0,4/15,14.36%,MMRN1;TMEM236;SLC40A1;SLC26A3
prerank,GO_Biological_Process_2021__mammary gland development (GO:0030879),-0.3542715083109485,-0.5528470597509787,0.9183673469387755,1.0,1.0,2/8,11.19%,PRLR;VEGFA
prerank,GO_Biological_Process_2021__regulation of dephosphorylation (GO:0035303),-0.30750135883875857,-0.5525105999749234,1.0,1.0,1.0,2/12,18.95%,INPP5K;PPP1R16B
prerank,GO_Biological_Process_2021__negative regulation of mRNA catabolic process (GO:1902373),0.28015888617224644,0.5514362612799709,0.9534883720930233,0.9961475972549642,1.0,3/17,19.56%,TENT5A;THRAP3;HNRNPU
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle contraction (GO:0003056),0.33525611262508026,0.5513000066956486,0.9259259259259259,0.9958874485767981,1.0,2/5,28.10%,CHRM3;DOCK4
prerank,GO_Biological_Process_2021__mRNA splice site selection (GO:0006376),-0.2828963234478741,-0.5498116705669828,0.9836065573770492,1.0,1.0,10/23,31.43%,SLU7;LUC7L3;SF3A1;SF3A3;YTHDC1;SRSF5;PSIP1;SRSF9;SNRPC;SRSF10
prerank,GO_Biological_Process_2021__sister chromatid segregation (GO:0000819),0.2716453840707769,0.5497486471624223,1.0,0.996140471698734,1.0,3/21,12.59%,NSL1;SMC4;ZNF207
prerank,Reactome_2022__Role Of Phospholipids In Phagocytosis R-HSA-2029485,0.2815023186966786,0.5496447645739825,1.0,0.9958659387197322,1.0,5/20,17.35%,PLPP5;PRKCSH;AHCYL1;PLD4;PIK3CA
prerank,Reactome_2022__Interconversion Of Nucleotide Di- And Triphosphates R-HSA-499943,0.27243272413950875,0.5493201961066191,0.9411764705882353,0.9956970237769829,1.0,1/21,2.17%,AK6
prerank,Reactome_2022__Processing Of Intronless Pre-mRNAs R-HSA-77595,-0.2975406071201367,-0.5487979524130268,0.967741935483871,1.0,1.0,3/17,14.41%,CSTF2T;NCBP2;COLEC12
prerank,"GO_Biological_Process_2021__alternative mRNA splicing, via spliceosome (GO:0000380)",-0.3089747403668923,-0.5487945476533703,0.9848484848484849,1.0,1.0,3/14,16.52%,DDX5;SLU7;SCNM1
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial translation (GO:0070131),-0.3329174562881803,-0.5486777167784914,0.9152542372881356,1.0,1.0,5/10,22.19%,RPUSD4;TRUB2;UQCC2;C1QBP;RPUSD3
prerank,GO_Biological_Process_2021__positive regulation of toll-like receptor 2 signaling pathway (GO:0034137),-0.35355700782780275,-0.5482294583737602,0.8709677419354839,1.0,1.0,1/5,12.67%,CYBA
prerank,GO_Biological_Process_2021__negative regulation of interferon-gamma production (GO:0032689),0.28273444697780553,0.5481970272502353,0.975609756097561,0.9957644865869578,1.0,4/16,15.40%,DDIT3;LGALS9;LAPTM5;CR1
prerank,GO_Biological_Process_2021__porphyrin-containing compound catabolic process (GO:0006787),0.3365807013869396,0.5474754138244208,0.9545454545454546,0.9954016070222322,1.0,1/6,13.92%,SLCO2B1
prerank,GO_Biological_Process_2021__heme catabolic process (GO:0042167),0.3365807013869396,0.5474754138244208,0.9545454545454546,0.9954016070222322,1.0,1/6,13.92%,SLCO2B1
prerank,GO_Biological_Process_2021__negative regulation of peptide hormone secretion (GO:0090278),0.32028346915805117,0.5470764153677405,1.0,0.9952076263975214,1.0,2/8,25.41%,KCNB1;SIRT4
prerank,Reactome_2022__Defects In Vitamin And Cofactor Metabolism R-HSA-3296482,-0.31630509521657046,-0.5466256169033196,0.9818181818181818,1.0,1.0,4/13,30.78%,MCCC2;MMAB;MTRR;LMBRD1
prerank,GO_Biological_Process_2021__dopamine metabolic process (GO:0042417),-0.35963812733751177,-0.5463488476532482,0.9629629629629629,1.0,1.0,1/6,9.85%,COMT
prerank,GO_Biological_Process_2021__cardiolipin metabolic process (GO:0032048),-0.33099662162162163,-0.5460647245887182,0.9682539682539683,1.0,1.0,9/9,66.93%,PLA2G4A;HADHB;PNPLA8;TAMM41;HADHA;PLA2G6;PGS1;LCLAT1;SLC27A1
prerank,GO_Biological_Process_2021__calcium ion export (GO:1901660),-0.3537110529426666,-0.5455775585927191,0.9387755102040817,1.0,1.0,6/6,64.66%,ATP2B4;SLC8B1;SLC8A2;ATP2B1;LETM1;SLC35G1
prerank,GO_Biological_Process_2021__acyl-CoA metabolic process (GO:0006637),-0.2982660934142672,-0.5454855300832898,0.9464285714285714,1.0,1.0,5/21,18.11%,THEM4;ACOT9;MCEE;ACSM5;DLST
prerank,GO_Biological_Process_2021__regulation of aerobic respiration (GO:1903715),0.31985326599995006,0.5450458363260416,0.9411764705882353,0.9956164180335773,1.0,1/9,3.96%,CBFA2T3
prerank,Reactome_2022__tRNA Modification In Nucleus And Cytosol R-HSA-6782315,0.257651299837048,0.5448389593582146,1.0,0.995346276043431,1.0,6/27,24.74%,NSUN2;PUS1;DUS2;PUS7;TRIT1;CDKAL1
prerank,Reactome_2022__Thromboxane Signaling Thru TP Receptor R-HSA-428930,-0.31540716899089744,-0.5446533877583213,0.9655172413793104,1.0,1.0,1/13,4.88%,GNB5
prerank,GO_Biological_Process_2021__regulation of histone deacetylation (GO:0031063),-0.34607628777071364,-0.5445732339076342,0.9827586206896551,1.0,1.0,4/8,28.16%,AKAP8;CTBP1;AKAP8L;SPHK2
prerank,GO_Biological_Process_2021__lipid phosphorylation (GO:0046834),-0.3174457063068927,-0.5436608025313043,0.9811320754716981,1.0,1.0,2/9,23.87%,DGKD;DGKH
prerank,Reactome_2022__MECP2 Regulates Transcription Of Neuronal Ligands R-HSA-9022702,0.36285298634428914,0.5434736898652864,0.9649122807017544,0.9955116826110991,1.0,1/5,9.84%,HDAC1
prerank,GO_Biological_Process_2021__pre-miRNA processing (GO:0031054),0.2958785197268701,0.5433847759734319,1.0,0.9952417413739574,1.0,3/11,23.72%,DROSHA;AGO1;MRPL44
prerank,GO_Biological_Process_2021__regulation of antigen receptor-mediated signaling pathway (GO:0050854),0.3025568293478392,0.54190314985789,0.9473684210526315,0.9954179552731833,1.0,1/9,6.90%,RUNX1
prerank,"GO_Biological_Process_2021__regulation of DNA-templated transcription, initiation (GO:2000142)",0.22549434920408898,0.5418217943362285,1.0,0.9951409615472131,1.0,10/49,22.38%,MITF;TCF7L2;PTEN;JUN;TNRC6C;CBFB;TRIM28;MED24;AGO1;MED13
prerank,Reactome_2022__Branched-chain Amino Acid Catabolism R-HSA-70895,0.2761451094372913,0.541465054368452,0.9714285714285714,0.9949511078474232,1.0,4/17,26.76%,DBT;AUH;SOAT1;PPM1K
prerank,GO_Biological_Process_2021__recombinational repair (GO:0000725),-0.2473337564527264,-0.5407940845233722,0.9855072463768116,1.0,1.0,17/56,26.15%,HUS1;BRCA2;XRCC3;NABP1;RPA3;BRCA1;RECQL5;ZSWIM7;WRN;NUCKS1;AP5Z1;EXD2;SLX4;RECQL;POLQ;LIG3;MMS22L
prerank,GO_Biological_Process_2021__cellular response to amino acid starvation (GO:0034198),-0.2523849109049943,-0.5397426894198846,1.0,1.0,1.0,5/58,10.33%,ATP6V1F;LAMTOR5;EIF2AK2;ITFG2;LARS1
prerank,GO_Biological_Process_2021__mitotic metaphase plate congression (GO:0007080),-0.26310441235583987,-0.5396566991722164,1.0,1.0,1.0,6/31,20.58%,RAB11A;MIS12;PSRC1;DCTN2;RMDN1;CHMP6
prerank,GO_Biological_Process_2021__regulation of gene expression by genetic imprinting (GO:0006349),-0.35338682866614746,-0.5394934385810226,0.9310344827586207,1.0,1.0,1/6,16.76%,KDM1B
prerank,GO_Biological_Process_2021__positive regulation of interleukin-13 production (GO:0032736),-0.3767039242933009,-0.5394299738862179,0.9649122807017544,1.0,1.0,2/5,17.61%,HLA-E;IL18
prerank,GO_Biological_Process_2021__response to amino acid starvation (GO:1990928),-0.2515205347854987,-0.5392124965894386,1.0,1.0,1.0,5/59,10.33%,ATP6V1F;LAMTOR5;EIF2AK2;ITFG2;LARS1
prerank,GO_Biological_Process_2021__regulation of mRNA 3'-end processing (GO:0031440),0.2885615626175605,0.5383360608698152,1.0,0.9955547063640421,1.0,3/10,16.20%,BARD1;AHCYL1;PAPOLA
prerank,GO_Biological_Process_2021__positive regulation of viral entry into host cell (GO:0046598),-0.3384427800661617,-0.5379973779794728,0.9607843137254902,1.0,1.0,4/8,24.40%,LGALS1;CD74;HLA-DRB1;CD4
prerank,GO_Biological_Process_2021__positive regulation by symbiont of entry into host (GO:0075294),-0.3384427800661617,-0.5379973779794728,0.9607843137254902,1.0,1.0,4/8,24.40%,LGALS1;CD74;HLA-DRB1;CD4
prerank,GO_Biological_Process_2021__positive regulation of small GTPase mediated signal transduction (GO:0051057),0.2689821628459477,0.5379022767215774,1.0,0.9953503564677922,1.0,4/20,13.55%,RELN;ITGAV;SHOC2;VAV1
prerank,GO_Biological_Process_2021__positive regulation of viral life cycle (GO:1903902),-0.28133136730409464,-0.5376427519537242,0.9841269841269841,1.0,1.0,4/19,18.79%,VPS37B;LGALS1;CD74;HLA-DRB1
prerank,Reactome_2022__PI3K/AKT Activation R-HSA-198203,-0.34207030866660554,-0.5371909245618658,0.96,1.0,1.0,1/5,13.75%,PIK3CB
prerank,GO_Biological_Process_2021__positive regulation of histone H4 acetylation (GO:0090240),0.3568263391726072,0.5367617351716623,1.0,0.9953705908843873,1.0,1/6,8.34%,AUTS2
prerank,GO_Biological_Process_2021__positive regulation of IRE1-mediated unfolded protein response (GO:1903896),-0.38521443804733324,-0.5367606714062039,0.9583333333333334,1.0,1.0,1/5,19.79%,TMEM33
prerank,GO_Biological_Process_2021__negative regulation of cell communication (GO:0010648),-0.32233695715307487,-0.5339790211057104,0.9649122807017544,1.0,1.0,1/9,7.60%,NLRP12
prerank,GO_Biological_Process_2021__phagosome maturation (GO:0090382),0.26248288293636757,0.5336928007738937,1.0,0.9960060691673702,1.0,12/28,27.25%,RAB7A;ATP6V1B2;RAB14;TCIRG1;ATP6V0B;ATP6V0D1;RAB38;ATP6V0E2;SLAMF8;RAB20;ATP6V1G1;PIKFYVE
prerank,Reactome_2022__TNFR1-induced Proapoptotic Signaling R-HSA-5357786,-0.30898916182896485,-0.533378397984375,0.9661016949152542,1.0,1.0,1/11,8.14%,TNFAIP3
prerank,Reactome_2022__Beta Oxidation Of decanoyl-CoA To octanoyl-CoA-CoA R-HSA-77346,-0.3504179684201638,-0.5317858939756029,0.9347826086956522,1.0,1.0,6/6,64.98%,HADHB;ECHS1;HADHA;HADH;ACADM;MECR
prerank,Reactome_2022__TRAF6 Mediated NF-kB Activation R-HSA-933542,0.2647381259067546,0.5317260822189487,0.9642857142857143,0.996322766060114,1.0,4/21,24.74%,TRAF6;MAP3K1;AGER;TANK
prerank,GO_Biological_Process_2021__transcription initiation from RNA polymerase III promoter (GO:0006384),0.3257345491388045,0.5313723387256863,0.9210526315789473,0.9961003469324554,1.0,5/5,67.44%,BDP1;CRCP;BRF1;POLR3H;GTF3C1
prerank,GO_Biological_Process_2021__negative regulation of defense response to virus (GO:0050687),0.35201915417279833,0.5310991853014015,1.0,0.9958816816114838,1.0,3/6,26.66%,ILRUN;MICB;TRAF3IP1
prerank,Reactome_2022__PKA Activation In Glucagon Signaling R-HSA-164378,-0.3036646247008215,-0.5305067943502966,0.9818181818181818,1.0,1.0,2/13,17.40%,PRKAR1B;PRKAR2B
prerank,GO_Biological_Process_2021__oligosaccharide catabolic process (GO:0009313),-0.31519653046511953,-0.5301091609114044,1.0,1.0,1.0,2/7,27.10%,GBA3;MANBA
prerank,Reactome_2022__Initial Triggering Of Complement R-HSA-166663,-0.3288086197101044,-0.5299353279012157,0.953125,1.0,1.0,3/7,21.85%,C3;C1QB;C1QC
prerank,GO_Biological_Process_2021__rRNA catabolic process (GO:0016075),-0.30516433133015186,-0.5292654177547477,0.96875,1.0,1.0,3/11,19.17%,EXOSC10;DEDD2;TRIR
prerank,GO_Biological_Process_2021__regulation of protein K63-linked ubiquitination (GO:1900044),0.3040960416963316,0.5291181011168363,0.9512195121951219,0.9960752237750582,1.0,2/8,17.16%,SASH1;DDX3X
prerank,GO_Biological_Process_2021__intracellular pH reduction (GO:0051452),-0.27129166983594816,-0.5290513080160296,0.9836065573770492,1.0,1.0,2/28,10.20%,ATP6V1F;SLC11A1
prerank,GO_Biological_Process_2021__cell junction disassembly (GO:0150146),-0.3711060838674958,-0.5290208590283512,0.9482758620689655,1.0,1.0,3/5,29.52%,C1QB;C1QC;C1QA
prerank,GO_Biological_Process_2021__kinetochore assembly (GO:0051382),-0.3372869990175374,-0.5288949347277266,0.9344262295081968,1.0,1.0,2/6,18.36%,MIS12;CENPF
prerank,GO_Biological_Process_2021__activation of cysteine-type endopeptidase activity (GO:0097202),-0.31149298695411554,-0.5288279012345883,1.0,1.0,1.0,1/10,12.39%,CYFIP2
prerank,GO_Biological_Process_2021__histone-threonine phosphorylation (GO:0035405),-0.3233704829449511,-0.5286900966928502,0.9791666666666666,1.0,1.0,5/5,67.69%,VRK1;PKN1;PRKCA;DCAF1;PRKCB
prerank,Reactome_2022__Uptake And Function Of Anthrax Toxins R-HSA-5210891,0.29825328055098976,0.5284141034296569,1.0,0.9959434269162707,1.0,5/10,25.02%,MAP2K1;ANTXR1;MAP2K2;MAP2K7;MAP2K4
prerank,GO_Biological_Process_2021__pyrimidine nucleoside salvage (GO:0043097),-0.3209317564801434,-0.5278433265294179,0.9838709677419355,1.0,1.0,1/8,8.20%,TYMP
prerank,GO_Biological_Process_2021__pyrimidine-containing compound salvage (GO:0008655),-0.3209317564801434,-0.5278433265294179,0.9838709677419355,1.0,1.0,1/8,8.20%,TYMP
prerank,GO_Biological_Process_2021__regulation of ER-associated ubiquitin-dependent protein catabolic process (GO:1903069),0.28727305756882515,0.5269108962332207,0.9787234042553191,0.9959995578287155,1.0,3/8,22.80%,USP14;SGTA;UBQLN1
prerank,GO_Biological_Process_2021__regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway (GO:1903376),-0.34619366515280536,-0.5266779175591387,0.9636363636363636,1.0,1.0,2/7,22.45%,HIF1A;PARK7
prerank,GO_Biological_Process_2021__regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),0.2967865377261933,0.5266052913084374,0.9666666666666667,0.995784806090355,1.0,2/15,8.54%,WASF2;CTNNA2
prerank,GO_Biological_Process_2021__prostaglandin biosynthetic process (GO:0001516),-0.293517831908867,-0.5264267880366829,0.9814814814814815,1.0,1.0,2/10,15.77%,PTGES2;CD74
prerank,GO_Biological_Process_2021__negative regulation of signaling (GO:0023057),-0.30367576516201794,-0.5258302490526628,0.9821428571428571,1.0,1.0,1/11,7.60%,NLRP12
prerank,Reactome_2022__Nucleotide-like (Purinergic) Receptors R-HSA-418038,0.3354879277036732,0.5254707793935469,1.0,0.9957434763399017,1.0,1/6,11.03%,P2RY12
prerank,GO_Biological_Process_2021__positive regulation of DNA replication (GO:0045740),0.3142512569951169,0.5252337865012593,1.0,0.9955036734464101,1.0,2/10,16.29%,BRPF3;FAF1
prerank,CellMarker_Augmented_2021__Keratinocyte Progenitor cell:Skin,-0.26778901239291425,-0.5250019374611115,0.987012987012987,1.0,1.0,5/31,14.85%,APOD;PTPRB;SPARCL1;ABCA8;C3
prerank,Reactome_2022__HSF1-dependent Transactivation R-HSA-3371571,0.24630421806355215,0.5248544509649692,1.0,0.9953037064951665,1.0,1/26,2.99%,MRPL18
prerank,Reactome_2022__Synthesis Of diphthamide-EEF2 R-HSA-5358493,0.340867281873233,0.5240236841561144,0.9523809523809523,0.9952517435187007,1.0,1/5,7.25%,DPH5
prerank,GO_Biological_Process_2021__regulation of interleukin-13 production (GO:0032656),-0.35396024064840476,-0.5237979081177832,1.0,1.0,1.0,4/6,29.40%,HLA-E;IL18;SPHK2;TNFRSF21
prerank,GO_Biological_Process_2021__glucuronate catabolic process to xylulose 5-phosphate (GO:0019640),-0.34408536013613433,-0.5224462390331832,0.9629629629629629,1.0,1.0,3/5,29.14%,CRYL1;AKR1A1;SORD
prerank,Reactome_2022__Formation Of Xylulose-5-Phosphate R-HSA-5661270,-0.34408536013613433,-0.5224462390331832,0.9629629629629629,1.0,1.0,3/5,29.14%,CRYL1;AKR1A1;SORD
prerank,GO_Biological_Process_2021__glucuronate catabolic process (GO:0006064),-0.34408536013613433,-0.5224462390331832,0.9629629629629629,1.0,1.0,3/5,29.14%,CRYL1;AKR1A1;SORD
prerank,GO_Biological_Process_2021__xylulose 5-phosphate biosynthetic process (GO:1901159),-0.34408536013613433,-0.5224462390331832,0.9629629629629629,1.0,1.0,3/5,29.14%,CRYL1;AKR1A1;SORD
prerank,Reactome_2022__Erythropoietin Activates RAS R-HSA-9027284,0.27113308756827137,0.5219451089456435,0.9767441860465116,0.9955026930127039,1.0,1/10,13.55%,VAV1
prerank,GO_Biological_Process_2021__cellular response to glucagon stimulus (GO:0071377),-0.2981720663174363,-0.5218386645410538,1.0,1.0,1.0,1/13,6.63%,PRKAR1B
prerank,Reactome_2022__Transport Of RCbl Within Body R-HSA-9758890,-0.3444782168186424,-0.5211050951823805,0.9444444444444444,1.0,1.0,5/5,65.58%,LMBRD1;LRP2;ABCC1;LDLRAP1;ABCD4
prerank,GO_Biological_Process_2021__zymogen activation (GO:0031638),0.26523046518334537,0.5208957185162156,0.972972972972973,0.9954903512633058,1.0,4/18,16.68%,MMP14;NLRC4;CTSH;GRIN2A
prerank,GO_Biological_Process_2021__regulation of collagen biosynthetic process (GO:0032965),0.3050341799019427,0.5205746080857511,0.9512195121951219,0.9952473939043986,1.0,1/8,6.90%,RUNX1
prerank,GO_Biological_Process_2021__DNA damage checkpoint signaling (GO:0000077),-0.2821980403733185,-0.520379732801818,1.0,1.0,1.0,2/23,13.39%,HUS1;RAD9A
prerank,GO_Biological_Process_2021__negative regulation of stress fiber assembly (GO:0051497),-0.26883241491176724,-0.5203552439257333,0.9814814814814815,1.0,1.0,4/19,17.44%,CGNL1;PFN1;STMN1;INPP5K
prerank,Reactome_2022__Deadenylation Of mRNA R-HSA-429947,0.23733182764832023,0.5202113934154442,1.0,0.9950189962479671,1.0,2/22,9.99%,CNOT7;CNOT2
prerank,GO_Biological_Process_2021__cardiolipin acyl-chain remodeling (GO:0035965),-0.34211415062478895,-0.5200956819477585,0.9272727272727272,1.0,1.0,5/5,65.81%,PLA2G4A;HADHB;HADHA;PLA2G6;LCLAT1
prerank,Reactome_2022__DNA Strand Elongation R-HSA-69190,0.26633204429381796,0.5196902268626643,1.0,0.9948267523623298,1.0,3/19,12.91%,GINS3;POLA1;GINS1
prerank,GO_Biological_Process_2021__response to potassium ion (GO:0035864),0.3499769161763598,0.5193441671978648,0.9019607843137255,0.9943238526084394,1.0,2/5,22.06%,SLC12A2;DLG2
prerank,GO_Biological_Process_2021__cellular response to potassium ion (GO:0035865),0.3499769161763598,0.5193441671978648,0.9019607843137255,0.9943238526084394,1.0,2/5,22.06%,SLC12A2;DLG2
prerank,GO_Biological_Process_2021__negative regulation of vascular associated smooth muscle cell differentiation (GO:1905064),-0.3172539840698609,-0.5191261753189549,0.9622641509433962,1.0,1.0,3/6,28.21%,DNMT1;PDGFB;PDCD4
prerank,GO_Biological_Process_2021__negative regulation of JNK cascade (GO:0046329),0.27992690133717585,0.5189054634048633,1.0,0.9941499910256065,1.0,7/22,24.31%,SIRPA;FKTN;AIDA;HDAC3;DNAJA1;PER1;HIPK3
prerank,GO_Biological_Process_2021__histone ubiquitination (GO:0016574),-0.29430535848994044,-0.5170434990450518,0.9827586206896551,1.0,1.0,4/18,21.66%,DTX3L;UHRF1;LEO1;ATXN7L3
prerank,GO_Biological_Process_2021__spliceosomal snRNP assembly (GO:0000387),-0.2724991080932445,-0.5170242101881495,1.0,1.0,1.0,3/29,16.62%,SNRPD2;PRPF3;LSM4
prerank,GO_Biological_Process_2021__response to mitochondrial depolarisation (GO:0098780),-0.3389902060114826,-0.5166178819075087,0.9482758620689655,1.0,1.0,5/5,66.12%,BECN1;AMBRA1;ATG14;GPS2;SQSTM1
prerank,Reactome_2022__HSF1 Activation R-HSA-3371511,0.2533416648594172,0.5161598111353471,0.9787234042553191,0.9945085653891997,1.0,1/22,2.99%,MRPL18
prerank,Reactome_2022__Lysosome Vesicle Biogenesis R-HSA-432720,0.24003369062004182,0.515191054295181,0.9705882352941176,0.9944318381442941,1.0,6/28,22.31%,DNAJC6;AP4E1;AP1M1;AP1G2;GNS;AP4B1
prerank,Reactome_2022__COPI-independent Golgi-to-ER Retrograde Traffic R-HSA-6811436,-0.25941341414450314,-0.5148918718505676,1.0,1.0,1.0,6/31,22.09%,DCTN6;DCTN4;DYNC1LI2;DCTN2;DYNC1I2;PAFAH1B2
prerank,GO_Biological_Process_2021__diacylglycerol metabolic process (GO:0046339),-0.26910790362744036,-0.5145321211502033,0.9636363636363636,1.0,1.0,5/16,33.45%,DGKD;DGKH;PNPLA2;DGKG;LIPE
prerank,GO_Biological_Process_2021__tail-anchored membrane protein insertion into ER membrane (GO:0071816),0.2920980491337743,0.5138778214783911,0.975,0.9944558069246892,1.0,4/11,21.12%,EMC8;BAG6;MMGT1;SGTA
prerank,GO_Biological_Process_2021__DNA replication-dependent nucleosome assembly (GO:0006335),-0.31634221006641616,-0.5138005371359055,0.9807692307692307,1.0,1.0,1/5,17.45%,HAT1
prerank,GO_Biological_Process_2021__DNA replication-dependent nucleosome organization (GO:0034723),-0.31634221006641616,-0.5138005371359055,0.9807692307692307,1.0,1.0,1/5,17.45%,HAT1
prerank,GO_Biological_Process_2021__Notch receptor processing (GO:0007220),-0.29200300409241176,-0.5136908443515168,0.9516129032258065,1.0,1.0,2/7,29.51%,APH1B;GALNT11
prerank,PanglaoDB_Augmented_2021__Keratinocytes,0.3197177573038956,0.5130744030292159,0.9523809523809523,0.9943539888527934,1.0,1/9,7.39%,IL13RA1
prerank,GO_Biological_Process_2021__positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),-0.29342991915959843,-0.5121362297657446,0.9655172413793104,1.0,1.0,6/16,27.18%,EIF2AK2;NOD2;MID1;LYN;CARD9;PDCD10
prerank,CellMarker_Augmented_2021__Secretory Progenitor cell:Esophagus,-0.2559432857986153,-0.5115826866398712,1.0,1.0,1.0,5/36,17.23%,OAS1;TMPRSS11D;GK;VASN;CACNB1
prerank,CellMarker_Augmented_2021__Muscle cell:Embryoid Body,0.2177054204148343,0.5113245801277098,1.0,0.9944067058937655,1.0,16/33,31.72%,PTPRD;RUNX1T1;RBFOX1;FBXL7;MAPK4;PRKG1;CXCL12;SEMA6D;COL14A1;SLIT2;SORBS1;LDB2;SYNDIG1;CACNA2D1;GPRC5B;ATP1A2
prerank,GO_Biological_Process_2021__cellular response to oxygen levels (GO:0071453),0.3307351538191105,0.5111312463683481,1.0,0.994139767151633,1.0,1/8,6.73%,CPEB4
prerank,GO_Biological_Process_2021__nucleoside salvage (GO:0043174),-0.3091356051211043,-0.5106181368305592,1.0,1.0,1.0,1/9,8.20%,TYMP
prerank,GO_Biological_Process_2021__regulation of mitochondrial translation (GO:0070129),-0.28524830873939055,-0.5080994065359764,0.9672131147540983,1.0,1.0,5/15,22.19%,RPUSD4;TRUB2;UQCC2;C1QBP;RPUSD3
prerank,GO_Biological_Process_2021__positive regulation of cell-cell adhesion mediated by cadherin (GO:2000049),0.34802065726148373,0.5077480522097052,1.0,0.9946233376957899,1.0,2/5,12.87%,AFDN;TJP1
prerank,CellMarker_Augmented_2021__Pancreatic Polypeptide cell:Pancreas,0.307822800779861,0.5069927501240938,0.9772727272727273,0.9944713466062624,1.0,2/7,12.79%,THSD7A;UBA2
prerank,GO_Biological_Process_2021__regulation of alpha-beta T cell proliferation (GO:0046640),-0.33713133968104925,-0.5051799649670404,0.9629629629629629,1.0,1.0,2/6,18.87%,IRF1;TNFRSF14
prerank,GO_Biological_Process_2021__prostanoid biosynthetic process (GO:0046457),-0.3024296141271077,-0.5048897744513382,0.98,1.0,1.0,1/7,15.77%,CD74
prerank,GO_Biological_Process_2021__myoblast fusion (GO:0007520),0.33125124846137954,0.5045812846030758,0.9459459459459459,0.9947033603864478,1.0,2/6,16.74%,JAM2;ADGRB3
prerank,Reactome_2022__Cytosolic Sulfonation Of Small Molecules R-HSA-156584,-0.29132528085142323,-0.5043630004041749,0.9642857142857143,1.0,1.0,10/10,70.90%,TPST2;PODXL2;PAPSS2;TPST1;SLC26A2;SLC35B3;SULT4A1;BPNT1;BPNT2;PAPSS1
prerank,CellMarker_Augmented_2021__Pit cell:Stomach,0.3115172214138646,0.5041955215664028,0.9787234042553191,0.9944653537914553,1.0,1/5,11.12%,GALNT7
prerank,GO_Biological_Process_2021__axo-dendritic transport (GO:0008088),-0.32390441611078274,-0.5038991811602181,0.9682539682539683,1.0,1.0,6/6,67.63%,SPG11;APBA1;DCTN1;APP;MAPT;HSPA8
prerank,GO_Biological_Process_2021__negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),0.29467557917313497,0.5036602571270938,0.9512195121951219,0.9942561796453154,1.0,2/7,23.37%,NEDD4;DAB2IP
prerank,GO_Biological_Process_2021__microtubule depolymerization (GO:0007019),-0.3121064617556454,-0.502348008159614,0.9818181818181818,1.0,1.0,1/8,14.46%,STMN1
prerank,GO_Biological_Process_2021__kinetochore organization (GO:0051383),-0.306743337430191,-0.502034537149859,0.9365079365079365,1.0,1.0,2/7,18.36%,MIS12;CENPF
prerank,GO_Biological_Process_2021__interleukin-15-mediated signaling pathway (GO:0035723),-0.2903116817298758,-0.5017996902783267,0.9516129032258065,1.0,1.0,10/10,71.00%,CD4;STAT3;IL15RA;STAT5B;JAK1;PLCB1;GRB2;IL15;JAK3;STAT5A
prerank,GO_Biological_Process_2021__cellular response to interleukin-15 (GO:0071350),-0.2903116817298758,-0.5017996902783267,0.9516129032258065,1.0,1.0,10/10,71.00%,CD4;STAT3;IL15RA;STAT5B;JAK1;PLCB1;GRB2;IL15;JAK3;STAT5A
prerank,GO_Biological_Process_2021__dosage compensation by inactivation of X chromosome (GO:0009048),-0.2815045533936647,-0.5014451549837646,0.9827586206896551,1.0,1.0,5/11,26.07%,BRCA1;LRIF1;SMCHD1;YTHDC1;METTL3
prerank,GO_Biological_Process_2021__positive regulation of interleukin-6 production (GO:0032755),-0.24029603379750586,-0.5010415907462115,1.0,1.0,1.0,15/47,28.41%,AIF1;TYROBP;CYBA;NOD2;CD74;TLR2;CLEC7A;CARD9;ARHGEF2;PTPN11;LILRB2;MYD88;BCL10;SPHK2;STAT3
prerank,GO_Biological_Process_2021__positive regulation of fibroblast migration (GO:0010763),0.2859917878267755,0.5006561682105813,0.9795918367346939,0.9945203073141197,1.0,3/8,25.72%,PTK2;PRKCE;TGFB1
prerank,GO_Biological_Process_2021__mitotic cytokinetic process (GO:1902410),-0.2732156486401256,-0.5000623248477276,0.9836065573770492,1.0,1.0,3/13,20.58%,CNTROB;MITD1;CHMP6
prerank,GO_Biological_Process_2021__positive regulation of heterochromatin assembly (GO:0031453),0.2634470465256611,0.49919072718574553,1.0,0.9944689207895869,1.0,3/12,19.62%,SIRT6;SETDB2;TRIM28
prerank,GO_Biological_Process_2021__cell surface receptor signaling pathway involved in heart development (GO:0061311),-0.3191365397682776,-0.49911834687491036,0.9811320754716981,1.0,1.0,2/8,13.87%,RBPJ;NOTCH2
prerank,GO_Biological_Process_2021__branched-chain amino acid metabolic process (GO:0009081),0.26462884939811093,0.49878434941146743,0.9655172413793104,0.9939973644606471,1.0,2/17,16.90%,DBT;AUH
prerank,GO_Biological_Process_2021__branched-chain amino acid catabolic process (GO:0009083),0.26462884939811093,0.49878434941146743,0.9655172413793104,0.9939973644606471,1.0,2/17,16.90%,DBT;AUH
prerank,GO_Biological_Process_2021__negative regulation of chromosome organization (GO:2001251),0.28265373454351206,0.49785358277665337,0.9347826086956522,0.9939139637966823,1.0,3/7,26.09%,ERCC4;ERCC1;WAPL
prerank,GO_Biological_Process_2021__positive regulation of protein localization to centrosome (GO:1904781),0.33753339635123414,0.497424713916236,0.9285714285714286,0.9937160818731973,1.0,1/5,15.67%,GSK3B
prerank,GO_Biological_Process_2021__neuron projection organization (GO:0106027),0.27249678153359136,0.4970087595347889,1.0,0.9934932751719915,1.0,2/11,19.43%,GSK3B;PLS1
prerank,GO_Biological_Process_2021__positive regulation of chromatin organization (GO:1905269),-0.29342084287145737,-0.4967262745783893,0.9814814814814815,1.0,1.0,1/11,12.59%,TERF2IP
prerank,GO_Biological_Process_2021__muscle cell migration (GO:0014812),-0.33525227339112695,-0.49522929038876035,1.0,1.0,1.0,3/7,29.93%,THBS4;PLAT;AAMP
prerank,KEGG_2021_Human__RIG-I-like receptor signaling pathway,-0.23746417923519653,-0.4950917150139429,1.0,1.0,1.0,1/41,2.65%,DHX58
prerank,GO_Biological_Process_2021__regulation of transferase activity (GO:0051338),-0.2832478293382935,-0.4945806474013133,0.9696969696969697,1.0,1.0,2/13,15.20%,NLRC5;PARP4
prerank,GO_Biological_Process_2021__tRNA methylation (GO:0030488),-0.26310415029068174,-0.49098405125399813,0.9855072463768116,1.0,1.0,13/24,32.31%,GTPBP3;TRMT44;THUMPD3;METTL2A;FTSJ1;WDR6;DALRD3;THUMPD2;ALKBH8;TARBP1;THADA;NSUN6;TRMT13
prerank,GO_Biological_Process_2021__positive regulation of oxidoreductase activity (GO:0051353),0.26069086949627296,0.4894064947974835,0.9772727272727273,0.9948587679929356,1.0,1/9,7.30%,TNF
prerank,GO_Biological_Process_2021__desensitization of G protein-coupled receptor signaling pathway (GO:0002029),-0.3109009541501309,-0.48930450157073574,0.98,1.0,1.0,6/6,68.93%,GRK2;GTF2H2;ADRB2;GRK3;ARRB1;ARRB2
prerank,GO_Biological_Process_2021__regulation of cAMP-mediated signaling (GO:0043949),-0.2725583860698977,-0.48775164737587634,0.9655172413793104,1.0,1.0,1/16,6.63%,PRKAR1B
prerank,KEGG_2021_Human__Renin-angiotensin system,0.27475270304594734,0.4857803980217305,1.0,0.9951721242349431,1.0,3/8,24.68%,PREP;THOP1;PRCP
prerank,GO_Biological_Process_2021__regulation of SMAD protein signal transduction (GO:0060390),0.259266581940564,0.48479976113814305,0.9545454545454546,0.9950992153763887,1.0,3/12,15.36%,BMPR1A;TGFBR1;KIAA0319
prerank,Reactome_2022__RHO GTPases Activate KTN1 R-HSA-5625970,-0.2892736486486487,-0.4844946269493488,0.9824561403508771,1.0,1.0,9/9,71.10%,KLC1;RNASE1;RHOG;KTN1;KLC4;KIF5A;CDC42;KIF5B;RHOA
prerank,GO_Biological_Process_2021__regulation of melanin biosynthetic process (GO:0048021),0.2932598419877033,0.4833818419864157,0.975609756097561,0.9950549404532218,1.0,5/7,28.19%,RAPGEF2;OPN3;ZEB2;MFSD12;GIPC1
prerank,GO_Biological_Process_2021__mitochondrial genome maintenance (GO:0000002),-0.2766439720869081,-0.4827582404610358,0.9710144927536232,1.0,1.0,4/12,24.47%,TYMP;MGME1;MEF2A;SLC25A36
prerank,GO_Biological_Process_2021__leukotriene biosynthetic process (GO:0019370),0.27014334293375486,0.4816653046703906,1.0,0.9950499908021336,1.0,3/9,27.72%,ALOX5AP;MGST3;MGST2
prerank,GO_Biological_Process_2021__regulation of hemopoiesis (GO:1903706),-0.2915457678640065,-0.48019329778314546,0.9636363636363636,1.0,1.0,2/8,17.08%,PTN;PURB
prerank,GO_Biological_Process_2021__negative regulation of microtubule polymerization (GO:0031115),0.275653103531694,0.4797639748063953,0.9787234042553191,0.9951521880466114,1.0,3/11,19.55%,DYRK1A;SNCA;MAP2
prerank,GO_Biological_Process_2021__regulation of lipase activity (GO:0060191),-0.270882488024562,-0.4793710446720048,0.9344262295081968,1.0,1.0,2/7,16.99%,PCSK5;LMF1
prerank,GO_Biological_Process_2021__positive regulation of protein polyubiquitination (GO:1902916),-0.31182426479048764,-0.47865050414608123,0.9846153846153847,1.0,1.0,2/7,19.00%,NOD2;PTPN22
prerank,GO_Biological_Process_2021__ribonucleoprotein complex disassembly (GO:0032988),-0.3046525373638436,-0.47755846793359985,0.9636363636363636,1.0,1.0,6/6,69.56%,KLC1;ZFAND1;TFIP11;DHX8;VCP;KIF5B
prerank,GO_Biological_Process_2021__positive regulation of nitric-oxide synthase activity (GO:0051000),-0.2854137521699323,-0.47727746247998964,0.9827586206896551,1.0,1.0,3/12,16.05%,HIF1A;PIK3CB;NOS1AP
prerank,GO_Biological_Process_2021__negative regulation of double-strand break repair via homologous recombination (GO:2000042),-0.2789979021923027,-0.4767903601582645,0.9841269841269841,1.0,1.0,4/14,25.75%,FANCB;SMCHD1;POLQ;PARPBP
prerank,GO_Biological_Process_2021__I-kappaB phosphorylation (GO:0007252),0.27025792435878504,0.47655216758868446,0.975,0.9954185595918256,1.0,2/8,16.34%,TLR7;MAP3K7
prerank,Reactome_2022__Synthesis Of Bile Acids And Bile Salts Via 7Alpha-Hydroxycholesterol R-HSA-193368,0.27153716216216217,0.4762566431257815,0.9767441860465116,0.9951600846422016,1.0,9/9,72.87%,NCOA2;NCOA1;HSD17B4;CYP7B1;RXRA;ACOT8;SYCP2;CYP27A1;SLC27A5
prerank,CellMarker_Augmented_2021__Bipolar cell:Retina,-0.23861981663488796,-0.47492779051184797,1.0,1.0,1.0,1/25,4.08%,SEZ6L2
prerank,GO_Biological_Process_2021__engulfment of apoptotic cell (GO:0043652),0.2677025171520179,0.4748964760109171,1.0,0.9950908815930294,1.0,5/10,30.82%,RHOBTB1;XKR6;MEGF10;RHOH;XKR4
prerank,GO_Biological_Process_2021__protein desumoylation (GO:0016926),-0.3114075825382082,-0.4743381394248505,0.9821428571428571,1.0,1.0,6/6,68.88%,SENP1;SENP7;SENP5;SENP2;USPL1;SENP6
prerank,GO_Biological_Process_2021__acetyl-CoA biosynthetic process (GO:0006085),-0.28496246477648773,-0.47418332950900327,0.9807692307692307,1.0,1.0,4/9,26.15%,PDHB;PDHA1;ACSS1;MLYCD
prerank,GO_Biological_Process_2021__axoneme assembly (GO:0035082),-0.2611597234363893,-0.4738281872613785,1.0,1.0,1.0,4/11,22.38%,CCDC39;TTC12;CFAP74;DNAI4
prerank,Reactome_2022__Regulated Proteolysis Of p75NTR R-HSA-193692,0.2633252870956745,0.4735377117057906,1.0,0.9949896171051731,1.0,1/8,14.94%,TRAF6
prerank,GO_Biological_Process_2021__miRNA metabolic process (GO:0010586),0.23659602131155408,0.47232830365708445,1.0,0.9949062445795152,1.0,3/15,24.72%,DROSHA;XPO5;SND1
prerank,GO_Biological_Process_2021__regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),-0.2565854016784242,-0.4711355393595593,1.0,1.0,1.0,1/15,8.36%,CALM1
prerank,GO_Biological_Process_2021__histone H3-K4 dimethylation (GO:0044648),-0.3050252659157785,-0.47073578516758663,1.0,1.0,1.0,1/6,14.77%,SETD1A
prerank,GO_Biological_Process_2021__motor neuron axon guidance (GO:0008045),-0.27577859996206056,-0.47065607645406976,0.9444444444444444,1.0,1.0,2/9,23.99%,RAC1;RAC2
prerank,GO_Biological_Process_2021__regulation of mitochondrial gene expression (GO:0062125),0.27273494891497085,0.46846150015271115,1.0,0.9953469643779953,1.0,6/6,72.74%,NSUN3;MTG1;MTG2;ALKBH1;METTL4;MTRES1
prerank,GO_Biological_Process_2021__N-glycan processing (GO:0006491),-0.26022209775858385,-0.46717659132023015,1.0,1.0,1.0,1/17,6.14%,ST8SIA1
prerank,GO_Biological_Process_2021__spliceosomal tri-snRNP complex assembly (GO:0000244),-0.2802537869024195,-0.46711039964822015,0.9807692307692307,1.0,1.0,1/12,11.55%,PRPF3
prerank,GO_Biological_Process_2021__mitotic recombination (GO:0006312),-0.26954863088220804,-0.4663695992914147,0.9821428571428571,1.0,1.0,1/11,9.58%,XRCC3
prerank,GO_Biological_Process_2021__purine ribonucleotide transport (GO:0015868),0.2534229639120373,0.4653730043049955,0.9761904761904762,0.9955094369183669,1.0,3/10,25.94%,SLC25A4;LRRC8D;ABCC5
prerank,GO_Biological_Process_2021__cellular response to arsenic-containing substance (GO:0071243),-0.2610426201012863,-0.46483910679602897,0.9841269841269841,1.0,1.0,1/12,12.13%,ATF3
prerank,Reactome_2022__Defects In Biotin (Btn) Metabolism R-HSA-3323169,-0.28238367561376937,-0.4647791719598597,1.0,1.0,1.0,1/6,17.35%,MCCC2
prerank,Reactome_2022__Defective HLCS Causes Multiple Carboxylase Deficiency R-HSA-3371599,-0.28238367561376937,-0.4647791719598597,1.0,1.0,1.0,1/6,17.35%,MCCC2
prerank,"Reactome_2022__Synthesis, Secretion, And Inactivation Of Glucose-dependent Insulinotropic Polypeptide (GIP) R-HSA-400511",-0.30951339062020944,-0.4639989620359097,1.0,1.0,1.0,2/6,23.96%,SEC11A;SPCS2
prerank,GO_Biological_Process_2021__negative regulation of telomere maintenance via telomerase (GO:0032211),-0.2604394782844659,-0.4630529504857283,1.0,1.0,1.0,1/14,7.08%,EXOSC10
prerank,GO_Biological_Process_2021__regulation of spindle assembly (GO:0090169),-0.24825060353123204,-0.46248845708852493,0.9848484848484849,1.0,1.0,2/20,14.43%,HSPA1B;HSPA1A
prerank,GO_Biological_Process_2021__negative regulation of insulin secretion (GO:0046676),0.26676025487403876,0.46136803340217114,0.9743589743589743,0.9958000682970252,1.0,3/8,25.41%,KLF7;KCNB1;SIRT4
prerank,GO_Biological_Process_2021__negative regulation of cyclin-dependent protein kinase activity (GO:1904030),-0.24839613246108197,-0.4609576022652601,1.0,1.0,1.0,6/16,30.85%,CDKN1C;CDKN1B;TFAP4;CDKN1A;CDKN2A;HEXIM1
prerank,Reactome_2022__EGFR Transactivation By Gastrin R-HSA-2179392,-0.30200945626477543,-0.460626157917104,0.9830508474576272,1.0,1.0,5/5,69.82%,EGFR;PRKCA;NRAS;GRB2;SOS1
prerank,GO_Biological_Process_2021__negative regulation of centriole replication (GO:0046600),-0.3066410234713736,-0.46054914590788276,0.9833333333333333,1.0,1.0,2/6,24.71%,BRCA1;MDM1
prerank,GO_Biological_Process_2021__positive regulation of sodium ion transmembrane transport (GO:1902307),-0.2717835943998607,-0.45693265657482174,0.9591836734693877,1.0,1.0,1/9,12.87%,ATP1B3
prerank,GO_Biological_Process_2021__immune response-regulating cell surface receptor signaling pathway (GO:0002768),-0.2941460732314173,-0.4567017743211371,1.0,1.0,1.0,4/7,26.56%,LYN;FGR;LILRB1;LILRB2
prerank,GO_Biological_Process_2021__histone H3-K4 monomethylation (GO:0097692),0.25883230367512855,0.4562161165850279,0.9811320754716981,0.9963540832664137,1.0,3/7,25.99%,SETD4;SETD1B;KMT2C
prerank,GO_Biological_Process_2021__protein localization to phagophore assembly site (GO:0034497),0.2592589549915546,0.45534526216400517,0.9811320754716981,0.9961422414133347,1.0,2/8,18.97%,ATG13;TRAPPC8
prerank,Reactome_2022__NF-kB Activation Thru FADD/RIP-1 Pathway Mediated By Caspase-8 And -10 R-HSA-933543,0.26271329616489275,0.45482847296927664,1.0,0.9959162911182631,1.0,11/11,73.75%,RIPK1;MAVS;IKBKG;TRIM4;IFIH1;RNF135;CASP8;TRIM25;IKBKB;CHUK;CASP10
prerank,GO_Biological_Process_2021__negative regulation by host of viral process (GO:0044793),-0.30677495339624344,-0.4524269903955275,0.984375,1.0,1.0,3/5,36.88%,PSMC3;CCNK;VAPA
prerank,GO_Biological_Process_2021__posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620),-0.2737529676379927,-0.4513210033150228,1.0,1.0,1.0,1/10,13.39%,SEC62
prerank,PanglaoDB_Augmented_2021__Pluripotent Stem Cells,-0.20458822752766692,-0.4503498780138511,1.0,1.0,1.0,11/52,22.11%,HK2;NPM1;SEPHS1;ZGRF1;FANCI;ATAD5;CENPF;MSH6;PHF6;NCL;CDC7
prerank,KEGG_2021_Human__Folate biosynthesis,-0.2715801259033427,-0.4482025501730847,1.0,1.0,1.0,3/12,22.86%,PTS;MOCOS;AKR1B1
prerank,Reactome_2022__Signaling By Cytosolic FGFR1 Fusion Mutants R-HSA-1839117,-0.2530431315604256,-0.44786328106355994,0.9818181818181818,1.0,1.0,1/16,9.56%,STAT1
prerank,GO_Biological_Process_2021__positive regulation of megakaryocyte differentiation (GO:0045654),-0.28489544856367954,-0.446493071555327,0.9482758620689655,1.0,1.0,2/8,20.77%,ZNF16;PITHD1
prerank,GO_Biological_Process_2021__regulation of oxidative stress-induced neuron death (GO:1903203),-0.28333679182729726,-0.44398272639881897,0.9795918367346939,1.0,1.0,3/6,31.99%,PINK1;REST;TREM2
prerank,GO_Biological_Process_2021__cytoskeleton-dependent cytokinesis (GO:0061640),-0.20651870465121178,-0.44108185091606605,1.0,1.0,1.0,8/49,22.36%,EFHC1;TTC19;STMN1;SNX9;MITD1;CKAP2;MYH10;SEPTIN9
prerank,GO_Biological_Process_2021__positive regulation of neuron differentiation (GO:0045666),-0.2265240252852435,-0.43639843510664755,1.0,1.0,1.0,3/24,14.45%,BRINP2;TCF3;FGF20
prerank,GO_Biological_Process_2021__Golgi disassembly (GO:0090166),0.2598784194528875,0.4353160021885778,0.9767441860465116,0.9984233114114031,1.0,5/5,74.02%,GBF1;PLK3;GOLGA2;VRK1;STX5
prerank,GO_Biological_Process_2021__regulation of response to oxidative stress (GO:1902882),-0.2600516142834637,-0.4352116376942389,1.0,1.0,1.0,2/8,27.12%,PINK1;HEBP2
prerank,GO_Biological_Process_2021__positive regulation of monooxygenase activity (GO:0032770),-0.24452265126115574,-0.4350003177000008,1.0,1.0,1.0,9/15,32.20%,HIF1A;PIK3CB;NOS1AP;PARK7;HTR2B;POR;IL1B;AKT1;TERF2
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial membrane potential (GO:0010918),-0.2953089058333328,-0.43482832346265976,1.0,1.0,1.0,1/5,16.70%,STOML2
prerank,GO_Biological_Process_2021__retinoic acid metabolic process (GO:0042573),0.26791916918294423,0.43217144263293195,1.0,0.9984849432186215,1.0,1/5,15.46%,SCPEP1
prerank,GO_Biological_Process_2021__regulation of phosphate metabolic process (GO:0019220),-0.25461820649427636,-0.43193096720310675,0.9850746268656716,1.0,1.0,1/11,13.28%,MCM7
prerank,GO_Biological_Process_2021__positive regulation of protein deacetylation (GO:0090312),0.2726621775406808,0.4311852095547517,1.0,0.9982620410864358,1.0,2/8,13.48%,DYRK1A;NIPBL
prerank,GO_Biological_Process_2021__hematopoietic stem cell differentiation (GO:0060218),-0.28873223271001025,-0.431113507597078,1.0,0.9999468377393823,1.0,1/5,19.66%,UFL1
prerank,GO_Biological_Process_2021__Golgi to endosome transport (GO:0006895),-0.2296763867544651,-0.4286199656008802,1.0,0.9999386776769785,1.0,3/14,21.27%,AP4M1;WIPI1;VPS13A
prerank,GO_Biological_Process_2021__positive regulation of ER-associated ubiquitin-dependent protein catabolic process (GO:1903071),-0.2591581781380621,-0.4249387512137355,1.0,0.9999811686706,1.0,3/6,28.04%,NFE2L2;BCAP31;HERPUD1
prerank,Reactome_2022__Tie2 Signaling R-HSA-210993,-0.26445873995505964,-0.4214354916824719,0.9827586206896551,0.9999898828585596,1.0,3/8,30.48%,PIK3CB;PTPN11;ANGPT2
prerank,GO_Biological_Process_2021__histone methylation (GO:0016571),0.2331359660835233,0.4208816208532163,1.0,0.998920944511689,1.0,7/17,33.88%,NSD3;PRMT7;SUV39H2;CREBBP;EZH2;SMYD2;NSD1
prerank,GO_Biological_Process_2021__negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),-0.23120642040168093,-0.41624915356536096,1.0,1.0,1.0,5/14,30.85%,CDKN1C;CDKN1B;TFAP4;CDKN2A;HEXIM1
prerank,GO_Biological_Process_2021__regulation of cyclase activity (GO:0031279),-0.2656197230665316,-0.4157954509523575,1.0,0.9999355990840592,1.0,5/5,73.46%,MAPK3;CAP2;MAPK8;CAP1;MAPK14
prerank,GO_Biological_Process_2021__genetic imprinting (GO:0071514),-0.2707090605364452,-0.4141859165177218,1.0,0.9997735432128882,1.0,1/5,16.76%,KDM1B
prerank,GO_Biological_Process_2021__positive regulation of mRNA binding (GO:1902416),0.2715029426553811,0.4110844398577336,0.9836065573770492,0.9994799330646074,1.0,1/5,20.63%,CDK9
prerank,GO_Biological_Process_2021__telomeric D-loop disassembly (GO:0061820),-0.2587132159076676,-0.41073893503352404,1.0,0.9997801899411181,1.0,2/6,25.12%,WRN;SLX4
prerank,Reactome_2022__Small Interfering RNA (siRNA) Biogenesis R-HSA-426486,-0.2536954349255408,-0.4095533442944208,1.0,0.9996077093915458,1.0,1/7,20.58%,DICER1
prerank,Reactome_2022__Removal Of Flap Intermediate R-HSA-69166,-0.2594661326769837,-0.4066701067907017,1.0,0.9995827889875716,1.0,2/8,20.14%,RPA3;PRIM1
prerank,GO_Biological_Process_2021__DNA conformation change (GO:0071103),-0.22769516728624534,-0.40643333355409483,1.0,0.9993640952027124,1.0,13/13,77.26%,HAT1;HMGB2;TOP3B;TOP2A;HMGB1;MTERF1;ERCC3;HHEX;TOP1;KAT6A;TOP3A;TOP2B;ABL1
prerank,GO_Biological_Process_2021__regulation of actin filament organization (GO:0110053),0.24864687119492787,0.40132642321929696,1.0,0.9998858038592622,1.0,3/7,22.44%,PIK3CA;ARHGAP35;CXCL12
prerank,Reactome_2022__TRAF6 Mediated IRF7 Activation R-HSA-933541,0.19742722439262983,0.40079264637650397,1.0,0.999630779697698,1.0,4/14,26.81%,TRAF6;TANK;CREBBP;SIKE1
prerank,GO_Biological_Process_2021__positive regulation of membrane potential (GO:0045838),0.2374266456582177,0.3986225819632523,1.0,0.9994398250976453,1.0,2/7,22.31%,AKT2;GLRX
prerank,GO_Biological_Process_2021__plasma membrane tubulation (GO:0097320),-0.24307499501231686,-0.39665612970094505,1.0,0.9996403823135821,1.0,2/7,22.98%,SNX9;BIN2
prerank,Reactome_2022__YAP1- And WWTR1 (TAZ)-stimulated Gene Expression R-HSA-2032785,-0.2730727011736891,-0.39431468245121126,1.0,0.9994954653273568,1.0,6/6,72.71%,WWTR1;KAT2B;RUNX2;HIPK1;TEAD1;HIPK2
prerank,GO_Biological_Process_2021__stress fiber assembly (GO:0043149),0.20218322388230406,0.39122297692656094,1.0,0.9992427932190623,1.0,7/13,36.81%,PHACTR1;SORBS1;RHOA;KCTD13;ARRB1;TNFAIP1;ZYX
prerank,GO_Biological_Process_2021__contractile actin filament bundle assembly (GO:0030038),0.20218322388230406,0.39122297692656094,1.0,0.9992427932190623,1.0,7/13,36.81%,PHACTR1;SORBS1;RHOA;KCTD13;ARRB1;TNFAIP1;ZYX
prerank,GO_Biological_Process_2021__ncRNA transcription (GO:0098781),-0.21692853522554487,-0.3880998165971717,1.0,0.9995400555602569,1.0,11/11,78.34%,GTF3A;GTF3C1;SIRT7;POLR1G;NIFK;BRF1;SNAPC3;USPL1;SPIN1;MARS1;RPAP2
prerank,GO_Biological_Process_2021__negative regulation of transmembrane transport (GO:0034763),-0.19227359076884154,-0.3276949213326016,1.0,1.0,1.0,3/8,31.45%,INPP5K;IL1B;AKT1
prerank,Reactome_2022__RNA Polymerase III Chain Elongation R-HSA-73780,-0.1789832955198154,-0.3237785520384838,1.0,1.0,1.0,3/13,27.22%,POLR3C;POLR3A;POLR3F
prerank,GO_Biological_Process_2021__positive regulation of DNA demethylation (GO:1901537),0.20584262073623777,0.3143074814175078,1.0,0.999996453536002,1.0,5/5,79.42%,USP7;STPG4;USP9X;OTUD4;TOX
prerank,GO_Biological_Process_2021__regulation of DNA demethylation (GO:1901535),0.20584262073623777,0.3143074814175078,1.0,0.999996453536002,1.0,5/5,79.42%,USP7;STPG4;USP9X;OTUD4;TOX
prerank,Reactome_2022__Mitotic Telophase/Cytokinesis R-HSA-68884,-0.19445736181392706,-0.31319681470307287,1.0,0.9999852795518255,1.0,1/10,14.70%,SMC1A
prerank,Reactome_2022__Cohesin Loading Onto Chromatin R-HSA-2470946,-0.19445736181392706,-0.31319681470307287,1.0,0.9999852795518255,1.0,1/10,14.70%,SMC1A
